PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhang, YX				Zhang, Yunxin			Growth and Shortening of Microtubules A TWO-STATE MODEL APPROACH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORCE-VELOCITY RELATION; MOLECULAR MOTORS; GROWING MICROTUBULES; DYNAMIC INSTABILITY; BIASED DIFFUSION; RING COMPLEX; DAM1 RING; MODEL; KINETOCHORES; DEPOLYMERIZATION	In this study, a two-state mechanochemical model is presented to describe the dynamic instability of microtubules (MTs) in cells. The MT switches between two states, the assembly and disassembly states. In assembly state, the growth of MTs includes two processes: free GTP-tubulin binding to the tip of protofilament (PF) and conformation change of PF, during which the first tubulin unit that curls outwards is rearranged onto the MT surface, using the energy released from the hydrolysis of GTP in the penultimate tubulin unit. In the disassembly state, the shortening of MTs also includes two processes, the release of GDP-tubulin from the tip of PF and the curling of one new tubulin unit out of the MT surface. Switches between these two states, which are usually called rescue and catastrophe, happen stochastically with external force-dependent rates. Using this two-state model with parameters obtained by fitting the recent experimental data, detailed properties of MT growth are obtained. I find that MT is mainly in the assembly state, its mean growth velocity increases with both the external force and the GTP-tubulin concentration, and an MT will shorten on average without an external force. To know more about the external force and GTP-tubulin concentration-dependent properties of MT growth, and for future experimental verification of this two-state model, 11 critical forces are defined and discussed numerically.	Fudan Univ, Sch Math Sci, Shanghai Key Lab Contemporary Appl Math, Lab Math Nonlinear Sci,Ctr Computat Syst Biol, Shanghai 200433, Peoples R China	Fudan University	Zhang, YX (corresponding author), Fudan Univ, Sch Math Sci, Shanghai Key Lab Contemporary Appl Math, Lab Math Nonlinear Sci,Ctr Computat Syst Biol, Shanghai 200433, Peoples R China.	xyz@fudan.edu.cn			Natural Science Foundation of Shanghai [11ZR1403700]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This work was supported by the Natural Science Foundation of Shanghai (Grant 11ZR1403700).	Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Armond JW, 2010, BIOPHYS J, V98, P1598, DOI 10.1016/j.bpj.2010.01.004; Asbury CL, 2011, TRENDS CELL BIOL, V21, P38, DOI 10.1016/j.tcb.2010.09.003; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bray D, 2001, CELL MOVEMENTS MOL M; Cooper GM, 2000, CELL MOL APPROACH; DERRIDA B, 1983, J STAT PHYS, V31, P433, DOI 10.1007/BF01019492; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Efremov A, 2007, P NATL ACAD SCI USA, V104, P19017, DOI 10.1073/pnas.0709524104; Fisher ME, 2001, P NATL ACAD SCI USA, V98, P7748, DOI 10.1073/pnas.141080498; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; Gao Q, 2010, P NATL ACAD SCI USA, V107, P13330, DOI 10.1073/pnas.1004887107; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Howard J, 2006, PHYS BIOL, V3, P54, DOI 10.1088/1478-3975/3/1/006; Howard J., 2001, MECH MOTOR PROTEINS; Howard J, 2009, NAT REV MOL CELL BIO, V10, P569, DOI 10.1038/nrm2713; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Joglekar AP, 2010, CURR OPIN CELL BIOL, V22, P57, DOI 10.1016/j.ceb.2009.12.010; Joglekar AP, 2002, BIOPHYS J, V83, P42, DOI 10.1016/S0006-3495(02)75148-5; JULICHER F, 1995, PHYS REV LETT, V75, P2618, DOI 10.1103/PhysRevLett.75.2618; Kolomeisky AB, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.031902; Kolomeisky AB, 2001, BIOPHYS J, V80, P149, DOI 10.1016/S0006-3495(01)76002-X; Kolomeisky AB, 2007, ANNU REV PHYS CHEM, V58, P675, DOI 10.1146/annurev.physchem.58.032806.104532; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Molodtsov MI, 2005, P NATL ACAD SCI USA, V102, P4353, DOI 10.1073/pnas.0501142102; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Pury PA, 2003, J PHYS A-MATH GEN, V36, P2695, DOI 10.1088/0305-4470/36/11/304; Redner S, 2001, GUIDE 1 PASSAGE PROC; Salmon ED, 2005, CURR BIOL, V15, pR299, DOI 10.1016/j.cub.2005.04.005; SCHLIWA M, 2003, MOL MOTORS; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Sperry A. O., 2007, MOL MOTORS METHODS P, V392; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; WALKER RA, 1991, J CELL BIOL, V114, P73, DOI 10.1083/jcb.114.1.73; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Zhang YX, 2009, PHYS LETT A, V373, P2629, DOI 10.1016/j.physleta.2009.05.061; Zhang YX, 2009, PHYSICA A, V388, P3465, DOI 10.1016/j.physa.2009.04.039	45	7	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39439	39449		10.1074/jbc.M111.260208	http://dx.doi.org/10.1074/jbc.M111.260208			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21903577	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000296759800061
J	Lee, SG; Haakenson, W; McCarter, JP; Williams, DJ; Hresko, MC; Jez, JM				Lee, Soon Goo; Haakenson, William; McCarter, James P.; Williams, D. Jeremy; Hresko, Michelle C.; Jez, Joseph M.			Thermodynamic Evaluation of Ligand Binding in the Plant-like Phosphoethanolamine Methyltransferases of the Parasitic Nematode Haemonchus contortus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE N-METHYLTRANSFERASE; PHOSPHATIDYLCHOLINE SYNTHESIS; PHOSPHOCHOLINE BIOSYNTHESIS; CAENORHABDITIS-ELEGANS; CRYSTAL-STRUCTURE; KINETIC-ANALYSIS; DRUG DISCOVERY; RAT-LIVER; METHYLATION; PATHWAY	Nematodes are a major cause of disease and the discovery of new pathways not found in hosts is critical for development of therapeutic targets. Previous studies suggest that Caenorhabditis elegans synthesizes phosphocholine via two S-adenosylmethionine (AdoMet)-dependent phosphoethanolamine methyltransferases (PMT). Here we examine two PMT from the parasitic nematode Haemonchus contortus. Sequence analysis suggests that HcPMT1 contains a methyltransferase domain in the N-terminal half of the protein and that HcPMT2 encodes a C-terminal methyltransferase domain, as in the C. elegans proteins. Kinetic analysis demonstrates that HcPMT1 catalyzes the conversion of phosphoethanolamine to phosphomonomethylethanolamine (pMME) and that HcPMT2 methylates pMME to phosphodimethylethanolamine (pDME) and pDME to phosphocholine. The IC50 values for miltefosine, sinefungin, amodiaquine, diphenhydramine, and tacrine suggest differences in the active sites of these two enzymes. To examine the interaction of AdoMet and S-adenosylhomocysteine (AdoCys), isothermal titration calorimetry confirmed the presence of a single binding site in each enzyme. Binding of AdoMet and AdoCys is tight (K-d similar to 2-25 mu M) over a range of temperatures (5-25 degrees C) and NaCl concentrations (0.05-0.5 M). Heat capacity changes for AdoMet and AdoCys binding suggests that each HcPMT differs in interaction surface area. Nonlinear van't Hoff plots also indicate a possible conformational change upon AdoMet/AdoCys binding. Functional analysis of the PMT from a parasitic nematode provides new insights on inhibitor and AdoMet/AdoCys binding to these enzymes.	[Lee, Soon Goo; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Haakenson, William; McCarter, James P.; Williams, D. Jeremy; Hresko, Michelle C.] Divergence Inc, St Louis, MO 63141 USA	Washington University (WUSTL)	Jez, JM (corresponding author), 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu		McCarter, James/0000-0001-7646-810X; Lee, Soon Goo/0000-0002-1541-8587	United States Environmental Protection Agency [X-83228201]; Department of Agriculture [2005-33610-16465]	United States Environmental Protection Agency(United States Environmental Protection Agency); Department of Agriculture	This work was supported by United States Environmental Protection Agency Grant X-83228201 (to J. P. M., D. J. W., M. C. H., and J. M. J.) and Department of Agriculture Grant 2005-33610-16465 (to M. C. H.).	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Bobenchik AM, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-4; Bolognese CP, 2000, PLANT PHYSIOL, V124, P1800, DOI 10.1104/pp.124.4.1800; Brendza KM, 2007, BIOCHEM J, V404, P439, DOI 10.1042/BJ20061815; CANTONI GL, 1975, ANNU REV BIOCHEM, V44, P435, DOI 10.1146/annurev.bi.44.070175.002251; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; Charron JBF, 2002, PLANT PHYSIOL, V129, P363, DOI 10.1104/pp.001776; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; DATKO AH, 1988, PLANT PHYSIOL, V88, P854, DOI 10.1104/pp.88.3.854; DATKO AH, 1988, PLANT PHYSIOL, V88, P1338, DOI 10.1104/pp.88.4.1338; Fu ZJ, 1996, BIOCHEMISTRY-US, V35, P11985, DOI 10.1021/bi961068n; Gilleard JS, 2006, INT J PARASITOL, V36, P1227, DOI 10.1016/j.ijpara.2006.06.010; GRENFELL BT, 1988, PHILOS T ROY SOC B, V321, P541, DOI 10.1098/rstb.1988.0107; Horn JR, 2002, BIOCHEMISTRY-US, V41, P7501, DOI 10.1021/bi025626b; Horton JR, 2005, J MOL BIOL, V353, P334, DOI 10.1016/j.jmb.2005.08.040; Horton JR, 2001, STRUCTURE, V9, P837, DOI 10.1016/S0969-2126(01)00643-8; Hunter WN, 2009, J BIOL CHEM, V284, P11749, DOI 10.1074/jbc.R800072200; Jez J.M., 2007, CURR ENZYM INHIB, V3, P133, DOI [10.2174/157340807780598378, DOI 10.2174/157340807780598378]; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kent C., 1995, ANNU REV BIOCHEM, V64, P314; Komoto J, 2002, J MOL BIOL, V320, P223, DOI 10.1016/S0022-2836(02)00448-5; Kumaran S, 2003, P NATL ACAD SCI USA, V100, P14828, DOI 10.1073/pnas.2432867100; Kumaran S, 2007, BIOCHEMISTRY-US, V46, P5586, DOI 10.1021/bi7001168; Lee Soon Goo, 2011, Curr Chem Biol, V5, P183, DOI 10.2174/2212796811105030183; Montange RK, 2010, J MOL BIOL, V396, P761, DOI 10.1016/j.jmb.2009.12.007; MUDD SH, 1986, PLANT PHYSIOL, V82, P126, DOI 10.1104/pp.82.1.126; Nuccio ML, 2000, J BIOL CHEM, V275, P14095, DOI 10.1074/jbc.275.19.14095; O'Brien R, 1998, J MOL BIOL, V279, P117, DOI 10.1006/jmbi.1998.1743; Palavalli LH, 2006, BIOCHEMISTRY-US, V45, P6056, DOI 10.1021/bi060199d; Pessi G, 2005, J BIOL CHEM, V280, P12461, DOI 10.1074/jbc.M414626200; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Redmond DL, 2001, MOL BIOCHEM PARASIT, V117, P107, DOI 10.1016/S0166-6851(01)00331-0; Renslo AR, 2006, NAT CHEM BIOL, V2, P701, DOI 10.1038/nchembio837; Ridley M., 2004, EVOLUTION; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Takata Y, 2003, BIOCHEMISTRY-US, V42, P8394, DOI 10.1021/bi034245a; WALSH CT, 1979, ENZYMATIC REACTION M; Wu Q, 2005, J MED CHEM, V48, P7243, DOI 10.1021/jm050568o; Zajac AM, 2006, VET CLIN N AM-FOOD A, V22, P529, DOI 10.1016/j.cvfa.2006.07.006	42	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38060	38068		10.1074/jbc.M111.290619	http://dx.doi.org/10.1074/jbc.M111.290619			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914812	Green Published, hybrid			2022-12-25	WOS:000296594200018
J	Cavaliere, S; Hodge, JJL				Cavaliere, Sonia; Hodge, James J. L.			Drosophila KCNQ Channel Displays Evolutionarily Conserved Electrophysiology and Pharmacology with Mammalian KCNQ Channels	PLOS ONE			English	Article							POTASSIUM CHANNELS; ACTIVATION; BINDING; ION	Of the five human KCNQ (Kv7) channels, KCNQ1 with auxiliary subunit KCNE1 mediates the native cardiac IKs current with mutations causing short and long QT cardiac arrhythmias. KCNQ4 mutations cause deafness. KCNQ2/3 channels form the native M-current controlling excitability of most neurons, with mutations causing benign neonatal febrile convulsions. Drosophila contains a single KCNQ (dKCNQ) that appears to serve alone the functions of all the duplicated mammalian neuronal and cardiac KCNQ channels sharing roughly 50-60% amino acid identity therefore offering a route to investigate these channels. Current information about the functional properties of dKCNQ is lacking therefore we have investigated these properties here. Using whole cell patch clamp electrophysiology we compare the biophysical and pharmacological properties of dKCNQ with the mammalian neuronal and cardiac KCNQ channels expressed in HEK cells. We show that Drosophila KCNQ (dKCNQ) is a slowly activating and slowly-deactivating K+ current open at sub-threshold potentials that has similar properties to neuronal KCNQ2/3 with some features of the cardiac KCNQ1/KCNE1 accompanied by conserved sensitivity to a number of clinically relevant KCNQ blockers (chromanol 293B, XE991, linopirdine) and opener (zinc pyrithione). We also investigate the molecular basis of the differential selectivity of KCNQ channels to the opener retigabine and show a single amino acid substitution (M217W) can confer sensitivity to dKCNQ. We show dKCNQ has similar electrophysiological and pharmacological properties as the mammalian KCNQ channels, allowing future study of physiological and pathological roles of KCNQ in Drosophila and whole organism screening for new modulators of KCNQ channelopathies.	[Cavaliere, Sonia; Hodge, James J. L.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England	University of Bristol	Cavaliere, S (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Med Sci Bldg, Bristol, Avon, England.	james.hodge@bristol.ac.uk		Hodge, James/0000-0003-4741-2363	EU [IRG200632]; Royal Society [2008/R1]; Biotechnology and Biological Sciences Research Council [BB/G008973/1]; BBSRC [BB/G008973/1] Funding Source: UKRI	EU(European Commission); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by research grants from EU FP7 Marie-Curie (IRG200632), Royal Society (2008/R1) and Biotechnology and Biological Sciences Research Council (BB/G008973/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; Berger SI, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3121er5; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lange W, 2009, MOL PHARMACOL, V75, P272, DOI 10.1124/mol.108.052282; Lerche C, 2007, MOL PHARMACOL, V71, P1503, DOI 10.1124/mol.106.031682; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Loscher W, 2009, EPILEPSIA, V50, P1, DOI 10.1111/j.1528-1167.2008.01716.x; Miceli F, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00002; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Prole DL, 2003, J GEN PHYSIOL, V122, P775, DOI 10.1085/jgp.200308897; Pusch M, 1998, BIOPHYS J, V75, P785, DOI 10.1016/S0006-3495(98)77568-X; Schenzer A, 2005, J NEUROSCI, V25, P5051, DOI 10.1523/JNEUROSCI.0128-05.2005; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Van Eyken E, 2006, HUM MUTAT, V27, P1007, DOI 10.1002/humu.20375; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wen H, 2005, J NEUROSCI, V25, P10147, DOI 10.1523/JNEUROSCI.3086-05.2005; Wessells RJ, 2004, NAT GENET, V36, P1275, DOI 10.1038/ng1476; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xiong QJ, 2008, P NATL ACAD SCI USA, V105, P3128, DOI 10.1073/pnas.0712256105; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zaczek R, 1993, CURR OPIN INVEST DR, V2, P1097	27	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e23898	10.1371/journal.pone.0023898	http://dx.doi.org/10.1371/journal.pone.0023898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915266	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802500016
J	Flandre, P				Flandre, Philippe			Statistical Methods in Recent HIV Noninferiority Trials: Reanalysis of 11 Trials	PLOS ONE			English	Article							SAMPLE CONFIDENCE-INTERVALS; NON-INFERIORITY TRIALS; BINOMIAL PROPORTIONS; INITIAL TREATMENT; INFECTED PATIENTS; NULL HYPOTHESIS; SIZE FORMULAS; EQUIVALENCE; LOPINAVIR/RITONAVIR; DIFFERENCE	Background: In recent years the "noninferiority'' trial has emerged as the new standard design for HIV drug development among antiretroviral patients often with a primary endpoint based on the difference in success rates between the two treatment groups. Different statistical methods have been introduced to provide confidence intervals for that difference. The main objective is to investigate whether the choice of the statistical method changes the conclusion of the trials. Methods: We presented 11 trials published in 2010 using a difference in proportions as the primary endpoint. In these trials, 5 different statistical methods have been used to estimate such confidence intervals. The five methods are described and applied to data from the 11 trials. The noninferiority of the new treatment is not demonstrated if the prespecified noninferiority margin it includes in the confidence interval of the treatment difference. Results: Results indicated that confidence intervals can be quite different according to the method used. In many situations, however, conclusions of the trials are not altered because point estimates of the treatment difference were too far from the prespecified noninferiority margins. Nevertheless, in few trials the use of different statistical methods led to different conclusions. In particular the use of "exact'' methods can be very confusing. Conclusion: Statistical methods used to estimate confidence intervals in noninferiority trials have a strong impact on the conclusion of such trials.	[Flandre, Philippe] Univ Paris 06, INSERM, UMR S 943, Paris, France; [Flandre, Philippe] Hop La Pitie Salpetriere, AP HP, Dept Virol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Flandre, P (corresponding author), Univ Paris 06, INSERM, UMR S 943, Paris, France.	pflandre@ccde.chups.jussieu.fr	Flandre, Philippe/N-6314-2017	Flandre, Philippe/0000-0002-2612-3522	Abbott; Bristol-Myers Squibb; Gilead; Janssen-Tibotec; ViiV Health Care	Abbott(Abbott Laboratories); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); Janssen-Tibotec(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); ViiV Health Care	The author has read the journal's policy and has the following conflicts: Philippe Flandre has received travel grant or consulting fees from Abbott, Bristol-Myers Squibb, Gilead, Janssen-Tibotec and ViiV Health Care. This does not alter the author's adherence to all the PLoS ONE policies on sharing data and materials.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Agresti A, 2001, BIOMETRICS, V57, P963, DOI 10.1111/j.0006-341X.2001.00963.x; [Anonymous], POINTS CONSIDER SWIT; [Anonymous], GUIDELINE CHOICE NON; [Anonymous], ICH TOP E9 STAT PRIN; Arribas JR, 2010, AIDS, V24, P223, DOI 10.1097/QAD.0b013e3283348944; Barker L, 2001, AM STAT, V55, P279, DOI 10.1198/000313001753272213; Bartlett JA, 2006, AIDS, V20, P2051, DOI 10.1097/01.aids.0000247578.08449.ff; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; Brittain E, 2005, STAT MED, V24, P1, DOI 10.1002/sim.1934; Cahn P, 2010, 17 C RETR OPP INF FE; Chan ISF, 1999, BIOMETRICS, V55, P1202, DOI 10.1111/j.0006-341X.1999.01202.x; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; De Castro N, 2009, CLIN INFECT DIS, V49, P1259, DOI 10.1086/605674; Division of Antiviral Drug Products OoDEI Center for Drug Evaluation and Research (CDER) Food and Drug Administration, GUID IND ANT DRUGS U; DUNNETT CW, 1977, BIOMETRICS, V33, P593, DOI 10.2307/2529457; Eron JJ, 2010, LANCET, V375, P396, DOI 10.1016/S0140-6736(09)62041-9; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Hill A, 2008, AIDS, V22, P913, DOI 10.1097/QAD.0b013e3282f5556d; Katlama C, 2010, AIDS, V24, P2365, DOI 10.1097/QAD.0b013e32833dec20; Martinez E, 2010, AIDS, V24, P1697, DOI 10.1097/QAD.0b013e32833a608a; Meynard JL, 2010, J ANTIMICROB CHEMOTH, V65, P2436, DOI 10.1093/jac/dkq327; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Ortiz R, 2008, AIDS, V22, P1389, DOI 10.1097/QAD.0b013e32830285fb; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Reynes JLA, 2010, 18 INT AIDS C JUL 18; Richert L, 2008, AIDS, V22, P996, DOI 10.1097/QAD.0b013e3282ff6490; ROEBRUCK P, 1995, STAT MED, V14, P1583, DOI 10.1002/sim.4780141409; SANTNER TJ, 1980, J AM STAT ASSOC, V75, P386, DOI 10.2307/2287464; Sax PE, 2009, NEW ENGL J MED, V361, P2230, DOI 10.1056/NEJMoa0906768; Sierra-Madero J, 2010, JAIDS-J ACQ IMM DEF, V53, P582, DOI 10.1097/QAI.0b013e3181cae4a1; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Wiens BL, 2002, CONTROL CLIN TRIALS, V23, P2, DOI 10.1016/S0197-2456(01)00196-9; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Zajdenverg R, 2010, JAIDS-J ACQ IMM DEF, V54, P143, DOI 10.1097/QAI.0b013e3181cbd21e	39	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e22871	10.1371/journal.pone.0022871	http://dx.doi.org/10.1371/journal.pone.0022871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915255	gold, Green Published, Green Submitted			2022-12-25	WOS:000294802500007
J	Toxopeus, CM; de Jong, BM; Valsan, G; Conway, BA; van der Hoeven, JH; Leenders, KL; Maurits, NM				Toxopeus, Carolien M.; de Jong, Bauke M.; Valsan, Gopal; Conway, Bernard A.; van der Hoeven, Johannes H.; Leenders, Klaus L.; Maurits, Natasha M.			Impairment of Gradual Muscle Adjustment during Wrist Circumduction in Parkinson's Disease	PLOS ONE			English	Article							AIMING MOVEMENTS; ARM MOVEMENTS; INHIBITION; CEREBELLUM; TRACKING; SUBMOVEMENTS; DISRUPTIONS; DISORDERS; EXECUTION; SELECTION	Purposeful movements are attained by gradually adjusted activity of opposite muscles, or synergists. This requires a motor system that adequately modulates initiation and inhibition of movement and selectively activates the appropriate muscles. In patients with Parkinson's disease (PD) initiation and inhibition of movements are impaired which may manifest itself in e.g. difficulty to start and stop walking. At single-joint level, impaired movement initiation is further accompanied by insufficient inhibition of antagonist muscle activity. As the motor symptoms in PD primarily result from cerebral dysfunction, quantitative investigation of gradually adjusted muscle activity during execution of purposeful movement is a first step to gain more insight in the link between impaired modulation of initiation and inhibition at the levels of (i) cerebrally coded task performance and (ii) final execution by the musculoskeletal system. To that end, the present study investigated changes in gradual adjustment of muscle synergists using a manipulandum that enabled standardized smooth movement by continuous wrist circumduction. Differences between PD patients (N = 15, off-medication) and healthy subjects (N = 16) concerning the relation between muscle activity and movement performance in these groups were assessed using kinematic and electromyographic (EMG) recordings. The variability in the extent to which a particular muscle was active during wrist circumduction - defined as muscle activity differentiation - was quantified by EMG. We demonstrated that more differentiated muscle activity indeed correlated positively with improved movement performance, i.e. higher movement speed and increased smoothness of movement. Additionally, patients employed a less differentiated muscle activity pattern than healthy subjects. These specific changes during wrist circumduction imply that patients have a decreased ability to gradually adjust muscles causing a decline in movement performance. We propose that less differentiated muscle use in PD patients reflects impaired control of modulated initiation and inhibition due to decreased ability to selectively and jointly activate muscles.	[Toxopeus, Carolien M.; de Jong, Bauke M.; van der Hoeven, Johannes H.; Leenders, Klaus L.; Maurits, Natasha M.] Univ Groningen, Dept Neurol, Univ Med Ctr Groningen, Groningen, Netherlands; [Valsan, Gopal; Conway, Bernard A.] Univ Strathclyde, Bioengn Unit, Glasgow, Lanark, Scotland	University of Groningen; University of Strathclyde	Toxopeus, CM (corresponding author), Univ Groningen, Dept Neurol, Univ Med Ctr Groningen, Groningen, Netherlands.	c.m.toxopeus@umcg.nl	Conway, Bernard/A-9625-2016	Conway, Bernard/0000-0002-0069-0131; Maurits, Natasha/0000-0001-6231-7044; de Jong, Bauke M./0000-0002-6568-5739				Alberts JL, 2000, EXP BRAIN RES, V134, P353, DOI 10.1007/s002210000468; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; BERARDELLI A, 1986, J NEUROL NEUROSUR PS, V49, P1273, DOI 10.1136/jnnp.49.11.1273; Berardelli A, 2001, BRAIN, V124, P2131, DOI 10.1093/brain/124.11.2131; Brown P, 1998, LANCET, V351, P1801, DOI 10.1016/S0140-6736(97)11225-9; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; de Jong BM, 2007, BRAIN RES, V1132, P139, DOI 10.1016/j.brainres.2006.11.017; de Jong BM, 2001, NEUROIMAGE, V14, P1128, DOI 10.1006/nimg.2001.0911; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dounskaia N, 2005, EXP BRAIN RES, V164, P311, DOI 10.1007/s00221-005-2251-8; Dounskaia N, 2009, NEUROPSYCHOLOGIA, V47, P2504, DOI 10.1016/j.neuropsychologia.2009.04.020; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Fitzgibbon A, 1999, IEEE T PATTERN ANAL, V21, P476, DOI 10.1109/34.765658; FLOWERS KA, 1976, BRAIN, V99, P269, DOI 10.1093/brain/99.2.269; Fradet L, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-28; Fradet L, 2009, EXP BRAIN RES, V195, P73, DOI 10.1007/s00221-009-1752-2; Giladi N, 2001, ADV NEUROL, V87, P191; HALLETT M, 1977, J NEUROL NEUROSUR PS, V40, P1129, DOI 10.1136/jnnp.40.12.1129; Hauber W, 1998, PROG NEUROBIOL, V56, P507, DOI 10.1016/S0301-0082(98)00041-0; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hoffman DS, 1999, J NEUROPHYSIOL, V81, P319, DOI 10.1152/jn.1999.81.1.319; Hornykiewicz O, 1987, Adv Neurol, V45, P19; Josephs KA, 2006, ARCH NEUROL-CHICAGO, V63, P354, DOI 10.1001/archneur.63.3.354; Leis BC, 2005, EXP NEUROL, V194, P393, DOI 10.1016/j.expneurol.2005.02.014; Majsak MJ, 2008, EXP NEUROL, V210, P479, DOI 10.1016/j.expneurol.2007.11.023; MARSDEN CD, 1994, J NEUROL NEUROSUR PS, V57, P672, DOI 10.1136/jnnp.57.6.672; Meunier S, 2000, BRAIN, V123, P1017, DOI 10.1093/brain/123.5.1017; Miall RC, 2001, NAT NEUROSCI, V4, P638, DOI 10.1038/88465; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Ohyama T, 2003, TRENDS NEUROSCI, V26, P222, DOI 10.1016/S0166-2236(03)00054-7; Pasalar S, 2005, EXP BRAIN RES, V163, P214, DOI 10.1007/s00221-004-2169-6; Rajput AH, 2008, NEUROLOGY, V70, P1403, DOI 10.1212/01.wnl.0000285082.18969.3a; Rascol O, 1997, BRAIN, V120, P103, DOI 10.1093/brain/120.1.103; Robichaud JA, 2004, EXP BRAIN RES, V156, P240, DOI 10.1007/s00221-003-1782-0; Romero DH, 2003, EXP BRAIN RES, V151, P249, DOI 10.1007/s00221-003-1452-2; SANES JN, 1985, NEUROPSYCHOLOGIA, V23, P381, DOI 10.1016/0028-3932(85)90024-7; SHERIDAN MR, 1987, BRAIN, V110, P1247, DOI 10.1093/brain/110.5.1247; Spencer RMC, 2005, BRAIN COGNITION, V58, P84, DOI 10.1016/j.bandc.2004.09.010; Toxopeus CM, 2007, NEUROREPORT, V18, P1557, DOI 10.1097/WNR.0b013e3282efa0a2; Wang Y, 2006, EXP BRAIN RES, V174, P679, DOI 10.1007/s00221-006-0513-8; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047	44	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24572	10.1371/journal.pone.0024572	http://dx.doi.org/10.1371/journal.pone.0024572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912704	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000294686100050
J	Cheetham, J; Regner, A; Jarvis, JC; Priest, D; Sanders, I; Soderholm, LV; Mitchell, LM; Ducharme, NG				Cheetham, Jon; Regner, Abby; Jarvis, Jonathan C.; Priest, David; Sanders, Ira; Soderholm, Leo V.; Mitchell, Lisa M.; Ducharme, Norm G.			Functional Electrical Stimulation of Intrinsic Laryngeal Muscles under Varying Loads in Exercising Horses	PLOS ONE			English	Article							PARALYZED HUMAN LARYNX; VOCAL FOLD PARALYSIS; THOROUGHBRED HORSES; CRICOARYTENOID MUSCLE; RESPIRATORY RESPONSES; TREADMILL EXERCISE; DENERVATED MUSCLES; SKELETAL-MUSCLE; HEMIPLEGIA; NERVE	Bilateral vocal fold paralysis (BVCP) is a life threatening condition and appears to be a good candidate for therapy using functional electrical stimulation (FES). Developing a working FES system has been technically difficult due to the inaccessible location and small size of the sole arytenoid abductor, the posterior cricoarytenoid (PCA) muscle. A naturally-occurring disease in horses shares many functional and etiological features with BVCP. In this study, the feasibility of FES for equine vocal fold paralysis was explored by testing arytenoid abduction evoked by electrical stimulation of the PCA muscle. Rheobase and chronaxie were determined for innervated PCA muscle. We then tested the hypothesis that direct muscle stimulation can maintain airway patency during strenuous exercise in horses with induced transient conduction block of the laryngeal motor nerve. Six adult horses were instrumented with a single bipolar intra-muscular electrode in the left PCA muscle. Rheobase and chronaxie were within the normal range for innervated muscle at 0.55 +/- 0.38 v and 0.38 +/- 0.19 ms respectively. Intramuscular stimulation of the PCA muscle significantly improved arytenoid abduction at all levels of exercise intensity and there was no significant difference between the level of abduction achieved with stimulation and control values under moderate loads. The equine larynx may provide a useful model for the study of bilateral fold paralysis.	[Cheetham, Jon; Regner, Abby; Priest, David; Soderholm, Leo V.; Mitchell, Lisa M.; Ducharme, Norm G.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA; [Jarvis, Jonathan C.] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England; [Sanders, Ira] Hackensack Univ, Med Ctr, Hackensack, NJ USA	Cornell University; University of Liverpool; Hackensack University Medical Center	Cheetham, J (corresponding author), Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA.	jc485@cornell.edu	Cheetham, Jonathan/A-7510-2013	Cheetham, Jonathan/0000-0001-6889-2023	Zweig Memorial Fund for Equine Research; Med-El, Innsbruck, Austria	Zweig Memorial Fund for Equine Research; Med-El, Innsbruck, Austria	This work was funded by a grant from the Zweig Memorial Fund for Equine Research and Med-El, Innsbruck, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley Z, 2007, AM J PHYSIOL-CELL PH, V292, pC440, DOI 10.1152/ajpcell.00085.2006; Ashley Z, 2005, ARTIF ORGANS, V29, P212, DOI 10.1111/j.1525-1594.2005.29037.x; Ashley Z, 2008, MUSCLE NERVE, V38, P875, DOI 10.1002/mus.21020; Borisov AB, 2001, ANAT REC, V264, P203, DOI 10.1002/ar.1155; BUTLER PJ, 1993, J EXP BIOL, V179, P159; CAHILL JI, 1986, NEW ZEAL VET J, V34, P186, DOI 10.1080/00480169.1986.35343; CAHILL JI, 1986, NEW ZEAL VET J, V34, P161, DOI 10.1080/00480169.1986.35334; CAHILL JI, 1986, NEW ZEAL VET J, V34, P170, DOI 10.1080/00480169.1986.35335; CARRARO U, 1988, MUSCLE NERVE, V11, P1016, DOI 10.1002/mus.880111003; Cheetham J, 2008, EQUINE VET J, V40, P70, DOI 10.2746/042516407X240465; Cheetham J, 2009, J APPL PHYSIOL, V107, P471, DOI 10.1152/japplphysiol.91177.2008; Chi FL, 2006, OTOLARYNG HEAD NECK, V135, P40, DOI 10.1016/j.otohns.2006.01.023; COLE CR, 1946, AM J VET RES, V7, P69; CONNALLY BA, 1994, AM J VET RES, V55, P589; Crumley RL, 2000, ANN OTO RHINOL LARYN, V109, P365, DOI 10.1177/000348940010900405; Curtis RA, 2005, VET J, V170, P67, DOI 10.1016/j.tvjl.2004.03.020; Dattilo DJ, 2004, J ORAL MAXIL SURG, V62, P164, DOI 10.1016/j.joms.2003.03.002; Daya H, 2000, ARCH OTOLARYNGOL, V126, P21, DOI 10.1001/archotol.126.1.21; Dedkov EI, 2001, ANAT REC, V263, P139, DOI 10.1002/ar.1087; DEDO DD, 1979, LARYNGOSCOPE, V89, P1378, DOI 10.1002/lary.5540890902; DIXON P, 2004, WORKSHOP SUMMARY, V11, P93; Dow DE, 2004, MUSCLE NERVE, V30, P77, DOI 10.1002/mus.20054; Ducharme NG, 2010, EQUINE VET J, V42, P534, DOI 10.1111/j.2042-3306.2010.00115.x; DUCHARME NG, 1994, AM J VET RES, V55, P368; DUNCAN ID, 1974, ACTA NEUROPATHOL, V27, P337, DOI 10.1007/BF00690698; DUNCAN ID, 1987, AM J VET RES, V48, P431; DUNCAN ID, 1991, EQUINE VET J, V23, P99, DOI 10.1111/j.2042-3306.1991.tb02729.x; EVANS DL, 1988, PFLUG ARCH EUR J PHY, V411, P316, DOI 10.1007/BF00585121; EVANS DL, 1988, J EXP BIOL, V134, P397; Gunn H M, 1972, Equine Vet J, V4, P144, DOI 10.1111/j.2042-3306.1972.tb03896.x; GUYTON AC, 2006, TXB MED PHYSL, pCH27; HADZIC A, 2004, PERIPHERAL NERVE BLO, P43; Herholz C, 1997, SCHWEIZ ARCH TIERH, V139, P558; HOYT DF, 1981, NATURE, V292, P239, DOI 10.1038/292239a0; Jarvis JC, 2001, MED ENG PHYS, V23, P3, DOI 10.1016/S1350-4533(01)00005-4; Katada A, 2004, NEUROSCI RES, V50, P153, DOI 10.1016/j.neures.2004.06.016; Lindegaard C, 2007, EQUINE VET J, V39, P553, DOI 10.2746/042516407X204177; MORRIS E, 1991, VET CLIN N AM-EQUINE, V7, P383, DOI 10.1016/S0749-0739(17)30505-9; OHNESORGE B, 1993, J VET MED A, V40, P134, DOI 10.1111/j.1439-0442.1993.tb00610.x; PASSMAN SN, 2011, EQUINE VET J    0505; QUINLAN JOHN, 1939, JOUR S AFRICAN VET MED ASSOC, V10, P157; QUINLAN TJ, 1982, NEW ZEAL VET J, V30, P43, DOI 10.1080/00480169.1982.34874; Radcliffe CH, 2006, VET SURG, V35, P643, DOI 10.1111/j.1532-950X.2006.00202.x; Rakesh V, 2008, EQUINE VET J, V40, P272, DOI 10.2746/042516408X281216; Rakesh V, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2913338; RAKESTRAW PC, 1991, VET SURG, V20, P122, DOI 10.1111/j.1532-950X.1991.tb00319.x; ROSE RJ, 1990, AUST VET J, V67, P345, DOI 10.1111/j.1751-0813.1990.tb07394.x; Salmons S, 2008, ARTIF ORGANS, V32, P597, DOI 10.1111/j.1525-1594.2008.00608.x; SANDERS I, 1991, OTOLARYNG CLIN N AM, V24, P1253; Schaaf KL, 2006, AUST VET J, V84, P297, DOI 10.1111/j.1751-0813.2006.00017.x; Tetens J, 1996, AM J VET RES, V57, P1668; THOMAS DP, 1981, J APPL PHYSIOL, V50, P864, DOI 10.1152/jappl.1981.50.4.864; Viguie CA, 1997, ANAT REC, V248, P346; WEBER JM, 1987, AM J PHYSIOL, V253, pR890, DOI 10.1152/ajpregu.1987.253.6.R890; Zbar RIS, 1996, OTOLARYNG HEAD NECK, V114, P18, DOI 10.1016/S0194-5998(96)70277-2; Zealear DL, 1996, ANN OTO RHINOL LARYN, V105, P689; Zealear DL, 2003, LARYNGOSCOPE, V113, P1149, DOI 10.1097/00005537-200307000-00010; Zealear DL, 2001, OTOLARYNG HEAD NECK, V125, P183, DOI 10.1067/mhn.2001.118246; ZRUNEK M, 1991, EUR ARCH OTO-RHINO-L, V248, P445, DOI 10.1007/BF00627631	59	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24258	10.1371/journal.pone.0024258	http://dx.doi.org/10.1371/journal.pone.0024258			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904620	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800073
J	Hu, WB; O'Leary, RA; Mengersen, K; Choy, SL				Hu, Wenbiao; O'Leary, Rebecca A.; Mengersen, Kerrie; Choy, Samantha Low			Bayesian Classification and Regression Trees for Predicting Incidence of Cryptosporidiosis	PLOS ONE			English	Article							ROSS RIVER VIRUS; MOSQUITO SPECIES DIPTERA; CART MODEL; TRANSMISSION; AUSTRALIA; QUEENSLAND; CULICIDAE; BRISBANE; DISEASES	Background: Classification and regression tree (CART) models are tree-based exploratory data analysis methods which have been shown to be very useful in identifying and estimating complex hierarchical relationships in ecological and medical contexts. In this paper, a Bayesian CART model is described and applied to the problem of modelling the cryptosporidiosis infection in Queensland, Australia. Methodology/Principal Findings: We compared the results of a Bayesian CART model with those obtained using a Bayesian spatial conditional autoregressive (CAR) model. Overall, the analyses indicated that the nature and magnitude of the effect estimates were similar for the two methods in this study, but the CART model more easily accommodated higher order interaction effects. Conclusions/Significance: A Bayesian CART model for identification and estimation of the spatial distribution of disease risk is useful in monitoring and assessment of infectious diseases prevention and control.	[Hu, Wenbiao; Mengersen, Kerrie; Choy, Samantha Low] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Hu, Wenbiao] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [O'Leary, Rebecca A.] Univ Western Australia, Australian Inst Marine Sci, Oceans Inst, Crawley, WA, Australia; [Choy, Samantha Low] Cooperat Res Ctr Natl Plant Biosecur, Canberra, ACT, Australia	Queensland University of Technology (QUT); University of Queensland; Australian Institute of Marine Science; University of Western Australia	Hu, WB (corresponding author), Queensland Univ Technol, Brisbane, Qld 4001, Australia.	w.hu@sph.uq.edu.au	Low Choy, Samantha/A-7161-2012; Mengersen, Kerrie/AHC-4096-2022	Low Choy, Samantha/0000-0002-1722-4428; Mengersen, Kerrie/0000-0001-8625-9168; Hu, Wenbiao/0000-0001-6422-9240				Anselin L, 2002, AGR ECON-BLACKWELL, V27, P247, DOI 10.1111/j.1574-0862.2002.tb00120.x; Anselin L, 2005, EXPLORING SPATIAL DA; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; BREIMAN L., 1984, CRC PRESS; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Chipman HA, 1998, J AM STAT ASSOC, V93, P935, DOI 10.2307/2669832; Chipman HA, 2010, ANN APPL STAT, V4, P266, DOI 10.1214/09-AOAS285; Clements ACA, 2006, TROP MED INT HEALTH, V11, P490, DOI 10.1111/j.1365-3156.2006.01594.x; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Duc H, 2009, AUST NZ J STAT, V51, P289, DOI 10.1111/j.1467-842X.2009.00545.x; Escaramis G, 2008, BIOMETRICS, V64, P1043, DOI 10.1111/j.1541-0420.2007.00981.x; Gelman A., 2004, BAYESIAN DATA ANAL; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Hoeting J, 1996, COMPUT STAT DATA AN, V22, P251, DOI 10.1016/0167-9473(95)00053-4; Hu W, 2010, ENVIRON ENTOMOL, V39, P88, DOI 10.1603/EN07037; Hu WB, 2006, J MED ENTOMOL, V43, P375, DOI 10.1603/0022-2585(2006)043[0375:MSDCAT]2.0.CO;2; Hu WB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-311; Hu WB, 2010, AM J TROP MED HYG, V83, P722, DOI 10.4269/ajtmh.2010.09-0551; Lamon EC, 2004, WATER RES, V38, P2764, DOI 10.1016/j.watres.2004.03.019; Lawson A. B., 2003, DIS MAPPING WINBUGS; Mabaso Musawenkoi L H, 2006, Int J Health Geogr, V5, P20; Meinhardt PL, 1996, EPIDEMIOL REV, V18, P118, DOI 10.1093/oxfordjournals.epirev.a017920; Moore DA, 1999, EPIDEMIOL REV, V21, P143, DOI 10.1093/oxfordjournals.epirev.a017993; O'Leary R, 2009, 18 WORLD IMACS MODSI; O'Leary R, 2008, THESIS QUEENSLAND U; OLEARY RA, 2008, J APPL PROBABILITY S, V3, P95; Therneau T, 2003, RPART PACKAGE SOFTWA; Therneau TM., 2015, INTRO RECURSIVE PART; WinBUGs, 2008, MRC BIOST UN; Yang GJ, 2005, INT J PARASITOL, V35, P155, DOI 10.1016/j.ijpara.2004.11.002	32	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23903	10.1371/journal.pone.0023903	http://dx.doi.org/10.1371/journal.pone.0023903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909377	Green Published, gold			2022-12-25	WOS:000294680800039
J	Tsao, D; Diatchenko, L; Dokholyan, NV				Tsao, Douglas; Diatchenko, Luda; Dokholyan, Nikolay V.			Structural Mechanism of S-Adenosyl Methionine Binding to Catechol O-Methyltransferase	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; ENZYME	Methyltransferases possess a homologous domain that requires both a divalent metal cation and S-adenosyl-L-methionine (SAM) to catalyze its reactions. The kinetics of several methyltransferases has been well characterized; however, the details regarding their structural mechanisms have remained unclear to date. Using catechol O-methyltransferase (COMT) as a model, we perform discrete molecular dynamics and computational docking simulations to elucidate the initial stages of cofactor binding. We find that COMT binds SAM via an induced-fit mechanism, where SAM adopts a different docking pose in the absence of metal and substrate in comparison to the holoenzyme. Flexible modeling of the active site side-chains is essential for observing the lowest energy state in the apoenzyme; rigid docking tools are unable to recapitulate the pose unless the appropriate side-chain conformations are given a priori. From our docking results, we hypothesize that the metal reorients SAM in a conformation suitable for donating its methyl substituent to the recipient ligand. The proposed mechanism enables a general understanding of how divalent metal cations contribute to methyltransferase function.	[Tsao, Douglas] Univ N Carolina, Dept Chem, Chapel Hill, NC 27514 USA; [Tsao, Douglas; Diatchenko, Luda; Dokholyan, Nikolay V.] Univ N Carolina, Sch Dent, Ctr Neurosensory Disorders, Chapel Hill, NC USA; [Dokholyan, Nikolay V.] Univ N Carolina, Sch Dent, Dept Biochem & Biophys, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Tsao, D (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27514 USA.	dokh@med.unc.edu	Dokholyan, Nikolay/D-8081-2018	Dokholyan, Nikolay/0000-0002-8225-4025	National Institutes of Health [R01GM080742, GM080742-03S1, GM066940-06S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080742, R01GM066940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (grant numbers R01GM080742, ARRA supplements GM080742-03S1, GM066940-06S1 to NVD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD J, 1958, J BIOL CHEM, V233, P702; Barnett JH, 2009, AM J PSYCHIAT, V166, P909, DOI 10.1176/appi.ajp.2009.08081251; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Ding F, 2010, J CHEM INF MODEL, V50, P1623, DOI 10.1021/ci100218t; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Ducci F, 2008, ADDICTION, V103, P1414, DOI 10.1111/j.1360-0443.2008.02203.x; Kuhn B, 2000, J AM CHEM SOC, V122, P2586, DOI 10.1021/ja992218v; Lee WJ, 2005, MOL PHARMACOL, V68, P1018, DOI 10.1124/mol.104.008367; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Roca M, 2003, J AM CHEM SOC, V125, P7726, DOI 10.1021/ja0299497; Rutherford K, 2008, J MOL BIOL, V380, P120, DOI 10.1016/j.jmb.2008.04.040; Tsuji E, 2009, J STRUCT BIOL, V165, P133, DOI 10.1016/j.jsb.2008.11.012; Yin S, 2008, J CHEM INF MODEL, V48, P1656, DOI 10.1021/ci8001167	14	24	25	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24287	10.1371/journal.pone.0024287	http://dx.doi.org/10.1371/journal.pone.0024287			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904625	Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800079
J	Wang, WY; Zhang, J; Wu, WY; Li, J; Ma, YL; Chen, WH; Yan, H; Wang, K; Xu, WW; Shen, JH; Wang, YP				Wang, Wen-yi; Zhang, Jie; Wu, Wen-yu; Li, Jie; Ma, Yan-ling; Chen, Wei-hai; Yan, Hong; Wang, Kai; Xu, Wen-wei; Shen, Jian-hua; Wang, Yi-ping			Inhibition of Lipoprotein-Associated Phospholipase A2 Ameliorates Inflammation and Decreases Atherosclerotic Plaque Formation in ApoE-Deficient Mice	PLOS ONE			English	Article							ACTIVATING-FACTOR-ACETYLHYDROLASE; CORONARY-HEART-DISEASE; OXIDIZED PHOSPHOLIPIDS; NEOINTIMA FORMATION; ENDOTHELIAL-CELLS; A(2); EXPRESSION; LYSOPHOSPHATIDYLCHOLINE; RISK; DARAPLADIB	Background: Lipoprotein-associated phospholipase A2 (Lp-PLA2) is thought to play modulatory roles in the development of atherosclerosis. Here we evaluated the effects of a specific lp-PLA2 inhibitor on atherosclerosis in ApoE-deficient mice and its associated mechanisms. Methodology/Principal Findings: ApoE-deficient mice fed an atherogenic high-fat diet for 17 weeks were divided into two groups. One group was administered the specific lp-PLA2 inhibitor, darapladib (50 mg/kg/day; p.o.) daily for 6 weeks, while the control group was administered saline. We observed no differences in body weight and serum lipids levels between the two groups at the end of the dietary period. Notably, serum lp-PLA2 activity as well as hs-CRP (C-reactive protein) and IL-6 (Interleukin-6) levels were significantly reduced in the darapladib group, compared with the vehicle group, while the serum PAF (platelet-activating factor) levels were similar between the two groups. Furthermore, the plaque area through the arch to the abdominal aorta was reduced in the darapladib group. Another finding of interest was that the macrophage content was decreased while collagen content was increased in atherosclerotic lesions at the aortic sinus in the darapladib group, compared with the vehicle group. Finally, quantitative RT-PCR performed to determine the expression patterns of specific inflammatory genes at atherosclerotic aortas revealed lower expression of MCP-1, VCAM-1 and TNF-alpha in the darapladib group. Conclusions/Significance: Inhibition of lp-PLA2 by darapladib leads to attenuation of in vivo inflammation and decreased plaque formation in ApoE-deficient mice, supporting an anti-atherogenic role during the progression of atherosclerosis.	[Wang, Wen-yi; Zhang, Jie; Wu, Wen-yu; Li, Jie; Ma, Yan-ling; Yan, Hong; Xu, Wen-wei; Wang, Yi-ping] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol 1, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Chen, Wei-hai] Southwest Univ, Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China; [Chen, Wei-hai; Wang, Kai] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Shen, Jian-hua] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Southwest University - China; Southwest University - China; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Wang, WY (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol 1, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	ypwang@mail.shcnc.ac.cn	MA, YAN/HHN-2912-2022	Ma, Yanling/0000-0003-0829-3285; Yan, Hong/0000-0001-6665-4419	Shanghai Committee of Science and Technology, China [11ZR1444800]; National Basic Research Program of China [2009CB930300]	Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by a grant from the Shanghai Committee of Science and Technology, China (No. 11ZR1444800), and National Basic Research Program of China (No. 2009CB930300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Arakawa H, 2005, CIRCULATION, V111, P3302, DOI 10.1161/CIRCULATIONAHA.104.476242; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Caslake MJ, 2005, NAT CLIN PRACT CARD, V2, P529, DOI 10.1038/ncpcardio0321; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Garza CA, 2007, MAYO CLIN PROC, V82, P159; Henig NR, 2000, AM J RESP CRIT CARE, V162, P523, DOI 10.1164/ajrccm.162.2.9911084; KUME N, 1992, J CLIN INVEST, V90, P1138, DOI 10.1172/JCI115932; Leitinger N, 2003, CURR OPIN LIPIDOL, V14, P421, DOI 10.1097/00041433-200310000-00002; Macphee CH, 1999, BIOCHEM J, V338, P479, DOI 10.1042/0264-6021:3380479; Mannheim D, 2008, STROKE, V39, P1448, DOI 10.1161/STROKEAHA.107.503193; Mohler ER, 2008, J AM COLL CARDIOL, V51, P1632, DOI 10.1016/j.jacc.2007.11.079; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Nonas S, 2008, CRIT CARE, V12, DOI 10.1186/cc6805; O'Donoghue M, 2006, CIRCULATION, V113, P1745, DOI 10.1161/CIRCULATIONAHA.105.612630; Oei HHS, 2005, CIRCULATION, V111, P570, DOI 10.1161/01.CIR.0000154553.12214.CD; Opal S, 2004, CRIT CARE MED, V32, P332, DOI 10.1097/01.CCM.0000108867.87890.6D; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Quarck R, 2001, CIRCULATION, V103, P2495; Rong JX, 2002, ARTERIOSCL THROM VAS, V22, P1617, DOI 10.1161/01.ATV.0000035408.93749.71; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Shi Y, 2007, ATHEROSCLEROSIS, V191, P54, DOI 10.1016/j.atherosclerosis.2006.05.001; Stafforini DM, 2009, CARDIOVASC DRUG THER, V23, P73, DOI 10.1007/s10557-008-6133-8; Stafforini DM, 1997, J BIOL CHEM, V272, P17895, DOI 10.1074/jbc.272.29.17895; Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211; Takahara N, 1996, METABOLISM, V45, P559, DOI 10.1016/S0026-0495(96)90024-4; Tellis CC, 2009, BBA-MOL CELL BIOL L, V1791, P327, DOI 10.1016/j.bbalip.2009.02.015; van Vark LC, 2006, EUR HEART J, V27, P2346, DOI 10.1093/eurheartj/ehl230; Wang WY, 2010, CARDIOVASC RES, V85, P845, DOI 10.1093/cvr/cvp367; Wilensky RL, 2008, NAT MED, V14, P1059, DOI 10.1038/nm.1870; Zalewski A, 2005, ARTERIOSCL THROM VAS, V25, P923, DOI 10.1161/01.ATV.0000160551.21962.a7; Zhu Y, 1997, BBA-LIPID LIPID MET, V1345, P93, DOI 10.1016/S0005-2760(96)00169-5	31	26	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23425	10.1371/journal.pone.0023425	http://dx.doi.org/10.1371/journal.pone.0023425			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909350	Green Submitted, Green Published, gold			2022-12-25	WOS:000294680800010
J	Wang, Z; Yang, L; Jiang, YH; Ling, ZQ; Li, ZG; Cheng, Y; Huang, H; Wang, LD; Pan, Y; Wang, ZZ; Yan, XQ; Chen, Y				Wang, Zheng; Yang, Ling; Jiang, Yuhui; Ling, Zhi-Qiang; Li, Zhigang; Cheng, Yuan; Huang, Heng; Wang, Lingdi; Pan, Yi; Wang, Zhenzhen; Yan, Xiaoqiang; Chen, Yan			High Fat Diet Induces Formation of Spontaneous Liposarcoma in Mouse Adipose Tissue with Overexpression of Interleukin 22	PLOS ONE			English	Article							IL-22; INFLAMMATION; CANCER; LIVER; MODEL; INHIBITION; EXPRESSION; PATHWAYS; CYTOKINE; DELIVERY	Interleukin 22 (IL-22) is a T-cell secreted cytokine that modulates inflammatory response in nonhematopoietic tissues such as epithelium and liver. The function of IL-22 in adipose tissue is currently unknown. We generated a transgenic mouse model with overexpression of IL-22 specifically in adipose tissue. The IL-22 transgenic mice had no apparent changes in obesity and insulin resistance after feeding with high fat diet (HFD). Unexpectedly, all the IL-22 transgenic mice fed with HFD for four months developed spontaneous tumors in epididymal adipose tissue. Histological analysis indicated that the tumors were well-differentiated liposarcomas with infiltration of inflammatory cells. IL-22 overexpression promotes production of inflammatory cytokines such as IL-1 beta and IL-10 and stimulates ERK phosphorylation in adipose tissue. Furthermore, IL-22 treatment in differentiated 3T3-L1 adipocytes could induce IL-1 beta and IL-10 expression, together with stimulation of ERK phosphorylation. Taken together, our study not only established a novel mouse model with spontaneous liposarcoma, but also revealed that IL-22 overexpression may collaborate with diet-induced obesity to impact on tumor development in mouse.	[Wang, Zheng; Yang, Ling; Jiang, Yuhui; Li, Zhigang; Cheng, Yuan; Huang, Heng; Wang, Lingdi; Pan, Yi; Wang, Zhenzhen; Chen, Yan] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China; [Ling, Zhi-Qiang] Zhejiang Prov Canc Hosp, Zhejiang Canc Ctr, Zhejiang Canc Res Inst, Hangzhou, Zhejiang, Peoples R China; [Yan, Xiaoqiang] Generon Corp, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang Cancer Hospital	Wang, Z (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China.	ychen3@sibs.ac.cn	Yang, Ling/F-4404-2016	Yang, Ling/0000-0002-7586-3922	Chinese Academy of Sciences [KSCX2-EW-R-08]; National Natural Science Foundation of China [30830037, 81021002, 30971660]; Ministry of Science and Technology of China [2007CB947100, 2010CB529506]; SIBS [2009KIP207]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); SIBS	This work was supported by research grants from the Chinese Academy of Sciences (KSCX2-EW-R-08), National Natural Science Foundation of China (30830037 and 81021002), and Ministry of Science and Technology of China (2007CB947100) to Y.C. The work was also supported by Ministry of Science and Technology of China (2010CB529506) to Y.P. and Z.W., and National Natural Science Foundation of China (30971660) and SIBS grant (2009KIP207) to Y.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Anand P, 2008, PHARM RES-DORDR, V25, P2097, DOI 10.1007/s11095-008-9661-9; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Chang H, 2006, J IMMUNOL, V177, P3635, DOI 10.4049/jimmunol.177.6.3635; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Dei Tos A P, 2000, Ann Diagn Pathol, V4, P252, DOI 10.1053/adpa.2000.8133; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Ki SH, 2010, HEPATOLOGY, V52, P1291, DOI 10.1002/hep.23837; Kraus MD, 1997, AM J SURG PATHOL, V21, P518, DOI 10.1097/00000478-199705000-00003; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Pan HN, 2004, CELL MOL IMMUNOL, V1, P43; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Park O, 2011, HEPATOLOGY, V54, P252, DOI 10.1002/hep.24339; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020; Riggi N, 2006, CANCER RES, V66, P7016, DOI 10.1158/0008-5472.CAN-05-3979; Rodriguez R, 2011, STEM CELLS, V29, P179, DOI 10.1002/stem.571; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Sandberg AA, 2004, CANCER GENET CYTOGEN, V155, P1, DOI 10.1016/j.cancergencyto.2004.08.005; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JCI33194, 10.1172/JC133194]; Weber GF, 2007, INFECT IMMUN, V75, P1690, DOI 10.1128/IAI.01564-06; Weber GF, 2006, J IMMUNOL, V177, P8266, DOI 10.4049/jimmunol.177.11.8266; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Witte E, 2010, CYTOKINE GROWTH F R, V21, P365, DOI 10.1016/j.cytogfr.2010.08.002; Wu PW, 2008, J MOL BIOL, V382, P1168, DOI 10.1016/j.jmb.2008.07.046; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Xie XD, 2008, CARCINOGENESIS, V29, P1632, DOI 10.1093/carcin/bgn139; Yang L, 2010, J HEPATOL, V53, P339, DOI 10.1016/j.jhep.2010.03.004; Yue FY, 1997, INT J CANCER, V71, P630, DOI 10.1002/(SICI)1097-0215(19970516)71:4<630::AID-IJC20>3.3.CO;2-H; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001; Zeng L, 2010, CYTOKINE, V49, P294, DOI 10.1016/j.cyto.2009.11.015; Zhang WC, 2008, CLIN CANCER RES, V14, P6432, DOI 10.1158/1078-0432.CCR-07-4401	35	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23737	10.1371/journal.pone.0023737	http://dx.doi.org/10.1371/journal.pone.0023737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897855	gold, Green Published, Green Submitted			2022-12-25	WOS:000294676900018
J	Arora, H; Qureshi, R; Park, AK; Park, WY				Arora, Himanshu; Qureshi, Rehana; Park, Ae-Kyung; Park, Woong-Yang			Coordinated Regulation of ATF2 by miR-26b in gamma-Irradiated Lung Cancer Cells	PLOS ONE			English	Article							RESPONSE ELEMENT; TARGET GENES; MICRORNA; EXPRESSION; BINDING; IDENTIFICATION; INVOLVEMENT; ACTIVATION; RESISTANCE; PATHWAYS	MicroRNA regulates cellular responses to ionizing radiation (IR) through translational control of target genes. We analyzed time-series changes in microRNA expression following gamma-irradiation in H1299 lung cancer cells using microarray analysis. Significantly changed IR-responsive microRNAs were selected based on analysis of variance analysis, and predicted target mRNAs were enriched in mitogen-activated protein kinase (MAPK) signaling. Concurrent analysis of time-series mRNA and microRNA profiles uncovered that expression of miR-26b was down regulated, and its target activating transcription factor 2 (ATF2) mRNA was up regulated in gamma-irradiated H1299 cells. IR in miR-26b overexpressed H1299 cells could not induce expression of ATF2. When gamma-Jun N-terminal kinase activity was inhibited using SP600125, expression of miR-26b was induced following gamma-irradiation in H1299 cells. From these results, we concluded that IR-induced up-regulation of ATF2 was coordinately enhanced by suppression of miR-26b in lung cancer cells, which may enhance the effect of IR in the MAPK signaling pathway.	[Arora, Himanshu; Qureshi, Rehana; Park, Ae-Kyung; Park, Woong-Yang] Seoul Natl Univ, Coll Med, Dept Biomed Sci Biochem & Mol Biol, Seoul, South Korea	Seoul National University (SNU)	Arora, H (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci Biochem & Mol Biol, Seoul, South Korea.	wypark@snu.ac.kr	park, woongyang/D-5727-2012; Arora, Himanshu/I-5230-2019	Arora, Himanshu/0000-0003-3143-6387	Korea Science and Engineering Foundation (KOSEF) [M20706000020-07M0600-02010]; Ministry of Education, Science and Technology [2009-0087452]; Ministry for Health, Welfare and Family Affairs [A084022]	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health, Welfare and Family Affairs	This paper is supported by a Korea Science and Engineering Foundation (KOSEF) grant (M20706000020-07M0600-02010), and by the Basic Research Laboratory (BRL) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2009-0087452) and by the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs (A084022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Arora H, 2011, EXP MOL MED; Bailey J, 2005, J MOL ENDOCRINOL, V34, P1, DOI 10.1677/jme.1.01594; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Brown L, 2006, J BIOL CHEM, V281, P3832, DOI 10.1074/jbc.M507951200; Buschmann T, 2000, J BIOL CHEM, V275, P16590, DOI 10.1074/jbc.M910045199; Cannell IG, 2010, P NATL ACAD SCI USA, V107, P5375, DOI 10.1073/pnas.0910015107; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; Huber W, 2002, BIOINFORMATICS, V18, pS96; Jeong SH, 2009, EXP MOL MED, V41, P912, DOI 10.3858/emm.2009.41.12.097; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; KERPPOLA TK, 1993, MOL CELL BIOL, V13, P5479, DOI 10.1128/MCB.13.9.5479; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lee SY, 2007, GENOM INFORM, V6, P36; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Park WY, 2002, ONCOGENE, V21, P8521, DOI 10.1038/sj.onc.1205977; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Tombes RM, 1998, BIOCHEM J, V330, P1451; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858	26	30	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23802	10.1371/journal.pone.0023802	http://dx.doi.org/10.1371/journal.pone.0023802			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901137	Green Submitted, Green Published, gold			2022-12-25	WOS:000294298000022
J	Gabrusiewicz, K; Ellert-Miklaszewska, A; Lipko, M; Sielska, M; Frankowska, M; Kaminska, B				Gabrusiewicz, Konrad; Ellert-Miklaszewska, Aleksandra; Lipko, Maciej; Sielska, Malgorzata; Frankowska, Marta; Kaminska, Bozena			Characteristics of the Alternative Phenotype of Microglia/Macrophages and its Modulation in Experimental Gliomas	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; COLONY-STIMULATING FACTOR; T-CELL RESPONSES; GLIOBLASTOMA CELLS; DENDRITIC CELLS; BREAST-CANCER; IN-VIVO; EXPRESSION; MICROGLIA; ARGINASE	Microglia (brain resident macrophages) accumulate in malignant gliomas and instead of initiating the anti-tumor response, they switch to a pro-invasive phenotype, support tumor growth, invasion, angiogenesis and immunosuppression by release of cytokines/chemokines and extracellular matrix proteases. Using immunofluorescence and flow cytometry, we demonstrate an early accumulation of activated microglia followed by accumulation of macrophages in experimental murine EGFP-GL261 gliomas. Those cells acquire the alternative phenotype, as evidenced by evaluation of the production of ten pro/anti-inflammatory cytokines and expression profiling of 28 genes in magnetically-sorted CD11b(+) cells from tumor tissues. Furthermore, we show that infiltration of implanted gliomas by amoeboid, Iba1-positive cells can be reduced by a systematically injected cyclosporine A (CsA) two or eight days after cell inoculation. The up-regulated levels of IL-10 and GM-CSF, increased expression of genes characteristic for the alternative and pro-invasive phenotype (arg-1, mt1-mmp, cxcl14) in glioma-derived CD11b(+) cells as well as enhanced angiogenesis and tumor growth were reduced in CsA-treated mice. Our findings define for the first time kinetics and biochemical characteristics of glioma-infiltrating microglia/macrophages. Inhibition of the alternative activation of tumor-infiltrating macrophages significantly reduced tumor growth. Thus, blockade of microglia/macrophage infiltration and their pro-invasive functions could be a novel therapeutic strategy in malignant gliomas.	[Gabrusiewicz, Konrad; Ellert-Miklaszewska, Aleksandra; Lipko, Maciej; Sielska, Malgorzata; Frankowska, Marta; Kaminska, Bozena] M Nencki Inst Expt Biol, Lab Transcript Regulat, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Gabrusiewicz, K (corresponding author), M Nencki Inst Expt Biol, Lab Transcript Regulat, PL-02093 Warsaw, Poland.	bozenakk@nencki.gov.pl	Kaminska, Bozena/H-4592-2011; Kaminska, Bozena/B-2915-2014; Ellert-Miklaszewska, Aleksandra/H-4423-2011; Ellert-Miklaszewska, Aleksandra/AAX-8715-2020	Kaminska, Bozena/0000-0002-2642-4616; Ellert-Miklaszewska, Aleksandra/0000-0002-7947-5660; Ellert-Miklaszewska, Aleksandra/0000-0002-7947-5660; Gabrusiewicz, Konrad/0000-0001-7857-8062	Ministry of Science and Higher Education (Poland) [P-N/024/2006, N N405 184435]	Ministry of Science and Higher Education (Poland)(Ministry of Science and Higher Education, Poland)	This work was supported by the grants P-N/024/2006 (BK) and N N405 184435 (KG) from the Ministry of Science and Higher Education (Poland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTERMAN RL, 1994, MOL CHEM NEUROPATHOL, V21, P177, DOI 10.1007/BF02815350; Badie B, 2000, NEUROSURGERY, V46, P957, DOI 10.1097/00006123-200004000-00035; Cha S, 2003, MAGNET RESON MED, V49, P848, DOI 10.1002/mrm.10446; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; FREI K, 1992, J IMMUNOL, V148, P3140; Galarneau H, 2007, CANCER RES, V67, P8874, DOI 10.1158/0008-5472.CAN-07-0177; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hata AN, 2005, MOL PHARMACOL, V67, P640, DOI 10.1124/mol.104.007971; Herbert DR, 2010, J IMMUNOL, V184, P6438, DOI 10.4049/jimmunol.0902009; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Hussain SF, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-15; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; KONARSKA L, 1986, BIOCHEM MED METAB B, V35, P156, DOI 10.1016/0885-4505(86)90070-8; Koochekpour S, 1997, CANCER RES, V57, P5391; Kurth I, 2001, J EXP MED, V194, P855, DOI 10.1084/jem.194.6.855; Lepique AP, 2009, CLIN CANCER RES, V15, P4391, DOI 10.1158/1078-0432.CCR-09-0489; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Markovic DS, 2009, P NATL ACAD SCI USA, V106, P12530, DOI 10.1073/pnas.0804273106; Markovic DS, 2005, J NEUROPATH EXP NEUR, V64, P754, DOI 10.1097/01.jnen.0000178445.33972.a9; Minniti G, 2009, ANTICANCER RES, V29, P5171; Munder M, 1998, J IMMUNOL, V160, P5347; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Nakano Y, 2008, J NEUROSURG, V108, P311, DOI 10.3171/JNS/2008/108/2/0311; Narumiya S, 2003, LIFE SCI, V74, P391, DOI 10.1016/j.lfs.2003.09.025; Nishie A, 1999, CLIN CANCER RES, V5, P1107; NITTA T, 1992, BRAIN RES, V571, P19, DOI 10.1016/0006-8993(92)90505-4; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Okada M, 2009, INT J ONCOL, V34, P1621, DOI 10.3892/ijo_00000292; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rodrigues JC, 2010, NEURO-ONCOLOGY, V12, P351, DOI 10.1093/neuonc/nop023; Rodriguez PC, 2004, CANCER RES, V64, P5839, DOI 10.1158/0008-5472.CAN-04-0465; Sarin H, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-77; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Shellenberger TD, 2004, CANCER RES, V64, P8262, DOI 10.1158/0008-5472.CAN-04-2056; Shurin GV, 2005, J IMMUNOL, V174, P5490, DOI 10.4049/jimmunol.174.9.5490; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sliwa M, 2007, BRAIN, V130, P476, DOI 10.1093/brain/awl263; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Wei J, 2010, CLIN CANCER RES, V16, P461, DOI 10.1158/1078-0432.CCR-09-1983; Wesolowska A, 2008, ONCOGENE, V27, P918, DOI 10.1038/sj.onc.1210683; Wierzba-Bobrowicz T, 1994, Folia Neuropathol, V32, P251; Wu A, 2010, NEURO-ONCOLOGY, V12, P1113, DOI 10.1093/neuonc/noq082; Yi LA, 2011, J NEUROIMMUNOL, V232, P75, DOI 10.1016/j.jneuroim.2010.10.011; Zhai HY, 2011, GLIA, V59, P472, DOI 10.1002/glia.21117; Zisakis A, 2007, CYTOKINE, V39, P99, DOI 10.1016/j.cyto.2007.05.012	52	205	216	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23902	10.1371/journal.pone.0023902	http://dx.doi.org/10.1371/journal.pone.0023902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901144	Green Submitted, gold, Green Published			2022-12-25	WOS:000294298000029
J	Holveck, MJ; Geberzahn, N; Riebel, K				Holveck, Marie-Jeanne; Geberzahn, Nicole; Riebel, Katharina			An Experimental Test of Condition-Dependent Male and Female Mate Choice in Zebra Finches	PLOS ONE			English	Article							EARLY DEVELOPMENTAL CONDITIONS; BROOD SIZE; SEXUAL ATTRACTIVENESS; LOW-QUALITY; SONG; PREFERENCES; EVOLUTION; SELECTION; WILD; PAIR	In mating systems with social monogamy and obligatory bi-parental care, such as found in many songbird species, male and female fitness depends on the combined parental investment. Hence, both sexes should gain from choosing mates in high rather than low condition. However, theory also predicts that an individual's phenotypic quality can constrain choice, if low condition individuals cannot afford prolonged search efforts and/or face higher risk of rejection. In systems with mutual mate choice, the interaction between male and female condition should thus be a better predictor of choice than either factor in isolation. To address this prediction experimentally, we manipulated male and female condition and subsequently tested male and female mating preferences in zebra finches Taeniopygia guttata, a songbird species with mutual mate choice and obligatory bi-parental care. We experimentally altered phenotypic quality by manipulating the brood size in which the birds were reared. Patterns of association for high- or low-condition individuals of the opposite sex differed for male and female focal birds when tested in an 8-way choice arena. Females showed repeatable condition-assortative preferences for males matching their own rearing background. Male preferences were also repeatable, but not predicted by their own or females' rearing background. In combination with a brief review of the literature on condition-dependent mate choice in the zebra finch we discuss whether the observed sex differences and between-studies differences arise because males and females differ in context sensitivity (e. g. male-male competition suppressing male mating preferences), sampling strategies or susceptibility to rearing conditions (e. g. sex-specific effect on physiology). While a picture emerges that juvenile and current state indeed affect preferences, the development and context-dependency of mutual state-dependent mate choice warrants further study.	[Holveck, Marie-Jeanne; Geberzahn, Nicole; Riebel, Katharina] Leiden Univ, Behav Biol Grp, IBL, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Holveck, MJ (corresponding author), Catholic Univ Louvain, Biodivers Res Ctr, B-1348 Louvain, Belgium.	marie-jeanne.holveck@uclouvain.be	Riebel, Katharina/F-5441-2010; Riebel, Katharina/AAC-7401-2021; Holveck, Marie-Jeanne/D-4004-2016	Riebel, Katharina/0000-0003-2373-8510; Riebel, Katharina/0000-0003-2373-8510; Holveck, Marie-Jeanne/0000-0002-6229-6367	Netherlands Organization for Scientific Research (NWO/ALW); Deutsche Forschungsgemeinschaft (DFG) [NG (GE 1253/3-1)];  [ANR-09-JCJC-0050-01]	Netherlands Organization for Scientific Research (NWO/ALW)(Netherlands Organization for Scientific Research (NWO)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); 	This research and MJH were funded by a grant of the Netherlands Organization for Scientific Research (NWO/ALW) to KR. A grant of the Deutsche Forschungsgemeinschaft (DFG) funded NG (GE 1253/3-1). ANR-09-JCJC-0050-01 funded MJH while working on the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; [Anonymous], 2010, R LANG ENV STAT COMP; Arnold KE, 2007, J AVIAN BIOL, V38, P356, DOI 10.1111/j.2007.0908-8857.03818.x; Bailey NW, 2008, BEHAV ECOL, V19, P960, DOI 10.1093/beheco/arn054; Bateson M, 2005, TRENDS ECOL EVOL, V20, P659, DOI 10.1016/j.tree.2005.08.013; Becker W. A, 1984, MANUAL QUANTITATIVE; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Bolund E, 2010, J EVOLUTION BIOL, V23, P586, DOI 10.1111/j.1420-9101.2009.01927.x; BURLEY N, 1987, ETHOLOGY, V76, P133; BURLEY N, 1982, ANIM BEHAV, V30, P444, DOI 10.1016/S0003-3472(82)80055-9; BURLEY N, 1986, AM NAT, V127, P415, DOI 10.1086/284493; Burley NT, 2006, ANIM BEHAV, V72, P713, DOI 10.1016/j.anbehav.2006.01.017; Candolin U, 2009, AM NAT, V173, P273, DOI 10.1086/595753; CLAYTON NS, 1990, ANIM BEHAV, V39, P474, DOI 10.1016/S0003-3472(05)80411-7; CLAYTON NS, 1990, PHILOS T R SOC B, V330, P351, DOI 10.1098/rstb.1990.0205; CLAYTON NS, 1990, ANIM BEHAV, V40, P1102, DOI 10.1016/S0003-3472(05)80176-9; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; DeKogel CH, 1997, J ANIM ECOL, V66, P167; DeKogel CH, 1996, ANIM BEHAV, V51, P699, DOI 10.1006/anbe.1996.0073; Fawcett TW, 2003, BEHAV ECOL, V14, P771, DOI 10.1093/beheco/arg075; Forstmeier W, 2007, MOL ECOL, V16, P4039, DOI 10.1111/j.1365-294X.2007.03444.x; Gil D, 2006, J NEUROBIOL, V66, P1602, DOI 10.1002/neu.20312; Griffith SC, 2010, ANIM BEHAV, V79, P261, DOI 10.1016/j.anbehav.2009.11.031; Hardling R, 2005, EVOL ECOL RES, V7, P697; Holveck MJ, 2008, BEHAV ECOL, V19, P1267, DOI 10.1093/beheco/arn078; Holveck MJ, 2007, ANIM BEHAV, V74, P297, DOI 10.1016/j.anbehav.2006.08.016; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Johnstone RA, 1997, BEHAV ECOL SOCIOBIOL, V40, P51, DOI 10.1007/s002650050315; Johnstone RA, 1996, EVOLUTION, V50, P1382, DOI [10.2307/2410876, 10.1111/j.1558-5646.1996.tb03912.x]; Jones KM, 2001, ANIM BEHAV, V62, P1021, DOI 10.1006/anbe.2001.1843; Kirkpatrick M, 2006, ANIM BEHAV, V71, P1215, DOI 10.1016/j.anbehav.2005.11.010; Kokko H, 2002, PHILOS T R SOC B, V357, P319, DOI 10.1098/rstb.2001.0926; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Kraaijeveld K, 2007, ANIM BEHAV, V74, P657, DOI 10.1016/j.anbehav.2006.12.027; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Martins TLF, 2004, BEHAV ECOL, V15, P174, DOI 10.1093/beheco/arg094; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; McNamara JM, 1999, PHILOS T R SOC B, V354, P223, DOI 10.1098/rstb.1999.0374; Monaghan P, 1996, P ROY SOC B-BIOL SCI, V263, P1183, DOI 10.1098/rspb.1996.0173; Naguib M, 2004, P ROY SOC B-BIOL SCI, V271, P833, DOI 10.1098/rspb.2003.2673; Naguib M, 2005, BIOL LETT-UK, V1, P95, DOI 10.1098/rsbl.2004.0277; Naguib M, 2008, ETHOLOGY, V114, P255, DOI 10.1111/j.1439-0310.2007.01466.x; Naguib M, 2006, P ROY SOC B-BIOL SCI, V273, P1901, DOI 10.1098/rspb.2006.3526; Pariser EC, 2010, BEHAV ECOL, V21, P264, DOI 10.1093/beheco/arp185; REAL LA, 1991, AM NAT, V138, P901, DOI 10.1086/285259; Riebel K, 2003, ANIM BIOL, V53, P73, DOI 10.1163/157075603769700304; Riebel K, 2000, P ROY SOC B-BIOL SCI, V267, P2553, DOI 10.1098/rspb.2000.1320; Riebel Katharina, 2010, Communicative & Integrative Biology, V3, P271; Riebel K, 2009, ANIM BEHAV, V78, P1397, DOI 10.1016/j.anbehav.2009.09.011; Riebel K, 2009, ADV STUD BEHAV, V40, P197, DOI 10.1016/S0065-3454(09)40006-8; Royle NJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P2015, DOI 10.1007/s00265-010-1013-1; Schuett W, 2011, ANIM BEHAV, V81, P609, DOI 10.1016/j.anbehav.2010.12.006; Slater P.J.B., 1988, Advances in the Study of Behavior, V18, P1; Tchernichovski O, 1998, P NATL ACAD SCI USA, V95, P8951, DOI 10.1073/pnas.95.15.8951; ten Cate C, 2006, CURR BIOL, V16, P1128, DOI 10.1016/j.cub.2006.03.068; TENCATE C, 1985, BEHAV PROCESS, V10, P369, DOI 10.1016/0376-6357(85)90037-3; Tschirren B, 2009, J EVOLUTION BIOL, V22, P387, DOI 10.1111/j.1420-9101.2008.01656.x; Venner S, 2010, AM NAT, V175, P650, DOI 10.1086/652432; Verhulst S, 2006, BIOL LETTERS, V2, P478, DOI 10.1098/rsbl.2006.0496; Vignal C, 2004, NATURE, V430, P448, DOI 10.1038/nature02645; Widemo F, 1999, TRENDS ECOL EVOL, V14, P26, DOI 10.1016/S0169-5347(98)01531-6; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809; Woodgate JL, 2010, ANIM BEHAV, V79, P1381, DOI 10.1016/j.anbehav.2010.03.018; WYNN SE, 1993, AUK, V110, P635; [No title captured]; [No title captured]	67	32	33	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23974	10.1371/journal.pone.0023974	http://dx.doi.org/10.1371/journal.pone.0023974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901147	Green Published, gold			2022-12-25	WOS:000294298000032
J	Yevenes, GE; Zeilhofer, HU				Yevenes, Gonzalo E.; Zeilhofer, Hanns Ulrich			Molecular Sites for the Positive Allosteric Modulation of Glycine Receptors by Endocannabinoids	PLOS ONE			English	Article							GATED ION-CHANNEL; SINGLE-CHANNEL; FATTY-ACID; GABA(A); DETERMINANTS; CANNABINOIDS; POTENTIATION; CONDUCTANCE; ACTIVATION; ANANDAMIDE	Glycine receptors (GlyRs) are transmitter-gated anion channels of the Cys-loop superfamily which mediate synaptic inhibition at spinal and selected supraspinal sites. Although they serve pivotal functions in motor control and sensory processing, they have yet to be exploited as drug targets partly because of hitherto limited possibilities for allosteric control. Endocannabinoids (ECs) have recently been characterized as direct allosteric GlyR modulators, but the underlying molecular sites have remained unknown. Here, we show that chemically neutral ECs (e. g. anandamide, AEA) are positive modulators of alpha 1, alpha 2 and alpha 3 GlyRs, whereas acidic ECs (e. g. N-arachidonoyl-glycine; NA-Gly) potentiate alpha(1) GlyRs but inhibit alpha(2) and alpha(3). This subunit-specificity allowed us to identify the underlying molecular sites through analysis of chimeric and mutant receptors. We found that alanine 52 in extracellular loop 2, glycine 254 in transmembrane (TM) region 2 and intracellular lysine 385 determine the positive modulation of alpha(1) GlyRs by NA-Gly. Successive substitution of non-conserved extracellular and TM residues in alpha(2) converted NA-Gly-mediated inhibition into potentiation. Conversely, mutation of the conserved lysine within the intracellular loop between TM3 and TM4 attenuated NA-Gly-mediated potentiation of alpha(1) GlyRs, without affecting inhibition of alpha(2) and alpha(3). Notably, this mutation reduced modulation by AEA of all three GlyRs. These results define molecular sites for allosteric control of GlyRs by ECs and reveal an unrecognized function for the TM3-4 intracellular loop in the allosteric modulation of Cys-loop ion channels. The identification of these sites may help to understand the physiological role of this modulation and facilitate the development of novel therapeutic approaches to diseases such as spasticity, startle disease and possibly chronic pain.	[Yevenes, Gonzalo E.; Zeilhofer, Hanns Ulrich] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Zeilhofer, Hanns Ulrich] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Yevenes, GE (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland.	yevenes@pharma.uzh.ch	Zeilhofer, Hanns Ulrich/A-4600-2008	Zeilhofer, Hanns Ulrich/0000-0001-6954-4629; Yevenes, Gonzalo/0000-0003-0294-4075	Forschungskredit of the University of Zurich; Schweizerischer National Fonds [3100A0-116064/1, 31003A-131093/1]	Forschungskredit of the University of Zurich; Schweizerischer National Fonds(Swiss National Science Foundation (SNSF))	This work was supported by the Forschungskredit of the University of Zurich and by the Schweizerischer National Fonds (3100A0-116064/1 and 31003A-131093/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arancibia-Carcamo IL, 2009, P NATL ACAD SCI USA, V106, P17552, DOI 10.1073/pnas.0905502106; Baenziger JE, 2011, NEUROPHARMACOLOGY, V60, P116, DOI 10.1016/j.neuropharm.2010.08.007; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Bruno MJ, 2007, P NATL ACAD SCI USA, V104, P9638, DOI 10.1073/pnas.0701015104; Buttner C, 2001, J BIOL CHEM, V276, P42978, DOI 10.1074/jbc.M102121200; Foadi N, 2010, N-S ARCH PHARMACOL, V381, P477, DOI 10.1007/s00210-010-0506-9; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Guo J, 2008, J NEUROPHYSIOL, V100, P1147, DOI 10.1152/jn.01204.2007; Harris RA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.128re7; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Hejazi N, 2006, MOL PHARMACOL, V69, P991, DOI 10.1124/mol.105.019174; Hillard CJ, 2003, BRIT J PHARMACOL, V140, P802, DOI 10.1038/sj.bjp.0705468; Huang SM, 2001, J BIOL CHEM, V276, P42639, DOI 10.1074/jbc.M107351200; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Lozovaya N, 2005, J NEUROSCI, V25, P7499, DOI 10.1523/JNEUROSCI.0977-05.2005; Lundbaek JA, 2008, J GEN PHYSIOL, V131, P421, DOI 10.1085/jgp.200709948; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Maione S, 2007, BRIT J PHARMACOL, V150, P766, DOI 10.1038/sj.bjp.0707145; Makriyannis A, 2005, PROSTAG OTH LIPID M, V77, P210, DOI 10.1016/j.prostaglandins.2004.01.010; Mangin JA, 2003, J PHYSIOL-LONDON, V553, P369, DOI 10.1113/jphysiol.2003.052142; Mascia MP, 1996, MOL PHARMACOL, V50, P402; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miller PS, 2008, NAT STRUCT MOL BIOL, V15, P1084, DOI 10.1038/nsmb.1492; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Miller PS, 2005, J BIOL CHEM, V280, P37877, DOI 10.1074/jbc.M508303200; Muller F, 2003, NEUROSCIENCE, V122, P799, DOI 10.1016/j.neuroscience.2003.07.009; Oz M, 2006, PHARMACOL THERAPEUT, V111, P114, DOI 10.1016/j.pharmthera.2005.09.009; Pernia-Andrade AJ, 2009, SCIENCE, V325, P760, DOI 10.1126/science.1171870; Peters JA, 2005, TRENDS PHARMACOL SCI, V26, P587, DOI 10.1016/j.tips.2005.09.011; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pless SA, 2009, J BIOL CHEM, V284, P27370, DOI 10.1074/jbc.M109.048405; Plested AJR, 2007, J PHYSIOL-LONDON, V581, P51, DOI 10.1113/jphysiol.2006.126920; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Suplita RL, 2006, NEUROPHARMACOLOGY, V50, P372, DOI 10.1016/j.neuropharm.2005.10.007; Wiles AL, 2006, J NEUROCHEM, V99, P781, DOI 10.1111/j.1471-4159.2006.04107.x; Xiong W, 2011, NAT CHEM BIOL, V7, P296, DOI 10.1038/nchembio.552; Xu TL, 2010, PROG NEUROBIOL, V91, P349, DOI 10.1016/j.pneurobio.2010.04.008; Yang Z, 2008, BIOCHEM PHARMACOL, V76, P1014, DOI 10.1016/j.bcp.2008.07.037; Yevenes GE, 2011, BR J PHARM IN PRESS; Yevenes GE, 2010, J BIOL CHEM, V285, P30203, DOI 10.1074/jbc.M110.134676; Yevenes GE, 2008, P NATL ACAD SCI USA, V105, P20523, DOI 10.1073/pnas.0806257105; Yevenes GE, 2006, J BIOL CHEM, V281, P39300, DOI 10.1074/jbc.M608272200; Zeilhofer HU, 2005, CELL MOL LIFE SCI, V62, P2027, DOI 10.1007/s00018-005-5107-2; Zhang L, 2009, VITAM HORM, V81, P315, DOI 10.1016/S0083-6729(09)81012-1	49	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23886	10.1371/journal.pone.0023886	http://dx.doi.org/10.1371/journal.pone.0023886			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901142	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000294298000027
J	Carpenter, S; Wochal, P; Dunne, A; O'Neill, LAJ				Carpenter, Susan; Wochal, Paulina; Dunne, Aisling; O'Neill, Luke A. J.			Toll-like Receptor 3 (TLR3) Signaling Requires TLR4 Interactor with Leucine-rich Repeats (TRIL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; TOLL-LIKE-RECEPTOR-4; RECOGNITION; ACTIVATION; COMPLEX; PRAT4A; RP105; CD14	Toll-like receptors (TLRs) are a family of proteins that act as the primary sensors of microbial products. Many TLRs require accessory molecules in order to recognize these microbial products and initiate signal transduction cascades. We have identified TRIL (TLR4 interactor with leucine-rich repeats) as a novel modulator of TLR4 signaling showing high expression in the brain. We now show that TRIL also plays a role in TLR3 signaling. TRIL is expressed intracellularly in the astrocytoma cell line U373 and in the monocytic cell line THP1. TRIL co-localizes with the endosomal compartment. These data are consistent with a role for TRIL in TLR3 signaling and endosomal TLR4 signaling. TRIL was induced by the TLR3 ligand poly(I: C). Overexpression of TRIL enhanced cytokine production and interferon-stimulated response element (ISRE) luciferase activity following poly(I: C) stimulation in U373. TRIL interacted with TLR3, and this interaction was enhanced following poly(I: C) stimulation. Transient knockdown of TRIL with siRNA or stable knockdown using shRNA in U373 cells inhibited TLR3 signaling, reducing ISRE luciferase, RANTES, and type I interferon production. Knockdown of TRIL did not affect TLR2 signaling. Most accessory molecules identified to date, such as CD14, gp96, PRAT4a, and Unc93B, all play roles in multiple TLR signaling pathways, and we now show that this is also the case for TRIL.	[O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; Trinity Coll Dublin, Trinity Biomed Sci Inst, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748; dunne, aisling/0000-0002-2342-9518	Science Foundation Ireland; FP7 Marie Curie Initial Training Network TranSIVR; Health Research Board; Marie Curie actions	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); FP7 Marie Curie Initial Training Network TranSIVR; Health Research Board; Marie Curie actions(European Commission)	This work is supported by Science Foundation Ireland, FP7 Marie Curie Initial Training Network TranSIVR, and the Health Research Board and Marie Curie actions. L. A. J. O'Neill is a cofounder, minority shareholder, and member of the scientific advisory board of Opsona Therapeutics Ltd., a University Start-up company involved in the development of anti-inflammatory therapeutics.	Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Carpenter S, 2009, J IMMUNOL, V183, P3989, DOI 10.4049/jimmunol.0901518; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Ogata H, 2000, J EXP MED, V192, P23, DOI 10.1084/jem.192.1.23; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Rabin SJ, 2010, HUM MOL GENET, V19, P313, DOI 10.1093/hmg/ddp498; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Wakabayashi Y, 2006, J IMMUNOL, V177, P1772, DOI 10.4049/jimmunol.177.3.1772; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005	18	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38795	38804		10.1074/jbc.M111.255893	http://dx.doi.org/10.1074/jbc.M111.255893			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911501	Green Published, hybrid			2022-12-25	WOS:000296594200090
J	Guo, XE; Chen, CF; Wang, DDH; Modrek, AS; Phan, VH; Lee, WH; Chen, PL				Guo, Xuning Emily; Chen, Chi-Fen; Wang, Dennis Ding-Hwa; Modrek, Aram Sandaldjian; Vy Hoai Phan; Lee, Wen-Hwa; Chen, Phang-Lang			Uncoupling the Roles of the SUV3 Helicase in Maintenance of Mitochondrial Genome Stability and RNA Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED DODECAMER SEQUENCE; INTRON-ENCODED PROTEIN; ESCHERICHIA-COLI; MESSENGER-RNA; POLYNUCLEOTIDE PHOSPHORYLASE; SACCHAROMYCES-CEREVISIAE; YEAST MITOCHONDRIA; POSTTRANSCRIPTIONAL PROCESSES; RIBONUCLEASE-E; IN-VIVO	Yeast SUV3 is a nuclear encoded mitochondrial RNA helicase that complexes with an exoribonuclease, DSS1, to function as an RNA degradosome. Inactivation of SUV3 leads to mitochondrial dysfunctions, such as respiratory deficiency; accumulation of aberrant RNA species, including excised group I introns; and loss of mitochondrial DNA (mtDNA). Although intron toxicity has long been speculated to be the major reason for the observed phenotypes, direct evidence to support or refute this theory is lacking. Moreover, it remains unknown whether SUV3 plays a direct role in mtDNA maintenance independently of its degradosome activity. In this paper, we address these questions by employing an inducible knockdown system in Saccharomyces cerevisiae with either normal or intronless mtDNA background. Expressing mutants defective in ATPase (K245A) or RNA binding activities (V272L or Delta CC, which carries an 8-amino acid deletion at the C-terminal conserved region) resulted in not only respiratory deficiencies but also loss of mtDNA under normal mtDNA background. Surprisingly, V272L, but not other mutants, can rescue the said deficiencies under intronless background. These results provide genetic evidence supporting the notion that the functional requirements of SUV3 for degradosome activity and maintenance of mtDNA stability are separable. Furthermore, V272L mutants and wild-type SUV3 associated with an active mtDNA replication origin and facilitated mtDNA replication, whereas K245A and Delta CC failed to support mtDNA replication. These results indicate a direct role of SUV3 in maintaining mitochondrial genome stability that is independent of intron turnover but requires the intact ATPase activity and the CC conserved region.	[Lee, Wen-Hwa; Chen, Phang-Lang] Univ Calif Irvine, Dept Biol Chem, Sch Med, Irvine, CA 92697 USA	University of California System; University of California Irvine	Lee, WH (corresponding author), Univ Calif Irvine, Dept Biol Chem, Sch Med, 124 Sprague Hall, Irvine, CA 92697 USA.	whlee@uci.edu; plchen@uci.edu	Lee, Wen-Hwa/C-2519-2014; Chen, Phang-Lang/J-5031-2013	Chen, Phang-Lang/0000-0002-0357-9017; Modrek, Aram/0000-0001-7586-9833; Chen, Chi-Fen/0000-0002-6391-821X	National Institutes of Health (NIH) [AG027877]; NIH, NIGMS (University of California, Irvine); Department of Defense [W81XWH-06-1-0767]; National Science Foundation (University of California, Irvine); NATIONAL CANCER INSTITUTE [T32CA113265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027877] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIGMS (University of California, Irvine)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)University of California System); Department of Defense(United States Department of Defense); National Science Foundation (University of California, Irvine)(National Science Foundation (NSF)University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant AG027877 (to W. H. L. and P. L. C.) and the NIH, NIGMS, Medical Scientist Training Program (University of California, Irvine) (to D.-H. W). W. H. L. serves as a member of the board of directors for GeneTex Inc. The term of this arrangement has been reviewed and approved by University of California, Irvine according to its conflict of interest policy.; Supported by Department of Defense Predoctoral Traineeship Award W81XWH-06-1-0767.; Supported by a National Science Foundation Lifechips Integrative Graduate Education and Research fellowship (University of California, Irvine).	Ahmed KM, 2010, J BIOL CHEM, V285, P4464, DOI 10.1074/jbc.M109.062265; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; BABITZKE P, 1991, P NATL ACAD SCI USA, V88, P1, DOI 10.1073/pnas.88.1.1; Bessarab DA, 1998, P NATL ACAD SCI USA, V95, P3157, DOI 10.1073/pnas.95.6.3157; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; BOULET A, 1990, CURR GENET, V17, P537, DOI 10.1007/BF00313085; Briani F, 2007, BIOCHIMIE, V89, P145, DOI 10.1016/j.biochi.2006.09.020; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; BUTOW RA, 1989, GENOME, V31, P757, DOI 10.1139/g89-134; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; CARPOUSIS AJ, 1994, CELL, V76, P889, DOI 10.1016/0092-8674(94)90363-8; Chandran V, 2006, J MOL BIOL, V358, P8, DOI 10.1016/j.jmb.2006.02.012; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; Chen YM, 2002, J BIOL CHEM, V277, P49408, DOI 10.1074/jbc.M207069200; Cheng X, 2007, MITOCHONDRION, V7, P211, DOI 10.1016/j.mito.2006.11.023; Coburn GA, 1999, PROG NUCLEIC ACID RE, V62, P55; CONRADWEBB H, 1990, NUCLEIC ACIDS RES, V18, P1369, DOI 10.1093/nar/18.6.1369; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; DMOCHOWSKA A, 1995, CURR GENET, V28, P108, DOI 10.1007/BF00315775; Dziembowski A, 2003, J BIOL CHEM, V278, P1603, DOI 10.1074/jbc.M208287200; Dziembowski A, 1998, MOL GEN GENET, V260, P108, DOI 10.1007/s004380050876; EHRETSMANN CP, 1992, GENE DEV, V6, P149, DOI 10.1101/gad.6.1.149; Fan HY, 1996, GENETICS, V142, P749; Gagliardi D, 2004, TRENDS GENET, V20, P260, DOI 10.1016/j.tig.2004.04.006; GOLIK P, 1995, CURR GENET, V28, P217, DOI 10.1007/BF00309780; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; KALMAN M, 1991, NEW BIOL, V3, P886; Khidr L, 2008, J BIOL CHEM, V283, P27064, DOI 10.1074/jbc.M802991200; Lecrenier N, 2000, GENE, V246, P37, DOI 10.1016/S0378-1119(00)00107-4; MACREADIE IG, 1985, CELL, V41, P395, DOI 10.1016/S0092-8674(85)80012-X; Malecki M, 2007, J MOL BIOL, V372, P23, DOI 10.1016/j.jmb.2007.06.074; Margossian SP, 1996, CELL, V84, P199, DOI 10.1016/S0092-8674(00)80975-7; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Meeusen S, 2003, J CELL BIOL, V163, P503, DOI 10.1083/jcb.200304040; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; Mohanty BK, 2000, P NATL ACAD SCI USA, V97, P11966, DOI 10.1073/pnas.220295997; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; MORTIMER RK, 1986, GENETICS, V113, P35; PY B, 1994, MOL MICROBIOL, V14, P717, DOI 10.1111/j.1365-2958.1994.tb01309.x; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Rogowska AT, 2006, MOL BIOL CELL, V17, P1184, DOI 10.1091/mbc.E05-08-0796; Sarkar D, 2006, CELL CYCLE, V5, P1080, DOI 10.4161/cc.5.10.2741; SERAPHIN B, 1987, P NATL ACAD SCI USA, V84, P6810, DOI 10.1073/pnas.84.19.6810; Shu ZY, 2004, BIOCHEMISTRY-US, V43, P4781, DOI 10.1021/bi0356449; Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282; STEPIEN PP, 1992, P NATL ACAD SCI USA, V89, P6813, DOI 10.1073/pnas.89.15.6813; STEPIEN PP, 1995, CURR GENET, V27, P234, DOI 10.1007/BF00326154; Turk EM, 2010, J BIOL CHEM, V285, P8585, DOI 10.1074/jbc.M109.090761; Vanzo NF, 1998, GENE DEV, V12, P2770, DOI 10.1101/gad.12.17.2770; Wang DDH, 2009, J BIOL CHEM, V284, P20812, DOI 10.1074/jbc.M109.009605; XU BJ, 1995, MOL CELL BIOL, V15, P580, DOI 10.1128/MCB.15.1.580; Zhong Q, 2002, J BIOL CHEM, V277, P28641, DOI 10.1074/jbc.M200748200; ZHU H, 1989, MOL CELL BIOL, V9, P1507, DOI 10.1128/MCB.9.4.1507; ZINN AR, 1985, CELL, V40, P887, DOI 10.1016/0092-8674(85)90348-4	56	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38783	38794		10.1074/jbc.M111.257956	http://dx.doi.org/10.1074/jbc.M111.257956			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911497	Green Published, hybrid			2022-12-25	WOS:000296594200089
J	O'Toole, KK; Jenkins, A				O'Toole, Kate K.; Jenkins, Andrew			Discrete M3-M4 Intracellular Loop Subdomains Control Specific Aspects of gamma-Aminobutyric Acid Type A Receptor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION CHANNELS; NICOTINIC ACETYLCHOLINE-RECEPTORS; MEMBRANE-SPANNING SEGMENT; CELL-SURFACE STABILITY; LARGE CYTOPLASMIC LOOP; GABA(A) RECEPTOR; 5-HYDROXYTRYPTAMINE TYPE-3; STRUCTURAL DETERMINANTS; CHARGED RESIDUES; 5-HT3A RECEPTOR	The GABA type A receptor (GABA(A)R) is a member of the pentameric ligand gated ion channel (pLGIC) family that mediates ionotropic neurotransmission. Residues in the intracellular loop domain (ILD) have recently been shown to define part of the ion permeation pathway in several closely related members of the pentameric ligand gated ion channel family. In this study, we investigated the role the ILD of the GABA(A)R alpha 1 subunit plays in channel function. Deletion of the alpha 1 ILD resulted in a significant increase in GABA EC50 and maximal current amplitude, suggesting that the ILD must be intact for proper receptor function. To test this hypothesis, we conducted a mutagenic screen of all amino acids harboring ionizable side chains within this domain to investigate the contribution of individual charged residues to ion permeation. Using macroscopic and single channel voltage-clamp recording techniques, we found that mutations within a subdomain of the alpha 1 ILD near M3 altered GABA apparent affinity; interestingly, alpha 1(K312E) exhibited reduced partial agonist efficacy. We introduced point mutations near M4, including alpha 1(K383E) and alpha 1(K384E), that enhanced receptor desensitization. Mutation of 5 charged residues within a 39-residue span contiguous with M4 reduced relative anion permeability of the channel and may represent a weak intracellular selectivity filter. Within this subdomain, the alpha 1(K378E) mutation induced a significant reduction in single channel conductance, consistent with our hypothesis that the GABA(A)R alpha 1 ILD contributes directly to the permeation pathway.	Emory Univ, Dept Anesthesiol, Atlanta, GA 30322 USA; Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University; Emory University	Jenkins, A (corresponding author), 1510 Clifton Rd,5013 O Wayne Rollins Res Ctr, Atlanta, GA 30322 USA.	ajenki2@emory.edu			National Institutes of Health [GM073959]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM073959.	Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brandon NJ, 1999, BIOCHEM SOC T, V27, P527, DOI 10.1042/bst0270527; Breitinger HG, 2002, J NEUROCHEM, V83, P30, DOI 10.1046/j.1471-4159.2002.01109.x; Carland JE, 2009, J BIOL CHEM, V284, P2023, DOI 10.1074/jbc.M806618200; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Corringer PJ, 2010, J PHYSIOL-LONDON, V588, P565, DOI 10.1113/jphysiol.2009.183160; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; Deeb TZ, 2007, J BIOL CHEM, V282, P6172, DOI 10.1074/jbc.M607698200; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hu XQ, 2006, J BIOL CHEM, V281, P21781, DOI 10.1074/jbc.M600676200; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Jensen ML, 2005, J NEUROCHEM, V92, P962, DOI 10.1111/j.1471-4159.2004.02970.x; Jensen ML, 2005, J NEUROCHEM, V92, P217, DOI 10.1111/j.1471-4159.2004.02883.x; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kash TL, 2004, BIOCHEM SOC T, V32, P540, DOI 10.1042/BST0320540; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2006, J PHYSIOL-LONDON, V575, P11, DOI 10.1113/jphysiol.2005.102756; Kuo YP, 2005, J PHARMACOL EXP THER, V314, P455, DOI 10.1124/jpet.105.084954; LEIDENHEIMER NJ, 1991, TRENDS PHARMACOL SCI, V12, P84, DOI 10.1016/0165-6147(91)90509-Q; Livesey MR, 2008, J BIOL CHEM, V283, P19301, DOI 10.1074/jbc.M802406200; Lo WY, 2008, J BIOL CHEM, V283, P29740, DOI 10.1074/jbc.M802856200; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Michels G, 2007, CRIT REV BIOCHEM MOL, V42, P3, DOI 10.1080/10409230601146219; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Mukerjee J., 2010, NEUR M PLANN SOC NEU; NODA M, 1983, NATURE, V302, P528, DOI 10.1038/302528a0; Nymann-Andersen J, 2002, J NEUROCHEM, V83, P1164, DOI 10.1046/j.1471-4159.2002.01222.x; Peran M, 2006, CELL MOTIL CYTOSKEL, V63, P747, DOI 10.1002/cm.20156; Peters JA, 2010, J PHYSIOL-LONDON, V588, P587, DOI 10.1113/jphysiol.2009.183137; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Williams DB, 1999, BIOPHYS J, V77, P2563, DOI 10.1016/S0006-3495(99)77091-8; Wotring VE, 1999, J PHYSIOL-LONDON, V521, P327, DOI 10.1111/j.1469-7793.1999.00327.x; Wotring VE, 2008, J GEN PHYSIOL, V131, P87, DOI 10.1085/jgp.200609701; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195	48	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					37990	37999		10.1074/jbc.M111.258012	http://dx.doi.org/10.1074/jbc.M111.258012			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21903587	Green Published, hybrid			2022-12-25	WOS:000296594200011
J	Weinman, EJ; Steplock, D; Shenolikar, S; Biswas, R				Weinman, Edward J.; Steplock, Deborah; Shenolikar, Shirish; Biswas, Rajatsubhra			Fibroblast Growth Factor-23-mediated Inhibition of Renal Phosphate Transport in Mice Requires Sodium-Hydrogen Exchanger Regulatory Factor-1 (NHERF-1) and Synergizes with Parathyroid Hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL TUBULE CELLS; DOMINANT HYPOPHOSPHATEMIC RICKETS; TUMOR-INDUCED OSTEOMALACIA; FGF23; IIA; PHOSPHORYLATION; EXPRESSION; DOPAMINE; KIDNEY; MEDIA	Fibroblast growth factor-23 (FGF-23) inhibits sodium-dependent phosphate transport in brush border membrane vesicles derived from hormone-treated kidney slices of the mouse and in mouse proximal tubule cells by processes involving mitogen-activated protein kinase (MAPK) but not protein kinase A (PKA) or protein kinase C (PKC). By contrast, phosphate transport in brush border membrane vesicles and proximal tubule cells from sodium-hydrogen exchanger regulatory factor-1 (NHERF-1)-null mice were resistant to the inhibitory effect of FGF-23 (10(-9) M). Infection of NHERF-1-null proximal tubule cells with wild-type adenovirus-GFP-NHERF-1 increased basal phosphate transport and restored the inhibitory effect of FGF-23. Infection with adenovirus-GFP-NHERF-1 containing a S77A or T95D mutation also increased basal phosphate transport, but the cells remained resistant to FGF-23 (10(-9) M). Low concentrations of FGF-23 (10(-13) M) and PTH (10(-11) M) individually did not inhibit phosphate transport or activate PKA, PKC, or MAPK. When combined, however, these hormones markedly inhibited phosphate transport associated with activation of PKC and PKA but not MAPK. These studies indicate that FGF-23 inhibits phosphate transport in the mouse kidney by processes that involve the scaffold protein NHERF-1. In addition, FGF-23 synergizes with PTH to inhibit phosphate transport by facilitating the activation of the PTH signal transduction pathway.	[Weinman, Edward J.; Steplock, Deborah; Biswas, Rajatsubhra] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Weinman, Edward J.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Weinman, Edward J.] Dept Vet Affairs Med Ctr, Med Serv, Baltimore, MD 21201 USA; [Shenolikar, Shirish] Duke NUS Grad Med Sch, Program Neurosci & Behav Disorders, Singapore 169857, Singapore	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National University of Singapore	Weinman, EJ (corresponding author), Univ Maryland Hosp, Div Nephrol, Rm N3W143,22 S Greene St, Baltimore, MD 21201 USA.	eweinman1440@yahoo.com			National Institutes of Health [DK55881]; Research Service, Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK55881 (to E. J. W.). This work was also supported by the Research Service, Department of Veterans Affairs (to E. J. W.).	Baum M, 2005, KIDNEY INT, V68, P1148, DOI 10.1111/j.1523-1755.2005.00506.x; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Cunningham R, 2006, AM J PHYSIOL-RENAL, V291, pF896, DOI 10.1152/ajprenal.00036.2006; Cunningham R, 2009, AM J PHYSIOL-RENAL, V296, pF355, DOI 10.1152/ajprenal.90426.2008; Deliot N, 2005, AM J PHYSIOL-CELL PH, V289, pC159, DOI 10.1152/ajpcell.00456.2004; Geller JL, 2007, J BONE MINER RES, V22, P931, DOI 10.1359/JBMR.070304; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; Seiler S, 2009, KIDNEY INT, V76, pS34, DOI 10.1038/ki.2009.405; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2010, J BIOL CHEM, V285, P25134, DOI 10.1074/jbc.M110.132423; Weinman EJ, 2010, J BIOL CHEM, V285, P13454, DOI 10.1074/jbc.M109.094359; Weinman EJ, 2003, AM J PHYSIOL-RENAL, V285, pF1225, DOI 10.1152/ajprenal.00215.2003; White KE, 2001, J CLIN ENDOCR METAB, V86, P497, DOI 10.1210/jc.86.2.497; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Yamashita T, 2002, J BIOL CHEM, V277, P28265, DOI 10.1074/jbc.M202527200; Yu XJ, 2005, CYTOKINE GROWTH F R, V16, P221, DOI 10.1016/j.cytogfr.2005.01.002	21	43	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37216	37221		10.1074/jbc.M111.288357	http://dx.doi.org/10.1074/jbc.M111.288357			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21908609	hybrid, Green Published			2022-12-25	WOS:000296542400022
J	Nagy, K; Greenlee, MW; Kovacs, G				Nagy, Krisztina; Greenlee, Mark W.; Kovacs, Gyula			Sensory Competition in the Face Processing Areas of the Human Brain	PLOS ONE			English	Article							HUMAN EXTRASTRIATE CORTEX; NEURAL MECHANISMS; INVERTED FACES; HUMAN OBJECT; ATTENTION; RESPONSES; NEURONS; REPRESENTATIONS; ADAPTATION; CATEGORY	The concurrent presentation of multiple stimuli in the visual field may trigger mutually suppressive interactions throughout the ventral visual stream. While several studies have been performed on sensory competition effects among non-face stimuli relatively little is known about the interactions in the human brain for multiple face stimuli. In the present study we analyzed the neuronal basis of sensory competition in an event-related functional magnetic resonance imaging (fMRI) study using multiple face stimuli. We varied the ratio of faces and phase-noise images within a composite display with a constant number of peripheral stimuli, thereby manipulating the competitive interactions between faces. For contralaterally presented stimuli we observed strong competition effects in the fusiform face area (FFA) bilaterally and in the right lateral occipital area (LOC), but not in the occipital face area (OFA), suggesting their different roles in sensory competition. When we increased the spatial distance among pairs of faces the magnitude of suppressive interactions was reduced in the FFA. Surprisingly, the magnitude of competition depended on the visual hemifield of the stimuli: ipsilateral stimulation reduced the competition effects somewhat in the right LOC while it increased them in the left LOC. This suggests a left hemifield dominance of sensory competition. Our results support the sensory competition theory in the processing of multiple faces and suggests that sensory competition occurs in several cortical areas in both cerebral hemispheres.	[Nagy, Krisztina; Kovacs, Gyula] Budapest Univ Technol & Econ, Dept Cognit Sci, H-1117 Budapest, Hungary; [Greenlee, Mark W.; Kovacs, Gyula] Univ Regensburg, Inst Psychol, D-8400 Regensburg, Germany	Budapest University of Technology & Economics; University of Regensburg	Nagy, K (corresponding author), Budapest Univ Technol & Econ, Dept Cognit Sci, H-1117 Budapest, Hungary.	gkovacs@cogsci.bme.hu	Kovacs, Gyula/E-4781-2010; Greenlee, Mark/M-6414-2018	Greenlee, Mark/0000-0003-2305-9286	Deutsche Forschungsgemeinschaft [KO 3918/1-1];  [DAAD-MA-B/821]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by the Deutsche Forschungsgemeinschaft (KO 3918/1-1), and by the DAAD-MA-B/821. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afraz A, 2010, CURR BIOL, V20, P2112, DOI 10.1016/j.cub.2010.11.017; Agam Y, 2010, CURR BIOL, V20, P872, DOI 10.1016/j.cub.2010.03.050; Axelrod V, 2011, J COGNITIVE NEUROSCI, V23, P746, DOI 10.1162/jocn.2010.21481; Beck DM, 2007, J VISION, V7, DOI 10.1167/7.2.19; Beck DM, 2009, VISION RES, V49, P1154, DOI 10.1016/j.visres.2008.07.012; Beck DM, 2005, NAT NEUROSCI, V8, P1110, DOI 10.1038/nn1501; Bindemann M, 2005, COGNITION, V98, P177, DOI 10.1016/j.cognition.2004.11.004; Bindemann M, 2007, EXP PSYCHOL, V54, P192, DOI 10.1027/1618-3169.54.3.192; Boutet I, 2001, PERCEPTION, V30, P743, DOI 10.1068/p3183; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Britten KH, 1999, J NEUROSCI, V19, P5074; Cichy RM, 2011, NEUROIMAGE, V54, P2297, DOI 10.1016/j.neuroimage.2010.09.044; Compton RJ, 2002, NEUROPSYCHOLOGIA, V40, P2409, DOI 10.1016/S0028-3932(02)00078-7; Cziraki C, 2010, J NEUROPHYSIOL, V103, P1410, DOI 10.1152/jn.00582.2009; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Duncan J., 1996, ATTENTION PERFORM, P549; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Gentile F, 2010, BRAIN RES, V1351, P172, DOI 10.1016/j.brainres.2010.06.050; Goris RLT, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.003.2009; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grill-Spector K., 2009, OBJECT CATEGORIZATIO, P102; Hemond CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000574; Jacques C, 2006, J VISION, V6, P154, DOI 10.1167/6.2.6; Jacques C, 2004, NEUROREPORT, V15, P2417, DOI 10.1097/00001756-200410250-00023; Jacques C, 2007, CEREB CORTEX, V17, P1055, DOI 10.1093/cercor/bhl015; Jemel B, 2003, NEUROREPORT, V14, P2035, DOI 10.1097/00001756-200311140-00006; Jenkins R, 2003, PERCEPT PSYCHOPHYS, V65, P298, DOI 10.3758/BF03194801; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kovacs G, 2006, CEREB CORTEX, V16, P742, DOI 10.1093/cercor/bhj020; Kovacs G, 2008, NEUROIMAGE, V43, P156, DOI 10.1016/j.neuroimage.2008.06.042; Kravitz DJ, 2010, CEREB CORTEX, V20, P2916, DOI 10.1093/cercor/bhq042; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; MacEvoy SP, 2007, J NEUROPHYSIOL, V98, P2089, DOI 10.1152/jn.00438.2007; MacEvoy SP, 2009, CURR BIOL, V19, P943, DOI 10.1016/j.cub.2009.04.020; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; McKyton A, 2007, CEREB CORTEX, V17, P1164, DOI 10.1093/cercor/bhl027; McMains S, 2011, J NEUROSCI, V31, P587, DOI 10.1523/JNEUROSCI.3766-10.2011; McMains SA, 2010, J COGNITIVE NEUROSCI, V22, P2417, DOI 10.1162/jocn.2009.21391; MILLER EK, 1993, BRAIN RES, V616, P25, DOI 10.1016/0006-8993(93)90187-R; Missal M, 1997, CEREB CORTEX, V7, P758, DOI 10.1093/cercor/7.8.758; Nasanen R, 1999, VISION RES, V39, P3824, DOI 10.1016/S0042-6989(99)00096-6; Neumann MF, 2007, NEUROREPORT, V18, P1305, DOI 10.1097/WNR.0b013e328273bc80; Neumann MF, 2011, NEUROIMAGE, V54, P3021, DOI 10.1016/j.neuroimage.2010.10.075; Neumann MF, 2009, BRAIN RES, V1270, P64, DOI 10.1016/j.brainres.2009.03.018; Ollinger JM, 2001, NEUROIMAGE, V13, P210, DOI 10.1006/nimg.2000.0710; Palermo R, 2002, COGNITION, V82, P225, DOI 10.1016/S0010-0277(01)00160-3; Pitcher D, 2007, CURR BIOL, V17, P1568, DOI 10.1016/j.cub.2007.07.063; Rainer G, 2002, NEUROIMAGE, V16, P607, DOI 10.1006/nimg.2002.1086; Recanzone GH, 1997, J NEUROPHYSIOL, V78, P2904, DOI 10.1152/jn.1997.78.6.2904; Reddy L, 2009, P NATL ACAD SCI USA, V106, P21447, DOI 10.1073/pnas.0907330106; Reddy L, 2007, CURR BIOL, V17, P2067, DOI 10.1016/j.cub.2007.10.043; Reynolds JH, 1999, NEURON, V24, P19, DOI 10.1016/S0896-6273(00)80819-3; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B, 2003, BRAIN, V126, P2381, DOI 10.1093/brain/awg241; Rossion B, 2008, NEUROIMAGE, V40, P423, DOI 10.1016/j.neuroimage.2007.10.047; Sadeh B, 2010, NEUROIMAGE, V53, P782, DOI 10.1016/j.neuroimage.2010.06.029; Sawamura H, 2005, J NEUROSCI, V25, P4294, DOI 10.1523/JNEUROSCI.0377-05.2005; Sayres R, 2008, J NEUROPHYSIOL, V100, P249, DOI 10.1152/jn.01383.2007; Schiltz C, 2006, NEUROIMAGE, V32, P1385, DOI 10.1016/j.neuroimage.2006.05.037; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; Schwarzlose RF, 2008, P NATL ACAD SCI USA, V105, P4447, DOI 10.1073/pnas.0800431105; Schweinberger SR, 2003, NEUROPSYCHOLOGIA, V41, P407, DOI 10.1016/S0028-3932(02)00173-2; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; Sorger B, 2007, NEUROIMAGE, V35, P836, DOI 10.1016/j.neuroimage.2006.09.051; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5	72	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24450	10.1371/journal.pone.0024450	http://dx.doi.org/10.1371/journal.pone.0024450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912694	Green Published, gold, Green Submitted			2022-12-25	WOS:000294686100041
J	Philips, GM; Chan, IS; Swiderska, M; Schroder, VT; Guy, C; Karaca, GF; Moylan, C; Venkatraman, T; Feuerlein, S; Syn, WK; Jung, YM; Witek, RP; Choi, S; Michelotti, GA; Rangwala, F; Merkle, E; Lascola, C; Diehl, AM				Philips, George M.; Chan, Isaac S.; Swiderska, Marzena; Schroder, Vanessa T.; Guy, Cynthia; Karaca, Gamze F.; Moylan, Cynthia; Venkatraman, Talaignair; Feuerlein, Sebastian; Syn, Wing-Kin; Jung, Youngmi; Witek, Rafal P.; Choi, Steve; Michelotti, Gregory A.; Rangwala, Fatima; Merkle, Elmar; Lascola, Christopher; Diehl, Anna Mae			Hedgehog Signaling Antagonist Promotes Regression of Both Liver Fibrosis and Hepatocellular Carcinoma in a Murine Model of Primary Liver Cancer	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; P-GLYCOPROTEIN GENE; NONALCOHOLIC STEATOHEPATITIS; PATHWAY ACTIVATION; SONIC-HEDGEHOG; KNOCKOUT MICE; HOMOZYGOUS DISRUPTION; MDR2-KNOCKOUT MICE; BILIARY FIBROSIS; ANIMAL-MODEL	Objective: Chronic fibrosing liver injury is a major risk factor for hepatocarcinogenesis in humans. Mice with targeted deletion of Mdr2 (the murine ortholog of MDR3) develop chronic fibrosing liver injury. Hepatocellular carcinoma (HCC) emerges spontaneously in such mice by 50-60 weeks of age, providing a model of fibrosis-associated hepatocarcinogenesis. We used Mdr2(-/-) mice to investigate the hypothesis that activation of the hedgehog (Hh) signaling pathway promotes development of both liver fibrosis and HCC. Methods: Hepatic injury and fibrosis, Hh pathway activation, and liver progenitor populations were compared in Mdr2(-/-) mice and age-matched wild type controls. A dose finding experiment with the Hh signaling antagonist GDC-0449 was performed to optimize Hh pathway inhibition. Mice were then treated with GDC-0449 or vehicle for 9 days, and effects on liver fibrosis and tumor burden were assessed by immunohistochemistry, qRT-PCR, Western blot, and magnetic resonance imaging. Results: Unlike controls, Mdr2(-/-) mice consistently expressed Hh ligands and progressively accumulated Hh-responsive liver myofibroblasts and progenitors with age. Treatment of aged Mdr2-deficient mice with GDC-0449 significantly inhibited hepatic Hh activity, decreased liver myofibroblasts and progenitors, reduced liver fibrosis, promoted regression of intrahepatic HCCs, and decreased the number of metastatic HCC without increasing mortality. Conclusions: Hh pathway activation promotes liver fibrosis and hepatocarcinogenesis, and inhibiting Hh signaling safely reverses both processes even when fibrosis and HCC are advanced.	[Philips, George M.; Chan, Isaac S.; Swiderska, Marzena; Karaca, Gamze F.; Moylan, Cynthia; Syn, Wing-Kin; Jung, Youngmi; Witek, Rafal P.; Choi, Steve; Michelotti, Gregory A.; Diehl, Anna Mae] Duke Univ, Med Ctr, Div Gastroenterol, Dept Med, Durham, NC 27710 USA; [Chan, Isaac S.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA; [Schroder, Vanessa T.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Guy, Cynthia] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Venkatraman, Talaignair; Feuerlein, Sebastian; Merkle, Elmar; Lascola, Christopher] Duke Univ, Dept Radiol, Durham, NC 27710 USA; [Jung, Youngmi] Pusan Natl Univ, Dept Biol Sci, Pusan 609735, South Korea; [Rangwala, Fatima] Duke Univ, Med Ctr, Div Cell Therapy, Durham, NC USA; [Rangwala, Fatima] Duke Univ, Med Ctr, Div Hematol, Durham, NC USA; [Rangwala, Fatima] Duke Univ, Med Ctr, Div Med Oncol, Durham, NC USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Duke University; Duke University; Pusan National University; Duke University; Duke University; Duke University	Philips, GM (corresponding author), Duke Univ, Med Ctr, Div Gastroenterol, Dept Med, Durham, NC 27710 USA.	annamae.diehl@duke.edu	Syn, Wing-Kin/AAB-8406-2020; Choi, Steve/GZH-1598-2022; Lascola, Christopher D/B-9126-2017	Lascola, Christopher D/0000-0002-8031-782X; , Gregory/0000-0002-3936-4675; Michelotti, Gregory/0000-0002-7908-1979; Chan, Isaac/0000-0003-2623-3163; Moylan, Cynthia/0000-0001-8454-7086	National Institutes of Health (NIH) [RO1 DK077794, NIH RO1 AA010154, NIH T32 DK007568, NIH T32 CA071341]; National Center for Research Resources National Biomedical Technology Research Center [P41 RR005959]; National Cancer Institute [U24 CA092656]; NATIONAL CANCER INSTITUTE [T32CA071341, U24CA092656] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK080980, T32DK007568, R01DK077794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010154] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources National Biomedical Technology Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in part, by National Institutes of Health (NIH) RO1 DK077794, NIH RO1 AA010154, NIH T32 DK007568, and NIH T32 CA071341. A portion of the imaging was performed at the Duke Center for In Vivo Microscopy, supported, in part, by National Center for Research Resources National Biomedical Technology Research Center (P41 RR005959) and National Cancer Institute Small Animal Imaging Resource Program (U24 CA092656). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankoma-Sey V, 2000, HEPATOLOGY, V31, P141, DOI 10.1002/hep.510310122; Baghdasaryan A, 2008, LIVER INT, V28, P948, DOI 10.1111/j.1478-3231.2008.01758.x; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Chen WW, 2011, P NATL ACAD SCI USA, V108, P9589, DOI 10.1073/pnas.1017945108; Choi SS, 2009, AM J PHYSIOL-GASTR L, V297, pG1093, DOI 10.1152/ajpgi.00292.2009; Das S, 2009, J BIOL CHEM, V284, P22888, DOI 10.1074/jbc.M109.021949; De Vree JML, 2000, GASTROENTEROLOGY, V119, P1720, DOI 10.1053/gast.2000.20222; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dennler S, 2009, J BIOL CHEM, V284, P31523, DOI 10.1074/jbc.M109.059964; Fickert P, 2002, GASTROENTEROLOGY, V123, P1238, DOI 10.1053/gast.2002.35948; Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009; Fleig SV, 2007, LAB INVEST, V87, P1227, DOI 10.1038/labinvest.3700689; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Frijters CMG, 1996, ADV ENZYME REGUL, V36, P351, DOI 10.1016/0065-2571(95)00019-4; Gonzales E, 2009, FRONT BIOSCI-LANDMRK, V14, P4242, DOI 10.2741/3526; HARAMAKI M, 1995, HEPATOLOGY, V21, P1276, DOI 10.1016/0270-9139(95)90048-9; Huang SH, 2006, CARCINOGENESIS, V27, P1334, DOI 10.1093/carcin/bgi378; Jacquemin E, 2001, SEMIN LIVER DIS, V21, P551, DOI 10.1055/s-2001-19033; Jung Y, 2008, GASTROENTEROLOGY, V134, P1532, DOI 10.1053/j.gastro.2008.02.022; Jung YM, 2007, HEPATOLOGY, V45, P1091, DOI 10.1002/hep.21660; Jung YM, 2010, GUT, V59, P655, DOI 10.1136/gut.2009.204354; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Katzenellenbogen M, 2006, CANCER RES, V66, P4001, DOI 10.1158/0008-5472.CAN-05-2937; Katzenellenbogen M, 2007, MOL CANCER RES, V5, P1159, DOI 10.1158/1541-7786.MCR-07-0172; Lee JS, 2007, HEPATOLOGY, V45, P817, DOI 10.1002/hep.21564; LoRusso PM, 2011, CLIN CANCER RES, V17, P2502, DOI 10.1158/1078-0432.CCR-10-2745; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Machado MV, 2011, HEPATOLOGY, V53, P382, DOI 10.1002/hep.24118; MAUAD TH, 1994, AM J PATHOL, V145, P1237; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Omenetti A, 2008, GUT, V57, P1275, DOI 10.1136/gut.2008.148619; Omenetti A, 2008, J CLIN INVEST, V118, P3331, DOI 10.1172/JCI35875; Omenetti A, 2008, AM J PHYSIOL-GASTR L, V294, pG595, DOI 10.1152/ajpgi.00543.2007; Omenetti A, 2007, LAB INVEST, V87, P499, DOI 10.1038/labinvest.3700537; Omenetti A, 2011, J HEPATOL, V54, P366, DOI 10.1016/j.jhep.2010.10.003; Omenetti A, 2009, HEPATOLOGY, V50, P518, DOI 10.1002/hep.23019; Orian-Rousseau V, 2010, EUR J CANCER, V46, P1271, DOI 10.1016/j.ejca.2010.02.024; Patil MA, 2006, CANCER BIOL THER, V5, P111, DOI 10.4161/cbt.5.1.2379; Pereira TD, 2010, LAB INVEST, V90, P1690, DOI 10.1038/labinvest.2010.147; Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025; Rahbari NN, 2011, ANN SURG, V253, P453, DOI 10.1097/SLA.0b013e31820d944f; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Rangwala F, 2011, J ONCOL, V2011, DOI 10.1155/2011/465343; Rangwala F, 2011, J PATHOL, V224, P401, DOI 10.1002/path.2888; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Sicklick JK, 2006, AM J PHYSIOL-GASTR L, V290, pG859, DOI 10.1152/ajpgi.00456.2005; Sicklick JK, 2006, CARCINOGENESIS, V27, P748, DOI 10.1093/carcin/bgi292; Sicklick JK, 2005, LAB INVEST, V85, P1368, DOI 10.1038/labinvest.3700349; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; Song Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017687; Syn WK, 2011, HEPATOLOGY, V53, P106, DOI 10.1002/hep.23998; Syn WK, 2009, GASTROENTEROLOGY, V137, P1478, DOI 10.1053/j.gastro.2009.06.051; Tanaka H, 2009, ANTICANCER RES, V29, P2147; Trauner M, 2007, SEMIN LIVER DIS, V27, P77, DOI 10.1055/s-2006-960172; Trauner M, 2008, WIEN MED WOCHENSCHR, V158, P542, DOI 10.1007/s10354-008-0592-1; vanNieuwkerk CMJ, 1996, GASTROENTEROLOGY, V111, P165, DOI 10.1053/gast.1996.v111.pm8698195; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Witek RP, 2009, HEPATOLOGY, V50, P1421, DOI 10.1002/hep.23167; Witek RP, 2009, GASTROENTEROLOGY, V136, P320, DOI 10.1053/j.gastro.2008.09.066; Yang GH, 2008, ONCOLOGIST, V13, P1155, DOI 10.1634/theoncologist.2008-0081; Yang L, 2008, J HEPATOL, V48, P98, DOI 10.1016/j.jhep.2007.07.032	62	125	141	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e23943	10.1371/journal.pone.0023943	http://dx.doi.org/10.1371/journal.pone.0023943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912653	Green Published, gold, Green Submitted			2022-12-25	WOS:000294686100008
J	Castagne, R; Rotival, M; Zeller, T; Wild, PS; Truong, V; Tregouet, DA; Munzel, T; Ziegler, A; Cambien, F; Blankenberg, S; Tiret, L				Castagne, Raphaele; Rotival, Maxime; Zeller, Tanja; Wild, Philipp S.; Truong, Vinh; Tregouet, David-Alexandre; Munzel, Thomas; Ziegler, Andreas; Cambien, Francois; Blankenberg, Stefan; Tiret, Laurence			The Choice of the Filtering Method in Microarrays Affects the Inference Regarding Dosage Compensation of the Active X-Chromosome	PLOS ONE			English	Article								Background: The hypothesis of dosage compensation of genes of the X chromosome, supported by previous microarray studies, was recently challenged by RNA-sequencing data. It was suggested that microarray studies were biased toward an over-estimation of X-linked expression levels as a consequence of the filtering of genes below the detection threshold of microarrays. Methodology/Principal Findings: To investigate this hypothesis, we used microarray expression data from circulating monocytes in 1,467 individuals. In total, 25,349 and 1,156 probes were unambiguously assigned to autosomes and the X chromosome, respectively. Globally, there was a clear shift of X-linked expressions toward lower levels than autosomes. We compared the ratio of expression levels of X-linked to autosomal transcripts (X: AA) using two different filtering methods: 1. gene expressions were filtered out using a detection threshold irrespective of gene chromosomal location (the standard method in microarrays); 2. equal proportions of genes were filtered out separately on the X and on autosomes. For a wide range of filtering proportions, the X: AA ratio estimated with the first method was not significantly different from 1, the value expected if dosage compensation was achieved, whereas it was significantly lower than 1 with the second method, leading to the rejection of the hypothesis of dosage compensation. We further showed in simulated data that the choice of the most appropriate method was dependent on biological assumptions regarding the proportion of actively expressed genes on the X chromosome comparative to the autosomes and the extent of dosage compensation. Conclusion/Significance: This study shows that the method used for filtering out lowly expressed genes in microarrays may have a major impact according to the hypothesis investigated. The hypothesis of dosage compensation of X-linked genes cannot be firmly accepted or rejected using microarray-based data.	[Castagne, Raphaele; Rotival, Maxime; Truong, Vinh; Tregouet, David-Alexandre; Cambien, Francois; Tiret, Laurence] Univ Paris 06, INSERM, UMRS 937, UPMC, Paris, France; [Castagne, Raphaele; Rotival, Maxime; Truong, Vinh; Tregouet, David-Alexandre; Cambien, Francois; Tiret, Laurence] Sch Med, Paris, France; [Zeller, Tanja; Wild, Philipp S.; Munzel, Thomas; Blankenberg, Stefan] Johannes Gutenberg Univ Mainz, Med Klin & Poliklin 2, Univ Med Mainz, D-6500 Mainz, Germany; [Ziegler, Andreas] Med Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Med Biometrie & Stat, D-23538 Lubeck, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Franche-Comte; Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck	Castagne, R (corresponding author), Univ Paris 06, INSERM, UMRS 937, UPMC, Paris, France.	laurence.tiret@upmc.fr	Tregouet, David-Alexandre/E-3961-2016; Munzel, Thomas/A-2912-2014; Trégouët, David-Alexandre/P-9210-2019; Cambien, Francois/AAP-9751-2020; Wild, Philipp S./M-2106-2019; Ziegler, Andreas/G-4246-2012	Munzel, Thomas/0000-0001-5503-4150; Trégouët, David-Alexandre/0000-0001-9084-7800; Zeller, Tanja/0000-0003-3379-2641; Rotival, Maxime/0000-0003-2519-8044; Ziegler, Andreas/0000-0002-8386-5397; Wild, Philipp/0000-0003-4413-9752; Castagne, Raphaele/0000-0003-0067-6775	government of Rheinland-Pfalz [AZ 961-386261/733]; Johannes Gutenberg-University of Mainz; Boehringer Ingelheim; PHILIPS Medical Systems; National Genome Network "NGFNplus'' [A3 01GS0833, 01GS0831]; Federal Ministry of Education and Research, Germany [BMBF 01KU0908A]; Agence Nationale de la Recherche, France [ANR 09 GENO 106 01]; Fondation pour la Recherche Medicale [FDT20101220928]	government of Rheinland-Pfalz; Johannes Gutenberg-University of Mainz; Boehringer Ingelheim(Boehringer Ingelheim); PHILIPS Medical Systems; National Genome Network "NGFNplus''; Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Agence Nationale de la Recherche, France(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	The Gutenberg Heart Study is funded through the government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation'', contract AZ 961-386261/733), the research programs "Wissen schafft Zukunft'' and "Schwerpunkt Vaskulare Pravention" of the Johannes Gutenberg-University of Mainz and its contract with Boehringer Ingelheim and PHILIPS Medical Systems including an unrestricted grant for the Gutenberg Heart Study. The present study was supported by the National Genome Network "NGFNplus'' (contract A3 01GS0833 and 01GS0831) and by a joint funding from the Federal Ministry of Education and Research, Germany (contract BMBF 01KU0908A) and from the Agence Nationale de la Recherche, France (contract ANR 09 GENO 106 01) for the project CARDomics. MR is supported by a grant from the Fondation pour la Recherche Medicale (FDT20101220928). For this particular research paper, Boehringer Ingelheim provided payment of two employees for expression microarray analyses and array purchase. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; GUPTA V, 2006, J BIOL, V5, P1, DOI DOI 10.1186/JBIOL30; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Ideker T, 2011, CELL, V144, P860, DOI 10.1016/j.cell.2011.03.007; Johnston CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040009; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Ohno S., 1967, SEX CHROMOSOMES SEX; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Vicoso B, 2011, GENOME BIOL EVOL, V3, P230, DOI 10.1093/gbe/evr010; Vicoso B, 2009, CHROMOSOME RES, V17, P585, DOI 10.1007/s10577-009-9053-y; Walters JR, 2011, GENOME BIOL EVOL, V3, P491, DOI 10.1093/gbe/evr036; Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	17	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e23956	10.1371/journal.pone.0023956	http://dx.doi.org/10.1371/journal.pone.0023956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21912656	Green Published, gold, Green Submitted			2022-12-25	WOS:000294683900016
J	Rayen, I; van den Hove, DL; Prickaerts, J; Steinbusch, HW; Pawluski, JL				Rayen, Ine; van den Hove, Daniel L.; Prickaerts, Jos; Steinbusch, Harry W.; Pawluski, Jodi L.			Fluoxetine during Development Reverses the Effects of Prenatal Stress on Depressive-Like Behavior and Hippocampal Neurogenesis in Adolescence	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; RESTRAINT STRESS; FEMALE RATS; MATERNAL STRESS; ANTIDEPRESSANT TREATMENT; POSTNATAL DEPRESSION; FETAL-DEVELOPMENT; DENTATE GYRUS; ADULT MICE; OPEN-FIELD	Depression during pregnancy and the postpartum period is a growing health problem, which affects up to 20% of women. Currently, selective serotonin reuptake inhibitor (SSRIs) medications are commonly used for treatment of maternal depression. Unfortunately, there is very little research on the long-term effect of maternal depression and perinatal SSRI exposure on offspring development. Therefore, the aim of this study was to determine the role of exposure to fluoxetine during development on affective-like behaviors and hippocampal neurogenesis in adolescent offspring in a rodent model of maternal depression. To do this, gestationally stressed and non-stressed Sprague-Dawley rat dams were treated with either fluoxetine (5 mg/kg/day) or vehicle beginning on postnatal day 1 (P1). Adolescent male and female offspring were divided into 4 groups: 1) prenatal stress+fluoxetine exposure, 2) prenatal stress+vehicle, 3) fluoxetine exposure alone, and 4) vehicle alone. Adolescent offspring were assessed for anxiety-like behavior using the Open Field Test and depressive-like behavior using the Forced Swim Test. Brains were analyzed for endogenous markers of hippocampal neurogenesis via immunohistochemistry. Results demonstrate that maternal fluoxetine exposure reverses the reduction in immobility evident in prenatally stressed adolescent offspring. In addition, maternal fluoxetine exposure reverses the decrease in hippocampal cell proliferation and neurogenesis in maternally stressed adolescent offspring. This research provides important evidence on the long-term effect of fluoxetine exposure during development in a model of maternal adversity.	[Rayen, Ine; van den Hove, Daniel L.; Prickaerts, Jos; Steinbusch, Harry W.; Pawluski, Jodi L.] Maastricht Univ, Dept Neurosci, Sch Mental Hlth & Neurosci, Maastricht, Netherlands	Maastricht University	Rayen, I (corresponding author), Maastricht Univ, Dept Neurosci, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.	j.pawluski@maastrichtuniversity.nl	Pawluski, Jodi L/K-5801-2015; Håkansson, Gustaf/F-5409-2011; Steinbusch, Heinrich/L-6950-2017	Pawluski, Jodi L/0000-0002-8240-8178; van den Hove, Daniel/0000-0003-4047-3198	Natural Sciences and Engineering Research Council of Canada; Fonds de la Recherche Scientifique in Belgium	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de la Recherche Scientifique in Belgium	JLP was funded by a postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada and is now funded by Fonds de la Recherche Scientifique in Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahmed S, 2008, NEUROSCIENCE, V157, P677, DOI 10.1016/j.neuroscience.2008.08.072; Almond P, 2009, PERSPECT PUBLIC HEAL, V129, P221, DOI 10.1177/1757913909343882; Ansorge MS, 2008, J NEUROSCI, V28, P199, DOI 10.1523/JNEUROSCI.3973-07.2008; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Bairy KL, 2007, PHARMACOLOGY, V79, P1, DOI 10.1159/000096645; Balthazart J, 2008, EUR J NEUROSCI, V27, P801, DOI 10.1111/j.1460-9568.2008.06059.x; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; Coe CL, 2003, BIOL PSYCHIAT, V54, P1025, DOI 10.1016/S0006-3223(03)00698-X; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; Darnaudery M, 2008, BRAIN RES REV, V57, P571, DOI 10.1016/j.brainresrev.2007.11.004; Epp JR, 2009, HIPPOCAMPUS, V19, P1040, DOI 10.1002/hipo.20546; Fleschler R, 2008, MCN-AM J MATERN-CHIL, V33, P355, DOI 10.1097/01.NMC.0000341255.80426.7b; Galea LAM, 2006, HIPPOCAMPUS, V16, P225, DOI 10.1002/hipo.20154; Gentile S, 2007, ARCH WOMEN MENT HLTH, V10, P39, DOI 10.1007/s00737-007-0173-0; Glover V, 2010, NEUROSCI BIOBEHAV R, V35, P17, DOI 10.1016/j.neubiorev.2009.11.008; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hansen HH, 1997, J PHARMACOL EXP THER, V283, P1333; Homberg JR, 2010, TRENDS PHARMACOL SCI, V31, P60, DOI 10.1016/j.tips.2009.11.003; Huizink AC, 2003, J CHILD PSYCHOL PSYC, V44, P810, DOI 10.1111/1469-7610.00166; Ishiwata H, 2005, NEUROSCIENCE, V133, P893, DOI 10.1016/j.neuroscience.2005.03.048; Karpova NN, 2009, EUR NEUROPSYCHOPHARM, V19, P97, DOI 10.1016/j.euroneuro.2008.09.002; Kawamura T, 2006, NEUROREPORT, V17, P1515, DOI 10.1097/01.wnr.0000236849.53682.6d; Laine K, 2003, ARCH GEN PSYCHIAT, V60, P720, DOI 10.1001/archpsyc.60.7.720; Laplante DP, 2004, PEDIATR RES, V56, P400, DOI 10.1203/01.PDR.0000136281.34035.44; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; Leung BMY, 2009, J AM DIET ASSOC, V109, P1566, DOI 10.1016/j.jada.2009.06.368; Limlomwongse N, 2006, ARCH WOMEN MENT HLTH, V9, P131, DOI 10.1007/s00737-005-0115-7; Lisboa SFS, 2007, PHARMACOLOGY, V80, P49, DOI 10.1159/000103097; Lopez-Duran NL, 2009, PSYCHONEUROENDOCRINO, V34, P1272, DOI 10.1016/j.psyneuen.2009.03.016; Lucassen PJ, 2009, EUR J NEUROSCI, V29, P97, DOI 10.1111/j.1460-9568.2008.06543.x; Maccari S, 2003, NEUROSCI BIOBEHAV R, V27, P119, DOI 10.1016/S0149-7634(03)00014-9; Maccari S, 2007, PSYCHONEUROENDOCRINO, V32, pS10, DOI 10.1016/j.psyneuen.2007.06.005; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Marcus Sheila M, 2009, Can J Clin Pharmacol, V16, pe15; McAdam TD, 2008, BEHAV BRAIN RES, V191, P202, DOI 10.1016/j.bbr.2008.03.029; McCormick CM, 2007, PHARMACOL BIOCHEM BE, V86, P220, DOI 10.1016/j.pbb.2006.07.012; Morrison JL, 2005, REPROD FERT DEVELOP, V17, P641, DOI 10.1071/RD05030; Moses-Kolko EL, 2005, JAMA-J AM MED ASSOC, V293, P2372, DOI 10.1001/jama.293.19.2372; Niederhofer H, 2004, FETAL DIAGN THER, V19, P160, DOI 10.1159/000075142; Noorlander CW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002782; Nulman I, 2002, AM J PSYCHIAT, V159, P1889, DOI 10.1176/appi.ajp.159.11.1889; O'Mahony SM, 2006, NEUROIMMUNOMODULAT, V13, P82, DOI 10.1159/000096090; Oberlander TF, 2009, CLIN PHARMACOL THER, V86, P672, DOI 10.1038/clpt.2009.201; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Oberlander TF, 2006, ARCH GEN PSYCHIAT, V63, P898, DOI 10.1001/archpsyc.63.8.898; Oberlander TF, 2010, ARCH PEDIAT ADOL MED, V164, P444, DOI 10.1001/archpediatrics.2010.51; Odagiri K, 2008, NEUROSCI LETT, V446, P25, DOI 10.1016/j.neulet.2008.09.028; Pawluski J. L., 2011, HORM BEHAV; Pawluski JL, 2009, PEDIATRICS, V124, pE662, DOI 10.1542/peds.2009-0442; Pawluski JL, 2009, PHYSIOL BEHAV, V96, P108, DOI 10.1016/j.physbeh.2008.09.004; Pawuski JL, 2009, BEHAV BRAIN RES, V197, P55, DOI 10.1016/j.bbr.2008.08.001; Perera TD, 2007, J NEUROSCI, V27, P4894, DOI 10.1523/JNEUROSCI.0237-07.2007; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Reed AL, 2008, PSYCHOPHARMACOLOGY, V197, P433, DOI 10.1007/s00213-007-1052-0; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Romeo RD, 2006, ANN NY ACAD SCI, V1094, P202, DOI 10.1196/annals.1376.022; Romeo RD, 2007, STRESS, V10, P101, DOI 10.1080/10253890701204270; Romeo RD, 2010, DEV PSYCHOBIOL, V52, P244, DOI 10.1002/dev.20437; ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4; Smith JW, 2004, PSYCHONEUROENDOCRINO, V29, P227, DOI 10.1016/S0306-4530(03)00025-8; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; TUOMISTO J, 1985, PHARMACOL REV, V37, P249; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P259, DOI 10.1016/j.neubiorev.2004.10.010; Van den Hove DVA, 2008, NEONATOLOGY, V93, P52, DOI 10.1159/000106433; Van den Hove DLA, 2005, DEV NEUROSCI-BASEL, V27, P313, DOI 10.1159/000086711; Ververs T, 2006, EUR J CLIN PHARMACOL, V62, P863, DOI 10.1007/s00228-006-0177-0; WARD IL, 1984, ENDOCRINOLOGY, V114, P1635, DOI 10.1210/endo-114-5-1635; Weaver KJ, 2010, ANAT REC, V293, P1920, DOI 10.1002/ar.21245; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Zagron G, 2006, BEHAV BRAIN RES, V175, P323, DOI 10.1016/j.bbr.2006.09.003; Zuena AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002170; [No title captured]; [No title captured]; [No title captured]	74	133	137	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24003	10.1371/journal.pone.0024003	http://dx.doi.org/10.1371/journal.pone.0024003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21912658	gold, Green Submitted, Green Published			2022-12-25	WOS:000294683900019
J	Bogdanovica, I; McNeill, A; Murray, R; Britton, J				Bogdanovica, Ilze; McNeill, Ann; Murray, Rachael; Britton, John			What Factors Influence Smoking Prevalence and Smoke Free Policy Enactment across the European Union Member States	PLOS ONE			English	Article							TOBACCO INDUSTRY	Background: Smoking prevention should be a primary public health priority for all governments, and effective preventive policies have been identified for decades. The heterogeneity of smoking prevalence between European Union (EU) Member States therefore reflects, at least in part, a failure by governments to prioritise public health over tobacco industry or possibly other financial interests, and hence potentially government corruption. The aims of this study were to test the hypothesis that smoking prevalence is higher in countries with high levels of public sector corruption, and explore the ecological association between smoking prevalence and a range of other national characteristics in current EU Member States. Methods: Ecological data from 27 EU Member States were used to estimate univariate and multivariate correlations between smoking prevalence and the Transparency International Corruption Perceptions Index, and a range of other national characteristics including economic development, social inclusion, quality of life and importance of religion. We also explored the association between the Corruption Perceptions Index and measures of the extent to which smoke-free policies have been enacted and are enforced. Results: In univariate analysis, smoking prevalence was significantly higher in countries with higher scores for corruption, material deprivation, and gender inequality; and lower in countries with higher per capita Gross Domestic Product, social spending, life satisfaction and human development scores. In multivariate analysis, only the corruption perception index was independently related to smoking prevalence. Exposure to tobacco smoke in the workplace was also correlated with corruption, independently from smoking prevalence, but not with the measures of national smoke-free policy implementation. Conclusions: Corruption appears to be an important risk factor for failure of national tobacco control activity in EU countries, and the extent to which key tobacco control policies have been implemented. Further research is needed to assess the causal relationships involved.	[Bogdanovica, Ilze; McNeill, Ann; Murray, Rachael; Britton, John] Univ Nottingham, UK Ctr Tobacco Control Studies, Nottingham NG7 2RD, England; [Bogdanovica, Ilze; McNeill, Ann; Murray, Rachael; Britton, John] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Bogdanovica, I (corresponding author), Univ Nottingham, UK Ctr Tobacco Control Studies, Nottingham NG7 2RD, England.	mcxib3@nottingham.ac.uk	Murray, Rachael/L-4922-2019; Britton, John R/G-9705-2011	Murray, Rachael/0000-0001-5477-2557; McNeill, Ann/0000-0002-6223-4000; BOGDANOVICA, ILZE/0000-0002-2662-6293	Medical Research Council; University of Nottingham; UK Centre for Tobacco Control Studies; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Department of Health under the UK Clinical Research Collaboration	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Nottingham; UK Centre for Tobacco Control Studies; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health under the UK Clinical Research Collaboration	This study was originally supported by the Medical Research Council, the University of Nottingham, and the UK Centre for Tobacco Control Studies, with core funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the Department of Health under the auspices of the UK Clinical Research Collaboration. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alechnowicz K, 2004, TOB CONTROL, V13, P71, DOI 10.1136/tc.2004.009324; Anderson R., 2009, 2 EUROPEAN QUALITY L; *ASPECT CONS EUR C, 2004, TOB HLTH EUR UN PAST; Bogdanovica I, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.036103; *CORP ACC INT, 2005, BIG TOB ATT DER GLOB; de Beyer J, 2001, TOB CONTROL, V10, P210, DOI 10.1136/tc.10.3.210; *EUR, EUR DAT GDP MAIN COM; *EUR COMM, EUR DAT MAT DEPR; *EUR COMM, EUR DAT EARL SCHOOL; *EUR COMM, EUR DAT UN RAT; *EUR COMM, 2008, 691 EUR COMM; *EUR COMM, EUR DAT IN INC DISTR; *EUR COMM, EUR DAT EXP SOC PROT; *EUR COMM, 2008, RAW TOB 2008 HARV; Grant N, 2009, INT J BEHAV MED, V16, P259, DOI 10.1007/s12529-009-9032-x; Gruer L, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b480; Joossens L, 2006, TOB CONTROL, V15, P247, DOI 10.1136/tc.2005.015347; Joossens L, 2007, PROGR TOBACCO CONTRO; Laaksonen M, 2005, EUR J PUBLIC HEALTH, V15, P262, DOI 10.1093/eurpub/cki115; Lambsdorff J. G., 2008, METHODOLOGY CORRUPTI; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Martinez-Sanchez JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013881; MELLOR JM, 2010, HLTH EC; Neuman M, 2002, LANCET, V359, P1323, DOI 10.1016/S0140-6736(02)08275-2; Polish. World Health Organization, 2004, BUILD BLOCKS TOB CON; Reijneveld SA, 1998, INT J EPIDEMIOL, V27, P33, DOI 10.1093/ije/27.1.33; Royal College of Physicians, 1962, SMOK HLTH; Siahpush M, 2006, SOC SCI MED, V63, P2801, DOI 10.1016/j.socscimed.2006.07.015; *SURG GEN ADV COMM, 1964, PUBL HLTH SERV PUBL, V1103; The Gallup Organisation Hungary, 2009, FLASH EUR 253 SURV T; *TNS OP SOC, 2010, SPEC EUR, V332; United Nations Development Programme, 2009, HUM DEV REP OV BARR; *WHO, WHO WHY TOB IS PUBL; Wilhelm PG, 2002, J BUS ETHICS, V35, P177, DOI 10.1023/A:1013882225402; *WORLD BANK, 1999, CURB TOB EP GOV EC T; World Health Organization, WHO FRAM CONV TOB CO; 2008, INDEPENDENT     1012; 1997, BRIT BROAD CORP 1117; INT CORR; TRANSPARENCY INT GLO	40	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23889	10.1371/journal.pone.0023889	http://dx.doi.org/10.1371/journal.pone.0023889			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	817NM	21909375	Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800037
J	Montgomery, MK; Hulbert, AJ; Buttemer, WA				Montgomery, Magdalene K.; Hulbert, A. J.; Buttemer, William A.			The Long Life of Birds: The Rat-Pigeon Comparison Revisited	PLOS ONE			English	Article							HYDROGEN-PEROXIDE PRODUCTION; FREE-RADICAL PRODUCTION; FATTY-ACID-COMPOSITION; SHORT-LIVED RAT; NAKED MOLE-RAT; OXIDATIVE STRESS; LIPID-PEROXIDATION; SKELETAL-MUSCLE; METABOLIC-RATE; SUPEROXIDE-PRODUCTION	The most studied comparison of aging and maximum lifespan potential (MLSP) among endotherms involves the 7-fold longevity difference between rats (MLSP 5y) and pigeons (MLSP 35y). A widely accepted theory explaining MLSP differences between species is the oxidative stress theory, which purports that reactive oxygen species (ROS) produced during mitochondrial respiration damage bio-molecules and eventually lead to the breakdown of regulatory systems and consequent death. Previous rat-pigeon studies compared only aspects of the oxidative stress theory and most concluded that the lower mitochondrial superoxide production of pigeons compared to rats was responsible for their much greater longevity. This conclusion is based mainly on data from one tissue (the heart) using one mitochondrial substrate (succinate). Studies on heart mitochondria using pyruvate as a mitochondrial substrate gave contradictory results. We believe the conclusion that birds produce less mitochondrial superoxide than mammals is unwarranted. We have revisited the rat-pigeon comparison in the most comprehensive manner to date. We have measured superoxide production (by heart, skeletal muscle and liver mitochondria), five different antioxidants in plasma, three tissues and mitochondria, membrane fatty acid composition (in seven tissues and three mitochondria), and biomarkers of oxidative damage. The only substantial and consistent difference that we have observed between rats and pigeons is their membrane fatty acid composition, with rats having membranes that are more susceptible to damage. This suggests that, although there was no difference in superoxide production, there is likely a much greater production of lipid-based ROS in the rat. We conclude that the differences in superoxide production reported previously were due to the arbitrary selection of heart muscle to source mitochondria and the provision of succinate. Had mitochondria been harvested from other tissues or other relevant mitochondrial metabolic substrates been used, then very different conclusions regarding differences in oxidative stress would have been reached.	[Montgomery, Magdalene K.] St Vincents Hosp, Garvan Inst Med Res, Diabet & Obes Program, Darlinghurst, NSW 2010, Australia; [Hulbert, A. J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Buttemer, William A.] Deakin Univ, Ctr Integrat Ecol, Waurn Ponds, Vic, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Wollongong; Deakin University	Montgomery, MK (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Diabet & Obes Program, Darlinghurst, NSW 2010, Australia.	mtt985@uowmail.edu.au	Buttemer, William A/F-9573-2019	Buttemer, William A/0000-0003-3176-4452; Montgomery, Magdalene/0000-0003-2551-4174	Australian Research Council [DP8079261]	Australian Research Council(Australian Research Council)	This research was supported by funding from the Australian Research Council (DP8079261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SK, 2010, BRIT J NUTR, V103, P522, DOI 10.1017/S0007114509992133; Agarwal S, 1996, EXP GERONTOL, V31, P365, DOI 10.1016/0531-5565(95)02039-X; Andziak B, 2006, AGING CELL, V5, P525, DOI 10.1111/j.1474-9726.2006.00246.x; Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; Baeza E, 2010, BRIT POULTRY SCI, V51, P344, DOI 10.1080/00071668.2010.503472; BARJA G, 1994, COMP BIOCHEM PHYS B, V108, P501, DOI 10.1016/0305-0491(94)90103-1; BARJA G, 1994, FREE RADICAL RES, V21, P317, DOI 10.3109/10715769409056584; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Bize P, 2008, ECOLOGY, V89, P2584, DOI 10.1890/07-1135.1; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; BRAND MD, 1991, BIOCHEM J, V275, P81, DOI 10.1042/bj2750081; Brown JCL, 2009, MECH AGEING DEV, V130, P467, DOI 10.1016/j.mad.2009.05.002; Buffenstein R, 2008, AGE, V30, P99, DOI 10.1007/s11357-008-9058-z; CAO GH, 1995, ARCH BIOCHEM BIOPHYS, V320, P106, DOI 10.1006/abbi.1995.1347; Chang CK, 2007, J NUTR BIOCHEM, V18, P39, DOI 10.1016/j.jnutbio.2006.02.007; Cordis GA, 1998, J MOL CELL CARDIOL, V30, P1939, DOI 10.1006/jmcc.1998.0752; CUTLER RG, 1985, P NATL ACAD SCI USA, V82, P4798, DOI 10.1073/pnas.82.14.4798; DARGEL R, 1974, FEBS LETT, V42, P57, DOI 10.1016/0014-5793(74)80278-4; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; GERSCHMAN R, 1954, SCIENCE, V119, P623, DOI 10.1126/science.119.3097.623; GironCalle J, 1997, LIPIDS, V32, P917, DOI 10.1007/s11745-997-0118-9; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; Gutierrez AM, 2000, INT J BIOCHEM CELL B, V32, P73, DOI 10.1016/S1357-2725(99)00105-3; Halliwell B., 2007, FREE RADICALS BIOL M; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Herrero A, 1997, MECH AGEING DEV, V98, P95, DOI 10.1016/S0047-6374(97)00076-6; HINKLE PC, 1979, J BIOL CHEM, V254, P2450; Hulbert AJ, 2008, EXP GERONTOL, V43, P729, DOI 10.1016/j.exger.2008.05.015; Hulbert AJ, 2008, COMP BIOCHEM PHYS A, V150, P196, DOI 10.1016/j.cbpa.2006.05.014; Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006; Hulbert AJ, 2006, J GERONTOL A-BIOL, V61, P1009, DOI 10.1093/gerona/61.10.1009; Hulbert AJ, 2006, MECH AGEING DEV, V127, P653, DOI 10.1016/j.mad.2006.03.002; Hulbert AJ, 2005, J THEOR BIOL, V234, P277, DOI 10.1016/j.jtbi.2004.11.024; Hulbert AJ, 2006, J COMP PHYSIOL B, V176, P93, DOI 10.1007/s00360-005-0025-z; Hulbert AJ, 2005, BIOL REV, V80, P155, DOI 10.1017/S1464793104006578; Hulbert AJ, 2010, LONGEVITY MITOCHONDR; Hulbert AJ, AGING ALBANY, V3, P81; Jacobson J, 2010, AGING CELL, V9, P466, DOI 10.1111/j.1474-9726.2010.00573.x; JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918; Jobson RW, 2010, MOL BIOL EVOL, V27, P840, DOI 10.1093/molbev/msp293; KOJIMA T, 1990, CHEM PHARM BULL, V38, P3414, DOI 10.1248/cpb.38.3414; KU HH, 1993, MECH AGEING DEV, V72, P67, DOI 10.1016/0047-6374(93)90132-B; KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q; Lambert AJ, 2007, AGING CELL, V6, P607, DOI 10.1111/j.1474-9726.2007.00312.x; Lambert AJ, 2010, AGING CELL, V9, P78, DOI 10.1111/j.1474-9726.2009.00538.x; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lapenna D, 2001, FREE RADICAL BIO MED, V31, P331, DOI 10.1016/S0891-5849(01)00584-6; Larrain RE, 2007, J ANIM SCI, V85, P3276, DOI 10.2527/jas.2006-830; LASIEWSKI RC, 1967, CONDOR, V69, P13, DOI 10.2307/1366368; LINDSTEDT SL, 1976, CONDOR, V78, P91, DOI 10.2307/1366920; LOPEZTORRES M, 1993, COMP BIOCHEM PHYS B, V105, P757, DOI 10.1016/0305-0491(93)90117-N; MARAL J, 1977, BIOCHEM BIOPH RES CO, V77, P1525, DOI 10.1016/S0006-291X(77)80151-4; MATKOVICS B, 1977, COMP BIOCHEM PHYS B, V56, P31, DOI 10.1016/0305-0491(77)90218-8; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Muller FL, 2008, BIOCHEM J, V409, P491, DOI 10.1042/BJ20071162; Onyango AN, 2010, FREE RADICAL BIO MED, V49, P1594, DOI 10.1016/j.freeradbiomed.2010.08.012; Pamplona R, 1996, MECH AGEING DEV, V86, P53, DOI 10.1016/0047-6374(95)01673-2; Pamplona R, 1999, MECH AGEING DEV, V106, P283, DOI 10.1016/S0047-6374(98)00121-3; Pearl R., 1928, RATE LIVING; Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106; PEREZCAMPO R, 1994, J COMP PHYSIOL B, V163, P682, DOI 10.1007/BF00369520; Pinho RA, 2006, CELL BIOL INT, V30, P848, DOI 10.1016/j.cellbi.2006.03.011; Portero-Otin M, 2004, EXP GERONTOL, V39, P1527, DOI 10.1016/j.exger.2004.08.001; Price ER, 2009, AM J PHYSIOL-REG I, V297, pR775, DOI 10.1152/ajpregu.00150.2009; REYNAFARJE B, 1985, ANAL BIOCHEM, V145, P406, DOI 10.1016/0003-2697(85)90381-1; Rubner M, 1908, PROBLEM LEBENSDAUER; Sasaki T, 2008, AGING CELL, V7, P459, DOI 10.1111/j.1474-9726.2008.00394.x; Shmookler Reis RJ, 2010, AGING ALBANY, V3, P125; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Staniek K, 2000, BBA-BIOENERGETICS, V1460, P268, DOI 10.1016/S0005-2728(00)00152-3; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Toppo S, 2009, BBA-GEN SUBJECTS, V1790, P1486, DOI 10.1016/j.bbagen.2009.04.007; Trzcionka M, 2008, J EXP BIOL, V211, P1911, DOI 10.1242/jeb.016519; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Wiersma P, 2004, P ROY SOC B-BIOL SCI, V271, pS360, DOI 10.1098/rsbl.2004.0171; Wilhelm D, 2007, COMP BIOCHEM PHYS C, V146, P214, DOI 10.1016/j.cbpc.2006.11.015	80	52	53	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24138	10.1371/journal.pone.0024138	http://dx.doi.org/10.1371/journal.pone.0024138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904609	Green Submitted, gold, Green Published			2022-12-25	WOS:000294680800058
J	Zampighi, GA; Zampighi, L; Lanzavecchia, S				Zampighi, Guido A.; Zampighi, Lorenzo; Lanzavecchia, Salvatore			The Three-Dimensional Distribution of alpha A-Crystalline in Rat Lenses and Its Possible Relation to Transparency	PLOS ONE			English	Article							EYE LENS; INTERMEDIATE-FILAMENTS; CYTOSKELETAL PROTEINS; ELECTRON-MICROSCOPE; CONICAL TOMOGRAPHY; CELL; ORGANIZATION; MORPHOLOGY; FILENSIN; FOURIER	Lens transparency depends on the accumulation of massive quantities (600-800 mg/ml) of twelve primary crystallines and two truncated crystallines in highly elongated "fiber" cells. Despite numerous studies, major unanswered questions are how this heterogeneous group of proteins becomes organized to bestow the lens with its unique optical properties and how it changes during cataract formation. Using novel methods based on conical tomography and labeling with antibody/gold conjugates, we have profiled the 3D-distribution of the alpha A-crystalline in rat lenses at similar to 2 nm resolutions and three-dimensions. Analysis of tomograms calculated from lenses labeled with anti-alpha A-crystalline and gold particles (similar to 3 nm and similar to 7 nm diameter) revealed geometric patterns shaped as lines, isosceles triangles and polyhedrons. A Gaussian distribution centered at similar to 7.5 nm fitted the distances between the similar to 3 nm diameter gold conjugates. A Gaussian distribution centered at similar to 14 nm fitted the Euclidian distances between the smaller and the larger gold particles and another Gaussian at 21-24 nm the distances between the larger particles. Independent of their diameters, tethers of 14-17 nm in length connected files of gold particles to thin filaments or clusters to similar to 15 nm diameter "beads." We used the information gathered from tomograms of labeled lenses to determine the distribution of the alpha A-crystalline in unlabeled lenses. We found that alpha A-crystalline monomers spaced similar to 7 nm or alpha A-crystalline dimers spaced similar to 15 nm center-to-center apart decorated thin filaments of the lens cytoskeleton. It thus seems likely that lost or gain of long-range order determines the 3D-structure of the fiber cell and possible also cataract formation.	[Zampighi, Guido A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Zampighi, Lorenzo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Zampighi, Guido A.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Res Inst, Los Angeles, CA 90095 USA; [Lanzavecchia, Salvatore] Univ Milan, Dipartimento Chim Strutturale, Milan, Italy	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Milan	Zampighi, GA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	gzampighi@mednet.ucla.edu			National Institutes of Health [EY-04410]; Jules Stein Eye Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jules Stein Eye Institute	This article was supported by National Institutes of Health EY-04410 (GZ) and the Jules Stein Eye Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AlGhoul KJ, 1996, CURR EYE RES, V15, P533, DOI 10.3109/02713689609000764; BASSNETT S, 1992, DEV DYNAM, V194, P85, DOI 10.1002/aja.1001940202; BENEDEK GB, 1971, APPL OPTICS, V10, P459, DOI 10.1364/AO.10.000459; Bettelheim F. A., 1985, OCULAR LENS STRUCTUR, P265; BLOEMENDAL H, 1981, MOL BIOL REP, V7, P167, DOI 10.1007/BF00778749; Cantele F, 2007, J STRUCT BIOL, V158, P59, DOI 10.1016/j.jsb.2006.10.015; Clark JI, 2001, MICRON, V32, P239, DOI 10.1016/S0968-4328(00)00044-5; Clark JI, 2004, EXP EYE RES, V78, P427, DOI 10.1016/j.exer.2003.10.008; Cvekl A, 1996, BIOESSAYS, V18, P621, DOI 10.1002/bies.950180805; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Georgatos SD, 1997, J CELL SCI, V110, P2629; Goulielmos G, 1996, J CELL BIOL, V132, P643, DOI 10.1083/jcb.132.4.643; Graw J, 1997, BIOL CHEM, V378, P1331; Haley DA, 1999, EXP EYE RES, V68, P133, DOI 10.1006/exer.1998.0610; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Kuszak JR, 2004, EXP EYE RES, V78, P673, DOI 10.1016/j.exer.2003.09.016; KUWABARA T, 1975, EXP EYE RES, V20, P427, DOI 10.1016/0014-4835(75)90085-8; KUWABARA T, 1974, INVEST OPHTH VISUAL, V13, P973; Lanzavecchia S, 2005, J STRUCT BIOL, V149, P87, DOI 10.1016/j.jsb.2004.09.004; MAISEL H, 1972, EXP EYE RES, V14, P7, DOI 10.1016/0014-4835(72)90136-4; Mathias RT, 1997, PHYSIOL REV, V77, P21, DOI 10.1152/physrev.1997.77.1.21; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Perng MD, 2005, EXP CELL RES, V305, P1, DOI 10.1016/j.yexcr.2004.11.021; Piatigorsky J, 1998, PROG RETIN EYE RES, V17, P145, DOI 10.1016/S1350-9462(97)00004-9; RAMAEKERS FCS, 1980, EXP CELL RES, V127, P309, DOI 10.1016/0014-4827(80)90437-1; RESNIK RA, 1960, J BIOPHYS BIOCHEM CY, V7, P403, DOI 10.1083/jcb.7.2.403; Robinson NE, 2006, MOL VIS, V12, P704; Rose KML, 2006, INVEST OPHTH VIS SCI, V47, P1562, DOI 10.1167/iovs.05-1313; Salvi E, 2008, J STRUCT BIOL, V161, P287, DOI 10.1016/j.jsb.2007.06.011; Schietroma C, 2009, EXP EYE RES, V88, P566, DOI 10.1016/j.exer.2008.11.029; Taylor VL, 1996, INVEST OPHTH VIS SCI, V37, P1396; WANKO T, 1959, J BIOPHYS BIOCHEM CY, V6, P97, DOI 10.1083/jcb.6.1.97; Wojdyr M, 2010, J APPL CRYSTALLOGR, V43, P1126, DOI 10.1107/S0021889810030499; ZAMPIGHI G, 1980, J CELL BIOL, V86, P190, DOI 10.1083/jcb.86.1.190; ZAMPIGHI G, 1980, J CELL BIOL, V87, P555, DOI 10.1083/jcb.87.3.555; ZAMPIGHI GA, 1989, J CELL BIOL, V108, P2255, DOI 10.1083/jcb.108.6.2255; Zampighi GA, 2005, J STRUCT BIOL, V151, P263, DOI 10.1016/j.jsb.2005.05.008	38	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23753	10.1371/journal.pone.0023753	http://dx.doi.org/10.1371/journal.pone.0023753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909355	Green Submitted, gold, Green Published			2022-12-25	WOS:000294680800018
J	Hayley, M; Bourbigot, S; Booth, V				Hayley, Michael; Bourbigot, Sarah; Booth, Valerie			Self-Association of an Activating Natural Killer Cell Receptor, KIR2DS1	PLOS ONE			English	Article							INHIBITORY RECEPTOR; CRYSTAL-STRUCTURE; HLA-C; RECOGNITION; PSORIASIS; CLONING	As a major component of the innate immune system, natural killer cells are responsible for activating the cytolytic killing of certain pathogen-infected or tumor cells. The self-recognition of natural killer cells is achieved in part by the killer cell immunoglobulin-like receptors (KIRs) protein family. In the current study, using a suite of biophysical methods, we investigate the self-association of an activating KIR, KIR2DS1. This KIR is of particular interest because when in the presence of the HLA-Cw6 protein, KIR2DS1 becomes a major risk factor for psoriasis, an autoimmune chronic skin disease. Using circular dichroism spectroscopy, dynamic light scattering, and atomic force microscopy, we reveal that KIR2DS1 self-associates in a well-defined fashion. Our novel results on an activating KIR allow us to suggest a working model for the KIR2DS1- HLA class I molecular mechanism.	[Hayley, Michael; Bourbigot, Sarah; Booth, Valerie] Mem Univ Newfoundland, Dept Biochem, St John, NF, Canada; [Booth, Valerie] Mem Univ Newfoundland, Dept Phys & Phys Oceanog, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Hayley, M (corresponding author), Mem Univ Newfoundland, Dept Biochem, St John, NF, Canada.	vbooth@mun.ca	Booth, Valerie/AAH-5932-2019	Booth, Valerie/0000-0001-9342-9217	National Sciences and Engineering Research Council of Canada	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the National Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bos JD, 2005, BRIT J DERMATOL, V152, P1098, DOI 10.1111/j.1365-2133.2005.06645.x; Boyington JC, 2001, IMMUNOL REV, V181, P66, DOI 10.1034/j.1600-065X.2001.1810105.x; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; DANDREA A, 1995, J IMMUNOL, V155, P2306; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; Germain RN, 1997, CURR BIOL, V7, pR640, DOI 10.1016/S0960-9822(06)00323-X; Graef T, 2009, J EXP MED, V206, P2557, DOI 10.1084/jem.20091010; Gudjonsson JE, 2002, J INVEST DERMATOL, V118, P362, DOI 10.1046/j.0022-202x.2001.01656.x; HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007; Krueger JG, 2005, ANN RHEUM DIS, V64, P30, DOI 10.1136/ard.2004.031120; Lepre CA, 1998, J BIOMOL NMR, V12, P493, DOI 10.1023/A:1008353000679; Maenaka K, 1999, STRUCTURE, V7, P391, DOI 10.1016/S0969-2126(99)80052-5; Ploski R, 2006, HUM IMMUNOL, V67, P521, DOI 10.1016/j.humimm.2006.04.001; Qian DP, 1997, CURR OPIN CELL BIOL, V9, P205, DOI 10.1016/S0955-0674(97)80064-6; Rahman P, 2005, ANN RHEUM DIS, V64, P37, DOI 10.1136/ard.2004.030775; Rajagopalan S, 2005, J EXP MED, V201, P1025, DOI 10.1084/jem.20050499; Saulquin X, 2003, J EXP MED, V197, P933, DOI 10.1084/jem.20021624; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Stewart CA, 2005, P NATL ACAD SCI USA, V102, P13224, DOI 10.1073/pnas.0503594102; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1	20	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e23052	10.1371/journal.pone.0023052	http://dx.doi.org/10.1371/journal.pone.0023052			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912587	gold, Green Published, Green Accepted			2022-12-25	WOS:000294678300002
J	Wang, JH; Wong, ESW; Whitley, JC; Li, J; Stringer, JM; Short, KR; Renfree, MB; Belov, K; Cocks, BG				Wang, Jianghui; Wong, Emily S. W.; Whitley, Jane C.; Li, Jian; Stringer, Jessica M.; Short, Kirsty R.; Renfree, Marilyn B.; Belov, Katherine; Cocks, Benjamin G.			Ancient Antimicrobial Peptides Kill Antibiotic-Resistant Pathogens: Australian Mammals Provide New Options	PLOS ONE			English	Article							TAMMAR WALLABY; LYMPHOID-TISSUES; RAINBOW-TROUT; CATHELICIDIN; IDENTIFICATION; EXPRESSION; COLISTIN; POUCH; GENE; PHARMACODYNAMICS	Background: To overcome the increasing resistance of pathogens to existing antibiotics the 10 x 20 Initiative declared the urgent need for a global commitment to develop 10 new antimicrobial drugs by the year 2020. Naturally occurring animal antibiotics are an obvious place to start. The recently sequenced genomes of mammals that are divergent from human and mouse, including the tammar wallaby and the platypus, provide an opportunity to discover novel antimicrobials. Marsupials and monotremes are ideal potential sources of new antimicrobials because they give birth to underdeveloped immunologically naive young that develop outside the sterile confines of a uterus in harsh pathogen-laden environments. While their adaptive immune system develops innate immune factors produced either by the mother or by the young must play a key role in protecting the immune-compromised young. In this study we focus on the cathelicidins, a key family of antimicrobial peptide genes. Principal Finding: We identified 14 cathelicidin genes in the tammar wallaby genome and 8 in the platypus genome. The tammar genes were expressed in the mammary gland during early lactation before the adaptive immune system of the young develops, as well as in the skin of the pouch young. Both platypus and tammar peptides were effective in killing a broad range of bacterial pathogens. One potent peptide, expressed in the early stages of tammar lactation, effectively killed multidrug-resistant clinical isolates of Pseudomonas aeruginosa, Klebsiella pneumoniae and Acinetobacter baumannii. Conclusions and Significance: Marsupial and monotreme young are protected by antimicrobial peptides that are potent, broad spectrum and salt resistant. The genomes of our distant relatives may hold the key for the development of novel drugs to combat multidrug-resistant pathogens.	[Wang, Jianghui; Whitley, Jane C.; Cocks, Benjamin G.] Dept Primary Ind, Biosci Res Div, Bundoora, Vic, Australia; [Wong, Emily S. W.; Belov, Katherine] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Wong, Emily S. W.; Stringer, Jessica M.; Renfree, Marilyn B.; Belov, Katherine] Australian Res Council, Ctr Excellence Kangaroo Genom, Parkville, Vic, Australia; [Li, Jian] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Stringer, Jessica M.; Renfree, Marilyn B.] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia; [Short, Kirsty R.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Cocks, Benjamin G.] La Trobe Univ, Bundoora, Vic, Australia	University of Sydney; Monash University; University of Melbourne; University of Melbourne; La Trobe University	Wang, JH (corresponding author), Dept Primary Ind, Biosci Res Div, Bundoora, Vic, Australia.	kathy.belov@sydney.edu.au	Stringer, Jessica/I-5525-2013; Wong, Emily/C-2302-2018; Li, Jian/I-5538-2016	Stringer, Jessica/0000-0003-4729-3026; Wong, Emily/0000-0003-0315-2942; Li, Jian/0000-0001-7953-8230; Belov, Katherine/0000-0002-9762-5554; Short, Kirsty/0000-0003-4963-6184; Renfree, Marilyn/0000-0002-4589-0436	Australian Research Council (ARC) Centre of Excellence in Kangaroo Genomics; University of Sydney; ARC Federation; Australian National Health and Medical Research Council; Australian Research Council	Australian Research Council (ARC) Centre of Excellence in Kangaroo Genomics(Australian Research Council); University of Sydney(University of Sydney); ARC Federation(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This research was supported by the Australian Research Council (ARC) Centre of Excellence in Kangaroo Genomics and a University of Sydney grant. MBR was funded by an ARC Federation fellowship, JL by an Australian National Health and Medical Research Council Senior Research Fellow and KB by an Australian Research Council Future Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Benton M, 2009, TIMETREE LIFE, P35; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Cai W, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-33; Carman RL, 2009, VET IMMUNOL IMMUNOP, V127, P269, DOI 10.1016/j.vetimm.2008.10.319; Chang CI, 2006, ANTIMICROB AGENTS CH, V50, P185, DOI 10.1128/AAC.50.1.185-195.2006; Chang CI, 2005, INFECT IMMUN, V73, P5053, DOI 10.1128/IAI.73.8.5053-5064.2005; Chhour KL, 2010, MICROBIOL-SGM, V156, P798, DOI 10.1099/mic.0.031997-0; Cirioni O, 2006, ANTIMICROB AGENTS CH, V50, P1672, DOI 10.1128/AAC.50.5.1672-1679.2006; Cole AM, 2001, BLOOD, V97, P297, DOI 10.1182/blood.V97.1.297; Connolly JH, 1999, J ANAT, V195, P161, DOI 10.1046/j.1469-7580.1999.19520161.x; Daly KA, 2008, COMP BIOCHEM PHYS B, V149, P524, DOI 10.1016/j.cbpb.2007.12.002; de Latour FA, BIOCH BIOPHYS RES CO, V396, P825; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edwards RJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-123; Goitsuka R, 2007, P NATL ACAD SCI USA, V104, P15063, DOI 10.1073/pnas.0707037104; Grant T., 1995, PLATYPUS UNIQUE MAMM; Green B., 1988, P41; Gronberg A, ACTA DERM VENEREOL; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Holland N, 2002, J ZOOL, V256, P279, DOI 10.1017/S0952836902000328; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Leonard BC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018756; Li J, 2001, ANTIMICROB AGENTS CH, V45, P781, DOI 10.1128/AAC.45.3.781-785.2001; Lim LM, 2010, PHARMACOTHERAPY, V30, P1279, DOI 10.1592/phco.30.12.1279; Lisanby MW, 2008, J IMMUNOL, V181, P4989, DOI 10.4049/jimmunol.181.7.4989; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Ohgami K, 2003, INVEST OPHTH VIS SCI, V44, P4412, DOI 10.1167/iovs.03-0246; Old JM, 2003, J ANAT, V203, P123, DOI 10.1046/j.1469-7580.2003.00207.x; Old JM, 2002, J ANAT, V201, P257, DOI 10.1046/j.1469-7580.2002.00090.x; Old JM, 2000, DEV COMP IMMUNOL, V24, P445, DOI 10.1016/S0145-305X(00)00008-2; Poudyal A, 2008, J ANTIMICROB CHEMOTH, V62, P1311, DOI 10.1093/jac/dkn425; RENFREE MB, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P323; Renfree MB, 1978, METHODS MAMMALIAN RE; Renfree MB, 2011, GENOME BIOL IN PRESS; Rozen S, 2000, Methods Mol Biol, V132, P365; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sang Y, 2007, DEV COMP IMMUNOL, V31, P1278, DOI 10.1016/j.dci.2007.03.007; Steinberg D A, 1997, Methods Mol Biol, V78, P169; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520; Tyndale-Biscoe CH., 1987, REPROD PHYSL MARSUPI; Uzzell T, 2003, PEPTIDES, V24, P1655, DOI 10.1016/j.peptides.2003.08.024; Wang YP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003217; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Whittington CM, 2009, AUST J ZOOL, V57, P211, DOI 10.1071/ZO09047; Xiao YJ, 2006, FEBS J, V273, P2581, DOI 10.1111/j.1742-4658.2006.05261.x; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; Zhang Y, 2010, PEPTIDES, V31, P1488, DOI 10.1016/j.peptides.2010.05.005; Zhao H, 2008, PEPTIDES, V29, P1685, DOI 10.1016/j.peptides.2008.06.008; Zhou H, PEPTIDES, V32, P1131	57	63	66	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24030	10.1371/journal.pone.0024030	http://dx.doi.org/10.1371/journal.pone.0024030			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912615	gold, Green Submitted, Green Published			2022-12-25	WOS:000294678300018
J	Kim, PY; Kim, YS; Koo, IG; Jung, JC; Kim, GJ; Choi, MY; Yu, ZQ; Collins, GJ				Kim, Paul Y.; Kim, Yoon-Sun; Koo, Il Gyo; Jung, Jae Chul; Kim, Gon Jun; Choi, Myeong Yeol; Yu, Zengqi; Collins, George J.			Bacterial Inactivation of Wound Infection in a Human Skin Model by Liquid-Phase Discharge Plasma	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS BIOFILM; SUBSTRATUM TOPOGRAPHY; CELLS; FIBRONECTIN; RESISTANCE; MECHANISMS; ADHERENCE; ADHESION; EFFICACY; BINDING	Background: We investigate disinfection of a reconstructed human skin model contaminated with biofilm-formative Staphylococcus aureus employing plasma discharge in liquid. Principal Findings: We observed statistically significant 3.83-log10 (p<0.001) and 1.59-log10 (p<0.05) decreases in colony forming units of adherent S. aureus bacteria and 24 h S. aureus biofilm culture with plasma treatment. Plasma treatment was associated with minimal changes in histological morphology and tissue viability determined by means of MTT assay. Spectral analysis of the plasma discharge indicated the presence of highly reactive atomic oxygen radicals (777 nm and 844 nm) and OH bands in the UV region. The contribution of these and other plasma-generated agents and physical conditions to the reduction in bacterial load are discussed. Conclusions: These findings demonstrate the potential of liquid plasma treatment as a potential adjunct therapy for chronic wounds.	[Kim, Paul Y.; Kim, Yoon-Sun; Koo, Il Gyo; Jung, Jae Chul; Kim, Gon Jun; Choi, Myeong Yeol; Yu, Zengqi; Collins, George J.] Colorado State Univ, Dept Elect & Comp Engn, Ft Collins, CO 80523 USA	Colorado State University	Kim, PY (corresponding author), Colorado State Univ, Dept Elect & Comp Engn, Ft Collins, CO 80523 USA.	gcollins@engr.colostate.edu	Kim, Paul/GYV-3258-2022	Kim, Paul/0000-0003-0943-4924	State of Colorado Bioscience Discovery Evaluation Grant Program [10BGF-25]	State of Colorado Bioscience Discovery Evaluation Grant Program	This study was supported by the State of Colorado Bioscience Discovery Evaluation Grant Program (grant # 10BGF-25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorena B, 1999, J ANTIMICROB CHEMOTH, V44, P43, DOI 10.1093/jac/44.1.43; Bogomaz A. A., 1991, Soviet Technical Physics Letters, V17, P448; BRANDT B, 1962, TEK VETENSKAPLIG FOR, V33, P222; Bruggeman P, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/5/053001; CANNON CL, 1994, S ALT ASS TOX THEOR; CHANG JS, 2008, ADV PLASMA TECHNOLOG, pCH24; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Deng XT, 2006, IEEE T PLASMA SCI, V34, P1310, DOI 10.1109/TPS.2006.877739; EDEBO L, 1968, J GEN MICROBIOL, V50, P253, DOI 10.1099/00221287-50-2-253; El-Azizi Mohamed, 2005, Ann Clin Microbiol Antimicrob, V4, P2, DOI 10.1186/1476-0711-4-2; EVANS RC, 1987, ANTIMICROB AGENTS CH, V31, P889, DOI 10.1128/AAC.31.6.889; HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693; Johnson M, 2005, J BACTERIOL, V187, P8211, DOI 10.1128/JB.187.23.8211-8215.2005; Joshi R, 2009, PLASMA PROCESS POLYM, V6, pS218, DOI 10.1002/ppap.200930601; KALGHATGI SU, 2009, 31 ANN INT C IEEE EM; KONG MG, 2009, NEW J PHYS, V11, DOI DOI 10.1088/1367-2630/11/11/115012; Koo IG, 2006, JPN J APPL PHYS 1, V45, P7888, DOI 10.1143/JJAP.45.7888; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Locke BR, 2006, IND ENG CHEM RES, V45, P882, DOI 10.1021/ie050981u; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Maillard JY, 1998, J HOSP INFECT, V40, P313, DOI 10.1016/S0195-6701(98)90309-7; McDonnell GE, 2007, ANTISEPSIS DISINFECT; Messager S, 2001, J MED MICROBIOL, V50, P284, DOI 10.1099/0022-1317-50-3-284; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Moretro T, 2003, APPL ENVIRON MICROB, V69, P5648, DOI 10.1128/AEM.69.9.5648-5655.2003; NICKEL JC, 1985, ANTIMICROB AGENTS CH, V27, P619, DOI 10.1128/AAC.27.4.619; PARK PW, 1991, J BIOL CHEM, V266, P23399; Perni S, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2458162; Resch A, 2006, PROTEOMICS, V6, P1867, DOI 10.1002/pmic.200500531; Sambanthamoorthy K, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-221; Sano N, 2001, NATURE, V414, P506, DOI 10.1038/35107141; Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717; Shekhter AB, 1998, B EXP BIOL MED+, V126, P829, DOI 10.1007/BF02446923; SPEZIALE P, 1986, J BACTERIOL, V167, P77, DOI 10.1128/jb.167.1.77-81.1986; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Taylor RL, 1998, J MATER SCI-MATER M, V9, P17, DOI 10.1023/A:1008874326324; Vankov A, 2007, J APPL PHYS, V101, DOI 10.1063/1.2738374; VAUDAUX PE, 1984, INFECT IMMUN, V45, P768, DOI 10.1128/IAI.45.3.768-774.1984	38	32	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e24104	10.1371/journal.pone.0024104	http://dx.doi.org/10.1371/journal.pone.0024104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897870	Green Submitted, Green Published, gold			2022-12-25	WOS:000294676900034
J	Zhang, Y; Paul, EM; Sathyendra, V; Davison, A; Sharkey, N; Bronson, S; Srinivasan, S; Gross, TS; Donahue, HJ				Zhang, Yue; Paul, Emmanuel M.; Sathyendra, Vikram; Davison, Andrew; Sharkey, Neil; Bronson, Sarah; Srinivasan, Sundar; Gross, Ted S.; Donahue, Henry J.			Enhanced Osteoclastic Resorption and Responsiveness to Mechanical Load in Gap Junction Deficient Bone	PLOS ONE			English	Article							OSTEOBLASTIC CELLS; FLUID-FLOW; INTERCELLULAR COMMUNICATION; MLO-Y4 CELLS; IN-VIVO; DIFFERENTIATION MARKERS; PARATHYROID-HORMONE; GENE-TRANSCRIPTION; ALTERS EXPRESSION; PROSTAGLANDIN E-2	Emerging evidence suggests that connexin mediated gap junctional intercellular communication contributes to many aspects of bone biology including bone development, maintenance of bone homeostasis and responsiveness of bone cells to diverse extracellular signals. Deletion of connexin 43, the predominant gap junction protein in bone, is embryonic lethal making it challenging to examine the role of connexin 43 in bone in vivo. However, transgenic murine models in which only osteocytes and osteoblasts are deficient in connexin 43, and which are fully viable, have recently been developed. Unfortunately, the bone phenotype of different connexin 43 deficient models has been variable. To address this issue, we used an osteocalcin driven Cre-lox system to create osteoblast and osteocyte specific connexin 43 deficient mice. These mice displayed bone loss as a result of increased bone resorption and osteoclastogenesis. The mechanism underlying this increased osteoclastogenesis included increases in the osteocytic, but not osteoblastic, RANKL/OPG ratio. Previous in vitro studies suggest that connexin 43 deficient bone cells are less responsive to biomechanical signals. Interestingly, and in contrast to in vitro studies, we found that connexin 43 deficient mice displayed an enhanced anabolic response to mechanical load. Our results suggest that transient inhibition of connexin 43 expression and gap junctional intercellular communication may prove a potentially powerful means of enhancing the anabolic response of bone to mechanical loading.	[Zhang, Yue; Paul, Emmanuel M.; Sathyendra, Vikram; Davison, Andrew; Sharkey, Neil; Donahue, Henry J.] Penn State Coll Med, Dept Orthopaed & Rehabil, Div Musculoskeletal Sci, Hershey, PA USA; [Bronson, Sarah; Donahue, Henry J.] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA USA; [Srinivasan, Sundar; Gross, Ted S.] Univ Washington, Dept Orthopaed, Seattle, WA 98195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Washington; University of Washington Seattle	Zhang, Y (corresponding author), Penn State Coll Med, Dept Orthopaed & Rehabil, Div Musculoskeletal Sci, Hershey, PA USA.	hdonahue@psu.edu		Bronson, Sarah/0000-0002-5456-953X	National Institute on Aging [R01 AG013087-13]; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health [R03 AR057546-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR057546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013087] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant R01 AG013087-13 from the National Institute on Aging, and R03 AR057546-01 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajubi NE, 1999, AM J PHYSIOL-ENDOC M, V276, pE171, DOI 10.1152/ajpendo.1999.276.1.E171; Alford AI, 2003, BONE, V33, P64, DOI 10.1016/S8756-3282(03)00167-4; Bakker AD, 2001, J BIOMECH, V34, P671, DOI 10.1016/S0021-9290(00)00231-1; Castro CHM, 2003, CELL COMMUN ADHES, V10, P445, DOI 10.1080/15419060390267700; Cheng BX, 2001, ENDOCRINOLOGY, V142, P3464, DOI 10.1210/en.142.8.3464; Cheng BX, 2001, J BONE MINER RES, V16, P249, DOI 10.1359/jbmr.2001.16.2.249; Cherian PP, 2003, J BIOL CHEM, V278, P43146, DOI 10.1074/jbc.M302993200; CHIBA H, 1993, CELL STRUCT FUNCT, V18, P419, DOI 10.1247/csf.18.419; Chung DJ, 2006, J CELL SCI, V119, P4187, DOI 10.1242/jcs.03162; CIVITELLI R, 1993, J CLIN INVEST, V91, P1888, DOI 10.1172/JCI116406; DONAHUE HJ, 1995, J BONE MINER RES, V10, P1359; Donahue HJ, 2000, AM J PHYSIOL-CELL PH, V278, pC315, DOI 10.1152/ajpcell.2000.278.2.C315; Donahue HJ, 2000, BONE, V26, P417, DOI 10.1016/S8756-3282(00)00245-3; DOTY SB, 1981, CALCIFIED TISSUE INT, V33, P509, DOI 10.1007/BF02409482; DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Garnero P, 2003, J BONE MINER RES, V18, P859, DOI 10.1359/jbmr.2003.18.5.859; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Grimston SK, 2008, J BONE MINER RES, V23, P879, DOI [10.1359/jbmr.080222, 10.1359/JBMR.080222]; JONES SJ, 1993, ANAT EMBRYOL, V187, P343; Kjaer AW, 2004, AM J MED GENET A, V127A, P152, DOI 10.1002/ajmg.a.20614; Koval M, 1997, J CELL BIOL, V137, P847, DOI 10.1083/jcb.137.4.847; Lang DH, 2005, J BONE MINER RES, V20, P748, DOI 10.1359/JBMR.041224; Lecanda F, 1998, MOL BIOL CELL, V9, P2249, DOI 10.1091/mbc.9.8.2249; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Li JL, 2005, J BIOL CHEM, V280, P42952, DOI 10.1074/jbc.M506415200; Li Z, 1999, BONE, V25, P661, DOI 10.1016/S8756-3282(99)00227-6; Li ZY, 2006, AM J PHYSIOL-CELL PH, V290, pC1248, DOI 10.1152/ajpcell.00428.2005; Liu JZ, 2005, J CELL BIOCHEM, V96, P716, DOI 10.1002/jcb.20569; Lozupone E, 1996, CLIN RHEUMATOL, V15, P563, DOI 10.1007/BF02238545; Morinaga T, 1998, EUR J BIOCHEM, V254, P685, DOI 10.1046/j.1432-1327.1998.2540685.x; PALUMBO C, 1990, BONE, V11, P401, DOI 10.1016/8756-3282(90)90134-K; PARFITT AM, 1977, CLIN ORTHOP RELAT R, P236; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Plotkin LI, 2008, J BONE MINER RES, V23, P1712, DOI 10.1359/JBMR.080617; Poliachik SL, 2008, BONE, V42, P653, DOI 10.1016/j.bone.2007.12.222; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Richardson RR, 2004, J MED GENET, V41, P60, DOI 10.1136/jmg.2003.012005; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Saunders MM, 2003, BONE, V32, P350, DOI 10.1016/S8756-3282(03)00025-5; Saunders MM, 2001, AM J PHYSIOL-CELL PH, V281, pC1917, DOI 10.1152/ajpcell.2001.281.6.C1917; Sawyer A, 2003, BIOTECH HISTOCHEM, V78, P271, DOI 10.1080/10520290310001646668; Schiller PC, 2001, J BIOL CHEM, V276, P14133, DOI 10.1074/jbc.M011055200; Schiller PC, 2001, BONE, V28, P362, DOI 10.1016/S8756-3282(00)00458-0; Schiller PC, 1997, J BONE MINER RES, V12, P2005, DOI 10.1359/jbmr.1997.12.12.2005; Srinivasan S, 2007, J APPL PHYSIOL, V102, P1945, DOI 10.1152/japplphysiol.00507.2006; Stains JP, 2005, MOL BIOL CELL, V16, P64, DOI 10.1091/mbc.E04-04-0339; Stains JP, 2003, J BIOL CHEM, V278, P24377, DOI 10.1074/jbc.M212554200; STEINBERG TH, 1994, EMBO J, V13, P744, DOI 10.1002/j.1460-2075.1994.tb06316.x; Su M, 1997, J DENT RES, V76, P1357, DOI 10.1177/00220345970760070501; TANAKA K, 1995, MINER ELECTROL METAB, V21, P189; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Taylor AF, 2007, AM J PHYSIOL-CELL PH, V292, pC545, DOI 10.1152/ajpcell.00611.2005; Thirunavukkarasu K, 2000, J BIOL CHEM, V275, P25163, DOI 10.1074/jbc.M000322200; TURNER CH, 1994, FASEB J, V8, P875, DOI 10.1096/fasebj.8.11.8070637; Vander Molen MA, 2000, BONE, V27, P227, DOI 10.1016/S8756-3282(00)00315-X; VanderMolen MA, 1996, J BIOL CHEM, V271, P12165, DOI 10.1074/jbc.271.21.12165; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhang Y, 2000, J BIOL CHEM, V275, P32628, DOI 10.1074/jbc.M002594200; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068; Ziambaras K, 1998, J BONE MINER RES, V13, P218, DOI 10.1359/jbmr.1998.13.2.218	62	99	104	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23516	10.1371/journal.pone.0023516	http://dx.doi.org/10.1371/journal.pone.0023516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897843	Green Published, Green Submitted, gold			2022-12-25	WOS:000294676900006
J	Tam, C; LeDue, J; Mun, JJ; Herzmark, P; Robey, EA; Evans, DJ; Fleiszig, SMJ				Tam, Connie; LeDue, Jeffrey; Mun, James J.; Herzmark, Paul; Robey, Ellen A.; Evans, David J.; Fleiszig, Suzanne M. J.			3D Quantitative Imaging of Unprocessed Live Tissue Reveals Epithelial Defense against Bacterial Adhesion and Subsequent Traversal Requires MyD88	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA KERATITIS; HUMAN TEAR FLUID; CORNEAL INFECTIONS; BARRIER FUNCTION; ANTIMICROBIAL PEPTIDES; MUCOSAL INFLAMMATION; TWITCHING MOTILITY; CELLS; MICROSCOPY; MEMBRANE	While a plethora of in vivo models exist for studying infectious disease and its resolution, few enable factors involved in the maintenance of health to be studied in situ. This is due in part to a paucity of tools for studying subtleties of bacterial-host interactions at a cellular level within live organs or tissues, requiring investigators to rely on overt outcomes (e. g. pathology) in their research. Here, a suite of imaging technologies were combined to enable 3D and temporal subcellular localization and quantification of bacterial distribution within the murine cornea without the need for tissue processing or dissection. These methods were then used to demonstrate the importance of MyD88, a central adaptor protein for Toll-Like Receptor (TLR) mediated signaling, in protecting a multilayered epithelium against both adhesion and traversal by the opportunistic bacterial pathogen Pseudomonas aeruginosa ex vivo and in vivo.	[Tam, Connie; LeDue, Jeffrey; Evans, David J.; Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Mun, James J.; Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Program Vis Sci, Berkeley, CA 94720 USA; [Herzmark, Paul; Robey, Ellen A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Evans, David J.] Touro Univ Calif, Coll Pharm, Vallejo, CA USA; [Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Program Infect Dis, Berkeley, CA 94720 USA; [Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Program Immun & Microbiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Touro University California; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Tam, C (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	fleiszig@berkeley.edu	LeDue, Jeffrey/C-9230-2012	Fleiszig, Suzanne/0000-0001-6324-3462; Evans, David/0000-0002-6885-2053; Tam, Connie/0000-0002-1566-7508	National Institutes of Health (NIH) [EY011221, AI079192, AI065831];  [EY003176]; NATIONAL EYE INSTITUTE [R01EY011221, P30EY003176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079192, P01AI065831] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH) EY011221 and AI079192 (SMJF), AI065831 (ER) and JL was supported by EY003176. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Alarcon I, 2011, INVEST OPHTH VIS SCI, V52, P1368, DOI 10.1167/iovs.10-6125; Alarcon I, 2009, INFECT IMMUN, V77, P3264, DOI 10.1128/IAI.00111-09; Alarcon I, 2009, INVEST OPHTH VIS SCI, V50, P2237, DOI 10.1167/iovs.08-2785; Angus AA, 2008, INFECT IMMUN, V76, P1992, DOI 10.1128/IAI.01221-07; Angus AA, 2010, INFECT IMMUN, V78, P4500, DOI 10.1128/IAI.00417-10; Augustin DK, 2011, INFECT IMMUN, V79, P595, DOI 10.1128/IAI.00854-10; Bernard JJ, 2010, J IMMUNOL, V185, P6535, DOI 10.4049/jimmunol.1002009; Bloemberg GV, 1997, APPL ENVIRON MICROB, V63, P4543, DOI 10.1128/AEM.63.11.4543-4551.1997; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Chen WL, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3247157; FLEISZIG SMJ, 1994, INFECT IMMUN, V62, P1799, DOI 10.1128/IAI.62.5.1799-1804.1994; Fleiszig SMJ, 2003, INFECT IMMUN, V71, P3866, DOI 10.1128/IAI.71.7.3866-3874.2003; Fleiszig SMJ, 1997, INFECT IMMUN, V65, P2861, DOI 10.1128/IAI.65.7.2861-2867.1997; GERKE JR, 1971, INFECT IMMUN, V3, P209, DOI 10.1128/IAI.3.2.209-216.1971; Gribar SC, 2008, MOL MED, V14, P645, DOI 10.2119/2008-00035.Gribar; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Huang X, 2005, INVEST OPHTH VIS SCI, V46, P4209, DOI 10.1167/iovs.05-0185; Huang X, 2006, INVEST OPHTH VIS SCI, V47, P4910, DOI 10.1167/iovs.06-0537; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Kim J, 2000, Curr Opin Ophthalmol, V11, P241, DOI 10.1097/00055735-200008000-00005; Kohler H, 2007, AM J PHYSIOL-GASTR L, V293, pG178, DOI 10.1152/ajpgi.00535.2006; Kwong MSF, 2007, INFECT IMMUN, V75, P2325, DOI 10.1128/IAI.01404-06; Lee EJ, 2003, INVEST OPHTH VIS SCI, V44, P3892, DOI 10.1167/iovs.02-1302; Lee HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-87; Macutkiewicz C, 2008, MICROBES INFECT, V10, P424, DOI 10.1016/j.micinf.2008.01.001; McDermott AM, 2009, OPHTHALMIC RES, V41, P60, DOI 10.1159/000187622; MCLICHAR HJ, 2010, IMMUNOL CELL BIOL; MEZA I, 1980, J CELL BIOL, V87, P746, DOI 10.1083/jcb.87.3.746; Milatz S, 2010, BBA-BIOMEMBRANES, V1798, P2048, DOI 10.1016/j.bbamem.2010.07.014; MONDINO BJ, 1977, ARCH OPHTHALMOL-CHIC, V95, P2222; Mun JJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00008; PISTON DW, 1995, J MICROSC-OXFORD, V178, P20, DOI 10.1111/j.1365-2818.1995.tb03576.x; Piston DW, 1999, METHOD ENZYMOL, V307, P351; PRESTON MJ, 1995, INFECT IMMUN, V63, P3497, DOI 10.1128/IAI.63.9.3497-3501.1995; RAMPHAL R, 1981, ANN OPHTHALMOL, V13, P421; Redfern RL, 2011, EXP EYE RES, V92, P209, DOI 10.1016/j.exer.2010.12.005; ROJANASAKUL Y, 1992, PHARMACEUT RES, V9, P1029, DOI 10.1023/A:1015802427428; Soong G, 2008, J BACTERIOL, V190, P2814, DOI 10.1128/JB.01567-07; Speier S, 2008, NAT PROTOC, V3, P1278, DOI 10.1038/nprot.2008.118; STEUHL KP, 1987, INVEST OPHTH VIS SCI, V28, P1559; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; Tam C, 2010, INVEST OPHTH VIS SCI, V51, P3100, DOI 10.1167/iovs.09-4593; VANHORN DL, 1978, INVEST OPHTH VIS SCI, V17, P1076; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Wu MH, 2009, J IMMUNOL, V183, P8054, DOI 10.4049/jimmunol.0902140; Zasloff M, 2007, J AM SOC NEPHROL, V18, P2810, DOI 10.1681/ASN.2007050611; Zolfaghar I, 2003, INFECT IMMUN, V71, P5389, DOI 10.1128/IAI.71.9.5389-5393.2003	51	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e24008	10.1371/journal.pone.0024008	http://dx.doi.org/10.1371/journal.pone.0024008			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901151	gold, Green Published, Green Submitted			2022-12-25	WOS:000294298000036
J	Visser, MB; Koh, A; Glogauer, M; Ellen, RP				Visser, Michelle B.; Koh, Adeline; Glogauer, Michael; Ellen, Richard P.			Treponema denticola Major Outer Sheath Protein Induces Actin Assembly at Free Barbed Ends by a PIP2-Dependent Uncapping Mechanism in Fibroblasts	PLOS ONE			English	Article							SURFACE PROTEIN; RHO-GTPASES; BINDING-PROPERTIES; PLASMA-MEMBRANE; FILAMENT; DYNAMICS; CYTOSKELETON; GELSOLIN; INSIGHTS; COFILIN	The major outer sheath protein (Msp) of Treponema denticola perturbs actin dynamics in fibroblasts by inducing actin reorganization, including subcortical actin filament assembly, leading to defective calcium flux, diminished integrin engagement of collagen, and retarded cell migration. Yet, its mechanisms of action are unknown. We challenged Rat-2 fibroblasts with enriched native Msp. Msp activated the small GTPases Rac1, RhoA and Ras, but not Cdc42, yet only Rac1 localized to areas of actin rearrangement. We used Rac1 dominant negative transfection and chemical inhibition of phosphatidylinositol-3 kinase (PI3K) to show that even though Rac1 activation was PI3K-dependent, neither was required for Msp-induced actin rearrangement. Actin free barbed end formation (FBE) by Msp was also PI3K-independent. Immunoblotting experiments showed that gelsolin and CapZ were released from actin filaments, whereas cofilin remained in an inactive state. Msp induced phosphatidylinositol (4,5)-bisphosphate (PIP2) formation through activation of a phosphoinositide 3-phosphatase and its recruitment to areas of actin assembly at the plasma membrane. Using a PIP2 binding peptide or lipid phosphatase inhibitor, PIP2 was shown to be required for Msp-mediated actin uncapping and FBE formation. Evidently, Msp induces actin assembly in fibroblasts by production and recruitment of PIP2 and release of the capping proteins CapZ and gelsolin from actin barbed ends.	[Visser, Michelle B.; Koh, Adeline; Glogauer, Michael; Ellen, Richard P.] Univ Toronto, Dent Res Inst, Matrix Dynam Grp, Toronto, ON, Canada	University of Toronto	Visser, MB (corresponding author), Univ Toronto, Dent Res Inst, Matrix Dynam Grp, Toronto, ON, Canada.	Michelle.visser@utoronto.ca	Visser, Michelle/L-1262-2019; Glogauer, Michael/D-2504-2011	Visser, Michelle/0000-0002-6467-3314; Glogauer, Michael/0000-0002-6248-5977	Canadian Institute of Health Research (CIHR) [MOP-86550, MOP-53136]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by operating grants MOP-86550 (R. P. E.) and MOP-53136 (M. G.) from Canadian Institute of Health Research (CIHR) and a CIHR New Investigator Award (M. G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin M, 2004, INFECT IMMUN, V72, P3650, DOI 10.1128/IAI.72.6.3650-3654.2004; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Arora PD, 1999, EXP CELL RES, V250, P155, DOI 10.1006/excr.1999.4521; BAEHNI PC, 1992, INFECT IMMUN, V60, P3360, DOI 10.1128/IAI.60.8.3360-3368.1992; BALLA T, 2002, SCI STKE, pP13; Barkalow K, 1996, J CELL BIOL, V134, P389, DOI 10.1083/jcb.134.2.389; Caimano MJ, 1999, INFECT IMMUN, V67, P4072, DOI 10.1128/IAI.67.8.4072-4083.1999; Capone R, 2008, ORAL MICROBIOL IMMUN, V23, P165, DOI 10.1111/j.1399-302X.2007.00404.x; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Cunningham CC, 2001, J BIOL CHEM, V276, P43390, DOI 10.1074/jbc.M105289200; da Silva APB, 2004, CELL MICROBIOL, V6, P485, DOI 10.1111/j.1462-5822.2004.00377.x; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Edwards AM, 2005, INFECT IMMUN, V73, P2891, DOI 10.1128/IAI.73.5.2891-2898.2005; EGLI C, 1993, INFECT IMMUN, V61, P1694, DOI 10.1128/IAI.61.5.1694-1699.1993; Ellen RP, 2005, PERIODONTOL 2000, V38, P13, DOI 10.1111/j.1600-0757.2005.00108.x; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fenno JC, 1996, J BACTERIOL, V178, P2489, DOI 10.1128/jb.178.9.2489-2497.1996; Fenno JC, 1998, FEMS MICROBIOL LETT, V163, P209, DOI 10.1111/j.1574-6968.1998.tb13047.x; Fenno JC, 1998, INFECT IMMUN, V66, P1869, DOI 10.1128/IAI.66.5.1869-1877.1998; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; HAAPASALO M, 1992, INFECT IMMUN, V60, P2058, DOI 10.1128/IAI.60.5.2058-2065.1992; Halet G, 2005, BIOL CELL, V97, P501; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Ishihara K, 1996, INFECT IMMUN, V64, P5178, DOI 10.1128/IAI.64.12.5178-5186.1996; Ishihara K, 2010, BIOL CHEM, V391, P1047, DOI 10.1515/BC.2010.113; Jobin MC, 2007, BIOCHEM BIOPH RES CO, V356, P213, DOI 10.1016/j.bbrc.2007.02.111; Liu Y, 2010, PROG LIPID RES, V49, P201, DOI 10.1016/j.plipres.2009.12.001; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Magalhaes MAO, 2008, CELL MICROBIOL, V10, P344, DOI 10.1111/j.1462-5822.2007.01045.x; Mao YS, 2007, PFLUG ARCH EUR J PHY, V455, P5, DOI 10.1007/s00424-007-0286-3; MASUDA K, 1989, MICROBIOL IMMUNOL, V33, P619, DOI 10.1111/j.1348-0421.1989.tb02012.x; Mathers DA, 1996, INFECT IMMUN, V64, P2904, DOI 10.1128/IAI.64.8.2904-2910.1996; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; Ou XM, 1999, DNA CELL BIOL, V18, P253, DOI 10.1089/104454999315475; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; RIDLEY AJ, 1992, COLD SPRING HARB SYM, V57, P661, DOI 10.1101/SQB.1992.057.01.072; Ridley AJ, 1997, INT J BIOCHEM CELL B, V29, P1225, DOI 10.1016/S1357-2725(97)00052-6; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Rottner K, 2005, DEV CELL, V9, P3, DOI 10.1016/j.devcel.2005.06.002; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sela MN, 2001, CRIT REV ORAL BIOL M, V12, P399, DOI 10.1177/10454411010120050301; Seshadri G, 2004, P NATL ACAD SCI USA, V101, P5646, DOI 10.1073/pnas.0307639101; Stebbins CE, 2004, CURR OPIN STRUC BIOL, V14, P731, DOI 10.1016/j.sbi.2004.09.011; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Thomas BP, 2006, INFECT IMMUN, V74, P1954, DOI 10.1128/IAI.74.3.1954-1957.2006; UITTO VJ, 1995, INFECT IMMUN, V63, P3401, DOI 10.1128/IAI.63.9.3401-3410.1995; van Rheenen J, 2002, MOL BIOL CELL, V13, P3257, DOI 10.1091/mbc.E02-04-0231; Visser MB, 2011, CLIN MICROBIOL INFEC, V17, P502, DOI 10.1111/j.1469-0691.2011.03460.x; Wang Q, 2001, J BIOL CHEM, V276, P23056, DOI 10.1074/jbc.M011735200; Yang PF, 1998, INFECT IMMUN, V66, P696, DOI 10.1128/IAI.66.2.696-702.1998; Zigmond SH, 2004, CURR TOP DEV BIOL, V63, P145, DOI 10.1016/S0070-2153(04)63005-5	59	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23736	10.1371/journal.pone.0023736	http://dx.doi.org/10.1371/journal.pone.0023736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901132	Green Published, Green Submitted, gold			2022-12-25	WOS:000294298000017
J	Ghai, R; Rodriguez-Valera, F; McMahon, KD; Toyama, D; Rinke, R; de Oliveira, TCS; Garcia, JW; de Miranda, FP; Henrique-Silva, F				Ghai, Rohit; Rodriguez-Valera, Francisco; McMahon, Katherine D.; Toyama, Danyelle; Rinke, Raquel; Souza de Oliveira, Tereza Cristina; Garcia, Jose Wagner; de Miranda, Fernando Pellon; Henrique-Silva, Flavio			Metagenomics of the Water Column in the Pristine Upper Course of the Amazon River	PLOS ONE			English	Article							BACTERIAL COMMUNITY COMPOSITION; GENE-SEQUENCES; LAKE; ACTINOBACTERIA; TEMPERATE; HABITATS; PATTERNS; CARBON; ASYMBIOTICUS; METABOLISM	River water is a small percentage of the total freshwater on Earth but represents an essential resource for mankind. Microbes in rivers perform essential ecosystem roles including the mineralization of significant quantities of organic matter originating from terrestrial habitats. The Amazon river in particular is famous for its size and importance in the mobilization of both water and carbon out of its enormous basin. Here we present the first metagenomic study on the microbiota of this river. It presents many features in common with the other freshwater metagenome available (Lake Gatun in Panama) and much less similarity with marine samples. Among the microbial taxa found, the cosmopolitan freshwater acI lineage of the actinobacteria was clearly dominant. Group I Crenarchaea and the freshwater sister group of the marine SAR11 clade, LD12, were found alongside more exclusive and well known freshwater taxa such as Polynucleobacter. A metabolism-centric analysis revealed a disproportionate representation of pathways involved in heterotrophic carbon processing, as compared to those found in marine samples. In particular, these river microbes appear to be specialized in taking up and mineralizing allochthonous carbon derived from plant material.	[Ghai, Rohit; Rodriguez-Valera, Francisco; McMahon, Katherine D.] Univ Miguel Hernandez, Evolutionary Genom Grp, Dept Prod Vegetal & Microbiol, Alicante, Spain; [Toyama, Danyelle; Rinke, Raquel; Henrique-Silva, Flavio] Univ Fed Sao Carlos, Mol Biol Lab, Dept Genet & Evolucao, BR-13560 Sao Carlos, SP, Brazil; [Souza de Oliveira, Tereza Cristina] Univ Fed Amazonas, Manaus, AM, Brazil; [Garcia, Jose Wagner] Noosfera Projetos Especiais Ltda, Sao Paulo, Brazil; [de Miranda, Fernando Pellon] Petr Brasileiro SA Petrobras, Ctr Pesquisas & Desenvolvimento Leopoldo Amer Mig, Rio De Janeiro, Brazil	Universidad Miguel Hernandez de Elche; Universidade Federal de Sao Carlos; Universidade Federal de Amazonas; Petrobras	Ghai, R (corresponding author), Univ Miguel Hernandez, Evolutionary Genom Grp, Dept Prod Vegetal & Microbiol, Alicante, Spain.	frvalera@umh.es; dfhs@ufscar.br	Ghai, Rohit/E-7086-2012; Rodriguez-Valera, Francisco/M-2782-2013; de Oliveira, Tereza Cristina Souza/AAM-2117-2021; McMahon, Katherine D/I-3651-2012; Henrique-Silva, Flavio/A-1937-2013	Ghai, Rohit/0000-0002-0591-6152; Rodriguez-Valera, Francisco/0000-0002-9809-2059; Souza de Oliveira, Tereza Cristina/0000-0001-6103-5192; McMahon, Katherine D./0000-0002-7038-026X	Petroleo Brasileiro S.A. - Petrobras, Federal University of Sao Carlos, SP, Brazil [0050.0045454.08-4]; National Council for Research and Development (CNPq) [305655/2009-4]; Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES); MAGYK [BIO2008-02444]; MICROGEN [CSD2009-00006]; METAGHALO [BIO2009-10138]; Spanish Ministerio de Ciencia e Innovacion [CGL2010-19303]; Generalitat Valenciana [PROMETEO/2010/089]; Spanish Ministerio de Ciencia e Innovacion	Petroleo Brasileiro S.A. - Petrobras, Federal University of Sao Carlos, SP, Brazil; National Council for Research and Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); MAGYK; MICROGEN; METAGHALO; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by Petroleo Brasileiro S.A. - Petrobras, as part of a research agreement (# 0050.0045454.08-4) with the Federal University of Sao Carlos, SP, Brazil, within the context of the Cognitus Project. FHS is recipient of a Research Productivity Scholarship from The National Council for Research and Development (CNPq # 305655/2009-4). DT and RR were recipients of a master scholarship from the Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES). This work was also supported by projects MAGYK (BIO2008-02444), MICROGEN (Programa CONSOLIDER-INGENIO 2010 CSD2009-00006), METAGHALO (BIO2009-10138) and HALOMET (CGL2010-19303) from the Spanish Ministerio de Ciencia e Innovacion, DIMEGEN (PROMETEO/2010/089) from the Generalitat Valenciana. RG was supported by a Juan de la Cierva scholarship, from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agogue H, 2008, NATURE, V456, P788, DOI 10.1038/nature07535; Allgaier M, 2007, ENVIRON MICROBIOL, V9, P2728, DOI 10.1111/j.1462-2920.2007.01385.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antoine R, 2003, J BACTERIOL, V185, P1470, DOI 10.1128/JB.185.4.1470-1474.2003; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; AUTRY AR, 1990, BIOL FERT SOILS, V10, P50; Callieri C, 2009, APPL ENVIRON MICROB, V75, P7298, DOI 10.1128/AEM.01231-09; Cateau E, 2011, FEMS MICROBIOL LETT, V319, P19, DOI 10.1111/j.1574-6968.2011.02261.x; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; Debroas D, 2009, ENVIRON MICROBIOL, V11, P2412, DOI 10.1111/j.1462-2920.2009.01969.x; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Downing JA, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002854; Fischer M, 2010, TRENDS MICROBIOL, V18, P471, DOI 10.1016/j.tim.2010.06.009; FISHER TR, 1979, COMP BIOCHEM PHYS A, V62, P31, DOI 10.1016/0300-9629(79)90739-4; GHAI R, 2011, BREAKING PA IN PRESS; Ghai R, 2010, ISME J, V4, P1154, DOI 10.1038/ismej.2010.44; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Hahn MW, 2010, INT J SYST EVOL MICR, V60, P166, DOI 10.1099/ijs.0.010595-0; Hahn MW, 2009, INT J SYST EVOL MICR, V59, P112, DOI 10.1099/ijs.0.001743-0; Hatamoto O, 1996, GENE, V175, P215, DOI 10.1016/0378-1119(96)00153-9; HEDGES JI, 1994, LIMNOL OCEANOGR, V39, P743, DOI 10.4319/lo.1994.39.4.0743; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jezbera J, 2011, ENVIRON MICROBIOL, V13, P922, DOI 10.1111/j.1462-2920.2010.02396.x; Jezbera J, 2009, INT J SYST EVOL MICR, V59, P2864, DOI 10.1099/ijs.0.010199-0; Jezberova J, 2010, ENVIRON MICROBIOL, V12, P658, DOI 10.1111/j.1462-2920.2009.02106.x; Jones SE, 2009, ENVIRON MICROBIOL, V11, P2463, DOI 10.1111/j.1462-2920.2009.01977.x; Jung J, 2010, J BACTERIOL, V192, P4794, DOI 10.1128/JB.00722-10; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Lemke MJ, 2009, MICROB ECOL, V57, P94, DOI 10.1007/s00248-008-9398-3; LIU Z, 2010, MICROBIOL RES; Lliros M, 2010, APPL ENVIRON MICROB, V76, P6853, DOI 10.1128/AEM.02864-09; Logares R, 2010, MOL BIOL EVOL, V27, P347, DOI 10.1093/molbev/msp239; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Merkens H, 2005, CURR MICROBIOL, V51, P59, DOI 10.1007/s00284-005-4531-8; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Narbad A, 1998, MICROBIOL-SGM, V144, P1397, DOI 10.1099/00221287-144-5-1397; Newton RJ, 2007, APPL ENVIRON MICROB, V73, P7169, DOI 10.1128/AEM.00794-07; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Oren A., 2002, HALOPHILIC MICROORGA; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Piccini C, 2006, APPL ENVIRON MICROB, V72, P6560, DOI 10.1128/AEM.01089-06; Pope PB, 2008, FEMS MICROBIOL ECOL, V64, P9, DOI 10.1111/j.1574-6941.2008.00448.x; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; RICHEY JE, 1990, LIMNOL OCEANOGR, V35, P352, DOI 10.4319/lo.1990.35.2.0352; Rogers DR, 2010, APPL ENVIRON MICROB, V76, P7938, DOI 10.1128/AEM.02056-09; Rubin MA, 2007, MICROB ECOL, V54, P374, DOI 10.1007/s00248-007-9209-2; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sharma AK, 2008, ENVIRON MICROBIOL, V10, P1039, DOI 10.1111/j.1462-2920.2007.01525.x; Shiklomanov IA., 2004, WORLD WATER RESOURCE; Sioli H., 1950, FORSCH FORTSCHRITTE, V26, P274; Urbach E, 2007, HYDROBIOLOGIA, V574, P161, DOI 10.1007/s10750-006-0351-5; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Warnecke F, 2004, ENVIRON MICROBIOL, V6, P242, DOI 10.1111/j.1462-2920.2004.00561.x; Winter C, 2007, APPL ENVIRON MICROB, V73, P421, DOI 10.1128/AEM.01849-06; Wu QL, 2006, FEMS MICROBIOL ECOL, V57, P67, DOI 10.1111/j.1574-6941.2006.00105.x; Yannarell AC, 2005, APPL ENVIRON MICROB, V71, P227, DOI 10.1128/AEM.71.1.227-239.2005; Yannarell AC, 2003, MICROB ECOL, V46, P391, DOI 10.1007/s00248-003-1008-9; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	66	141	143	5	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23785	10.1371/journal.pone.0023785	http://dx.doi.org/10.1371/journal.pone.0023785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21915244	Green Submitted, Green Published, gold			2022-12-25	WOS:000294128100031
J	Baker, PJ				Baker, Phillip J.			The pain of "chronic Lyme disease": moving the discourse in a different direction	FASEB JOURNAL			English	Article						antibiotic therapy; diagnosis; diagnostic tests		About 30% of the population of the United States suffers from acute or chronic pain, often of unknown cause. Among this group might be included patients with symptoms claimed to be caused by a poorly defined condition called "chronic Lyme disease" in which chronic pain is a major contributor. Since there is no evidence to indicate that chronic Lyme disease is due to a persistent infection and that extended antibiotic therapy is beneficial and safe, this condition should not be viewed solely as an infectious disease problem. Rather, it should be considered within the context of a broad-based, multidisciplinary approach to determining the cause of chronic pain per se and developing more effective strategies for its treatment as outlined in a recent report on pain issued by the Institute of Medicine.-Baker, P. J. The pain of "chronic Lyme disease": moving the discourse in a different direction. FASEB J. 26, 11-12 (2012). www.fasebj.org	Amer Lyme Dis Fdn, Lyme, CT 06371 USA		Baker, PJ (corresponding author), Amer Lyme Dis Fdn, POB 466, Lyme, CT 06371 USA.	executivedir@aldf.com						[Anonymous], 2011, REL PAIN AM BLUEP TR; Fallon BA, 2008, NEUROLOGY, V70, P992, DOI 10.1212/01.WNL.0000284604.61160.2d; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; Krupp LB, 2003, NEUROLOGY, V60, P1923, DOI 10.1212/01.WNL.0000071227.23769.9E; Kugeler KJ, 2011, CLIN INFECT DIS, V52, P364, DOI 10.1093/cid/ciq157; Schoen RT, 2011, NAT REV RHEUMATOL, V7, P179, DOI 10.1038/nrrheum.2010.209; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667	8	6	8	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					11	12		10.1096/fj.11-192898	http://dx.doi.org/10.1096/fj.11-192898			2	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21900506	hybrid, Green Published			2022-12-25	WOS:000299202200003
J	Tomita, T; Kuzuyama, T; Nishiyama, M				Tomita, Takeo; Kuzuyama, Tomohisa; Nishiyama, Makoto			Structural Basis for Leucine-induced Allosteric Activation of Glutamate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERINSULINISM/HYPERAMMONEMIA SYNDROME; REGULATORY MUTATIONS; CRYSTAL-STRUCTURE; MECHANISM; CHILDREN; INSIGHTS; REVEALS; DOMAIN; GENE	Glutamate dehydrogenase (GDH) catalyzes reversible conversion between glutamate and 2-oxoglutarate using NAD(P)(H) as a coenzyme. Although mammalian GDH is regulated by GTP through the antenna domain, little is known about the mechanism of allosteric activation by leucine. An extremely thermophilic bacterium, Thermus thermophilus, possesses GDH with a unique subunit configuration composed of two different subunits, GdhA (regulatory subunit) and GdhB (catalytic subunit). T. thermophilus GDH is unique in that the enzyme is subject to allosteric activation by leucine. To elucidate the structural basis for leucine-induced allosteric activation of GDH, we determined the crystal structures of the GdhB-Glu and GdhA-GdhB-Leu complexes at 2.1 and 2.6 angstrom resolution, respectively. The GdhB-Glu complex is a hexamer that binds 12 glutamate molecules: six molecules are bound at the substrate-binding sites, and the remaining six are bound at subunit interfaces, each composed of three subunits. The GdhA-GdhB-Leu complex is crystallized as a heterohexamer composed of four GdhA subunits and two GdhB subunits. In this complex, six leucine molecules are bound at subunit interfaces identified as glutamate-binding sites in the GdhB-Glu complex. Consistent with the structure, replacement of the amino acid residues of T. thermophilus GDH responsible for leucine binding made T. thermophilus GDH insensitive to leucine. Equivalent amino acid replacement caused a similar loss of sensitivity to leucine in human GDH2, suggesting that human GDH2 also uses the same allosteric site for regulation by leucine.	[Tomita, Takeo; Kuzuyama, Tomohisa; Nishiyama, Makoto] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan; [Nishiyama, Makoto] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	University of Tokyo; RIKEN	Nishiyama, M (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	umanis@mail.ecc.u-tokyo.ac.jp		Nishiyama, Makoto/0000-0001-8143-8052; Kuzuyama, Tomohisa/0000-0002-7221-5858	Ministry of Education, Culture, Sports, Science and Technology of Japan; Asahi Glass Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Asahi Glass Foundation	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the Asahi Glass Foundation.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hamza MA, 2008, FEBS LETT, V582, P1816, DOI 10.1016/j.febslet.2008.04.049; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kawakami R, 2007, J BACTERIOL, V189, P5626, DOI 10.1128/JB.00496-07; Kelly A, 2001, J CLIN ENDOCR METAB, V86, P3724, DOI 10.1210/jc.86.8.3724; Knapp S, 1997, J MOL BIOL, V267, P916, DOI 10.1006/jmbi.1996.0900; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li M, 2007, BIOCHEMISTRY-US, V46, P15089, DOI 10.1021/bi7018783; Li M, 2009, J BIOL CHEM, V284, P22988, DOI 10.1074/jbc.M109.020222; Lu CD, 2001, J BACTERIOL, V183, P490, DOI 10.1128/JB.183.2.490-499.2001; MacMullen C, 2001, J CLIN ENDOCR METAB, V86, P1782, DOI 10.1210/jc.86.4.1782; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minambres B, 2000, J BIOL CHEM, V275, P39529, DOI 10.1074/jbc.M005136200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noor S, 2005, MICROBIOL-SGM, V151, P1409, DOI 10.1099/mic.0.27751-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peterson PE, 1999, STRUCTURE, V7, P769, DOI 10.1016/S0969-2126(99)80101-4; Plaitakis A, 2000, J NEUROCHEM, V75, P1862, DOI 10.1046/j.1471-4159.2000.0751862.x; RICE DW, 1987, BIOCHEM J, V242, P789, DOI 10.1042/bj2420789; Smith TJ, 2008, TRENDS BIOCHEM SCI, V33, P557, DOI 10.1016/j.tibs.2008.07.007; Smith TJ, 2002, J MOL BIOL, V318, P765, DOI 10.1016/S0022-2836(02)00161-4; Smith TJ, 2001, J MOL BIOL, V307, P707, DOI 10.1006/jmbi.2001.4499; Stanley CA, 2000, DIABETES, V49, P667, DOI 10.2337/diabetes.49.4.667; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Stillman TJ, 1999, J MOL BIOL, V285, P875, DOI 10.1006/jmbi.1998.2335; STILLMAN TJ, 1993, J MOL BIOL, V234, P1131, DOI 10.1006/jmbi.1993.1665; Tomita T, 2010, MICROBIOL-SGM, V156, P3801, DOI 10.1099/mic.0.042721-0; WEST DJ, 1967, J BIOL CHEM, V242, P2134; YIP KSP, 1995, STRUCTURE, V3, P1147, DOI 10.1016/S0969-2126(01)00251-9	31	32	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37406	37413		10.1074/jbc.M111.260265	http://dx.doi.org/10.1074/jbc.M111.260265			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900230	Green Published, hybrid			2022-12-25	WOS:000296542400041
J	Boguslawska, J; Wojcicka, A; Piekielko-Witkowska, A; Master, A; Nauman, A				Boguslawska, Joanna; Wojcicka, Anna; Piekielko-Witkowska, Agnieszka; Master, Adam; Nauman, Alicja			MiR-224 Targets the 3 ' UTR of Type 1 5 '-Iodothyronine Deiodinase Possibly Contributing to Tissue Hypothyroidism in Renal Cancer	PLOS ONE			English	Article							MICRORNA EXPRESSION; GENE-EXPRESSION; IODOTHYRONINE DEIODINASE; HEPATOCELLULAR-CARCINOMA; TUMOR INVASIVENESS; THYROID-CARCINOMA; MESSENGER-RNA; MOUSE MODEL; KIDNEY; MICE	Type 1 iodothyronine deiodinase (DIO1) catalyses the conversion of prohormone thyroxine to the active thyroid hormone 3,3',5-triiodothyronine (T3), important regulator of cell proliferation and differentiation. DIO1 expression is reduced in the most common type of kidney neoplasia, clear cell Renal Cell Carcinoma (ccRCC). MicroRNAs are small, non-coding RNAs that regulate gene expression at posttranscriptional levels. The aim of this study was to analyze the potential regulation of DIO1 expression by microRNAs in ccRCC. Bioinformatic analysis revealed that 3'UTR of the human DIO1 gene transcript contains miR-224 and miR-383 target sites, which are conserved across mammalian species. Semi-quantitative real-time PCR was used to analyze the expression of miR-224 and miR-383 in 32 samples of ccRCC tumors (T) and in 32 matched control (C) samples. We observed statistically significant (p = 0.0002) more than four fold increase in miR-224 expression and nearly two fold increase in miR-383 expression in samples T compared to samples C. Tumor specific changes in expression of miR-224 negatively correlated with changes in DIO1 expression and intracellular T3 concentration. Transfection of HeLa cell line with miR-224 and miR-383 suppressed the activity of a luciferase reporter containing the 3'UTR of DIO1. This was abolished when constructs mutated at the miR-224 and miR-383 target sites were used instead, indicating that miR-224 and miR-383 directly bind to DIO1 3'UTR. Finally, induced expression of miR-224 in Caki-2 cells resulted in significant (p < 0.01) reduction of DIO1 mRNA. This study provides a novel miRNA-mediated regulatory mechanism of DIO1 expression in ccRCC.	[Boguslawska, Joanna; Wojcicka, Anna; Piekielko-Witkowska, Agnieszka; Master, Adam; Nauman, Alicja] Med Ctr Postgrad Educ, Dept Biochem & Mol Biol, Warsaw, Poland	Centre of Postgraduate Medical Education - Poland	Boguslawska, J (corresponding author), Med Ctr Postgrad Educ, Dept Biochem & Mol Biol, Warsaw, Poland.	anauman@cmkp.edu.pl	Piekielko-Witkowska, Agnieszka/V-1011-2019; Bogusławska, Joanna/I-7189-2019; Wojcicka, Anna/K-4134-2012	Piekielko-Witkowska, Agnieszka/0000-0002-5348-0760; Wojcicka, Anna/0000-0001-5803-6397; Master, Adam/0000-0001-9391-8846; Boguslawska, Joanna/0000-0003-2568-1546	Polish State Committee for Scientific Research [NN 401 071 939, NN 401 0386 37]; Medical Centre of Postgraduate Education [501-2-1-24-06/08]	Polish State Committee for Scientific Research(Polish State Committee for Scientific Research); Medical Centre of Postgraduate Education	The work was supported by the Polish State Committee for Scientific Research Grants (NN 401 071 939, NN 401 0386 37), and the Medical Centre of Postgraduate Education Grant (501-2-1-24-06/08) (to AN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroziak M, 2005, THYROID, V15, P1137, DOI 10.1089/thy.2005.15.1137; Anguiano B, 2008, ENDOCRINOLOGY, V149, P4209, DOI 10.1210/en.2007-1679; Arnaldi LAT, 2005, THYROID, V15, P210, DOI 10.1089/thy.2005.15.210; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Debski MG, 2007, THYROID, V17, P3, DOI 10.1089/thy.2006.0012; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Galton VA, 2009, ENDOCRINOLOGY, V150, P2957, DOI 10.1210/en.2008-1572; Garcia-Solis P, 2003, MOL CELL ENDOCRINOL, V201, P25, DOI 10.1016/S0303-7207(03)00007-8; Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grignon DJ, 2005, CLIN LAB MED, V25, P305, DOI 10.1016/j.cll.2005.01.012; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Huang Y, 2001, P NATL ACAD SCI USA, V98, P15044, DOI 10.1073/pnas.251547398; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jazdzewski K, 2011, J CLIN ENDOCR METAB, V96, pE546, DOI 10.1210/jc.2010-1594; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Klatte Tobias, 2007, Rev Urol, V9, P47; KOHRLE J, 1993, EXP CLIN ENDOCR S3, V101, P60; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lian J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.70; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Fontal R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008710; Martinez-Iglesias O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006428; Martinez-Iglesias O, 2009, CANCER RES, V69, P501, DOI 10.1158/0008-5472.CAN-08-2198; MASTER A, 2010, BIOCHIM BIOPHYS ACTA, V11, P995; Meyer ELD, 2005, CLIN ENDOCRINOL, V62, P672, DOI 10.1111/j.1365-2265.2005.02277.x; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nikiforova MN, 2008, J CLIN ENDOCR METAB, V93, P1600, DOI 10.1210/jc.2007-2696; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pachucki J, 2001, J ENDOCRINOL INVEST, V24, P253, DOI 10.1007/BF03343855; Petillo D, 2009, INT J ONCOL, V35, P109, DOI 10.3892/ijo_00000318; Piekielko-Witkowska A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013690; Piekielko-Witkowska A, 2009, THYROID, V19, P1105, DOI 10.1089/thy.2008.0284; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Suzuki H, 2002, THYROID, V12, P963, DOI 10.1089/105072502320908295; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Wu W, 2007, INT J CANCER, V120, P953, DOI 10.1002/ijc.22454; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Young AN, 2006, UROLOGY, V67, P873, DOI 10.1016/j.urology.2005.11.042; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhu XG, 2010, ONCOGENE, V29, P1909, DOI 10.1038/onc.2009.476	62	64	68	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24541	10.1371/journal.pone.0024541	http://dx.doi.org/10.1371/journal.pone.0024541			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912701	Green Published, Green Submitted, gold			2022-12-25	WOS:000294686100048
J	Chi, XX; Amet, T; Byrd, D; Chang, KH; Shah, K; Hu, NJ; Grantham, A; Hu, SS; Duan, JH; Tao, F; Nicol, G; Yu, QG				Chi, Xianxun; Amet, Tohti; Byrd, Daniel; Chang, Kuei-Hua; Shah, Kavita; Hu, Ningjie; Grantham, Ayslinn; Hu, Sishun; Duan, Jianhong; Tao, Feng; Nicol, Grant; Yu, Qigui			Direct Effects of HIV-1 Tat on Excitability and Survival of Primary Dorsal Root Ganglion Neurons: Possible Contribution to HIV-1-Associated Pain	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; RAT SENSORY NEURONS; AIDS DEMENTIA COMPLEX; CELL-DEATH; NMDA RECEPTORS; PROTEIN TAT; NEUROPATHIC PAIN; NEURAL CELLS; IN-VIVO; MEDIATED NEUROTOXICITY	The vast majority of people living with human immunodeficiency virus type 1 (HIV-1) have pain syndrome, which has a significant impact on their quality of life. The underlying causes of HIV-1-associated pain are not likely attributable to direct viral infection of the nervous system due to the lack of evidence of neuronal infection by HIV-1. However, HIV-1 proteins are possibly involved as they have been implicated in neuronal damage and death. The current study assesses the direct effects of HIV-1 Tat, one of potent neurotoxic viral proteins released from HIV-1-infected cells, on the excitability and survival of rat primary dorsal root ganglion (DRG) neurons. We demonstrated that HIV-1 Tat triggered rapid and sustained enhancement of the excitability of small-diameter rat primary DRG neurons, which was accompanied by marked reductions in the rheobase and resting membrane potential (RMP), and an increase in the resistance at threshold (R-Th). Such Tat-induced DRG hyperexcitability may be a consequence of the inhibition of cyclin-dependent kinase 5 (Cdk5) activity. Tat rapidly inhibited Cdk5 kinase activity and mRNA production, and roscovitine, a well-known Cdk5 inhibitor, induced a very similar pattern of DRG hyperexcitability. Indeed, pre-application of Tat prevented roscovitine from having additional effects on the RMP and action potentials (APs) of DRGs. However, Tat-mediated actions on the rheobase and R-Th were accelerated by roscovitine. These results suggest that Tat-mediated changes in DRG excitability are partly facilitated by Cdk5 inhibition. In addition, Cdk5 is most abundant in DRG neurons and participates in the regulation of pain signaling. We also demonstrated that HIV-1 Tat markedly induced apoptosis of primary DRG neurons after exposure for longer than 48 h. Together, this work indicates that HIV-1 proteins are capable of producing pain signaling through direct actions on excitability and survival of sensory neurons.	[Chi, Xianxun; Duan, Jianhong; Nicol, Grant] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN USA; [Amet, Tohti; Byrd, Daniel; Hu, Ningjie; Grantham, Ayslinn; Hu, Sishun; Yu, Qigui] Indiana Univ Sch Med, Ctr AIDS Res, Indianapolis, IN USA; [Amet, Tohti; Byrd, Daniel; Hu, Ningjie; Grantham, Ayslinn; Hu, Sishun; Yu, Qigui] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN USA; [Chang, Kuei-Hua; Shah, Kavita] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Chang, Kuei-Hua; Shah, Kavita] Purdue Univ, Purdue Univ Ctr Canc Res, W Lafayette, IN 47907 USA; [Tao, Feng] Johns Hopkins Univ Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Johns Hopkins University	Chi, XX (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN USA.	andyu@iupui.edu	Shah, Kavita/Y-9755-2019; Tao, Feng/Q-7827-2016	Shah, Kavita/0000-0002-0451-1305; Tao, Feng/0000-0002-0623-6298	National Center for Research Resources, National Institutes of Health (NIH) [C06 RR015481-01];  [R21AI073250]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073250, R33AI104268] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grant R21AI073250 (Dr. Yu), and by the Research Facilities Improvement Program Grant Number C06 RR015481-01 from the National Center for Research Resources, National Institutes of Health (NIH) to Indiana University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharjee S, 2010, FASEB J, V24, P4343, DOI 10.1096/fj.10-162313; APOSTOLSKI S, 1993, ANN NEUROL, V34, P855, DOI 10.1002/ana.410340616; Avraham HK, 2004, J IMMUNOL, V173, P6228, DOI 10.4049/jimmunol.173.10.6228; Bagetta G, 1996, NEUROREPORT, V7, P1722, DOI 10.1097/00001756-199607290-00005; Bodner A, 2004, EXP NEUROL, V188, P246, DOI 10.1016/j.expneurol.2004.04.009; Bodner A, 2003, J NEUROIMMUNOL, V140, P1, DOI 10.1016/S0165-5728(03)00162-0; Breitbart W, 2002, ONCOLOGY-NY, V16, P818; Buscemi L, 2007, NEUROBIOL DIS, V26, P661, DOI 10.1016/j.nbd.2007.03.004; Campbell GR, 2011, AIDS RES HUM RETROV, V27, P647, DOI [10.1089/aid.2010.0192, 10.1089/AID.2010.0192]; Center RJ, 2000, J VIROL, V74, P4448, DOI 10.1128/JVI.74.10.4448-4455.2000; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Chergui K, 2004, P NATL ACAD SCI USA, V101, P2191, DOI 10.1073/pnas.0308652100; Cheung ZH, 2004, NEUROSCI LETT, V361, P47, DOI 10.1016/j.neulet.2003.12.117; Chi XX, 2007, J NEUROPHYSIOL, V98, P2683, DOI 10.1152/jn.00437.2007; Choe W, 2000, J NEUROVIROL, V6, pS61; Corasaniti MT, 2001, FUNCT NEUROL, V16, P31; Darbinian N, 2008, J CELL PHYSIOL, V216, P128, DOI 10.1002/jcp.21382; Del Borgo C, 2001, AIDS PATIENT CARE ST, V15, P95, DOI 10.1089/108729101300003690; DELAMONTE SM, 1987, NEUROLOGY, V37, P562, DOI 10.1212/WNL.37.4.562; DIXON P, 1991, POSTGRAD MED J, V67, pS92; Edmunds-Oguokiri Tina, 2007, HIV Clin, V19, P7; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Eugenin EA, 2011, NEUROTOX RES, V19, P138, DOI 10.1007/s12640-010-9150-x; Eugenin EA, 2003, J NEUROCHEM, V85, P1299, DOI 10.1046/j.1471-4159.2003.01775.x; Eugenin EA, 2007, P NATL ACAD SCI USA, V104, P3438, DOI 10.1073/pnas.0611699104; Evans AR, 1999, J PHYSIOL-LONDON, V516, P163, DOI 10.1111/j.1469-7793.1999.163aa.x; GRAHAM DR, 2010, J NEUROVIROL; Gray G, 2007, PAIN, V132, pS13, DOI 10.1016/j.pain.2007.10.009; Haughey NJ, 1999, J NEUROCHEM, V73, P1363, DOI 10.1046/j.1471-4159.1999.0731363.x; Haughey NJ, 2001, J NEUROCHEM, V78, P457, DOI 10.1046/j.1471-4159.2001.00396.x; Hayashi K, 2006, J CEREBR BLOOD F MET, V26, P1052, DOI 10.1038/sj.jcbfm.9600254; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; Hesselgesser J, 1997, CURR BIOL, V7, P112, DOI 10.1016/S0960-9822(06)00055-8; Hewitt DJ, 1997, PAIN, V70, P117, DOI 10.1016/S0304-3959(96)03281-2; HIRSCHFELD S, 1995, PEDIATR AIDS HIV INF, V6, P63; Hirschfeld S, 1998, AIDS PATIENT CARE ST, V12, P91, DOI 10.1089/apc.1998.12.91; HOLZER P, 1991, ADV EXP MED BIOL, V298, P3; HOLZER P, 1991, PHARMACOL REV, V43, P143; Hughes AM, 1999, AM J NURS, V99, P20, DOI 10.2307/3472132; Jones G, 2006, NEUROBIOL DIS, V21, P1, DOI 10.1016/j.nbd.2005.07.018; Kanungo J, 2008, J NEUROCHEM, V106, P2236, DOI 10.1111/j.1471-4159.2008.05551.x; Keswani SC, 2003, ANN NEUROL, V54, P287, DOI 10.1002/ana.10645; Kim HJ, 2008, J NEUROSCI, V28, P12604, DOI 10.1523/JNEUROSCI.2958-08.2008; King JE, 2006, MICROBES INFECT, V8, P1347, DOI 10.1016/j.micinf.2005.11.014; King JE, 2010, AM J PATHOL, V176, P2819, DOI 10.2353/ajpath.2010.090642; Kruman II, 1998, EXP NEUROL, V154, P276, DOI 10.1006/exnr.1998.6958; LEBOVITS AH, 1989, CLIN J PAIN, V5, P245, DOI 10.1097/00002508-198909000-00009; Li BS, 2002, EMBO J, V21, P324, DOI 10.1093/emboj/21.3.324; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Li W, 2005, NEUROTOX RES, V8, P119, DOI 10.1007/BF03033824; Li WX, 2008, J NEUROSCI, V28, P12190, DOI 10.1523/JNEUROSCI.3019-08.2008; Lim SP, 2000, J VIROL, V74, P1632, DOI 10.1128/JVI.74.4.1632-1640.2000; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Longordo F, 2006, J PHARMACOL EXP THER, V317, P1097, DOI 10.1124/jpet.105.099630; Lopshire JC, 1998, J NEUROSCI, V18, P6081; MAGNUSON DSK, 1995, ANN NEUROL, V37, P373, DOI 10.1002/ana.410370314; Mattson MP, 2005, CELL DEATH DIFFER, V12, P893, DOI 10.1038/sj.cdd.4401577; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Minami T, 2003, NEUROPHARMACOLOGY, V45, P96, DOI 10.1016/S0028-3908(03)00133-3; NAVIA BA, 1986, ANN NEUROL, V19, P525, DOI 10.1002/ana.410190603; NAVIA BA, 1986, ANN NEUROL, V19, P517, DOI 10.1002/ana.410190602; Norval DA, 2004, SAMJ S AFR MED J, V94, P450; Oh SB, 2001, J NEUROSCI, V21, P5027, DOI 10.1523/JNEUROSCI.21-14-05027.2001; ONEILL WM, 1993, PAIN, V54, P3, DOI 10.1016/0304-3959(93)90093-5; Pareek TK, 2006, CELL CYCLE, V5, P585, DOI 10.4161/cc.5.6.2578; Pareek TK, 2006, P NATL ACAD SCI USA, V103, P791, DOI 10.1073/pnas.0510405103; PENFOLD J, 1992, CAN J ANAESTH, V39, P724, DOI 10.1007/BF03008237; Perry SW, 2010, J NEUROSCI, V30, P14153, DOI 10.1523/JNEUROSCI.1042-10.2010; Peruzzi F, 2002, J NEUROVIROL, V8, P91, DOI 10.1080/13550280290167885; Price RW, 2000, TRENDS MICROBIOL, V8, P387, DOI 10.1016/S0966-842X(00)01821-7; Ramirez SH, 2001, J NEUROCHEM, V78, P874, DOI 10.1046/j.1471-4159.2001.00467.x; RANKI A, 1995, AIDS, V9, P1001, DOI 10.1097/00002030-199509000-00004; Richardson JD, 2002, J PHARMACOL EXP THER, V302, P839, DOI 10.1124/jpet.102.032797; Robertson K, 1998, J NEUROVIROL, V4, P90, DOI 10.3109/13550289809113485; Robinson B, 2007, J NEUROVIROL, V13, P160, DOI 10.1080/13550280701200102; Sambamoorthi U, 2000, AIDS PUBLIC POLICY J, V15, P136; Self RL, 2004, BRAIN RES, V995, P39, DOI 10.1016/j.brainres.2003.09.052; Sharma M, 2007, BIOCHEM BIOPH RES CO, V358, P379, DOI 10.1016/j.bbrc.2007.04.149; SINGER EJ, 1993, PAIN, V54, P15, DOI 10.1016/0304-3959(93)90094-6; Song L, 2003, J NEUROVIROL, V9, P399, DOI 10.1080/13550280390201704; Sun KH, 2008, J NEUROCHEM, V107, P265, DOI 10.1111/j.1471-4159.2008.05616.x; Sun KH, 2008, MOL BIOL CELL, V19, P3052, DOI 10.1091/mbc.E07-11-1106; Tanaka T, 2001, J NEUROSCI, V21, P550, DOI 10.1523/JNEUROSCI.21-02-00550.2001; TARDIEU M, 1992, ANN NEUROL, V32, P11, DOI 10.1002/ana.410320104; Tong CK, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-44; Utreras E, 2009, NEUROSCIENCE, V161, P978, DOI 10.1016/j.neuroscience.2009.04.002; Utreras E, 2009, J BIOL CHEM, V284, P2275, DOI 10.1074/jbc.M805052200; Verma S, 2005, CNS DRUGS, V19, P325, DOI 10.2165/00023210-200519040-00005; Wallace VCJ, 2007, PAIN, V133, P47, DOI 10.1016/j.pain.2007.02.015; Wallace VCJ, 2007, BRAIN, V130, P2688, DOI 10.1093/brain/awm195; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Yao HH, 2009, J NEUROSCI, V29, P1657, DOI 10.1523/JNEUROSCI.2781-08.2009	94	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24412	10.1371/journal.pone.0024412	http://dx.doi.org/10.1371/journal.pone.0024412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912693	Green Published, Green Submitted, gold			2022-12-25	WOS:000294686100040
J	Sandholt, CH; Vestmar, MA; Bille, DS; Borglykke, A; Almind, K; Hansen, L; Sandaek, A; Lauritzen, T; Witte, D; Jorgensen, T; Pedersen, O; Hansen, T				Sandholt, Camilla Helene; Vestmar, Marie Aare; Bille, Dorthe Sadowa; Borglykke, Anders; Almind, Katrine; Hansen, Lars; Sandaek, Annelli; Lauritzen, Torsten; Witte, Daniel; Jorgensen, Torben; Pedersen, Oluf; Hansen, Torben			Studies of Metabolic Phenotypic Correlates of 15 Obesity Associated Gene Variants	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NEUROTROPHIC FACTOR BDNF; BODY-MASS INDEX; FTO GENE; COMMON VARIANTS; ENERGY-BALANCE; EARLY-ONSET; FAT MASS; ADULT; MC4R	Aims: Genome-wide association studies have identified novel BMI/obesity associated susceptibility loci. The purpose of this study is to determine associations with overweight, obesity, morbid obesity and/or general adiposity in a Danish population. Moreover, we want to investigate if these loci associate with type 2 diabetes and to elucidate potential underlying metabolic mechanisms. Methods: 15 gene variants in 14 loci including TMEM18 (rs7561317), SH2B1 (rs7498665), KCTD15 (rs29941), NEGR1 (rs2568958), ETV5 (rs7647305), BDNF (rs4923461, rs925946), SEC16B (rs10913469), FAIM2 (rs7138803), GNPDA2 (rs10938397), MTCH2 (rs10838738), BAT2 (rs2260000), NPC1 (rs1805081), MAF (rs1424233), and PTER (rs10508503) were genotyped in 18,014 middle-aged Danes. Results: Five of the 15 gene variants associated with overweight, obesity and/or morbid obesity. Per allele ORs ranged from 1.15-1.20 for overweight, 1.10-1.25 for obesity, and 1.41-1.46 for morbid obesity. Five of the 15 variants moreover associated with increased measures of adiposity. BDNF rs4923461 displayed a borderline BMI-dependent protective effect on type 2 diabetes (0.87 (0.78-0.96, p = 0.008)), whereas SH2B1 rs7498665 associated with nominally BMI-independent increased risk of type 2 diabetes (1.16 (1.07-1.27, p = 7.8x10(-4))). Conclusions: Associations with overweight and/or obesity and measures of obesity were confirmed for seven out of the 15 gene variants. The obesity risk allele of BDNF rs4923461 protected against type 2 diabetes, which could suggest neuronal and peripheral distinctive ways of actions for the protein. SH2B1 rs7498665 associated with type 2 diabetes independently of BMI.	[Sandholt, Camilla Helene; Vestmar, Marie Aare; Bille, Dorthe Sadowa; Pedersen, Oluf; Hansen, Torben] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Fac Hlth Sci, Copenhagen, Denmark; [Sandholt, Camilla Helene; Almind, Katrine] Novo Nordisk AS, Biomarkers Inflammat & GH, Global Dev, Bagsvaerd, Denmark; [Vestmar, Marie Aare; Jorgensen, Torben; Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Bille, Dorthe Sadowa] Holbaek Cent Hosp, Dept Paediat, Holbaek, Denmark; [Borglykke, Anders; Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Hansen, Lars] Bristol Meyers Squibb & Co, Discovery Med & Clin Pharmacol, CV Metab Dis, Princeton, NJ USA; [Sandaek, Annelli; Lauritzen, Torsten] Univ Aarhus, Dept Gen Practice, Aarhus, Denmark; [Witte, Daniel] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark	Novo Nordisk Foundation; University of Copenhagen; Novo Nordisk; University of Copenhagen; Holbaek Hospital; University of Copenhagen; Aarhus University; Steno Diabetes Center; Aarhus University; University of Southern Denmark	Sandholt, CH (corresponding author), Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Fac Hlth Sci, Copenhagen, Denmark.	cila@novonordisk.com	Pedersen, Oluf/AAG-8015-2020; Witte, Daniel/AAF-9535-2019; Witte, Daniel R/C-1722-2008; Jørgensen, Torben/Z-1335-2018; Pedersen, Oluf/Z-1731-2019	Witte, Daniel/0000-0002-0769-2922; Witte, Daniel R/0000-0002-0769-2922; Pedersen, Oluf/0000-0002-3321-3972; Jorgensen, Torben/0000-0001-9453-2830; Hansen, Torben/0000-0001-8748-3831	Novo Nordisk Foundation; Lundbeck Foundation Centre; Danish Health Research Council; FOOD Study Group/the Danish Ministry of Food, Agriculture and Fisheries and Ministry of Family and Consumer Affairs [2101-05-0044]; Novo Nordisk A/S Research & Development Corporate Research Affairs; Danish Ministry of Science Technology and Innovation; Faculty of Health Sciences of Aarhus University; Danish Clinical Intervention Research Academy; Danish Diabetes Association; European Commission [LSHM-CT-2005-018734]; The Danish Obesity Research centre (DanORC); Danish Council for Strategic Research [2101-06-0005]; Danish Research Counsil; Danish Centre for Health Technology Assessment; Novo Nordisk Inc.; Research Foundation of Copenhagen County; Ministry of Internal Affaires and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Becket Foundation; National Health Services in the counties of Copenhagen, Aarhus, Ringkobing, Ribe; South Jutland in Denmark; Danish Research Foundation for General Practice; Danish Centre for Evaluation and Health Technology Assessment; National Board of Health; Danish Medical Research Council; Aarhus University Research Foundation; Novo Nordisk A/S; Novo Nordisk Scandinavia AB, ASTRA Denmark; Pfizer Denmark; GlaxoSmithKline Pharma Denmark; SERVIER Denmark A/S; HemoCue Denmark A/S	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation Centre; Danish Health Research Council; FOOD Study Group/the Danish Ministry of Food, Agriculture and Fisheries and Ministry of Family and Consumer Affairs; Novo Nordisk A/S Research & Development Corporate Research Affairs(Novo Nordisk); Danish Ministry of Science Technology and Innovation; Faculty of Health Sciences of Aarhus University; Danish Clinical Intervention Research Academy; Danish Diabetes Association; European Commission(European CommissionEuropean Commission Joint Research Centre); The Danish Obesity Research centre (DanORC); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Research Counsil; Danish Centre for Health Technology Assessment; Novo Nordisk Inc.(Novo Nordisk); Research Foundation of Copenhagen County; Ministry of Internal Affaires and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Becket Foundation; National Health Services in the counties of Copenhagen, Aarhus, Ringkobing, Ribe; South Jutland in Denmark; Danish Research Foundation for General Practice; Danish Centre for Evaluation and Health Technology Assessment; National Board of Health; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Aarhus University Research Foundation; Novo Nordisk A/S(Novo Nordisk); Novo Nordisk Scandinavia AB, ASTRA Denmark(Novo Nordisk); Pfizer Denmark(Pfizer); GlaxoSmithKline Pharma Denmark(GlaxoSmithKline); SERVIER Denmark A/S; HemoCue Denmark A/S	The Novo Nordisk Foundation Center for Basic Metabolic Research is funded by the Novo Nordisk Foundation. The study was supported by the Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCAMP), and by grants from the Danish Health Research Council, the FOOD Study Group/the Danish Ministry of Food, Agriculture and Fisheries and Ministry of Family and Consumer Affairs (grant no. 2101-05-0044), Novo Nordisk A/S Research & Development Corporate Research Affairs, the Danish Ministry of Science Technology and Innovation, the Faculty of Health Sciences of Aarhus University, the Danish Clinical Intervention Research Academy, and the Danish Diabetes Association. This study is moreover a part of the project "Hepatic and adipose tissue and functions in the metabolic syndrome'' (HEPADIP; www.hepadip.org), which is supported by the European Commission as an integrated project under the 6th Framework Programme (LSHM-CT-2005-018734), and it received support from The Danish Obesity Research centre (DanORC; www.danorc.dk), which is supported by The Danish Council for Strategic Research (Grant No 2101-06-0005). The Inter99 project was initiated by: T. Jorgensen (PI), K. Borch-Johnsen (co-PI), H. Ibsen and T. F. Thomsen. The steering committee comprises the former two and C. Pisinger. The Inter99 project was financially supported by research grants from the Danish Research Counsil, The Danish Centre for Health Technology Assessment, Novo Nordisk Inc., Research Foundation of Copenhagen County, Ministry of Internal Affaires and Health, The Danish Heart Foundation, The Danish Pharmaceutical Association, The Augustinus Foundation, The Ib Henriksen Foundation, and the Becket Foundation. The ADDITION Denmark trial was supported by the National Health Services in the counties of Copenhagen, Aarhus, Ringkobing, Ribe, and South Jutland in Denmark, the Danish Research Foundation for General Practice, the Danish Centre for Evaluation and Health Technology Assessment, the Diabetes Fund of the National Board of Health, the Danish Medical Research Council, the Aarhus University Research Foundation, and Novo Nordisk Foundation. The ADDITION Denmark trial has been given unrestricted grants from Novo Nordisk A/S, Novo Nordisk Scandinavia AB, ASTRA Denmark, Pfizer Denmark, GlaxoSmithKline Pharma Denmark, SERVIER Denmark A/S, and HemoCue Denmark A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almen MS, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-58; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Bauer F, 2009, AM J CLIN NUTR, V90, P951, DOI 10.3945/ajcn.2009.27781; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Cornes BK, 2009, INT J OBESITY, V33, P75, DOI 10.1038/ijo.2008.223; Duan CJ, 2004, MOL CELL BIOL, V24, P7435, DOI 10.1128/MCB.24.17.7435-7443.2004; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Haupt A, 2010, OBESITY, V18, P1212, DOI 10.1038/oby.2009.413; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hofker M, 2009, NAT GENET, V41, P139, DOI 10.1038/ng0209-139; Holzapfel C, 2010, INT J OBESITY, V34, P1538, DOI 10.1038/ijo.2010.79; Hotta K, 2009, J HUM GENET, V54, P727, DOI 10.1038/jhg.2009.106; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kilpelainen TO, 2009, HUM MOL GENET, V18, P3496, DOI 10.1093/hmg/ddp280; Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4; Kring SII, 2010, INT J OBESITY, V34, P182, DOI 10.1038/ijo.2009.215; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Li M, 2006, ENDOCRINOLOGY, V147, P2163, DOI 10.1210/en.2005-1313; Liu QR, 2005, AM J MED GENET B, V134B, P93, DOI 10.1002/ajmg.b.30109; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Maures TJ, 2007, TRENDS ENDOCRIN MET, V18, P38, DOI 10.1016/j.tem.2006.11.007; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Morris DL, 2009, DIABETES, V58, P2039, DOI 10.2337/db08-1388; Nakagawa T, 2000, DIABETES, V49, P436, DOI 10.2337/diabetes.49.3.436; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Ono M, 1997, BIOCHEM BIOPH RES CO, V238, P633, DOI 10.1006/bbrc.1997.7220; Peeters A, 2008, MOL GENET METAB, V93, P481, DOI 10.1016/j.ymgme.2007.10.011; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Sandholt CH, 2010, DIABETES, V59, P1667, DOI 10.2337/db09-1042; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; SORENSEN TIA, 1989, REV EPIDEMIOL SANTE, V37, P525; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Zobel DP, 2009, DIABETES, V58, P757, DOI 10.2337/db08-0620	44	50	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e23531	10.1371/journal.pone.0023531	http://dx.doi.org/10.1371/journal.pone.0023531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912638	Green Published, Green Submitted, gold			2022-12-25	WOS:000294686100003
J	Zeng, Z; Shi, F; Zhou, L; Zhang, MN; Chen, Y; Chang, XJ; Lu, YY; Bai, WL; Qu, JH; Wang, CP; Wang, H; Lou, M; Wang, FS; Lv, JY; Yang, YP				Zeng, Zhen; Shi, Feng; Zhou, Lin; Zhang, Min-Na; Chen, Yan; Chang, Xiu-Juan; Lu, Yin-Ying; Bai, Wen-Lin; Qu, Jian-Hui; Wang, Chun-Ping; Wang, Hong; Lou, Min; Wang, Fu-Sheng; Lv, Ji-Yun; Yang, Yong-Ping			Upregulation of Circulating PD-L1/PD-1 Is Associated with Poor Post-Cryoablation Prognosis in Patients with HBV-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							T-CELL APOPTOSIS; BREAST-CANCER; B7-H1 PD-L1; POSTOPERATIVE RECURRENCE; CLINICAL-SIGNIFICANCE; CRYO-IMMUNOLOGY; TUMOR; EXPRESSION; ANTIGEN; DEATH-1	Background: The programmed cell death-1 receptor/programmed cell death-1 ligand (PD-1/PD-L1) pathway plays a crucial role in tumor evasion from host immunity. This study was designed to evaluate the association between circulating PD-L1/PD-1 and prognosis after cryoablation in patients with HBV-related hepatocellular carcinoma (HCC). Methodology/Principal Findings: In the present study, 141 HBV-related HCC patients were enrolled and of those 109 patients received cryoablation. Circulating PD-L1/PD-1 expression was tested by flow cytometry, and 23 patients were simultaneously evaluated for intratumoral PD-L1 expression by immunohistochemical staining. Circulating PD-1/PD-L1 expression was associated with severity of diseases in patients with HCC, and the circulating PD-L1 expression was closely correlated with intratumoral PD-L1 expression. Of the clinical parameters, PD-1/PD-L1 expression was associated with tumor size, blood vessel invasion and BCLC staging. Moreover, PD-1/PD-L1 expression dropped after cryoablation while being elevated at the time of tumor recurrence. Patients with higher expression of circulating PD-L1, as well as circulating PD-1, had a significantly shorter overall survival and tumor-free survival than those with lower expression. Multivariate analysis confirmed that circulating PD-L1 could serve as an independent predictor of overall survival and tumor-recurrence survival in HCC patients after cryoablation. Conclusions/Significance: Upregulation of circulating PD-L1/PD-1 is associated with poor post-cryoablation prognosis in patients with HBV-related hepatocellular carcinoma.	[Zeng, Zhen; Zhou, Lin; Zhang, Min-Na; Chen, Yan; Chang, Xiu-Juan; Lu, Yin-Ying; Bai, Wen-Lin; Qu, Jian-Hui; Wang, Chun-Ping; Wang, Hong; Lou, Min; Lv, Ji-Yun; Yang, Yong-Ping] Beijing 302 Hosp, Ctr Therapeut Res Hepatocellular Carcinoma, Beijing, Peoples R China; [Shi, Feng; Wang, Fu-Sheng; Lv, Ji-Yun] Beijing 302 Hosp, Res Ctr Biol Therapy, Beijing, Peoples R China; [Shi, Feng] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Chinese Academy of Sciences; Institute of Microbiology, CAS	Zeng, Z (corresponding author), Beijing 302 Hosp, Ctr Therapeut Res Hepatocellular Carcinoma, Beijing, Peoples R China.	yongpingyang@hotmail.com			Key Scientific and Technological Research Foundation of the National Special-Purpose Program [2008ZX10002-018]; Fund of Capital Medical Development and Research [2007-1021, 2009-2041]	Key Scientific and Technological Research Foundation of the National Special-Purpose Program; Fund of Capital Medical Development and Research	This study is supported by the Key Scientific and Technological Research Foundation of the National Special-Purpose Program, No. 2008ZX10002-018; Fund of Capital Medical Development and Research (2007-1021, 2009-2041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Ascierto PA, 2010, SEMIN ONCOL, V37, P508, DOI 10.1053/j.seminoncol.2010.09.008; Campbell DE, 2009, CLIN VACCINE IMMUNOL, V16, P1648, DOI 10.1128/CVI.00259-09; Chen J, 2008, WORLD J GASTROENTERO, V14, P6853, DOI 10.3748/wjg.14.6853; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Fourcade J, 2009, J IMMUNOL, V182, P5240, DOI 10.4049/jimmunol.0803245; Gao Q, 2009, CLIN CANCER RES, V15, P971, DOI 10.1158/1078-0432.CCR-08-1608; Gehring AJ, 2009, GASTROENTEROLOGY, V137, P682, DOI 10.1053/j.gastro.2009.04.045; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hayakawa S, 2006, MED HYPOTHESES, V66, P888, DOI 10.1016/j.mehy.2005.12.010; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Lencioni R, 2010, ONCOLOGIST, V15, P42, DOI 10.1634/theoncologist.2010-S4-42; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Martin-Orozco N, 2007, SEMIN CANCER BIOL, V17, P288, DOI 10.1016/j.semcancer.2007.06.003; Nakanishi J, 2007, CANCER IMMUNOL IMMUN, V56, P1173, DOI 10.1007/s00262-006-0266-z; Nishimura H, 2001, TRENDS IMMUNOL, V22, P265, DOI 10.1016/S1471-4906(01)01888-9; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469; Osada S, 2007, J SURG ONCOL, V95, P491, DOI 10.1002/jso.20712; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Peng GP, 2008, MOL IMMUNOL, V45, P963, DOI 10.1016/j.molimm.2007.07.038; Poon RTP, 2007, ANN SURG ONCOL, V14, P1835, DOI 10.1245/s10434-007-9366-z; Poon RTP, 2000, CANCER, V89, P500, DOI 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.3.CO;2-F; Poston G, 2001, HEPATO-GASTROENTEROL, V48, P323; Rilling WS, 2002, J VASC INTERV RADIOL, V13, pS259, DOI 10.1016/S1051-0443(07)61794-1; Sabel MS, 2006, CRYOBIOLOGY, V53, P360, DOI 10.1016/j.cryobiol.2006.07.004; Sabel MS, 2009, CRYOBIOLOGY, V58, P1, DOI 10.1016/j.cryobiol.2008.10.126; Sabel MS, 2005, BREAST CANCER RES TR, V90, P97, DOI 10.1007/s10549-004-3289-1; Samuel M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001199.pub2; Schreiner B, 2004, J NEUROIMMUNOL, V155, P172, DOI 10.1016/j.jneuroim.2004.06.013; Shi F, 2011, INT J CANCER, V128, P887, DOI 10.1002/ijc.25397; SHULMAN S, 1968, IMMUNOLOGY, V14, P149; Thompson RH, 2007, CLIN CANCER RES, V13, P1757, DOI 10.1158/1078-0432.CCR-06-2599; Wang CP, 2009, CLIN EXP METASTAS, V26, P839, DOI 10.1007/s10585-009-9283-6; Wang ZL, 2008, J GASTROINTEST SURG, V12, P327, DOI 10.1007/s11605-007-0310-0; Xie ZY, 2009, IMMUNOL INVEST, V38, P624, DOI 10.1080/08820130903062210; Yamamoto R, 2008, BLOOD, V111, P3220, DOI 10.1182/blood-2007-05-085159; YANTORNO C, 1967, IMMUNOLOGY, V12, P395; Zhou L, 2010, J GASTROENTEROL, V45, P968, DOI 10.1007/s00535-010-0243-3	43	136	147	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e23621	10.1371/journal.pone.0023621	http://dx.doi.org/10.1371/journal.pone.0023621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21912640	Green Published, Green Submitted, gold			2022-12-25	WOS:000294683900005
J	Paxson, JA; Gruntman, A; Parkin, CD; Mazan, MR; Davis, A; Ingenito, EP; Hoffman, AM				Paxson, Julia A.; Gruntman, Alisha; Parkin, Christopher D.; Mazan, Melissa R.; Davis, Airiel; Ingenito, Edward P.; Hoffman, Andrew M.			Age-Dependent Decline in Mouse Lung Regeneration with Loss of Lung Fibroblast Clonogenicity and Increased Myofibroblastic Differentiation	PLOS ONE			English	Article							POSTPNEUMONECTOMY LUNG; GENE-EXPRESSION; GROWTH; CELLS; PNEUMONECTOMY; PROFILES; MATRIX	While aging leads to a reduction in the capacity for regeneration after pneumonectomy (PNX) in most mammals, this biological phenomenon has not been characterized over the lifetime of mice. We measured the age-specific (3, 9, 24 month) effects of PNX on physiology, morphometry, cell proliferation and apoptosis, global gene expression, and lung fibroblast phenotype and clonogenicity in female C57BL6 mice. The data show that only 3 month old mice were fully capable of restoring lung volumes by day 7 and total alveolar surface area by 21 days. By 9 months, the rate of regeneration was slower (with incomplete regeneration by 21 days), and by 24 months there was no regrowth 21 days post-PNX. The early decline in regeneration rate was not associated with changes in alveolar epithelial cell type II (AECII) proliferation or apoptosis rate. However, significant apoptosis and lack of cell proliferation was evident after PNX in both total cells and AECII cells in 24 mo mice. Analysis of gene expression at several time points (1, 3 and 7 days) post-PNX in 9 versus 3 month mice was consistent with a myofibroblast signature (increased Tnc, Lox1, Col3A1, Eln and Tnfrsf12a) and more alpha smooth muscle actin (alpha SMA) positive myofibroblasts were present after PNX in 9 month than 3 month mice. Isolated lung fibroblasts showed a significant age-dependent loss of clonogenicity. Moreover, lung fibroblasts isolated from 9 and 17 month mice exhibited higher alpha SMA, Col3A1, Fn1 and S100A expression, and lower expression of the survival gene Mdk consistent with terminal differentiation. These data show that concomitant loss of clonogenicity and progressive myofibroblastic differentiation contributes to the age-dependent decline in the rate of lung regeneration.	[Paxson, Julia A.; Gruntman, Alisha; Mazan, Melissa R.; Davis, Airiel; Hoffman, Andrew M.] Tufts Univ, Cummings Sch Vet Med, North Grafton, MA 01536 USA; [Parkin, Christopher D.] Tufts Univ, Sch Med, Ctr Neurosci Res, Boston, MA 02111 USA; [Ingenito, Edward P.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	Tufts University; Tufts University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Paxson, JA (corresponding author), Tufts Univ, Cummings Sch Vet Med, North Grafton, MA 01536 USA.	andrew.hoffman@tufts.edu	Mazan, Melissa/L-3290-2019		NHLBI [072780-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072780] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by NHLBI 072780-02 (EI/AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bocchino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014003; BRODY JS, 1978, AM REV RESPIR DIS, V117, P307; CAGLE PT, 1988, PEDIATR PULM, V5, P92, DOI 10.1002/ppul.1950050205; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chapman KE, 2005, AM J PHYSIOL-LUNG C, V289, pL834, DOI 10.1152/ajplung.00069.2005; COLEBATCH HJH, 1979, J APPL PHYSIOL, V47, P683, DOI 10.1152/jappl.1979.47.4.683; CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617, DOI 10.1152/physrev.1993.73.3.617; Daly HE, 1997, TOXICOL APPL PHARM, V142, P303, DOI 10.1006/taap.1996.8056; Drummond-Barbosa D, 2008, GENETICS, V180, P1787, DOI 10.1534/genetics.108.098244; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fehrenbach H, 2008, EUR RESPIR J, V31, P515, DOI 10.1183/09031936.00109407; Gonda TA, 2010, SEMIN CELL DEV BIOL, V21, P2, DOI 10.1016/j.semcdb.2009.10.001; Han JH, 2010, CARDIOVASC RES, V87, P147, DOI 10.1093/cvr/cvq024; Hoffman AM, 2010, AM J PHYSIOL-LUNG C, V298, pL158, DOI 10.1152/ajplung.90594.2008; HOLMES C, 1979, AM REV RESPIR DIS, V120, P1125; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Jin JL, 2009, AGING-US, V1, P582, DOI 10.18632/aging.100060; Katsara O, 2011, STEM CELLS DEV; LAROS CD, 1987, J THORAC CARDIOV SUR, V93, P570; Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230; Li JN, 2007, J LEUKOCYTE BIOL, V81, P328, DOI 10.1189/jlb.0206124; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Miller MR, 2010, SEMIN RESP CRIT CARE, V31, P521, DOI 10.1055/s-0030-1265893; Misra V, 2007, PHYSIOL GENOMICS, V31, P429, DOI 10.1152/physiolgenomics.00060.2007; Mora AL, 2008, J CELL BIOCHEM, V105, P641, DOI 10.1002/jcb.21890; Nolen-Walston RD, 2008, AM J PHYSIOL-LUNG C, V294, pL1158, DOI 10.1152/ajplung.00298.2007; Paxson JA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-92; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SCHERLE W, 1970, Mikroskopie, V26, P57; Shifren A, 2007, AM J PHYSIOL-LUNG C, V292, pL778, DOI 10.1152/ajplung.00352.2006; Silva H., 2008, AGING STEM CELL RENE; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Srisuma S, 2010, AM J RESP CRIT CARE, V181, P838, DOI 10.1164/rccm.200904-0544OC; Stoner G D, 1980, Methods Cell Biol, V21A, P65, DOI 10.1016/S0091-679X(08)60758-X; Sugahara K, 1998, CELL TISSUE RES, V291, P295, DOI 10.1007/s004410050999; Sun Y, 2011, FASEB J; Voswinckel R, 2004, EUR RESPIR J, V24, P524, DOI 10.1183/09031936.04.10004904; Votteler M, 2010, MACROMOL BIOSCI, V10, P1302, DOI 10.1002/mabi.201000102; Wagner W, 2010, AGING-US, V2, P224, DOI 10.18632/aging.100136; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Wolff JC, 2010, EUR RESPIR J, V35, P655, DOI 10.1183/09031936.00059709	42	44	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e23232	10.1371/journal.pone.0023232	http://dx.doi.org/10.1371/journal.pone.0023232			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912590	gold, Green Published, Green Submitted			2022-12-25	WOS:000294678300003
J	Alic, L; Haeck, JC; Bol, K; Klein, S; van Tiel, ST; Wielepolski, PA; de Jong, M; Niessen, WJ; Bernsen, M; Veenland, JF				Alic, Lejla; Haeck, Joost C.; Bol, Karin; Klein, Stefan; van Tiel, Sandra T.; Wielepolski, Piotr A.; de Jong, Marion; Niessen, Wiro J.; Bernsen, Monique; Veenland, Jifke F.			Facilitating Tumor Functional Assessment by Spatially Relating 3D Tumor Histology and In Vivo MRI: Image Registration Approach	PLOS ONE			English	Article							MUTUAL INFORMATION; SECTIONS; OPTIMIZATION; METHODOLOGY; PROSTATE; ANIMALS; CANCER	Background: Magnetic resonance imaging (MRI), together with histology, is widely used to diagnose and to monitor treatment in oncology. Spatial correspondence between these modalities provides information about the ability of MRI to characterize cancerous tissue. However, registration is complicated by deformations during pathological processing, and differences in scale and information content. Methodology/Principal Findings: This study proposes a methodology for establishing an accurate 3D relation between histological sections and high resolution in vivo MRI tumor data. The key features of the methodology are: 1) standardized acquisition and processing, 2) use of an intermediate ex vivo MRI, 3) use of a reference cutting plane, 4) dense histological sampling, 5) elastic registration, and 6) use of complete 3D data sets. Five rat pancreatic tumors imaged by T2*-w MRI were used to evaluate the proposed methodology. The registration accuracy was assessed by root mean squared (RMS) distances between manually annotated landmark points in both modalities. After elastic registration the average RMS distance decreased from 1.4 to 0.7 mm. The intermediate ex vivo MRI and the reference cutting plane shared by all three 3D images (in vivo MRI, ex vivo MRI, and 3D histology data) were found to be crucial for the accurate co-registration between the 3D histological data set and in vivo MRI. The MR intensity in necrotic regions, as manually annotated in 3D histology, was significantly different from other histologically confirmed regions (i.e., viable and hemorrhagic). However, the viable and the hemorrhagic regions showed a large overlap in T2*-w MRI signal intensity. Conclusions: The established 3D correspondence between tumor histology and in vivo MRI enables extraction of MRI characteristics for histologically confirmed regions. The proposed methodology allows the creation of a tumor database of spatially registered multi-spectral MR images and multi-stained 3D histology.	[Alic, Lejla; Haeck, Joost C.; Bol, Karin; Klein, Stefan; Niessen, Wiro J.; Veenland, Jifke F.] Erasmus MC, Dept Radiol & Med Informat, Biomed Imaging Grp Rotterdam, Rotterdam, Netherlands; [Alic, Lejla; Haeck, Joost C.; Bol, Karin; Klein, Stefan; van Tiel, Sandra T.; Wielepolski, Piotr A.; Niessen, Wiro J.; Bernsen, Monique; Veenland, Jifke F.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Haeck, Joost C.; Bol, Karin; de Jong, Marion] Erasmus MC, Dept Nucl Med, Rotterdam, Netherlands; [Niessen, Wiro J.] Delft Univ Technol, Fac Sci Appl, Delft, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology	Alic, L (corresponding author), Erasmus MC, Dept Radiol & Med Informat, Biomed Imaging Grp Rotterdam, Rotterdam, Netherlands.	LejlaResearch@gmail.com	Alic, Lejla/N-9589-2019	Klein, Stefan/0000-0003-4449-6784; Veenland, Jifke/0000-0003-0456-6143; Niessen, Wiro/0000-0002-5822-1995; van Tiel, Sandra/0000-0002-3057-3032; Bernsen, Monique/0000-0002-5203-5083; Alic, Lejla/0000-0001-6487-6958	NWO - Mozaiek [017.002.019]; Dutch Cancer Society - KWF [2008-4037]; Erasmus MC	NWO - Mozaiek(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society - KWF(KWF Kankerbestrijding); Erasmus MC	This work was funded by NWO - Mozaiek (grant no. 017.002.019), the Dutch Cancer Society - KWF (grant no. 2008-4037), and an Erasmus MC seed grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIC L, 2010, SPIE MED IM SAN DIEG; BOL K, 2011, SPIE MED IM; Breen MS, 2003, J MAGN RESON IMAGING, V18, P90, DOI 10.1002/jmri.10324; Evans PM, 2008, PHYS MED BIOL, V53, pR151, DOI 10.1088/0031-9155/53/12/R01; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hill DLG, 2001, PHYS MED BIOL, V46, pR1, DOI 10.1088/0031-9155/46/3/201; Humm JL, 2003, MED PHYS, V30, P2303, DOI 10.1118/1.1600738; Ibanez L., 2005, ITK SOFTWARE GUIDE; Imaizumi T, 2003, STROKE, V34, P1693, DOI 10.1161/01.STR.0000075771.88719.CE; Jacobs MA, 1999, MED PHYS, V26, P1568, DOI 10.1118/1.598671; Klein S, 2007, IEEE T IMAGE PROCESS, V16, P2879, DOI 10.1109/TIP.2007.909412; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lazebnik RS, 2003, IEEE T MED IMAGING, V22, P653, DOI 10.1109/TMI.2003.812246; Lester H, 1999, PATTERN RECOGN, V32, P129, DOI 10.1016/S0031-3203(98)00095-8; Li G, 2006, J NEUROSCI METH, V156, P368, DOI 10.1016/j.jneumeth.2006.03.016; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Meyer CR, 2006, MOL IMAGING, V5, P16, DOI 10.2310/7290.2006.00002; Modersitzki J., 2003, NUMERICAL METHODS IM; OURSELIN S, 2001, FUSION HISTOLOGICAL, P743; Park H, 2008, ACAD RADIOL, V15, P1027, DOI 10.1016/j.acra.2008.01.022; Pitiot A, 2006, MED IMAGE ANAL, V10, P465, DOI 10.1016/j.media.2005.03.008; Pluim JPW, 2000, COMPUT VIS IMAGE UND, V77, P211, DOI 10.1006/cviu.1999.0816; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Schlemmer HP, 2010, CANC IMAGING, V10, pS73; Schormann T, 1998, HUM BRAIN MAPP, V6, P339, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<339::AID-HBM3>3.3.CO;2-H; Thevenaz P, 2000, IEEE T IMAGE PROCESS, V9, P2083, DOI 10.1109/83.887976; Wang HJ, 2009, INVEST RADIOL, V44, P44, DOI 10.1097/RLI.0b013e31818e5ace; Zhan YQ, 2007, ACAD RADIOL, V14, P1367, DOI 10.1016/j.acra.2007.07.018	28	33	35	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e22835	10.1371/journal.pone.0022835	http://dx.doi.org/10.1371/journal.pone.0022835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897840	Green Submitted, Green Published, gold			2022-12-25	WOS:000294676900003
J	Erdei, E; Sheng, HP; Maestas, E; Mackey, A; White, KA; Li, L; Dong, Y; Taylor, J; Berwick, M; Morse, DE				Erdei, Esther; Sheng, Huiping; Maestas, Erika; Mackey, Amanda; White, Kirsten A.; Li, Lin; Dong, Yan; Taylor, Justin; Berwick, Marianne; Morse, Douglas E.			Self-Reported Ethnicity and Genetic Ancestry in Relation to Oral Cancer and Pre-Cancer in Puerto Rico	PLOS ONE			English	Article							ADMIXTURE; HISPANICS	Background: Hispanics are known to be an extremely diverse and genetically admixed ethnic group. The lack of methodologies to control for ethnicity and the unknown admixture in complex study populations of Hispanics has left a gap in understanding certain cancer disparity issues. Incidence rates for oral and pharyngeal cancer (OPC) in Puerto Rico are among the highest in the Western Hemisphere. We conducted an epidemiological study to examine risk and protective factors, in addition to possible genetic susceptibility components, for oral cancer and precancer in Puerto Rico. Methodology/Principal Findings: We recruited 310 Puerto Rico residents who had been diagnosed with either an incident oral squamous cell carcinoma, oral precancer, or benign oral condition. Participants completed an in-person interview and contributed buccal cells for DNA extraction. ABI Biosystem Taqman (TM) primer sets were used for genotyping 12 ancestry informative markers (AIMs). Ancestral group estimates were generated using maximum likelihood estimation software (LEADMIX), and additional principal component analysis was carried out to detect population substructures. We used unconditional logistic regression to assess the contribution of ancestry to the risk of being diagnosed with either an oral cancer or precancer while controlling for other potential confounders. The maximum likelihood estimates showed that study participants had a group average ancestry contribution of 69.9% European, 24.5% African, and 5.7% detectable Native American. The African and Indigenous American group estimates were significantly higher than anticipated. Neither self-identified ethnicity nor ancestry markers showed any significant associations with oral cancer/precancer risk in our study. Conclusions/Significance: The application of ancestry informative markers (AIMs), specifically designed for Hispanics, suggests no hidden population substructure is present based on our sampling and provides a viable approach for the evaluation and control of ancestry in future studies involving Hispanic populations.	[Erdei, Esther; Sheng, Huiping; Maestas, Erika; Mackey, Amanda; White, Kirsten A.; Dong, Yan; Taylor, Justin; Berwick, Marianne] Univ New Mexico, Sch Med, Hlth Sci Ctr, Mol Epidemiol Lab,Div Epidemiol & Biostat,Dept In, Albuquerque, NM 87131 USA; [Erdei, Esther; Sheng, Huiping; Maestas, Erika; Mackey, Amanda; White, Kirsten A.; Dong, Yan; Taylor, Justin; Berwick, Marianne] Univ New Mexico, Sch Med, Hlth Sci Ctr, Univ New Mexico Canc Ctr,Canc Epidemiol & Canc Pr, Albuquerque, NM 87131 USA; [Li, Lin; Morse, Douglas E.] NYU, Coll Dent, Dept Epidemiol & Hlth Promot, New York, NY USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; New York University	Erdei, E (corresponding author), Univ New Mexico, Sch Med, Hlth Sci Ctr, Mol Epidemiol Lab,Div Epidemiol & Biostat,Dept In, Albuquerque, NM 87131 USA.	EErdei@salud.unm.edu	Berwick, Marianne/E-9608-2010	Berwick, Marianne/0000-0001-5062-2180	National Institutes of Health [5U54DE014257]; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U54DE014257] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project was funded by National Institutes of Health grant 5U54DE014257. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2010, CANC FACTS FIG 2010; Burchard EG, 2005, AM J PUBLIC HEALTH, V95, P2161, DOI 10.2105/AJPH.2005.068668; Cruz GD, 2006, AM J PUBLIC HEALTH, V96, P2194, DOI 10.2105/AJPH.2005.079137; FERLAY J, 2010, 10 IARC; Lopez I, 2008, HISPANIC J BEHAV SCI, V30, P161, DOI 10.1177/0739986307313116; Mayne S. T., 2006, CANC EPIDEMIOLOGY PR; Morse DE, 2008, AM J PUBLIC HEALTH, V98, P1200, DOI 10.2105/AJPH.2007.118679; Morse DE, 2009, CANCER DETECT PREV, V32, P424, DOI 10.1016/j.cdp.2009.01.004; National Cancer Institute, SEER STAT SOFTW VERS; Pinheiro PS, 2009, CANCER EPIDEM BIOMAR, V18, P2162, DOI 10.1158/1055-9965.EPI-09-0329; Rouse I, 1992, TAINOS RISE DECLINE; Salari K, 2005, GENET EPIDEMIOL, V29, P76, DOI 10.1002/gepi.20079; Via M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016513; Wang JL, 2003, GENETICS, V164, P747; Ziv E, 2006, CANCER EPIDEM BIOMAR, V15, P1878, DOI 10.1158/1055-9965.EPI-06-0092; YEAR 2010 CENSUS DAT; YEAR 2000 CENSUS DAT	17	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23950	10.1371/journal.pone.0023950	http://dx.doi.org/10.1371/journal.pone.0023950			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	817MF	21897864	Green Submitted, Green Published, gold			2022-12-25	WOS:000294676900028
J	Puntel, M; Barrett, R; Sanderson, NSR; Kroeger, KM; Bondale, N; Wibowo, M; Kennedy, S; Liu, CY; Castro, MG; Lowenstein, PR				Puntel, Mariana; Barrett, Robert; Sanderson, Nicholas S. R.; Kroeger, Kurt M.; Bondale, Niyati; Wibowo, Mia; Kennedy, Sean; Liu, Chunyan; Castro, Maria G.; Lowenstein, Pedro R.			Identification and Visualization of CD8(+) T Cell Mediated IFN-gamma Signaling in Target Cells during an Antiviral Immune Response in the Brain	PLOS ONE			English	Article							IMMUNOLOGICAL SYNAPSES; ADENOVIRUS VECTORS; HIGH-CAPACITY; IN-VIVO; VIRUS-INFECTION; GENE-TRANSFER; INFLAMMATION; EXPRESSION; CLEARANCE; POLARIZATION	CD8(+) T cells infiltrate the brain during an anti-viral immune response. Within the brain CD8+ T cells recognize cells expressing target antigens, become activated, and secrete IFN gamma. However, there are no methods to recognize individual cells that respond to IFN gamma. Using a model that studies the effects of the systemic anti-adenoviral immune response upon brain cells infected with an adenoviral vector in mice, we describe a method that identifies individual cells that respond to IFN gamma. To identify individual mouse brain cells that respond to IFN gamma we constructed a series of adenoviral vectors that contain a transcriptional response element that is selectively activated by IFN gamma signaling, the gamma-activated site (GAS) promoter element; the GAS element drives expression of a transgene, Cre recombinase (Ad-GAS-Cre). Upon binding of IFN gamma to its receptor, the intracellular signaling cascade activates the GAS promoter, which drives expression of the transgene Cre recombinase. We demonstrate that upon activation of a systemic immune response against adenovirus, CD8+ T cells infiltrate the brain, interact with target cells, and cause an increase in the number of cells expressing Cre recombinase. This method can be used to identify, study, and eventually determine the long term fate of infected brain cells that are specifically targeted by IFN gamma. The significance of this method is that it will allow to characterize the networks in the brain that respond to the specific secretion of IFN gamma by anti-viral CD8(+) T cells that infiltrate the brain. This will allow novel insights into the cellular and molecular responses underlying brain immune responses.	Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr, Board Governors Gene Therapeut Res Inst,Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr,Dept Mol & Med Pharmacol, Board Governors Gene Therapeut Res Inst, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Puntel, M (corresponding author), Inst Leloir Fdn, IIBBA, Natl Council Sci & Tech Res, Lab Regenerat & Protect Therapies Nervous Syst, Buenos Aires, DF, Argentina.	pedrol@umich.edu	Castro, Maria/ABC-5182-2021; sanderson, nicholas/GQH-2848-2022; Barrett, Robert/AAG-1941-2021	Castro, Maria/0000-0003-2237-2756; sanderson, nicholas/0000-0003-1711-7275; 	National Institutes of Health/National Institute of Neurological Disorders and Stroke [1UO1 NS052465.01, 1RO1-NS 057711, 1R21-NSO54143, 1 RO1 NS 054193, RO1 NS 42893]; Medallions Group Endowed Chairs in Gene Therapeutics; Drown Foundation; Linda Tallen & David Paul Kane Foundation; Board of Governors at Cedars-Sinai Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042893, R01NS057711, R01NS061107, U01NS052465, R01NS054193] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medallions Group Endowed Chairs in Gene Therapeutics; Drown Foundation; Linda Tallen & David Paul Kane Foundation; Board of Governors at Cedars-Sinai Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work in the Board of Governors' Gene Therapeutic Research Institute was funded by National Institutes of Health/National Institute of Neurological Disorders and Stroke Grant 1UO1 NS052465.01. The brain tumor program in the authors' institute was funded by National Institutes of Health/National Institute of Neurological Disorders and Stroke Grants 1RO1-NS 057711 and 1R21-NSO54143 (to M.G.C.) and National Institutes of Health/National Institute of Neurological Disorders and Stroke Grants 1 RO1 NS 054193 and RO1 NS 42893 (to P.R.L.). The authors also acknowledge support from The Bram and Elaine Goldsmith and the Medallions Group Endowed Chairs in Gene Therapeutics (to P.R.L. and M.G.C., respectively). The Drown Foundation, the Linda Tallen & David Paul Kane Foundation Annual Fellowship and the Board of Governors at Cedars-Sinai Medical Center also provided support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcia C, 2008, J IMMUNOL, V180, P1344, DOI 10.4049/jimmunol.180.3.1344; Barcia C, 2007, MOL THER, V15, P2154, DOI 10.1038/sj.mt.6300305; Barcia C, 2006, J EXP MED, V203, P2095, DOI 10.1084/jem.20060420; Barcia C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002977; Bennett MS, 2007, J VIROL, V81, P4973, DOI 10.1128/JVI.02362-06; Burdeinick-Kerr R, 2009, J VIROL, V83, P3429, DOI 10.1128/JVI.02381-08; Byrnes AP, 1996, J NEUROSCI, V16, P3045; Byrnes AP, 1996, GENE THER, V3, P644; BYRNES AP, 1995, NEUROSCIENCE, V66, P1015, DOI 10.1016/0306-4522(95)00068-T; DUSTIN ML, 2010, IMMUNOL REV DENMARK, P24; Gattacceca F, 2002, CLIN CANCER RES, V8, P3298; Griffin DE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002004; Hailman E, 2002, IMMUNITY, V16, P839, DOI 10.1016/S1074-7613(02)00326-6; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; Jenkins MR, 2009, IMMUNITY, V31, P621, DOI 10.1016/j.immuni.2009.08.024; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; LEHMANNGRUBE F, 1987, J IMMUNOL, V138, P2282; Lowenstein PR, 2002, TRENDS IMMUNOL, V23, P23, DOI 10.1016/S1471-4906(01)02063-4; Ndhlovu ZM, 2010, P NATL ACAD SCI USA, V107, P3669, DOI 10.1073/pnas.0915168107; Puntel Mariana, 2010, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0424s50; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rutebemberwa A, 2008, J IMMUNOL, V181, P8215, DOI 10.4049/jimmunol.181.12.8215; Sanderson N, 2011, J IMMUNOL, V186; SOUTHGATE T, 2008, CURR PROTOC NEUROSCI; Stevenson PG, 1997, J VIROL, V71, P145, DOI 10.1128/JVI.71.1.145-151.1997; Stinchcombe JC, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-45; Suwelack D, 2004, GENE THER, V11, P1742, DOI 10.1038/sj.gt.3302377; Thomas CE, 2000, P NATL ACAD SCI USA, V97, P7482, DOI 10.1073/pnas.120474397; Thomas CE, 2001, HUM GENE THER, V12, P839, DOI 10.1089/104303401750148829; Topham DJ, 1997, J IMMUNOL, V159, P5197; Wolfl M, 2008, J IMMUNOL, V181, P6435, DOI 10.4049/jimmunol.181.9.6435; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; ZIRGER JM, 2011, MOL THERAPY IN PRESS	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23523	10.1371/journal.pone.0023523	http://dx.doi.org/10.1371/journal.pone.0023523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897844	Green Submitted, Green Published, gold			2022-12-25	WOS:000294676900007
J	Zhou, XH; Xia, ZX; Lan, Q; Wang, J; Su, WR; Han, YP; Fan, HM; Liu, ZM; Stohl, W; Zheng, SG				Zhou, Xiaohui; Xia, Zanxian; Lan, Qin; Wang, Julie; Su, Wenru; Han, Yuan-Ping; Fan, Huimin; Liu, Zhongmin; Stohl, William; Zheng, Song Guo			BAFF Promotes Th17 Cells and Aggravates Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							B-LYMPHOCYTE STIMULATOR; SYSTEMIC-LUPUS-ERYTHEMATOSUS; REGULATORY T-CELLS; COLLAGEN-INDUCED ARTHRITIS; NECROSIS-FACTOR FAMILY; CUTTING EDGE; ACTIVATING FACTOR; MULTIPLE-SCLEROSIS; SJOGRENS-SYNDROME; IMMUNE-RESPONSES	Background: BAFF, in addition to promoting B cell survival and differentiation, may affect T cells. The objective of this study was to determine the effect of BAFF on Th17 cell generation and its ramifications for the Th17 cell-driven disease, EAE. Methodology/Principal Findings: Th17 cells were increased in BAFF-Tg B6 (B6.BTg) mice and decreased in B6. Baff(-/-) mice. Th17 cells in B6.Baff(-/-) mice bearing a BAFF Tg (B6.Baff(-/-). BTg mice) were identical to those in B6. BTg mice, indicating that membrane BAFF is dispensable for Th17 cell generation as long as soluble BAFF is plentiful. In T + non-T cell criss-cross co-cultures, Th17 cell generation was greatest in cultures containing B6.BTg T cells and lowest in cultures containing B6.Baff(-/-) T cells, regardless of the source of non-T cells. In cultures containing only T cells, Th17 cell generation followed an identical pattern. CD4(+) cell expression of CD126 (IL-6R alpha chain) was increased in B6. BTg mice and decreased in B6.Baff(-/-) mice, and activation of STAT3 following stimulation with IL-6 + TGF-beta was also greatest in B6. BTg cells and lowest in B6.Baff(-/-) cells. EAE was clinically and pathologically most severe in B6.BTg mice and least severe in B6.Baff(-/-) mice and correlated with MOG(35-55) peptide-induced Th17 cell responses. Conclusions/Significance: Collectively, these findings document a contribution of BAFF to pathogenic Th17 cell responses and suggest that BAFF antagonism may be efficacious in Th17 cell-driven diseases.	[Zhou, Xiaohui; Xia, Zanxian; Lan, Qin; Wang, Julie; Su, Wenru; Stohl, William; Zheng, Song Guo] Univ So Calif, Keck Sch Med, Dept Med, Div Rheumatol, Los Angeles, CA 90033 USA; [Zhou, Xiaohui; Lan, Qin; Fan, Huimin; Liu, Zhongmin] Tongji Univ, Sch Med, Shanghai E Hosp, Shanghai 200092, Peoples R China; [Su, Wenru] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Peoples R China; [Han, Yuan-Ping] Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA	University of Southern California; Tongji University; Sun Yat Sen University; University of Southern California	Zhou, XH (corresponding author), Univ So Calif, Keck Sch Med, Dept Med, Div Rheumatol, Los Angeles, CA 90033 USA.	stohl@usc.edu; szheng@usc.edu		Su, Wenru/0000-0002-0506-6362	National Institutes of Health [R01 AR059193, R01 AR059103]; American College of Rheumatology; Arthritis Foundation; National Natural Science Foundation of China [30728007]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059103, R01AR050193, R01AR059193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Rheumatology(General Electric); Arthritis Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a grant from the National Institutes of Health (R01 AR059193) to WS, by grants from the National Institutes of Health (R01 AR059103), the American College of Rheumatology (Within Our Reach), the Arthritis Foundation, and by an Outstanding Youth Scientist Investigator Award from the National Natural Science Foundation of China (30728007) (all to SGZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Begum-Haque S, 2010, J NEUROIMMUNOL, V219, P47, DOI 10.1016/j.jneuroim.2009.11.016; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Chang SK, 2006, BLOOD, V108, P2687, DOI 10.1182/blood-2005-12-017319; Chang SK, 2008, J IMMUNOL, V180, P7394, DOI 10.4049/jimmunol.180.11.7394; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; Gorelik L, 2003, J EXP MED, V198, P937, DOI 10.1084/jem.20030789; Groom J, 2002, J CLIN INVEST, V109, P59, DOI 10.1172/JCI200214121; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hjelmstrom P, 1998, J IMMUNOL, V161, P4480; Huard B, 2001, J IMMUNOL, V167, P6225, DOI 10.4049/jimmunol.167.11.6225; Huntington ND, 2006, INT IMMUNOL, V18, P1473, DOI 10.1093/intimm/dxl080; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Krumbholz M, 2005, J EXP MED, V201, P195, DOI 10.1084/jem.20041674; LAABI Y, 1994, NUCLEIC ACIDS RES, V22, P1147, DOI 10.1093/nar/22.7.1147; Lam QLK, 2008, P NATL ACAD SCI USA, V105, P14993, DOI 10.1073/pnas.0806044105; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Lu L, 2010, J IMMUNOL, V184, P4295, DOI 10.4049/jimmunol.0903418; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Magliozzi R, 2004, J NEUROIMMUNOL, V148, P11, DOI 10.1016/j.jneuroim.2003.10.056; Mariette X, 2003, ANN RHEUM DIS, V62, P168, DOI 10.1136/ard.62.2.168; Matsushita T, 2006, ARTHRITIS RHEUM-US, V54, P192, DOI 10.1002/art.21526; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807; Petri M, 2008, ARTHRITIS RHEUM, V58, P2453, DOI 10.1002/art.23678; Ramanujam M, 2006, J CLIN INVEST, V116, P724, DOI 10.1172/JCI26385; Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5; Scapini P, 2003, J EXP MED, V197, P297, DOI 10.1084/jem.20021343; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Stohl W, 2003, ARTHRITIS RHEUM-US, V48, P3475, DOI 10.1002/art.11354; Stohl W, 2008, J IMMUNOL, V181, P833, DOI 10.4049/jimmunol.181.1.833; Sutherland APR, 2005, J IMMUNOL, V174, P5537, DOI 10.4049/jimmunol.174.9.5537; Thangarajh M, 2004, J NEUROIMMUNOL, V152, P183, DOI 10.1016/j.jneuroim.2004.03.017; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Tribouley C, 1999, BIOL CHEM, V380, P1443, DOI 10.1515/BC.1999.186; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Wallace DJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P1168, DOI 10.1002/art.24699; Wang H, 2001, NAT IMMUNOL, V2, P632, DOI 10.1038/89782; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yoshimoto K, 2006, INT IMMUNOL, V18, P1189, DOI 10.1093/intimm/dxl053; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6; Zhang M, 2005, INT IMMUNOL, V17, P1081, DOI 10.1093/intimm/dxh287; Zheng SG, 2008, J IMMUNOL, V180, P7112, DOI 10.4049/jimmunol.180.11.7112; Zhou XH, 2010, J IMMUNOL, V185, P2675, DOI 10.4049/jimmunol.1000598; Zhou XH, 2010, J MOL CELL BIOL, V2, P164, DOI 10.1093/jmcb/mjq007	60	53	57	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23629	10.1371/journal.pone.0023629	http://dx.doi.org/10.1371/journal.pone.0023629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897850	Green Submitted, Green Published, gold			2022-12-25	WOS:000294676900013
J	Tschaikowsky, K; Hedwig-Geissing, M; Schmidt, J; Braun, GG				Tschaikowsky, Klaus; Hedwig-Geissing, Monika; Schmidt, Joachim; Braun, Giovanni G.			Lipopolysaccharide-Binding Protein for Monitoring of Postoperative Sepsis: Complemental to C-Reactive Protein or Redundant?	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; ACUTE-PHASE PROTEIN; SEPTIC SHOCK; INFLAMMATORY RESPONSE; PLASMA-CONCENTRATIONS; EPITHELIAL-CELLS; DIAGNOSTIC-VALUE; PROCALCITONIN; LPS	Introduction: To prospectively evaluate the performance of Lipopolysaccharide-Binding Protein (LBP) in prediction of hospital mortality and its correlation to C-reactive Protein (CRP), we studied sixty consecutive, postoperative patients with sepsis admitted to the university hospital intensive care unit. Measurements and Methods: Plasma LBP and CRP were serially measured from day(d)1 (onset of sepsis) to d14 in parallel with clinical data until d28. Predictive value and correlation of LBP and CRP were analyzed by Receiver Operating Characteristic (ROC) curve analysis and Pearson's test, respectively. Main Results: LBP and CRP showed the highest levels on d2 or d3 after the onset of sepsis with no significant difference between survivors and nonsurvivors. Only at d7, nonsurvivors had significantly (p = .03) higher levels of CRP than survivors. Accordingly, in ROC analysis, concentration of CRP and LBP on d7 poorly discriminated survivors from nonsurvivors (area under curve = .62 and .55, respectively) without significant difference between LBP- and CRP-ROC curves for paired comparison. LBP and CRP plasma levels allocated to quartiles correlated well with each other (r(2) = .95; p = .02). Likewise, changes in plasma concentrations of LBP and CRP from one observation to the next showed a marked concordance as both parameters concomitantly increased or decreased in 76% of all cases. Conclusions: During the first 14 days of postoperative sepsis, LBP plasma concentrations showed a time course that was very similar to CRP with a high concordance in the pattern of day-to-day changes. Furthermore, like CRP, LBP does not provide a reliable clue for outcome in this setting.	[Tschaikowsky, Klaus; Hedwig-Geissing, Monika; Schmidt, Joachim; Braun, Giovanni G.] Univ Erlangen Nurnberg, Dept Anesthesiol, Erlangen, Germany	University of Erlangen Nuremberg	Tschaikowsky, K (corresponding author), Univ Erlangen Nurnberg, Dept Anesthesiol, Erlangen, Germany.	klaus.tschaikowsky@kfa.imed.uni-erlangen.de			Department of Anesthesiology, University of Erlangen-Nurnberg	Department of Anesthesiology, University of Erlangen-Nurnberg	The study was supported by the Department of Anesthesiology, University of Erlangen-Nurnberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti C, 2003, AM J RESP CRIT CARE, V168, P77, DOI 10.1164/rccm.200208-785OC; ARDITI M, 1993, INFECT IMMUN, V61, P3149, DOI 10.1128/IAI.61.8.3149-3156.1993; Clec'h C, 2006, CRIT CARE MED, V34, P102, DOI 10.1097/01.CCM.0000195012.54682.F3; Clec'h C, 2004, CRIT CARE MED, V32, P1166, DOI 10.1097/01.CCM.0000126263.00551.06; Dentener MA, 2000, AM J RESP CELL MOL, V23, P146, DOI 10.1165/ajrcmb.23.2.3855; Gaini S, 2006, CRIT CARE, V10, DOI 10.1186/cc4866; GALLAY P, 1994, J INFECT DIS, V170, P1319, DOI 10.1093/infdis/170.5.1319; Groselj-Grenc M, 2009, INTENS CARE MED, V35, P1950, DOI 10.1007/s00134-009-1637-7; Harbarth S, 2001, AM J RESP CRIT CARE, V164, P396, DOI 10.1164/ajrccm.164.3.2009052; Jabs WJ, 2003, EUR J IMMUNOL, V33, P152, DOI 10.1002/immu.200390018; Jensen JU, 2006, CRIT CARE MED, V34, P2596, DOI 10.1097/01.CCM.0000239116.01855.61; Kitz R, 2008, MED MICROBIOL IMMUN, V197, P13, DOI 10.1007/s00430-007-0053-2; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Meisner M, 1998, INTENS CARE MED, V24, P680, DOI 10.1007/s001340050644; Novotny A, 2007, AM J SURG, V194, P35, DOI 10.1016/j.amjsurg.2006.10.026; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Pavcnik-Arnol M, 2004, INTENS CARE MED, V30, P1454, DOI 10.1007/s00134-004-2307-4; Prucha M, 2003, CRIT CARE, V7, pR154, DOI 10.1186/cc2386; RAMADORI G, 1990, PATHOBIOLOGY, V58, P89, DOI 10.1159/000163569; Randolph AG, 1998, CRIT CARE MED, V26, P767, DOI 10.1097/00003246-199804000-00031; Sakr Y, 2008, CRIT CARE MED, V36, P2014, DOI 10.1097/CCM.0b013e31817b86e3; Sands Kenneth E., 1997, JAMA (Journal of the American Medical Association), V278, P234, DOI 10.1001/jama.278.3.234; Schumann RR, 1999, CLIN CHEM LAB MED, V37, P271, DOI 10.1515/CCLM.1999.047; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Tschaikowsky K, 2002, CRIT CARE MED, V30, P1015, DOI 10.1097/00003246-200205000-00010; Tschaikowsky K, 2011, J CRIT CARE, V26, P54, DOI 10.1016/j.jcrc.2010.04.011; Villar J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006818; Vreugdenhil ACE, 1999, J IMMUNOL, V163, P2792; Wunder C, 2004, INFLAMM RES, V53, P158, DOI 10.1007/s00011-003-1239-3	31	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23615	10.1371/journal.pone.0023615	http://dx.doi.org/10.1371/journal.pone.0023615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901123	gold, Green Published, Green Submitted			2022-12-25	WOS:000294298000008
J	Walia, V; Yu, Y; Cao, D; Sun, M; McLean, JR; Hollier, BG; Cheng, J; Mani, SA; Rao, K; Premkumar, L; Elble, RC				Walia, V.; Yu, Y.; Cao, D.; Sun, M.; McLean, J. R.; Hollier, B. G.; Cheng, J.; Mani, S. A.; Rao, K.; Premkumar, L.; Elble, R. C.			Loss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasis	ONCOGENE			English	Article						hCLCA2; epithelial-to-mesenchymal transition; differentiation; breast; metastasis; chloride	TUMOR PROGRESSION; CANCER CELLS; E-CADHERIN; IN-VITRO; ION CHANNELS; CLAUDIN-LOW; EXPRESSION; GENE; PH; TRANSFORMATION	Transition between epithelial and mesenchymal states is a feature of both normal development and tumor progression. We report that expression of chloride channel accessory protein hCLCA2 is a characteristic of epithelial differentiation in the immortalized MCF10A and HMLE models, while induction of epithelial-to-mesenchymal transition by cell dilution, TGF beta or mesenchymal transcription factors sharply reduces hCLCA2 levels. Attenuation of hCLCA2 expression by lentiviral small hairpin RNA caused cell overgrowth and focus formation, enhanced migration and invasion, and increased mammosphere formation in methylcellulose. These changes were accompanied by downregulation of E-cadherin and upregulation of mesenchymal markers such as vimentin and fibronectin. Moreover, hCLCA2 expression is greatly downregulated in breast cancer cells with a mesenchymal or claudin-low profile. These observations suggest that loss of hCLCA2 may promote metastasis. We find that higher-than-median expression of hCLCA2 is associated with a one-third lower rate of metastasis over an 18-year period among breast cancer patients compared with lower-than- median (n = 344, unfiltered for subtype). Thus, hCLCA2 is required for epithelial differentiation, and its loss during tumor progression contributes to metastasis. Overexpression of hCLCA2 has been reported to inhibit cell proliferation and is accompanied by increases in chloride current at the plasma membrane and reduced intracellular pH (pHi). We found that knockdown cells have sharply reduced chloride current and higher pHi, both characteristics of tumor cells. These results suggest a mechanism for the effects on differentiation. Loss of hCLCA2 may allow escape from pHi homeostatic mechanisms, permitting the higher intracellular and lower extracellular pH that are characteristic of aggressive tumor cells. Oncogene (2012) 31, 2237-2246; doi:10.1038/onc.2011.392; published online 12 September 2011	[Walia, V.; Cao, D.; Premkumar, L.; Elble, R. C.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA; [Walia, V.; Yu, Y.; Cheng, J.; Rao, K.; Elble, R. C.] So Illinois Univ, Sch Med, Simmons Canc Inst, Springfield, IL 62794 USA; [Sun, M.] Univ Chicago, Comm Genet Genom & Syst Biol GGSB, Chicago, IL 60637 USA; [McLean, J. R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Hollier, B. G.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Mani, S. A.] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; University of Chicago; Vanderbilt University; Queensland University of Technology (QUT); University of Texas System; UTMD Anderson Cancer Center	Elble, RC (corresponding author), So Illinois Univ, Sch Med, Dept Pharmacol, POB 19629, Springfield, IL 62794 USA.	relble2@siumed.edu	Mani, Sendurai A./A-7244-2009; Cao, Deshou/G-8697-2014	Mani, Sendurai A./0000-0002-5918-4276; 	NIH [1R15CA151094-01, DK065742, DA028017]; Excellence in Academic Medicine [56252, 56253]; NATIONAL CANCER INSTITUTE [R15CA151094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065742, R56DK065742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028017] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Excellence in Academic Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the following grants: NIH grant 1R15CA151094-01 and Excellence in Academic Medicine grants 56252 and 56253 to RCE; and NIH grants DK065742 and DA028017 to LP.	Agiostratidou G, 2009, CANCER RES, V69, P5030, DOI 10.1158/0008-5472.CAN-08-4007; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Barriere H, 2001, AM J PHYSIOL-CELL PH, V281, pC810, DOI 10.1152/ajpcell.2001.281.3.C810; BARRY MA, 1992, BIOCHEM BIOPH RES CO, V186, P782, DOI 10.1016/0006-291X(92)90814-2; Beckley JR, 2004, J BIOL CHEM, V279, P41634, DOI 10.1074/jbc.M408334200; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Cheng JM, 2006, INT J CANCER, V118, P2957, DOI 10.1002/ijc.21739; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; D'Assoro AB, 2010, INT J ONCOL, V37, P1167, DOI 10.3892/ijo_00000768; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Elble RC, 2006, J BIOL CHEM, V281, P29448, DOI 10.1074/jbc.M605919200; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Enerback C, 2002, CANCER RES, V62, P43; Furlong IJ, 1997, J CELL SCI, V110, P653; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Grigoriadis A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1604; Gruber AD, 1999, CANCER RES, V59, P5488; Hajra KM, 2002, CANCER RES, V62, P1613; Hamann M, 2009, J PHYSIOL-LONDON, V587, P2255, DOI 10.1113/jphysiol.2009.170159; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; HESKETH TR, 1985, NATURE, V313, P481, DOI 10.1038/313481a0; Hsu YM, 2007, CANCER RES, V67, P11064, DOI 10.1158/0008-5472.CAN-07-2443; Jiang Z, 2010, J CLIN INVEST, V120, P3296, DOI 10.1172/JCI41490; Kogan-Sakin I, 2011, CELL DEATH DIFFER, V18, P271, DOI 10.1038/cdd.2010.94; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Li XR, 2004, ONCOGENE, V23, P1474, DOI 10.1038/sj.onc.1207249; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Malo ME, 2007, J BIOL CHEM, V282, P6292, DOI 10.1074/jbc.M611073200; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marshall A, 2009, CELL TISSUE RES, V335, P383, DOI 10.1007/s00441-008-0719-0; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; MOOLENAAR WH, 1983, NATURE, V304, P645, DOI 10.1038/304645a0; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; PERONA R, 1988, NATURE, V334, P438, DOI 10.1038/334438a0; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rao K, 2003, CANCER LETT, V201, P79, DOI 10.1016/S0304-3835(03)00423-3; Rao K, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-15; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sontheimer H, 2008, EXP BIOL MED, V233, P779, DOI 10.3181/0711-MR-308; Tanaka H, 2006, INT J CANCER, V118, P1680, DOI 10.1002/ijc.21559; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Walia V, 2010, STEM CELLS DEV, V19, P1175, DOI 10.1089/scd.2009.0430; Walia V, 2009, CANCER RES, V69, P6624, DOI 10.1158/0008-5472.CAN-08-4101; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1	57	52	52	3	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2012	31	17					2237	2246		10.1038/onc.2011.392	http://dx.doi.org/10.1038/onc.2011.392			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	934BS	21909135	Green Accepted			2022-12-25	WOS:000303415900011
J	Schreurs, MPH; Houston, EM; May, V; Cipolla, MJ				Schreurs, Malou P. H.; Houston, Emily M.; May, Victor; Cipolla, Marilyn J.			The adaptation of the blood-brain barrier to vascular endothelial growth factor and placental growth factor during pregnancy	FASEB JOURNAL			English	Article						cerebral endothelium; circulating angiogenic factors; gestation; sFlt1	FACTOR RECEPTOR-2; SOLUBLE FLT-1; NITRIC-OXIDE; VEGF; PERMEABILITY; EXPRESSION; RAT; VASODILATOR; INDUCTION; NEURONS	Vascular endothelial growth factor (VEGF) and placental growth factor (PLGF) are increased in the maternal circulation during pregnancy. These factors may increase blood-brain barrier (BBB) permeability, yet brain edema does not normally occur during pregnancy. We therefore hypothesized that in pregnancy, the BBB adapts to high levels of these permeability factors. We investigated the influence of pregnancy-related circulating factors on VEGF-induced BBB permeability by perfusing cerebral veins with plasma from nonpregnant (NP) or late-pregnant (LP) rats (n=6/group) and measuring permeability in response to VEGF. The effect of VEGF, PLGF, and VEGF-receptor (VEGFR) activation on BBB permeability was also determined. Results showed that VEGF significantly increased permeability (x10(7) mu m(3)/min) from 9.7 +/- 3.5 to 21.0 +/- 1.5 (P<0.05) in NP veins exposed to NP plasma, that was prevented when LP veins were exposed to LP plasma; (9.7 +/- 3.8; P>0.05). Both LP plasma and soluble FMS-like tyrosine-kinase 1 (sFlt1) in NP plasma abolished VEGF-induced BBB permeability in NP veins (9.5 +/- 2.9 and 12 +/- 2.6; P>0.05). PLGF significantly increased BBB permeability in NP plasma (18 +/- 1.4; P<0.05), and required only VEGFR1 activation, whereas VEGF-induced BBB permeability required both VEGFR1 and VEGFR2. Our findings suggest that VEGF and PLGF enhance BBB permeability through different VEGFR pathways and that circulating sFlt1 prevents VEGF- and PLGF-induced BBB permeability during pregnancy.-Schreurs, M. P. H., Houston, E. M., May, V., Cipolla, M. J. The adaptation of the blood-brain barrier to vascular endothelial growth factor and placental growth factor during pregnancy. FASEB J. 26, 355-362 (2012). www.fasebj.org	[Schreurs, Malou P. H.; Houston, Emily M.; Cipolla, Marilyn J.] Univ Vermont, Dept Neurol, Coll Med, Burlington, VT 05405 USA; [Cipolla, Marilyn J.] Univ Vermont, Dept Obstet Gynecol & Reprod Sci, Coll Med, Burlington, VT 05405 USA; [Cipolla, Marilyn J.] Univ Vermont, Dept Pharmacol, Coll Med, Burlington, VT 05405 USA; [May, Victor] Univ Vermont, Dept Anat & Neurobiol, Coll Med, Burlington, VT 05405 USA	University of Vermont; University of Vermont; University of Vermont; University of Vermont	Cipolla, MJ (corresponding author), Univ Vermont, Dept Neurol, Coll Med, 89 Beaumont Ave, Burlington, VT 05405 USA.	marilyn.cipolla@uvm.edu			U.S. National Institute of Neurological Disorders and Stroke [RO1 NS045940]; Neural Environment Cluster supplement [RO1 NS045940-06S1]; ARRA [RO1 NS045940-05S1]; U.S. National Heart, Lung, and Blood Institute [PO1 HL095488]; Totman Medical Research Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045940] Funding Source: NIH RePORTER	U.S. National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Neural Environment Cluster supplement; ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Totman Medical Research Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors gratefully acknowledge the support of U.S. National Institute of Neurological Disorders and Stroke grant RO1 NS045940, the Neural Environment Cluster supplement RO1 NS045940-06S1, and ARRA supplement RO1 NS045940-05S1. The authors also gratefully acknowledge the support of U.S. National Heart, Lung, and Blood Institute grant PO1 HL095488 and of the Totman Medical Research Trust.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Amburgey OA, 2010, HYPERTENSION, V56, P1003, DOI 10.1161/HYPERTENSIONAHA.110.158931; Ananth S. Karumanchi, 2009, ANNU REV PATHOL-MECH, V5, P173; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Banks RE, 1998, MOL HUM REPROD, V4, P377, DOI 10.1093/molehr/4.4.377; Breen EC, 2007, J CELL BIOCHEM, V102, P1358, DOI 10.1002/jcb.21579; Celia G, 2005, J VASC RES, V42, P47, DOI 10.1159/000082976; Chrusciel M, 2011, REPROD DOMEST ANIM, V46, P434, DOI 10.1111/j.1439-0531.2010.01686.x; Cindrova-Davies T, 2011, CARDIOVASC RES, V89, P671, DOI 10.1093/cvr/cvq346; Cipolla MJ, 2007, HYPERTENSION, V50, P14, DOI 10.1161/HYPERTENSIONAHA.106.079442; Cipolla Marilyn J, 2011, Fetal Matern Med Rev, V22, P91, DOI 10.1017/S0965539511000040; Espinoza J, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2009.10.891; Euser AG, 2007, HYPERTENSION, V49, P334, DOI 10.1161/01.HYP.0000255791.54655.29; Evans P, 1997, CLIN SCI, V92, P567, DOI 10.1042/cs0920567; Fischer S, 1999, AM J PHYSIOL-CELL PH, V276, pC812; Foidart JM, 2009, J REPROD IMMUNOL, V82, P106, DOI 10.1016/j.jri.2009.09.001; Girard BM, 2002, REGUL PEPTIDES, V109, P89, DOI 10.1016/S0167-0115(02)00191-X; Hayashi T, 1997, STROKE, V28, P2039, DOI 10.1161/01.STR.28.10.2039; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Karumanchi SA, 2008, CURR HYPERTENS REP, V10, P305, DOI 10.1007/s11906-008-0057-3; Klinger MB, 2008, J COMP NEUROL, V507, P1379, DOI 10.1002/cne.21627; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Makrydimas G, 2008, PRENATAL DIAG, V28, P175, DOI 10.1002/pd.1916; Mayhan WG, 1999, AM J PHYSIOL-CELL PH, V276, pC1148, DOI 10.1152/ajpcell.1999.276.5.C1148; MAYHAN WG, 1995, BRAIN RES, V686, P99, DOI 10.1016/0006-8993(95)00460-8; Maynard SE, 2005, PEDIATR RES, V57, p1R, DOI 10.1203/01.PDR.0000159567.85157.B7; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; MONACCI WT, 1993, AM J PHYSIOL, V264, pC995, DOI 10.1152/ajpcell.1993.264.4.C995; Odorisio T, 2002, J CELL SCI, V115, P2559; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Osol G, 2008, AM J PHYSIOL-HEART C, V294, pH1381, DOI 10.1152/ajpheart.00922.2007; Oura H, 2003, BLOOD, V101, P560, DOI 10.1182/blood-2002-05-1516; Rajakumar A, 2009, PLACENTA, V30, P25, DOI 10.1016/j.placenta.2008.10.006; Roberts TJM, 2009, AM J PHYSIOL-HEART C, V297, pH1347, DOI 10.1152/ajpheart.00630.2009; Roy H, 2006, FEBS LETT, V580, P2879, DOI 10.1016/j.febslet.2006.03.087; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Shibuya M, 2001, INT J BIOCHEM CELL B, V33, P409, DOI 10.1016/S1357-2725(01)00026-7; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Tripathi R, 2009, YONSEI MED J, V50, P656, DOI 10.3349/ymj.2009.50.5.656; Vaisbuch E., 2010, AM J OBSTET GYNECOL, V204, p152e151; Valdes G., PLACENTA S2, V32, pS170; Valdes G, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-13; Waltenberger J, 1996, CIRCULATION, V94, P1647, DOI 10.1161/01.CIR.94.7.1647; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6; Zygmunt M, 2003, EUR J OBSTET GYN R B, V110, pS10, DOI 10.1016/S0301-2115(03)00168-4	45	43	46	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					355	362		10.1096/fj.11-191916	http://dx.doi.org/10.1096/fj.11-191916			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21911594	Green Published			2022-12-25	WOS:000299202200035
J	Deng, Y; Fong, SS				Deng, Yu; Fong, Stephen S.			Laboratory Evolution and Multi-platform Genome Re-sequencing of the Cellulolytic Actinobacterium Thermobifida fusca	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA HYDROLASE; PEPTIDYL-TRANSFER-RNA; FATTY ACYL-COENZYME; AMINO-ACID-RESIDUES; ESCHERICHIA-COLI; ADAPTIVE EVOLUTION; THERMOMONOSPORA-FUSCA; 10,000-GENERATION EXPERIMENT; BACTERIAL-POPULATIONS; CELLULOSIC BIOMASS	Biological utilization of cellulose is a complex process involving the coordinated expression of different cellulases, often in a synergistic manner. One possible means of inducing an organism-level change in cellulase activity is to use laboratory adaptive evolution. In this study, evolved strains of the cellulolytic actinobacterium, Thermobifida fusca, were generated for two different scenarios: continuous exposure to cellobiose (strain muC) or alternating exposure to cellobiose and glucose (strain muS). These environmental conditions produced a phenotype specialized for growth on cellobiose (muC) and an adaptable, generalist phenotype (muS). Characterization of cellular phenotypes and whole genome re-sequencing were conducted for both the muC and muS strains. Phenotypically, the muC strain showed decreased cell yield over the course of evolution concurrent with decreased cellulase activity, increased intracellular ATP concentrations, and higher end-product secretions. The muS strain increased its cell yield for growth on glucose and exhibited a more generalist phenotype with higher cellulase activity and growth capabilities on different substrates. Whole genome re-sequencing identified 48 errors in the reference genome and 18 and 14 point mutations in the muC and muS strains, respectively. Among these mutations, the site mutation of Tfu_1867 was found to contribute the specialist phenotype and the site mutation of Tfu_0423 was found to contribute the generalist phenotype. By conducting and characterizing evolution experiments on Thermobifida fusca, we were able to show that evolutionary changes balance ATP energetic considerations with cellulase activity. Increased cellulase activity is achieved in stress environments (switching carbon sources), otherwise cellulase activity is minimized to conserve ATP.	[Deng, Yu; Fong, Stephen S.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA 23284 USA; [Deng, Yu] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA	Virginia Commonwealth University; Dartmouth College	Fong, SS (corresponding author), Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Med Coll Virginia Campus, Richmond, VA 23284 USA.	ssfong@vcu.edu	Deng, Yu/F-7066-2012	Deng, Yu/0000-0003-3101-5160				Ai YC, 2003, ENZYME MICROB TECH, V32, P331, DOI 10.1016/S0141-0229(02)00276-4; Babu MM, 2006, TRENDS MICROBIOL, V14, P11, DOI 10.1016/j.tim.2005.11.005; Bevillard E, 2004, J BACTERIOL, V186, P136, DOI 10.1128/JB.186.1.136-145.2004; Black PN, 1997, J BIOL CHEM, V272, P4896, DOI 10.1074/jbc.272.8.4896; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen SL, 2007, J BACTERIOL, V189, P6260, DOI 10.1128/JB.00584-07; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; Deng Y, 2011, METAB ENG, V13, P570, DOI 10.1016/j.ymben.2011.06.007; Deng Y, 2010, APPL ENVIRON MICROB, V76, P2098, DOI 10.1128/AEM.02626-09; Deng Y, 2010, APPL MICROBIOL BIOT, V85, P965, DOI 10.1007/s00253-009-2155-9; Eaves HL, 2009, BIOINFORMATICS, V25, P969, DOI 10.1093/bioinformatics/btp092; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; FERCHAK JD, 1983, BIOTECHNOL BIOENG, V25, P2855, DOI 10.1002/bit.260251204; FERCHAK JD, 1983, BIOTECHNOL BIOENG, V25, P2865, DOI 10.1002/bit.260251205; Ferenci T, 2008, HEREDITY, V100, P446, DOI 10.1038/sj.hdy.6801077; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Fong SS, 2005, BIOTECHNOL BIOENG, V91, P643, DOI 10.1002/bit.20542; Fong SS, 2003, J BACTERIOL, V185, P6400, DOI 10.1128/JB.185.21.6400-6408.2003; Gowen CM, 2010, CHEM BIODIVERS, V7, P1086, DOI 10.1002/cbdv.200900314; Heidenreich E, 2007, CRIT REV BIOCHEM MOL, V42, P285, DOI 10.1080/10409230701507773; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Himmel ME, 1999, CURR OPIN BIOTECH, V10, P358, DOI 10.1016/S0958-1669(99)80065-2; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Igarashi K, 1999, J BIOL CHEM, V274, P3338, DOI 10.1074/jbc.274.6.3338; Irwin DC, 2000, EUR J BIOCHEM, V267, P4988, DOI 10.1046/j.1432-1327.2000.01546.x; Jeoh T, 2002, BIOTECHNOL PROGR, V18, P760, DOI 10.1021/bp0200402; Jung H, 2003, BIOTECHNOL BIOENG, V84, P151, DOI 10.1002/bit.10743; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Lykidis A, 2007, J BACTERIOL, V189, P2477, DOI 10.1128/JB.01899-06; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; MENNINGER JR, 1979, J BACTERIOL, V137, P694, DOI 10.1128/JB.137.1.694-696.1979; Notley-McRobb L, 2002, J BACTERIOL, V184, P806, DOI 10.1128/JB.184.3.806-811.2002; Papadopoulos D, 1999, P NATL ACAD SCI USA, V96, P3807, DOI 10.1073/pnas.96.7.3807; Singh NS, 2004, NUCLEIC ACIDS RES, V32, P6028, DOI 10.1093/nar/gkh924; Spector MP, 1999, MICROBIOL-SGM, V145, P15, DOI 10.1099/13500872-145-1-15; Spiridonov NA, 1999, J BIOL CHEM, V274, P13127, DOI 10.1074/jbc.274.19.13127; Spiridonov NA, 2001, CURR MICROBIOL, V42, P295, DOI 10.1007/s002840010220; Suto M, 2001, J BIOSCI BIOENG, V92, P305, DOI 10.1263/jbb.92.305; Watson DL, 2002, APPL BIOCHEM BIOTECH, V101, P97, DOI 10.1385/ABAB:101:2:097; Weimar JD, 2002, J BIOL CHEM, V277, P29369, DOI 10.1074/jbc.M107022200; Wright BE, 2004, MOL MICROBIOL, V52, P643, DOI 10.1111/j.1365-2958.2004.04012.x; Xiao ZZ, 2004, BIOTECHNOL BIOENG, V88, P832, DOI 10.1002/bit.20286; Zhang YH, 2003, ANAL CHEM, V75, P219, DOI 10.1021/ac020271n; Zhou WL, 2004, BIOCHEMISTRY-US, V43, P9655, DOI 10.1021/bi049394n	48	29	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39958	39966		10.1074/jbc.M111.239616	http://dx.doi.org/10.1074/jbc.M111.239616			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21914801	Green Published, hybrid			2022-12-25	WOS:000296925700029
J	Sheng, L; Cho, KW; Zhou, YJ; Shen, H; Rui, LY				Sheng, Liang; Cho, Kae Won; Zhou, Yingjiang; Shen, Hong; Rui, Liangyou			Lipocalin 13 Protein Protects against Hepatic Steatosis by Both Inhibiting Lipogenesis and Stimulating Fatty Acid beta-Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; ELEMENT-BINDING PROTEIN; SKELETAL-MUSCLE; LIVER-DISEASE; MICE; DEFICIENCY; EXPRESSION; OBESITY; RETINOL-BINDING-PROTEIN-4; IDENTIFICATION	Obesity is associated with hepatic steatosis, partially due to increased lipogenesis and decreased fatty acid beta-oxidation in the liver; however, the underlying mechanism of abnormal lipid metabolism is not fully understood. We reported previously that obesity is associated with LCN13 (lipocalin 13) deficiency. LCN13 is a lipocalin family member involved in glucose metabolism, and LCN13 deficiency appears to contribute to hyperglycemia in obese mice. Here, we show that LCN13 is also an important regulator of lipogenesis and beta-oxidation in the liver. In primary hepatocytes, recombinant LCN13 directly suppressed lipogenesis and increased fatty acid beta-oxidation, whereas neutralization of endogenous LCN13 had an opposite effect. Transgenic overexpression of LCN13 protected against hepatic steatosis in mice with either dietary or genetic (ob/ob) obesity. LCN13 transgenic overexpression also improved hyperglycemia, glucose intolerance, and insulin resistance in ob/ob mice. Short-term LCN13 overexpression via an adenovirus-mediated gene transfer similarly attenuated hepatic steatosis in db/db mice. LCN13 inhibited the expression of important lipogenic genes and stimulated the genes that promote beta-oxidation. These results suggest that LCN13 decreases liver lipid levels by both inhibiting hepatic lipogenesis and stimulating beta-oxidation. LCN13 deficiency is likely to contribute to fatty liver disease in obese mice.	[Sheng, Liang; Cho, Kae Won; Zhou, Yingjiang; Shen, Hong; Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Rui, LY (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	ruily@umich.edu	shen, hong/I-6179-2016	SHEN, HONG/0000-0002-1559-3633	National Institutes of Health [R01 DK065122, R01 DK073601, 5P60 DK20572, 5P30 CA46592, P30 AG013283, DK34933]; American Diabetes Association [1-09-RA-156]; Michigan Diabetes Research and Training Center; University of Michigan Cancer Center; University of Michigan Nathan Shock Center; University of Michigan Gut Peptide Research Center; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, P60DK020572, R01DK073601, R01DK065122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Michigan Diabetes Research and Training Center; University of Michigan Cancer Center(University of Michigan System); University of Michigan Nathan Shock Center; University of Michigan Gut Peptide Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK065122 and R01 DK073601. This work was also supported by American Diabetes Association Research Award 1-09-RA-156. This work utilized the cores supported by the Michigan Diabetes Research and Training Center (funded by National Institutes of Health Grant 5P60 DK20572), the University of Michigan Cancer Center (funded by National Institutes of Health Grant 5P30 CA46592), the University of Michigan Nathan Shock Center (funded by National Institutes of Health Grant P30 AG013283), and the University of Michigan Gut Peptide Research Center (funded by National Institutes of Health Grant DK34933).	Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Caldwell S, 2010, J HEPATOL, V53, P719, DOI 10.1016/j.jhep.2010.04.031; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Cho KW, 2011, MOL CELL BIOL, V31, P450, DOI 10.1128/MCB.00459-10; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kim YB, 2002, J BIOL CHEM, V277, P32915, DOI 10.1074/jbc.M204710200; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; Lewis JR, 2010, DIGEST DIS SCI, V55, P560, DOI 10.1007/s10620-009-1081-0; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Mendez-Sanchez N, 2007, LIVER INT, V27, P423, DOI 10.1111/j.1478-3231.2007.01483.x; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; More L, 2006, CHEM SENSES, V31, P393, DOI 10.1093/chemse/bjj043; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012; Schlehuber S, 2005, DRUG DISCOV TODAY, V10, P23, DOI 10.1016/S1359-6446(04)03294-5; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Suzuki K, 2004, GENE, V339, P49, DOI 10.1016/j.gene.2004.06.027; Taube A, 2009, AM J PHYSIOL-ENDOC M, V297, pE1004, DOI 10.1152/ajpendo.00241.2009; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zhou YJ, 2010, VITAM HORM, V83, P151, DOI 10.1016/S0083-6729(10)83006-7; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	38	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38128	38135		10.1074/jbc.M111.256677	http://dx.doi.org/10.1074/jbc.M111.256677			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908604	hybrid, Green Published			2022-12-25	WOS:000296594200026
J	Wade, R; Brimer, N; Lyons, C; Vande Pol, S				Wade, Ramon; Brimer, Nicole; Lyons, Charles; Vande Pol, Scott			Paxillin Enables Attachment-independent Tyrosine Phosphorylation of Focal Adhesion Kinase and Transformation by RAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSFORMATION; PAPILLOMAVIRUS E6 ONCOPROTEIN; RECEPTOR COACTIVATOR; PROTEIN PAXILLIN; CELL-SURVIVAL; LIM PROTEIN; NUDE MICE; PTP-PEST; HIC-5; MOTIF	Paxillin and HIC5 are closely related adapter proteins that regulate cell migration and are tyrosine-phosphorylated by focal adhesion kinase (FAK). Paxillin, HIC5, and FAK tyrosine phosphorylation increase upon cell attachment and decrease upon detachment from extracellular matrix. Unexpectedly, we found that although FAK tyrosine phosphorylation in attached cells did not require paxillin, in detached fibroblasts there was remaining FAK tyrosine phosphorylation that required expression of paxillin and was not supported by HIC5. The support of attachment-independent FAK tyrosine phosphorylation required the paxillin LIM domains and suggested that paxillin might facilitate oncogenic transformation. Paxillin but not HIC5 augmented anchorage-independent cell proliferation induced by RAS. Both anchorage-independent FAK tyrosine phosphorylation and RAS-induced colony formation required multiple docking sites on paxillin, including LD4 (docking sites for FAK-Src and GIT1/2-PIX-NCK-PAK complex), LD5, and all four carboxyl-terminal LIM domains (that bind tubulin and PTP-PEST). Analysis using paxillin mutants dissociated domains of paxillin that are required for regulation of cell migration from domains that are required for anchorage-independent cell proliferation and demonstrated essential functions of the paxillin LIM domains that are not found in HIC5 LIM domains. These results highlight the role of paxillin in facilitating attachment-independent signal transduction implicated in cancer.	[Wade, Ramon; Brimer, Nicole; Lyons, Charles; Vande Pol, Scott] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia	Vande Pol, S (corresponding author), Univ Virginia, Dept Pathol, POB 800904, Charlottesville, VA 22908 USA.	vandepol@virginia.edu			National Institutes of Health [CA-69292, CA-120352]; University of Virginia; NATIONAL CANCER INSTITUTE [R01CA069292, R01CA120352, R29CA069292, R01CA134737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-69292 and CA-120352 (to S. V.). This work was also supported by the University of Virginia.	Avraamides C, 2007, AM J PHYSIOL-HEART C, V293, pH193, DOI 10.1152/ajpheart.00728.2006; Bohl J, 2000, VIROLOGY, V271, P163, DOI 10.1006/viro.2000.0316; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Cote JF, 1999, J BIOL CHEM, V274, P20550, DOI 10.1074/jbc.274.29.20550; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Dong JM, 2009, BIOCHEM J, V418, P173, DOI 10.1042/BJ20080170; Drori S, 2005, GENE DEV, V19, P362, DOI 10.1101/gad.1240705; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Fujimoto N, 1999, J BIOL CHEM, V274, P8316, DOI 10.1074/jbc.274.12.8316; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Heitzer MD, 2006, CANCER RES, V66, P7326, DOI 10.1158/0008-5472.CAN-05-2379; Ili D, 1995, NATURE, V377, P539, DOI 10.1038/377539a07566154; Jamieson JS, 2005, J CELL SCI, V118, P5835, DOI 10.1242/jcs.02693; MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; Nishiya N, 2001, MOL CELL BIOL, V21, P5332, DOI 10.1128/MCB.21.16.5332-5345.2001; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Renshaw MW, 1999, J CELL BIOL, V147, P611, DOI 10.1083/jcb.147.3.611; Shen Y, 1998, J BIOL CHEM, V273, P6474, DOI 10.1074/jbc.273.11.6474; Shibanuma M, 2004, J CELL BIOCHEM, V91, P633, DOI 10.1002/jcb.10754; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; STOKER M, 1968, INT J CANCER, V3, P683, DOI 10.1002/ijc.2910030517; Tong XA, 1997, P NATL ACAD SCI USA, V94, P4412, DOI 10.1073/pnas.94.9.4412; Tumbarello DA, 2005, J CELL SCI, V118, P4849, DOI 10.1242/jcs.02615; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Valles AM, 2004, J BIOL CHEM, V279, P44490, DOI 10.1074/jbc.M405144200; Vande Pol SB, 1998, ONCOGENE, V16, P43, DOI 10.1038/sj.onc.1201504; Wade R, 2006, BIOCHEM J, V393, P565, DOI 10.1042/BJ20051241; Wade R, 2002, ONCOGENE, V21, P96, DOI 10.1038/sj.onc.1205013; Wade R, 2008, J VIROL, V82, P5962, DOI 10.1128/JVI.02747-07; Wang H, 2005, J BIOL CHEM, V280, P5154, DOI 10.1074/jbc.M411575200; Wang H, 2008, ONCOGENE, V27, P6791, DOI 10.1038/onc.2008.291; Webb DJ, 2003, CURR OPIN CELL BIOL, V15, P614, DOI 10.1016/S0955-0674(03)00105-4; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Zhang ZWM, 2008, J BIOL CHEM, V283, P18685, DOI 10.1074/jbc.M801274200; Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005	46	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					37932	37944		10.1074/jbc.M111.294504	http://dx.doi.org/10.1074/jbc.M111.294504			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900245	Green Published, hybrid			2022-12-25	WOS:000296594200006
J	Dunlop, MH; Dray, E; Zhao, WX; Tsai, MS; Wiese, C; Schild, D; Sung, P				Dunlop, Myun Hwa; Dray, Eloise; Zhao, Weixing; Tsai, Miaw-Sheue; Wiese, Claudia; Schild, David; Sung, Patrick			RAD51-associated Protein 1 (RAD51AP1) Interacts with the Meiotic Recombinase DMC1 through a Conserved Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; BINDING PROTEIN; MEIOSIS; DNA; COMPLEXES; PROMOTES; ROLES; RAD54; MECHANISM	Homologous recombination (HR) reactions mediated by the RAD51 recombinase are essential for DNA and replication fork repair, genome stability, and tumor suppression. RAD51-associated protein 1 (RAD51AP1) is an important HR factor that associates with and stimulates the recombinase activity of RAD51. We have recently shown that RAD51AP1 also partners with the meiotic recombinase DMC1, displaying isoform-specific interactions with DMC1. Here, we have characterized the DMC1 interaction site in RAD51AP1 by a series of truncations and point mutations to uncover a highly conserved WVPP motif critical for DMC1 interaction but dispensable for RAD51 association. This RAD51AP1 motif is reminiscent of the FVPP motif in the tumor suppressor protein BRCA2 that mediates DMC1 interaction. These results further implicate RAD51AP1 in meiotic HR via RAD51 and DMC1.	[Dunlop, Myun Hwa; Dray, Eloise; Zhao, Weixing; Sung, Patrick] Yale Univ, Dept Mol Biophys & Biochem, Sch Med, New Haven, CT 06520 USA; [Tsai, Miaw-Sheue; Wiese, Claudia; Schild, David] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	Yale University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Sung, P (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, Sch Med, 333 Cedar St,SHM C-130, New Haven, CT 06520 USA.	patrick.sung@yale.edu	Dray, Eloise/E-3938-2012; Dray, Eloise/AAD-5147-2021; zhao, weixing/H-3154-2013; Classen, Scott/AAY-8176-2020	Dray, Eloise/0000-0001-6793-9838; zhao, weixing/0000-0001-5746-3696	National Institutes of Health [RO1 ES015252, RO1 ES015632, RO1 ES07061, PO1 CA092584, PO1 CA129186, R01 CA120315]; NATIONAL CANCER INSTITUTE [P01CA129186, P01CA092584, R01CA120315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015252, R01ES015632, R01ES007061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 ES015252, RO1 ES015632, RO1 ES07061, PO1 CA092584, PO1 CA129186, and R01 CA120315.	ADZUMA K, 1992, GENE DEV, V6, P1679, DOI 10.1101/gad.6.9.1679; Anderson LK, 1997, P NATL ACAD SCI USA, V94, P6868, DOI 10.1073/pnas.94.13.6868; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Busygina V, 2008, GENE DEV, V22, P786, DOI 10.1101/gad.1638708; Chen YK, 2004, P NATL ACAD SCI USA, V101, P10572, DOI 10.1073/pnas.0404195101; Chi P, 2009, DNA REPAIR, V8, P279, DOI 10.1016/j.dnarep.2008.10.012; Dray E, 2011, P NATL ACAD SCI USA, V108, P3560, DOI 10.1073/pnas.1016454108; Dresser ME, 1997, GENETICS, V147, P533; Ferrari SR, 2009, J BIOL CHEM, V284, P11766, DOI 10.1074/jbc.C900023200; FERRIN LJ, 1991, SCIENCE, V254, P1494, DOI 10.1126/science.1962209; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Kagawa W, 2010, FEBS J, V277, P590, DOI 10.1111/j.1742-4658.2009.07503.x; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Klein HL, 1997, GENETICS, V147, P1533; Kovalenko OV, 2006, NUCLEIC ACIDS RES, V34, P5081, DOI 10.1093/nar/gkl665; Kovalenko OV, 1997, NUCLEIC ACIDS RES, V25, P4946, DOI 10.1093/nar/25.24.4946; Leu JY, 1998, CELL, V94, P375, DOI 10.1016/S0092-8674(00)81480-4; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Sehorn MG, 2004, NATURE, V429, P433, DOI 10.1038/nature02563; Sheridan S, 2006, GENE DEV, V20, P1685, DOI 10.1101/gad.1447606; Shinohara A, 2004, CYTOGENET GENOME RES, V107, P201, DOI 10.1159/000080598; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Shinohara M, 1997, GENETICS, V147, P1545; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; Tempest HG, 2011, SYST BIOL REPROD MED, V57, P93, DOI 10.3109/19396368.2010.504879; TERASAWA M, 1995, GENE DEV, V9, P925, DOI 10.1101/gad.9.8.925; Thorslund T, 2007, EMBO J, V26, P2915, DOI 10.1038/sj.emboj.7601739; Tsubouchi H, 2004, GENETICS, V168, P1219, DOI 10.1534/genetics.103.025700; Tsubouchi H, 2003, DEV CELL, V5, P915, DOI 10.1016/S1534-5807(03)00357-5; Tsubouchi H, 2006, GENE DEV, V20, P1766, DOI 10.1101/gad.1422506; Wiese C, 2007, MOL CELL, V28, P482, DOI 10.1016/j.molcel.2007.08.027	42	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37328	37334		10.1074/jbc.M111.290015	http://dx.doi.org/10.1074/jbc.M111.290015			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21903585	Green Published, hybrid			2022-12-25	WOS:000296542400033
J	Haig, NA; Guan, ZQ; Li, DM; McMichael, A; Raetz, CRH; Xu, XN				Haig, Neil A.; Guan, Ziqiang; Li, Demin; McMichael, Andrew; Raetz, Christian R. H.; Xu, Xiao-Ning			Identification of Self-lipids Presented by CD1c and CD1d Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL RECOGNITION; ANTIGEN PRESENTATION; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; ENDOPLASMIC-RETICULUM; MEMBRANE DIGESTION; BINDING GROOVE; MOUSE CD1D; NKT CELLS; MOLECULES	The CD1 family consists of five proteins that are related to the peptide-presenting MHC class I family. T cells can recognize the presentation of both foreign and self-derived lipids on four CD1 family members. The identities of the self-lipids capable of stimulating autoreactive T cell responses remain elusive or controversial. Here, we employed mass spectrometry to analyze the lipid content of highly purified CD1c and CD1d protein samples. We report the identification of 11 novel self-lipids presented by CD1c and nine by CD1d. Rigorous controls provide strong evidence that the identified lipids were specifically loaded into the lipid-binding site of the CD1 molecules. The diverse but distinct population of lipids identified from each CD1 family member implies each present a different subset of self-lipids, and the enrichment of particular motifs indicates that the lipids that are presented by CD1 family members could be predicted. Finally, our results imply the CD1 system surveys the endoplasmic reticulum, Golgi apparatus, and/or secretory compartments, in addition to its well characterized surveillance of the endocytic and lysosomal compartments.	[Haig, Neil A.; Li, Demin; McMichael, Andrew; Xu, Xiao-Ning] Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Guan, Ziqiang; Raetz, Christian R. H.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	University of Oxford; Duke University	McMichael, A (corresponding author), Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	andrew.mcmichael@ndm.ox.ac.uk	Li, Demin/O-4065-2019; Guan, Ziqiang/AAE-5110-2019	Li, Demin/0000-0002-7118-3401; 	Medical Research Council; National Institutes of Health [GM-069338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER; Medical Research Council [G1000800j, MC_U137884177] Funding Source: researchfish; MRC [MC_U137884177] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (to N. A. H., D. L., X.-N. X., and A. M.). This work was also supported by LIPID MAPS Large Scale Collaborative Grant GM-069338 from the National Institutes of Health (to Z. G. and C. R. H. R.).	Agea E, 2005, J EXP MED, V202, P295, DOI 10.1084/jem.20050773; Batuwangala T, 2004, J IMMUNOL, V172, P2382, DOI 10.4049/jimmunol.172.4.2382; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2006, J IMMUNOL, V176, P3625, DOI 10.4049/jimmunol.176.6.3625; Briken V, 2002, EMBO J, V21, P825, DOI 10.1093/emboj/21.4.825; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; Chen DLN, 2008, J IMMUNOL METHODS, V330, P57, DOI 10.1016/j.jim.2007.10.018; Christiansen D, 2008, PLOS BIOL, V6, P1527, DOI 10.1371/journal.pbio.0060172; Cox D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005325; de Jong A, 2007, CHEM BIOL, V14, P1232, DOI 10.1016/j.chembiol.2007.09.010; de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956; de la Salle H, 2005, SCIENCE, V310, P1321, DOI 10.1126/science.1115301; de Lalla C, 2011, EUR J IMMUNOL, V41, P602, DOI 10.1002/eji.201041211; De Libero G, 2005, NAT REV IMMUNOL, V5, P485, DOI 10.1038/nri1631; De Libero G, 2005, IMMUNITY, V22, P763, DOI 10.1016/j.immuni.2005.04.013; De Silva AD, 2002, J IMMUNOL, V168, P723, DOI 10.4049/jimmunol.168.2.723; Dias BR, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-116; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Gadola SD, 2006, J EXP MED, V203, P2293, DOI 10.1084/jem.20060921; Garcia-Alles LF, 2006, EMBO J, V25, P3684, DOI 10.1038/sj.emboj.7601244; Giabbai B, 2005, J IMMUNOL, V175, P977, DOI 10.4049/jimmunol.175.2.977; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Guiard J, 2009, J IMMUNOL, V182, P7030, DOI 10.4049/jimmunol.0804044; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Kolter T, 2005, J BIOL CHEM, V280, P41125, DOI 10.1074/jbc.R500015200; Li DM, 2009, J IMMUNOL, V182, P1033, DOI 10.4049/jimmunol.182.2.1033; Li YS, 2008, GLYCOBIOLOGY, V18, P158, DOI 10.1093/glycob/cwm129; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Moody D. B, 2007, T CELL ACTIVATION CD; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Muindi K, 2010, P NATL ACAD SCI USA, V107, P3052, DOI 10.1073/pnas.0915056107; Park JJ, 2004, P NATL ACAD SCI USA, V101, P1022, DOI 10.1073/pnas.0307847100; Paul W. E, 2008, FUNDAMENTAL IMMUNOLO, P518; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Porubsky S, 2007, P NATL ACAD SCI USA, V104, P5977, DOI 10.1073/pnas.0611139104; Scharf L, 2010, IMMUNITY, V33, P853, DOI 10.1016/j.immuni.2010.11.026; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Silk JD, 2008, J IMMUNOL, V180, P6452, DOI 10.4049/jimmunol.180.10.6452; Speak AO, 2007, P NATL ACAD SCI USA, V104, P5971, DOI 10.1073/pnas.0607285104; Sugita M, 2000, TRAFFIC, V1, P295, DOI 10.1034/j.1600-0854.2000.010401.x; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; Sullivan BA, 2005, TRENDS IMMUNOL, V26, P282, DOI 10.1016/j.it.2005.03.002; Van Rhijn I, 2009, J EXP MED, V206, P1409, DOI 10.1084/jem.20082480; Winau F, 2004, NAT IMMUNOL, V5, P169, DOI 10.1038/ni1035; Wu D, 2006, P NATL ACAD SCI USA, V103, P3972, DOI 10.1073/pnas.0600285103; Yuan WM, 2009, J IMMUNOL, V182, P4784, DOI 10.4049/jimmunol.0803981; Zajonc DM, 2008, J MOL BIOL, V377, P1104, DOI 10.1016/j.jmb.2008.01.061; Zajonc DM, 2008, P NATL ACAD SCI USA, V105, P17925, DOI 10.1073/pnas.0809814105; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	63	30	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37692	37701		10.1074/jbc.M111.267948	http://dx.doi.org/10.1074/jbc.M111.267948			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900247	Green Published, hybrid			2022-12-25	WOS:000296542400065
J	Salmaso, N; Cossette, MP; Woodside, B				Salmaso, Natalina; Cossette, Marie-Pierre; Woodside, Barbara			Pregnancy and Maternal Behavior Induce Changes in Glia, Glutamate and Its Metabolism within the Cingulate Cortex	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; SUPRAOPTIC NUCLEUS; NEURONAL INTERACTIONS; LACTATING RATS; FEMALE RATS; PLASTICITY; HYPOTHALAMUS; EXPRESSION	An upregulation of the astrocytic proteins GFAP and bFGF within area 2 of the cingulate cortex (Cg2) occurs within 3 hours of parturition in rats. These changes are the result of an interaction between hormonal state and maternal experience and are associated with increased dendritic spine density in this area. Here, we examined whether this upregulation of astrocytic proteins generalized to other glial markers and, in particular those associated with glutamate metabolism. We chose glial markers commonly used to reflect different aspects of glial function: vimentin, like GFAP, is a marker of intermediate filaments; glutamine synthetase (GS), and S-100beta, are used as markers for mature astrocytes and GS has also been used as a specific marker for glutamatergic enzymatic activity. In addition, we examined levels of proteins associated with glutamine synthetase, glutamate, glutamine and two excitatory amino acid transporters found in astrocytes, glt-1 and glast. S100beta immunoreactivity did not vary with reproductive state in either Cg2 or MPOA suggesting no change in the number of mature astrocytes across these conditions. Vimentin-ir did not differ across groups in Cg2, but expression of this protein decreased from Day 1 postpartum onwards in the MPOA. By contrast, GS-ir was increased within 24 h postpartum in Cg2 but not MPOA and similarly to GFAP and bFGF this upregulation of GS resulted from an interaction between hormonal state and maternal experience. Within Cg2, upregulation of GS was not accompanied by changes in the astrocytic glutamatergic transporters, glt-1 and glast, however, an increase in both glutamate and glutamine proteins were observed within the Cg2 of postpartum animals. Together, these changes suggest postpartum upregulation of glutamatergic activity and metabolism within Cg2 that is stimulated by pregnancy hormones and maternal experience.	[Salmaso, Natalina] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Cossette, Marie-Pierre; Woodside, Barbara] Concordia Univ, Ctr Studies Behav Neurobiol, Montreal, PQ H3G 1M8, Canada	Yale University; Concordia University - Canada	Salmaso, N (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.	nsalmaso@gmail.com		Salmaso, Natalina/0000-0002-9661-5194	NSERC [NSERC 7938]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by an NSERC grant (NSERC 7938) to B.W. and an NSERC PGSD2 doctoral scholarship to N.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abe K, 2001, PHARMACOL RES, V43, P307, DOI 10.1006/phrs.2000.0794; Albrecht J, 2007, FRONT BIOSCI-LANDMRK, V12, P332, DOI 10.2741/2067; Eclancher F, 1996, BRAIN RES, V737, P201, DOI 10.1016/0006-8993(96)00732-9; El Majdoubi M, 2000, BIOCHEM CELL BIOL, V78, P317; Featherstone RE, 2000, BEHAV NEUROSCI, V114, P158, DOI 10.1037/0735-7044.114.1.158; GARCIASEGURA LM, 1995, GLIA, V13, P209, DOI 10.1002/glia.440130307; Gomes FCA, 1999, BRAZ J MED BIOL RES, V32, P619, DOI 10.1590/S0100-879X1999000500016; Grattan DR, 2008, J NEUROENDOCRINOL, V20, P497, DOI 10.1111/j.1365-2826.2008.01661.x; Hatton GI, 2002, ADV PHYSIOL EDUC, V26, P225, DOI 10.1152/advan.00038.2002; Lambert K G, 2000, Stress, V3, P275, DOI 10.3109/10253890009001133; Lonstein JS, 1998, NEUROSCIENCE, V82, P267; MONTAGNESE C, 1988, BRAIN RES BULL, V20, P681, DOI 10.1016/0361-9230(88)90078-0; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Pawluski JL, 2009, PHYSIOL BEHAV, V96, P108, DOI 10.1016/j.physbeh.2008.09.004; SALM AK, 1985, CELL TISSUE RES, V242, P9, DOI 10.1007/BF00225557; Salmaso N, 2008, NEUROSCIENCE, V154, P932, DOI 10.1016/j.neuroscience.2008.03.063; Salmaso N, 2006, HORM BEHAV, V50, P448, DOI 10.1016/j.yhbeh.2006.05.006; Salmaso N, 2005, NEUROSCIENCE, V134, P1431, DOI 10.1016/j.neuroscience.2005.05.038; Salmaso N, 2010, NEUROSCIENCE, V169, P637, DOI 10.1016/j.neuroscience.2010.05.057; SALMASO N, 2009, EUR J NEUROSCI; SALMASO N, 2008, NEUROSCIENC IN PRESS; Sheng JG, 1997, J NEUROPATH EXP NEUR, V56, P285, DOI 10.1097/00005072-199703000-00007; Suzuki A, 2005, PHOTOSYNTH RES, V83, P191, DOI 10.1007/s11120-004-3478-0; Theodosis D T, 2001, Prog Brain Res, V133, P49; THEODOSIS DT, 1986, NATURE, V322, P738, DOI 10.1038/322738a0; THEODOSIS DT, 1984, CELL TISSUE RES, V235, P217, DOI 10.1007/BF00213745; THEODOSIS DT, 1984, NEUROSCIENCE, V11, P183, DOI 10.1016/0306-4522(84)90222-7; Vaccarino FM, 2007, NEUROSCIENTIST, V13, P173, DOI 10.1177/1073858406298336; VOGT BA, 1983, J COMP NEUROL, V216, P192, DOI 10.1002/cne.902160207; VOGT BA, 1981, J COMP NEUROL, V201, P265, DOI 10.1002/cne.902010210; Zilles K, 1995, CORTEX AREAL LAMINAR; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	33	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e23529	10.1371/journal.pone.0023529	http://dx.doi.org/10.1371/journal.pone.0023529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21909402	Green Published, Green Submitted, gold			2022-12-25	WOS:000294689200007
J	Sciamanna, G; Tassone, A; Martella, G; Mandolesi, G; Puglisi, F; Cuomo, D; Madeo, G; Ponterio, G; Standaert, DG; Bonsi, P; Pisani, A				Sciamanna, Giuseppe; Tassone, Annalisa; Martella, Giuseppina; Mandolesi, Georgia; Puglisi, Francesca; Cuomo, Dario; Madeo, Grazia; Ponterio, Giulia; Standaert, David George; Bonsi, Paola; Pisani, Antonio			Developmental Profile of the Aberrant Dopamine D2 Receptor Response in Striatal Cholinergic Interneurons in DYT1 Dystonia	PLOS ONE			English	Article							PRIMARY TORSION DYSTONIA; MEDIUM SPINY NEURONS; MOUSE MODEL; CALCIUM CURRENTS; BASAL GANGLIA; RAT STRIATUM; HUMAN BRAIN; EXPRESSION; ACETYLCHOLINE; TRANSMISSION	Background: DYT1 dystonia, a severe form of genetically determined human dystonia, exhibits reduced penetrance among carriers and begins usually during adolescence. The reasons for such age dependence and variability remain unclear. Methods and Results: We characterized the alterations in D2 dopamine receptor (D2R) signalling in striatal cholinergic interneurons at different ages in mice overexpressing human mutant torsinA (hMT). An abnormal excitatory response to the D2R agonist quinpirole was recorded at postnatal day 14, consisting of a membrane depolarization coupled to an increase in spiking frequency, and persisted unchanged at 3 and 9 months in hMT mice, compared to mice expressing wild-type human torsinA and non-transgenic mice. This response was blocked by the D2R antagonist sulpiride and depended upon G-proteins, as it was prevented by intrapipette GDP-beta-S. Patch-clamp recordings from dissociated interneurons revealed a significant increase in the Cav2.2-mediated current fraction at all ages examined. Consistently, chelation of intracellular calcium abolished the paradoxical response to quinpirole. Finally, no gross morphological changes were observed during development. Conclusions: These results suggest that an imbalanced striatal dopaminergic/cholinergic signaling occurs early in DYT1 dystonia and persists along development, representing a susceptibility factor for symptom generation.	[Sciamanna, Giuseppe; Tassone, Annalisa; Martella, Giuseppina; Puglisi, Francesca; Cuomo, Dario; Madeo, Grazia; Ponterio, Giulia; Pisani, Antonio] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [Sciamanna, Giuseppe; Tassone, Annalisa; Mandolesi, Georgia; Puglisi, Francesca; Bonsi, Paola; Pisani, Antonio] Fdn Santa Lucia IRCCS, Lab Neurophysiol & Plast, Rome, Italy; [Standaert, David George] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA	University of Rome Tor Vergata; IRCCS Santa Lucia; University of Alabama System; University of Alabama Birmingham	Sciamanna, G (corresponding author), Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy.	pisani@uniroma2.it	Bonsi, Paola/K-4688-2012; Mandolesi, Georgia/G-6595-2011; Sciamanna, Giuseppe/B-6553-2013; tassone, annalisa/J-9950-2016; Madeo, Graziella/K-4748-2016; Ponterio, Giulia/K-2114-2016; G, Martella/H-5142-2018; Martella, Giuseppina/L-9465-2019; Pisani, Antonio/G-2492-2012	Bonsi, Paola/0000-0001-5940-9028; Sciamanna, Giuseppe/0000-0002-0070-1638; tassone, annalisa/0000-0001-9643-2446; Madeo, Graziella/0000-0001-7557-471X; Ponterio, Giulia/0000-0001-5886-3368; G, Martella/0000-0002-8927-7107; Martella, Giuseppina/0000-0002-8927-7107; Pisani, Antonio/0000-0002-8432-594X; Standaert, David/0000-0003-2921-8348; Mandolesi, Georgia/0000-0003-3612-6820	Bachmann-Strauss Dystonia-Parkinson Foundation; Dystonia Medical Research Foundation; NIH [P50NS037409]; Istituto Superiore Sanita (Malattie Rare); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS037409] Funding Source: NIH RePORTER	Bachmann-Strauss Dystonia-Parkinson Foundation; Dystonia Medical Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Istituto Superiore Sanita (Malattie Rare); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Bachmann-Strauss Dystonia-Parkinson Foundation, Dystonia Medical Research Foundation; NIH P50NS037409; Istituto Superiore Sanita (Malattie Rare) to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyelan M, 2009, J NEUROSCI, V29, P9740, DOI 10.1523/JNEUROSCI.2300-09.2009; Asanuma K, 2005, NEUROLOGY, V64, P347, DOI 10.1212/01.WNL.0000149764.34953.BF; Augood SJ, 1999, ANN NEUROL, V46, P761, DOI 10.1002/1531-8249(199911)46:5<761::AID-ANA12>3.3.CO;2-Q; Augood SJ, 2003, BRAIN RES, V986, P12, DOI 10.1016/S0006-8993(03)03164-0; Augood SJ, 2002, NEUROLOGY, V59, P445, DOI 10.1212/WNL.59.3.445; Aznavour N, 2003, J COMP NEUROL, V460, P280, DOI 10.1002/cne.10660; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Bonsi P, 2005, NEUROPHARMACOLOGY, V49, P104, DOI 10.1016/j.neuropharm.2005.05.012; Bonsi P, 2008, J NEUROSCI, V28, P6258, DOI 10.1523/JNEUROSCI.1678-08.2008; Bonsi P, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00006; Bragg DC, 2011, NEUROBIOL DIS, V42, P136, DOI 10.1016/j.nbd.2010.11.015; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Calabresi P, 1998, J PHYSIOL-LONDON, V510, P421, DOI 10.1111/j.1469-7793.1998.421bk.x; Carbon M, 2009, NEUROLOGY, V72, P2097, DOI 10.1212/WNL.0b013e3181aa538f; DeBoer P, 1996, EUR J PHARMACOL, V317, P257, DOI 10.1016/S0014-2999(96)00761-3; Deng P, 2007, J NEUROSCI, V27, P3148, DOI 10.1523/JNEUROSCI.5535-06.2007; Ding JB, 2010, NEURON, V67, P294, DOI 10.1016/j.neuron.2010.06.017; Fahn S, 1983, Adv Neurol, V37, P177; Fahn S, 1998, ADV NEUROL, V50, P1; Ferre S, 1997, TRENDS NEUROSCI, V20, P482, DOI 10.1016/S0166-2236(97)01096-5; Furukawa Y, 2000, NEUROLOGY, V54, P1193, DOI 10.1212/WNL.54.5.1193; Goldberg JA, 2005, J NEUROSCI, V25, P10230, DOI 10.1523/JNEUROSCI.2734-05.2005; Granata A, 2008, J BIOL CHEM, V283, P7568, DOI 10.1074/jbc.M704097200; Guzman JN, 2003, J NEUROSCI, V23, P8931; Hewett J, 2010, J NEUROCHEM, V113, P228, DOI 10.1111/j.1471-4159.2010.06590.x; Jankovic J, 2006, LANCET NEUROL, V5, P864, DOI 10.1016/S1474-4422(06)70574-9; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Konakova M, 2001, BRAIN RES, V922, P1, DOI 10.1016/S0006-8993(01)03014-1; LEMOINE C, 1990, NEUROSCI LETT, V117, P248, DOI 10.1016/0304-3940(90)90671-U; LeMoine C, 1996, NEUROSCIENCE, V73, P131, DOI 10.1016/0306-4522(96)00029-2; Martella G, 2008, NEUROSCIENCE, V152, P469, DOI 10.1016/j.neuroscience.2007.12.040; Martella G, 2011, NEUROSCIENCE, V177, P240, DOI 10.1016/j.neuroscience.2010.12.057; Martella G, 2009, BRAIN, V132, P2336, DOI 10.1093/brain/awp194; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Momiyama T, 2003, J PHYSIOL-LONDON, V546, P483, DOI 10.1113/jphysiol.2002.031773; Napolitano F, 2010, NEUROBIOL DIS, V38, P434, DOI 10.1016/j.nbd.2010.03.003; Neychev VK, 2008, BRAIN, V131, P2499, DOI 10.1093/brain/awn168; Oberlin Shelley R, 2004, Adv Neurol, V94, P61; Ozelius LJ, 2011, NEUROBIOL DIS, V42, P127, DOI 10.1016/j.nbd.2010.12.012; Perlmutter Joel S, 2004, Adv Neurol, V94, P163; Perlmutter JS, 1997, J NEUROSCI, V17, P843; Pisani A, 2006, NEUROBIOL DIS, V24, P318, DOI 10.1016/j.nbd.2006.07.006; Pisani A, 1999, J NEUROPHYSIOL, V81, P2508, DOI 10.1152/jn.1999.81.5.2508; Pisani A, 2000, J NEUROSCI, V20, part. no.; Pisani A, 2007, TRENDS NEUROSCI, V30, P545, DOI 10.1016/j.tins.2007.07.008; Rostasy K, 2003, NEUROBIOL DIS, V12, P11, DOI 10.1016/S0969-9961(02)00010-4; Sciamanna G, 2009, NEUROBIOL DIS, V34, P133, DOI 10.1016/j.nbd.2009.01.001; Sharma N, 2005, J NEUROSCI, V25, P5351, DOI 10.1523/JNEUROSCI.0855-05.2005; Shashidharan P, 2000, BRAIN RES, V853, P197, DOI 10.1016/S0006-8993(99)02232-5; Standaert DG, 2011, NEUROBIOL DIS, V42, P148, DOI 10.1016/j.nbd.2011.01.012; Tanabe LM, 2009, NAT REV NEUROL, V5, P598, DOI 10.1038/nrneurol.2009.160; Tozzi A, 2011, J NEUROSCI, V31, P1850, DOI 10.1523/JNEUROSCI.4082-10.2011; Vasudevan A, 2006, BRAIN RES, V1073, P139, DOI 10.1016/j.brainres.2005.12.087; Velumian AA, 1999, J PHYSIOL-LONDON, V517, P201, DOI 10.1111/j.1469-7793.1999.0201z.x; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Wichmann T, 2008, EXP NEUROL, V212, P242, DOI 10.1016/j.expneurol.2008.04.020; Xiao HF, 2004, DEV BRAIN RES, V152, P47, DOI 10.1016/j.devbrainres.2004.05.012; Yan Z, 1997, J NEUROPHYSIOL, V77, P1003, DOI 10.1152/jn.1997.77.2.1003; Zhao Y, 2008, EXP NEUROL, V210, P719, DOI 10.1016/j.expneurol.2007.12.027	60	62	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24261	10.1371/journal.pone.0024261	http://dx.doi.org/10.1371/journal.pone.0024261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912682	Green Published, Green Submitted, gold			2022-12-25	WOS:000294686100029
J	Wu, CYC; Jia, ZH; Wang, W; Ballou, LM; Jiang, YP; Chen, BY; Mathias, RT; Cohen, IS; Song, LS; Entcheva, E; Lin, RZ				Wu, Chia-Yen C.; Jia, Zhiheng; Wang, Wei; Ballou, Lisa M.; Jiang, Ya-Ping; Chen, Biyi; Mathias, Richard T.; Cohen, Ira S.; Song, Long-Sheng; Entcheva, Emilia; Lin, Richard Z.			PI3Ks Maintain the Structural Integrity of T-Tubules in Cardiac Myocytes	PLOS ONE			English	Article							INDUCED HEART-FAILURE; PHOSPHOINOSITIDE 3-KINASE; MYOCARDIAL-CONTRACTILITY; MICE; REGULATOR; JUNCTOPHILIN-2; CARDIOMYOPATHY; CAVEOLIN-3; P110-ALPHA; PROTEINS	Background: Phosphoinositide 3-kinases (PI3Ks) regulate numerous physiological processes including some aspects of cardiac function. Although regulation of cardiac contraction by individual PI3K isoforms has been studied, little is known about the cardiac consequences of downregulating multiple PI3Ks concurrently. Methods and Results: Genetic ablation of both p110 alpha and p110 beta in cardiac myocytes throughout development or in adult mice caused heart failure and death. Ventricular myocytes from double knockout animals showed transverse tubule (T-tubule) loss and disorganization, misalignment of L-type Ca2+ channels in the T-tubules with ryanodine receptors in the sarcoplasmic reticulum, and reduced Ca2+ transients and contractility. Junctophilin-2, which is thought to tether T-tubules to the sarcoplasmic reticulum, was mislocalized in the double PI3K-null myocytes without a change in expression level. Conclusions: PI3K p110 alpha and p110 beta are required to maintain the organized network of T-tubules that is vital for efficient Ca2+-induced Ca2+ release and ventricular contraction. PI3Ks maintain T-tubule organization by regulating junctophilin-2 localization. These results could have important medical implications because several PI3K inhibitors that target both isoforms are being used to treat cancer patients in clinical trials.	[Wu, Chia-Yen C.; Jiang, Ya-Ping; Mathias, Richard T.; Cohen, Ira S.; Lin, Richard Z.] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Wu, Chia-Yen C.; Jiang, Ya-Ping; Mathias, Richard T.; Cohen, Ira S.; Lin, Richard Z.] SUNY Stony Brook, Inst Mol Cardiol, Stony Brook, NY 11794 USA; [Jia, Zhiheng; Entcheva, Emilia] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Ballou, Lisa M.; Lin, Richard Z.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Lin, Richard Z.] Dept Vet Affairs Med Ctr, Northport, NY USA; [Chen, Biyi; Song, Long-Sheng] Univ Iowa Carver Coll Med, Div Cardiovasc Med, Dept Internal Med, Iowa City, IA USA; [Wang, Wei] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Iowa; Baylor College of Medicine	Wu, CYC (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.	richard.lin@sunysb.edu	Song, Long-Sheng/D-5899-2012; Chen, Biyi/AAF-3077-2021; jia, zhiheng/D-9354-2012; Lin, Richard/J-1754-2014	Lin, Richard/0000-0002-3473-7276; Song, Long-Sheng/0000-0002-6035-8106	American Diabetes Association; Department of Veterans Affairs; National Institutes of Health [DK62722, CA136754, HL085221, GM071558, HL090905]; NATIONAL CANCER INSTITUTE [R01CA136754] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090905, R01HL085221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded in part by grants from the American Diabetes Association (to R.Z.L.), the Department of Veterans Affairs Merit Review Program (to R.Z.L.) and the National Institutes of Health (DK62722 and CA136754 to R.Z.L.; HL085221 to R.T.M.; GM071558 to E.E. and HL090905 to L.S.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balijepalli RC, 2003, CARDIOVASC RES, V59, P67, DOI 10.1016/S0008-6363(03)00325-0; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Brette F, 2003, CIRC RES, V92, P1182, DOI 10.1161/01.RES.0000074908.17214.FD; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cannell MB, 2006, J MUSCLE RES CELL M, V27, P297, DOI 10.1007/s10974-006-9089-y; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Dou ZX, 2010, J CELL BIOL, V191, P827, DOI 10.1083/jcb.201006056; Fan GF, 2005, J BIOL CHEM, V280, P40337, DOI 10.1074/jbc.M506810200; Feiner EC, 2011, J CARD FAIL, V17, P253, DOI 10.1016/j.cardfail.2010.10.008; Franzini-Armstrong C, 2009, APPL PHYSIOL NUTR ME, V34, P323, DOI 10.1139/H09-017; Garbino A, 2010, ACTA PHARMACOL SIN, V31, P1019, DOI 10.1038/aps.2010.116; He JQ, 2001, CARDIOVASC RES, V49, P298, DOI 10.1016/S0008-6363(00)00256-X; Heinzel FR, 2008, CIRC RES, V102, P338, DOI 10.1161/CIRCRESAHA.107.160085; Im YJ, 2007, J BIOL CHEM, V282, P5443, DOI 10.1074/jbc.M611342200; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Landstrom AP, 2007, J MOL CELL CARDIOL, V42, P1026, DOI 10.1016/j.yjmcc.2007.04.006; Lu ZJ, 2007, DIABETES, V56, P2780, DOI 10.2337/db06-1629; Lu ZJ, 2009, CIRCULATION, V120, P318, DOI 10.1161/CIRCULATIONAHA.109.873380; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; Ma H, 2006, CELL RES, V16, P466, DOI 10.1038/sj.cr.7310058; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Minamisawa S, 2004, BIOCHEM BIOPH RES CO, V325, P852, DOI 10.1016/j.bbrc.2004.10.107; Nishi M, 2000, BIOCHEM BIOPH RES CO, V273, P920, DOI 10.1006/bbrc.2000.3011; Rosati B, 2007, J PHYSIOL-LONDON, V579, P465, DOI 10.1113/jphysiol.2006.127480; Rose RA, 2007, CIRC RES, V101, P1274, DOI 10.1161/CIRCRESAHA.107.158428; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; van Oort RJ, 2011, CIRCULATION, V123, P979, DOI 10.1161/CIRCULATIONAHA.110.006437; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; Woodman SE, 2002, J BIOL CHEM, V277, P38988, DOI 10.1074/jbc.M205511200; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8; Yano N, 2008, AM J PHYSIOL-HEART C, V295, pH1690, DOI 10.1152/ajpheart.00531.2008; Ziman AP, 2010, J MOL CELL CARDIOL, V48, P379, DOI 10.1016/j.yjmcc.2009.09.016	36	36	36	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24404	10.1371/journal.pone.0024404	http://dx.doi.org/10.1371/journal.pone.0024404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912691	gold, Green Submitted, Green Published			2022-12-25	WOS:000294686100038
J	Zhang, J; Lazarenko, OP; Blackburn, ML; Shankar, K; Badger, TM; Ronis, MJJ; Chen, JR				Zhang, Jian; Lazarenko, Oxana P.; Blackburn, Michael L.; Shankar, Kartik; Badger, Thomas M.; Ronis, Martin J. J.; Chen, Jin-Ran			Feeding Blueberry Diets in Early Life Prevent Senescence of Osteoblasts and Bone Loss in Ovariectomized Adult Female Rats	PLOS ONE			English	Article							OSTEOPOROSIS; CHILDHOOD; MASS; ACQUISITION; EXPRESSION; ESTROGEN; CHILDREN; ETHANOL; GROWTH; CBFA1	Background: Appropriate nutrition during early development is essential for maximal bone mass accretion; however, linkage between early nutrition, childhood bone mass, peak bone mass in adulthood, and prevention of bone loss later in life has not been studied. Methodology and Principal Findings: In this report, we show that feeding a high quality diet supplemented with blueberries (BB) to pre-pubertal rats throughout development or only between postnatal day 20 (PND20) and PND34 prevented ovariectomy (OVX)-induced bone loss in adult life. This protective effect of BB is due to suppression of osteoblastic cell senescence associated with acute loss of myosin expression after OVX. Early exposure of pre-osteoblasts to serum from BB-fed rats was found to consistently increase myosin expression. This led to maintenance osteoblastic cell development and differentiation and delay of cellular entrance into senescence through regulation of the Runx2 gene. High bone turnover after OVX results in insufficient collagenous matrix support for new osteoblasts and their precursors to express myosin and other cytoskeletal elements required for osteoblast activity and differentiation. Conclusions/Significance: These results indicate: 1) a significant prevention of OVX-induced bone loss from adult rats can occur with only 14 days consumption of a BB-containing diet immediately prior to puberty; and 2) the molecular mechanisms underlying these effects involves increased myosin production which stimulates osteoblast differentiation and reduces mesenchymal stromal cell senescence.	[Zhang, Jian; Lazarenko, Oxana P.; Blackburn, Michael L.; Shankar, Kartik; Badger, Thomas M.; Ronis, Martin J. J.; Chen, Jin-Ran] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Zhang, Jian; Shankar, Kartik; Badger, Thomas M.; Ronis, Martin J. J.; Chen, Jin-Ran] Arkansas Childrens Nutr Ctr, Little Rock, AR USA; [Lazarenko, Oxana P.; Blackburn, Michael L.; Badger, Thomas M.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Ronis, Martin J. J.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Zhang, J (corresponding author), Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA.	chenjinran@uams.edu		Shankar, Kartik/0000-0002-7964-9026	United States Department of Agriculture, Agricultural Research Service, the Current Research Information System (USDA ARS CRIS) [6251-51000-005-03S]	United States Department of Agriculture, Agricultural Research Service, the Current Research Information System (USDA ARS CRIS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported by United States Department of Agriculture, Agricultural Research Service, the Current Research Information System (USDA ARS CRIS) #6251-51000-005-03S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; [Anonymous], 2000, NIH Consens Statement, V17, P1; Chen JR, 2008, EXP BIOL MED, V233, P1348, DOI 10.3181/0802-RM-63; Chen JR, 2006, J PHARMACOL EXP THER, V319, P1182, DOI 10.1124/jpet.106.109454; Chen JR, 2010, J BONE MINER RES, V25, P2399, DOI 10.1002/jbmr.137; Chen JR, 2009, J BONE MINER RES, V24, P221, DOI 10.1359/JBMR.081011; Cho SJ, 2010, J BIOL CHEM, V285, P27159, DOI 10.1074/jbc.M110.142117; Davies JH, 2005, ARCH DIS CHILD, V90, P373, DOI 10.1136/adc.2004.053553; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fewtrell MS, 2009, BONE, V45, P142, DOI 10.1016/j.bone.2009.03.657; Foley S, 2008, J BONE MINER RES, V23, P994, DOI [10.1359/jbmr.080223, 10.1359/JBMR.080223]; Gilsanz V, 2007, PEDIATRICS, V119, pS145, DOI 10.1542/peds.2006-2023G; Gunter K, 2008, J BONE MINER RES, V23, P986, DOI 10.1359/JBMR.071201; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Ji J, 2007, MOL CELL BIOL, V27, P1531, DOI 10.1128/MCB.00629-06; Kaludjerovic J, 2010, J NUTR, V140, P766, DOI 10.3945/jn.109.116343; Kulak CAM, 1998, INT J FERTIL WOMEN M, V43, P56; Lanham-New SA, 2006, AM J CLIN NUTR, V83, P1254, DOI 10.1093/ajcn/83.6.1254; Lash RW, 2009, PRIMARY CARE, V36, P181, DOI 10.1016/j.pop.2008.10.009; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; McMichael BK, 2009, J BIOL CHEM, V284, P12266, DOI 10.1074/jbc.M808621200; Ogita M, 2008, ENDOCRINOLOGY, V149, P5713, DOI 10.1210/en.2008-0369; Piccone CM, 2005, EXP PHYSIOL, V90, P87, DOI 10.1113/expphysiol.2004.028373; Pockwinse SM, 2006, J CELL PHYSIOL, V206, P354, DOI 10.1002/jcp.20469; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rodan GA, 1998, P NATL ACAD SCI USA, V95, P13361, DOI 10.1073/pnas.95.23.13361; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Shalet S, 2006, HORM RES, V65, P17, DOI 10.1159/000091750; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; Shankar K, 2010, ENDOCRINOLOGY, V151, P153, DOI 10.1210/en.2009-0840; Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107; Tylavsky FA, 2004, AM J CLIN NUTR, V79, P311; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Zaidi SK, 2003, P NATL ACAD SCI USA, V100, P14852, DOI 10.1073/pnas.2533076100	36	47	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24486	10.1371/journal.pone.0024486	http://dx.doi.org/10.1371/journal.pone.0024486			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912699	Green Submitted, Green Published, gold			2022-12-25	WOS:000294686100046
J	Leite, J; Carvalho, S; Fregni, F; Goncalves, OF				Leite, Jorge; Carvalho, Sandra; Fregni, Felipe; Goncalves, Oscar F.			Task-Specific Effects of tDCS-Induced Cortical Excitability Changes on Cognitive and Motor Sequence Set Shifting Performance	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; OBSESSIVE-COMPULSIVE DISORDER; TRANSCRANIAL DC-STIMULATION; FRONTAL-LOBE DAMAGE; PARKINSONS-DISEASE; PREFRONTAL CORTEX; WORKING-MEMORY; BASAL GANGLIA; NEURAL EVIDENCE; MECHANISMS	In this study, we tested the effects of transcranial Direct Current Stimulation (tDCS) on two set shifting tasks. Set shifting ability is defined as the capacity to switch between mental sets or actions and requires the activation of a distributed neural network. Thirty healthy subjects (fifteen per site) received anodal, cathodal and sham stimulation of the dorsolateral prefrontal cortex (DLPFC) or the primary motor cortex (M1). We measured set shifting in both cognitive and motor tasks. The results show that both anodal and cathodal single session tDCS can modulate cognitive and motor tasks. However, an interaction was found between task and type of stimulation as anodal tDCS of DLPFC and M1 was found to increase performance in the cognitive task, while cathodal tDCS of DLPFC and M1 had the opposite effect on the motor task. Additionally, tDCS effects seem to be most evident on the speed of changing sets, rather than on reducing the number of errors or increasing the efficacy of irrelevant set filtering.	[Leite, Jorge; Carvalho, Sandra; Goncalves, Oscar F.] Univ Minho, Neuropsychophysiol Lab, CIPsi, Sch Psychol EPsi, Braga, Portugal; [Fregni, Felipe] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Neuromodulat Lab, Boston, MA USA	Universidade do Minho; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital	Leite, J (corresponding author), Univ Minho, Neuropsychophysiol Lab, CIPsi, Sch Psychol EPsi, Braga, Portugal.	jorgel@psi.uminho.pt	Westwood, Sam/P-7000-2015; Gonçalves, Óscar F./G-5278-2010; Carvalho, Sandra/H-1214-2014; Leite, Jorge/E-4404-2013; Leite, Jorge/M-9341-2019	Gonçalves, Óscar F./0000-0003-2735-9155; Carvalho, Sandra/0000-0003-1759-5146; Leite, Jorge/0000-0002-0323-9012; Leite, Jorge/0000-0002-0323-9012; Fregni, Felipe/0000-0001-9359-8643	Portuguese Foundation for Science and Technology [SFRH/BD/41484/2007, SFRH/BD/64355/2009]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was supported by the Portuguese Foundation for Science and Technology with individual grants (SFRH/BD/41484/2007 and SFRH/BD/64355/2009), http://alfa.fct.mctes.pt/index.phtml.en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2006, BRAIN RES BULL, V68, P459, DOI 10.1016/j.brainresbull.2005.10.006; Boggio PS, 2007, J AFFECT DISORDERS, V101, P91, DOI 10.1016/j.jad.2006.10.026; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Calzavara R, 2007, EUR J NEUROSCI, V26, P2005, DOI 10.1111/j.1460-9568.2007.05825.x; Cools R, 2001, BRAIN, V124, P2503, DOI 10.1093/brain/124.12.2503; Cools R, 2006, J COGNITIVE NEUROSCI, V18, P1973, DOI 10.1162/jocn.2006.18.12.1973; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; Dockery CA, 2009, J NEUROSCI, V29, P7271, DOI 10.1523/JNEUROSCI.0065-09.2009; Dreher JC, 2003, CEREB CORTEX, V13, P329, DOI 10.1093/cercor/13.4.329; Fales CL, 2006, NEUROPSYCHOLOGIA, V44, P1041, DOI 10.1016/j.neuropsychologia.2005.11.002; Ferry AT, 2000, J COMP NEUROL, V425, P447, DOI 10.1002/1096-9861(20000925)425:3<447::AID-CNE9>3.0.CO;2-V; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fregni F, 2006, MOVEMENT DISORD, V21, P1693, DOI 10.1002/mds.21012; Galea JM, 2009, J NEUROPHYSIOL, V102, P294, DOI 10.1152/jn.00184.2009; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hayes AE, 1998, J COGNITIVE NEUROSCI, V10, P178, DOI 10.1162/089892998562645; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Keeser D, 2011, NEUROIMAGE, V55, P644, DOI 10.1016/j.neuroimage.2010.12.004; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Konishi S, 2002, P NATL ACAD SCI USA, V99, P7803, DOI 10.1073/pnas.122644899; Konishi S, 1998, NAT NEUROSCI, V1, P80, DOI 10.1038/283; Lawrence AD, 1999, NEUROPSYCHOLOGIA, V37, P1359, DOI 10.1016/S0028-3932(99)00035-4; Lawrence NS, 2006, NEUROPSYCHOLOGY, V20, P409, DOI 10.1037/0894-4105.20.4.409; Leichnetz GR, 2001, ANAT RECORD, V263, P215, DOI 10.1002/ar.1082; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Maia TV, 2011, NAT NEUROSCI, V14, P154, DOI 10.1038/nn.2723; Mehta MA, 2004, PSYCHOPHARMACOLOGY, V176, P331, DOI 10.1007/s00213-004-1899-2; Meiran N, 2004, BRAIN COGNITION, V54, P260, DOI 10.1016/j.bandc.2004.02.043; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2007, J NEUROSCI, V27, P3807, DOI 10.1523/JNEUROSCI.5348-06.2007; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OWEN AM, 1993, BRAIN, V116, P1159, DOI 10.1093/brain/116.5.1159; Pollmann S, 2000, J COGNITIVE NEUROSCI, V12, P480, DOI 10.1162/089892900562156; Purcell R, 1998, BIOL PSYCHIAT, V43, P348, DOI 10.1016/S0006-3223(97)00201-1; Ravizza SM, 2002, J COGNITIVE NEUROSCI, V14, P472, DOI 10.1162/089892902317361985; Ravizza SM, 2008, NEUROPSYCHOLOGIA, V46, P2924, DOI 10.1016/j.neuropsychologia.2008.06.006; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; Rogers RD, 2000, J COGNITIVE NEUROSCI, V12, P142, DOI 10.1162/089892900561931; Rogers RD, 1998, BRAIN, V121, P815, DOI 10.1093/brain/121.5.815; Rubia K, 2006, HUM BRAIN MAPP, V27, P973, DOI 10.1002/hbm.20237; Rushworth MFS, 2005, EXP PSYCHOL, V52, P83, DOI 10.1027/1618-3169.52.2.83; Smith AB, 2004, HUM BRAIN MAPP, V21, P247, DOI 10.1002/hbm.20007; Spiro R. J., 1990, COGNITION ED MULTIME, P163, DOI DOI 10.1016/J.JBUSRES.2003.10.007; Steinglass JE, 2006, J INT NEUROPSYCH SOC, V12, P431, DOI 10.1017/S1355617706060528; Wagner T, 2007, NEUROIMAGE, V35, P1113, DOI 10.1016/j.neuroimage.2007.01.027	51	49	53	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24140	10.1371/journal.pone.0024140	http://dx.doi.org/10.1371/journal.pone.0024140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	817OO	21909415	gold, Green Published			2022-12-25	WOS:000294683900031
J	Ghara, M; Kundanati, L; Borges, RM				Ghara, Mahua; Kundanati, Lakshminath; Borges, Renee M.			Nature's Swiss Army Knives: Ovipositor Structure Mirrors Ecology in a Multitrophic Fig Wasp Community	PLOS ONE			English	Article							HYMENOPTERA; PARASITOIDS; FICUS; DIPTERA; LENGTH; HOST; ADAPTATIONS; MECHANISMS; MORPHOLOGY; SPECIATION	Background: Resource partitioning is facilitated by adaptations along niche dimensions that range from morphology to behaviour. The exploitation of hidden resources may require specially adapted morphological or sensory tools for resource location and utilisation. Differences in tool diversity and complexity can determine not only how many species can utilize these hidden resources but also how they do so. Methodology and Principal Findings: The sclerotisation, gross morphology and ultrastructure of the ovipositors of a seven-member community of parasitic wasps comprising of gallers and parasitoids developing within the globular syconia (closed inflorescences) of Ficus racemosa (Moraceae) was investigated. These wasps also differ in their parasitism mode (external versus internal oviposition) and their timing of oviposition into the expanding syconium during its development. The number and diversity of sensilla, as well as ovipositor teeth, increased from internally ovipositing to externally ovipositing species and from gallers to parasitoids. The extent of sclerotisation of the ovipositor tip matched the force required to penetrate the syconium at the time of oviposition of each species. The internally ovipositing pollinator had only one type of sensillum and a single notch on the ovipositor tip. Externally ovipositing species had multiple sensilla types and teeth on their ovipositors. Chemosensilla were most concentrated at ovipositor tips while mechanoreceptors were more widely distributed, facilitating the precise location of hidden hosts in these wasps which lack larval host-seeking behaviour. Ovipositor traits of one parasitoid differed from those of its syntopic galler congeners and clustered with those of parasitoids within a different wasp subfamily. Thus ovipositor tools can show lability based on adaptive necessity, and are not constrained by phylogeny. Conclusions/Significance: Ovipositor structure mirrored the increasingly complex trophic ecology and requirements for host accessibility in this parasite community. Ovipositor structure could be a useful surrogate for predicting the biology of parasites in other communities.	[Ghara, Mahua; Borges, Renee M.] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Kundanati, Lakshminath] Indian Inst Sci, Dept Mech Engn, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Ghara, M (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India.	renee@ces.iisc.ernet.in		kundanati, lakshminath/0000-0003-3997-9415	Ministry of Environment and Forests, Government of India	Ministry of Environment and Forests, Government of India(Ministry of Environment, Forest and Climate Change (MoEFCC), Government of India)	This work was funded by the Ministry of Environment and Forests, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Albrecht M, 2001, OECOLOGIA, V126, P134, DOI 10.1007/s004420000494; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Bailey R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000179; BRANDL R, 1987, BIOL J LINN SOC, V32, P351, DOI 10.1111/j.1095-8312.1987.tb00436.x; Brodeur J, 2004, ANNU REV ENTOMOL, V49, P27, DOI 10.1146/annurev.ento.49.061703.153618; BRONSTEIN JL, 1991, OIKOS, V61, P175, DOI 10.2307/3545335; Chapman R.F., 2012, INSECTS STRUCTURE FU; Compton SG, 2009, AFR ENTOMOL, V17, P215, DOI 10.4001/003.017.0212; Compton SG, 2009, AFR NAT HIST, V5, P9; Compton Stephen G., 1994, P343; Cook JM, 2002, EVOLUTION, V56, P1821, DOI 10.1111/j.0014-3820.2002.tb00196.x; Cook JM, 2003, TRENDS ECOL EVOL, V18, P241, DOI 10.1016/S0169-5347(03)00062-4; Cruaud A, 2011, J BIOGEOGR, V38, P209, DOI 10.1111/j.1365-2699.2010.02429.x; DONALDSON JS, 1992, BIOL J LINN SOC, V47, P23, DOI 10.1111/j.1095-8312.1992.tb00653.x; EGGLETON P, 1993, BIOL J LINN SOC, V48, P213, DOI 10.1111/j.1095-8312.1993.tb00888.x; FARRELL BD, 1991, AM NAT, V138, P881, DOI 10.1086/285258; FIELD SA, 1994, INT J INSECT MORPHOL, V23, P135, DOI 10.1016/0020-7322(94)90007-8; GALIL J, 1968, NEW PHYTOL, V67, P745, DOI 10.1111/j.1469-8137.1968.tb05497.x; Gerling D, 1998, BIOCONTROL, V43, P289, DOI 10.1023/A:1009905525300; Ghara M, 2010, ECOL ENTOMOL, V35, P139, DOI 10.1111/j.1365-2311.2010.01176.x; GRUNERT U, 1987, ZOOMORPHOLOGY, V106, P320, DOI 10.1007/BF00312006; HAWKE SD, 1973, TISSUE CELL, V5, P171, DOI 10.1016/S0040-8166(73)80014-X; Herre EA, 2008, ANNU REV ECOL EVOL S, V39, P439, DOI 10.1146/annurev.ecolsys.37.091305.110232; Jousselin E, 2008, EVOLUTION, V62, P1777, DOI 10.1111/j.1558-5646.2008.00406.x; Keil TA, 1997, MICROSC RES TECHNIQ, V39, P506, DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; Kerdelhue C, 1996, OIKOS, V75, P3, DOI 10.2307/3546315; Kjellberg Finn, 2005, P539; Krishnan A, 2010, FUNCT ECOL, V24, P741, DOI 10.1111/j.1365-2435.2010.01696.x; Laurenne N, 2009, BIOL J LINN SOC, V96, P82, DOI 10.1111/j.1095-8312.2008.01114.x; LeRalec A, 1996, CAN ENTOMOL, V128, P413; Lin RC, 2011, BIOTROPICA, V43, P200, DOI 10.1111/j.1744-7429.2010.00686.x; McLeish MJ, 2010, MOL PHYLOGENET EVOL, V57, P122, DOI 10.1016/j.ympev.2010.05.025; Moses DN, 2006, J BIOL CHEM, V281, P34826, DOI 10.1074/jbc.M603429200; Nyman T, 2010, BIOL REV, V85, P393, DOI 10.1111/j.1469-185X.2009.00109.x; PRICE PW, 1972, ECOLOGY, V53, P190, DOI 10.2307/1935729; Proffit M, 2007, J ANIM ECOL, V76, P296, DOI 10.1111/j.1365-2656.2007.01213.x; Quicke D., 1999, RENDICONTI, V47, P197; Quicke D. L. J., 1997, PARASITIC WASPS; QUICKE DLJ, 1995, P ROY SOC B-BIOL SCI, V261, P99, DOI 10.1098/rspb.1995.0122; QUICKE DLJ, 1994, J NAT HIST, V28, P635, DOI 10.1080/00222939400770301; R Development Core Team, 2009, R FDN STAT COMP; Ranganathan Y, 2010, ENTOMOL EXP APPL, V137, P50, DOI 10.1111/j.1570-7458.2010.01038.x; Ranganathan Y, 2009, ANIM BEHAV, V77, P1539, DOI 10.1016/j.anbehav.2009.03.010; ROHDE K, 1994, PARASITOLOGY, V109, pS69, DOI 10.1017/S0031182000085097; Rouquette J, 2003, EUR J ENTOMOL, V100, P351, DOI 10.14411/eje.2003.056; Sanver D, 2000, BASIC APPL ECOL, V1, P3, DOI 10.1078/1439-1791-00001; Siemers BM, 2006, BEHAV ECOL SOCIOBIOL, V59, P373, DOI 10.1007/s00265-005-0060-5; Silvieus SI, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P225; Sivinski J, 2001, ANN ENTOMOL SOC AM, V94, P886, DOI 10.1603/0013-8746(2001)094[0886:OLIAGO]2.0.CO;2; SLIFER EH, 1970, ANNU REV ENTOMOL, V15, P121, DOI 10.1146/annurev.en.15.010170.001005; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Stone GN, 2003, TRENDS ECOL EVOL, V18, P512, DOI 10.1016/S0169-5347(03)00247-7; VANVEEN JC, 1981, ANN ENTOMOL FENN, V47, P77; Vilhelmsen L, 2011, ARTHROPOD STRUCT DEV, V40, P2, DOI 10.1016/j.asd.2010.10.001; VINCENT JFV, 1979, J INSECT PHYSIOL, V25, P653, DOI 10.1016/0022-1910(79)90115-X; Wang RW, 2008, SYMBIOSIS, V45, P113; Weiblen GD, 2004, SYST BIOL, V53, P128, DOI 10.1080/10635150490265012; Weiblen GD, 2002, MOL ECOL, V11, P1573, DOI 10.1046/j.1365-294X.2002.01529.x; Wittman SE, 2010, OIKOS, V119, P551, DOI 10.1111/j.1600-0706.2009.17792.x; Zhen WQ, 2005, PHYTOPARASITICA, V33, P113, DOI 10.1007/BF03029967	61	38	41	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23642	10.1371/journal.pone.0023642	http://dx.doi.org/10.1371/journal.pone.0023642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909352	Green Published, Green Accepted, gold			2022-12-25	WOS:000294680800015
J	Owens, KM; Kulawiec, M; Desouki, MM; Vanniarajan, A; Singh, KK				Owens, Kjerstin M.; Kulawiec, Mariola; Desouki, Mohamad Mokhtar; Vanniarajan, Ayyasamy; Singh, Keshav K.			Impaired OXPHOS Complex III in Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; CYTOCHROME-C REDUCTASE; IRON-SULFUR CLUSTER; REACTIVE OXYGEN; OXIDATIVE-PHOSPHORYLATION; CELL MITOCHONDRIA; BC(1) COMPLEX; NADPH OXIDASE; PROTEIN; ROS	We measured the mitochondrial oxidative phosphorylation (mtOXPHOS) activities of all five complexes and determined the activity and gene expression in detail of the Complex III subunits in human breast cancer cell lines and primary tumors. Our analysis revealed dramatic differences in activity of complex III between normal and aggressive metastatic breast cancer cell lines. Determination of Complex III subunit gene expression identified over expression and co-regulation of UQCRFS1 (encoding RISP protein) and UQCRH (encoding Hinge protein) in 6 out of 9 human breast tumors. Analyses of UQCRFS1/RISP expression in additional matched normal and breast tumors demonstrated an over expression in 14 out of 40 (35%) breast tumors. UQCRFS1/RISP knockdown in breast tumor cell line led to decreased mitochondrial membrane potential as well as a decrease in matrigel invasion. Furthermore, reduced matrigel invasion was mediated by reduced ROS levels coinciding with decreased expression of NADPH oxidase 2, 3, 4 and 5 involved in ROS production. These studies provide direct evidence for contribution of impaired mtOXPHOS Complex III to breast tumorigenesis.	[Owens, Kjerstin M.; Vanniarajan, Ayyasamy; Singh, Keshav K.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Kulawiec, Mariola] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Desouki, Mohamad Mokhtar] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Singh, Keshav K.] Univ Alabama Birmingham, Dept Pathol, Ctr Free Radical Biol, Dept Environm Hlth,Dept Genet,Ctr Aging, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Birmingham, AL USA	Roswell Park Cancer Institute; Fred Hutchinson Cancer Center; Medical University of South Carolina; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Owens, KM (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA.	kksingh@uab.edu	Vanniarajan, A./AAB-4896-2022	Owens, Kjerstin/0000-0001-5210-319X	US National Institutes of Health [R01 CA121904, 113655]; NATIONAL CANCER INSTITUTE [R01CA121904] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the US National Institutes of Health grant R01 CA121904 and 113655 to KKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Desouki MM, 2005, CANCER BIOL THER, V4, P1367, DOI 10.4161/cbt.4.12.2233; Dworakowski R, 2006, BIOCHEM SOC T, V34, P960, DOI 10.1042/BST0340960; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Graham KA, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.3.12207; Gurung B, 2005, J BIOL CHEM, V280, P24895, DOI 10.1074/jbc.M503319200; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kaneko SJ, 2003, GYNECOL ONCOL, V90, P29, DOI 10.1016/S0090-8258(03)00144-6; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Kulawiec M, 2006, CANCER BIOL THER, V5, P967, DOI 10.4161/cbt.5.8.2880; Kulawiec M, 2009, CANCER BIOL THER, V8, P1378, DOI 10.4161/cbt.8.14.8751; Kulawiec M, 2008, CANCER BIOL THER, V7, P1732, DOI 10.4161/cbt.7.11.6729; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lhee S, 2010, J BIOL CHEM, V285, P9233, DOI 10.1074/jbc.M109.043505; Logsdon CD, 2003, CANCER RES, V63, P2649; Maia S, 2005, CANCER RES, V65, P10050, DOI 10.1158/0008-5472.CAN-05-1574; MIKI T, 1991, BIOCHEMISTRY-US, V30, P230, DOI 10.1021/bi00215a033; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08; Morrison C, 2004, AM J PATHOL, V165, P565, DOI 10.1016/S0002-9440(10)63321-4; O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200; Ohashi Y, 2004, GYNECOL ONCOL, V93, P54, DOI 10.1016/j.ygyno.2004.01.019; PULLMAN ME, 1960, J BIOL CHEM, V235, P3322; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Sait SNJ, 2002, GENE CHROMOSOME CANC, V34, P42, DOI 10.1002/gcc.10038; Shai R, 2003, ONCOGENE, V22, P4918, DOI 10.1038/sj.onc.1206753; Singh KK, 2009, J HUM GENET, V54, P516, DOI 10.1038/jhg.2009.71; Vanaja DK, 2003, CANCER RES, V63, P3877; Voet D., 2002, FUNDAMENTALS BIOCH 2, V1st; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Wang F, 2007, CANCER LETT, V257, P274, DOI 10.1016/j.canlet.2007.08.001; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P319; Yusenko MV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-152; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077	38	64	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23846	10.1371/journal.pone.0023846	http://dx.doi.org/10.1371/journal.pone.0023846			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901141	Green Submitted, Green Published, gold			2022-12-25	WOS:000294298000026
J	Ryan, CM; Mehlert, A; Richardson, JM; Ferguson, MAJ; Johnson, PJ				Ryan, Christopher M.; Mehlert, Angela; Richardson, Julia M.; Ferguson, Michael A. J.; Johnson, Patricia J.			Chemical Structure of Trichomonas vaginalis Surface Lipoglycan A ROLE FOR SHORT GALACTOSE (beta 1-4/3) N-ACETYLGLUCOSAMINE REPEATS IN HOST CELL INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRITRICHOMONAS-FETUS; EPITHELIAL-CELLS; LIPOPHOSPHOGLYCAN; SACCHARIDES; STRAINS; ANTIBODIES; PROTEINS; ENZYMES; RISK	The extracellular parasite Trichomonas vaginalis contains a surface glycoconjugate that appears to mediate parasite-host cell interaction via binding to human galectin-1. This glycoconjugate also elicits cytokine production from human vaginal epithelial cells, implicating its role in modulation of host immune responses. We have analyzed the structure of this glycoconjugate, previously described to contain the sugars rhamnose (Rha), N-acetylglucosamine (GlcNAc), galactose (Gal), xylose (Xyl), N-acetylgalactosamine (GalNAc), and glucose (Glc), using gas chromatograph mass spectrometry (GC-MS), matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF), electrospray MS/MS, and nuclear magnetic resonance (NMR), combined with chemical and enzymatic digestions. Our data reveal a complex structure, named T. vaginalis lipoglycan (TvLG), that differs markedly from Leishmania lipophosphoglycan and Entamoeba lipopeptidophosphoglycan and is devoid of phosphosaccharide repeats. TvLG is composed of an alpha 1-3 linked polyrhamnose core, where Rha residues are substituted at the 2-position with either beta-Xyl or chains of, on average, five N-acetyllactosamine (-3Gal beta 1-4GlcNAc beta 1-) (LacNAc) units and occasionally lacto-N-biose (-3Gal beta 1-3GlcNAc beta 1-) (LNB). These chains are themselves periodically substituted at the Gal residues with Xyl-Rha. These structural analyses led us to test the role of the poly-LacNAc/LNB chains in parasite binding to host cells. We found that reduction of poly-LacNAc/LNB chains decreased the ability of TvLG to compete parasite binding to host cells. In summary, our data provide a new model for the structure of TvLG, composed of a polyrhamnose backbone with branches of Xyl and poly-LacNAc/LNB. Furthermore, the poly-LacNAc side chains are shown to be involved in parasite-host cell interaction.	[Mehlert, Angela; Ferguson, Michael A. J.] Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee DD1 4HN, Scotland; [Ryan, Christopher M.; Johnson, Patricia J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Richardson, Julia M.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland	University of Dundee; University of California System; University of California Los Angeles; University of Edinburgh	Ferguson, MAJ (corresponding author), Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee DD1 4HN, Scotland.	m.a.j.ferguson@dundee.ac.uk; johnsonp@ucla.edu	Richardson, Julia/D-1808-2013	Richardson, Julia/0000-0002-1547-3009; Ferguson, Michael/0000-0003-1321-8714	National Institutes of Health [R01 AI069058]; American Cancer Society; Boehringer Ingelheim Fonds; Wellcome Trust [083481, 085622]; Medical Research Council, United Kingdom; MRC [G0500923] Funding Source: UKRI; Medical Research Council [G0500923] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI069058 (to P. J. J.). This work was also supported by a postdoctoral fellowship from the American Cancer Society and a travel grant from Boehringer Ingelheim Fonds (to C. M. R.). The Mass Spectrometry facility at the College of Life Sciences, University of Dundee, is supported by Wellcome Trust Strategic Award 083481.; Supported by Wellcome Trust Grant 085622 and a grant from the Medical Research Council, United Kingdom.	AKHER MA, 1953, NATURE, V171, P474; Alderete JF, 2001, CELL MICROBIOL, V3, P359, DOI 10.1046/j.1462-5822.2001.00126.x; Bastida-Corcuera FD, 2005, EUKARYOT CELL, V4, P1951, DOI 10.1128/EC.4.11.1951-1958.2005; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; CHOROMANSKI L, 1985, Z PARASITENKD, V71, P443, DOI 10.1007/BF00928347; Clark CG, 2002, CLIN MICROBIOL REV, V15, P329, DOI 10.1128/CMR.15.3.329-341.2002; COSTELLO CE, 1993, GLYCOBIOLOGY, V3, P261, DOI 10.1093/glycob/3.3.261; Cotch MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008; de Miguel N, 2010, MOL CELL PROTEOMICS, V9, P1554, DOI 10.1074/mcp.M000022-MCP201; Ferguson M. A. J., 1992, LIPID MODIFICATION P, P191; FERGUSON MAJ, 1993, BIOCHEM J, V291, P51, DOI 10.1042/bj2910051; Fichorova RN, 2006, INFECT IMMUN, V74, P5773, DOI 10.1128/IAI.00631-06; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; GARDNER WA, 1986, ARCH PATHOL LAB MED, V110, P430; Gilbert RO, 2000, INFECT IMMUN, V68, P4200, DOI 10.1128/IAI.68.7.4200-4206.2000; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Hirt RP, 2007, TRENDS PARASITOL, V23, P540, DOI 10.1016/j.pt.2007.08.020; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Lloyd GL, 2003, J UROLOGY, V170, P924, DOI 10.1097/01.ju.0000080375.18547.cc; Ma YF, 2001, ANTIMICROB AGENTS CH, V45, P1407, DOI 10.1128/AAC.45.5.1407-1416.2001; MCCONVILLE MJ, 1987, P NATL ACAD SCI USA, V84, P8941, DOI 10.1073/pnas.84.24.8941; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; MCCONVILLE MJ, 1995, BIOCHEM J, V310, P807, DOI 10.1042/bj3100807; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P19611; MINKOFF H, 1984, AM J OBSTET GYNECOL, V150, P965, DOI 10.1016/0002-9378(84)90392-2; Moody-Haupt S, 2000, J MOL BIOL, V297, P409, DOI 10.1006/jmbi.2000.3577; Okumura CYM, 2008, CELL MICROBIOL, V10, P2078, DOI 10.1111/j.1462-5822.2008.01190.x; Petrin D, 1998, CLIN MICROBIOL REV, V11, P300, DOI 10.1128/CMR.11.2.300; Singh BN, 2009, GLYCOCONJUGATE J, V26, P3, DOI 10.1007/s10719-008-9157-1; SINGH BN, 1994, ARCH BIOCHEM BIOPHYS, V309, P273, DOI 10.1006/abbi.1994.1113; SINGH BN, 1993, MOL BIOCHEM PARASIT, V57, P281, DOI 10.1016/0166-6851(93)90204-B; SINGH BN, 1994, PARASITOL TODAY, V10, P152, DOI 10.1016/0169-4758(94)90267-4; Singh BN, 1999, INFECT IMMUN, V67, P3847, DOI 10.1128/IAI.67.8.3847-3854.1999; Soper D, 2004, AM J OBSTET GYNECOL, V190, P281, DOI 10.1016/j.ajog.2003.08.023; Sorvillo F, 1998, LANCET, V351, P213, DOI 10.1016/S0140-6736(05)78181-2; Sutcliffe S, 2006, CANCER EPIDEM BIOMAR, V15, P939, DOI 10.1158/1055-9965.EPI-05-0781; TURCO SJ, 1992, ANNU REV MICROBIOL, V46, P65, DOI 10.1146/annurev.mi.46.100192.000433; Van Der Pol B, 2008, J INFECT DIS, V197, P548, DOI 10.1086/526496; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; WARTON A, 1983, Z PARASITENKD, V69, P149, DOI 10.1007/BF00926951; WARTON A, 1988, J ELECTRON MICROSC, V37, P134; WARTON A, 1980, J PROTOZOOL, V27, P410, DOI 10.1111/j.1550-7408.1980.tb05386.x; Wilson IBH, 2004, CELL MOL LIFE SCI, V61, P794, DOI 10.1007/s00018-003-3278-2; World Health Organization, 1996, SEX TRANSM DIS STDS; YAP EH, 1995, GENITOURIN MED, V71, P402; ZHANG ZF, 1994, INT J EPIDEMIOL, V23, P682, DOI 10.1093/ije/23.4.682	46	28	29	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40494	40508		10.1074/jbc.M111.280578	http://dx.doi.org/10.1074/jbc.M111.280578			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21900246	Green Published, hybrid			2022-12-25	WOS:000297315400009
J	Jankowitsch, F; Kuhm, C; Kellner, R; Kalinowski, J; Pelzer, S; Macheroux, P; Mack, M				Jankowitsch, Frank; Kuehm, Christian; Kellner, Roland; Kalinowski, Joern; Pelzer, Stefan; Macheroux, Peter; Mack, Matthias			A Novel N,N-8-Amino-8-demethyl-D-riboflavin Dimethyltransferase (RosA) Catalyzing the Two Terminal Steps of Roseoflavin Biosynthesis in Streptomyces davawensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ANTIBIOTIC ROSEOFLAVIN; BACILLUS-SUBTILIS; CONJUGAL TRANSFER; RIBOFLAVIN; DNA; METHYLTRANSFERASES; METHYLATION; EXPRESSION; RESISTANCE	Streptomyces davawensis synthesizes the antibiotic roseoflavin (RoF) (8-dimethylamino-8-demethyl-D-riboflavin). It was postulated that RoF is synthesized from riboflavin via 8-amino( AF) and 8-methylamino-8-demethyl-D-riboflavin (MAF). In a cell-free extract of S. davawensis, an S-adenosyl methionine-dependent conversion of AF into MAF and RoF was observed. The corresponding N,N-8-amino-8-demethyl-D-riboflavin dimethyltransferase activity was enriched by column chromatography. The final most active fraction still contained at least five different proteins that were analyzed by enzymatic digestion and concomitant de novo sequencing by MS/MS. One of the sequences matched a hypothetical peptide fragment derived from an as yet uncharacterized open reading frame (sda77220) located in the middle of a (putative) gene cluster within the S. davawensis genome. Expression of ORF sda77220 in Escherichia coli revealed that the corresponding gene product had N,N-8-amino-8-demethyl-D-riboflavin dimethyltransferase activity. Inactivation of ORF sda77220 led to a S. davawensis strain that synthesized AF but not MAF or RoF. Accordingly, as the first identified gene of RoF biosynthesis, ORF sda77220 was named rosA. RosA (347 amino acids; 38 kDa) was purified from a recombinant E. coli strain (as a His(6)-tagged protein) and was biochemically characterized (apparent K-m for AF = 57.7 +/- 9.2 mu M; apparent K-D for AF = 10.0 mu M; k(cat) = 0.37 +/- 0.02 s(-1)). RosA is a unique enzyme and may be useful for a variety of applications.	[Jankowitsch, Frank; Kuehm, Christian; Mack, Matthias] Mannheim Univ Appl Sci, Inst Tech Microbiol, Dept Biotechnol, D-68163 Mannheim, Germany; [Kellner, Roland] Merck Serono, Dept Prot & Cell Sci, D-64271 Darmstadt, Germany; [Kalinowski, Joern] Univ Bielefeld, Ctr Biotechnol CeBiTec, D-33615 Bielefeld, Germany; [Pelzer, Stefan] BRAIN AG, D-64723 Zwingenberg, Germany; [Macheroux, Peter] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria	Merck KGaA; EMD Serono Inc.; University of Bielefeld; Graz University of Technology	Mack, M (corresponding author), Mannheim Univ Appl Sci, Inst Tech Microbiol, Dept Biotechnol, Paul Wittsack Str 10, D-68163 Mannheim, Germany.	m.mack@hs-mannheim.de	Macheroux, Peter/AAB-5157-2019; Mack, Matthias/AAB-8660-2022	Macheroux, Peter/0000-0002-0242-454X; Mack, Matthias/0000-0002-7753-2422	Anneliese Konanz-Stiftung; German Federal Ministry of Education and Research	Anneliese Konanz-Stiftung; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Anneliese Konanz-Stiftung and the German Federal Ministry of Education and Research.	Abbas CA, 2011, MICROBIOL MOL BIOL R, V75, P321, DOI 10.1128/MMBR.00030-10; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Blaesing F, 2005, J BIOTECHNOL, V120, P146, DOI [10.1016/j.jbiotec.2005.06.023, 10.1016/j.biotec.2005.06.023]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen HW, 2002, BIOCHEMISTRY-US, V41, P9165, DOI 10.1021/bi020245j; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Grill S, 2008, J BACTERIOL, V190, P1546, DOI 10.1128/JB.01586-07; Grill S, 2007, ARCH MICROBIOL, V188, P377, DOI 10.1007/s00203-007-0258-1; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; JURI N, 1987, J BIOCHEM-TOKYO, V101, P705, DOI 10.1093/jb/101.3.705; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Kieser T, 2000, PRACTICAL STREPTOMYC, P168; KODAKI T, 1989, EUR J BIOCHEM, V185, P243, DOI 10.1111/j.1432-1033.1989.tb15109.x; Lee ER, 2009, RNA BIOL, V6, P187, DOI 10.4161/rna.6.2.7727; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; MANSJO M, 2011, RNA BIOL IN PRESS, V8; Mast YJ, 2011, J BIOTECHNOL, V155, P63, DOI 10.1016/j.jbiotec.2010.12.001; MATSUI K, 1979, J BIOCHEM-TOKYO, V86, P167; Ostash B, 2009, BIOCHEMISTRY-US, V48, P8830, DOI 10.1021/bi901018q; OTANI S, 1974, J ANTIBIOT, V27, P88, DOI 10.7164/antibiotics.27.88; Otani S, 1980, Methods Enzymol, V66, P235; Otani Shohei, 1997, Osaka City Medical Journal, V43, P107; Ott E, 2009, RNA BIOL, V6, P276, DOI 10.4161/rna.6.3.8342; Sambrook J., 2002, MOL CLONING LAB MANU; STROHL WR, 1992, NUCLEIC ACIDS RES, V20, P961, DOI 10.1093/nar/20.5.961; Thompson CC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-258; Vogl C, 2007, J BACTERIOL, V189, P7367, DOI 10.1128/JB.00590-07; WALSH C, 1978, BIOCHEMISTRY-US, V17, P1942, DOI 10.1021/bi00603a022; Yu TW, 2002, P NATL ACAD SCI USA, V99, P7968, DOI 10.1073/pnas.092697199; ZALACAIN M, 1989, J BACTERIOL, V171, P4254, DOI 10.1128/JB.171.8.4254-4260.1989	33	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38275	38285		10.1074/jbc.M111.292300	http://dx.doi.org/10.1074/jbc.M111.292300			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911488	Green Published, hybrid			2022-12-25	WOS:000296594200041
J	Kawai, F; Grass, S; Kim, Y; Choi, KJ; St Geme, JW; Yeo, HJ				Kawai, Fumihiro; Grass, Susan; Kim, Youngchang; Choi, Kyoung-Jae; St Geme, Joseph W., III; Yeo, Hye-Jeong			Structural Insights into the Glycosyltransferase Activity of the Actinobacillus pleuropneumoniae HMW1C-like Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; O-GLCNAC TRANSFERASE; 2-PARTNER SECRETION; CRYSTAL-STRUCTURE; HMW1 ADHESIN; GLYCOGEN-SYNTHASE; SUBSTRATE-BINDING; FAMILY; GLYCOSYLATION; IDENTIFICATION	Glycosylation of proteins is a fundamental process that influences protein function. The Haemophilus influenzae HMW1 adhesin is an N-linked glycoprotein that mediates adherence to respiratory epithelium, an essential early step in the pathogenesis of H. influenzae disease. HMW1 is glycosylated by HMW1C, a novel glycosyltransferase in the GT41 family that creates N-glycosidic linkages with glucose and galactose at asparagine residues and di-glucose linkages at sites of glucose modification. Here we report the crystal structure of Actinobacillus pleuropneumoniae HMW1C (ApHMW1C), a functional homolog of HMW1C. The structure of ApHMW1C contains an N-terminal all alpha-domain (AAD) fold and a C-terminal GT-B fold with two Rossmann-like domains and lacks the tetratricopeptide repeat fold characteristic of the GT41 family. The GT-B fold harbors the binding site for UDP-hexose, and the interface of the AAD fold and the GT-B fold forms a unique groove with potential to accommodate the acceptor protein. Structure-based functional analyses demonstrated that the HMW1C protein shares the same structure as ApHMW1C and provided insights into the unique bi-functional activity of HMW1C and ApHMW1C, suggesting an explanation for the similarities and differences of the HMW1C-like proteins compared with other GT41 family members.	[Kawai, Fumihiro; Choi, Kyoung-Jae; Yeo, Hye-Jeong] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Grass, Susan; St Geme, Joseph W., III] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Grass, Susan; St Geme, Joseph W., III] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Kim, Youngchang] Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA	University of Houston System; University of Houston; Duke University; Duke University; United States Department of Energy (DOE); Argonne National Laboratory	Yeo, HJ (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	hyeo@uh.edu	Kawai, Fumihiro/O-2712-2018	Kim, Youngchang/0000-0002-1610-4889; Choi, Kyoungjae/0000-0001-9541-4182; Kawai, Fumihiro/0000-0003-0909-0789	National Institutes of Health from the Welch Foundation [AI068943, E-1616]; National Institutes of Health [R01-DC02873]; U.S. Dept. of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002873] Funding Source: NIH RePORTER	National Institutes of Health from the Welch Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Dept. of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant AI068943 and Grant E-1616 from the Welch Foundation (to H.-J. Y.) and by National Institutes of Health Grant R01-DC02873 (to J. W. S.).; Results shown in this report are derived from work performed at the Argonne National Laboratory, Structural Biology Center (19ID) at the Advanced Photon Source. Argonne is operated by the University of Chicago, Argonne, LLC, for the U.S. Dept. of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; BARENKAMP SJ, 1994, INFECT IMMUN, V62, P3320, DOI 10.1128/IAI.62.8.3320-3328.1994; BARENKAMP SJ, 1992, INFECT IMMUN, V60, P1302, DOI 10.1128/IAI.60.4.1302-1313.1992; Buscher AZ, 2006, MOL MICROBIOL, V61, P470, DOI 10.1111/j.1365-2958.2006.05236.x; Buscher AZ, 2004, J BACTERIOL, V186, P4209, DOI 10.1128/JB.186.13.4209-4217.2004; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; Charbonneau ME, 2007, J BACTERIOL, V189, P8880, DOI 10.1128/JB.00969-07; Choi KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015888; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleckenstein JM, 2006, INFECT IMMUN, V74, P2245, DOI 10.1128/IAI.74.4.2245-2258.2006; Geme JWS, 2009, TRENDS MICROBIOL, V17, P355, DOI 10.1016/j.tim.2009.06.002; Geme JWS, 1998, MOL MICROBIOL, V27, P617; Grass S, 2000, MOL MICROBIOL, V36, P55, DOI 10.1046/j.1365-2958.2000.01812.x; Grass S, 2003, MOL MICROBIOL, V48, P737, DOI 10.1046/j.1365-2958.2003.03450.x; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Gross J, 2008, J BIOL CHEM, V283, P26010, DOI 10.1074/jbc.M801819200; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Horcajada C, 2006, J BIOL CHEM, V281, P2923, DOI 10.1074/jbc.M507394200; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Liu F, 2006, J BIOL CHEM, V281, P20902, DOI 10.1074/jbc.M602972200; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morera S, 1999, J MOL BIOL, V292, P717, DOI 10.1006/jmbi.1999.3094; Murray BW, 1997, BIOCHEMISTRY-US, V36, P823, DOI 10.1021/bi962284z; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nelson KM, 2001, INFECT IMMUN, V69, P6201, DOI 10.1128/IAI.69.10.6201-6208.2001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Ruane KM, 2008, PROTEINS, V73, P784, DOI 10.1002/prot.22171; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Schmidt MA, 2003, TRENDS MICROBIOL, V11, P554, DOI 10.1016/j.tim.2003.10.004; Sheng F, 2009, J BIOL CHEM, V284, P17796, DOI 10.1074/jbc.M809804200; STGEME JW, 1993, P NATL ACAD SCI USA, V90, P2875, DOI 10.1073/pnas.90.7.2875; STGEME JW, 1993, INFECT AGENT DIS, V2, P1; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195	44	42	43	4	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38546	38557		10.1074/jbc.M111.237602	http://dx.doi.org/10.1074/jbc.M111.237602			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908603	hybrid, Green Published			2022-12-25	WOS:000296594200068
J	Lin, KY; Zhang, XJ; Feng, DD; Zhang, H; Zeng, CW; Han, BW; Zhou, AD; Qu, LH; Xu, L; Chen, YQ				Lin, Kang-Yu; Zhang, Xing-Ju; Feng, Dan-Dan; Zhang, Hua; Zeng, Cheng-Wu; Han, Bo-Wei; Zhou, Ai-Dong; Qu, Liang-Hu; Xu, Ling; Chen, Yue-Qin			miR-125b, a Target of CDX2, Regulates Cell Differentiation through Repression of the Core Binding Factor in Hematopoietic Malignancies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; HOMEOBOX GENE CDX2; ACUTE LYMPHOBLASTIC-LEUKEMIA; CBF-BETA; MICRORNAS; EXPRESSION; CANCER; TRANSCRIPTION; PROLIFERATION	MicroRNA-125b (miR-125b), a small noncoding RNA molecule, has been found to be deregulated and functions as an oncogene in many cancers including hematopoietic malignancies. However, the mechanisms accounting for miR-125b dysregulation remain to be elucidated. The present study aims to identify the factors that might contribute to up-regulation of miR-125b in human hematopoietic malignancies and its downstream targets for lineage-specific differentiation. We at first reported that CDX2, a homeobox transcription factor, binds to promoter regions of the miR-125b gene and activates transcriptional regulation of miR-125b in malignant myeloid cells. We further revealed that increasing levels of CDX2 in malignant myeloid cells activate miR-125b expression, which in turn inhibits core binding factor beta (CBF beta) translation, thereby counteracting myeloid cell differentiation, at least for granulocytic lineage, and promoting leukemogenesis. Interestingly, we found that this novel pathway including CDX2, miR-125b, and CBF beta was mediated by undergoing all-trans-retinoic acid induction. Once differentiation ensues with all-trans-retinoic acid treatment, CDX2 activity decreases, leading to a reduction in miR-125b transcription and up-regulation of CBF beta in myeloid cells and in patients. The study provides a new mechanism that contributes to hematopoietic malignancies, which could involve deregulation of miR-125b and its up-and downstream factors. As altered expression of miRNAs has been reported in a wide range of malignancies, delineating the underlying molecular mechanisms of aberrant miRNA expression and characterizing the upstream and downstream factors will help to understand important steps in the pathogenesis of these afflictions.	[Xu, Ling] Sun Yat Sen Univ, Affiliated Hosp 2, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Kang-Yu; Zhang, Xing-Ju; Feng, Dan-Dan; Zhang, Hua; Zeng, Cheng-Wu; Han, Bo-Wei; Zhou, Ai-Dong; Qu, Liang-Hu; Chen, Yue-Qin] Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Xu, L (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 2, Guangzhou 510275, Guangdong, Peoples R China.	luoxul64@yahoo.com; lsscyq@mail.sysu.edu.cn	Zhang, Hua/AAA-2164-2022; Zhang, Hua/AAF-3999-2020; Xie, Huangming/B-2260-2012; Zeng, Chengwu/AAA-8920-2019; Lin, Kangyu/I-8050-2016	Zhang, Hua/0000-0001-9731-2737; Lin, Kangyu/0000-0003-0140-2557; Zhang, Xingju/0000-0003-0717-2510; Qu, Liang-Hu/0000-0003-3657-2863; Zhou, Aidong/0000-0001-8389-9522; Zeng, Chengwu/0000-0002-1333-3918	National Science and Technology Department [2011CBA01105, 2011CB811301, 2009ZX09103-641]; National Natural Science Foundation of China [30672254, 30872784]; Fundamental Research Funds for the Central Universities	National Science and Technology Department; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Science and Technology Department 973 Program Grants 2011CBA01105, 2011CB811301, and 2009ZX09103-641, National Natural Science Foundation of China Grants 30672254 and 30872784, and the Fundamental Research Funds for the Central Universities.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bousquet M, 2008, J EXP MED, V205, P2499, DOI 10.1084/jem.20080285; Chawengsaksophak K, 2004, P NATL ACAD SCI USA, V101, P7641, DOI 10.1073/pnas.0401654101; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; De Marchis ML, 2009, LEUKEMIA, V23, P856, DOI 10.1038/leu.2008.372; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Hart SM, 2002, HAEMATOLOGICA, V87, P1307; Kuckenberg P, 2010, MOL CELL BIOL, V30, P3310, DOI 10.1128/MCB.01215-09; Kundu M, 2002, BLOOD, V100, P2449, DOI 10.1182/blood-2002-04-1064; Kuo YH, 2006, CANCER CELL, V9, P57, DOI 10.1016/j.ccr.2005.12.014; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Link KA, 2010, J CELL PHYSIOL, V222, P50, DOI 10.1002/jcp.21950; Lo Coco F, 2002, CANCER RES, V62, P5618; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Rawat VPS, 2008, BLOOD, V111, P309, DOI 10.1182/blood-2007-04-085407; Riedt T, 2009, BLOOD, V113, P4049, DOI 10.1182/blood-2008-12-196634; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Roudaia L, 2009, BLOOD, V113, P3070, DOI 10.1182/blood-2008-03-147207; Roussel MJS, 2001, ONCOGENE, V20, P7287, DOI 10.1038/sj.onc.1204863; Scholl C, 2007, J CLIN INVEST, V117, P1037, DOI 10.1172/JCI30182; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Smirnov DA, 2008, AM J HUM GENET, V83, P243, DOI 10.1016/j.ajhg.2008.07.003; SUH E, 1994, MOL CELL BIOL, V14, P7340, DOI 10.1128/MCB.14.11.7340; Talebian L, 2007, BLOOD, V109, P11, DOI 10.1182/blood-2006-05-021188; Tallman MS, 2002, BLOOD, V99, P759, DOI 10.1182/blood.V99.3.759; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Thoene S, 2009, LEUKEMIA, V23, P649, DOI 10.1038/leu.2008.355; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007826; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	39	58	60	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38253	38263		10.1074/jbc.M111.269670	http://dx.doi.org/10.1074/jbc.M111.269670			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21903586	hybrid, Green Published			2022-12-25	WOS:000296594200039
J	Gonzalez, A; Perez-Acle, T; Pardo, L; Deupi, X				Gonzalez, Angel; Perez-Acle, Tomas; Pardo, Leonardo; Deupi, Xavier			Molecular Basis of Ligand Dissociation in beta-Adrenergic Receptors	PLOS ONE			English	Article							2ND EXTRACELLULAR LOOP; PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; DYNAMICS SIMULATIONS; AROMATIC RESIDUES; HORMONE RECEPTOR; BINDING; AGONIST; SELECTIVITY; IDENTIFICATION	The important and diverse biological functions of beta-adrenergic receptors (beta ARs) have promoted the search for compounds to stimulate or inhibit their activity. In this regard, unraveling the molecular basis of ligand binding/unbinding events is essential to understand the pharmacological properties of these G protein-coupled receptors. In this study, we use the steered molecular dynamics simulation method to describe, in atomic detail, the unbinding process of two inverse agonists, which have been recently co-crystallized with beta(1) and beta(2)ARs subtypes, along four different channels. Our results indicate that this type of compounds likely accesses the orthosteric binding site of bARs from the extracellular water environment. Importantly, reconstruction of forces and energies from the simulations of the dissociation process suggests, for the first time, the presence of secondary binding sites located in the extracellular loops 2 and 3 and transmembrane helix 7, where ligands are transiently retained by electrostatic and Van der Waals interactions. Comparison of the residues that form these new transient allosteric binding sites in both bARs subtypes reveals the importance of non-conserved electrostatic interactions as well as conserved aromatic contacts in the early steps of the binding process.	[Gonzalez, Angel; Pardo, Leonardo] Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Bellaterra, Catalunya, Spain; [Gonzalez, Angel] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Santiago, Chile; [Perez-Acle, Tomas] Univ Chile, Fac Ciencias Fis & Matemat, Ctr Math Modeling, Computat Biol Lab, Santiago, Chile; [Perez-Acle, Tomas] Ctr Interdisciplinario Neurociencias Valparaiso, Valparaiso, Chile; [Perez-Acle, Tomas] Fdn Ciencia Vida, Santiago, Chile; [Deupi, Xavier] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; [Deupi, Xavier] Paul Scherrer Inst, Condensed Matter Theory Grp, Villigen, Switzerland	Autonomous University of Barcelona; Universidad Andres Bello; Universidad de Chile; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Gonzalez, A (corresponding author), Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Bellaterra, Catalunya, Spain.	xavier.deupi@psi.ch	Perez-Acle, Tomas/F-7176-2012; Gonzalez, Angel/AAU-5927-2020; Deupi, Xavier/B-2424-2009; Gonzalez, Angel/B-2492-2010	Perez-Acle, Tomas/0000-0002-3769-390X; Gonzalez, Angel/0000-0002-2284-8307; Deupi, Xavier/0000-0003-4572-9316; Gonzalez, Angel/0000-0002-2284-8307; Pardo, Leonardo/0000-0003-1778-7420	Swiss National Science Foundation (SNF) [31003A_132815]; ETH Zurich; Ministerio de Ciencia e Innovacion (MICINN) [SAF2010-22198-C02-02]; Instituto de Salud Carlos III (ISCIII) [RD07/0067/0008]; Proyectos de Financiamiento Basal [PFB03, PFB16]; Millenium Institute Centro Interdisciplinario de Neurociencias de Valparaiso (CINV); Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT)	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); ETH Zurich(ETH Zurich); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Proyectos de Financiamiento Basal(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Millenium Institute Centro Interdisciplinario de Neurociencias de Valparaiso (CINV); Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by the Swiss National Science Foundation (SNF) grant 31003A_132815 and the ETH Zurich within the framework of the National Center for Competence in Research Structural Biology Program (to XD); by grants from Ministerio de Ciencia e Innovacion (MICINN) SAF2010-22198-C02-02 and Instituto de Salud Carlos III (ISCIII) RD07/0067/0008 (to LP); and by the Proyectos de Financiamiento Basal PFB03 and PFB16 grants and the Millenium Institute Centro Interdisciplinario de Neurociencias de Valparaiso (CINV) (to TPA). AG is recipient of a Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT) doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bonner G, 2000, EUR J PHARMACOL, V403, P37, DOI 10.1016/S0014-2999(00)00578-1; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Fagerberg L, 2010, PROTEOMICS, V10, P1141, DOI 10.1002/pmic.200900258; Fishelovitch D, 2009, J PHYS CHEM B, V113, P13018, DOI 10.1021/jp810386z; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gerber BO, 2001, J BIOL CHEM, V276, P3394, DOI 10.1074/jbc.M007748200; GETHER U, 1994, J BIOL CHEM, V269, P23959; Gkountelias K, 2009, MOL PHARMACOL, V75, P793, DOI 10.1124/mol.108.052423; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Hoffmann SH, 2000, MOL ENDOCRINOL, V14, P1099, DOI 10.1210/me.14.7.1099; Hogan K, 2006, J MED CHEM, V49, P911, DOI 10.1021/jm050780s; Hovelmann S, 2002, BIOCHEMISTRY-US, V41, P1129, DOI 10.1021/bi0113162; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Isralewitz B, 1997, BIOPHYS J, V73, P2972, DOI 10.1016/S0006-3495(97)78326-7; Isralewitz B, 2001, J MOL GRAPH MODEL, V19, P13, DOI 10.1016/S1093-3263(00)00133-9; Jarnagin K, 1996, J BIOL CHEM, V271, P28277, DOI 10.1074/jbc.271.45.28277; Jensen MO, 2002, P NATL ACAD SCI USA, V99, P6731, DOI 10.1073/pnas.102649299; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Liu XL, 2008, J PHYS CHEM B, V112, P4087, DOI 10.1021/jp0716738; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Minh DDL, 2008, J PHYS CHEM B, V112, P5892, DOI 10.1021/jp0733163; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311; Patra M, 2003, BIOPHYS J, V84, P3636, DOI 10.1016/S0006-3495(03)75094-2; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Roth BL, 1997, MOL PHARMACOL, V52, P259, DOI 10.1124/mol.52.2.259; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samson M, 1997, J BIOL CHEM, V272, P24934, DOI 10.1074/jbc.272.40.24934; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Shimamura T, 2011, NATURE; Simpson MM, 1999, MOL PHARMACOL, V56, P1116, DOI 10.1124/mol.56.6.1116; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; Spalding TA, 1998, J BIOL CHEM, V273, P21563, DOI 10.1074/jbc.273.34.21563; Sugimoto Y, 2002, J PHARMACOL EXP THER, V301, P51, DOI 10.1124/jpet.301.1.51; SURYANARAYANA S, 1993, MOL PHARMACOL, V44, P111; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wang T, 2009, J MOL BIOL, V392, P1102, DOI 10.1016/j.jmb.2009.07.093; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wieland K, 1996, P NATL ACAD SCI USA, V93, P9276, DOI 10.1073/pnas.93.17.9276; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xie KQ, 2006, BIOCHEM PHARMACOL, V71, P865, DOI 10.1016/j.bcp.2005.12.013; Yang LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008470	57	70	71	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e23815	10.1371/journal.pone.0023815	http://dx.doi.org/10.1371/journal.pone.0023815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915263	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802500014
J	Mooijaart, SP; Sattar, N; Trompet, S; Polisecki, E; de Craen, AJM; Schaefer, EJ; Jahn, SE; van Himbergen, T; Welsh, P; Ford, I; Stott, DJ; Westendorp, RGJ				Mooijaart, Simon P.; Sattar, Naveed; Trompet, Stella; Polisecki, Eliana; de Craen, Anton J. M.; Schaefer, Ernst J.; Jahn, Sabine E.; van Himbergen, Thomas; Welsh, Paul; Ford, Ian; Stott, David J.; Westendorp, Rudi G. J.		PROSPER Study Grp	C-Reactive Protein and Genetic Variants and Cognitive Decline in Old Age: The PROSPER Study	PLOS ONE			English	Article							INFLAMMATORY PROTEINS; VASCULAR-DISEASE; RISK; DEMENTIA; MARKERS; POPULATION; ROTTERDAM; PLASMA; SERUM	Background: Plasma concentrations of C-reactive protein (CRP), a marker of chronic inflammation, have been associated with cognitive impairment in old age. However, it is unknown whether CRP is causally linked to cognitive decline. Methods and Findings: Within the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) trial, with 5680 participants with a mean age of 75 years, we examined associations of CRP levels and its genetic determinants with cognitive performance and decline over 3.2 years mean follow-up. Higher plasma CRP concentrations were associated with poorer baseline performance on the Stroop test (P = 0.001) and Letter Digit Tests (P, 0.001), but not with the immediate and delayed Picture Learning Test (PLT; both P>0.5). In the prospective analyses, higher CRP concentrations associated with increased rate of decline in the immediate PLT (P = 0.016), but not in other cognitive tests (all p>0.11). Adjustment for prevalent cardiovascular risk factors and disease did not change the baseline associations nor associations with cognitive decline during follow-up. Four haplotypes of CRP were used and, compared to the common haplotype, carrierships associated strongly with levels of CRP (all P < 0.007). In comparison to strong associations of apolipoprotein E with cognitive measures, associations of CRP haplotypes with such measures were inconsistent. Conclusion: Plasma CRP concentrations associate with cognitive performance in part through pathways independent of (risk factors for) cardiovascular disease. However, lifelong exposure to higher CRP levels does not associate with poorer cognitive performance in old age. The current data weaken the argument for a causal role of CRP in cognitive performance, but further study is warranted to draw definitive conclusions.	[Mooijaart, Simon P.; Trompet, Stella; de Craen, Anton J. M.; Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Sattar, Naveed] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Trompet, Stella] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Polisecki, Eliana; Schaefer, Ernst J.; Jahn, Sabine E.; van Himbergen, Thomas] Tufts Univ, Boston, MA 02111 USA; [Welsh, Paul] Univ Glasgow, Div Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Stott, David J.] Univ Glasgow, Dept Geriatr Med, Glasgow, Lanark, Scotland; [Westendorp, Rudi G. J.] Netherlands Consortium Healthy Aging, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Glasgow; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Tufts University; University of Glasgow; University of Glasgow; University of Glasgow	Mooijaart, SP (corresponding author), Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands.	s.p.mooijaart@lumc.nl	Welsh, Paul/H-5249-2019; Ford, Ian/ABE-6145-2020; Mooijaart, Simon P./A-5306-2008	Welsh, Paul/0000-0002-7970-3643; Mooijaart, Simon P./0000-0003-3106-3568; van Himbergen, Thomas/0000-0002-2313-1834	Bristol-Myers Squibb, USA	Bristol-Myers Squibb, USA(Bristol-Myers Squibb)	PROSPER was supported by an investigator initiated grant from Bristol-Myers Squibb, USA. The funder had no role in analysis and interpretation of the data nor in writing and publishing of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BRAND N, 1985, J GEN PSYCHOL, V112, P201, DOI 10.1080/00221309.1985.9711004; Dik MG, 2005, NEUROLOGY, V64, P1371, DOI 10.1212/01.WNL.0000158281.08946.68; Engelhart MJ, 2004, ARCH NEUROL-CHICAGO, V61, P668, DOI 10.1001/archneur.61.5.668; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Harel O, 2007, STAT MED, V26, P3057, DOI 10.1002/sim.2787; HAVEKES LM, 1987, J LIPID RES, V28, P455; Houx PJ, 2002, J NEUROL NEUROSUR PS, V73, P385, DOI 10.1136/jnnp.73.4.385; Kuo HK, 2005, LANCET NEUROL, V4, P371, DOI 10.1016/S1474-4422(05)70099-5; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Marioni RE, 2010, BEHAV GENET, V40, P3, DOI 10.1007/s10519-009-9302-z; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Packard CJ, 2007, J AM GERIATR SOC, V55, P1777, DOI 10.1111/j.1532-5415.2007.01415.x; Schmidt R, 2002, ANN NEUROL, V52, P168, DOI 10.1002/ana.10265; Schram MT, 2007, J AM GERIATR SOC, V55, P708, DOI 10.1111/j.1532-5415.2007.01159.x; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Teunissen CE, 2003, J NEUROIMMUNOL, V134, P142, DOI 10.1016/S0165-5728(02)00398-3; Trompet S, 2010, J NEUROL, V257, P85, DOI 10.1007/s00415-009-5271-7; van den Biggelaar AHJ, 2007, EXP GERONTOL, V42, P693, DOI 10.1016/j.exger.2007.01.011; Wallenstein S, 1998, GENET EPIDEMIOL, V15, P173, DOI 10.1002/(SICI)1098-2272(1998)15:2<173::AID-GEPI5>3.0.CO;2-7; Weaver JD, 2002, NEUROLOGY, V59, P371, DOI 10.1212/WNL.59.3.371; Welsh P, 2008, BRIT J HAEMATOL, V141, P852, DOI 10.1111/j.1365-2141.2008.07133.x; Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	25	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e23890	10.1371/journal.pone.0023890	http://dx.doi.org/10.1371/journal.pone.0023890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915265	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000294802500015
J	Zollinger, SA; Goller, F; Brumm, H				Zollinger, Sue Anne; Goller, Franz; Brumm, Henrik			Metabolic and Respiratory Costs of Increasing Song Amplitude in Zebra Finches	PLOS ONE			English	Article							ENVIRONMENTAL NOISE; ENERGY-EXPENDITURE; VOCAL INTENSITY; VOCALIZATION; SPEECH; SIGNAL; FLIGHT; VOICE; WATER; POWER	Bird song is a widely used model in the study of animal communication and sexual selection, and several song features have been shown to reflect the quality of the singer. Recent studies have demonstrated that song amplitude may be an honest signal of current condition in males and that females prefer high amplitude songs. In addition, birds raise the amplitude of their songs to communicate in noisy environments. Although it is generally assumed that louder song should be more costly to produce, there has been little empirical evidence to support this assumption. We tested the assumption by measuring oxygen consumption and respiratory patterns in adult male zebra finches (Taeniopygia guttata) singing at different amplitudes in different background noise conditions. As background noise levels increased, birds significantly increased the sound pressure level of their songs. We found that louder songs required significantly greater subsyringeal air sac pressure than quieter songs. Though increased pressure is probably achieved by increasing respiratory muscle activity, these increases did not correlate with measurable increases in oxygen consumption. In addition, we found that oxygen consumption increased in higher background noise, independent of singing behaviour. This observation supports previous research in mammals showing that high levels of environmental noise can induce physiological stress responses. While our study did not find that increasing vocal amplitude increased metabolic costs, further research is needed to determine whether there are other non-metabolic costs of singing louder or costs associated with chronic noise exposure.	[Zollinger, Sue Anne; Brumm, Henrik] Max Planck Inst Ornithol, Commun & Social Behav Grp, Seewiesen, Germany; [Goller, Franz] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Zollinger, Sue Anne] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	Max Planck Society; Utah System of Higher Education; University of Utah; University of St Andrews	Zollinger, SA (corresponding author), Max Planck Inst Ornithol, Commun & Social Behav Grp, Seewiesen, Germany.	saz@sueannezollinger.com	Zollinger, Sue Anne/C-2152-2012; Zollinger, Sue Anne/X-1359-2019	Zollinger, Sue Anne/0000-0001-8819-2606	Biotechnology and Biological Sciences Research Council [BB/E003494/1]; German Research Foundation [BR 2309/6-1]; National Institutes of Health (NIH) [DC 04390, DC 06876]; BBSRC [BB/E003494/1] Funding Source: UKRI; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004390, R01DC006876] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); German Research Foundation(German Research Foundation (DFG)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Financial support was provided by the Biotechnology and Biological Sciences Research Council (award BB/E003494/1 to P.J.B. Slater and H. B.), the German Research Foundation (DFG Emmy Noether fellowship to H. B., award BR 2309/6-1) and the National Institutes of Health (NIH DC 04390 and DC 06876 to F. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERLUND L, 1992, J VOICE, V6, P55, DOI 10.1016/S0892-1997(05)80009-8; ARNOLD GE, 1962, J SPEECH HEAR DISORD, V27, P205, DOI 10.1044/jshd.2703.205; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Bayne EM, 2008, CONSERV BIOL, V22, P1186, DOI 10.1111/j.1523-1739.2008.00973.x; Blumstein DT, 2008, ANIM BEHAV, V76, P1055, DOI 10.1016/j.anbehav.2008.06.002; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Brumm H, 2004, ANIM BEHAV, V67, P281, DOI 10.1016/j.anbehav.2003.06.006; Brumm H, 2002, ANIM BEHAV, V63, P891, DOI 10.1006/anbe.2001.1968; Brumm H, 2004, J ANIM ECOL, V73, P434, DOI 10.1111/j.0021-8790.2004.00814.x; Brumm H, 2011, BEHAV ECOLOGY; Brumm H, 2006, ANIM BEHAV, V72, P699, DOI 10.1016/j.anbehav.2006.01.020; Brumm H, 2009, ADV STUD BEHAV, V40, P1, DOI 10.1016/S0065-3454(09)40001-9; Brumm H, 2009, ANIM BEHAV, V78, P741, DOI 10.1016/j.anbehav.2009.07.004; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Cooke M, 2010, J ACOUST SOC AM, V128, P2059, DOI 10.1121/1.3478775; Cynx J, 1998, ANIM BEHAV, V56, P107, DOI 10.1006/anbe.1998.0746; Dabelsteen Torben, 2006, P38; Fernandez-Juricic Esteban, 2005, Urban Habitats, V3, P49; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; Franz M, 2003, J EXP BIOL, V206, P967, DOI 10.1242/jeb.00196; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Goller F, 2004, ANN NY ACAD SCI, V1016, P130, DOI 10.1196/annals.1298.009; Goller F, 2004, J NEUROBIOL, V59, P289, DOI 10.1002/neu.10327; Goller F, 1999, J NEUROBIOL, V41, P513, DOI 10.1002/(SICI)1097-4695(199912)41:4<513::AID-NEU7>3.0.CO;2-P; Habib L, 2007, J APPL ECOL, V44, P176, DOI 10.1111/j.1365-2664.2006.01234.x; Hasselquist D, 2008, J AVIAN BIOL, V39, P384, DOI 10.1111/j.0908-8857.2008.04427.x; Jessen M, 2005, INT J SPEECH LANG LA, V12, P174, DOI 10.1558/sll.2005.12.2.174; LARSEN ON, 1990, ORNIS SCAND, V21, P37, DOI 10.2307/3676376; Mann EA, 1999, J VOICE, V13, P294, DOI 10.1016/S0892-1997(99)80035-6; McAllister AM, 2009, J VOICE, V23, P587, DOI 10.1016/j.jvoice.2007.10.017; Morris CR, 2010, J EXP BIOL, V213, P2788, DOI 10.1242/jeb.035717; Nemeth E, 2009, ANIM BEHAV, V78, P637, DOI 10.1016/j.anbehav.2009.06.016; Oberweger K, 2001, J EXP BIOL, V204, P3379; Osmanski MS, 2009, J ACOUST SOC AM, V126, P911, DOI 10.1121/1.3158928; Peters G, 2004, BIOACOUSTICS, V14, P99, DOI 10.1080/09524622.2004.9753517; Plummer EM, 2008, J EXP BIOL, V211, P66, DOI 10.1242/jeb.011908; Riebel K, 2009, ADV STUD BEHAV, V40, P197, DOI 10.1016/S0065-3454(09)40006-8; Riede T, 2007, J ACOUST SOC AM, V121, P1758, DOI 10.1121/1.2427115; Riede T, 2010, J ANAT, V216, P23, DOI 10.1111/j.1469-7580.2009.01161.x; Ritschard M, 2010, ANIM BEHAV, V79, P877, DOI 10.1016/j.anbehav.2009.12.038; Ritschard M, EVOLUTIONAR IN PRESS; Russell BA, 1998, J SPEECH LANG HEAR R, V41, P239, DOI 10.1044/jslhr.4102.239; Seifert E, 2006, ARCH OTOLARYNGOL, V132, P1128, DOI 10.1001/archotol.132.10.1128; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Suthers RA, 1997, CURR ORNITHOL, V14, P235; Suthers RA, 2009, NEUROSCIENCE BIRDSON, P78; TITZE IR, 1992, J ACOUST SOC AM, V91, P2936, DOI 10.1121/1.402929; Vannoni E, 2009, ANIM BEHAV, V78, P3, DOI 10.1016/j.anbehav.2009.03.015; Ward S, 2004, J EXP BIOL, V207, P4291, DOI 10.1242/jeb.01281; Ward S, 2003, ANIM BEHAV, V66, P893, DOI 10.1006/anbe.2003.2250; Ward S, 2004, BEHAV ECOL, V15, P477, DOI 10.1093/beheco/arh038; Wilden I., 1998, Bioacoustics, V9, P171; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120; Wood WE, 2006, AUK, V123, P650, DOI 10.1642/0004-8038(2006)123[650:SSMMSV]2.0.CO;2; Zheng KC, 2007, J OCCUP HEALTH, V49, P32, DOI 10.1539/joh.49.32	57	40	40	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e23198	10.1371/journal.pone.0023198	http://dx.doi.org/10.1371/journal.pone.0023198			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915258	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000294802500010
J	Stankovich, BL; Aguayo, E; Barragan, F; Sharma, A; Pallavicini, MG				Stankovich, Basha L.; Aguayo, Esmeralda; Barragan, Fatima; Sharma, Aniket; Pallavicini, Maria G.			Differential Adhesion Molecule Expression during Murine Embryonic Stem Cell Commitment to the Hematopoietic and Endothelial Lineages	PLOS ONE			English	Article							GAP-JUNCTIONS; PROGENITOR CELLS; TIGHT JUNCTIONS; IN-VITRO; MESODERM; GROWTH; HEMANGIOBLAST; RECEPTOR; GENE; SPECIFICATION	Mouse embryonic stem cells (ESC) make cell fate decisions based on intrinsic and extrinsic factors. The decision of ESC to differentiate to multiple lineages in vitro occurs during the formation of embryoid bodies (EB) and is influenced by cell-environment interactions. However, molecular mechanisms underlying cell-environmental modulation of ESC fate decisions are incompletely understood. Since adhesion molecules (AM) influence proliferation and differentiation in developing and adult tissues, we hypothesized that specific AM interactions influence ESC commitment toward hematopoietic and endothelial lineages. Expression of AM in the adherens, tight and gap junction pathways in ESC subpopulations were quantified. E-cadherin (E-cad), Claudin-4 (Cldn4), Connexin-43 (Cx43), Zona Occludens-1 (ZO-1) and Zona Occludens-2 (ZO-2) transcript levels were differentially expressed during early stages of hematopoietic/endothelial commitment. Stable ESC lines were generated with reduced expression of E-cad, Cldn4, Cx43, ZO-1 and ZO-2 using shRNA technology. Functional and phenotypic consequences of modulating AM expression were assessed using hematopoietic colony forming assays, endothelial sprouting assays and surface protein expression. A decrease in E-cad, Cldn4, Cx43 and ZO-1 expression was associated with less commitment to the hematopoietic lineage and increased endothelial differentiation as evidenced by functional and phenotypic analysis. A reduction in ZO-2 expression did not influence endothelial differentiation, but decreased hematopoietic commitment two-fold. These data indicate that a subset of AM influence ESC decisions to commit to endothelial and hematopoietic lineages. Furthermore, differentially expressed AM may provide novel markers to delineate early stages of ESC commitment to hematopoietic/endothelial lineages.	[Stankovich, Basha L.; Aguayo, Esmeralda; Barragan, Fatima; Sharma, Aniket; Pallavicini, Maria G.] Univ Calif Merced, Sch Nat Sci, Merced, CA 95344 USA	University of California System; University of California Merced	Stankovich, BL (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA 95344 USA.	mpallavicini@pacific.edu			California Institute for Regenerative Medicine (CIRM) [T1-00006]	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine)	This work was supported in part by the California Institute for Regenerative Medicine (CIRM) Training Grant T1-00006 to B. L. S. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL; Cancelas JA, 2000, BLOOD, V96, P498; D'Souza SL, 2005, BLOOD, V105, P3862, DOI 10.1182/blood-2004-09-3611; Dang SM, 2002, BIOTECHNOL BIOENG, V78, P442, DOI 10.1002/bit.10220; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; *DOHHS, 2001, HEM STEM CELLS STEM; Dzau VJ, 2005, HYPERTENSION, V46, P7, DOI 10.1161/01.HYP.0000168923.92885.f7; Eichmann A, 1997, P NATL ACAD SCI USA, V94, P5141, DOI 10.1073/pnas.94.10.5141; Elefanty AG, 1998, P NATL ACAD SCI USA, V95, P11897, DOI 10.1073/pnas.95.20.11897; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Fok EYL, 2005, STEM CELLS, V23, P1333, DOI 10.1634/stemcells.2005-0112; FRASER IDC, 2004, VECTOR SET PLASMID B; Fujimoto T, 2001, GENES CELLS, V6, P1113, DOI 10.1046/j.1365-2443.2001.00490.x; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; HELGASON CD, IN VITRO HEMATOPOIET; Hermant Bastien, 2007, BMC Biotechnol, V7, P20, DOI 10.1186/1472-6750-7-20; Itoh M, 1999, J BIOL CHEM, V274, P5981, DOI 10.1074/jbc.274.9.5981; Kabrun N, 1997, DEVELOPMENT, V124, P2039; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KENNEDY M, 2003, HEMATOPOIETIC COMMIT, P39; Krtolica A, 2007, STEM CELLS, V25, P2215, DOI 10.1634/stemcells.2007-0230; Lacaud G, 2004, TRENDS CARDIOVAS MED, V14, P314, DOI 10.1016/j.tcm.2004.09.004; Ling V, 1997, J CELL PHYSIOL, V171, P104, DOI 10.1002/(SICI)1097-4652(199704)171:1<104::AID-JCP12>3.0.CO;2-G; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; Mimeault M, 2007, CLIN PHARMACOL THER, V82, P252, DOI 10.1038/sj.clpt.6100301; Moriwaki K, 2007, DEV BIOL, V312, P509, DOI 10.1016/j.ydbio.2007.09.049; Nagano K, 2005, PROTEOMICS, V5, P1346, DOI 10.1002/pmic.200400990; Nowak G, 2004, CIRCULATION, V110, P3699, DOI 10.1161/01.CIR.0000143626.16576.51; Palmqvist L, 2005, STEM CELLS, V23, P663, DOI 10.1634/stemcells.2004-0157; Patan S, 1998, MICROVASC RES, V56, P1, DOI 10.1006/mvre.1998.2081; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; Robertson SM, 2000, DEVELOPMENT, V127, P2447; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; Wang HH, 2008, DEV BIOL, V318, P112, DOI 10.1016/j.ydbio.2008.03.008; WILLISON K, 1990, TRENDS GENET, V6, P104, DOI 10.1016/0168-9525(90)90106-G; Wong RCB, 2006, BIOCHEM BIOPH RES CO, V344, P181, DOI 10.1016/j.bbrc.2006.03.127; Xu JL, 2008, MOL CELL BIOL, V28, P1669, DOI 10.1128/MCB.00891-07; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yang XJ, 1996, J NEUROSCI, V16, P6089	44	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e23810	10.1371/journal.pone.0023810	http://dx.doi.org/10.1371/journal.pone.0023810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21909405	gold, Green Submitted, Green Published			2022-12-25	WOS:000294689200009
J	Aebischer, J; Sturny, R; Andrieu, D; Rieusset, A; Schaller, F; Geib, S; Raoul, C; Muscatelli, F				Aebischer, Julianne; Sturny, Rachel; Andrieu, David; Rieusset, Anne; Schaller, Fabienne; Geib, Sandrine; Raoul, Cedric; Muscatelli, Francoise			Necdin Protects Embryonic Motoneurons from Programmed Cell Death	PLOS ONE			English	Article							PRADER-WILLI-SYNDROME; P75 NEUROTROPHIN RECEPTOR; GROWTH SUPPRESSOR NECDIN; PRENATAL MICE LACKING; SYNDROME GENE NECDIN; TRANSCRIPTION FACTOR; NEURONAL APOPTOSIS; AXONAL OUTGROWTH; CANDIDATE GENE; MAGE PROTEINS	NECDIN belongs to the type II Melanoma Associated Antigen Gene Expression gene family and is located in the Prader-Willi Syndrome (PWS) critical region. Necdin-deficient mice develop symptoms of PWS, including a sensory and motor deficit. However, the mechanisms underlying the motor deficit remain elusive. Here, we show that the genetic ablation of Necdin, whose expression is restricted to post-mitotic neurons in the spinal cord during development, leads to a loss of 31% of specified motoneurons. The increased neuronal loss occurs during the period of naturally-occurring cell death and is not confined to specific pools of motoneurons. To better understand the role of Necdin during the period of programmed cell death of motoneurons we used embryonic spinal cord explants and primary motoneuron cultures from Necdin-deficient mice. Interestingly, while Necdin-deficient motoneurons present the same survival response to neurotrophic factors, we demonstrate that deletion of Necdin leads to an increased susceptibility of motoneurons to neurotrophic factor deprivation. We show that by neutralizing TNF alpha this increased susceptibility of Necdin-deficient motoneurons to trophic factor deprivation can be reduced to the normal level. We propose that Necdin is implicated through the TNF-receptor 1 pathway in the developmental death of motoneurons.	[Aebischer, Julianne; Raoul, Cedric] INMED, Inserm Avenir, Mediterranean Inst Neurobiol, Marseille, France; [Aebischer, Julianne; Sturny, Rachel; Andrieu, David; Rieusset, Anne; Schaller, Fabienne; Geib, Sandrine; Raoul, Cedric; Muscatelli, Francoise] Univ Aix Marseille, Fac Sci, Marseille, France; [Sturny, Rachel] IBDML, Dev Biol Inst Marseille Luminy, Marseille, France; [Andrieu, David; Rieusset, Anne; Schaller, Fabienne; Geib, Sandrine; Muscatelli, Francoise] INMED, INSERM, U901, Mediterranean Inst Neurobiol, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Aebischer, J (corresponding author), INMED, Inserm Avenir, Mediterranean Inst Neurobiol, Marseille, France.	muscatelli@inmed.univ-mrs.fr	Muscatelli, Françoise/P-4650-2016; Raoul, Cedric/H-6517-2016	Muscatelli, Françoise/0000-0003-4001-6528; Raoul, Cedric/0000-0003-0561-6851	Association Francaise contre les Myopathies (AFM) [14884]; European Community [512136 PWS]; PACA conseil regional; Trophos SA	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); European Community(European Commission); PACA conseil regional; Trophos SA	This work was supported by the Association Francaise contre les Myopathies (AFM, grant no. 14884), and the European Community (grant no. 512136 PWS). JA is a recipient of a Ph.D fellowship from PACA conseil regional, Trophos SA and AFM. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aebischer J, 2011, CELL DEATH DIFFER, V18, P754, DOI 10.1038/cdd.2010.143; Andrieu D, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-56; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Barker V, 2001, NAT NEUROSCI, V4, P1194, DOI 10.1038/nn755; Bertrand MJM, 2008, CELL DEATH DIFFER, V15, P1921, DOI 10.1038/cdd.2008.127; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Bush JR, 2010, GENESIS, V48, P540, DOI 10.1002/dvg.20658; Caira A, 2003, Minerva Chir, V58, P341; Cassidy SB, 2009, EUR J HUM GENET, V17, P3, DOI 10.1038/ejhg.2008.165; Chapman EJ, 2009, MOL CARCINOGEN, V48, P975, DOI 10.1002/mc.20567; Chomez P, 2001, CANCER RES, V61, P5544; Cushing BS, 2003, DEV BRAIN RES, V143, P129, DOI 10.1016/S0165-3806(03)00105-6; de Smith AJ, 2009, HUM MOL GENET, V18, P3257, DOI 10.1093/hmg/ddp263; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Duker AL, 2010, EUR J HUM GENET, V18, P1196, DOI 10.1038/ejhg.2010.102; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; Ferraiuolo L, 2007, J NEUROSCI, V27, P9201, DOI 10.1523/JNEUROSCI.1470-07.2007; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Gerard M, 1999, NAT GENET, V23, P199, DOI 10.1038/13828; Haase G, 2008, CURR OPIN NEUROBIOL, V18, P284, DOI 10.1016/j.conb.2008.07.013; Hasegawa K, 2008, J NEUROSCI, V28, P8772, DOI 10.1523/JNEUROSCI.3052-08.2008; Ingraham CA, 2009, EXP CELL RES, V315, P3532, DOI 10.1016/j.yexcr.2009.10.001; Islam A, 2006, J BIOL CHEM, V281, P6860, DOI 10.1074/jbc.M509397200; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Kobayashi M, 2002, J BIOL CHEM, V277, P42128, DOI 10.1074/jbc.M205024200; Kurita M, 2006, J NEUROSCI, V26, P12003, DOI 10.1523/JNEUROSCI.3002-06.2006; Kuwako K, 2005, J NEUROSCI, V25, P7090, DOI 10.1523/JNEUROSCI.2083-05.2005; Kuwako K, 2004, J BIOL CHEM, V279, P1703, DOI 10.1074/jbc.M308454200; Lee S, 2005, HUM MOL GENET, V14, P627, DOI 10.1093/hmg/ddi059; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; McManamny P, 2002, HUM MOL GENET, V11, P2103, DOI 10.1093/hmg/11.18.2103; Miller NLG, 2009, HUM MOL GENET, V18, P248, DOI 10.1093/hmg/ddn344; Murray SS, 1999, NEUROSCI LETT, V267, P45, DOI 10.1016/S0304-3940(99)00330-4; Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101; Pagliardini S, 2005, AM J PATHOL, V167, P175, DOI 10.1016/S0002-9440(10)62964-1; Pagliardini S, 2008, ADV EXP MED BIOL, V605, P139; Paland N, 2008, J BIOL CHEM, V283, P6438, DOI 10.1074/jbc.M708422200; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Reus L, 2011, NEUROSCI BIOBEHAV R, V35, P956, DOI 10.1016/j.neubiorev.2010.10.015; Russo F, 2008, ANAT REC, V291, P169, DOI 10.1002/ar.20641; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Sciorati C, 2009, J CELL SCI, V122, P1119, DOI 10.1242/jcs.041665; Sedel F, 2004, J NEUROSCI, V24, P2236, DOI 10.1523/JNEUROSCI.4464-03.2004; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sutcliffe JS, 1997, LANCET, V350, P1520, DOI 10.1016/S0140-6736(05)63943-8; Suzuki K, 2008, BRAIN, V131, P229, DOI 10.1093/brain/awm289; Takazaki R, 2002, EXP CELL RES, V277, P220, DOI 10.1006/excr.2002.5558; Taniguchi N, 2000, J BIOL CHEM, V275, P31674, DOI 10.1074/jbc.M005103200; Taniura H, 1999, J BIOL CHEM, V274, P16242, DOI 10.1074/jbc.274.23.16242; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; Tcherpakov M, 2002, J BIOL CHEM, V277, P49101, DOI 10.1074/jbc.C200533200; Tennese AA, 2008, DEV DYNAM, V237, P1935, DOI 10.1002/dvdy.21615; Ugolini G, 2003, J NEUROSCI, V23, P8526; Williams ME, 2006, NAT NEUROSCI, V9, P996, DOI 10.1038/nn1736; Yamamoto Y, 1999, DEV BIOL, V214, P60, DOI 10.1006/dbio.1999.9413	56	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e23764	10.1371/journal.pone.0023764	http://dx.doi.org/10.1371/journal.pone.0023764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912643	Green Published, gold, Green Submitted			2022-12-25	WOS:000294686100004
J	Rajput, PS; Kharmate, G; Norman, M; Liu, SH; Sastry, BR; Brunicardi, CF; Kumar, U				Rajput, Padmesh S.; Kharmate, Geetanjali; Norman, Michael; Liu, Shi-He; Sastry, Bhagavatula R.; Brunicardi, Charles F.; Kumar, Ujendra			Somatostatin Receptor 1 and 5 Double Knockout Mice Mimic Neurochemical Changes of Huntington's Disease Transgenic Mice	PLOS ONE			English	Article							STRIATAL PROJECTION NEURONS; CAMP-REGULATED PHOSPHOPROTEIN; D-ASPARTATE RECEPTORS; NMDA RECEPTOR; QUINOLINIC ACID; NADPH-DIAPHORASE; RAT-BRAIN; CALBINDIN-D-28K IMMUNOREACTIVITY; IMMUNOHISTOCHEMICAL ANALYSIS; ALZHEIMERS-DISEASE	Background: Selective degeneration of medium spiny neurons and preservation of medium sized aspiny interneurons in striatum has been implicated in excitotoxicity and pathophysiology of Huntington's disease (HD). However, the molecular mechanism for the selective sparing of medium sized aspiny neurons and vulnerability of projection neurons is still elusive. The pathological characteristic of HD is an extensive reduction of the striatal mass, affecting caudate putamen. Somatostatin (SST) positive neurons are selectively spared in HD and Quinolinic acid/N-methyl-D-aspartic acid induced excitotoxicity, mimic the model of HD. SST plays neuroprotective role in excitotoxicity and the biological effects of SST are mediated by five somatostatin receptor subtypes (SSTR1-5). Methods and Findings: To delineate subtype selective biological responses we have here investigated changes in SSTR1 and 5 double knockout mice brain and compared with HD transgenic mouse model (R6/2). Our study revealed significant loss of dopamine and cAMP regulated phosphoprotein of 32 kDa (DARPP-32) and comparable changes in SST, N-methyl-D-aspartic acid receptors subtypes, calbindin and brain nitric oxide synthase expression as well as in key signaling proteins including calpain, phospho-extracellular-signal-regulated kinases1/2, synapsin-IIa, protein kinase C-alpha and calcineurin in SSTR1/5(-/-) and R6/2 mice. Conversely, the expression of somatostatin receptor subtypes, enkephalin and phosphatidylinositol 3-kinases were strain specific. SSTR1/5 appears to be important in regulating NMDARs, DARPP-32 and signaling molecules in similar fashion as seen in HD transgenic mice. Conclusions: This is the first comprehensive description of disease related changes upon ablation of G- protein coupled receptor gene. Our results indicate that SST and SSTRs might play an important role in regulation of neurodegeneration and targeting this pathway can provide a novel insight in understanding the pathophysiology of Huntington's disease.	[Rajput, Padmesh S.; Kharmate, Geetanjali; Kumar, Ujendra] Univ British Columbia, Fac Pharmaceut Sci, Div Pharmacol & Toxicol, Vancouver, BC V6T 1W5, Canada; [Norman, Michael; Liu, Shi-He; Brunicardi, Charles F.] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Sastry, Bhagavatula R.] Univ British Columbia, Neurosci Res Lab, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1W5, Canada	University of British Columbia; Baylor College of Medicine; University of British Columbia	Rajput, PS (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Div Pharmacol & Toxicol, Vancouver, BC V6T 1W5, Canada.	ujkumar@interchange.ubc.ca			Canadian Institute for Health Research [MOP-10268, MOP-74465]; NIH [RO1-DK46441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046441] Funding Source: NIH RePORTER	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from Canadian Institute for Health Research (MOP-10268 and MOP-74465 to UK) and NIH Grant (RO1-DK46441 to FCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1990, NEW ENGL J MED, V322, P1293, DOI 10.1056/NEJM199005033221807; Ali NJ, 2006, DEV NEUROSCI-BASEL, V28, P230, DOI 10.1159/000091921; ARONIN N, 1983, ANN NEUROL, V13, P519, DOI 10.1002/ana.410130508; AUGOOD SJ, 1994, NEUROSCIENCE, V59, P7, DOI 10.1016/0306-4522(94)90093-0; Baragli A, 2007, CELL SIGNAL, V19, P2304, DOI 10.1016/j.cellsig.2007.07.007; Bastia Elena, 2003, Sci STKE, V2003, pPE2, DOI 10.1126/stke.2003.165.pe2; BEAL MF, 1991, J NEUROSCI, V11, P1649; BEAL MF, 1984, NEUROLOGY, V34, P663, DOI 10.1212/WNL.34.5.663; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Billova S, 2007, NEUROSCIENCE, V147, P403, DOI 10.1016/j.neuroscience.2007.04.039; Binaschi A, 2003, REV NEUROSCIENCE, V14, P285; Blank T, 1997, P NATL ACAD SCI USA, V94, P14859, DOI 10.1073/pnas.94.26.14859; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; Cepeda C, 2001, J NEUROSCI RES, V66, P525, DOI 10.1002/jnr.1244; Chen NS, 1999, J NEUROCHEM, V72, P1890, DOI 10.1046/j.1471-4159.1999.0721890.x; Chen Q, 1996, NEUROSCIENCE, V73, P715, DOI 10.1016/0306-4522(96)00011-5; Cicchetti F, 1996, MOVEMENT DISORD, V11, P619, DOI 10.1002/mds.870110605; Cowan CM, 2008, J NEUROSCI, V28, P12725, DOI 10.1523/JNEUROSCI.4619-08.2008; DAWBARN D, 1985, BRAIN RES, V340, P251, DOI 10.1016/0006-8993(85)90921-7; Dawson VL, 1996, J NEUROSCI, V16, P2479; De Wied D, 2002, NEUROTOX RES, V4, P453, DOI 10.1080/10298420290031432; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; Doggrell SA, 2004, EXPERT OPIN INV DRUG, V13, P69, DOI 10.1517/13543784.13.1.69; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; Fernandes HB, 2007, J NEUROSCI, V27, P13614, DOI 10.1523/JNEUROSCI.3455-07.2007; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; Fox L, 1997, J NEUROPATH EXP NEUR, V56, P360, DOI 10.1097/00005072-199704000-00004; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Giampa C, 2006, EUR J NEUROSCI, V23, P11, DOI 10.1111/j.1460-9568.2005.04545.x; Gladding CM, 2011, MOL CELL NEUROSCI; Grant M, 2004, J BIOL CHEM, V279, P36179, DOI 10.1074/jbc.M407310200; Grant M, 2004, J BIOL CHEM, V279, P38636, DOI 10.1074/jbc.M406276200; Grant M, 2010, REGUL PEPTIDES, V159, P3, DOI 10.1016/j.regpep.2009.08.011; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Helyes Z, 2009, P NATL ACAD SCI USA, V106, P13088, DOI 10.1073/pnas.0900681106; Hernandez-Espinosa D, 2006, BRAIN RES BULL, V69, P669, DOI 10.1016/j.brainresbull.2006.03.013; HUANG Q, 1995, NEUROSCIENCE, V65, P397, DOI 10.1016/0306-4522(94)00494-P; KIYAMA H, 1990, BRAIN RES, V525, P209, DOI 10.1016/0006-8993(90)90866-A; KOH JY, 1986, SCIENCE, V234, P73, DOI 10.1126/science.2875522; Kumar U, 2005, NEUROSCIENCE, V134, P525, DOI 10.1016/j.neuroscience.2005.04.001; Kumar U, 1997, EXP NEUROL, V145, P412, DOI 10.1006/exnr.1997.6473; Kumar U, 2008, J MOL NEUROSCI, V35, P345, DOI 10.1007/s12031-008-9093-3; Kumar U, 2007, J COMP NEUROL, V504, P185, DOI 10.1002/cne.21444; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Lione LA, 1999, J NEUROSCI, V19, P10428; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Menalled L, 2000, EXP NEUROL, V162, P328, DOI 10.1006/exnr.1999.7327; Milnerwood AJ, 2010, TRENDS NEUROSCI, V33, P513, DOI 10.1016/j.tins.2010.08.002; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; NEMEROFF CB, 1983, SCIENCE, V221, P972, DOI 10.1126/science.6136092; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Ozawa S, 1998, PROG NEUROBIOL, V54, P581, DOI 10.1016/S0301-0082(97)00085-3; PATEL SC, 1991, J NEUROCHEM, V56, P1286, DOI 10.1111/j.1471-4159.1991.tb11423.x; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; Pfeiffer M, 2002, J BIOL CHEM, V277, P19762, DOI 10.1074/jbc.M110373200; Rajput PS, 2009, NEUROSCI RES, V65, P53, DOI 10.1016/j.neures.2009.05.005; Rajput PS, 2009, J CHEM NEUROANAT, V38, P20, DOI 10.1016/j.jchemneu.2009.05.004; Ramirez JL, 2004, MOL CELL ENDOCRINOL, V221, P105, DOI 10.1016/j.mce.2004.02.001; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Somvanshi RK, 2009, CELL SIGNAL, V21, P1396, DOI 10.1016/j.cellsig.2009.04.007; Sun Z, 2005, NEUROBIOL DIS, V20, P907, DOI 10.1016/j.nbd.2005.05.023; Sun Z, 2002, NEUROBIOL DIS, V11, P369, DOI 10.1006/nbdi.2002.0554; Svenningsson P, 2000, P NATL ACAD SCI USA, V97, P1856, DOI 10.1073/pnas.97.4.1856; Tallent M, 1996, NEUROSCIENCE, V71, P1073, DOI 10.1016/0306-4522(95)00510-2; Torres-Peraza J, 2007, NEUROSCIENCE, V144, P462, DOI 10.1016/j.neuroscience.2006.09.038; VINCENT SR, 1983, J COMP NEUROL, V217, P264, DOI 10.1002/cne.902170304; Viollet C, 2000, EUR J NEUROSCI, V12, P3761, DOI 10.1046/j.1460-9568.2000.00249.x; Wang XP, 2004, SURGERY, V136, P585, DOI 10.1016/j.surg.2004.05.042; YOUNG AB, 1988, SCIENCE, V241, P981, DOI 10.1126/science.2841762	75	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24467	10.1371/journal.pone.0024467	http://dx.doi.org/10.1371/journal.pone.0024467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912697	Green Published, gold, Green Submitted			2022-12-25	WOS:000294686100044
J	Scharein, B; Groth, G				Scharein, Benjamin; Groth, Georg			Phosphorylation Alters the Interaction of the Arabidopsis Phosphotransfer Protein AHP1 with Its Sensor Kinase ETR1	PLOS ONE			English	Article							CYTOKININ-SIGNALING PATHWAY; ETHYLENE RECEPTOR ETR1; HISTIDINE KINASE; RESPONSE REGULATORS; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ASP PHOSPHORELAY; THALIANA; TRANSDUCTION	The ethylene receptor ethylene response 1 (ETR1) and the Arabidopsis histidine-containing phosphotransfer protein 1 (AHP1) form a tight complex in vitro. According to our current model ETR1 and AHP1 together with a response regulator form a phosphorelay system controlling the gene expression response to the plant hormone ethylene, similar to the two-component signaling in bacteria. The model implies that ETR1 functions as a sensor kinase and is autophosphorylated in the absence of ethylene. The phosphoryl group is then transferred onto a histidine at the canonical phosphorylation site in AHP1. For phosphoryl group transfer both binding partners need to form a tight complex. After ethylene binding the receptor is switched to the non-phosphorylated state. This switch is accompanied by a conformational change that decreases the affinity to the phosphorylated AHP1. To test this model we used fluorescence polarization and examined how the phosphorylation status of the proteins affects formation of the suggested ETR1-AHP1 signaling complex. We have employed various mutants of ETR1 and AHP1 mimicking permanent phosphorylation or preventing phosphorylation, respectively. Our results show that phosphorylation plays an important role in complex formation as affinity is dramatically reduced when the signaling partners are either both in their non-phosphorylated form or both in their phosphorylated form. On the other hand, affinity is greatly enhanced when either protein is in the phosphorylated state and the corresponding partner in its non-phosphorylated form. Our results indicate that interaction of ETR1 and AHP1 requires that ETR1 is a dimer, as in its functional state as receptor in planta.	[Scharein, Benjamin; Groth, Georg] Univ Dusseldorf, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Scharein, B (corresponding author), Univ Dusseldorf, Dusseldorf, Germany.	georg.groth@uni-duesseldorf.de			Deutsche Forschungsgemeinschaft [GR1616/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft to G. G. (GR1616/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bleecker AB, 1999, TRENDS PLANT SCI, V4, P269, DOI 10.1016/S1360-1385(99)01427-2; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; Chang C, 2001, BIOESSAYS, V23, P619, DOI 10.1002/bies.1087; D'Agostino IB, 1999, TRENDS BIOCHEM SCI, V24, P452, DOI 10.1016/S0968-0004(99)01465-6; DeLano W.L., PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dortay H, 2006, FEBS J, V273, P4631, DOI 10.1111/j.1742-4658.2006.05467.x; GEGNER JA, 1991, P NATL ACAD SCI USA, V88, P750, DOI 10.1073/pnas.88.3.750; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Hall AE, 2000, PLANT PHYSIOL, V123, P1449, DOI 10.1104/pp.123.4.1449; Hass C, 2004, EMBO J, V23, P3290, DOI 10.1038/sj.emboj.7600337; Horak J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-77; HSIEH WT, 1985, BIOCHEMISTRY-US, V24, P3043, DOI 10.1021/bi00333a036; Huffine ME, 1996, J BIOL CHEM, V271, P28898, DOI 10.1074/jbc.271.46.28898; Hwang D, 2002, PLANT PHYSIOL, V129, P500, DOI 10.1104/pp.005504; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Kato M, 1997, CELL, V88, P717, DOI 10.1016/S0092-8674(00)81914-5; Ke SH, 1997, NUCLEIC ACIDS RES, V25, P3371, DOI 10.1093/nar/25.16.3371; Kuntal Bhusan K, 2010, BMC Res Notes, V3, P226, DOI 10.1186/1756-0500-3-226; LAKOWICZ JR, PRINCIPLES FLUORESCE, P367; Lohrmann J, 2002, PLANT PHYSIOL, V128, P363, DOI 10.1104/pp.010907; Mattison K, 2002, J BIOL CHEM, V277, P11143, DOI 10.1074/jbc.M111128200; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Park Sang-Hyun, 2004, Methods Mol Biol, V261, P161; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHALLER GE, 1995, J BIOL CHEM, V270, P12526, DOI 10.1074/jbc.270.21.12526; Scharein B, 2008, ANAL BIOCHEM, V377, P72, DOI 10.1016/j.ab.2008.03.015; SISLER E C, 1977, Tobacco Science, V21, P43; SOLOMOS T, 1974, PLANT PHYSIOL, V54, P506, DOI 10.1104/pp.54.4.506; Stepanova AN, 2000, CURR OPIN PLANT BIOL, V3, P353, DOI 10.1016/S1369-5266(00)00096-0; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Suzuki T, 2000, BIOSCI BIOTECH BIOCH, V64, P2486, DOI 10.1271/bbb.64.2486; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; TAKEDA K, 1991, J PROTEIN CHEM, V10, P17, DOI 10.1007/BF01024651; Tournaviti S, 2009, TRAFFIC, V10, P1047, DOI 10.1111/j.1600-0854.2009.00921.x; Ueguchi C, 2001, PLANT CELL PHYSIOL, V42, P751, DOI 10.1093/pcp/pce094; Urao T, 2000, FEBS LETT, V478, P227, DOI 10.1016/S0014-5793(00)01860-3; Urao T, 1999, PLANT CELL, V11, P1743, DOI 10.1105/tpc.11.9.1743; Varughese KI, 1998, MOL CELL, V2, P485, DOI 10.1016/S1097-2765(00)80148-3; Voet-van-Vormizeele J, 2008, MOL PLANT, V1, P380, DOI 10.1093/mp/ssn004; Xu QP, 1999, J MOL BIOL, V292, P1039, DOI 10.1006/jmbi.1999.3143; ZHOU HJ, 1995, BIOCHEMISTRY-US, V34, P13858, DOI 10.1021/bi00042a018	48	24	24	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24173	10.1371/journal.pone.0024173	http://dx.doi.org/10.1371/journal.pone.0024173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912672	Green Published, Green Submitted, gold			2022-12-25	WOS:000294686100019
J	Wang, P; Bai, YJ; Song, BR; Wang, YD; Liu, D; Lai, YQ; Bi, XL; Yuan, ZQ				Wang, Pei; Bai, Yujie; Song, Bangrong; Wang, Yadong; Liu, Dong; Lai, Yongqiang; Bi, Xiaolin; Yuan, Zengqiang			PP1A-Mediated Dephosphorylation Positively Regulates YAP2 Activity	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; HIPPO SIGNALING PATHWAY; SIZE-CONTROL; TEAD/TEF FAMILY; APOPTOSIS; COMPLEX; GROWTH; DOMAIN; PHOSPHORYLATION; PURIFICATION	Background: The Hippo/MST1 signaling pathway plays an important role in the regulation of cell proliferation and apoptosis. As a major downstream target of the Hippo/MST1 pathway, YAP2 (Yes-associated protein 2) functions as a transcriptional cofactor that has been implicated in many biological processes, including organ size control and cancer development. MST1/Lats kinase inhibits YAP2's nuclear accumulation and transcriptional activity through inducing the phosphorylation at serine 127 and the sequential association with 14-3-3 proteins. However, the dephosphorylation of YAP2 is not fully appreciated. Methodology/Principal Findings: In the present study, we demonstrate that PP1A (catalytic subunit of protein phosphatase-1) interacts with and dephosphorylates YAP2 in vitro and in vivo, and PP1A-mediated dephosphorylation induces the nuclear accumulation and transcriptional activation of YAP2. Inhibition of PP1 by okadiac acid (OA) increases the phosphorylation at serine 127 and cytoplasmic translocation of YAP2 proteins, thereby mitigating its transcription activity. PP1A expression enhances YAP2's pro-survival capability and YAP2 knockdown sensitizes ovarian cancer cells to cisplatin treatment. Conclusions/Significance: Our findings define a novel molecular mechanism that YAP2 is positively regulated by PP1-mediated dephosphorylation in the cell survival.	[Wang, Pei; Bai, Yujie; Wang, Yadong; Yuan, Zengqiang] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Wang, Pei; Bai, Yujie; Wang, Yadong] Chinese Acad Sci, Grad Sch, Coll Life Sci, Beijing 100080, Peoples R China; [Song, Bangrong; Liu, Dong; Lai, Yongqiang] Capital Med Univ, Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China; [Bi, Xiaolin] Chinese Acad Sci, Inst High Energy Phys, Lab Biol Effects Nanomat & Nanosafety, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Capital Medical University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS	Wang, P (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	bixl@ihep.ac.cn; zqyuan@ibp.ac.cn	Bi, Xiaolin/C-7038-2014; Bi, Xiaolin/E-7469-2010	Bi, Xiaolin/0000-0003-2837-9457; Bi, Xiaolin/0000-0002-7172-7851; Yuan, Zengqiang/0000-0001-5739-2867	National Science Foundation of China [30870792, 81030025, 30871388]; National Basic Research Program of China (973 Program) [2009CB918704, 2010CB934004]; Chinese Academy of Sciences	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Science Foundation of China (Grant No. 30870792, 81030025 and 30871388), the National Basic Research Program of China (973 Program, Grant No. 2009CB918704 and 2010CB934004) and the Chinese Academy of Sciences Knowledge Innovation Program to X. B. and Z.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; GRANDORI C, 1991, ONCOGENE, V6, P1063; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; HILMAN D, 2011, MOL BIOL EVOL; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Liu AM, 2010, EXPERT OPIN THER TAR, V14, P855, DOI 10.1517/14728222.2010.499361; Liu CY, 2011, J BIOL CHEM, V286, P5558, DOI 10.1074/jbc.M110.194019; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Ren FF, 2010, DEV BIOL, V337, P303, DOI 10.1016/j.ydbio.2009.10.046; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Schumacher B, 2010, ACTA CRYSTALLOGR F, V66, P978, DOI 10.1107/S1744309110025479; SHENOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P1; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Striedinger K, 2008, NEOPLASIA, V10, P1204, DOI 10.1593/neo.08642; Tian W, 2010, P NATL ACAD SCI USA, V107, P7293, DOI 10.1073/pnas.1000293107; Ura S, 2001, GENES CELLS, V6, P519, DOI 10.1046/j.1365-2443.2001.00439.x; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vigneron AM, 2010, GENE DEV, V24, P2430, DOI 10.1101/gad.1954310; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Xu MZ, 2010, ONCOGENE; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yuan F, 2011, J BIOL CHEM, V286, P6940, DOI 10.1074/jbc.M110.182543; Yuan ZQ, 2010, J BIOL CHEM, V285, P3815, DOI 10.1074/jbc.M109.059675; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang X, 2011, ONCOGENE; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	41	61	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24288	10.1371/journal.pone.0024288	http://dx.doi.org/10.1371/journal.pone.0024288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909427	Green Published, Green Submitted, gold			2022-12-25	WOS:000294683900043
J	Faurholt-Jepsen, D; Range, N; PrayGod, G; Jeremiah, K; Faurholt-Jepsen, M; Aabye, MG; Changalucha, J; Christensen, DL; Pipper, CB; Krarup, H; Witte, DR; Andersen, AB; Friis, H				Faurholt-Jepsen, Daniel; Range, Nyagosya; PrayGod, George; Jeremiah, Kidola; Faurholt-Jepsen, Maria; Aabye, Martine Grosos; Changalucha, John; Christensen, Dirk Lund; Pipper, Christian Bressen; Krarup, Henrik; Witte, Daniel Rinse; Andersen, Aase Bengaard; Friis, Henrik			Diabetes Is a Risk Factor for Pulmonary Tuberculosis: A Case-Control Study from Mwanza, Tanzania	PLOS ONE			English	Article							MELLITUS; INFECTIONS; PREVALENCE; HIV; MECHANISMS; DISEASE; BURDEN; CARE	Background: Diabetes and TB are associated, and diabetes is increasingly common in low-income countries where tuberculosis (TB) is highly endemic. However, the role of diabetes for TB has not been assessed in populations where HIV is prevalent. Methods: A case-control study was conducted in an urban population in Tanzania among culture-confirmed pulmonary TB patients and non-TB neighbourhood controls. Participants were tested for diabetes according to WHO guidelines and serum concentrations of acute phase reactants were measured. The association between diabetes and TB, and the role of HIV as an effect modifier, were examined using logistic regression. Since blood glucose levels increase during the acute phase response, we adjusted for elevated serum acute phase reactants. Results: Among 803 cases and 350 controls the mean (SD) age was 34.8 (11.9) and 33.8 (12.0) years, and the prevalence of diabetes was 16.7% (95% CI: 14.2; 19.4) and 9.4% (6.6; 13.0), respectively. Diabetes was associated with TB (OR 2.2, 95% CI: 1.5; 3.4, p < 0.001). However, the association depended on HIV status (interaction, p = 0.01) due to a stronger association among HIV uninfected (OR 4.2, 95% CI: 1.5; 11.6, p = 0.01) compared to HIV infected (OR 0.1, 95% CI: 0.01; 1.8, p = 0.13) after adjusting for age, sex, demographic factors and elevated serum acute phase reactants. Conclusion: Diabetes is a risk factor for TB in HIV uninfected, whereas the association in HIV infected patients needs further study. The increasing diabetes prevalence may be a threat to TB control.	[Faurholt-Jepsen, Daniel; Faurholt-Jepsen, Maria; Friis, Henrik] Univ Copenhagen, Dept Human Nutr, Frederiksberg, Denmark; [Range, Nyagosya] Natl Inst Med Res, Muhimbili Res Ctr, Dar Es Salaam, Tanzania; [PrayGod, George; Jeremiah, Kidola; Changalucha, John] Natl Inst Med Res, Mwanza Res Ctr, Mwanza, Tanzania; [Aabye, Martine Grosos] Univ Copenhagen, Hvidovre Hosp, Clin Res Ctr, DK-2650 Hvidovre, Denmark; [Christensen, Dirk Lund] Univ Copenhagen, Dept Int Hlth, Copenhagen, Denmark; [Christensen, Dirk Lund; Witte, Daniel Rinse] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Pipper, Christian Bressen] Univ Copenhagen, Dept Basic Sci & Environm, Frederiksberg, Denmark; [Krarup, Henrik] Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark; [Andersen, Aase Bengaard] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark	University of Copenhagen; National Institute of Medical Research; National Institute of Medical Research; University of Copenhagen; University of Copenhagen; Steno Diabetes Center; University of Copenhagen; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Odense University Hospital	Faurholt-Jepsen, D (corresponding author), Univ Copenhagen, Dept Human Nutr, Frederiksberg, Denmark.	dfa@life.ku.dk	Friis, Henrik/P-2891-2019; Witte, Daniel/AAF-9535-2019; Faurholt-Jepsen, Daniel/M-6324-2019; Faurholt-Jepsen, Daniel/D-9453-2012; Witte, Daniel R/C-1722-2008; Friis, Henrik/N-2047-2014; PrayGod, George/L-7098-2018	Friis, Henrik/0000-0002-2848-2940; Witte, Daniel/0000-0002-0769-2922; Faurholt-Jepsen, Daniel/0000-0001-8561-0155; Faurholt-Jepsen, Daniel/0000-0001-8561-0155; Witte, Daniel R/0000-0002-0769-2922; Friis, Henrik/0000-0002-2848-2940; Krarup, Henrik/0000-0001-5294-2428; Andersen, Aase Bengaard/0000-0003-4779-7603; Jeremiah, Kidola/0000-0001-7900-9689; Pipper, Christian Bressen/0000-0003-0261-616X; PrayGod, George/0000-0002-0329-4839	Danish Council for Independent Research - Medical Sciences [22-04-0404]; Danida through the Consultative Research Committee for Development Research [104.Dan.8-898]; University of Copenhagen through the Cluster in International Health	Danish Council for Independent Research - Medical Sciences(Det Frie Forskningsrad (DFF)); Danida through the Consultative Research Committee for Development Research; University of Copenhagen through the Cluster in International Health	This study was supported by the Danish Council for Independent Research - Medical Sciences (grant 22-04-0404), by Danida through the Consultative Research Committee for Development Research (104.Dan.8-898) and the University of Copenhagen through the Cluster in International Health. The funding bodies had no role in the study design, data collection, data analysis, data interpretation or decision to publish the findings.	Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Calvet HM, 2001, INFECT DIS CLIN N AM, V15, P407, DOI 10.1016/S0891-5520(05)70153-7; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Clyne B, 1999, J EMERG MED, V17, P1019, DOI 10.1016/S0736-4679(99)00135-3; Dati F, 1996, EUR J CLIN CHEM CLIN, V34, P517; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Friis Henrik, 2009, Afr J Reprod Health, V13, P61; Gearhart MM, 2006, AACN ADV CRIT CARE, V17, P50, DOI 10.1097/00044067-200601000-00007; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; Hallett TB, 2010, AIDS, V24, P147, DOI 10.1097/QAD.0b013e32833062dc; Harries AD, 2010, TROP MED INT HEALTH, V15, P659, DOI 10.1111/j.1365-3156.2010.02523.x; IDF, 2009, DIAB ATL; Jeon CY, 2010, TROP MED INT HEALTH, V15, P1300, DOI 10.1111/j.1365-3156.2010.02632.x; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kolling M, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-8; Kuhnlein H, 2003, DIETARY CHANGE TRADI, DOI DOI 10.1146/ANNUREV.NU.16.070196.002221; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; MOUTSCHEN MP, 1992, DIABETES METAB, V18, P187; MUGUSI F, 1990, TUBERCLE, V71, P271, DOI 10.1016/0041-3879(90)90040-F; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; POZZILLI P, 1994, DIABETIC MED, V11, P935, DOI 10.1111/j.1464-5491.1994.tb00250.x; Praygod G, EFFECT ENER IN PRESS; PrayGod G, 2011, J NUTR, V141, P685, DOI 10.3945/jn.110.131672; PrayGod G, 2011, T ROY SOC TROP MED H, V105, P140, DOI 10.1016/j.trstmh.2010.11.009; Range N, 2007, ANN TROP MED PARASIT, V101, P343, DOI 10.1179/136485907X176373; WHO, 2009, TREATM TUB GUID NAT; *WHO, 2009, GLOB TUB CONTR SHORT; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2006, DEF DIAGN DIAB MELL; Young F, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-9; Ziraba AK, 2009, BMC HEALTH SERV RES, V9, DOI [10.1186/1471-2458-9-465, 10.1186/1472-6963-9-46]	34	91	92	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24215	10.1371/journal.pone.0024215	http://dx.doi.org/10.1371/journal.pone.0024215			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912626	gold, Green Published			2022-12-25	WOS:000294678300032
J	Stakic, J; Suchanek, JM; Ziegler, GP; Griff, ER				Stakic, Josif; Suchanek, Jessica M.; Ziegler, Geoffrey P.; Griff, Edwin R.			The Source of Spontaneous Activity in the Main Olfactory Bulb of the Rat	PLOS ONE			English	Article							MITRAL/TUFTED CELL-ACTIVITY; ODOR-INDUCED ACTIVITY; TUFTED CELLS; MITRAL CELLS; SYNAPTIC RESPONSES; GABAERGIC CONTROL; NEURONS; MODULATION; ACTIVATION; LAYER	Introduction: In vivo, most neurons in the main olfactory bulb exhibit robust spontaneous activity. This paper tests the hypothesis that spontaneous activity in olfactory receptor neurons drives much of the spontaneous activity in mitral and tufted cells via excitatory synapses. Methods: Single units were recorded in vivo from the main olfactory bulb of a rat before, during, and after application of lidocaine to the olfactory nerve. The effect of lidocaine on the conduction of action potentials from the olfactory epithelium to the olfactory bulb was assessed by electrically stimulating the olfactory nerve rostral to the application site and monitoring the field potential evoked in the bulb. Results: Lidocaine caused a significant decrease in the amplitude of the olfactory nerve evoked field potential that was recorded in the olfactory bulb. By contrast, the lidocaine block did not significantly alter the spontaneous activity of single units in the bulb, nor did it alter the field potential evoked by electrical stimulation of the lateral olfactory tract. Lidocaine block also did not change the temporal patters of action potential or their synchronization with respiration. Conclusions: Spontaneous activity in neurons of the main olfactory bulb is not driven mainly by activity in olfactory receptor neurons despite the extensive convergence onto mitral and tufted cells. These results suggest that spontaneous activity of mitral and tufted is either an inherent property of these cells or is driven by centrifugal inputs to the bulb.	[Stakic, Josif; Suchanek, Jessica M.; Ziegler, Geoffrey P.; Griff, Edwin R.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Stakic, J (corresponding author), Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA.	edwin.griff@uc.edu			National Institutes of Health [1R15DCD04548-01A2]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant 1R15DCD04548-01A2 to ERG (www.nidcd.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; AroniadouAnderjaska V, 1997, NEUROSCIENCE, V79, P425, DOI 10.1016/S0306-4522(96)00706-3; Biju KC, 2008, J COMP NEUROL, V506, P161, DOI 10.1002/cne.21540; Buonviso N, 2006, CHEM SENSES, V31, P145, DOI 10.1093/chemse/bjj010; CHAPUT M, 1983, CHEM SENSES, V8, P161, DOI 10.1093/chemse/8.2.161; CHAPUT MA, 1992, EUR J NEUROSCI, V4, P813, DOI 10.1111/j.1460-9568.1992.tb00191.x; De Saint Jan D, 2009, J NEUROSCI, V29, P2043, DOI 10.1523/JNEUROSCI.5317-08.2009; Duchamp-Viret P, 2005, J NEUROBIOL, V65, P97, DOI 10.1002/neu.20177; DUCHAMPVIRET P, 1993, NEUROSCIENCE, V56, P905, DOI 10.1016/0306-4522(93)90136-4; DUCHAMPVIRET P, 1993, NEUROSCIENCE, V53, P111, DOI 10.1016/0306-4522(93)90289-R; Ennis M, 2006, J NEUROPHYSIOL, V95, P2233, DOI 10.1152/jn.01150.2005; Ennis M, 1996, NEUROREPORT, V7, P989, DOI 10.1097/00001756-199604100-00007; GRAY CM, 1988, EXP BRAIN RES, V69, P378; Griff ER, 2008, CHEM SENSES, V33, P779, DOI 10.1093/chemse/bjn041; Grosmaitre X, 2007, NAT NEUROSCI, V10, P348, DOI 10.1038/nn1856; Hamilton KA, 2005, NEUROSCIENCE, V133, P819, DOI 10.1016/j.neuroscience.2005.03.008; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; Jiang MR, 1996, J NEUROSCI, V16, P6319; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kiselycznyk CL, 2006, LEARN MEMORY, V13, P575, DOI 10.1101/lm.285706; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Matsutani S, 2008, ANAT SCI INT, V83, P218, DOI 10.1111/j.1447-073X.2007.00223.x; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; Nica R, 2010, BRAIN RES, V1358, P81, DOI 10.1016/j.brainres.2010.08.026; Nickell WT, 1996, BRAIN RES BULL, V39, P57, DOI 10.1016/0361-9230(95)02042-X; Palouzier-Paulignan B, 2002, NEUROSCIENCE, V111, P241, DOI 10.1016/S0306-4522(02)00003-9; Philpot BD, 1997, J NEUROBIOL, V33, P374, DOI 10.1002/(SICI)1097-4695(199710)33:4<374::AID-NEU3>3.0.CO;2-7; Puopolo M, 2005, J NEUROPHYSIOL, V94, P3618, DOI 10.1152/jn.00225.2005; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P980, DOI 10.1097/00000542-199810000-00023; RAVEL N, 1990, NEUROSCI LETT, V115, P213, DOI 10.1016/0304-3940(90)90457-K; ROSPARS JP, 1994, BRAIN RES, V662, P31, DOI 10.1016/0006-8993(94)90793-5; Schaefer AT, 2007, TRENDS NEUROSCI, V30, P92, DOI 10.1016/j.tins.2007.01.001; Schoenfeld TA, 2004, J COMP NEUROL, V476, P186, DOI 10.1002/cne.20218; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Yamada A, 2010, P NATL ACAD SCI USA, V107, P7562, DOI 10.1073/pnas.0900613107; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; YU GZ, 1993, BRAIN RES BULL, V31, P701, DOI 10.1016/0361-9230(93)90144-Z	38	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e23990	10.1371/journal.pone.0023990	http://dx.doi.org/10.1371/journal.pone.0023990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912614	Green Published, Green Submitted, gold			2022-12-25	WOS:000294678300016
J	Amoedo, ND; Afonso, AO; Cunha, SM; Oliveira, RH; Machado, ES; Soares, MA				Amoedo, Nivea D.; Afonso, Adriana O.; Cunha, Silvia M.; Oliveira, Ricardo H.; Machado, Elizabeth S.; Soares, Marcelo A.			Expression of APOBEC3G/3F and G-to-A Hypermutation Levels in HIV-1-Infected Children with Different Profiles of Disease Progression	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BLOOD MONONUCLEAR-CELLS; MESSENGER-RNA LEVELS; LONG-TERM SURVIVORS; HIV-1 IN-VIVO; CYTIDINE DEAMINATION; VIF; INFECTION; PROTEINS; HOST	Objective: Increasing evidence has accumulated showing the role of APOBEC3G (A3G) and 3F (A3F) in the control of HIV-1 replication and disease progression in humans. However, very few studies have been conducted in HIV-infected children. Here, we analyzed the levels of A3G and A3F expression and induced G-to-A hypermutation in a group of children with distinct profiles of disease progression. Methodology/Principal Findings: Perinatally HIV-infected children were classified as progressors or long-term non-progressors according to criteria based on HIV viral load and CD4 T-cell counts over time. A group of uninfected control children were also enrolled in the study. PBMC proviral DNA was assessed for G-to-A hypermutation, whereas A3G and A3F mRNA were isolated and quantified through TaqMan (R) real-time PCR. No correlation was observed between disease progression and A3G/A3F expression or hypermutation levels. Although all children analyzed showed higher expression levels of A3G compared to A3F (an average fold of 5 times), a surprisingly high A3F-related hypermutation rate was evidenced in the cohort, irrespective of the child's disease progression profile. Conclusion: Our results contribute to the current controversy as to whether HIV disease progression is related to A3G/A3F enzymatic activity. To our knowledge, this is the first study analyzing A3G/F expression in HIV-infected children, and it may pave the way to a better understanding of the host factors governing HIV disease in the pediatric setting.	[Amoedo, Nivea D.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Afonso, Adriana O.; Machado, Elizabeth S.; Soares, Marcelo A.] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil; [Afonso, Adriana O.] Univ Catolica Petropolis, Ctr Ciencias Saude, Petropolis, Brazil; [Cunha, Silvia M.] Hosp Municipal Jesus, Rio De Janeiro, Brazil; [Oliveira, Ricardo H.; Machado, Elizabeth S.] Univ Fed Rio de Janeiro, Inst Puericultura & Pediat Martagao Gesteira, Rio De Janeiro, Brazil; [Soares, Marcelo A.] Inst Nacl Canc, Programa Genet, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Catolica de Petropolis; Universidade Federal do Rio de Janeiro; National Cancer Institute (Inca)	Amoedo, ND (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.	masoares@biologia.ufrj.br	Soares, Marcelo A/G-5662-2010		Brazilian AIDS Department (Ministry of Health); Brazilian Research Council (CNPq)	Brazilian AIDS Department (Ministry of Health); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by the Brazilian AIDS Department (Ministry of Health) and by the Brazilian Research Council (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EJ, 2003, AIDS, V17, P867, DOI 10.1097/00002030-200304110-00012; Albin JS, 2010, J BIOL CHEM, V285, P40785, DOI 10.1074/jbc.M110.173161; Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Alexander L, 2006, PEDIATR INFECT DIS J, V25, P135, DOI 10.1097/01.inf.0000199299.00345.83; Armitage AE, 2008, J VIROL, V82, P8743, DOI 10.1128/JVI.00584-08; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Cho SJ, 2006, J VIROL, V80, P2069, DOI 10.1128/JVI.80.4.2069-2072.2006; De Maio FA, 2011, INFECT GENET EVOL, V11, P1256, DOI 10.1016/j.meegid.2011.04.020; Foster C, 2007, CURR OPIN HIV AIDS, V2, P431, DOI 10.1097/COH.0b013e3282ced150; Gandhi SK, 2008, J VIROL, V82, P3125, DOI 10.1128/JVI.01533-07; Gasparoni A, 2003, BIOL NEONATE, V84, P297, DOI 10.1159/000073638; Gourraud PA, 2011, HUM IMMUNOL, V72, P207, DOI 10.1016/j.humimm.2010.12.008; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Janini M, 2001, J VIROL, V75, P7973, DOI 10.1128/JVI.75.17.7973-7986.2001; Jin X, 2005, J VIROL, V79, P11513, DOI 10.1128/JVI.79.17.11513-11516.2005; Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005; Kijak GH, 2008, VIROLOGY, V376, P101, DOI 10.1016/j.virol.2008.03.017; Komohara Y, 2006, J MOL HISTOL, V37, P327, DOI 10.1007/s10735-006-9059-0; Koulinska IN, 2003, AIDS RES HUM RETROV, V19, P1115, DOI 10.1089/088922203771881211; Land AM, 2008, J VIROL, V82, P8172, DOI 10.1128/JVI.01115-08; Larue RS, 2010, J VIROL, V84, P8193, DOI 10.1128/JVI.00685-10; Li MMH, 2010, J VIROL, V84, P88, DOI 10.1128/JVI.01344-09; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Nielsen K, 1997, PEDIATRICS, V99, DOI 10.1542/peds.99.4.e4; Pace C, 2006, J VIROL, V80, P9259, DOI 10.1128/JVI.00888-06; Pauli EK, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-38; PIANTADOSI A, 2009, J VIROL; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Smith JL, 2010, J VIROL, V84, P12599, DOI 10.1128/JVI.01437-10; Soares EAJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000730; *STATSDIRECTLTD, 2008, STATSDIRECT STAT SOF; Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200; Ulenga NK, 2008, AIDS RES HUM RETROV, V24, P1285, DOI 10.1089/aid.2008.0072; Ulenga NK, 2008, J INFECT DIS, V198, P486, DOI 10.1086/590212; Vazquez-Perez JA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-23; Vetter ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000292; Walker RC, 2010, J VIROL, V84, P5201, DOI 10.1128/JVI.02318-09; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Zennou V, 2006, VIROLOGY, V349, P31, DOI 10.1016/j.virol.2005.12.035; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	51	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e24118	10.1371/journal.pone.0024118	http://dx.doi.org/10.1371/journal.pone.0024118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897871	Green Submitted, Green Published, gold			2022-12-25	WOS:000294676900036
J	Gadermaier, G; Hauser, M; Egger, M; Ferrara, R; Briza, P; Santos, KS; Zennaro, D; Girbl, T; Zuidmeer-Jongejan, L; Mari, A; Ferreira, F				Gadermaier, Gabriele; Hauser, Michael; Egger, Matthias; Ferrara, Rosetta; Briza, Peter; Santos, Keity Souza; Zennaro, Danila; Girbl, Tamara; Zuidmeer-Jongejan, Laurian; Mari, Adriano; Ferreira, Fatima			Sensitization Prevalence, Antibody Cross-Reactivity and Immunogenic Peptide Profile of Api g 2, the Non-Specific Lipid Transfer Protein 1 of Celery	PLOS ONE			English	Article							PRU P 3; MAJOR PEACH ALLERGEN; COMPONENT-RESOLVED DIAGNOSIS; CONTROLLED FOOD CHALLENGE; T-CELL RESPONSE; DOUBLE-BLIND; PLANT FOODS; IGE-BINDING; CLINICAL EXPRESSION; MUGWORT POLLEN	Background: Celery (Apium graveolens) represents a relevant allergen source that can elicit severe reactions in the adult population. To investigate the sensitization prevalence and cross-reactivity of Api g 2 from celery stalks in a Mediterranean population and in a mouse model. Methodology: 786 non-randomized subjects from Italy were screened for IgE reactivity to rApi g 2, rArt v 3 (mugwort pollen LTP) and nPru p 3 (peach LTP) using an allergen microarray. Clinical data of 32 selected patients with reactivity to LTP under investigation were evaluated. Specific IgE titers and cross-inhibitions were performed in ELISA and allergen microarray. Balb/c mice were immunized with purified LTPs; IgG titers were determined in ELISA and mediator release was examined using RBL-2H3 cells. Simulated endolysosomal digestion was performed using microsomes obtained from human DCs. Results: IgE testing showed a sensitization prevalence of 25.6% to Api g 2, 18.6% to Art v 3, and 28.6% to Pru p 3 and frequent co-sensitization and correlating IgE-reactivity was observed. 10/32 patients suffering from LTP-related allergy reported symptoms upon consumption of celery stalks which mainly presented as OAS. Considerable IgE cross-reactivity was observed between Api g 2, Art v 3, and Pru p 3 with varying inhibition degrees of individual patients' sera. Simulating LTP mono-sensitization in a mouse model showed development of more congruent antibody specificities between Api g 2 and Art v 3. Notably, biologically relevant murine IgE cross-reactivity was restricted to the latter and diverse from Pru p 3 epitopes. Endolysosomal processing of LTP showed generation of similar clusters, which presumably represent T-cell peptides. Conclusions: Api g 2 represents a relevant celery stalk allergen in the LTP-sensitized population. The molecule displays common B cell epitopes and endolysosomal peptides that encompass T cell epitopes with pollen and plant-food derived LTP.	[Gadermaier, Gabriele; Hauser, Michael; Egger, Matthias; Briza, Peter; Girbl, Tamara; Ferreira, Fatima] Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria; [Ferrara, Rosetta; Zennaro, Danila; Mari, Adriano] IDI IRCCS, Ctr Mol Allergol, Rome, Italy; [Santos, Keity Souza] Univ Sao Paulo, Sch Med, Discipline Allergy & Immunol, Sao Paulo, Brazil; [Zuidmeer-Jongejan, Laurian] Univ Amsterdam, Acad Med Ctr, Lab Allergy, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands	Salzburg University; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Universidade de Sao Paulo; University of Amsterdam; Academic Medical Center Amsterdam	Gadermaier, G (corresponding author), Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria.	Gabriele.Gadermaier@sbg.ac.at	Santos, Keity/M-9401-2015; Briza, Peter/D-7309-2012; Ferreira, Fatima/E-4889-2011; Gadermaier, Gabriele/L-5997-2015; Santos, Keity Souza/Q-5704-2019; Hauser, Michael/P-6148-2017; Santos, Keity/E-2553-2012; Souza, Keity/AEX-0817-2022; Ferreira, Fatima/AAB-4321-2019	Briza, Peter/0000-0002-4941-6782; Ferreira, Fatima/0000-0003-0989-2335; Gadermaier, Gabriele/0000-0002-4886-417X; Santos, Keity Souza/0000-0001-5271-4011; Hauser, Michael/0000-0001-6558-755X; Souza, Keity/0000-0001-5271-4011; Ferreira, Fatima/0000-0003-0989-2335; Zuidmeer-Jongejan, Laurian/0000-0003-3245-5555; Egger, Matthias/0000-0001-7462-5132; Girbl, Tamara/0000-0001-7632-478X	Christian-Doppler Research Association, Biomay AG, Vienna, Austria; Italian Ministry of Health	Christian-Doppler Research Association, Biomay AG, Vienna, Austria; Italian Ministry of Health(Ministry of Health, Italy)	The study was supported by the Christian-Doppler Research Association, Biomay AG, Vienna, Austria, and the Italian Ministry of Health - Current Research Program 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asero R, 2006, CLIN EXP ALLERGY, V36, P658, DOI 10.1111/j.1365-2222.2006.02477.x; Asero R, 2009, INT ARCH ALLERGY IMM, V150, P271, DOI 10.1159/000222679; Asero R, 2009, CLIN EXP ALLERGY, V39, P547, DOI 10.1111/j.1365-2222.2008.03167.x; Ballmer-Weber BK, 2000, J ALLERGY CLIN IMMUN, V106, P373, DOI 10.1067/mai.2000.107196; Ballmer-Weber BK, 2002, ALLERGY, V57, P228, DOI 10.1034/j.1398-9995.2002.1o3319.x; Barber D, 2009, CLIN EXP ALLERGY, V39, P1764, DOI 10.1111/j.1365-2222.2009.03351.x; Bauermeister K, 2009, J ALLERGY CLIN IMMUN, V124, P1273, DOI 10.1016/j.jaci.2009.07.033; Borges JP, 2008, BIOCHEM BIOPH RES CO, V365, P685, DOI 10.1016/j.bbrc.2007.11.046; BREITENEDER H, 1995, EUR J BIOCHEM, V233, P484, DOI 10.1111/j.1432-1033.1995.484_2.x; Bublin M, 2003, FASEB J, V17, P1697, DOI 10.1096/fj.02-0872fje; Bublin M, 2008, MOL NUTR FOOD RES, V52, pS241, DOI 10.1002/mnfr.200700270; CAVATORTA V, 2010, MOL NUTR FOOD RES; Ciardiello MA, 2010, ALLERGY, V65, P597, DOI 10.1111/j.1398-9995.2009.02277.x; Egger M, 2006, ALLERGY, V61, P461, DOI 10.1111/j.1398-9995.2006.00994.x; Egger M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017278; Egger M, 2010, CURR ALLERGY ASTHM R, V10, P326, DOI 10.1007/s11882-010-0128-9; Fernandez-Rivas M, 2006, J ALLERGY CLIN IMMUN, V118, P481, DOI 10.1016/j.jaci.2006.05.012; Figueroa J, 2005, ALLERGY, V60, P48, DOI 10.1111/j.1398-9995.2005.00644.x; Fotisch K, 1999, INT ARCH ALLERGY IMM, V120, P30, DOI 10.1159/000024217; Gadermaier G, 2011, MOL NUTR FOOD RES, V55, P568, DOI 10.1002/mnfr.201000443; Gadermaier G, 2009, MOL IMMUNOL, V46, P1919, DOI 10.1016/j.molimm.2009.03.021; Gaier S, 2008, MOL NUTR FOOD RES, V52, pS220, DOI 10.1002/mnfr.200700274; Garcia-Casado G, 2003, J ALLERGY CLIN IMMUN, V112, P599, DOI 10.1037/mai.2003.1638; Garcia-Selles FJ, 2002, INT ARCH ALLERGY IMM, V128, P115, DOI 10.1159/000059401; Hochreiter R, 2003, EUR J IMMUNOL, V33, P1667, DOI 10.1002/eji.200323377; Hoffmann-Sommergruber K, 1999, J ALLERGY CLIN IMMUN, V104, P478, DOI 10.1016/S0091-6749(99)70397-0; Jankiewicz A, 1996, INT ARCH ALLERGY IMM, V111, P268, DOI 10.1159/000237377; Lombardero M, 2004, CLIN EXP ALLERGY, V34, P1415, DOI 10.1111/j.1365-2222.2004.02053.x; Luttkopf D, 2000, J ALLERGY CLIN IMMUN, V106, P390, DOI 10.1067/mai.2000.108711; MUTSCHLECHNER S, 2010, J ALLERGY CLIN IMMUN; Pacios LF, 2008, MOL IMMUNOL, V45, P2269, DOI 10.1016/j.molimm.2007.11.022; Palacin A, 2006, J ALLERGY CLIN IMMUN, V117, P1423, DOI 10.1016/j.jaci.2006.01.026; Pastorello EA, 2010, INT ARCH ALLERGY IMM, V153, P1, DOI 10.1159/000301573; Pastorello EA, 2002, J ALLERGY CLIN IMMUN, V110, P310, DOI 10.1067/mai.2002.125830; Ruckrich T, 2006, BIOL CHEM, V387, P1503, DOI 10.1515/BC.2006.188; Scala E, 2010, CLIN EXP ALLERGY, V40, P911, DOI 10.1111/j.1365-2222.2010.03470.x; Scheurer S, 2000, CLIN EXP ALLERGY, V30, P962, DOI 10.1046/j.1365-2222.2000.00821.x; Schulten V, 2011, ALLERGY, V66, P1005, DOI 10.1111/j.1398-9995.2011.02567.x; Schulten V, 2009, J ALLERGY CLIN IMMUN, V124, P100, DOI 10.1016/j.jaci.2009.02.010; Toda M., 2011, J ALLERGY CLIN IMMUN; Tordesillas L, 2009, MOL IMMUNOL, V46, P722, DOI 10.1016/j.molimm.2008.10.018; VALLIER P, 1992, CLIN EXP ALLERGY, V22, P774, DOI 10.1111/j.1365-2222.1992.tb02818.x; Wijesinha-Bettoni R, 2010, BIOCHEMISTRY-US, V49, P2130, DOI 10.1021/bi901939z; Zuidmeer L, 2005, INT ARCH ALLERGY IMM, V137, P273, DOI 10.1159/000086420; Zuidmeer L, 2007, CURR OPIN ALLERGY CL, V7, P269, DOI 10.1097/ACI.0b013e32814a5401	45	44	46	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e24150	10.1371/journal.pone.0024150	http://dx.doi.org/10.1371/journal.pone.0024150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897872	Green Published, gold, Green Submitted			2022-12-25	WOS:000294676900037
J	Wang, JP; Hui, YJ; Wang, ST; Yu, HHM; Huang, YC; Chiang, ER; Liu, CL; Chen, TH; Hung, SC				Wang, Jung-Pan; Hui, Yun-Ju; Wang, Shih-Tien; Yu, Hsiang-Hsuan Michael; Huang, Yi-Chao; Chiang, En-Rung; Liu, Chien-Lin; Chen, Tain-Hsiung; Hung, Shih-Chieh			Recapitulation of Fibromatosis Nodule by Multipotential Stem Cells in Immunodeficient Mice	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; GROWTH-FACTOR-BETA; INSULIN-PRODUCING CELLS; SMOOTH MUSCLE ACTIN; TRICHOSTATIN-A; IN-VITRO; DUPUYTRENS-DISEASE; PROMOTE DIFFERENTIATION; SKIN FIBROBLASTS; MYOFIBROBLAST	Musculoskeletal fibromatosis remains a disease of unknown etiology. Surgical excision is the standard of care, but the recurrence rate remains high. Superficial fibromatosis typically presents as subcutaneous nodules caused by rapid myofibroblast proliferation followed by slow involution to dense acellular fibrosis. In this study, we demonstrate that fibromatosis stem cells (FSCs) can be isolated from palmar nodules but not from cord or normal palm tissues. We found that FSCs express surface markers such as CD29, CD44, CD73, CD90, CD105, and CD166 but do not express CD34, CD45, or CD133. We also found that FSCs are capable of expanding up to 20 passages, that these cells include myofibroblasts, osteoblasts, adipocytes, chondrocytes, hepatocytes, and neural cells, and that these cells possess multipotentiality to develop into the three germ layer cells. When implanted beneath the dorsal skin of nude mice, FSCs recapitulated human fibromatosis nodules. Two weeks after implantation, the cells expressed immunodiagnostic markers for myofibroblasts such as a-smooth muscle actin and type III collagen. Two months after implantation, there were fewer myofibroblasts and type I collagen became evident. Treatment with the antifibrogenic compound Trichostatin A (TSA) inhibited the proliferation and differentiation of FSCs in vitro. Treatment with TSA before or after implantation blocked formation of fibromatosis nodules. These results suggest that FSCs are the cellular origin of fibromatosis and that these cells may provide a promising model for developing new therapeutic interventions.	[Wang, Jung-Pan; Chiang, En-Rung; Hung, Shih-Chieh] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei 112, Taiwan; [Hung, Shih-Chieh] Natl Yang Ming Univ, Dept Pharmacol, Sch Med, Taipei 112, Taiwan; [Wang, Jung-Pan; Wang, Shih-Tien; Huang, Yi-Chao; Liu, Chien-Lin; Chen, Tain-Hsiung] Natl Yang Ming Univ, Dept Surg, Sch Med, Taipei 112, Taiwan; [Wang, Jung-Pan; Wang, Shih-Tien; Huang, Yi-Chao; Chiang, En-Rung; Liu, Chien-Lin; Chen, Tain-Hsiung; Hung, Shih-Chieh] Taipei Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei, Taiwan; [Yu, Hsiang-Hsuan Michael] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL 33612 USA	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Hung, SC (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei 112, Taiwan.	hungsc@vghtpe.gov.tw		Yu, Hsiang-Hsuan/0000-0002-0621-9519	Taipei Veterans General Hospital [V99B1-001]; National Science Council [(NSC98-2314-B-075-038-MY2]; National Yang-Ming University; Ministry of Education	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan); National Yang-Ming University; Ministry of Education	This study was supported in part by grants from Taipei Veterans General Hospital (V99B1-001), National Science Council (NSC98-2314-B-075-038-MY2) and National Yang-Ming University, Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alao JP, 2004, CLIN CANCER RES, V10, P8094, DOI 10.1158/1078-0432.CCR-04-1023; AUBERT B, 1990, BIOCHEM BIOPH RES CO, V170, P1144, DOI 10.1016/0006-291X(90)90512-L; BAIRD KS, 1993, J CLIN PATHOL, V46, P425, DOI 10.1136/jcp.46.5.425; Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Bayat A, 2006, ANN ROY COLL SURG, V88, P3, DOI 10.1308/003588406X83104; Bayat A, 2007, BRIT J HOSP MED, V68, P604, DOI 10.12968/hmed.2007.68.11.27683; BECKETT JH, 1977, PEDIATRICS, V59, P401; Bisson MA, 2003, J HAND SURG-BRIT EUR, V28B, P351, DOI 10.1016/S0266-7681(03)00135-9; Bitu CC, 2006, J CLIN PERIODONTOL, V33, P393, DOI 10.1111/j.1600-051X.2006.00928.x; Chang CF, 2008, J BIOMED MATER RES A, V86A, P1097, DOI 10.1002/jbm.a.31767; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; CHOI KC, 1990, J CUTAN PATHOL, V17, P225, DOI 10.1111/j.1600-0560.1990.tb00090.x; Connelly TJ, 1999, J AM ACAD DERMATOL, V41, P106, DOI 10.1016/S0190-9622(99)70415-9; Dias JJ, 2006, J HAND SURG-BRIT EUR, V31B, P514, DOI 10.1016/j.jhsb.2006.05.005; Dinauer PA, 2007, RADIOGRAPHICS, V27, P173, DOI 10.1148/rg.271065065; ElSakka AI, 1997, J UROLOGY, V158, P1391, DOI 10.1016/S0022-5347(01)64223-X; Eyden B, 2009, J CLIN PATHOL, V62, P236, DOI 10.1136/jcp.2008.061630; FRINGES B, 1986, Pediatric Pathology, V6, P311; Ghosh AK, 2007, BIOCHEM BIOPH RES CO, V354, P420, DOI 10.1016/j.bbrc.2006.12.204; Hamner JB, 2008, J PEDIATR SURG, V43, P177, DOI 10.1016/j.jpedsurg.2007.09.048; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Hung SC, 2002, STEM CELLS, V20, P522, DOI 10.1634/stemcells.20-6-522; Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249; Katsura T, 2009, CANCER GENE THER, V16, P237, DOI 10.1038/cgt.2008.81; Khan ZA, 2008, J CLIN INVEST, V118, P2592, DOI 10.1172/JCI33493; Kumar R, 2009, CURR OPIN UROL, V19, P589, DOI 10.1097/MOU.0b013e3283314a87; LARSEN RD, 1958, J BONE JOINT SURG AM, V40, P773, DOI 10.2106/00004623-195840040-00002; Lazar AJF, 2009, CURR OPIN ONCOL, V21, P352, DOI 10.1097/CCO.0b013e32832c9502; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; LEE TH, 1993, J BONE JOINT SURG AM, V75A, P1080, DOI 10.2106/00004623-199307000-00016; Lin HY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-56; Liu JM, 2008, ADV THER, V25, P389, DOI 10.1007/s12325-008-0050-x; Lu Y, 2010, HUM REPROD, V25, P1014, DOI 10.1093/humrep/dep472; LUCK JV, 1959, J BONE JOINT SURG AM, V41, P635, DOI 10.2106/00004623-195941040-00008; Mauviel A, 2005, METH MOLEC MED, V117, P69; Nasu Y, 2008, OSTEOARTHR CARTILAGE, V16, P723, DOI 10.1016/j.joca.2007.10.014; Niki T, 1999, HEPATOLOGY, V29, P858, DOI 10.1002/hep.510290328; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Robbin MR, 2001, RADIOGRAPHICS, V21, P585, DOI 10.1148/radiographics.21.3.g01ma21585; Rombouts K, 2002, EXP CELL RES, V278, P184, DOI 10.1006/excr.2002.5577; Rombouts K, 2001, ACTA GASTRO-ENT BELG, V64, P239; ROMERO JA, 1995, J COMPUT ASSIST TOMO, V19, P782, DOI 10.1097/00004728-199509000-00016; Silverman JS, 1996, HISTOPATHOLOGY, V29, P411, DOI 10.1046/j.1365-2559.1996.d01-510.x; Sommer M, 2005, CELLS TISSUES ORGANS, V180, P204, DOI 10.1159/000088937; Starkweather KD, 1996, J HAND SURG-AM, V21A, P490, DOI 10.1016/S0363-5023(96)80368-6; Strutz Frank, 2009, Front Biosci (Schol Ed), V1, P125, DOI 10.2741/e12; Taylor SJ, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-5; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Wang Zhi-min, 2002, Ai Zheng, V21, P1100; Wolter M, 2001, HAUTARZT, V52, P236; Yanase M, 2003, BIOCHEM BIOPH RES CO, V305, P223, DOI 10.1016/S0006-291X(03)00726-5	51	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e24050	10.1371/journal.pone.0024050	http://dx.doi.org/10.1371/journal.pone.0024050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901157	Green Published, gold, Green Submitted			2022-12-25	WOS:000294298000042
J	Vandermoten, S; Francis, F; Haubruge, E; Leal, WS				Vandermoten, Sophie; Francis, Frederic; Haubruge, Eric; Leal, Walter S.			Conserved Odorant-Binding Proteins from Aphids and Eavesdropping Predators	PLOS ONE			English	Article							PHEROMONE-BINDING; ALARM PHEROMONE; BEHAVIORAL-RESPONSES; BOMBYX-MORI; LADY BEETLE; CRYSTAL-STRUCTURE; NATURAL ENEMIES; LIGAND-BINDING; CEREAL APHIDS; NMR STRUCTURE	Background: The sesquiterpene (E)-beta-farnesene is the main component of the alarm pheromone system of various aphid species studied to date, including the English grain aphid, Sitobion avenae. Aphid natural enemies, such as the marmalade hoverfly Episyrphus balteatus and the multicolored Asian lady beetle Harmonia axyridis, eavesdrop on aphid chemical communication and utilize (E)-beta-farnesene as a kairomone to localize their immediate or offspring preys. These aphid-predator systems are important models to study how the olfactory systems of distant insect taxa process the same chemical signal. We postulated that odorant-binding proteins (OBPs), which are highly expressed in insect olfactory tissues and involved in the first step of odorant reception, have conserved regions involved in binding (E)-beta-farnesene. Methodology: We cloned OBP genes from the English grain aphid and two major predators of this aphid species. We then expressed these proteins and compare their binding affinities to the alarm pheromone/kairomone. By using a fluorescence reporter, we tested binding of (E)-beta-farnesene and other electrophysiologically and behaviorally active compounds, including a green leaf volatile attractant. Conclusion: We found that OBPs from disparate taxa of aphids and their predators are highly conserved proteins, with apparently no orthologue genes in other insect species. Properly folded, recombinant proteins from the English grain aphid, SaveOBP3, and the marmalade hoverfly, EbalOBP3, specifically bind (E)-beta-farnesene with apparent high affinity. For the first time we have demonstrated that insect species belonging to distinct Orders have conserved OBPs, which specifically bind a common semiochemical and has no binding affinity for related compounds.	[Vandermoten, Sophie; Francis, Frederic; Haubruge, Eric] Univ Liege, Gembloux, Belgium; [Vandermoten, Sophie; Leal, Walter S.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	University of Liege; University of California System; University of California Davis	Vandermoten, S (corresponding author), Univ Liege, Gembloux, Belgium.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021	Haubruge, Eric/0000-0002-8138-0476; Leal Filho, Walter/0000-0002-1241-5225; Leal, Walter/0000-0002-6800-1240	Belgian National Fund for Scientific Research (FNRS); United States Department of Agriculture, USDA-NIFA-AFRI [2010-65105-20582]; National Science Foundation (NSF) [0918177]	Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); United States Department of Agriculture, USDA-NIFA-AFRI(United States Department of Agriculture (USDA)); National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by the Belgian National Fund for Scientific Research (FNRS), the United States Department of Agriculture, USDA-NIFA-AFRI award 2010-65105-20582 (to WSL), and the National Science Foundation (NSF) award 0918177 (to WSL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar EB, 2001, CAN ENTOMOL, V133, P389, DOI 10.4039/Ent133389-3; Al Abassi S, 2000, J CHEM ECOL, V26, P1765, DOI 10.1023/A:1005555300476; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blackman RL, 2006, APHIDS WORLD HERBACE; BOWERS WS, 1972, SCIENCE, V177, P1121, DOI 10.1126/science.177.4054.1121; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; CHAMBERS RJ, 1986, J APPL ECOL, V23, P895, DOI 10.2307/2403942; Damberger FF, 2007, J MOL BIOL, V373, P811, DOI 10.1016/j.jmb.2007.07.078; Francis F, 2005, J APPL ENTOMOL, V129, P6, DOI 10.1111/j.1439-0418.2005.00925.x; Francis F, 2004, J CHEM ECOL, V30, P741, DOI 10.1023/B:JOEC.0000028429.13413.a2; Francis FD, 2005, EUR J ENTOMOL, V102, P431, DOI 10.14411/eje.2005.061; Hatano E, 2008, EUR J ENTOMOL, V105, P797, DOI 10.14411/eje.2008.106; Hatano E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011188; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Kielty JP, 1996, J INSECT BEHAV, V9, P237, DOI 10.1007/BF02213868; KISLOW CJ, 1972, NATURE, V235, P108, DOI 10.1038/235108a0; Kunert G, 2005, ECOL LETT, V8, P596, DOI 10.1111/j.1461-0248.2005.00754.x; Lartigue A, 2004, J BIOL CHEM, V279, P4459, DOI 10.1074/jbc.M311212200; Lartigue A, 2003, J BIOL CHEM, V278, P30213, DOI 10.1074/jbc.M304688200; Leal Walter S., 2003, P447, DOI 10.1016/B978-012107151-6/50017-7; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; MAIER CT, 1979, ANN ENTOMOL SOC AM, V72, P54, DOI 10.1093/aesa/72.1.54; NAKAMUTA K, 1991, APPL ENTOMOL ZOOL, V26, P1; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PICKETT JA, 1980, J CHEM ECOL, V6, P349, DOI 10.1007/BF01402913; PICKETT JA, 1992, ANNU REV ENTOMOL, V37, P67, DOI 10.1146/annurev.en.37.010192.000435; Podjasek JO, 2005, CAN J ZOOL, V83, P1138, DOI [10.1139/Z05-108, 10.1139/z05-108]; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; Scaloni A, 1999, BIOCHEM BIOPH RES CO, V266, P386, DOI 10.1006/bbrc.1999.1791; TENHUMBERG B, 1995, AGR ECOSYST ENVIRON, V52, P39, DOI 10.1016/0167-8809(94)09007-T; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Verheggen FJ, 2008, J CHEM ECOL, V34, P301, DOI 10.1007/s10886-008-9434-2; Verheggen FJ, 2007, J CHEM ECOL, V33, P2148, DOI 10.1007/s10886-007-9370-6; VOGT RG, 2005, COMPREHENSIVE INSECT, V3, P753, DOI DOI 10.1016/B0-44-451924-6/00047-8; WIENTJEN.WH, 1973, EXPERIENTIA, V29, P658, DOI 10.1007/BF01944756; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Xu W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015403; Yang G, 2011, PROTEIN EXPRES PURIF, V75, P165, DOI 10.1016/j.pep.2010.09.004; ZHOU JJ, 2009, OUTLOOKS PEST MANAGE, V21, P31; Zhu JW, 1999, J CHEM ECOL, V25, P1163, DOI 10.1023/A:1020846212465	40	35	42	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23608	10.1371/journal.pone.0023608	http://dx.doi.org/10.1371/journal.pone.0023608			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21912599	gold, Green Published			2022-12-25	WOS:000294253500018
J	Khmelinskii, A; Meurer, M; Duishoev, N; Delhomme, N; Knop, M				Khmelinskii, Anton; Meurer, Matthias; Duishoev, Nurlanbek; Delhomme, Nicolas; Knop, Michael			Seamless Gene Tagging by Endonuclease-Driven Homologous Recombination	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; FLUORESCENT PROTEINS; GLOBAL ANALYSIS; MESSENGER-RNAS; YEAST GENES; SYSTEM; LOCALIZATION; DNA; TRANSCRIPTION; EXPRESSION	Gene tagging facilitates systematic genomic and proteomic analyses but chromosomal tagging typically disrupts gene regulatory sequences. Here we describe a seamless gene tagging approach that preserves endogenous gene regulation and is potentially applicable in any species with efficient DNA double-strand break repair by homologous recombination. We implement seamless tagging in Saccharomyces cerevisiae and demonstrate its application for protein tagging while preserving simultaneously upstream and downstream gene regulatory elements. Seamless tagging is compatible with high-throughput strain construction using synthetic genetic arrays (SGA), enables functional analysis of transcription antisense to open reading frames and should facilitate systematic and minimally-invasive analysis of gene functions.	[Khmelinskii, Anton; Meurer, Matthias; Duishoev, Nurlanbek; Knop, Michael] EMBL, Cell Biol & Biophys Unit, Heidelberg, Germany; [Delhomme, Nicolas] EMBL, Genome Biol Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Khmelinskii, A (corresponding author), Heidelberg Univ, DKFZ ZMBH Alliance, Zentrum Mol Biol Univ Heidelberg ZMBH, Heidelberg, Germany.	m.knop@zmbh.uni-heidelberg.de	Delhomme, Nicolas/B-9187-2015; Khmelinskii, Anton/B-2830-2008	Delhomme, Nicolas/0000-0002-3053-0796; Khmelinskii, Anton/0000-0002-0256-5190	European Molecular Biology Organization (EMBO) [ALTF 1124-2010]	European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	This work was supported by a Long-Term fellowship from the European Molecular Biology Organization (EMBO ALTF 1124-2010) to A.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; COLLEAUX L, 1986, CELL, V44, P521, DOI 10.1016/0092-8674(86)90262-X; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Haim L, 2007, NAT METHODS, V4, P409, DOI 10.1038/NMETH1040; Hardy S, 2010, BIOL CELL, V102, P561, DOI 10.1042/BC20100038; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lind K, 2009, YEAST, V26, P407, DOI 10.1002/yea.1675; Maeder CI, 2007, METHOD MICROBIOL, V36, P55, DOI 10.1016/S0580-9517(06)36004-7; MEZARD C, 1992, CELL, V70, P659, DOI 10.1016/0092-8674(92)90434-E; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen S, 2009, MOL BIOL CELL, V20, P2438, DOI 10.1091/mbc.E08-10-0987; SIKORSKI RS, 1989, GENETICS, V122, P19; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Sugawara N, 2000, MOL CELL BIOL, V20, P5300, DOI 10.1128/MCB.20.14.5300-5309.2000; Taxis C, 2006, BIOTECHNIQUES, V40, P73, DOI 10.2144/000112040; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B	33	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23794	10.1371/journal.pone.0023794	http://dx.doi.org/10.1371/journal.pone.0023794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21915245	Green Published, Green Submitted, gold			2022-12-25	WOS:000294251800031
J	Kouki, A; Haataja, S; Loimaranta, V; Pulliainen, AT; Nilsson, UJ; Finne, J				Kouki, Annika; Haataja, Sauli; Loimaranta, Vuokko; Pulliainen, Arto T.; Nilsson, Ulf J.; Finne, Jukka			Identification of a Novel Streptococcal Adhesin P (SadP) Protein Recognizing Galactosyl-alpha 1-4-galactose-containing Glycoconjugates CONVERGENT EVOLUTION OF BACTERIAL PATHOGENS TO BINDING OF THE SAME HOST RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; SUIS SEROTYPE-2; GLYCOLIPID BINDING; ENDOTHELIAL-CELLS; STRUCTURAL BASIS; H2O2 RESISTANCE; SURFACE PROTEIN; GORDONII DL1; SIALIC-ACID; E. COLI	Bacterial adhesion is often a prerequisite for infection, and host cell surface carbohydrates play a major role as adhesion receptors. Streptococci are a leading cause of infectious diseases. However, only few carbohydrate-specific streptococcal adhesins are known. Streptococcus suis is an important pig pathogen and a zoonotic agent causing meningitis in pigs and humans. In this study, we have identified an adhesin that mediates the binding of S. suis to galactosyl-alpha 1-4-galactose (Gal alpha 1-4Gal)-containing host receptors. A functionally unknown S. suis cell wall protein (SSU0253), designated here as SadP (streptococcal adhesin P), was identified using a Gal alpha 1-4Gal-containing affinity matrix and LC-ESI mass spectrometry. Although the function of the protein was not previously known, it was recently identified as an immunogenic cell wall protein in a proteomic study. Insertional inactivation of the sadP gene abolished S. suis Gal alpha 1-4Gal-dependent binding. The adhesin gene sadP was cloned and expressed in Escherichia coli. Characterization of its binding specificity showed that SadP recognizes Gal alpha 1-4Gal-oligosaccharides and binds its natural glycolipid receptor, GbO(3) (CD77). The N terminus of SadP was shown to contain a Gal alpha 1-Gal-binding site and not to have apparent sequence similarity to other bacterial adhesins, including the E. coli P fimbrial adhesins, or to E. coli verotoxin or Pseudomonas aeruginosa lectin I also recognizing the same Gal alpha 1-4Gal disaccharide. The SadP and E. coli P adhesins represent a unique example of convergent evolution toward binding to the same host receptor structure.	[Kouki, Annika; Haataja, Sauli; Loimaranta, Vuokko; Pulliainen, Arto T.] Univ Turku, Dept Med Biochem & Genet, FI-20520 Turku, Finland; [Finne, Jukka] Univ Helsinki, Dept Biosci, Div Biochem & Biotechnol, FI-00014 Helsinki, Finland; [Pulliainen, Arto T.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Nilsson, Ulf J.] Lund Univ, SE-22100 Lund, Sweden	University of Turku; University of Helsinki; University of Basel; Lund University	Haataja, S (corresponding author), Univ Turku, Dept Med Biochem & Genet, Kiinamyllynkatu 10, FI-20520 Turku, Finland.	sauli.haataja@utu.fi	Nilsson, Ulf J./L-3219-2014; Haataja, Sauli/AAR-5103-2020; Pulliainen, Arto/AAX-2052-2021; Finne, Jukka/B-6881-2008	Nilsson, Ulf J./0000-0001-5815-9522; Loimaranta, Vuokko/0000-0002-6873-2270; Finne, Jukka/0000-0002-8076-3344; Pulliainen, Arto Tapio/0000-0002-9361-8963	Finnish Academy [114100]; Turku University Foundation; Duodecim Society of Turunmaa; Finnish Graduate School of Glycosciences	Finnish Academy(Academy of Finland); Turku University Foundation; Duodecim Society of Turunmaa; Finnish Graduate School of Glycosciences	This study was supported by Finnish Academy Grant 114100, the Turku University Foundation, the Duodecim Society of Turunmaa and the Finnish Graduate School of Glycosciences.	Baron MJ, 2004, J BIOL CHEM, V279, P24714, DOI 10.1074/jbc.M402164200; Berthelot-Herault F, 2005, CAN J VET RES, V69, P236; Berthelot-Herault F, 2001, CAN J VET RES, V65, P196; Blanchard B, 2008, J MOL BIOL, V383, P837, DOI 10.1016/j.jmb.2008.08.028; BOYD B, 1993, J EXP MED, V177, P1745, DOI 10.1084/jem.177.6.1745; Charland N, 1998, MICROBIOL-SGM, V144, P325, DOI 10.1099/00221287-144-2-325; Chen B, 2010, FEMS MICROBIOL LETT, V307, P12, DOI 10.1111/j.1574-6968.2010.01944.x; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; de Greeff A, 2002, INFECT IMMUN, V70, P1319, DOI 10.1128/IAI.70.3.1319-1325.2002; Devenica D., 2010, MED ONCOL IN PRESS; Dodson KW, 2001, CELL, V105, P733, DOI 10.1016/S0092-8674(01)00388-9; Duensing TD, 1999, INFECT IMMUN, V67, P4463, DOI 10.1128/IAI.67.9.4463-4468.1999; Feng YJ, 2010, TRENDS MICROBIOL, V18, P124, DOI 10.1016/j.tim.2009.12.003; Fittipaldi N, 2008, MOL MICROBIOL, V70, P1120, DOI 10.1111/j.1365-2958.2008.06463.x; FRANCOISGERARD C, 1979, BIOCHEM J, V177, P679, DOI 10.1042/bj1770679; Frick IM, 2003, EUR J BIOCHEM, V270, P2303, DOI 10.1046/j.1432-1033.2003.03600.x; Gu HW, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-201; HAATAJA S, 1993, J BIOL CHEM, V268, P4311; HAATAJA S, 1994, J BIOL CHEM, V269, P27466; Hansen HC, 1997, J AM CHEM SOC, V119, P6974, DOI 10.1021/ja970859p; HIGGINS R, 2005, DIS SWINE, P769; Jakubovics NS, 2005, INFECT IMMUN, V73, P6629, DOI 10.1128/IAI.73.10.6629-6638.2005; Joosten JAF, 2004, J MED CHEM, V47, P6499, DOI 10.1021/jm049476+; KARLSSON KA, 1986, CHEM PHYS LIPIDS, V42, P153, DOI 10.1016/0009-3084(86)90050-2; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; KRIVAN HC, 1988, P NATL ACAD SCI USA, V85, P6157, DOI 10.1073/pnas.85.16.6157; KURL DN, 1989, INFECT IMMUN, V57, P384, DOI 10.1128/IAI.57.2.384-389.1989; Li W, 2010, INT J MED MICROBIOL, V300, P482, DOI 10.1016/j.ijmm.2010.04.018; LINDBERG AA, 1987, J BIOL CHEM, V262, P1779; Lingwood CA, 2010, FEBS LETT, V584, P1879, DOI 10.1016/j.febslet.2009.11.089; LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834; LIUKKONEN J, 1992, J BIOL CHEM, V267, P21105; Loimaranta V, 2005, INFECT IMMUN, V73, P2245, DOI 10.1128/IAI.73.4.2245-2252.2005; Mandanici F, 2010, J PROTEOMICS, V73, P2365, DOI 10.1016/j.jprot.2010.07.009; Moschioni M, 2010, INFECT IMMUN, V78, P5033, DOI 10.1128/IAI.00601-10; Navarre WW, 1998, J BIOL CHEM, V273, P29135, DOI 10.1074/jbc.273.44.29135; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Ofek I, 2003, FEMS IMMUNOL MED MIC, V38, P181, DOI 10.1016/S0928-8244(03)00228-1; Ohlsson J, 2005, ORG BIOMOL CHEM, V3, P886, DOI 10.1039/b416878j; Osaki M, 2002, J BACTERIOL, V184, P971, DOI 10.1128/jb.184.4.971-982.2002; Parker D, 2009, INFECT IMMUN, V77, P3722, DOI 10.1128/IAI.00228-09; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Pulliainen AT, 2008, J BACTERIOL, V190, P3225, DOI 10.1128/JB.01843-07; Pulliainen AT, 2005, MOL MICROBIOL, V57, P1086, DOI 10.1111/j.1365-2958.2005.04756.x; Pulliainen AT, 2003, J BIOL CHEM, V278, P7996, DOI 10.1074/jbc.M210174200; SCHMIDT KH, 1993, ZBL BAKT-INT J MED M, V279, P472, DOI 10.1016/S0934-8840(11)80419-6; Schweppe CH, 2008, GLYCOCONJUGATE J, V25, P291, DOI 10.1007/s10719-007-9091-7; Sharon N, 2000, GLYCOCONJUGATE J, V17, P659, DOI 10.1023/A:1011091029973; Sikora S, 2005, TRENDS MICROBIOL, V13, P522, DOI 10.1016/j.tim.2005.08.010; Smith HE, 1999, INFECT IMMUN, V67, P1750; STROMBERG N, 1990, EMBO J, V9, P2001, DOI 10.1002/j.1460-2075.1990.tb08328.x; STROMBERG N, 1991, P NATL ACAD SCI USA, V88, P9340, DOI 10.1073/pnas.88.20.9340; Suzuki N, 2001, J BIOL CHEM, V276, P23221, DOI 10.1074/jbc.M101379200; Takamatsu D, 2006, INFECT IMMUN, V74, P1933, DOI 10.1128/IAI.74.3.1933-1940.2006; Takamatsu D, 2009, VET MICROBIOL, V138, P132, DOI 10.1016/j.vetmic.2009.02.013; Tan C, 2008, FEMS MICROBIOL LETT, V278, P108, DOI 10.1111/j.1574-6968.2007.00980.x; TIKKANEN K, 1995, J BIOL CHEM, V270, P28874, DOI 10.1074/jbc.270.48.28874; TYRRELL GJ, 1992, P NATL ACAD SCI USA, V89, P524, DOI 10.1073/pnas.89.2.524; Uchiyama S, 2009, J EXP MED, V206, P1845, DOI 10.1084/jem.20090386; Urano-Tashiro Y, 2008, INFECT IMMUN, V76, P4686, DOI 10.1128/IAI.00238-08; Vanier G, 2008, VET MICROBIOL, V127, P417, DOI 10.1016/j.vetmic.2007.08.032; Wilson TL, 2007, VET MICROBIOL, V122, P135, DOI 10.1016/j.vetmic.2006.12.025; WINTERS BD, 1993, INFECT IMMUN, V61, P3259, DOI 10.1128/IAI.61.8.3259-3264.1993; Yajima A, 2008, MICROBIOL IMMUNOL, V52, P69, DOI 10.1111/j.1348-0421.2008.00015.x; Ye CY, 2009, J INFECT DIS, V199, P97, DOI 10.1086/594370; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang AD, 2008, PROTEOMICS, V8, P3506, DOI 10.1002/pmic.200800007	68	33	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38854	38864		10.1074/jbc.M111.260992	http://dx.doi.org/10.1074/jbc.M111.260992			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21908601	Green Published, hybrid			2022-12-25	WOS:000296759800004
J	Yoo, BH; Wang, YF; Erdogan, M; Sasazuki, T; Shirasawa, S; Corcos, L; Sabapathy, K; Rosen, KV				Yoo, Byong Hoon; Wang, Yanfei; Erdogan, Mete; Sasazuki, Takehiko; Shirasawa, Senji; Corcos, Laurent; Sabapathy, Kanaga; Rosen, Kirill V.			Oncogenic ras-induced Down-regulation of Pro-apoptotic Protease Caspase-2 Is Required for Malignant Transformation of Intestinal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; ANOIKIS RESISTANCE; PROMOTES APOPTOSIS; SERINE-PROTEASE; UP-REGULATION; IN-VIVO; GROWTH; DETACHMENT; DEATH; GENE	Resistance of carcinoma cells to anoikis, apoptosis that is normally induced by loss of cell-to-extracellular matrix adhesion, is thought to be essential for the ability of these cells to form primary tumors, invade adjacent tissues, and metastasize to distant organs. Current knowledge about the mechanisms by which cancer cells evade anoikis is far from complete. In an effort to understand these mechanisms, we found that ras, a major oncogene, down-regulates protease caspase-2 (which initiates certain steps of the cellular apoptotic program) in malignant human and rat intestinal epithelial cells. This down-regulation could be reversed by inhibition of a protein kinase Mek, a mediator of Ras signaling. We also found that enforced down-regulation of caspase-2 in nonmalignant intestinal epithelial cells by RNA interference protected them from anoikis. Furthermore, the reversal of the effect of Ras on caspase-2 achieved by the expression of exogenous caspase-2 in detached ras-transformed intestinal epithelial cells promoted well established apoptotic events, such as the release of the pro-apoptotic mitochondrial factors cytochrome c and HtrA2/Omi into the cytoplasm of these cells, significantly enhanced their anoikis susceptibility, and blocked their long term growth in the absence of adhesion to the extracellular matrix. Finally, the blockade of the effect of Ras on caspase-2 substantially suppressed growth of tumors formed by the ras-transformed cells in mice. We conclude that ras-induced down-regulation of caspase-2 represents a novel mechanism by which oncogenic Ras protects malignant intestinal epithelial cells from anoikis, promotes their anchorage-independent growth, and allows them to form tumors in vivo.	[Rosen, Kirill V.] Dalhousie Univ, Atlantic Res Ctr, CRC, Dept Pediat, Halifax, NS B3H 4H7, Canada; [Yoo, Byong Hoon; Wang, Yanfei; Erdogan, Mete; Rosen, Kirill V.] Dalhousie Univ, Atlantic Res Ctr, Dept Biochem & Mol Biol, Halifax, NS B3H 4H7, Canada; [Sasazuki, Takehiko] Int Med Ctr Japan, Dept Pathol, Res Inst, Tokyo 1638655, Japan; [Shirasawa, Senji] Fukuoka Univ, Dept Cell Biol, Sch Med, Fukuoka 8140180, Japan; [Corcos, Laurent] INSERM, Fac Med, F-29200 Brest, France; [Sabapathy, Kanaga] Natl Canc Ctr, Mol Carcinogenesis Lab, Singapore 169610, Singapore	Dalhousie University; Dalhousie University; National Center for Global Health & Medicine - Japan; Fukuoka University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; National Cancer Centre Singapore (NCCS)	Rosen, KV (corresponding author), Dalhousie Univ, Atlantic Res Ctr, CRC, Dept Pediat, Room C-302,5849 Univ Ave, Halifax, NS B3H 4H7, Canada.	kirill.rosen@dal.ca	Corcos, Laurent/K-1859-2015; Corcos, Laurent/M-8915-2017; Corcos, Laurent/AAJ-2692-2020	Corcos, Laurent/0000-0001-8019-2505; Corcos, Laurent/0000-0001-8019-2505; Rosen, Kirill/0000-0002-4317-9907	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from Canadian Institutes of Health Research.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Berezovskaya O, 2005, CANCER RES, V65, P2378, DOI 10.1158/0008-5472.CAN-04-2649; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Colussi PA, 1998, J BIOL CHEM, V273, P24535, DOI 10.1074/jbc.273.38.24535; Derouet M, 2007, NEOPLASIA, V9, P536, DOI 10.1593/neo.07217; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; FILMUS J, 1994, ONCOGENE, V9, P3627; Frankel A, 2001, CANCER RES, V61, P4837; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gottfried Y, 2004, EMBO J, V23, P1627, DOI 10.1038/sj.emboj.7600155; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Ho LH, 2009, P NATL ACAD SCI USA, V106, P5336, DOI 10.1073/pnas.0811928106; Jacks T, 2002, CELL, V111, P923, DOI 10.1016/S0092-8674(02)01229-1; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; KhosraviFar R, 1998, ADV CANCER RES, V72, P57; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Li FZ, 2003, J CELL PHYSIOL, V197, P8, DOI 10.1002/jcp.10327; Li HB, 2009, J BIOL CHEM, V284, P2012, DOI 10.1074/jbc.M805612200; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Liu Z, 2006, ONCOGENE, V25, P7680, DOI 10.1038/sj.onc.1209753; Liu ZP, 2006, J BIOL CHEM, V281, P14738, DOI 10.1074/jbc.M508664200; Liu ZP, 2005, J BIOL CHEM, V280, P37383, DOI 10.1074/jbc.M503724200; LJUBIMOV AV, 1992, INT J CANCER, V50, P562, DOI 10.1002/ijc.2910500412; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Logette E, 2003, ONCOGENE, V22, P935, DOI 10.1038/sj.onc.1206172; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Manzl C, 2009, J CELL BIOL, V185, P291, DOI 10.1083/jcb.200811105; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Meredith JE, 1997, TRENDS CELL BIOL, V7, P146, DOI 10.1016/S0962-8924(97)01002-7; Olson M., 2001, Current Molecular Medicine (Hilversum), V1, P91, DOI 10.2174/1566524013364239; RAK J, 1995, J CELL BIOL, V131, P1587, DOI 10.1083/jcb.131.6.1587; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Rosen K, 1998, CURR BIOL, V8, P1331, DOI 10.1016/S0960-9822(07)00564-7; Rosen K, 2000, J CELL BIOL, V149, P447, DOI 10.1083/jcb.149.2.447; Rosen K, 2002, J BIOL CHEM, V277, P46123, DOI 10.1074/jbc.M207883200; Rosen K, 2001, J BIOL CHEM, V276, P37273, DOI 10.1074/jbc.M106424200; RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7; Rytomaa M, 2000, ONCOGENE, V19, P4461, DOI 10.1038/sj.onc.1203805; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scotlandi K, 2002, CANCER GENE THER, V9, P296, DOI 10.1038/sj.cgt.7700442; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wagner KW, 2004, J BIOL CHEM, V279, P35047, DOI 10.1074/jbc.M400708200; Yoo BH, 2010, J BIOL CHEM, V285, P5438, DOI 10.1074/jbc.M109.046789; Yoo NJ, 2004, APMIS, V112, P330; Zohrabian VM, 2007, ONCOL REP, V18, P321; Zouq NK, 2009, J CELL SCI, V122, P357, DOI 10.1242/jcs.030478	66	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38894	38903		10.1074/jbc.M111.290692	http://dx.doi.org/10.1074/jbc.M111.290692			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21903589	hybrid, Green Published			2022-12-25	WOS:000296759800008
J	Du, ZM; Liu, JJ; Albracht, CD; Hsu, A; Chen, W; Marieni, MD; Colelli, KM; Williams, JE; Reitter, JN; Mills, KV; Wang, CY				Du, Zhenming; Liu, Jiajing; Albracht, Clayton D.; Hsu, Alice; Chen, Wen; Marieni, Michelle D.; Colelli, Kathryn M.; Williams, Jennie E.; Reitter, Julie N.; Mills, Kenneth V.; Wang, Chunyu			Structural and Mutational Studies of a Hyperthermophilic Intein from DNA Polymerase II of Pyrococcus abyssi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODEL-FREE APPROACH; MAGNETIC-RESONANCE RELAXATION; CRYSTAL-STRUCTURE; HOMING ENDONUCLEASE; BACKBONE DYNAMICS; PROTEIN-STRUCTURE; VMA1-DERIVED ENDONUCLEASE; CHEMICAL-SHIFT; PEPTIDE-BOND; NMR	Protein splicing is a precise self-catalyzed process in which an intein excises itself from a precursor with the concomitant ligation of the flanking polypeptides (exteins). Protein splicing proceeds through a four-step reaction but the catalytic mechanism is not fully understood at the atomic level. We report the solution NMR structures of the hyperthermophilic Pyrococcus abyssi PolII intein, which has a noncanonical C-terminal glutamine instead of an asparagine. The NMR structures were determined to a backbone root mean square deviation of 0.46 angstrom and a heavy atom root mean square deviation of 0.93 angstrom. The Pab PolII intein has a common HINT (hedgehog intein) fold but contains an extra beta-hairpin that is unique in the structures of thermophilic inteins. The NMR structures also show that the Pab PolII intein has a long and disordered loop in place of an endonuclease domain. The N-terminal Cys-1 amide is hydrogen bonded to the Thr-90 hydroxyl in the conserved block-B TXXH motif and the Cys-1 thiol forms a hydrogen bond with the block F Ser-166. Mutating Thr-90 to Ala dramatically slows N-terminal cleavage, supporting its pivotal role in promoting the N-S acyl shift. Mutagenesis also showed that Thr-90 and His-93 are synergistic in catalyzing the N-S acyl shift. The block F Ser-166 plays an important role in coordinating the steps of protein splicing. NMR spin relaxation indicates that the Pab PolII intein is significantly more rigid than mesophilic inteins, which may contribute to the higher optimal temperature for protein splicing.	[Marieni, Michelle D.; Colelli, Kathryn M.; Williams, Jennie E.; Reitter, Julie N.; Mills, Kenneth V.] Coll Holy Cross, Dept Chem, Worcester, MA 01610 USA; [Du, Zhenming; Liu, Jiajing; Albracht, Clayton D.; Hsu, Alice; Chen, Wen; Wang, Chunyu] Rensselaer Polytech Inst, Dept Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	College of the Holy Cross; Rensselaer Polytechnic Institute	Mills, KV (corresponding author), Coll Holy Cross, Dept Chem, Worcester, MA 01610 USA.	kmills@holycross.edu; wangc5@rpi.edu	Wang, Chunyu/AAH-5952-2019; Chen, Wen/P-3663-2014	Wang, Chunyu/0000-0001-5165-7959	National Institutes of Health [GM081408]; National Science Foundation [0950245]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM081408 (to C. W.) and National Science Foundation Grant 0950245 (to K. V. M.).	Amitai G, 2004, J BIOL CHEM, V279, P3121, DOI 10.1074/jbc.M311343200; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Buskirk AR, 2004, P NATL ACAD SCI USA, V101, P10505, DOI 10.1073/pnas.0402762101; Butterwick JA, 2004, J MOL BIOL, V339, P855, DOI 10.1016/j.jmb.2004.03.055; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Du ZM, 2011, J AM CHEM SOC, V133, P10275, DOI 10.1021/ja203209f; Du ZM, 2010, J MOL BIOL, V400, P755, DOI 10.1016/j.jmb.2010.05.044; Du ZM, 2009, J AM CHEM SOC, V131, P11581, DOI 10.1021/ja904318w; Duan XQ, 1997, CELL, V89, P555, DOI 10.1016/S0092-8674(00)80237-8; ERAUSO G, 1993, ARCH MICROBIOL, V160, P338; Evans TC, 1999, J BIOL CHEM, V274, P18359, DOI 10.1074/jbc.274.26.18359; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Frutos S, 2010, NAT CHEM BIOL, V6, P527, DOI [10.1038/NCHEMBIO.371, 10.1038/nchembio.371]; Goodman JL, 2000, J MOL BIOL, V295, P963, DOI 10.1006/jmbi.1999.3419; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu DL, 2000, J BIOL CHEM, V275, P2705, DOI 10.1074/jbc.275.4.2705; Ichiyanagi K, 2000, J MOL BIOL, V300, P889, DOI 10.1006/jmbi.2000.3873; Johnson MA, 2007, PROTEIN SCI, V16, P1316, DOI 10.1110/ps.072816707; Klabunde T, 1998, NAT STRUCT BIOL, V5, P31, DOI 10.1038/nsb0198-31; Kwon Y, 2006, ANGEW CHEM INT EDIT, V45, P1726, DOI 10.1002/anie.200503475; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu J., 2011, BIOMOL NMR ASSIGN; Matsumura H, 2006, PROTEINS, V63, P711, DOI 10.1002/prot.20858; Mills KV, 2004, J BIOL CHEM, V279, P20685, DOI 10.1074/jbc.M400887200; Mizutani R, 2004, J SYNCHROTRON RADIAT, V11, P109, DOI 10.1107/S0909049503023495; Mizutani R, 2002, J MOL BIOL, V316, P919, DOI 10.1006/jmbi.2001.5357; Mootz HD, 2003, J AM CHEM SOC, V125, P10561, DOI 10.1021/ja0362813; Moure CM, 2002, NAT STRUCT BIOL, V9, P764, DOI 10.1038/nsb840; Oeemig JS, 2009, FEBS LETT, V583, P1451, DOI 10.1016/j.febslet.2009.03.058; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Palmer AG, 2001, ANNU REV BIOPH BIOM, V30, P129, DOI 10.1146/annurev.biophys.30.1.129; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Paulus H, 1998, CHEM SOC REV, V27, P375, DOI 10.1039/a827375z; Paulus H, 2007, DRUG FUTURE, V32, P973, DOI 10.1358/dof.2007.032.11.1140690; Pereira B, 2011, J MOL BIOL, V406, P430, DOI 10.1016/j.jmb.2010.12.024; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Pietrokovski S, 1998, CURR BIOL, V8, pR634, DOI 10.1016/S0960-9822(07)00409-5; Poland BW, 2000, J BIOL CHEM, V275, P16408, DOI 10.1074/jbc.275.22.16408; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Romanelli A, 2004, P NATL ACAD SCI USA, V101, P6397, DOI 10.1073/pnas.0306616101; Saleh L, 2006, CHEM REC, V6, P183, DOI 10.1002/tcr.20082; Savard PY, 2006, BIOCHEMISTRY-US, V45, P11414, DOI 10.1021/bi060414q; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Seyedsayamdost MR, 2006, J AM CHEM SOC, V128, P1562, DOI 10.1021/ja055927j; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sun P, 2005, J MOL BIOL, V353, P1093, DOI 10.1016/j.jmb.2005.09.039; Tyszkiewicz AB, 2008, NAT METHODS, V5, P303, DOI [10.1038/nmeth.1189, 10.1038/NMETH.1189]; Van Roey P, 2007, J MOL BIOL, V367, P162, DOI 10.1016/j.jmb.2006.12.050; Werner E, 2002, NUCLEIC ACIDS RES, V30, P3962, DOI 10.1093/nar/gkf523; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wood DW, 2000, BIOTECHNOL PROGR, V16, P1055, DOI 10.1021/bp0000858; Wood DW, 1999, NAT BIOTECHNOL, V17, P889, DOI 10.1038/12879; Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979; Zuger S, 2005, NAT BIOTECHNOL, V23, P736, DOI 10.1038/nbt1097	62	21	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38638	38648		10.1074/jbc.M111.290569	http://dx.doi.org/10.1074/jbc.M111.290569			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914805	hybrid, Green Published			2022-12-25	WOS:000296594200076
J	Rapley, J; Oshiro, N; Ortiz-Vega, S; Avruch, J				Rapley, Joseph; Oshiro, Noriko; Ortiz-Vega, Sara; Avruch, Joseph			The Mechanism of Insulin-stimulated 4E-BP Protein Binding to Mammalian Target of Rapamycin (mTOR) Complex 1 and Its Contribution to mTOR Complex 1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH AKT SUBSTRATE; AMINO-ACID SUFFICIENCY; P70 S6 KINASE; 40 KDA PRAS40; CELL-GROWTH; DISTINCT ROLES; RAG GTPASES; TOS MOTIF; IN-VITRO; RAPTOR	Insulin activation of mTOR complex 1 is accompanied by enhanced binding of substrates. We examined the mechanism and contribution of this enhancement to insulin activation of mTORC1 signaling in 293E and HeLa cells. In 293E, insulin increased the amount of mTORC1 retrieved by the transiently expressed nonphosphorylatable 4E-BP[5A] to an extent that varied inversely with the amount of PRAS40 bound to mTORC1. RNAi depletion of PRAS40 enhanced 4E-BP[5A] binding to similar to 70% the extent of maximal insulin, and PRAS40 RNAi and insulin together did not increase 4E-BP[5A] binding beyond insulin alone, suggesting that removal of PRAS40 from mTORC1 is the predominant mechanism of an insulin-induced increase in substrate access. As regards the role of increased substrate access in mTORC1 signaling, RNAi depletion of PRAS40, although increasing 4E-BP[5A] binding, did not stimulate phosphorylation of endogenous mTORC1 substrates S6K1(Thr(389)) or 4E-BP (Thr(37)/Thr(46)), the latter already similar to 70% of maximal in amino acid replete, serum-deprived 293E cells. In HeLa cells, insulin and PRAS40 RNAi also both enhanced the binding of 4E-BP[5A] to raptor but only insulin stimulated S6K1 and 4E-BP phosphorylation. Furthermore, Rheb overexpression in 293E activated mTORC1 signaling completely without causing PRAS40 release. In the presence of Rheb and insulin, PRAS40 release is abolished by Akt inhibition without diminishing mTORC1 signaling. In conclusion, dissociation of PRAS40 from mTORC1 and enhanced mTORC1 substrate binding results from Akt and mTORC1 activation and makes little or no contribution to mTORC1 signaling, which rather is determined by Rheb activation of mTOR catalytic activity, through mechanisms that remain to be fully elucidated.	[Avruch, Joseph] Massachusetts Gen Hosp, Diabet Res Lab, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Med Serv, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Avruch, J (corresponding author), Massachusetts Gen Hosp, Diabet Res Lab, Dept Mol Biol, Simches Res Bldg 6408,185 Cambridge St, Boston, MA 02114 USA.	avruch@molbio.mgh.harvard.edu			National Institutes of Health [DK17776, CA73818]; NATIONAL CANCER INSTITUTE [R01CA073818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK017776, R37DK017776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK17776 and CA73818.	Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Beugnet A, 2003, J BIOL CHEM, V278, P40717, DOI 10.1074/jbc.M308573200; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Choi KM, 2003, J BIOL CHEM, V278, P19667, DOI 10.1074/jbc.M301142200; Fonseca BD, 2008, BIOCHEM J, V411, P141, DOI 10.1042/BJ20071001; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Gwinn DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009197; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hong-Brown LQ, 2010, J CELL BIOCHEM, V109, P1172, DOI 10.1002/jcb.22496; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Ramirez-Valle F, 2010, MOL CELL BIOL, V30, P3151, DOI 10.1128/MCB.00322-09; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Sun YT, 2008, CELL CYCLE, V7, P3118, DOI 10.4161/cc.7.20.6881; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Wang L, 2009, J BIOL CHEM, V284, P14693, DOI 10.1074/jbc.C109.002907; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	42	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38043	38053		10.1074/jbc.M111.245449	http://dx.doi.org/10.1074/jbc.M111.245449			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914810	Green Published, hybrid			2022-12-25	WOS:000296594200016
J	Raj, A; Chen, YH				Raj, Ashish; Chen, Yu-hsien			The Wiring Economy Principle: Connectivity Determines Anatomy in the Human Brain	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MRI; CORTICAL AREAS; NERVOUS-SYSTEM; GRAPH-THEORY; COMPLEXITY; NETWORKS; INTERNEURONS; NEUROANATOMY; OPTIMIZATION; DIVERSITY	Minimization of the wiring cost of white matter fibers in the human brain appears to be an organizational principle. We investigate this aspect in the human brain using whole brain connectivity networks extracted from high resolution diffusion MRI data of 14 normal volunteers. We specifically address the question of whether brain anatomy determines its connectivity or vice versa. Unlike previous studies we use weighted networks, where connections between cortical nodes are real-valued rather than binary off-on connections. In one set of analyses we found that the connectivity structure of the brain has near optimal wiring cost compared to random networks with the same number of edges, degree distribution and edge weight distribution. A specifically designed minimization routine could not find cheaper wiring without significantly degrading network performance. In another set of analyses we kept the observed brain network topology and connectivity but allowed nodes to freely move on a 3D manifold topologically identical to the brain. An efficient minimization routine was written to find the lowest wiring cost configuration. We found that beginning from any random configuration, the nodes invariably arrange themselves in a configuration with a striking resemblance to the brain. This confirms the widely held but poorly tested claim that wiring economy is a driving principle of the brain. Intriguingly, our results also suggest that the brain mainly optimizes for the most desirable network connectivity, and the observed brain anatomy is merely a result of this optimization.	[Raj, Ashish] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Chen, Yu-hsien] Cornell Univ, Dept Comp Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Raj, A (corresponding author), Weill Cornell Med Coll, Dept Radiol, New York, NY USA.	asr2004@med.cornell.edu			National Institutes of Health [R21 EB008138-02, P41 RR023953-02, P41 RR023953-02S1]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	AR was partially supported by grant numbers R21 EB008138-02, P41 RR023953-02 and P41 RR023953-02S1 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Aleman-Gomez Y., 2006, 12 ANN M ORG HUM BRA; Allman J. M., 1998, EVOLVING BRAINS; Bassett DS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000748; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; Friston K. J., 2003, STAT PARAMETRIC MAPP; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HALL KM, 1970, MANAGE SCI, V17, P219, DOI 10.1287/mnsc.17.3.219; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; IVKOVIC M, 2010, PLOS COMPUT S UNPUB; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Klyachko VA, 2003, P NATL ACAD SCI USA, V100, P7937, DOI 10.1073/pnas.0932745100; Koch C, 1999, SCIENCE, V284, P96, DOI 10.1126/science.284.5411.96; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Ojala M, 2009, STAT ANAL DATA MIN, V2, P209, DOI [10.1002/sam.10042, DOI 10.1002/SAM.10042]; POWELL MJD, 1983, VARIABLE METRIC METH, P288; Sarpeshkar R, 1998, NEURAL COMPUT, V10, P1601, DOI 10.1162/089976698300017052; SCHMAHMANN JD, 2006, FIBER PATHWAYS BRAIN, P420; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2000, NEURAL NETWORKS, V13, P909, DOI 10.1016/S0893-6080(00)00053-8; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wen Q, 2005, PLOS COMPUT BIOL, V1, P617, DOI 10.1371/journal.pcbi.0010078	31	49	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e14832	10.1371/journal.pone.0014832	http://dx.doi.org/10.1371/journal.pone.0014832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915250	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802500002
J	Anchoori, RK; Khan, SR; Sueblinvong, T; Felthauser, A; Iizuka, Y; Gavioli, R; Destro, F; Vogel, RI; Peng, SW; Roden, RBS; Bazzaro, M				Anchoori, Ravi K.; Khan, Saeed R.; Sueblinvong, Thanasak; Felthauser, Alicia; Iizuka, Yoshie; Gavioli, Riccardo; Destro, Federica; Vogel, Rachel Isaksson; Peng, Shiwen; Roden, Richard B. S.; Bazzaro, Martina			Stressing the Ubiquitin-Proteasome System without 20S Proteolytic Inhibition Selectively Kills Cervical Cancer Cells	PLOS ONE			English	Article							GREEN TEA POLYPHENOLS; OVARIAN-CANCER; BORTEZOMIB; APOPTOSIS; PROSTAGLANDINS; DEGRADATION; EXPRESSION; RECEPTOR; SUBUNIT; GROWTH	Cervical cancer cells exhibit an increased requirement for ubiquitin-dependent protein degradation associated with an elevated metabolic turnover rate, and for specific signaling pathways, notably HPV E6-targeted degradation of p53 and PDZ proteins. Natural compounds with antioxidant properties including flavonoids and triterpenoids hold promise as anticancer agents by interfering with ubiquitin-dependent protein degradation. An increasing body of evidence indicates that their alpha-beta unsaturated carbonyl system is the molecular determinant for inhibition of ubiquitin-mediated protein degradation upstream of the catalytic sites of the 20S proteasome. Herein we report the identification and characterization of a new class of chalcone-based, potent and cell permeable chemical inhibitors of ubiquitin-dependent protein degradation, and a lead compound RAMB1. RAMB1 inhibits ubiquitin-dependent protein degradation without compromising the catalytic activities of the 20S proteasome, a mechanism distinct from that of Bortezomib. Treatment of cervical cancer cells with RAMB1 triggers unfolded protein responses, including aggresome formation and Hsp90 stabilization, and increases p53 steady state levels. RAMB1 treatment results in activation of lysosomal-dependent degradation pathways as a mechanism to compensate for increasing levels of poly-ubiquitin enriched toxic aggregates. Importantly, RAMB1 synergistically triggers cell death of cervical cancer cells when combined with the lysosome inhibitor Chloroquine.	[Anchoori, Ravi K.; Roden, Richard B. S.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA; [Anchoori, Ravi K.; Khan, Saeed R.; Peng, Shiwen; Roden, Richard B. S.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Gavioli, Riccardo; Destro, Federica] Univ Ferrara, Dept Biochem & Mol Biol, I-44100 Ferrara, Italy; [Khan, Saeed R.] US FDA, CDER, Div Prod Qual Res, Silver Spring, MD USA; [Sueblinvong, Thanasak; Felthauser, Alicia; Iizuka, Yoshie; Vogel, Rachel Isaksson; Bazzaro, Martina] Univ Minnesota Twin Cities, Masonic Canc Ctr, Minneapolis, MN USA; [Sueblinvong, Thanasak; Felthauser, Alicia; Iizuka, Yoshie; Vogel, Rachel Isaksson; Bazzaro, Martina] Univ Minnesota Twin Cities, Dept Obstet Gynecol & Womens Heath, Minneapolis, MN USA; [Roden, Richard B. S.] Johns Hopkins Univ, Dept Gynecol & Obstet, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; University of Ferrara; US Food & Drug Administration (FDA); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University	Anchoori, RK (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA.	mbazzaro@umn.edu	Gavioli, Riccardo/K-7594-2016; Destro, Federica/K-5904-2016	Gavioli, Riccardo/0000-0002-7805-4290; Destro, Federica/0000-0002-3014-0165; Vogel, Rachel/0000-0003-0149-8464	National Institutes of Health ATIP; SPORE in Cervical Cancer [P50 CA098252]; HERA foundation (Health, Empowerment, Research, and Awareness); Department of Defense [OC093424]; NATIONAL CANCER INSTITUTE [P50CA098252] Funding Source: NIH RePORTER	National Institutes of Health ATIP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPORE in Cervical Cancer; HERA foundation (Health, Empowerment, Research, and Awareness); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health ATIP and SPORE in Cervical Cancer P50 CA098252 to SRK, RKA and RBSR and HERA foundation (Health, Empowerment, Research, and Awareness) and Department of Defense Ovarian Cancer Research Program (OCRP) OC093424 to MB. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Achanta G, 2006, MOL PHARMACOL, V70, P426, DOI 10.1124/mol.105.021311; Baldisserotto A, 2009, BIOORGAN MED CHEM, V17, P5535, DOI 10.1016/j.bmc.2009.06.025; Bazzaro M, 2006, CANCER RES, V66, P3754, DOI 10.1158/0008-5472.CAN-05-2321; Bazzaro M, 2008, CLIN CANCER RES, V14, P7340, DOI 10.1158/1078-0432.CCR-08-0642; Bazzaro M, 2011, J MED CHEM, V54, P449, DOI 10.1021/jm100589p; Belguise K, 2007, CANCER RES, V67, P11742, DOI 10.1158/0008-5472.CAN-07-2730; Belguise K, 2007, CANCER RES, V67, P5763, DOI 10.1158/0008-5472.CAN-06-4327; Bisht S, 2010, MOL CANCER THER, V9, P2255, DOI 10.1158/1535-7163.MCT-10-0172; Bjorklund M, 2011, CANCER CHEMOTH PHARM, V68, P1459, DOI 10.1007/s00280-011-1640-x; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Colland F, 2010, BIOCHEM SOC T, V38, P137, DOI 10.1042/BST0380137; Daviet L, 2008, BIOCHIMIE, V90, P270, DOI 10.1016/j.biochi.2007.09.013; Driscoll JJ, 2010, TARGET ONCOL, V5, P281, DOI 10.1007/s11523-010-0165-2; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Ganapathy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015627; HAWLEYNELSON P, 1989, EMBO J, V8, P3905, DOI 10.1002/j.1460-2075.1989.tb08570.x; Hengstermann A, 2001, P NATL ACAD SCI USA, V98, P1218, DOI 10.1073/pnas.031470698; Horner SM, 2004, J VIROL, V78, P4063, DOI 10.1128/JVI.78.8.4063-4073.2004; Jing H, 2010, CANCER LETT, V294, P167, DOI 10.1016/j.canlet.2010.01.035; Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636; Lee JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011051; Lin ZH, 2009, CLIN CANCER RES, V15, P570, DOI 10.1158/1078-0432.CCR-08-1813; Luker GD, 2003, NAT MED, V9, P969, DOI 10.1038/nm894; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; Milacic V, 2008, CANCER RES, V68, P7283, DOI 10.1158/0008-5472.CAN-07-6246; Mullally JE, 2001, J BIOL CHEM, V276, P30366, DOI 10.1074/jbc.M102198200; Nawrocki ST, 2006, CANCER RES, V66, P3773, DOI 10.1158/0008-5472.CAN-05-2961; O'Sullivan-Coyne G, 2009, BRIT J CANCER, V101, P1585, DOI 10.1038/sj.bjc.6605308; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Rolen U, 2006, MOL CARCINOGEN, V45, P260, DOI 10.1002/mc.20177; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sun Y, 2006, NEOPLASIA, V8, P645, DOI 10.1593/neo.06376; Verbitski SM, 2004, J MED CHEM, V47, P2062, DOI 10.1021/jm030448l; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Xiao XY, 2011, CANCER LETT, V302, P69, DOI 10.1016/j.canlet.2010.12.016; Yang H, 2008, CURR PROTEIN PEPT SC, V9, P227, DOI 10.2174/138920308784533998; Yang H, 2011, CURR CANCER DRUG TAR, V11, P296, DOI 10.2174/156800911794519743; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529	41	35	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23888	10.1371/journal.pone.0023888	http://dx.doi.org/10.1371/journal.pone.0023888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909374	Green Submitted, Green Published, gold			2022-12-25	WOS:000294680800036
J	Dobrin, R; Greenawalt, DM; Hu, GH; Kemp, DM; Kaplan, LM; Schadt, EE; Emilsson, V				Dobrin, Radu; Greenawalt, Danielle M.; Hu, Guanghui; Kemp, Daniel M.; Kaplan, Lee M.; Schadt, Eric E.; Emilsson, Valur			Dissecting Cis Regulation of Gene Expression in Human Metabolic Tissues	PLOS ONE			English	Article							VARIANTS; RISK; ASSOCIATION; CANCER	Complex diseases such as obesity and type II diabetes can result from a failure in multiple organ systems including the central nervous system and tissues involved in partitioning and disposal of nutrients. Studying the genetics of gene expression in tissues that are involved in the development of these diseases can provide insights into how these tissues interact within the context of disease. Expression quantitative trait locus (eQTL) studies identify mRNA expression changes linked to proximal genetic signals (cis eQTLs) that have been shown to affect disease. Given the high impact of recent eQTL studies, it is important to understand what role sample size and environment plays in identification of cis eQTLs. Here we show in a genotyped obese human population that the number of cis eQTLs obey precise scaling laws as a function of sample size in three profiled tissues, i.e. omental adipose, subcutaneous adipose and liver. Also, we show that genes (or transcripts) with cis eQTL associations detected in a small population are detected at approximately 90% rate in the largest population available for our study, indicating that genes with strong cis acting regulatory elements can be identified with relatively high confidence in smaller populations. However, by increasing the sample size we allow for better detection of weaker and more distantly located cis-regulatory elements. Yet, we determined that the number of tissue specific cis eQTLs saturates in a modestly sized cohort while the number of cis eQTLs common to all tissues fails to reach a maximum value. Understanding the power laws that govern the number and specificity of eQTLs detected in different tissues, will allow a better utilization of genetics of gene expression to inform the molecular mechanism underlying complex disease traits.	[Dobrin, Radu; Hu, Guanghui; Kemp, Daniel M.] Merck Res Labs, Rahway, NJ USA; [Greenawalt, Danielle M.] Merck Res Labs, Boston, MA USA; [Kaplan, Lee M.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Schadt, Eric E.] Pacific Biosci, Menlo Pk, CA USA; [Emilsson, Valur] Iceland Heart Assoc, Kopavogur, Iceland	Merck & Company; Merck & Company; Harvard University; Massachusetts General Hospital; Icelandic Heart Association	Dobrin, R (corresponding author), Johnson & Johnson Pharmaceut Res & Dev, Radnor, PA 19087 USA.	r.dobrin@gmail.com		Emilsson, Valur/0000-0001-9982-0524; Dobrin, Radu/0000-0002-3336-0091	Merck Co., Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Merck Co., Inc.(Merck & Company); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by Merck & Co., Inc. which employed several of the authors responsible for study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Dahlman I, 2010, BRIT J CANCER, V102, P1541, DOI 10.1038/sj.bjc.6605665; Davis DB, 2010, MOL ENDOCRINOL; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Langeveld M, 2009, PROG LIPID RES, V48, P196, DOI 10.1016/j.plipres.2009.03.002; Li YF, 2010, LANCET ONCOL, V11, P321, DOI 10.1016/S1470-2045(10)70042-5; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; van Nas A, 2010, GENETICS, V185, P1059, DOI 10.1534/genetics.110.116087; Vergeer M, 2010, CIRCULATION, V122, P470, DOI 10.1161/CIRCULATIONAHA.109.912519; Vinuela A, 2010, GENOME RES, V20, P929, DOI 10.1101/gr.102160.109; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	24	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23480	10.1371/journal.pone.0023480	http://dx.doi.org/10.1371/journal.pone.0023480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21912597	Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800012
J	Diez-Padrisa, N; Aguilar, R; Machevo, S; Morais, L; Nhampossa, T; O'Callaghan-Gordo, C; Nhalungo, D; Menendez, C; Roca, A; Alonso, PL; Bassat, Q				Diez-Padrisa, Nuria; Aguilar, Ruth; Machevo, Sonia; Morais, Luis; Nhampossa, Tacilta; O'Callaghan-Gordo, Cristina; Nhalungo, Delino; Menendez, Clara; Roca, Anna; Alonso, Pedro L.; Bassat, Quique			Erythropoietin Levels Are Not Independently Associated with Malaria-Attributable Severe Disease in Mozambican Children	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; C-REACTIVE PROTEIN; TUMOR-NECROSIS-FACTOR; RURAL MOZAMBIQUE; AFRICAN CHILDREN; SEVERE ANEMIA; BACTERIAL-MENINGITIS; MANHICA DISTRICT; CONTROLLED-TRIAL; CHILDHOOD	Background: Severe malaria is difficult to differentiate from other forms of malaria or other infections with similar symptoms. Any parameter associated to malaria-attributable severe disease could help to improve severe malaria diagnosis. Methodology: This study assessed the relation between erythropoietin (EPO) and malaria-attributable severe disease in an area of Mozambique with moderate malaria transmission. 211 children <5 years, recruited at Manhica District Hospital or in the surrounding villages, were included in one of the following groups: severe malaria (SM, n = 44), hospital malaria without severity (HM, n = 49), uncomplicated malaria (UM, n = 47), invasive bacterial infection without malaria parasites (IBI, n = 39) and healthy community controls (C, n = 32). Malaria was diagnosed by microscopy and IBI by blood/cerebrospinal fluid culture. Principal Findings: Mean EPO concentration in the control group was 20.95 U/l (SD = 2.96 U/l). Values in this group were lower when compared to each of the clinical groups (p = 0.026 C versus UM, p<0.001 C vs HM, p<0.001 C vs SM and p<0.001 C vs IBI). In the 3 malaria groups, values increased with severity [mean = 40.82 U/l (SD = 4.07 U/l), 125.91 U/l (SD = 4.99U/l) and 320.87 U/l (SD = 5.91U/l) for UM, HM and SM, respectively, p<0.001]. The IBI group [mean = 101.75 U/l (SD = 4.12 U/l)] presented lower values than the SM one (p = 0.002). In spite of the differences, values overlapped between study groups and EPO levels were only associated to hemoglobin. Hemoglobin means of the clinical groups were 93.98 g/dl (SD = 14.77 g/dl) for UM, 75.96 g/dl (SD = 16.48 g/dl) for HM, 64.34 g/dl (SD = 22.99 g/dl) for SM and 75.67 g/dl (SD = 16.58 g/dl) for IBI. Conclusions: Although EPO levels increase according to malaria severity and are higher in severe malaria than in bacteremia, the utility of EPO to distinguish malaria-attributable severe disease is limited due to the overlap of values between the study groups and the main role of hemoglobin in the expression of EPO.	[Diez-Padrisa, Nuria; Aguilar, Ruth; O'Callaghan-Gordo, Cristina; Menendez, Clara; Roca, Anna; Alonso, Pedro L.; Bassat, Quique] Univ Barcelona, Hosp Clin, Ctr Recerca & Salut Int Barcelona, Barcelona, Spain; [Diez-Padrisa, Nuria; Machevo, Sonia; Morais, Luis; Nhampossa, Tacilta; O'Callaghan-Gordo, Cristina; Nhalungo, Delino; Menendez, Clara; Roca, Anna; Alonso, Pedro L.; Bassat, Quique] Ctr Invest Saude Manhica, Manhica, Mozambique; [Aguilar, Ruth; Bassat, Quique] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Machevo, Sonia] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique; [Nhampossa, Tacilta] Minist Saude, Inst Nacl Saude, Maputo, Mozambique	University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Eduardo Mondlane University	Diez-Padrisa, N (corresponding author), Univ Barcelona, Hosp Clin, Ctr Recerca & Salut Int Barcelona, Barcelona, Spain.	quique.bassat@cresib.cat	Bassat, Quique/P-2341-2016; Menéndez, Clara/Q-3446-2016; Alonso, Pedro L/AAZ-3645-2020; Diez-Padrisa, Nuria/AAE-1000-2020; Aguilar, Ruth/D-2147-2018	Bassat, Quique/0000-0003-0875-7596; Menéndez, Clara/0000-0002-2641-6907; Alonso, Pedro L/0000-0003-3292-3443; Aguilar, Ruth/0000-0003-3277-3107; O'Callaghan-Gordo, Cristina/0000-0002-4229-2991	Bill and Melinda Gates Foundation [45 452]; Spanish Agency of International Cooperation; Spanish Ministry of Science and Innovation [FIS: CM05/00134]; Ramon y Cajal [RYC-2008-02777]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Spanish Agency of International Cooperation(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ramon y Cajal(Spanish Government)	This study was supported by a grant from the Bill and Melinda Gates Foundation (45 452, http://www.gatesfoundation.org/Pages/home.aspx). The CISM receives major core funding from the Spanish Agency of International Cooperation (http://www.micinn.es/portal/site/MICINN/). QB and AR were supported during the time of the study by grants from the Spanish Ministry of Science and Innovation (FIS: CM05/00134 and Ramon y Cajal: RYC-2008-02777, respectively; http://www.micinn.es/portal/site/MICINN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Bassat Q, 2009, TROP MED INT HEALTH, V14, P1011, DOI 10.1111/j.1365-3156.2009.02326.x; Bassat Q, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-37; Bejon P, 2007, PLOS MED, V4, P1333, DOI 10.1371/journal.pmed.0040251; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; BURCHARD GD, 1995, AM J TROP MED HYG, V53, P547, DOI 10.4269/ajtmh.1995.53.547; Carnot P, 1906, CR HEBD ACAD SCI, V143, P384; Casals-Pascual C, 2006, BLOOD, V108, P2569, DOI 10.1182/blood-2006-05-018697; CLARK IA, 1988, BRIT J HAEMATOL, V70, P99, DOI 10.1111/j.1365-2141.1988.tb02440.x; Day NPJ, 2000, CRIT CARE MED, V28, P1833, DOI 10.1097/00003246-200006000-00025; Dhaliwal G, 2004, AM FAM PHYSICIAN, V69, P2599; Dondorp AM, 2002, T ROY SOC TROP MED H, V96, P282, DOI 10.1016/S0035-9203(02)90100-8; DRAPIER JC, 1988, J IMMUNOL, V140, P2829; English M, 1996, T ROY SOC TROP MED H, V90, P658, DOI 10.1016/S0035-9203(96)90423-X; English M, 1997, QJM-MON J ASSOC PHYS, V90, P563, DOI 10.1093/qjmed/90.9.563; English M, 1997, QJM-INT J MED, V90, P263, DOI 10.1093/qjmed/90.4.263; Giha HA, 2009, EUR J CLIN MICROBIOL, V28, P661, DOI 10.1007/s10096-008-0665-5; Guinovart C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-36; Gwer S, 2007, AM J TROP MED HYG, V77, P6, DOI 10.4269/ajtmh.2007.77.6; HURT N, 1994, T ROY SOC TROP MED H, V88, P182, DOI 10.1016/0035-9203(94)90287-9; HURT N, 1994, CLIN DIAGN LAB IMMUN, V1, P437, DOI 10.1128/CDLI.1.4.437-444.1994; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; Koram KA, 2007, AM J TROP MED HYG, V77, P1; Koury MJ, 2005, EXP HEMATOL, V33, P1263, DOI 10.1016/j.exphem.2005.06.031; Kurtzhals JAL, 1997, BRIT J HAEMATOL, V97, P169, DOI 10.1046/j.1365-2141.1997.82654.x; Maiese K, 2005, JAMA-J AM MED ASSOC, V293, P90, DOI 10.1001/jama.293.1.90; Maiese K, 2008, CURR NEUROVASC RES, V5, P125, DOI 10.2174/156720208784310231; Maiese K, 2008, CYTOKINE GROWTH F R, V19, P145, DOI 10.1016/j.cytogfr.2008.01.004; Maitland K, 2004, ACTA TROP, V90, P131, DOI 10.1016/j.actatropica.2003.11.010; Marsh K, 1996, ANN TROP MED PARASIT, V90, P395, DOI 10.1080/00034983.1996.11813068; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; McGuire W, 1996, T ROY SOC TROP MED H, V90, P10, DOI 10.1016/S0035-9203(96)90461-7; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Naniche D, 2009, AM J TROP MED HYG, V80, P870, DOI 10.4269/ajtmh.2009.80.870; Newton CRJC, 1997, TROP MED INT HEALTH, V2, P165, DOI 10.1046/j.1365-3156.1997.d01-238.x; Nhacolo AQ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-291; Nussenblatt V, 2001, CLIN DIAGN LAB IMMUN, V8, P1164, DOI 10.1128/CDLI.8.6.1164-1170.2001; O'Donnell A, 2007, P NATL ACAD SCI USA, V104, P9440, DOI 10.1073/pnas.0703424104; PHILLIPS RE, 1986, Q J MED, V58, P305; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Roca A, 2009, CLIN INFECT DIS, V48, pS172, DOI 10.1086/596497; Roca A, 2006, TROP MED INT HEALTH, V11, P1422, DOI 10.1111/j.1365-3156.2006.01697.x; Saute F, 2003, T ROY SOC TROP MED H, V97, P661, DOI 10.1016/S0035-9203(03)80098-6; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Valles X, 2006, TROP MED INT HEALTH, V11, P358, DOI 10.1111/j.1365-3156.2006.01565.x	47	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24090	10.1371/journal.pone.0024090	http://dx.doi.org/10.1371/journal.pone.0024090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912616	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000294678300021
J	Felix, RC; Silveira, H				Felix, Rute C.; Silveira, Henrique			The Interplay between Tubulins and P450 Cytochromes during Plasmodium berghei Invasion of Anopheles gambiae Midgut	PLOS ONE			English	Article							HUMAN HEPATOCYTES; EXPRESSION; GENE; MICROTUBULES; MICROARRAY; INDUCTION; RESPONSES; STRAIN	Background: Plasmodium infection increases the oxidative stress inside the mosquito, leading to a significant alteration on transcription of Anopheles gambiae detoxification genes. Among these detoxification genes several P450 cytochromes and tubulins were differently expressed, suggesting their involvement in the mosquito's response to parasite invasion. P450 cytochromes are usually involved in the metabolism and detoxification of several compounds, but are also regulated by several pathogens, including malaria parasite. Tubulins are extremely important as components of the cytoskeleton, which rearrangement functions as a response to malaria parasite invasion. Methodology/Principal Findings: Gene silencing methods were used to uncover the effects of cytochrome P450 reductase, tubulinA and tubulinB silencing on the A. gambiae response to Plasmodium berghei invasion. The role of tubulins in counter infection processes was also investigated by inhibiting their effect. Colchicine, vinblastine and paclitaxel, three different tubulin inhibitors were injected into A. gambiae mosquitoes. Twenty-four hours post injection these mosquitoes were infected with P. berghei through a blood meal from infected CD1 mice. Cytochrome P450 gene expression was measured using RT-qPCR to detect differences in cytochrome expression between silenced, inhibited and control mosquitoes. Results showed that cytochrome P450 reductase silencing, as well as tubulin (A and B) silencing and inhibition affected the efficiency of Plasmodium infection. Silencing and inhibition also affected the expression levels of cytochromes P450. Conclusions: Our results suggest the existence of a relationship between tubulins and P450 cytochromes during A. gambiae immune response to P. berghei invasion. One of the P450 cytochromes in this study, CYP6Z2, stands out as the potential link in this association. Further work is needed to fully understand the role of tubulin genes in the response to Plasmodium infection.	[Felix, Rute C.; Silveira, Henrique] Univ Nova Lisboa, Inst Higiene & Med Trop, Ctr Malaria & Outras Doencas Trop, UEI Parasitol Med, P-1200 Lisbon, Portugal	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Felix, RC (corresponding author), Univ Nova Lisboa, Inst Higiene & Med Trop, Ctr Malaria & Outras Doencas Trop, UEI Parasitol Med, P-1200 Lisbon, Portugal.	rfelix@ihmt.unl.pt; hsilveira@ihmt.unl.pt	Silveira, Henrique/G-2229-2011; Félix, Rute/AAC-2912-2020; Félix, Rute C/M-6164-2013; Silveira, Henrique/AAB-4948-2022	Silveira, Henrique/0000-0002-7939-772X; Félix, Rute/0000-0002-4144-3452; Félix, Rute C/0000-0002-4144-3452; Silveira, Henrique/0000-0002-7939-772X	Fundacao para a Ciencia e Tecnologia [SFRH/BD/28024/2006];  [PTDC/SAU-MII/102596/2008]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); 	This work was supported by a Fundacao para a Ciencia e Tecnologia (www.fct.mctes.pt) grant to RCF (SFRH/BD/28024/2006) and research funds from project PTDC/SAU-MII/102596/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002587; Bell A, 1998, PARASITOL TODAY, V14, P234, DOI 10.1016/S0169-4758(98)01246-0; Chiu TL, 2008, P NATL ACAD SCI USA, V105, P8855, DOI 10.1073/pnas.0709249105; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dvorak Z, 2005, CURR DRUG METAB, V6, P545, DOI 10.2174/138920005774832623; Dvorak Z, 2003, MOL PHARMACOL, V64, P160, DOI 10.1124/mol.64.1.160; Felix RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-312; Fennell BJ, 2008, EXPERT OPIN DRUG DIS, V3, P501, DOI 10.1517/17460441.3.5.501; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Guengerich F Peter, 2003, Mol Interv, V3, P194, DOI 10.1124/mi.3.4.194; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; Marinotti O, 2005, INSECT MOL BIOL, V14, P365, DOI 10.1111/j.1365-2583.2005.00567.x; Modriansky Martin, 2005, Biomedical Papers (Olomouc), V149, P213; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; Nikou D, 2003, GENE, V318, P91, DOI 10.1016/S0378-1119(03)00763-7; Oviedo MN, 2008, INSECT MOL BIOL, V17, P61, DOI 10.1111/j.1365-2583.2008.00779.x; Poupardin R, 2010, INSECT MOL BIOL, V19, P185, DOI 10.1111/j.1365-2583.2009.00967.x; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Sodja A, 2007, J INSECT PHYSIOL, V53, P833, DOI 10.1016/j.jinsphys.2007.03.017; Stephens RE, 1997, MOL BIOL CELL, V8, P2187, DOI 10.1091/mbc.8.11.2187; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Vorobjev IA, 1999, J CELL SCI, V112, P2277; Vrzal R, 2008, EUR J PHARMACOL, V581, P244, DOI 10.1016/j.ejphar.2007.11.059	28	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24181	10.1371/journal.pone.0024181	http://dx.doi.org/10.1371/journal.pone.0024181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912622	Green Published, Green Submitted, gold			2022-12-25	WOS:000294678300027
J	Johnson, MB; Lafferty, KD; van Oosterhout, C; Cable, J				Johnson, Mirelle B.; Lafferty, Kevin D.; van Oosterhout, Cock; Cable, Joanne			Parasite Transmission in Social Interacting Hosts: Monogenean Epidemics in Guppies	PLOS ONE			English	Article							POECILIA-RETICULATA PISCES; TRINIDADIAN GUPPY; POPULATION-DYNAMICS; GYRODACTYLID INFECTIONS; PLODIA-INTERPUNCTELLA; BEHAVIOR; MODEL; TURNBULLI; PATHOGEN; FISH	Background: Infection incidence increases with the average number of contacts between susceptible and infected individuals. Contact rates are normally assumed to increase linearly with host density. However, social species seek out each other at low density and saturate their contact rates at high densities. Although predicting epidemic behaviour requires knowing how contact rates scale with host density, few empirical studies have investigated the effect of host density. Also, most theory assumes each host has an equal probability of transmitting parasites, even though individual parasite load and infection duration can vary. To our knowledge, the relative importance of characteristics of the primary infected host vs. the susceptible population has never been tested experimentally. Methodology/Principal Findings: Here, we examine epidemics using a common ectoparasite, Gyrodactylus turnbulli infecting its guppy host (Poecilia reticulata). Hosts were maintained at different densities (3, 6, 12 and 24 fish in 40 L aquaria), and we monitored gyrodactylids both at a population and individual host level. Although parasite population size increased with host density, the probability of an epidemic did not. Epidemics were more likely when the primary infected fish had a high mean intensity and duration of infection. Epidemics only occurred if the primary infected host experienced more than 23 worm days. Female guppies contracted infections sooner than males, probably because females have a higher propensity for shoaling. Conclusions/Significance: These findings suggest that in social hosts like guppies, the frequency of social contact largely governs disease epidemics independent of host density.	[Johnson, Mirelle B.; Cable, Joanne] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Lafferty, Kevin D.] Univ Calif Santa Barbara, Inst Marine Sci, Western Ecol Res Ctr, US Geol Survey, Santa Barbara, CA 93106 USA; [van Oosterhout, Cock] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	Cardiff University; United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Barbara; University of East Anglia	Johnson, MB (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	cablej@cardiff.ac.uk	Lafferty, Kevin D./B-3888-2009; Cable, Joanne/A-4360-2010	Cable, Joanne/0000-0002-8510-7055; van Oosterhout, Cock/0000-0002-5653-738X	European Community [MTKD-CT-2005-030018]	European Community(European Commission)	This work was supported by a European Community Framework Programme 6 Marie Curie Host Fellowship for transfer of knowledge (MTKD-CT-2005-030018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; ANTONOVICS J, 1995, AM NAT, V145, P661, DOI 10.1086/285761; Arneberg P, 1998, P ROY SOC B-BIOL SCI, V265, P1283, DOI 10.1098/rspb.1998.0431; Bakke TA, 2007, ADV PARASIT, V64, P161, DOI 10.1016/S0065-308X(06)64003-7; Barber I, 2000, REV FISH BIOL FISHER, V10, P131, DOI 10.1023/A:1016658224470; Begon M, 1999, P ROY SOC B-BIOL SCI, V266, P1939, DOI 10.1098/rspb.1999.0870; Begon M, 1998, ECOL LETT, V1, P82; Berthier K, 2000, P ROY SOC B-BIOL SCI, V267, P2049, DOI 10.1098/rspb.2000.1248; Boeger WA, 2005, J PARASITOL, V91, P1000, DOI 10.1645/GE-515R.1; Brown CR, 2004, ECOLOGY, V85, P1619, DOI 10.1890/03-0206; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Cable J, 2007, INT J PARASITOL, V37, P1449, DOI 10.1016/j.ijpara.2007.04.013; Cable J, 2007, BIOL J LINN SOC, V90, P647, DOI 10.1111/j.1095-8312.2006.00755.x; Cable J, 2002, J PARASITOL, V88, P183, DOI 10.1645/0022-3395(2002)088[0183:BFTITV]2.0.CO;2; CABLE J, 2011, ECOLOGY EVO IN PRESS; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Croft DP, 2003, OIKOS, V100, P429, DOI 10.1034/j.1600-0706.2003.12023.x; de Castro F, 2005, OIKOS, V111, P501, DOI 10.1111/j.1600-0706.2005.14101.x; Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103; ENDLER JA, 1987, ANIM BEHAV, V35, P1376, DOI 10.1016/S0003-3472(87)80010-6; Faria PJ, 2010, BIOL CONSERV, V143, P35, DOI 10.1016/j.biocon.2009.06.002; Fraser BA, 2010, GENETICA, V138, P273, DOI 10.1007/s10709-009-9402-y; GETZ WM, 1983, AM NAT, V121, P892, DOI 10.1086/284112; Griffiths SW, 1998, ANIM BEHAV, V56, P689, DOI 10.1006/anbe.1998.0767; Huxel GR, 1999, ECOL LETT, V2, P256; Knell RJ, 1996, P ROY SOC B-BIOL SCI, V263, P75, DOI 10.1098/rspb.1996.0013; Knell RJ, 1998, J ANIM ECOL, V67, P592, DOI 10.1046/j.1365-2656.1998.00219.x; Lafferty KD, 2004, ECOL APPL, V14, P1566, DOI 10.1890/03-5088; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Lyles A. M., 1990, THESIS PRINCETON U; MAGURRAN AE, 1994, BEHAVIOUR, V128, P121, DOI 10.1163/156853994X00073; Martin CH, 2007, BEHAV ECOL SOCIOBIOL, V61, P1897, DOI 10.1007/s00265-007-0430-2; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; Ramsey D, 2002, J APPL ECOL, V39, P806, DOI 10.1046/j.1365-2664.2002.00760.x; Richards EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013285; Richards GR, 1998, PARASITOL RES, V84, P753, DOI 10.1007/s004360050481; Ryder JJ, 2007, OIKOS, V116, P2017, DOI 10.1111/j.2007.0030-1299.15863.x; Schelkle B, 2009, DIS AQUAT ORGAN, V86, P65, DOI 10.3354/dao02087; SCOTT ME, 1984, PARASITOLOGY, V89, P159, DOI 10.1017/S0031182000001207; van Oosterhout C, 2008, INT J PARASITOL, V38, P541, DOI 10.1016/j.ijpara.2007.09.016; van Oosterhout C, 2007, INT J PARASITOL, V37, P805, DOI 10.1016/j.ijpara.2006.12.016; Van Oosterhout C, 2003, BIOL J LINN SOC, V79, P645, DOI 10.1046/j.1095-8312.2003.00203.x	42	36	36	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e22634	10.1371/journal.pone.0022634	http://dx.doi.org/10.1371/journal.pone.0022634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897838	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000294676900001
J	Otero, J; Jensen, AJ; L'Abee-Lund, JH; Stenseth, NC; Storvik, GO; Vollestad, LA				Otero, Jaime; Jensen, Arne J.; L'Abee-Lund, Jan Henning; Stenseth, Nils Chr.; Storvik, Geir O.; Vollestad, Leif Asbjorn			Quantifying the Ocean, Freshwater and Human Effects on Year-to-Year Variability of One-Sea-Winter Atlantic Salmon Angled in Multiple Norwegian Rivers	PLOS ONE			English	Article							POST-SMOLT GROWTH; CHINOOK SALMON; ONCORHYNCHUS-TSHAWYTSCHA; RETURN MIGRATION; FARM SALMON; SALAR L.; JUVENILE; SURVIVAL; POPULATIONS; ABUNDANCE	Many Atlantic salmon, Salmo salar, populations are decreasing throughout the species' distributional range probably due to several factors acting in concert. A number of studies have documented the influence of freshwater and ocean conditions, climate variability and human impacts resulting from impoundment and aquaculture. However, most previous research has focused on analyzing single or only a few populations, and quantified isolated effects rather than handling multiple factors in conjunction. By using a multi-river mixed-effects model we estimated the effects of oceanic and river conditions, as well as human impacts, on year-to-year and between-river variability across 60 time series of recreational catch of one-sea-winter salmon (grilse) from Norwegian rivers over 29 years (1979-2007). Warm coastal temperatures at the time of smolt entrance into the sea and increased water discharge during upstream migration of mature fish were associated with higher rod catches of grilse. When hydropower stations were present in the course of the river systems the strength of the relationship with runoff was reduced. Catches of grilse in the river increased significantly following the reduction of the harvesting of this life-stage at sea. However, an average decreasing temporal trend was still detected and appeared to be stronger in the presence of salmon farms on the migration route of smolts in coastal/fjord areas. These results suggest that both ocean and freshwater conditions in conjunction with various human impacts contribute to shape interannual fluctuations and between-river variability of wild Atlantic salmon in Norwegian rivers. Current global change altering coastal temperature and water flow patterns might have implications for future grilse catches, moreover, positioning of aquaculture facilities as well as the implementation of hydropower schemes or other encroachments should be made with care when implementing management actions and searching for solutions to conserve this species.	[Otero, Jaime; Stenseth, Nils Chr.; Storvik, Geir O.; Vollestad, Leif Asbjorn] Univ Oslo, Dept Biol, CEES, Oslo, Norway; [Jensen, Arne J.] Norwegian Inst Nat Res NINA, Trondheim, Norway; [L'Abee-Lund, Jan Henning] Norwegian Water Resources & Energy Directorate NV, Oslo, Norway; [Stenseth, Nils Chr.] Inst Marine Res, Flodevigen Marine Res Stn, His, Norway; [Storvik, Geir O.] Univ Oslo, Dept Math, Oslo, Norway	University of Oslo; Norwegian Institute Nature Research; Norwegian Water Resources & Energy Directorate; Institute of Marine Research - Norway; University of Oslo	Otero, J (corresponding author), Univ Oslo, Dept Biol, CEES, Oslo, Norway.	j.o.villar@bio.uio.no	L'Abée-Lund, Jan Henning/A-9475-2008; Storvik, Geir/HHR-8538-2022; Vøllestad, Leif Asbjørn/H-7305-2019; Otero, Jaime/C-4848-2015; Stenseth, Nils Chr./G-5212-2016; Jensen, Arne Johan/B-8292-2012; L'Abée-lund, Jan Henning/AAE-4422-2019	Vøllestad, Leif Asbjørn/0000-0002-9389-7982; Stenseth, Nils Chr./0000-0002-1591-5399; Jensen, Arne Johan/0000-0002-7274-344X; Storvik, Geir Olve/0000-0001-8198-1426	Research Council of Norway [183989/S30]	Research Council of Norway(Research Council of Norway)	This study was funded by the Research Council of Norway (http://www.forskningsradet.no/no/Forsiden/1173185591033) project no 183989/S30. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; Bacon PJ, 2009, ICES J MAR SCI, V66, P844, DOI 10.1093/icesjms/fsp096; Beldring S, 2003, HYDROL EARTH SYST SC, V7, P304, DOI 10.5194/hess-7-304-2003; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Costello MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3385, DOI 10.1098/rspb.2009.0771; Crozier L, 2006, J ANIM ECOL, V75, P1100, DOI 10.1111/j.1365-2656.2006.01130.x; Cryer JD, 2008, SPRINGER TEXTS STAT, P1; Erkinaro J, 1999, J FISH BIOL, V55, P506, DOI 10.1111/j.1095-8649.1999.tb00695.x; ERKINARO J, 2010, 24 ICES N ATL SALM W; Finstad AG, 2009, J ANIM ECOL, V78, P226, DOI 10.1111/j.1365-2656.2008.01476.x; Ford JS, 2008, PLOS BIOL, V6, P411, DOI 10.1371/journal.pbio.0060033; Friedland KD, 1998, FISH OCEANOGR, V7, P22, DOI 10.1046/j.1365-2419.1998.00047.x; Friedland KD, 2003, ICES J MAR SCI, V60, P343, DOI 10.1016/S1054-3139(03)00022-5; Friedland KD, 2000, ICES J MAR SCI, V57, P419, DOI 10.1006/jmsc.1999.0639; Friedland KD, 2009, ICES J MAR SCI, V66, P289, DOI 10.1093/icesjms/fsn210; Fromentin JM, 1998, MAR ECOL PROG SER, V162, P265, DOI 10.3354/meps162265; Hodgson S, 2006, FISH OCEANOGR, V15, P1, DOI 10.1111/j.1365-2419.2005.00354.x; Hoekstra JM, 2007, ECOL APPL, V17, P2061, DOI 10.1890/06-1637.1; Hvidsten NA, 2009, J FISH BIOL, V74, P1532, DOI 10.1111/j.1095-8649.2009.02219.x; HVIDSTEN NA, 1988, J FISH BIOL, V33, P121, DOI 10.1111/j.1095-8649.1988.tb05453.x; IBANEZ F, 1992, J RECH OCEANOGR, V16, P27; Jensen AJ, 1999, ICES J MAR SCI, V56, P84, DOI 10.1006/jmsc.1998.0419; Jensen AJ, 1999, FUNCT ECOL, V13, P778, DOI 10.1046/j.1365-2435.1999.00358.x; Johnsen Bjorn Ove, 2011, P351; Jonsson B, 2007, J FISH BIOL, V71, P943, DOI 10.1111/j.1095-8649.2007.01555.x; Jonsson B, 2004, CAN J FISH AQUAT SCI, V61, P2369, DOI 10.1139/f04-215; Jonsson N, 1998, J ANIM ECOL, V67, P751, DOI 10.1046/j.1365-2656.1998.00237.x; L'Abee-Lund JH, 2006, CAN J FISH AQUAT SCI, V63, P2318, DOI 10.1139/F06-123; L'Abee-Lund JH, 2004, T AM FISH SOC, V133, P743, DOI 10.1577/T03-108.1; Levin PS, 2001, ANIM CONSERV, V4, P291, DOI 10.1017/S1367943001001342; Liu YJ, 2011, MAR POLICY, V35, P413, DOI 10.1016/j.marpol.2010.11.007; Marty GD, 2010, P NATL ACAD SCI USA, V107, P22599, DOI 10.1073/pnas.1009573108; Mccarthy JL, 2008, J FISH BIOL, V72, P1572, DOI 10.1111/j.1095-8649.2008.01820.x; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Middlemas SJ, 2006, P ROY SOC B-BIOL SCI, V273, P193, DOI 10.1098/rspb.2005.3215; Mueter FJ, 2002, CAN J FISH AQUAT SCI, V59, P456, DOI 10.1139/f02-020; Niemela E, 2004, CAN J FISH AQUAT SCI, V61, P2384, DOI 10.1139/f04-208; NIEMELA E, 2004, THESIS U OULU FINLAN; Parrish DL, 1998, CAN J FISH AQUAT SCI, V55, P281, DOI 10.1139/cjfas-55-S1-281; Pinheiro J, 2001, MIXED EFFECTS MODELS; Post JR, 2008, ECOL APPL, V18, P1038, DOI 10.1890/07-0465.1; R Core Team, 2022, R LANG ENV STAT COMP; Rechisky EL, 2009, CAN J FISH AQUAT SCI, V66, P1019, DOI 10.1139/F09-078; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; THORPE JE, 1992, ENVIRON BIOL FISH, V33, P331, DOI 10.1007/BF00010944; Thorstad E.B., 2008, 36 NINA; Thorstad EB, 2008, REV FISH BIOL FISHER, V18, P345, DOI 10.1007/s11160-007-9076-4; Thorstad Eva B., 2011, P1; Todd CD, 2008, GLOBAL CHANGE BIOL, V14, P958, DOI 10.1111/j.1365-2486.2007.01522.x; UGEDAL O, 2007, 281 NINA; Ugedal O, 2008, HYDROBIOLOGIA, V609, P9, DOI 10.1007/s10750-008-9404-2; Vollestad LA, 2009, P ROY SOC B-BIOL SCI, V276, P1021, DOI 10.1098/rspb.2008.1600; Ward DM, 2008, OECOLOGIA, V156, P515, DOI 10.1007/s00442-008-1011-4; Welch DW, 2008, PLOS BIOL, V6, P2101, DOI 10.1371/journal.pbio.0060265	54	39	39	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e24005	10.1371/journal.pone.0024005	http://dx.doi.org/10.1371/journal.pone.0024005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897867	Green Published, gold			2022-12-25	WOS:000294676900031
J	Wu, XL; Wang, XH; Drlica, K; Zhao, XL				Wu, Xiangli; Wang, Xiuhong; Drlica, Karl; Zhao, Xilin			A Toxin-Antitoxin Module in Bacillus subtilis Can Both Mitigate and Amplify Effects of Lethal Stress	PLOS ONE			English	Article							MULTIPLE ANTIBIOTIC-RESISTANCE; PROGRAMMED CELL-DEATH; MESSENGER-RNA INTERFERASE; ESCHERICHIA-COLI; RESPONSE SYSTEMS; OXIDATIVE DAMAGE; MAZEF; LOCI; MECHANISM; MAR	Background: Bacterial type-2 (protein-protein) toxin-antitoxin (TA) modules are two-gene operons that are thought to participate in the response to stress. Previous work with Escherichia coli has led to a debate in which some investigators conclude that the modules protect from stress, while others argue that they amplify lethal stress and lead to programmed cell death. To avoid ambiguity arising from the presence of multiple TA modules in E. coli, the effect of the sole type-2 toxin-antitoxin module of Bacillus subtilis was examined for several types of lethal stress. Methodology/Principal Findings: Genetic knockout of the toxin gene, ndoA (ydcE), conferred protection to lethal stressors that included kanamycin, moxifloxacin, hydrogen peroxide, and UV irradiation. However, at low doses of UV irradiation the ndoA deficiency increased lethality. Indeed, gradually increasing UV dose with the ndoA mutant revealed a crossover response - from the mutant being more sensitive than wild-type cells to being less sensitive. For high temperature and nutrient starvation, the toxin deficiency rendered cells hypersensitive. The ndoA deficiency also reduced sporulation frequency, indicating a role for toxin-antitoxin modules in this developmental process. In the case of lethal antimicrobial treatment, deletion of the toxin eliminated a surge in hydrogen peroxide accumulation observed in wild-type cells. Conclusions: A single toxin-antitoxin module can mediate two opposing effects of stress, one that lowers lethality and another that raises it. Protective effects are thought to arise from toxin-mediated inhibition of translation based on published work. The enhanced, stress-mediated killing probably involves toxin-dependent accumulation of reactive oxygen species, since a deficiency in the NdoA toxin suppressed peroxide accumulation following antimicrobial treatment. The type and perhaps the level of stress appear to be important for determining whether this toxin will have a protective or detrimental effect.	[Wu, Xiangli; Wang, Xiuhong; Drlica, Karl; Zhao, Xilin] Univ Med & Dent New Jersey, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Wu, Xiangli] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Wu, Xiangli] China Agr Univ, Dept Microbiol, Beijing 100094, Peoples R China; [Wang, Xiuhong] Harbin Med Coll, Dept Biochem, Harbin, Heilongjiang, Peoples R China; [Drlica, Karl; Zhao, Xilin] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; China Agricultural University; China Agricultural University; Harbin Medical University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Wu, XL (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing 100193, Peoples R China.	zhaox5@umdnj.edu	Zhao, Xilin/Y-6795-2019	Zhao, Xilin/0000-0001-8375-8658	National Institutes of Health [AI068014, AI073491]; China Scholarship Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073491, R21AI068014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by Grants AI068014 and AI073491 from the National Institutes of Health. Xiangli Wu was supported by a grant from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; Burger RM, 2009, J INORG BIOCHEM, V103, P1273, DOI 10.1016/j.jinorgbio.2009.07.009; CAMPBELL A, 1961, EPISOMES ADV GENET, V11, P101; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; DALESSANDRI RM, 1976, ANTIMICROB AGENTS CH, V10, P889, DOI 10.1128/AAC.10.6.889; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; DEITZ WH, 1966, J BACTERIOL, V91, P768, DOI 10.1128/JB.91.2.768-773.1966; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Falla TJ, 1998, ANTIMICROB AGENTS CH, V42, P3282, DOI 10.1128/AAC.42.12.3282; Fernandes P M, 1987, Braz J Med Biol Res, V20, P873; Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; Guglielmini J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-104; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Inouye M, 2006, J CELL PHYSIOL, V209, P670, DOI 10.1002/jcp.20801; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Kim YH, 2009, J BACTERIOL, V191, P1258, DOI 10.1128/JB.01465-08; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kolodkin-Gal I, 2006, J BACTERIOL, V188, P3420, DOI 10.1128/JB.188.9.3420-3423.2006; Kolodkin-Gal I, 2008, PLOS BIOL, V6, P2774, DOI 10.1371/journal.pbio.0060319; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Malik M, 2007, ANTIMICROB AGENTS CH, V51, P28, DOI 10.1128/AAC.00739-06; Matthijssens F, 2008, FREE RADICAL BIO MED, V45, P708, DOI 10.1016/j.freeradbiomed.2008.05.023; Miller J.H., 1972, EXPT MOL GENETICS; MILLER PF, 1994, ANTIMICROB AGENTS CH, V38, P1773, DOI 10.1128/AAC.38.8.1773; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pellegrini O, 2005, MOL MICROBIOL, V56, P1139, DOI 10.1111/j.1365-2958.2005.04606.x; Randall LP, 2002, RES VET SCI, V72, P87, DOI 10.1053/rvsc.2001.0537; ROSNER JL, 1994, J BACTERIOL, V176, P6262, DOI 10.1128/jb.176.20.6262-6269.1994; RUDE JM, 1973, J BACTERIOL, V113, P1161; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Silvaggi JM, 2005, J BACTERIOL, V187, P6641, DOI 10.1128/JB.187.19.6641-6650.2005; Suzuki M, 2005, MOL CELL, V18, P253, DOI 10.1016/j.molcel.2005.03.011; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	46	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23909	10.1371/journal.pone.0023909	http://dx.doi.org/10.1371/journal.pone.0023909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897862	Green Published, Green Submitted, gold			2022-12-25	WOS:000294676900026
J	Ciucci, A; Gabriele, I; Percario, ZA; Affabris, E; Colizzi, V; Mancino, G				Ciucci, Alessandra; Gabriele, Ida; Percario, Zulema A.; Affabris, Elisabetta; Colizzi, Vittorio; Mancino, Giorgio			HMGB1 and Cord Blood: Its Role as Immuno-Adjuvant Factor in Innate Immunity	PLOS ONE			English	Article							DELTA T-CELLS; MOLECULAR-PATTERN MOLECULES; ZOLEDRONIC ACID; DENDRITIC CELLS; PROTEIN HMGB1; LATE MEDIATOR; TUMOR-CELLS; ACTIVATION; MIGRATION; STIMULATION	In newborn the innate immune system provides essential protection during primary infections before the generation of an appropriate adaptive immune response that is initially not fully operative. Innate immune response is evoked and perpetuated by molecules derived from microorganisms or by the damage/death of host cells. These are collectively known as damage-associated molecular-pattern (DAMP) molecules. High-mobility group box 1 protein (HMGB1) or amphoterin, which previously was considered to be only a nuclear factor, has been recently identified as a DAMP molecule. When it is actively secreted by inflammatory cells or passively released from necrotic cells, HMGB1 mediates the response to infection, injury and inflammation, inducing dendritic cells maturation and T helper-1-cell responses. To characterize the role of HMGB1 in the innate and immature defense mechanisms in newborns, human cord blood (CB) mononuclear cells, in comparison to adult peripheral blood (PB) mononuclear cells, have been analyzed for its expression. By flow cytometry and western blot analysis, we observed that in CB and PB cells: i) HMGB1 is expressed on cell surface membranes of myeloid dendritic cell precursors, mostly, and lymphocytes (gamma/delta and CD4(+) T cells) to a lesser extent; ii) different pro-inflammatory stimuli or molecules that mimic infection increased cell surface expression of HMGB1 as well as its secretion into extracellular environment; iii) the treatment with synthetic molecules such as aminobisphosphonates (ABs), identified to be gamma delta T cell antigens, triggered up-regulation of HMGB1 expression on mononuclear cells, as well gamma delta T lymphocytes, inducing its secretion. The modulation of its secretion and the HMGB1-mediated migration of monocytes indicated HMGB1 as regulator of immune response in an immature system, like CB, through engagement of gamma delta T lymphocytes and myeloid dendritic cell precursors, essential components of innate immunity. In addition, the increased HMGB1 expression/secretion triggered by ABs, previously characterized for their immuno-modulating and immune-adjuvant capabilities, indicated that immunomodulation might represent a new therapeutical approach for neonatal and adult pathologies.	[Ciucci, Alessandra; Gabriele, Ida; Mancino, Giorgio] San Pietro Hosp, Res Ctr, Immunopathol Unit, Rome, Italy; [Percario, Zulema A.; Affabris, Elisabetta] Univ Rome RomaTre, Dept Biol, Rome, Italy; [Colizzi, Vittorio] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	Roma Tre University; University of Rome Tor Vergata	Ciucci, A (corresponding author), San Pietro Hosp, Res Ctr, Immunopathol Unit, Rome, Italy.	ale_ciucci@yahoo.it; mancino@uniroma2.it		AFFABRIS, Elisabetta/0000-0001-5142-8144				Apetoh L, 2008, CANCER RES, V68, P4026, DOI 10.1158/0008-5472.CAN-08-0427; Berenson JR, 2005, ONCOLOGIST, V10, P52, DOI 10.1634/theoncologist.10-1-52; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bonneville M, 2005, MICROBES INFECT, V7, P503, DOI 10.1016/j.micinf.2005.03.004; Buhimschi CS, 2009, AM J PATHOL, V175, P958, DOI 10.2353/ajpath.2009.090156; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Cairo C, 2008, MOL IMMUNOL, V45, P3190, DOI 10.1016/j.molimm.2008.02.029; Castiglioni A, 2011, CELL TISSUE RES, V343, P189, DOI 10.1007/s00441-010-1033-1; CHRISTENSEN RD, 1989, PEDIATR RES, V26, P531, DOI 10.1203/00006450-198912000-00001; Conti L, 2005, J IMMUNOL, V174, P252, DOI 10.4049/jimmunol.174.1.252; Cravens PD, 2002, IMMUNOL CELL BIOL, V80, P497, DOI 10.1046/j.1440-1711.2002.01118.x; Demirjian A, 2009, EUR J IMMUNOL, V39, P36, DOI 10.1002/eji.200838620; Dieli F, 2003, BLOOD, V102, P2310, DOI 10.1182/blood-2003-05-1655; Dumitriu IE, 2007, J LEUKOCYTE BIOL, V81, P84, DOI 10.1189/jlb.0306171; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; GOODWIN GH, 1973, EUR J BIOCHEM, V38, P14, DOI 10.1111/j.1432-1033.1973.tb03026.x; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; Harris HE, 2006, EMBO REP, V7, P774, DOI 10.1038/sj.embor.7400759; Ishii KJ, 2007, J CLIN IMMUNOL, V27, P363, DOI 10.1007/s10875-007-9087-x; Kalyan S, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/819408; KLEIN J, 2001, INFECT DIS FETUS NEW, P1; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kunzmann V, 2000, BLOOD, V96, P384; Lewis D. B., 2001, INFECT DIS FETUS NEW; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Luan ZG, 2010, IMMUNOBIOLOGY, V215, P956, DOI 10.1016/j.imbio.2009.11.001; Mariani S, 2005, LEUKEMIA, V19, P664, DOI 10.1038/sj.leu.2403693; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Matzinger P, 2002, ANN NY ACAD SCI, V961, P341, DOI 10.1111/j.1749-6632.2002.tb03118.x; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; Messmer D, 2004, J IMMUNOL, V173, P307, DOI 10.4049/jimmunol.173.1.307; Miyagawa F, 2001, J IMMUNOL, V166, P5508, DOI 10.4049/jimmunol.166.9.5508; Mullins GE, 2004, SCAND J IMMUNOL, V60, P566, DOI 10.1111/j.0300-9475.2004.01518.x; Okazaki K, 2008, NEONATOLOGY, V94, P105, DOI 10.1159/000116635; Placido R, 2011, INT J IMMUNOPATH PH, V24, P101, DOI 10.1177/039463201102400112; Poupot M, 2004, IMMUNOL LETT, V95, P129, DOI 10.1016/j.imlet.2004.06.013; Raucci A, 2007, AUTOIMMUNITY, V40, P285, DOI 10.1080/08916930701356978; Rouhiainen A, 2004, BLOOD, V104, P1174, DOI 10.1182/blood-2003-10-3536; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; TANAKA Y, 1994, P NATL ACAD SCI USA, V91, P8175, DOI 10.1073/pnas.91.17.8175; Telusma G, 2006, INT IMMUNOL, V18, P1563, DOI 10.1093/intimm/dxl089; Velilla PA, 2006, CLIN IMMUNOL, V121, P251, DOI 10.1016/j.clim.2006.08.010; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang HH, 2001, AM J RESP CRIT CARE, V164, P1768, DOI 10.1164/ajrccm.164.10.2106117; Yamashita S, 2003, INT IMMUNOL, V15, P1301, DOI 10.1093/intimm/dxg129; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Zinkernagel RM, 2001, NEW ENGL J MED, V345, P1331, DOI 10.1056/NEJMra012493	53	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23766	10.1371/journal.pone.0023766	http://dx.doi.org/10.1371/journal.pone.0023766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21915243	Green Published, Green Submitted, gold			2022-12-25	WOS:000294251800030
J	Noetzel, E; Rose, M; Bornemann, J; Gajewski, M; Knuchel, R; Dahl, E				Noetzel, E.; Rose, M.; Bornemann, J.; Gajewski, M.; Knuechel, R.; Dahl, E.			Nuclear transport receptor karyopherin-alpha 2 promotes malignant breast cancer phenotypes in vitro	ONCOGENE			English	Article						KPNA2; colony spreading; migration; adhesion; human breast cancer	GENE-EXPRESSION DATA; NF-KAPPA-B; CELL-MIGRATION; IMPORTIN-ALPHA; PROGNOSTIC MARKER; OVARIAN-CANCER; TUMOR; CARCINOMA; P53; OVEREXPRESSION	Tumorigenesis and tumor progression are associated with dysfunction of the nuclear transport machinery at the level of import and export receptors (karyopherins). Recent studies have shown that the nuclear import factor karyopherin-alpha 2 (KPNA2) is a novel prognostic marker for poor prognosis in human breast cancer. Based on the well-defined hallmarks of cancer progression, we performed a detailed in vitro characterization of the phenotypic effects caused by KPNA2 overexpression and KPNA2 silencing in benign and malignant human breast cells. KPNA2 overexpression clearly increased proliferation of MCF7 tumor cells and further led to a reduction of cell-matrix adhesion in benign MCF10A cells, whereas cell migration was significantly increased (P<0.0001) in both tumor models. Remarkably, these individual effects of KPNA2 overexpression on proliferation, cell-matrix adhesion and migration resulted in an increased colony spreading of benign MCF10A breast cells and malignant MCF7 tumor cells (P<0.001), which is a hallmark of cancer progression. Conversely, RNA interference-mediated KPNA2 silencing caused a complete inhibition of MCF7 tumor cell proliferation and migration (P<0.0001). In addition, in these experiments apoptosis was increased (P<0.05) and formation of tumor cell colonies was reduced (P<0.01). Thus, KPNA2 overexpression provoked increased aggressiveness of malignant MCF7 breast tumor cells and induced a shift in benign MCF10A breast cells toward a malignant breast cancer phenotype. In conclusion, we demonstrate for the first time in experimental tumor models that forced KPNA2 expression drives malignant features relevant for breast cancer progression, while its silencing is required for the remission of those progressive phenotypes. This study gives clear evidence that KPNA2 acts as a novel oncogenic factor in human breast cancer, in vitro. Oncogene (2012) 31, 2101-2114; doi: 10.1038/onc.2011.403; published online 12 September 2011	[Noetzel, E.; Rose, M.; Gajewski, M.; Knuechel, R.; Dahl, E.] Rhein Westfal TH Aachen, Fac Med, Inst Pathol, Mol Oncol Grp, Aachen, Germany; [Bornemann, J.] Rhein Westfal TH Aachen, Fac Med, Electron Microscop Facil, Aachen, Germany	RWTH Aachen University; RWTH Aachen University	Dahl, E (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Inst Pathol, Mol Oncol Grp, Pauwelsstr 30, D-52074 Aachen, Germany.	edahl@ukaachen.de	Noetzel-Reiss, Erik/GYV-0999-2022	Noetzel-Reiss, Erik/0000-0003-3163-6848	Mediacal Faculty of the RWTH Aachen (START)	Mediacal Faculty of the RWTH Aachen (START)	The excellent technical assistance of Sonja von Serenyi is thankfully acknowledged. This work was supported by a grant from the Mediacal Faculty of the RWTH Aachen (START program 'Tumor marker and their function' Project 1: Inflammation and Cancer).	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Brunet Anne, 1995, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V189, P43; Cavallaro U, 2001, BBA-REV CANCER, V1552, P39, DOI 10.1016/S0304-419X(01)00038-5; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Cunningham MD, 2003, BIOCHEM BIOPH RES CO, V300, P403, DOI 10.1016/S0006-291X(02)02863-2; Dahl E, 2005, J PATHOL, V205, P21, DOI 10.1002/path.1687; Dahl E, 2006, CLIN CANCER RES, V12, P3950, DOI 10.1158/1078-0432.CCR-05-2090; Dankof A, 2007, VIRCHOWS ARCH, V451, P877, DOI 10.1007/s00428-007-0513-5; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Flamini G, 1996, EUR J CANCER, V32A, P802, DOI 10.1016/0959-8049(95)00625-7; Gluz O, 2008, INT J CANCER, V123, P1433, DOI 10.1002/ijc.23628; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorlich D, 1998, EMBO J, V17, P2721, DOI 10.1093/emboj/17.10.2721; HALL PA, 1990, J PATHOL, V162, P285, DOI 10.1002/path.1711620403; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harreman MT, 2003, J BIOL CHEM, V278, P21361, DOI 10.1074/jbc.M301114200; Hu TS, 2008, CANCER RES, V68, P6533, DOI 10.1158/0008-5472.CAN-07-6642; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Klein A, 2007, INT J CANCER, V121, P683, DOI 10.1002/ijc.22630; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lu WG, 2000, ONCOGENE, V19, P232, DOI 10.1038/sj.onc.1203262; Mayhew TM, 2009, ANN ANAT, V191, P153, DOI 10.1016/j.aanat.2008.11.001; Mortezavi A, 2011, CLIN CANCER RES, V17, P1111, DOI 10.1158/1078-0432.CCR-10-0081; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Noetzel E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-154; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Paris S, 2002, INT J CANCER, V97, P615, DOI 10.1002/ijc.10120; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Runnebaum IB, 1996, GYNECOL ONCOL, V61, P266, DOI 10.1006/gyno.1996.0137; Sakai M, 2010, ANTICANCER RES, V30, P851; Sandrock K, 2010, TRAFFIC, V11, P198, DOI 10.1111/j.1600-0854.2009.01015.x; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stuart-Harris R, 2008, BREAST, V17, P323, DOI 10.1016/j.breast.2008.02.002; Veeck J, 2008, ONCOGENE, V27, P865, DOI 10.1038/sj.onc.1210669; Wang CI, 2011, INT J CANCER, V128, P2364, DOI 10.1002/ijc.25568	44	62	65	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2012	31	16					2101	2114		10.1038/onc.2011.403	http://dx.doi.org/10.1038/onc.2011.403			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	928TP	21909132				2022-12-25	WOS:000303008600010
J	Liang, K; Du, W; Zhu, WZ; Liu, S; Cui, YQ; Sun, HC; Luo, B; Xue, YH; Yang, L; Chen, LY; Li, F				Liang, Kuo; Du, Wen; Zhu, Wenzhen; Liu, Shuang; Cui, Yeqing; Sun, Haichen; Luo, Bin; Xue, Yanhong; Yang, Lu; Chen, Liangyi; Li, Fei			Contribution of Different Mechanisms to Pancreatic Beta-cell Hyper-secretion in Non-obese Diabetic (NOD) Mice during Pre-diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM CA2+-ATPASE; INSULIN-SECRETION; CA2+ HOMEOSTASIS; CALCIUM; GLUCOSE; MOUSE; ISLETS; RELEASE; EXPRESSION; DYNAMICS	The development of insulin-dependent diabetes mellitus (IDDM) results from the selective destruction of pancreatic beta-cells. Both humans and spontaneous models of IDDM, such as NOD mice, have an extended pre-diabetic stage. Dynamic changes in beta-cell mass and function during pre-diabetes, such as insulin hyper-secretion, remain largely unknown. In this paper, we evaluated pre-diabetic female NOD mice at different ages (6, 10, and 14 weeks old) to illustrate alterations in beta-cell mass and function as disease progressed. We found an increase in beta-cell mass in 6-week-old NOD mice that may account for improved glucose tolerance in these mice. As NOD mice aged, beta-cell mass progressively reduced with increasing insulitis. In parallel, secretory ability of individual beta-cells was enhanced due to an increase in the size of slowly releasable pool (SRP) of vesicles. Moreover, expression of both SERCA2 and SERCA3 genes were progressively down-regulated, which facilitated depolarization-evoked secretion by prolonging Ca2+ elevation upon glucose stimulation. In summary, we propose that different mechanisms contribute to the insulin hyper-secretion at different ages of pre-diabetic NOD mice, which may provide some new ideas concerning the progression and management of type I diabetes.	[Zhu, Wenzhen; Yang, Lu; Chen, Liangyi] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; [Zhu, Wenzhen; Yang, Lu; Chen, Liangyi] Natl Ctr Nanosci & Technol, Beijing 100871, Peoples R China; [Liang, Kuo; Liu, Shuang; Cui, Yeqing; Sun, Haichen; Luo, Bin; Li, Fei] Capital Med Univ, XuanWu Hosp, Dept Gen Surg, Beijing 100053, Peoples R China; [Du, Wen; Xue, Yanhong] Chinese Acad Sci, Inst Biophys, Natl Key Lab Biomacromol, Beijing 100101, Peoples R China	Peking University; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Capital Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Chen, LY (corresponding author), Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.	lychen@pku.edu.cn; feili36@ccmu.edu.cn	Chen, Liangyi/F-1352-2010	Chen, Liangyi/0000-0003-1270-7321	National Science Foundation of China [30871225]; Beijing Municipal Health Bureau [QN2008-029]; Beijing Science and Technology Program Project [D070501350706]; Beijing Municipal Science and Technology Commission [7082042]; Department of Education of China	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Health Bureau; Beijing Science and Technology Program Project; Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Department of Education of China	This work was supported by grants from the National Science Foundation of China (No. 30871225), a Youth Research Grant from Beijing Municipal Health Bureau (QN2008-029), the Beijing Science and Technology Program Project (D070501350706), and a grant from Beijing Municipal Science and Technology Commission (7082042) and a '985' fund from the Department of Education of China to Peking Univesity.	Amrani A, 1998, ENDOCRINOLOGY, V139, P1115, DOI 10.1210/en.139.3.1115; Amrani A, 1996, J ENDOCRINOL, V148, P139, DOI 10.1677/joe.0.1480139; Arredouani A, 2002, DIABETES, V51, P3245, DOI 10.2337/diabetes.51.11.3245; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; Beauvois MC, 2006, AM J PHYSIOL-CELL PH, V290, pC1503, DOI 10.1152/ajpcell.00400.2005; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Borge PD, 2002, DIABETES, V51, pS427, DOI 10.2337/diabetes.51.2007.S427; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chen LY, 2003, DIABETES, V52, P1723, DOI 10.2337/diabetes.52.7.1723; Cho JH, 2010, ENDOCRINOLOGY, V151, P1541, DOI 10.1210/en.2009-0362; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Dula SB, 2010, CELL CALCIUM, V48, P133, DOI 10.1016/j.ceca.2010.07.007; Duman JG, 2006, TRAFFIC, V7, P859, DOI 10.1111/j.1600-0854.2006.00432.x; Finegood DT, 2001, DIABETES, V50, P1021, DOI 10.2337/diabetes.50.5.1021; Gaisano HY, 2002, ENDOCRINOLOGY, V143, P4218, DOI 10.1210/en.2002-220237; He ZX, 2008, TRAFFIC, V9, P910, DOI 10.1111/j.1600-0854.2008.00730.x; Homo-Delarche F, 1997, DIABETES METAB, V23, P473; HomoDelarche F, 1997, DIABETES METAB, V23, P181; Hughes E, 2006, ENDOCRINOLOGY, V147, P1396, DOI 10.1210/en.2005-1023; Islam MS, 2002, DIABETES, V51, P1299, DOI 10.2337/diabetes.51.5.1299; Kang LJ, 2006, CELL METAB, V3, P463, DOI 10.1016/j.cmet.2006.04.012; KANO Y, 1986, DIABETES, V35, P486, DOI 10.2337/diabetes.35.4.486; Kruglikov I, 2004, PFLUG ARCH EUR J PHY, V448, P395, DOI 10.1007/s00424-004-1263-8; Kulkarni RN, 2004, DIABETES, V53, P1517, DOI 10.2337/diabetes.53.6.1517; Lemmens R, 2001, J BIOL CHEM, V276, P9971, DOI 10.1074/jbc.M009463200; Levy J, 1998, METABOLISM, V47, P185, DOI 10.1016/S0026-0495(98)90218-9; Lu JZ, 2008, BIOCHEM BIOPH RES CO, V371, P315, DOI 10.1016/j.bbrc.2008.04.077; Orban T, 2001, METABOLISM, V50, P1369, DOI 10.1053/meta.2001.27191; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Rabinovitch A, 2007, CELL BIOCHEM BIOPHYS, V48, P159, DOI 10.1007/s12013-007-0029-2; Racz G, 2009, ACTA BIOCHIM POL, V56, P487; Randriamboavonjy V, 2008, CIRCULATION, V117, P52, DOI 10.1161/CIRCULATIONAHA.107.719807; REDDY S, 1992, DIABETES RES CLIN PR, V17, P17, DOI 10.1016/0168-8227(92)90039-T; ROE MW, 1994, J BIOL CHEM, V269, P18279; Rorsman P, 1997, DIABETOLOGIA, V40, P487, DOI 10.1007/s001250050706; Searls YM, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-8; Sherry NA, 2005, DIABETES, V54, pS32, DOI 10.2337/diabetes.54.suppl_2.S32; STRANDELL E, 1990, J CLIN INVEST, V85, P1944, DOI 10.1172/JCI114657; Suarez-Pinzon WL, 2005, DIABETES, V54, P2596, DOI 10.2337/diabetes.54.9.2596; TERUYA M, 1993, DIABETES, V42, P1310, DOI 10.2337/diabetes.42.9.1310; Vandecaetsbeek I, 2009, BIOFACTORS, V35, P484, DOI 10.1002/biof.63; Varadi A, 1999, DIABETOLOGIA, V42, P1240, DOI 10.1007/s001250051298; Varadi A, 1996, BIOCHEM J, V319, P521, DOI 10.1042/bj3190521; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; Willcox A, 2010, DIABETOLOGIA, V53, P2020, DOI 10.1007/s00125-010-1817-6; Xie L, 2006, TRAFFIC, V7, P429, DOI 10.1111/j.1600-0854.2006.00401.x; Zaitsev S, 1997, BIOCHEM BIOPH RES CO, V239, P129, DOI 10.1006/bbrc.1997.7441	47	10	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39537	39545		10.1074/jbc.M111.295931	http://dx.doi.org/10.1074/jbc.M111.295931			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21914804	Green Published, hybrid			2022-12-25	WOS:000296759800071
J	Pierson, HE; Uhlemann, EME; Dmitriev, OY				Pierson, Hannah E.; Uhlemann, Eva-Maria E.; Dmitriev, Oleg Y.			Interaction with Monomeric Subunit c Drives Insertion of ATP Synthase Subunit a into the Membrane and Primes a-c Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-TRANSLOCATING ATPASE; ESCHERICHIA-COLI; CROSS-LINKING; F-0 SECTOR; TRANSMEMBRANE HELICES; FOF1-ATP SYNTHASE; ALPHA-SUBUNIT; ROTOR RING; NMR SYSTEM; PROTEIN	Subunit a is the main part of the membrane stator of the ATP synthase molecular turbine. Subunit c is the building block of the membrane rotor. We have generated two molecular fusions of a and c subunits with different orientations of the helical hairpin of subunit c. The a/c fusion protein with correct orientation of transmembrane helices was inserted into the membrane, and co-incorporated into the F-0 complex of ATP synthase with wild type subunit c. The fused c subunit was incorporated into the c-ring tethering the ATP synthase rotor to the stator. The a/c fusion with incorrect orientation of the c-helices required wild type subunit c for insertion into the membrane. In this case, the fused c subunit remained on the periphery of the c-ring and did not interfere with rotor movement. Wild type subunit a inserted into the membrane equally well with wild type subunit c and c-ring assembly mutants that remained monomeric in the membrane. These results show that interaction with monomeric subunit c triggers insertion of subunit a into the membrane, and initiates formation of the a-c complex, the ion-translocating module of the ATP synthase. Correct assembly of the ATP synthase incorporating topologically correct fusion of subunits a and c validates using this model protein for high resolution structural studies of the ATP synthase proton channel.	[Pierson, Hannah E.; Uhlemann, Eva-Maria E.; Dmitriev, Oleg Y.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Dmitriev, OY (corresponding author), 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	Oleg.Dmitriev@usask.ca	Dmitriev, Oleg/AAB-7830-2019		Saskatchewan Health Research Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC)	Saskatchewan Health Research Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Saskatchewan Health Research Foundation New Investigator grant and a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant (to O. Y. D.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Akiyama Y, 1996, FEBS LETT, V399, P26, DOI 10.1016/S0014-5793(96)01283-5; Akiyama Y, 2002, P NATL ACAD SCI USA, V99, P8066, DOI 10.1073/pnas.122616899; Arechaga I, 2003, FEBS LETT, V547, P97, DOI 10.1016/S0014-5793(03)00677-X; Arechaga I, 2002, FEBS LETT, V515, P189, DOI 10.1016/S0014-5793(02)02447-X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Dmitriev OY, 2008, BBA-BIOENERGETICS, V1777, P227, DOI 10.1016/j.bbabio.2007.11.011; Dmitriev OY, 2004, J BIOMOL NMR, V29, P439, DOI 10.1023/B:JNMR.0000032519.14221.20; Dmitriev OY, 2004, FEBS LETT, V556, P35, DOI 10.1016/S0014-5793(03)01360-7; Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785; EKMAN P, 1993, ANAL BIOCHEM, V214, P138, DOI 10.1006/abio.1993.1468; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; Fillingame RH, 2002, BBA-BIOMEMBRANES, V1565, P232, DOI 10.1016/S0005-2736(02)00572-2; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; GAY NJ, 1984, J BACTERIOL, V158, P820, DOI 10.1128/JB.158.3.820-825.1984; Girvin ME, 1998, BIOCHEMISTRY-US, V37, P8817, DOI 10.1021/bi980511m; HARTZOG PE, 1994, J BIOL CHEM, V269, P32313; HATCH LP, 1995, J BIOL CHEM, V270, P29407, DOI 10.1074/jbc.270.49.29407; HERMOLIN J, 1995, J BIOL CHEM, V270, P2815, DOI 10.1074/jbc.270.6.2815; IWAMOTO A, 1991, J BIOL CHEM, V266, P16350; JANS DA, 1983, BIOCHEM J, V211, P717, DOI 10.1042/bj2110717; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jones PC, 1998, J BIOL CHEM, V273, P29701, DOI 10.1074/jbc.273.45.29701; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; KANAZAWA H, 1984, J BACTERIOL, V158, P300, DOI 10.1128/JB.158.1.300-306.1984; KLIONSKY DJ, 1983, J BIOL CHEM, V258, P136; Kol S, 2009, J MOL BIOL, V390, P893, DOI 10.1016/j.jmb.2009.05.074; Krebstakies T, 2005, J BIOL CHEM, V280, P33338, DOI 10.1074/jbc.M506251200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; MOSHER ME, 1985, J BIOL CHEM, V260, P4807; Ono S, 2004, J BIOL CHEM, V279, P33409, DOI 10.1074/jbc.M404993200; Ozaki Y, 2008, BIOCHEM BIOPH RES CO, V367, P663, DOI 10.1016/j.bbrc.2007.12.170; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; ROTTENBERG H, 1993, BIOCHIM BIOPHYS ACTA, V1183, P161, DOI 10.1016/0005-2728(93)90014-7; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHNEIDER E, 1986, METHOD ENZYMOL, V126, P569; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; Stalz WD, 2003, J BIOL CHEM, V278, P27068, DOI 10.1074/jbc.M302027200; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Suzuki T, 2007, P NATL ACAD SCI USA, V104, P20776, DOI 10.1073/pnas.0708075105; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; Vik SB, 2000, BBA-BIOENERGETICS, V1458, P457, DOI 10.1016/S0005-2728(00)00094-3; Vik SB, 2005, J BIOENERG BIOMEMBR, V37, P445, DOI 10.1007/s10863-005-9488-6; VIK SB, 1994, J BIOL CHEM, V269, P30364; VONMEYENBURG K, 1985, EMBO J, V4, P2357, DOI 10.1002/j.1460-2075.1985.tb03939.x; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	56	11	11	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38583	38591		10.1074/jbc.M111.294868	http://dx.doi.org/10.1074/jbc.M111.294868			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900248	Green Published, hybrid			2022-12-25	WOS:000296594200071
J	Thakur, AK; Srivastava, AK; Srinivas, V; Chary, KVR; Rao, CM				Thakur, Abhay Kumar; Srivastava, Atul Kumar; Srinivas, Volety; Chary, Kandala Venkata Ramana; Rao, Chintalagiri Mohan			Copper Alters Aggregation Behavior of Prion Protein and Induces Novel Interactions between Its N- and C-terminal Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTHALPY-ENTROPY COMPENSATION; BINDING-SITES; STRUCTURAL-CHARACTERIZATION; CONFORMATIONAL-CHANGES; AMYLOIDOGENIC REGION; PEPTIDE-FRAGMENTS; OCTAREPEAT DOMAIN; HEAT-CAPACITY; ALPHA-HELIX; PRPC	Copper is reported to promote and prevent aggregation of prion protein. Conformational and functional consequences of Cu2+-binding to prion protein (PrP) are not well understood largely because most of the Cu2+-binding studies have been performed on fragments and truncated variants of the prion protein. In this context, we set out to investigate the conformational consequences of Cu2+-binding to full-length prion protein (PrP) by isothermal calorimetry, NMR, and small angle x-ray scattering. In this study, we report altered aggregation behavior of full-length PrP upon binding to Cu2+. At physiological temperature, Cu2+ did not promote aggregation suggesting that Cu2+ may not play a role in the aggregation of PrP at physiological temperature (37 degrees C). However, Cu2+-bound PrP aggregated at lower temperatures. This temperature-dependent process is reversible. Our results show two novel intraprotein interactions upon Cu2+-binding. The N-terminal region (residues 90-120 that contain the site His-96/His-111) becomes proximal to helix-1 (residues 144-147) and its nearby loop region (residues 139-143), which may be important in preventing amyloid fibril formation in the presence of Cu2+. In addition, we observed another novel interaction between the N-terminal region comprising the octapeptide repeats (residues 60-91) and helix-2 (residues 174-185) of PrP. Small angle x-ray scattering studies of full-length PrP show significant compactness upon Cu2+-binding. Our results demonstrate novel long range inter-domain interactions of the N- and C-terminal regions of PrP upon Cu2+ binding, which might have physiological significance.	[Thakur, Abhay Kumar; Srinivas, Volety; Rao, Chintalagiri Mohan] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Srivastava, Atul Kumar; Chary, Kandala Venkata Ramana] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Tata Institute of Fundamental Research (TIFR)	Rao, CM (corresponding author), CSIR, Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	mohan@ccmb.res.in	Thakur, Abhay/K-4167-2012	Srivastava, Atul/0000-0003-2314-8457	Council of Scientific and Industrial Research, New Delhi, India; Department of Science and Technology, Government of India; Department of Science and Technology; Department of Biotechnology; Tata Institute of Fundamental Research, Mumbai, India	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology; Tata Institute of Fundamental Research, Mumbai, India	Recipient of a senior research fellowship from Council of Scientific and Industrial Research, New Delhi, India.; Recipient of a J. C. Bose National Fellowship from the Department of Science and Technology, Government of India.; We thank T. Ramakrishna, T. K. Chowdary, Z. Kamal, and B. Raman for insightful discussion and critical reading of the manuscript. A. K. S. and K. V. R. C. acknowledge the facilities provided by the National Facility for High Field NMR, supported by Department of Science and Technology, Department of Biotechnology, Council of Scientific and Industrial Research, New Delhi, India, and Tata Institute of Fundamental Research, Mumbai, India.	Aronoff-Spencer E, 2000, BIOCHEMISTRY-US, V39, P13760, DOI 10.1021/bi001472t; Badrick AC, 2009, J INORG BIOCHEM, V103, P1169, DOI 10.1016/j.jinorgbio.2009.06.005; BALDWIN MA, 1994, PHILOS T ROY SOC B, V343, P435, DOI 10.1098/rstb.1994.0041; Banci L, 2002, ADV PROTEIN CHEM, V60, P397; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernado P, 2010, EUR BIOPHYS J BIOPHY, V39, P769, DOI 10.1007/s00249-009-0549-3; Bocharova OV, 2005, BIOCHEMISTRY-US, V44, P6776, DOI 10.1021/bi050251q; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 2002, MOL BIOTECHNOL, V22, P165, DOI 10.1385/MB:22:2:165; Brown DR, 2004, J INORG BIOCHEM, V98, P133, DOI 10.1016/j.jinorgbio.2003.09.006; Cereghetti GM, 2001, BIOPHYS J, V81, P516, DOI 10.1016/S0006-3495(01)75718-9; Cereghetti GM, 2003, BIOPHYS J, V84, P1985, DOI 10.1016/S0006-3495(03)75007-3; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Chattopadhyay M, 2005, J AM CHEM SOC, V127, P12647, DOI 10.1021/ja053254z; Colombo MC, 2008, PROTEINS, V70, P1084, DOI 10.1002/prot.21604; Cooper A, 2001, BIOPHYS CHEM, V93, P215, DOI 10.1016/S0301-4622(01)00222-8; Di Natale G, 2005, INORG CHEM, V44, P7214, DOI 10.1021/ic050754k; Di Natale G, 2009, INORG CHEM, V48, P4239, DOI 10.1021/ic802190v; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Giese A, 2004, BIOCHEM BIOPH RES CO, V320, P1240, DOI 10.1016/j.bbrc.2004.06.075; Guinier A., 1955, SMALL ANGLE SCATTERI, P5; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Hasnain SS, 2001, J MOL BIOL, V311, P467, DOI 10.1006/jmbi.2001.4795; Hodak M, 2009, P NATL ACAD SCI USA, V106, P11576, DOI 10.1073/pnas.0903807106; Hornemann S, 2009, J BIOL CHEM, V284, P22713, DOI 10.1074/jbc.M109.000430; Hortells P, 2010, ZOONOSES PUBLIC HLTH, V57, P358, DOI 10.1111/j.1863-2378.2009.01230.x; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Jones CE, 2004, J BIOL CHEM, V279, P32018, DOI 10.1074/jbc.M403467200; Kachel N, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-16; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Leclerc E, 2006, ARCH VIROL, V151, P2103, DOI 10.1007/s00705-006-0804-1; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li RL, 2000, J MOL BIOL, V301, P567, DOI 10.1006/jmbi.2000.3986; LUMRY R, 1970, BIOPOLYMERS, V9, P1125, DOI 10.1002/bip.1970.360091002; Miura T, 1996, FEBS LETT, V396, P248, DOI 10.1016/0014-5793(96)01104-0; Monnet C, 2004, FEBS LETT, V576, P114, DOI 10.1016/j.febslet.2004.08.076; Morrissey MP, 1999, P NATL ACAD SCI USA, V96, P11293, DOI 10.1073/pnas.96.20.11293; Nadal RC, 2009, BIOCHEMISTRY-US, V48, P8929, DOI 10.1021/bi9011397; Nishina K, 2004, J BIOL CHEM, V279, P40788, DOI 10.1074/jbc.M406548200; Norstrom EM, 2006, J VIROL, V80, P8521, DOI 10.1128/JVI.00366-06; Orem NR, 2006, J NEUROCHEM, V96, P1409, DOI 10.1111/j.1471-4159.2006.03650.x; Osz K, 2007, CHEM-EUR J, V13, P7129, DOI 10.1002/chem.200601568; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Perez DR, 2010, J MOL BIOL, V400, P121, DOI 10.1016/j.jmb.2010.04.066; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Quaglio E, 2001, J BIOL CHEM, V276, P11432, DOI 10.1074/jbc.M009666200; Redecke L, 2007, J STRUCT BIOL, V157, P308, DOI 10.1016/j.jsb.2006.06.013; Ricchelli F, 2006, BIOCHEMISTRY-US, V45, P6724, DOI 10.1021/bi0601454; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwarzinger S, 2006, J BIOMOL STRUCT DYN, V23, P581, DOI 10.1080/07391102.2006.10507083; Sigurdsson EM, 2003, J BIOL CHEM, V278, P46199, DOI 10.1074/jbc.C300303200; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; Stevens DJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000390; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TAGLIAVINI F, 1993, P NATL ACAD SCI USA, V90, P9678, DOI 10.1073/pnas.90.20.9678; Thakur AK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002688; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Tsiroulnikov K, 2006, BBA-PROTEINS PROTEOM, V1764, P1218, DOI 10.1016/j.bbapap.2006.04.013; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Watanabe Y, 2010, BIOCHEM BIOPH RES CO, V394, P522, DOI 10.1016/j.bbrc.2010.03.003; Watzlawik J, 2006, J BIOL CHEM, V281, P30242, DOI 10.1074/jbc.M605141200; Yu SL, 2008, FEBS J, V275, P5564, DOI 10.1111/j.1742-4658.2008.06680.x; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zahn R, 2003, J MOL BIOL, V334, P477, DOI 10.1016/j.jmb.2003.09.048; Ziegler J, 2006, FEBS LETT, V580, P2033, DOI 10.1016/j.febslet.2006.03.002	73	54	54	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38533	38545		10.1074/jbc.M111.265645	http://dx.doi.org/10.1074/jbc.M111.265645			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900252	hybrid, Green Published			2022-12-25	WOS:000296594200067
J	Pourebrahim, R; Houtmeyers, R; Ghogomu, S; Janssens, S; Thelie, A; Tran, HT; Langenberg, T; Vleminckx, K; Bellefroid, E; Cassiman, JJ; Tejpar, S				Pourebrahim, Rasoul; Houtmeyers, Rob; Ghogomu, Stephen; Janssens, Sylvie; Thelie, Aurore; Hong Thi Tran; Langenberg, Tobias; Vleminckx, Kris; Bellefroid, Eric; Cassiman, Jean-Jacques; Tejpar, Sabine			Transcription Factor Zic2 Inhibits Wnt/beta-Catenin Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; BETA-CATENIN; POLY(ADP-RIBOSE) POLYMERASE-1; XENOPUS-LAEVIS; WNT; GENE; ACTIVATION; EXPRESSION; MUTATIONS; HINDBRAIN	The Zic transcription factors play critical roles during embryonic development. Mutations in the ZIC2 gene are associated with human holoprosencephaly, but the etiology is still unclear. Here, we report a novel function for ZIC2 as a regulator of beta-catenin.TCF4-mediated transcription. We show that ZIC2 can bind directly to the DNA-binding high mobility group box of TCF4 via its zinc finger domain and inhibit the transcriptional activity of the beta-catenin.TCF4 complex. However, the binding of TCF4 to DNA was not affected by ZIC2. Zic2 RNA injection completely inhibited beta-catenin-induced axis duplication in Xenopus embryos and strongly blocked the ability of beta-catenin to induce expression of known Wnt targets in animal caps. Moreover, Zic2 knockdown in transgenic Xenopus Wnt reporter embryos led to ectopic Wnt signaling activity mainly at the midbrain-hindbrain boundary. Together, our results demonstrate a previously unknown role for ZIC2 as a transcriptional regulator of the beta-catenin.TCF4 complex.	[Pourebrahim, Rasoul; Houtmeyers, Rob; Cassiman, Jean-Jacques; Tejpar, Sabine] Katholieke Univ Leuven, Dept Human Genet, B-3000 Louvain, Belgium; [Tejpar, Sabine] Katholieke Univ Leuven, Dept Gastroenterol, B-3000 Louvain, Belgium; [Ghogomu, Stephen; Thelie, Aurore; Bellefroid, Eric] Univ Libre Bruxelles, Lab Embryol Mol, B-6041 Gosselies, Belgium; [Langenberg, Tobias] VRC, B-3000 Louvain, Belgium; [Janssens, Sylvie; Hong Thi Tran; Vleminckx, Kris] Univ Ghent, Dept Mol Biomed Res, VIB, B-9052 Ghent, Belgium; [Janssens, Sylvie; Hong Thi Tran; Vleminckx, Kris] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium	KU Leuven; KU Leuven; Universite Libre de Bruxelles; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Tejpar, S (corresponding author), Katholieke Univ Leuven, Dept Human Genet, O&N1, B-3000 Louvain, Belgium.	sabine.tejpar@med.kuleuven.be	Tran, Hong/C-6831-2015; Vleminckx, Kris/J-5699-2013; Ghogomu, Stephen/AAF-6825-2020	Houtmeyers, Rob/0000-0002-1126-6010; THELIE, Aurore/0000-0002-2951-2523; Pourebrahim, Rasoul/0000-0003-1175-2032	Belgian Federation	Belgian Federation	Supported by research grants from the Belgian Federation against Cancer. S. T. is senior clinical investigator for the Fund for Scientific Research-Flanders (FWO). To whom correspondence should be addressed: Katholieke Universiteit Leuven, O&N1, 3000 Leuven, Belgium. Tel.: 32-16-345-860; Fax: 32-16-345-997; E-mail: sabine.tejpar@med.kuleuven.be.	Aoki M, 1999, P NATL ACAD SCI USA, V96, P139, DOI 10.1073/pnas.96.1.139; Aruga J, 1998, J NEUROSCI, V18, P284; Aruga J, 2011, NEUROCHEM RES, V36, P1286, DOI 10.1007/s11064-011-0422-5; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; Bellefroid EJ, 1996, CELL, V87, P1191, DOI 10.1016/S0092-8674(00)81815-2; BENEDYK MJ, 1994, GENE DEV, V8, P105, DOI 10.1101/gad.8.1.105; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Brannon M, 1999, DEVELOPMENT, V126, P3159; Brown L, 2005, HUM MOL GENET, V14, P411, DOI 10.1093/hmg/ddi037; Brown L, 2009, GENE EXPR PATTERNS, V9, P43, DOI 10.1016/j.gep.2008.08.002; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; Buckles GR, 2004, MECH DEVELOP, V121, P437, DOI 10.1016/j.mod.2004.03.026; CUI YZ, 1995, DEVELOPMENT, V121, P2177; Elms P, 2003, DEV BIOL, V264, P391, DOI 10.1016/j.ydbio.2003.09.005; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; Heeg-Truesdell E, 2006, DEV BIOL, V298, P71, DOI 10.1016/j.ydbio.2006.06.015; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Houston DW, 2005, DEVELOPMENT, V132, P4845, DOI 10.1242/dev.02066; Idogawa M, 2005, GASTROENTEROLOGY, V128, P1919, DOI 10.1053/j.gastro.2005.03.007; Idogawa M, 2007, CANCER RES, V67, P911, DOI 10.1158/0008-5472.CAN-06-2360; Inoue T, 2007, DEV BIOL, V306, P669, DOI 10.1016/j.ydbio.2007.04.003; Ishiguro A, 2007, J BIOL CHEM, V282, P9983, DOI 10.1074/jbc.M610821200; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kong XB, 2009, IN VITRO CELL DEV-AN, V45, P185, DOI 10.1007/s11626-008-9157-2; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Mahmoudi T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000539; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; MCGREW LL, 1992, DEVELOPMENT, V115, P463; Merzdorf CS, 2006, INT J DEV BIOL, V50, P611, DOI 10.1387/ijdb.052110cm; Mizugishi K, 2004, BIOCHEM BIOPH RES CO, V320, P233, DOI 10.1016/j.bbrc.2004.05.158; Moens CB, 2002, DEV DYNAM, V224, P1, DOI 10.1002/dvdy.10086; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Salero E, 2001, J BIOL CHEM, V276, P1881, DOI 10.1074/jbc.M007008200; Sen A, 2010, DEV BIOL, V343, P167, DOI 10.1016/j.ydbio.2010.04.003; Snider L, 2001, MOL CELL BIOL, V21, P1866, DOI 10.1128/MCB.21.5.1866-1873.2001; Tran HT, 2010, P NATL ACAD SCI USA, V107, P16160, DOI 10.1073/pnas.1007725107; Vleminckx K, 1999, MECH DEVELOP, V81, P65, DOI 10.1016/S0925-4773(98)00225-1; Warr N, 2008, HUM MOL GENET, V17, P2986, DOI 10.1093/hmg/ddn197; WOLDA SL, 1993, DEV BIOL, V155, P46, DOI 10.1006/dbio.1993.1005; Yang Y, 2000, J BIOL CHEM, V275, P38863, DOI 10.1074/jbc.M007906200	44	58	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37732	37740		10.1074/jbc.M111.242826	http://dx.doi.org/10.1074/jbc.M111.242826			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21908606	Green Published, hybrid			2022-12-25	WOS:000296542400069
J	Ganguly, A; Yang, HL; Pedroza, M; Bhattacharya, R; Cabral, F				Ganguly, Anutosh; Yang, Hailing; Pedroza, Mesias; Bhattacharya, Rajat; Cabral, Fernando			Mitotic Centromere-associated Kinesin (MCAK) Mediates Paclitaxel Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-TUBULIN ISOTYPES; HAMSTER OVARY CELLS; MICROTUBULE DYNAMIC INSTABILITY; CONFERS RESISTANCE; DEPENDENT MUTANTS; SPINDLE FORMATION; MEIOTIC SPINDLE; ALPHA-TUBULIN; CENTROSOME; EXPRESSION	Paclitaxel has powerful anticancer activity, but some tumors are inherently resistant to the drug, whereas others are initially sensitive but acquire resistance during treatment. To deal with this problem, it will be necessary to understand the mechanisms of drug action and resistance. Recent studies indicate that paclitaxel blocks cell division by inhibiting the detachment of micro-tubules from centrosomes. Here, we demonstrate that mitotic centromere-associated kinesin (MCAK), a kinesin-related protein that destabilizes microtubules, plays an important role in microtubule detachment. Depletion of MCAK altered mitotic spindle morphology, increased the frequency of lagging chromosomes, and inhibited the proliferation of WT CHO cells, confirming that it is an essential protein for cell division. In contrast, MCAK depletion rescued the proliferation of mutant paclitaxel-dependent cell lines that are unable to divide because of defective spindle function resulting from altered alpha-tubulin or class III beta-tubulin overexpression. In concert with the correction of mitotic defects, loss of MCAK reversed an aberrantly high frequency of microtubule detachment in the mutant cells and increased their sensitivity to paclitaxel. The results indicate that MCAK affects cell sensitivity to mitotic inhibitors by modulating the frequency of microtubule detachment, and they demonstrate that changes in a microtubule-interacting protein can reverse the effects of mutant tubulin expression.	[Ganguly, Anutosh; Yang, Hailing; Pedroza, Mesias; Bhattacharya, Rajat; Cabral, Fernando] Univ Texas Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Cabral, F (corresponding author), Univ Texas Med Sch, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	fernando.r.cabral@uth.tmc.edu		Ganguly, Anutosh/0000-0002-7228-7827; Bhattacharya, Rajat/0000-0001-5693-6754	National Institutes of Health [CA085935]; NATIONAL CANCER INSTITUTE [R01CA085935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA085935 (to F. C.).	Abal M, 2002, J CELL BIOL, V159, P731, DOI 10.1083/jcb.200207076; ABRAHAM I, 1983, J CELL BIOL, V97, P1055, DOI 10.1083/jcb.97.4.1055; Barlow SB, 2002, J CELL SCI, V115, P3469; Blade K, 1999, J CELL SCI, V112, P2213; Burbank KS, 2006, J CELL BIOL, V175, P369, DOI 10.1083/jcb.200511112; CABRAL F, 1991, PHARMACOL THERAPEUT, V52, P159, DOI 10.1016/0163-7258(91)90006-8; CABRAL F, 1980, CELL, V20, P29, DOI 10.1016/0092-8674(80)90231-7; Cabral F., 2000, DRUG RESIST UPDATE, V3, P1; Cabral Fernando, 2008, P337, DOI 10.1007/978-1-59745-336-3_14; CABRAL FR, 1983, J CELL BIOL, V97, P22, DOI 10.1083/jcb.97.1.22; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Ems-McClung SC, 2010, SEMIN CELL DEV BIOL, V21, P276, DOI 10.1016/j.semcdb.2010.01.016; Gaglio T, 1997, J CELL BIOL, V138, P1055, DOI 10.1083/jcb.138.5.1055; Ganguly A, 2008, CELL CYCLE, V7, P3187, DOI 10.4161/cc.7.20.6814; Ganguly A, 2011, MOL CANCER THER, V10, P929, DOI 10.1158/1535-7163.MCT-10-1109; Ganguly A, 2010, MOL CANCER THER, V9, P2914, DOI 10.1158/1535-7163.MCT-10-0552; Gonzalez-Garay ML, 1999, J BIOL CHEM, V274, P23875, DOI 10.1074/jbc.274.34.23875; Hari M, 2003, CELL MOTIL CYTOSKEL, V56, P45, DOI 10.1002/cm.10132; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Keating TJ, 1997, P NATL ACAD SCI USA, V94, P5078, DOI 10.1073/pnas.94.10.5078; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Kline-Smith SL, 2002, MOL BIOL CELL, V13, P2718, DOI 10.1091/mbc.E01-12-0143; KUNG AL, 1990, P NATL ACAD SCI USA, V87, P9553, DOI 10.1073/pnas.87.24.9553; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; LOPATA MA, 1987, J CELL BIOL, V105, P1707, DOI 10.1083/jcb.105.4.1707; Luduena RF, 1998, INT REV CYTOL, V178, P207; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; OLSON KR, 1995, J CELL BIOL, V130, P639, DOI 10.1083/jcb.130.3.639; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; Rizk RS, 2009, MOL BIOL CELL, V20, P1639, DOI 10.1091/mbc.E08-09-0985; Rusan NM, 2005, J CELL BIOL, V168, P21, DOI 10.1083/jcb.200409153; SAWADA T, 1989, J BIOL CHEM, V264, P3013; SCHIBLER MJ, 1986, J CELL BIOL, V102, P1522, DOI 10.1083/jcb.102.4.1522; Srayko M, 2006, CURR BIOL, V16, P1944, DOI 10.1016/j.cub.2006.08.029; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; SULLIVAN KF, 1988, ANNU REV CELL BIOL, V4, P687, DOI 10.1146/annurev.cb.04.110188.003351; Tulu US, 2003, CURR BIOL, V13, P1894, DOI 10.1016/j.cub.2003.10.002; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Yang G, 2007, NAT CELL BIOL, V9, P1233, DOI 10.1038/ncb1643; Yang HL, 2010, J BIOL CHEM, V285, P32242, DOI 10.1074/jbc.M110.160820	44	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36378	36384		10.1074/jbc.M111.296483	http://dx.doi.org/10.1074/jbc.M111.296483			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21903575	Green Published, hybrid			2022-12-25	WOS:000296538300023
J	Lin, MY; Pedrosa, E; Shah, A; Hrabovsky, A; Maqbool, S; Zheng, DY; Lachman, HM				Lin, Mingyan; Pedrosa, Erika; Shah, Abhishek; Hrabovsky, Anastasia; Maqbool, Shahina; Zheng, Deyou; Lachman, Herbert M.			RNA-Seq of Human Neurons Derived from iPS Cells Reveals Candidate Long Non-Coding RNAs Involved in Neurogenesis and Neuropsychiatric Disorders	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; GENOME-WIDE ASSOCIATION; GLYCOGEN-SYNTHASE KINASE-3; AUTISM SPECTRUM DISORDER; CART MESSENGER-RNA; GENE-EXPRESSION; BIPOLAR DISORDER; HUMAN BRAIN; SCHIZOPHRENIA SUSCEPTIBILITY; EUROPEAN ANCESTRY	Genome-wide expression analysis using next generation sequencing (RNA-Seq) provides an opportunity for in-depth molecular profiling of fundamental biological processes, such as cellular differentiation and malignant transformation. Differentiating human neurons derived from induced pluripotent stem cells (iPSCs) provide an ideal system for RNA-Seq since defective neurogenesis caused by abnormalities in transcription factors, DNA methylation, and chromatin modifiers lie at the heart of some neuropsychiatric disorders. As a preliminary step towards applying next generation sequencing using neurons derived from patient-specific iPSCs, we have carried out an RNA-Seq analysis on control human neurons. Dramatic changes in the expression of coding genes, long non-coding RNAs (lncRNAs), pseudogenes, and splice isoforms were seen during the transition from pluripotent stem cells to early differentiating neurons. A number of genes that undergo radical changes in expression during this transition include candidates for schizophrenia (SZ), bipolar disorder (BD) and autism spectrum disorders (ASD) that function as transcription factors and chromatin modifiers, such as POU3F2 and ZNF804A, and genes coding for cell adhesion proteins implicated in these conditions including NRXN1 and NLGN1. In addition, a number of novel lncRNAs were found to undergo dramatic changes in expression, one of which is HOTAIRM1, a regulator of several HOXA genes during myelopoiesis. The increase we observed in differentiating neurons suggests a role in neurogenesis as well. Finally, several lncRNAs that map near SNPs associated with SZ in genome wide association studies also increase during neuronal differentiation, suggesting that these novel transcripts may be abnormally regulated in a subgroup of patients.	[Lin, Mingyan; Maqbool, Shahina; Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Pedrosa, Erika; Shah, Abhishek; Hrabovsky, Anastasia; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dominick Purpura Dept Neurosci, Bronx, NY 10467 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Lachman, Herbert M.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Lin, MY (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	Herb.Lachman@einstein.yu.edu	lin, mingyan/HDL-9420-2022	Zheng, Deyou/0000-0003-4354-5337	National Institute of Mental Health (NIMH) [MH087840, MH073164]; National Heart, Lung and Blood Institute (NHLBI) [HL104444]; Einstein Pluripotent Stem Cell Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL104444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087840, R01MH073164, R33MH087840] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Einstein Pluripotent Stem Cell Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Dr. Lachman is supported by grants from the National Institute of Mental Health (NIMH) (MH087840 and MH073164). Dr. Zheng is supported by a grant from NIMH(MH087840) and the National Heart, Lung and Blood Institute (NHLBI) (HL104444). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Epigenomic Shared Facility and Computational Genomics Core Facility for help in carrying out the RNA-Seq analysis and preliminary computational work, and the Einstein Pluripotent Stem Cell Center for their advice and support.	Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Alekseev OM, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-50; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Anselme I, 2007, DEV BIOL, V304, P208, DOI 10.1016/j.ydbio.2006.12.025; Arion D, 2010, NEUROBIOL DIS, V37, P738, DOI 10.1016/j.nbd.2009.12.013; Barnett JH, 2009, NEUROSCIENCE, V164, P331, DOI 10.1016/j.neuroscience.2009.03.080; Bartnik M, 2011, CLIN GENET, V80, P191, DOI 10.1111/j.1399-0004.2010.01526.x; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Bosley TM, 2007, NEUROLOGY, V69, P1245, DOI 10.1212/01.wnl.0000276947.59704.cf; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Bruck T, 2011, STEM CELL RES, V6, P187, DOI 10.1016/j.scr.2010.12.001; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Butler JT, 2009, J CELL BIOCHEM, V107, P609, DOI 10.1002/jcb.22183; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Chiang CH, 2011, MOL PSYCHIATR, V16, P358, DOI 10.1038/mp.2011.13; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Chu TT, 2010, J HUM GENET, V55, P285, DOI 10.1038/jhg.2010.24; Cohen DR, 2000, MECH DEVELOP, V91, P317, DOI 10.1016/S0925-4773(99)00263-4; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; de la Cruz JM, 2002, HUM GENET, V110, P422, DOI 10.1007/s00439-002-0709-3; Deep-Soboslay A, 2008, BIPOLAR DISORD, V10, P822, DOI 10.1111/j.1399-5618.2008.00607.x; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Eberhart CG, 2006, J AUTISM DEV DISORD, V36, P1131, DOI 10.1007/s10803-006-0135-9; Fagergren P, 2007, PHYSIOL BEHAV, V92, P218, DOI 10.1016/j.physbeh.2007.05.027; Feng JX, 2011, J COMPUT BIOL, V18, P305, DOI 10.1089/cmb.2010.0243; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Ghosh G, 2011, FEBS J, V278, P587, DOI 10.1111/j.1742-4658.2010.07992.x; Ginsberg SD, 2006, PROG BRAIN RES, V158, P15, DOI 10.1016/S0079-6123(06)58002-1; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Glaser B, 2005, MOL PSYCHIATR, V10, P920, DOI 10.1038/sj.mp.4001689; Glaser B, 2006, SCHIZOPHR RES, V87, P21, DOI 10.1016/j.schres.2006.05.024; Gould TD, 2006, CURR DRUG TARGETS, V7, P1399, DOI 10.2174/1389450110607011399; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Hentschke M, 2006, J BIOL CHEM, V281, P33497, DOI 10.1074/jbc.M606975200; Hill C, 1996, AM J PSYCHIAT, V153, P533; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunter RG, 2007, BRAIN RES, V1152, P234, DOI 10.1016/j.brainres.2007.03.042; Ingason A, 2011, MOL PSYCHIATR, V16, P17, DOI 10.1038/mp.2009.101; Ingason A, 2011, AM J PSYCHIAT, V168, P408, DOI 10.1176/appi.ajp.2010.09111660; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Johansson H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013678; Kang YH, 2008, J BIOL CHEM, V283, P2323, DOI 10.1074/jbc.M703957200; Kastler S, 2010, PROSTATE, V70, P666, DOI 10.1002/pros.21100; Khachane AN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010316; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim DH, 2011, SEMIN CELL DEV BIOL, V22, P336, DOI 10.1016/j.semcdb.2011.02.025; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2009, MOL PSYCHIATR, V14, P796, DOI 10.1038/mp.2008.33; Koziol MJ, 2007, CURR BIOL, V17, P801, DOI 10.1016/j.cub.2007.03.062; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; Kurotani R, 2011, LUNG CANCER, V71, P42, DOI 10.1016/j.lungcan.2010.04.001; Lachman HM, 2007, HUM MOL GENET, V16, P1327, DOI 10.1093/hmg/ddm081; Le-Niculescu H, 2007, AM J MED GENET B, V144B, P129, DOI 10.1002/ajmg.b.30481; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lee MTM, 2011, MOL PSYCHIATR, V16, P548, DOI 10.1038/mp.2010.43; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Liu Y, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/536918; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Magri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013422; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marchetto MCN, 2010, HUM MOL GENET, V19, pR71, DOI 10.1093/hmg/ddq159; Marikawa Y, 2011, STEM CELLS DEV, V20, P621, DOI 10.1089/scd.2010.0209; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MCCARREY JR, 1986, P NATL ACAD SCI USA, V83, P679, DOI 10.1073/pnas.83.3.679; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Meisler MH, 2010, J PHYSIOL-LONDON, V588, P1841, DOI 10.1113/jphysiol.2010.188482; Mercer TR, 2008, NEUROSCIENTIST, V14, P434, DOI 10.1177/1073858408319187; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-14; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Moreno-De-Luca D, 2010, AM J HUM GENET, V87, P618, DOI 10.1016/j.ajhg.2010.10.004; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Nizzardo M, 2010, CELL MOL LIFE SCI, V67, P3837, DOI 10.1007/s00018-010-0463-y; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; O'Donovan MC, 2009, HUM GENET, V126, P3, DOI 10.1007/s00439-009-0703-0; O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pal P, 2009, PROSTATE, V69, P1548, DOI 10.1002/pros.20999; Pedrosa E, 2007, AM J MED GENET B, V144B, P45, DOI 10.1002/ajmg.b.30386; Pedrosa E, 2010, J NEUROGENET, V24, P182, DOI 10.3109/01677063.2010.495182; Pedrosa E, 2010, J NEUROGENET, V24, P5, DOI 10.3109/01677060903305658; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P96, DOI 10.1093/schbul/sbn155; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Qureshi IA, 2010, ANN NY ACAD SCI, V1204, pE20, DOI 10.1111/j.1749-6632.2010.05718.x; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rogge G, 2008, NAT REV NEUROSCI, V9, P747, DOI 10.1038/nrn2493; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; Singer T, 2010, TRENDS NEUROSCI, V33, P345, DOI 10.1016/j.tins.2010.04.001; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Sun C, 2008, BIOCHEM BIOPH RES CO, V377, P215, DOI 10.1016/j.bbrc.2008.09.113; Sun H, 2011, INT REV CEL MOL BIO, V288, P1, DOI 10.1016/B978-0-12-386041-5.00001-7; Swistowski A, 2010, STEM CELLS, V28, P1893, DOI 10.1002/stem.499; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tischfield MA, 2005, NAT GENET, V37, P1035, DOI 10.1038/ng1636; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; van Neerven S, 2008, PROG NEUROBIOL, V85, P433, DOI 10.1016/j.pneurobio.2008.04.006; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wang KS, 2010, SCHIZOPHR RES, V124, P192, DOI 10.1016/j.schres.2010.09.002; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Weiss LA, 2003, MOL PSYCHIATR, V8, P186, DOI 10.1038/sj.mp.4001241; Weiss LA, 2009, EXPERT REV MOL DIAGN, V9, P795, DOI 10.1586/ERM.09.59; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Williams HJ, 2009, J HUM GENET, V54, P9, DOI 10.1038/jhg.2008.7; Williams JM, 2009, AM J MED GENET A, V149A, P1758, DOI 10.1002/ajmg.a.32941; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Xu CA, 2011, INT J ONCOL, V39, P169, DOI 10.3892/ijo.2011.1007; Yanagida M, 2001, PROTEOMICS, V1, P1390, DOI 10.1002/1615-9861(200111)1:11<1390::AID-PROT1390>3.0.CO;2-Z; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16; Zhang D, 2007, J NEUROSCI RES, V85, P3515, DOI 10.1002/jnr.21356; Zhang XQ, 2009, BLOOD, V113, P2526, DOI 10.1182/blood-2008-06-162164; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307; Zollino M, 2011, EUR J HUM GENET, V19, P239, DOI 10.1038/ejhg.2010.172; Zoltewicz JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006191; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	140	162	179	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e23356	10.1371/journal.pone.0023356	http://dx.doi.org/10.1371/journal.pone.0023356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915259	gold, Green Published, Green Submitted			2022-12-25	WOS:000294802500011
J	Mouliere, F; Robert, B; Peyrotte, EA; Del Rio, M; Ychou, M; Molina, F; Gongora, C; Thierry, AR				Mouliere, Florent; Robert, Bruno; Peyrotte, Erika Arnau; Del Rio, Maguy; Ychou, Marc; Molina, Franck; Gongora, Celine; Thierry, Alain R.			High Fragmentation Characterizes Tumour-Derived Circulating DNA	PLOS ONE			English	Article							CELL-FREE DNA; COLORECTAL-CANCER; PLASMA DNA; NUCLEIC-ACIDS; ORIGIN; SERUM; MUTATIONS; INTEGRITY; BIOMARKER; BLOOD	Background: Circulating DNA (ctDNA) is acknowledged as a potential diagnostic tool for various cancers including colorectal cancer, especially when considering the detection of mutations. Certainly due to lack of normalization of the experimental conditions, previous reports present many discrepancies and contradictory data on the analysis of the concentration of total ctDNA and on the proportion of tumour-derived ctDNA fragments. Methodology: In order to rigorously analyse ctDNA, we thoroughly investigated ctDNA size distribution. We used a highly specific Q-PCR assay and athymic nude mice xenografted with SW620 or HT29 human colon cancer cells, and we correlated our results by examining plasma from metastatic CRC patients. Conclusion/Significance: Fragmentation and concentration of tumour-derived ctDNA is positively correlated with tumour weight. CtDNA quantification by Q-PCR depends on the amplified target length and is optimal for 60-100 bp fragments. Q-PCR analysis of plasma samples from xenografted mice and cancer patients showed that tumour-derived ctDNA exhibits a specific amount profile based on ctDNA size and significant higher ctDNA fragmentation. Metastatic colorectal patients (n = 12) showed nearly 5-fold higher mean ctDNA fragmentation than healthy individuals (n = 16).	[Mouliere, Florent; Peyrotte, Erika Arnau; Molina, Franck; Thierry, Alain R.] Natl Ctr Sci Res BIO RAD, CNRS, SysDiag UMR3145, Montpellier, France; [Robert, Bruno; Del Rio, Maguy; Gongora, Celine] Univ Montpellier 1, Natl Inst Hlth & Med Res, Inst Oncol Res Montpellier, IRCM,INSERM,U896, Montpellier, France; [Ychou, Marc] Reg Canc Ctr, CRLC, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Universite de Montpellier	Mouliere, F (corresponding author), Natl Ctr Sci Res BIO RAD, CNRS, SysDiag UMR3145, Montpellier, France.	alain.thierry@sysdiag.cnrs.fr	Mouliere, Florent/H-7119-2019; ROBERT, Bruno/AAB-7581-2020; thierry, alain/F-9492-2014	Mouliere, Florent/0000-0001-7043-0514; ROBERT, Bruno/0000-0001-5573-6945; Ychou, Marc/0000-0001-7378-9469; GONGORA, Celine/0000-0001-9034-4031	INSERM (France); CNRS; Region of Languedoc-Roussillon [CNRS044406]; GEFLUC (France)	INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Region of Languedoc-Roussillon(Region Occitanie); GEFLUC (France)	A.R. Thierry is supported by INSERM (France). F. Mouliere is supported by a grant from the CNRS and the Region of Languedoc-Roussillon (CNRS044406). The study was granted from the GEFLUC (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi J, 2001, INT J ONCOL, V18, P1085; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Deligezer U, 2006, EXP MOL PATHOL, V80, P72, DOI 10.1016/j.yexmp.2005.05.001; Deligezer U, 2008, CLIN CHEM LAB MED, V46, P311, DOI 10.1515/CCLM.2008.080; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Ellinger J, 2008, INT J CANCER, V122, P138, DOI 10.1002/ijc.23057; Ellinger J, 2009, BJU INT, V104, P48, DOI 10.1111/j.1464-410X.2008.08289.x; Ellinger J, 2009, J UROLOGY, V181, P363, DOI 10.1016/j.juro.2008.08.118; Flamini E, 2006, CLIN CANCER RES, V12, P6985, DOI 10.1158/1078-0432.CCR-06-1931; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Frattini M, 2008, CANCER LETT, V263, P170, DOI 10.1016/j.canlet.2008.03.021; Gongora C, 2008, CANCER BIOL THER, V7, P822, DOI 10.4161/cbt.7.6.5838; Gormally E, 2004, INT J CANCER, V111, P746, DOI 10.1002/ijc.20327; Guadalajara H, 2008, CANCER DETECT PREV, V32, P39, DOI 10.1016/j.cdp.2008.01.002; Holdenrieder S, 2005, ANTICANCER RES, V25, P1795; Jahr S, 2001, CANCER RES, V61, P1659; Jung K, 2010, CLIN CHIM ACTA, V411, P1611, DOI 10.1016/j.cca.2010.07.032; Liu KJ, 2010, J AM CHEM SOC, V132, P5793, DOI 10.1021/ja100342q; Mamon H, 2008, CLIN CHEM, V54, P1582, DOI 10.1373/clinchem.2008.104612; Mori Sayaka, 2007, Lab Hematol, V13, P1, DOI 10.1532/LH96.06031; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Schmidt B, 2008, ANN NY ACAD SCI, V1137, P207, DOI 10.1196/annals.1448.034; Schwarzenbach H, 2008, ANN NY ACAD SCI, V1137, P190, DOI 10.1196/annals.1448.025; Smith G, 2002, P NATL ACAD SCI USA, V99, P9433, DOI 10.1073/pnas.122612899; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; Thierry AR, 2010, NUCLEIC ACIDS RES, V38, P6159, DOI 10.1093/nar/gkq421; Umetani N, 2006, J CLIN ONCOL, V24, P4270, DOI 10.1200/JCO.2006.05.9493; van der Vaart M, 2008, ANN NY ACAD SCI, V1137, P18, DOI 10.1196/annals.1448.022; Wang BG, 2003, CANCER RES, V63, P3966	31	341	378	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e23418	10.1371/journal.pone.0023418	http://dx.doi.org/10.1371/journal.pone.0023418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21909401	Green Published, Green Submitted, gold			2022-12-25	WOS:000294689200006
J	Burn, RW; Underwood, FM; Blanc, J				Burn, Robert W.; Underwood, Fiona M.; Blanc, Julian			Global Trends and Factors Associated with the Illegal Killing of Elephants: A Hierarchical Bayesian Analysis of Carcass Encounter Data	PLOS ONE			English	Article							IVORY SALES; BIODIVERSITY; POPULATIONS; GOVERNANCE; MORTALITY; TRADE	Elephant poaching and the ivory trade remain high on the agenda at meetings of the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES). Well-informed debates require robust estimates of trends, the spatial distribution of poaching, and drivers of poaching. We present an analysis of trends and drivers of an indicator of elephant poaching of all elephant species. The site-based monitoring system known as Monitoring the Illegal Killing of Elephants (MIKE), set up by the 10(th) Conference of the Parties of CITES in 1997, produces carcass encounter data reported mainly by anti-poaching patrols. Data analyzed were site by year totals of 6,337 carcasses from 66 sites in Africa and Asia from 2002-2009. Analysis of these observational data is a serious challenge to traditional statistical methods because of the opportunistic and non-random nature of patrols, and the heterogeneity across sites. Adopting a Bayesian hierarchical modeling approach, we used the proportion of carcasses that were illegally killed (PIKE) as a poaching index, to estimate the trend and the effects of site-and country-level factors associated with poaching. Important drivers of illegal killing that emerged at country level were poor governance and low levels of human development, and at site level, forest cover and area of the site in regions where human population density is low. After a drop from 2002, PIKE remained fairly constant from 2003 until 2006, after which it increased until 2008. The results for 2009 indicate a decline. Sites with PIKE ranging from the lowest to the highest were identified. The results of the analysis provide a sound information base for scientific evidence-based decision making in the CITES process.	[Burn, Robert W.; Underwood, Fiona M.] Univ Reading, Sch Math & Phys Sci, Dept Math & Stat, Reading, Berks, England; [Blanc, Julian] UNEP DELC, CITES Secretariat, Nairobi, Kenya	University of Reading	Burn, RW (corresponding author), Univ Reading, Sch Math & Phys Sci, Dept Math & Stat, Reading, Berks, England.	f.m.underwood@reading.ac.uk	; Underwood, Fiona/O-6072-2016	Blanc, Julian/0000-0003-4331-5339; Underwood, Fiona/0000-0001-8701-7136	European Commission; MIKE	European Commission(European CommissionEuropean Commission Joint Research Centre); MIKE	Monitoring the Illegal Killing of Elephants (MIKE) is financed by the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JJB is the data analyst for the MIKE programme. RWB was a resource specialist for MIKE since its inception and then a co-opted member of the MIKE Technical Advisory Group from 2003 to 2009. RWB and FMU were contracted by MIKE to carry out the analysis of the data presented in this publication for a report to the 15th meeting of the Conference of the Parties in Doha (Qatar) 2010. This does not alter the author's adherence to all the PLoS ONE policies on sharing data and materials.	Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Balfour D., 2007, REV OPTIONS MANAGING; Barrett CB, 2006, CONSERV BIOL, V20, P1358, DOI 10.1111/j.1523-1739.2006.00521.x; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Blanc Julian J., 2007, AFRICAN ELEPHANT STA; Bulte EH, 2007, J WILDLIFE MANAGE, V71, P613, DOI 10.2193/2005-721; BURN RW, 2007, SIGNIFICANCE, V4, P118; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; DOUGLASHAMILTON I, 1981, ILCA MONOGRAPH, P113; Dublin H.T., 1995, 4 YEARS CITES BAN IL; Dunham KM, 2008, ORYX, V42, P36, DOI 10.1017/S0030605308000471; Gelman A., 2003, BAYESIAN DATA ANAL; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 1006, BAYESIAN ANAL, V1, P515, DOI [10.1214/06-BA117AQ6, DOI 10.1214/06-BA117AQ6]; Kahindi O, 2010, AFR J ECOL, V48, P972, DOI 10.1111/j.1365-2028.2009.01200.x; Keane A, 2011, J APPL ECOL, V48, P1164, DOI 10.1111/j.1365-2664.2011.02034.x; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lemieux AM, 2009, BRIT J CRIMINOL, V49, P451, DOI 10.1093/bjc/azp030; Milner-Gulland, 2007, CONSERVATION SUSTAIN; Royle J. A., 2008, HIERARCHICAL MODELIN; Smith RJ, 2003, NATURE, V426, P67, DOI 10.1038/nature02025; Sudha Vasan, 2002, Economic and Political Weekly, V37, P4125; Van Aarde RJ, 2009, ENVIRON CONSERV, V36, P8, DOI 10.1017/S0376892909005438; Wasser S, 2010, SCIENCE, V327, P1331, DOI 10.1126/science.1187811; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	25	70	72	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24165	10.1371/journal.pone.0024165	http://dx.doi.org/10.1371/journal.pone.0024165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912670	Green Published, Green Submitted, gold			2022-12-25	WOS:000294686100017
J	Darc, M; Hait, SH; Soares, EA; Cicala, C; Seuanez, HN; Machado, ES; Arthos, JA; Soares, MA				Darc, Mirela; Hait, Sabrina H.; Soares, Esmeralda A.; Cicala, Claudia; Seuanez, Hector N.; Machado, Elizabeth S.; Arthos, James A.; Soares, Marcelo A.			Polymorphisms in the alpha 4 Integrin of Neotropical Primates: Insights for Binding of Natural Ligands and HIV-1 gp120 to the Human alpha 4 beta 7	PLOS ONE			English	Article							CYCLOPHILIN-A; EVOLUTION; ADHESION; MONKEY; CELLS; INFECTION; RECEPTOR; VLA-4; RETROTRANSPOSITION; NATALIZUMAB	The alpha 4 integrin subunit associates with beta 7 and beta 1 and plays important roles in immune function and cell trafficking. The gut-homing receptor alpha 4 beta 7 has been recently described as a new receptor for HIV. Here, we describe polymorphisms of ITGA4 gene in New World primates (NWP), and tested their impact on the binding to monoclonal antibodies, natural ligands (MAdCAM and VCAM), and several gp120 HIV-1 envelope proteins. Genomic DNA of NWP specimens comprising all genera of the group had their exons 5 and 6 (encoding the region of binding to the ligands studied) analyzed. The polymorphisms found were introduced into an ITGA4 cDNA clone encoding the human alpha 4 subunit. Mutant alpha 4 proteins were co-expressed with beta 7 and were tested for binding of mAbs, MAdCAM, VCAM and gp120 of HIV-1, which was compared to the wild-type (human) alpha 4. Mutant alpha 4 proteins harboring the K201E/I/N substitution had reduced binding of all ligands tested, including HIV-1 gp120 envelopes. The mAbs found with reduced biding included one from which a clinically-approved drug for the treatment of neurological disorders has been derived. alpha 4 polymorphisms in other primate species may influence outcomes in the development and treatment of infectious and autoimmune diseases in humans and in non-human primates.	[Darc, Mirela; Hait, Sabrina H.; Seuanez, Hector N.; Machado, Elizabeth S.; Soares, Marcelo A.] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil; [Darc, Mirela; Hait, Sabrina H.; Soares, Esmeralda A.; Seuanez, Hector N.; Soares, Marcelo A.] Inst Nacl Canc, Programa Genet, Rio De Janeiro, Brazil; [Cicala, Claudia; Arthos, James A.] NIAID, NIH, Bethesda, MD 20892 USA; [Machado, Elizabeth S.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; National Cancer Institute (Inca); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade Federal do Rio de Janeiro	Darc, M (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil.	masoares@inca.gov.br	Soares, Marcelo A/G-5662-2010		National Institutes of Health; Brazilian Ministry of Education (CAPES); Brazilian Research Council (CNPq) [151595/2008-9]; Rio de Janeiro State Science Foundation (FAPERJ) [E-26/102.858/2008]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000883, ZIAAI000887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brazilian Ministry of Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Science Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MD and SHH were recipients of a National Institutes of Health training grant to sponsor their visiting program at that Institution. Both authors were also sponsored by the Brazilian Ministry of Education (CAPES). This work was developed as part of the requirements of MD and SHH for obtaining their Masters of Sciences degrees at the Graduate Program of Genetics of the Federal University of Rio de Janeiro, Brazil. JAA and CC were supported by the Intramural Research Program of the National Institutes of Health, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was additionally supported by the Brazilian Research Council (CNPq) grant no. 151595/2008-9 and by the Rio de Janeiro State Science Foundation (FAPERJ) grant no. E-26/102.858/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari AA, 2011, J IMMUNOL, V186, P1044, DOI 10.4049/jimmunol.1003052; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Budde ML, 2010, J VIROL, V84, P6344, DOI 10.1128/JVI.00430-10; Coisne C, 2009, J IMMUNOL, V182, P5909, DOI 10.4049/jimmunol.0803418; Colombel Jean Frederic, 2006, Expert Rev Clin Immunol, V2, P677, DOI 10.1586/1744666X.2.5.677; Day ES, 2002, CELL COMMUN ADHES, V9, P205, DOI 10.1080/15419060216014; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dorner M, 2010, J VIROL, V84, P6667, DOI 10.1128/JVI.02675-09; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Edula Raja Gr, 2009, Ther Clin Risk Manag, V5, P935; Engelhardt B, 2008, NEURODEGENER DIS, V5, P16, DOI 10.1159/000109933; Graham KL, 2005, J GEN VIROL, V86, P3397, DOI 10.1099/vir.0.81102-0; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kader M, 2009, J MED PRIMATOL, V38, P24, DOI 10.1111/j.1600-0684.2009.00372.x; Maillard PV, 2010, J VIROL, V84, P5790, DOI 10.1128/JVI.02413-09; Mittelbrunn M, 2004, P NATL ACAD SCI USA, V101, P11058, DOI 10.1073/pnas.0307927101; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; Pacheco B, 2010, J VIROL, V84, P4095, DOI 10.1128/JVI.02631-09; Pender SLF, 2000, AM J PATHOL, V157, P1955, DOI 10.1016/S0002-9440(10)64834-1; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Perez-Caballero D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000181; PULIDO R, 1991, J BIOL CHEM, V266, P10241; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Reeves RK, 2010, J VIROL, V84, P8959, DOI 10.1128/JVI.01126-10; Ribeiro Ieda P., 2005, Infection Genetics and Evolution, V5, P271, DOI 10.1016/j.meegid.2004.07.009; Ribeiro IP, 2005, J VIROL, V79, P14998, DOI 10.1128/JVI.79.23.14998-15003.2005; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; SCHIFFER SG, 1995, J BIOL CHEM, V270, P14270, DOI 10.1074/jbc.270.24.14270; Schneider H, 2001, CHROMOSOMA, V109, P515, DOI 10.1007/s004120000106; Soares EA, 2010, INFECT GENET EVOL, V10, P246, DOI 10.1016/j.meegid.2009.11.012; Triantafilou K, 2001, CRIT REV IMMUNOL, V21, P311; Wang JH, 1998, IMMUNOL REV, V163, P197, DOI 10.1111/j.1600-065X.1998.tb01198.x; Wong SK, 2009, J VIROL, V83, P8771, DOI 10.1128/JVI.00112-09; Zubair S, 2000, AIDS RES HUM RETROV, V16, P1179, DOI 10.1089/088922200415036	38	5	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24461	10.1371/journal.pone.0024461	http://dx.doi.org/10.1371/journal.pone.0024461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912696	Green Published, gold, Green Submitted			2022-12-25	WOS:000294686100043
J	Poultney, CS; Butterfoss, GL; Gutwein, MR; Drew, K; Gresham, D; Gunsalus, KC; Shasha, DE; Bonneau, R				Poultney, Christopher S.; Butterfoss, Glenn L.; Gutwein, Michelle R.; Drew, Kevin; Gresham, David; Gunsalus, Kristin C.; Shasha, Dennis E.; Bonneau, Richard			Rational Design of Temperature-Sensitive Alleles Using Computational Structure Prediction	PLOS ONE			English	Article							PROTEIN; DATABASE; MUTANTS	Temperature-sensitive (ts) mutations are mutations that exhibit a mutant phenotype at high or low temperatures and a wild-type phenotype at normal temperature. Temperature-sensitive mutants are valuable tools for geneticists, particularly in the study of essential genes. However, finding ts mutations typically relies on generating and screening many thousands of mutations, which is an expensive and labor-intensive process. Here we describe an in silico method that uses Rosetta and machine learning techniques to predict a highly accurate "top 5'' list of ts mutations given the structure of a protein of interest. Rosetta is a protein structure prediction and design code, used here to model and score how proteins accommodate point mutations with side-chain and backbone movements. We show that integrating Rosetta relax-derived features with sequence-based features results in accurate temperature-sensitive mutation predictions.	[Poultney, Christopher S.; Butterfoss, Glenn L.; Gutwein, Michelle R.; Drew, Kevin; Gresham, David; Gunsalus, Kristin C.; Shasha, Dennis E.; Bonneau, Richard] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Shasha, Dennis E.; Bonneau, Richard] NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10012 USA	New York University; New York University	Poultney, CS (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	bonneau@nyu.edu	Bonneau, Richard/ABD-6737-2021; Bonneau, Richard/GZL-2900-2022	Drew, Kevin/0000-0002-1260-4413	United States National Science Foundation [IIS-0414763, DBI-0445666, N2010 IOB-0519985, N2010 DBI-0519984, DBI-0421604, MCB-0209754]	United States National Science Foundation(National Science Foundation (NSF))	Funding was provided by the United States National Science Foundation grants IIS-0414763, DBI-0445666, N2010 IOB-0519985, N2010 DBI-0519984, DBI-0421604, and MCB-0209754. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bajaj K, 2008, BIOCHEMISTRY-US, V47, P12964, DOI 10.1021/bi8014345; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chakshusmathi G, 2004, P NATL ACAD SCI USA, V101, P7925, DOI 10.1073/pnas.0402222101; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; DREW K, 2007, STRUCTURAL BIOINFORM; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; HARRIS TW, 2001, NUCLEIC ACIDS RES, V38, pD463; KELLOGG EH, 2010, PROTEINS STRUCTURE F; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Muller HM, 2004, PLOS BIOL, V2, P1984, DOI 10.1371/journal.pbio.0020309; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Quinlan J.R, 2014, C4 5 PROGRAMS MACHIN; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; SANDBERG WS, 1995, BIOCHEMISTRY-US, V34, P11970, DOI 10.1021/bi00037a039; Siew N, 2000, BIOINFORMATICS, V16, P776, DOI 10.1093/bioinformatics/16.9.776; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Vapnik V. N., 1995, MACHINE LEARNING, DOI DOI 10.1007/BF00994018; Varadarajan R, 1996, P NATL ACAD SCI USA, V93, P13908, DOI 10.1073/pnas.93.24.13908; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400	24	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e23947	10.1371/journal.pone.0023947	http://dx.doi.org/10.1371/journal.pone.0023947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912654	gold, Green Submitted, Green Published			2022-12-25	WOS:000294686100009
J	Guan, WH; Somanath, PR; Kozak, A; Goc, A; El-Remessy, AB; Ergul, A; Johnson, MH; Alhusban, A; Soliman, S; Fagan, SC				Guan, Weihua; Somanath, Payaningal R.; Kozak, Anna; Goc, Anna; El-Remessy, Azza B.; Ergul, Adviye; Johnson, Maribeth H.; Alhusban, Ahmed; Soliman, Sahar; Fagan, Susan C.			Vascular Protection by Angiotensin Receptor Antagonism Involves Differential VEGF Expression in Both Hemispheres after Experimental Stroke	PLOS ONE			English	Article							GROWTH FACTOR-B; ANGIOGENESIS; PERMEABILITY; APOPTOSIS; INJURY	We identified that the angiotensin receptor antagonist, candesartan, has profound neurovascular protective properties when administered after ischemic stroke and was associated with a proangiogenic state at least partly explained by vascular endothelial growth factor A (VEGFA). However, the spatial distribution of vascular endothelial growth factor (VEGF) isoforms and their receptors remained unknown. Protein analysis identified a significant increase in vascular endothelial grow factor B (VEGFB) in the cerebrospinal fluid (CSF) and the ischemic hemispheres (with increased VEGF receptor 1 activation) of treated animals (p < 0.05) which was co-occurring with an increase in protein kinase B (Akt) phosphorylation (p < 0.05). An increase in VEGFA protein in the contralesional hemisphere corresponded to a significant increase in vascular density at seven days (p < 0.01) after stroke onset. Vascular restoration by candesartan after stroke maybe related to differential regional upregulation of VEGFB and VEGFA, promoting a "prosurvival state'' in the ischemic hemisphere and angiogenesis in the contralesional side, respectively. These vascular changes in both hemispheres after effective treatment are likely to contribute to enhanced recovery after stroke.	[Guan, Weihua; Somanath, Payaningal R.; Kozak, Anna; Goc, Anna; El-Remessy, Azza B.; Ergul, Adviye; Alhusban, Ahmed; Soliman, Sahar; Fagan, Susan C.] Univ Georgia, Coll Pharm, Program Clin & Expt Therapeut, Augusta, GA USA; [Guan, Weihua; Somanath, Payaningal R.; Kozak, Anna; Goc, Anna; El-Remessy, Azza B.; Ergul, Adviye; Alhusban, Ahmed; Soliman, Sahar; Fagan, Susan C.] Charlie Norwood VA Med Ctr, Augusta, GA USA; [Ergul, Adviye] Georgia Hlth Sci Univ, Dept Physiol, Augusta, GA USA; [Fagan, Susan C.] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA USA; [Johnson, Maribeth H.] Georgia Hlth Sci Univ, Dept Biostat, Augusta, GA USA	University System of Georgia; University of Georgia; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Guan, WH (corresponding author), Univ Georgia, Coll Pharm, Program Clin & Expt Therapeut, Augusta, GA USA.	sfagan@georgiahealth.edu	Alhusban, Ahmed/AEO-4211-2022; El-Remessy, Azza B./AAA-3771-2020	El-Remessy, Azza B./0000-0003-4386-1989; Rammohan Shenoy, Somanath/0000-0003-3017-0230; Alhusban, Ahmed/0000-0003-1105-0620	Veterans Affairs Merit Review [RO1-NS063965]; American Heart Association (AHA); AHA Established Investigator [RO1-DK074385]; Juvenile Diabetes Research Fund (JDRF) [3-2008-149]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063965, R21NS070239] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000347] Funding Source: NIH RePORTER	Veterans Affairs Merit Review(US Department of Veterans Affairs); American Heart Association (AHA)(American Heart Association); AHA Established Investigator(American Heart Association); Juvenile Diabetes Research Fund (JDRF)(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was funded by Veterans Affairs Merit Review (SCF and AE), RO1-NS063965 (SCF), American Heart Association (AHA) Scientist Development Grant (PRS and ABE), AHA Established Investigator (AE), RO1-DK074385 (AE), and Juvenile Diabetes Research Fund (JDRF) 3-2008-149 (ABE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2002, TRANSPLANTATION, V73, P1703, DOI 10.1097/00007890-200206150-00003; Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Brkovic A, 2007, J CELL BIOCHEM, V100, P727, DOI 10.1002/jcb.21124; Carey JR, 2002, BRAIN, V125, P773, DOI 10.1093/brain/awf091; Fagan SC, 2004, STROKE, V35, P2220, DOI 10.1161/01.STR.0000138023.60272.9e; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Guan WH, 2011, TRANSL STROKE RES, V2, P179, DOI 10.1007/s12975-010-0061-1; Igarashi M, 2001, HYPERTENSION, V38, P1255, DOI 10.1161/hy1101.095537; Issbrucker K, 2002, FASEB J, V16, P262, DOI 10.1096/fj.02-0329fje; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kozak A, 2009, STROKE, V40, P1870, DOI 10.1161/STROKEAHA.108.537225; Li Y, 2008, J CLIN INVEST, V118, P913, DOI 10.1172/JCI33673; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Reichelt M, 2003, CLIN EXP OPHTHALMOL, V31, P61, DOI 10.1046/j.1442-9071.2003.00602.x; Shin YJ, 2010, J NEUROIMMUNOL, V229, P81, DOI 10.1016/j.jneuroim.2010.07.008; Shin YJ, 2010, NEUROSCI LETT, V469, P194, DOI 10.1016/j.neulet.2009.11.073; Sun YJ, 2004, J CEREBR BLOOD F MET, V24, P1146, DOI 10.1097/01.WCB.0000134477.38980.38; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Zhang F, 2009, P NATL ACAD SCI USA, V106, P6152, DOI 10.1073/pnas.0813061106; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhao H, 2009, J CEREBR BLOOD F MET, V29, P873, DOI 10.1038/jcbfm.2009.13	21	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24551	10.1371/journal.pone.0024551	http://dx.doi.org/10.1371/journal.pone.0024551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21912702	Green Published, gold, Green Submitted			2022-12-25	WOS:000294683900055
J	Mooij, CF; Kroese, JM; Sweep, FCGJ; Hermus, ARMM; Tack, CJ				Mooij, Christiaan F.; Kroese, Jeanne Margot; Sweep, Fred C. G. J.; Hermus, Ad R. M. M.; Tack, Cees J.			Adult Patients with Congenital Adrenal Hyperplasia Have Elevated Blood Pressure but Otherwise a Normal Cardiovascular Risk Profile	PLOS ONE			English	Article							21-HYDROXYLASE DEFICIENCY; INSULIN-RESISTANCE; ADIPONECTIN LEVELS; PLASMINOGEN ACTIVATORS; METABOLIC PROFILE; BODY-COMPOSITION; MORTALITY; UROKINASE; DISEASE	Objective: Treatment with glucocorticoids and mineralocorticoids has changed congenital adrenal hyperplasia (CAH) from a fatal to a chronic lifelong disease. Long-term treatment, in particular the chronic (over-)treatment with glucocorticoids, may have an adverse effect on the cardiovascular risk profile in adult CAH patients. The objective of this study was to evaluate the cardiovascular risk profile of adult CAH patients. Design: Case-control study. Patients and Measurements: In this case-control study the cardiovascular risk profile of 27 adult CAH patients and 27 controls, matched for age, sex and body mass index was evaluated by measuring ambulatory 24-hour blood pressure, insulin sensitivity (HOMA-IR), lipid profiles, albuminuria and circulating cardiovascular risk markers (PAI-1, tPA, uPA, tPA/PAI-1 complex, hsCRP, adiponectin, IL-6, IL-18 and leptin). Results: 24-Hour systolic (126.3 mmHg +/- 15.5 vs 124.8 mmHg +/- 15.1 in controls, P = 0.019) and diastolic (76.4 mmHg +/- 12.7 vs 73.5 mmHg +/- 12.4 in controls, P<0.001) blood pressure was significantly elevated in CAH patients compared to the control population. CAH patients had higher HDL cholesterol levels (P<0.01), lower hsCRP levels (P = 0.03) and there was a trend toward elevated adiponectin levels compared to controls. Other cardiovascular risk factors were similar in both groups. Conclusion: Adult CAH patients have higher ambulatory blood pressure compared to healthy matched controls. Other cardiovascular risk markers did not differ, while HDL-cholesterol, hsCRP and adiponectin levels tended to be more favorable.	[Mooij, Christiaan F.; Kroese, Jeanne Margot; Hermus, Ad R. M. M.] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6525 ED Nijmegen, Netherlands; [Mooij, Christiaan F.] Radboud Univ Nijmegen, Med Ctr, Dept Paediat Endocrinol, NL-6525 ED Nijmegen, Netherlands; [Kroese, Jeanne Margot; Tack, Cees J.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Sweep, Fred C. G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Mooij, CF (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6525 ED Nijmegen, Netherlands.	c.mooij@cukz.umcn.nl	Tack, Cees J/A-2368-2014; Hermus, A.R.M.M./H-8043-2014; Sweep, C.G.J./H-8096-2014; Mooij, Christiaan/O-4732-2015	Hermus, A.R.M.M./0000-0003-1075-2655; Sweep, C.G.J./0000-0003-1103-3070; Mooij, Christiaan/0000-0001-7977-6271	Eli Lilly Netherlands [H6E-UT-O013]	Eli Lilly Netherlands(Eli LillyNetherlands Government)	This study was supported by an unrestricted grant from Eli Lilly Netherlands (H6E-UT-O013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt W, 2010, J CLIN ENDOCR METAB, V95, P5110, DOI 10.1210/jc.2010-0917; Bergthorsdottir R, 2006, J CLIN ENDOCR METAB, V91, P4849, DOI 10.1210/jc.2006-0076; Bottner A, 2004, J CLIN ENDOCR METAB, V89, P4053, DOI 10.1210/jc.2004-0303; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Degawa-Yamauchi M, 2005, OBES RES, V13, P662, DOI 10.1038/oby.2005.74; ETXABE J, 1994, CLIN ENDOCRINOL, V40, P479, DOI 10.1111/j.1365-2265.1994.tb02486.x; Falhammar H, 2011, EUR J ENDOCRINOL, V164, P285, DOI 10.1530/EJE-10-0877; Falhammar H, 2007, J CLIN ENDOCR METAB, V92, P110, DOI 10.1210/jc.2006-1350; Fuller PJ, 2005, HYPERTENSION, V46, P1227, DOI 10.1161/01.HYP.0000193502.77417.17; Grebenschikov N, 1997, INT J BIOL MARKER, V12, P6, DOI 10.1177/172460089701200102; Grebenschikov N, 1999, INT J CANCER, V81, P598, DOI 10.1002/(SICI)1097-0215(19990517)81:4<598::AID-IJC16>3.3.CO;2-0; Hammer F, 2006, BEST PRACT RES CL EN, V20, P337, DOI 10.1016/j.beem.2006.07.001; Kroese JM, 2009, EUR J ENDOCRINOL, V161, P887, DOI 10.1530/EJE-09-0523; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Merke Deborah P., 2002, Annals of Internal Medicine, V136, P320; Mooij CF, 2010, CLIN ENDOCRINOL, V73, P137, DOI 10.1111/j.1365-2265.2009.03690.x; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Sartorato P, 2007, J CLIN ENDOCR METAB, V92, P1015, DOI 10.1210/jc.2006-1711; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Volkl TMK, 2009, ACTA PAEDIATR, V98, P885, DOI 10.1111/j.1651-2227.2009.01231.x; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245	22	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24204	10.1371/journal.pone.0024204	http://dx.doi.org/10.1371/journal.pone.0024204			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909422	Green Published, gold, Green Submitted			2022-12-25	WOS:000294683900038
J	Xia, L; Hou, SY; Ren, XM; Wang, ZR				Xia, Lei; Hou, Shaoying; Ren, Xiaomei; Wang, Zhuoran			Effects of Thioglycolic Acid on in vivo Oocytes Maturation in Mice	PLOS ONE			English	Article							CORTICAL GRANULES; MOUSE OOCYTES; SPINDLE CONFIGURATION; MICROTUBULE DYNAMICS; MEIOTIC SPINDLE; VITRO; KINASE; EGGS; INVOLVEMENT	Background: Thioglycolic acid (TGA) is widely used in the hairdressing industry, which mostly caters to women. Recently, TGA has been reported to impair several organs, especially reproductive ones such as testes and ovaries. The reproductive toxicity of TGA on females has become an issue that cannot be neglected. Methodology/Principal Findings: In the present work, superovulated female mice were percutaneously treated with different doses of TGA (37.81, 75.62, and 151.25 mg/kg). The mice were sacrificed to collect ovulated oocytes, whose numbers were counted and compared. Immunofluorescence-stained oocytes were observed under a confocal microscope to investigate the effects of TGA on spindle morphology, distribution of cortical granules (CGs), and parthenogenetic activation. The number of ovulated oocytes was decreased by TGA. The ovulated oocytes in the 151.25 mg/kg TGA group were significantly less than in the control and in the 37.81 mg/kg TGA groups. The ovulated oocytes in the 75.62 mg/kg TGA group were less than in the 37.81 mg/kg dose group. Abnormal spindle configuration in vivo was also induced by TGA. The spindle areas in the 75.62 and 151.25 mg/kg TGA groups were significantly larger than in the control and 37.81 mg/kg TGA groups. The parthenogenetic activation of ovulated oocytes in vitro was inhibited as well. The percentage of activated oocytes in the 75.62 and 151.25 mg/kg TGA groups was significantly lower than in the control and 37.81 mg/kg TGA groups. The percentage in the 151.25 mg/kg TGA group was also less than in the 75.62 mg/kg group. CG distribution was not affected by TGA. Conclusion: Mice were percutaneously treated with TGA. Consequently, the number of ovulated oocytes decreased, abnormal spindle configurations were induced, and the parthenogenetic activation of ovulated oocytes was inhibited. CG distribution was not affected.	[Xia, Lei; Wang, Zhuoran] Harbin Med Coll, Affiliated Hosp 1, Dept Reprod Med, Harbin, Peoples R China; [Hou, Shaoying; Ren, Xiaomei] Harbin Med Coll, Dept Nutr & Food Hyg, Sch Publ Hlth, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Xia, L (corresponding author), Harbin Med Coll, Affiliated Hosp 1, Dept Reprod Med, Harbin, Peoples R China.	wangzhuoran0147@126.com			National Nature Science Foundation of China [30400356]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Nature Science Foundation of China (number 30400356). The funder Lei Xia conceived and designed the experiments and contributed to performing the experiments and reagents/materials/analysis tools.	Avazeri N, 2006, BIOCHIMIE, V88, P1823, DOI 10.1016/j.biochi.2006.04.011; Chen BY, 1997, ACUPUNCTURE ELECTRO, V22, P97, DOI 10.3727/036012997816356734; Connors SA, 1998, DEV BIOL, V200, P103, DOI 10.1006/dbio.1998.8945; ESBENSHADE KL, 1987, J ANIM SCI, V65, P1768, DOI 10.2527/jas1987.6561768x; Gan HF, 2003, J OCCUP HEALTH, V45, P400, DOI 10.1539/joh.45.400; GAN HF, 1988, J HLTH TOXICOL, V2, P93; GAN HF, 1993, CHINA OCCUP MED, V20, P142; GOTOH Y, 1991, NATURE, V349, P251, DOI 10.1038/349251a0; Goudeau H, 1998, DEV BIOL, V193, P225, DOI 10.1006/dbio.1997.8799; HOODBHOY T, 1994, MOL REPROD DEV, V39, P439, DOI 10.1002/mrd.1080390413; Hou SY, 2008, TOXICOL IND HEALTH, V24, P227, DOI 10.1177/0748233708095862; HOU SY, 2008, MUTAGENESIS, V20, P107; JIN XY, 1999, J HYG RES, V28, P25; Ju JC, 2005, THERIOGENOLOGY, V64, P1677, DOI 10.1016/j.theriogenology.2005.03.025; Kishigami S, 2006, NAT PROTOC, V1, P125, DOI 10.1038/nprot.2006.21; Liu XY, 2005, HUM REPROD, V20, P3402, DOI 10.1093/humrep/dei265; LONGO FJ, 1985, DEV BIOL, V107, P382, DOI 10.1016/0012-1606(85)90320-3; Meo SC, 2005, THERIOGENOLOGY, V63, P2089, DOI 10.1016/j.theriogenology.2004.08.012; Miao YL, 2007, THERIOGENOLOGY, V68, P640, DOI 10.1016/j.theriogenology.2007.04.061; Pahlavan G, 2000, DEV BIOL, V220, P392, DOI 10.1006/dbio.2000.9656; Prunier A, 2000, ANIM REPROD SCI, V60, P185, DOI 10.1016/S0378-4320(00)00093-2; RABINOVICI J, 1993, BAILLIERE CLIN OB GY, V7, P263, DOI 10.1016/S0950-3552(05)80130-0; Rylander L, 2002, OCCUP ENVIRON MED, V59, P517, DOI 10.1136/oem.59.8.517; Sanfins A, 2003, BIOL REPROD, V69, P2059, DOI 10.1095/biolreprod.103.020537; SONG CH, 2002, CHI OCCUP MED, V29, P65; SONG CH, 1990, IND HLTH OCCUP DIS, V16, P145; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0; Wang Wei-Hua, 2002, Cloning and Stem Cells, V4, P269, DOI 10.1089/15362300260339557; Zak LJ, 1997, J REPROD FERTIL, V110, P99, DOI 10.1530/jrf.0.1100099; Zamboni L., 1970, Biol. Reprod., V2, P44, DOI 10.1095/biolreprod2.Supplement_2.44; ZHANG GQ, 1990, J HEAL TOXICOL, V4, P89; ZHANG L, 1993, CHIN J IND HYG OCCUP, V11, P69; Zhang L, 2009, J TOXICOL ENV HEAL A, V72, P1123, DOI 10.1080/15287390902953519; Zhu ZY, 2003, BIOL REPROD, V68, P943, DOI 10.1095/biolreprod.102.009910	34	3	3	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e23996	10.1371/journal.pone.0023996	http://dx.doi.org/10.1371/journal.pone.0023996			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909408	Green Published, gold, Green Submitted			2022-12-25	WOS:000294683900018
J	Biron, KE; Dickstein, DL; Gopaul, R; Jefferies, WA				Biron, Kaan E.; Dickstein, Dara L.; Gopaul, Rayshad; Jefferies, Wilfred A.			Amyloid Triggers Extensive Cerebral Angiogenesis Causing Blood Brain Barrier Permeability and Hypervascularity in Alzheimer's Disease	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VASCULAR RISK-FACTORS; A-BETA PEPTIDE; TRANSGENIC MOUSE MODEL; PRECURSOR PROTEIN; ENDOGLIN CD105; PROGNOSTIC MARKERS; MULTIPLE-SCLEROSIS; WHITE-MATTER; IN-VIVO	Evidence of reduced blood-brain barrier (BBB) integrity preceding other Alzheimer's disease (AD) pathology provides a strong link between cerebrovascular angiopathy and AD. However, the "Vascular hypothesis", holds that BBB leakiness in AD is likely due to hypoxia and neuroinflammation leading to vascular deterioration and apoptosis. We propose an alternative hypothesis: amyloidogenesis promotes extensive neoangiogenesis leading to increased vascular permeability and subsequent hypervascularization in AD. Cerebrovascular integrity was characterized in Tg2576 AD model mice that overexpress the human amyloid precursor protein (APP) containing the double missense mutations, APPsw, found in a Swedish family, that causes early-onset AD. The expression of tight junction (TJ) proteins, occludin and ZO-1, were examined in conjunction with markers of apoptosis and angiogenesis. In aged Tg2576 AD mice, a significant increase in the incidence of disrupted TJs, compared to age matched wild-type littermates and young mice of both genotypes, was directly linked to an increased microvascular density but not apoptosis, which strongly supports amyloidogenic triggered hypervascularity as the basis for BBB disruption. Hypervascularity in human patients was corroborated in a comparison of postmortem brain tissues from AD and controls. Our results demonstrate that amylodogenesis mediates BBB disruption and leakiness through promoting neoangiogenesis and hypervascularity, resulting in the redistribution of TJs that maintain the barrier and thus, provides a new paradigm for integrating vascular remodeling with the pathophysiology observed in AD. Thus the extensive angiogenesis identified in AD brain, exhibits parallels to the neovascularity evident in the pathophysiology of other diseases such as age-related macular degeneration.	[Biron, Kaan E.; Gopaul, Rayshad; Jefferies, Wilfred A.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Biron, Kaan E.; Gopaul, Rayshad; Jefferies, Wilfred A.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Biron, Kaan E.; Gopaul, Rayshad; Jefferies, Wilfred A.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Dickstein, Dara L.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA; [Dickstein, Dara L.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [Gopaul, Rayshad; Jefferies, Wilfred A.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Gopaul, Rayshad; Jefferies, Wilfred A.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of British Columbia; University of British Columbia	Biron, KE (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	wilf@brc.ubc.ca	Dickstein, Dara/AAH-6603-2020; Dickstein, Dara/F-3036-2013		Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by grants to Dr. Jefferies from the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bertrand SJ, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-38; Boscolo E, 2007, INT J MOL MED, V19, P581; Burger S, 2009, INT J DEV NEUROSCI, V27, P517, DOI 10.1016/j.ijdevneu.2009.06.011; Cadavid D, 2000, J NEUROPATH EXP NEUR, V59, P768, DOI 10.1093/jnen/59.9.768; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Desai BS, 2009, J NEURAL TRANSM, V116, P587, DOI 10.1007/s00702-009-0226-9; Dickstein DL, 2006, FASEB J, V20, P426, DOI 10.1096/fj.05-3956com; Dickstein DL, 2010, MT SINAI J MED, V77, P82, DOI 10.1002/msj.20155; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Duff SE, 2003, FASEB J, V17, P984, DOI 10.1096/fj.02-0634rev; El-Gohary YM, 2007, AM J CLIN PATHOL, V127, P572, DOI 10.1309/X6NXYE57DLUE2NQ8; Esteban JA, 2004, TRENDS NEUROSCI, V27, P1, DOI 10.1016/j.tins.2003.10.008; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; FERREIRO JA, 1989, J NEUROL, V236, P267, DOI 10.1007/BF00314454; Fossati S, 2010, FASEB J, V24, P229, DOI 10.1096/fj.09-139584; Giatromanolaki A, 1999, ONCOL RES, V11, P205; Goddard Jonathan Charles, 2002, Angiogenesis, V5, P15, DOI 10.1023/A:1021518315757; Gonzalez-Velasquez FJ, 2008, J NEUROCHEM, V107, P466, DOI 10.1111/j.1471-4159.2008.05618.x; Guo Linlang, 2001, Angiogenesis, V4, P187, DOI 10.1023/A:1014010801754; Hagihara H., 2009, J VIS EXP; Hardy John, 2006, Current Alzheimer Research, V3, P71, DOI 10.2174/156720506775697098; Herzig MC, 2006, BRAIN PATHOL, V16, P40, DOI 10.1111/j.1750-3639.2006.tb00560.x; Holley JE, 2010, NEUROSCI LETT, V470, P65, DOI 10.1016/j.neulet.2009.12.059; Holton JL, 2001, AM J PATHOL, V158, P515, DOI 10.1016/S0002-9440(10)63993-4; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jantaratnotai N, 2010, CURR ALZHEIMER RES, V7, P625, DOI 10.2174/156720510793499039; Jellinger KA, 2007, ACTA NEUROPATHOL, V113, P349, DOI 10.1007/s00401-006-0185-2; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kametani F, 2008, CURR ALZHEIMER RES, V5, P165, DOI 10.2174/156720508783954776; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Kumar-Singh S, 2005, AM J PATHOL, V167, P527, DOI 10.1016/S0002-9440(10)62995-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Marco S, 2006, NEUROSCI LETT, V401, P219, DOI 10.1016/j.neulet.2006.03.047; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Nagababu E, 2009, J ALZHEIMERS DIS, V17, P845, DOI 10.3233/JAD-2009-1104; Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7; OLICHNEY JM, 1995, ARCH NEUROL-CHICAGO, V52, P702, DOI 10.1001/archneur.1995.00540310076019; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Ott A, 1998, LANCET, V351, P1840, DOI 10.1016/S0140-6736(97)07541-7; Paris D, 2005, MOL BRAIN RES, V136, P212, DOI 10.1016/j.molbrainres.2005.02.011; Paris D, 2004, NEUROSCI LETT, V366, P80, DOI 10.1016/j.neulet.2004.05.017; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Pearson HA, 2006, J PHYSIOL-LONDON, V575, P5, DOI 10.1113/jphysiol.2006.111203; Plumb J, 2002, BRAIN PATHOL, V12, P154; Pogue AI, 2004, NEUROREPORT, V15, P1507, DOI 10.1097/01.wnr.0000130539.39937.1d; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Richard E, 2010, J NEUROPATH EXP NEUR, V69, P1158, DOI 10.1097/NEN.0b013e3181fab558; Saad RS, 2003, INT J GYNECOL PATHOL, V22, P248, DOI 10.1097/01.PGP.0000070852.25718.37; Saad RS, 2004, MODERN PATHOL, V17, P197, DOI 10.1038/modpathol.3800034; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Schultheiss Caroline, 2006, Angiogenesis, V9, P59, DOI 10.1007/s10456-006-9030-4; Shibuya M, 2009, FEBS J, V276, P4636, DOI 10.1111/j.1742-4658.2009.07175.x; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Solito R, 2009, EXP CELL RES, V315, P385, DOI 10.1016/j.yexcr.2008.11.002; Spalton D, 2005, ATLAS CLIN OPHTHALMO; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Tarkowski E, 2002, NEUROBIOL AGING, V23, P237, DOI 10.1016/S0197-4580(01)00285-8; Ujiie M, 2003, MICROCIRCULATION, V10, P463, DOI 10.1038/sj.mn.7800212; Verbeek MM, 1997, BIOL CHEM, V378, P937; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Zhu XW, 2007, J NEUROL SCI, V257, P240, DOI 10.1016/j.jns.2007.01.039; Zlokovic BV, 2008, NEUROTHERAPEUTICS, V5, P409, DOI 10.1016/j.nurt.2008.05.011; Zlokovic BV, 2010, NAT MED, V16, P1370, DOI 10.1038/nm1210-1370	71	196	207	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23789	10.1371/journal.pone.0023789	http://dx.doi.org/10.1371/journal.pone.0023789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909359	Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800022
J	Laco, GS				Laco, Gary S.			Evaluation of Two Models for Human Topoisomerase I Interaction with dsDNA and Camptothecin Derivatives	PLOS ONE			English	Article							DNA BINARY COMPLEX; CLEAVABLE COMPLEXES; INHIBITION; MECHANISM; COVALENT; DRUGS; SPECIFICITY; BINDING; AGENTS	Human topoisomerase I (Top1) relaxes supercoiled DNA during cell division. Camptothecin stabilizes Top1/dsDNA covalent complexes which ultimately results in cell death, and this makes Top1 an anti-cancer target. There are two current models for how camptothecin and derivatives bind to Top1/dsDNA covalent complexes (Staker, et al., 2002, Proc Natl Acad Sci USA 99: 15387-15392; and Laco, et al., 2004, Bioorg Med Chem 12: 5225-5235). The interaction energies between bound camptothecin, and derivatives, and Top1/dsDNA in the two models were calculated. The published structure-activity-relationships for camptothecin and derivatives correlated with the interaction energies for camptothecin and derivatives in the Laco et al. model, however, this was not the case for several camptothecin derivatives in the Stacker et al. model. By defining the binding orientation of camptothecin and derivatives in the Top1/dsDNA active-site these results allow for the rational design of potentially more efficacious camptothecin derivatives.	Lake Erie Coll Osteopath Med, Lab Computat & Mol Biochem, Bradenton, FL 34211 USA		Laco, GS (corresponding author), Lake Erie Coll Osteopath Med, Lab Computat & Mol Biochem, Bradenton, FL 34211 USA.	glaco@lecom.edu			Lake Erie College of Osteopathic Medicine	Lake Erie College of Osteopathic Medicine	This work was supported solely by an intramural grant from the Lake Erie College of Osteopathic Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDIXEN C, 1990, BIOCHEMISTRY-US, V29, P5613, DOI 10.1021/bi00475a028; Biffinger JC, 2004, CHEMBIOCHEM, V5, P622, DOI 10.1002/cbic.200300910; BURGIN AB, 1995, NUCLEIC ACIDS RES, V23, P2973, DOI 10.1093/nar/23.15.2973; Du W, 2003, TETRAHEDRON, V59, P8649, DOI 10.1016/S0040-4020(03)01203-1; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Henningfeld KA, 1996, J AM CHEM SOC, V118, P11701, DOI 10.1021/ja961788h; HERTZBERG RP, 1989, BIOCHEMISTRY-US, V28, P4629, DOI 10.1021/bi00437a018; HSIANG YH, 1989, CANCER RES, V49, P5077; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Kerrigan JE, 2001, BIOCHEMISTRY-US, V40, P9792, DOI 10.1021/bi010913l; KINGSBURY WD, 1991, J MED CHEM, V34, P98, DOI 10.1021/jm00105a017; Laco GS, 2008, BIOCHEM J, V411, P523, DOI 10.1042/BJ20071436; Laco GS, 2004, BIOORGAN MED CHEM, V12, P5225, DOI 10.1016/j.bmc.2004.06.046; Laco GS, 2002, BIOCHEMISTRY-US, V41, P1428, DOI 10.1021/bi011774a; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Mancini G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010934; NAKAGAWA M, 1992, CANCER RES, V52, P6175; NITISS J, 1988, P NATL ACAD SCI USA, V85, P7501, DOI 10.1073/pnas.85.20.7501; PORTER SE, 1989, MOL CELL BIOL, V9, P541, DOI 10.1128/MCB.9.2.541; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Staker BL, 2005, J MED CHEM, V48, P2336, DOI 10.1021/jm049146p; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Steiner T, 2002, ANGEW CHEM INT EDIT, V41, P48, DOI 10.1002/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO;2-U; STREET IP, 1986, BIOCHEMISTRY-US, V25, P6021, DOI 10.1021/bi00368a028; TANIZAWA A, 1995, BIOCHEMISTRY-US, V34, P7200, DOI 10.1021/bi00021a035; Teicher BA, 2008, BIOCHEM PHARMACOL, V75, P1262, DOI 10.1016/j.bcp.2007.10.016; Urasaki Y, 2001, CANCER RES, V61, P1964; WALL ME, 1966, J AM CHEM SOC, V88, P3888, DOI 10.1021/ja00968a057; Wang XY, 1999, BIOCHEMISTRY-US, V38, P4374, DOI 10.1021/bi982708k	29	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24314	10.1371/journal.pone.0024314	http://dx.doi.org/10.1371/journal.pone.0024314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912628	Green Published, gold, Green Submitted			2022-12-25	WOS:000294678300039
J	Basith, S; Manavalan, B; Govindaraj, RG; Choi, S				Basith, Shaherin; Manavalan, Balachandran; Govindaraj, Rajiv Gandhi; Choi, Sangdun			In Silico Approach to Inhibition of Signaling Pathways of Toll-Like Receptors 2 and 4 by ST2L	PLOS ONE			English	Article							MYD88 ADAPTER-LIKE; INTERLEUKIN-1 RECEPTOR; CRYSTAL-STRUCTURE; TIR-DOMAIN; INNATE IMMUNITY; ENDOTOXIN TOLERANCE; QUALITY ASSESSMENT; STRUCTURAL BASIS; PROTEIN-DOCKING; IL-1 RECEPTOR	Toll-like receptors (TLRs) activate a potent immunostimulatory response. There is clear evidence that overactivation of TLRs leads to infectious and inflammatory diseases. Recent biochemical studies have shown that the membrane-bound form of ST2 (ST2L), a member of the Toll-like/IL-1 receptor superfamily, negatively regulates MyD88-dependent TLR signaling pathways by sequestrating the adapters MyD88 and Mal (TIRAP). Specifically, ST2L attenuates the recruitment of Mal and MyD88 adapters to their receptors through its intracellular TIR domain. Thus, ST2L is a potent molecule that acts as a key regulator of endotoxin tolerance and modulates innate immunity. So far, the inhibitory mechanism of ST2L at the molecular level remains elusive. To develop a working hypothesis for the interactions between ST2L, TLRs (TLR1, 2, 4, and 6), and adapter molecules (MyD88 and Mal), we constructed three-dimensional models of the TIR domains of TLR4, 6, Mal, and ST2L based on homology modeling. Since the crystal structures of the TIR domains of TLR1, 2 as well as the NMR solution structure of MyD88 are known, we utilized these structures in our analysis. The TIR domains of TLR1, 2, 4, 6, MyD88, Mal and ST2L were subjected to molecular dynamics (MD) simulations in an explicit solvent environment. The refined structures obtained from the MD simulations were subsequently used in molecular docking studies to probe for potential sites of interactions. Through protein-protein docking analysis, models of the essential complexes involved in TLR2 and 4 signaling and ST2L inhibiting processes were developed. Our results suggest that ST2L may exert its inhibitory effect by blocking the molecular interface of Mal and MyD88 adapters mainly through its BB-loop region. Our predicted oligomeric signaling models may provide a basis for the understanding of the assembly process of TIR domain interactions, which has thus far proven to be difficult via in vivo studies.	[Basith, Shaherin; Manavalan, Balachandran; Govindaraj, Rajiv Gandhi; Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea	Ajou University	Basith, S (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.	sangdunchoi@ajou.ac.kr	Govindaraj, Rajiv Gandhi/X-1809-2019; Manavalan, Balachandran/Q-8279-2019	Govindaraj, Rajiv Gandhi/0000-0003-2364-5429; Manavalan, Balachandran/0000-0003-0697-9419	National Research Foundation of Korea; Ministry of Education, Science, and Technology [2010-0016256]; Korea Food & Drug Administration [10182KFDA992]; Priority Research Centers Program [NRF 2010-0028294]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Food & Drug Administration(Ministry of Food & Drug Safety (MFDS), Republic of Korea); Priority Research Centers Program	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2010-0016256). This work was also partly supported by a grant from the Korea Food & Drug Administration (10182KFDA992) and the Priority Research Centers Program (NRF 2010-0028294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Basith S, 2011, EXPERT OPIN THER PAT, V21, P927, DOI 10.1517/13543776.2011.569494; BERGERS G, 1994, EMBO J, V13, P1176, DOI 10.1002/j.1460-2075.1994.tb06367.x; Brint EK, 2002, J BIOL CHEM, V277, P49205, DOI 10.1074/jbc.M209685200; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Brown V, 2006, EUR J IMMUNOL, V36, P742, DOI 10.1002/eji.200535158; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Chan SL, 2010, PROTEIN SCI, V19, P155, DOI 10.1002/pro.275; Chan SL, 2009, J BIOL CHEM, V284, P21386, DOI 10.1074/jbc.C109.007591; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Gautam JK, 2006, J BIOL CHEM, V281, P30132, DOI 10.1074/jbc.M602057200; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; Gong J, 2010, J STRUCT BIOL, V169, P323, DOI 10.1016/j.jsb.2009.12.007; Govindaraj RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012713; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; KLEMENZ R, 1989, P NATL ACAD SCI USA, V86, P5708, DOI 10.1073/pnas.86.15.5708; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Krishnan J, 2009, ARCH PHARM RES, V32, P1485, DOI 10.1007/s12272-009-2100-6; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li CS, 2005, J BIOL CHEM, V280, P26152, DOI 10.1074/jbc.M503262200; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Manavalan B, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00041; Manavalan B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015782; McGuffin LJ, 2008, BIOINFORMATICS, V24, P586, DOI 10.1093/bioinformatics/btn014; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Monie TP, 2009, IMMUNOL REV, V227, P161, DOI 10.1111/j.1600-065X.2008.00735.x; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Palsson-McDermott EM, 2007, BIOCHEM SOC T, V35, P1437, DOI 10.1042/BST0351437; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; Piao W, 2008, J BIOL CHEM, V283, P3109, DOI 10.1074/jbc.M707400200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Ronni T, 2003, MOL CELL BIOL, V23, P2543, DOI 10.1128/MCB.23.7.2543-2555.2003; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wallner B, 2003, PROTEINS, V53, P534, DOI 10.1002/prot.10536; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Zhu JZ, 2009, MOL IMMUNOL, V46, P978, DOI 10.1016/j.molimm.2008.09.024	62	44	46	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23989	10.1371/journal.pone.0023989	http://dx.doi.org/10.1371/journal.pone.0023989			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897866	Green Published, gold, Green Submitted			2022-12-25	WOS:000294676900030
J	Blanford, S; Shi, WP; Christian, R; Marden, JH; Koekemoer, LL; Brooke, BD; Coetzee, M; Read, AF; Thomas, MB				Blanford, Simon; Shi, Wangpeng; Christian, Riann; Marden, James H.; Koekemoer, Lizette L.; Brooke, Basil D.; Coetzee, Maureen; Read, Andrew F.; Thomas, Matthew B.			Lethal and Pre-Lethal Effects of a Fungal Biopesticide Contribute to Substantial and Rapid Control of Malaria Vectors	PLOS ONE			English	Article							CELLULAR DEFENSE RESPONSE; ANOPHELES-GAMBIAE-S.S.; ADULT AEDES-AEGYPTI; ANISOPLIAE IP 46; ENTOMOPATHOGENIC FUNGUS; METARHIZIUM-ANISOPLIAE; BEAUVERIA-BASSIANA; INSECTICIDE RESISTANCE; MOSQUITO RESISTANCE; FOOD-CONSUMPTION	Rapidly emerging insecticide resistance is creating an urgent need for new active ingredients to control the adult mosquitoes that vector malaria. Biopesticides based on the spores of entomopathogenic fungi have shown considerable promise by causing very substantial mortality within 7-14 days of exposure. This mortality will generate excellent malaria control if there is a high likelihood that mosquitoes contact fungi early in their adult lives. However, where contact rates are lower, as might result from poor pesticide coverage, some mosquitoes will contact fungi one or more feeding cycles after they acquire malaria, and so risk transmitting malaria before the fungus kills them. Critics have argued that 'slow acting' fungal biopesticides are, therefore, incapable of delivering malaria control in real-world contexts. Here, utilizing standard WHO laboratory protocols, we demonstrate effective action of a biopesticide much faster than previously reported. Specifically, we show that transient exposure to clay tiles sprayed with a candidate biopesticide comprising spores of a natural isolate of Beauveria bassiana, could reduce malaria transmission potential to zero within a feeding cycle. The effect resulted from a combination of high mortality and rapid fungal-induced reduction in feeding and flight capacity. Additionally, multiple insecticide-resistant lines from three key African malaria vector species were completely susceptible to fungus. Thus, fungal biopesticides can block transmission on a par with chemical insecticides, and can achieve this where chemical insecticides have little impact. These results support broadening the current vector control paradigm beyond fast-acting chemical toxins.	[Blanford, Simon; Read, Andrew F.] Penn State Univ, Dept Biol, Mueller Lab, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Blanford, Simon; Shi, Wangpeng; Read, Andrew F.; Thomas, Matthew B.] Penn State Univ, Dept Entomol, Merkle Lab, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Shi, Wangpeng] China Agr Univ, Minist Agr, Key Lab Biol Control, Beijing 100094, Peoples R China; [Christian, Riann; Koekemoer, Lizette L.; Brooke, Basil D.; Coetzee, Maureen] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Vector Control Reference Unit, Johannesburg, South Africa; [Christian, Riann; Koekemoer, Lizette L.; Brooke, Basil D.; Coetzee, Maureen] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Malaria Entomol Res Unit, Johannesburg, South Africa; [Read, Andrew F.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; China Agricultural University; Ministry of Agriculture & Rural Affairs; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Blanford, S (corresponding author), Penn State Univ, Dept Biol, Mueller Lab, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	mbt13@psu.edu	Coetzee, Maureen/AAI-1413-2020; Shi, wp/AAF-9334-2020; Coetzee, Maureen/AAW-4739-2020	Coetzee, Maureen/0000-0003-2019-866X; Brooke, Basil/0000-0002-8857-1304; Koekemoer, Lizette/0000-0003-4236-6345	Gates Grand Challenges Explorations [53066]; National Institutes of Health [AI088094-01]; Innovative Vector Control Consortium; China Scholarship Council; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088094] Funding Source: NIH RePORTER; Direct For Biological Sciences [0950416] Funding Source: National Science Foundation	Gates Grand Challenges Explorations; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Innovative Vector Control Consortium; China Scholarship Council(China Scholarship Council); Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was part-funded by grants from Gates Grand Challenges Explorations (No. 53066), the National Institutes of Health (AI088094-01), the Innovative Vector Control Consortium, and a China Scholarship Council Grant to WP. This project was also funded, in part, under a grant with the Pennsylvania Department of Health using Tobacco Settlement Funds. The Department specifically disclaims responsibility for any analyses, interpretations or conclusions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achonduh OA, 2008, AFR J BIOTECHNOL, V7, P931; Ahmed AM, 2006, MICROBES INFECT, V8, P308, DOI 10.1016/j.micinf.2005.06.026; [Anonymous], 1949, MALARIOLOGY COMPREHE; Arthurs S, 2001, ECOL ENTOMOL, V26, P227, DOI 10.1046/j.1365-2311.2001.00317.x; Arthurs S, 2000, BIOCONTROL SCI TECHN, V10, P321, DOI 10.1080/09583150050044592; Bell AS, 2009, J INVERTEBR PATHOL, V100, P160, DOI 10.1016/j.jip.2009.01.006; Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423; Charlwood JD, 1997, B ENTOMOL RES, V87, P445, DOI 10.1017/S0007485300041304; Costantini C, 1996, MED VET ENTOMOL, V10, P203, DOI 10.1111/j.1365-2915.1996.tb00733.x; de Paula AR, 2008, BIOCONTROL SCI TECHN, V18, P1017, DOI 10.1080/09583150802509199; Dolgin E, 2009, SCIENTIST, V23, P44; Fang WG, 2011, SCIENCE, V331, P1074, DOI 10.1126/science.1199115; Farenhorst M, 2008, AM J TROP MED HYG, V78, P910, DOI 10.4269/ajtmh.2008.78.910; Farenhorst M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012081; Farenhorst M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-27; Farenhorst M, 2009, P NATL ACAD SCI USA, V106, P17443, DOI 10.1073/pnas.0908530106; Ferguson HM, 2002, TRENDS PARASITOL, V18, P256, DOI 10.1016/S1471-4922(02)02281-X; GILLIES MT, 1961, B ENTOMOL RES, V48, P553; HAJEK AE, 1994, ANNU REV ENTOMOL, V39, P293, DOI 10.1146/annurev.en.39.010194.001453; Hancock PA, 2009, P ROY SOC B-BIOL SCI, V276, P71, DOI 10.1098/rspb.2008.0689; Hancock PA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000525; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Hodjati MH, 1999, B ENTOMOL RES, V89, P329, DOI 10.1017/S0007485399000462; HUNG SY, 1992, J INVERTEBR PATHOL, V60, P152, DOI 10.1016/0022-2011(92)90089-M; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Hurd H, 2007, TRENDS PARASITOL, V23, P135, DOI 10.1016/j.pt.2007.01.011; Hutchinson OC, 2005, SCIENCE, V310, P49; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Kershaw MJ, 1999, J INVERTEBR PATHOL, V74, P213, DOI 10.1006/jipa.1999.4884; Kikankie CK, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-71; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Koella JC, 2009, EVOL APPL, V2, P469, DOI 10.1111/j.1752-4571.2009.00072.x; Lacey LA, 2001, BIOL CONTROL, V21, P230, DOI 10.1006/bcon.2001.0938; Lambrechts L, 2006, P ROY SOC B-BIOL SCI, V273, P1501, DOI 10.1098/rspb.2006.3483; LINES JD, 1991, MED VET ENTOMOL, V5, P261, DOI 10.1111/j.1365-2915.1991.tb00550.x; Lwetoijera DW, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-18; Matambo TS, 2007, MED VET ENTOMOL, V21, P97, DOI 10.1111/j.1365-2915.2007.00671.x; Mnyone LL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-309; Mnyone LL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-59; Mohanty SS, 2008, PARASITOL RES, V103, P171, DOI 10.1007/s00436-008-0946-z; Nauen R, 2007, PEST MANAG SCI, V63, P628, DOI 10.1002/ps.1406; Oliver SV, 2010, TROP MED INT HEALTH, V15, P127, DOI 10.1111/j.1365-3156.2009.02416.x; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Rivero A, 2003, P ROY SOC B-BIOL SCI, V270, P1365, DOI 10.1098/rspb.2003.2389; ROWLAND M, 1987, PESTIC BIOCHEM PHYS, V28, P239, DOI 10.1016/0048-3575(87)90022-8; Scholte EJ, 2006, J INVERTEBR PATHOL, V91, P43, DOI 10.1016/j.jip.2005.10.006; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Scholte EJ, 2007, ACTA TROP, V102, P151, DOI 10.1016/j.actatropica.2007.04.011; Sewify GH, 2001, J APPL ENTOMOL, V125, P533, DOI 10.1046/j.1439-0418.2001.00564.x; SEYOUM E, 1994, J APPL ENTOMOL, V118, P310, DOI 10.1111/j.1439-0418.1994.tb00805.x; Seyoum E, 2002, J APPL ENTOMOL, V126, P119, DOI 10.1046/j.1439-0418.2002.00609.x; SINGH K, 1989, Journal of Communicable Diseases, V21, P339; Tefera T, 2003, J INVERTEBR PATHOL, V84, P220, DOI 10.1016/j.jip.2003.11.001; Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638; Thomas MB, 1998, ENTOMOL EXP APPL, V87, P93, DOI 10.1023/A:1003298103716; Vatandoost H, 2009, J VECTOR DIS, V46, P261; Wang CS, 2007, NAT BIOTECHNOL, V25, P1455, DOI 10.1038/nbt1357; WIYGUL G, 1981, COMP BIOCHEM PHYS A, V68, P103, DOI 10.1016/0300-9629(81)90326-1; Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6	61	62	65	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23591	10.1371/journal.pone.0023591	http://dx.doi.org/10.1371/journal.pone.0023591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897846	Green Published, gold, Green Submitted			2022-12-25	WOS:000294676900009
J	Pan, KY				Pan, Keyao			Understanding Original Antigenic Sin in Influenza with a Dynamical System	PLOS ONE			English	Article							A VIRUS-INFECTION; ANTIVIRAL IMMUNE-RESPONSE; MATHEMATICAL-MODEL; RUGGED LANDSCAPES; HEPATITIS-B; VACCINE; EVOLUTION; MEMORY; EFFICACY; DISQUISITIONS	Original antigenic sin is the phenomenon in which prior exposure to an antigen leads to a subsequent suboptimal immune response to a related antigen. Immune memory normally allows for an improved and rapid response to antigens previously seen and is the mechanism by which vaccination works. I here develop a dynamical system model of the mechanism of original antigenic sin in influenza, clarifying and explaining the detailed spin-glass treatment of original antigenic sin. The dynamical system describes the viral load, the quantities of healthy and infected epithelial cells, the concentrations of naive and memory antibodies, and the affinities of naive and memory antibodies. I give explicit correspondences between the microscopic variables of the spin-glass model and those of the present dynamical system model. The dynamical system model reproduces the phenomenon of original antigenic sin and describes how a competition between different types of B cells compromises the overall effect of immune response. I illustrate the competition between the naive and the memory antibodies as a function of the antigenic distance between the initial and subsequent antigens. The suboptimal immune response caused by original antigenic sin is observed when the host is exposed to an antigen which has intermediate antigenic distance to a second antigen previously recognized by the host's immune system.	Rice Univ, Dept Bioengn, Houston, TX 77251 USA	Rice University	Pan, KY (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	keyaop@gmail.com						Atassi M. Z., 1984, MOL IMMUNOLOGY; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Beauchemin C, 2005, J THEOR BIOL, V232, P223, DOI 10.1016/j.jtbi.2004.08.001; Beauchemin CAA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S7; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; BOCHAROV GA, 1994, J THEOR BIOL, V167, P323, DOI 10.1006/jtbi.1994.1074; Bogarad LD, 1999, P NATL ACAD SCI USA, V96, P2591, DOI 10.1073/pnas.96.6.2591; Brandler S, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000096; Chang DB, 2007, J THEOR BIOL, V246, P621, DOI 10.1016/j.jtbi.2007.02.004; Ciupe SM, 2011, J THEOR BIOL, V277, P55, DOI 10.1016/j.jtbi.2011.01.050; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Deem MW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.068101; DESTGROTH SF, 1966, J EXP MED, V124, P347, DOI 10.1084/jem.124.3.347; DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331; Durrett R, 2003, ANN PROBAB, V31, P1713, DOI 10.1214/aop/1068646364; Engelkirk PG, 2010, BURTONS MICROBIOLOGY; FitzSimons D, 2005, VACCINE, V23, P4158, DOI 10.1016/j.vaccine.2005.03.017; Flindt R, 2006, AMAZING NUMBERS BIOL; FLYVBJERG H, 1992, PHYS REV A, V46, P6714, DOI 10.1103/PhysRevA.46.6714; FRANCIS T, 1953, ANN INTERN MED, V39, P203, DOI 10.7326/0003-4819-39-2-203; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; Hancioglu B, 2007, J THEOR BIOL, V246, P70, DOI 10.1016/j.jtbi.2006.12.015; Janeway C., 2001, IMMUNOBIOLOGY, V5th; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub4; KAUFFMAN S, 1987, J THEOR BIOL, V128, P11, DOI 10.1016/S0022-5193(87)80029-2; KEENAN KP, 1982, VIRCHOWS ARCH B, V41, P193, DOI 10.1007/BF02890281; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104; MACKEN CA, 1989, P NATL ACAD SCI USA, V86, P6191, DOI 10.1073/pnas.86.16.6191; MARCHUK GI, 1991, J THEOR BIOL, V151, P1, DOI 10.1016/S0022-5193(05)80142-0; Nobusawa E, 2006, J VIROL, V80, P3675, DOI 10.1128/JVI.80.7.3675-3678.2006; Nowak M. A., 2000, VIRUS DYNAMICS MATH; Pan KY, 2011, J CHEM THEORY COMPUT, V7, P1259, DOI 10.1021/ct100540p; Pan K, 2011, PROTEIN ENG DES SEL, V24, P291, DOI 10.1093/protein/gzq105; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Segovia-Juarez JL, 2004, J THEOR BIOL, V231, P357, DOI 10.1016/j.jtbi.2004.06.031; Sibani P, 1999, EUROPHYS LETT, V48, P346, DOI 10.1209/epl/i1999-00487-7; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001	39	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23910	10.1371/journal.pone.0023910	http://dx.doi.org/10.1371/journal.pone.0023910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897863	Green Submitted, gold, Green Published			2022-12-25	WOS:000294676900027
J	Borengasser, SJ; Lau, F; Kang, P; Blackburn, ML; Ronis, MJJ; Badger, TM; Shankar, K				Borengasser, Sarah J.; Lau, Franchesca; Kang, Ping; Blackburn, Michael L.; Ronis, Martin J. J.; Badger, Thomas M.; Shankar, Kartik			Maternal Obesity during Gestation Impairs Fatty Acid Oxidation and Mitochondrial SIRT3 Expression in Rat Offspring at Weaning	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; HEPATIC STEATOSIS; GLUCOSE-HOMEOSTASIS; LYSINE ACETYLATION; INSULIN-RESISTANCE; GENE-EXPRESSION; CHRONIC ETHANOL; LIVER-DISEASE; IN-UTERO	In utero exposure to maternal obesity increases the offspring's risk of obesity in later life. We have also previously reported that offspring of obese rat dams develop hepatic steatosis, mild hyperinsulinemia, and a lipogenic gene signature in the liver at postnatal day (PND)21. In the current study, we examined systemic and hepatic adaptations in male Sprague-Dawley offspring from lean and obese dams at PND21. Indirect calorimetry revealed decreases in energy expenditure (p<0.001) and increases in RER values (p<0.001), which were further exacerbated by high fat diet (45% kcals from fat) consumption indicating an impaired ability to utilize fatty acids in offspring of obese dams as analyzed by PRCF. Mitochondrial function is known to be associated with fatty acid oxidation (FAO) in the liver. Several markers of hepatic mitochondrial function were reduced in offspring of obese dams. These included SIRT3 mRNA (p = 0.012) and mitochondrial protein content (p = 0.002), electron transport chain complexes (II, III, and ATPase), and fasting PGC-1 alpha mRNA expression (p<0.001). Moreover, hepatic LCAD, a SIRT3 target, was not only reduced 2-fold (p<0.001) but was also hyperacetylated in offspring of obese dams (p<0.005) suggesting decreased hepatic FAO. In conclusion, exposure to maternal obesity contributes to early perturbations in whole body and liver energy metabolism. Mitochondrial dysfunction may be an underlying event that reduces hepatic fatty acid oxidation and precedes the development of detrimental obesity associated co-morbidities such as insulin resistance and NAFLD.	[Borengasser, Sarah J.; Badger, Thomas M.; Shankar, Kartik] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Ronis, Martin J. J.; Shankar, Kartik] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Blackburn, Michael L.; Badger, Thomas M.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Borengasser, Sarah J.; Lau, Franchesca; Kang, Ping; Blackburn, Michael L.; Ronis, Martin J. J.; Badger, Thomas M.; Shankar, Kartik] Arkansas Childrens Nutr Ctr, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Borengasser, SJ (corresponding author), Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA.	ShankarKartik@uams.edu		Shankar, Kartik/0000-0002-7964-9026; Borengasser, Sarah/0000-0002-9984-0178	National Institutes for Health [R01-DK084225]; U.S. Department of Agriculture-ARS CRIS [6251-51000-005-00D]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084225] Funding Source: NIH RePORTER	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture-ARS CRIS(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported in part by the National Institutes for Health R01-DK084225 (K. S.) and the U.S. Department of Agriculture-ARS CRIS # 6251-51000-005-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Araujo RL, 2010, ENDOCRINOLOGY, V151, P3460, DOI 10.1210/en.2010-0026; Aucouturier J, 2011, OBES REV, V12, pe44, DOI 10.1111/j.1467-789X.2010.00812.x; BADGER TM, 1993, J PHARMACOL EXP THER, V264, P938; BADGER TM, 1993, J PHARMACOL EXP THER, V264, P438; Bao JJ, 2010, FREE RADICAL BIO MED, V49, P1230, DOI 10.1016/j.freeradbiomed.2010.07.009; Baumgardner JN, 2008, AM J PHYSIOL-GASTR L, V294, pG27, DOI 10.1152/ajpgi.00296.2007; Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Catalano PM, 2003, J CLIN ENDOCR METAB, V88, P3505, DOI 10.1210/jc.2003-031046; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Divi RL, 2010, TOXICOL SCI, V118, P191, DOI 10.1093/toxsci/kfq235; Dolan MS, 2006, OBES REV, V7, P25, DOI 10.1111/j.1467-789X.2006.00219.x; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Hayashida S, 2010, MOL CELL BIOCHEM, V339, P285, DOI 10.1007/s11010-010-0391-z; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Jackman MR, 2010, AM J PHYSIOL-REG I, V299, pR1097, DOI 10.1152/ajpregu.00549.2009; Jarvie E, 2010, CLIN SCI, V119, P123, DOI 10.1042/CS20090640; Kawamura Y, 2010, J CLIN INVEST, V120, P2817, DOI 10.1172/JCI42020; Kendrick AA, 2010, BIOCH J; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; KNAPIK JJ, 1988, J APPL PHYSIOL, V64, P1923, DOI 10.1152/jappl.1988.64.5.1923; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Korourian S, 1999, TOXICOL SCI, V47, P110, DOI 10.1093/toxsci/47.1.110; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Mei ZG, 2003, SOZ PRAVENTIV MED, V48, P161, DOI 10.1007/s00038-003-2022-x; Mortensen OH, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S38; Nathanlelsz PW, 2007, CLIN PERINATOL, V34, P515, DOI 10.1016/j.clp.2007.09.005; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Perseghin G, 2006, AM J PHYSIOL-ENDOC M, V291, pE697, DOI 10.1152/ajpendo.00017.2006; Philp LK, 2008, AM J PHYSIOL-REG I, V295, pR1982, DOI 10.1152/ajpregu.90492.2008; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Racette SB, 2008, OBESITY, V16, P1826, DOI 10.1038/oby.2008.320; Rao MS, 2001, SEMIN LIVER DIS, V21, P43, DOI 10.1055/s-2001-12928; Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030; Riachi M, 2004, CAN J PHYSIOL PHARM, V82, P1075, DOI [10.1139/y04-117, 10.1139/Y04-117]; Rising R, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-15; Ritchie LD, 2003, SOZ PRAVENTIV MED, V48, P168, DOI 10.1007/s00038-003-2054-2; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schiffelers SLH, 2001, INT J OBESITY, V25, P33, DOI 10.1038/sj.ijo.0801528; Shankar K, 2008, ENDOCRINOLOGY, V149, P1748, DOI 10.1210/en.2007-0903; Shankar K, 2008, AM J PHYSIOL-REG I, V294, pR528, DOI 10.1152/ajpregu.00316.2007; Shankar K, 2006, EXP BIOL MED, V231, P1379, DOI 10.1177/153537020623100812; Shankar K, 2010, ENDOCRINOLOGY, V151, P2577, DOI 10.1210/en.2010-0017; Shankar K, 2010, ENDOCRINOLOGY, V151, P153, DOI 10.1210/en.2009-0840; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Shi T, 2010, J DIGEST DIS, V11, P55, DOI 10.1111/j.1751-2980.2009.00416.x; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Stroebele N, 2011, PUBLIC HEALTH NUTR, V14, P44, DOI 10.1017/S1368980010000686; Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR134, DOI 10.1152/ajpregu.00355.2004; Theys N, 2009, AM J PHYSIOL-REG I, V297, pR1516, DOI 10.1152/ajpregu.00280.2009; Thyfault JP, 2009, J PHYSIOL-LONDON, V587, P1805, DOI 10.1113/jphysiol.2009.169060; Tong J, 2008, J ANIM SCI, V86, P1296, DOI 10.2527/jas.2007-0794; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Wilms L, 2010, ACTA PAEDIATR, V99, P906, DOI 10.1111/j.1651-2227.2009.01635.x; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zhu MJ, 2008, J PHYSIOL-LONDON, V586, P2651, DOI 10.1113/jphysiol.2007.149633; ZINKER BA, 1990, J APPL PHYSIOL, V69, P1849, DOI 10.1152/jappl.1990.69.5.1849	66	83	83	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e24068	10.1371/journal.pone.0024068	http://dx.doi.org/10.1371/journal.pone.0024068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901160	Green Published, Green Submitted, gold			2022-12-25	WOS:000294298000045
J	Yu, FQ; Al-Shyoukh, I; Feng, JY; Li, XD; Liao, CW; Ho, CM; Shamma, JS; Sun, R				Yu, Fuqu; Al-Shyoukh, Ibrahim; Feng, Jiaying; Li, Xudong; Liao, Chia Wei; Ho, Chih-Ming; Shamma, Jeff S.; Sun, Ren			Control of Kaposi's Sarcoma-Associated Herpesvirus Reactivation Induced by Multiple Signals	PLOS ONE			English	Article							NF-KAPPA-B; POLYADENYLATED NUCLEAR-RNA; PROTEIN-KINASE-A; GENE-EXPRESSION; ACTIVATION; IDENTIFICATION; CYTOTOXICITY; INHIBITION; PROTEASOME; CELLS	The ability to control cellular functions can bring about many developments in basic biological research and its applications. The presence of multiple signals, internal as well as externally imposed, introduces several challenges for controlling cellular functions. Additionally the lack of clear understanding of the cellular signaling network limits our ability to infer the responses to a number of signals. This work investigates the control of Kaposi's sarcoma-associated herpesvirus reactivation upon treatment with a combination of multiple signals. We utilize mathematical model-based as well as experiment-based approaches to achieve the desired goals of maximizing virus reactivation. The results show that appropriately selected control signals can induce virus lytic gene expression about ten folds higher than a single drug; these results were validated by comparing the results of the two approaches, and experimentally using multiple assays. Additionally, we have quantitatively analyzed potential interactions between the used combinations of drugs. Some of these interactions were consistent with existing literature, and new interactions emerged and warrant further studies. The work presents a general method that can be used to quantitatively and systematically study multi-signal induced responses. It enables optimization of combinations to achieve desired responses. It also allows identifying critical nodes mediating the multi-signal induced responses. The concept and the approach used in this work will be directly applicable to other diseases such as AIDS and cancer.	[Yu, Fuqu; Al-Shyoukh, Ibrahim; Feng, Jiaying; Li, Xudong; Liao, Chia Wei; Sun, Ren] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Al-Shyoukh, Ibrahim; Ho, Chih-Ming] Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Los Angeles, CA USA; [Shamma, Jeff S.] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University System of Georgia; Georgia Institute of Technology	Yu, FQ (corresponding author), Johnson & Johnson Pharmaceut Res & Dev LLC, San Diego, CA USA.	rsun@mednet.ucla.edu	Li, Xudong/A-9065-2017; Ho, Chih-Ming/I-6537-2012	Ho, Chih-Ming/0000-0001-7369-5446	National Institutes of Health (NIH) [CA091791, CA127042, PN2 EY018228]; Jonsson Comprehensive Cancer Center Foundation - Stop Cancer Foundation [01072177]; Burroughs Wellcome Fund [003697]; National Science Foundation (NSF) [ECS-0501394]; NATIONAL CANCER INSTITUTE [R01CA091791, R21CA127042] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018228] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jonsson Comprehensive Cancer Center Foundation - Stop Cancer Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH): CA091791, CA127042, and PN2 EY018228 (www.nih.gov); the Jonsson Comprehensive Cancer Center Foundation - Stop Cancer Foundation: 01072177 (www.cancer.ucla.edu); Burroughs Wellcome Fund: 003697 (www.www.bwfund.org); and National Science Foundation (NSF) grant: ECS-0501394 (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; ALSHYOUKH I, 2011, BMC SYSTEMS IN PRESS; ALSHYOUKH I, 2007, THESIS U CALIFORNIA; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Brown HJ, 2005, ANTIVIR THER, V10, P745; Calzolari D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000249; Chang M, 2005, J VIROL, V79, P13538, DOI 10.1128/JVI.79.21.13538-13547.2005; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chauhan D, 2002, ONCOGENE, V21, P1346, DOI 10.1038/sj.onc.1205205; CHEN CY, 1995, HUM GENE THER, V6, P1467, DOI 10.1089/hum.1995.6.11-1467; Davis DA, 2007, CANCER RES, V67, P7003, DOI 10.1158/0008-5472.CAN-07-0939; De Boer PT, 2005, ANN OPER RES, V134, P19, DOI 10.1007/s10479-005-5724-z; Deng H, 2007, CURR TOP MICROBIOL, V312, P157; Dowd DR, 1997, MOL CELL ENDOCRINOL, V128, P29, DOI 10.1016/S0303-7207(96)04012-9; FICK J, 1995, P NATL ACAD SCI USA, V92, P11071, DOI 10.1073/pnas.92.24.11071; Geladi P., 1986, ANAL CHIMICA ACTA; GOLDBERG D, 1989, OPTIMIZATION MACHINE, V372; Gupta MM, 2003, STATIC DYNAMIC NEURA; Haykin S, 1999, P842; Hermann-Kleiter N, 2006, BLOOD, V107, P4841, DOI 10.1182/blood-2005-10-4044; Hideshima T, 2001, CANCER RES, V61, P3071; HOFMANN M, 2007, COMPUTATIONAL STAT D; Israel BF, 2003, ONCOGENE, V22, P5122, DOI 10.1038/sj.onc.1206548; Krappmann D, 2001, MOL CELL BIOL, V21, P6640, DOI 10.1128/MCB.21.19.6640-6650.2001; Kroese DP, 2006, METHODOL COMPUT APPL, V8, P383, DOI 10.1007/s11009-006-9753-0; Krug LT, 2007, PLOS PATHOG, V3, P97, DOI 10.1371/journal.ppat.0030011; Kutner M., 2005, APPL LINEAR STAT MOD; Montgomery D. C, 2012, INTRO LINEAR REGRESS, V5th, P289; Rabbi MF, 1998, VIROLOGY, V245, P257, DOI 10.1006/viro.1998.9158; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; ROIZMAN B, 2001, FIELDS VIROLOGY; RUBENSTEIN R, 1999, METHODOL COMPUT APPL, V2, P127; Shaw RN, 2000, AIDS, V14, P899, DOI 10.1097/00002030-200005050-00021; Snyman J., 2005, PRACTICAL MATH OPTIM; Song MJ, 2002, J VIROL, V76, P5000, DOI 10.1128/JVI.76.10.5000-5013.2002; Song MJ, 2001, J VIROL, V75, P3129, DOI 10.1128/JVI.75.7.3129-3140.2001; Sun CP, 2009, INTEGR BIOL-UK, V1, P123, DOI 10.1039/b815225j; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; Sun R, 1996, P NATL ACAD SCI USA, V93, P11883, DOI 10.1073/pnas.93.21.11883; Tai TC, 2003, J NEUROCHEM, V85, P816, DOI 10.1046/j.1471-4159.2003.01728.x; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Wong PK, 2008, P NATL ACAD SCI USA, V105, P5105, DOI 10.1073/pnas.0800823105; YU F, 2007, THESIS U CALIFORNIA; Yu FQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030044; Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641; Zoeteweij JP, 2002, J MED VIROL, V66, P378, DOI 10.1002/jmv.2155; ZURHAUSEN H, 1979, P NATL ACAD SCI USA, V76, P782; 2009, SUPPLEMENTAL WEBPAGE	51	4	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e20998	10.1371/journal.pone.0020998	http://dx.doi.org/10.1371/journal.pone.0020998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21904595	Green Published, gold			2022-12-25	WOS:000292142800007
J	Nunez, N; Clifton, MMK; Funnell, APW; Artuz, C; Hallal, S; Quinlan, KGR; Font, J; Vandevenne, M; Setiyaputra, S; Pearson, RCM; Mackay, JP; Crossley, M				Nunez, Noelia; Clifton, Molly M. K.; Funnell, Alister P. W.; Artuz, Crisbel; Hallal, Samantha; Quinlan, Kate G. R.; Font, Josep; Vandevenne, Marylene; Setiyaputra, Surya; Pearson, Richard C. M.; Mackay, Joel P.; Crossley, Merlin			The Multi-zinc Finger Protein ZNF217 Contacts DNA through a Two-finger Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR-8; BOX-BINDING-PROTEIN; CRYSTAL-STRUCTURE; TRANSCRIPTIONAL REPRESSOR; RECOGNITION MOTIFS; COREPRESSOR CTBP; GAGA FACTOR; COMPLEX; SEQUENCE; PEPTIDE	Classical C2H2 zinc finger proteins are among the most abundant transcription factors found in eukaryotes, and the mechanisms through which they recognize their target genes have been extensively investigated. In general, a tandem array of three fingers separated by characteristic TGERP links is required for sequence-specific DNA recognition. Nevertheless, a significant number of zinc finger proteins do not contain a hallmark three-finger array of this type, raising the question of whether and how they contact DNA. We have examined the multi-finger protein ZNF217, which contains eight classical zinc fingers. ZNF217 is implicated as an oncogene and in repressing the E-cadherin gene. We show that two of its zinc fingers, 6 and 7, can mediate contacts with DNA. We examine its putative recognition site in the E-cadherin promoter and demonstrate that this is a suboptimal site. NMR analysis and mutagenesis is used to define the DNA binding surface of ZNF217, and we examine the specificity of the DNA binding activity using fluorescence anisotropy titrations. Finally, sequence analysis reveals that a variety of multi-finger proteins also contain two-finger units, and our data support the idea that these may constitute a distinct subclass of DNA recognition motif.	[Funnell, Alister P. W.; Artuz, Crisbel; Pearson, Richard C. M.; Crossley, Merlin] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Nunez, Noelia; Clifton, Molly M. K.; Funnell, Alister P. W.; Hallal, Samantha; Quinlan, Kate G. R.; Font, Josep; Vandevenne, Marylene; Setiyaputra, Surya; Pearson, Richard C. M.; Mackay, Joel P.; Crossley, Merlin] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney	Crossley, M (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	m.crossley@unsw.edu.au	Crossley, Merlin/D-7888-2011; Pearson, Richard/J-4411-2012; Sadurni, Josep Font/A-2499-2010; Mackay, Joel/D-6834-2011	Crossley, Merlin/0000-0003-2057-3642; Pearson, Richard/0000-0002-7918-9111; Sadurni, Josep Font/0000-0001-5284-1344; Hallal, Samantha/0000-0003-1884-7579; Mackay, Joel/0000-0001-7508-8033; Quinlan, Kate/0000-0002-5722-8183; Vandevenne, Marylene/0000-0002-4492-2635; Funnell, Alister/0000-0002-1062-5296	National Health and Medical Research Council; Australian Research Council; Prostate Cancer Foundation of Australia; Australian Postgraduate Awards	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Prostate Cancer Foundation of Australia; Australian Postgraduate Awards(Australian Government)	This work was supported by grants from the National Health and Medical Research Council, Australian Research Council, and the Prostate Cancer Foundation of Australia (to M. C. and J. P. M.).; Supported by Australian Postgraduate Awards.	AFFOLTER M, 1990, P NATL ACAD SCI USA, V87, P4093, DOI 10.1073/pnas.87.11.4093; Amoutzias GD, 2007, MOL BIOL EVOL, V24, P827, DOI 10.1093/molbev/msl211; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Banck MS, 2009, EPIGENETICS-US, V4, P100, DOI 10.4161/epi.4.2.7953; Bessiere D, 2008, J BIOL CHEM, V283, P4352, DOI 10.1074/jbc.M707537200; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bohm S, 1997, NUCLEIC ACIDS RES, V25, P2464, DOI 10.1093/nar/25.12.2464; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Cowger JJM, 2007, ONCOGENE, V26, P3378, DOI 10.1038/sj.onc.1210126; Crossley M, 1996, MOL CELL BIOL, V16, P1695; FAIRALL L, 1992, J MOL BIOL, V226, P349, DOI 10.1016/0022-2836(92)90952-G; FAIRALL L, 1993, NATURE, V366, P483, DOI 10.1038/366483a0; Foster MP, 1997, NAT STRUCT BIOL, V4, P605, DOI 10.1038/nsb0897-605; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Huang GQ, 2005, HUM MOL GENET, V14, P3219, DOI 10.1093/hmg/ddi352; Immink RGH, 2010, SEMIN CELL DEV BIOL, V21, P87, DOI 10.1016/j.semcdb.2009.10.004; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Iwahara J, 2006, P NATL ACAD SCI USA, V103, P15062, DOI 10.1073/pnas.0605868103; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; Klug A, 2010, Q REV BIOPHYS, V43, P1, DOI 10.1017/S0033583510000089; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krig SR, 2007, J BIOL CHEM, V282, P9703, DOI 10.1074/jbc.M611752200; Krizek BA, 1996, P NATL ACAD SCI USA, V93, P4063, DOI 10.1073/pnas.93.9.4063; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Kwan AHY, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng124; Liew CK, 2005, P NATL ACAD SCI USA, V102, P583, DOI 10.1073/pnas.0407511102; Liew CK, 2000, STRUCTURE, V8, P1157, DOI 10.1016/S0969-2126(00)00527-X; Lo Surdo P, 2004, NAT STRUCT MOL BIOL, V11, P382, DOI 10.1038/nsmb745; Mackay JP, 2011, NAT STRUCT MOL BIOL, V18, P256, DOI 10.1038/nsmb.2005; Magner DB, 2008, TRENDS ENDOCRIN MET, V19, P153, DOI 10.1016/j.tem.2008.02.005; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Matharu NK, 2010, J MOL BIOL, V400, P434, DOI 10.1016/j.jmb.2010.05.010; Matthews JM, 2000, EUR J BIOCHEM, V267, P1030, DOI 10.1046/j.1432-1327.2000.01095.x; Nolte RT, 1998, P NATL ACAD SCI USA, V95, P2938, DOI 10.1073/pnas.95.6.2938; Nonet GH, 2001, CANCER RES, V61, P1250; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; OMICHINSKI JG, 1993, P NATL ACAD SCI USA, V90, P1676, DOI 10.1073/pnas.90.5.1676; Papworth M, 2006, GENE, V366, P27, DOI 10.1016/j.gene.2005.09.011; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Qin Z, 2009, MOL CELL BIOL, V29, P3633, DOI 10.1128/MCB.00362-09; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8202, DOI 10.1128/MCB.00445-06; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8159, DOI 10.1128/MCB.00680-06; Sakai T, 2003, DNA RES, V10, P155, DOI 10.1093/dnares/10.4.155; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; Segal DJ, 2006, J MOL BIOL, V363, P405, DOI 10.1016/j.jmb.2006.08.016; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Thillainadesan G, 2008, MOL CELL BIOL, V28, P6066, DOI 10.1128/MCB.00246-08; Trainor CD, 2000, J BIOL CHEM, V275, P28157; Ueda J, 2006, J BIOL CHEM, V281, P20120, DOI 10.1074/jbc.M603087200; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Wolfe SA, 2001, STRUCTURE, V9, P717, DOI 10.1016/S0969-2126(01)00632-3; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Wuttke DS, 1997, J MOL BIOL, V273, P183, DOI 10.1006/jmbi.1997.1291	64	17	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38190	38201		10.1074/jbc.M111.301234	http://dx.doi.org/10.1074/jbc.M111.301234			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908891	Green Published, hybrid			2022-12-25	WOS:000296594200033
J	Bahl, N; Du, RJ; Winarsih, I; Ho, B; Tucker-Kellogg, L; Tidor, B; Ding, JL				Bahl, Neha; Du, Ruijuan; Winarsih, Imelda; Ho, Bow; Tucker-Kellogg, Lisa; Tidor, Bruce; Ding, Jeak Ling			Delineation of Lipopolysaccharide (LPS)-binding Sites on Hemoglobin FROM IN SILICO PREDICTIONS TO BIOPHYSICAL CHARACTERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-CONTAINING PROTEINS; BIOLOGICAL-ACTIVITY; BACTERIAL LIPOPOLYSACCHARIDES; LIPID-A; ENDOTOXINS; BINDING; LPS; RECOGNITION; ACTIVATION; MYOGLOBIN		[Du, Ruijuan; Winarsih, Imelda; Ding, Jeak Ling] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; Singapore Massachusetts Inst Technol Alliance, Singapore 117576, Singapore; [Ho, Bow] Natl Univ Singapore, Dept Microbiol, Singapore 117597, Singapore; [Tidor, Bruce] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Tidor, Bruce] MIT, Dept Elect Engn, Cambridge, MA 02139 USA; [Tidor, Bruce] MIT, Dept Comp Sci, Cambridge, MA 02139 USA	National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Ding, JL (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsdjl@nus.edu.sg	Tucker-Kellogg, Lisa/G-3376-2012; Ding, Jeak/H-8057-2012; Tucker-Kellogg, Lisa/AAD-9265-2022	Tucker-Kellogg, Lisa/0000-0002-1301-7069; /0000-0002-3320-3969	Singapore-Massachusetts Institute of Technology Alliance; Ministry of Education [T208B3109]	Singapore-Massachusetts Institute of Technology Alliance; Ministry of Education	This work was supported by the Singapore-Massachusetts Institute of Technology Alliance and Tier 2 Grant T208B3109 from the Ministry of Education.	Alayash AI, 2001, ANTIOXID REDOX SIGN, V3, P313, DOI 10.1089/152308601300185250; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; BELANGER M, 1995, INFECT IMMUN, V63, P656; BONE RC, 1991, CHEST, V100, P802, DOI 10.1378/chest.100.3.802; Brandenburg K, 2003, J BIOL CHEM, V278, P47660, DOI 10.1074/jbc.M304743200; CORRIVEAU CC, 1993, INFECT AGENT DIS, V2, P35; Cunningham MD, 2000, J IMMUNOL, V164, P3255, DOI 10.4049/jimmunol.164.6.3255; DAVID SA, 1992, BIOCHIM BIOPHYS ACTA, V1165, P147, DOI 10.1016/0005-2760(92)90180-4; Ding JL, 2001, TRENDS BIOTECHNOL, V19, P277, DOI 10.1016/S0167-7799(01)01694-8; Du RJ, 2010, EMBO J, V29, P632, DOI 10.1038/emboj.2009.380; Erridge C, 2002, MICROBES INFECT, V4, P837, DOI 10.1016/S1286-4579(02)01604-0; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Ferguson AD, 2000, STRUCTURE, V8, P585; GIULIVI C, 1990, J BIOL CHEM, V265, P19453; Habich C, 2005, J IMMUNOL, V174, P1298, DOI 10.4049/jimmunol.174.3.1298; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Howe J, 2008, INNATE IMMUN-LONDON, V14, P39, DOI 10.1177/1753425907087257; Howe J, 2007, MED CHEM, V3, P13, DOI 10.2174/157340607779317625; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Jiang N, 2007, NAT IMMUNOL, V8, P1114, DOI 10.1038/ni1501; Joughin BA, 2005, PROTEIN SCI, V14, P131, DOI 10.1110/ps.04964705; Jurgens G, 2001, EUR J BIOCHEM, V268, P4233, DOI 10.1046/j.1432-1327.2001.02338.x; KACA W, 1995, BIOCHEMISTRY-US, V34, P11176, DOI 10.1021/bi00035a024; KACA W, 1994, J BIOL CHEM, V269, P25078; KACA W, 1994, J ENDOTOXIN RES, V1, P243; Lamping N, 1996, J IMMUNOL, V157, P4648; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Mak P, 2000, ANTON LEEUW INT J G, V77, P197, DOI 10.1023/A:1002081605784; Mancek M, 2002, BIOCHEM BIOPH RES CO, V292, P880, DOI 10.1006/bbrc.2002.6748; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Payne Shelley M., 1993, Trends in Microbiology, V1, P66, DOI 10.1016/0966-842X(93)90036-Q; RIETSCHEL ET, 1971, EUR J BIOCHEM, V22, P218, DOI 10.1111/j.1432-1033.1971.tb01535.x; RIETSCHEL ET, 1992, SCI AM, V267, P54, DOI 10.1038/scientificamerican0892-54; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; WATSON HC, 1961, NATURE, V190, P670, DOI 10.1038/190670a0	39	22	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37793	37803		10.1074/jbc.M111.245472	http://dx.doi.org/10.1074/jbc.M111.245472			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900232	Green Published, hybrid			2022-12-25	WOS:000296542400074
J	Hayward, MW; Hayward, GJ; Tambling, CJ; Kerley, GIH				Hayward, Matt W.; Hayward, Gina J.; Tambling, Craig J.; Kerley, Graham I. H.			Do Lions Panthera leo Actively Select Prey or Do Prey Preferences Simply Reflect Chance Responses via Evolutionary Adaptations to Optimal Foraging?	PLOS ONE			English	Article							AFRICAN WILD DOGS; ELEPHANT NATIONAL-PARK; LYCAON-PICTUS; ACTIVITY PATTERNS; HUNTING BEHAVIOR; EASTERN-CAPE; SOUTH-AFRICA; SUCCESS; DIET; FOOD	Research on coursing predators has revealed that actions throughout the predatory behavioral sequence (using encounter rate, hunting rate, and kill rate as proxy measures of decisions) drive observed prey preferences. We tested whether similar actions drive the observed prey preferences of a stalking predator, the African lion Panthera leo. We conducted two 96 hour, continuous follows of lions in Addo Elephant National Park seasonally from December 2003 until November 2005 (16 follows), and compared prey encounter rate with prey abundance, hunt rate with prey encounter rate, and kill rate with prey hunt rate for the major prey species in Addo using Jacobs' electivity index. We found that lions encountered preferred prey species far more frequently than expected based on their abundance, and they hunted these species more frequently than expected based on this higher encounter rate. Lions responded variably to non-preferred and avoided prey species throughout the predatory sequence, although they hunted avoided prey far less frequently than expected based on the number of encounters of them. We conclude that actions of lions throughout the predatory behavioural sequence, but particularly early on, drive the prey preferences that have been documented for this species. Once a hunt is initiated, evolutionary adaptations to the predator-prey interactions drive hunting success.	[Hayward, Matt W.; Hayward, Gina J.; Tambling, Craig J.; Kerley, Graham I. H.] Nelson Mandela Metropolitan Univ, Ctr African Conservat Ecol, Port Elizabeth, South Africa	Nelson Mandela University	Hayward, MW (corresponding author), Australian Wildlife Conservancy, Scotia Sanctuary, Wentworth, NSW, Australia.	hayers111@aol.com	Hayward, Matt W./F-3569-2010; Tambling, Craig/H-3554-2019	Hayward, Matt W./0000-0002-5574-1653; Tambling, Craig/0000-0001-9830-5985	Budget Rent-a-Car; Eveready Batteries; CR Kennedy Pty Ltd; Leica; Continental Tyres; Wayne Linklater; Centre for African Conservation Ecology at the Nelson Mandela Metropolitan University; Nelson Mandela Metropolitan University; National Research Foundation	Budget Rent-a-Car; Eveready Batteries; CR Kennedy Pty Ltd; Leica; Continental Tyres; Wayne Linklater; Centre for African Conservation Ecology at the Nelson Mandela Metropolitan University; Nelson Mandela Metropolitan University; National Research Foundation	This project was supported by Budget Rent-a-Car, Eveready Batteries, CR Kennedy Pty Ltd, Leica, Continental Tyres, Wayne Linklater and the Centre for African Conservation Ecology at the Nelson Mandela Metropolitan University. MWH was supported by a Nelson Mandela Metropolitan University and then a National Research Foundation post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 2001, SCIENCE, V291, P1036, DOI 10.1126/science.1056466; Bradfield M, 2005, ADDO ELEPHANT NATL P; Carbone C, 1997, J ANIM ECOL, V66, P318, DOI 10.2307/5978; CHESSON J, 1978, ECOLOGY, V59, P211, DOI 10.2307/1936364; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; Creel S., 2002, AFRICAN WILD DOG BEH; ESTES RD, 1967, J WILDLIFE MANAGE, V31, P52, DOI 10.2307/3798360; FULLER TK, 1993, J MAMMAL, V74, P464, DOI 10.2307/1382403; Funston PJ, 1998, ANIM BEHAV, V56, P1333, DOI 10.1006/anbe.1998.0884; Funston PJ, 2001, J ZOOL, V253, P419, DOI 10.1017/S0952836901000395; Gough KF, 2006, ORYX, V40, P434, DOI 10.1017/S0030605306001189; Hayward MW, 2007, ORYX, V41, P205, DOI 10.1017/S0030605307001767; Hayward MW, 2006, J ZOOL, V270, P615, DOI 10.1111/j.1469-7998.2006.00184.x; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Hayward MW, 2006, J MAMMAL, V87, P1122, DOI 10.1644/05-MAMM-A-304R2.1; Hayward MW, 2007, J WILDLIFE MANAGE, V71, P1567, DOI 10.2193/2006-264; Hayward MW, 2007, AFR J ECOL, V45, P135, DOI 10.1111/j.1365-2028.2006.00686.x; Hayward MW, 2007, AFR J ECOL, V45, P103, DOI 10.1111/j.1365-2028.2006.00673.x; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Hayward MW, 2009, BIODIVERS CONSERV, DOI [10.1007/s10531-10008-19452-y, DOI 10.1007/S10531-10008-19452-Y]; Hunter LTB, 1998, BEHAVIOUR, V135, P195, DOI 10.1163/156853998793066320; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; JEDRZEJEWSKI W, 1993, OIKOS, V68, P251, DOI 10.2307/3544837; Joubert D, 2006, AFR J ECOL, V44, P279, DOI 10.1111/j.1365-2028.2006.00626.x; Krebs C. J., 2014, ECOLOGICAL METHODOLO; Kruger SC, 1999, J ZOOL, V248, P543, DOI 10.1111/j.1469-7998.1999.tb01054.x; Lehmann MB, 2008, S AFR J WILDL RES, V38, P66, DOI 10.3957/0379-4369-38.1.66; MILLS MGL, 1992, WILDLIFE 2001 : POPULATIONS, P1112; NORBURY GL, 1992, AUST J ECOL, V17, P1, DOI 10.1111/j.1442-9993.1992.tb00774.x; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; PACKER C, 1988, AM NAT, V132, P159, DOI 10.1086/284844; Pole A, 2004, J ZOOL, V262, P207, DOI 10.1017/S0952836903004576; Rapson JA, 2007, S AFR J WILDL RES, V37, P179, DOI 10.3957/0379-4369-37.2.179; Reich A., 1981, BEHAV ECOLOGY AFRICA; Schaller G. B., 1972, SERENGETI LION; SCHEEL D, 1993, BEHAV ECOL, V4, P90, DOI 10.1093/beheco/4.1.90; Skead CJ, 1987, HIST MAMMAL INCIDENC, V2, P1; Somers MJ, 1997, AFR J ECOL, V35, P73, DOI 10.1111/j.1365-2028.1997.045-89045.x; STANDER PE, 1992, BEHAV ECOL SOCIOBIOL, V29, P445; STRAUSS RE, 1979, T AM FISH SOC, V108, P344, DOI 10.1577/1548-8659(1979)108<344:REFIEI>2.0.CO;2; Vlok JHJ, 2003, S AFR J BOT, V69, P27, DOI 10.1016/S0254-6299(15)30358-6; Whitehouse AM, 2000, ORYX, V34, P46, DOI 10.1046/j.1365-3008.2000.00093.x	42	27	29	2	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e23607	10.1371/journal.pone.0023607	http://dx.doi.org/10.1371/journal.pone.0023607			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915261	gold, Green Submitted, Green Published			2022-12-25	WOS:000294802500012
J	Xu, X; Tan, QW; Sullivan, C; Han, FL; Xiao, D				Xu, Xing; Tan, Qingwei; Sullivan, Corwin; Han, Fenglu; Xiao, Dong			A Short-Armed Troodontid Dinosaur from the Upper Cretaceous of Inner Mongolia and Its Implications for Troodontid Evolution	PLOS ONE			English	Article							STENONYCHOSAURUS-INEQUALIS SAURISCHIA; THEROPOD DINOSAUR; YIXIAN FORMATION; CRANIAL MORPHOLOGY; OLDMAN FORMATION; CHINA; MANIRAPTORAN; INFORMATION; PATAGONIA	Background: The Troodontidae represents one of the most bird-like theropod groups and plays an important role in our understanding of avian origins. Although troodontids have been known for over 150 years, few known derived troodontid specimens preserve significant portions of both the forelimb and the hindlimb. Methodology/Principal Findings: Here, we report a new troodontid taxon, Linhevenator tani gen. et sp. nov., based on a partial, semi-articulated skeleton recovered from the Upper Cretaceous Wulansuhai Formation of Wulatehouqi, Inner Mongolia, China. L. tani has an unusual combination of primitive and derived character states, though our phylogenetic analysis places it in a derived clade within the Troodontidae. As a derived taxon, L. tani has a dromaeosaurid-like pedal digit II, and this species also possesses a humerus that is proportionally much shorter and more robust than those of most other troodontids. Conclusion/Significance: The combination of features present in Linhevenator indicates a complex pattern of character evolution within the Troodontidae. In particular, the discovery of Linhevenator suggests that derived troodontids have independently evolved a highly specialized pedal digit II and have significantly shortened the forelimb over the course of their evolution.	[Xu, Xing; Sullivan, Corwin; Han, Fenglu] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China; [Xiao, Dong] Dept Land & Resources, Linhe, Inner Mongolia, Peoples R China; [Tan, Qingwei] Long Hao Inst Geol & Paleontol, Hohhot, Inner Mongolia, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China.	xingxu@vip.sina.com		Sullivan, Corwin/0000-0002-5488-6797	National Natural Science Foundation of China [40830210]; Department of Land and Resources, Inner Mongolia, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Land and Resources, Inner Mongolia, China	This work was funded by the National Natural Science Foundation of China (40830210) and the Department of Land and Resources, Inner Mongolia, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averianov AO, 2007, J VERTEBR PALEONTOL, V27, P87, DOI 10.1671/0272-4634(2007)27[87:ANTDTF]2.0.CO;2; BARSBOLD R, 1987, Acta Palaeontologica Polonica, V32, P121; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Bever GS, 2009, AM MUS NOVIT, P1, DOI 10.1206/650.1; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Chiappe Luis M., 2002, P87; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Chure Daniel J., 1994, Brigham Young University Geology Studies, V40, P11; Coria RA, 2002, J VERTEBR PALEONTOL, V22, P460, DOI 10.1671/0272-4634(2002)022[0460:ANCROC]2.0.CO;2; Currie P.J., 1987, Journal of Vertebrate Paleontology, V7, P72; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2224, DOI 10.1139/e93-193; Currie PJ, 2004, LIFE O PAST, P112; Currie PJ, 2001, CAN J EARTH SCI, V38, P1753, DOI 10.1139/e01-065; CURRIE PJ, 1985, CAN J EARTH SCI, V22, P1643, DOI 10.1139/e85-173; Elzanowski A, 1996, J VERTEBR PALEONTOL, V16, P81, DOI 10.1080/02724634.1996.10011286; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; Gilmore C.W., 1924, U ALBERTA B, V1, P1; Goloboff P, 2008, CLADISTICS, V24, P91; Hartman S, 2005, J VERTEBR PALEONTOL, V25, p67A; Holtz Jr T. R., 2000, GAIA, V15, P5; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Holtz Thomas R. Jr, 2000, Gaia (Lisboa), V15, P159; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Huene F. v., 1920, Zeitschrift fuer Induktive Abstammungs und Vererbungslehre Berlin, V22, P209, DOI 10.1007/BF01785394; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; Jasinoski SC, 2006, ZOOL J LINN SOC-LOND, V146, P301, DOI 10.1111/j.1096-3642.2006.00200.x; JERZYKIEWICZ T, 1993, CAN J EARTH SCI, V30, P2180, DOI 10.1139/e93-190; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; [Ji Qiang 季强], 2005, [地质通报, Geological Bulletin of China], V24, P197; KURZANOV S M, 1991, Acta Palaeontologica Polonica, V36, P69; Kurzanov S.M., 1987, T SOVMESTNOI SOVETSK, V31, P1; Leidy J., 1856, P ACAD NAT SCI PHILA, V8, P72; Lu JC, 2010, ACTA PALAEONTOL POL, V55, P381, DOI 10.4202/app.2009.0047; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P184; Makovicky PJ, 2003, AM MUS NOVIT, P1; Marsh O.C., 1881, AM J SCI 3, V23, P81, DOI DOI 10.2475/AJS.S3-23.133.81; Maryanska T, 2002, ACTA PALAEONTOL POL, V47, P97; Naish D, 2004, NEUES JAHRB GEOL P-M, P385; Norell MA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P49; Norell MA, 2000, J VERTEBR PALEONTOL, V20, P7, DOI 10.1671/0272-4634(2000)020[0007:ANTTFU]2.0.CO;2; Norell MA, 2004, DINOSAURIA, 2ND EDITION, P196; Norell Mark A., 1999, American Museum Novitates, V3282, P1; Norell Mark A., 1997, American Museum Novitates, V3215, P1; Norell MA, 2009, AM MUS NOVIT, P1; Norell MA, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3545[1:ANDTFU]2.0.CO;2; Novas FE, 2008, CRETACEOUS RES, V29, P468, DOI 10.1016/j.cretres.2008.01.001; Novas FE, 2009, P ROY SOC B-BIOL SCI, V276, P1101, DOI 10.1098/rspb.2008.1554; OSBORN H.F., 1924, AM MUS NOVIT, V144, P1; OSMOLSKA H, 1987, Acta Palaeontologica Polonica, V32, P133; OSTROM J H, 1978, Zitteliana, V4, P73; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; Paul G., 1988, PREDATORY DINOSAURS; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2107, DOI 10.1139/e93-183; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2163, DOI 10.1139/e93-187; RUSSELL DA, 1969, CAN J EARTH SCI, V6, P595, DOI 10.1139/e69-059; Saurornithoididae BarsboldR., 1974, PALAENTOL POL, V30, P5; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Varricchio D. J, 1997, ENCY DINOSAURS, P749; Wellnhofer P, 2008, ARCHAEOPTERYX URVOGE; WILSON MC, 1985, CAN J EARTH SCI, V22, P1813, DOI 10.1139/e85-192; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511; Xu X, 2004, NATURE, V431, P838, DOI 10.1038/nature02898; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X, 2001, CAN J EARTH SCI, V38, P1739, DOI 10.1139/e01-082; XU X, 2002, DEINONYCHOSAURIAN FO, P1; Xu X, 2000, PALEONTOLOGY SOC KOR, V2000, P179; Xu X, 2011, P NATL ACAD SCI USA, V108, P2338, DOI 10.1073/pnas.1011052108; Xu Xing, 2010, Zootaxa, V2403, P1; Xu X, 2009, NATURE, V459, P940, DOI 10.1038/nature08124; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zanno LE, 2009, P ROY SOC B-BIOL SCI, V276, P3505, DOI 10.1098/rspb.2009.1029; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447	78	14	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e22916	10.1371/journal.pone.0022916	http://dx.doi.org/10.1371/journal.pone.0022916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915256	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802500008
J	Lu, SM; Tremblay, ME; King, IL; Qi, J; Reynolds, HM; Marker, DF; Varrone, JJP; Majewska, AK; Dewhurst, S; Gelbard, HA				Lu, Shao-Ming; Tremblay, Marie-Eve; King, Irah L.; Qi, Jin; Reynolds, Holly M.; Marker, Daniel F.; Varrone, John J. P.; Majewska, Ania K.; Dewhurst, Stephen; Gelbard, Harris A.			HIV-1 Tat-Induced Microgliosis and Synaptic Damage via Interactions between Peripheral and Central Myeloid Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; MCP-1 GENE-TRANSCRIPTION; FIND-ME SIGNAL; IN-VIVO; TRANSGENIC MICE; BRAIN-INJURY; PROTEIN TAT; MOUSE MODEL; MONOCYTES	Despite the ability of combination antiretroviral treatment (cART) to reduce viral burden to nearly undetectable levels in cerebrospinal fluid and serum, HIV-1 associated neurocognitive disorders (HAND) continue to persist in as many as half the patients living with this disease. There is growing consensus that the actual substrate for HAND is destruction of normal synaptic architecture but the sequence of cellular events that leads to this outcome has never been resolved. To address whether central vs. peripheral myeloid lineage cells contribute to synaptic damage during acute neuroinflammation we injected a single dose of the HIV-1 transactivator of transcription protein (Tat) or control vehicle into hippocampus of wildtype or chimeric C57Bl/6 mice genetically marked to distinguish infiltrating and resident immune cells. Between 8-24 hr after injection of Tat, invading CD11b(+) and/or myeloperoxidase-positive leukocytes with granulocyte characteristics were found to engulf both microglia and synaptic structures, and microglia reciprocally engulfed invading leukocytes. By 24 hr, microglial processes were also seen ensheathing dendrites, followed by inclusion of synaptic elements in microglia 7 d after Tat injection, with a durable microgliosis lasting at least 28 d. Thus, central nervous system (CNS) exposure to Tat induces early activation of peripheral myeloid lineage cells with phagocytosis of synaptic elements and reciprocal microglial engulfment of peripheral leukocytes, and enduring microgliosis. Our data suggest that a single exposure to a foreign antigen such as HIV-1 Tat can lead to long-lasting disruption of normal neuroimmune homeostasis with deleterious consequences for synaptic architecture, and further suggest a possible mechanism for enduring neuroinflammation in the absence of productive viral replication in the CNS.	[Lu, Shao-Ming; Marker, Daniel F.; Gelbard, Harris A.] Univ Rochester, Sch Med & Dent, Ctr Neural Dev & Dis, Rochester, NY 14627 USA; [Lu, Shao-Ming; Marker, Daniel F.; Gelbard, Harris A.] Univ Rochester, Sch Med & Dent, Dept Neurol, Child Neurol Div, Rochester, NY 14642 USA; [Majewska, Ania K.] Univ Rochester, Sch Med & Dent, Dept Neurobiol & Anat, Rochester, NY 14642 USA; [Majewska, Ania K.] Univ Rochester, Sch Med & Dent, Ctr Visual Sci, Rochester, NY USA; [Varrone, John J. P.] Univ Rochester, Sch Med & Dent, Dept Lab Med & Pathol, Rochester, NY USA; [Dewhurst, Stephen; Gelbard, Harris A.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Tremblay, Marie-Eve] Univ Rochester, Sch Med & Dent, Dept Psychiat, Rochester, NY 14642 USA; [King, Irah L.] Trudeau Inst Inc, Saranac Lake, NY 12983 USA; [Qi, Jin] Evanston Hosp Corp, N Shore Univ Hlth Syst Res Inst, Evanston, IL USA; [Reynolds, Holly M.] Diffin Genom, W Henrietta, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; Trudeau Institute; NorthShore University Health System	Lu, SM (corresponding author), Univ Rochester, Sch Med & Dent, Ctr Neural Dev & Dis, Rochester, NY 14627 USA.	pat_lu@urmc.rochester.edu	Gelbard, Harris/M-9260-2019	Gelbard, Harris/0000-0001-5095-7976; Tremblay, Marie-Eve/0000-0003-2863-9626; Dewhurst, Stephen/0000-0001-7729-7920; Majewska, Ania/0000-0002-2167-6849; Marker, Daniel/0000-0001-6171-0688	Geoffrey Waisdorp Pediatric Neurology Fund; National Institutes of Health (NIH) [RO1 MH083581, MH56838, PO1 MH64570, T32 GM07356, T32 AI049815, EY019277]; Fonds de la Recherche en Sante du Quebec (FRSQ); Whitehall Foundation; Alfred P. Sloan Foundation; Burroughs Wellcome Fund; NATIONAL EYE INSTITUTE [R01EY019277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH064570, R21MH083581, R01MH056838] Funding Source: NIH RePORTER	Geoffrey Waisdorp Pediatric Neurology Fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Whitehall Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a generous gift from the Geoffrey Waisdorp Pediatric Neurology Fund and National Institutes of Health (NIH) grants RO1 MH083581, MH56838 and PO1 MH64570. Marie-Eve Tremblay was supported by a Fonds de la Recherche en Sante du Quebec (FRSQ) postdoctoral fellowship. Daniel F. Marker is a trainee in the Medical Scientist Training Program, funded by NIH T32 GM07356 and T32 AI049815. Ania K. Majewska is funded by the NIH (EY019277), Whitehall Foundation, the Alfred P. Sloan Foundation and a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2005, J NEUROIMMUNOL, V160, P219, DOI 10.1016/j.jneuroim.2004.11.009; Abraham S, 2003, VIROLOGY, V309, P196, DOI 10.1016/S0042-6822(03)00112-0; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Anderson E, 2002, JAIDS-J ACQ IMM DEF, V31, pS43, DOI 10.1097/00126334-200210012-00004; Arese M, 2001, J IMMUNOL, V166, P1380, DOI 10.4049/jimmunol.166.2.1380; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Avgeropoulos N G, 1998, J NeuroAIDS, V2, P1, DOI 10.1300/J128v02n01_01; BARKS JDE, 1995, EXP NEUROL, V132, P123, DOI 10.1016/0014-4886(95)90066-7; Burudi EME, 2001, ADV VIRUS RES, V56, P435, DOI 10.1016/S0065-3527(01)56035-2; Cervantes-Sandoval I, 2008, PARASITOL INT, V57, P307, DOI 10.1016/j.parint.2008.01.006; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Clifford David B, 2008, Top HIV Med, V16, P94; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; Cowley D, 2011, J NEUROVIROL, V17, P70, DOI 10.1007/s13365-010-0002-5; Dash PK, 2011, J NEUROSCI, V31, P3148, DOI 10.1523/JNEUROSCI.5473-10.2011; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Del Sorbo L, 2001, EUR J IMMUNOL, V31, P376, DOI 10.1002/1521-4141(200102)31:2<376::AID-IMMU376>3.0.CO;2-5; Deshpande P, 2007, J IMMUNOL, V178, P6695, DOI 10.4049/jimmunol.178.11.6695; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Ernst T, 2009, ANN NEUROL, V65, P316, DOI 10.1002/ana.21594; Everall IP, 1999, BRAIN PATHOL, V9, P209; EVERALL IP, 1994, ACTA NEUROPATHOL, V88, P538; Fitting S, 2008, BRAIN RES, V1232, P139, DOI 10.1016/j.brainres.2008.07.032; Fitting S, 2010, HIPPOCAMPUS, V20, P469, DOI 10.1002/hipo.20648; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hudson L, 2000, J NEUROVIROL, V6, P145, DOI 10.3109/13550280009013158; Jones M, 1998, J NEUROPATH EXP NEUR, V57, P563, DOI 10.1097/00005072-199806000-00004; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Keblesh JP, 2009, J NEUROIMMUNE PHARM, V4, P317, DOI 10.1007/s11481-009-9161-7; Khiati A, 2010, J NEUROVIROL, V16, P150, DOI 10.3109/13550281003735691; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; Kim HJ, 2008, J NEUROSCI, V28, P12604, DOI 10.1523/JNEUROSCI.2958-08.2008; Lelekov-Boissard T, 2009, PHILOS T R SOC A, V367, P4699, DOI 10.1098/rsta.2009.0184; MA Q, 2011, J CEREB BLOOD FLOW M; Marcondes MCG, 2007, J IMMUNOL, V178, P5812, DOI 10.4049/jimmunol.178.9.5812; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; McColl BW, 2007, J NEUROSCI, V27, P4403, DOI 10.1523/JNEUROSCI.5376-06.2007; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; New DR, 1998, J BIOL CHEM, V273, P17852, DOI 10.1074/jbc.273.28.17852; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Norman JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003731; Okamoto SI, 2007, CELL STEM CELL, V1, P230, DOI 10.1016/j.stem.2007.07.010; ONOE K, 1981, J EXP MED, V153, P1009, DOI 10.1084/jem.153.4.1009; Orandle MS, 2002, J VIROL, V76, P5797, DOI 10.1128/JVI.76.11.5797-5802.2002; OsterGranite ML, 1996, J NEUROSCI, V16, P6732; Perry SW, 1998, J BIOL CHEM, V273, P17660, DOI 10.1074/jbc.273.28.17660; Persidsky Y, 1996, AM J PATHOL, V149, P1027; Peters A, 2004, CEREB CORTEX, V14, P995, DOI 10.1093/cercor/bhh060; Peters A, 1991, FINE STRUCTURE NERVO, P528; Potash MJ, 2005, P NATL ACAD SCI USA, V102, P3760, DOI 10.1073/pnas.0500649102; Pu H, 2003, MOL CELL NEUROSCI, V24, P224, DOI 10.1016/S1044-7431(03)00171-4; Ransohoff RM, 2007, NAT NEUROSCI, V10, P1507, DOI 10.1038/nn1207-1507; RAUSCH PG, 1978, BLOOD CELLS, V4, P369; Satoh S, 1999, JPN J PHARMACOL, V80, P41, DOI 10.1254/jjp.80.41; Shapiro LA, 2009, BRAIN RES, V1266, P29, DOI 10.1016/j.brainres.2009.02.031; SHARER LR, 1992, J NEUROPATH EXP NEUR, V51, P3, DOI 10.1097/00005072-199201000-00002; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200; Toborek M, 2003, J NEUROCHEM, V84, P169, DOI 10.1046/j.1471-4159.2003.01543.x; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; Tremblay M.E., 2010, J VIS EXP; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; Weiss JM, 1999, J IMMUNOL, V163, P2953; Yang DS, 2008, AM J PATHOL, V173, P665, DOI 10.2353/ajpath.2008.071176; Yao HH, 2010, J NEUROIMMUNE PHARM, V5, P489, DOI 10.1007/s11481-010-9211-1	71	60	61	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e23915	10.1371/journal.pone.0023915	http://dx.doi.org/10.1371/journal.pone.0023915			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912650	gold, Green Published, Green Submitted			2022-12-25	WOS:000294686100007
J	Cantu, D; Govindarajulu, M; Kozik, A; Wang, MN; Chen, XM; Kojima, KK; Jurka, J; Michelmore, RW; Dubcovsky, J				Cantu, Dario; Govindarajulu, Manjula; Kozik, Alex; Wang, Meinan; Chen, Xianming; Kojima, Kenji K.; Jurka, Jerzy; Michelmore, Richard W.; Dubcovsky, Jorge			Next Generation Sequencing Provides Rapid Access to the Genome of Puccinia striiformis f. sp tritici, the Causal Agent of Wheat Stripe Rust	PLOS ONE			English	Article							PLANT; HAUSTORIA; ALIGNMENT; PROTEINS; DOMAIN; FUNGI; CELLS	Background: The wheat stripe rust fungus (Puccinia striiformis f. sp. tritici, PST) is responsible for significant yield losses in wheat production worldwide. In spite of its economic importance, the PST genomic sequence is not currently available. Fortunately Next Generation Sequencing (NGS) has radically improved sequencing speed and efficiency with a great reduction in costs compared to traditional sequencing technologies. We used Illumina sequencing to rapidly access the genomic sequence of the highly virulent PST race 130 (PST-130). Methodology/Principal Findings: We obtained nearly 80 million high quality paired-end reads (>50x coverage) that were assembled into 29,178 contigs (64.8 Mb), which provide an estimated coverage of at least 88% of the PST genes and are available through GenBank. Extensive micro-synteny with the Puccinia graminis f. sp. tritici (PGTG) genome and high sequence similarity with annotated PGTG genes support the quality of the PST-130 contigs. We characterized the transposable elements present in the PST-130 contigs and using an ab initio gene prediction program we identified and tentatively annotated 22,815 putative coding sequences. We provide examples on the use of comparative approaches to improve gene annotation for both PST and PGTG and to identify candidate effectors. Finally, the assembled contigs provided an inventory of PST repetitive elements, which were annotated and deposited in Repbase. Conclusions/Significance: The assembly of the PST-130 genome and the predicted proteins provide useful resources to rapidly identify and clone PST genes and their regulatory regions. Although the automatic gene prediction has limitations, we show that a comparative genomics approach using multiple rust species can greatly improve the quality of gene annotation in these species. The PST-130 sequence will also be useful for comparative studies within PST as more races are sequenced. This study illustrates the power of NGS for rapid and efficient access to genomic sequence in non-model organisms.	[Cantu, Dario; Michelmore, Richard W.; Dubcovsky, Jorge] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Govindarajulu, Manjula; Kozik, Alex; Michelmore, Richard W.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Wang, Meinan; Chen, Xianming] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Chen, Xianming] ARS, Wheat Genet Qual Physiol & Dis Res Unit, USDA, Pullman, WA USA; [Kojima, Kenji K.; Jurka, Jerzy] Genet Informat Res Inst, Mountain View, CA USA; [Dubcovsky, Jorge] Howard Hughes Med Inst, Chevy Chase, MD USA; [Dubcovsky, Jorge] Gordon & Betty Moore Fdn, Palo Alto, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; Washington State University; United States Department of Agriculture (USDA); Howard Hughes Medical Institute	Cantu, D (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	jdubcovsky@ucdavis.edu	Dubcovsky, Jorge/T-5214-2019; Kojima, Kenji/AAO-2213-2021; Dubcovsky, Jorge/A-4969-2008; Cantu, Dario/E-7658-2010; WANG, Meinan/P-5671-2014	Dubcovsky, Jorge/0000-0002-7571-4345; Cantu, Dario/0000-0002-4858-1508; WANG, Meinan/0000-0001-9595-3995; Kojima, Kenji/0000-0003-2715-5531	Bill & Melinda Gates Foundation; USDA National Institute of Food and Agriculture [2009-65300-05640]; ARS [ARS-0422979] Funding Source: Federal RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported in part by funds provided through a grant from the Bill & Melinda Gates Foundation to RWM and JD and in part by the National Research Initiative Competitive Grant no. 2009-65300-05640 from the USDA National Institute of Food and Agriculture to JD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Cantu D, BMC GENOMICS UNPUB; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; CHEN XM, 1993, PHYTOPATHOLOGY, V83, P1489, DOI 10.1094/Phyto-83-1489; Chen XM, 2010, CAN J PLANT IN PRESS; CLARKE L, 1976, CELL, V9, P91, DOI 10.1016/0092-8674(76)90055-6; Cohen SX, 2003, EMBO J, V22, P1835, DOI 10.1093/emboj/cdg182; Dubcovsky J, 2001, PLANT PHYSIOL, V125, P1342, DOI 10.1104/pp.125.3.1342; Duplessis S, 2011, P NATL ACAD SCI USA, V108, P9166, DOI 10.1073/pnas.1019315108; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Godfrey D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-317; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hovmoller MS, 2010, SCIENCE, V329, P369, DOI 10.1126/science.1194925; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kemen E, 2005, MOL PLANT MICROBE IN, V18, P1130, DOI 10.1094/MPMI-18-1130; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ling P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-145; Milus EA, 2009, PHYTOPATHOLOGY, V99, P89, DOI 10.1094/PHYTO-99-1-0089; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Wellings C, 2010, BORL GLOB RUST IN 20; Yin C, MOL PLANT MICROBE IN, V24, P554; Yin CT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-626; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-203	31	142	150	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24230	10.1371/journal.pone.0024230	http://dx.doi.org/10.1371/journal.pone.0024230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909385	Green Submitted, Green Published, gold			2022-12-25	WOS:000294680800068
J	Hahn, C; Wang, C; Orr, AW; Coon, BG; Schwartz, MA				Hahn, Cornelia; Wang, Chong; Orr, A. Wayne; Coon, Brian G.; Schwartz, Martin Alexander			JNK2 Promotes Endothelial Cell Alignment under Flow	PLOS ONE			English	Article							FLUID SHEAR-STRESS; GENE-EXPRESSION; ACTIVATION; KINASES; ATHEROSCLEROSIS; FIBRONECTIN; INFLAMMATION; MIGRATION; PAXILLIN; CDC42	Endothelial cells in straight, unbranched segments of arteries elongate and align in the direction of flow, a feature which is highly correlated with reduced atherosclerosis in these regions. The mitogen-activated protein kinase c-Jun N-terminal kinase (JNK) is activated by flow and is linked to inflammatory gene expression and apoptosis. We previously showed that JNK activation by flow is mediated by integrins and is observed in cells plated on fibronectin but not on collagen or basement membrane proteins. We now show thatJNK2 activation in response to laminar shear stress is biphasic, with an early peak and a later peak. Activated JNK localizes to focal adhesions at the ends of actin stress fibers, correlates with integrin activation and requires integrin binding to the extracellular matrix. Reducing JNK2 activation by siRNA inhibits alignment in response to shear stress. Cells on collagen, where JNK activity is low, align slowly. These data show that an inflammatory pathway facilitates adaptation to laminar flow, thereby revealing an unexpected connection between adaptation and inflammatory pathways.	[Hahn, Cornelia; Schwartz, Martin Alexander] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Wang, Chong; Schwartz, Martin Alexander] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA USA; [Orr, A. Wayne] Louisiana State Univ, Hlth Sci Ctr, Dept Pathol, Shreveport, LA 71105 USA; [Coon, Brian G.; Schwartz, Martin Alexander] Yale Univ, Dept Med, New Haven, CT 06520 USA; [Schwartz, Martin Alexander] Univ Virginia, Mellon Prostate Canc Res Ctr, Charlottesville, VA USA; [Schwartz, Martin Alexander] Univ Virginia, Dept Cell Biol, Charlottesville, VA USA; [Schwartz, Martin Alexander] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA	University of Virginia; University of Virginia; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Yale University; University of Virginia; University of Virginia; University of Virginia	Hahn, C (corresponding author), Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA.	maschwartz@virginia.edu	Orr, Anthony/P-8927-2015; Wang, Chong/L-3732-2013	Orr, Anthony/0000-0002-2377-213X; schwartz, martin/0000-0002-2071-1243	USPHS [HL75092]; American Heart Association [10POST4140009, 0325654U];  [5T32-HL007284-28];  [5T32-HL007284-29];  [5T32-HL007284-30]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007284, R01HL075092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); American Heart Association(American Heart Association); ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by USPHS grant HL75092 to MAS; training grant 5T32-HL007284-28, 29, 30 to CH; American Heart Association Mid-Atlantic Affiliate fellowship 10POST4140009 to CW; American Heart Association Mid-Atlantic Affiliate fellowship 0325654U to AWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida EAC, 2000, J CELL BIOL, V149, P741, DOI 10.1083/jcb.149.3.741; Bogoyevitch MA, 2006, BIOESSAYS, V28, P923, DOI 10.1002/bies.20458; Boon RA, 2010, BLOOD, V115, P2533, DOI 10.1182/blood-2009-06-228726; Chiang HY, 2009, ARTERIOSCL THROM VAS, V29, P1074, DOI 10.1161/ATVBAHA.108.181081; Feaver RE, 2010, CIRC RES, V106, P1703, DOI 10.1161/CIRCRESAHA.109.216283; Girard Peggy R., 1993, Frontiers of Medical and Biological Engineering, V5, P31; Go YM, 1998, AM J PHYSIOL-HEART C, V275, pH1898, DOI 10.1152/ajpheart.1998.275.5.H1898; Hahn C, 2008, ARTERIOSCL THROM VAS, V28, P2101, DOI 10.1161/ATVBAHA.108.165951; Hahn C, 2009, CIRC RES, V104, P995, DOI 10.1161/CIRCRESAHA.108.186486; Hamel M, 2006, ENDOTHELIUM-J ENDOTH, V13, P157, DOI 10.1080/10623320600760191; Heutinck KM, 2010, MOL IMMUNOL, V47, P1943, DOI 10.1016/j.molimm.2010.04.020; Hu YH, 1998, EXP GERONTOL, V33, P601, DOI 10.1016/S0531-5565(98)00034-5; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Jalali S, 1998, ARTERIOSCL THROM VAS, V18, P227, DOI 10.1161/01.ATV.18.2.227; Jiang BB, 2010, J CARDIOVASC TRANSL, V3, P410, DOI 10.1007/s12265-010-9193-7; Kimura K, 2008, INVEST OPHTH VIS SCI, V49, P125, DOI 10.1167/iovs.07-0725; Li S, 1999, J CLIN INVEST, V103, P1141, DOI 10.1172/JCI5367; Li YS, 1996, MOL CELL BIOL, V16, P5947; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Mengistu M, 2011, J CELL PHYSIOL, V226, P110, DOI 10.1002/jcp.22311; Orr AW, 2006, MOL BIOL CELL, V17, P4686, DOI 10.1091/mbc.E06-04-0289; Ramos JW, 1996, DEVELOPMENT, V122, P2873; Silvestre JS, 2008, CARDIOVASC RES, V78, P242, DOI 10.1093/cvr/cvn027; Sumara G, 2005, CELL MOL LIFE SCI, V62, P2487, DOI 10.1007/s00018-005-5253-6; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Tzima E, 2002, EMBO J, V21, P6791, DOI 10.1093/emboj/cdf688; Tzima E, 2003, J BIOL CHEM, V278, P31020, DOI 10.1074/jbc.M301179200; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005	31	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24338	10.1371/journal.pone.0024338	http://dx.doi.org/10.1371/journal.pone.0024338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909388	Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800084
J	Lewis, SN; Brannan, L; Guri, AJ; Lu, PY; Hontecillas, R; Bassaganya-Riera, J; Bevan, DR				Lewis, Stephanie N.; Brannan, Lera; Guri, Amir J.; Lu, Pinyi; Hontecillas, Raquel; Bassaganya-Riera, Josep; Bevan, David R.			Dietary alpha-Eleostearic Acid Ameliorates Experimental Inflammatory Bowel Disease in Mice by Activating Peroxisome Proliferator-Activated Receptor-gamma	PLOS ONE			English	Article							CONJUGATED TRIENE SYSTEM; PPAR-GAMMA; LIGAND-BINDING; PUNICIC ACID; GLUCOSE-TOLERANCE; STRUCTURAL BASIS; GENE-EXPRESSION; ABSCISIC-ACID; INFLIXIMAB; DOCKING	Background: Treatments for inflammatory bowel disease (IBD) are modestly effective and associated with side effects from prolonged use. As there is no known cure for IBD, alternative therapeutic options are needed. Peroxisome proliferator-activated receptor-gamma (PPAR gamma) has been identified as a potential target for novel therapeutics against IBD. For this project, compounds were screened to identify naturally occurring PPAR gamma agonists as a means to identify novel anti-inflammatory therapeutics for experimental assessment of efficacy. Methodology/Principal Findings: Here we provide complementary computational and experimental methods to efficiently screen for PPAR gamma agonists and demonstrate amelioration of experimental IBD in mice, respectively. Computational docking as part of virtual screening (VS) was used to test binding between a total of eighty-one compounds and PPAR gamma. The test compounds included known agonists, known inactive compounds, derivatives and stereoisomers of known agonists with unknown activity, and conjugated trienes. The compound identified through VS as possessing the most favorable docked pose was used as the test compound for experimental work. With our combined methods, we have identified alpha-eleostearic acid (ESA) as a natural PPAR gamma agonist. Results of ligand-binding assays complemented the screening prediction. In addition, ESA decreased macrophage infiltration and significantly impeded the progression of IBD-related phenotypes through both PPAR gamma-dependent and -independent mechanisms in mice with experimental IBD. Conclusions/Significance: This study serves as the first significant step toward a large-scale VS protocol for natural PPAR gamma agonist screening that includes a massively diverse ligand library and structures that represent multiple known target pharmacophores.	[Lewis, Stephanie N.; Lu, Pinyi; Bassaganya-Riera, Josep; Bevan, David R.] Virginia Tech, Genet Bioinformat & Computat Biol Program, Blacksburg, VA 24061 USA; [Lewis, Stephanie N.; Brannan, Lera; Bevan, David R.] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [Lewis, Stephanie N.; Guri, Amir J.; Lu, Pinyi; Hontecillas, Raquel; Bassaganya-Riera, Josep] Virginia Bioinformat Inst, Nutr Immunol & Mol Med Lab, Blacksburg, VA USA; [Lewis, Stephanie N.; Lu, Pinyi; Hontecillas, Raquel; Bassaganya-Riera, Josep; Bevan, David R.] Virginia Bioinformat Inst, Ctr Modeling Immunol Enter Pathogens, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Lewis, SN (corresponding author), Virginia Tech, Genet Bioinformat & Computat Biol Program, Blacksburg, VA 24061 USA.	snl@vt.edu	Lu, Pinyi/U-4513-2017	Lewis, Stephanie/0000-0001-8724-2069; Lu, Pinyi/0000-0003-1962-5783; Bevan, David/0000-0001-9974-1105	NIH [R25 GM072767]; National Center for Complementary and Alternative Medicine [5R01AT4308]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK091186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM072767] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH Biomedical and Behavioral Sciences Research Training Grant R25 GM072767 (Virginia Tech Initiative to Maximize Student Diversity). National Center for Complementary and Alternative Medicine Grant 5R01AT4308. The Genetics, Bioinformatics, and Computational Biology PhD program, Virginia Tech, Blacksburg, VA 24601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artis DR, 2009, P NATL ACAD SCI USA, V106, P262, DOI 10.1073/pnas.0811325106; Badami R C, 1980, Prog Lipid Res, V19, P119; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Bassaganya-Riera J, 2011, BRIT J NUTR IN PRESS; Bassaganya-Riera J., 2009, E SPEN EUR E J CLIN, V4, pe90, DOI [10.1016/j.eclnm.2008.11.005, DOI 10.1016/J.ECLNM.2008.11.005]; Bassaganya-Riera J, 2011, J OBESITY, P1; Bassaganya-Riera J, 2006, CLIN NUTR, V25, P454, DOI 10.1016/j.clnu.2005.12.008; Bassaganya-Riera J, 2011, J BIOL CHEM, V286, P2504, DOI 10.1074/jbc.M110.160077; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boussetta T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006458; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chang MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011955; COMPSTON JE, 1995, ALIMENT PHARM THER, V9, P237; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; Eom J-M, 2009, BIOCH BIOPHYSICAL RE, V391, P903; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gani OABSM, 2009, MED CHEM RES, V18, P8, DOI 10.1007/s00044-008-9102-7; GOLDSMITH P, 1990, DIGEST DIS SCI, V35, P1409, DOI 10.1007/BF01536749; Guri AJ, 2008, J NUTR BIOCHEM, V19, P216, DOI 10.1016/j.jnutbio.2007.02.010; Guri AJ, 2007, CLIN NUTR, V26, P107, DOI 10.1016/j.clnu.2006.07.008; Guri AJ, 2010, CLIN NUTR, V29, P824, DOI 10.1016/j.clnu.2010.02.009; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hennessy AA, 2011, LIPIDS, V46, P105, DOI 10.1007/s11745-010-3501-5; Hontecillas R, 2002, J NUTR, V132, P2019, DOI 10.1093/jn/132.7.2019; Hontecillas R, 2008, CLIN NUTR, V27, P764, DOI 10.1016/j.clnu.2008.07.007; Hontecillas R, 2009, J AM COLL NUTR, V28, P184, DOI 10.1080/07315724.2009.10719770; Huang THW, 2009, PHARMACOL RES, V60, P195, DOI 10.1016/j.phrs.2009.03.020; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Kellenberger E, 2004, PROTEINS, V57, P225, DOI 10.1002/prot.20149; Klebe G, 2006, DRUG DISCOV TODAY, V11, P580, DOI 10.1016/j.drudis.2006.05.012; Kuroda M, 2010, BIOORGAN MED CHEM, V18, P962, DOI 10.1016/j.bmc.2009.11.027; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; Li Y, 2008, J BIOL CHEM, V283, P19132, DOI 10.1074/jbc.M802040200; Lichtenstein GR, 2006, GASTROENTEROLOGY, V130, P940, DOI 10.1053/j.gastro.2006.01.048; Ljung T, 2004, GUT, V53, P849, DOI 10.1136/gut.2003.018515; Mahindroo N, 2006, J MED CHEM, V49, P1212, DOI 10.1021/jm0510373; Mahindroo N, 2006, J MED CHEM, V49, P6421, DOI 10.1021/jm060663c; Markt P, 2007, J COMPUT AID MOL DES, V21, P575, DOI 10.1007/s10822-007-9140-0; Martin H, 2009, MUTAT RES-FUND MOL M, V669, P1, DOI 10.1016/j.mrfmmm.2009.06.009; Meerts IATM, 2009, FOOD CHEM TOXICOL, V47, P1085, DOI 10.1016/j.fct.2009.01.031; Mohapatra SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010215; Moon HS, 2010, CANCER SCI, V101, P396, DOI 10.1111/j.1349-7006.2009.01389.x; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nagao K, 2008, PROG LIPID RES, V47, P127, DOI 10.1016/j.plipres.2007.12.002; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pochetti G, 2007, J BIOL CHEM, V282, P17314, DOI 10.1074/jbc.M702316200; Popovich DG, 2011, J MED FOOD, V14, P201, DOI 10.1089/jmf.2010.1150; Ramakers JD, 2007, J CLIN IMMUNOL, V27, P275, DOI 10.1007/s10875-007-9074-2; Reiss AB, 2006, CURR MED CHEM, V13, P3227, DOI 10.2174/092986706778742909; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Saha SS, 2009, FOOD CHEM TOXICOL, V47, P2551, DOI 10.1016/j.fct.2009.07.012; Salam NK, 2008, CHEM BIOL DRUG DES, V71, P57, DOI 10.1111/j.1747-0285.2007.00606.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwartz R., 2008, LEARNING PERL; Shah YM, 2007, AM J PHYSIOL-GASTR L, V292, pG657, DOI 10.1152/ajpgi.00381.2006; Tanrikulu Y, 2009, CHEMBIOCHEM, V10, P75, DOI 10.1002/cbic.200800520; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tran HNA, 2010, ENDOCR RES, V35, P1, DOI 10.3109/07435800903524161; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsuzuki T, 2004, CARCINOGENESIS, V25, P1417, DOI 10.1093/carcin/bgh109; Tsuzuki T, 2008, CARCINOGENESIS, V29, P797, DOI 10.1093/carcin/bgm298; van der Spoel D., 2005, GROMACS USER MANUAL; Vroegrijk I, 2011, FOOD CHEM T IN PRESS; Wahli W, 2008, J INTERN MED, V263, P613, DOI 10.1111/j.1365-2796.2008.01951.x; Waku T, 2009, J MOL BIOL, V385, P188, DOI 10.1016/j.jmb.2008.10.039; Wu GD, 2003, GASTROENTEROLOGY, V124, P1538, DOI 10.1016/S0016-5085(03)00345-7; Yasui Y, 2005, PROSTAG LEUKOTR ESS, V73, P113, DOI 10.1016/j.plefa.2005.04.013; Yuan GF, 2009, J SCI FOOD AGR, V89, P2331, DOI 10.1002/jsfa.3729; Zhang T, 2011, J NATURAL MED, P1	74	26	27	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24031	10.1371/journal.pone.0024031	http://dx.doi.org/10.1371/journal.pone.0024031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904603	gold, Green Published, Green Submitted			2022-12-25	WOS:000294680800048
J	Nalls, D; Tang, SN; Rodova, M; Srivastava, RK; Shankar, S				Nalls, Dara; Tang, Su-Ni; Rodova, Marianna; Srivastava, Rakesh K.; Shankar, Sharmila			Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells	PLOS ONE			English	Article							SIGNALING PATHWAY; TUMOR-SUPPRESSOR; NERVOUS-SYSTEM; P53 PROTEIN; NOTCH; MICRORNAS; EXPRESSION; APOPTOSIS; BIOMARKERS; TRAIL	Background: MicroRNA-34a (miR-34a) is a transcriptional target of p53 and is down-regulated in pancreatic cancer. This study aimed to investigate the functional significance of miR-34a in pancreatic cancer progression through its epigenetic restoration with chromatin modulators, demethylating agent 5-Aza-29-deoxycytidine (5-Aza-dC) and HDAC inhibitor Vorinostat (SAHA). Methodology/ Principal Findings: Re-expression of miR-34a in human pancreatic cancer stem cells (CSCs) and in human pancreatic cancer cell lines upon treatment with 5-Aza-dC and SAHA strongly inhibited the cell proliferation, cell cycle progression, self-renewal, epithelial to mesenchymal transition (EMT) and invasion. In pancreatic CSCs, modulation of miR-34a induced apoptosis by activating caspase-3/7. Treatment of pancreatic CSCs with the chromatin-modulating agents resulted in the inhibition of Bcl-2, CDK6 and SIRT1, which are the putative targets of miR-34a. MiR-34a upregulation by these agents also induced acetylated p53, p21(WAF1), p27(KIP1) and PUMA in pancreatic CSCs. Inhibition of miR-34a by antagomiR abrogates the effects of 5-Aza-dC and SAHA, suggesting that 5-Aza-dC and SAHA regulate stem cell characteristics through miR-34a. In CSCs, SAHA inhibited Notch pathway, suggesting its suppression may contribute to inhibition of the self-renewal capacity and induction of apoptosis. Interestingly, treatment of pancreatic CSCs with SAHA resulted in the inhibition of EMT with the transcriptional up-regulation of E-Cadherin and down-regulation of N-Cadherin. Expression of EMT inducers (Zeb-1, Snail and Slug) was inhibited in CSCs upon treatment with SAHA. 5-Aza-dC and SAHA also retard in vitro migration and invasion of CSCs. Conclusions: The present study thus demonstrates the role of miR-34a as a critical regulator of pancreatic cancer progression by the regulating CSC characteristics. The restoration of its expression by 5-Aza-dC and SAHA in CSCs will not only provide mechanistic insight and therapeutic targets for pancreatic cancer but also promising reagents to boost patient response to existing chemotherapies or as a standalone cancer drug by eliminating the CSC characteristics.	[Nalls, Dara; Rodova, Marianna; Shankar, Sharmila] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66103 USA; [Nalls, Dara; Rodova, Marianna; Shankar, Sharmila] Univ Kansas, Med Ctr, Dept Lab Med, Kansas City, KS 66103 USA; [Tang, Su-Ni; Rodova, Marianna; Srivastava, Rakesh K.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Srivastava, Rakesh K.] Univ Kansas, Med Ctr, Dept Med, Kansas City, KS 66103 USA; [Srivastava, Rakesh K.; Shankar, Sharmila] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Nalls, D (corresponding author), Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66103 USA.	sshankar@kumc.edu			National Institutes of Health [R01CA125262, RO1CA114469, 3R01CA114469-05S1, 3R01CA125262-03S1]; Kansas Bioscience Authority; Susan G. Komen Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA125262, R01CA114469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas Bioscience Authority; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Institutes of Health (R01CA125262, RO1CA114469, 3R01CA114469-05S1, and 3R01CA125262-03S1), Kansas Bioscience Authority, and Susan G. Komen Breast Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azmi AS, 2010, CURR CANCER DRUG TAR, V10, P319, DOI 10.2174/156800910791190229; Bandres E, 2007, DNA CELL BIOL, V26, P273, DOI 10.1089/dna.2006.0544; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Bartels CL, 2010, ANN BIOL CLIN-PARIS, V68, P263, DOI 10.1684/abc.2010.0429; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Bergan A, 2000, INT J ONCOL, V17, P921; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Buchler P, 2005, ANN SURG, V242, P791, DOI 10.1097/01.sla.0000189115.94847.f1; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chim CS, 2010, CARCINOGENESIS, V31, P745, DOI 10.1093/carcin/bgq033; Corney DC, 2010, CLIN CANCER RES, V16, P1119, DOI 10.1158/1078-0432.CCR-09-2642; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; De la O JP, 2009, GASTROENTEROLOGY, V136, P1499, DOI 10.1053/j.gastro.2009.03.022; Fandy TE, 2005, NEOPLASIA, V7, P646, DOI 10.1593/neo.04655; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Hu YX, 1999, BRIT J CANCER, V80, P1075, DOI 10.1038/sj.bjc.6690466; Immervoll H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-48; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Katoh M, 2006, INT J MOL MED, V17, P681; Kawahira H, 2000, HEPATO-GASTROENTEROL, V47, P973; Kimura K, 2007, CANCER SCI, V98, P155, DOI 10.1111/j.1349-7006.2006.00369.x; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Li CW, 2009, METHODS MOL BIOL, V568, P161, DOI 10.1007/978-1-59745-280-9_10; Li J, 2010, AAPS J, V12, P223, DOI 10.1208/s12248-010-9181-5; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Morton JP, 2008, AM J PATHOL, V172, P1081, DOI 10.2353/ajpath.2008.070778; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Mullendore ME, 2009, CLIN CANCER RES, V15, P2291, DOI 10.1158/1078-0432.CCR-08-2004; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; O'Rourke Jason R., 2006, Birth Defects Research, V78, P172, DOI 10.1002/bdrc.20071; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Shankar S, 2005, INT J MOL MED, V16, P1125; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P5039, DOI 10.2741/2446; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Shankar S, 2009, MOL CANCER THER, V8, P1596, DOI 10.1158/1535-7163.MCT-08-1004; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Voorhoeve PM, 2010, BBA-REV CANCER, V1805, P72, DOI 10.1016/j.bbcan.2009.09.003; Waldman SA, 2007, JAMA-J AM MED ASSOC, V297, P1923, DOI 10.1001/jama.297.17.1923; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Wang ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI 10.1038/nrgastro.2010.188; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475	52	205	218	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24099	10.1371/journal.pone.0024099	http://dx.doi.org/10.1371/journal.pone.0024099			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909380	Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800054
J	Sorenmo, KU; Krick, E; Coughlin, CM; Overley, B; Gregor, TP; Vonderheide, RH; Mason, NJ				Sorenmo, Karin U.; Krick, Erika; Coughlin, Christina M.; Overley, Beth; Gregor, Thomas P.; Vonderheide, Robert H.; Mason, Nicola J.			CD40-Activated B Cell Cancer Vaccine Improves Second Clinical Remission and Survival in Privately Owned Dogs with Non-Hodgkin's Lymphoma	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; T-CELLS; IMMUNOTHERAPY; CHEMOTHERAPY; COMBINATION; RESPONSES; IMMUNITY; SUBSETS; HUMANS	Cell-based active immunotherapy for cancer is a promising novel strategy, with the first dendritic cell (DC) vaccine achieving regulatory approval for clinical use last year. Manufacturing remains arduous, especially for DC vaccines, and the prospect of using cell-based immunotherapy in the adjuvant setting or in combination with chemotherapy remains largely untested. Here, we used a comparative oncology approach to test the safety and potential efficacy of tumor RNA-loaded, CD40-activated B cells in privately owned dogs presenting with non-Hodgkin's lymphoma (NHL), a clinical scenario that represents not only a major problem in veterinary medicine but also a bona fide spontaneous animal model for the human condition. When administered to NHL dogs in remission after induction chemotherapy, CD40-B cells electroporated ex vivo with autologous tumor RNA safely stimulated immunity in vivo. Although chemotherapy plus CD40-B vaccination did not improve time-to-progression or lymphoma-specific survival compared to dogs treated with chemotherapy alone, vaccination potentiated the effects of salvage therapy and improved the rate of durable second remissions as well as subsequent lymphoma-specific survival following salvage therapy. Several of these relapsed dogs are now long-term survivors and free of disease for more than a year. Overall, these clinical and immunological results suggest that cell-based CD40 cancer vaccination is safe and synergizes with chemotherapy to improve clinical outcome in canine NHL. More broadly, our findings underscore the unique value of clinical investigations in tumor-bearing companion animals.	[Sorenmo, Karin U.; Krick, Erika; Overley, Beth; Gregor, Thomas P.; Mason, Nicola J.] Univ Penn, Dept Clin Studies, Philadelphia, PA 19104 USA; [Mason, Nicola J.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Coughlin, Christina M.; Vonderheide, Robert H.] Univ Penn, Dept Med, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Vonderheide, Robert H.; Mason, Nicola J.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Sorenmo, KU (corresponding author), Univ Penn, Dept Clin Studies, Philadelphia, PA 19104 USA.	karins@vet.upenn.edu; rhv@exchange.upenn.edu; nmason@vet.upenn.edu			Alliance for Cancer Gene Therapy; Onyx and Breezy Foundation; Barry and Savannah Poodle Memorial Fund; Mari Lowe Comparative Oncology Center; Abramson Cancer Center at the University of Pennsylvania (NIH) [P30 CA016520]; Veterinary Hospital of the University of Pennsylvania; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER	Alliance for Cancer Gene Therapy; Onyx and Breezy Foundation; Barry and Savannah Poodle Memorial Fund; Mari Lowe Comparative Oncology Center; Abramson Cancer Center at the University of Pennsylvania (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterinary Hospital of the University of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Alliance for Cancer Gene Therapy (R.H.V.), the Onyx and Breezy Foundation (K.U.S.), the Barry and Savannah Poodle Memorial Fund and the Mari Lowe Comparative Oncology Center (N.J.M.), the Immunobiology Program of the Abramson Cancer Center at the University of Pennsylvania (NIH grant P30 CA016520, R.H.V.), and the Oncology Research fund at the Veterinary Hospital of the University of Pennsylvania (K.U.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonia SJ, 2006, CLIN CANCER RES, V12, P878, DOI 10.1158/1078-0432.CCR-05-2013; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Coughlin CM, 2006, J CLIN ONCOL, V24, P5725, DOI 10.1200/JCO.2005.05.3314; Coughlin CM, 2004, BLOOD, V103, P2046, DOI 10.1182/blood-2003-07-2379; Ercolini AM, 2005, J EXP MED, V201, P1591, DOI 10.1084/jem.20042167; Gabrilovich DI, 2007, LANCET ONCOL, V8, P2, DOI 10.1016/S1470-2045(06)70985-8; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Gordon I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000161; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lanzavecchia A, 1998, NATURE, V393, P413, DOI 10.1038/30845; Lapointe R, 2003, CANCER RES, V63, P2836; MARCONATO L, 2010, VET J; Mason NJ, 2008, GENE THER, V15, P955, DOI 10.1038/gt.2008.22; Nakahara T, 2010, BLOOD, V115, P4384, DOI 10.1182/blood-2009-11-251231; Nowak AK, 2003, CANCER RES, V63, P4490; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Ramakrishnan R, 2010, J CLIN INVEST, V120, P1111, DOI 10.1172/JCI40269; Schultze JL, 1997, J CLIN INVEST, V100, P2757, DOI 10.1172/JCI119822; Sorenmo K, 2010, VET COMP ONCOL, V8, P196, DOI 10.1111/j.1476-5829.2010.00222.x; Vonderheide RH, 2001, J CLIN ONCOL, V19, P3280, DOI 10.1200/JCO.2001.19.13.3280; Vonderheide RH, 2007, J CLIN ONCOL, V25, P876, DOI 10.1200/JCO.2006.08.3311; Vonderheide RH, 2007, CLIN CANCER RES, V13, P1083, DOI 10.1158/1078-0432.CCR-06-1893; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	26	47	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24167	10.1371/journal.pone.0024167	http://dx.doi.org/10.1371/journal.pone.0024167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904611	Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800061
J	Yoshimitsu, Y; Tanaka, K; Fukuda, W; Asami, T; Yoshida, S; Hayashi, K; Kamiya, Y; Jikumaru, Y; Shigeta, T; Nakamura, Y; Matsuo, T; Okamoto, S				Yoshimitsu, Yuya; Tanaka, Kiwamu; Fukuda, Wataru; Asami, Tadao; Yoshida, Shigeo; Hayashi, Ken-ichiro; Kamiya, Yuji; Jikumaru, Yusuke; Shigeta, Tomoaki; Nakamura, Yasushi; Matsuo, Tomoaki; Okamoto, Shigehisa			Transcription of DWARF4 Plays a Crucial Role in Auxin-Regulated Root Elongation in Addition to Brassinosteroid Homeostasis in Arabidopsis thaliana	PLOS ONE			English	Article							BOX PROTEIN TIR1; BIOSYNTHESIS INHIBITOR; GENE-EXPRESSION; GROWTH; PLANTS; PERCEPTION; RESPONSES; CYTOCHROME-P450; GIBBERELLIN; ETHYLENE	The expression of DWARF4 (DWF4), which encodes a C-22 hydroxylase, is crucial for brassinosteroid (BR) biosynthesis and for the feedback control of endogenous BR levels. To advance our knowledge of BRs, we examined the effects of different plant hormones on DWF4 transcription in Arabidopsis thaliana. Semi-quantitative reverse-transcriptase PCR showed that the amount of the DWF4 mRNA precursor either decreased or increased, similarly with its mature form, in response to an exogenously applied bioactive BR, brassinolide (BL), and a BR biosynthesis inhibitor, brassinazole (Brz), respectively. The response to these chemicals in the levels of beta-glucuronidase (GUS) mRNA and its enzymatic activity is similar to the response of native DWF4 mRNA in DWF4::GUS plants. Contrary to the effects of BL, exogenous auxin induced GUS activity, but this enhancement was suppressed by anti-auxins, such as alpha-(phenylethyl-2-one)-IAA and alpha-tert-butoxycarbonylaminohexyl-IAA, suggesting the involvement of SCFTIR1-mediated auxin signaling in auxin-induced DWF4 transcription. Auxin-enhanced GUS activity was observed exclusively in roots; it was the most prominent in the elongation zones of both primary and lateral roots. Furthermore, auxin-induced lateral root elongation was suppressed by both Brz application and the dwf4 mutation, and this suppression was rescued by BL, suggesting that BRs act positively on root elongation under the control of auxin. Altogether, our results indicate that DWF4 transcription plays a novel role in the BR-auxin crosstalk associated with root elongation, in addition to its role in BR homeostasis.	[Yoshimitsu, Yuya; Fukuda, Wataru; Okamoto, Shigehisa] Kagoshima Univ, Dept Agr Sci & Nat Resources, Kagoshima 890, Japan; [Tanaka, Kiwamu] Univ Missouri, Div Plant Sci, Columbia, MO USA; [Asami, Tadao] Univ Tokyo, Bunkyo Ku, Dept Appl Biol Chem, Tokyo 113, Japan; [Yoshida, Shigeo; Kamiya, Yuji; Jikumaru, Yusuke] RIKEN, Plant Sci Ctr, Tsurumi Ku, Kanagawa, Japan; [Hayashi, Ken-ichiro] Okayama Univ Sci, Dept Biochem, Okayama, Japan; [Shigeta, Tomoaki; Matsuo, Tomoaki] Kagoshima Univ, Dept Biochem Sci & Technol, Kagoshima 890, Japan; [Nakamura, Yasushi] Kyoto Prefectural Univ, Dept Food Sci & Nutr Hlth, Sakyo Ku, Kyoto 606, Japan	Kagoshima University; University of Missouri System; University of Missouri Columbia; University of Tokyo; RIKEN; Okayama University of Science; Kagoshima University; Kyoto Prefectural University	Yoshimitsu, Y (corresponding author), Kagoshima Univ, Dept Agr Sci & Nat Resources, Kagoshima 890, Japan.	okamoto@agri.kagoshima-u.ac.jp	Tanaka, Kiwamu/E-9942-2013; Kamiya, Yuji/F-9420-2010; Hayashi, Ken-ichiro/AAP-3513-2021	Tanaka, Kiwamu/0000-0001-5045-560X; Kamiya, Yuji/0000-0003-4415-520X; Hayashi, Ken-ichiro/0000-0002-9812-2801; Shigeta, Tomoaki/0000-0002-6454-9663	Frontier Science Research Center (FSRC) of Kagoshima University	Frontier Science Research Center (FSRC) of Kagoshima University	This study was partially supported by a grant in aid from the special funding from the Frontier Science Research Center (FSRC) of Kagoshima University. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabadi D, 2009, INT J DEV BIOL, V53, P1597, DOI 10.1387/ijdb.072423da; Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Bancos S, 2002, PLANT PHYSIOL, V130, P504, DOI 10.1104/pp.005439; Bao F, 2004, PLANT PHYSIOL, V134, P1624, DOI 10.1104/pp.103.036897; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Benkova E, 2009, PLANT MOL BIOL, V69, P383, DOI 10.1007/s11103-008-9393-6; Bishop GJ, 2001, PLANT CELL PHYSIOL, V42, P114, DOI 10.1093/pcp/pce018; Bolduc N, 2009, PLANT CELL, V21, P1647, DOI 10.1105/tpc.109.068221; Choe S, 2001, PLANT J, V26, P573, DOI 10.1046/j.1365-313x.2001.01055.x; Choe SW, 1998, PLANT CELL, V10, P231, DOI 10.1105/tpc.10.2.231; Chung Y, 2011, PLANT J IN PRESS, DOI [10.1111/j.1365-313X.2011.04513.x, DOI 10.1111/J.1365-313X.2011.04513.X]; Clouse SD, 2002, MOL CELL, V10, P973, DOI 10.1016/S1097-2765(02)00744-X; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; CLOUSE SD, 1993, J PLANT GROWTH REGUL, V12, P61, DOI 10.1007/BF00193234; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Divi UK, 2009, NEW BIOTECHNOL, V26, P131, DOI 10.1016/j.nbt.2009.07.006; Fukaki H, 2007, INT REV CYTOL, V256, P111, DOI 10.1016/S0074-7696(07)56004-3; Goda H, 2004, PLANT PHYSIOL, V134, P1555, DOI 10.1104/pp.103.034736; Hardtke CS, 2007, TRENDS CELL BIOL, V17, P485, DOI 10.1016/j.tcb.2007.08.003; Hayashi K, 2008, P NATL ACAD SCI USA, V105, P5632, DOI 10.1073/pnas.0711146105; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kim HB, 2006, PLANT PHYSIOL, V140, P548, DOI 10.1104/pp.105.067918; Kim TW, 2007, PLANT CELL ENVIRON, V30, P679, DOI 10.1111/j.1365-3040.2007.01659.x; KOSUGI S, 1990, PLANT SCI, V70, P133, DOI 10.1016/0168-9452(90)90042-M; Lamb K, 1996, MOL REPROD DEV, V44, P460; MASUCCI JD, 1990, GENE DEV, V4, P2011, DOI 10.1101/gad.4.11.2011; Michniewicz M, 2007, ARABIDOPSIS BOOK, V5, P1; Min YK, 1999, BIOORG MED CHEM LETT, V9, P425, DOI 10.1016/S0960-894X(99)00008-6; Mouchel CF, 2006, NATURE, V443, P458, DOI 10.1038/nature05130; Nakamoto D, 2006, PLANT PHYSIOL, V141, P456, DOI 10.1104/pp.105.076273; Nakamura A, 2009, PLANT CELL PHYSIOL, V50, P1627, DOI 10.1093/pcp/pcp106; Nemhauser JL, 2004, PLOS BIOL, V2, P1460, DOI 10.1371/journal.pbio.0020258; Nishimura T, 2009, PLANT CELL PHYSIOL, V50, P1874, DOI 10.1093/pcp/pcp129; Okamoto S, 2005, PLANT SCI, V168, P37, DOI 10.1016/j.plantsci.2004.07.010; Oono Y, 2003, PLANT PHYSIOL, V133, P1135, DOI 10.1104/pp.103.027847; Rao SSR, 2002, CURR SCI INDIA, V82, P1239; Ren CM, 2009, PLANT PHYSIOL, V151, P1412, DOI 10.1104/pp.109.140202; Shibuya K, 2009, P NATL ACAD SCI USA, V106, P1660, DOI 10.1073/pnas.0809294106; Stepanova AN, 2007, PLANT CELL, V19, P2169, DOI 10.1105/tpc.107.052068; Swarup R, 2007, PLANT CELL, V19, P2186, DOI 10.1105/tpc.107.052100; Tanaka K, 2005, PLANT PHYSIOL, V138, P1117, DOI 10.1104/pp.104.058040; Tanaka K, 2003, J PLANT GROWTH REGUL, V22, P259, DOI 10.1007/s00344-003-0119-3; Thimann KV, 1937, J GEN PHYSIOL, V21, P123, DOI 10.1085/jgp.21.2.123; YANG MZ, 1994, EUR J BIOCHEM, V222, P651, DOI 10.1111/j.1432-1033.1994.tb18909.x; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Yoshimitsu Y, 2009, J PLANT BIOL, V52, P524, DOI 10.1007/s12374-009-9068-0; Yoshimoto K, 2009, PLANT CELL, V21, P2914, DOI 10.1105/tpc.109.068635	49	50	56	7	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23851	10.1371/journal.pone.0023851	http://dx.doi.org/10.1371/journal.pone.0023851			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909364	Green Published, Green Submitted, gold			2022-12-25	WOS:000294680800026
J	Armesto, M; Evans, S; Cavanagh, D; Abu-Median, AB; Keep, S; Britton, P				Armesto, Maria; Evans, Sharon; Cavanagh, David; Abu-Median, Abu-Bakr; Keep, Sarah; Britton, Paul			A Recombinant Avian Infectious Bronchitis Virus Expressing a Heterologous Spike Gene Belonging to the 4/91 Serotype	PLOS ONE			English	Article							TRACHEAL ORGAN-CULTURES; S1 GLYCOPROTEIN; MOLECULAR EPIZOOTIOLOGY; HARDERIAN-GLAND; RT-PCR; PROTEIN; IDENTIFICATION; PROTECTION; VACCINE; CHALLENGE	We have shown previously that replacement of the spike (S) gene of the apathogenic IBV strain Beau-R with that from the pathogenic strain of the same serotype, M41, resulted in an apathogenic virus, BeauR-M41(S), that conferred protection against challenge with M41 [1]. We have constructed a recombinant IBV, BeauR-4/91(S), with the genetic backbone of BeauR but expressing the spike protein of the pathogenic IBV strain 4/91(UK), which belongs to a different serogroup as Beaudette or M41. Similar to our previous findings with BeauR-M41(S), clinical signs observations showed that the S gene of the pathogenic 4/91 virus did not confer pathogenicity to the rIBV BeauR-4/91(S). Furthermore, protection studies showed there was homologous protection; BeauR-4/91(S) conferred protection against challenge with wild type 4/91 virus as shown by the absence of clinical signs, IBV RNA assessed by qRT-PCR and the fact that no virus was isolated from tracheas removed from birds primarily infected with BeauR-4/91(S) and challenged with IBV 4/91(UK). A degree of heterologous protection against M41 challenge was observed, albeit at a lower level. Our results confirm and extend our previous findings and conclusions that swapping of the ectodomain of the S protein is a precise and effective way of generating genetically defined candidate IBV vaccines.	[Armesto, Maria; Evans, Sharon; Cavanagh, David; Abu-Median, Abu-Bakr; Keep, Sarah; Britton, Paul] AFRC, Inst Anim Hlth, Compton Lab, Newbury RG16 0NN, Berks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Armesto, M (corresponding author), AFRC, Inst Anim Hlth, Compton Lab, Newbury RG16 0NN, Berks, England.	paul.britton@iah.ac.uk			Department of Environment, Food and Rural Affairs (DEFRA) [OD0717]; Biotechnology and Biological Sciences Research Council (BBSRC); Intervet Schering-Plough UK	Department of Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Intervet Schering-Plough UK	This work was supported by the Department of Environment, Food and Rural Affairs (DEFRA; http://www.defra.gov.uk/) project code OD0717, the Biotechnology and Biological Sciences Research Council (BBSRC; http://www.bbsrc.ac.uk/) and Intervet Schering-Plough UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhar A, 1997, AVIAN PATHOL, V26, P625, DOI 10.1080/03079459708419239; Armesto M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007384; Armesto Maria, 2008, V454, P255, DOI 10.1007/978-1-59745-181-9_19; BEAUDETTE F. R., 1937, Journal of the American Veterinary Medical Association, V90, P51; Bijlenga G, 2004, AVIAN PATHOL, V33, P550, DOI 10.1080/03079450400013154; Bochkov YA, 2007, VIRUS GENES, V35, P65, DOI 10.1007/s11262-006-0037-0; Bochkov YA, 2006, AVIAN PATHOL, V35, P379, DOI 10.1080/03079450600921008; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Britton P, 2005, J VIROL METHODS, V123, P203, DOI 10.1016/j.jviromet.2004.09.017; Britton P, 2008, NIDOVIRUSES, P29; Britton Paul, 2007, P161; Callison SA, 2006, J VIROL METHODS, V138, P60, DOI 10.1016/j.jviromet.2006.07.018; Carstens EB, 2010, ARCH VIROL, V155, P133, DOI 10.1007/s00705-009-0547-x; Casais R, 2003, J VIROL, V77, P9084, DOI 10.1128/JVI.77.16.9084-9089.2003; Casais R, 2001, J VIROL, V75, P12359, DOI 10.1128/JVI.75.24.12359-12369.2001; Cavanagh D, 2005, AVIAN PATHOL, V34, P439, DOI 10.1080/03079450500367682; CAVANAGH D, 1986, J GEN VIROL, V67, P1443, DOI 10.1099/0022-1317-67-7-1443; Cavanagh D, 1997, AVIAN PATHOL, V26, P63, DOI 10.1080/03079459708419194; Cavanagh D, 2003, AVIAN PATHOL, V32, P567, DOI 10.1080/03079450310001621198; CAVANAGH D, 1992, AVIAN PATHOL, V21, P33, DOI 10.1080/03079459208418816; Cavanagh D., 2008, DIS POULTRY, P117; Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055; Cook J. K. A., 1995, The coronaviridae., P317; COOK JKA, 1976, ARCH VIROL, V50, P109, DOI 10.1007/BF01318005; Cook JKA, 1999, AVIAN PATHOL, V28, P477, DOI 10.1080/03079459994506; Cook JKA, 1996, VET REC, V138, P178, DOI 10.1136/vr.138.8.178; DARBYSHIRE JH, 1979, ARCH VIROL, V61, P227, DOI 10.1007/BF01318057; Davelaar F G, 1976, Avian Pathol, V5, P39, DOI 10.1080/03079457608418168; DAVELAAR FG, 1980, AVIAN PATHOL, V9, P489, DOI 10.1080/03079458008418436; de Vries AAF, 1997, SEMIN VIROL, V8, P33, DOI 10.1006/smvy.1997.0104; de Wit JJ, 2011, AVIAN PATHOL, V40, P223, DOI 10.1080/03079457.2011.566260; DEGROOT RJ, 1987, J MOL BIOL, V196, P963, DOI 10.1016/0022-2836(87)90422-0; DELMAS B, 1990, J VIROL, V64, P5367, DOI 10.1128/JVI.64.11.5367-5375.1990; Dolz R, 2008, VIROLOGY, V374, P50, DOI 10.1016/j.virol.2007.12.020; Farsang A, 2002, AVIAN PATHOL, V31, P229, DOI 10.1080/03079450220136530; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Godeke GJ, 2000, J VIROL, V74, P1566, DOI 10.1128/JVI.74.3.1566-1571.2000; GOUGH RE, 1992, VET REC, V130, P493, DOI 10.1136/vr.130.22.493; Guo Y, 2009, J MOL BIOL, V394, P600, DOI 10.1016/j.jmb.2009.10.032; Hiscox JA, 2001, J VIROL, V75, P506, DOI 10.1128/JVI.75.1.506-512.2001; Hodgson T, 2004, J VIROL, V78, P13804, DOI 10.1128/JVI.78.24.13804-13811.2004; IGNJATOVIC J, 1994, ARCH VIROL, V138, P117, DOI 10.1007/BF01310043; Jackwood M, 2020, DIS OFPOULTRY, V14th, P167, DOI DOI 10.1002/9781119371199.CH4; Johnson MA, 2003, VACCINE, V21, P2730, DOI 10.1016/S0264-410X(03)00227-5; Jones Brenda V., 2008, V454, P103, DOI 10.1007/978-1-59745-181-9_9; Jones RC, 2010, BRIT POULTRY SCI, V51, P1, DOI 10.1080/00071660903541378; Keeler CL, 1998, AVIAN DIS, V42, P275, DOI 10.2307/1592477; Kingham BF, 2000, AVIAN DIS, V44, P325, DOI 10.2307/1592547; KOCH G, 1990, J GEN VIROL, V71, P1929, DOI 10.1099/0022-1317-71-9-1929; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; LAMBRECHTS C, 1993, AVIAN PATHOL, V22, P577, DOI 10.1080/03079459308418945; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CW, 2001, AVIAN DIS, V45, P164, DOI 10.2307/1593024; Luo ZL, 1998, VIROLOGY, V244, P483, DOI 10.1006/viro.1998.9121; MARQUARDT WW, 1982, AVIAN DIS, V26, P828, DOI 10.2307/1589869; PARSONS D, 1992, VET REC, V131, P408, DOI 10.1136/vr.131.18.408; Picault J. P., 1995, P 1 JOURN RECH AV AN, P177; Sapats SI, 1996, J GEN VIROL, V77, P413, DOI 10.1099/0022-1317-77-3-413; SCHULTZE B, 1992, VIROLOGY, V189, P792, DOI 10.1016/0042-6822(92)90608-R; Shimazaki Y, 2008, AVIAN DIS, V52, P618, DOI 10.1637/8359-051408-Reg.1; Shulla A, 2009, J BIOL CHEM, V284, P32725, DOI 10.1074/jbc.M109.043547; Song CS, 1998, J GEN VIROL, V79, P719, DOI 10.1099/0022-1317-79-4-719; Toro H, 1996, AVIAN DIS, V40, P114, DOI 10.2307/1592380; Tripet B, 2004, J BIOL CHEM, V279, P20836, DOI 10.1074/jbc.M400759200; VENNEMA H, 1990, ADV EXP MED BIOL, V276, P9; Worthington KJ, 2008, AVIAN PATHOL, V37, P247, DOI 10.1080/03079450801986529; Ziegler AF, 2002, AVIAN DIS, V46, P847, DOI 10.1637/0005-2086(2002)046[0847:NIBIPC]2.0.CO;2	67	42	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24352	10.1371/journal.pone.0024352	http://dx.doi.org/10.1371/journal.pone.0024352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912629	Green Published, gold, Green Submitted			2022-12-25	WOS:000294678300040
J	Hanses, F; Park, S; Rich, J; Lee, JC				Hanses, Frank; Park, Sunny; Rich, Jeremy; Lee, Jean C.			Reduced Neutrophil Apoptosis in Diabetic Mice during Staphylococcal Infection Leads to Prolonged Tnf alpha Production and Reduced Neutrophil Clearance	PLOS ONE			English	Article							RISK-FACTORS; BACTERICIDAL FUNCTION; AUREUS INFECTIONS; PHAGOCYTOSIS; MACROPHAGES; INFLAMMATION; INVOLVEMENT; CELLS; EPIDEMIOLOGY; RECOGNITION	Diabetes is a frequent underlying medical condition among individuals with Staphylococcus aureus infections, and diabetic patients often suffer from chronic inflammation and prolonged infections. Neutrophils are the most abundant inflammatory cells during the early stages of bacterial diseases, and previous studies have reported deficiencies in neutrophil function in diabetic hosts. We challenged age-matched hyperglycemic and normoglycemic NOD mice intraperitoneally with S. aureus and evaluated the fate of neutrophils recruited to the peritoneal cavity. Neutrophils were more abundant in the peritoneal fluids of infected diabetic mice by 48 h after bacterial inoculation, and they showed prolonged viability ex vivo compared to neutrophils from infected nondiabetic mice. These differences correlated with reduced apoptosis of neutrophils from diabetic mice and were dependent upon the presence of S. aureus and a functional neutrophil respiratory burst. Decreased apoptosis correlated with impaired clearance of neutrophils by macrophages both in vitro and in vivo and prolonged production of proinflammatory tumor necrosis factor alpha by neutrophils from diabetic mice. Our results suggest that defects in neutrophil apoptosis may contribute to the chronic inflammation and the inability to clear staphylococcal infections observed in diabetic patients.	[Hanses, Frank] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hanses, F (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA.	jclee@rics.bwh.harvard.edu	Hanses, Frank/I-6298-2019	Hanses, Frank/0000-0002-0007-8014; Lee, Jean/0000-0002-8094-5180	German Academy of Sciences Leopoldina [BMBF-LPD 9901/8-157]; Juvenile Diabetes Research Foundation [3-2004- 546]; National Institutes of Health Infectious Disease [T32 AI07061]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007061] Funding Source: NIH RePORTER	German Academy of Sciences Leopoldina; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	FH was supported by grant BMBF-LPD 9901/8-157 from the German Academy of Sciences Leopoldina (http://www.leopoldina-halle.de/cms/en.html). JR was the recipient of a Juvenile Diabetes Research Foundation award (3-2004- 546; www.jdrf.org). JR and SP were supported by National Institutes of Health Infectious Disease Training Grant T32 AI07061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeghate E, 2006, ANN NY ACAD SCI, V1084, P1, DOI 10.1196/annals.1372.029; Akbar DH, 2001, ACTA DIABETOL, V38, P77, DOI 10.1007/s005920170017; Alba-Loureiro TC, 2006, J ENDOCRINOL, V188, P295, DOI 10.1677/joe.1.06438; Bader MS, 2008, AM FAM PHYSICIAN, V78, P71; Balasoiu D, 1997, DIABETES CARE, V20, P392, DOI 10.2337/diacare.20.3.392; BOYKO EJ, 1989, DIABETES CARE, V12, P189, DOI 10.2337/diacare.12.3.189; BREEN JD, 1995, INFECT DIS CLIN N AM, V9, P11; Chanchamroen S, 2009, INFECT IMMUN, V77, P456, DOI 10.1128/IAI.00503-08; Daeschlein G, 2006, J HOSP INFECT, V63, P216, DOI 10.1016/j.jhin.2005.12.014; DeLeo FR, 2004, APOPTOSIS, V9, P399, DOI 10.1023/B:APPT.0000031448.64969.fa; Devitt A, 2003, CELL DEATH DIFFER, V10, P371, DOI 10.1038/sj.cdd.4401168; Eledrisi MS, 2006, AM J MED SCI, V331, P243, DOI 10.1097/00000441-200605000-00002; Fadeel B, 1998, BLOOD, V92, P4808, DOI 10.1182/blood.V92.12.4808.424k01_4808_4818; Filep JG, 2009, J CELL BIOCHEM, V108, P1039, DOI 10.1002/jcb.22351; Francois S, 2005, J IMMUNOL, V174, P3633, DOI 10.4049/jimmunol.174.6.3633; Glowacka E, 2002, SCAND J IMMUNOL, V55, P210, DOI 10.1046/j.1365-3083.2002.01046.x; Graves DT, 2005, J DENT RES, V84, P324, DOI 10.1177/154405910508400406; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; Hampton MB, 2002, J LEUKOCYTE BIOL, V71, P775; Jacobsson G, 2007, SCAND J INFECT DIS, V39, P6, DOI 10.1080/00365540600810026; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Khatib R, 2006, SCAND J INFECT DIS, V38, P7, DOI 10.1080/00365540500372846; Kobayashi SD, 2003, J IMMUNOL, V170, P3357, DOI 10.4049/jimmunol.170.6.3357; Koedel U, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000461; Kourany WM, 2006, SCAND J INFECT DIS, V38, P613, DOI 10.1080/00365540600617017; Laupland KB, 2008, J INFECT DIS, V198, P336, DOI 10.1086/589717; Leiter EH, 2001, CURR PROTOC IMMUNOL, V15, P15; Liberatore RD, 2005, PEDIATR DIABETES, V6, P206, DOI 10.1111/j.1399-543X.2005.00136.x; Lipsky BA, 2006, PLAST RECONSTR SURG, V117, p212S, DOI 10.1097/01.prs.0000222737.09322.77; Ludvigsson J, 2006, ANN NY ACAD SCI, V1079, P374, DOI 10.1196/annals.1375.058; Lundqvist-Gustafsson H, 2001, J LEUKOCYTE BIOL, V70, P642; Luo HBR, 2008, AM J HEMATOL, V83, P288, DOI 10.1002/ajh.21078; Makino S, 1985, CURRENT TOPICS CLIN, P25; MARHOFFER W, 1993, DIABETES RES CLIN PR, V19, P183, DOI 10.1016/0168-8227(93)90112-I; MARHOFFER W, 1992, DIABETES CARE, V15, P256, DOI 10.2337/diacare.15.2.256; McColl A, 2009, J IMMUNOL, V183, P2167, DOI 10.4049/jimmunol.0803503; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; NOLAN CM, 1978, DIABETES, V27, P889, DOI 10.2337/diab.27.9.889; O'Brien BA, 2002, DIABETES, V51, P2481, DOI 10.2337/diabetes.51.8.2481; Pierce GF, 2001, AM J PATHOL, V159, P399, DOI 10.1016/S0002-9440(10)61709-9; RAYFIELD EJ, 1982, AM J MED, V72, P439, DOI 10.1016/0002-9343(82)90511-3; REPINE JE, 1980, J INFECT DIS, V142, P869, DOI 10.1093/infdis/142.6.869; Rich J, 2005, DIABETES, V54, P2904, DOI 10.2337/diabetes.54.10.2904; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; SAVILL JS, 1989, J CLIN INVEST, V84, P1518, DOI 10.1172/JCI114328; Sudo Chiaki, 2007, Lab Hematol, V13, P108; Tennenberg SD, 1999, ARCH SURG-CHICAGO, V134, P1229, DOI 10.1001/archsurg.134.11.1229; TUAZON CU, 1975, JAMA-J AM MED ASSOC, V231, P1272, DOI 10.1001/jama.231.12.1272; TUAZON CU, 1984, AM J MED, V76, P166, DOI 10.1016/0002-9343(84)90260-2; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Yamamoto A, 2002, CLIN EXP IMMUNOL, V129, P479, DOI 10.1046/j.1365-2249.2002.01930.x; Zhang B, 2003, J BIOL CHEM, V278, P28443, DOI 10.1074/jbc.M210727200; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	54	51	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e23633	10.1371/journal.pone.0023633	http://dx.doi.org/10.1371/journal.pone.0023633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912601	Green Published, gold, Green Submitted			2022-12-25	WOS:000294678300005
J	Schuldt, NJ; Aldhamen, YA; Appledorn, DM; Seregin, SS; Kousa, Y; Godbehere, S; Amalfitano, A				Schuldt, Nathaniel J.; Aldhamen, Yasser A.; Appledorn, Daniel M.; Seregin, Sergey S.; Kousa, Youssef; Godbehere, Sarah; Amalfitano, Andrea			Vaccine Platforms Combining Circumsporozoite Protein and Potent Immune Modulators, rEA or EAT-2, Paradoxically Result in Opposing Immune Responses	PLOS ONE			English	Article							T-CELL RESPONSES; FACTOR-KAPPA-B; MALARIA VACCINE; PROTECTIVE IMMUNITY; RECOMBINANT ADENOVIRUS; DENDRITIC CELLS; LIVER STAGES; IFN-GAMMA; IN-VIVO; INNATE	Background: Malaria greatly impacts the health and wellbeing of over half of the world's population. Promising malaria vaccine candidates have attempted to induce adaptive immune responses to Circumsporozoite (CS) protein. Despite the inclusion of potent adjuvants, these vaccines have limited protective efficacy. Conventional recombinant adenovirus (rAd) based vaccines expressing CS protein can induce CS protein specific immune responses, but these are essentially equivalent to those generated after use of the CS protein subunit based vaccines. In this study we combined the use of rAds expressing CS protein along with rAds expressing novel innate immune response modulating proteins in an attempt to significantly improve the induction of CS protein specific cell mediated immune (CMI) responses. Methods and Findings: BALB/cJ mice were co-vaccinated with a rAd vectors expressing CS protein simultaneous with a rAd expressing either TLR agonist (rEA) or SLAM receptors adaptor protein (EAT-2). Paradoxically, expression of the TLR agonist uncovered a potent immunosuppressive activity inherent to the combined expression of the CS protein and rEA. Fortunately, use of the rAd vaccine expressing EAT-2 circumvented CS protein's suppressive activity, and generated a fivefold increase in the number of CS protein responsive, IFN gamma secreting splenocytes, as well as increased the breadth of T cells responsive to peptides present in the CS protein. These improvements were positively correlated with the induction of a fourfold improvement in CS protein specific CTL functional activity in vivo. Conclusion: Our results emphasize the need for caution when incorporating CS protein into malaria vaccine platforms expressing or containing other immunostimulatory compounds, as the immunological outcomes may be unanticipated and/or counter-productive. However, expressing the SLAM receptors derived signaling adaptor EAT-2 at the same time of vaccination with CS protein can overcome these concerns, as well as significantly improve the induction of malaria antigen specific adaptive immune responses in vivo.	[Schuldt, Nathaniel J.; Amalfitano, Andrea] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Aldhamen, Yasser A.; Appledorn, Daniel M.; Seregin, Sergey S.; Godbehere, Sarah; Amalfitano, Andrea] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Kousa, Youssef] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Kousa, Youssef; Amalfitano, Andrea] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA; [Amalfitano, Andrea] Michigan State Univ, Dept Pediat, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University College of Osteopathic Medicine; Michigan State University	Schuldt, NJ (corresponding author), Michigan State Univ, Genet Program, E Lansing, MI 48824 USA.	amalfit1@msu.edu		Schuldt, Nathan/0000-0001-7692-4814; Aldhamen, Yasser/0000-0002-9560-8013; Kousa, MS, DO, PhD, Youssef A/0000-0001-6049-8144	National Institutes of Health [RO1 AR056981, P01 CA078673]; MSU Foundation; Osteopathic Heritage Foundation; NATIONAL CANCER INSTITUTE [P01CA078673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSU Foundation; Osteopathic Heritage Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	These works were supported by the National Institutes of Health grants RO1 AR056981 and P01 CA078673, the MSU Foundation, as well the Osteopathic Heritage Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Aldhamen YA, 2011, J IMMUNOL, V186, P722, DOI 10.4049/jimmunol.1002105; Appledorn DM, 2008, GENE THER, V15, P885, DOI 10.1038/gt.2008.18; Appledorn DM, 2009, J INNATE IMMUN, V1, P376, DOI 10.1159/000207194; Appledorn DM, 2008, GENE THER, V15, P1606, DOI 10.1038/gt.2008.114; Appledorn DM, 2008, J IMMUNOL, V181, P2134, DOI 10.4049/jimmunol.181.3.2134; Appledorn DM, 2010, PLOS ONE, V5, pA130, DOI 10.1371/journal.pone.0009579; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bleharski JR, 2001, J IMMUNOL, V167, P3174, DOI 10.4049/jimmunol.167.6.3174; BLUMTIROUVANZIAM U, 1994, J IMMUNOL, V153, P4134; Bruna-Romero O, 2004, VACCINE, V22, P3575, DOI 10.1016/j.vaccine.2004.03.050; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; Detre C, 2010, SEMIN IMMUNOPATHOL, V32, P157, DOI 10.1007/s00281-009-0193-0; Dong ZJ, 2010, TRENDS IMMUNOL, V31, P295, DOI 10.1016/j.it.2010.05.008; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; Gregson AL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001556; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; Hartman ZC, 2008, VIRUS RES, V132, P1, DOI 10.1016/j.virusres.2007.10.005; Hartman ZC, 2007, VIROLOGY, V358, P357, DOI 10.1016/j.virol.2006.08.041; Hartman ZC, 2007, J VIROL, V81, P1796, DOI 10.1128/JVI.01936-06; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hedhli D, 2009, VACCINE, V27, P2274, DOI 10.1016/j.vaccine.2009.01.100; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; KESTER KE, 2009, RANDOMIZED DOUBLE BL; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Li CJ, 2008, CELL SIGNAL, V20, P1960, DOI 10.1016/j.cellsig.2008.07.004; Lindsay RWB, 2010, J IMMUNOL, V185, P1513, DOI 10.4049/jimmunol.1000338; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Martins MA, 2010, J VIROL, V84, P4352, DOI 10.1128/JVI.02365-09; Ng Philip, 2002, Methods Mol Med, V69, P389; Ophorst OJAE, 2006, INFECT IMMUN, V74, P313, DOI 10.1128/IAI.74.1.313-320.2006; Ostrakhovitch EA, 2009, CELL SIGNAL, V21, P540, DOI 10.1016/j.cellsig.2008.12.006; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Rodrigues EG, 1998, VACCINE, V16, P1812, DOI 10.1016/S0264-410X(98)00181-9; Rodrigues EG, 1997, J IMMUNOL, V158, P1268; Rodriguez A, 2009, VACCINE, V27, P6226, DOI 10.1016/j.vaccine.2009.07.106; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; SADOFF JC, 1988, SCIENCE, V240, P336, DOI 10.1126/science.3281260; Schmidt NW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000998; Shinoda K, 2010, HUM IMMUNOL, V71, P763, DOI 10.1016/j.humimm.2010.05.009; Shott JP, 2008, VACCINE, V26, P2818, DOI 10.1016/j.vaccine.2008.03.080; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; Takeshita F, 2006, J VIROL, V80, P6218, DOI 10.1128/JVI.00121-06; Torgler R, 2008, J IMMUNOL, V180, P3990, DOI 10.4049/jimmunol.180.6.3990; *WHO, 2008, WORLD MAL REP 2009; Yang YP, 2004, NAT IMMUNOL, V5, P508, DOI 10.1038/ni1059	54	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24147	10.1371/journal.pone.0024147	http://dx.doi.org/10.1371/journal.pone.0024147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912619	Green Published, Green Submitted, gold			2022-12-25	WOS:000294678300024
J	Wang, YM; Lu, L				Wang, Yumei; Lu, Luo			Activation of Oxidative Stress-Regulated Bcl-3 Suppresses CTCF in Corneal Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; CANDIDATE PROTOONCOGENE BCL-3; ONCOPROTEIN BCL-3; EGFR ACTIVATION; P50 HOMODIMERS; TRANSCRIPTION; EXPRESSION; BINDING; APOPTOSIS; PROLIFERATION	Epigenetic factor CTCF (CCCTC binding factor) plays important roles in genetic controls of the cell fate. Previous studies found in corneal epithelial cells that CTCF is regulated by epidermal growth factor (EGF) through activation of NF-kappa B p65/p50. It also found that CTCF is suppressed in ultraviolet (UV) stress-induced corneal epithelial cells. However, it is still unknown how UV stress down-regulates CTCF affecting the cell fate. In the present study, we report that regulation of CTCF by extracellular stress signals is dependent upon activations of an oxidative stress-regulated protein Bcl-3. We found that activated Bcl-3 was able to bind to the kappa B sites identified in the CTCF promoter region. Bcl-3 was activated by UV irradiation to interact with NF-kappa B p50 by forming a Bcl-3/p50 heterodimer complex. The Bcl-3/p50 complex suppressed CTCF promoter activity to down-regulate CTCF transcription. Unlike the effect of EGF, UV stress-induced Bcl-3 activation suppressed CTCF activity without involving the I kappa B alpha and p65 pathway. Thus, results of the study reveal a novel mechanism for regulatory control of CTCF in UV stress-induced human corneal epithelial cells, which requires activation and formation of Bcl-3/p50 complex through a noncanonical NF-kappa B pathway.	[Wang, Yumei; Lu, Luo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA 90502 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wang, YM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA 90502 USA.	lluou@ucla.edu			National Institutes of Health [R01-EY015282]; NATIONAL EYE INSTITUTE [R01EY015281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the grant from National Institutes of Health (R01-EY015282) to LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Bell KD, 2000, CORNEA, V19, P40, DOI 10.1097/00003226-200001000-00009; Brocke-Heidrich K, 2006, ONCOGENE, V25, P7297, DOI 10.1038/sj.onc.1209711; Chi ZL, 2007, EXP EYE RES, V84, P254, DOI 10.1016/j.exer.2006.09.016; Cristofanon S, 2009, FASEB J, V23, P45, DOI 10.1096/fj.07-104109; CROSSEN PE, 1989, CANCER GENET CYTOGEN, V43, P143, DOI 10.1016/0165-4608(89)90027-7; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; FRANZOSO G, 1993, EMBO J, V12, P3893, DOI 10.1002/j.1460-2075.1993.tb06067.x; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hishiki T, 2007, J BIOL CHEM, V282, P28335, DOI 10.1074/jbc.M702656200; Kabuta T, 2010, BIOCHEM BIOPH RES CO, V394, P697, DOI 10.1016/j.bbrc.2010.03.054; KANG SM, 1992, SCIENCE, V256, P1452, DOI 10.1126/science.1604322; Kashatus D, 2006, GENE DEV, V20, P225, DOI 10.1101/gad.1352206; Keutgens A, 2006, BIOCHEM PHARMACOL, V72, P1069, DOI 10.1016/j.bcp.2006.06.011; Khan KA, 2009, J IMMUNOL, V182, P7784, DOI 10.4049/jimmunol.0803800; Lee DH, 2005, OPHTHAL RES, V37, P83, DOI 10.1159/000084249; Li T, 2005, J BIOL CHEM, V280, P12988, DOI 10.1074/jbc.M412458200; Li T, 2007, EXP CELL RES, V313, P3057, DOI 10.1016/j.yexcr.2007.05.018; Lu L, 2003, INVEST OPHTH VIS SCI, V44, P5102, DOI 10.1167/iovs.03-0591; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; LU L, J BIOL CHEM, V285, P9373; Lu L, 2006, PROG RETIN EYE RES, V25, P515, DOI 10.1016/j.preteyeres.2006.07.004; Lu L, 2010, J BIOL CHEM, V285, P9373, DOI 10.1074/jbc.M109.094425; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Miyamoto T, 2006, J CATARACT REFR SURG, V32, P1736, DOI 10.1016/j.jcrs.2006.05.005; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; Palmer S, 2008, IMMUNOL RES, V42, P210, DOI 10.1007/s12026-008-8075-4; Thornburg NJ, 2007, J VIROL, V81, P12954, DOI 10.1128/JVI.01601-07; Wang L, 2003, INVEST OPHTH VIS SCI, V44, P5095, DOI 10.1167/iovs.03-0590; Watanabe SI, 1997, EXP EYE RES, V64, P1027, DOI 10.1006/exer.1997.0293; Xiao WH, 2004, CELL MOL IMMUNOL, V1, P425; Xu KP, 2004, INVEST OPHTH VIS SCI, V45, P813, DOI 10.1167/iovs.03-0851; Yang J, 2009, MOL CELL BIOL, V29, P4091, DOI 10.1128/MCB.01669-08; Yin J, 2009, INVEST OPHTH VIS SCI, V50, P132, DOI 10.1167/iovs.08-2246; Zhang MC, 2006, OCUL IMMUNOL INFLAMM, V14, P359, DOI 10.1080/09273940601001322; ZHANG Q, 1994, MOL CELL BIOL, V14, P3915, DOI 10.1128/MCB.14.6.3915	40	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e23984	10.1371/journal.pone.0023984	http://dx.doi.org/10.1371/journal.pone.0023984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912613	Green Published, gold, Green Submitted			2022-12-25	WOS:000294678300015
J	Lv, CQ; Huang, BL; Qiao, MJ; Wei, JG; Ding, B				Lv, Chengqun; Huang, Baoling; Qiao, Mengji; Wei, Jiguang; Ding, Bo			Entomopathogenic Fungi on Hemiberlesia pitysophila	PLOS ONE			English	Article							DIVERSITY	Hemiberlesia pitysophila Takagi is an extremely harmful exotic insect in forest to Pinus species, including Pinus massoniana. Using both morphological taxonomy and molecular phylogenetics, we identified 15 strains of entomogenous fungi, which belong to 9 genera with high diversities. Surprisingly, we found that five strains that were classified as species of Pestalotiopsis, which has been considered plant pathogens and endophytes, were the dominant entomopathogenic fungus of H. pitysophila. Molecular phylogenetic tree established by analyzing sequences of ribosomal DNA internal transcribed spacer showed that entomopathogenic Pestalotiopsis spp. were similar to plant Pestalotiopsis, but not to other pathogens and endophytes of its host plant P. massoniana. We were the first to isolate entomopathogenic Pestalotiopsis spp. from H. pitysophila. Our findings suggest a potential and promising method of H. pitysophila bio-control.	[Lv, Chengqun; Huang, Baoling; Qiao, Mengji; Wei, Jiguang; Ding, Bo] Guangxi Univ, Coll Forestry, Nanning 530004, Peoples R China	Guangxi University	Lv, CQ (corresponding author), Guangxi Univ, Coll Forestry, Nanning 530004, Peoples R China.	luchengqun8@126.com			Guangxi Forestry Science Foundation of China [01]	Guangxi Forestry Science Foundation of China	This work was supported by the Guangxi Forestry Science Foundation of China (2008, No. 01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett HL, 1977, ILLUSTRATED GENERA I; CHARNLEY A. K., 1997, ENV MICROBIAL RELATI, P185; Chen Ming-jun, 2007, Yingyong Shengtai Xuebao, V18, P2075; Crous PW, 2006, STUD MYCOL, P53, DOI 10.3114/sim.55.1.53; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; ESPINOSAGARCIA FJ, 1990, NEW PHYTOL, V116, P89, DOI 10.1111/j.1469-8137.1990.tb00513.x; Evans Harry C., 2005, Mycological Progress, V4, P91, DOI 10.1007/s11557-006-0112-x; Guo LiangDong, 2002, Mycosystema, V21, P455; Huang ZY, 2001, ENTOMOLOGICAL J E CH, V10, P101; Jillian ML, 1990, TROPICAL GRASSLANDS, V24, P1; Keith LM, 2006, PLANT DIS, V90, P16, DOI 10.1094/PD-90-0016; Kirk PM, 2001, DICT FUNGI; Kolarik M, 2007, MYCOL RES, V111, P1298, DOI 10.1016/j.mycres.2007.06.010; Kumar DSS, 2004, FUNGAL DIVERS, V17, P69; Landeweert R, 2003, APPL ENVIRON MICROB, V69, P327, DOI 10.1128/AEM.69.1.327-333.2003; Li LZ, 1989, FOREST SCI TECHNOLOG, V12, P23; Li Wen-ying, 2003, Forest Research, V16, P339; [李文英 Li Wenying], 2003, [生物多样性, Chinese Biodiversity], V11, P53; Maurer P, 1997, MYCOL RES, V101, P159, DOI 10.1017/S0953756296002213; Nnis MA, 1990, PCR PROTOCOLS GUIDE, P315; Pan W. Y., 1989, Forest Pest and Disease, P22; Shah PA, 2003, APPL MICROBIOL BIOT, V61, P413, DOI 10.1007/s00253-003-1240-8; Song Dong-hui, 2001, Forest Research, V14, P628; Tejesvi MV, 2009, FUNGAL DIVERS, V38, P167; Tzean S.S., 1997, ATLAS ENTOMOPATHOGEN; Wang Bin, 2005, Yingyong Shengtai Xuebao, V16, P2357; Wang Sibao, 2004, Ying Yong Sheng Tai Xue Bao, V15, P883; Wang Yu, 2004, Mycosystema, V23, P24; Wei JC, 1979, IDENTIFICATION HDB F; Wei JG, 2007, FUNGAL DIVERS, V24, P55; Wei JiGuang, 2003, Mycosystema, V22, P666; [Wei Jiguang 韦继光], 2005, [菌物学报, Mygosystema], V24, P481; Wei JiGuang, 2008, Journal of Zhejiang University (Agriculture and Life Sciences), V34, P367; [韦精卫 WEI Jingwei], 2006, [广西农业生物科学, Journal of Guangxi Agricultural and Biological Science], V25, P96; Wu J, 2004, SCI TECHNOLOGY REV, V4, P41; Zeng FY, 2006, POPULATION DYNAMICS; Zhang YuBo, 2007, Journal of Anhui Agricultural University, V34, P342	37	5	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23649	10.1371/journal.pone.0023649	http://dx.doi.org/10.1371/journal.pone.0023649			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901126	Green Published, gold, Green Submitted			2022-12-25	WOS:000294298000011
J	Thanseem, I; Nakamura, K; Anitha, A; Suda, S; Yamada, K; Iwayama, Y; Toyota, T; Tsujii, M; Iwata, Y; Suzuki, K; Matsuzaki, H; Iwata, K; Sugiyama, T; Yoshikawa, T; Mori, N				Thanseem, Ismail; Nakamura, Kazuhiko; Anitha, Ayyappan; Suda, Shiro; Yamada, Kazuo; Iwayama, Yoshimi; Toyota, Tomoko; Tsujii, Masatsugu; Iwata, Yasuhide; Suzuki, Katsuaki; Matsuzaki, Hideo; Iwata, Keiko; Sugiyama, Toshiro; Yoshikawa, Takeo; Mori, Norio			Association of Transcription Factor Gene LMX1B with Autism	PLOS ONE			English	Article							NAIL-PATELLA SYNDROME; SEROTONERGIC NEURONS; TRANSPORTER; DISORDER; SLC6A4; POLYMORPHISMS; EXPRESSION; CHILDHOOD; MUTATIONS; SPECTRUM	Multiple lines of evidence suggest a serotoninergic dysfunction in autism. The role of LMX1B in the development and maintenance of serotoninergic neurons is well known. In order to examine the role, if any, of LMX1B with autism pathophysiology, a trio-based SNP association study using 252 family samples from the AGRE was performed. Using pair-wise tagging method, 24 SNPs were selected from the HapMap data, based on their location and minor allele frequency. Two SNPs (rs10732392 and rs12336217) showed moderate association with autism with p values 0.018 and 0.022 respectively in transmission disequilibrium test. The haplotype AGCGTG also showed significant association (p = 0.008). Further, LMX1B mRNA expressions were studied in the postmortem brain tissues of autism subjects and healthy controls samples. LMX1B transcripts was found to be significantly lower in the anterior cingulate gyrus region of autism patients compared with controls (p = 0.049). Our study suggests a possible role of LMX1B in the pathophysiology of autism. Based on previous reports, it is likely to be mediated through a seretoninergic mechanism. This is the first report on the association of LMX1B with autism, though it should be viewed with some caution considering the modest associations we report.	[Thanseem, Ismail; Nakamura, Kazuhiko; Iwata, Yasuhide; Mori, Norio] Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Hamamatsu, Shizuoka 4313192, Japan; [Anitha, Ayyappan; Tsujii, Masatsugu; Suzuki, Katsuaki; Matsuzaki, Hideo; Iwata, Keiko; Mori, Norio] Hamamatsu Univ Sch Med, Res Ctr Child Mental Dev, Hamamatsu, Shizuoka 4313192, Japan; [Suda, Shiro] Jichi Med Univ, Dept Psychiat, Shimotsuke, Japan; [Yamada, Kazuo; Iwayama, Yoshimi; Toyota, Tomoko; Yoshikawa, Takeo] RIKEN, Brain Sci Inst, Lab Mol Psychiat, Saitama, Japan; [Tsujii, Masatsugu] Chukyo Univ, Fac Sociol, Aichi, Japan; [Sugiyama, Toshiro] Aichi Childrens Hlth & Med Ctr, Aichi, Japan; [Sugiyama, Toshiro] Hamamatsu Univ Sch Med, Dept Child & Adolescent Psychiat, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Jichi Medical University; RIKEN; Chukyo University; Hamamatsu University School of Medicine	Thanseem, I (corresponding author), Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Hamamatsu, Shizuoka 4313192, Japan.	nakamura@hama-med.ac.jp	Yoshikawa, Takeo/F-9599-2019; MATSUZAKI, HIDEO/AAE-5246-2020	MATSUZAKI, HIDEO/0000-0002-6869-1261; Anitha, Ayyappan/0000-0001-6767-2694; Suzuki, Katsuaki/0000-0003-0446-3355	Ministry of Education, Culture, Sports, Science, and Technology of Japan; PHS [R 24 MH 068855]; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to Dr. K. Nakamura. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Jane Pickett, Director of Brain Resources and Data, Autism Tissue Program, for facilitating brain tissue collection. Human tissue was obtained from the NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, Maryland. Tissue samples were also provided by the Harvard Brain Tissue Resource Center, which is supported in part by PHS grant number R 24 MH 068855. We thank Ms. Tae Takahashi for technical assistance.	Anderson GM, 2002, MOL PSYCHIATR, V7, P831, DOI 10.1038/sj.mp.4001099; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bergman O, 2010, PROG NEURO-PSYCHOPH, V34, P1094, DOI 10.1016/j.pnpbp.2010.05.032; Chandana SR, 2005, INT J DEV NEUROSCI, V23, P171, DOI 10.1016/j.ijdevneu.2004.08.002; Cheng LP, 2003, J NEUROSCI, V23, P9961; Cook Edwin H. Jr., 1996, Current Opinion in Pediatrics, V8, P348, DOI 10.1097/00008480-199608000-00008; Ding YQ, 2003, NAT NEUROSCI, V6, P933, DOI 10.1038/nn1104; Dolmazon V, 2011, STEM CELLS DEV, V20, P301, DOI 10.1089/scd.2010.0224; Fombonne Eric, 2009, Mcgill J Med, V12, P73; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Haznedar MM, 1997, AM J PSYCHIAT, V154, P1047; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Knoers NVAM, 2000, J AM SOC NEPHROL, V11, P1762, DOI 10.1681/ASN.V1191762; Kolevzon A, 2006, J CLIN PSYCHIAT, V67, P407, DOI 10.4088/JCP.v67n0311; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Makkonen I, 2008, DEV MED CHILD NEUROL, V50, P593, DOI 10.1111/j.1469-8749.2008.03027.x; Marini M, 2010, GENET MED, V12, P431, DOI 10.1097/GIM.0b013e3181e21afa; McCauley JL, 2004, AM J MED GENET B, V127B, P104, DOI 10.1002/ajmg.b.20151; McDougle CJ, 1996, ARCH GEN PSYCHIAT, V53, P993; Milla E, 2007, MOL VIS, V13, P639; Nakamura K, 2010, ARCH GEN PSYCHIAT, V67, P59, DOI 10.1001/archgenpsychiatry.2009.137; Ohnishi T, 2000, BRAIN, V123, P1838, DOI 10.1093/brain/123.9.1838; Pattyn A, 2003, DEVELOPMENT, V130, P4149, DOI 10.1242/dev.00641; Ramoz N, 2006, BIOL PSYCHIAT, V60, P186, DOI 10.1016/j.biopsych.2006.01.009; Ranade K, 2001, GENOME RES, V11, P1262; Song NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015998; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006	29	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23738	10.1371/journal.pone.0023738	http://dx.doi.org/10.1371/journal.pone.0023738			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901133	Green Published, gold, Green Submitted			2022-12-25	WOS:000294298000018
J	Gancarz, BL; Hao, LH; He, QL; Newton, MA; Ahlquist, P				Gancarz, Brandi L.; Hao, Linhui; He, Qiuling; Newton, Michael A.; Ahlquist, Paul			Systematic Identification of Novel, Essential Host Genes Affecting Bromovirus RNA Replication	PLOS ONE			English	Article							BROME MOSAIC-VIRUS; IRON-SULFUR PROTEINS; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; GENOME REPLICATION; DECAPPING FACTORS; CRUCIAL ROLES; ACTIVE-SITE; YEAST	Positive-strand RNA virus replication involves viral proteins and cellular proteins at nearly every replication step. Brome mosaic virus (BMV) is a well-established model for dissecting virus-host interactions and is one of very few viruses whose RNA replication, gene expression and encapsidation have been reproduced in the yeast Saccharomyces cerevisiae. Previously, our laboratory identified similar to 100 non-essential host genes whose loss inhibited or enhanced BMV replication at least 3-fold. However, our isolation of additional BMV-modulating host genes by classical genetics and other results underscore that genes essential for cell growth also contribute to BMV RNA replication at a frequency that may be greater than that of non-essential genes. To systematically identify novel, essential host genes affecting BMV RNA replication, we tested a collection of similar to 900 yeast strains, each with a single essential gene promoter replaced by a doxycycline-repressible promoter, allowing repression of gene expression by adding doxycycline to the growth medium. Using this strain array of similar to 81% of essential yeast genes, we identified 24 essential host genes whose depleted expression reproducibly inhibited or enhanced BMV RNA replication. Relevant host genes are involved in ribosome biosynthesis, cell cycle regulation and protein homeostasis, among other cellular processes. BMV 2a(Pol) levels were significantly increased in strains depleted for a heat shock protein (HSF1) or proteasome components (PRE1 and RPT6), suggesting these genes may affect BMV RNA replication by directly or indirectly modulating 2a(Pol) localization, post-translational modification or interacting partners. Investigating the diverse functions of these newly identified essential host genes should advance our understanding of BMV-host interactions and normal cellular pathways, and suggest new modes of virus control.	[Gancarz, Brandi L.; Hao, Linhui; Ahlquist, Paul] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; [Hao, Linhui; Ahlquist, Paul] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI USA; [He, Qiuling; Newton, Michael A.] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Newton, Michael A.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gancarz, BL (corresponding author), Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA.	ahlquist@wisc.edu			National Institutes of Health (NIH) [GM35072]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035072, R01GM035072] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant GM35072 (http://grants.nih.gov/grants/oer.htm.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2006, NAT REV MICROBIOL, V4, P371, DOI 10.1038/nrmicro1389; Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Ahola T, 2000, J VIROL, V74, P8803, DOI 10.1128/JVI.74.19.8803-8811.2000; Barajas D, 2010, VIROLOGY, V397, P358, DOI 10.1016/j.virol.2009.11.010; Barajas D, 2009, J VIROL, V83, P11751, DOI 10.1128/JVI.00789-09; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Belov GA, 2007, J VIROL, V81, P9259, DOI 10.1128/JVI.00840-07; Belov GA, 2007, J VIROL, V81, P558, DOI 10.1128/JVI.01820-06; Belov GA, 2007, CELL CYCLE, V6, P36, DOI 10.4161/cc.6.1.3683; Bode JG, 2009, BIOL CHEM, V390, P1013, DOI 10.1515/BC.2009.118; Bruce JW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000207; Camborde L, 2010, PLANT CELL, V22, P3142, DOI 10.1105/tpc.109.072090; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chen JB, 2000, J VIROL, V74, P4310, DOI 10.1128/JVI.74.9.4310-4318.2000; Diaz A, 2010, P NATL ACAD SCI USA, V107, P16291, DOI 10.1073/pnas.1011105107; Dye BT, 2005, BIOTECHNIQUES, V38, P868, DOI 10.2144/05386BM04; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Fauquet C. M., 2000, VIRUS TAXONOMY; Gaither LA, 2010, VIROLOGY, V397, P43, DOI 10.1016/j.virol.2009.10.043; Gorchakov R, 2005, J VIROL, V79, P9397, DOI 10.1128/JVI.79.15.9397-9409.2005; Grdzelishvili VZ, 2005, J VIROL, V79, P1438, DOI 10.1128/JVI.79.3.1438-1451.2005; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ishikawa M, 1997, J VIROL, V71, P7781, DOI 10.1128/JVI.71.10.7781-7790.1997; JANDA M, 1993, CELL, V72, P961, DOI 10.1016/0092-8674(93)90584-D; Jiang Y, 2006, J VIROL, V80, P7394, DOI 10.1128/JVI.02686-05; Jungkunz I, 2011, PLANT J, V66, P983, DOI 10.1111/j.1365-313X.2011.04558.x; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kash JC, 2006, VIRUS RES, V119, P111, DOI 10.1016/j.virusres.2005.10.013; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Krol MA, 1999, P NATL ACAD SCI USA, V96, P13650, DOI 10.1073/pnas.96.24.13650; Kushner DB, 2003, P NATL ACAD SCI USA, V100, P15764, DOI 10.1073/pnas.2536857100; Lee WM, 2003, J VIROL, V77, P12819, DOI 10.1128/JVI.77.23.12819-12828.2003; Lee WM, 2001, J VIROL, V75, P2097, DOI 10.1128/JVI.75.5.2097-2106.2001; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lindenbach BD, 2002, J VIROL, V76, P3905, DOI 10.1128/JVI.76.8.3905-3919.2002; Liu L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000351; Liu Z, 2009, J VIROL, V83, P6554, DOI 10.1128/JVI.02550-08; Mas A, 2006, J VIROL, V80, P246, DOI 10.1128/JVI.80.1.246-251.2006; Mendu V, 2010, VIROLOGY, V406, P342, DOI 10.1016/j.virol.2010.07.022; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Munk C, 2002, P NATL ACAD SCI USA, V99, P13843, DOI 10.1073/pnas.212400099; Noueiry AO, 2000, P NATL ACAD SCI USA, V97, P12985, DOI 10.1073/pnas.240460897; Noueiry AO, 2003, MOL CELL BIOL, V23, P4094, DOI 10.1128/MCB.23.12.4094-4106.2003; Panavas T, 2003, VIROLOGY, V314, P315, DOI 10.1016/S0042-6822(03)00436-7; Pathak KB, 2008, VIROLOGY, V379, P294, DOI 10.1016/j.virol.2008.06.044; Pukszta S, 2010, EMBO REP, V11, P360, DOI 10.1038/embor.2010.29; Raaben M, 2010, J VIROL, V84, P7869, DOI 10.1128/JVI.00485-10; RestrepoHartwig MA, 1996, J VIROL, V70, P8908, DOI 10.1128/JVI.70.12.8908-8916.1996; Scheller N, 2009, P NATL ACAD SCI USA, V106, P13517, DOI 10.1073/pnas.0906413106; Schwartz M, 2004, P NATL ACAD SCI USA, V101, P11263, DOI 10.1073/pnas.0404157101; Schwartz M, 2002, MOL CELL, V9, P505, DOI 10.1016/S1097-2765(02)00474-4; Shaw PE, 2007, EMBO REP, V8, P40, DOI 10.1038/sj.embor.7400873; Si XN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002585; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Taylor MP, 2008, AUTOPHAGY, V4, P286, DOI 10.4161/auto.5377; Tomita Y, 2003, J VIROL, V77, P2990, DOI 10.1128/JVI.77.5.2990-2997.2003; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Wang RYL, 2009, J VIROL, V83, P3276, DOI 10.1128/JVI.02313-08; Wang XF, 2005, J VIROL, V79, P13747, DOI 10.1128/JVI.79.21.13747-13758.2005; Wang XF, 2011, J VIROL, V85, P5494, DOI 10.1128/JVI.02031-10; White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006; Widjaja I, 2010, J VIROL, V84, P9625, DOI 10.1128/JVI.01048-10; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118	67	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23988	10.1371/journal.pone.0023988	http://dx.doi.org/10.1371/journal.pone.0023988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21915247	Green Published, Green Submitted, gold			2022-12-25	WOS:000294251800043
J	Yue, P; Zhang, X; Paladino, D; Sengupta, B; Ahmad, S; Holloway, RW; Ingersoll, SB; Turkson, J				Yue, P.; Zhang, X.; Paladino, D.; Sengupta, B.; Ahmad, S.; Holloway, R. W.; Ingersoll, S. B.; Turkson, J.			Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells	ONCOGENE			English	Article						cisplatin-resistance; ovarian cancer; EGF receptor; Stat3; Jaks; cancer aggressiveness	GROWTH-FACTOR RECEPTOR; MESENCHYMAL TRANSITION; CONSTITUTIVE ACTIVATION; CONFERS RESISTANCE; PLATINUM COMPLEXES; MATRIX DEGRADATION; TUMOR PROGRESSION; INDUCED APOPTOSIS; DRUG-RESISTANCE; CARCINOMA CELLS	We present evidence that the cisplatin-resistant human ovarian cancer lines, A2780S/CP1 (S/CP1), A2780S/CP3 (S/CP3) and A2780S/CP5 (S/CP5), derived by subjecting the sensitive A2780S ovarian cancer line to multiple rounds of cisplatin treatments followed by recovery and are resistant to 1, 3 and 5 mu M cisplatin, respectively, have increased colony-forming ability and altered morphology that is consistent with enhanced motility, migration and invasiveness in vitro. The malignant phenotype progresses with increasing resistance and is associated with hyperactive epidermal growth factor receptor (EGFR)/extracellular signal-regulated kinase (Erk)1/2 and janus kinases (Jaks), aberrant signal transducer and activator of transcription (Stat) 3 activation promoted by EGFR and Jaks, and epithelial-mesenchymal transition (EMT) in vitro. Survivin and FLIP anti-apoptotic factors, vascular endothelial growth factor (VEGF) and matrix metalloproteinase activities are also elevated in the resistant cells. Accordingly, the ectopic expression of constitutively-active Stat3C in the sensitive A2780S cells diminished cisplatin sensitivity. The inhibition of EGFR or Stat3 activity repressed Survivin, VEGF and Vimentin expression and the colony-forming potential, viability, motility and migration of the resistant cells, and sensitized them to cisplatin. Analysis of human ovarian cancer patients' tumor tissues shows aberrantly-active EGFR and Stat3 that in certain cases correlate with Vimentin over-expression. Intra-peritoneal mouse xenograft studies revealed, compared with the sensitive A2780S line that had low tumor incidence restricted to the ovary, a high tumor incidence for the resistant S/CP3 and S/CP5 lines that formed tumor nodules at several locations on the small intestine and colon, and which responded poorly to cisplatin, but were sensitive to concurrent treatment with cisplatin and EGFR or Stat3 inhibitor. Hyperactive EGFR signaling through Stat3 and the Jak-Stat3 activity together promote ovarian cancer progression to cisplatin resistance and therefore represent targets for preventing the development of cisplatin resistance and the recurrent disease during cisplatin therapy in ovarian cancer. Oncogene (2012) 31, 2309-2322; doi:10.1038/onc.2011.409; published online 12 September 2011	[Yue, P.; Zhang, X.; Paladino, D.; Sengupta, B.; Turkson, J.] Univ Cent Florida, Coll Med, Barnett Sch Biomed Sci, Orlando, FL 32816 USA; [Ahmad, S.; Holloway, R. W.; Ingersoll, S. B.] Florida Hosp Canc Inst, Florida Hosp Gynecol Oncol, Orlando, FL USA	State University System of Florida; University of Central Florida; Adventist Health Services; AdventHealth	Turkson, J (corresponding author), Univ Hawaii Manoa, Univ Hawaii Canc Ctr, Canc Biol Program, Biomed Sci Bldg,Suite 222J,651 ILALO St, Honolulu, HI 96813 USA.	jturkson@cc.hawaii.edu	zhang, xiaolei/D-7698-2012; Yue, Peibin/J-9836-2015	Zhang, Xiaolei/0000-0003-2395-2453	National Cancer Institute [CA106439, CA128865]; Florida Hospital-UCF; State of Florida Bankhead-Coley Cancer Research Program; NATIONAL CANCER INSTITUTE [R01CA106439, R01CA128865, P30CA071789] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Hospital-UCF; State of Florida Bankhead-Coley Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all colleagues and members of our laboratory for the stimulating discussions and the University of Central Florida Confocal Microscopy and the Transgenic Animal facilities for their assistance. This work was supported by the National Cancer Institute Grants CA106439 and CA128865 (to JT) and the Florida Hospital-UCF-Gala Endowed Program for Oncologic Research Award (JT and RWH) and the State of Florida Bankhead-Coley Cancer Research Program (SBI, RWH and SA).	Ahmed N, 2007, J CELL PHYSIOL, V213, P581, DOI 10.1002/jcp.21240; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Arany I, 2004, AM J PHYSIOL-RENAL, V287, pF543, DOI 10.1152/ajprenal.00112.2004; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brabec V, 2005, DRUG RESIST UPDATE, V8, P131, DOI 10.1016/j.drup.2005.04.006; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Burke WM, 2001, ONCOGENE, V20, P7925, DOI 10.1038/sj.onc.1204990; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chan JK, 2005, CANCER RES, V65, P3243, DOI 10.1158/0008-5472.CAN-03-3013; Cui W, 2000, MOL CARCINOGEN, V29, P219, DOI 10.1002/1098-2744(200012)29:4<219::AID-MC1004>3.0.CO;2-D; Dancey JE, 2003, LANCET, V362, P62, DOI 10.1016/S0140-6736(03)13810-X; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; Desai B, 2008, J BIOL CHEM, V283, P13856, DOI 10.1074/jbc.M709401200; Duan Z, 2006, CANCER RES, V12, P5056; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Fajac A, 1996, INT J CANCER, V68, P67, DOI 10.1002/(SICI)1097-0215(19960927)68:1<67::AID-IJC13>3.0.CO;2-3; Gallagher WM, 1997, ONCOGENE, V14, P185; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Huang M, 2000, GYNECOL ONCOL, V79, P67, DOI 10.1006/gyno.2000.5931; Ikuta K, 2005, ONCOL REP, V13, P1229; Kassouf W, 2005, CANCER RES, V65, P10524, DOI 10.1158/0008-5472.CAN-05-1536; Kelland LR, 1999, J INORG BIOCHEM, V77, P111, DOI 10.1016/S0162-0134(99)00141-5; Kim YK, 2005, J APPL TOXICOL, V25, P374, DOI 10.1002/jat.1081; Lee MY, 2008, CLIN CANCER RES, V14, P4743, DOI 10.1158/1078-0432.CCR-08-0234; Matsuo M, 2007, CANCER LETT, V251, P288, DOI 10.1016/j.canlet.2006.11.027; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Richardson A, 2005, DRUG RESIST UPDATE, V8, P311, DOI 10.1016/j.drup.2005.09.001; Selvendiran K, 2008, CELL CYCLE, V7, P81, DOI 10.4161/cc.7.1.5103; Selvendiran K, 2009, INT J CANCER, V125, P2198, DOI 10.1002/ijc.24601; Shao H, 2003, CANCER RES, V63, P3923; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Siddiquee KAZ, 2007, ACS CHEM BIOL, V2, P787, DOI 10.1021/cb7001973; Song H, 2004, INT J ONCOL, V24, P1017; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Turkson J, 2004, EXPERT OPIN THER TAR, V8, P409, DOI 10.1517/14728222.8.5.409; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Villedieu M, 2006, GYNECOL ONCOL, V101, P507, DOI 10.1016/j.ygyno.2005.11.017; Wang GD, 2004, ONCOL REP, V12, P955; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang XL, 2010, BIOCHEM PHARMACOL, V79, P1398, DOI 10.1016/j.bcp.2010.01.001; Zhang Y, 2000, J BIOL CHEM, V275, P24935, DOI 10.1074/jbc.M002383200	49	103	108	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2012	31	18					2309	2322		10.1038/onc.2011.409	http://dx.doi.org/10.1038/onc.2011.409			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	936SR	21909139	Green Accepted			2022-12-25	WOS:000303610800006
J	Hillringhaus, L; Yue, WW; Rose, NR; Ng, SS; Gileadi, C; Loenarz, C; Bello, SH; Bray, JE; Schofield, CJ; Oppermann, U				Hillringhaus, Lars; Yue, Wyatt W.; Rose, Nathan R.; Ng, Stanley S.; Gileadi, Carina; Loenarz, Christoph; Bello, Simon H.; Bray, James E.; Schofield, Christopher J.; Oppermann, Udo			Structural and Evolutionary Basis for the Dual Substrate Selectivity of Human KDM4 Histone Demethylase Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED MENTAL-RETARDATION; JMJD2 FAMILY; ANDROGEN RECEPTOR; JUMONJI-DOMAIN; JARID1C GENE; PHF8; METHYLATION; MUTATIONS; HYPOXIA; SPECIFICITY	N-epsilon-Methylations of histone lysine residues play critical roles in cell biology by "marking" chromatin for transcriptional activation or repression. Lysine demethylases reverse Art-methylation in a sequence- and rnethylation-selective manner. The determinants of sequence selectivity for histone demethylases have been unclear. The human JMJD2 (KDM4) H3K9 and H3K36 demethylases can be divided into members that act on both H3K9 and H3K36 and H3K9 alone. Kinetic, crystallographic, and mutagenetic studies in vitro and in cells on KDM4A-E reveal that selectivity is determined by multiple interactions within the catalytic domain but outside the active site. Structurally informed phylogenetic analyses reveal that KDM4A-C orthologues exist in all genome-sequenced vertebrates with earlier animals containing only a single KDM4 enzyme. KDM4D orthologues only exist in eutherians (placental mammals) where they are conserved, including proposed substrate sequence-determining residues. The results will be useful for the identification of inhibitors for specific histone demethylases.	[Hillringhaus, Lars; Rose, Nathan R.; Loenarz, Christoph; Bello, Simon H.; Schofield, Christopher J.] Univ Oxford, Dept Chem, Oxford OX1 3TA, England; [Hillringhaus, Lars; Rose, Nathan R.; Loenarz, Christoph; Bello, Simon H.; Schofield, Christopher J.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Chem Res Lab, Oxford OX1 3TA, England; [Yue, Wyatt W.; Ng, Stanley S.; Gileadi, Carina; Bray, James E.; Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Headington OX3 7DQ, England; [Oppermann, Udo] Botnar Res Ctr, Natl Inst Hlth Res Oxford Biomed Res Unit, Nuffield Dept Orthoped Rheumatol & Musculoskeleta, Oxford OX3 7LD, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	Schofield, CJ (corresponding author), Univ Oxford, Dept Chem, 12 Mansfield Rd, Oxford OX1 3TA, England.	christopher.schofield@chem.ox.ac.uk; udo.oppermann@sgc.ox.ac.uk	Rose, Nathan R/A-9270-2013	Rose, Nathan R/0000-0002-1871-1156; BRAY, JAMES/0000-0003-3554-4254; Loenarz, Christoph/0000-0002-8843-2531; Schofield, Christopher/0000-0002-0290-6565	Biotechnology and Biological Sciences Research Council; Wellcome Trust; Oxford National Institute for Health Research Oxford Biomedical Research Biomedical Research Unit	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Oxford National Institute for Health Research Oxford Biomedical Research Biomedical Research Unit	This work was supported in part by the Biotechnology and Biological Sciences Research Council, the Wellcome Trust, and by the Oxford National Institute for Health Research Oxford Biomedical Research Biomedical Research Unit.	Abidi FE, 2008, J MED GENET, V45, P787, DOI 10.1136/jmg.2008.058990; Adegbola A, 2008, AM J MED GENET A, V146A, P505, DOI 10.1002/ajmg.a.32142; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Chen ZZ, 2007, P NATL ACAD SCI USA, V104, P10818, DOI 10.1073/pnas.0704525104; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Fortschegger K, 2010, MOL CELL BIOL, V30, P3286, DOI 10.1128/MCB.01520-09; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Ishimura A, 2009, BIOCHEM BIOPH RES CO, V389, P366, DOI 10.1016/j.bbrc.2009.08.155; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Katoh M, 2004, INT J ONCOL, V24, P1623; Katoh Y, 2007, INT J MOL MED, V20, P269; King ONF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015535; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Klose RJ, 2007, MOL CELL BIOL, V27, P3951, DOI 10.1128/MCB.02180-06; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Koivisto AM, 2007, CLIN GENET, V72, P145, DOI 10.1111/j.1399-0004.2007.00836.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Laumonnier F, 2005, J MED GENET, V42, P780, DOI 10.1136/jmg.2004.029439; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P109, DOI 10.1038/nsmb1326; Leung IKH, 2010, CHEM BIOL, V17, P1316, DOI 10.1016/j.chembiol.2010.09.016; Liu G, 2009, ONCOGENE, V28, P4491, DOI 10.1038/onc.2009.297; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Loenarz C, 2010, HUM MOL GENET, V19, P217, DOI 10.1093/hmg/ddp480; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pfau R, 2008, P NATL ACAD SCI USA, V105, P1907, DOI 10.1073/pnas.0711865105; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Ponnaluri VKC, 2011, BIOCHEM BIOPH RES CO, V405, P588, DOI 10.1016/j.bbrc.2011.01.073; Ponnaluri VKC, 2009, BIOCHEM BIOPH RES CO, V390, P280, DOI 10.1016/j.bbrc.2009.09.107; Rose NR, 2008, J MED CHEM, V51, P7053, DOI 10.1021/jm800936s; Rose NR, 2010, J MED CHEM, V53, P1810, DOI 10.1021/jm901680b; Santos C, 2006, EUR J HUM GENET, V14, P583, DOI 10.1038/sj.ejhg.5201608; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; Strobl-Mazzulla PH, 2010, DEV CELL, V19, P460, DOI 10.1016/j.devcel.2010.08.009; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tzschach A, 2006, HUM MUTAT, V27, P389, DOI 10.1002/humu.9420; Wang JL, 2010, BIOL REPROD, V82, P105, DOI 10.1095/biolreprod.109.078055; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Yang J, 2010, CANCER RES, V70, P6456, DOI 10.1158/0008-5472.CAN-10-0413; Yu L, 2010, CELL RES, V20, P166, DOI 10.1038/cr.2010.8; Yue WW, 2010, FEBS LETT, V584, P825, DOI 10.1016/j.febslet.2009.12.055	68	112	115	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41616	41625		10.1074/jbc.M111.283689	http://dx.doi.org/10.1074/jbc.M111.283689			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21914792	Green Published, hybrid			2022-12-25	WOS:000298057500046
J	Collard, F; Vertommen, D; Constantinescu, S; Buts, L; Van Schaftingen, E				Collard, Francois; Vertommen, Didier; Constantinescu, Stefan; Buts, Lieven; Van Schaftingen, Emile			Molecular Identification of beta-Citrylglutamate Hydrolase as Glutamate Carboxypeptidase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CITRYL-L-GLUTAMATE; ALPHA-ASPARTYLGLUTAMIC ACID; L-ASPARTIC ACID; N-ACETYLASPARTYLGLUTAMATE; MEMBRANE ANTIGEN; RAT; BRAIN; DIPEPTIDASE; SYNTHASE; RECEPTOR	beta-Citrylglutamate (BCG), a compound present in adult testis and in the CNS during the pre- and perinatal periods is synthesized by an intracellular enzyme encoded by the RIMKLB gene and hydrolyzed by an as yet unidentified ectoenzyme. To identify beta-citrylglutamate hydrolase, this enzyme was partially purified from mouse testis and characterized. Interestingly, in the presence of Ca2+, the purified enzyme specifically hydrolyzed beta-citrylglutamate and did not act on N-acetyl-aspartylglutamate (NAAG). However, both compounds were hydrolyzed in the presence of Mn2+. This behavior and the fact that the enzyme was glycosylated and membrane-bound suggested that beta-citrylglutamate hydrolase belonged to the same family of protein as glutamate carboxypeptidase 2 (GCP2), the enzyme that catalyzes the hydrolysis of N-acetyl-aspartylglutamate. The mouse tissue distribution of beta-citrylglutamate hydrolase was strikingly similar to that of the glutamate carboxypeptidase 3 (GCP3) mRNA, but not that of the GCP2 mRNA. Furthermore, similarly to beta-citrylglutamate hydrolase purified from testis, recombinant GCP3 specifically hydrolyzed beta-citrylglutamate in the presence of Ca2+, and acted on both N-acetyl-aspartylglutamate and beta-citrylglutamate in the presence of Mn2+, whereas recombinant GCP2 only hydrolyzed N-acetyl-aspartylglutamate and this, in a metal-independent manner. A comparison of the structures of the catalytic sites of GCP2 and GCP3, as well as mutagenesis experiments revealed that a single amino acid substitution (Asn-519 in GCP2, Ser-509 in GCP3) is largely responsible for GCP3 being able to hydrolyze beta-citrylglutamate. Based on the crystal structure of GCP3 and kinetic analysis, we propose that GCP3 forms a labile catalytic Zn-Ca cluster that is critical for its beta-citrylglutamate hydrolase activity.	[Collard, Francois; Vertommen, Didier; Constantinescu, Stefan; Van Schaftingen, Emile] Duve Inst, B-1200 Brussels, Belgium; [Collard, Francois; Vertommen, Didier; Constantinescu, Stefan; Van Schaftingen, Emile] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Buts, Lieven] Vrije Univ Brussel, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Buts, Lieven] VIB, B-1050 Brussels, Belgium	Universite Catholique Louvain; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Van Schaftingen, E (corresponding author), Duve Inst, Ave Hippocrate 75, B-1200 Brussels, Belgium.	emile.vanschaftingen@uclouvain.be	Constantinescu, Stefan N/E-5277-2012; Van+Schaftingen, Emile/AAF-5532-2020	Constantinescu, Stefan N./0000-0002-8599-2699; Van Schaftingen, Emile/0000-0002-6199-7647; Vertommen, Didier/0000-0001-7648-8282	Interuniversity Attraction Poles Program-Belgian Science Policy [P6/05, P6/28]; DIANE Center of Excellence program of the Region Wallonne; Fonds de la Recherche Scientifique Medicale; ASCO industries	Interuniversity Attraction Poles Program-Belgian Science Policy(Belgian Federal Science Policy Office); DIANE Center of Excellence program of the Region Wallonne; Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); ASCO industries	This work was supported by grants from the Interuniversity Attraction Poles Program-Belgian Science Policy (Networks P6/05 and P6/28), by the DIANE Center of Excellence program of the Region Wallonne, by the Fonds de la Recherche Scientifique Medicale, and by a grant from ASCO industries (to E. V. S.).	ASAKURA M, 1995, BBA-PROTEIN STRUCT M, V1250, P35, DOI 10.1016/0167-4838(95)00077-8; Barinka C, 2004, PROTEIN SCI, V13, P1627, DOI 10.1110/ps.04622104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carter RE, 1996, P NATL ACAD SCI USA, V93, P749, DOI 10.1073/pnas.93.2.749; Chopra M, 2009, J PHARMACOL EXP THER, V330, P212, DOI 10.1124/jpet.109.152553; Collard F, 2010, J BIOL CHEM, V285, P29826, DOI 10.1074/jbc.M110.152629; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Fricker AC, 2009, NEUROPHARMACOLOGY, V56, P1060, DOI 10.1016/j.neuropharm.2009.03.002; Halsted CH, 1998, J BIOL CHEM, V273, P20417, DOI 10.1074/jbc.273.32.20417; Hamada-Kanazawa M, 2010, BIOL PHARM BULL, V33, P729, DOI 10.1248/bpb.33.729; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Hlouchova K, 2007, J NEUROCHEM, V101, P682, DOI 10.1111/j.1471-4159.2006.04341.x; Hlouchova K, 2009, FEBS J, V276, P4448, DOI 10.1111/j.1742-4658.2009.07152.x; Hourvitz A, 2006, J ENDOCRINOL, V188, P531, DOI 10.1677/joe.1.06231; Maliekal P, 2007, J BIOL CHEM, V282, P31844, DOI 10.1074/jbc.M706818200; Mesters JR, 2006, EMBO J, V25, P1375, DOI 10.1038/sj.emboj.7600969; Michalke B, 2010, ANAL CHIM ACTA, V682, P23, DOI 10.1016/j.aca.2010.09.054; MIYAKE M, 1982, BIOCHIM BIOPHYS ACTA, V719, P495, DOI 10.1016/0304-4165(82)90238-0; MIYAKE M, 1978, BIOCHIM BIOPHYS ACTA, V544, P656, DOI 10.1016/0304-4165(78)90340-9; MIYAKE M, 1983, BIOCHIM BIOPHYS ACTA, V760, P206, DOI 10.1016/0304-4165(83)90165-4; MIYAKE M, 1981, J NEUROCHEM, V36, P804, DOI 10.1111/j.1471-4159.1981.tb01665.x; MIYAKE M, 1981, J NEUROCHEM, V37, P1064, DOI 10.1111/j.1471-4159.1981.tb04500.x; Narahara M, 2000, BIOL PHARM BULL, V23, P1287; Narahara M, 2010, BIOL PHARM BULL, V33, P1938, DOI 10.1248/bpb.33.1938; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; NEALE JH, 2011, J NEUROCHEM IN PRESS; Pangalos MN, 1999, J BIOL CHEM, V274, P8470, DOI 10.1074/jbc.274.13.8470; Pinto JT, 1996, CLIN CANCER RES, V2, P1445; ROBINSON MB, 1987, J BIOL CHEM, V262, P14498; Rzem R, 2004, P NATL ACAD SCI USA, V101, P16849, DOI 10.1073/pnas.0404840101; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tsukamoto T, 2007, DRUG DISCOV TODAY, V12, P767, DOI 10.1016/j.drudis.2007.07.010; Wiame E, 2010, BIOCHEM J, V425, P127, DOI 10.1042/BJ20091024; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	35	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38220	38230		10.1074/jbc.M111.287318	http://dx.doi.org/10.1074/jbc.M111.287318			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908619	hybrid, Green Published			2022-12-25	WOS:000296594200036
J	Rietdorf, K; Funnell, TM; Ruas, M; Heinemann, J; Parrington, J; Galione, A				Rietdorf, Katja; Funnell, Tim M.; Ruas, Margarida; Heinemann, Jennifer; Parrington, John; Galione, Antony			Two-pore Channels Form Homo- and Heterodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; ION CHANNELS; MOLECULAR DETERMINANTS; ACIDIC ORGANELLES; COMPLEX-FORMATION; CALCIUM-CHANNEL; CA2+ CHANNEL; NAADP; TRAFFICKING; AUTOPHAGY	Two-pore channels (TPCs) have been recently identified as NAADP-regulated Ca2+ release channels, which are localized on the endolysosomal system. TPCs have a 12-transmembrane domain (TMD) structure and are evolutionary intermediates between the 24-TMD alpha-subunits of Na+ or Ca2+ channels and the transient receptor potential channel superfamily, which have six TMDs in a single subunit and form tetramers with 24 TMDs as active channels. Based on this relationship, it is predicted that TPCs dimerize to form functional channels, but the dimerization of human TPCs has so far not been studied. Using co-immunoprecipitation studies and a mass spectroscopic analysis of the immunocomplex, we show the presence of homo-and heteromeric complexes for human TPC1 and TPC2. Despite their largely distinct localization, we identified a discrete number of endosomes that coexpressed TPC1 and TPC2. Homo-and heteromerization were confirmed by a FRET study, showing that both proteins interacted in a rotational (N- to C-terminal/head-to-tail) symmetry. This is the first report describing the presence of homomultimeric TPC1 channels and the first study showing that TPCs are capable of forming heteromers.	[Rietdorf, Katja; Funnell, Tim M.; Ruas, Margarida; Heinemann, Jennifer; Parrington, John; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford	Galione, A (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.	antony.galione@pharm.ox.ac.uk		Ruas, Margarida/0000-0002-4872-7618; Galione, Antony/0000-0002-4132-7646	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported by a Wellcome Trust project programme grant (to A. G. and J. P.).	Abel M, 2005, N-S ARCH PHARMACOL, V371, P295, DOI 10.1007/s00210-005-1021-2; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chang Q, 2004, J BIOL CHEM, V279, P54304, DOI 10.1074/jbc.M406222200; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Chung JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1153; Clapham DE, 2005, PHARMACOL REV, V57, P451, DOI 10.1124/pr.57.4.7; Curcio-Morelli C, 2010, J CELL PHYSIOL, V222, P328, DOI 10.1002/jcp.21956; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Galione A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004036; Galione A, 2010, BIOCHEM SOC T, V38, P1424, DOI 10.1042/BST0381424; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Grimm C, 2010, CHEM BIOL, V17, P135, DOI 10.1016/j.chembiol.2009.12.016; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hooper R, 2011, J BIOL CHEM, V286, P9141, DOI 10.1074/jbc.M110.189985; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; JOSEPH SK, 1995, J BIOL CHEM, V270, P23310, DOI 10.1074/jbc.270.40.23310; Karacsonyi C, 2007, TRAFFIC, V8, P1404, DOI 10.1111/j.1600-0854.2007.00619.x; Kim HJ, 2009, TRAFFIC, V10, P1157, DOI 10.1111/j.1600-0854.2009.00924.x; Lepage PK, 2007, BIOCHEM SOC T, V35, P81, DOI 10.1042/BST0350081; Luzio JP, 2007, BIOCHEM SOC T, V35, P1088, DOI 10.1042/BST0351088; Martina JA, 2009, TRAFFIC, V10, P1143, DOI 10.1111/j.1600-0854.2009.00935.x; MONKAWA T, 1995, J BIOL CHEM, V270, P14700, DOI 10.1074/jbc.270.24.14700; Murata K, 2001, BIOCHEM BIOPH RES CO, V282, P284, DOI 10.1006/bbrc.2001.4529; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Nucifora FC, 1996, MOL BIOL CELL, V7, P949, DOI 10.1091/mbc.7.6.949; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Pereira GJS, 2011, J BIOL CHEM, V286, P27875, DOI 10.1074/jbc.C110.216580; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Puertollano R, 2009, AM J PHYSIOL-RENAL, V296, pF1245, DOI 10.1152/ajprenal.90522.2008; Rosenbaum T, 2002, NEURON, V33, P703, DOI 10.1016/S0896-6273(02)00599-8; Rottach A, 2008, HYBRIDOMA, V27, P337, DOI 10.1089/hyb.2008.0031; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Schilling William P, 2004, Novartis Found Symp, V258, P18; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang MC, 2004, J BIOL CHEM, V279, P7159, DOI 10.1074/jbc.M308057200; Xu L, 2008, J BIOL CHEM, V283, P6321, DOI 10.1074/jbc.M707353200; Yamaguchi S, 2011, J BIOL CHEM, V286, P22934, DOI 10.1074/jbc.M110.210930; Zeevi DA, 2007, BBA-MOL BASIS DIS, V1772, P851, DOI 10.1016/j.bbadis.2007.01.004; Zeevi DA, 2010, J CELL SCI, V123, P3112, DOI 10.1242/jcs.067330; Zeevi DA, 2009, J PATHOL, V219, P153, DOI 10.1002/path.2587; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	54	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37058	37062		10.1074/jbc.C111.289835	http://dx.doi.org/10.1074/jbc.C111.289835			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21903581	hybrid, Green Published			2022-12-25	WOS:000296542400005
J	Ward, RJ; Pediani, JD; Milligan, G				Ward, Richard J.; Pediani, John D.; Milligan, Graeme			Heteromultimerization of Cannabinoid CB1 Receptor and Orexin OX1 Receptor Generates a Unique Complex in Which Both Protomers Are Regulated by Orexin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; TIME-RESOLVED FRET; ALLOSTERIC MODULATION; REVEALS OLIGOMERS; PHARMACOLOGY; HETEROMERS; INTERNALIZATION; ANTAGONIST; AGONIST; BINDING	Agonist-induced internalization was observed for both inducible and constitutively expressed forms of the cannabinoid CB1 receptor. These were also internalized by the peptide orexin A, which has no direct affinity for the cannabinoid CB1 receptor, but only when the orexin OX1 receptor was co-expressed along with the cannabinoid CB1 receptor. This effect of orexin A was concentration-dependent and blocked by OX1 receptor antagonists. Moreover, the ability of orexin A to internalize the CB1 receptor was also blocked by CB1 receptor antagonists. Remarkably, orexin A was substantially more potent in producing internalization of the CB1 receptor than in causing internalization of the bulk OX1 receptor population, and this was true in cells in which the CB1 receptor was maintained at a constant level, whereas levels of OX1 could be varied and vice versa. Both co-immunoprecipitation and cell surface, homogenous time-resolved fluorescence resonance energy transfer based on covalent labeling of N-terminal "SNAP" and "CLIP" tags present in the extracellular N-terminal domain of the receptors confirmed the capacity of these two receptors to heteromultimerize. These studies confirm the capacity of the CB1 and OX1 receptors to interact directly and demonstrate that this complex has unique regulatory characteristics. The higher potency of the agonist orexin A to regulate the CB1-OX1 heteromer compared with the OX1-OX1 homomer present in the same cells and the effects of CB1 receptor antagonists on the function of orexin A suggest an interplay between these two systems that may modulate appetite, feeding, and wakefulness.	[Ward, Richard J.; Pediani, John D.; Milligan, Graeme] Univ Glasgow, Mol Pharmacol Grp, Inst Neurosci & Psychol, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Milligan, G (corresponding author), Univ Glasgow, Mol Pharmacol Grp, Inst Neurosci & Psychol, Coll Med Vet & Life Sci, Wolfson Link Bldg 253, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk	Pediani, John/F-2708-2019; Milligan, Graeme/F-9426-2011	Pediani, John/0000-0001-6615-537X; Milligan, Graeme/0000-0002-6946-3519	Medical Research Council [G0900050]; MRC [G0900050] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0900050.	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Alvarez-Curto E, 2010, J BIOL CHEM, V285, P23316, DOI 10.1074/jbc.M110.122184; Bennett KA, 2009, MOL PHARMACOL, V76, P802, DOI 10.1124/mol.109.056101; Birdsall NJM, 2010, TRENDS PHARMACOL SCI, V31, P499, DOI 10.1016/j.tips.2010.08.003; Borroto-Escuela DO, 2011, J MOL BIOL, V406, P687, DOI 10.1016/j.jmb.2011.01.022; Canals M, 2008, J BIOL CHEM, V283, P11424, DOI 10.1074/jbc.M710300200; Casado V, 2009, PHARMACOL THERAPEUT, V124, P248, DOI 10.1016/j.pharmthera.2009.07.005; Christopoulou FD, 2011, J CLIN PHARM THER, V36, P10, DOI 10.1111/j.1365-2710.2010.01164.x; Coleman PJ, 2011, CURR TOP MED CHEM, V11, P696; Comps-Agrar L, 2011, EMBO J, V30, P2336, DOI 10.1038/emboj.2011.143; Dalrymple MB, 2008, PHARMACOL THERAPEUT, V118, P359, DOI 10.1016/j.pharmthera.2008.03.004; Ecke D, 2008, BIOCHEM J, V409, P107, DOI 10.1042/BJ20070671; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Ferre S, 2010, PROG MOL BIOL TRANSL, V91, P41, DOI 10.1016/S1877-1173(10)91002-8; Filizola M, 2010, LIFE SCI, V86, P590, DOI 10.1016/j.lfs.2009.05.004; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Gomes I, 2011, MOL PHARMACOL, V79, P1044, DOI 10.1124/mol.110.070847; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; He SQ, 2011, NEURON, V69, P120, DOI 10.1016/j.neuron.2010.12.001; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Hilairet S, 2003, J BIOL CHEM, V278, P23731, DOI 10.1074/jbc.M212369200; Hojo M, 2008, J PHARMACOL SCI, V108, P308, DOI 10.1254/jphs.08244FP; Hudson BD, 2010, BRIT J PHARMACOL, V160, P627, DOI 10.1111/j.1476-5381.2010.00681.x; Hudson BD, 2010, MOL PHARMACOL, V77, P1, DOI 10.1124/mol.109.060251; Klco JM, 2003, J BIOL CHEM, V278, P35345, DOI 10.1074/jbc.M305606200; Laburthe M., 2011, BR J PHARM IN PRESS; Langmead CJ, 2004, BRIT J PHARMACOL, V141, P340, DOI 10.1038/sj.bjp.0705610; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Marcellino D, 2008, NEUROPHARMACOLOGY, V54, P815, DOI 10.1016/j.neuropharm.2007.12.011; Martini L, 2007, FASEB J, V21, P802, DOI 10.1096/fj.06-7132com; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Milan-Lobo L, 2011, J PHARMACOL EXP THER, V337, P868, DOI 10.1124/jpet.111.179093; Milligan G, 2008, BRIT J PHARMACOL, V153, pS216, DOI 10.1038/sj.bjp.0707490; Milligan G, 2007, ERNST SCHERING FOUND, V2, P145, DOI 10.1007/2789_2006_007; Milligan G, 2007, TRENDS PHARMACOL SCI, V28, P615, DOI 10.1016/j.tips.2007.11.001; Milligan G, 2006, DRUG DISCOV TODAY, V11, P541, DOI 10.1016/j.drudis.2006.04.007; Milligan G, 2010, CURR OPIN PHARMACOL, V10, P23, DOI 10.1016/j.coph.2009.09.010; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Monnier C, 2011, EMBO J, V30, P32, DOI 10.1038/emboj.2010.270; Panetta R, 2008, DRUG DISCOV TODAY, V13, P1059, DOI 10.1016/j.drudis.2008.09.002; Pei L, 2010, NAT MED, V16, P1393, DOI 10.1038/nm.2263; Pin JP, 2009, J PHYSIOL-LONDON, V587, P5337, DOI 10.1113/jphysiol.2009.179978; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Pisterzi LF, 2010, J BIOL CHEM, V285, P16723, DOI 10.1074/jbc.M109.069443; Przybyla JA, 2010, J PHARMACOL EXP THER, V332, P710, DOI 10.1124/jpet.109.162701; Raicu V, 2009, NAT PHOTONICS, V3, P107, DOI 10.1038/NPHOTON.2008.291; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Rios C, 2006, BRIT J PHARMACOL, V148, P387, DOI 10.1038/sj.bjp.0706757; Rovira X, 2009, BRIT J PHARMACOL, V156, P28, DOI 10.1111/j.1476-5381.2008.00031.x; Rovira X, 2010, TRENDS PHARMACOL SCI, V31, P15, DOI 10.1016/j.tips.2009.10.008; Rozenfeld R, 2011, EMBO J, V30, P2350, DOI 10.1038/emboj.2011.139; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; Scammell TE, 2011, ANNU REV PHARMACOL, V51, P243, DOI 10.1146/annurev-pharmtox-010510-100528; Schroder H, 2009, NEUROPHARMACOLOGY, V56, P768, DOI 10.1016/j.neuropharm.2008.12.010; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Smith NJ, 2009, J BIOL CHEM, V284, P17527, DOI 10.1074/jbc.M109.012849; Soriano A, 2009, J MED CHEM, V52, P5590, DOI 10.1021/jm900298c; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; van Rijn RM, 2010, CURR OPIN PHARMACOL, V10, P73, DOI 10.1016/j.coph.2009.09.007; Voisin T, 2011, CANCER RES, V71, P3341, DOI 10.1158/0008-5472.CAN-10-3473; Ward RJ, 2011, BRIT J PHARMACOL, V162, P1439, DOI 10.1111/j.1476-5381.2010.01156.x; Wu YK, 2011, CURR TOP MED CHEM, V11, P1421, DOI 10.2174/156802611795860997; Xu TR, 2011, BIOCHEM J, V439, P171, DOI 10.1042/BJ20110230; Yu XH, 2010, PAIN, V151, P337, DOI 10.1016/j.pain.2010.07.019	67	65	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37414	37428		10.1074/jbc.M111.287649	http://dx.doi.org/10.1074/jbc.M111.287649			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21908614	Green Published, hybrid			2022-12-25	WOS:000296542400042
J	Wilson, EB; El-Jawhari, JJ; Neilson, AL; Hall, GD; Melcher, AA; Meade, JL; Cook, GP				Wilson, Erica B.; El-Jawhari, Jehan J.; Neilson, Abbie L.; Hall, Geoffrey D.; Melcher, Alan A.; Meade, Josephine L.; Cook, Graham P.			Human Tumour Immune Evasion via TGF-beta Blocks NK Cell Activation but Not Survival Allowing Therapeutic Restoration of Anti-Tumour Activity	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; REGULATORY T-CELLS; IN-VIVO; OVARIAN-CANCER; IFN-GAMMA; EXPRESSION; GROWTH; NKG2D; CYTOTOXICITY; DEFICIENT	Immune evasion is now recognized as a key feature of cancer progression. In animal models, the activity of cytotoxic lymphocytes is suppressed in the tumour microenvironment by the immunosuppressive cytokine, Transforming Growth Factor (TGF)-beta. Release from (TGF)-beta-mediated inhibition restores anti-tumour immunity, suggesting a therapeutic strategy for human cancer. We demonstrate that human natural killer (NK) cells are inhibited in a (TGF)-beta dependent manner following chronic contact-dependent interactions with tumour cells in vitro. In vivo, NK cell inhibition was localised to the human tumour microenvironment and primary ovarian tumours conferred (TGF)-beta dependent inhibition upon autologous NK cells ex vivo. (TGF)-beta antagonized the interleukin (IL)-15 induced proliferation and gene expression associated with NK cell activation, inhibiting the expression of both NK cell activation receptor molecules and components of the cytotoxic apparatus. Interleukin-15 also promotes NK cell survival and IL-15 excluded the pro-apoptotic transcription factor FOXO3 from the nucleus. However, this IL-15 mediated pathway was unaffected by (TGF)-beta treatment, allowing NK cell survival. This suggested that NK cells in the tumour microenvironment might have their activity restored by (TGF)-beta blockade and both anti-(TGF)-beta antibodies and a small molecule inhibitor of (TGF)-beta signalling restored the effector function of NK cells inhibited by autologous tumour cells. Thus, (TGF)-beta blunts NK cell activation within the human tumour microenvironment but this evasion mechanism can be therapeutically targeted, boosting anti-tumour immunity.	[Wilson, Erica B.; El-Jawhari, Jehan J.; Neilson, Abbie L.; Hall, Geoffrey D.; Melcher, Alan A.; Meade, Josephine L.; Cook, Graham P.] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Wellcome Brenner Bldg, Leeds, W Yorkshire, England	Saint James's University Hospital; University of Leeds	Wilson, EB (corresponding author), Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Wellcome Brenner Bldg, Leeds, W Yorkshire, England.	g.p.cook@leeds.ac.uk	Hall, Geoff D/A-1717-2010; El-Jawhari, Jehan/C-6880-2017	Hall, Geoff D/0000-0002-8864-5932; El-Jawhari, Jehan/0000-0002-0580-4492; Cook, Graham/0000-0003-0223-3652	Yorkshire Cancer Research via a Project Award; Researcher Award; Cancer Research UK; Egyptian Government; Leeds Institute of Molecular Medicine	Yorkshire Cancer Research via a Project Award; Researcher Award; Cancer Research UK(Cancer Research UK); Egyptian Government; Leeds Institute of Molecular Medicine	This work was supported by Yorkshire Cancer Research via a Project Award (to GPC) and a Researcher Award (to JLM) and by Cancer Research UK. JJE-J was supported by an Egyptian Government Scholarship and ALN by a studentship from the Leeds Institute of Molecular Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carlsten M, 2007, CANCER RES, V67, P1317, DOI 10.1158/0008-5472.CAN-06-2264; Carlsten M, 2009, J IMMUNOL, V183, P4921, DOI 10.4049/jimmunol.0901226; Castriconi R, 2003, P NATL ACAD SCI USA, V100, P4120, DOI 10.1073/pnas.0730640100; Cooper MA, 2002, BLOOD, V100, P3633, DOI 10.1182/blood-2001-12-0293; Crane CA, 2010, NEURO-ONCOLOGY, V12, P7, DOI 10.1093/neuonc/nop009; Della Chiesa M, 2006, BLOOD, V108, P4118, DOI 10.1182/blood-2006-06-006700; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; Drake CG, 2006, ADV IMMUNOL, V90, P51, DOI 10.1016/S0065-2776(06)90002-9; Esendagli G, 2008, LUNG CANCER, V59, P32, DOI 10.1016/j.lungcan.2007.07.022; Fauriat C, 2007, BLOOD, V109, P323, DOI 10.1182/blood-2005-08-027979; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Friese MA, 2004, CANCER RES, V64, P7596, DOI 10.1158/0008-5472.CAN-04-1627; Gallimore AM, 2008, ONCOGENE, V27, P5886, DOI 10.1038/onc.2008.269; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Halfteck GG, 2009, J IMMUNOL, V182, P2221, DOI 10.4049/jimmunol.0801878; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holmes TD, 2011, J IMMUNOL, V186, P1538, DOI 10.4049/jimmunol.1000951; Huntington ND, 2007, NAT IMMUNOL, V8, P856, DOI 10.1038/ni1487; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; JIN B, 1989, IMMUNOLOGY, V66, P570; Konner JA, 2010, CLIN CANCER RES, V16, P5288, DOI 10.1158/1078-0432.CCR-10-0700; Krockenberger M, 2008, J IMMUNOL, V180, P7338, DOI 10.4049/jimmunol.180.11.7338; Le Maux Chansac B, 2005, J IMMUNOL, V175, P5790, DOI 10.4049/jimmunol.175.9.5790; Lee JC, 2004, J IMMUNOL, V172, P7335, DOI 10.4049/jimmunol.172.12.7335; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Liu B, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-7; Meade JL, 2009, J IMMUNOL, V183, P803, DOI 10.4049/jimmunol.0713829; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Prlic M, 2003, J EXP MED, V197, P967, DOI 10.1084/jem.20021847; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Robson NC, 2009, BLOOD, V113, P3218, DOI 10.1182/blood-2008-07-166926; Sanjabi S, 2009, IMMUNITY, V31, P131, DOI 10.1016/j.immuni.2009.04.020; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Trotta R, 2008, J IMMUNOL, V181, P3784, DOI 10.4049/jimmunol.181.6.3784; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Wilkinson GWG, 2008, J CLIN VIROL, V41, P206, DOI 10.1016/j.jcv.2007.10.027; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	50	106	109	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e22842	10.1371/journal.pone.0022842	http://dx.doi.org/10.1371/journal.pone.0022842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21909397	gold, Green Published, Green Submitted			2022-12-25	WOS:000294689200001
J	Haile, S; Lal, A; Myung, JK; Sadar, MD				Haile, Simon; Lal, Aaron; Myung, Jae-Kyung; Sadar, Marianne D.			FUS/TLS Is a Co-Activator of Androgen Receptor in Prostate Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEINS; TLS; IDENTIFICATION; TRANSCRIPTION; LIPOSARCOMA; INDUCTION; ACTIVATOR; HORMONE; BINDING	Androgen receptor (AR) is a member of the nuclear receptor family of transcription factors. Upon binding to androgens, AR becomes transcriptionally active to regulate the expression of target genes that harbor androgen response elements (AREs) in their promoters and/or enhancers. AR is essential for the growth and survival of prostate cancer cells and is therefore a target for current and next-generation therapeutic modalities against prostate cancer. Pathophysiologically relevant protein-protein interaction networks involving AR are, however, poorly understood. In this study, we identified the protein FUsed/Translocated in LipoSarcoma (FUS/TLS) as an AR-interacting protein by co-immunoprecipitation of endogenous proteins in LNCaP human prostate cancer cells. The hormonal response of FUS expression in LNCaP cells was shown to resemble that of other AR co-activators. FUS displayed a strong intrinsic transactivation capacity in prostate cancer cells when tethered to basal promoters using the GAL4 system. Chromatin immunoprecipitation experiments showed that FUS was recruited to ARE III of the enhancer region of the PSA gene. Data from ectopic overexpression and "knock-down" approaches demonstrated that AR transcriptional activity was enhanced by FUS. Depletion of FUS reduced androgen-dependent proliferation of LNCaP cells. Thus, FUS is a novel co-activator of AR in prostate cancer cells.	[Haile, Simon; Lal, Aaron; Myung, Jae-Kyung; Sadar, Marianne D.] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada	British Columbia Cancer Agency	Haile, S (corresponding author), BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada.	msadar@bcgsc.ca	Sadar, Marianne/E-9136-2012	Sadar, Marianne/0000-0003-0599-9215	Canadian Institutes of Health Research [MOP-79308]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research grant MOP-79308. www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RJ, CANC CELL, V17, P535; BRINKMANN AO, 1989, UROL RES, V17, P87, DOI 10.1007/BF00262026; BROOKE GN, CANC RES; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cleutjens KBJM, 1996, J BIOL CHEM, V271, P6379, DOI 10.1074/jbc.271.11.6379; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Heemers HV, 2010, PROSTATE, V70, P959, DOI 10.1002/pros.21130; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015; Molina A, 2011, J UROLOGY, V185, P787, DOI 10.1016/j.juro.2010.10.042; Perani M, 2005, J BIOL CHEM, V280, P42863, DOI 10.1074/jbc.M502963200; Powers CA, 1998, MOL ENDOCRINOL, V12, P4, DOI 10.1210/mend.12.1.0043; Romanuik TL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-476; Rossow KL, 2001, CANCER RES, V61, P2690; Sadar MD, 2011, CANCER RES, V71, P1208, DOI 10.1158/0008-5472.CAN_10-3398; Sadar MD, 1999, J BIOL CHEM, V274, P7777, DOI 10.1074/jbc.274.12.7777; Schauwaers K, 2007, P NATL ACAD SCI USA, V104, P4961, DOI 10.1073/pnas.0610814104; Schuur ER, 1996, J BIOL CHEM, V271, P7043, DOI 10.1074/jbc.271.12.7043; Snoek R, 1996, J STEROID BIOCHEM, V59, P243, DOI 10.1016/S0960-0760(96)00116-1; Tan AY, 2009, J MOL CELL BIOL, V1, P82, DOI 10.1093/jmcb/mjp025; Uranishi H, 2001, J BIOL CHEM, V276, P13395, DOI 10.1074/jbc.M011176200; Urbanucci A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-219; Wang G, 2006, J CELL BIOCHEM, V98, P36, DOI 10.1002/jcb.20802; Wang G, 2006, ONCOGENE; Wang G, 2008, CANCER RES, V68, P9918, DOI 10.1158/0008-5472.CAN-08-1718; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e	29	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24197	10.1371/journal.pone.0024197	http://dx.doi.org/10.1371/journal.pone.0024197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909421	Green Submitted, gold, Green Published			2022-12-25	WOS:000294683900037
J	Faratian, D; Sims, AH; Mullen, P; Kay, C; Um, I; Langdon, SP; Harrison, DJ				Faratian, Dana; Sims, Andrew H.; Mullen, Peter; Kay, Charlene; Um, Inhwa; Langdon, Simon P.; Harrison, David J.			Sprouty 2 Is an Independent Prognostic Factor in Breast Cancer and May Be Useful in Stratifying Patients for Trastuzumab Therapy	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; ADJUVANT CHEMOTHERAPY; TISSUE MICROARRAYS; HISTOLOGIC GRADE; PROSTATE-CANCER; RESISTANCE; SUPPRESSOR; PROTEINS; RECEPTOR; PATHWAY	Background: Resistance to trastuzumab is a clinical problem, partly due to overriding activation of MAPK/PI3K signalling. Sprouty-family proteins are negative regulators of MAPK/PI3K signalling, but their role in HER2-therapy resistance is unknown. Patients and Methods: Associations between Sprouty gene expression and clinicopathological features were investigated in a breast cancer microarray meta-analysis. Changes in expression of Spry2 and feedback inhibition on trastuzumab resistance were studied in SKBr3 and BT474 breast carcinoma cell lines using cell viability assays. Spry2 protein expression was measured by quantitative immunofluorescence in a cohort of 122 patients treated with trastuzumab. Results: Low gene expression of Spry2 was associated with increased pathological grade, high HER2 expression, and was a significant independent prognostic factor. Overexpression of Spry2 in SKBr3s resulted in enhanced inhibition of cell viability after trastuzumab treatment, and the PI3K-inhibitor LY294002 had a similar effect. Low Spry2 expression was associated with increased risk of death (HR = 2.28, 95% CI 1.22-4.26; p = 0.008) in trastuzumab-treated patients, including in multivariate analysis. Stratification of trastuzumab-treated patients using PTEN and Spry2 was superior to either marker in isolation. Conclusion: In breast cancers with deficient feedback inhibition, combinatorial therapy with negative regulators of growth factor signalling may be an effective therapeutic strategy.	[Faratian, Dana] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Breakthrough Res Unit, Edinburgh, Midlothian, Scotland; Univ Edinburgh, Inst Genet & Mol Med, Div Pathol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Faratian, D (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Breakthrough Res Unit, Edinburgh, Midlothian, Scotland.	d.faratian@ed.ac.uk	Sims, Andrew/E-4819-2012	Sims, Andrew/0000-0001-9082-3665; harrison, david/0000-0001-9041-9988	Pathological Society; Cancer Research United Kingdom [C20693/A8253]; Cancer Research United Kingdom Experimental Cancer Medicine Centre; Breakthrough Breast Cancer	Pathological Society; Cancer Research United Kingdom(Cancer Research UK); Cancer Research United Kingdom Experimental Cancer Medicine Centre; Breakthrough Breast Cancer	The work was partially funded by grants from the Pathological Society (www.pathsoc.org), Cancer Research United Kingdom through a Clinical Bursary (to DF, C20693/A8253, www.cancerresearchuk.org), the Cancer Research United Kingdom Experimental Cancer Medicine Centre (http://www.cancerresearchuk.org/), and Breakthrough Breast Cancer (http://breakthrough.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Chen DT, 2010, BREAST CANCER RES TR, V119, P335, DOI 10.1007/s10549-009-0344-y; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Desmedt C, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-40; Edwin F, 2006, J BIOL CHEM, V281, P4816, DOI 10.1074/jbc.M508300200; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Faratian D, 2009, CANCER RES, V69, P6713, DOI 10.1158/0008-5472.CAN-09-0777; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Fritzsche S, 2006, ENDOCR-RELAT CANCER, V13, P839, DOI 10.1677/erc.1.01190; Giltnane JM, 2008, ARCH PATHOL LAB MED, V132, P1635, DOI 10.1043/1543-2165(2008)132[1635:COQIWC]2.0.CO;2; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Leeksma OC, 2002, EUR J BIOCHEM, V269, P2546, DOI 10.1046/j.1432-1033.2002.02921.x; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; McKie AB, 2005, ONCOGENE, V24, P2166, DOI 10.1038/sj.onc.1208371; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Sims AH, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-42; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Valabrega G, 2007, ANN ONCOL, V18, P977, DOI 10.1093/annonc/mdl475; Wang JH, 2006, PROSTATE, V66, P613, DOI 10.1002/pros.20353; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200	38	36	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23772	10.1371/journal.pone.0023772	http://dx.doi.org/10.1371/journal.pone.0023772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909357	Green Published, Green Submitted, gold			2022-12-25	WOS:000294680800020
J	Huang, PS; Ban, YEA; Richter, F; Andre, I; Vernon, R; Schief, WR; Baker, D				Huang, Po-Ssu; Ban, Yih-En Andrew; Richter, Florian; Andre, Ingemar; Vernon, Robert; Schief, William R.; Baker, David			RosettaRemodel: A Generalized Framework for Flexible Backbone Protein Design	PLOS ONE			English	Article							COMPUTATIONAL DESIGN; STRUCTURE PREDICTION; BINDING; SPECIFICITY; STABILITY	We describe RosettaRemodel, a generalized framework for flexible protein design that provides a versatile and convenient interface to the Rosetta modeling suite. RosettaRemodel employs a unified interface, called a blueprint, which allows detailed control over many aspects of flexible backbone protein design calculations. RosettaRemodel allows the construction and elaboration of customized protocols for a wide range of design problems ranging from loop insertion and deletion, disulfide engineering, domain assembly, loop remodeling, motif grafting, symmetrical units, to de novo structure modeling.	[Huang, Po-Ssu; Ban, Yih-En Andrew; Richter, Florian; Schief, William R.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Richter, Florian] Univ Washington, Interdisciplinary Program Biomol Struct & Design, Seattle, WA 98195 USA; [Andre, Ingemar] Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden; [Vernon, Robert] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Lund University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Huang, PS (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	schief@scripps.edu; dabaker@uw.edu	André, Ingemar/O-4777-2014; Schief, William/ABF-3645-2020; Baker, David/K-8941-2012	André, Ingemar/0000-0002-4753-8233; Schief, William/0000-0002-1120-0150; Baker, David/0000-0001-7896-6217; Huang, Possu/0000-0002-7948-2895	International AIDS Vaccine Initiative Neutralizing Antibody Consortium; Howard Hughes Medical Institute; Bill and Melinda Gates Foundation; International AIDS Vaccine Initiative	International AIDS Vaccine Initiative Neutralizing Antibody Consortium; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); International AIDS Vaccine Initiative	Funding was provided by International AIDS Vaccine Initiative Neutralizing Antibody Consortium (www.iavi.org) and the Howard Hughes Medical Institute (www.hhmi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Rosetta development community for contributing to the software foundation and scientific models. We thank Anna Tonkonogui for comments on the manuscript. We thank the Baker lab and Schief lab members and other collaborators that provided suggestions and modeling challenges to improve our methods. We thank the Bill and Melinda Gates Foundation, the International AIDS Vaccine Initiative, and the Howard Hughes Medical Institute for funding.	Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Ashworth J, 2010, NUCLEIC ACIDS RES, V38, P5601, DOI 10.1093/nar/gkq283; Calhoun JR, 2003, J MOL BIOL, V334, P1101, DOI 10.1016/j.jmb.2003.10.004; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Cochran FV, 2005, J AM CHEM SOC, V127, P1346, DOI 10.1021/ja044129a; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Correia BE, 2011, PROTEIN SCI IN PRESS; Correia BE, 2011, J MOL BIOL, V405, P284, DOI 10.1016/j.jmb.2010.09.061; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Goreshnik I, 2010, J AM CHEM SOC, V132, P938, DOI 10.1021/ja907886v; Grigoryan G, 2011, SCIENCE, V332, P1071, DOI 10.1126/science.1198841; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Guntas G, 2009, J BIOMOL STRUCT DYN, V26, P854; Havranek JJ, 2009, PROTEIN SCI, V18, P1293, DOI 10.1002/pro.142; Hu XZ, 2007, P NATL ACAD SCI USA, V104, P17668, DOI 10.1073/pnas.0707977104; Huang PS, 2007, PROTEIN SCI, V16, P2770, DOI 10.1110/ps.073125207; Jha RK, 2010, J MOL BIOL, V400, P257, DOI 10.1016/j.jmb.2010.05.006; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Micklatcher C, 1999, CURR OPIN CHEM BIOL, V3, P724, DOI 10.1016/S1367-5931(99)00031-9; Murphy PM, 2009, P NATL ACAD SCI USA, V106, P9215, DOI 10.1073/pnas.0811070106; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; Robbins A, 2008, LEARNING VI VIM EDIT; Rohl CA, 2004, PROTEINS, V55, P656, DOI 10.1002/prot.10629; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Sammond DW, 2011, J AM CHEM SOC, V133, P4190, DOI 10.1021/ja110296z; Shah PS, 2007, J MOL BIOL, V372, P1, DOI 10.1016/j.jmb.2007.06.032; Shukla UJ, 2004, J AM CHEM SOC, V126, P13914, DOI 10.1021/ja0456858; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Slovic AM, 2004, P NATL ACAD SCI USA, V101, P1828, DOI 10.1073/pnas.0306417101; Smagghe BJ, 2010, J BIOL CHEM, V285, P32954, DOI 10.1074/jbc.M110.145177; Swift J, 2006, J AM CHEM SOC, V128, P6611, DOI 10.1021/ja057069x; Thyme SB, 2009, NATURE, V461, P1300, DOI 10.1038/nature08508; Treynor TP, 2007, P NATL ACAD SCI USA, V104, P48, DOI 10.1073/pnas.0609647103; Van Montfort T, 2011, J BIOL CHEM, V286, P22250, DOI 10.1074/jbc.M111.229625; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wollacott AM, 2007, PROTEIN SCI, V16, P165, DOI 10.1110/ps.062270707; Yosef E, 2009, J MOL BIOL, V385, P1470, DOI 10.1016/j.jmb.2008.09.053	45	197	202	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24109	10.1371/journal.pone.0024109	http://dx.doi.org/10.1371/journal.pone.0024109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909381	Green Submitted, Green Published, gold			2022-12-25	WOS:000294680800055
J	Mao, DB; Lu, SQ; Li, N; Zhang, Y; Long, M				Mao, Debin; Lu, Shouqin; Li, Ning; Zhang, Yan; Long, Mian			Conformational Stability Analyses of Alpha Subunit I Domain of LFA-1 and Mac-1	PLOS ONE			English	Article							A-DOMAIN; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; INTEGRIN ACTIVATION; CRYSTAL-STRUCTURE; CELL-ADHESION; T-CELL; NEUTROPHILS; AFFINITY; MIGRATION	beta(2) integrin of lymphocyte function-associated antigen-1 (LFA-1) or macrophage-1 antigen (Mac-1) binds to their common ligand of intercellular adhesion molecule-1 (ICAM-1) and mediates leukocyte-endothelial cell (EC) adhesions in inflammation cascade. Although the two integrins are known to have distinct functions, the corresponding micro-structural bases remain unclear. Here (steered-)molecular dynamics simulations were employed to elucidate the conformational stability of a subunit I domains of LFA-1 and Mac-1 in different affinity states and relevant I domain-ICAM-1 interaction features. Compared with low affinity (LA) Mac-1, the LA LFA-1 I domain was unstable in the presence or absence of ICAM-1 ligand, stemming from diverse orientations of its alpha(7)-helix with different motifs of zipper-like hydrophobic junction between alpha(1)- and alpha(7)-helices. Meanwhile, spontaneous transition of LFA-1 I domain from LA state to intermediate affinity (IA) state was first visualized. All the LA, IA, and high affinity (HA) states of LFA-1 I domain and HA Mac-1 I domain were able to bind to ICAM-1 ligand effectively, while LA Mac-1 I domain was unfavorable for binding ligand presumably due to the specific orientation of S144 side-chain that capped the MIDAS ion. These results furthered our understanding in correlating the structural bases with their functions of LFA-1 and Mac-1 integrins from the viewpoint of I domain conformational stability and of the characteristics of I domain-ICAM-1 interactions.	[Mao, Debin; Lu, Shouqin; Li, Ning; Zhang, Yan; Long, Mian] Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Beijing 100080, Peoples R China; [Mao, Debin; Lu, Shouqin; Li, Ning; Zhang, Yan; Long, Mian] Chinese Acad Sci, Inst Mech, Natl Micrograv Lab, Beijing 100080, Peoples R China; [Mao, Debin; Lu, Shouqin; Li, Ning; Zhang, Yan; Long, Mian] Chinese Acad Sci, Inst Mech, Ctr Biomech & Bioengn, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Mechanics, CAS	Mao, DB (corresponding author), Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Beijing 100080, Peoples R China.	lsq@imech.ac.cn; mlong@imech.ac.cn			National Natural Science Foundation of China [30730032, 11072251]; National Key Basic Research Foundation of China [2011CB710904]; CAS [KJCX2-YW-L08]; Scientific Research Equipment Project [Y2010030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China); CAS(Chinese Academy of Sciences); Scientific Research Equipment Project	This work was supported by National Natural Science Foundation of China grants 30730032 and 11072251 (www.nsfc.gov.cn), National Key Basic Research Foundation of China grant 2011CB710904 (www.most.gov.cn), and CAS Knowledge Innovation Program grant KJCX2-YW-L08 and Scientific Research Equipment Project of grant Y2010030 (http://english.cas.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Chen W, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001086; Chen W, 2010, J BIOL CHEM, V285, P35967, DOI 10.1074/jbc.M110.155770; Chen XH, 2007, P NATL ACAD SCI USA, V104, P15358, DOI 10.1073/pnas.0707406104; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; Gahmberg CG, 1997, CURR OPIN CELL BIOL, V9, P643, DOI 10.1016/S0955-0674(97)80117-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jin M, 2004, STRUCTURE, V12, P2137, DOI 10.1016/j.str.2004.10.005; Kuwano Y, 2010, BLOOD, V116, P617, DOI 10.1182/blood-2010-01-266122; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Lomakina EB, 2010, CELL MOL BIOENG, V3, P106, DOI 10.1007/s12195-009-0099-x; Lue Shouqin, 2005, Molecular & Cellular Biomechanics, V2, P161; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Park EJ, 2010, BLOOD, V115, P1572, DOI 10.1182/blood-2009-08-237917; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Phillipson M, 2009, J IMMUNOL, V182, P6870, DOI 10.4049/jimmunol.0803414; Puklin-Faucher E, 2006, J CELL BIOL, V175, P349, DOI 10.1083/jcb.200602071; Puklin-Faucher E, 2009, J BIOL CHEM, V284, P36557, DOI 10.1074/jbc.M109.041194; Qu AD, 1996, STRUCTURE, V4, P931, DOI 10.1016/S0969-2126(96)00100-1; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Rocco M, 2008, STRUCTURE, V16, P954, DOI 10.1016/j.str.2008.02.019; Shimaoka M, 2002, P NATL ACAD SCI USA, V99, P16737, DOI 10.1073/pnas.252633099; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Sumagin R, 2010, J IMMUNOL, V185, P7057, DOI 10.4049/jimmunol.1001638; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Yang YT, 2004, MOL CELL, V14, P269, DOI 10.1016/S1097-2765(04)00204-7; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200; Zhang HM, 2008, MOL CELL, V31, P432, DOI 10.1016/j.molcel.2008.06.022; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	45	17	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24188	10.1371/journal.pone.0024188	http://dx.doi.org/10.1371/journal.pone.0024188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909384	Green Submitted, Green Published, gold			2022-12-25	WOS:000294680800064
J	Naka, I; Nishida, N; Ohashi, J				Naka, Izumi; Nishida, Nao; Ohashi, Jun			No Evidence for Strong Recent Positive Selection Favoring the 7 Repeat Allele of VNTR in the DRD4 Gene	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; DOPAMINE-D4 RECEPTOR VARIANTS; NOVELTY SEEKING; LINKAGE DISEQUILIBRIUM; DEFICIT/HYPERACTIVITY DISORDER; NATURAL-SELECTION; 7-REPEAT ALLELE; HUMAN GENOME; D4 GENE; ASSOCIATION	The human dopamine receptor D4 (DRD4) gene contains a 48-bp variable number of tandem repeat (VNTR) in exon 3, encoding the third intracellular loop of this dopamine receptor. The DRD4 7R allele, which seems to have a single origin, is commonly observed in various human populations and the nucleotide diversity of the DRD4 7R haplotype at the DRD4 locus is reduced compared to the most common DRD4 4R haplotype. Based on these observations, previous studies have hypothesized that positive selection has acted on the DRD4 7R allele. However, the degrees of linkage disequilibrium (LD) of the DRD4 7R allele with single nucleotide polymorphisms (SNPs) outside the DRD4 locus have not been evaluated. In this study, to re-examine the possibility of recent positive selection favoring the DRD4 7R allele, we genotyped HapMap subjects for DRD4 VNTR, and conducted several neutrality tests including long range haplotype test and iHS test based on the extended haplotype homozygosity. Our results indicated that LD of the DRD4 7R allele was not extended compared to SNP alleles with the similar frequency. Thus, we conclude that the DRD4 7R allele has not been subjected to strong recent positive selection.	[Naka, Izumi; Ohashi, Jun] Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Biomed Sci, Ibaraki, Japan; [Nishida, Nao] Univ Tokyo, Grad Sch Med, Dept Human Genet, Bunkyo Ku, Tokyo, Japan; [Nishida, Nao] Japan Konodai Hosp, Int Med Ctr, Res Ctr Hepatitis & Immunol, Chiba, Japan	University of Tsukuba; University of Tokyo	Naka, I (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Biomed Sci, Ibaraki, Japan.	juno-tky@umin.ac.jp	NAKA, IZUMI/G-5495-2015; OHASHI, JUN/G-5907-2015		Ministry of Education, Culture, Sports, Science, and Technology of Japan [22370084]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a KAKENHI (22370084) Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benjamin J, 1996, NAT GENET, V12, P81, DOI 10.1038/ng0196-81; Castellanos FX, 1998, MOL PSYCHIATR, V3, P431, DOI 10.1038/sj.mp.4000430; Chang FM, 1996, HUM GENET, V98, P91, DOI 10.1007/s004390050166; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faraone SV, 2001, AM J PSYCHIAT, V158, P1052, DOI 10.1176/appi.ajp.158.7.1052; Gelernter J, 1997, AM J HUM GENET, V61, P1144, DOI 10.1086/301595; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hattori E, 2009, EUR J HUM GENET, V17, P793, DOI 10.1038/ejhg.2008.247; Kotler M, 2000, AM J MED GENET, V96, P278, DOI 10.1002/1096-8628(20000612)96:3<278::AID-AJMG8>3.0.CO;2-R; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; LIVAK KJ, 1995, P NATL ACAD SCI USA, V92, P427, DOI 10.1073/pnas.92.2.427; Malhotra AK, 1996, MOL PSYCHIATR, V1, P388; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; Ohashi J, 2011, MOL BIOL EVOL, V28, P849, DOI 10.1093/molbev/msq264; Qian Q, 2004, AM J MED GENET B, V128B, P84, DOI 10.1002/ajmg.b.30079; Sabeti PC, 2005, PLOS BIOL, V3, P1963, DOI 10.1371/journal.pbio.0030378; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Saunders MA, 2005, GENETICS, V171, P1219, DOI 10.1534/genetics.105.048140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schoots O, 2003, PHARMACOGENOMICS J, V3, P343, DOI 10.1038/sj.tpj.6500208; Spencer CCA, 2004, BIOINFORMATICS, V20, P3673, DOI 10.1093/bioinformatics/bth417; Swanson J, 2000, P NATL ACAD SCI USA, V97, P4754, DOI 10.1073/pnas.080070897; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; VANTOL HHM, 1992, NATURE, V358, P149; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; WATTERSON GA, 1978, GENETICS, V88, P405; WRIGHT S, 1951, ANN EUGENIC, V15, P323	34	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24410	10.1371/journal.pone.0024410	http://dx.doi.org/10.1371/journal.pone.0024410			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909391	Green Published, Green Submitted, gold			2022-12-25	WOS:000294680800087
J	Ruzagira, E; Wandiembe, S; Abaasa, A; Bwanika, AN; Bahemuka, U; Amornkul, P; Price, MA; Grosskurth, H; Kamali, A				Ruzagira, Eugene; Wandiembe, Symon; Abaasa, Andrew; Bwanika, Agnes N.; Bahemuka, Ubaldo; Amornkul, Pauli; Price, Matthew A.; Grosskurth, Heiner; Kamali, Anatoli			HIV Incidence and Risk Factors for Acquisition in HIV Discordant Couples in Masaka, Uganda: An HIV Vaccine Preparedness Study	PLOS ONE			English	Article							MALE CIRCUMCISION; VIRAL LOAD; COITAL ACT; CONDOM USE; TRANSMISSION; PREVENTION; INFECTION; RAKAI; PARTNERSHIPS; EXPERIENCE	Objectives: To determine the incidence of and risk factors for HIV acquisition in a cohort of HIV-uninfected partners from HIV discordant couples in Masaka, Uganda, and to establish its suitability for HIV vaccine trials. Methods: HIV-uninfected adults living in HIV discordant couple relationships were enrolled and followed for 2 years. Interviews, medical investigations, HIV counseling and testing, syphilis and urine pregnancy (women) tests were performed at quarterly visits. Sexual risk behaviour data were collected every 6 months. Results: 495 participants were enrolled, of whom 34 seroconverted during 786.6 person-years of observation (PYO). The overall HIV incidence rate [95% confidence interval (CI)] was 4.3 [3.1-6]; and 4.3 [2.8-6.4] and 4.4 [2.5-8] per 100 PYO in men and women respectively. Independent baseline predictors for HIV acquisition were young age [18-24 (aRR = 4.1, 95% CI 1.6-10.8) and 25-34 (aRR = 2.7, 95% CI 1.2-5.8) years]; alcohol use (aRR = 2.6, 95% CI 1.1-6); and reported genital discharge (aRR = 3.4, 95% CI 1.6-7.2) in the past year. Condom use frequency in the year preceding enrolment was predictive of a reduced risk of HIV acquisition [sometimes (aRR = 0.4, 95% CI 0.2-0.8); always (aRR = 0.1, 95% CI 0.02-0.9)]. In the follow-up risk analysis, young age [18-24 (aRR = 6.2, 95% CI 2.2-17.3) and 25-34 (aRR = 2.3, 95% CI 1.1-5.0) years], reported genital discharge (aRR = 2.5, 95% CI 1.1-5.5), serological syphilis (aRR 3.2, 95% CI 1.3-7.7) and the partner being ART naive (aRR = 4.8, 95% CI 1.4-16.0) were independently associated with HIV acquisition. There were no seroconversions among participants who reported consistent condom use during the study. Conclusions: The study has identified important risk factors for HIV acquisition among HIV discordant couples. HIV-uninfected partners in discordant couples may be a suitable population for HIV vaccine efficacy trials. However, recent confirmation that ART reduces heterosexual HIV transmission may make it unfeasible to conduct HIV prevention trials in this population.	[Ruzagira, Eugene; Wandiembe, Symon; Abaasa, Andrew; Bwanika, Agnes N.; Bahemuka, Ubaldo; Grosskurth, Heiner; Kamali, Anatoli] UVRI, MRC, Uganda Res Unit AIDS, Entebbe, Uganda; [Amornkul, Pauli; Price, Matthew A.] Int AIDS Vaccine Initiat, New York, NY USA; [Grosskurth, Heiner; Kamali, Anatoli] London Sch Hyg & Trop Med, London WC1, England	International AIDS Vaccine Initiative; University of London; London School of Hygiene & Tropical Medicine	Ruzagira, E (corresponding author), UVRI, MRC, Uganda Res Unit AIDS, Entebbe, Uganda.	Eugene.ruzagira@mrcuganda.org	Price, Matt/AAK-6881-2021	Price, Matt/0000-0002-2918-1373; Grosskurth, Heiner/0000-0001-9960-7280; Ruzagira, Eugene/0000-0002-7291-1693; Bwanika Naggirinya, Agnes/0000-0001-6795-3138	International AIDS Vaccine Initiative (IAVI); Medical Research Council [MC_U950080930] Funding Source: researchfish; MRC [MC_U950080930] Funding Source: UKRI	International AIDS Vaccine Initiative (IAVI); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was sponsored by the International AIDS Vaccine Initiative (IAVI). IAVI contributed to the study design, decision to publish, and preparation of the manuscript. In addition, this work was made possible in part by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the study authors and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Chen HY, 2004, AIDS RES HUM RETROV, V20, P513, DOI 10.1089/088922204323087769; De Cock KM, 2009, B WORLD HEALTH ORGAN, V87, P488, DOI 10.2471/BLT.09.067330; De Vincenzi I for The European Study Group on Heterosexual Transmission of HIV, NEW ENGLAND J MED, V331, P341; De Walque D, 2007, POPUL DEV REV, V33, P501, DOI 10.1111/j.1728-4457.2007.00182.x; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Esparza J, 2001, AIDS, V15, pS49, DOI 10.1097/00002030-200100005-00008; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Guthrie BL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008276; HIV Prevention Trials Network, 2011, IN ANT TREATM PROT U; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hugonnet S, 2002, J ACQ IMMUN DEF SYND, V30, P73, DOI 10.1097/00042560-200205010-00010; Katabira TE, 2003, NATL ANTIRETROVIRAL; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Maharaj P, 2004, STUD FAMILY PLANN, V35, P116, DOI 10.1111/j.1728-4465.2004.00013.x; Nunn A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-99; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ramjee G, 2008, JAIDS-J ACQ IMM DEF, V47, P93, DOI 10.1097/QAI.0b013e31815c71f7; Robinson NJ, 1999, INT J STD AIDS, V10, P718, DOI 10.1258/0956462991913394; Sarkar K, 2006, J INFECTION, V53, P255, DOI 10.1016/j.jinf.2005.11.009; Singh KA, 2007, ALCOHOL, V41, P519; Smith DJ, 2007, AM J PUBLIC HEALTH, V97, P997, DOI 10.2105/AJPH.2006.088583; TURNBULL BW, 1976, J R STAT SOC B, V38, P290; *UNAIDS, 2009, AIDS EP UPD; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; World Health Organisation, 2011, TRIAL SHOWS ANT TREA; Zablotska IB, 2006, AIDS, V20, P1191, DOI 10.1097/01.aids.0000226960.25589.72	32	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24037	10.1371/journal.pone.0024037	http://dx.doi.org/10.1371/journal.pone.0024037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909379	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000294680800049
J	Gao, JJ; Huang, XM; Park, Y; Hollenbeck, A; Chen, HL				Gao, Jianjun; Huang, Xuemei; Park, YikYung; Hollenbeck, Albert; Chen, Honglei			An Exploratory Study on CLU, CR1 and PICALM and Parkinson Disease	PLOS ONE			English	Article							APOLIPOPROTEIN-E GENOTYPE; GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; CLUSTERIN/APOLIPOPROTEIN-J; IDENTIFIES VARIANTS; RISK; DEMENTIA; AGGREGATION; CHOLESTEROL; RELATIVES	Background: Recent GWAS and subsequent confirmation studies reported several single-nucleotide polymorphisms (SNPs) at the CLU, CR1 and PICALM loci in association with late-onset Alzheimer's disease (AD). Parkinson disease (PD) shares several clinical and pathologic characteristics with AD; we therefore explored whether these SNPs were also associated with PD risk. Methodology/Principal Findings: 791 non-Hispanic Whites cases and 1,580 matched controls were included in the study. Odds ratios (OR) and 95% confidence intervals (CI) were obtained from logistic regression models. rs11136000 at the CLU locus was associated with PD risk under the recessive model (comparing TT versus CC+CT: OR = 0.71, 95% CI: 0.55-0.92, p = 0.008) after adjusting for year of birth, gender, smoking, and caffeine intake. Further adjustment for family history of PD and ApoE epsilon 4 status did not change the result. In addition, we did not find evidence for effect modification by ApoE or known PD risk factors. The association, however, appeared to be stronger for PD with dementia (OR = 0.49, 95% CI: 0.27-0.91) than for PD without dementia (OR = 0.81, 95% CI: 0.61-1.06). The two other SNPs, rs6656401 from CR1, and rs3851179 from PICALM region were not associated with PD (p > 0.05). Conclusion: Our exploratory analysis suggests an association of CLU with PD. This exploratory finding and the role of dementia in explaining this finding needs further investigation.	[Gao, Jianjun; Chen, Honglei] Natl Inst Environm Hlth Sci, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA; [Park, YikYung] NCI, Nutr Epidemiol Branch, Rockville, MD USA; [Hollenbeck, Albert] AARP, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Association of Retired Persons (AARP)	Gao, JJ (corresponding author), Natl Inst Environm Hlth Sci, Epidemiol Branch, Res Triangle Pk, Res Triangle Pk, NC 27709 USA.	chenh2@niehs.nih.gov	Hollenbeck, Albert/AAG-9461-2020	Park, Yikyung/0000-0002-6281-489X; Chen, Honglei/0000-0003-3446-7779	NIH; National Institute of Environmental Health Sciences [Z01-ES-101986]; National Cancer Institute [Z01 CP010196-02]; NATIONAL CANCER INSTITUTE [Z01CP010196, ZIACP010196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060722] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the intramural research program of the NIH, the National Institute of Environmental Health Sciences (Z01-ES-101986) and the National Cancer Institute (Z01 CP010196-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors have financial conflict of interest.	Ascherio A, 2001, ANN NEUROL, V50, P56, DOI 10.1002/ana.1052; Blazquez L, 2006, NEUROSCI LETT, V406, P235, DOI 10.1016/j.neulet.2006.07.037; Caballol N, 2007, MOVEMENT DISORD, V22, pS358, DOI 10.1002/mds.21677; Carreras I, 2005, J NEUROSCI RES, V79, P495, DOI 10.1002/jnr.20374; Chen H, 2010, NEUROLOGY, V74, P878, DOI 10.1212/WNL.0b013e3181d55f38; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Chen HL, 2002, ANN NEUROL, V52, P793, DOI 10.1002/ana.10381; Costello S, 2010, EUR J NEUROL, V17, P871, DOI 10.1111/j.1468-1331.2010.02974.x; de Lau LML, 2006, AM J EPIDEMIOL, V164, P998, DOI 10.1093/aje/kwj283; Durr A, 1997, J NEUROL NEUROSUR PS, V63, P394; GAO JJ, NEUROBIOL A IN PRESS; Gauderman W, QUANTO 1 1 COMPUTER; Ghebremedhin E, 2006, J NEUROPATH EXP NEUR, V65, P116, DOI 10.1097/01.jnen.0000199572.96472.1c; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; HOFMAN A, 1989, NEUROLOGY, V39, P1589, DOI 10.1212/WNL.39.12.1589; Huang XM, 2004, NEUROLOGY, V62, P2198, DOI 10.1212/01.WNL.0000130159.28215.6A; Huang XM, 2008, MOVEMENT DISORD, V23, P1013, DOI 10.1002/mds.22013; HUGHES AJ, 1993, ADV NEUROL, V60, P595; Hughes AJ, 2001, NEUROLOGY, V57, P1497, DOI 10.1212/WNL.57.8.1497; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Levy G, 2004, ARCH NEUROL-CHICAGO, V61, P1033, DOI 10.1001/archneur.61.7.1033; Marder K, 1999, NEUROLOGY, V52, P719, DOI 10.1212/WNL.52.4.719; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; Papapetropoulos S, 2007, NEUROSCI LETT, V414, P141, DOI 10.1016/j.neulet.2006.12.008; Rosen AR, 2007, NEUROGENETICS, V8, P263, DOI 10.1007/s10048-007-0100-6; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sasaki K, 2002, ACTA NEUROPATHOL, V104, P225, DOI 10.1007/s00401-002-0546-4; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Simon KC, 2007, NEUROLOGY, V69, P1688, DOI 10.1212/01.wnl.0000271883.45010.8a; Sleegers K, 2010, TRENDS GENET, V26, P84, DOI 10.1016/j.tig.2009.12.004; Vranova HP, 2010, J NEURAL TRANSM, V117, P1177, DOI 10.1007/s00702-010-0462-z; Williams-Gray CH, 2009, J NEUROL, V256, P493, DOI 10.1007/s00415-009-0119-8; Wilson RS, 2000, NEUROLOGY, V54, P1284, DOI 10.1212/WNL.54.6.1284	34	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24211	10.1371/journal.pone.0024211	http://dx.doi.org/10.1371/journal.pone.0024211			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912625	Green Submitted, Green Published, gold			2022-12-25	WOS:000294678300031
J	Kovacic, MB; Myers, JMB; Wang, N; Martin, LJ; Lindsey, M; Ericksen, MB; He, H; Patterson, TL; Baye, TM; Torgerson, D; Roth, LA; Gupta, J; Sivaprasad, U; Gibson, AM; Tsoras, AM; Hu, DL; Eng, C; Chapela, R; Rodriguez-Santana, JR; Rodriguez-Cintron, W; Avila, PC; Beckman, K; Seibold, MA; Gignoux, C; Musaad, SM; Chen, WG; Burchard, EG; Hershey, GKK				Kovacic, Melinda Butsch; Myers, Jocelyn M. Biagini; Wang, Ning; Martin, Lisa J.; Lindsey, Mark; Ericksen, Mark B.; He, Hua; Patterson, Tia L.; Baye, Tesfaye M.; Torgerson, Dara; Roth, Lindsey A.; Gupta, Jayanta; Sivaprasad, Umasundari; Gibson, Aaron M.; Tsoras, Anna M.; Hu, Donglei; Eng, Celeste; Chapela, Rocio; Rodriguez-Santana, Jose R.; Rodriguez-Cintron, William; Avila, Pedro C.; Beckman, Kenneth; Seibold, Max A.; Gignoux, Chris; Musaad, Salma M.; Chen, Weiguo; Burchard, Esteban Gonzalez; Hershey, Gurjit K. Khurana			Identification of KIF3A as a Novel Candidate Gene for Childhood Asthma Using RNA Expression and Population Allelic Frequencies Differences	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; PUERTO-RICAN; ETHNIC-DIFFERENCES; NATURAL-SELECTION; RISK-FACTORS; CHILDREN; CILIA; LINKAGE; PREVALENCE	Background: Asthma is a chronic inflammatory disease with a strong genetic predisposition. A major challenge for candidate gene association studies in asthma is the selection of biologically relevant genes. Methodology/Principal Findings: Using epithelial RNA expression arrays, HapMap allele frequency variation, and the literature, we identified six possible candidate susceptibility genes for childhood asthma including ADCY2, DNAH5, KIF3A, PDE4B, PLAU, SPRR2B. To evaluate these genes, we compared the genotypes of 194 predominantly tagging SNPs in 790 asthmatic, allergic and non-allergic children. We found that SNPs in all six genes were nominally associated with asthma (p<0.05) in our discovery cohort and in three independent cohorts at either the SNP or gene level (p<0.05). Further, we determined that our selection approach was superior to random selection of genes either differentially expressed in asthmatics compared to controls (p = 0.0049) or selected based on the literature alone (p = 0.0049), substantiating the validity of our gene selection approach. Importantly, we observed that 7 of 9 SNPs in the KIF3A gene more than doubled the odds of asthma (OR = 2.3, p<0.0001) and increased the odds of allergic disease (OR = 1.8, p<0.008). Our data indicate that KIF3A rs7737031 (T-allele) has an asthma population attributable risk of 18.5%. The association between KIF3A rs7737031 and asthma was validated in 3 independent populations, further substantiating the validity of our gene selection approach. Conclusions/Significance: Our study demonstrates that KIF3A, a member of the kinesin superfamily of microtubule associated motors that are important in the transport of protein complexes within cilia, is a novel candidate gene for childhood asthma. Polymorphisms in KIF3A may in part be responsible for poor mucus and/or allergen clearance from the airways. Furthermore, our study provides a promising framework for the identification and evaluation of novel candidate susceptibility genes.	[Kovacic, Melinda Butsch; Myers, Jocelyn M. Biagini; Wang, Ning; Lindsey, Mark; Ericksen, Mark B.; Patterson, Tia L.; Baye, Tesfaye M.; Gupta, Jayanta; Sivaprasad, Umasundari; Gibson, Aaron M.; Tsoras, Anna M.; Musaad, Salma M.; Chen, Weiguo; Hershey, Gurjit K. Khurana] Cincinnati Childrens Hosp, Div Asthma Res, Med Ctr, Cincinnati, OH 45229 USA; [Kovacic, Melinda Butsch; Martin, Lisa J.; He, Hua] Cincinnati Childrens Hosp, Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH USA; [Hu, Donglei; Eng, Celeste; Burchard, Esteban Gonzalez] San Francisco Gen Hosp, Lung Biol Ctr, San Francisco, CA 94110 USA; [Hu, Donglei; Eng, Celeste; Gignoux, Chris; Burchard, Esteban Gonzalez] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Chapela, Rocio] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Rodriguez-Santana, Jose R.] CSP, Ctr Neumol Pediat, San Juan, PR USA; [Rodriguez-Cintron, William] Univ Puerto Rico, Sch Med, San Juan Vet Affairs Med Ctr, San Juan, PR 00936 USA; [Avila, Pedro C.] Northwestern Univ, Div Allergy Immunol, Chicago, IL 60611 USA; [Beckman, Kenneth] Univ Minnesota, Biomed Genom Ctr, Minneapolis, MN USA; [Seibold, Max A.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Torgerson, Dara; Roth, Lindsey A.; Burchard, Esteban Gonzalez] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Northwestern University; University of Minnesota System; University of Minnesota Twin Cities; National Jewish Health; University of California System; University of California San Francisco	Kovacic, MB (corresponding author), Cincinnati Childrens Hosp, Div Asthma Res, Med Ctr, Cincinnati, OH 45229 USA.	gurjit.hershey@cchmc.org	Martin, Lisa/E-2425-2016	Martin, Lisa/0000-0001-8702-9946; Biagini, Jocelyn/0000-0002-4378-6133	National Institutes of Health [U19A170235, R21016830, U19AI77439]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health [U19A170235 to GKKH, R21016830 to MBK, and U19AI77439 to EGB]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Akinbami LJ, 2005, PEDIATRICS, V115, P1254, DOI 10.1542/peds.2004-0897; Amato R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007927; Arif AA, 2003, EUR RESPIR J, V21, P827, DOI 10.1183/09031936.03.00054103a; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Beckett WS, 1996, AM J RESP CRIT CARE, V154, P894, DOI 10.1164/ajrccm.154.4.8887582; Burchard EG, 2004, AM J RESP CRIT CARE, V169, P386, DOI 10.1164/rccm.200309-1293OC; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; CARTERPOKRAS OD, 1993, AM J PUBLIC HEALTH, V83, P580, DOI 10.2105/AJPH.83.4.580; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Flores G, 2002, JAMA-J AM MED ASSOC, V288, P82, DOI 10.1001/jama.288.1.82; Franke L, 2009, METHODS MOL BIOL, V573, P311, DOI 10.1007/978-1-60761-247-6_17; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frieri M, 2005, ALLERGY ASTHMA PROC, V26, P83; Gaga M, 2000, CLIN EXP ALLERGY, V30, P663; Guajardo JR, 2005, J ALLERGY CLIN IMMUN, V115, P243, DOI 10.1016/j.jaci.2004.10.032; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V112, P893, DOI 10.1016/j.jaci.2003.08.033; Ke XY, 2003, BIOINFORMATICS, V19, P287, DOI 10.1093/bioinformatics/19.2.287; Kim JH, 2011, J CLIN IMMUNOL, V31, P112, DOI 10.1007/s10875-010-9462-x; Kleinrath T, 2007, J CLIN ONCOL, V25, P845, DOI 10.1200/JCO.2006.07.8154; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lara M, 2006, PEDIATRICS, V117, P43, DOI 10.1542/peds.2004-1714; Mall MA, 2008, J AEROSOL MED PULM D, V21, P13, DOI 10.1089/jamp.2007.0659; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McDougall CM, 2008, AM J RESP CELL MOL, V39, P560, DOI 10.1165/rcmb.2007-0325OC; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; NARAYANASWAMY CR, 1991, APPL STAT-J ROY ST C, V40, P309; NEI M, 1986, EVOLUTION, V40, P643, DOI 10.1111/j.1558-5646.1986.tb00516.x; Nothnagel M, 2009, HUM GENET, V125, P163, DOI 10.1007/s00439-008-0606-5; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramsch C, 2009, COMPUT METH PROG BIO, V94, P88, DOI 10.1016/j.cmpb.2008.10.006; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Sebastiani P, 2003, P NATL ACAD SCI USA, V100, P9900, DOI 10.1073/pnas.1633613100; Sivaprasad U, 2009, J ALLERGY CLIN IMMUN, V123, pS81, DOI 10.1016/j.jaci.2008.12.284; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weiss ST, 2009, CURR OPIN GENET DEV, V19, P279, DOI 10.1016/j.gde.2009.05.001; WRIGHT S, 1951, ANN EUGENIC, V15, P323; WRIGHT S, VARIABILITY NATURAL; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Zhang YR, 2004, BIOPHYS J, V87, P1795, DOI 10.1529/biophysj.104.039842; 1987, AM REV RESP DIS, V136, P225	48	38	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e23714	10.1371/journal.pone.0023714	http://dx.doi.org/10.1371/journal.pone.0023714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912604	Green Published, gold, Green Submitted			2022-12-25	WOS:000294678300007
J	Snowdon, J; Zhang, X; Childs, T; Tron, VA; Feilotter, H				Snowdon, Jaime; Zhang, Xiao; Childs, Tim; Tron, Victor A.; Feilotter, Harriet			The MicroRNA-200 Family Is Upregulated in Endometrial Carcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MIR-200 FAMILY; REPRESSORS ZEB1; STEM-CELLS; GENES; RNAS; SENSITIVITY; APOPTOSIS; MIRNAS; ROLES	Background: MicroRNAs (miRNAs, miRs) are small non-coding RNAs that negatively regulate gene expression at the post-transcriptional level. MicroRNAs are dysregulated in cancer and may play essential roles in tumorigenesis. Additionally, miRNAs have been shown to have prognostic and diagnostic value in certain types of cancer. The objective of this study was to identify dysregulated miRNAs in endometrioid endometrial adenocarcinoma (EEC) and the precursor lesion, complex atypical hyperplasia (CAH). Methodology: We compared the expression profiles of 723 human miRNAs from 14 cases of EEC, 10 cases of CAH, and 10 normal proliferative endometria controls using Agilent Human miRNA arrays following RNA extraction from formalin-fixed paraffin-embedded (FFPE) tissues. The expression of 4 dysregulated miRNAs was validated using real time reverse transcription-PCR. Results: Forty-three miRNAs were dysregulated in EEC and CAH compared to normal controls (p<0.05). The entire miR-200 family (miR-200a/b/c, miR-141, and miR-429) was up-regulated in cases of EEC. Conclusions: This information contributes to the candidate miRNA expression profile that has been generated for EEC and shows that certain miRNAs are dysregulated in the precursor lesion, CAH. These miRNAs in particular may play important roles in tumorigenesis. Examination of miRNAs that are consistently dysregulated in various studies of EEC, like the miR-200 family, will aid in the understanding of the role that miRNAs play in tumorigenesis in this tumour type.	[Snowdon, Jaime] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; Kingston Gen Hosp, Kingston, ON K7L 2V7, Canada	McMaster University; Queens University - Canada; Queens University - Canada	Snowdon, J (corresponding author), Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada.	feilotth@KGH.KARI.NET			P.S.I. Foundation, Ontario; Queen's University Department of Pathology and Molecular Medicine Clinical Trust	P.S.I. Foundation, Ontario; Queen's University Department of Pathology and Molecular Medicine Clinical Trust	This research is supported by the physicians of Ontario through the P.S.I. Foundation (http://www.psifoundation.org/) and the Queen's University Department of Pathology and Molecular Medicine Clinical Trust Fund (http://www.path.queensu.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; [Anonymous], CANADIAN CANC STAT 2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boren T, 2008, GYNECOL ONCOL, V110, P206, DOI 10.1016/j.ygyno.2008.03.023; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cheng LC, 2005, NEURON, V46, P363, DOI 10.1016/j.neuron.2005.04.027; Chung TKH, 2009, INT J CANCER, V124, P1358, DOI 10.1002/ijc.24071; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; COCHRANE DR, 2010, STEROIDS IN PRESS, DOI DOI 10.1016/J.STEROIDS.2010.11.003; Cohn DE, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.051; Elson-Schwab I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013176; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hu XX, 2009, GYNECOL ONCOL, V114, P457, DOI 10.1016/j.ygyno.2009.05.022; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Krasner C, 2007, J STEROID BIOCHEM, V106, P76, DOI 10.1016/j.jsbmb.2007.05.026; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Liu Fu-Shing, 2007, Taiwan J Obstet Gynecol, V46, P26, DOI 10.1016/S1028-4559(08)60102-3; Llobet D, 2009, J CLIN PATHOL, V62, P777, DOI 10.1136/jcp.2008.056101; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Ratner ES, 2010, GYNECOL ONCOL, V118, P251, DOI 10.1016/j.ygyno.2010.05.010; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tanno B, 2005, CELL DEATH DIFFER, V12, P213, DOI 10.1038/sj.cdd.4401546; Wu WG, 2009, EUR J CANCER PREV, V18, P50, DOI 10.1097/CEJ.0b013e328305a07a; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang BH, 2006, J CELL PHYSIOL, V209, P266, DOI 10.1002/jcp.20713; MICROCOSM TARGETS VE	40	113	123	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e22828	10.1371/journal.pone.0022828	http://dx.doi.org/10.1371/journal.pone.0022828			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897839	Green Published, gold, Green Submitted			2022-12-25	WOS:000294676900002
J	Choudhary, S; Rosenblatt, KP; Fang, L; Tian, B; Wu, ZH; Brasier, AR				Choudhary, Sanjeev; Rosenblatt, Kevin P.; Fang, Ling; Tian, Bing; Wu, Zhao-Hui; Brasier, Allan R.			High Throughput Short Interfering RNA (siRNA) Screening of the Human Kinome Identifies Novel Kinases Controlling the Canonical Nuclear Factor-kappa B (NF-kappa B) Activation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; GENE-EXPRESSION; SER(276) PHOSPHORYLATION; IKK-BETA; ZETA-PKC; ALPHA; UBIQUITINATION; ATM; TRANSCRIPTION; NEMO	Nuclear factor-kappa B (NF-kappa B) is an inducible cytoplasmic transcription factor that plays a role as a master regulator of airway mucosal inflammation. The prototypical ("canonical") NF-kappa B pathway controls cytoplasmic to nuclear translocation in response to stimulation by the mononuclear cytokine, TNF. Despite intensive investigation, the spectrum of kinases involved in the canonical NF-kappa B pathway has not yet been systematically determined. Here we have applied a high throughput siRNA-mediated loss-of-function screening assay to identify novel kinases important in TNF-induced NF-kappa B signaling. Type II A549 epithelial cells stably expressing an IL-8/luciferase reporter gene optimized for high throughput siRNA format (Z' score of 0.65) and siRNAs for 636 human kinases were reverse-transfected and screened in the assay. 36 candidate genes were identified that inhibited TNF signaling with a Z score deviation of <-1.3 in replicate plates. From this group, 11 kinases were selected for independent validation, of which eight were successfully silenced. Six kinases were validated, including ATM, CDK2, -5, and -7, CALM3, MAPAKP5, and MAP3K/MEKK3. The surprising function of ATM in TNF signaling was confirmed where reduced NF-kappa B/RelA translocation and Ser-276 phosphorylation were seen in ATM(-/-) mouse embryo fibroblasts. These data indicate that ATM is a key regulatory kinase that may control global NF-kappa B activation in the TNF-induced canonical pathway.	[Choudhary, Sanjeev; Brasier, Allan R.] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Choudhary, Sanjeev; Tian, Bing; Brasier, Allan R.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Fang, Ling] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Brasier, Allan R.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Wu, Zhao-Hui] Univ Tennessee, Hlth Sci Ctr, Dept Pathol, Memphis, TN USA; [Rosenblatt, Kevin P.] Univ Texas Hlth Sci Ctr, Ctr Clin Prote, Houston, TX 77030 USA; [Rosenblatt, Kevin P.] Univ Texas Hlth Sci Ctr, Ctr Clin & Translat Sci, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Rosenblatt, Kevin P.] Univ Texas Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Tennessee System; University of Tennessee Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Choudhary, S (corresponding author), Univ Texas Med Branch, Sealy Ctr Mol Med, MRB 8-138,301 Univ Blvd, Galveston, TX 77555 USA.	sachoudh@utmb.edu		Choudhary, Sanjeev/0000-0001-8290-7420; Brasier, Allan/0000-0002-5012-4090	National Institutes of Health (NIH) [AI062885]; NHLBI, NIH, Proteomics Center [HHSN268201000037C]; University of Texas Medical Branch Clinical and Translational Science [1U54RR02614]; NIDDK (NIH) [DK079053]; NHLBI (NIH) Proteomics Initiative [N01-HV-00245]; John S. Dunn Gulf Coast Consortium for Chemical Genomics; Welch Foundation [L-AU-0002]; American Diabetes Association [1-08-CR-65]; University of Texas Health Science Center [U54CTSA]; NATIONAL CANCER INSTITUTE [R01CA149251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079053] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, NIH, Proteomics Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Texas Medical Branch Clinical and Translational Science; NIDDK (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI (NIH) Proteomics Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); John S. Dunn Gulf Coast Consortium for Chemical Genomics; Welch Foundation(The Welch Foundation); American Diabetes Association(American Diabetes Association); University of Texas Health Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants AI062885 (to A. R. B.), NHLBI, NIH, Proteomics Center Grant HHSN268201000037C (to A. R. B.), University of Texas Medical Branch Clinical and Translational Science Award Grant 1U54RR02614 (to A. R. B.), NIDDK (NIH) Grant DK079053 (to S. C.), and NHLBI (NIH) Proteomics Initiative Grant N01-HV-00245 (to K. P. R.). This work was also supported by a Discovery Project pilot grant from the John S. Dunn Gulf Coast Consortium for Chemical Genomics (to A. R. B. and S. C.), a Welch Foundation Endowment in Chemistry and Related Science Fellowship award (Grant L-AU-0002; to K. P. R.), American Diabetes Association Grant 1-08-CR-65 (to K. P. R.), and University of Texas Health Science Center Clinical and Translational Science Award U54CTSA.	Brasier AR, 2008, CELL CYCLE, V7, P2661, DOI 10.4161/cc.7.17.6594; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Choudhary S, 2005, J VIROL, V79, P8948, DOI 10.1128/JVI.79.14.8948-8959.2005; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fan YH, 2009, J BIOL CHEM, V284, P29290, DOI 10.1074/jbc.M109.018994; Folmer F, 2006, BIOCHEM PHARMACOL, V71, P1206, DOI 10.1016/j.bcp.2005.12.032; Forbus J, 2006, PROTEOMICS, V6, P2656, DOI 10.1002/pmic.200500652; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Harper JW, 1998, GENE DEV, V12, P285, DOI 10.1101/gad.12.3.285; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Huang X, 2009, J IMMUNOL, V182, P5810, DOI 10.4049/jimmunol.0804073; Jamaluddin M, 2007, CELL SIGNAL, V19, P1419, DOI 10.1016/j.cellsig.2007.01.020; Jhou RS, 2009, CELL PROLIFERAT, V42, P141, DOI 10.1111/j.1365-2184.2009.00584.x; Kai M, 2009, FEBS LETT, V583, P3265, DOI 10.1016/j.febslet.2009.09.017; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loyer P, 2005, CELL SIGNAL, V17, P1033, DOI 10.1016/j.cellsig.2005.02.005; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; New L, 2003, MOL BIOL CELL, V14, P2603, DOI 10.1091/mbc.E02-08-0538; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Rieber N, 2009, BIOINFORMATICS, V25, P678, DOI 10.1093/bioinformatics/btp014; Rosato RR, 2010, J BIOL CHEM, V285, P10064, DOI 10.1074/jbc.M109.095208; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Sun WJ, 2010, J BIOL CHEM, V285, P7911, DOI 10.1074/jbc.M109.051219; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tian B., 2005, NUCL FACTOR KAPPAB N, P1; Vanden Bush T.J., 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019468; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	46	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37187	37195		10.1074/jbc.M111.224923	http://dx.doi.org/10.1074/jbc.M111.224923			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900239	Green Published, hybrid			2022-12-25	WOS:000296542400019
J	Verstraete, E; Veldink, JH; Mandl, RCW; van den Berg, LH; van den Heuvel, MP				Verstraete, Esther; Veldink, Jan H.; Mandl, Rene C. W.; van den Berg, Leonard H.; van den Heuvel, Martijn P.			Impaired Structural Motor Connectome in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; VOXEL-BASED MORPHOMETRY; STATE FUNCTIONAL CONNECTIVITY; ANISOTROPIC WATER DIFFUSION; RESTING-STATE; WHITE-MATTER; CORTICOSPINAL TRACT; SMALL-WORLD; NETWORK STRUCTURE; FIBER TRACKING	Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease selectively affecting upper and lower motor neurons. Patients with ALS suffer from progressive paralysis and eventually die on average after three years. The underlying neurobiology of upper motor neuron degeneration and its effects on the complex network of the brain are, however, largely unknown. Here, we examined the effects of ALS on the structural brain network topology in 35 patients with ALS and 19 healthy controls. Using diffusion tensor imaging (DTI), the brain network was reconstructed for each individual participant. The connectivity of this reconstructed brain network was compared between patients and controls using complexity theory without - a priori selected - regions of interest. Patients with ALS showed an impaired sub-network of regions with reduced white matter connectivity (p = 0.0108, permutation testing). This impaired sub-network was strongly centered around primary motor regions (bilateral precentral gyrus and right paracentral lobule), including secondary motor regions (bilateral caudal middle frontal gyrus and pallidum) as well as high-order hub regions (right posterior cingulate and precuneus). In addition, we found a significant reduction in overall efficiency (p = 0.0095) and clustering (p = 0.0415). From our findings, we conclude that upper motor neuron degeneration in ALS affects both primary motor connections as well as secondary motor connections, together composing an impaired sub-network. The degenerative process in ALS was found to be widespread, but interlinked and targeted to the motor connectome.	[Verstraete, Esther; Veldink, Jan H.; van den Berg, Leonard H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Verstraete, E (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands.	m.p.vandenheuvel@umcutrecht.nl	Mandl, René C.W./AAU-7037-2020; van den Heuvel, Martijn/AFR-3213-2022	van den Heuvel, Martijn/0000-0003-1570-1195	Netherlands Amyotrophic Lateral Sclerosis (ALS) foundation; Prinses Beatrix fonds; Rudolf Magnus Institute of Neuroscience; Baxter	Netherlands Amyotrophic Lateral Sclerosis (ALS) foundation; Prinses Beatrix fonds; Rudolf Magnus Institute of Neuroscience; Baxter	This work was supported by the Netherlands Amyotrophic Lateral Sclerosis (ALS) foundation and the 'Prinses Beatrix fonds'. MPH is supported by a Fellowship of the Rudolf Magnus Institute of Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Dr. van den Berg received travel grants and consultancy fees from Baxter. The other authors report no disclosures. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Agosta F, 2007, HUM BRAIN MAPP, V28, P1430, DOI 10.1002/hbm.20364; Agosta F, 2010, AM J NEURORADIOL, V31, P1457, DOI 10.3174/ajnr.A2105; Agosta F, 2009, J NEUROL NEUROSUR PS, V80, P53, DOI 10.1136/jnnp.2008.154252; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Andersson JLR, 2002, NEUROIMAGE, V16, P177, DOI 10.1006/nimg.2001.1039; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; BEAULIEU C, 1994, MAGNET RESON MED, V31, P394, DOI 10.1002/mrm.1910310408; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Chen G, 2011, RADIOLOGY, V259, P213, DOI 10.1148/radiol.10100734; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Filippini N, 2010, NEUROLOGY, V75, P1645, DOI 10.1212/WNL.0b013e3181fb84d1; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Gordon PH, 2010, AMYOTROPH LATERAL SC, V11, P312, DOI 10.3109/17482961003622585; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Iwata NK, 2008, NEUROLOGY, V70, P528, DOI 10.1212/01.wnl.0000299186.72374.19; Jelsone-Swain LM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00158; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; KAISER M, 2011, NEUROIMAGE; Kassubek J, 2005, AMYOTROPH LATERAL SC, V6, P213, DOI 10.1080/14660820510038538; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Logroscino G, 2008, J NEUROL NEUROSUR PS, V79, P6, DOI 10.1136/jnnp.2006.104828; Mandl RCW, 2010, SCHIZOPHRENIA BULL, V36, P778, DOI 10.1093/schbul/sbn161; Mandl RCW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003631; Mohammadi B, 2009, EXP NEUROL, V217, P147, DOI 10.1016/j.expneurol.2009.01.025; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nelles M, 2008, AM J NEURORADIOL, V29, P1708, DOI 10.3174/ajnr.A1201; Ngai S, 2007, AM J NEURORADIOL, V28, P250; Raaphorst J, 2010, AMYOTROPH LATERAL SC, V11, P27, DOI 10.3109/17482960802645008; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Roccatagliata L, 2009, AMYOTROPH LATERAL SC, V10, P47, DOI 10.1080/17482960802267530; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sage CA, 2007, NEUROIMAGE, V34, P486, DOI 10.1016/j.neuroimage.2006.09.025; Sage CA, 2009, HUM BRAIN MAPP, V30, P3657, DOI 10.1002/hbm.20794; Senda J, 2011, AMYOTROPH LATERAL SC, V12, P59, DOI 10.3109/17482968.2010.517850; Senda J, 2009, AMYOTROPH LATERAL SC, V10, P288, DOI 10.3109/17482960802651717; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Thivard L, 2007, J NEUROL NEUROSUR PS, V78, P889, DOI 10.1136/jnnp.2006.101758; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel M, 2008, J NEUROSCI, V28, P10844, DOI 10.1523/JNEUROSCI.2964-08.2008; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; van der Graaff MM, 2011, BRAIN, V134, P1211, DOI 10.1093/brain/awr016; van Eimeren T, 2009, ARCH NEUROL-CHICAGO, V66, P877, DOI 10.1001/archneurol.2009.97; Verstraete E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013664; Wong JCT, 2007, J NEUROIMAGING, V17, P234, DOI 10.1111/j.1552-6569.2007.00100.x; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Zalesky A, 2008, IEEE T MED IMAGING, V27, P1458, DOI 10.1109/TMI.2008.923644; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041	72	109	112	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24239	10.1371/journal.pone.0024239	http://dx.doi.org/10.1371/journal.pone.0024239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912680	Green Published, Green Submitted, gold			2022-12-25	WOS:000294686100027
J	Donnelly, N; Zurcher, NR; Cornes, K; Snyder, J; Naik, P; Hadwin, J; Hadjikhani, N				Donnelly, Nick; Zuercher, Nicole R.; Cornes, Katherine; Snyder, Josh; Naik, Paulami; Hadwin, Julie; Hadjikhani, Nouchine			Discriminating Grotesque from Typical Faces: Evidence from the Thatcher Illusion	PLOS ONE			English	Article							PERCEPTION; BRAIN; PROSOPAGNOSIA; INFORMATION; ACTIVATION; FEATURES; OBJECTS; CORTEX; ROBUST; ORDER	The discrimination of thatcherized faces from typical faces was explored in two simultaneous alternative forced choice tasks. Reaction times (RTs) and errors were measured in a behavioural task. Brain activation was measured in an equivalent fMRI task. In both tasks, participants were tested with upright and inverted faces. Participants were also tested on churches in the behavioural task. The behavioural task confirmed the face specificity of the illusion (by comparing inversion effects for faces against churches) but also demonstrated that the discrimination was primarily, although not exclusively, driven by attending to eyes. The fMRI task showed that, relative to inverted faces, upright grotesque faces are discriminated via activation of a network of emotion/social evaluation processing areas. On the other hand, discrimination of inverted thatcherized faces was associated with increased activation of brain areas that are typically involved in perceptual processing of faces.	[Donnelly, Nick; Cornes, Katherine; Hadwin, Julie] Univ Southampton, Sch Psychol, Southampton, Hants, England; [Zuercher, Nicole R.; Hadjikhani, Nouchine] Swiss Fed Inst Technol, Brain Mind Inst, Zurich, Switzerland; [Snyder, Josh; Naik, Paulami; Hadjikhani, Nouchine] Harvard Univ, Dept Radiol, Cambridge, MA 02138 USA	University of Southampton; ETH Zurich; Harvard University	Donnelly, N (corresponding author), Univ Southampton, Sch Psychol, Southampton, Hants, England.	n.donnelly@soton.ac.uk	Zurcher, Nicole/AGF-1440-2022; Hadjikhani, Nouchine/C-2018-2008	Zurcher, Nicole/0000-0003-0271-6304; Hadjikhani, Nouchine/0000-0003-4075-3106; Donnelly, Nick/0000-0002-3577-5434	Swiss National Science Foundation [PPOOB-110741]; Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL); Swiss Federal Institute of Technology Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaires de Geneve (HUG); Leenaards; Jeantet Foundations; Economic and Social Research Council	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL); Swiss Federal Institute of Technology Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaires de Geneve (HUG); Leenaards; Jeantet Foundations; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work is supported by the Swiss National Science Foundation (http://www.snf.ch) PPOOB-110741 and by the Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL), the Swiss Federal Institute of Technology Lausanne (EPFL), the University of Geneva (UniGe), the Centre Hospitalier Universitaire Vaudois (CHUV), the Hopitaux Universitaires de Geneve (HUG) and the Leenaards (http://www.leenaards.ch/fr) and the Jeantet Foundations (http://www.jeantet.ch). It was also supported by a studentship from the Economic and Social Research Council awarded to Katherine Cornes (http://www.esrc.ac.uk). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLETT JC, 1993, COGNITIVE PSYCHOL, V25, P281, DOI 10.1006/cogp.1993.1007; Boutsen L, 2006, NEUROIMAGE, V32, P352, DOI 10.1016/j.neuroimage.2006.03.023; Calder AJ, 2000, J EXP PSYCHOL HUMAN, V26, P527, DOI 10.1037/0096-1523.26.2.527; Carbon CC, 2005, PERCEPTION, V34, P1117, DOI 10.1068/p5192; Carbon CC, 2005, COGNITIVE BRAIN RES, V24, P544, DOI 10.1016/j.cogbrainres.2005.03.008; Carbon CC, 2007, PERCEPTION, V36, P1635, DOI 10.1068/p5467; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Donnelly N, 2003, VIS COGN, V10, P1001, DOI 10.1080/13506280344000202; Hadjikhani N, 2002, HUM BRAIN MAPP, V16, P176, DOI 10.1002/hbm.10043; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HILLIARD R D, 1973, Cortex, V9, P246; HINES D, 1990, BRAIN COGNITION, V14, P165, DOI 10.1016/0278-2626(90)90027-L; Ishai A, 2008, NEUROIMAGE, V40, P415, DOI 10.1016/j.neuroimage.2007.10.040; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; Milivojevic B, 2003, PSYCHOPHYSIOLOGY, V40, P967, DOI 10.1111/1469-8986.00115; Morris JP, 2007, SOC COGN AFFECT NEUR, V2, P31, DOI 10.1093/scan/nsl023; PERRETT DI, 1988, BEHAV BRAIN RES, V29, P245, DOI 10.1016/0166-4328(88)90029-0; RAAB DH, 1962, T NEW YORK ACAD SCI, V24, P574, DOI 10.1111/j.2164-0947.1962.tb01433.x; Rotshtein P, 2001, NEURON, V32, P747, DOI 10.1016/S0896-6273(01)00513-X; Rouse H, 2004, J CHILD PSYCHOL PSYC, V45, P1246, DOI 10.1111/j.1469-7610.2004.00317.x; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sturzel F, 2000, PERCEPTION, V29, P937, DOI 10.1068/p2888; THOMPSON P, 1980, PERCEPTION, V9, P483, DOI 10.1068/p090483; van der Kouwe AJW, 2005, NEUROIMAGE, V27, P222, DOI 10.1016/j.neuroimage.2005.03.035; Whitfield-Gabrieli S, 2011, NEUROIMAGE, V55, P225, DOI 10.1016/j.neuroimage.2010.11.048; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	30	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23340	10.1371/journal.pone.0023340	http://dx.doi.org/10.1371/journal.pone.0023340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	817NM	21912594	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000294680800009
J	Enoki, M; Shinzato, N; Sato, H; Nakamura, K; Kamagata, Y				Enoki, Miho; Shinzato, Naoya; Sato, Hiroaki; Nakamura, Kohei; Kamagata, Yoichi			Comparative Proteomic Analysis of Methanothermobacter themautotrophicus Delta H in Pure Culture and in Co-Culture with a Butyrate-Oxidizing Bacterium	PLOS ONE			English	Article							ASSISTED-LASER-DESORPTION/IONIZATION; PROTEASOME CORE PARTICLE; MASS-SPECTROMETRY; 20S PROTEASOME; METHANOBACTERIUM-THERMOAUTOTROPHICUM; METHANOGENESIS GENES; ARCHAEON; YEAST; PHOSPHORYLATION; GROWTH	To understand the physiological basis of methanogenic archaea living on interspecies H(2) transfer, the protein expression of a hydrogenotrophic methanogen, Methanothermobacter thermautotrophicus strain Delta H, was investigated in both pure culture and syntrophic coculture with an anaerobic butyrate oxidizer Syntrophothermus lipocalidus strain TGB-C1 as an H(2) supplier. Comparative proteomic analysis showed that global protein expression of methanogen cells in the model coculture was substantially different from that of pure cultured cells. In brief, in syntrophic coculture, although methanogenesis-driven energy generation appeared to be maintained by shifting the pathway to the alternative methyl coenzyme M reductase isozyme I and cofactor F(420)-dependent process, the machinery proteins involved in carbon fixation, amino acid synthesis, and RNA/DNA metabolisms tended to be down-regulated, indicating restrained cell growth rather than vigorous proliferation. In addition, our proteome analysis revealed that a subunits of proteasome were differentially acetylated between the two culture conditions. Since the relevant modification has been suspected to regulate proteolytic activity of the proteasome, the global protein turnover rate could be controlled under syntrophic growth conditions. To our knowledge, the present study is the first report on N-acetylation of proteasome subunits in methanogenic archaea. These results clearly indicated that physiological adaptation of hydrogenotrophic methanogens to syntrophic growth is more complicated than that of hitherto proposed.	[Enoki, Miho; Shinzato, Naoya; Nakamura, Kohei; Kamagata, Yoichi] Natl Inst Adv Ind Sci & Technol, Res Inst Biol Resources, Tsukuba, Ibaraki, Japan; [Enoki, Miho] Marine Biotechnol Inst, Kamaishi, Iwate, Japan; [Sato, Hiroaki] Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, Tsukuba, Ibaraki, Japan; [Kamagata, Yoichi] Natl Inst Adv Ind Sci & Technol, Res Inst Genome Based Biofactory, Toyohira Ku, Sapporo, Hokkaido, Japan; [Shinzato, Naoya] Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 90301, Japan; [Nakamura, Kohei] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); University of the Ryukyus; Gifu University	Enoki, M (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Biol Resources, Tsukuba, Ibaraki, Japan.	naoya-s@comb.u-ryukyu.ac.jp	Sato, Hiroaki/AAC-3683-2019; Sato, Hiroaki/N-4160-2013	Sato, Hiroaki/0000-0003-2558-9248; Sato, Hiroaki/0000-0003-2558-9248	New Energy and Industrial Technology Development Organization (NEDO) of Japan	New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afting C, 2000, ARCH MICROBIOL, V174, P225, DOI 10.1007/s002030000197; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Brioukhanov AL, 2006, MICROBIOL-SGM, V152, P1671, DOI 10.1099/mic.0.28542-0; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Falb M, 2006, J MOL BIOL, V362, P915, DOI 10.1016/j.jmb.2006.07.086; Farhoud MH, 2005, MOL CELL PROTEOMICS, V4, P1653, DOI 10.1074/mcp.M500171-MCP200; Goodchild A, 2005, J PROTEOME RES, V4, P473, DOI 10.1021/pr049760p; Groll M, 2003, INT J BIOCHEM CELL B, V35, P606, DOI 10.1016/S1357-2725(02)00390-4; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Hendrickson EL, 2007, P NATL ACAD SCI USA, V104, P8930, DOI 10.1073/pnas.0701157104; Humbard MA, 2006, J BACTERIOL, V188, P7521, DOI 10.1128/JB.00943-06; Ishii S, 2005, APPL ENVIRON MICROB, V71, P7838, DOI 10.1128/AEM.71.12.7838-7845.2005; Ishii S, 2006, APPL ENVIRON MICROB, V72, P5093, DOI 10.1128/AEM.00333-06; Iwafune Y, 2004, ARCH BIOCHEM BIOPHYS, V431, P9, DOI 10.1016/j.abb.2004.07.020; Iwafune Y, 2002, ELECTROPHORESIS, V23, P329, DOI 10.1002/1522-2683(200202)23:2<329::AID-ELPS329>3.0.CO;2-1; Katayama H, 2001, RAPID COMMUN MASS SP, V15, P1416, DOI 10.1002/rcm.379; Kimura Y, 2000, J BIOL CHEM, V275, P4635, DOI 10.1074/jbc.275.7.4635; Li QB, 2005, J PROTEOME RES, V4, P112, DOI 10.1021/pr049832c; Li QB, 2005, J PROTEOME RES, V4, P129, DOI 10.1021/pr049831k; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Luo HW, 2002, APPL ENVIRON MICROB, V68, P1173, DOI 10.1128/AEM.68.3.1173-1179.2002; Morgan RM, 1997, J BACTERIOL, V179, P889, DOI 10.1128/jb.179.3.889-898.1997; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PIHL TD, 1994, J BACTERIOL, V176, P6384, DOI 10.1128/jb.176.20.6384-6391.1994; Reeve JN, 1997, J BACTERIOL, V179, P5975, DOI 10.1128/jb.179.19.5975-5986.1997; RUBIN DM, 1995, CURR BIOL, V5, P854, DOI 10.1016/S0960-9822(95)00172-2; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Sekiguchi Y, 2000, INT J SYST EVOL MICR, V50, P771, DOI 10.1099/00207713-50-2-771; STAMS AJM, 1994, ANTON LEEUW INT J G, V66, P271, DOI 10.1007/BF00871644; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Zhu WH, 2004, J PROTEOME RES, V3, P538, DOI 10.1021/pr034109s	34	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24309	10.1371/journal.pone.0024309	http://dx.doi.org/10.1371/journal.pone.0024309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904627	gold, Green Submitted, Green Published			2022-12-25	WOS:000294680800081
J	Obara, Y; Ueno, S; Yanagihata, Y; Nakahata, N				Obara, Yutaro; Ueno, Sanae; Yanagihata, Yoshimi; Nakahata, Norimichi			Lysophosphatidylinositol Causes Neurite Retraction via GPR55, G(13) and RhoA in PC12 Cells	PLOS ONE			English	Article							CANNABINOID RECEPTOR; ENDOCANNABINOID SYSTEM; FIREFLY LUCIFERASE; ACTIVATION; ACID; IDENTIFICATION; PHARMACOLOGY; LIGAND; BRAIN; EXPRESSION	GPR55 was recently identified as a putative receptor for certain cannabinoids, and lysophosphatidylinositol (LPI). Recently, the role of cannabinoids as GPR55 agonists has been disputed by a number of reports, in part, because studies investigating GPR55 often utilized overexpression systems, such as the GPR55-overexpressing HEK293 cells, which make it difficult to deduce the physiological role of endogenous GPR55. In the present study, we found that PC12 cells, a neural model cell line, express endogenous GPR55, and by using these cells, we were able to examine the role of endogenous GPR55. Although GPR55 mRNA and protein were expressed in PC12 cells, neither CB1 nor CB2 mRNA was expressed in these cells. GPR55 was predominantly localized on the plasma membrane in undifferentiated PC12 cells. However, GPR55 was also localized in the growth cones or the ruffled border in differentiated PC12 cells, suggesting a potential role for GPR55 in the regulation of neurite elongation. LPI increased intracellular Ca2+ concentration and RhoA activity, and induced ERK1/2 phosphorylation, whereas endogenous and synthetic cannabinoids did not, thereby suggesting that cannabinoids are not GPR55 agonists. LPI also caused neurite retraction in a time-dependent manner accompanied by the loss of neurofilament light chain and redistribution of actin in PC12 cells differentiated by NGF. This LPI-induced neurite retraction was found to be G(q)-independent and G(13)-dependent. Furthermore, inactivation of RhoA function via C3 toxin and GPR55 siRNA knockdown prevented LPI-induced neurite retraction. These results suggest that LPI, and not cannabinoids, causes neurite retraction in differentiated PC12 cells via a GPR55, G(13) and RhoA signaling pathway.	[Obara, Yutaro; Ueno, Sanae; Yanagihata, Yoshimi; Nakahata, Norimichi] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Cellular Signaling, Sendai, Miyagi 980, Japan	Tohoku University	Obara, Y (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Cellular Signaling, Sendai, Miyagi 980, Japan.	obaray@mail.pharm.tohoku.ac.jp			Japan Society for the Promotion of Science [20790053, 19659011]; Tohoku University; The Research Foundation for Pharmaceutical Sciences	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tohoku University; The Research Foundation for Pharmaceutical Sciences	This work was supported, in part, by Grants-in-Aid from the Japan Society for the Promotion of Science (No. 20790053 to YO and No. 19659011 to NN), the Exploratory Research Program for Young Scientists of Tohoku University (to YO) and The Research Foundation for Pharmaceutical Sciences (to YO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2004, J BIOL CHEM, V279, P713, DOI 10.1074/jbc.M306382200; Binkowski B, 2009, CURR OPIN BIOTECH, V20, P14, DOI 10.1016/j.copbio.2009.02.013; Brown AJ, 2007, BRIT J PHARMACOL, V152, P567, DOI 10.1038/sj.bjp.0707481; Centonze D, 2007, TRENDS PHARMACOL SCI, V28, P180, DOI 10.1016/j.tips.2007.02.004; Chiba T, 2011, J PHARM PHARMACOL, V63, P636, DOI 10.1111/j.2042-7158.2011.01250.x; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Fan F, 2008, ACS CHEM BIOL, V3, P346, DOI 10.1021/cb8000414; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; Henstridge CM, 2009, FASEB J, V23, P183, DOI 10.1096/fj.08-108670; Higgs HN, 1998, J BIOL CHEM, V273, P5468, DOI 10.1074/jbc.273.10.5468; Honma S, 2006, EUR J PHARMACOL, V545, P100, DOI 10.1016/j.ejphar.2006.06.062; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Kapur A, 2009, J BIOL CHEM, V284, P29817, DOI 10.1074/jbc.M109.050187; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Ma MT, 2010, J NEURAL TRANSM, V117, P301, DOI 10.1007/s00702-009-0355-1; Maruyama Y, 2002, CIRC RES, V91, P961, DOI 10.1161/01.RES.0000043282.39776.7C; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; METZ SA, 1986, BIOCHEM BIOPH RES CO, V138, P720, DOI 10.1016/S0006-291X(86)80556-3; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Nakamura T, 2005, MOL BRAIN RES, V139, P277, DOI 10.1016/j.molbrainres.2005.05.030; Obara Y, 2004, J CELL SCI, V117, P6085, DOI 10.1242/jcs.01527; Obara Yutaro, 2010, Folia Pharmacologica Japonica, V136, P285, DOI 10.1254/fpj.136.285; Obara Y, 2009, J BIOL CHEM, V284, P23564, DOI 10.1074/jbc.M109.027821; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Oka S, 2009, J BIOCHEM, V145, P13, DOI 10.1093/jb/mvn136; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Pineiro R, 2011, ONCOGENE, V30, P142, DOI 10.1038/onc.2010.417; Ross RA, 2009, TRENDS PHARMACOL SCI, V30, P156, DOI 10.1016/j.tips.2008.12.004; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sawzdargo M, 1999, MOL BRAIN RES, V64, P193, DOI 10.1016/S0169-328X(98)00277-0; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tigyi G, 1996, J NEUROCHEM, V66, P537; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200; Yamashita A, 2010, BBA-MOL CELL BIOL L, V1801, P711, DOI 10.1016/j.bbalip.2010.03.012; Yamazaki J, 2008, BIOL PHARM BULL, V31, P2216, DOI 10.1248/bpb.31.2216	40	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24284	10.1371/journal.pone.0024284	http://dx.doi.org/10.1371/journal.pone.0024284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904624	Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800078
J	Kim, ED; Chen, ZJ				Kim, Eun-Deok; Chen, Z. Jeffery			Unstable Transcripts in Arabidopsis Allotetraploids Are Associated with Nonadditive Gene Expression in Response to Abiotic and Biotic Stresses	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; GENOME-WIDE ANALYSIS; MODEL DATA-ANALYSIS; MICROARRAY ANALYSIS; KEY PATHWAYS; DECAY-RATES; DATA SET; POLYPLOIDY; MECHANISMS; ACCUMULATION	Genome-wide analysis has documented differential gene expression between closely related species in plants and animals and nonadditive gene expression in hybrids and allopolyploids compared to the parents. In Arabidopsis, 15-43% of genes are expressed differently between the related species, Arabidopsis thaliana and Arabidopsis arenosa, the majority of which are nonadditively expressed (differently from mid-parent value) in allotetraploids. Nonadditive gene expression can be caused by transcriptional regulation through chromatin modifications, but the role of posttranscriptional regulation in nonadditive gene expression is largely unknown. Here we reported genome-wide analysis of mRNA decay in resynthesized Arabidopsis allotetraploids. Among,26,000 annotated genes, over 1% of gene transcripts showed rapid decay with an estimated half-life of less than 60 minutes, and they are called allotetraploid genes with unstable transcripts (AlloGUTs). Remarkably, 30% of alloGUTs matched the nonadditively expressed genes, and their expression levels were negatively correlated with the decay rate. Compared to all genes, these nonadditively expressed alloGUTs were overrepresented 2-6-fold in the Gene Ontology (GOSlim) classifications in response to abiotic and biotic stresses, signal transduction, and transcription. Interestingly, the AlloGUTs include transcription factor genes that are highly inducible under stress conditions and circadian clock regulators that regulate growth in A. thaliana. These data suggest a role of mRNA stability in homoeologous gene expression in Arabidopsis allopolyploids. The enrichment of nonadditively expressed genes in stress-related pathways were commonly observed in Arabidopsis and other allopolyploids such as wheat and cotton, which may suggest a role for stress-mediated growth vigor in hybrids and allopolyploids.	[Kim, Eun-Deok] Univ Texas Austin, Sect Mol Cell & Dev Biol, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Kim, ED (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA.	zjchen@mail.utexas.edu		KIM, EUN-DEOK/0000-0002-0593-4553	National Institutes of Health [GM067015]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work is supported by the grant from the National Institutes of Health (GM067015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becak ML, 1998, CYTOGENET CELL GENET, V80, P28, DOI 10.1159/000014952; Berrocal-Lobo M, 2002, PLANT PHYSIOL, V128, P951, DOI 10.1104/pp.010685; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; Casneuf T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r13; Chague V, 2010, NEW PHYTOL, V187, P1181, DOI 10.1111/j.1469-8137.2010.03339.x; Chen CYA, 2008, METHOD ENZYMOL, V448, P335, DOI 10.1016/S0076-6879(08)02617-7; Chen M, 2008, GENETICS, V178, P1845, DOI 10.1534/genetics.107.086272; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Chen ZJ, 2010, TRENDS PLANT SCI, V15, P57, DOI 10.1016/j.tplants.2009.12.003; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elkon R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-259; Fan JS, 2002, P NATL ACAD SCI USA, V99, P10611, DOI 10.1073/pnas.162212399; Farina L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000141; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Flagel L, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-16; Foat BC, 2005, P NATL ACAD SCI USA, V102, P17675, DOI 10.1073/pnas.0503803102; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Goda H, 2008, PLANT J, V55, P526, DOI [10.1111/j.1365-313X.2008.03510.x, 10.1111/j.0960-7412.2008.03510.x]; Grant V., 1981, PLANT SPECIATION, Vsecond; Grant-Downton RT, 2006, ANN BOT-LONDON, V97, P11, DOI 10.1093/aob/mcj001; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Gutierrez RA, 2002, P NATL ACAD SCI USA, V99, P11513, DOI 10.1073/pnas.152204099; Ha M, 2009, P NATL ACAD SCI USA, V106, P2295, DOI 10.1073/pnas.0807350106; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hazen SP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r17; Hovav R, 2008, P NATL ACAD SCI USA, V105, P6191, DOI 10.1073/pnas.0711569105; Jackson S, 2010, CURR OPIN PLANT BIOL, V13, P153, DOI 10.1016/j.pbi.2009.11.004; Johnson MA, 2000, P NATL ACAD SCI USA, V97, P13991, DOI 10.1073/pnas.240354097; JORGENSEN R, 1990, TRENDS BIOTECHNOL, V8, P340, DOI 10.1016/0167-7799(90)90220-R; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; KOSHIBA T, 1995, J MOL BIOL, V253, P396, DOI 10.1006/jmbi.1995.0562; Kumpatla SP, 1997, PLANT PHYSIOL, V115, P361, DOI 10.1104/pp.115.2.361; Lam LT, 2001, GENOME BIOL, V2; Lee HS, 2004, PLANT BIOTECHNOL J, V2, P45, DOI 10.1046/j.1467-7652.2003.00048.x; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Liu ZL, 2007, CURR BIOL, V17, P1669, DOI 10.1016/j.cub.2007.08.030; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; MCCLURE BA, 1989, SCIENCE, V243, P91, DOI 10.1126/science.11540631; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Molina-Navarro MM, 2008, J BIOL CHEM, V283, P17908, DOI 10.1074/jbc.M800295200; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Narsai R, 2007, PLANT CELL, V19, P3418, DOI 10.1105/tpc.107.055046; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; PalBhadra M, 1997, CELL, V90, P479, DOI 10.1016/S0092-8674(00)80508-5; Peltz Stuart W., 1992, Current Opinion in Cell Biology, V4, P979, DOI 10.1016/0955-0674(92)90129-Z; Pikaard CS, 2000, TRENDS GENET, V16, P495, DOI 10.1016/S0168-9525(00)02113-2; Pruneda-Paz JL, 2010, TRENDS PLANT SCI, V15, P259, DOI 10.1016/j.tplants.2010.03.003; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Pumphrey M, 2009, GENETICS, V181, P1147, DOI 10.1534/genetics.108.096941; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; SEELEY KA, 1992, PLANT CELL, V4, P29, DOI 10.1105/tpc.4.1.29; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Tian L, 2005, GENETICS, V169, P337, DOI 10.1534/genetics.104.033142; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; Wang JL, 2004, GENETICS, V167, P1961, DOI 10.1534/genetics.104.027896; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; WILSON T, 1988, EMBO J, V7, P4193, DOI 10.1002/j.1460-2075.1988.tb03316.x; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Yakir E, 2007, FEBS J, V274, P335, DOI 10.1111/j.1742-4658.2006.05616.x; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Zimmermann P, 2008, MOL PLANT, V1, P1088, DOI 10.1093/mp/ssn093	76	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e24251	10.1371/journal.pone.0024251	http://dx.doi.org/10.1371/journal.pone.0024251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897874	Green Submitted, gold, Green Published			2022-12-25	WOS:000294676900039
J	Koefoed, P; Andreassen, OA; Bennike, B; Dam, H; Djurovic, S; Hansen, T; Jorgensen, MB; Kessing, LV; Melle, I; Moller, GL; Mors, O; Werge, T; Mellerup, E				Koefoed, Pernille; Andreassen, Ole A.; Bennike, Bente; Dam, Henrik; Djurovic, Srdjan; Hansen, Thomas; Jorgensen, Martin Balslev; Kessing, Lars Vedel; Melle, Ingrid; Moller, Gert Lykke; Mors, Ole; Werge, Thomas; Mellerup, Erling			Combinations of SNPs Related to Signal Transduction in Bipolar Disorder	PLOS ONE			English	Article							EPISTATIC INTERACTIONS; BIAXIAL MODEL; SCHIZOPHRENIA; ASSOCIATION; GENES; DYSFUNCTION; MECHANISM; PATHWAYS; GENETICS; CHANNELS	Any given single nucleotide polymorphism (SNP) in a genome may have little or no functional impact. A biologically significant effect may possibly emerge only when a number of key SNP-related genotypes occur together in a single organism. Thus, in analysis of many SNPs in association studies of complex diseases, it may be useful to look at combinations of genotypes. Genes related to signal transmission, e.g., ion channel genes, may be of interest in this respect in the context of bipolar disorder. In the present study, we analysed 803 SNPs in 55 genes related to aspects of signal transmission and calculated all combinations of three genotypes from the 3x803 SNP genotypes for 1355 controls and 607 patients with bipolar disorder. Four clusters of patient-specific combinations were identified. Permutation tests indicated that some of these combinations might be related to bipolar disorder. The WTCCC bipolar dataset were use for replication, 469 of the 803 SNP were present in the WTCCC dataset either directly (n = 132) or by imputation (n = 337) covering 51 of our selected genes. We found three clusters of patient-specific 3xSNP combinations in the WTCCC dataset. Different SNPs were involved in the clusters in the two datasets. The present analyses of the combinations of SNP genotypes support a role for both genetic heterogeneity and interactions in the genetic architecture of bipolar disorder.	[Koefoed, Pernille; Bennike, Bente; Mellerup, Erling] Univ Copenhagen, Dept Neurosci & Pharmacol, Lab Neuropsychiat, Copenhagen, Denmark; [Koefoed, Pernille; Dam, Henrik; Jorgensen, Martin Balslev; Kessing, Lars Vedel] Rigshosp, Copenhagen Univ Hosp, Dept O, Psychiat Ctr Copenhagen, DK-2100 Copenhagen, Denmark; [Andreassen, Ole A.; Melle, Ingrid] Oslo Univ Hosp, Dept Psychiat, Oslo, Norway; [Andreassen, Ole A.; Djurovic, Srdjan; Melle, Ingrid] Univ Oslo, Inst Psychiat, Oslo, Norway; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Hansen, Thomas; Werge, Thomas] Copenhagen Univ Hosp, Dept Biol Psychiat, Mental Hlth Ctr Sct Hans, Roskilde, Denmark; [Mors, Ole] Aarhus Univ Hosp, Ctr Psychiat Res, Risskov, Denmark; [Moller, Gert Lykke] Tech Univ Denmark, ScionDTU, Genokey ApS, Horsholm, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Oslo; University of Oslo; University of Oslo; University of Copenhagen; Aarhus University; Technical University of Denmark	Koefoed, P (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Lab Neuropsychiat, Copenhagen, Denmark.	pkoefoed@sund.ku.dk	Werge, Thomas/G-7263-2012; Hansen, Thomas/GWZ-2858-2022; Melle, Ingrid S/B-4858-2011; Andreassen, Ole A./AAY-7531-2020; Jorgensen, Martin Balslev MBJ/K-5758-2012; Hansen, Thomas Folkmann/O-5965-2014	Melle, Ingrid S/0000-0002-9783-548X; Jorgensen, Martin Balslev MBJ/0000-0002-1321-8901; Hansen, Thomas Folkmann/0000-0001-6703-7762; Djurovic, Srdjan/0000-0002-8140-8061; Kessing, Lars/0000-0001-9377-9436; Mors, Ole/0000-0002-5660-0393; Andreassen, Ole A./0000-0002-4461-3568	Lundbeck Foundation; Danish National Psychiatric Research Foundation; A. P. Moeller and Hustru Chastine Mc-Kinney Moellers Foundation; Ivan Nielsen Foundation; Stanley Research Foundation; Stanley Medical Research Institute; University of Oslo; Research Council of Norway; South East Norway Health Authority; Uppsala University; Uppsala University Hospital; Knut and Alice Wallenberg Foundation; Wellcome Trust [076113]; MRC [G1001799] Funding Source: UKRI; Medical Research Council [G1001799] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Danish National Psychiatric Research Foundation; A. P. Moeller and Hustru Chastine Mc-Kinney Moellers Foundation; Ivan Nielsen Foundation; Stanley Research Foundation; Stanley Medical Research Institute; University of Oslo; Research Council of Norway(Research Council of Norway); South East Norway Health Authority; Uppsala University; Uppsala University Hospital; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by the Lundbeck Foundation, the Danish National Psychiatric Research Foundation, A. P. Moeller and Hustru Chastine Mc-Kinney Moellers Foundation, Ivan Nielsen Foundation, Stanley Research Foundation, Stanley Medical Research Institute, grants to the TOP study group from the University of Oslo, the Research Council of Norway, and the South East Norway Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank patients and controls for their participation in the study and the health professionals who facilitated our work. We thank Kristina Larsson, Per Lundmark, Tomas Axelsson, and Ann-Christine Syvanen at the SNP Technology Platform in Uppsala for performing the genotyping. The SNP Technology Platform is supported by Uppsala University, Uppsala University Hospital, and by the Knut and Alice Wallenberg Foundation.; This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for that project was provided by the Wellcome Trust under award 076113.	Alvarez J, 2001, MED HYPOTHESES, V56, P672, DOI 10.1054/mehy.2000.1269; Askland K, 2006, J AFFECT DISORDERS, V94, P35, DOI 10.1016/j.jad.2006.01.033; Askland K, 2006, J AFFECT DISORDERS, V94, P15, DOI 10.1016/j.jad.2006.02.024; Askland K, 2009, HUM GENET, V125, P63, DOI 10.1007/s00439-008-0600-y; BANKS RE, 1989, J AFFECT DISORDERS, V16, P259, DOI 10.1016/0165-0327(89)90081-5; Barnett JH, 2009, NEUROSCIENCE, V164, P331, DOI 10.1016/j.neuroscience.2009.03.080; Bosetti F, 2005, BRAIN RES BULL, V65, P331, DOI 10.1016/j.brainresbull.2005.01.004; Boulesteix AL, 2007, STAT APPL GENET MOL, V6; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carter CJ, 2007, NEUROCHEM INT, V50, P461, DOI 10.1016/j.neuint.2006.11.009; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Espinosa F, 2004, GENES BRAIN BEHAV, V3, P90, DOI 10.1046/j.1601-183x.2003.00054.x; Faraone SV, 2003, AM J MED GENET C, V123C, P1, DOI 10.1002/ajmg.c.20017; Franksen OI, 1994, BOST STUD PHILOS SCI, V187, P303; Garcia-Magarinos M, 2009, ANN HUM GENET, V73, P360, DOI 10.1111/j.1469-1809.2009.00511.x; Hoffman RE, 2001, BIOL PSYCHIAT, V49, P500, DOI 10.1016/S0006-3223(00)01071-4; Hong MG, 2009, HUM GENET, V126, P289, DOI 10.1007/s00439-009-0676-z; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; Kahler AK, 2010, AM J MED GENET B, V153B, P86, DOI 10.1002/ajmg.b.30958; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mellerup E, 2004, MED HYPOTHESES, V63, P464, DOI 10.1016/j.mehy.2004.03.007; MORE T, 1973, IBM J RES DEV, V17, P135, DOI 10.1147/rd.172.0135; Newton JR, 1999, MED HYPOTHESES, V52, P77, DOI 10.1054/mehy.1997.0610; O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7; Ogden CA, 2004, MOL PSYCHIATR, V9, P1007, DOI 10.1038/sj.mp.4001547; PETTEGREW JW, 1982, J AFFECT DISORDERS, V4, P237, DOI 10.1016/0165-0327(82)90008-8; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Rasband MN, 2004, J NEUROSCI RES, V76, P749, DOI 10.1002/jnr.20073; Roy K, 2007, P NATL ACAD SCI USA, V104, P8131, DOI 10.1073/pnas.0702157104; Saugstad LF, 2001, MED HYPOTHESES, V57, P679, DOI 10.1054/mehy.2001.1391; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Tang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019073; Tesli M, 2009, PSYCHIAT GENET, V19, P269, DOI 10.1097/YPG.0b013e32832d302f; Thiruvengadam A, 2001, J AFFECT DISORDERS, V65, P95, DOI 10.1016/S0165-0327(00)00216-0; Thornton-Wells TA, 2004, TRENDS GENET, V20, P640, DOI 10.1016/j.tig.2004.09.007; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; van West D, 2004, MOL PSYCHIATR, V9, P287, DOI 10.1038/sj.mp.4001420; Wilson GM, 2006, HUM MOL GENET, V15, P743, DOI 10.1093/hmg/ddi489; Wu J, 2010, GENET EPIDEMIOL, V34, P275, DOI 10.1002/gepi.20459; Xie Q, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S4; Yang C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S18; Yang C, 2009, BIOINFORMATICS, V25, P504, DOI 10.1093/bioinformatics/btn652; Zamar D, 2009, BIOINFORMATICS, V25, P2444, DOI 10.1093/bioinformatics/btp431; Zandi PP, 2007, MOL PSYCHIATR, V12, P630, DOI 10.1038/sj.mp.4002027	48	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23812	10.1371/journal.pone.0023812	http://dx.doi.org/10.1371/journal.pone.0023812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897858	Green Published, Green Submitted, gold			2022-12-25	WOS:000294676900021
J	Wang, CB; Cao, DS; Wang, Q; Wang, DZ				Wang, Chunbo; Cao, Dongsun; Wang, Qing; Wang, Da-Zhi			Synergistic Activation of Cardiac Genes by Myocardin and Tbx5	PLOS ONE			English	Article							HOLT-ORAM-SYNDROME; SMOOTH-MUSCLE DIFFERENTIATION; SERUM RESPONSE FACTOR; CONGENITAL HEART-DISEASE; TRANSCRIPTION FACTOR-B; CARDIOVASCULAR DEVELOPMENT; SUBCELLULAR-LOCALIZATION; EXPRESSION; MUTATIONS; FAMILY	Myocardial differentiation is associated with the activation and expression of an array of cardiac specific genes. However, the transcriptional networks that control cardiac gene expression are not completely understood. Myocardin is a cardiac and smooth muscle-specific expressed transcriptional coactivator of Serum Response Factor (SRF) and is able to potently activate cardiac and smooth muscle gene expression during development. We hypothesize that myocardin discriminates between cardiac and smooth muscle specific genes by associating with distinct co-factors. Here, we show that myocardin directly interacts with Tbx5, a member of the T-box family of transcription factors involved in the Holt-Oram syndrome. Tbx5 synergizes with myocardin to activate expression of the cardiac specific genes atrial natriuretic factor (ANF) and alpha myosin heavy chain (alpha-MHC), but not that of smooth muscle specific genes SM22 or smooth muscle myosin heavy chain (SM-MHC). We found that this synergistic activation of shared target genes is dependent on the binding sites for Tbx5, T-box factor-Binding Elements (TBEs). Myocardin and Tbx5 physically interact and their interaction domains were mapped to the basic domain and the coil domain of myocardin and Tbx5, respectively. Our analysis demonstrates that the Tbx5G80R mutation, which leads to the Holt-Oram syndrome in humans, failed to synergize with myocardin to activate cardiac gene expression. These data uncover a key role for Tbx5 and myocardin in establishing the transcriptional foundation for cardiac gene activation and suggest that the interaction of myocardin and Tbx5 maybe involved in cardiac development and diseases.	[Wang, Chunbo; Cao, Dongsun; Wang, Da-Zhi] Univ N Carolina, UNC McAllister Heart Inst, Chapel Hill, NC 27515 USA; [Wang, Da-Zhi] Harvard Univ, Sch Med, Dept Cardiol, Childrens Hosp Boston, Boston, MA USA; [Wang, Chunbo; Cao, Dongsun; Wang, Da-Zhi] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Wang, Qing] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44106 USA	University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Boston Children's Hospital; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; Cleveland Clinic Foundation	Wang, CB (corresponding author), Univ N Carolina, UNC McAllister Heart Inst, Chapel Hill, NC 27515 USA.	dwang@enders.tch.harvard.edu			National Heart, Lung, and Blood Institute of the National Institutes of Health [HL085635, HL075251]; March of Dimes Foundation; Muscular Dystrophy Association; American Heart Association; Wang lab; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085635, R01HL075251] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); March of Dimes Foundation(March of Dimes); Muscular Dystrophy Association(Muscular Dystrophy Association); American Heart Association(American Heart Association); Wang lab; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The project was supported by HL085635 and HL075251 from the National Heart, Lung, and Blood Institute of the National Institutes of Health, March of Dimes Foundation, Muscular Dystrophy Association and American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the Wang lab for their support and discussion. We thank Dr. Frank Conlon for discussion and Dr. John Mably for reading the manuscript and comments. DZ Wang is an Established Investigator of the American Heart Association.	Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Bimber B, 2007, DEV BIOL, V302, P230, DOI 10.1016/j.ydbio.2006.09.023; Brown DD, 2005, DEVELOPMENT, V132, P553, DOI 10.1242/dev.01596; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Callis TE, 2005, CIRC RES, V97, P992, DOI 10.1161/01.RES.0000190670.92879.7d; Camarata T, 2006, J CELL BIOL, V174, P339, DOI 10.1083/jcb.200511109; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Clark KL, 2006, ANNU REV PHYSIOL, V68, P97, DOI 10.1146/annurev.physiol.68.040104.113828; DIXON JW, 1993, J MED GENET, V30, P70, DOI 10.1136/jmg.30.1.70; Fan C, 2003, J BIOL CHEM, V278, P8780, DOI 10.1074/jbc.M208120200; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Ghosh TK, 2001, HUM MOL GENET, V10, P1983, DOI 10.1093/hmg/10.18.1983; Ghosh TK, 2009, MOL CELL BIOL, V29, P2205, DOI 10.1128/MCB.01923-08; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Heinritz Wolfram, 2005, Hum Mutat, V26, P397, DOI 10.1002/humu.9375; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Huang JH, 2009, P NATL ACAD SCI USA, V106, P18734, DOI 10.1073/pnas.0910749106; Koshiba-Takeuchi K, 2006, NAT GENET, V38, P175, DOI 10.1038/ng1707; Li J, 2005, P NATL ACAD SCI USA, V102, P8916, DOI 10.1073/pnas.0503741102; Li QY, 1997, NAT GENET, V15, P21; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Liberatore CM, 2000, DEV BIOL, V223, P169, DOI 10.1006/dbio.2000.9748; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Maitra M, 2009, DEV BIOL, V326, P368, DOI 10.1016/j.ydbio.2008.11.004; MELNYK AR, 1981, AM J MED GENET, V10, P357, DOI 10.1002/ajmg.1320100408; Mori AD, 2004, CURR OPIN CARDIOL, V19, P211, DOI 10.1097/00001573-200405000-00004; Mori AD, 2006, DEV BIOL, V297, P566, DOI 10.1016/j.ydbio.2006.05.023; Moskowitz IPG, 2007, CELL, V129, P1365, DOI 10.1016/j.cell.2007.04.036; Oh J, 2004, MOL CELL BIOL, V24, P8519, DOI 10.1128/MCB.24.19.8519-8528.2004; Oh JY, 2005, P NATL ACAD SCI USA, V102, P15122, DOI 10.1073/pnas.0507346102; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Stennard FA, 2005, DEVELOPMENT, V132, P4897, DOI 10.1242/dev.02099; Sun Y, 2006, MOL CELL BIOL, V26, P5809, DOI 10.1128/MCB.00024-06; Tang RH, 2008, P NATL ACAD SCI USA, V105, P3362, DOI 10.1073/pnas.0705842105; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Zhu Y, 2008, P NATL ACAD SCI USA, V105, P5519, DOI 10.1073/pnas.0801779105	45	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e24242	10.1371/journal.pone.0024242	http://dx.doi.org/10.1371/journal.pone.0024242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897873	Green Published, gold, Green Submitted			2022-12-25	WOS:000294676900038
J	Trigg, J; Gutwin, K; Keating, AE; Berger, B				Trigg, Jason; Gutwin, Karl; Keating, Amy E.; Berger, Bonnie			Multicoil2: Predicting Coiled Coils and Their Oligomerization States from Sequence in the Twilight Zone	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; SPINDLE POLE; PROTEIN; DOMAINS; TRIMERIZATION; PARALLEL; DATABASE; REVEALS; PROGRAM; ASTRIN	The alpha-helical coiled coil can adopt a variety of topologies, among the most common of which are parallel and antiparallel dimers and trimers. We present Multicoil2, an algorithm that predicts both the location and oligomerization state (two versus three helices) of coiled coils in protein sequences. Multicoil2 combines the pairwise correlations of the previous Multicoil method with the flexibility of Hidden Markov Models (HMMs) in a Markov Random Field (MRF). The resulting algorithm integrates sequence features, including pairwise interactions, through multinomial logistic regression to devise an optimized scoring function for distinguishing dimer, trimer and non-coiled-coil oligomerization states; this scoring function is used to produce Markov Random Field potentials that incorporate pairwise correlations localized in sequence. Multicoil2 significantly improves both coiled-coil detection and dimer versus trimer state prediction over the original Multicoil algorithm retrained on a newly-constructed database of coiled-coil sequences. The new database, comprised of 2,105 sequences containing 124,088 residues, includes reliable structural annotations based on experimental data in the literature. Notably, the enhanced performance of Multicoil2 is evident when tested in stringent leave-family-out cross-validation on the new database, reflecting expected performance on challenging new prediction targets that have minimal sequence similarity to known coiled-coil families. The Multicoil2 program and training database are available for download from http://multicoil2.csail.mit.edu.	[Trigg, Jason; Berger, Bonnie] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Gutwin, Karl; Keating, Amy E.] MIT, Dept Biol, Cambridge, MA USA; [Berger, Bonnie] MIT, Dept Math, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Trigg, J (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	keating@mit.edu; bab@mit.edu		Keating, Amy/0000-0003-4074-8980	National Institute of Health [1R01GM081871]; National Science Foundation [MCB-0347203, 0821391]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081871] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute of Health: 1R01GM081871 (to BB) and by the National Science Foundation: MCB-0347203 (to AEK), and used computing equipment provided under National Science Foundation Grant No. 0821391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agou F, 2002, J BIOL CHEM, V277, P17464, DOI 10.1074/jbc.M201964200; Alfadhli A, 2002, J BIOL CHEM, V277, P27103, DOI 10.1074/jbc.M203395200; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Apgar JR, 2008, PROTEINS, V72, P1048, DOI 10.1002/prot.22118; Bartoli L, 2009, BIOINFORMATICS, V25, P2757, DOI 10.1093/bioinformatics/btp539; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Benson DA, 2009, NUCLEIC ACIDS RES, V37, pD26, DOI 10.1093/nar/gkn723; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Craig AWB, 1999, J BIOL CHEM, V274, P19934, DOI 10.1074/jbc.274.28.19934; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Frank S, 2002, J BIOL CHEM, V277, P19071, DOI 10.1074/jbc.M202146200; Galkin VE, 2008, SCIENCE, V320, P382, DOI 10.1126/science.1155307; Gruber J, 2002, J CELL SCI, V115, P4053, DOI 10.1242/jcs.00088; Gruber M, 2006, J STRUCT BIOL, V155, P140, DOI 10.1016/j.jsb.2006.03.009; HARBORTH J, 1995, EMBO J, V14, P2447, DOI 10.1002/j.1460-2075.1995.tb07242.x; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hase ME, 2001, MOL BIOL CELL, V12, P2433, DOI 10.1091/mbc.12.8.2433; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Holland RCG, 2008, BIOINFORMATICS, V24, P2096, DOI 10.1093/bioinformatics/btn397; Hubbard TJP, 1997, NUCLEIC ACIDS RES, V25, P236, DOI 10.1093/nar/25.1.236; Kammerer RA, 1998, J BIOL CHEM, V273, P10602, DOI 10.1074/jbc.273.17.10602; KILMARTIN JV, 1993, J CELL BIOL, V123, P1175, DOI 10.1083/jcb.123.5.1175; Krause A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-15; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Martin SL, 2000, J MOL BIOL, V304, P11, DOI 10.1006/jmbi.2000.4182; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Misenheimer TM, 2000, J BIOL CHEM, V275, P40938, DOI 10.1074/jbc.M007022200; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Rackham OJL, 2010, J MOL BIOL, V403, P480, DOI 10.1016/j.jmb.2010.08.032; Ramos J, 2006, J AM CHEM SOC, V128, P15499, DOI 10.1021/ja0655284; Rose A, 2004, CELL MOL LIFE SCI, V61, P1996, DOI 10.1007/s00018-004-4039-6; StataCorp, 2009, STAT STAT SOFTW REL; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tai LJ, 2002, J BIOL CHEM, V277, P735, DOI 10.1074/jbc.M108604200; Testa OD, 2009, NUCLEIC ACIDS RES, V37, pD315, DOI 10.1093/nar/gkn675; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606	41	54	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23519	10.1371/journal.pone.0023519	http://dx.doi.org/10.1371/journal.pone.0023519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901122	Green Published, gold, Green Submitted			2022-12-25	WOS:000294298000007
J	Aimbetov, R; Chen, CH; Bulgakova, O; Abetov, D; Bissenbaev, AK; Bersimbaev, RI; Sarbassov, DD				Aimbetov, R.; Chen, C-H; Bulgakova, O.; Abetov, D.; Bissenbaev, A. K.; Bersimbaev, R. I.; Sarbassov, D. D.			Integrity of mTORC2 is dependent on the rictor Gly-934 site	ONCOGENE			English	Article						cell signaling; mTORC2; Akt; complex assembly; kinase	PROTEIN-KINASE B; CAENORHABDITIS-ELEGANS; TYROSINE KINASE; GROWTH-FACTORS; BREAST-CANCER; PHOSPHORYLATION; ACTIVATION; PATHWAY; COMPONENT; AKT/PKB	Growth factor signaling coupled to activation of the phosphatidylinositol-3-OH kinase (PI3K)/Akt pathway plays a crucial role in the regulation of cell proliferation and survival. The key regulatory kinase of Akt has been identified as mammalian target of rapamycin complex 2 (mTORC2), which functions as the PI3K-dependent Ser-473 kinase of Akt. This kinase complex is assembled by mTOR and its essential components rictor, Sin1 and mLST8. The recent genetic screening study in Caenorhabditis elegans has linked a specific point mutation of rictor to an elevated storage of fatty acids that resembles the rictor deficiency phenotype. In our study, we show that in mammalian cells the analogous single rictor point mutation (G934E) prevents the binding of rictor to Sin1 and the assembly of mTORC2, but this mutation does not interfere with the binding of the rictor-interacting protein Protor. A substitution of the rictor Gly-934 residue to a charged amino acid prevents formation of the rictor/Sin1 heterodimer. The cells expressing the rictor G934E mutant remain deficient in the mTORC2 signaling, as detected by the reduced phosphorylation of Akt on Ser-473 and a low cell proliferation rate. Thus, although a full length of rictor is required to interact with its binding partner Sin1, a single amino acid of rictor Gly-934 controls its interaction with Sin1 and assembly of mTORC2. Oncogene (2012) 31, 2115-2120; doi: 10.1038/onc.2011.404; published online 12 September 2011	[Aimbetov, R.; Chen, C-H; Bulgakova, O.; Abetov, D.; Sarbassov, D. D.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Aimbetov, R.; Abetov, D.; Bissenbaev, A. K.] al Farabi Kazakh Natl Univ, Dept Genet & Mol Biol, Alma Ata, Kazakhstan; [Chen, C-H; Sarbassov, D. D.] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX USA; [Bulgakova, O.; Bersimbaev, R. I.] LN Gumilyov Eurasian Natl Univ, Dept Nat Sci, Astana, Kazakhstan	University of Texas System; UTMD Anderson Cancer Center; Al-Farabi Kazakh National University; L.N. Gumilyov Eurasian National University	Sarbassov, DD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	dsarbass@mdanderson.org	Abetov, Danysh/P-7853-2014; Sarbassov, Dos/AAS-4950-2020; Aimbetov, Rakhan/H-2966-2015; Bulgakova, Olga/P-7825-2014; Bissenbaev, Amangeldy/B-1767-2015	Aimbetov, Rakhan/0000-0003-0131-4530; Bulgakova, Olga/0000-0003-3272-0638; Sarbassov, Dos/0000-0002-6848-1133; Bissenbaev, Amangeldy/0000-0001-7837-8685	MD Anderson Trust; NIH [CA133522]; Ph.D. training grants from Kazakhstan; NATIONAL CANCER INSTITUTE [R01CA133522] Funding Source: NIH RePORTER	MD Anderson Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ph.D. training grants from Kazakhstan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the MD Anderson Trust Fellow Fund and NIH grant CA133522 (DDS). R Aimbetov and O Bulgakova have been partially supported by the Ph.D. training grants from Kazakhstan. We are thankful to our laboratory member Dr Tattym Shaikenov for providing the Akt substrate. We are also thankful to Dr Dario Alessi (University of Dundee, Dundee, England) for providing the Protor 1 alpha expression plasmid.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bayascas JR, 2008, CELL CYCLE, V7, P2978, DOI 10.4161/cc.7.19.6810; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen C-H, 2011, J BIOL CHEM UNPUB; Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cordes MHJ, 1996, CURR OPIN STRUC BIOL, V6, P3, DOI 10.1016/S0959-440X(96)80088-1; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gross JM, 2003, CANCER METAST REV, V22, P327, DOI 10.1023/A:1023720928680; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jones KT, 2009, PLOS BIOL, V7, P604, DOI 10.1371/journal.pbio.1000060; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Pearce LR, 2011, BIOCHEM J, V436, P169, DOI 10.1042/BJ20102103; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Zhang XH, 2000, BREAST CANCER RES, V2, P170, DOI 10.1186/bcr50	27	15	15	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2012	31	16					2115	2120		10.1038/onc.2011.404	http://dx.doi.org/10.1038/onc.2011.404			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	928TP	21909137	Green Published, Green Accepted			2022-12-25	WOS:000303008600011
J	Peric, D; Chvalova, K; Rousselet, G				Peric, D.; Chvalova, K.; Rousselet, G.			Identification of microprocessor-dependent cancer cells allows screening for growth-sustaining micro-RNAs	ONCOGENE			English	Article						microprocessor; growth arrest; drosha; DGCR8; PTEN; micro-RNA	TUMOR-SUPPRESSOR; STABLE EXPRESSION; BREAST-CANCER; IN-VIVO; COMPLEX; DGCR8; GENE; TRANSFORMATION; BIOGENESIS; LET-7	Micro-RNAs are deregulated in cancer cells, and some are either tumor suppressive or oncogenic. In addition, a link has been established between decreased expression of micro-RNAs and transformation, and several proteins of the RNA interference pathway have been shown to be haploinsufficient tumor suppressors. Oncogenic microRNAs (oncomiRs) could represent new therapeutic targets, and their identification is therefore crucial. However, structural and functional redundancy between micro-RNAs hampers approaches relying on individual micro-RNA inhibition. We reasoned that in cancer cells that depend on oncomiRs, impairing the micro-RNA pathway could lead to growth perturbation rather than increased tumorigenesis. Identifying such cells could allow functional analyses of individual micro-RNAs by complementation of the phenotypes observed upon global micro-RNA inhibition. Therefore, we developed episomal vectors coding for small hairpin RNAs targeting either Drosha or DGCR8, the two components of the microprocessor, the nuclear micro-RNA maturation complex. We identified cancer cell lines in which both vectors induced colony growth arrest. We then screened for individual micro-RNAs complementing this growth arrest, and identified miR-19a, miR-19b, miR-20a and miR-27b as major growth-sustaining micro-RNAs. However, the effect of miR-19a and miR-19b was only transient. In addition, embryonic stem cell-derived micro-RNAs with miR-20a seeds were much less efficient than miR-20a in sustaining cancer cell growth, a finding that contrasted with results obtained in stem cells. Finally, we showed that the tumor suppressor phosphatase and tensin homologue deleted on chromosome 10, a shared target of miR-19 and miR-20, was functionally involved in the growth arrest induced by microprocessor inhibition. We conclude that our approach allowed to identify microprocessor-dependent cancer cells, which could be used to screen for growth-sustaining micro-RNAs. This complementation screen unveiled functional differences between homologous micro-RNAs. Phenotypic characterization of the complemented cells will allow precise functional studies of these micro-RNAs. Oncogene (2012) 31, 2039-2048; doi:10.1038/onc.2011.391; published online 12 September 2011	[Peric, D.; Chvalova, K.; Rousselet, G.] CEA, DSV, IRCM, LGR, F-92265 Fontenay Aux Roses, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Rousselet, G (corresponding author), CEA, DSV, IRCM, LGR, Bat 5 P 219,18 Route Panorama, F-92265 Fontenay Aux Roses, France.	germain.rousselet@cea.fr	Rousselet, Germain/E-3525-2018	Rousselet, Germain/0000-0002-1710-1639	Angulo laboratory; Electricite De France [V3-104]	Angulo laboratory; Electricite De France	We thank V Neuville for assistance with the in vivo experiments, B Vogelstein and B Bugler for the HCT116 cell lines, J Lebeau for the A549, T-47D, ZR751, MDA-MB-157 and MDA-MB-231 cell lines, and DSF Biard for the pEBP and pEBH vectors and advice for their use. We also thank M Mangeney, C Pique and all members of the Angulo laboratory for helpful discussions and support. This work was supported by the Electricite De France grant no. V3-104 to G.R.	Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Biard DSF, 2007, NUCLEIC ACIDS RES, V35, P3535, DOI 10.1093/nar/gkm195; Biard DSF, 2005, MOL CANCER RES, V3, P519, DOI 10.1158/1541-7786.MCR-05-0044; Boehler C, 2011, P NATL ACAD SCI USA, V108, P2783, DOI 10.1073/pnas.1016574108; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Colmont C, 2001, AM J PHYSIOL-CELL PH, V280, pC614, DOI 10.1152/ajpcell.2001.280.3.C614; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Desaint S, 2004, J BIOL CHEM, V279, P31157, DOI 10.1074/jbc.M401888200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hand NJ, 2009, HEPATOLOGY, V49, P618, DOI 10.1002/hep.22656; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Kadener S, 2009, RNA, V15, P537, DOI 10.1261/rna.1319309; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuchenbauer F, 2011, BLOOD, DOI 10.1182; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Le May N, 2010, MOL CELL, V38, P54, DOI 10.1016/j.molcel.2010.03.004; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Qi JL, 2009, CELL CYCLE, V8, P3729, DOI 10.4161/cc.8.22.10033; RUNNEBAUM IB, 1991, P NATL ACAD SCI USA, V88, P10657, DOI 10.1073/pnas.88.23.10657; Shenoy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006971; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Triboulet R, 2009, RNA, V15, P1005, DOI 10.1261/rna.1591709; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Weng LP, 1999, CANCER RES, V59, P5808	56	11	11	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	16					2039	2048		10.1038/onc.2011.391	http://dx.doi.org/10.1038/onc.2011.391			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	928TP	21909134				2022-12-25	WOS:000303008600005
J	Willis, DN; Liu, BY; Ha, MA; Jordt, SE; Morris, JB				Willis, Daniel N.; Liu, Boyi; Ha, Michael A.; Jordt, Sven-Eric; Morris, John B.			Menthol attenuates respiratory irritation responses to multiple cigarette smoke irritants	FASEB JOURNAL			English	Article						chemosensation; sensory nerves; TRP channels	SENSORY IRRITATION; TOBACCO-SMOKE; METABOLIC-ACTIVATION; VANILLOID RECEPTOR; RISK-ASSESSMENT; COLD RECEPTOR; TRP CHANNELS; TRACT UPTAKE; VAPORS; ACID	Menthol, the cooling agent in peppermint, is added to almost all commercially available cigarettes. Menthol stimulates olfactory sensations, and interacts with transient receptor potential melastatin 8 (TRPM8) ion channels in cold-sensitive sensory neurons, and transient receptor potential ankyrin 1 (TRPA1), an irritant-sensing channel. It is highly controversial whether menthol in cigarette smoke exerts pharmacological actions affecting smoking behavior. Using plethysmography, we investigated the effects of menthol on the respiratory sensory irritation response in mice elicited by smoke irritants (acrolein, acetic acid, and cyclohexanone). Menthol, at a concentration (16 ppm) lower than in smoke of mentholated cigarettes, immediately abolished the irritation response to acrolein, an agonist of TRPA1, as did eucalyptol (460 ppm), another TRPM8 agonist. Menthol's effects were reversed by a TRPM8 antagonist, AMTB. Menthol's effects were not specific to acrolein, as menthol also attenuated irritation responses to acetic acid, and cyclohexanone, an agonist of the capsaicin receptor, TRPV1. Menthol was efficiently absorbed in the respiratory tract, reaching local concentrations sufficient for activation of sensory TRP channels. These experiments demonstrate that menthol and eucalyptol, through activation of TRPM8, act as potent counterirritants against a broad spectrum of smoke constituents. Through suppression of respiratory irritation, menthol may facilitate smoke inhalation and promote nicotine addiction and smoking-related morbidities.-Willis, D. N., Liu, B., Ha, M. A., Jordt, S.-E., Morris, J. B. Menthol attenuates respiratory irritation responses to multiple cigarette smoke irritants. FASEB J. 25, 4434-4444 (2011). www.fasebj.org	[Liu, Boyi; Jordt, Sven-Eric] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Willis, Daniel N.; Ha, Michael A.; Morris, John B.] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Toxicol Program, Storrs, CT USA	Yale University; University of Connecticut	Jordt, SE (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	sven.jordt@yale.edu	Liu, Boyi/J-5396-2014; Liu, Boyi/C-9181-2012; Jordt, Sven-Eric/ABE-6517-2020	Jordt, Sven-Eric/0000-0001-6171-5622	U.S. National Institutes of Health [R01HL105365, R01ES015056]; American Asthma Foundation [07-0212]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105635, U01HL105365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015056] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by U.S. National Institutes of Health grants R01HL105365 (to J.B.M. and S.E.J.) and R01ES015056 (to S.E.J.), and by the American Asthma Foundation (07-0212 to S.E.J.).	Agency for Toxic Substances and Disease Registry, 2007, TOX PROF ACR; Alarie Y, 1973, CRC Crit Rev Toxicol, V2, P299, DOI 10.3109/10408447309082020; Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Bessac BF, 2009, FASEB J, V23, P1102, DOI 10.1096/fj.08-117812; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Bi XH, 2005, CHEMOSPHERE, V61, P1512, DOI 10.1016/j.chemosphere.2005.04.057; Blot WJ, 2011, JNCI-J NATL CANCER I, V103, P810, DOI 10.1093/jnci/djr102; Brown RP, 1997, TOXICOL IND HEALTH, V13, P407, DOI 10.1177/074823379701300401; Deering-Rice CE, 2011, CHEM RES TOXICOL, V24, P950, DOI 10.1021/tx200123z; DeSesa CR, 2008, TOXICOL SCI, V104, P198, DOI 10.1093/toxsci/kfn061; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; ECCLES R, 1989, ACTA OTO-LARYNGOL, V108, P268, DOI 10.3109/00016488909125527; Escalera J, 2008, J BIOL CHEM, V283, P24136, DOI 10.1074/jbc.M710280200; GERDE P, 1991, TOXICOL APPL PHARM, V109, P276, DOI 10.1016/0041-008X(91)90175-E; Harrington AM, 2011, PAIN, V152, P1459, DOI 10.1016/j.pain.2011.01.027; Hazari MS, 2011, ENVIRON HEALTH PERSP, V119, P951, DOI 10.1289/ehp.1003200; Honore P, 2002, PAIN, V96, P99, DOI 10.1016/S0304-3959(01)00434-1; Igaz P, 2008, CURR MED CHEM, V15, P2734, DOI 10.2174/092986708786242921; JOHANSON G, 1991, ANN OCCUP HYG, V35, P323, DOI 10.1093/annhyg/35.3.323; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Klausner K., 2010, MENTHOL CIGARETTES I; Lanosa MJ, 2010, TOXICOL SCI, V115, P589, DOI 10.1093/toxsci/kfq057; Lashinger ESR, 2008, AM J PHYSIOL-RENAL, V295, pF803, DOI 10.1152/ajprenal.90269.2008; LAUDE EA, 1994, PULM PHARMACOL, V7, P179, DOI 10.1006/pulp.1994.1021; Lawrence D, 2011, TOBACCO INDUCED D S1, V9, pS3, DOI [10.1186/1617-9625-9-S1-S3, DOI 10.1186/1617-9625-9-S1-S3]; Levy DT, 2011, AM J PUBLIC HEALTH, V101, P1241, DOI 10.2105/AJPH.2011.300178; Lin YS, 2010, J APPL PHYSIOL, V108, P1293, DOI 10.1152/japplphysiol.01048.2009; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; McCoy DD, 2011, AM J PHYSIOL-REG I, V300, pR1278, DOI 10.1152/ajpregu.00631.2010; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; MEDINSKY MA, 1993, FUND APPL TOXICOL, V20, P265, DOI 10.1006/faat.1993.1035; Mendiondo MS, 2010, ADDICTION, V105, P124, DOI 10.1111/j.1360-0443.2010.03202.x; MORICE AH, 1994, THORAX, V49, P1024, DOI 10.1136/thx.49.10.1024; Morris JB, 1999, INHAL TOXICOL, V11, P943, DOI 10.1080/089583799196727; Morris JB, 2000, TOXICOL SCI, V54, P222, DOI 10.1093/toxsci/54.1.222; Morris JB, 2003, J APPL PHYSIOL, V94, P1563, DOI 10.1152/japplphysiol.00572.2002; Morris JB, 2010, TARG ORG T, P99; Morris JB, 2009, TOXICOL SCI, V111, P383, DOI 10.1093/toxsci/kfp138; Morris JB, 2009, TOXICOL SCI, V108, P173, DOI 10.1093/toxsci/kfn222; Muscat JE, 2009, CANCER EPIDEM BIOMAR, V18, P35, DOI 10.1158/1055-9965.EPI-08-0744; Nielsen GD, 2007, REGUL TOXICOL PHARM, V48, P6, DOI 10.1016/j.yrtph.2006.11.005; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perfetti R., 2009, CHEM COMPONENTS TOBA, P215; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Rising Joshua, 2011, Tob Induc Dis, V9 Suppl 1, pS4, DOI 10.1186/1617-9625-9-S1-S4; ROSSI M, 1983, J MED CHEM, V26, P1246, DOI 10.1021/jm00363a008; Silver WL, 2006, CHEM SENSES, V31, P807, DOI 10.1093/chemse/bjl022; STEDMAN RL, 1968, CHEM REV, V68, P153, DOI 10.1021/cr60252a002; Stott WT, 1983, J APPL TOXICOL, V3, P310, DOI 10.1002/jat.2550030607; Su T, 2000, CANCER RES, V60, P5074; Symanowicz PT, 2004, NEUROSCI LETT, V362, P150, DOI 10.1016/j.neulet.2004.03.016; ThorntonManning JR, 1997, MUTAT RES-FUND MOL M, V380, P43, DOI 10.1016/S0027-5107(97)00126-7; Tobacco Industry Stakeholders, 2011, MENTH CIG DISPR IMP; Tobacco Products Scientific Advisory Committee to the Food and Drug Administration, 2011, MENTH CIG PUBL HLTH; Vaughan RP, 2006, TOXICOL SCI, V93, P411, DOI 10.1093/toxsci/kfl061; VIJAYARAGHAVAN R, 1993, ARCH TOXICOL, V67, P478, DOI 10.1007/BF01969919; Vogt-Eisele AK, 2007, BRIT J PHARMACOL, V151, P530, DOI 10.1038/sj.bjp.0707245; Williams JM, 2007, NICOTINE TOB RES, V9, P873, DOI 10.1080/14622200701484995; YAMAGUCHI T, 1994, DRUG METAB DISPOS, V22, P616	64	128	132	2	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2011	25	12					4434	4444		10.1096/fj.11-188383	http://dx.doi.org/10.1096/fj.11-188383			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21903934	Green Published			2022-12-25	WOS:000298138100034
J	Lee, SJ; Cho, KS; Kim, HN; Kim, HJ; Koh, JY				Lee, Sook-Jeong; Cho, Kyung-Sook; Kim, Ha Na; Kim, Hyun-Jae; Koh, Jae-Young			Role of Zinc Metallothionein-3 (ZnMt3) in Epidermal Growth Factor (EGF)-induced c-Abl Protein Activation and Actin Polymerization in Cultured Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL CORTICAL-NEURONS; METAL-THIOLATE CLUSTERS; CENTRAL-NERVOUS-SYSTEM; DISEASE BRAIN EXTRACT; INHIBITORY FACTOR; TYROSINE KINASE; ALZHEIMERS-DISEASE; F-ACTIN; BINDING PROTEINS; FAMILY KINASES	Recent evidence indicates that zinc plays a major role in neurochemistry. Of the many zinc-binding proteins, metallothionein-3 (Mt3) is regarded as one of the major regulators of cellular zinc in the brain. However, biological functions of Mt3 are not yet well characterized. Recently, we found that lysosomal dysfunction in metallothionein-3 (Mt3)-null astrocytes involves down-regulation of c-Abl. In this study, we investigated the role of Mt3 in c-Abl activation and actin polymerization in cultured astrocytes following treatment with epidermal growth factor (EGF). Compared with wildtype (WT) astrocytes, Mt3-null cells exhibited a substantial reduction in the activation of c-Abl upon treatment with EGF. Consistent with previous studies, activation of c-Abl by EGF induced dissociation of c-Abl from F-actin. Mt3 added to astrocytic cell lysates bound F-actin, augmented F-actin polymerization, and promoted the dissociation of c-Abl from F-actin, suggesting a possible role for Mt3 in this process. Conversely, Mt3-deficient astrocytes showed significantly reduced dissociation of c-Abl from F-actin following EGF treatment. Experiments using various peptide fragments of Mt3 showed that a fragment containing the N-terminal TCPCP motif (peptide 1) is sufficient for this effect. Removal of zinc from Mt3 or pep 1 with tetrakis(2-pyridylmethyl)ethylenediamine abrogated the effect of Mt3 on the association of c-Abl and F-actin, indicating that zinc binding is necessary for this action. These results suggest that ZnMt3 in cultured astrocytes may be a normal component of c-Abl activation in EGF receptor signaling. Hence, modulation of Mt3 levels or distribution may prove to be a useful strategy for controlling cytoskeletal mobilization following EGT stimulation in brain cells.	[Lee, Sook-Jeong; Cho, Kyung-Sook; Kim, Ha Na; Kim, Hyun-Jae; Koh, Jae-Young] Univ Ulsan, Coll Med, Neural Injury Res Lab, Seoul 138736, South Korea; [Koh, Jae-Young] Univ Ulsan, Coll Med, Dept Neurol, Seoul 138736, South Korea; [Lee, Sook-Jeong; Cho, Kyung-Sook; Kim, Ha Na; Kim, Hyun-Jae; Koh, Jae-Young] Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul 138736, South Korea	University of Ulsan; University of Ulsan; University of Ulsan	Koh, JY (corresponding author), 388-1 Poongnap Dong, Seoul 138736, South Korea.	jkko@amc.seoul.kr	Koh, Jae-Young/C-9014-2011	Koh, Jae-Young/0000-0002-4318-495X	National Research Foundation of Korea [2005-0093836, 2006-0052326, 2009-0081487]; Korean Government; Korean Health Technology RD Project [A092042]; Ministry of Health and Welfare	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government); Korean Health Technology RD Project; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants 2005-0093836, 2006-0052326, and 2009-0081487 from the National Research Foundation of Korea funded by the Korean Government and Grant A092042 from the Korean Health Technology R&D Project funded by the Ministry of Health and Welfare.	Alvarez AR, 2004, NEUROBIOL DIS, V17, P326, DOI 10.1016/j.nbd.2004.06.007; Bell SG, 2009, CHEMBIOCHEM, V10, P55, DOI 10.1002/cbic.200800511; Cancino GI, 2008, BRAIN, V131, P2425, DOI 10.1093/brain/awn125; Cao HM, 2004, EXP CELL RES, V294, P159, DOI 10.1016/j.yexcr.2003.11.010; Carrasco J, 2000, EXP NEUROL, V163, P46, DOI 10.1006/exnr.1999.7335; DENHARTIGH JC, 1992, J CELL BIOL, V119, P349, DOI 10.1083/jcb.119.2.349; Ding ZC, 2008, J INORG BIOCHEM, V102, P1965, DOI 10.1016/j.jinorgbio.2008.07.007; Ding ZC, 2010, FEBS J, V277, P2912, DOI 10.1111/j.1742-4658.2010.07716.x; DITSCH A, 1994, EUR J BIOCHEM, V224, P223, DOI 10.1111/j.1432-1033.1994.tb20015.x; El Ghazi I, 2006, EXP BIOL MED, V231, P1500; El Ghazi I., 2010, INT J ALZHEIMERS DIS, DOI DOI 10.4061/2011/20863421234102; Faller P, 2010, FEBS J, V277, P2921, DOI 10.1111/j.1742-4658.2010.07717.x; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; HARTWIG JH, 1989, J CELL BIOL, V108, P467, DOI 10.1083/jcb.108.2.467; Hasler DW, 1998, BIOCHEMISTRY-US, V37, P14966, DOI 10.1021/bi9813734; Hernandez SE, 2004, TRENDS CELL BIOL, V14, P36, DOI 10.1016/j.tcb.2003.11.003; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Jing Z, 2009, J ALZHEIMERS DIS, V17, P409, DOI 10.3233/JAD-2009-1062; KAGI JHR, 1988, BIOCHEMISTRY-US, V27, P8509, DOI 10.1021/bi00423a001; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Lahti DW, 2005, PROTEIN SCI, V14, P1151, DOI 10.1110/ps.041113005; Lee JY, 2003, EXP NEUROL, V184, P337, DOI 10.1016/S0014-4886(03)00382-0; MCCABE MJ, 1993, LAB INVEST, V69, P101; Mendoza-Naranjo A, 2007, J CELL SCI, V120, P279, DOI 10.1242/jcs.03323; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; Ni FY, 2007, PROTEINS, V68, P255, DOI 10.1002/prot.21404; OTVOS JD, 1980, P NATL ACAD SCI-BIOL, V77, P7094, DOI 10.1073/pnas.77.12.7094; Palumaa P, 2002, BIOCHEMISTRY-US, V41, P6158, DOI 10.1021/bi025664v; Pedersen MO, 2009, PROG HISTOCHEM CYTO, V44, P1, DOI 10.1016/j.proghi.2008.10.002; Penkowa M, 1999, GLIA, V25, P343; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; REDDY EP, 1983, P NATL ACAD SCI-BIOL, V80, P3623, DOI 10.1073/pnas.80.12.3623; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; SCHLIWA M, 1982, PHILOS T ROY SOC B, V299, P199, DOI 10.1098/rstb.1982.0126; SEWELL AK, 1995, BIOCHEMISTRY-US, V34, P4740, DOI 10.1021/bi00014a031; SHERIDAN RE, 1995, TOXICON, V33, P539, DOI 10.1016/0041-0101(94)00185-B; Shumaker DK, 1998, CELL CALCIUM, V23, P151, DOI 10.1016/S0143-4160(98)90114-2; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Smith JM, 2002, FRONT BIOSCI, V7, pD31; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; UCHIDA Y, 1995, J BIOL CHEM, V270, P3365, DOI 10.1074/jbc.270.7.3365; UCHIDA Y, 1989, BRAIN RES, V481, P190, DOI 10.1016/0006-8993(89)90503-9; UCHIDA Y, 1988, BIOCHEM BIOPH RES CO, V150, P1263, DOI 10.1016/0006-291X(88)90765-6; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; West AK, 2008, NEUROTOXICOLOGY, V29, P489, DOI 10.1016/j.neuro.2007.12.006; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Yu WH, 2001, BRAIN RES, V894, P37, DOI 10.1016/S0006-8993(00)03196-6; Zangger K, 1999, PROTEIN SCI, V8, P2630, DOI 10.1110/ps.8.12.2630; Zigmond SH, 1996, CURR OPIN CELL BIOL, V8, P66, DOI 10.1016/S0955-0674(96)80050-0	57	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40847	40856		10.1074/jbc.M111.245993	http://dx.doi.org/10.1074/jbc.M111.245993			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21900236	Green Published, hybrid			2022-12-25	WOS:000297315400045
J	Bonocora, RP; Decker, PK; Glass, S; Knipling, L; Hinton, DM				Bonocora, Richard P.; Decker, Phillip K.; Glass, Stephanie; Knipling, Leslie; Hinton, Deborah M.			Bacteriophage T4 MotA Activator and the beta-Flap Tip of RNA Polymerase Target the Same Set of sigma(70) Carboxyl-terminal Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATOR; PROTEIN-PROTEIN; PROMOTER RECOGNITION; ABORTIVE INITIATION; ANGSTROM RESOLUTION; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; OPEN-COMPLEX; REGION 4	Sigma factors, the specificity subunits of RNA polymerase, are involved in interactions with promoter DNA, the core subunits of RNA polymerase, and transcription factors. The bacteriophage T4-encoded activator, MotA, is one such factor, which engages the C terminus of the Escherichia coli housekeeping sigma factor, sigma(70). MotA functions in concert with a phage-encoded co-activator, AsiA, as a molecular switch. This process, termed sigma appropriation, inhibits host transcription while activating transcription from a class of phage promoters. Previous work has demonstrated that MotA contacts the C terminus of sigma(70), H5, a region that is normally bound within RNA polymerase by its interaction with the beta-flap tip. To identify the specific sigma(70) residues responsible for interacting with MotA and the beta-flap tip, we generated single substitutions throughout the C terminus of sigma(70). We find that MotA targets H5 residues that are normally engaged by the beta-flap. In two-hybrid assays, the interaction of sigma(70) with either the beta-flap tip or MotA is impaired by alanine substitutions at residues Leu-607, Arg-608, Phe-610, Leu-611, and Asp-613. Transcription assays identify Phe-610 and Leu-611 as the key residues for MotA/AsiA-dependent transcription. Phe-610 is a crucial residue in the H5/beta-flap tip interaction using promoter clearance assays with RNA polymerase alone. Our results show how the actions of small transcriptional factors on a defined local region of RNA polymerase can fundamentally change the specificity of polymerase.	[Bonocora, Richard P.; Decker, Phillip K.; Glass, Stephanie; Knipling, Leslie; Hinton, Deborah M.] NIDDK, Gene Express & Regulat Sect, Lab Cell & Mol Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hinton, DM (corresponding author), NIDDK, Gene Express & Regulat Sect, Lab Cell & Mol Biol, NIH, Bldg 8,Rm 2A-13, Bethesda, MD 20892 USA.	dhinton@helix.nih.gov	Hinton, Deborah/AAQ-2596-2021	Knipling, Leslie/0000-0002-2636-6460	NIDDK, National Institutes of Health	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Intramural Research Program of the NIDDK, National Institutes of Health.	Arthur TM, 2000, J BIOL CHEM, V275, P23113, DOI 10.1074/jbc.M002040200; Baxter K, 2006, J MOL BIOL, V363, P931, DOI 10.1016/j.jmb.2006.08.074; Bonocora RP, 2008, MOL MICROBIOL, V69, P331, DOI 10.1111/j.1365-2958.2008.06276.x; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Burgess RR, 2001, CURR OPIN MICROBIOL, V4, P126, DOI 10.1016/S1369-5274(00)00177-6; Burns HD, 1996, BIOCHEM J, V317, P305, DOI 10.1042/bj3170305; CARPOUSIS AJ, 1982, J MOL BIOL, V157, P619, DOI 10.1016/0022-2836(82)90502-2; Chen Q, 2010, MOL MICROBIOL, V77, P1326, DOI 10.1111/j.1365-2958.2010.07293.x; Decker KB, 2009, MOL MICROBIOL, V73, P137, DOI 10.1111/j.1365-2958.2009.06759.x; Dove SL, 2000, P NATL ACAD SCI USA, V97, P13215, DOI 10.1073/pnas.97.24.13215; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; Geszvain K, 2004, J MOL BIOL, V343, P569, DOI 10.1016/j.jmb.2004.08.063; Gregory BD, 2004, P NATL ACAD SCI USA, V101, P4554, DOI 10.1073/pnas.0400923101; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Hinton DM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-289; HINTON DM, 1991, J BIOL CHEM, V266, P18034; Hinton DM, 1996, METHOD ENZYMOL, V274, P43; Hinton DM, 2000, J MOL BIOL, V304, P731, DOI 10.1006/jmbi.2000.4113; Hook-Barnard I, 2006, J BACTERIOL, V188, P8352, DOI 10.1128/JB.00853-06; HOOKBARNARD IG, 2007, GENE REGULATION SYST; Hsu LM, 2009, METHODS, V47, P25, DOI 10.1016/j.ymeth.2008.10.010; Hu JC, 2000, METHODS, V20, P80, DOI 10.1006/meth.1999.0908; KEILTY S, 1987, J BIOL CHEM, V262, P6389; Klocko AD, 2009, MOL MICROBIOL, V73, P152, DOI 10.1111/j.1365-2958.2009.06758.x; KUMAR A, 1994, J MOL BIOL, V235, P405, DOI 10.1006/jmbi.1994.1001; KUMAR A, 1993, J MOL BIOL, V232, P406, DOI 10.1006/jmbi.1993.1400; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; Lambert LJ, 2004, EMBO J, V23, P2952, DOI 10.1038/sj.emboj.7600312; MARCHAMEGADZIE R, 1995, MOL MICROBIOL, V15, P649, DOI 10.1111/j.1365-2958.1995.tb02374.x; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Miller JH., 1972, EXPT MOL GENETICS; Minakhin L, 2001, J MOL BIOL, V306, P631, DOI 10.1006/jmbi.2001.4445; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Nickels BE, 2005, P NATL ACAD SCI USA, V102, P4488, DOI 10.1073/pnas.0409850102; Nickels BE, 2002, J MOL BIOL, V324, P17, DOI 10.1016/S0022-2836(02)01043-4; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Pal D, 2003, J MOL BIOL, V325, P827, DOI 10.1016/S0022-2836(02)01307-4; Pande S, 2002, J BACTERIOL, V184, P3957, DOI 10.1128/JB.184.14.3957-3964.2002; Patikoglou GA, 2007, J MOL BIOL, V372, P649, DOI 10.1016/j.jmb.2007.06.081; Rhodius VA, 2000, J MOL BIOL, V299, P311, DOI 10.1006/jmbi.2000.3737; SCHERZINGER E, 1977, NUCLEIC ACIDS RES, V4, P4151, DOI 10.1093/nar/4.12.4151; Stevens A., 1976, RNA POLYMERASE, P617; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Vo NV, 2003, BIOCHEMISTRY-US, V42, P3798, DOI 10.1021/bi026962v; Yuan AH, 2009, MOL MICROBIOL, V74, P1018, DOI 10.1111/j.1365-2958.2009.06916.x; Yuan AH, 2009, P NATL ACAD SCI USA, V106, P6597, DOI 10.1073/pnas.0812832106	47	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39290	39296		10.1074/jbc.M111.278762	http://dx.doi.org/10.1074/jbc.M111.278762			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21911499	Green Published, hybrid			2022-12-25	WOS:000296759800047
J	Warfel, NA; Niederst, M; Newton, AC				Warfel, Noel A.; Niederst, Matt; Newton, Alexandra C.			Disruption of the Interface between the Pleckstrin Homology (PH) and Kinase Domains of Akt Protein Is Sufficient for Hydrophobic Motif Site Phosphorylation in the Absence of mTORC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; GROWTH-FACTORS; IN-VIVO; ACTIVATION; PATHWAY; INHIBITION; MECHANISM; COMPLEX; RICTOR; DEGRADATION	The pro-survival kinase Akt requires phosphorylation at two conserved residues, the activation loop site (Thr-308) and the hydrophobic motif site (Ser-473), for maximal activation. Previous reports indicate that mTORC2 is necessary for phosphorylation of the hydrophobic motif and that this site is not phosphorylated in cells lacking components of the mTORC2 complex, such as Sin1. Here we show that Akt can be phosphorylated at the hydrophobic motif site (Ser-473) in the absence of mTORC2. First, increasing the levels of PIP3 in Sin1(-/-) MEFs by (i) expression of a constitutively active PI3K or (ii) relief of a negative feedback loop on PI3K by prolonged inhibition of mTORC1 or S6K is sufficient to rescue hydrophobic motif phosphorylation of Akt. The resulting accumulation of PIP3 at the plasma membrane results in Ser-473 phosphorylation. Second, constructs of Akt in which the PH domain is constitutively dis-engaged from the kinase domain are phosphorylated at the hydrophobic motif site in Sin1(-/-) MEFs; both myristoylated-Akt and Akt lacking the PH domain are phosphorylated at Ser-473. Thus, disruption of the interface between the PH and kinase domains of Akt bypasses the requirement for mTORC2. In summary, these data support a model in which Akt can be phosphorylated at Ser-473 and activated in the absence of mTORC2 by mechanisms that depend on removal of the PH domain from the kinase domain.	[Warfel, Noel A.; Niederst, Matt; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Warfel, Noel A.; Niederst, Matt] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), 9500 Gilman Dr,MC 0721, La Jolla, CA 92093 USA.	anewton@ucsd.edu		Warfel, Noel/0000-0001-6410-9011	National Institutes of Health [GM43154, NIH GM067946]; DoD BCRP [BC093021]; UCSD through National Institute of General Medical Sciences [T32 GM007752]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043154, T32GM007752, R01GM067946, R37GM043154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD BCRP(United States Department of Defense); UCSD through National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM43154 and NIH GM067946 (to A. C. N.) and DoD BCRP award BC093021 (to N. A. W.). This work was also supported by the UCSD Graduate Training Program in Cellular and Molecular Pharmacology through an institutional training grant from the National Institute of General Medical Sciences T32 GM007752 (to N. A. W. and M. N.).	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Behn-Krappa A, 1999, CURR BIOL, V9, P728, DOI 10.1016/S0960-9822(99)80332-7; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bornancin F, 1996, CURR BIOL, V6, P1114, DOI 10.1016/S0960-9822(02)70678-7; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Edwards AS, 1999, J BIOL CHEM, V274, P6461, DOI 10.1074/jbc.274.10.6461; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hartley D, 2002, J CELL BIOCHEM, V85, P304, DOI 10.1002/jcb.10135; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kim JH, 2006, CARCINOGENESIS, V27, P475, DOI 10.1093/carcin/bgi272; Lau C, 2008, J IMMUNOL, V180, P870, DOI 10.4049/jimmunol.180.2.870; Liu JY, 2011, J BIOL CHEM, V286, P6510, DOI 10.1074/jbc.M110.183087; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Rodik-Outmezguine V. S., 2011, CANCER DISCOV, V1, P248; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Xie XD, 2011, P NATL ACAD SCI USA, V108, P6474, DOI 10.1073/pnas.1016132108; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	43	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39122	39129		10.1074/jbc.M111.278747	http://dx.doi.org/10.1074/jbc.M111.278747			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21908613	Green Published, hybrid			2022-12-25	WOS:000296759800031
J	Chauhan, AK; Moore, TL				Chauhan, Anil K.; Moore, Terry L.			T Cell Activation by Terminal Complex of Complement and Immune Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MEMBRANE ATTACK COMPLEX; PROTEIN-KINASE PATHWAY; IMMUNOLOGICAL SYNAPSE; ACTIN CYTOSKELETON; LIPID RAFTS; REGULATORY PROTEINS; ADHESION MOLECULES; ACQUIRED-IMMUNITY; ENDOTHELIAL-CELLS	T cell hyperactivation and complement consumption are prominent features of the immunopathology of systemic lupus erythematosus. Although complement activation is secondary to autoantibodies that form immune complexes (ICs), the trigger for alterations in human peripheral blood T cells is poorly understood. To study the impact (on T cells) of several types of preformed ICs and terminal complement complex, also referred to as C5b-9, we incubated these immune reactants with peripheral blood naive CD4(+) T cells as well as Jurkat cells and analyzed their effects on cellular behavior. We first assembled the C5b-9 in situ on the membrane and observed its assembly primarily on a single site where it promoted aggregation of membrane rafts and recruitment of the CD3 signaling complex. However, C5b-9 alone did not initiate proliferation or commencement of downstream signaling events associated with T cell activation. When T cells were treated with ICs together with nonlytic C5b-9, changes associated with T cell activation by possible antigen engagement then occurred. T cell antigen receptor signaling proteins, including zeta-chain, ZAP-70, Syk, Src, and Lck, were phosphorylated and organized in a synapse-like structure. The cytoskeleton formed F-actin spindles and a distal pole complex, resulting in a bipolar distribution of phosphorylated ezrin-radixin-moesin and F-actin. Furthermore, ICs and nonlytic C5b-9 induced T cell proliferation and IFN-gamma production. These results raise the possibility that ICs and the nonlytic C5b-9 modulate T cell-mediated responses in systemic lupus erythematosus and other related chronic inflammatory disorders.	[Chauhan, Anil K.; Moore, Terry L.] St Louis Univ, Sch Med, Div Adult & Pediat Rheumatol, St Louis, MO 63104 USA	Saint Louis University	Chauhan, AK (corresponding author), St Louis Univ, Sch Med, Div Adult & Pediat Rheumatol, 1402 S Grand Blvd, St Louis, MO 63104 USA.	chauhana@slu.edu			Campbell-Avery Charitable Trust; Dorr Family Charitable Trust; Lupus/Juvenile Research Group of St. Louis, MO	Campbell-Avery Charitable Trust; Dorr Family Charitable Trust; Lupus/Juvenile Research Group of St. Louis, MO	This work was supported by The Campbell-Avery Charitable Trust, The Dorr Family Charitable Trust, and Lupus/Juvenile Research Group of St. Louis, MO.	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; ACCARDOPALUMBO A, 1993, J IMMUNOL METHODS, V163, P169, DOI 10.1016/0022-1759(93)90119-R; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Bangs SC, 2006, TRENDS IMMUNOL, V27, P518, DOI 10.1016/j.it.2006.09.006; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; BENZAQUEN LR, 1994, J EXP MED, V179, P985, DOI 10.1084/jem.179.3.985; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Blanchard N, 2002, IMMUNITY, V17, P389, DOI 10.1016/S1074-7613(02)00421-1; Bossi F, 2004, J IMMUNOL, V173, P6921, DOI 10.4049/jimmunol.173.11.6921; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Casarsa C, 2003, EUR J IMMUNOL, V33, P1260, DOI 10.1002/eji.200323574; Chauhan AK, 2006, CLIN EXP IMMUNOL, V145, P398, DOI 10.1111/j.1365-2249.2006.03135.x; Chiu YY, 1998, J INVEST ALLERG CLIN, V8, P239; Crispin JC, 2010, NAT REV RHEUMATOL, V6, P317, DOI 10.1038/nrrheum.2010.60; Cullinan P, 2002, IMMUNOL REV, V189, P111, DOI 10.1034/j.1600-065X.2002.18910.x; CYBULSKY AV, 1989, AM J PHYSIOL, V257, pF826, DOI 10.1152/ajprenal.1989.257.5.F826; Czermak BJ, 1999, AM J PATHOL, V154, P1513, DOI 10.1016/S0002-9440(10)65405-3; Dashiell SM, 2000, GLIA, V30, P187, DOI 10.1002/(SICI)1098-1136(200004)30:2<187::AID-GLIA8>3.0.CO;2-7; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Deng GM, 2008, J IMMUNOL, V181, P4019, DOI 10.4049/jimmunol.181.6.4019; Dykstra M, 2001, J LEUKOCYTE BIOL, V70, P699; EICHMANN K, 1995, IMMUNOL LETT, V44, P87, DOI 10.1016/0165-2478(94)00197-Y; Enyedy EJ, 2001, ARTHRITIS RHEUM, V44, P1114, DOI 10.1002/1529-0131(200105)44:5<1114::AID-ANR192>3.0.CO;2-B; ESSER AF, 1979, P NATL ACAD SCI USA, V76, P1410, DOI 10.1073/pnas.76.3.1410; Fang YF, 1998, J IMMUNOL, V160, P5273; FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.immunol.13.1.127; Fishelson Z, 2001, MOL IMMUNOL, V38, P207, DOI 10.1016/S0161-5890(01)00055-4; Fosbrink M, 2006, J BIOL CHEM, V281, P19009, DOI 10.1074/jbc.M602055200; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GREEN H, 1960, ANN NY ACAD SCI, V87, P352, DOI 10.1111/j.1749-6632.1960.tb23205.x; HAMMER CH, 1975, P NATL ACAD SCI USA, V72, P5076, DOI 10.1073/pnas.72.12.5076; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; He HT, 2008, EMBO REP, V9, P525, DOI 10.1038/embor.2008.78; HEYNINGEN SV, 1974, SCIENCE, V183, P656, DOI DOI 10.1126/SCIENCE.183.4125.656; Holst J, 2008, NAT IMMUNOL, V9, P658, DOI 10.1038/ni.1611; Jury EC, 2004, J CLIN INVEST, V113, P1176, DOI 10.1172/JCI200420345; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Krishnan S, 2004, J IMMUNOL, V172, P7821, DOI 10.4049/jimmunol.172.12.7821; Leitinger B, 2002, J CELL SCI, V115, P963; Low JM, 2009, PROTEOM CLIN APPL, V3, P829, DOI 10.1002/prca.200800073; MANNIK M, 1987, J RHEUMATOL, V14, P35; MARMONT AM, 1980, LANCET, V1, P1088; MaStellos D., 2005, Current Drug Targets - Inflammation and Allergy, V4, P125, DOI 10.2174/1568010053622993; Mellbye OJ, 1996, CLIN RHEUMATOL, V15, P441, DOI 10.1007/BF02229640; MERRILL JE, 1980, CLIN EXP IMMUNOL, V42, P345; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Mitchell JS, 2002, J IMMUNOL, V168, P2737, DOI 10.4049/jimmunol.168.6.2737; MORGAN BP, 1988, CLIN EXP IMMUNOL, V73, P473; MORGAN BP, 1987, J IMMUNOL, V138, P246; MORGAN BP, 1989, BIOCHEM J, V264, P1; Moskovich O, 2007, J BIOL CHEM, V282, P29977, DOI 10.1074/jbc.M703742200; NICULESCU F, 1994, J BIOL CHEM, V269, P4417; NICULESCU F, 1993, J IMMUNOL, V150, P214; Niculescu F, 1997, J IMMUNOL, V158, P4405; Niculescu F, 2001, IMMUNOL RES, V24, P191, DOI 10.1385/IR:24:2:191; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Palmer E, 2009, NAT REV IMMUNOL, V9, P206, DOI 10.1038/nri2469; Pilzer D, 2005, SPRINGER SEMIN IMMUN, V27, P375, DOI 10.1007/s00281-005-0004-1; PODACK ER, 1979, P NATL ACAD SCI USA, V76, P897, DOI 10.1073/pnas.76.2.897; Rus H, 1997, IMMUNOPHARMACOLOGY, V38, P177, DOI 10.1016/S0162-3109(97)00063-5; SANTANA V, 1975, IMMUNOLOGY, V28, P1173; SHIN ML, 1996, BIOMEMBRANE, P119; STOUT RD, 1975, J EXP MED, V142, P611, DOI 10.1084/jem.142.3.611; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Tedesco F, 1997, J EXP MED, V185, P1619, DOI 10.1084/jem.185.9.1619; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Viallard JF, 1999, CLIN EXP IMMUNOL, V115, P189; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; WENER MH, 1987, MEDICINE, V66, P85, DOI 10.1097/00005792-198703000-00001; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; ZWIRNER J, 1989, IMMUNOLOGY, V66, P270	82	11	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38627	38637		10.1074/jbc.M111.266809	http://dx.doi.org/10.1074/jbc.M111.266809			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900254	Green Published, hybrid			2022-12-25	WOS:000296594200075
J	Fassler, M; Li, XL; Kaether, C				Fassler, Matthias; Li, Xiaolin; Kaether, Christoph			Polar Transmembrane-based Amino Acids in Presenilin 1 Are Involved in Endoplasmic Reticulum Localization, Pen2 Protein Binding, and gamma-Secretase Complex Stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; PLASMA-MEMBRANE; TRAFFICKING; DOMAIN; NICASTRIN; ENDOPROTEOLYSIS; ASSOCIATION; RETENTION; TRANSPORT	gamma-Secretase is composed of the four membrane proteins presenilin, nicastrin, Pen2, and Aph1. These four proteins assemble in a coordinated and regulated manner into a high molecular weight complex. The subunits constitute a total of 19 transmembrane domains (TMD), with many carrying important amino acids involved in catalytic activity, interaction with other subunits, or in ER retention/retrieval of unassembled subunits. We here focus on TMD4 of presenilin 1 (PS1) and show that a number of polar amino acids are critical for gamma-secretase assembly and function. An asparagine, a threonine, and an aspartate form a polar interface important for endoplasmic reticulum retention/retrieval. A single asparagine in TMD4 of PS1 is involved in a protein-protein interaction by binding to another asparagine in Pen2. Intriguingly, a charged aspartate in TMD4 is critical for gamma-secretase activity, most likely by stabilizing the newly formed complex.	[Fassler, Matthias; Li, Xiaolin; Kaether, Christoph] Fritz Lipmann Inst, Leibniz Inst Altersforsch, D-07745 Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Kaether, C (corresponding author), Fritz Lipmann Inst, Leibniz Inst Altersforsch, Beutenbergstr 11, D-07745 Jena, Germany.	ckaether@fli-leibniz.de	LI, Xiaolin/GXH-0388-2022	LI, Xiaolin/0000-0003-1524-051X	Deutsche Forschungsgemeinschaft [KA 1751/4-1]; Hans-and-Ilse-Breuer Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hans-and-Ilse-Breuer Stiftung	This work was supported by Grant KA 1751/4-1 from the Deutsche Forschungsgemeinschaft (to C. K.) and the Hans-and-Ilse-Breuer Stiftung (to M. F.).	Capell A, 1997, J NEUROCHEM, V69, P2432; Chiang P. M., 2010, NEUROBIOL AGING; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Fassler M, 2010, TRAFFIC, V11, P250, DOI 10.1111/j.1600-0854.2009.01014.x; Gong P, 2010, J BIOL CHEM, V285, P38042, DOI 10.1074/jbc.M110.132613; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Kaether C, 2006, NEURODEGENER DIS, V3, P275, DOI 10.1159/000095267; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kim SH, 2005, J BIOL CHEM, V280, P1992, DOI 10.1074/jbc.M412404200; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; McCarthy JV, 2009, CELL MOL LIFE SCI, V66, P1534, DOI 10.1007/s00018-009-8435-9; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Pardossi-Piquard R, 2009, J BIOL CHEM, V284, P16298, DOI 10.1074/jbc.M109.000067; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schwappach B, 2008, MOL MEMBR BIOL, V25, P270, DOI 10.1080/09687680801960998; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; Spasic D, 2008, J CELL SCI, V121, P413, DOI 10.1242/jcs.015255; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Takagi S, 2010, J NEUROSCI, V30, P15943, DOI 10.1523/JNEUROSCI.3318-10.2010; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Wacker I, 1997, J CELL SCI, V110, P1453; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Watanabe N, 2010, J BIOL CHEM, V285, P19738, DOI 10.1074/jbc.M110.101287; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	38	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38390	38396		10.1074/jbc.M111.252429	http://dx.doi.org/10.1074/jbc.M111.252429			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914807	Green Published, hybrid			2022-12-25	WOS:000296594200053
J	Kapeli, K; Hurlin, PJ				Kapeli, Katannya; Hurlin, Peter J.			Differential Regulation of N-Myc and c-Myc Synthesis, Degradation, and Transcriptional Activity by the Ras/Mitogen-activated Protein Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; GENE-REGULATION; MESSENGER-RNAS; CODING REGIONS; E-BOX; PHOSPHORYLATION; RAS; CELLS; TRANSFORMATION; TRANSLATION	Myc transcription factors are important regulators of proliferation and can promote oncogenesis when deregulated. Deregulated Myc expression in cancers can result from MYC gene amplification and translocation but also from alterations in mitogenic signaling pathways that affect Myc levels through both transcriptional and post-transcription mechanisms. For example, mutations in Ras family GTPase proteins that cause their constitutive activation can increase cellular levels of c-Myc by interfering with its rapid proteasomal degradation. Although enhanced protein stability is generally thought to be applicable to other Myc family members, here we show that c-Myc and its paralog N-Myc respond to oncogenic H-Ras (H-Ras(G12V)) in very different ways. H-Ras(G12V) promotes accumulation of both c-Myc and N-Myc, but although c-Myc accumulation is achieved by enhanced protein stability, N-Myc accumulation is associated with an accelerated rate of translation that overcomes a surprising H-Ras(G12V)-mediated destabilization of N-Myc. We show that H-Ras(G12V)-mediated degradation of N-Myc functions independently of key phosphorylation sites in the highly conserved Myc homology box I region that controls c-Myc protein stability by oncogenic Ras. Finally, we found that N-Myc and c-Myc transcriptional activity is associated with their proteasomal degradation but that N-Myc may be uniquely dependent on Ras-stimulated proteolysis for target gene expression. Taken together, these studies provide mechanistic insight into how oncogenic Ras augments N-Myc levels in cells and suggest that enhanced N-Myc translation and degradation-coupled transactivation may contribute to oncogenesis.	[Hurlin, Peter J.] Shriners Hosp Children, Res Ctr, Portland, OR 97239 USA; [Kapeli, Katannya; Hurlin, Peter J.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA	Oregon Health & Science University	Hurlin, PJ (corresponding author), Shriners Hosp Children, Res Ctr, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	pjh@shcc.org			N. L. Tartar Trust; Shriners Hospitals for Children	N. L. Tartar Trust; Shriners Hospitals for Children	This work was supported by an N. L. Tartar Trust award (to K. K.) and a Shriners Hospitals for Children grant (to P. J. H.).	AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dhall G, 2009, J CHILD NEUROL, V24, P1418, DOI 10.1177/0883073809341668; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Forman JJ, 2010, CELL CYCLE, V9, P1533, DOI 10.4161/cc.9.8.11202; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Gomez-Roman N, 2006, BIOCHEM SOC SYMP, V73, P141, DOI 10.1042/bss0730141; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; Hurlin Peter J., 2005, Birth Defects Research, V75, P340, DOI 10.1002/bdrc.20059; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Jang JH, 2001, CANCER RES, V61, P3541; Jones RM, 1996, MOL CELL BIOL, V16, P4754; Karreth FA, 2009, CURR OPIN GENET DEV, V19, P4, DOI 10.1016/j.gde.2008.12.006; KATO GJ, 1990, MOL CELL BIOL, V10, P5914, DOI 10.1128/MCB.10.11.5914; Katoh M, 2008, INT J ONCOL, V33, P233, DOI 10.3892/ijo_00000001; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Keppler BR, 2011, BBA-GENE REGUL MECH, V1809, P109, DOI 10.1016/j.bbagrm.2010.08.005; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lonard DM, 2009, PROG MOL BIOL TRANSL, V87, P117, DOI 10.1016/S1877-1173(09)87004-X; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; MILTENBERGER RJ, 1995, MOL CELL BIOL, V15, P2527; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Origanti S, 2007, CANCER RES, V67, P4834, DOI 10.1158/0008-5472.CAN-06-4627; Ota S, 2007, DEVELOPMENT, V134, P1583, DOI 10.1242/dev.000703; Ota S, 2009, HUM MOL GENET, V18, P2609, DOI 10.1093/hmg/ddp195; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; SAWAI S, 1991, NEW BIOL, V3, P861; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Seo HR, 2008, J BIOL CHEM, V283, P15601, DOI 10.1074/jbc.M800987200; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; Spence J, 2006, MOL CANCER RES, V4, P47, DOI 10.1158/1541-7786.MCR-04-0187; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697; Tanaka T, 2005, CANCER LETT, V228, P267, DOI 10.1016/j.canlet.2004.12.051; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Tsuneoka M, 1998, J BIOCHEM-TOKYO, V124, P1013, DOI 10.1093/oxfordjournals.jbchem.a022193; van Bokhoven H, 2005, NAT GENET, V37, P465, DOI 10.1038/ng1546; Wang XM, 2007, METHOD ENZYMOL, V431, P113, DOI 10.1016/S0076-6879(07)31007-0; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yaari S, 2005, CLIN CANCER RES, V11, P4321, DOI 10.1158/1078-0432.CCR-04-2071; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; YANCOPOULOS GD, 1985, P NATL ACAD SCI USA, V82, P5455, DOI 10.1073/pnas.82.16.5455; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhu Q, 2007, ONCOGENE, V26, P4199, DOI 10.1038/sj.onc.1210191	65	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38498	38508		10.1074/jbc.M111.276675	http://dx.doi.org/10.1074/jbc.M111.276675			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908617	Green Published, hybrid			2022-12-25	WOS:000296594200064
J	Lorente, E; Garcia, R; Lopez, D				Lorente, Elena; Garcia, Ruth; Lopez, Daniel			Allele-dependent Processing Pathways Generate the Endogenous Human Leukocyte Antigen (HLA) Class I Peptide Repertoire in Transporters Associated with Antigen Processing (TAP)-deficient Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD8(+) T-LYMPHOCYTES; EPSTEIN-BARR-VIRUS; TRIPEPTIDYL-PEPTIDASE; PROTEASOME INHIBITORS; ENDOPLASMIC-RETICULUM; VIRAL-ANTIGEN; MONOCLONAL-ANTIBODY; CONVERTING-ENZYME; MOLECULES; PROTEIN	The transporters associated with antigen processing (TAP) allow the supply of peptides derived from the cytosol to translocate to the endoplasmic reticulum, where they complex with nascent human leukocyte antigen (HLA) class I molecules. However, infected and tumor cells with TAP molecules blocked or individuals with nonfunctional TAP complexes are able to present HLA class I ligands generated by TAP-independent processing pathways. These peptides are detected by the CD8(+) lymphocyte cellular response. Here, the generation of the overall peptide repertoire associated with four different HLA class I molecules in TAP-deficient cells was studied. Using different protease inhibitors, four different proteolytic specificities were identified. These data demonstrate the different allele-dependent complex processing pathways involved in the generation of the HLA class I peptide repertoire in TAP-deficient cells.	[Lopez, Daniel] Inst Salud Carlos III, Unidad Procesamiento Antigen, Ctr Nacl Microbiol, Majadahonda 28220, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Lopez, D (corresponding author), Inst Salud Carlos III, Unidad Procesamiento Antigen, Ctr Nacl Microbiol, Majadahonda 28220, Madrid, Spain.	dlopez@isciii.es	Lorente, Elena/B-1219-2019; López, Daniel/I-2632-2014	Lorente, Elena/0000-0002-2246-6851; López, Daniel/0000-0003-0268-5878	Fundacion para la Investigacion y Prevencion del SIDA en Espana Foundation	Fundacion para la Investigacion y Prevencion del SIDA en Espana Foundation	This work was supported by Fundacion para la Investigacion y Prevencion del SIDA en Espana Foundation grants.	ANDERSON KS, 1993, J IMMUNOL, V151, P3407; Bangert I, 2011, BIOL CHEM, V392, P61, DOI 10.1515/BC.2011.007; Cerundolo V, 2006, SEMIN IMMUNOL, V18, P330, DOI 10.1016/j.smim.2006.07.006; CHESNUT RW, 1982, J IMMUNOL, V129, P2382; Contin C, 2003, J BIOL CHEM, V278, P32801, DOI 10.1074/jbc.M209993200; Del-Val M, 2002, MOL IMMUNOL, V39, P235, DOI 10.1016/S0161-5890(02)00104-9; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fromm SV, 2002, CELL IMMUNOL, V215, P207; Gil-Torregrosa BC, 2000, TRAFFIC, V1, P641, DOI 10.1034/j.1600-0854.2000.010808.x; Gil-Torregrosa BC, 1998, J EXP MED, V188, P1105, DOI 10.1084/jem.188.6.1105; Guil S, 2006, J BIOL CHEM, V281, P39925, DOI 10.1074/jbc.M608522200; HANADA K, 1978, AGR BIOL CHEM TOKYO, V42, P523, DOI 10.1080/00021369.1978.10863014; HANADA M, 1992, J ANTIBIOT, V45, P1746, DOI 10.7164/antibiotics.45.1746; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Johnstone C, 2008, J GEN VIROL, V89, P2194, DOI 10.1099/vir.0.2008/002485-0; Johnstone C, 2007, TRAFFIC, V8, P1486, DOI 10.1111/j.1600-0854.2007.00635.x; Kessler JH, 2011, NAT IMMUNOL, V12, P45, DOI 10.1038/ni.1974; KOZLOWSKI S, 1993, J IMMUNOL, V151, P4033; Larsen Mette Voldby, 2006, Current Immunology Reviews, V2, P233; Lautscham G, 2003, MICROBES INFECT, V5, P291, DOI 10.1016/S1286-4579(03)00031-5; Lautscham G, 2001, J EXP MED, V194, P1053, DOI 10.1084/jem.194.8.1053; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lopez D, 2001, J IMMUNOL, V167, P4238, DOI 10.4049/jimmunol.167.8.4238; Lopez D, 2011, J BIOL CHEM, V286, P16910, DOI 10.1074/jbc.M111.234658; Lopez D, 2010, J IMMUNOL, V184, P5193, DOI 10.4049/jimmunol.1000050; Luckey CJ, 2001, J IMMUNOL, V167, P1212, DOI 10.4049/jimmunol.167.3.1212; MCDONALD JK, 1968, J BIOL CHEM, V243, P2028; Neumeister C, 2001, J GEN VIROL, V82, P441, DOI 10.1099/0022-1317-82-2-441; NUCHTERN JG, 1989, NATURE, V339, P223, DOI 10.1038/339223a0; OMURA S, 1991, J ANTIBIOT, V44, P113, DOI 10.7164/antibiotics.44.113; PARHAM P, 1978, NATURE, V276, P397, DOI 10.1038/276397a0; Parmentier N, 2010, NAT IMMUNOL, V11, P449, DOI 10.1038/ni.1862; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Rose C, 1996, NATURE, V380, P403, DOI 10.1038/380403a0; SALTER RD, 1986, EMBO J, V5, P943, DOI 10.1002/j.1460-2075.1986.tb04307.x; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; SCHIRMBECK R, 1995, EUR J IMMUNOL, V25, P1063, DOI 10.1002/eji.1830250431; Schwarz K, 2000, J IMMUNOL, V164, P6147, DOI 10.4049/jimmunol.164.12.6147; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; THORNBERRY NA, 1994, METHOD ENZYMOL, V244, P615; Tiwari N, 2007, J IMMUNOL, V178, P7932, DOI 10.4049/jimmunol.178.12.7932; Umezawa H, 1976, Methods Enzymol, V45, P678; van den Hoorn T, 2011, CURR OPIN IMMUNOL, V23, P88, DOI 10.1016/j.coi.2010.11.002; van Endert P, 2011, CELL MOL LIFE SCI, V68, P1553, DOI 10.1007/s00018-011-0662-1; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Weinzierl AO, 2008, EUR J IMMUNOL, V38, P1503, DOI 10.1002/eji.200838136; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; York IA, 2006, J IMMUNOL, V177, P1434, DOI 10.4049/jimmunol.177.3.1434; ZIEGLER HK, 1982, P NATL ACAD SCI-BIOL, V79, P175, DOI 10.1073/pnas.79.1.175	58	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38054	38059		10.1074/jbc.M111.281808	http://dx.doi.org/10.1074/jbc.M111.281808			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914809	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000296594200017
J	Sandtner, W; Egwolf, B; Khalili-Araghi, F; Sanchez-Rodriguez, JE; Roux, B; Bezanilla, F; Holmgren, M				Sandtner, Walter; Egwolf, Bernhard; Khalili-Araghi, Fatemeh; Sanchez-Rodriguez, Jorge E.; Roux, Benoit; Bezanilla, Francisco; Holmgren, Miguel			Ouabain Binding Site in a Functioning Na+/K+ ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; NA,K-ATPASE ALPHA-SUBUNIT; SODIUM-POTASSIUM PUMP; CARDIAC GLYCOSIDE BINDING; BETA-SUBUNIT; DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; EXTRACELLULAR DOMAIN; STRUCTURAL INSIGHTS; NA+,K+-ATPASE PUMP	The Na+/K+ ATPase is an almost ubiquitous integral membrane protein within the animal kingdom. It is also the selective target for cardiotonic derivatives, widely prescribed inhibitors for patients with heart failure. Functional studies revealed that ouabain-sensitive residues distributed widely throughout the primary sequence of the protein. Recently, structural work has brought some consensus to the functional observations. Here, we use a spectroscopic approach to estimate distances between a fluorescent ouabain and a lanthanide binding tag (LBT), which was introduced at five different positions in the Na+/K+ ATPase sequence. These five normally functional LBT-Na+/K+ ATPase constructs were expressed in the cell membrane of Xenopus laevis oocytes, operating under physiological internal and external ion conditions. The spectroscopic data suggest two mutually exclusive distances between the LBT and the fluorescent ouabain. From the estimated distances and using homology models of the LBT-Na+/K+ ATPase constructs, approximate ouabain positions could be determined. Our results suggest that ouabain binds at two sites along the ion permeation pathway of the Na+/K+ ATPase. The external site (low apparent affinity) occupies the same region as previous structural findings. The high apparent affinity site is, however, slightly deeper toward the intracellular end of the protein. Interestingly, in both cases the lactone ring faces outward. We propose a sequential ouabain binding mechanism that is consistent with all functional and structural studies.	Med Univ Vienna, Dept Pharmacol, A-1090 Vienna, Austria; [Egwolf, Bernhard] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, D-37077 Gottingen, Germany; [Khalili-Araghi, Fatemeh; Sanchez-Rodriguez, Jorge E.; Roux, Benoit; Bezanilla, Francisco] Univ Chicago, Gordon Ctr Integrat Sci, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Holmgren, Miguel] NINDS, Mol Neurophysiol Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	Medical University of Vienna; Max Planck Society; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Roux, B (corresponding author), 929 E 57 St, Chicago, IL 60637 USA.	roux@uchicago.edu; fbezanilla@uchicago.edu; holmgren@ninds.nih.gov		Khalili-Araghi, Fatemeh/0000-0002-0756-5560; Sanchez-Rodriguez, Jorge E./0000-0001-8747-7239	National Institutes of Health [R01-GM062342, R01-GM030376, U54-GM087519]; NINDS, National Institutes of Health; Consejo Nacional de Ciencia y TecnologIa (Mexico); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062342, R01GM030376, U54GM087519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003019, ZIANS002993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Consejo Nacional de Ciencia y TecnologIa (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM062342, R01-GM030376, and U54-GM087519. This work was also supported by the Intramural Research Program NINDS, National Institutes of Health.; Recipient of a postdoctoral fellowship from Consejo Nacional de Ciencia y TecnologIa (Mexico).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; ANTOLOVIC R, 1995, FEBS LETT, V368, P169, DOI 10.1016/0014-5793(95)00637-O; Brinkmann K, 1997, EUR J BIOCHEM, V249, P301, DOI 10.1111/j.1432-1033.1997.t01-2-00301.x; CANESSA CM, 1993, J BIOL CHEM, V268, P17722; CANESSA CM, 1992, EMBO J, V11, P1681, DOI 10.1002/j.1460-2075.1992.tb05218.x; Colina C, 2007, NAT STRUCT MOL BIOL, V14, P427, DOI 10.1038/nsmb1237; Croyle ML, 1997, EUR J BIOCHEM, V248, P488, DOI 10.1111/j.1432-1033.1997.00488.x; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; De Pont JJHHM, 2009, PFLUG ARCH EUR J PHY, V457, P623, DOI 10.1007/s00424-008-0467-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FORBUSH B, 1978, BIOCHEMISTRY-US, V17, P3667, DOI 10.1021/bi00610a037; GADSBY DC, 1993, SCIENCE, V260, P100, DOI 10.1126/science.7682009; Heyduk T, 2001, ANAL BIOCHEM, V289, P60, DOI 10.1006/abio.2000.4925; HILGEMANN DW, 1994, SCIENCE, V263, P1429, DOI 10.1126/science.8128223; Holmgren M, 2000, NATURE, V403, P898, DOI 10.1038/35002599; JAISSER F, 1992, J BIOL CHEM, V267, P16895; JEFFREY PD, 1995, J MOL BIOL, V248, P344, DOI 10.1016/S0022-2836(95)80055-7; KAWAMURA M, 1984, BIOCHIM BIOPHYS ACTA, V774, P188, DOI 10.1016/0005-2736(84)90290-6; KIRLEY TL, 1989, J BIOL CHEM, V264, P7185; LINGREL JB, 1991, SOC GEN PHY, V46, P1; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Martinez-Francois JR, 2010, J GEN PHYSIOL, V135, P149, DOI 10.1085/jgp.200910324; Middleton DA, 2000, P NATL ACAD SCI USA, V97, P13602, DOI 10.1073/pnas.250471997; MILLER RP, 1990, BIOCHEMISTRY-US, V29, P1524, DOI 10.1021/bi00458a025; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nitz M, 2004, ANGEW CHEM INT EDIT, V43, P3682, DOI 10.1002/anie.200460028; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; PRICE EM, 1989, J BIOL CHEM, V264, P21902; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; PRICE EM, 1990, J BIOL CHEM, V265, P6638; Qiu LY, 2005, J BIOL CHEM, V280, P32349, DOI 10.1074/jbc.M505168200; Reyes N, 2006, NATURE, V443, P470, DOI 10.1038/nature05129; Sandtner W, 2007, BIOPHYS J, V93, pL45, DOI 10.1529/biophysj.107.119073; Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436; Segall L, 2005, P NATL ACAD SCI USA, V102, P11106, DOI 10.1073/pnas.0504323102; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; STURMER W, 1992, FEBS LETT, V300, P1, DOI 10.1016/0014-5793(92)80151-6; Takeuchi A, 2008, NATURE, V456, P413, DOI 10.1038/nature07350; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	46	42	45	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38177	38183		10.1074/jbc.M111.267682	http://dx.doi.org/10.1074/jbc.M111.267682			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911500	Green Published, hybrid			2022-12-25	WOS:000296594200031
J	Syson, K; Stevenson, CEM; Rejzek, M; Fairhurst, SA; Nair, A; Bruton, CJ; Field, RA; Chater, KF; Lawson, DM; Bornemann, S				Syson, Karl; Stevenson, Clare E. M.; Rejzek, Martin; Fairhurst, Shirley A.; Nair, Alap; Bruton, Celia J.; Field, Robert A.; Chater, Keith F.; Lawson, David M.; Bornemann, Stephen			Structure of Streptomyces Maltosyltransferase GlgE, a Homologue of a Genetically Validated Anti-tuberculosis Target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMYLASE FAMILY; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURE; TREHALOSE METABOLISM; MALTOGENIC AMYLASE; COELICOLOR A3(2); GLYCOGEN; GLUCAN; SPECIFICITY; SOFTWARE	GlgE is a recently identified (1 -> 4)-alpha-D-glucan:phosphate alpha-D-maltosyltransferase involved in alpha-glucan biosynthesis in bacteria and is a genetically validated anti-tuberculosis drug target. It is a member of the GH13_3 CAZy subfamily for which no structures were previously known. We have solved the structure of GlgE isoform I from Streptomyces coelicolor and shown that this enzyme has the same catalytic and very similar kinetic properties to GlgE from Mycobacterium tuberculosis. The S. coelicolor enzyme forms a homodimer with each subunit comprising five domains, including a core catalytic alpha-amylase-type domain A with a (beta/alpha)(8) fold. This domain is elaborated with domain B and two inserts that are specifically configured to define a well conserved donor pocket capable of binding maltose. Domain A, together with domain N from the neighboring subunit, forms a hydrophobic patch that is close to the maltose-binding site and capable of binding cyclodextrins. Cyclodextrins competitively inhibit the binding of maltooligosaccharides to the S. coelicolor enzyme, showing that the hydrophobic patch overlaps with the acceptor binding site. This patch is incompletely conserved in the M. tuberculosis enzyme such that cyclodextrins do not inhibit this enzyme, despite acceptor length specificity being conserved. The crystal structure reveals two further domains, C and S, the latter being a helix bundle not previously reported in GH13 members. The structure provides a framework for understanding how GlgE functions and will help guide the development of inhibitors with therapeutic potential.	[Syson, Karl; Stevenson, Clare E. M.; Rejzek, Martin; Fairhurst, Shirley A.; Nair, Alap; Field, Robert A.; Lawson, David M.; Bornemann, Stephen] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Bruton, Celia J.; Chater, Keith F.] John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Bornemann, S (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	stephen.bornemann@jic.ac.uk	Bornemann, Stephen/K-2938-2012	Bornemann, Stephen/0000-0001-5930-9473; Field, Rob/0000-0001-8574-0275	United Kingdom Biotechnology and Biological Sciences Research Council [BB/I012850/1]; Metabolism Institute; BBSRC [BBS/E/J/000C0647, BBS/E/J/000C0618, BB/I012850/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0647, BBS/E/J/000C0618, BB/I012850/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Metabolism Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by United Kingdom Biotechnology and Biological Sciences Research Council Grant BB/I012850/1 and the Metabolism Institute Strategic Programme Grant to the John Innes Centre.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Chandra G, 2011, MICROBIOL-SGM, V157, P1565, DOI 10.1099/mic.0.044263-0; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Damager I, 2004, CARBOHYD RES, V339, P1727, DOI 10.1016/j.carres.2004.05.019; Damager I, 2010, CHEM REV, V110, P2049, DOI 10.1021/cr900227t; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano WL, 2002, PYMOL USERS MANUAL; DEWAARD P, 1989, J MAGN RESON, V81, P173, DOI 10.1016/0022-2364(89)90276-X; Dinadayala P, 2004, J BIOL CHEM, V279, P12369, DOI 10.1074/jbc.M308908200; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Elbein AD, 2010, J BIOL CHEM, V285, P9803, DOI 10.1074/jbc.M109.033944; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gagliardi MC, 2007, CELL MICROBIOL, V9, P2081, DOI 10.1111/j.1462-5822.2007.00940.x; GENGHOF DS, 1978, CARBOHYD RES, V61, P291, DOI 10.1016/S0008-6215(00)84489-4; Goedl C, 2008, CARBOHYD RES, V343, P2032, DOI 10.1016/j.carres.2008.01.029; Henrissat B, 2008, CURR OPIN STRUC BIOL, V18, P527, DOI 10.1016/j.sbi.2008.09.003; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jackson M, 2009, J BIOL CHEM, V284, P1949, DOI 10.1074/jbc.R800047200; Janecek S, 1997, J MOL EVOL, V45, P322, DOI 10.1007/PL00006236; JUNNEMANN J, 1993, CARBOHYD RES, V249, P91, DOI 10.1016/0008-6215(93)84062-B; Kalscheuer R, 2010, DRUG NEWS PERSPECT, V23, P619, DOI 10.1358/dnp.2010.23.10.1534855; Kalscheuer R, 2010, NAT CHEM BIOL, V6, P376, DOI 10.1038/nchembio.340; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kim JS, 1999, J BIOL CHEM, V274, P26279, DOI 10.1074/jbc.274.37.26279; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lairson LL, 2004, CHEM COMMUN, P2243, DOI 10.1039/b406490a; Lee HS, 2002, J BIOL CHEM, V277, P21891, DOI 10.1074/jbc.M201623200; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; Machius M, 1996, J MOL BIOL, V260, P409, DOI 10.1006/jmbi.1996.0410; MacRae IJ, 2007, ACTA CRYSTALLOGR D, V63, P993, DOI 10.1107/S0907444907036128; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PLASKITT KA, 1995, PHILOS T R SOC B, V347, P105, DOI 10.1098/rstb.1995.0016; Preiss J., 2009, ENCY MICROBIOLOGY, P145; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Roujeinikova A, 2002, J MOL BIOL, V321, P149, DOI 10.1016/S0022-2836(02)00570-3; Roujeinikova A, 2001, J MOL BIOL, V312, P119, DOI 10.1006/jmbi.2001.4944; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Skov LK, 2002, J BIOL CHEM, V277, P47741, DOI 10.1074/jbc.M207860200; Skov LK, 2001, J BIOL CHEM, V276, P25273, DOI 10.1074/jbc.M010998200; SOGAARD M, 1993, CARBOHYD POLYM, V21, P137, DOI 10.1016/0144-8617(93)90008-R; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Yeo M, 2005, MICROBIOL-SGM, V151, P855, DOI 10.1099/mic.0.27428-0	53	41	48	6	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38298	38310		10.1074/jbc.M111.279315	http://dx.doi.org/10.1074/jbc.M111.279315			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914799	hybrid, Green Published			2022-12-25	WOS:000296594200043
J	Jang, JE; Lee, JB; Kim, KH; Park, SM; Shim, BS; Cheon, IS; Song, MK; Chang, J				Jang, Ji-Eun; Lee, Jee-Boong; Kim, Kyung-Hyo; Park, Sung Moo; Shim, Byoung-Shik; Cheon, In Soo; Song, Man Ki; Chang, Jun			Evaluation of Protective Efficacy of Respiratory Syncytial Virus Vaccine against A and B Subgroup Human Isolates in Korea	PLOS ONE			English	Article							G-PROTEIN; G-GLYCOPROTEIN; GROUP-A; MONOCLONAL-ANTIBODIES; ATTACHMENT PROTEIN; CHILDHOOD ASTHMA; 60 NUCLEOTIDES; INFECTION; BRONCHIOLITIS; IMMUNITY	Human respiratory syncytial virus (HRSV) is a significant cause of upper and lower respiratory tract illness mainly in infants and young children worldwide. HRSV is divided into two subgroups, HRSV-A and HRSV-B, based on sequence variation within the G gene. Despite its importance as a respiratory pathogen, there is currently no safe and effective vaccine for HRSV. In this study, we have detected and identified the HRSV by RT-PCR from nasopharyngeal aspirates of Korean pediatric patients. Interestingly, all HRSV-B isolates exhibited unique deletion of 6 nucleotides and duplication of 60 nucleotides in the G gene. We successfully amplified two isolates ('KR/A/09-8' belonging to HRSV-A and 'KR/B/10-12' to HRSV-B) on large-scale, and evaluated the cross-protective efficacy of our recombinant adenovirus-based HRSV vaccine candidate, rAd/3xG, by challenging the immunized mice with these isolates. The single intranasal immunization with rAd/3xG protected the mice completely from KR/A/09-8 infection and partially from KR/B/10-12 infection. Our study contributes to the understanding of the genetic characteristics and distribution of subgroups in the seasonal HRSV epidemics in Korea and, for the first time, to the evaluation of the cross-protective efficacy of RSV vaccine against HRSV-A and -B field-isolates.	[Jang, Ji-Eun; Lee, Jee-Boong; Chang, Jun] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Div Life & Pharmaceut Sci, Seoul, South Korea; [Kim, Kyung-Hyo] Ewha Womans Univ, Sch Med, Dept Pediat, Ctr Vaccine Evaluat & Study, Seoul, South Korea; [Park, Sung Moo; Shim, Byoung-Shik; Cheon, In Soo; Song, Man Ki] Int Vaccine Inst, Div Sci Lab, Seoul, South Korea	Ewha Womans University; Ewha Womans University; International Vaccine Institute	Jang, JE (corresponding author), Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Div Life & Pharmaceut Sci, Seoul, South Korea.	tcell@ewha.ac.kr		Tripp, Ralph/0000-0002-2924-9956; CHANG, JUN/0000-0002-8423-5987	Ministry of Health and Welfare, Republic of Korea [A084555]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of the Korean Health Technology Research and Development project, Ministry of Health and Welfare, Republic of Korea (A084555). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoti CN, 2010, J VIROL, V84, P10425, DOI 10.1128/JVI.01181-10; ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; CANE PA, 1995, J VIROL, V69, P2918, DOI 10.1128/JVI.69.5.2918-2925.1995; Chang J, 2011, BMB REP, V44, P232, DOI 10.5483/BMBRep.2011.44.4.232; Choi EH, 2000, J INFECT DIS, V181, P1547, DOI 10.1086/315468; Coggins WB, 1998, J CLIN MICROBIOL, V36, P3552, DOI 10.1128/JCM.36.12.3552-3557.1998; Falsey AR, 2007, SEMIN RESP CRIT CARE, V28, P171, DOI 10.1055/s-2007-976489; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Galiano MC, 2005, J CLIN MICROBIOL, V43, P2266, DOI 10.1128/JCM.43.5.2266-2273.2005; GARCIA O, 1994, J VIROL, V68, P5448; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Graham BS, 2011, IMMUNOL REV, V239, P149, DOI 10.1111/j.1600-065X.2010.00972.x; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Han LL, 1999, J INFECT DIS, V179, P25, DOI 10.1086/314567; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Martinez FD, 2003, PEDIATR INFECT DIS J, V22, pS76, DOI 10.1097/00006454-200302001-00011; Melero JA, 1997, J GEN VIROL, V78, P2411, DOI 10.1099/0022-1317-78-10-2411; Murata Y, 2007, ANTIVIR THER, V12, P659; Nagai K, 2004, J MED VIROL, V74, P161, DOI 10.1002/jmv.20160; Openshaw PJM, 2003, PEDIATR INFECT DIS J, V22, pS58, DOI 10.1097/00006454-200302001-00009; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; RUEDA P, 1991, J VIROL, V65, P3374, DOI 10.1128/JVI.65.6.3374-3378.1991; Sampalis JS, 2003, J PEDIATR-US, V143, pS150, DOI 10.1067/S0022-3476(03)00513-4; Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Yu JR, 2008, J VIROL, V82, P2350, DOI 10.1128/JVI.02372-07	30	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e23797	10.1371/journal.pone.0023797	http://dx.doi.org/10.1371/journal.pone.0023797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915262	gold, Green Submitted, Green Published			2022-12-25	WOS:000294802500013
J	Tang, B; Di Lena, P; Schaffer, L; Head, SR; Baldi, P; Thomas, EA				Tang, Bin; Di Lena, Pietro; Schaffer, Lana; Head, Steven R.; Baldi, Pierre; Thomas, Elizabeth A.			Genome-Wide Identification of Bcl11b Gene Targets Reveals Role in Brain-Derived Neurotrophic Factor Signaling	PLOS ONE			English	Article							COUP-TF; TRANSCRIPTION FACTOR; BASAL GANGLIA; DNA; EXPRESSION; RECOGNITION; DISEASE; CTIP2	B-cell leukemia/lymphoma 11B (Bcl11b) is a transcription factor showing predominant expression in the striatum. To date, there are no known gene targets of Bcl11b in the nervous system. Here, we define targets for Bcl11b in striatal cells by performing chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) in combination with genome-wide expression profiling. Transcriptome-wide analysis revealed that 694 genes were significantly altered in striatal cells over-expressing Bcl11b, including genes showing striatal-enriched expression similar to Bcl11b. ChIP-seq analysis demonstrated that Bcl11b bound a mixture of coding and non-coding sequences that were within 10 kb of the transcription start site of an annotated gene. Integrating all ChIP-seq hits with the microarray expression data, 248 direct targets of Bcl11b were identified. Functional analysis on the integrated gene target list identified several zinc-finger encoding genes as Bcl11b targets, and further revealed a significant association of Bcl11b to brain-derived neurotrophic factor/neurotrophin signaling. Analysis of ChIP-seq binding regions revealed significant consensus DNA binding motifs for Bcl11b. These data implicate Bcl11b as a novel regulator of the BDNF signaling pathway, which is disrupted in many neurological disorders. Specific targeting of the Bcl11b-DNA interaction could represent a novel therapeutic approach to lowering BDNF signaling specifically in striatal cells.	[Tang, Bin; Thomas, Elizabeth A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Di Lena, Pietro; Baldi, Pierre] Univ Calif Irvine, Dept Comp Sci, Irvine, CA USA; [Di Lena, Pietro; Baldi, Pierre] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA USA; [Schaffer, Lana; Head, Steven R.] Scripps Res Inst, Dept Shared Res Serv, La Jolla, CA 92037 USA	Scripps Research Institute; University of California System; University of California Irvine; University of California System; University of California Irvine; Scripps Research Institute	Tang, B (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bthomas@scripps.edu	Di Lena, Pietro/B-1334-2011	DI LENA, PIETRO/0000-0002-1838-8918	NIH [NS44169]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044169] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by NIH grant NS44169 to E. A. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Arlotta P, 2008, J NEUROSCI, V28, P622, DOI 10.1523/JNEUROSCI.2986-07.2008; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bateman E, 1998, PROG NUCLEIC ACID RE, V60, P133, DOI 10.1016/S0079-6603(08)60892-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Desplats PA, 2006, J NEUROCHEM, V96, P743, DOI 10.1111/j.1471-4159.2005.03588.x; Desplats PA, 2008, NEUROBIOL DIS, V31, P298, DOI 10.1016/j.nbd.2008.05.005; FOSTER GA, 1988, INT J DEV NEUROSCI, V6, P367, DOI 10.1016/0736-5748(88)90020-2; Gottesfeld JM, 1997, NATURE, V387, P202, DOI 10.1038/387202a0; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; GRAYBIEL AM, 1995, TRENDS NEUROSCI, V18, P60; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; Lin HB, 1999, J BIOL CHEM, V274, P36796, DOI 10.1074/jbc.274.51.36796; LIU P, IMMUNOL REV, V238, P138; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Nilsson P, 2010, J CELL MOL MED, V14, P741, DOI 10.1111/j.1582-4934.2010.01038.x; Pardon MC, 2010, VITAM HORM, V82, P185, DOI 10.1016/S0083-6729(10)82010-2; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; Trauger JW, 1996, NATURE, V382, P559, DOI 10.1038/382559a0; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Xie XH, 2009, BIOINFORMATICS, V25, P167, DOI 10.1093/bioinformatics/btn605; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	31	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e23691	10.1371/journal.pone.0023691	http://dx.doi.org/10.1371/journal.pone.0023691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21912641	Green Published, gold, Green Submitted			2022-12-25	WOS:000294683900007
J	Yonkers, NL; Rodriguez, B; Asaad, R; Lederman, MM; Anthony, DD				Yonkers, Nicole L.; Rodriguez, Benigno; Asaad, Robert; Lederman, Michael M.; Anthony, Donald D.			Systemic Immune Activation in HIV Infection Is Associated with Decreased MDC Responsiveness to TLR Ligand and Inability to Activate Naive CD4 T-Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PLASMACYTOID DENDRITIC CELLS; HEPATITIS-C VIRUS; DISEASE PROGRESSION; IN-VIVO; ANTIRETROVIRAL THERAPY; RECEPTOR LIGANDS; BLOOD; RESPONSES; INDIVIDUALS	Background: HIV infection is characterized by ineffective anti-viral T-cell responses and impaired dendritic cell (DC) functions, including response to Toll-Like Receptor (TLR) ligands. Because TLR responsiveness may affect a host's response to virus, we examined TLR ligand induced Myeloid and Plasmacytoid DC (MDC and PDC) activation of naive T-cells in HIV+ subjects. Methods: Freshly purified MDC and PDC obtained from HIV+ subjects and healthy controls were cultured in the presence and absence of TLR ligands (poly I: C or R-848). We evaluated indices of maturation/activation (CD83, CD86, and HLA-DR expression), cytokine secretion (IFN-alpha and IL-6), and ability to activate allogeneic naive CD4 T-cells to secrete IFNgamma and IL-2. Results: MDC from HIV+ subjects had increased spontaneous IL-6 production and increased CD83 and CD86 expression when compared to MDC of controls. MDC IL-6 expression was associated with plasma HIV level. At the same time, poly I: C induced HLA-DR up-regulation on MDC was reduced in HIV+ persons when compared to controls. The latter finding was associated with impaired ability of MDC from HIV+ subjects to activate allogeneic naive CD4 T-cells. PDC from HIV+ persons had increased spontaneous and TLR ligand induced IL-6 expression, and increased HLA-DR expression at baseline. The latter was associated with an intact ability of HIV PDC to activate allogeneic naive CD4 T-cells. Conclusion: These results have implications for the ability of the HIV+ host to form innate and adaptive responses to HIV and other pathogens.	[Yonkers, Nicole L.; Lederman, Michael M.; Anthony, Donald D.] Case Western Reserve Univ, Dept Pathol, Div Infect & Rheumat Dis, Ctr AIDS Res,Case Med Ctr, Cleveland, OH 44106 USA; [Yonkers, Nicole L.; Rodriguez, Benigno; Asaad, Robert; Lederman, Michael M.; Anthony, Donald D.] Univ Hosp Cleveland, VA Med Ctr, Cleveland, OH 44106 USA; [Rodriguez, Benigno; Asaad, Robert; Lederman, Michael M.; Anthony, Donald D.] Case Western Reserve Univ, Dept Med, Div Infect & Rheumat Dis, Ctr AIDS Res,Case Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University	Yonkers, NL (corresponding author), Case Western Reserve Univ, Dept Pathol, Div Infect & Rheumat Dis, Ctr AIDS Res,Case Med Ctr, Cleveland, OH 44106 USA.	dda3@case.edu	Rodriguez, Benigno/C-3365-2009	Rodriguez, Benigno/0000-0001-9736-7957	NIH [R01 DK068361]; CWRU Center for AIDS Research Core facilities [AI 36219]; NIAAA NRSA [1F31AA017853]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA017853] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CWRU Center for AIDS Research Core facilities; NIAAA NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH R01 DK068361, the CWRU Center for AIDS Research Core facilities (AI 36219), and NIAAA NRSA 1F31AA017853 to NLY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony DD, 2004, J IMMUNOL, V172, P4907, DOI 10.4049/jimmunol.172.8.4907; Anthony DD, 2001, CLIN IMMUNOL, V99, P232, DOI 10.1006/clim.2001.5018; Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BAZIL V, 1991, J IMMUNOL, V147, P1567; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cai GF, 2004, CELL IMMUNOL, V230, P89, DOI 10.1016/j.cellimm.2004.09.004; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; Cohen DE, 2001, CLIN INFECT DIS, V32, P1756, DOI 10.1086/320759; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dillon SM, 2008, JAIDS-J ACQ IMM DEF, V48, P1, DOI 10.1097/QAI.0b013e3181664b60; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; Fanales-Belasio E, 2002, J IMMUNOL, V168, P197, DOI 10.4049/jimmunol.168.1.197; Feldman S, 2001, CLIN IMMUNOL, V101, P201, DOI 10.1006/clim.2001.5111; Granelli-Piperno A, 2006, J IMMUNOL, V176, P991, DOI 10.4049/jimmunol.176.2.991; Grassi F, 1999, AIDS, V13, P759, DOI 10.1097/00002030-199905070-00004; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Habicht A, 2007, AM J TRANSPLANT, V7, P2683, DOI 10.1111/j.1600-6143.2007.01999.x; Hay CM, 1999, J VIROL, V73, P5509, DOI 10.1128/JVI.73.7.5509-5519.1999; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Karulin AY, 2000, J IMMUNOL, V164, P1862, DOI 10.4049/jimmunol.164.4.1862; Lanzavecchia A, 2001, CURR OPIN IMMUNOL, V13, P291, DOI 10.1016/S0952-7915(00)00218-1; Laurence JC, 2005, AM J MED, V118, P75, DOI 10.1016/j.amjmed.2005.07.024; Lehmann C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011110; Lester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35; Lien E, 1998, BLOOD, V92, P2084, DOI 10.1182/blood.V92.6.2084.418k26_2084_2092; Lore K, 2003, J IMMUNOL, V171, P4320, DOI 10.4049/jimmunol.171.8.4320; Mahnke K, 2002, IMMUNOL CELL BIOL, V80, P477, DOI 10.1046/j.1440-1711.2002.01115.x; Martinson JA, 2007, CELL IMMUNOL, V250, P75, DOI 10.1016/j.cellimm.2008.01.007; Meera S, 2010, VIRAL IMMUNOL, V23, P241, DOI 10.1089/vim.2009.0112; Meier A, 2008, AIDS, V22, P655, DOI 10.1097/QAD.0b013e3282f4de23; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Neilsen GA, 1997, J INFECT DIS, V176, P1064, DOI 10.1086/516512; Nowroozalizadeh S, 2009, CYTOKINE, V46, P325, DOI 10.1016/j.cyto.2009.03.003; Pacanowski J, 2001, BLOOD, V98, P3016, DOI 10.1182/blood.V98.10.3016; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Phillips AN, 2008, ANTIVIR THER, V13, P177; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; SABADO RL, 2010, BLOOD; Soumelis V, 2001, BLOOD, V98, P906, DOI 10.1182/blood.V98.4.906; Tilton JC, 2008, J VIROL, V82, P3997, DOI 10.1128/JVI.01545-07; Trabattoni D, 2003, BLOOD, V101, P2514, DOI 10.1182/blood-2002-10-3065; Vlad G, 2009, HUM IMMUNOL, V70, P340, DOI 10.1016/j.humimm.2009.03.004; Wang XO, 2008, J OPT NETW, V7, P1, DOI 10.1364/JON.7.000001; Yonkers NL, 2007, J IMMUNOL, V178, P4436, DOI 10.4049/jimmunol.178.7.4436	49	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e23884	10.1371/journal.pone.0023884	http://dx.doi.org/10.1371/journal.pone.0023884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21912648	Green Published, Green Submitted, gold			2022-12-25	WOS:000294683900011
J	Gallego-Bartolome, J; Alabadi, D; Blazquez, MA				Gallego-Bartolome, Javier; Alabadi, David; Blazquez, Miguel A.			DELLA-Induced Early Transcriptional Changes during Etiolated Development in Arabidopsis thaliana	PLOS ONE			English	Article							SCARECROW-LIKE 3; GIBBERELLIN METABOLISM; SIGNAL-TRANSDUCTION; SEED-GERMINATION; GENE-EXPRESSION; TARGET GENES; LIGHT; GROWTH; REGULATOR; BINDING	The hormones gibberellins (GAs) control a wide variety of processes in plants, including stress and developmental responses. This task largely relies on the activity of the DELLA proteins, nuclear-localized transcriptional regulators that do not seem to have DNA binding capacity. The identification of early target genes of DELLA action is key not only to understand how GAs regulate physiological responses, but also to get clues about the molecular mechanisms by which DELLAs regulate gene expression. Here, we have investigated the global, early transcriptional response triggered by the Arabidopsis DELLA protein GAI during skotomorphogenesis, a developmental program tightly regulated by GAs. Our results show that the induction of GAI activity has an almost immediate effect on gene expression. Although this transcriptional regulation is largely mediated by the PIFs and HY5 transcription factors based on target meta-analysis, additional evidence points to other transcription factors that would be directly involved in DELLA regulation of gene expression. First, we have identified cis elements recognized by Dofs and type-B ARRs among the sequences enriched in the promoters of GAI targets; and second, an enrichment in additional cis elements appeared when this analysis was extended to a dataset of early targets of the DELLA protein RGA: CArG boxes, bound by MADS-box proteins, and the E-box CACATG that links the activity of DELLAs to circadian transcriptional regulation. Finally, Gene Ontology analysis highlights the impact of DELLA regulation upon the homeostasis of the GA, auxin, and ethylene pathways, as well as upon pre-existing transcriptional networks.	[Gallego-Bartolome, Javier; Alabadi, David; Blazquez, Miguel A.] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Gallego-Bartolome, J (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain.	dalabadi@ibmcp.upv.es	Gallego-Bartolomé, Javier/AAV-7369-2020; Alabadi, David/AAS-3408-2020; Blazquez, Miguel A/B-1495-2008	Alabadi, David/0000-0001-8492-6713; Blazquez, Miguel A/0000-0001-5743-0448; Gallego-Bartolome, Javier/0000-0003-2225-7168	Spanish Ministry of Science and Innovation [BIO2007-60293, Consolider-TRANSPLANTA]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Work in the laboratory of Dr. Blazquez and Dr. Alabadi is supported by grants from the Spanish Ministry of Science and Innovation (BIO2007-60293 and Consolider-TRANSPLANTA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2005, BIOINFORMATICS, V21, P2988, DOI 10.1093/bioinformatics/bti457; Alabadi D, 2004, PLANT PHYSIOL, V134, P1050, DOI 10.1104/pp.103.035451; Alabadi D, 2008, PLANT J, V53, P324, DOI 10.1111/j.1365-313X.2007.03346.x; Alabadi D, 2009, INT J DEV BIOL, V53, P1597, DOI 10.1387/ijdb.072423da; Alabadi D, 2009, PLANT MOL BIOL, V69, P409, DOI 10.1007/s11103-008-9400-y; Arnaud N, 2010, GENE DEV, V24, P2127, DOI 10.1101/gad.593410; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Bueso E, 2007, PLANT J, V52, P1052, DOI 10.1111/j.1365-313X.2007.03305.x; Cao DN, 2006, PLANT PHYSIOL, V142, P509, DOI 10.1104/pp.106.082289; Casal JJ, 2004, TRENDS PLANT SCI, V9, P309, DOI 10.1016/j.tplants.2004.04.007; Cheminant S, 2011, PLANT CELL, V23, P1849, DOI 10.1105/tpc.111.085233; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; FOSTER R, 1994, FASEB J, V8, P192, DOI 10.1096/fasebj.8.2.8119490; Fu XD, 2002, PLANT CELL, V14, P3191, DOI 10.1105/tpc.006197; Gabriele S, 2010, PLANT J, V61, P312, DOI 10.1111/j.1365-313X.2009.04055.x; Gallego-Bartolome J, 2011, PLANT J, V67, P622, DOI 10.1111/j.1365-313X.2011.04621.x; Gallego-Bartolome J, 2011, PLANT PHYSIOL, V156, P1819, DOI 10.1104/pp.111.173971; Gallego-Bartolome J, 2010, MOL BIOL EVOL, V27, P1247, DOI 10.1093/molbev/msq012; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Harberd NP, 2009, PLANT CELL, V21, P1328, DOI 10.1105/tpc.109.066969; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Heo JO, 2011, P NATL ACAD SCI USA, V108, P2166, DOI 10.1073/pnas.1012215108; Hirano K, 2010, PLANT CELL, V22, P2680, DOI 10.1105/tpc.110.075549; Hornitschek P, 2009, EMBO J, V28, P3893, DOI 10.1038/emboj.2009.306; Hou XL, 2008, PLANT PHYSIOL, V147, P1126, DOI 10.1104/pp.108.121301; Hou XL, 2010, DEV CELL, V19, P884, DOI 10.1016/j.devcel.2010.10.024; Huq E, 2002, EMBO J, V21, P2441, DOI 10.1093/emboj/21.10.2441; Itoh H, 2003, TRENDS PLANT SCI, V8, P492, DOI 10.1016/j.tplants.2003.08.002; Jaillais Y, 2010, NAT STRUCT MOL BIOL, V17, P642, DOI 10.1038/nsmb0610-642; Jiang CF, 2007, PLANT PHYSIOL, V145, P1460, DOI 10.1104/pp.107.103788; Kim K, 2011, P NATL ACAD SCI USA, V108, P1729, DOI 10.1073/pnas.1011066108; King KE, 2001, GENETICS, V159, P767; Kuppusamy K, 2009, PLANT MOL BIOL, V69, P375, DOI 10.1007/s11103-008-9389-2; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Lee S, 2006, PLANT CELL PHYSIOL, V47, P591, DOI 10.1093/pcp/pcj026; Leivar P, 2009, PLANT CELL, V21, P3535, DOI 10.1105/tpc.109.070672; Li LC, 2008, PLANT CELL REP, V27, P575, DOI 10.1007/s00299-007-0458-9; Loreti E, 2008, NEW PHYTOL, V179, P1004, DOI 10.1111/j.1469-8137.2008.02511.x; Martinez GA, 1996, J PLANT GROWTH REGUL, V15, P139, DOI 10.1007/BF00198929; Mena M, 2002, PLANT PHYSIOL, V130, P111, DOI 10.1104/pp.005561; Michael TP, 2008, PLOS BIOL, V6, P1887, DOI 10.1371/journal.pbio.0060225; Moubayidin L, 2010, CURR BIOL, V20, P1138, DOI 10.1016/j.cub.2010.05.035; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Nemhauser JL, 2004, PLOS BIOL, V2, P1460, DOI 10.1371/journal.pbio.0020258; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Qin GJ, 2005, PLANT CELL, V17, P2693, DOI 10.1105/tpc.105.034959; Riechmann JL, 1996, P NATL ACAD SCI USA, V93, P4793, DOI 10.1073/pnas.93.10.4793; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Shimada A, 2008, NATURE, V456, P520, DOI 10.1038/nature07546; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Stavang JA, 2009, PLANT J, V60, P589, DOI 10.1111/j.1365-313X.2009.03983.x; Sun Y, 2010, DEV CELL, V19, P765, DOI 10.1016/j.devcel.2010.10.010; Tatematsu K, 2004, PLANT CELL, V16, P379, DOI 10.1105/tpc.018630; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Arana MV, 2011, P NATL ACAD SCI USA, V108, P9292, DOI 10.1073/pnas.1101050108; Vogel JP, 1998, P NATL ACAD SCI USA, V95, P4766, DOI 10.1073/pnas.95.8.4766; WEISS D, 1995, PLANT PHYSIOL, V107, P695, DOI 10.1104/pp.107.3.695; Yamagami T, 2003, J BIOL CHEM, V278, P49102, DOI 10.1074/jbc.M308297200; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yanagisawa S, 2004, PLANT CELL PHYSIOL, V45, P386, DOI 10.1093/pcp/pch055; Yu XF, 2011, PLANT J, V65, P634, DOI 10.1111/j.1365-313X.2010.04449.x; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Zhang ZL, 2011, P NATL ACAD SCI USA, V108, P2160, DOI 10.1073/pnas.1012232108; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zou XL, 2008, PLANT PHYSIOL, V148, P176, DOI 10.1104/pp.108.123653	73	44	48	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23918	10.1371/journal.pone.0023918	http://dx.doi.org/10.1371/journal.pone.0023918			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904598	Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800041
J	Rocha, MF; Passamani, M; Louzada, J				Rocha, Mariana Ferreira; Passamani, Marcelo; Louzada, Julio			A Small Mammal Community in a Forest Fragment, Vegetation Corridor and Coffee Matrix System in the Brazilian Atlantic Forest	PLOS ONE			English	Article							TROPICAL LANDSCAPES; CONSERVATION; ABUNDANCE; MOVEMENTS; REMNANTS; QUALITY; STRIPS; BIRD; SIZE	The objective of our work was to verify the value of the vegetation corridor in the conservation of small mammals in fragmented tropical landscapes, using a model system in the southeastern Minas Gerais. We evaluated and compared the composition and structure of small mammals in a vegetation corridor, forest fragments and a coffee matrix. A total of 15 species were recorded, and the highest species richness was observed in the vegetation corridor (13 species), followed by the forest fragments (10) and the coffee matrix (6). The absolute abundance was similar between the vegetation corridor and fragments (F = 22.94; p = 0.064), and the greatest differences occurred between the vegetation corridor and the matrix (F = 22.94; p = 0.001) and the forest fragments and the matrix (F = 22.94; p = 0.007). Six species showed significant habitat preference possibly related to the sensitivity of the species to the forest disturbance. Marmosops incanus was the species most sensitive to disturbance; Akodon montensis, Cerradomys subflavus, Gracilinanus microtarsus and Rhipidomys sp. displayed little sensitivity to disturbance, with a high relative abundance in the vegetation corridor. Calomys sp. was the species least affected by habitat disturbance, displaying a high relative abundance in the coffee matrix. Although the vegetation corridors are narrow (4 m width), our results support the hypothesis in which they work as a forest extension, share most species with the forest fragment and support species richness and abundance closer to forest fragments than to the coffee matrix. Our work highlights the importance and cost-effectiveness of these corridors to biodiversity management in the fragmented Atlantic Forest landscapes and at the regional level.	[Rocha, Mariana Ferreira; Passamani, Marcelo; Louzada, Julio] Univ Fed Lavras, Dept Biol, Setor Ecol, Lavras, Brazil	Universidade Federal de Lavras	Rocha, MF (corresponding author), Univ Fed Lavras, Dept Biol, Setor Ecol, Lavras, Brazil.	marianafrocha@hotmail.com	Louzada, Julio/F-1265-2010; Passamani, Marcelo/H-3361-2015; Passamani, Marcelo/ABG-8886-2020; Passamani, Marcelo/N-1168-2019	Louzada, Julio/0000-0002-1481-3112; Passamani, Marcelo/0000-0002-0940-4074; 	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), (http://www.fapemig.br/) and Coordenacao de Aperfeicoamento de Pessoal de Nivel (CAPES), (http://www.capes.gov.br/) awarded to Dr. Rocha. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow J, 2010, J APPL ECOL, V47, P779, DOI 10.1111/j.1365-2664.2010.01825.x; Bolger DT, 2001, BIOL CONSERV, V102, P213, DOI 10.1016/S0006-3207(01)00028-3; Brasil, 1992, NORM CLIM 1961 1990; Castro GC, 2008, THESIS U FEDERAL LAV; Colwell RK, ESTIMATES STAT ESTIM; Darveau M, 2001, FOREST ECOL MANAG, V143, P95, DOI 10.1016/S0378-1127(00)00509-0; de Castro EBV, 2004, BIOL CONSERV, V119, P73, DOI 10.1016/j.biocon.2003.10.023; de Lima MG, 1999, BIOL CONSERV, V91, P241, DOI 10.1016/S0006-3207(99)00084-1; Dean Warren, 1995, BROADAX FIREBRAND DE; Downes SJ, 1997, CONSERV BIOL, V11, P718, DOI 10.1046/j.1523-1739.1997.96094.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; FONSECA GAB, 1989, B FLORIDA STATE MUSE, V34, P99; Forero-Medina G, 2009, J TROP ECOL, V25, P53, DOI 10.1017/S0266467408005543; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Gomez Mendez HA, 2007, THESIS U FEDERAL LAV; Grelle CEV, 2003, STUD NEOTROP FAUNA E, V38, P81, DOI 10.1076/snfe.38.2.81.15926; Hawes J, 2008, BIOL CONSERV, V141, P2262, DOI 10.1016/j.biocon.2008.06.017; Hilty J. A., 2006, CORRIDOR ECOLOGY SCI; HOBBS RJ, 1992, TRENDS ECOL EVOL, V7, P389, DOI 10.1016/0169-5347(92)90010-9; INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA - IBGE, 1983, GEOL GEOM PED VEG US; Lees AC, 2008, CONSERV BIOL, V22, P439, DOI 10.1111/j.1523-1739.2007.00870.x; Lomolino MV, 2000, ECOLOGY, V81, P1517, DOI 10.2307/177303; Mesquita AO, 2009, THESIS U FEDERAL LAV; Naxara LRC, 2008, THESIS U SAO PAULO; OMETTO JC, 1981, BIOCLIMATOLOGIA VEGE; Pardini R, 2004, BIODIVERS CONSERV, V13, P2567, DOI 10.1023/B:BIOC.0000048452.18878.2d; Pardini R, 2005, BIOL CONSERV, V124, P253, DOI 10.1016/j.biocon.2005.01.033; Pardini R, 2009, BIOL CONSERV, V142, P1178, DOI 10.1016/j.biocon.2009.02.010; Passamani M, 2011, J NAT HIST, V45, P553, DOI 10.1080/00222933.2010.534561; Passamani M, 2009, BRAZ J BIOL, V69, P305, DOI 10.1590/S1519-69842009000200010; Passamani M, 2011, MAMMALIA, V75, P83, DOI 10.1515/MAMM.2010.064; Pires AS, 2002, BIOL CONSERV, V108, P229, DOI 10.1016/S0006-3207(02)00109-X; Puttker T, 2008, STUD NEOTROP FAUNA E, V43, P11, DOI 10.1080/01650520701553651; Puettker Thomas, 2008, BMC Ecology, V8, P9, DOI 10.1186/1472-6785-8-9; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Uezu A, 2005, BIOL CONSERV, V123, P507, DOI 10.1016/j.biocon.2005.01.001; Umetsu F, 2008, ECOGRAPHY, V31, P359, DOI 10.1111/j.0906-7590.2008.05302.x; Umetsu F, 2007, LANDSCAPE ECOL, V22, P517, DOI 10.1007/s10980-006-9041-y	39	22	25	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23312	10.1371/journal.pone.0023312	http://dx.doi.org/10.1371/journal.pone.0023312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21912591	Green Published, Green Submitted, gold			2022-12-25	WOS:000294680800006
J	Begcy, K; Mariano, ED; Mattiello, L; Nunes, AV; Mazzafera, P; Maia, IG; Menossi, M				Begcy, Kevin; Mariano, Eduardo D.; Mattiello, Lucia; Nunes, Alessandra V.; Mazzafera, Paulo; Maia, Ivan G.; Menossi, Marcelo			An Arabidopsis Mitochondrial Uncoupling Protein Confers Tolerance to Drought and Salt Stress in Transgenic Tobacco Plants	PLOS ONE			English	Article							ALTERNATIVE OXIDASE; EXPRESSION PROFILES; ELECTRON-TRANSPORT; OXIDATIVE STRESS; ABSCISIC-ACID; WATER-USE; COLD; SALINITY; RESPONSES; PHOTOSYNTHESIS	Background: Plants are challenged by a large number of environmental stresses that reduce productivity and even cause death. Both chloroplasts and mitochondria produce reactive oxygen species under normal conditions; however, stress causes an imbalance in these species that leads to deviations from normal cellular conditions and a variety of toxic effects. Mitochondria have uncoupling proteins (UCPs) that uncouple electron transport from ATP synthesis. There is evidence that UCPs play a role in alleviating stress caused by reactive oxygen species overproduction. However, direct evidence that UCPs protect plants from abiotic stress is lacking. Methodology/Principal Findings: Tolerances to salt and water deficit were analyzed in transgenic tobacco plants that overexpress a UCP (AtUCP1) from Arabidopsis thaliana. Seeds of AtUCP1 transgenic lines germinated faster, and adult plants showed better responses to drought and salt stress than wild-type (WT) plants. These phenotypes correlated with increased water retention and higher gas exchange parameters in transgenic plants that overexpress AtUCP1. WT plants exhibited increased respiration under stress, while transgenic plants were only slightly affected. Furthermore, the transgenic plants showed reduced accumulation of hydrogen peroxide in stressed leaves compared with WT plants. Conclusions/Significance: Higher levels of AtUCP1 improved tolerance to multiple abiotic stresses, and this protection was correlated with lower oxidative stress. Our data support previous assumptions that UCPs reduce the imbalance of reactive oxygen species. Our data also suggest that UCPs may play a role in stomatal closure, which agrees with other evidence of a direct relationship between these proteins and photosynthesis. Manipulation of the UCP protein expression in mitochondria is a new avenue for crop improvement and may lead to crops with greater tolerance for challenging environmental conditions.	[Begcy, Kevin; Mariano, Eduardo D.; Mattiello, Lucia; Menossi, Marcelo] Univ Estadual Campinas, Inst Biol, Lab Genoma Func, Dept Genet Evolucao & Bioagentes, Campinas, Brazil; [Nunes, Alessandra V.; Maia, Ivan G.] Univ Estadual Paulista, Inst Biociencias, Dept Genet, Botucatu, SP, Brazil; [Mazzafera, Paulo] Univ Estadual Campinas, Inst Biol, Dept Biol Vegetal, Campinas, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas	Begcy, K (corresponding author), Univ Estadual Campinas, Inst Biol, Lab Genoma Func, Dept Genet Evolucao & Bioagentes, Campinas, Brazil.	menossi@lgf.ib.unicamp.br	Mariano, Eduardo D/B-8382-2012; Mattiello, Lucia/H-4177-2012; Menossi, Marcelo/A-4364-2012; Maia, Ivan G/H-7832-2012; Mazzafera, Paulo/D-4766-2012; Menossi, Marcelo/C-6305-2014; Begcy, Kevin/AAK-6264-2020; de Godoy Maia, Ivan/AAW-8584-2021	Mariano, Eduardo D/0000-0002-6465-6397; Menossi, Marcelo/0000-0002-9211-3787; Maia, Ivan G/0000-0002-3875-8664; Mazzafera, Paulo/0000-0001-9073-4056; Menossi, Marcelo/0000-0002-9211-3787; Begcy, Kevin/0000-0002-5046-8029; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Financiadora Nacional de Projetos (FINEP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora Nacional de Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Financiadora Nacional de Projetos (FINEP) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Atkin OK, 2009, ANN BOT-LONDON, V103, P581, DOI 10.1093/aob/mcn094; Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Bartoli CG, 2005, J EXP BOT, V56, P1269, DOI 10.1093/jxb/eri111; BEWLEY J. D, 2013, SEEDS, V3, DOI [DOI 10.1007/978-1-4614-4693-4_1, 10.1017/S0960258513000287]; Borecky J, 2006, J EXP BOT, V57, P849, DOI 10.1093/jxb/erj070; Borecky J, 2001, BIOSCIENCE REP, V21, P201, DOI 10.1023/A:1013604526175; Brandalise M, 2003, PLANT SCI, V165, P329, DOI 10.1016/S0168-9452(03)00159-6; Brandalise M, 2003, J BIOENERG BIOMEMBR, V35, P203, DOI 10.1023/A:1024603530043; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Considine MJ, 2003, J BIOL CHEM, V278, P22298, DOI 10.1074/jbc.M301075200; Desikan R, 2001, PLANT PHYSIOL, V127, P159, DOI 10.1104/pp.127.1.159; Dinakar C, 2010, PLANTA, V231, P461, DOI 10.1007/s00425-009-1067-3; Ducic T, 2003, BIOL PLANTARUM, V47, P527, DOI 10.1023/B:BIOP.0000041057.11390.58; Escobar MA, 2004, PLANT PHYSIOL, V136, P2710, DOI 10.1104/pp.104.046698; Vercesi AE, 2006, ANNU REV PLANT BIOL, V57, P383, DOI 10.1146/annurev.arplant.57.032905.105335; Flexas J, 2006, PHYSIOL PLANTARUM, V127, P343, DOI 10.1111/j.1399-3054.2006.00621.x; Garlid KD, 1996, J BIOL CHEM, V271, P2615, DOI 10.1074/jbc.271.5.2615; Gay C, 1999, ANAL BIOCHEM, V273, P149, DOI 10.1006/abio.1999.4208; Guo QF, 2008, J PLANT PHYSIOL, V165, P1745, DOI 10.1016/j.jplph.2007.10.002; HARDEGREE SP, 1990, PLANT PHYSIOL, V92, P462, DOI 10.1104/pp.92.2.462; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; Hernandez JA, 2000, PLANT CELL ENVIRON, V23, P853, DOI 10.1046/j.1365-3040.2000.00602.x; Hourton-Cabassa U, 2004, PLANT PHYSIOL BIOCH, V42, P283, DOI 10.1016/j.plaphy.2004.01.007; Ito K, 1999, PLANT SCI, V149, P167, DOI 10.1016/S0168-9452(99)00159-4; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Laloi M, 1997, NATURE, V389, P135, DOI 10.1038/38156; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittova V, 2004, J EXP BOT, V55, P1105, DOI 10.1093/jxb/erh113; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Murata Y, 2001, PLANT CELL, V13, P2513, DOI 10.1105/tpc.13.11.2513; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nicholls DG, 1999, J BIOENERG BIOMEMBR, V31, P399, DOI 10.1023/A:1005436121005; Nunes-Nesi A, 2007, PLANT J, V50, P1093, DOI 10.1111/j.1365-313X.2007.03115.x; Outlaw WH, 2003, CRIT REV PLANT SCI, V22, P503, DOI 10.1080/713608316; Pastore D, 2002, FEBS LETT, V516, P15, DOI 10.1016/S0014-5793(02)02454-7; Pastore D, 2007, J EXP BOT, V58, P195, DOI 10.1093/jxb/erl273; Pinelli P, 2003, J EXP BOT, V54, P1761, DOI 10.1093/jxb/erg187; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Pinheiro HA, 2005, ANN BOT-LONDON, V96, P101, DOI 10.1093/aob/mci154; Pukacka S, 2005, J PLANT PHYSIOL, V162, P873, DOI 10.1016/j.jplph.2004.10.012; Royal S, 2009, REAP BEN SCI SUST IN; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Slot M, 2008, FUNCT PLANT BIOL, V35, P1135, DOI 10.1071/FP08113; Sluse FE, 2006, BBA-BIOENERGETICS, V1757, P480, DOI 10.1016/j.bbabio.2006.02.004; Smith AMO, 2004, J BIOL CHEM, V279, P51944, DOI 10.1074/jbc.M408920200; Sweetlove LJ, 2006, P NATL ACAD SCI USA, V103, P19587, DOI 10.1073/pnas.0607751103; Umbach AL, 2005, PLANT PHYSIOL, V139, P1806, DOI 10.1104/pp.105.070763; VERCESI AE, 1995, NATURE, V375, P24, DOI 10.1038/375024a0; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wang YH, 2004, PLANT SCI, V167, P671, DOI 10.1016/j.plantsci.2004.03.032; Wullschleger SD, 1998, TREE PHYSIOL, V18, P499; Zhang XX, 2008, PLANT MOL BIOL, V68, P131, DOI 10.1007/s11103-008-9357-x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, CURR OPIN PLANT BIOL, V4, P401, DOI 10.1016/S1369-5266(00)00192-8; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	60	64	68	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e23776	10.1371/journal.pone.0023776	http://dx.doi.org/10.1371/journal.pone.0023776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912606	gold, Green Published			2022-12-25	WOS:000294678300009
J	Gammill, HS; Waldorf, KMA; Aydelotte, TM; Lucas, J; Leisenring, WM; Lambert, NC; Nelson, JL				Gammill, Hilary S.; Waldorf, Kristina M. Adams; Aydelotte, Tessa M.; Lucas, Joelle; Leisenring, Wendy M.; Lambert, Nathalie C.; Nelson, J. Lee			Pregnancy, Microchimerism, and the Maternal Grandmother	PLOS ONE			English	Article							FETAL; CELLS; TOLERANCE; ANTIGENS; PREECLAMPSIA; WOMEN; SERUM; DNA	Background: A woman of reproductive age often harbors a small number of foreign cells, referred to as microchimerism: a preexisting population of cells acquired during fetal life from her own mother, and newly acquired populations from her pregnancies. An intriguing question is whether the population of cells from her own mother can influence either maternal health during pregnancy and/or the next generation (grandchildren). Methodology/Principal Findings: Microchimerism from a woman's (i.e. proband's) own mother (mother-of-the-proband, MP) was studied in peripheral blood samples from women followed longitudinally during pregnancy who were confirmed to have uncomplicated obstetric outcomes. Women with preeclampsia were studied at the time of diagnosis and comparison made to women with healthy pregnancies matched for parity and gestational age. Participants and family members were HLA-genotyped for DRB1, DQA1, and DQB1 loci. An HLA polymorphism unique to the woman's mother was identified, and a panel of HLA-specific quantitative PCR assays was employed to identify and quantify microchimerism. Microchimerism from the MP was identified during normal, uncomplicated pregnancy, with a peak concentration in the third trimester. The likelihood of detection increased with advancing gestational age. For each advancing trimester, there was a 12.7-fold increase in the probability of detecting microchimerism relative to the prior trimester, 95% confidence intervals 3.2, 50.3, p<0.001. None of the women with preeclampsia, compared with 30% of matched healthy women, had microchimerism (p = 0.03). Conclusions/Significance: These results show that microchimerism from a woman's own mother is detectable in normal pregnancy and diminished in preeclampsia, supporting the previously unexplored hypothesis that MP microchimerism may be a marker reflecting healthy maternal adaptation to pregnancy.	[Gammill, Hilary S.; Waldorf, Kristina M. Adams; Aydelotte, Tessa M.; Lucas, Joelle; Leisenring, Wendy M.; Nelson, J. Lee] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Gammill, Hilary S.; Waldorf, Kristina M. Adams] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Lambert, Nathalie C.] INSERM, UMR639, F-13258 Marseille, France; [Nelson, J. Lee] Univ Washington, Div Rheumatol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Washington; University of Washington Seattle	Gammill, HS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	hgammill@u.washington.edu	Lambert, Nathalie C/P-6816-2016	Lambert, Nathalie C/0000-0001-5817-8686; Leisenring, Wendy/0000-0001-7405-0906	NIH (National Institutes of Health) [HD01264, AI45659, AI41721]; Preeclampsia Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001264] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041721, R01AI045659] Funding Source: NIH RePORTER	NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Preeclampsia Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIH (National Institutes of Health) grants HD01264, AI45659, and AI41721, and the Preeclampsia Foundation (http://www.preeclampsia.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG, 2002, OBSTET GYNECOL, V99, P869; Akiyama Y, 2011, J IMMUNOL, V186, P1442, DOI 10.4049/jimmunol.1003023; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; DUTTA P, 2011, AM J TRANSPLANT, V11, P1; Dutta P, 2009, BLOOD, V114, P3578, DOI 10.1182/blood-2009-03-213561; Dutta P, 2009, CURR OPIN ORGAN TRAN, V14, P439, DOI 10.1097/MOT.0b013e32832d6683; Feitsma AL, 2007, P NATL ACAD SCI USA, V104, P19966, DOI 10.1073/pnas.0710260104; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Gammill HS, 2010, BLOOD, V116, P2706, DOI 10.1182/blood-2010-02-270942; Gammill HS, 2010, INT J DEV BIOL, V54, P531, DOI 10.1387/ijdb.082767hg; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Jonsson AM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.047; Lambert NC, 2004, ARTHRITIS RHEUM-US, V50, P906, DOI 10.1002/art.20200; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Loubiere LS, 2006, LAB INVEST, V86, P1185, DOI 10.1038/labinvest.3700471; Luppi P, 2010, REPROD SCI, V17, P643, DOI 10.1177/1933719110366164; Maloney S, 1999, J CLIN INVEST, V104, P41, DOI 10.1172/JCI6611; Milman N, 1997, INT J HEMATOL, V66, P159; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; OWEN RD, 1954, P NATL ACAD SCI USA, V40, P420, DOI 10.1073/pnas.40.6.420; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Stevens AM, 2003, LANCET, V362, P1617, DOI 10.1016/S0140-6736(03)14795-2; Sunku Chennakesava Cuddapah, 2010, Chimerism, V1, P11, DOI 10.4161/chim.1.1.13098; van Rood JJ, 2002, BLOOD, V99, P1572, DOI 10.1182/blood.V99.5.1572; Waldorf KMA, 2010, PLACENTA, V31, P589, DOI 10.1016/j.placenta.2010.04.013	27	16	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24101	10.1371/journal.pone.0024101	http://dx.doi.org/10.1371/journal.pone.0024101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912617	Green Published, Green Submitted, gold			2022-12-25	WOS:000294678300022
J	Belaganahalli, MN; Maan, S; Maan, NS; Tesh, R; Attoui, H; Mertens, PPC				Belaganahalli, Manjunatha N.; Maan, Sushila; Maan, Narender S.; Tesh, Robert; Attoui, Houssam; Mertens, Peter P. C.			Umatilla Virus Genome Sequencing and Phylogenetic Analysis: Identification of Stretch Lagoon Orbivirus as a New Member of the Umatilla virus Species	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; EPIZOOTIC HEMORRHAGIC-DISEASE; RT-PCR ASSAY; BLUETONGUE-VIRUS; GENETIC-CHARACTERIZATION; SOUTH-AFRICA; MOSQUITOS; REOVIRIDAE; SEROTYPE-1; EXPRESSION	The genus Orbivirus, family Reoviridae, includes 22 species of viruses with genomes composed of ten segments of linear dsRNA that are transmitted between their vertebrate hosts by insects or ticks, or with no identified vectors. Full-genome sequence data are available for representative isolates of the insect borne mammalian orbiviruses (including bluetongue virus), as well as a tick borne avian orbivirus (Great Island virus). However, no sequence data are as yet available for the mosquito borne avian orbiviruses. We report full-length, whole-genome sequence data for Umatilla virus (UMAV), a mosquito borne avian orbivirus from the USA, which belongs to the species Umatilla virus. Comparisons of conserved genome segments 1, 2 and 8 (Seg-1, Seg-2 and Seg-8) - encoding the polymerase-VP1, sub-core 'T2' protein and core-surface 'T13' protein, respectively, show that UMAV groups with the mosquito transmitted mammalian orbiviruses. The highest levels of sequence identity were detected between UMAV and Stretch Lagoon orbivirus (SLOV) from Australia, showing that they belong to the same virus species (with nt/aa identity of 76.04%/88.07% and 77.96%/95.36% in the polymerase and T2 genes and protein, respectively). The data presented here has assisted in identifying the SLOV as a member of the Umatilla serogroup. This sequence data reported here will also facilitate identification of new isolates, and epidemiological studies of viruses belonging to the species Umatilla virus.	[Belaganahalli, Manjunatha N.; Maan, Sushila; Maan, Narender S.; Attoui, Houssam; Mertens, Peter P. C.] Inst Anim Hlth, Vector Borne Dis Programme, Surrey, England; [Tesh, Robert] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Texas System; University of Texas Medical Branch Galveston	Belaganahalli, MN (corresponding author), Inst Anim Hlth, Vector Borne Dis Programme, Surrey, England.	peter.mertens@bbsrc.ac.uk	Belaganahalli, Manjunatha N/I-1688-2019	Belaganahalli, Manjunatha N/0000-0003-3401-5799; Attoui, Houssam/0000-0001-9639-9981; Mertens, Peter/0000-0002-3438-3738	Commonwealth Scholarship Commission; Department for Environment, Food and Rural Affairs (Defra) [SE2617]; Biotechnology and Biological Sciences Research Council (BBSRC); European Union (EU) [SANCO/940/2002]; European Commission	Commonwealth Scholarship Commission; Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union (EU)(CGIAREuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	MB is funded by Commonwealth Scholarship Commission; SM by the Department for Environment, Food and Rural Affairs (Defra)(SE2617); NSM by the Biotechnology and Biological Sciences Research Council (BBSRC) and the European Union (EU) (SANCO/940/2002); PCM and HA by Defra, the European Commission and BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AB, 2010, J GEN VIROL, V91, P430, DOI 10.1099/vir.0.015651-0; Vieira CDA, 2009, J GEN VIROL, V90, P2183, DOI 10.1099/vir.0.010165-0; Anthony S, 2007, J VIROL METHODS, V141, P188, DOI 10.1016/j.jviromet.2006.12.013; Anthony SJ, 2009, VIRUS RES, V145, P187, DOI 10.1016/j.virusres.2009.07.011; ANTHONY SJ, 2009, VIRUS RES; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Attoui H, 2005, J GEN VIROL, V86, P3409, DOI 10.1099/vir.0.81258-0; Attoui H, 2001, J GEN VIROL, V82, P795, DOI 10.1099/0022-1317-82-4-795; Attoui H, 2009, VIROLOGY, V394, P298, DOI 10.1016/j.virol.2009.08.032; Bansal OB, 1998, J VIROL, V72, P3362, DOI 10.1128/JVI.72.4.3362-3369.1998; Belhouchet M, 2010, J GEN VIROL, V91, P2985, DOI 10.1099/vir.0.024760-0; Cowled C, 2009, J GEN VIROL, V90, P1433, DOI 10.1099/vir.0.010074-0; EATON BT, 1987, VIRUS RES, V6, P363, DOI 10.1016/0168-1702(87)90067-0; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-48; FRENCH TJ, 1989, J VIROL, V63, P3270, DOI 10.1128/JVI.63.8.3270-3278.1989; GIBBS EPJ, 1989, VET MICROBIOL, V19, P141, DOI 10.1016/0378-1135(89)90079-5; GOULD AR, 1987, VIRUS RES, V7, P169, DOI 10.1016/0168-1702(87)90078-5; GOULD AR, 1991, VIRUS RES, V21, P1, DOI 10.1016/0168-1702(91)90068-7; GOULD AR, 1990, VIRUS RES, V17, P31, DOI 10.1016/0168-1702(90)90078-P; GUMM ID, 1982, ARCH VIROL, V72, P83, DOI 10.1007/BF01314453; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; HUISMANS H, 1981, ONDERSTEPOORT J VET, V48, P51; Jansen CC, 2009, J AM MOSQUITO CONTR, V25, P272, DOI 10.2987/09-5908.1; JOHNSON DJ, P ANN C AM ASS VET L; Karabatsos N., 1985, INT CATALOGUE ARBOVI; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maan N.S., 2010, PLOS ONE, V5, P12782; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; Martins LC, 2007, INT J EXP PATHOL, V88, P63, DOI 10.1111/j.1365-2613.2006.00516.x; Mertens P., 2005, 8 ICTV, P466; MERTENS PPC, 1989, VIROLOGY, V170, P561, DOI 10.1016/0042-6822(89)90447-9; NAMP, 2009, NAT ARB MON PROGR NA; Nomikou K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006437; *OIE, 2008, REP DAT 11 09 2008 C; PRITCHARD LI, 1995, VIRUS RES, V35, P247, DOI 10.1016/0168-1702(94)00072-K; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Quan M, 2010, J VIROL METHODS, V167, P45, DOI 10.1016/j.jviromet.2010.03.009; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shaw AE, 2007, J VIROL METHODS, V145, P115, DOI 10.1016/j.jviromet.2007.05.014; Slenning BD, 2010, VET PATHOL, V47, P28, DOI 10.1177/0300985809354465; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WADEEVANS AM, 1992, J GEN VIROL, V73, P3023, DOI 10.1099/0022-1317-73-11-3023; Wilson K, 2000, MOL BIOL EVOL, V17, P863, DOI 10.1093/oxfordjournals.molbev.a026366; Yamakawa M, 1999, J GEN VIROL, V80, P937, DOI 10.1099/0022-1317-80-4-937; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	50	32	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23605	10.1371/journal.pone.0023605	http://dx.doi.org/10.1371/journal.pone.0023605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897849	Green Published, gold, Green Submitted			2022-12-25	WOS:000294676900012
J	Fernandez-Triana, J; Smith, MA; Boudreault, C; Goulet, H; Hebert, PDN; Smith, AC; Roughley, R				Fernandez-Triana, Jose; Smith, M. Alex; Boudreault, Caroline; Goulet, Henri; Hebert, Paul D. N.; Smith, Adam C.; Roughley, Rob			A Poorly Known High-Latitude Parasitoid Wasp Community: Unexpected Diversity and Dramatic Changes through Time	PLOS ONE			English	Article							CLIMATE-CHANGE; NATURAL-HISTORY; FLIES DIPTERA; HYMENOPTERA; COLLECTIONS; BRACONIDAE; MICROGASTRINAE; INSECTS; BARCODE	Climate change will have profound and unanticipated effects on species distributions. The pace and nature of this change is largely unstudied, especially for the most diverse elements of terrestrial communities - the arthropods - here we have only limited knowledge concerning the taxonomy and the ecology of these groups. Because Arctic ecosystems have already experienced significant increases in temperature over the past half century, shifts in community structure may already be in progress. Here we utilise collections of a particularly hyperdiverse insect group - parasitoid wasps (Hymenoptera; Braconidae; Microgastrinae) - at Churchill, Manitoba, Canada in the early and mid-twentieth century to compare the composition of the contemporary community to that present 50-70 years ago. Morphological and DNA barcoding results revealed the presence of 79 species of microgastrine wasps in collections from Churchill, but we estimate that 20% of the local fauna awaits detection. Species composition and diversity between the two time periods differ significantly; species that were most common in historic collections were not found in contemporary collections and vice versa. Using barcodes we compared these collections to others from across North America; contemporary Churchill species are most affiliated with more south-western collections, while historic collections were more affiliated with eastern collections. The past five decades has clearly seen a dramatic change of species composition within the area studied coincident with rising temperature.	[Fernandez-Triana, Jose; Smith, M. Alex; Hebert, Paul D. N.] Inst Ontario, Dept Integrat Biol & Biodivers, Guelph, ON, Canada; [Fernandez-Triana, Jose; Boudreault, Caroline; Goulet, Henri] Agr & Agri Food Canada, Canadian Natl Collect Insects, Ottawa, ON, Canada; [Smith, Adam C.] Carleton Univ, Natl Wildlife Res Ctr, Canadian Wildlife Serv, Environm Canada, Ottawa, ON K1S 5B6, Canada; [Roughley, Rob] Univ Manitoba, Dept Entomol, Winnipeg, MB R3T 2N2, Canada	Agriculture & Agri Food Canada; Carleton University; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; University of Manitoba	Fernandez-Triana, J (corresponding author), Inst Ontario, Dept Integrat Biol & Biodivers, Guelph, ON, Canada.	salex@uoguelph.ca	Smith, M Alex/B-4468-2013; Hebert, Paul DN/C-4161-2013	Smith, M Alex/0000-0002-8650-2575; Hebert, Paul DN/0000-0002-3081-6700; Smith, Adam Clark/0000-0002-2829-4843; Fernandez-Triana, Jose/0000-0003-0425-0309	Natural Sciences and Engineering Research Council of Canada (NSERC) International Polar Year (IPY); Government of Canada through Genome Canada; Ontario Genomics Institute [2008-0GI-ICI-03]	Natural Sciences and Engineering Research Council of Canada (NSERC) International Polar Year (IPY)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute	Grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) International Polar Year (IPY) supported this work. This Project was also funded by the Government of Canada through Genome Canada and the Ontario Genomics Institute (2008-0GI-ICI-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs Z, 2010, MOL PHYLOGENET EVOL, V55, P210, DOI 10.1016/j.ympev.2009.12.004; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Axford Y, 2009, P NATL ACAD SCI USA, V106, P18443, DOI 10.1073/pnas.0907094106; BRZUSTOWSKI J, 2008, RAREFACTION METHOD R; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Coristine LE, 2011, CAN J ZOOL, V89, P435, DOI [10.1139/Z11-023, 10.1139/z11-023]; DANKS HV, 1992, ARCTIC, V45, P159; *ENVIRONMENTCANADA, 2010, NAT CLIM DAT INF ARC; Eveleigh ES, 2007, P NATL ACAD SCI USA, V104, P16976, DOI 10.1073/pnas.0704301104; Fernandez-Triana Jose, 2009, ZooKeys, V20, P285; Fernandez-Triana Jose, 2009, Newsletter of the Biological Survey of Canada (Terrestrial Arthropods), V28, P21; Fernandez-Triana J, 2009, BIOCONTROL SCI TECHN, V19, P237, DOI 10.1080/09583150802684406; GADAGKAR R, 1990, Journal of the Bombay Natural History Society, V87, P337; GAGNON AS, 2005, TRENDS DATES ICE FRE, P370; Gitay, 2002, CLIMATE CHANGE BIODI; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Hoye TT, 2008, ADV ECOL RES, V40, P299, DOI 10.1016/S0065-2504(07)00013-X; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Johnson KG, 2011, BIOSCIENCE, V61, P147, DOI 10.1525/bio.2011.61.2.10; LaSalle J., 1991, Redia, V74, P315; Lewis CN, 1999, ENVIRON ENTOMOL, V28, P986, DOI 10.1093/ee/28.6.986; Magurran A E, 1988, ECOLOGICAL DIVERSITY; MARSHALL SA, 1994, TERRESTRIAL ARTHROPO; MASON W R M, 1972, Canadian Field-Naturalist, V86, P363; MASON WRM, 1981, MEMOIRS ENTOMOLOGICA, V115, P1, DOI DOI 10.4039/ENTM113115FV; McClure H. Elliot, 1943, ECOL MONOGR, V13, P1, DOI 10.2307/1943588; Pachauri R.K, 2007, CONTRIBUTION WORKING, P104, DOI DOI 10.1017/CBO9780511546013; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Shaffer HB, 1998, TRENDS ECOL EVOL, V13, P27, DOI 10.1016/S0169-5347(97)01177-4; Shaw M.R., 1991, Handbooks for the Identification of British Insects, V7, P1; SHAW SR, 2002, U WYOMING NATL PARK, V26, P47; SIMBERLOFF D, 1972, AM NAT, V106, P414, DOI 10.1086/282781; SIMBERLOFF DS, 1978, USE RAREFACTION RELA, P150; Singer MC, 2010, PHILOS T R SOC B, V365, P3161, DOI 10.1098/rstb.2010.0144; Skinner WR, 1998, GLOB CHANGE BIOL, V4, P3, DOI 10.1046/j.1365-2486.1998.00097.x; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014424; Smith MA, 2009, MOL ECOL RESOUR, V9, P208, DOI 10.1111/j.1755-0998.2009.02646.x; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Taylor R.W., 1983, P93; Tingley MW, 2009, TRENDS ECOL EVOL, V24, P625, DOI 10.1016/j.tree.2009.05.009; Valerio AA, 2009, ZOOTAXA, P1; VANACHTERBERG K, 2006, ZOOL MED LEIDEN, V80, P13; Vincent WF, 2009, POLAR SCI, V3, P171, DOI 10.1016/j.polar.2009.05.004; Whitfield J. B., 1997, SPECIAL PUBLICATION, V1, P333; Whitfield JB, 2006, ZOOTAXA, P1; WHITFIELD JB, 1995, J KANSAS ENTOMOL SOC, V68, P245; Whitfield JB, 2002, SYST ENTOMOL, V27, P337, DOI 10.1046/j.1365-3113.2002.00183.x; Whitfield JB, 2001, ANN ENTOMOL SOC AM, V94, P230, DOI 10.1603/0013-8746(2001)094[0230:ASOTBW]2.0.CO;2; Yu D. S., 2005, WORLD ICHNEUMONOIDEA	57	40	45	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23719	10.1371/journal.pone.0023719	http://dx.doi.org/10.1371/journal.pone.0023719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897854	Green Submitted, Green Published, gold			2022-12-25	WOS:000294676900017
J	Keightley, MC; Layton, JE; Hayman, JW; Heath, JK; Lieschke, GJ				Keightley, Maria-Cristina; Layton, Judith E.; Hayman, John W.; Heath, Joan K.; Lieschke, Graham J.			Mediator Subunit 12 Is Required for Neutrophil Development in Zebrafish	PLOS ONE			English	Article							TRANSGENIC ZEBRAFISH; MENTAL-RETARDATION; GENE-EXPRESSION; NEURAL CREST; COMPLEX; TRANSCRIPTION; COACTIVATOR; MYC; ASSOCIATION; ERYTHROPOIESIS	Hematopoiesis requires the spatiotemporal organization of regulatory factors to successfully orchestrate diverse lineage specificity from stem and progenitor cells. Med12 is a regulatory component of the large Mediator complex that enables contact between the general RNA polymerase II transcriptional machinery and enhancer bound regulatory factors. We have identified a new zebrafish med12 allele, syr, with a single missense mutation causing a valine to aspartic acid change at position 1046. Syr shows defects in hematopoiesis, which predominantly affect the myeloid lineage. Syr has identified a hematopoietic cell-specific requirement for Med12, suggesting a new role for this transcriptional regulator.	[Keightley, Maria-Cristina; Hayman, John W.; Lieschke, Graham J.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Keightley, Maria-Cristina; Layton, Judith E.; Hayman, John W.; Lieschke, Graham J.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Canc & Haematol Div, Parkville, Vic 3050, Australia; [Lieschke, Graham J.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Heath, Joan K.] Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne Branch, Colon Mol & Cell Biol Lab, Parkville, Vic 3050, Australia	Australian Regenerative Medicine Institute; Monash University; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Ludwig Institute for Cancer Research; Royal Melbourne Hospital	Keightley, MC (corresponding author), Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia.	Graham.Lieschke@monash.edu	Heath, Joan/D-3054-2012	Heath, Joan/0000-0001-6955-232X; Keightley, Maria-Cristina/0000-0001-8141-4069; Lieschke, Graham/0000-0003-0325-798X	National Institutes of Health (NIH) [RO1 HL079545]; National Health and Medical Research Council (NHMRC) [234708, 461208, 516750, 637395]; Australian Research Council (ARC) [DP0346823]; Victorian State Government; Australian Government; Royal Melbourne Hospital Bone Marrow Research laboratory; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079545] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Victorian State Government; Australian Government(Australian GovernmentCGIAR); Royal Melbourne Hospital Bone Marrow Research laboratory; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants to GL from the National Institutes of Health (NIH www.nih.gov: RO1 HL079545), the National Health and Medical Research Council (NHMRC www.nhmrc.gov.au: 234708, 461208, 516750, 637395) and Australian Research Council (ARC www.arc.gov.au: DP0346823). The Walter and Eliza Hall Institute of Medical Research receives infrastructure support from Commonwealth NHMRC Independent Research Institutes Infrastructure Support Scheme (361646) and a Victorian State Government Operational Infrastructure Support Scheme grant. The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Sony Varma for technical assistance; Mark Greer, Kelly Turner and Prue Chamberlain for animal care in the aquarium; Steve Jane, David Curtis and the Royal Melbourne Hospital Bone Marrow Research laboratory for support.	Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; BOLLI N, 2011, BLOOD; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Craven SE, 2005, BLOOD, V105, P3528, DOI 10.1182/blood-2004-03-1089; Crowhurst MO, 2002, INT J DEV BIOL, V46, P483; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; DALE DC, 2001, WILLIAMS HEMATOLOGY, P823; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Gobert V, 2010, MOL CELL BIOL, V30, P2837, DOI 10.1128/MCB.01625-09; Gwack Y, 2003, MOL CELL BIOL, V23, P2055, DOI 10.1128/MCB.23.6.2055-2067.2003; Hoffman B, 1996, CURR TOP MICROBIOL, V211, P17; Hogan BM, 2006, CURR BIOL, V16, P506, DOI 10.1016/j.cub.2006.01.047; Hong SK, 2005, P NATL ACAD SCI USA, V102, P18473, DOI 10.1073/pnas.0509457102; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kato Y, 2002, NATURE, V418, P641, DOI 10.1038/nature00969; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lieschke GJ, 2002, DEV BIOL, V246, P274, DOI 10.1006/dbio.2002.0657; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Liu XH, 2008, MOL CELL BIOL, V28, P108, DOI 10.1128/MCB.01402-07; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; O'Neil J, 2007, ONCOGENE, V26, P6838, DOI 10.1038/sj.onc.1210766; Philibert RA, 2006, PSYCHIAT GENET, V16, P73, DOI 10.1097/01.ypg.0000194443.81813.f0; Philibert RA, 1998, MOL PSYCHIATR, V3, P303, DOI 10.1038/sj.mp.4000442; Rau MJ, 2006, DEV BIOL, V296, P83, DOI 10.1016/j.ydbio.2006.04.437; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Rocha PP, 2010, DEVELOPMENT, V137, P2723, DOI 10.1242/dev.053660; Shin CH, 2008, DEV BIOL, V317, P467, DOI 10.1016/j.ydbio.2008.02.031; Spinks R, 2004, AM J MED GENET B, V127B, P20, DOI 10.1002/ajmg.b.20175; Stumpf M, 2006, P NATL ACAD SCI USA, V103, P18504, DOI 10.1073/pnas.0604494103; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Taussig MJ, 2007, NAT METHODS, V4, P13, DOI 10.1038/nmeth0107-13; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Uechi T, 2008, HUM MOL GENET, V17, P3204, DOI 10.1093/hmg/ddn216; Wang X, 2006, P NATL ACAD SCI USA, V103, P17284, DOI 10.1073/pnas.0605414103; Zhou HY, 2006, MOL CELL BIOL, V26, P8667, DOI 10.1128/MCB.00443-06; Zhou RJ, 2002, NUCLEIC ACIDS RES, V30, P3245, DOI 10.1093/nar/gkf443	44	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23845	10.1371/journal.pone.0023845	http://dx.doi.org/10.1371/journal.pone.0023845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901140	Green Published, Green Submitted, gold			2022-12-25	WOS:000294298000025
J	Xu, TJ; Sun, YN; Shi, G; Cheng, YZ; Wang, RX				Xu, Tianjun; Sun, Yuena; Shi, Ge; Cheng, Yuanzhi; Wang, Rixin			Characterization of the Major Histocompatibility Complex Class II Genes in Miiuy Croaker	PLOS ONE			English	Article							DISEASE RESISTANCE; PHYLOGENETIC ANALYSIS; VIBRIO-ANGUILLARUM; POLYMORPHISM; SELECTION; ASSOCIATION; INFERENCE; ALPHA	Major histocompatibility complex (MHC) has a central role in the adaptive immune system by presenting foreign peptide to the T-cell receptor. In order to study the molecular function and genomic characteristic of class II genes in teleost, the full lengths of MHC class IIA and IIB cDNA and genomic sequence were cloned from miiuy croaker (Miichthys miiuy). As in other teleost, four exons and three introns were identified in miiuy croaker class IIA gene; but the difference is that six exons and five introns were identified in the miiuy croaker class IIB gene. The deduced amino acid sequence of class IIA and class IIB had 26.3-85.7% and 11.0-88.8% identity with those of mammal and teleost, respectively. Real-time quantitative RT-PCR demonstrated that the MHC class IIA and IIB were ubiquitously expressed in ten normal tissues; expression levels of MHC genes were found first upregulated and then downregulated, and finally by a recovery to normal level throughout the pathogenic bacteria infection process. In addition, we report on the underlying mechanism that maintains sequences diversity among many fish species. A series of site-model tests implemented in the CODEML program revealed that positive Darwinian selection is likely the cause of the molecular evolution in the fish MHC class II genes.	[Xu, Tianjun; Sun, Yuena; Shi, Ge; Cheng, Yuanzhi; Wang, Rixin] Zhejiang Ocean Univ, Coll Marine Sci, Lab Marine Living Resources & Mol Engn, Zhoushan, Peoples R China	Zhejiang Ocean University	Xu, TJ (corresponding author), Zhejiang Ocean Univ, Coll Marine Sci, Lab Marine Living Resources & Mol Engn, Zhoushan, Peoples R China.	tianjunxu@163.com; wangrixin1123@126.com	Xu, Tianjun/G-2545-2013		National Natural Science Foundation of China [31001120]; Zhejiang Provincial Natural Science Foundation of China [Y3100013]; Foundation of Zhejiang Educational Committee [Y200908463]; Science and Technology Project of Zhoushan City [12048]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Foundation of Zhejiang Educational Committee; Science and Technology Project of Zhoushan City	This study was supported by National Natural Science Foundation of China (31001120), Zhejiang Provincial Natural Science Foundation of China (Y3100013), Foundation of Zhejiang Educational Committee (Y200908463) and Science and Technology Project of Zhoushan City (12048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACON LD, 1987, POULTRY SCI, V66, P802, DOI 10.3382/ps.0660802; Chen JSC, 2008, FISH SHELLFISH IMMUN, V24, P234, DOI 10.1016/j.fsi.2007.11.005; COSSON P, 1992, SCIENCE, V258, P659, DOI 10.1126/science.1329208; DIXON B, 1995, DEV COMP IMMUNOL, V19, P109, DOI 10.1016/0145-305X(94)00056-L; Fernandes JMO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009501; Ford MJ, 2002, MOL ECOL, V11, P1245, DOI 10.1046/j.1365-294X.2002.01536.x; Glover KA, 2007, DIS AQUAT ORGAN, V76, P57, DOI 10.3354/dao076057; Grimholt U, 2000, DEV COMP IMMUNOL, V24, P751, DOI 10.1016/S0145-305X(00)00034-3; Kimura M., 1983, NEUTRAL THEORY MOL E, DOI [10.1017/CBO9780511623486, DOI 10.1017/CBO9780511623486]; Kjoglum S, 2006, FISH SHELLFISH IMMUN, V21, P431, DOI 10.1016/j.fsi.2006.02.001; KLEIN J, 1986, NATURAL HIST MAJOR H; Langefors A, 2001, P ROY SOC B-BIOL SCI, V268, P479, DOI 10.1098/rspb.2000.1378; Lou B., 2004, CHIN J MOD FISH, V6, P11; Padhi A, 2007, MOL DIVERS, V11, P119, DOI 10.1007/s11030-007-9066-4; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Rodrigues PNS, 1995, DEV COMP IMMUNOL, V19, P483, DOI 10.1016/0145-305X(95)00033-P; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Srisapoome P, 2004, FISHERIES SCI, V70, P264, DOI 10.1111/j.1444-2906.2003.00800.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wynne JW, 2007, FISH SHELLFISH IMMUN, V22, P707, DOI 10.1016/j.fsi.2006.08.019; Xu TJ, 2008, FISH SHELLFISH IMMUN, V25, P213, DOI 10.1016/j.fsi.2008.05.007; Xu TJ, 2010, FISH SHELLFISH IMMUN, V29, P1099, DOI 10.1016/j.fsi.2010.08.013; Xu TJ, 2009, FISH SHELLFISH IMMUN, V27, P192, DOI 10.1016/j.fsi.2009.04.009; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang YX, 2006, MAR BIOTECHNOL, V8, P600, DOI 10.1007/s10126-005-6185-8; Zhang YX, 2006, MAR BIOTECHNOL, V8, P611, DOI 10.1007/s10126-005-6174-y	29	45	54	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23823	10.1371/journal.pone.0023823	http://dx.doi.org/10.1371/journal.pone.0023823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901139	Green Submitted, gold, Green Published			2022-12-25	WOS:000294298000024
J	Braunschweig, A; Jozsi, M				Braunschweig, Anne; Jozsi, Mihaly			Human Pentraxin 3 Binds to the Complement Regulator C4b-Binding Protein	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INNATE IMMUNE-RESPONSE; AMYLOID-P COMPONENT; MATRIX IN-VITRO; FACTOR-H; EXTRACELLULAR-MATRIX; APOPTOTIC CELLS; INHIBITORY-ACTIVITY; ENDOTHELIAL-CELLS; PTX3	The long pentraxin 3 (PTX3) is a soluble recognition molecule with multiple functions including innate immune defense against certain microbes and the clearance of apoptotic cells. PTX3 interacts with recognition molecules of the classical and lectin complement pathways and thus initiates complement activation. In addition, binding of PTX3 to the alternative complement pathway regulator factor H was shown. Here, we show that PTX3 binds to the classical and lectin pathway regulator C4b-binding protein (C4BP). A PTX3-binding site was identified within short consensus repeats 1-3 of the C4BP alpha-chain. PTX3 did not interfere with the cofactor activity of C4BP in the fluid phase and C4BP maintained its complement regulatory activity when bound to PTX3 on surfaces. While C4BP and factor H did not compete for PTX3 binding, the interaction of C4BP with PTX3 was inhibited by C1q and by L-ficolin. PTX3 bound to human fibroblast-and endothelial cell-derived extracellular matrices and recruited functionally active C4BP to these surfaces. Whereas PTX3 enhanced the activation of the classical/lectin pathway and caused enhanced C3 deposition on extracellular matrix, deposition of terminal pathway components and the generation of the inflammatory mediator C5a were not increased. Furthermore, PTX3 enhanced the binding of C4BP to late apoptotic cells, which resulted in an increased rate of inactivation of cell surface bound C4b and a reduction in the deposition of C5b-9. Thus, in addition to complement activators, PTX3 interacts with complement inhibitors including C4BP. This balanced interaction on extracellular matrix and on apoptotic cells may prevent excessive local complement activation that would otherwise lead to inflammation and host tissue damage.	[Braunschweig, Anne; Jozsi, Mihaly] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jr Res Grp Cellular Immunobiol, Jena, Germany	Hans Knoll Institute (HKI)	Braunschweig, A (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jr Res Grp Cellular Immunobiol, Jena, Germany.	mihaly.jozsi@hki-jena.de	Jozsi, Mihaly/I-7872-2018	Jozsi, Mihaly/0000-0002-5520-5535	Jena School for Microbial Communication, a graduate school of the Friedrich Schiller University Jena; Deutsche Forschungsgemeinschaft	Jena School for Microbial Communication, a graduate school of the Friedrich Schiller University Jena; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Jena School for Microbial Communication, a graduate school of the Friedrich Schiller University Jena supported by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biro A, 2007, IMMUNOLOGY, V121, P40, DOI 10.1111/j.1365-2567.2007.02535.x; Blom AM, 2004, MOL IMMUNOL, V40, P1333, DOI 10.1016/j.molimm.2003.12.002; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Deban L, 2011, CELL TISSUE RES, V343, P237, DOI 10.1007/s00441-010-1018-0; Deban L, 2008, J IMMUNOL, V181, P8433, DOI 10.4049/jimmunol.181.12.8433; Diniz SN, 2004, J LEUKOCYTE BIOL, V75, P649, DOI 10.1189/jlb.0803371; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Gershov D, 2000, J EXP MED, V192, P1353, DOI 10.1084/jem.192.9.1353; Gout E, 2011, J IMMUNOL, V186, P5815, DOI 10.4049/jimmunol.1100180; Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002; Happonen KE, 2009, J IMMUNOL, V182, P1518, DOI 10.4049/jimmunol.182.3.1518; Hebecker M, 2010, MOL IMMUNOL, V47, P1347, DOI 10.1016/j.molimm.2009.12.005; Hindmarsh EJ, 1998, J IMMUNOL, V160, P6128; Hindmarsh EJ, 1998, EUR J IMMUNOL, V28, P1052, DOI 10.1002/(SICI)1521-4141(199803)28:03<1052::AID-IMMU1052>3.0.CO;2-W; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Inforzato A, 2010, J BIOL CHEM, V285, P17681, DOI 10.1074/jbc.M109.085639; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Jarva H, 1999, J IMMUNOL, V163, P3957; Jones J, 1995, IMMUNOLOGY, V86, P651; Kask L, 2004, J BIOL CHEM, V279, P23869, DOI 10.1074/jbc.C400159200; Kresl JJ, 1998, INT J BIOCHEM CELL B, V30, P1415, DOI 10.1016/S1357-2725(98)00078-8; LEE GW, 1993, J IMMUNOL, V150, P1804; LEE TH, 1990, MOL CELL BIOL, V10, P1982, DOI 10.1128/MCB.10.5.1982; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; Luchetti MM, 2000, CLIN EXP IMMUNOL, V119, P196, DOI 10.1046/j.1365-2249.2000.01110.x; Ma YJ, 2009, J BIOL CHEM, V284, P28263, DOI 10.1074/jbc.M109.009225; Ma YJ, 2011, J BIOL CHEM, V286, P3405, DOI 10.1074/jbc.M110.190637; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Mihlan M, 2009, CELL DEATH DIFFER, V16, P1630, DOI 10.1038/cdd.2009.103; Moalli F, 2010, BLOOD, V116, P5170, DOI 10.1182/blood-2009-12-258376; Nauta AJ, 2003, TRENDS IMMUNOL, V24, P148, DOI 10.1016/S1471-4906(03)00030-9; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Ng PML, 2007, EMBO J, V26, P3431, DOI 10.1038/sj.emboj.7601762; Rolph MS, 2002, ARTERIOSCL THROM VAS, V22, pE10, DOI 10.1161/01.ATV.0000015595.95497.2F; Rovere P, 2000, BLOOD, V96, P4300; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Sjoberg AP, 2008, MOL IMMUNOL, V45, P3213, DOI 10.1016/j.molimm.2008.02.023; Sjoberg AP, 2006, J IMMUNOL, V176, P7612, DOI 10.4049/jimmunol.176.12.7612; Sjoberg AP, 2009, MOL IMMUNOL, V46, P830, DOI 10.1016/j.molimm.2008.09.018; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; VOLANAKIS JE, 1974, J IMMUNOL, V113, P9; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Webb JH, 2002, J IMMUNOL, V169, P2580, DOI 10.4049/jimmunol.169.5.2580	49	50	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23991	10.1371/journal.pone.0023991	http://dx.doi.org/10.1371/journal.pone.0023991			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21915248	gold, Green Published, Green Submitted			2022-12-25	WOS:000294251800044
J	Chacko, BK; Scott, DW; Chandler, RT; Patel, RP				Chacko, Balu K.; Scott, David W.; Chandler, Robert T.; Patel, Rakesh P.			Endothelial Surface N-Glycans Mediate Monocyte Adhesion and Are Targets for Anti-inflammatory Effects of Peroxisome Proliferator-activated Receptor gamma Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA; CELL; GLYCOSYLATION; GLYCOCALYX; EXPRESSION; SELECTIN; FLOW; INFLAMMATION; BINDING; ISOFLAVONES	Endothelial-monocyte interactions are regulated by adhesion molecules and key in the development of vascular inflammatory disease. Peroxisome proliferator-activated receptor (PPAR) gamma activation in endothelial cells is recognized to mediate anti-inflammatory effects that inhibit monocyte rolling and adhesion. Herein, evidence is provided for a novel mechanism for the anti-inflammatory effects of PPAR gamma ligand action that involves inhibition of proinflammatory cytokine-dependent up-regulation of endothelial N-glycans. TNF alpha treatment of human umbilical vein endothelial cells increased surface expression of high mannose/hybrid N-glycans. A role for these sugars in mediating THP-1 or primary human monocyte rolling and adhesion was indicated by competition studies in which addition of alpha-methylmannose, but not alpha-methylglucose, inhibited monocyte rolling and adhesion during flow, but not under static conditions. This result supports the notion that adhesion molecules provide scaffolds for sugar epitopes to mediate adhesion with cognate receptors. A panel of structurally distinct PPAR gamma agonists all decreased TNF alpha-dependent expression of endothelial high mannose/hybrid N-glycans. Using rosiglitazone as a model PPAR gamma agonist, which decreased TNF alpha-induced high mannose N-glycan expression, we demonstrate a role for these carbohydrate residues in THP-1 rolling and adhesion that is independent of endothelial surface adhesion molecule expression (ICAM-1 and E-selectin). Data from N-glycan processing gene arrays identified alpha-mannosidases (MAN1A2 and MAN1C1) as targets for down-regulation by TNF alpha, which was reversed by rosiglitazone, a result consistent with altered high mannose/hybrid N-glycan epitopes. Taken together we propose a novel anti-inflammatory mechanism of endothelial PPAR gamma activation that involves targeting protein post-translational modification of adhesion molecules, specifically N-glycosylation.	[Chacko, Balu K.; Scott, David W.; Chandler, Robert T.; Patel, Rakesh P.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Patel, RP (corresponding author), 901 19th St S,BMR-2,Rm 532, Birmingham, AL 35294 USA.	rakeshp@uab.edu		Patel, Rakesh/0000-0002-1526-4303	American Heart Association; Howard Hughes Medical Institute through Med into Grad Initiative; Purdue-UAB Botanicals center	American Heart Association(American Heart Association); Howard Hughes Medical Institute through Med into Grad Initiative; Purdue-UAB Botanicals center	This work was supported in part by a American Heart Association Postdoctoral fellowship (to B. K. C.), a American Heart Association Predoctoral fellowship (to D. S.), a grant from the Howard Hughes Medical Institute through the Med into Grad Initiative (to D. W. S.), and a pilot grant from the Purdue-UAB Botanicals center (to R. P. P.).	Becker BF, 2010, BASIC RES CARDIOL, V105, P687, DOI 10.1007/s00395-010-0118-z; Chacko BK, 2007, J NUTR, V137, P351, DOI 10.1093/jn/137.2.351; Chacko BK, 2005, AM J PHYSIOL-HEART C, V289, pH908, DOI 10.1152/ajpheart.00781.2004; Chappell D, 2009, CIRC RES, V104, P1313, DOI 10.1161/CIRCRESAHA.108.187831; Chappell D, 2009, BASIC RES CARDIOL, V104, P78, DOI 10.1007/s00395-008-0749-5; Cummings RD, 1999, BRAZ J MED BIOL RES, V32, P519, DOI 10.1590/S0100-879X1999000500004; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Garcia-Vallejo JJ, 2006, J CELL PHYSIOL, V206, P203, DOI 10.1002/jcp.20458; Gouverneur M, 2006, J INTERN MED, V259, P393, DOI 10.1111/j.1365-2796.2006.01625.x; Henry CBS, 2000, AM J PHYSIOL-HEART C, V279, pH2815, DOI 10.1152/ajpheart.2000.279.6.H2815; Iiyama K, 1999, CIRC RES, V85, P199, DOI 10.1161/01.RES.85.2.199; Jackson SM, 1999, ARTERIOSCL THROM VAS, V19, P2094, DOI 10.1161/01.ATV.19.9.2094; Jimenez D, 2005, J BIOL CHEM, V280, P5854, DOI 10.1074/jbc.M412104200; Ketsawatsomkron P, 2010, J BIOL CHEM, V285, P9311, DOI 10.1074/jbc.R109.025031; Kevil CG, 2003, AM J PHYSIOL-CELL PH, V285, pC112, DOI 10.1152/ajpcell.00334.2002; Knouff C, 2004, ENDOCR REV, V25, P899, DOI 10.1210/er.2003-0036; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; LIS H, 1993, EUR J BIOCHEM, V218, P1, DOI 10.1111/j.1432-1033.1993.tb18347.x; Liu Y, 2004, CIRCULATION, V110, P1128, DOI 10.1161/01.CIR.0000139850.08365.EC; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Methe H, 2007, AM J PHYSIOL-HEART C, V292, pH2167, DOI 10.1152/ajpheart.00403.2006; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002; Mundhekar AN, 2006, AM J PHYSIOL-CELL PH, V291, pC130, DOI 10.1152/ajpcell.00261.2005; Nieuwdorp A, 2009, ATHEROSCLEROSIS, V202, P296, DOI 10.1016/j.atherosclerosis.2008.03.024; PAHLSSON P, 1995, EUR J IMMUNOL, V25, P2452, DOI 10.1002/eji.1830250907; Peng YL, 2010, MOL CELL BIOCHEM, V340, P143, DOI 10.1007/s11010-010-0411-z; Pinho S. S., 2011, CELL MOL LIFE SCI, V1218, P1379; Plutzky J, 2003, J AM COLL CARDIOL, V42, P1764, DOI 10.1016/j.jacc.2003.08.017; Potter DR, 2009, CIRC RES, V104, P1318, DOI 10.1161/CIRCRESAHA.108.191585; Rachmilewitz J., 2010, SELF NONSELF, V1, P250, DOI DOI 10.4161/SELF.1.3.12330; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Renkonen J, 2002, AM J PATHOL, V161, P543, DOI 10.1016/S0002-9440(10)64210-1; RENKONEN R, 1991, EUR J IMMUNOL, V21, P777, DOI 10.1002/eji.1830210334; Rivera-Marrero CA, 2001, MICROB PATHOGENESIS, V30, P9, DOI 10.1006/mpat.2000.0407; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; SELLAK H, 1994, BLOOD, V83, P2669; Sperandio M, 2009, IMMUNOL REV, V230, P97, DOI 10.1111/j.1600-065X.2009.00795.x; Srikrishna G, 2001, J IMMUNOL, V166, P624, DOI 10.4049/jimmunol.166.1.624; SRIRAMARAO P, 1993, J CELL BIOCHEM, V51, P360, DOI 10.1002/jcb.240510316; Sumagin R, 2010, J IMMUNOL, V184, P5242, DOI 10.4049/jimmunol.0903319; Thornton BP, 1996, J IMMUNOL, V156, P1235; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vaisar Tomas, 2007, Curr Atheroscler Rep, V9, P417, DOI 10.1007/s11883-007-0054-z; Varki A, 1997, J CLIN INVEST, V100, pS31; Varki AP, 2008, GLYCOBIOLOGY, V18, P747, DOI 10.1093/glycob/cwn065; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Willhauck-Fleckenstein M, 2010, ANGIOGENESIS, V13, P25, DOI 10.1007/s10456-010-9162-4; Yang XJ, 2004, BIOCHEM CELL BIOL, V82, P559, DOI 10.1139/O04-058	50	52	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38738	38747		10.1074/jbc.M111.247981	http://dx.doi.org/10.1074/jbc.M111.247981			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911496	Green Published, hybrid			2022-12-25	WOS:000296594200085
J	Stoltzman, CA; Kaadige, MR; Peterson, CW; Ayer, DE				Stoltzman, Carrie A.; Kaadige, Mohan R.; Peterson, Christopher W.; Ayer, Donald E.			MondoA Senses Non-glucose Sugars REGULATION OF THIOREDOXIN-INTERACTING PROTEIN (TXNIP) AND THE HEXOSE TRANSPORT CURB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE RESPONSE ELEMENT; D-ALLOSE; AEROBIC GLYCOLYSIS; CHREBP; MUTANT; PHOSPHORYLATION; METABOLISM; MLX; TRANSCRIPTION; TUNICAMYCIN	Glucose is required for cell growth and proliferation. The MondoA.Mlx transcription factor is glucose-responsive and accumulates in the nucleus by sensing glucose 6-phosphate. One direct and glucose-induced target of MondoA.Mlx complexes is thioredoxin-interacting protein (TXNIP). TXNIP is a potent negative regulator of glucose uptake, and hence its regulation by MondoA.Mlx triggers a feedback loop that restricts glucose uptake. This feedback loop is similar to the "hexose transport curb" first described almost 30 years ago. We show here that MondoA responds to the non-glucose hexoses, allose, 3-O-methylglucose, and glucosamine by accumulating in the nucleus and activating TXNIP transcription. The metabolic inhibitor 3-bromopyruvate blocks the transcriptional response to allose and 3-O-methylglucose, indicating that their metabolism, or a parallel pathway, is required to stimulate MondoA activity. Our dissection of the hexosamine biosynthetic pathway suggests that in addition to sensing glucose 6-phosphate, MondoA can also sense glucosamine 6-phosphate. Analysis of glucose uptake in wild-type, MondoA-null, or TXNIP-null murine embryonic fibroblasts indicates a role for the MondoA-TXNIP regulatory circuit in the hexose transport curb, although other redundant pathways also contribute.	Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Ayer, DE (corresponding author), 4365 Huntsman Canc Inst, 2000 Circle Hope, Salt Lake City, UT 84112 USA.	don.ayer@hci.utah.edu		Ayer, Donald/0000-0002-5595-3269	National Institutes of Health [GM55668, GM60387]; Huntsman Cancer Foundation; Cancer Center [2P30 CA42014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055668, R01GM060387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huntsman Cancer Foundation; Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM55668 and GM60387 (to D. E. A.). This work was also supported by the Huntsman Cancer Foundation. DNA sequencing and oligonucleotide synthesis were supported by the Cancer Center Support Grant 2P30 CA42014.	Ai J., 2005, ANAL CHEM, V77, P8086; Billin AN, 2006, CURR TOP MICROBIOL, V302, P255; Billin AN, 2000, MOL CELL BIOL, V20, P8845, DOI 10.1128/MCB.20.23.8845-8854.2000; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Cortes S, 2003, PLANT PHYSIOL, V131, P824, DOI 10.1104/pp.010538; Elgort Marc G, 2010, Genes Cancer, V1, P893, DOI 10.1177/1947601910389604; GATLEY SJ, 1984, BIOCHEM BIOPH RES CO, V119, P1008, DOI 10.1016/0006-291X(84)90874-X; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Kaadige MR, 2010, TRANSCR-AUSTIN, V1, P36, DOI 10.4161/trns.1.1.12142; Kaadige MR, 2009, P NATL ACAD SCI USA, V106, P14878, DOI 10.1073/pnas.0901221106; KALCKAR HM, 1979, P NATL ACAD SCI USA, V76, P6453, DOI 10.1073/pnas.76.12.6453; KALCKAR HM, 1984, P NATL ACAD SCI-BIOL, V81, P1126, DOI 10.1073/pnas.81.4.1126; Kim SY, 2007, CELL MOL IMMUNOL, V4, P345; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; McClain DA, 2002, J DIABETES COMPLICAT, V16, P72, DOI 10.1016/S1056-8727(01)00188-X; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Minn AH, 2006, BIOCHEMISTRY-US, V45, P11047, DOI 10.1021/bi0603625; Muoio DM, 2007, CELL METAB, V5, P412, DOI 10.1016/j.cmet.2007.05.011; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Peterson CW, 2010, MOL CELL BIOL, V30, P2887, DOI 10.1128/MCB.01613-09; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; POUYSSEGUR J, 1980, NATURE, V287, P445, DOI 10.1038/287445a0; POUYSSEGUR J, 1980, P NATL ACAD SCI-BIOL, V77, P2698, DOI 10.1073/pnas.77.5.2698; Sans CL, 2006, MOL CELL BIOL, V26, P4863, DOI 10.1128/MCB.00657-05; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; ULLREY DB, 1986, P NATL ACAD SCI USA, V83, P5858, DOI 10.1073/pnas.83.16.5858; ULLREY DB, 1982, P NATL ACAD SCI-BIOL, V79, P3777, DOI 10.1073/pnas.79.12.3777; ULLREY DB, 1989, P NATL ACAD SCI USA, V86, P4350, DOI 10.1073/pnas.86.12.4350; ULLREY DB, 1987, P NATL ACAD SCI USA, V84, P3678, DOI 10.1073/pnas.84.11.3678; ULLREY DB, 1991, P NATL ACAD SCI USA, V88, P1504, DOI 10.1073/pnas.88.4.1504; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Yamaguchi F, 2008, INT J ONCOL, V32, P377	34	45	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38027	38034		10.1074/jbc.M111.275503	http://dx.doi.org/10.1074/jbc.M111.275503			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908621	Green Published, hybrid			2022-12-25	WOS:000296594200014
J	Jin, X; Stamnaes, J; Klock, C; DiRaimondo, TR; Sollid, LM; Khosla, C				Jin, Xi; Stamnaes, Jorunn; Klock, Cornelius; DiRaimondo, Thomas R.; Sollid, Ludvig M.; Khosla, Chaitan			Activation of Extracellular Transglutaminase 2 by Thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE TRANSGLUTAMINASE; STRUCTURAL BASIS; MECHANISM; PLASMA; DISULFIDES; CANCER; ENZYME; CELLS; IDENTIFICATION; LOCALIZATION	The mechanism of activation of transglutaminase 2 (TG2) in the extracellular matrix remains a fundamental mystery in our understanding of the biology of this multifunctional mammalian enzyme. Earlier investigations have highlighted the role of a disulfide bond formed by vicinal Cys residues in maintaining calcium-bound TG2 in an inactive state. Here, we have shown that the redox potential of this disulfide bond is approximately -190 mV, a high value for a disulfide bond in proteins. Consistent with this observation, TG2 activity in a freshly wounded fibroblast culture depends upon the redox potential of the environment. We sought to identify a physiological mechanism for the activation of oxidized TG2. With a k(cat)/K-m of 1.6 mu M-1 min(-1), human thioredoxin (Trx) was a highly specific activator of oxidized human TG2. Trx-mediated activation of TG2 was blocked by PX-12, a small molecule Trx inhibitor that is undergoing clinical trials as a cancer chemotherapeutic agent. In a mixed culture containing fibroblasts and monocytic cells, interferon-gamma stimulated Trx release from monocytes, which in turn activated TG2 around the fibroblasts. Recombinant human Trx could also activate extracellular TG2 in cryosections of human and mouse small intestinal biopsies. In addition to explaining how TG2 can be activated by dietary gluten in the small intestinal mucosa of celiac sprue patients, our findings reveal a new strategy for inhibiting the undesirable consequences of TG2 activity in this widespread, lifelong disease.	[Jin, Xi; Klock, Cornelius; Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Jin, Xi; Klock, Cornelius; Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Stamnaes, Jorunn; Sollid, Ludvig M.] Univ Oslo, Ctr Immune Regulat, N-0027 Oslo, Norway; [Stamnaes, Jorunn; Sollid, Ludvig M.] Univ Oslo, Dept Immunol, N-0027 Oslo, Norway; Oslo Univ Hosp, Rikshosp, N-0027 Oslo, Norway	Stanford University; Stanford University; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway	Khosla, C (corresponding author), Stanford Univ, Dept Chem & Chem Engn, Stanford, CA 94305 USA.	khosla@stanford.edu	Sollid, Ludvig/N-9691-2015	Sollid, Ludvig/0000-0001-8860-704X; Stamnaes, Jorunn/0000-0002-0257-2112; Khosla, Chaitan/0000-0001-6529-495X	National Institutes of Health [R01 DK63158]; Research Council of Norway; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of Norway(Research Council of Norway); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK63158 (to C. K.). This work was also supported by the Research Council of Norway (to L. M. S.).	Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Arner E S, 2001, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0704s05; Azimi I, 2010, J BIOL CHEM, V285, P40072, DOI 10.1074/jbc.M110.185371; Azimi I, 2011, ANTIOXID REDOX SIGN, V14, P113, DOI 10.1089/ars.2010.3620; Baker AF, 2006, J LAB CLIN MED, V147, P83, DOI 10.1016/j.lab.2005.09.001; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; Chaiswing L, 2010, ANTIOXID REDOX SIGN, V13, P449, DOI 10.1089/ars.2009.3020; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Gelderman KA, 2006, P NATL ACAD SCI USA, V103, P12831, DOI 10.1073/pnas.0604571103; HOLMGREN A, 1978, BIOCHEMISTRY-US, V17, P4071, DOI 10.1021/bi00612a031; HOLMGREN A, 1979, J BIOL CHEM, V254, P9113; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Kim SH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-64; Kirkpatrick DL, 1998, BIOCHEM PHARMACOL, V55, P987, DOI 10.1016/S0006-2952(97)00597-2; Klock C, 2011, BIOORG MED CHEM LETT, V21, P2692, DOI 10.1016/j.bmcl.2010.12.037; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Miyazaki K, 1998, BIOTHERAPY, V11, P277, DOI 10.1023/A:1008032703468; Nakamura H, 1998, FREE RADICAL BIO MED, V24, P1176, DOI 10.1016/S0891-5849(97)00429-2; Nakamura H, 1996, INT IMMUNOL, V8, P603, DOI 10.1093/intimm/8.4.603; Nakamura H, 2006, SEMIN CANCER BIOL, V16, P444, DOI 10.1016/j.semcancer.2006.09.001; Pekkari K, 2004, ANTIOXID REDOX SIGN, V6, P53, DOI 10.1089/152308604771978345; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; RADEK JT, 1993, P NATL ACAD SCI USA, V90, P3152, DOI 10.1073/pnas.90.8.3152; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sido B, 2005, EUR J IMMUNOL, V35, P408, DOI 10.1002/eji.200424500; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Tonissen KF, 2009, MOL NUTR FOOD RES, V53, P87, DOI 10.1002/mnfr.200700492; UPCHURCH HF, 1991, J CELL PHYSIOL, V149, P375, DOI 10.1002/jcp.1041490304; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414	36	84	85	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37866	37873		10.1074/jbc.M111.287490	http://dx.doi.org/10.1074/jbc.M111.287490			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21908620	Green Published, hybrid			2022-12-25	WOS:000296542400081
J	Zhang, J; Ye, F; Lan, LF; Jiang, HL; Luo, C; Yang, CG				Zhang, Jie; Ye, Fei; Lan, Lefu; Jiang, Hualiang; Luo, Cheng; Yang, Cai-Guang			Structural Switching of Staphylococcus aureus Clp Protease A KEY TO UNDERSTANDING PROTEASE DYNAMICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CLPP; STRESS TOLERANCE; N-TERMINUS; MODEL; SPECIFICITY; ACTIVATION; CHAPERONES; PROTEINS; INSIGHTS; SUBUNITS	ATP-dependent Clp protease (ClpP) is an attractive new target for the development of anti-infective agents. The ClpP protease consists of two heptameric rings that enclose a large chamber containing 14 proteolytic active sites. Recent studies indicate that ClpP likely undergoes conformational switching between an extended and degraded active state required for substrate proteolysis and a compacted and catalytically inactive state allowing product release. Here, we present the wild-type ClpP structures in two distinct states from Staphylococcus aureus. One structure is very similar to those solved ClpP structures in the extended states. The other is strikingly different from both the extended and the compacted state as observed in ClpP from other species; the handle domain of this structure kinks to take on a compressed conformation. Structural analysis and molecular dynamic simulations show that the handle domain predominantly controls the way in which degradation products exit the chamber through dynamic conformational switching from the extended state to the compressed state. Given the highly conserved sequences among ClpP from different species, this compressed conformation is unexpected and novel, which is potentially valuable for understanding the enzymatic dynamics and the acting mechanisms of ClpP.	[Zhang, Jie; Ye, Fei; Lan, Lefu; Jiang, Hualiang; Luo, Cheng; Yang, Cai-Guang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Luo, C (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	cluo@mail.shcnc.ac.cn; yangcg@mail.shcnc.ac.cn			National Natural Science Foundation of China [20972173, 20972174, 90913010, 91029704, 21021063, 21172234]; Chinese Academy of Sciences [XDA01040305]; Science and Technology Commission of Shanghai Municipality [09PJ1411600, 10410703900]; Key Project of Chinese National Programs for Fundamental Research and Development [2009CB918502]; National Science and Technology Major Project [2009ZX09301-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Key Project of Chinese National Programs for Fundamental Research and Development; National Science and Technology Major Project	This work was supported by National Natural Science Foundation of China Grants 20972173, 20972174, 90913010, 91029704, 21021063, and 21172234, by the Hundred Talent Program of the Chinese Academy of Sciences (to C.-G. Y. and L. L.), and by Science and Technology Commission of Shanghai Municipality Grants 09PJ1411600 and 10410703900, Key Project of Chinese National Programs for Fundamental Research and Development Grant 2009CB918502, National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" Grant 2009ZX09301-001), and Special Grant of the Chinese Academy of Sciences Grant XDA01040305.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bewley MC, 2009, J STRUCT BIOL, V165, P118, DOI 10.1016/j.jsb.2008.10.005; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Butler SM, 2006, MOL MICROBIOL, V60, P553, DOI 10.1111/j.1365-2958.2006.05128.x; Chandu D, 2004, RES MICROBIOL, V155, P710, DOI 10.1016/j.resmic.2004.06.003; Chatterjee I, 2005, J BACTERIOL, V187, P4488, DOI 10.1128/JB.187.13.4488-4496.2005; Corydon TJ, 1998, BIOCHEM J, V331, P309, DOI 10.1042/bj3310309; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Donegan NP, 2010, J BACTERIOL, V192, P1416, DOI 10.1128/JB.00233-09; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Effantin G, 2010, J BIOL CHEM, V285, P14834, DOI 10.1074/jbc.M109.090498; El Bakkouri M, 2010, J MOL BIOL, V404, P456, DOI 10.1016/j.jmb.2010.09.051; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fletcher R., 1980, PRACTICAL METHODS OP, V1, P1; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; Geiger SR, 2011, ANGEW CHEM INT EDIT, V50, P5748, DOI 10.1002/anie.201100666; Gottesman S, 1997, CELL, V91, P435, DOI 10.1016/S0092-8674(00)80428-6; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gribun A, 2005, J BIOL CHEM, V280, P16185, DOI 10.1074/jbc.M414124200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Ingvarsson H, 2007, ACTA CRYSTALLOGR D, V63, P249, DOI 10.1107/S0907444906050530; Jennings LD, 2008, BIOCHEMISTRY-US, V47, P11536, DOI 10.1021/bi801101p; Jennings LD, 2008, BIOCHEMISTRY-US, V47, P11031, DOI 10.1021/bi8010169; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kang SG, 2004, J STRUCT BIOL, V148, P338, DOI 10.1016/j.jsb.2004.07.004; Kim DY, 2008, J MOL BIOL, V379, P760, DOI 10.1016/j.jmb.2008.04.036; Kimber MS, 2010, STRUCTURE, V18, P798, DOI 10.1016/j.str.2010.04.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Li DHS, 2010, CHEM BIOL, V17, P959, DOI 10.1016/j.chembiol.2010.07.008; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Maurizi MR, 1998, BIOCHEMISTRY-US, V37, P7778, DOI 10.1021/bi973093e; Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ortega J, 2004, J STRUCT BIOL, V146, P217, DOI 10.1016/j.jsb.2003.11.023; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Szyk A, 2006, J STRUCT BIOL, V156, P165, DOI 10.1016/j.jsb.2006.03.013; THOMPSON MW, 1994, J BIOL CHEM, V269, P18201; THOMPSON MW, 1994, J BIOL CHEM, V269, P18209; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WAWRZYNOW A, 1995, EMBO J, V14, P1867, DOI 10.1002/j.1460-2075.1995.tb07179.x; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; WOO KM, 1989, J BIOL CHEM, V264, P2088; Yu AYH, 2007, FEBS LETT, V581, P3749, DOI 10.1016/j.febslet.2007.04.076	54	44	45	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37590	37601		10.1074/jbc.M111.277848	http://dx.doi.org/10.1074/jbc.M111.277848			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900233	Green Published, hybrid			2022-12-25	WOS:000296542400057
J	Guo, XL; Gao, L; Wei, CS; Yang, XF; Zhao, Y; Dong, AG				Guo, Xingli; Gao, Lin; Wei, Chunshui; Yang, Xiaofei; Zhao, Yi; Dong, Anguo			A Computational Method Based on the Integration of Heterogeneous Networks for Predicting Disease-Gene Associations	PLOS ONE			English	Article							ALZHEIMER-DISEASE; PROTEIN; INTERACTOME; PHENOME	The identification of disease-causing genes is a fundamental challenge in human health and of great importance in improving medical care, and provides a better understanding of gene functions. Recent computational approaches based on the interactions among human proteins and disease similarities have shown their power in tackling the issue. In this paper, a novel systematic and global method that integrates two heterogeneous networks for prioritizing candidate disease-causing genes is provided, based on the observation that genes causing the same or similar diseases tend to lie close to one another in a network of protein-protein interactions. In this method, the association score function between a query disease and a candidate gene is defined as the weighted sum of all the association scores between similar diseases and neighbouring genes. Moreover, the topological correlation of these two heterogeneous networks can be incorporated into the definition of the score function, and finally an iterative algorithm is designed for this issue. This method was tested with 10-fold cross-validation on all 1,126 diseases that have at least a known causal gene, and it ranked the correct gene as one of the top ten in 622 of all the 1,428 cases, significantly outperforming a state-of-the-art method called PRINCE. The results brought about by this method were applied to study three multi-factorial disorders: breast cancer, Alzheimer disease and diabetes mellitus type 2, and some suggestions of novel causal genes and candidate disease-causing subnetworks were provided for further investigation.	[Guo, Xingli; Gao, Lin; Wei, Chunshui] Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi Prov, Peoples R China; [Guo, Xingli; Yang, Xiaofei] Xidian Univ, Sch Software Engn, Xian, Shaanxi Prov, Peoples R China; [Zhao, Yi] Chinese Acad Sci, Inst Comp Technol, Beijing, Peoples R China; [Dong, Anguo] Changan Univ, Sch Sci, Xian, Shaanxi Prov, Peoples R China	Xidian University; Xidian University; Chinese Academy of Sciences; Institute of Computing Technology, CAS; Chang'an University	Guo, XL (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi Prov, Peoples R China.	lgao@mail.xidian.edu.cn	Zhao, Yi/A-2962-2011	Zhao, Yi/0000-0001-6046-8420; Yang, Xiaofei/0000-0002-5118-7755	National Natural Science Foundation of China [60933009]; Specialized Research Fund for the Doctoral Program of Higher Education [200807010013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (Grant No. 60933009), the website is http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm; the Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 200807010013), the website is http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 2006, LOCAL GRAPH PARTITIO, P475; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Biesecker LG, 2005, CLIN GENET, V68, P320, DOI 10.1111/j.1399-0004.2005.00509.x; Farrer LA, 2003, HUM MOL GENET, V12, P415, DOI 10.1093/hmg/ddg037; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Gaulton KJ, 2007, BIOINFORMATICS, V23, P1132, DOI 10.1093/bioinformatics/btm001; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; HUANG Y, 2011, OPHTHALMOLOGY; JURI R, 2007, NUC ACI RES, V35, pW193, DOI DOI 10.1093/NAR/GKM226; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; LIANG H, 2011, MED ONCOL; MIMMINERA A, ONLINE MENDELIAN INH; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oldenburg RA, 2007, CRIT REV ONCOL HEMAT, V63, P125, DOI 10.1016/j.critrevonc.2006.12.004; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Prince JA, 2003, HUM MUTAT, V22, P363, DOI 10.1002/humu.10282; REITZ C, 2011, NAT REV NEUROL; Rzhetsky A, 2007, P NATL ACAD SCI USA, V104, P11694, DOI 10.1073/pnas.0704820104; Schjeide BMM, 2011, ARCH GEN PSYCHIAT, V68, P207, DOI 10.1001/archgenpsychiatry.2010.196; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Wu XB, 2009, BIOINFORMATICS, V25, P98, DOI 10.1093/bioinformatics/btn593; Zou F, 2010, NEUROLOGY, V74, P480, DOI 10.1212/WNL.0b013e3181d07654; CIPHER CORRELATING P; G PROFILER A WEB SER	30	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24171	10.1371/journal.pone.0024171	http://dx.doi.org/10.1371/journal.pone.0024171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912671	Green Submitted, gold, Green Published			2022-12-25	WOS:000294686100018
J	Kodl, J; Ganesh, G; Burdet, E				Kodl, Jindrich; Ganesh, Gowrishankar; Burdet, Etienne			The CNS Stochastically Selects Motor Plan Utilizing Extrinsic and Intrinsic Representations	PLOS ONE			English	Article							ARM MOVEMENTS; MODEL; COORDINATION; DYNAMICS; ACCURATE; SPEED; REACH; GOAL; HAND	Traditionally motor studies have assumed that motor tasks are executed according to a single plan characterized by regular patterns, which corresponds to the minimum of a cost function in extrinsic or intrinsic coordinates. However, the novel via-point task examined in this paper shows distinct planning and execution stages in motion production and demonstrates that subjects randomly select from several available motor plans to perform a task. Examination of the effect of pre-training and via-point orientation on subject behavior reveals that the selection of a plan depends on previous movements and is affected by constraints both intrinsic and extrinsic of the body. These results provide new insights into the hierarchical structure of motion planning in humans, which can only be explained if the current models of motor control integrate an explicit plan selection stage.	[Kodl, Jindrich; Burdet, Etienne] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Ganesh, Gowrishankar] Natl Inst Informat & Commun Technol, Adv Informat & Commun Technol Res Inst, Kobe, Hyogo, Japan; [Ganesh, Gowrishankar] ATR Int, Computat Neurosci Labs, Kyoto, Japan	Imperial College London; National Institute of Information & Communications Technology (NICT) - Japan	Kodl, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, S Kensington Campus, London, England.	e.burdet@imperial.ac.uk		Burdet, Etienne/0000-0002-2123-0185	European Union	European Union(European Commission)	This work was funded by the European Union FP7 HUMOUR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein N.A., 1967, COORDINATION REGULAT; Burdet E, 1998, BIOL CYBERN, V78, P307, DOI 10.1007/s004220050435; Bursztyn LLCD, 2006, CURR BIOL, V16, P2440, DOI 10.1016/j.cub.2006.10.051; Cothros N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001990; d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Franklin DW, 2008, J NEUROSCI, V28, P11165, DOI 10.1523/JNEUROSCI.3099-08.2008; GANDOLFO F, 1996, P NATL ACAD SCI USA, V93, P3343; Ganesh G, 2010, J NEUROPHYSIOL, V104, P382, DOI 10.1152/jn.01058.2009; GANESH G, 2010, ROB AUT IEEE INT C, pE2705; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hoffman DS, 1999, J NEUROPHYSIOL, V81, P319, DOI 10.1152/jn.1999.81.1.319; Hoffmann H, 2011, EXP BRAIN RES, V208, P73, DOI 10.1007/s00221-010-2461-6; HOLLERBACH JM, 1981, BIOL CYBERN, V39, P139, DOI 10.1007/BF00336740; Ijspeert AJ, 2007, SCIENCE, V315, P1416, DOI 10.1126/science.1138353; KAKEI S, 1997, SCIENCE, V24, P2136; Kistemaker DA, 2010, J NEUROPHYSIOL, V104, P2985, DOI 10.1152/jn.00483.2010; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Mosier KM, 2005, J NEUROPHYSIOL, V94, P4362, DOI 10.1152/jn.00380.2005; Muller H, 2004, J EXP PSYCHOL HUMAN, V30, P212, DOI 10.1037/0096-1523.30.1.212; O'Sullivan I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000345; Osu R, 2003, J NEUROPHYSIOL, V90, P3255, DOI 10.1152/jn.00073.2003; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; Pollick FE, 2009, CORTEX, V45, P325, DOI 10.1016/j.cortex.2008.03.010; Tee KP, 2010, BIOL CYBERN, V102, P31, DOI 10.1007/s00422-009-0348-z; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Todorov E, 1998, J NEUROPHYSIOL, V80, P696, DOI 10.1152/jn.1998.80.2.696; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; VIVIANI P, 1995, J EXP PSYCHOL HUMAN, V21, P32, DOI 10.1037/0096-1523.21.1.32; VIVIANI P, 1982, NEUROSCIENCE, V7, P431, DOI 10.1016/0306-4522(82)90277-9	31	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24229	10.1371/journal.pone.0024229	http://dx.doi.org/10.1371/journal.pone.0024229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912679	Green Published, Green Submitted, gold			2022-12-25	WOS:000294686100026
J	Wang, X; Liu, XY; Yan, XL; Zhao, P; Ding, Y; Xu, P				Wang, Xia; Liu, Xueying; Yan, Xiuling; Zhao, Peng; Ding, Yi; Xu, Ping			Enzyme-Nanoporous Gold Biocomposite: Excellent Biocatalyst with Improved Biocatalytic Performance and Stability	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; IMMOBILIZATION; LIPASE; STABILIZATION; NANOPARTICLES; NANOFIBERS; PROTEINS; SURFACE; METALS; SILICA	Background: Applications involving biomolecules, such as enzymes, antibodies, and other proteins as well as whole cells, are often hampered by their unstable nature at extremely high temperature and in organic solvents. Methodology/Principal Findings: We constructed enzyme-NPG biocomposites by assembling various enzymes onto the surface of nanoporous gold (NPG), which showed much enhanced biocatalytic performance and stability. Various enzymes with different molecular sizes were successfully tethered onto NPG, and the loadings were 3.6, 3.1 and 0.8 mg g(-1) for lipase, catalase and horseradish peroxidase, respectively. The enzyme-NPG biocomposites exhibited remarkable catalytic activities which were fully comparable to those of free enzymes. They also presented enhanced stability, with 74, 78 and 53% of enzymatic activity retained after 20 successive batch reactions. Moreover, these novel biocomposites possessed significantly enhanced reaction durability under various thermal and in organic solvent systems. In a sample transesterification reaction, a high conversion rate was readily achieved by using the lipase-NPG biocomposite. Conclusion/Significance: These nano-biocomposite materials hold great potential in applications such as biosensing, molecular electronics, catalysis, and controlled delivery.	[Wang, Xia; Liu, Xueying; Zhao, Peng; Xu, Ping] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Yan, Xiuling; Ding, Yi] Shandong Univ, Sch Chem & Chem Engn, Jinan 250100, Peoples R China; [Xu, Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shandong University; Shandong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, X (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	yding@sdu.edu.cn; pingxu@sjtu.edu.cn	DING, YI/F-6990-2013	DING, YI/0000-0002-1347-2811	National Natural Science Foundation of China [20706035]; New Teacher Foundation of Ministry of Education of China [20090131120005]; Excellent Middle-Aged and Youth Scientist Award Foundation of Shandong Province [BS2010SW016]; Independent Innovation Foundation of Shandong University; Shandong Natural Science Fund for Distinguished Young Scholars	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Teacher Foundation of Ministry of Education of China(Ministry of Education, China); Excellent Middle-Aged and Youth Scientist Award Foundation of Shandong Province; Independent Innovation Foundation of Shandong University; Shandong Natural Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by grants from National Natural Science Foundation of China (20706035), New Teacher Foundation of Ministry of Education of China (20090131120005), and Excellent Middle-Aged and Youth Scientist Award Foundation of Shandong Province (BS2010SW016). Y. Ding is a Tai-Shan scholar supported by Independent Innovation Foundation of Shandong University and Shandong Natural Science Fund for Distinguished Young Scholars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alptekin O, 2010, J MOL CATAL B-ENZYM, V64, P177, DOI 10.1016/j.molcatb.2009.09.010; Bensebaa F, 1998, SURF SCI, V405, pL472; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchwald P, 1998, PROTEINS, V30, P86, DOI 10.1002/(SICI)1097-0134(19980101)30:1<86::AID-PROT8>3.0.CO;2-I; Ding Y, 2004, ADV MATER, V16, P1897, DOI 10.1002/adma.200400792; Ding Y, 2003, J AM CHEM SOC, V125, P7772, DOI 10.1021/ja035318g; Ding Y, 2009, MRS BULL, V34, P569, DOI 10.1557/mrs2009.156; Drechsler U, 2004, ADV MATER, V16, P271, DOI 10.1002/adma.200306022; Dyal A, 2003, J AM CHEM SOC, V125, P1684, DOI 10.1021/ja021223n; FITA I, 1985, P NATL ACAD SCI USA, V82, P1604, DOI 10.1073/pnas.82.6.1604; Ge XB, 2007, CHEM MATER, V19, P5827, DOI 10.1021/cm702335f; GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M; Hersleth HP, 2008, BIOCHEM J, V412, P257, DOI 10.1042/BJ20070921; Hudson S, 2008, ANGEW CHEM INT EDIT, V47, P8582, DOI 10.1002/anie.200705238; KANNER J, 1983, J AGR FOOD CHEM, V31, P370, DOI 10.1021/jf00116a047; Karra-Chaabounia M, 2008, COLLOID SURFACE B, V66, P168, DOI 10.1016/j.colsurfb.2008.06.010; Kim J, 2006, CHEM ENG SCI, V61, P1017, DOI 10.1016/j.ces.2005.05.067; Kim J, 2006, ENZYME MICROB TECH, V39, P474, DOI 10.1016/j.enzmictec.2005.11.042; Kim KK, 1997, STRUCTURE, V5, P173, DOI 10.1016/S0969-2126(97)00177-9; Kumar A, 2003, LANGMUIR, V19, P6277, DOI 10.1021/la034209c; Lu JK, 2007, PROCESS BIOCHEM, V42, P1367, DOI 10.1016/j.procbio.2007.06.004; Moreno I, 2011, EUR POLYM J, V47, P1264, DOI 10.1016/j.eurpolymj.2011.03.005; Nednoor P, 2004, BIOCONJUGATE CHEM, V15, P12, DOI 10.1021/bc0341526; Noureddini H, 2005, BIORESOURCE TECHNOL, V96, P769, DOI 10.1016/j.biortech.2004.05.029; Qiu HJ, 2008, J PHYS CHEM C, V112, P14781, DOI 10.1021/jp805600k; Qiu HJ, 2009, J PHYS CHEM C, V113, P2521, DOI 10.1021/jp8090304; Ravindra R, 2004, J AM CHEM SOC, V126, P12224, DOI 10.1021/ja046900n; Schlossbauer A, 2008, J AM CHEM SOC, V130, P12558, DOI 10.1021/ja803018w; Schmid RD, 1998, ANGEW CHEM INT EDIT, V37, P1609; Sotiropoulou S, 2005, BIOSENS BIOELECTRON, V20, P1674, DOI 10.1016/j.bios.2004.07.019; Sotiropoulou S, 2003, BIOSENS BIOELECTRON, V18, P211, DOI 10.1016/S0956-5663(02)00183-5; THAMARA MS, 2010, MAT SCI ENG C, V30, P526; Wang X, 2009, CHEMSUSCHEM, V2, P947, DOI 10.1002/cssc.200900174; Wang YJ, 2005, CHEM MATER, V17, P953, DOI 10.1021/cm0483137; Zhang F, 2010, J PHYS CHEM C, V114, P8469, DOI 10.1021/jp101073b; Zhang YZ, 2006, BIOMACROMOLECULES, V7, P1049, DOI 10.1021/bm050743i; Zhao HY, 2009, BIOSENS BIOELECTRON, V25, P463, DOI 10.1016/j.bios.2009.08.005; Zhou HX, 2001, BIOCHEMISTRY-US, V40, P11289, DOI 10.1021/bi0155504	38	34	34	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24207	10.1371/journal.pone.0024207	http://dx.doi.org/10.1371/journal.pone.0024207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912676	gold, Green Submitted, Green Published			2022-12-25	WOS:000294686100023
J	Dong, C; Liu, RH; Zhang, Q; Li, HL; Zhang, MX; Lei, GC; Yu, FH				Dong, Cheng; Liu, Rui-Hua; Zhang, Qian; Li, Hong-Li; Zhang, Ming-Xiang; Lei, Guang-Chun; Yu, Fei-Hai			Burial Depth and Stolon Internode Length Independently Affect Survival of Small Clonal Fragments	PLOS ONE			English	Article							ALTERNANTHERA-PHILOXEROIDES; SAND BURIAL; VEGETATIVE REGENERATION; GENETIC DIVERSITY; ALLIGATOR WEED; ELYMUS-FARCTUS; GROWTH; GERMINATION; INTEGRATION; ALLOCATION	Disturbance can fragment plant clones into different sizes and unstabilize soils to different degrees, so that clonal fragments of different sizes can be buried in soils at different depths. As a short-term storage organ, solon internode may help fragmented clones of stoloniferous plants to withstand deeper burial in soils. We address (1) whether burial in soils decreases survival and growth of small clonal fragments, and (2) whether increasing internode length increases survival and growth of small fragments under burial. We conducted an experiment with the stoloniferous, invasive herb Alternanthera philoxeroides, in which single-node fragments with stolon internode of 0, 2, 4 and 8 cm were buried in soils at 0, 2, 4 and 8 cm depth, respectively. Increasing burial depth significantly reduced survival of the A. philoxeroides plants and increased root to shoot ratio and total stolon length, but did not change growth measures. Increasing internode length significantly increased survival and growth measures, but there was no interaction effect with burial depth on any traits measured. These results indicate that reserves stored in stolon internodes can contribute to the fitness of the A. philoxeroides plants subject to disturbance. Although burial reduced the regeneration capacity of the A. philoxeroides plants, the species may maintain the fitness by changing biomass allocation and stolon length once it survived the burial. Such responses may play an important role for A. philoxeroides in establishment and invasiveness in frequently disturbed habitats.	[Dong, Cheng; Liu, Rui-Hua; Zhang, Qian; Li, Hong-Li; Zhang, Ming-Xiang; Lei, Guang-Chun; Yu, Fei-Hai] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China	Beijing Forestry University	Dong, C (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.	feihaiyu@bjfu.edu.cn	Guangchun, Lei/ABC-8081-2021; Yu, Fei-Hai/O-9395-2016	Yu, Fei-Hai/0000-0001-5007-1745; Dong, Bi-Cheng/0000-0002-9658-9969; Zhang, Qian/0000-0003-4591-7755	Fundamental Research Funds for the Central Universities [BLJ200910]; Forestry Commonwealth Project [201004078]; NSFC [31070371]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Forestry Commonwealth Project; NSFC(National Natural Science Foundation of China (NSFC))	This research is supported by the Fundamental Research Funds for the Central Universities (BLJ200910), the Forestry Commonwealth Project (201004078) and NSFC (31070371). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN KA, 1983, CAN J BOT, V61, P241, DOI 10.1139/b83-028; Barrat-Segretain MH, 1998, AQUAT BOT, V60, P201, DOI 10.1016/S0304-3770(97)00091-0; BAURHOCH B, 1990, J EXP BOT, V41, P573, DOI 10.1093/jxb/41.5.573; Brown JF, 1997, J ECOL, V85, P151, DOI 10.2307/2960647; Chen JS, 2010, ACTA OECOL, V36, P23, DOI 10.1016/j.actao.2009.09.006; DANCKWERTS JE, 1989, ANN BOT-LONDON, V64, P533, DOI 10.1093/oxfordjournals.aob.a087875; Dong BC, 2010, EVOL ECOL, V24, P1447, DOI 10.1007/s10682-010-9390-5; Dong BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013631; Grime J.P., 2002, PLANT STRATEGIES VEG; HARRIS D, 1986, J ECOL, V74, P1057, DOI 10.2307/2260233; HARRIS D, 1988, ANN BOT-LONDON, V61, P147, DOI 10.1093/oxfordjournals.aob.a087537; HARTNETT DC, 1983, ECOLOGY, V64, P779, DOI 10.2307/1937201; Holm L.G., 1997, WORLD WEEDS NATURAL, P37; Huang ZY, 2004, PLANT SOIL, V259, P231, DOI 10.1023/B:PLSO.0000020971.66784.fc; Huang ZY, 1998, J ARID ENVIRON, V38, P27, DOI 10.1006/jare.1997.0329; JULIEN MH, 1995, J AQUAT PLANT MANAGE, V33, P55; KLIMES L, 1993, VEGETATIO, V109, P153, DOI 10.1007/BF00044747; Klimesova J, 2007, PERSPECT PLANT ECOL, V8, P115, DOI 10.1016/j.ppees.2006.10.002; Larcher W, 2003, PHYSL PLANT ECOLOGY; Li SL, 2010, TREES-STRUCT FUNCT, V24, P515, DOI 10.1007/s00468-010-0422-0; Li SL, 2010, ECOL RES, V25, P655, DOI 10.1007/s11284-010-0699-x; Li Z., 2002, INVASIVE ALIEN SPECI; Liu J, 2008, PHOTOSYNTHETICA, V46, P299, DOI 10.1007/s11099-008-0054-4; [马瑞燕 Ma Ruiyan], 2005, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V11, P246; Maun M. A., 2008, V171, P119; Maun MA, 1998, CAN J BOT, V76, P713, DOI 10.1139/cjb-76-5-713; Maun MA, 1996, ECOSCIENCE, V3, P93, DOI 10.1080/11956860.1996.11682320; MAUN MA, 1984, J ECOL, V72, P827, DOI 10.2307/2259534; MAUN MA, 1994, VEGETATIO, V111, P59; Pan XY, 2007, ACTA PHYTOTAXON SIN, V45, P884, DOI 10.1360/aps06134; PARSONS WT, 2001, NOXIOUS WEEDS AUSTR, P154; Perumal JV, 1999, FUNCT ECOL, V13, P560, DOI 10.1046/j.1365-2435.1999.00348.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Sainty G., 1997, WETLANDS ECOLOGY MAN, V5, P195, DOI DOI 10.1023/A:1008248921849; Shen JY, 2005, WEED SCI, V53, P471, DOI 10.1614/WS-04-198R; Shi L, 2004, ANN BOT-LONDON, V94, P553, DOI 10.1093/aob/mch174; Sosnova M, 2010, AQUAT BOT, V92, P33, DOI 10.1016/j.aquabot.2009.09.005; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Stuefer JF, 1999, ECOL LETT, V2, P135; Suzuki Jun-ichirou, 1999, Plant Species Biology, V14, P11, DOI 10.1046/j.1442-1984.1999.00002.x; SYKES MT, 1990, ACTA BOT NEERL, V39, P171, DOI 10.1111/j.1438-8677.1990.tb01485.x; Wang BR, 2005, AQUAT BOT, V81, P277, DOI 10.1016/j.aquabot.2005.01.004; Xu CY, 2003, BIODIVERS CONSERV, V12, P637, DOI 10.1023/A:1022453129662; Ye WH, 2003, WEED RES, V43, P297, DOI 10.1046/j.1365-3180.2003.00346.x; Yu FH, 2004, NEW PHYTOL, V162, P697, DOI 10.1111/j.1469-8137.2004.01073.x; YU HF, 2002, EVOL ECOL, V15, P303; YUAN T, 1993, FUNCT ECOL, V7, P676, DOI 10.2307/2390188; ZHANG JH, 1990, CAN J BOT, V68, P304, DOI 10.1139/b90-041	48	10	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e23942	10.1371/journal.pone.0023942	http://dx.doi.org/10.1371/journal.pone.0023942			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21912652	Green Published, gold			2022-12-25	WOS:000294683900015
J	Kummerli, R				Kuemmerli, Rolf			A Test of Evolutionary Policing Theory with Data from Human Societies	PLOS ONE			English	Article							ALTRUISTIC PUNISHMENT; HUMAN COOPERATION; STRONG RECIPROCITY; COSTLY PUNISHMENT; HOST SANCTIONS; CRIME; COMPETITION; REPRESSION; MAINTENANCE; DETERRENCE	In social groups where relatedness among interacting individuals is low, cooperation can often only be maintained through mechanisms that repress competition among group members. Repression-of-competition mechanisms, such as policing and punishment, seem to be of particular importance in human societies, where cooperative interactions often occur among unrelated individuals. In line with this view, economic games have shown that the ability to punish defectors enforces cooperation among humans. Here, I examine a real-world example of a repression-of-competition system, the police institutions common to modern human societies. Specifically, I test evolutionary policing theory by comparing data on policing effort, per capita crime rate, and similarity (used as a proxy for genetic relatedness) among citizens across the 26 cantons of Switzerland. This comparison revealed full support for all three predictions of evolutionary policing theory. First, when controlling for policing efforts, crime rate correlated negatively with the similarity among citizens. This is in line with the prediction that high similarity results in higher levels of cooperative self-restraint (i.e. lower crime rates) because it aligns the interests of individuals. Second, policing effort correlated negatively with the similarity among citizens, supporting the prediction that more policing is required to enforce cooperation in low-similarity societies, where individuals' interests diverge most. Third, increased policing efforts were associated with reductions in crime rates, indicating that policing indeed enforces cooperation. These analyses strongly indicate that humans respond to cues of their social environment and adjust cheating and policing behaviour as predicted by evolutionary policing theory.	[Kuemmerli, Rolf] Swiss Fed Inst Aquat Sci & Technol Eawag, Dept Environm Microbiol, Dubendorf, Switzerland; [Kuemmerli, Rolf] Swiss Fed Inst Technol, Dept Environm Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich	Kummerli, R (corresponding author), Swiss Fed Inst Aquat Sci & Technol Eawag, Dept Environm Microbiol, Dubendorf, Switzerland.	rolf.kuemmerli@eawag.ch	Kümmerli, Rolf/E-2844-2016	Kümmerli, Rolf/0000-0003-4084-6679	Swiss National Science Foundation [PZ00P3_126337]; European Community [256435]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community(European Commission)	This work was funded by a grant (No. PZ00P3_126337) from the Swiss National Science Foundation and a Marie-Curie Reintegration grant (No. 256435) by the European Community. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R., 2008, ESSAYS PEDAGOGY; Alexander R. D., 1979, DARWINISM HUMAN AFFA; Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Brandt H, 2006, P NATL ACAD SCI USA, V103, P495, DOI 10.1073/pnas.0507229103; CAMERON S, 1988, KYKLOS, V41, P301, DOI 10.1111/j.1467-6435.1988.tb02311.x; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Corman H, 2000, AM ECON REV, V90, P584, DOI 10.1257/aer.90.3.584; Cornelis I, 2011, EUR J WORK ORGAN PSY, V20, P388, DOI 10.1080/13594321003630055; Darwin C., 1877, DIFFERENT FORMS FLOW; Di Tella R, 2004, AM ECON REV, V94, P115, DOI 10.1257/000282804322970733; dos Santos M, 2011, P ROY SOC B-BIOL SCI, V278, P371, DOI 10.1098/rspb.2010.1275; Efferson C, 2008, SCIENCE, V321, P1844, DOI 10.1126/science.1155805; Egas M, 2008, P ROY SOC B-BIOL SCI, V275, P871, DOI 10.1098/rspb.2007.1558; El Mouden C, 2010, EVOLUTION, V64, P2139, DOI 10.1111/j.1558-5646.2010.00963.x; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fischer I, 2009, J EXP PSYCHOL GEN, V138, P341, DOI 10.1037/a0016073; Frank SA, 2003, EVOLUTION, V57, P693; FRANK SA, 1995, NATURE, V377, P520, DOI 10.1038/377520a0; Frank SA, 2009, SPRINGER SER GAME TH, P3, DOI 10.1007/978-3-540-85436-4_1; Gachter S, 2009, PHILOS T R SOC B, V364, P791, DOI 10.1098/rstb.2008.0275; Gardner A, 2004, AM NAT, V164, P753, DOI 10.1086/425623; Gardner A, 2011, J EVOLUTION BIOL, V24, P1020, DOI 10.1111/j.1420-9101.2011.02236.x; Gardner A, 2009, J EVOLUTION BIOL, V22, P659, DOI 10.1111/j.1420-9101.2008.01681.x; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hammond RL, 2004, PLOS BIOL, V2, P1472, DOI 10.1371/journal.pbio.0020248; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Hilbe C, 2010, P ROY SOC B-BIOL SCI, V277, P2427, DOI 10.1098/rspb.2010.0065; Jander KC, 2010, P ROY SOC B-BIOL SCI, V277, P1481, DOI 10.1098/rspb.2009.2157; KAPLOW L, 2002, HDB PUBLIC EC, P1661; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; Kummerli R, 2010, J EVOLUTION BIOL, V23, P699, DOI 10.1111/j.1420-9101.2010.01936.x; Kummerli R, 2007, P R SOC B, V274, P2965, DOI 10.1098/rspb.2007.0793; Kummerli R, 2010, P NATL ACAD SCI USA, V107, P10125, DOI 10.1073/pnas.1000829107; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Lehmann L, 2007, AM NAT, V170, P21, DOI 10.1086/518568; LEIGH EG, 1977, P NATL ACAD SCI USA, V74, P4542, DOI 10.1073/pnas.74.10.4542; Leimar O, 2010, PHILOS T R SOC B, V365, P2619, DOI 10.1098/rstb.2010.0116; Levitt SD, 1997, AM ECON REV, V87, P270; Levitt SD, 2006, ANNU REV LAW SOC SCI, V2, P147, DOI 10.1146/annurev.lawsocsci.2.081805.105856; Marlowe FW, 2008, P R SOC B, V275, P587, DOI 10.1098/rspb.2007.1517; Marvell TB, 1996, CRIMINOLOGY, V34, P609, DOI 10.1111/j.1745-9125.1996.tb01221.x; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; Ratnieks FLW, 2005, SCIENCE, V307, P54, DOI 10.1126/science.1106934; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Rosenfeld R, 2007, CRIMINOLOGY, V45, P355, DOI 10.1111/j.1745-9125.2007.00081.x; Ruddell R, 2009, POLICING, V32, P654, DOI 10.1108/13639510911000759; Sefton M, 2007, ECON INQ, V45, P671, DOI 10.1111/j.1465-7295.2007.00051.x; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Szathmary E, 1995, MAJOR TRANSITIONS EV; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wenseleers T, 2006, AM NAT, V168, pE163, DOI 10.1086/508619; Wenseleers T, 2006, NATURE, V444, P50, DOI 10.1038/444050a; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; Wu JJ, 2009, P NATL ACAD SCI USA, V106, P17448, DOI 10.1073/pnas.0905918106	76	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24350	10.1371/journal.pone.0024350	http://dx.doi.org/10.1371/journal.pone.0024350			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	817OO	21909429	gold, Green Published			2022-12-25	WOS:000294683900045
J	Renfrew, PD; Campbell, G; Strauss, CEM; Bonneau, R				Renfrew, P. Douglas; Campbell, Gabrielle; Strauss, Charlie E. M.; Bonneau, Richard			The 2010 Rosetta Developers Meeting: Macromolecular Prediction and Design Meets Reproducible Publishing	PLOS ONE			English	Editorial Material							PROTEIN-STRUCTURE PREDICTION; SEQUENCES		[Renfrew, P. Douglas; Bonneau, Richard] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Strauss, Charlie E. M.] Los Alamos Natl Labs, Biosci Div, Los Alamos, NM USA; [Bonneau, Richard] NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10012 USA; [Bonneau, Richard] NYU, Computat Biol Program, New York, NY USA; [Campbell, Gabrielle] Assoc Amer Med Coll, Washington, DC USA	New York University; United States Department of Energy (DOE); Los Alamos National Laboratory; New York University; New York University; Association of American Medical Colleges	Renfrew, PD (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	cems@lanl.gov; bonneau@cs.nyu.edu	Bonneau, Richard/ABD-6737-2021; Bonneau, Richard/GZL-2900-2022	Strauss, Charlie/0000-0003-3639-4673	NCI NIH HHS [U54 CA143907, I U54CA143907-01] Funding Source: Medline; NIAID NIH HHS [RC4 AI092765-01, RC4 AI092765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA143907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC4AI092765] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2011, PDF WORKSH; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bonneau R, 2002, J MOL BIOL, V322, P65, DOI 10.1016/S0022-2836(02)00698-8; Bonneau R, 2001, PROTEINS, P119; Bourne PE, 2005, PLOS COMPUT BIOL, V1, P1, DOI 10.1371/journal.pcbi.0010004; Bourne PE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000787; Bradley P, 2005, PROTEINS, V61, P128, DOI 10.1002/prot.20729; Butterfoss GL, 2006, ANNU REV BIOPH BIOM, V35, P49, DOI 10.1146/annurev.biophys.35.040405.102046; Callahan S.P., 2006, P 2006 ACM SIGMOD IN, P745, DOI DOI 10.1145/1142473.1142574; Chevalier BS, 2002, MOL CELL, V10, P895, DOI 10.1016/S1097-2765(02)00690-1; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goble CA, 2007, P 2 WORKSH WORKFL SU, P1, DOI DOI 10.1145/1273360.1273361; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Koop D, 2011, P INT C COM IN PRESS; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Manegold S., 2009, SIGMOD REC, V38, P40; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Simons KT, 1999, PROTEINS, P171; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Thyme SB, 2009, NATURE, V461, P1300, DOI 10.1038/nature08508	26	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e22431	10.1371/journal.pone.0022431	http://dx.doi.org/10.1371/journal.pone.0022431			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909349	Green Published, Green Submitted, gold			2022-12-25	WOS:000294680800002
J	Westram, AM; Jokela, J; Baumgartner, C; Keller, I				Westram, Anja Marie; Jokela, Jukka; Baumgartner, Caroline; Keller, Irene			Spatial Distribution of Cryptic Species Diversity in European Freshwater Amphipods (Gammarus fossarum) as Revealed by Pyrosequencing	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; GENETIC DIFFERENTIATION; CRUSTACEA-AMPHIPODA; SPP. CRUSTACEA; LAKE CONSTANCE; CONTACT ZONE; PULEX-GROUP; PHYLOGEOGRAPHY; REFUGIA; COLONIZATION	In order to understand and protect ecosystems, local gene pools need to be evaluated with respect to their uniqueness. Cryptic species present a challenge in this context because their presence, if unrecognized, may lead to serious misjudgement of the distribution of evolutionarily distinct genetic entities. In this study, we describe the current geographical distribution of cryptic species of the ecologically important stream amphipod Gammarus fossarum (types A, B and C). We use a novel pyrosequencing assay for molecular species identification and survey 62 populations in Switzerland, plus several populations in Germany and eastern France. In addition, we compile data from previous publications (mainly Germany). A clear transition is observed from type A in the east (Danube and Po drainages) to types B and, more rarely, C in the west (Meuse, Rhone, and four smaller French river systems). Within the Rhine drainage, the cryptic species meet in a contact zone which spans the entire G. fossarum distribution range from north to south. This large-scale geographical sorting indicates that types A and B persisted in separate refugia during Pleistocene glaciations. Within the contact zone, the species rarely co-occur at the same site, suggesting that ecological processes may preclude long-term coexistence. The clear phylogeographical signal observed in this study implies that, in many parts of Europe, only one of the cryptic species is present.	[Westram, Anja Marie; Jokela, Jukka; Baumgartner, Caroline] Swiss Fed Inst Aquat Sci & Technol, Eawag, Dubendorf, Switzerland; [Westram, Anja Marie; Jokela, Jukka; Baumgartner, Caroline] ETH, Inst Integrat Biol, Zurich, Switzerland; [Keller, Irene] Swiss Fed Inst Aquat Sci & Technol, Eawag, Kastanienbaum, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Westram, AM (corresponding author), Swiss Fed Inst Aquat Sci & Technol, Eawag, Dubendorf, Switzerland.	anjamarie.westram@eawag.ch	Jokela, Jukka/F-8626-2010; Keller, Irene/F-6043-2012	Jokela, Jukka/0000-0002-1731-727X; Westram, Anja Marie/0000-0003-1050-4969	CCES (Competence Center Environment and Sustainability of the ETH Domain)	CCES (Competence Center Environment and Sustainability of the ETH Domain)	This work was funded by the CCES (Competence Center Environment and Sustainability of the ETH Domain) BioChange project (http://www.cces.ethz.ch/projects/clench/BioChange). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barluenga M, 2006, MOL ECOL, V15, P3583, DOI 10.1111/j.1365-294X.2006.03045.x; Behrmann-Godel J, 2004, MOL ECOL, V13, P491, DOI 10.1046/j.1365-294X.2003.02082.x; BRAUER A, 1961, SUSSWASSERFAUNA DEUT; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; DICK JTA, 1993, J ANIM ECOL, V62, P79, DOI 10.2307/5484; Durand JD, 1999, MOL ECOL, V8, P989, DOI 10.1046/j.1365-294x.1999.00654.x; Eggers Thomas Ols, 2001, Lauterbornia, V42, P1; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Garcia de Leaniz C, 2007, BIOL REV, V82, P173, DOI 10.1111/j.1469-185X.2006.00004.x; Gomez A, 2002, EVOLUTION, V56, P1431; Gruber JD, 2002, HUM GENET, V110, P395, DOI 10.1007/s00439-002-0722-6; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; JANETZKY WG, 1994, HYDROBIOLOGIA, V294, P23, DOI 10.1007/BF00017622; KARAMAN GS, 1977, BIJDR DIERKD, V47, P1; Kinzelbach R., 1977, Crustaceana Supplement (Leiden), P164; Kotlik P, 2001, MOL ECOL, V10, P2177, DOI 10.1046/j.0962-1083.2001.01344.x; KUHN K, 1994, B ENVIRON CONTAM TOX, V53, P398, DOI 10.1007/BF00197232; LUKANCIC S, 2010, B ENV CONTAMINATION, P1; MacNeil C, 1997, BIOL REV, V72, P349, DOI 10.1017/S0006323196005038; Macneil C, 1999, BIOL REV, V74, P375, DOI 10.1017/S0006323199005368; MAYR E, ANIMAL SPECIES EVOLU; MEIJERING M P D, 1974, Limnologica, V9, P247; MEIJERING M P D, 1972, Crustaceana Supplement (Leiden), V3, P313; MEIJERING MPD, 1991, HYDROBIOLOGIA, V223, P159, DOI 10.1007/BF00047637; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; Muller J, 1998, J EVOLUTION BIOL, V11, P79, DOI 10.1046/j.1420-9101.1998.11010079.x; Muller J, 2000, BIOL J LINN SOC, V69, P41, DOI 10.1111/j.1095-8312.2000.tb01668.x; Muller J, 2000, MOL PHYLOGENET EVOL, V15, P260, DOI 10.1006/mpev.1999.0740; Muller J, 1998, P 4 INT CRUST C, P279; Nesemann H., 1995, Miscellanea Zoologica Hungarica, V10, P49; Peeters ETHM, 1998, FRESHWATER BIOL, V39, P605, DOI 10.1046/j.1365-2427.1998.00304.x; PINKSTER S, 1994, CRUSTACEANA, P129; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; SCHEEPMAKER M, 1989, BIJDR DIERKD, V59, P127, DOI 10.1163/26660644-05903001; SCHEEPMAKER M, 1990, BIJDR DIERKD, V60, P3, DOI 10.1163/26660644-06001001; SIEGISMUND HR, 1991, HEREDITY, V66, P419, DOI 10.1038/hdy.1991.52; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; STRANGE CD, 1979, P ROY IRISH ACAD B, V79, P145; Straskraba M, 1962, ACTA SOC ZOOLOGICAE, V26, P117; Stucki P., 2010, METHODEN UNTERSUCHUN; Sturzbecher C., 1998, P 4 INT CRUST C, P287; SWANSON GA, 1984, J WILDLIFE MANAGE, V48, P988, DOI 10.2307/3801453; TIMM T, 1994, ERW ZUS JAHR 1994 HA; Verovnik R, 2005, MOL ECOL, V14, P4355, DOI 10.1111/j.1365-294X.2005.02745.x; Vonlanthen P, 2007, MOL ECOL, V16, P4572, DOI 10.1111/j.1365-294X.2007.03531.x; Williams HC, 2006, MOL PHYLOGENET EVOL, V40, P370, DOI 10.1016/j.ympev.2006.03.004	47	46	46	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23879	10.1371/journal.pone.0023879	http://dx.doi.org/10.1371/journal.pone.0023879			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909373	Green Published, gold, Green Accepted			2022-12-25	WOS:000294680800035
J	Lai, LC; Su, YY; Chen, KC; Tsai, MH; Sher, YP; Lu, TP; Lee, CY; Chuang, EY				Lai, Liang-Chuan; Su, Yi-Yu; Chen, Kuo-Chih; Tsai, Mong-Hsun; Sher, Yuh-Pyng; Lu, Tzu-Pin; Lee, Chien-Yueh; Chuang, Eric Y.			Down-Regulation of NDRG1 Promotes Migration of Cancer Cells during Reoxygenation	PLOS ONE			English	Article							TUMOR HYPOXIA; MALIGNANT PROGRESSION; MICROARRAY ANALYSIS; GENE-EXPRESSION; PROSTATE-CANCER; SUPPRESSOR GENE; DNA-DAMAGE; IN-VITRO; DIFFERENTIATION; GROWTH	One characteristic of tumor microenvironment is oxygen fluctuation, which results from hyper-proliferation and abnormal metabolism of tumor cells as well as disorganized neo-vasculature. Reoxygenation of tumors can induce oxidative stress, which leads to DNA damage and genomic instability. Although the cellular responses to hypoxia are well known, little is known about the dynamic response upon reoxygenation. In order to investigate the transcriptional responses of tumor adaptation to reoxygenation, breast cancer MCF-7 cells were cultured under 0.5% oxygen for 24 h followed by 24 h of reoxygenation in normoxia. Cells were harvested at 0, 1, 4, 8, 12, and 24 h during reoxygenation. The transcriptional profile of MCF-7 cells upon reoxygenation was examined using Illumina Human-6 v3 BeadChips. We identified 127 differentially expressed genes, of which 53.1% were up-regulated and 46.9% were down-regulated upon reoxygenation. Pathway analysis revealed that the HIF-1-alpha transcription factor network and validated targets of C-MYC transcriptional activation were significantly enriched in these differentially expressed genes. Among these genes, a subset of interest genes was further validated by quantitative reverse-transcription PCR. In particular, human N-MYC down-regulated gene 1 (NDRG1) was highly suppressed upon reoxygenation. NDRG1 is associated with a variety of stress and cell growth-regulatory conditions. To determine whether NDRG1 plays a role in reoxygenation, NDRG1 protein was overexpressed in MCF-7 cells. Upon reoxygenation, overexpression of NDRG1 significantly inhibited cell migration. Our results revealed the dynamic nature of gene expression in MCF-7 cells upon reoxygenation and demonstrated that NDRG1 is involved in tumor adaptation to reoxygenation.	[Lai, Liang-Chuan; Su, Yi-Yu; Chen, Kuo-Chih] Natl Taiwan Univ, Grad Inst Physiol, Taipei 10764, Taiwan; [Tsai, Mong-Hsun] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Sher, Yuh-Pyng] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Lu, Tzu-Pin; Lee, Chien-Yueh; Chuang, Eric Y.] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; China Medical University Taiwan; National Taiwan University	Lai, LC (corresponding author), Natl Taiwan Univ, Grad Inst Physiol, Taipei 10764, Taiwan.	chuangey@ntu.edu.tw	Lu, Tzupin/ABC-2195-2021; Lai, Liang-Chuan/B-4768-2009	Lu, Tzupin/0000-0003-3697-0386; Lai, Liang-Chuan/0000-0002-3913-5338; Lee, Chien-Yueh/0000-0002-4304-974X; TSAI, MONG-HSUN/0000-0001-8777-5818	China Medical University, Taiwan [97F008-119, 99F008-308]; Center of Genomic Medicine, National Taiwan University [99R81400]; National Science Council [98-2320-B-002-044-MY3]	China Medical University, Taiwan(China Medical University); Center of Genomic Medicine, National Taiwan University(National Taiwan University); National Science Council(Ministry of Science and Technology, Taiwan)	This research was supported in part by grants from China Medical University, Taiwan (grant no. 97F008-119; 99F008-308; http://english.cmu.edu.tw/) and the Center of Genomic Medicine, National Taiwan University (grant no. 99R81400; http://www.cgm.ntu.edu.tw/chinese2007/eng_index.asp), and National Science Council (Grant No. 98-2320-B-002-044-MY3, http://web1.nsc.gov.tw/mp.aspx?mp=7). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Brown JM, 1998, CANCER RES, V58, P1408; Cangul H, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-27; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Corn PG, 2007, CANCER BIOL THER, V6, P1858, DOI 10.4161/cbt.6.12.5330; Gomez-Casero E, 2001, MOL CARCINOGEN, V32, P100, DOI 10.1002/mc.1069; Guang RJ, 2000, CANCER RES, V60, P749; Guimbellot JS, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-15; Gulledge CJ, 1996, ANTICANCER RES, V16, P741; Hockel M, 1996, CANCER RES, V56, P4509; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Karihtala P, 2007, APMIS, V115, P81, DOI 10.1111/j.1600-0463.2007.apm_514.x; Komatsu M, 1997, ONCOGENE, V15, P1123, DOI 10.1038/sj.onc.1201283; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kurdistani SK, 1998, CANCER RES, V58, P4439; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Piquemal D, 1999, BBA-MOL CELL RES, V1450, P364, DOI 10.1016/S0167-4889(99)00056-7; Prabhakar NR, 2001, J APPL PHYSIOL, V90, P1986, DOI 10.1152/jappl.2001.90.5.1986; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rofstad EK, 1996, BRIT J CANCER, V74, pS136; Salnikow K, 2000, CANCER RES, V60, P5630; Salnikow K, 2002, MOL CELL BIOL, V22, P1734, DOI 10.1128/MCB.22.6.1734-1741.2002; SANNA K, 1994, INT J CANCER, V58, P258, DOI 10.1002/ijc.2910580219; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Taketomi Y, 2003, BIOCHEM BIOPH RES CO, V306, P339, DOI 10.1016/S0006-291X(03)00942-2; Toffoli S, 2009, ANGIOGENESIS, V12, P339, DOI 10.1007/s10456-009-9156-2; Vaupel P, 2004, METHOD ENZYMOL, V381, P335; VAUPEL P, 1989, CANCER RES, V49, P6449; WELBOURN CRB, 1991, BRIT J SURG, V78, P651, DOI 10.1002/bjs.1800780607; Williams KJ, 2001, BREAST CANCER RES, V3, P328, DOI 10.1186/bcr316; YOUNG SD, 1988, P NATL ACAD SCI USA, V85, P9533, DOI 10.1073/pnas.85.24.9533; Zajac-Kaye M, 2001, LUNG CANCER-J IASLC, V34, pS43, DOI 10.1016/S0169-5002(01)00343-9	38	22	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24375	10.1371/journal.pone.0024375	http://dx.doi.org/10.1371/journal.pone.0024375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912630	Green Submitted, gold, Green Published			2022-12-25	WOS:000294678300041
J	Lee, JM; Pinto, RM; Gillis, T; St Claire, JC; Wheeler, VC				Lee, Jong-Min; Pinto, Ricardo Mouro; Gillis, Tammy; St Claire, Jason C.; Wheeler, Vanessa C.			Quantification of Age-Dependent Somatic CAG Repeat Instability in Hdh CAG Knock-In Mice Reveals Different Expansion Dynamics in Striatum and Liver	PLOS ONE			English	Article							HUNTINGTONS-DISEASE; TRINUCLEOTIDE REPEAT; LENGTH; MOUSE; MUTATION; CELLS; GENE; VULNERABILITY; NEURONS; BRAIN	Background: Age at onset of Huntington's disease (HD) is largely determined by the CAG trinucleotide repeat length in the HTT gene. Importantly, the CAG repeat undergoes tissue-specific somatic instability, prevalent in brain regions that are disease targets, suggesting a potential role for somatic CAG repeat instability in modifying HD pathogenesis. Thus, understanding underlying mechanisms of somatic CAG repeat instability may lead to discoveries of novel therapeutics for HD. Investigation of the dynamics of the CAG repeat size changes over time may provide insights into the mechanisms underlying CAG repeat instability. Methodology/Principal Findings: To understand how the HTT CAG repeat length changes over time, we quantified somatic instability of the CAG repeat in Huntington's disease CAG knock-in mice from 2-16 months of age in liver, striatum, spleen and tail. The HTT CAG repeat in spleen and tail was very stable, but that in liver and striatum expanded over time at an average rate of one CAG per month. Interestingly, the patterns of repeat instability were different between liver and striatum. Unstable CAG repeats in liver repeatedly gained similar sizes of additional CAG repeats (approximately two CAGs per month), maintaining a distinct population of unstable repeats. In contrast, unstable CAG repeats in striatum gained additional repeats with different sizes resulting in broadly distributed unstable CAG repeats. Expanded CAG repeats in the liver were highly enriched in polyploid hepatocytes, suggesting that the pattern of liver instability may reflect the restriction of the unstable repeats to a unique cell type. Conclusions/Significance: Our results are consistent with repeat expansion occurring as a consequence of recurrent small repeat insertions that differ in different tissues. Investigation of the specific mechanisms that underlie liver and striatal instability will contribute to our understanding of the relationship between instability and disease and the means to intervene in this process.	[Lee, Jong-Min; Pinto, Ricardo Mouro; Gillis, Tammy; St Claire, Jason C.; Wheeler, Vanessa C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Lee, JM (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	jlee51@partners.org; wheeler@chgr.mgh.harvard.edu	Pinto, Ricardo Mouro/AAD-1048-2021	Pinto, Ricardo Mouro/0000-0001-6744-2805	National Institute of Neurological Disorders and Stroke [NS049206]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049206] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by National Institute of Neurological Disorders and Stroke grant NS049206 to VCW. The funder had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Brodsky VYa., 1985, GENOME MULTIPLICATIO; Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123; Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677; Dragileva E, 2009, NEUROBIOL DIS, V33, P37, DOI 10.1016/j.nbd.2008.09.014; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Gonitel R, 2008, P NATL ACAD SCI USA, V105, P3467, DOI 10.1073/pnas.0800048105; Huntington G., 1872, MED SURGICAL REPORTE, V26, P320; Ishiguro H, 2001, J NEUROSCI RES, V65, P289, DOI 10.1002/jnr.1153; Jung J, 2011, GENETICS, V187, P61, DOI 10.1534/genetics.110.121418; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kennedy L, 2000, HUM MOL GENET, V9, P2539, DOI 10.1093/hmg/9.17.2539; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Lee JM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-29; Lloret A, 2006, HUM MOL GENET, V15, P2015, DOI 10.1093/hmg/ddl125; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Mollersen L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001242; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; SCHOENFELD M, 1984, J NEUROL NEUROSUR PS, V47, P1283, DOI 10.1136/jnnp.47.12.1283; Shelbourne PF, 2007, HUM MOL GENET, V16, P1133, DOI 10.1093/hmg/ddm054; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Swami M, 2009, HUM MOL GENET, V18, P3039, DOI 10.1093/hmg/ddp242; van den Broek WJAA, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-61; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Wheeler VC, 2003, HUM MOL GENET, V12, P273, DOI 10.1093/hmg/ddg056	28	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23647	10.1371/journal.pone.0023647	http://dx.doi.org/10.1371/journal.pone.0023647			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897851	Green Published, Green Submitted, gold			2022-12-25	WOS:000294676900014
J	Tsai, YC; Pestka, S; Wang, LH; Runnels, LW; Wan, S; Lyu, YL; Liu, LF				Tsai, Yu-Chen; Pestka, Sidney; Wang, Lu-Hai; Runnels, Loren W.; Wan, Shan; Lyu, Yi Lisa; Liu, Leroy F.			Interferon-beta Signaling Contributes to Ras Transformation	PLOS ONE			English	Article							NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITIONS; UBIQUITIN-LIKE PROTEIN; TUMOR-GROWTH; PI3 KINASE; EXPRESSION; CANCER; GENE; CELLS; ISG15	Increasing evidence has pointed to activated type I interferon signaling in tumors. However, the molecular basis for such activation and its role in tumorigenesis remain unclear. In the current studies, we report that activation of type I interferon (IFN) signaling in tumor cells is primarily due to elevated secretion of the type I interferon, IFN-beta. Studies in oncogene-transformed cells suggest that oncogenes such as Ras and Src can activate IFN-beta signaling. Significantly, elevated IFN-beta signaling in Ras-transformed mammary epithelial MCF-10A cells was shown to contribute to Ras transformation as evidenced by morphological changes, anchorage-independent growth, and migratory properties. Our results demonstrate for the first time that the type I IFN, IFN-beta, contributes to Ras transformation and support the notion that oncogene-induced cytokines play important roles in oncogene transformation.	[Tsai, Yu-Chen; Runnels, Loren W.; Wan, Shan; Lyu, Yi Lisa; Liu, Leroy F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Pestka, Sidney] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA; [Wang, Lu-Hai] Natl Hlth Res Inst, Div Mol & Genom Med, Miaoli Cty, Taiwan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Health Research Institutes - Taiwan	Tsai, YC (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	lliu@umdnj.edu	Wang, Lu-Hai/E-3986-2010	Runnels, Loren/0000-0002-2537-7360; Liu, Leroy/0000-0001-9396-763X	NIH [RO1-CA39662, GM080753]; NATIONAL CANCER INSTITUTE [R01CA039662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants RO1-CA39662 (LFL) and GM080753 (LWR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 2006, BRIT J CANCER, V94, P1465, DOI 10.1038/sj.bjc.6603099; Andersen JB, 2006, CYTOKINE GROWTH F R, V17, P411, DOI 10.1016/j.cytogfr.2006.10.001; Bektas N, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2117; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chi LM, 2009, MOL CELL PROTEOMICS, V8, P1453, DOI 10.1074/mcp.M800460-MCP200; da Silva AJ, 2002, J INTERF CYTOK RES, V22, P173, DOI 10.1089/107999002753536149; Dawson PJ, 1996, AM J PATHOL, V148, P313; Desai SD, 2006, CANCER RES, V66, P921, DOI 10.1158/0008-5472.CAN-05-1123; DORUDI S, 1995, BRIT J CANCER, V71, P614, DOI 10.1038/bjc.1995.119; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hajra KM, 1999, ONCOGENE, V18, P7274, DOI 10.1038/sj.onc.1203336; JOURDAN M, 1991, J IMMUNOL, V147, P4402; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; KEYDAR I, 1979, EUR J CANCER, V15, P659, DOI 10.1016/0014-2964(79)90139-7; Kiessling A, 2009, ONCOGENE, V28, P2606, DOI 10.1038/onc.2009.115; Kowalski PJ, 2003, BREAST CANCER RES, V5, pR217, DOI 10.1186/bcr651; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; LUDWIG CU, 1983, EUR J CANCER CLIN ON, V19, P1625, DOI 10.1016/0277-5379(83)90095-0; MACDONALD NJ, 1990, CELL, V60, P767, DOI 10.1016/0092-8674(90)90091-R; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Nguyen KT, 2000, ONCOGENE, V19, P5385, DOI 10.1038/sj.onc.1203911; NIELSCH U, 1992, J VIROL, V66, P1884, DOI 10.1128/JVI.66.4.1884-1890.1992; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; RUBINSTEIN S, 1981, J VIROL, V37, P755, DOI 10.1128/JVI.37.2.755-758.1981; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vinas-Castells R, 2010, J BIOL CHEM, V285, P3794, DOI 10.1074/jbc.M109.065995; Wenzel J, 2008, INT J CANCER, V123, P2605, DOI 10.1002/ijc.23799; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; Yong VW, 1998, NEUROLOGY, V51, P682	35	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e24291	10.1371/journal.pone.0024291	http://dx.doi.org/10.1371/journal.pone.0024291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897875	gold, Green Published, Green Submitted			2022-12-25	WOS:000294676900040
J	Fukuda, H; Tokuda, I; Hashimoto, S; Hayasaka, N				Fukuda, Hirokazu; Tokuda, Isao; Hashimoto, Seiichi; Hayasaka, Naoto			Quantitative Analysis of Phase Wave of Gene Expression in the Mammalian Central Circadian Clock Network	PLOS ONE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; VPAC(2) RECEPTOR; CELLS; NEURONS; RHYTHMS; SYSTEM; SYNCHRONIZATION; OSCILLATORS; BRAIN; ORGANIZATION	Background: The suprachiasmatic nucleus (SCN), the master circadian clock, is a heterogeneous oscillator network, yet displays a robust synchronization dynamics. Recent single-cell bioluminescent imaging revealed temporal gradients in circadian clock gene expression in the SCN ex vivo. However, due to technical difficulty in biological approaches to elucidate the entire network structure of the SCN, characteristics of the gradient, which we refer to as phase wave, remain unknown. Methodology/Principal Findings: We implemented new approaches, i.e., quantitative analysis and model simulation to characterize the phase waves in Per2::Luciferase clock reporter gene expression of the rat SCN slice. Our quantitative study demonstrated not only a high degree of synchronization between the neurons and regular occurrence of the phase wave propagation, but also a significant amount of phase fluctuations contained in the wave. In addition, our simulations based on local coupling model suggest that the intercellular coupling strength estimated by the model simulations is significantly higher than the critical value for generating the phase waves. Model simulations also suggest that heterogeneity of the SCN neurons is one of the main factors causing the phase wave fluctuations. Furthermore, robustness of the SCN network against dynamical noise and variation of the natural frequencies inherent in these neurons was quantitatively assessed. Conclusions/Significance: To our knowledge, this is the first quantitative evaluation of the phase wave and further characterization of the SCN neuronal network features generating the wave i.e., intercellular synchrony, phase fluctuation, strong local coupling, heterogeneous periodicity and robustness. Our present study provides an approach, which will lead to a comprehensive understanding of mechanistic and/or biological significance of the phase wave in the central circadian oscillatory system.	[Fukuda, Hirokazu] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Appl Life Sci, Sakai, Osaka 591, Japan; [Fukuda, Hirokazu] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama, Japan; [Tokuda, Isao] Ritsumeikan Univ, Dept Micro Syst Technol, Shiga, Japan; [Hashimoto, Seiichi] Astellas Pharma Inc, Drug Discovery Res, Mol Med Res Labs, Tsukuba, Ibaraki, Japan; [Hayasaka, Naoto] Kinki Univ, Sch Med, Dept Anat & Neurobiol, Osaka 589, Japan	Osaka Metropolitan University; Japan Science & Technology Agency (JST); Ritsumeikan University; Astellas Pharmaceuticals; Kindai University (Kinki University)	Fukuda, H (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Appl Life Sci, Sakai, Osaka 591, Japan.	hayasaka@med.kindai.ac.jp		Tokuda, Isao/0000-0001-6212-0022	Japan Society for the Promotion of Science [19590235]; Ministry of Education, Science, Sports, and Culture of Japan [20560352]; Grants-in-Aid for Scientific Research [23560446, 23360047] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Scientific Research No. 19590235 from the Japan Society for the Promotion of Science, and No. 20560352 from the Ministry of Education, Science, Sports, and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Akashi M, 2008, J NEUROSCI, V28, P4619, DOI 10.1523/JNEUROSCI.3410-07.2008; Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Barabasi A.-L., 1995, FRACTAL CONCEPTS SUR; Bernard S, 2007, PLOS COMPUT BIOL, V3, P667, DOI 10.1371/journal.pcbi.0030068; CARD JP, 1981, J NEUROSCI, V1, P1289; Colwell CS, 2000, J NEUROBIOL, V43, P379, DOI 10.1002/1097-4695(20000615)43:4<379::AID-NEU6>3.0.CO;2-0; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Doi M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1316; Evans JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015869; Fukuda H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.098102; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; HALPINHEALY T, 1995, PHYS REP, V254, P215, DOI 10.1016/0370-1573(94)00087-J; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hayasaka N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017655; He PJ, 2007, J ENDOCRINOL, V193, P413, DOI 10.1677/JOE-07-0044; Honma S, 2004, NEUROSCI LETT, V358, P173, DOI 10.1016/j.neulet.2004.01.022; Hughes AT, 2004, J NEUROSCI, V24, P3522, DOI 10.1523/JNEUROSCI.5345-03.2004; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Kunz H, 2003, J THEOR BIOL, V224, P63, DOI 10.1016/S0022-5193(03)00141-3; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; Liu C, 2000, NEURON, V25, P123, DOI 10.1016/S0896-6273(00)80876-4; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; MOORE RY, 1983, FED PROC, V42, P2783; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Nakamura W, 2001, EUR J NEUROSCI, V14, P666, DOI 10.1046/j.0953-816x.2001.01684.x; Noguchi T, 2004, EUR J NEUROSCI, V20, P3199, DOI 10.1111/j.1460-9568.2004.03784.x; Pennartz CMA, 1998, J PHYSIOL-LONDON, V506, P775, DOI 10.1111/j.1469-7793.1998.775bv.x; PIGGINS HD, 1995, J NEUROSCI, V15, P5612; Pikovsky A., 2001, SYNCHRONIZATION UNIV; SHIBATA S, 1982, BRAIN RES, V247, P154, DOI 10.1016/0006-8993(82)91041-1; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; VANDENPOL AN, 1980, J COMP NEUROL, V191, P661, DOI 10.1002/cne.901910410; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yan LL, 2002, EUR J NEUROSCI, V15, P1153, DOI 10.1046/j.1460-9568.2002.01955.x; ZAIKIN AN, 1970, NATURE, V225, P535, DOI 10.1038/225535b0	45	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23568	10.1371/journal.pone.0023568	http://dx.doi.org/10.1371/journal.pone.0023568			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21912598	gold, Green Submitted, Green Published			2022-12-25	WOS:000294298800015
J	Liang, YJ; Yin, DL; Hou, LM; Zheng, TS; Wang, JB; Meng, XZ; Lu, ZY; Song, X; Pan, SH; Jiang, HC; Liu, LX				Liang, Yingjian; Yin, Dalong; Hou, Limin; Zheng, Tongsen; Wang, Jiabei; Meng, Xianzhi; Lu, Zhaoyang; Song, Xuan; Pan, Shangha; Jiang, Hongchi; Liu, Lianxin			Diphenyl Difluoroketone: A Potent Chemotherapy Candidate for Human Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATOMA G2 CELLS; FACTOR-KAPPA-B; ANTICANCER ACTIVITY; CURCUMIN ANALOGS; CANCER-CELLS; APOPTOSIS; EF24; ANGIOGENESIS; DOXORUBICIN; RECEPTOR	Diphenyl difluoroketone (EF24), a molecule having structural similarity to curcumin, was recently reported to inhibit proliferation of various cancer cells significantly. Here we try to determine the effect and mechanism of EF24 on hepatocellular carcinoma. 2 mu M EF24 was found to inhibit the proliferation of PLC/PRF/5, Hep3B, HepG2, SK-HEP-1 and Huh 7 cell lines. However, even 8 mu M EF24 treatment did not affect the proliferation of normal liver LO2 cells. Accordingly, 20 mg/kg/d EF24 inhibited the growth of the tumor xenografts conspicuously while causing no apparent change in liver, spleen or body weight. In addition, significant apoptosis and G(2)/M phase cell cycle arrest were found using flow cytometry. Besides, caspases and PARP activation and features typical of apoptosis including fragmented nuclei with condensed chromatin were also observed. Furthermore, the mechanism was targeted at the reduction of nuclear factor kappa b (NF-kappa kB) pathway and the NF-kappa B-regulated gene products Bcl-2, COX-2, Cyclin B1. Our study has offered a strategy that EF24 being a therapeutic agent for hepatocellular carcinoma.	[Liang, Yingjian; Yin, Dalong; Zheng, Tongsen; Wang, Jiabei; Meng, Xianzhi; Lu, Zhaoyang; Song, Xuan; Pan, Shangha; Jiang, Hongchi; Liu, Lianxin] Harbin Med Coll, Key Lab Hepatosplen Surg, Dept Gen Surg, Minist Educ,Affiliated Hosp 1, Harbin, Heilongjiang Pr, Peoples R China; [Hou, Limin] Harbin Med Coll, Dept Emergency Surg, Affiliated Hosp 1, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University	Liang, YJ (corresponding author), Harbin Med Coll, Key Lab Hepatosplen Surg, Dept Gen Surg, Minist Educ,Affiliated Hosp 1, Harbin, Heilongjiang Pr, Peoples R China.	liulianxin@medmail.com.cn	Jiang, HongChi/M-5031-2018; zheng, tongsen/ABB-9572-2021; Liu, LianXin/D-6712-2013	Jiang, HongChi/0000-0001-8215-8984; zheng, tongsen/0000-0002-7539-3924; 	Program for Innovative Research Team (in Science and Technology) in Higher Educational Institutions of Heilongjiang Province [2009td06]; Heilongjiang Province Science Fund for Outstanding Youths [JC200616]; Foundation of Harbin Science and Technology Bureau for Creative Young Talents [2010RFQXS069]; Foundation of Health Department of Heilongjiang Province [2009-043]	Program for Innovative Research Team (in Science and Technology) in Higher Educational Institutions of Heilongjiang Province; Heilongjiang Province Science Fund for Outstanding Youths; Foundation of Harbin Science and Technology Bureau for Creative Young Talents; Foundation of Health Department of Heilongjiang Province	This study was supported by Program for Innovative Research Team (in Science and Technology) in Higher Educational Institutions of Heilongjiang Province (2009td06); Heilongjiang Province Science Fund for Outstanding Youths (JC200616); Foundation of Harbin Science and Technology Bureau for Creative Young Talents (2010RFQXS069); Foundation of Health Department of Heilongjiang Province. (Grant No. 2009-043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BK, 2005, ANTI-CANCER DRUG, V16, P263, DOI 10.1097/00001813-200503000-00005; Adams BK, 2004, BIOORGAN MED CHEM, V12, P3871, DOI 10.1016/j.bmc.2004.05.006; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025; [Anonymous], 1995, N ENGL J MED, V332, P1256; Antoon J.W., 2011, CANC BIOL THER, V11; Bae MK, 2006, ONCOL REP, V15, P1557; Bruix J, 1997, HEPATOLOGY, V25, P259; Cao J, 2007, FREE RADICAL BIO MED, V43, P968, DOI 10.1016/j.freeradbiomed.2007.06.006; Cao J, 2006, TOXICOL SCI, V91, P476, DOI 10.1093/toxsci/kfj153; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123; Choi H, 2006, MOL PHARMACOL, V70, P1664, DOI 10.1124/mol.106.025817; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; DUSHEIKO GM, 1992, LANCET, V340, P285, DOI 10.1016/0140-6736(92)92367-O; Guha S, 2005, CANCER RES, V65, P2738, DOI 10.1158/0008-5472.CAN-04-3197; Hussain SA, 2001, ANN ONCOL, V12, P161, DOI 10.1023/A:1008370324827; Ikeda Kenji, 2010, Nihon Rinsho, V68, P1129; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kasinski AL, 2008, MOL PHARMACOL, V74, P654, DOI 10.1124/mol.108.046201; Kawakami H, 2005, INT J CANCER, V115, P967, DOI 10.1002/ijc.20954; Khoshnan A, 2000, J IMMUNOL, V165, P1743, DOI 10.4049/jimmunol.165.4.1743; Labbozzetta M, 2006, ANN NY ACAD SCI, V1089, P268, DOI 10.1196/annals.1386.014; Lencioni R, 2010, ONCOLOGY-BASEL, V78, P107, DOI 10.1159/000315238; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; Mosley CA, 2007, ADV EXP MED BIOL, V595, P77; Nagano H, 2010, ONCOLOGY-BASEL, V78, P142, DOI 10.1159/000315243; Nakajima A, 2004, INT J ONCOL, V24, P635; Pastorelli D, 2006, ANN ONCOL, V17, pV153, DOI 10.1093/annonc/mdj972; Selvendiran K, 2007, J BIOL CHEM, V282, P28609, DOI 10.1074/jbc.M703796200; Shoba G, 1998, PLANTA MED, V64, P353, DOI 10.1055/s-2006-957450; Siegel AB, 2010, HEPATOLOGY, V52, P360, DOI 10.1002/hep.23633; Subramaniam D, 2008, CANCER RES, V68, P1962, DOI 10.1158/0008-5472.CAN-07-6011; Sun AM, 2006, J MED CHEM, V49, P3153, DOI 10.1021/jm051141k; Thomas SL, 2008, CELL CYCLE, V7, P2409, DOI 10.4161/cc.6410; Thomas SL, 2010, BIOCHEM PHARMACOL, V80, P1309, DOI 10.1016/j.bcp.2010.06.048; Toso C, 2010, J HEPATOL, V52, P930, DOI 10.1016/j.jhep.2009.12.032; VENOOK AP, 1994, J CLIN ONCOL, V12, P1323, DOI 10.1200/JCO.1994.12.6.1323; Yang TS, 2002, ANN ONCOL, V13, P1771, DOI 10.1093/annonc/mdf303; Yuan ST, 2004, ANTI-CANCER DRUG, V15, P641, DOI 10.1097/01.cad.0000132238.23050.f5	40	23	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23908	10.1371/journal.pone.0023908	http://dx.doi.org/10.1371/journal.pone.0023908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901145	gold, Green Submitted, Green Published			2022-12-25	WOS:000294298000030
J	Martin, C; Herrero, M; Hormaza, JI				Martin, Carolina; Herrero, Maria; Hormaza, Jose I.			Molecular Characterization of Apricot Germplasm from an Old Stone Collection	PLOS ONE			English	Article							PRUNUS-ARMENIACA L.; GENETIC DIVERSITY; POPULATION-STRUCTURE; MICROSATELLITE LOCI; DNA; VARIABILITY; MARKERS; IDENTIFICATION; INFERENCE; UTILITY	Increasing germplasm erosion requires the recovery and conservation of traditional cultivars before they disappear. Here we present a particular case in Spain where a thorough prospection of local fruit tree species was performed in the 1950s with detailed data of the origin of each genotype but, unfortunately, the accessions are no longer conserved in ex situ germplasm collections. However, for most of those cultivars, an old stone collection is still preserved. In order to analyze the diversity present at the time when the prospection was made and to which extent variability has been eroded, we developed a protocol in apricot (Prunus armeniaca L.) to obtain DNA from maternal tissues of the stones of a sufficient quality to be amplified by PCR. The results obtained have been compared with the results from the profiles developed from apricot cultivars currently conserved in ex situ germplasm collections. The results highlight the fact that most of the old accessions are not conserved ex situ but provide a tool to prioritize the recovery of particular cultivars. The approach used in this work can also be applied to other plant species where seeds have been preserved.	[Martin, Carolina; Hormaza, Jose I.] CSIC, IHSM La Mayora, Malaga, Spain; [Herrero, Maria] CSIC, Dept Pomol, EE Aula Dei, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Aula Dei (EEAD)	Martin, C (corresponding author), CSIC, IHSM La Mayora, Malaga, Spain.	ihormaza@eelm.csic.es	Herrero, Maria/B-7978-2015; Hormaza, Jose/D-8066-2011	Herrero, Maria/0000-0002-3499-1602; Hormaza, Jose/0000-0001-5449-7444	Spanish Ministry of Science and Innovation [AGL2010-15140, AGL2009-12621-CO2-01, RF2008-00028-CO2-02]; Gobierno de Aragon [A-43]; Mediterranean Agronomic Institute of Zaragoza (IAMZ)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Gobierno de Aragon(Gobierno de Aragon); Mediterranean Agronomic Institute of Zaragoza (IAMZ)	Financial support for this work was provided by the Spanish Ministry of Science and Innovation - European Regional Development Fund (Project Grants AGL2010-15140, AGL2009-12621-CO2-01 and RF2008-00028-CO2-02), and Gobierno de Aragon (Grupo de Excelencia A-43). C. M. was supported by a grant from the Mediterranean Agronomic Institute of Zaragoza (IAMZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, MOL BIOL BIOTECHNOLO; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Badenes ML, 1996, PLANT BREEDING, V115, P133, DOI 10.1111/j.1439-0523.1996.tb00888.x; Badenes ML, 1997, DESCRIPCION VARIEDAD; Cheng FS, 1997, HORTSCIENCE, V32, P921, DOI 10.21273/HORTSCI.32.5.921; Cipriani G, 1999, THEOR APPL GENET, V99, P65, DOI 10.1007/s001220051209; de Vicente MC, 1998, PLANT BREEDING, V117, P153, DOI 10.1111/j.1439-0523.1998.tb01470.x; Egea-Sanchez JM, 2008, ACT 8 C SEAE; Esquinas-Alcazar J, 2005, NAT REV GENET, V6, P946, DOI 10.1038/nrg1729; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Faust M., 1998, Horticultural Reviews, V22, P225, DOI 10.1002/9780470650738.ch6; Fowler C, 1990, SHATTERING FOOD POLI; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Godoy JA, 2001, MOL ECOL, V10, P2275, DOI 10.1046/j.0962-1083.2001.01342.x; Got N, 1958, ABRICOTIER; Gugerli F, 2005, NEW PHYTOL, V166, P409, DOI 10.1111/j.1469-8137.2005.01360.x; Hagen LS, 2002, THEOR APPL GENET, V105, P298, DOI 10.1007/s00122-002-0910-8; Herrero J, 1964, CARTOGRAFIA FRUTALES, V5; Hormaza JI, 2002, THEOR APPL GENET, V104, P321, DOI 10.1007/s001220100684; Hormaza JI, 2007, GENOME MAPPING MOL B, V4, P171, DOI DOI 10.1007/978-3-540-34533-6_7; Jarvis DI, 2008, P NATL ACAD SCI USA, V105, P5326, DOI 10.1073/pnas.0800607105; Khan MA, 2008, SILVAE GENET, V57, P157, DOI 10.1515/sg-2008-0024; Khoury C, 2010, GENET RESOUR CROP EV, V57, P625, DOI 10.1007/s10722-010-9534-z; Lamia K, 2010, SCI HORTIC-AMSTERDAM, V127, P54, DOI 10.1016/j.scienta.2010.09.012; Layne REC, 1996, FRUIT BREEDING, VII, P79; Leino MW, 2009, SEED SCI RES, V19, P125, DOI 10.1017/S0960258509990055; Lopes MS, 2002, MOL ECOL NOTES, V2, P24, DOI 10.1046/j.1471-8286.2002.00132.x; Maghuly F, 2005, TREE GENET GENOMES, V1, P151, DOI 10.1007/s11295-005-0018-9; Martinez-Mora C, 2009, SPAN J AGRIC RES, V7, P855, DOI 10.5424/sjar/2009074-1099; Messina R, 2004, MOL ECOL NOTES, V4, P432, DOI 10.1111/j.1471-8286.2004.00674.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Pedryc A, 2009, SCI HORTIC-AMSTERDAM, V121, P19, DOI 10.1016/j.scienta.2009.01.014; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2004, DOCUMENTATION STRUCT; Rodrigo J., 2005, ITEA, V101, P333; Romero C, 2003, GENOME, V46, P244, DOI 10.1139/G02-128; Sanchez-Perez R, 2006, GENET RESOUR CROP EV, V53, P763, DOI 10.1007/s10722-004-4636-0; Sanchez-Perez R, 2005, SCI HORTIC-AMSTERDAM, V103, P305, DOI 10.1016/j.scienta.2004.06.009; Sosinski B, 2000, THEOR APPL GENET, V101, P421, DOI 10.1007/s001220051499; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Testolin R, 2000, GENOME, V43, P512, DOI 10.1139/gen-43-3-512; van de Wouw M, 2010, PLANT GENET RESOUR-C, V8, P1, DOI 10.1017/S1479262109990062; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Walters C, 2006, SEED SCI RES, V16, P169, DOI [10.1079/ssr2006246, 10.1079/SSR2006246]; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zhebentyayeva TN, 2003, THEOR APPL GENET, V106, P435, DOI 10.1007/s00122-002-1069-z; Zohary D., 1993, DOMESTICATION PLANTS	50	18	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23979	10.1371/journal.pone.0023979	http://dx.doi.org/10.1371/journal.pone.0023979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901149	Green Published, gold			2022-12-25	WOS:000294298000034
J	Kumadaki, S; Karasawa, T; Matsuzaka, T; Ema, M; Nakagawa, Y; Nakakuki, M; Saito, R; Yahagi, N; Iwasaki, H; Sone, H; Takekoshi, K; Yatoh, S; Kobayashi, K; Takahashi, A; Suzuki, H; Takahashi, S; Yamada, N; Shimano, H				Kumadaki, Shin; Karasawa, Tadayoshi; Matsuzaka, Takashi; Ema, Masatsugu; Nakagawa, Yoshimi; Nakakuki, Masanori; Saito, Ryo; Yahagi, Naoya; Iwasaki, Hitoshi; Sone, Hirohito; Takekoshi, Kazuhiro; Yatoh, Shigeru; Kobayashi, Kazuto; Takahashi, Akimitsu; Suzuki, Hiroaki; Takahashi, Satoru; Yamada, Nobuhiro; Shimano, Hitoshi			Inhibition of Ubiquitin Ligase F-box and WD Repeat Domain-containing 7 alpha (Fbw7 alpha) Causes Hepatosteatosis through Kruppel-like Factor 5 (KLF5)/Peroxisome Proliferator-activated Receptor gamma 2 (PPAR gamma 2) Pathway but Not SREBP-1c Protein in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROL REGULATORY ELEMENT; PHOSPHORYLATION-DEPENDENT DEGRADATION; LEUCINE ZIPPER PROTEIN; LEPTIN-DEFICIENT MICE; TRANSCRIPTION FACTOR; BINDING-PROTEIN; INSULIN-RESISTANCE; PPAR-GAMMA; C-MYC; HEPATIC STEATOSIS	F-box and WD repeat domain-containing 7 alpha (Ebw7 alpha) is the substrate recognition component of a ubiquitin ligase that controls the degradation of factors involved in cellular growth, including c-Myc, cyclin E, and c-Jun. In addition, Fbw7 alpha degrades the nuclear form of sterol regulatory element-binding protein (SREBP)-1a, a global regulator of lipid synthesis, particularly during mitosis in cultured cells. This study investigated the in vivo role of Ebw7 alpha in hepatic lipid metabolism. siRNA knockdown of Ebw7 alpha in mice caused marked hepatosteatosis with the accumulation of triglycerides. However, inhibition of Ebw7 alpha did not change the level of nuclear SREBP-1 protein or the expression of genes involved in fatty acid synthesis and oxidation. In vivo experiments on the gain and loss of Fbw7 alpha function indicated that Fbw7 alpha regulated the expression of peroxisome proliferator-activated receptor (PPAR) gamma 2 and its target genes involved in fatty acid uptake and triglyceride synthesis. These genes included fatty acid transporter Cd36, diacylglycerol acyltransferase 1 (Dgatl), and fat-specific protein 27 (Cidec). The regulation of PPAR gamma 2 by Fbw7 alpha was mediated, at least in part, by the direct degradation of the Krtippel-like factor 5 (KI.F5) protein, upstream of PPAR gamma 2 expression. Hepatic Fbw7 alpha contributes to normal fatty acid and triglyceride metabolism, functions that represent novel aspects of this cell growth regulator.	[Kumadaki, Shin; Karasawa, Tadayoshi; Matsuzaka, Takashi; Nakagawa, Yoshimi; Nakakuki, Masanori; Saito, Ryo; Yahagi, Naoya; Iwasaki, Hitoshi; Sone, Hirohito; Takekoshi, Kazuhiro; Yatoh, Shigeru; Kobayashi, Kazuto; Takahashi, Akimitsu; Suzuki, Hiroaki; Yamada, Nobuhiro; Shimano, Hitoshi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Internal Med Endocrinol & Metab, Tsukuba, Ibaraki 3058575, Japan; [Ema, Masatsugu; Takahashi, Satoru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Anat & Embryol, Tsukuba, Ibaraki 3058575, Japan	University of Tsukuba; University of Tsukuba	Shimano, H (corresponding author), 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	hshimano@md.tsukuba.ac.jp	Shimano, Hitoshi/V-1761-2019; Shimano, Hitoshi/AAI-5648-2020; Yahagi, Naoya/D-2360-2014; Sone, Hirohito/ABC-9346-2021	Shimano, Hitoshi/0000-0002-5562-5572; Yahagi, Naoya/0000-0002-1823-1865; Sone, Hirohito/0000-0003-1263-2817; Ema, Masatsugu/0000-0003-0645-6183; Karasawa, Tadayoshi/0000-0002-6738-2360	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [21591123] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Bengoechea-Alonso MT, 2005, P NATL ACAD SCI USA, V102, P11681, DOI 10.1073/pnas.0501494102; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carmona MC, 2005, INT J OBESITY, V29, P864, DOI 10.1038/sj.ijo.0802943; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Inoue N, 2005, MOL CELL BIOL, V25, P8938, DOI 10.1128/MCB.25.20.8938-8947.2005; Kato T, 2006, CELL METAB, V4, P143, DOI 10.1016/j.cmet.2006.06.009; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kumadaki S, 2008, BIOCHEM BIOPH RES CO, V368, P261, DOI 10.1016/j.bbrc.2008.01.075; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; Matsumoto A, 2006, BIOCHEM BIOPH RES CO, V350, P114, DOI 10.1016/j.bbrc.2006.09.003; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Matsuzaka T, 2002, J LIPID RES, V43, P911; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334; Nakakuki M, 2007, FEBS J, V274, P4440, DOI 10.1111/j.1742-4658.2007.05973.x; Nandan MO, 2005, FEBS LETT, V579, P4757, DOI 10.1016/j.febslet.2005.07.053; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Rahimian R, 2001, MOL CELL BIOCHEM, V224, P29, DOI 10.1023/A:1011927113563; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Reed SE, 2004, CANCER RES, V64, P795, DOI 10.1158/0008-5472.CAN-03-3417; Riu E, 2003, FASEB J, V17, P1715, DOI 10.1096/fj.02-1163fje; Riu E, 1996, P NATL ACAD SCI USA, V93, P2198, DOI 10.1073/pnas.93.5.2198; Schroeder-Gloeckler JM, 2007, J BIOL CHEM, V282, P15717, DOI 10.1074/jbc.M701329200; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimano H, 2002, VITAM HORM, V65, P167, DOI 10.1016/S0083-6729(02)65064-2; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Spruck CH, 2002, CANCER RES, V62, P4535; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040	53	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40835	40846		10.1074/jbc.M111.235283	http://dx.doi.org/10.1074/jbc.M111.235283			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21911492	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000297315400044
J	Cvetkov, TL; Huynh, KW; Cohen, MR; Moiseenkova-Bell, VY				Cvetkov, Teresa L.; Huynh, Kevin W.; Cohen, Matthew R.; Moiseenkova-Bell, Vera Y.			Molecular Architecture and Subunit Organization of TRPA1 Ion Channel Revealed by Electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; AUTOMATIC PARTICLE PICKUP; ANKYRIN REPEAT DOMAIN; YEAST SACCHAROMYCES-CEREVISIAE; RECEPTOR POTENTIAL CHANNELS; PROTEIN SECONDARY STRUCTURE; MEMBRANE-PROTEIN; CRYSTAL-STRUCTURE; CATION CHANNEL; I-TASSER	Transient receptor potential ankyrin 1 (TRPA1) is a non-selective ion channel, which is expressed in nociceptor sensory neurons and transduces chemical, inflammatory, and neuropathic pain signals. Numerous non-reactive compounds and electrophilic compounds, such as endogenous inflammatory mediators and exogenous pungent chemicals, can activate TRPA1. Here we report a 16-angstrom resolution structure of purified, functional, amphipol-stabilized TRPA1 analyzed by single-particle EM. Molecular models of the N and C termini of the channel were generated using the I-TASSER protein structure prediction server and docked into the EM density to provide insight into the TRPA1 subunit organization. This structural analysis suggests a location for critical N-terminal cysteine residues involved in electrophilic activation at the interface between neighboring subunits. Our results indicate that covalent modifications within this pocket may alter interactions between subunits and promote conformational changes that lead to channel activation.	[Cvetkov, Teresa L.; Huynh, Kevin W.; Cohen, Matthew R.; Moiseenkova-Bell, Vera Y.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Moiseenkova-Bell, VY (corresponding author), 10900 Euclid Ave,Wood Bldg,W151D, Cleveland, OH 44106 USA.	vxm102@case.edu			American Lung Association [RG-166985-N]	American Lung Association	This work was supported by American Lung Association Biomedical Research Grant RG-166985-N (to V. Y. M.-B.).	Anand U, 2008, NEUROSCI LETT, V438, P221, DOI 10.1016/j.neulet.2008.04.007; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Banke TG, 2011, BRAIN RES, V1381, P21, DOI 10.1016/j.brainres.2011.01.021; Baraldi PG, 2010, J MED CHEM, V53, P5085, DOI 10.1021/jm100062h; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Bobkov YV, 2011, BBA-BIOMEMBRANES, V1808, P1120, DOI 10.1016/j.bbamem.2010.12.024; Caterina MJ, 2007, NATURE, V445, P491, DOI 10.1038/nature05565; Catoire LJ, 2010, EUR BIOPHYS J BIOPHY, V39, P623, DOI 10.1007/s00249-009-0513-2; Cavanaugh EJ, 2008, NEUROSCIENCE, V154, P1467, DOI 10.1016/j.neuroscience.2008.04.048; Chiu PL, 2007, STRUCTURE, V15, P1053, DOI 10.1016/j.str.2007.06.020; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; Cvetkov TL, 2007, PROTEIN EXPRES PURIF, V56, P189, DOI 10.1016/j.pep.2007.07.012; De Petrocellis L, 2008, J PHARMACOL EXP THER, V325, P1007, DOI 10.1124/jpet.107.134809; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Fernandez-Ballester G, 2008, J MEMBRANE BIOL, V223, P161, DOI 10.1007/s00232-008-9123-7; Figler RA, 2000, ARCH BIOCHEM BIOPHYS, V376, P34, DOI 10.1006/abbi.2000.1712; Flotenmeyer M, 2007, J MICROSC-OXFORD, V227, P229, DOI 10.1111/j.1365-2818.2007.01805.x; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Gohon Y, 2003, CURR OPIN COLLOID IN, V8, P15, DOI 10.1016/S1359-0294(03)00013-X; Gohon Y, 2008, BIOPHYS J, V94, P3523, DOI 10.1529/biophysj.107.121848; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Karashima Y, 2010, BIOPHYS J, V98, P773, DOI 10.1016/j.bpj.2009.11.007; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Lee SP, 2008, BRIT J PHARMACOL, V153, P1739, DOI 10.1038/bjp.2008.85; Levine JD, 2007, BBA-MOL BASIS DIS, V1772, P989, DOI 10.1016/j.bbadis.2007.01.008; Li MH, 2011, ADV EXP MED BIOL, V704, P1, DOI 10.1007/978-94-007-0265-3_1; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Maruyama Y, 2007, J BIOL CHEM, V282, P36961, DOI 10.1074/jbc.M705694200; McCleverty CJ, 2006, PROTEIN SCI, V15, P2201, DOI 10.1110/ps.062357206; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mio K, 2005, BIOCHEM BIOPH RES CO, V333, P768, DOI 10.1016/j.bbrc.2005.05.181; Mio K, 2007, J MOL BIOL, V367, P373, DOI 10.1016/j.jmb.2006.12.043; Moiseenkova VY, 2003, BIOCHEM BIOPH RES CO, V310, P196, DOI 10.1016/j.bbrc.2003.09.011; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Moiseenkova-Bell VY, 2009, J GEN PHYSIOL, V133, P239, DOI 10.1085/jgp.200810123; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; NILIUS B, 2005, SCI STKE, pRE8; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Ogura T, 2004, J STRUCT BIOL, V145, P63, DOI 10.1016/S1047-8477(03)00139-4; Ogura T, 2004, J STRUCT BIOL, V146, P344, DOI 10.1016/j.jsb.2004.01.007; Ogura T, 2001, J STRUCT BIOL, V136, P227, DOI 10.1006/jsbi.2002.4442; Orlova EV, 2003, J MOL BIOL, V326, P1005, DOI 10.1016/S0022-2836(02)00708-8; Petri ET, 2010, P NATL ACAD SCI USA, V107, P9176, DOI 10.1073/pnas.0912295107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Popot JL, 2011, ANNU REV BIOPHYS, V40, P379, DOI 10.1146/annurev-biophys-042910-155219; Popot JL, 2003, CELL MOL LIFE SCI, V60, P1559, DOI 10.1007/s00018-003-3169-6; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schumann F, 2009, J BIOL CHEM, V284, P24372, DOI 10.1074/jbc.M109.025635; Shigematsu H, 2010, J BIOL CHEM, V285, P11210, DOI 10.1074/jbc.M109.090712; Sokolova O, 2004, FEBS LETT, V564, P251, DOI 10.1016/S0014-5793(04)00254-6; Sokolova O, 2001, STRUCTURE, V9, P215, DOI 10.1016/S0969-2126(01)00578-0; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Tribet C, 2009, LANGMUIR, V25, P12623, DOI 10.1021/la9018772; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Wilkens S, 2000, J BIOENERG BIOMEMBR, V32, P333, DOI 10.1023/A:1005567717821; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zoonens M, 2005, P NATL ACAD SCI USA, V102, P8893, DOI 10.1073/pnas.0503750102	83	92	94	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38168	38176		10.1074/jbc.M111.288993	http://dx.doi.org/10.1074/jbc.M111.288993			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908607	Green Published, hybrid			2022-12-25	WOS:000296594200030
J	Mei, XH; Atkinson, D				Mei, Xiaohu; Atkinson, David			Crystal Structure of C-terminal Truncated Apolipoprotein A-I Reveals the Assembly of High Density Lipoprotein (HDL) by Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-FREE STRUCTURE; SECONDARY STRUCTURE; HELIX STABILIZATION; AMPHIPATHIC HELIX; APOA-I; STABILITY; PROTEIN; LECITHIN; BINDING; MILANO	Apolipoprotein A-I (apoA-I) plays important structural and functional roles in plasma high density lipoprotein (HDL) that is responsible for reverse cholesterol transport. However, a molecular understanding of HDL assembly and function remains enigmatic. The 2.2-angstrom crystal structure of Delta(185-243) apoA-I reported here shows that it forms a half-circle dimer. The backbone of the dimer consists of two elongated antiparallel proline-kinked helices (five AB tandem repeats). The N-terminal domain of each molecule forms a four-helix bundle with the helical C-terminal region of the symmetry-related partner. The central region forms a flexible domain with two antiparallel helices connecting the bundles at each end. The two-domain dimer structure based on helical repeats suggests the role of apoA-I in the formation of discoidal HDL particles. Furthermore, the structure suggests the possible interaction with lecithin-cholesterol acyltransferase and may shed light on the molecular details of the effect of the Milano, Paris, and Fin mutations.	[Mei, Xiaohu; Atkinson, David] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Boston University	Atkinson, D (corresponding author), 700 Albany St,W302, Boston, MA 02118 USA.	atkinson@bu.edu	Mei, Xiaohu/B-7513-2012	Mei, Xiaohu/0000-0002-4868-2288; Atkinson, David/0000-0002-4796-7396	National Institutes of Health [P01-HL026335]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL026335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-HL026335.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANDREWS AL, 1976, EUR J BIOCHEM, V64, P549, DOI 10.1111/j.1432-1033.1976.tb10335.x; Bashtovyy D, 2011, J LIPID RES, V52, P435, DOI 10.1194/jlr.R012658; Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; Bhat S, 2007, BIOCHEMISTRY-US, V46, P7811, DOI 10.1021/bi700384t; Bielicki JK, 2002, BIOCHEMISTRY-US, V41, P2089, DOI 10.1021/bi011716p; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Catte A, 2008, BIOPHYS J, V94, P2306, DOI 10.1529/biophysj.107.115857; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; Chroni A, 2004, BIOCHEMISTRY-US, V43, P10442, DOI 10.1021/bi049782p; Davidson WS, 2005, CURR OPIN LIPIDOL, V16, P295, DOI 10.1097/01.mol.0000169349.38321.ad; Davidson WS, 2003, J BIOL CHEM, V278, P27199, DOI 10.1074/jbc.M302764200; Fang YL, 2003, BIOCHEMISTRY-US, V42, P13260, DOI 10.1021/bi0354031; Fang YL, 2003, BIOCHEMISTRY-US, V42, P6881, DOI 10.1021/bi034152t; FIELDING CJ, 1995, J LIPID RES, V36, P211; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; FRANCESCHINI G, 1982, J BIOL CHEM, V257, P9926; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gorshkova IN, 2006, BIOCHEMISTRY-US, V45, P1242, DOI 10.1021/bi051669r; Gorshkova IN, 2002, BIOCHEMISTRY-US, V41, P10529, DOI 10.1021/bi025807d; Gorshkova IN, 2000, BIOCHEMISTRY-US, V39, P15910, DOI 10.1021/bi0014406; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; Gursky O, 1996, P NATL ACAD SCI USA, V93, P2991, DOI 10.1073/pnas.93.7.2991; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Jones MK, 2009, BIOCHEMISTRY-US, V48, P11196, DOI 10.1021/bi901242k; Jones MK, 2009, BIOPHYS J, V96, P354, DOI 10.1016/j.bpj.2008.09.041; Klon AE, 2002, BIOCHEMISTRY-US, V41, P10895, DOI 10.1021/bi020315m; Laccotripe M, 1997, J BIOL CHEM, V272, P17511, DOI 10.1074/jbc.272.28.17511; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Marcel YL, 2003, CURR OPIN LIPIDOL, V14, P151, DOI 10.1097/00041433-200304000-00006; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; McManus DC, 2001, J BIOL CHEM, V276, P21292, DOI 10.1074/jbc.M100463200; Nallamsetty S, 2007, NAT PROTOC, V2, P383, DOI 10.1038/nprot.2007.50; NOLTE RT, 1992, BIOPHYS J, V63, P1221, DOI 10.1016/S0006-3495(92)81698-3; Okon M, 2002, FEBS LETT, V517, P139, DOI 10.1016/S0014-5793(02)02600-5; Okon M, 2001, FEBS LETT, V487, P390, DOI 10.1016/S0014-5793(00)02375-9; Olson CA, 2001, PROTEINS, V44, P123, DOI 10.1002/prot.1079; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Perez-Mendez O, 2000, ATHEROSCLEROSIS, V148, P317, DOI 10.1016/S0021-9150(99)00279-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P11714, DOI 10.1021/bi973112k; Roosbeek S, 2001, J LIPID RES, V42, P31; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; SEGREST JP, 1992, J LIPID RES, V33, P141; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P8600, DOI 10.1021/bi050421z; Sirtori CR, 2001, CIRCULATION, V103, P1949; Sorci-Thomas MG, 1998, J BIOL CHEM, V273, P11776, DOI 10.1074/jbc.273.19.11776; SORCITHOMAS M, 1993, J BIOL CHEM, V268, P21403; SorciThomas MG, 1997, J BIOL CHEM, V272, P7278, DOI 10.1074/jbc.272.11.7278	56	153	155	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38570	38582		10.1074/jbc.M111.260422	http://dx.doi.org/10.1074/jbc.M111.260422			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914797	hybrid, Green Published			2022-12-25	WOS:000296594200070
J	Balasubramanian, R; Kenney, GE; Rosenzweig, AC				Balasubramanian, Ramakrishnan; Kenney, Grace E.; Rosenzweig, Amy C.			Dual Pathways for Copper Uptake by Methanotrophic Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLOSINUS-TRICHOSPORIUM OB3B; SUBSTITUTED BOROSILICATE GLASS; CONTAINING N2O REDUCTASE; MEMBRANE RECEPTOR FPVA; OUTER-MEMBRANE; METHANE MONOOXYGENASE; PSEUDOMONAS-AERUGINOSA; THERMODYNAMIC PROPERTIES; MASS-SPECTROMETRY; METHANOBACTIN	Methanobactin (Mb), a 1217-Da copper chelator produced by the methanotroph Methylosinus trichosporium OB3b, is hypothesized to mediate copper acquisition from the environment, particularly from insoluble copper mineral sources. Although indirect evidence suggests that Mb provides copper for the regulation and activity of methane monooxygenase enzymes, experimental data for direct uptake of copper loaded Mb (Cu-Mb) are lacking. Uptake of intact Cu-Mb by M. trichosporium OB3b was demonstrated by isotopic and fluorescent labeling experiments. Confocal microscopy data indicate that Cu-Mb is localized in the cytoplasm. Both Cu-Mb and unchelated Cu are taken up by M. trichosporium OB3b, but by different mechanisms. Uptake of unchelated Cu is inhibited by spermine, suggesting a porin-dependent passive transport process. By contrast, uptake of Cu-Mb is inhibited by the uncoupling agents carbonyl cyanide m-chlorophenylhydrazone and methylamine, but not by spermine, consistent with an active transport process. Cu-Mb from M. trichosporium OB3b can also be internalized by other strains of methanotroph, but not by Escherichia coli, suggesting that Cu-Mb uptake is specific to methanotrophic bacteria. These findings are consistent with a key role for Cu-Mb in copper acquisition by methanotrophs and have important implications for further investigation of the copper uptake machinery.	[Rosenzweig, Amy C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	amyr@northwestern.edu	Balasubramanian, Ramakrishnan/C-7620-2011	Kenney, Grace/0000-0002-9579-3351	National Science Foundation [MCB0842366]; National Institutes of Health through the NCI [CCSG P30 CA060553]; National Institutes of Health [GM08061]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Science Foundation Grant MCB0842366. Imaging work was performed at the Northwestern University Cell Imaging Facility supported by National Institutes of Health Grant CCSG P30 CA060553 through the NCI, awarded to the Robert H. Lurie Comprehensive Cancer Center.; Supported in part by National Institutes of Health Training Grant GM08061.	Balasubramanian R, 2008, CURR OPIN CHEM BIOL, V12, P245, DOI 10.1016/j.cbpa.2008.01.043; Balasubramanian R, 2010, APPL ENVIRON MICROB, V76, P7356, DOI 10.1128/AEM.00935-10; Balasubramanian R, 2010, NATURE, V465, P115, DOI 10.1038/nature08992; Behling LA, 2008, J AM CHEM SOC, V130, P12604, DOI 10.1021/ja804747d; Braun M, 1999, MOL MICROBIOL, V33, P1037, DOI 10.1046/j.1365-2958.1999.01546.x; Choi DW, 2010, J INORG BIOCHEM, V104, P1240, DOI 10.1016/j.jinorgbio.2010.08.002; Choi DW, 2006, J INORG BIOCHEM, V100, P2150, DOI 10.1016/j.jinorgbio.2006.08.017; Choi DW, 2006, BIOCHEMISTRY-US, V45, P1442, DOI 10.1021/bi051815t; Clement E, 2004, BIOCHEMISTRY-US, V43, P7954, DOI 10.1021/bi049768c; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; DEMANGE P, 1990, BIOCHEMISTRY-US, V29, P11041, DOI 10.1021/bi00502a005; DiSpirito AA, 1998, J BACTERIOL, V180, P3606, DOI 10.1128/JB.180.14.3606-3613.1998; Drechsel H, 1998, J PEPT SCI, V4, P147, DOI 10.1002/(SICI)1099-1387(199805)4:3<147::AID-PSC136>3.0.CO;2-C; El Ghazouani A, 2011, INORG CHEM, V50, P1378, DOI 10.1021/ic101965j; Hakemian AS, 2008, BIOCHEMISTRY-US, V47, P6793, DOI 10.1021/bi800598h; Hakemian AS, 2007, ANNU REV BIOCHEM, V76, P223, DOI 10.1146/annurev.biochem.76.061505.175355; Hakemian AS, 2005, J AM CHEM SOC, V127, P17142, DOI 10.1021/ja0558140; Iyer R, 1997, J BIOL CHEM, V272, P18595, DOI 10.1074/jbc.272.30.18595; Jelinkova A, 2010, PLANT J, V61, P883, DOI 10.1111/j.1365-313X.2009.04102.x; Journo D, 2008, METHOD ENZYMOL, V451, P79, DOI 10.1016/S0076-6879(08)03207-2; Kim HJ, 2004, SCIENCE, V305, P1612, DOI 10.1126/science.1098322; Kim HJ, 2005, BIOCHEMISTRY-US, V44, P5140, DOI 10.1021/bi047367r; Knapp CW, 2007, P NATL ACAD SCI USA, V104, P12040, DOI 10.1073/pnas.0702879104; Krentz BD, 2010, BIOCHEMISTRY-US, V49, P10117, DOI 10.1021/bi1014375; Krewulak KD, 2011, BIOCHEM CELL BIOL, V89, P87, DOI [10.1139/o10-141, 10.1139/O10-141]; Kulczycki E, 2007, GEOBIOLOGY, V5, P251, DOI 10.1111/j.1472-4669.2007.00102.x; Kulczycki E, 2011, GEOMICROBIOL J, V28, P1, DOI 10.1080/01490451003614971; Larsen RA, 1999, MOL MICROBIOL, V31, P1809, DOI 10.1046/j.1365-2958.1999.01317.x; LEE HS, 1989, J BACTERIOL, V171, P2096, DOI 10.1128/jb.171.4.2096-2100.1989; LEE HS, 1991, J BACTERIOL, V173, P5406, DOI 10.1128/jb.173.17.5406-5413.1991; Marechal CN, 1999, CHEM GEOL, V156, P251, DOI 10.1016/S0009-2541(98)00191-0; Martinho M, 2007, J AM CHEM SOC, V129, P15783, DOI 10.1021/ja077682b; Minato Y, 2008, BIOL PHARM BULL, V31, P516, DOI 10.1248/bpb.31.516; Mokhele H., 1987, J BACTERIOL, V169, P5721; Muchova K, 2010, RES MICROBIOL, V161, P783, DOI 10.1016/j.resmic.2010.07.006; Murrell JC, 2000, TRENDS MICROBIOL, V8, P221, DOI 10.1016/S0966-842X(00)01739-X; Navarrete JU, 2011, APPL GEOCHEM, V26, pS319, DOI 10.1016/j.apgeochem.2011.04.002; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Paixao Laura, 2009, J Biol Eng, V3, P18, DOI 10.1186/1754-1611-3-18; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; Schalk IJ, 2004, MOL MICROBIOL, V54, P14, DOI 10.1111/j.1365-2958.2004.04241.x; Schalk IJ, 2001, MOL MICROBIOL, V39, P351, DOI 10.1046/j.1365-2958.2001.02207.x; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Semrau JD, 2010, FEMS MICROBIOL REV, V34, P496, DOI 10.1111/j.1574-6976.2010.00212.x; Stein LY, 2010, J BACTERIOL, V192, P6497, DOI 10.1128/JB.01144-10; Summer KH, 2011, J TRACE ELEM MED BIO, V25, P36, DOI 10.1016/j.jtemb.2010.12.002; Tellez CM, 1998, APPL ENVIRON MICROB, V64, P1115; Turovskiy Y, 2009, PROBIOTICS ANTIMICRO, V1, P67, DOI 10.1007/s12602-008-9003-6; Yoneyama H, 1996, MICROBIOL-UK, V142, P2137, DOI 10.1099/13500872-142-8-2137; Yoon S, 2010, ENV MICROBIOL REP, V2, P295, DOI 10.1111/j.1758-2229.2009.00125.x; Zumft WG, 2005, J MOL MICROB BIOTECH, V10, P154, DOI 10.1159/000091562	54	63	67	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37313	37319		10.1074/jbc.M111.284984	http://dx.doi.org/10.1074/jbc.M111.284984			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900235	Green Published, hybrid			2022-12-25	WOS:000296542400031
J	He, KY; Chan, CB; Liu, X; Jia, YH; Luo, HBR; France, SA; Liu, Y; Wilson, WD; Ye, KQ				He, Kunyan; Chan, Chi-Bun; Liu, Xia; Jia, Yonghui; Luo, Hongbo R.; France, Stefan A.; Liu, Yang; Wilson, W. David; Ye, Keqiang			Identification of a Molecular Activator for Insulin Receptor with Potent Anti-diabetic Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; 1,4-NAPHTHOQUINONE DERIVATIVES; SERUM-ALBUMIN; PLUMBAGIN; NAPHTHOQUINONES; DISCOVERY; AGENTS; CELLS; MICE; VIVO	Insulin exerts its actions through the insulin receptor (IR) and plays an essential role in diabetes. The inconvenient daily injection and undesirable side-effects associated with insulin injection demand novel drugs for the diseases. To search for bioactive insulin mimetics, we developed an in vitro screening assay using phospho-IR ELISA. After screening the small molecule chemical libraries, we have obtained a compound (5,8-diacetyloxy-2,3-dichloro-1,4-naphthoquinone) that provokes IR activation by directly binding to the receptor kinase domain to trigger its kinase activity at micromolar concentrations. This compound selectively activates IR but not other receptors and sensitizes insulin's action. Moreover, it elevates glucose uptake in adipocytes and has oral hypoglycemic effect in wild-type C57BL/6J mice and db/db and ob/ob mice without demonstrable toxicity. Hence, this promising compound mimics the biological functions of insulin and is useful for further drug development for diabetes treatment.	[He, Kunyan; Chan, Chi-Bun; Liu, Xia; Ye, Keqiang] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Jia, Yonghui; Luo, Hongbo R.] Harvard Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02115 USA; [Jia, Yonghui; Luo, Hongbo R.] Childrens Hosp, Boston, MA 02115 USA; [France, Stefan A.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Liu, Yang; Wilson, W. David] Georgia State Univ, Dept Chem, Atlanta, GA 30033 USA	Emory University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia State University	Chan, CB (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	cbchan@emory.edu; kye@emory.edu		France, Stefan/0000-0001-5998-6167	National Institutes of Health, NCI [CA127119]; NATIONAL CANCER INSTITUTE [R01CA127119] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA127119 from NCI (to K. Y.).	BABICH H, 1993, TOXICOL LETT, V69, P69, DOI 10.1016/0378-4274(93)90147-P; Babula P, 2007, Ceska Slov Farm, V56, P114; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Campbell RK, 2009, J AM PHARM ASSOC, V49, pS3, DOI 10.1331/JAPhA.2009.09077; Fonseca VA, 2008, J AM DIET ASSOC, V108, pS29, DOI 10.1016/j.jada.2008.01.047; FUJII N, 1992, ANTIMICROB AGENTS CH, V36, P2589, DOI 10.1128/AAC.36.12.2589; Hsu YL, 2006, J PHARMACOL EXP THER, V318, P484, DOI 10.1124/jpet.105.098863; Jayabharathi J, 2011, SPECTROCHIM ACTA A, V79, P502, DOI 10.1016/j.saa.2011.03.020; Kim BH, 2006, ARCH PHARM RES, V29, P123, DOI 10.1007/BF02974272; KRISHNASWAMY M, 1980, INDIAN J EXP BIOL, V18, P876; Lin B, 2007, J PHARMACOL EXP THER, V323, P579, DOI 10.1124/jpet.107.126102; Liu K, 2000, J MED CHEM, V43, P3487, DOI 10.1021/jm000285q; Maiti TK, 2008, J PHOTOCH PHOTOBIO A, V194, P297, DOI 10.1016/j.jphotochem.2007.08.028; Manchem VP, 2001, DIABETES, V50, P824, DOI 10.2337/diabetes.50.4.824; Pender C, 2002, J BIOL CHEM, V277, P43565, DOI 10.1074/jbc.M202426200; Prasad V. Satya, 1996, Indian Journal of Experimental Biology, V34, P857; Singh U. V., 1997, Indian Journal of Physiology and Pharmacology, V41, P171; SMITH MT, 1985, J TOXICOL ENV HEALTH, V16, P665, DOI 10.1080/15287398509530776; Ueki K, 2003, J BIOL CHEM, V278, P48453, DOI 10.1074/jbc.M305602200; Wilkie N, 2001, J NEUROCHEM, V78, P1135, DOI 10.1046/j.1471-4159.2001.00504.x; YAMASHITA N, 1991, CLIN IMMUNOL IMMUNOP, V59, P335, DOI 10.1016/0090-1229(91)90029-A; Zaccaro MC, 2005, CHEM BIOL, V12, P1015, DOI 10.1016/j.chembiol.2005.06.015; Zhang B, 1999, SCIENCE, V284, P974, DOI 10.1126/science.284.5416.974	23	28	29	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37379	37388		10.1074/jbc.M111.247387	http://dx.doi.org/10.1074/jbc.M111.247387			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21908618	Green Published, hybrid			2022-12-25	WOS:000296542400038
J	Vohwinkel, CU; Lecuona, E; Sun, HY; Sommer, N; Vadasz, I; Chandel, NS; Sznajder, JI				Vohwinkel, Christine U.; Lecuona, Emilia; Sun, Haying; Sommer, Natascha; Vadasz, Istvan; Chandel, Navdeep S.; Sznajder, Jacob I.			Elevated CO2 Levels Cause Mitochondrial Dysfunction and Impair Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ACUTE EXACERBATION; CARBON-DIOXIDE; HYPERCAPNIA; METABOLISM; ACID; FIBROBLASTS; RESPIRATION; NA,K-ATPASE; MUTATIONS	Elevated CO2 concentrations (hypercapnia) occur in patients with severe lung diseases. Here, we provide evidence that high CO2 levels decrease O-2 consumption and ATP production and impair cell proliferation independently of acidosis and hypoxia in fibroblasts (N12) and alveolar epithelial cells (A549). Cells exposed to elevated CO2 died in galactose medium as well as when glucose-6-phosphate isomerase was knocked down, suggesting mitochondrial dysfunction. High CO2 levels led to increased levels of microRNA-183 (miR-183), which in turn decreased expression of IDH2 (isocitrate dehydrogenase 2). The high CO2-induced decrease in cell proliferation was rescued by alpha-ketoglutarate and overexpression of IDH2, whereas proliferation decreased in normocapnic cells transfected with siRNA for IDH2. Also, overexpression of miR-183 decreased IDH2 (mRNA and protein) as well as cell proliferation under normocapnic conditions, whereas inhibition of miR-183 rescued the normal proliferation phenotype in cells exposed to elevated levels of CO2. Accordingly, we provide evidence that high CO2 induces miR-183, which down-regulates IDH2, thus impairing mitochondrial function and cell proliferation. These results are of relevance to patients with hypercapnia such as those with chronic obstructive pulmonary disease, asthma, cystic fibrosis, bronchopulmonary dysplasia, and muscular dystrophies.	[Vohwinkel, Christine U.; Lecuona, Emilia; Sun, Haying; Chandel, Navdeep S.; Sznajder, Jacob I.] Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Vohwinkel, Christine U.] Northwestern Univ, Div Pediat Crit Care Med, Childrens Mem Hosp, Feinberg Sch Med, Chicago, IL 60614 USA; [Sommer, Natascha; Vadasz, Istvan] Univ Giessen, Lung Ctr, Dept Internal Med, D-35390 Giessen, Germany	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Justus Liebig University Giessen	Sznajder, JI (corresponding author), Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, 240 E Huron,McGaw M300, Chicago, IL 60611 USA.	j-sznajder@northwestern.edu	Sommer, Natascha/AAD-5406-2020; Vadasz, Istvan/AAO-8288-2021	Vadasz, Istvan/0000-0003-1370-9783; Sommer, Natascha/0000-0002-8915-7762; Vohwinkel, Christine/0000-0001-8959-157X	National Institutes of Health [HL-85534]; Deutsche Forschungsgemeinschaft [IRTG 1062]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-85534. This work was also supported by Deutsche Forschungsgemeinschaft Grant IRTG 1062.	Barr RG, 2010, NEW ENGL J MED, V362, P217, DOI 10.1056/NEJMoa0808836; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Belkin RA, 2006, AM J RESP CRIT CARE, V173, P659, DOI 10.1164/rccm.200410-1369OC; Briva A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001238; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Darzynkiewicz Z, 2001, CURR PROTOC CYTOM, V7, P771; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; deZengotita VM, 2002, BIOTECHNOL BIOENG, V78, P741, DOI 10.1002/bit.10255; Doerr CH, 2005, AM J RESP CRIT CARE, V171, P1371, DOI 10.1164/rccm.200309-1223OC; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fritz KI, 2005, PEDIATR RES, V57, P299, DOI 10.1203/01.PDR.0000148718.47137.9B; Gokhale A, 2010, J CANCER RES THER, V6, P521, DOI 10.4103/0973-1482.77072; GonzalezMeler MA, 1996, PLANT PHYSIOL, V112, P1349, DOI 10.1104/pp.112.3.1349; Goyal MMZA, 2005, BIOTECHNOL PROGR, V21, P70, DOI 10.1021/bp049815s; GULY MF, 1979, UKR BIOKHIM ZH+, V51, P160; Hand SC, 2008, J EXP BIOL, V211, P1829, DOI 10.1242/jeb.000299; Hartong DT, 2008, NAT GENET, V40, P1230, DOI 10.1038/ng.223; Hashimoto M, 2006, NAT CELL BIOL, V8, P391, DOI 10.1038/ncb1387; Holz O, 2004, EUR RESPIR J, V24, P575, DOI 10.1183/09031936.04.00143703; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095; Kessler R, 1999, AM J RESP CRIT CARE, V159, P158, DOI 10.1164/ajrccm.159.1.9803117; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lang JD, 2000, AM J PHYSIOL-LUNG C, V279, pL994, DOI 10.1152/ajplung.2000.279.5.L994; Lowery AJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-502; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Mannino DM, 2006, EUR RESPIR J, V27, P627, DOI 10.1183/09031936.06.00024605; Matzi V, 2007, EUR J CARDIO-THORAC, V32, P776, DOI 10.1016/j.ejcts.2007.07.016; Monnet X, 2007, CURR OPIN CRIT CARE, V13, P6, DOI 10.1097/MCC.0b013e328013c865; O'Toole D, 2009, THORAX, V64, P976, DOI 10.1136/thx.2008.110304; PARDO A, 1991, CONNECT TISSUE RES, V26, P259, DOI 10.3109/03008209109152443; PARDO A, 1992, CHEST, V102, P1085, DOI 10.1378/chest.102.4.1085; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Ridge KM, 2002, MOL BIOL CELL, V13, P1381, DOI 10.1091/mbc.01-07-0323; Sgarbi G, 2009, ARCH NEUROL-CHICAGO, V66, P951, DOI 10.1001/archneurol.2009.134; SHEVCHENKO MI, 1979, UKR BIOKHIM ZH+, V51, P53; Sin DD, 2005, CAN J PHYSIOL PHARM, V83, P8, DOI 10.1139/Y04-116; Sin DD, 2005, AM J MED, V118, P145, DOI 10.1016/j.amjmed.2004.10.014; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Varughese M, 2002, PEDIATR PULM, V33, P56, DOI 10.1002/ppul.10032; Vitacca M, 2005, CHEST, V128, P1209, DOI 10.1378/chest.128.3.1209; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x; Zhou YH, 2005, P NATL ACAD SCI USA, V102, P3875, DOI 10.1073/pnas.0500423102	48	119	126	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37067	37076		10.1074/jbc.M111.290056	http://dx.doi.org/10.1074/jbc.M111.290056			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21903582	Green Published, hybrid			2022-12-25	WOS:000296542400007
J	Yang, XJ; Zhang, WH; Dong, M; Boubriak, I; Huang, ZY				Yang, Xuejun; Zhang, Wenhao; Dong, Ming; Boubriak, Ivan; Huang, Zhenying			The Achene Mucilage Hydrated in Desert Dew Assists Seed Cells in Maintaining DNA Integrity: Adaptive Strategy of Desert Plant Artemisia sphaerocephala	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; COMET ASSAY; OSMOTIC-STRESS; NEGEV DESERT; GERMINATION; REPAIR; DAMAGE; ARABIDOPSIS; MAINTENANCE; WATER	Despite proposed ecological importance of mucilage in seed dispersal, germination and seedling establishment, little is known about the role of mucilage in seed pre-germination processes. Here we investigated the role of mucilage in assisting achene cells to repair DNA damage during dew deposition in the desert. Artemisia sphaerocephala achenes were first treated gamma-irradiation to induce DNA damage, and then they were repaired in situ in the desert dew. Dew deposition duration can be as long as 421 min in early mornings. Intact achenes absorbed more water than demucilaged achenes during dew deposition and also carried water for longer time following sunrise. After 4-d dew treatment, DNA damage of irradiated intact and demucilaged achenes was reduced to 24.38% and 46.84%, respectively. The irradiated intact achenes exhibited much higher DNA repair ratio than irradiated demucilaged achenes. Irradiated intact achenes showed an improved germination and decreased nonviable achenes after dew treatment, and significant differences in viability between the two types of achenes were detected after 1020 min of dew treatment. Achene mucilage presumably plays an ecologically important role in the life cycle of A. sphaerocephala by aiding DNA repair of achene cells in genomic-stressful habitats.	[Yang, Xuejun; Zhang, Wenhao; Dong, Ming; Huang, Zhenying] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Yang, Xuejun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Boubriak, Ivan] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Boubriak, Ivan] Inst Cell Biol & Genet Engn, Kiev, Ukraine	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Oxford; National Academy of Sciences Ukraine; Institute of Cell Biology & Genetic Engineering of the National Academy of Sciences of Ukraine	Huang, ZY (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	zhenying@ibcas.ac.cn	Zhang, Wen-Hao/B-5805-2009; Yang, Xuejun/B-4718-2014; Boubriak, Ivan/GPX-1231-2022	Zhang, Wen-Hao/0000-0003-2708-2221; Yang, Xuejun/0000-0002-8595-545X; Boubriak, Ivan/0000-0001-9845-2969	Key Basic Research and Development Plan of China [2010CB951304, 2007CB106802]; National Natural Science Foundation of P. R. China [30872074, 30970461]	Key Basic Research and Development Plan of China(National Basic Research Program of China); National Natural Science Foundation of P. R. China(National Natural Science Foundation of China (NSFC))	Funds for this study were provided by the Key Basic Research and Development Plan of China (2010CB951304, 2007CB106802) and National Natural Science Foundation of P. R. China (30872074, 30970461). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaithamby A, 2009, NUCLEIC ACIDS RES, V37, P3912, DOI 10.1093/nar/gkp237; Barzel A, 2008, NAT REV GENET, V9, P27, DOI 10.1038/nrg2224; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Boubriak I, 1997, SEED SCI RES, V7, P97, DOI 10.1017/S0960258500003433; BOUBRIAK I, 2001, CYTOL GENET+, V35, P54; Bray CM, 2005, NEW PHYTOL, V168, P511, DOI 10.1111/j.1469-8137.2005.01548.x; CHEAH KSE, 1978, NATURE, V272, P593, DOI 10.1038/272593a0; *CHIN ACAD SCIEMC, 1991, FLOR CHIN, V76; Cools T, 2009, CURR OPIN PLANT BIOL, V12, P23, DOI 10.1016/j.pbi.2008.09.012; de Castro RD, 2000, PLANT PHYSIOL, V122, P327, DOI 10.1104/pp.122.2.327; ELDER RH, 1987, MUTAT RES, V181, P61, DOI 10.1016/0027-5107(87)90288-0; EVANS RA, 1979, WEED SCI, V27, P327, DOI 10.1017/S0043174500044118; EVENARI M., 1971, NEGEV CHALLENGE DESE; Gardner G, 2009, PLANT CELL ENVIRON, V32, P1573, DOI 10.1111/j.1365-3040.2009.02021.x; GARWOOD NC, 1985, AM J BOT, V72, P1095, DOI 10.2307/2443455; GRUBERT M, 1974, Acta Biologica Venezuelica, V8, P315; Gutterman Y, 1997, ISR J PLANT SCI, V45, P317, DOI 10.1080/07929978.1997.10676695; GUTTERMAN Y, 1973, ANN BOT-LONDON, V37, P1051, DOI 10.1093/oxfordjournals.aob.a084770; Gutterman Y., 1993, SEED GERMINATION DES; Gutterman Yitzchak, 2002, P1; HARPER JL, 1966, J ECOL, V54, P151, DOI 10.2307/2257664; HEDGE I C, 1970, Notes from the Royal Botanic Garden Edinburgh, V30, P79; Herrnstadt I, 2005, BRYOLOGIST, V108, P101, DOI 10.1639/0007-2745(2005)108[101:RSOBDI]2.0.CO;2; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huang ZY, 2008, ANN BOT-LONDON, V101, P277, DOI 10.1093/aob/mcm089; Huang ZY, 2004, TREES-STRUCT FUNCT, V18, P669, DOI 10.1007/s00468-004-0349-4; Huang ZY, 1999, ISR J PLANT SCI, V47, P27, DOI 10.1080/07929978.1999.10676748; Huang ZY, 2000, ISRAEL J PLANT SCI, V48, P255, DOI 10.1560/49G5-CNE7-H6UD-PWVW; Jacobs AFG, 1999, J ARID ENVIRON, V42, P211, DOI 10.1006/jare.1999.0523; Jovtchev G, 2001, MUTAT RES-GEN TOX EN, V493, P95, DOI 10.1016/S1383-5718(01)00166-8; Kanaar R, 2008, EMBO J, V27, P581, DOI 10.1038/emboj.2008.11; Khan AA, 2002, J FOOD SCI, V67, P493, DOI 10.1111/j.1365-2621.2002.tb10625.x; Kidron GJ, 2002, J ARID ENVIRON, V52, P517, DOI 10.1006/jare.2002.1014; Koppen G, 1997, FOOD SCI TECHNOL-LEB, V30, P452, DOI 10.1006/fstl.1996.0205; Kovalchuk I, 2004, PLANT PHYSIOL, V135, P357, DOI 10.1104/pp.104.040477; Kozak J, 2009, DNA REPAIR, V8, P413, DOI 10.1016/j.dnarep.2008.11.012; Kranner I, 2010, NEW PHYTOL, V188, P655, DOI 10.1111/j.1469-8137.2010.03461.x; LI Y, 2008, J ARID LAND RESOURCE, V22, P61; Ma JY, 2006, S AFR J BOT, V72, P46, DOI 10.1016/j.sajb.2005.05.002; Menke M, 2001, MUTAT RES-GEN TOX EN, V493, P87, DOI 10.1016/S1383-5718(01)00165-6; Nagy Z, 2009, TRENDS CELL BIOL, V19, P617, DOI 10.1016/j.tcb.2009.08.010; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; OLIVE PL, 1991, CANCER RES, V51, P4671; Osborne DJ, 1994, SEED SCI RES, V4, P175, DOI 10.1017/S0960258500002166; Osborne DJ, 2000, ISRAEL J PLANT SCI, V48, P173, DOI 10.1560/JNXX-M1TH-2UM3-5UF6; Rajjou L, 2008, PLANT PHYSIOL, V148, P620, DOI 10.1104/pp.108.123141; Schubert I, 2004, CYTOGENET GENOME RES, V104, P104, DOI 10.1159/000077473; SWARBRICK JT, 1971, BOT J LINN SOC, V64, P157, DOI 10.1111/j.1095-8339.1971.tb02142.x; Thapliyal RC, 2008, AUST J BOT, V56, P583, DOI 10.1071/BT08022; Watanabe K, 2009, PLANT CELL, V21, P2688, DOI 10.1105/tpc.108.060525; WITZTUM A, 1969, BOT GAZ, V130, P238, DOI 10.1086/336497; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yang XJ, 2010, PLANT PHYSIOL BIOCH, V48, P131, DOI 10.1016/j.plaphy.2009.12.006; Zhang X., 2008, ARID METEOROLOGY, V26, P8	55	30	32	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24346	10.1371/journal.pone.0024346	http://dx.doi.org/10.1371/journal.pone.0024346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912689	Green Submitted, Green Published, gold			2022-12-25	WOS:000294686100036
J	Sidera, K; El Hamidieh, A; Mamalaki, A; Patsavoudi, E				Sidera, Katerina; El Hamidieh, Avraam; Mamalaki, Avgi; Patsavoudi, Evangelia			The 4C5 Cell-Impermeable Anti-HSP90 Antibody with Anti-Cancer Activity, Is Composed of a Single Light Chain Dimer	PLOS ONE			English	Article							DEVELOPING NERVOUS-SYSTEM; EXTRACELLULAR HSP90-ALPHA; REGULATORY MECHANISM; CANCER METASTASIS; ESCHERICHIA-COLI; SURFACE-ANTIGEN; HSP90; BINDING; MOTILITY; EXPRESSION	MAb 4C5 is a cell impermeable, anti-HSP90 murine monoclonal antibody, originally produced using hybridoma technology. We have previously shown that mAb 4C5 specifically recognizes both the a-and to a lesser extent the b-isoform of HSP90. Additionally, in vitro and in vivo studies revealed that by selectively inhibiting the function of cell-surface HSP90, mAb 4C5 significantly impairs cancer cell invasion and metastasis. Here we describe the reconstitution of mAb 4C5 into a mouse-human chimera. More importantly we report that mAb 4C5 and consequently its chimeric counterpart are completely devoid of heavy chain and consist only of a functional kappa light chain dimer. The chimeric antibody is shown to retain the original antibody's specificity and functional properties. Thus it is capable of inhibiting the function of surface HSP90, leading to reduced cancer cell invasion in vitro. Finally, we present in vivo evidence showing that the chimeric 4C5 significantly inhibits the metastatic deposit formation of MDA-MB-453 cells into the lungs of SCID mice. These data suggest that a chimeric kappa light chain antibody could be potentially used as an anti-cancer agent, thereby introducing a novel type of antibody fragment, with reduced possible adverse immunogenic effects, into cancer therapeutics.	[Sidera, Katerina; El Hamidieh, Avraam; Mamalaki, Avgi; Patsavoudi, Evangelia] Hellenic Pasteur Inst, Dept Biochem, Athens, Greece; [Patsavoudi, Evangelia] Technol Educ Inst Athens, Dept Med Instruments Technol, Athens, Greece	University of West Attica	Sidera, K (corresponding author), Hellenic Pasteur Inst, Dept Biochem, Athens, Greece.	epatsavoudi@pasteur.gr						Bagatell R, 2004, MOL CANCER THER, V3, P1021; BARBAS CF, MONOCLONAL ANTIBODIE; BOULIANNE GL, 1984, NATURE, V312, P643, DOI 10.1038/312643a0; Bradwell AR, 2003, LANCET, V361, P489, DOI 10.1016/S0140-6736(03)12457-9; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Charlton Keith A, 2004, Methods Mol Biol, V248, P245; CHENG CF, 2008, MOL CELL BIOL; Dubnovitsky AP, 2000, BIOCHEMISTRY-MOSCOW+, V65, P1011; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Gaitanou M, 2001, BIOCHEM J, V355, P715, DOI 10.1042/bj3550715; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Heimburg J, 2006, NEOPLASIA, V8, P939, DOI 10.1593/neo.06493; KABAT EA, 1991, J IMMUNOL, V147, P1709; LEDBETTER JA, 1987, MOL IMMUNOL, V24, P1255, DOI 10.1016/0161-5890(87)90119-2; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; MASAT L, 1994, P NATL ACAD SCI USA, V91, P893, DOI 10.1073/pnas.91.3.893; McCready J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-294; MORRISON SL, 1988, CANCER INVEST, V6, P185, DOI 10.3109/07357908809077046; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Nishimura Eisaku, 1999, Human Antibodies, V9, P111; NOVOTNY J, 1989, BIOCHEMISTRY-US, V28, P4735, DOI 10.1021/bi00437a034; PATSAVOUDI E, 1991, J NEUROCHEM, V56, P782, DOI 10.1111/j.1471-4159.1991.tb01992.x; Pereira B, 1998, BIOCHEMISTRY-US, V37, P1430, DOI 10.1021/bi972277q; SAHAGAN BG, 1986, J IMMUNOL, V137, P1066; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SASTRY L, 1989, P NATL ACAD SCI USA, V86, P5728, DOI 10.1073/pnas.86.15.5728; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Sidera K, 2008, CELL CYCLE, V7, P1564, DOI 10.4161/cc.7.11.6054; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Song XM, 2010, J BIOL CHEM, V285, P40039, DOI 10.1074/jbc.M110.181941; Stellas D, 2007, CLIN CANCER RES, V13, P1831, DOI 10.1158/1078-0432.CCR-06-1585; Stellas D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-51; STEVENS FJ, 1991, BIOCHEMISTRY-US, V30, P6803, DOI 10.1021/bi00242a001; SUN M, 1994, J BIOL CHEM, V269, P734; THOMAIDOU D, 1995, J NEUROCHEM, V64, P1937; THOMAIDOU D, 1993, NEUROSCIENCE, V53, P813, DOI 10.1016/0306-4522(93)90626-Q; Tsutsumi S, 2008, ONCOGENE, V27, P2478, DOI 10.1038/sj.onc.1210897; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0; Yfanti E, 1998, J NEUROCHEM, V71, P1381; Yfanti E, 2004, GLIA, V45, P39, DOI 10.1002/glia.10307	45	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e23906	10.1371/journal.pone.0023906	http://dx.doi.org/10.1371/journal.pone.0023906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21912649	Green Published, gold, Green Submitted			2022-12-25	WOS:000294683900012
J	Bishop, CW; Miller, LM				Bishop, Christopher W.; Miller, Lee M.			Speech Cues Contribute to Audiovisual Spatial Integration	PLOS ONE			English	Article							SUPERIOR COLLICULUS NEURONS; MULTISENSORY INTEGRATION; AUDITORY-CORTEX; ATTENTION; DETERMINANTS; PERCEPTION; HEARING; SENSES	Speech is the most important form of human communication but ambient sounds and competing talkers often degrade its acoustics. Fortunately the brain can use visual information, especially its highly precise spatial information, to improve speech comprehension in noisy environments. Previous studies have demonstrated that audiovisual integration depends strongly on spatiotemporal factors. However, some integrative phenomena such as McGurk interference persist even with gross spatial disparities, suggesting that spatial alignment is not necessary for robust integration of audiovisual place-of-articulation cues. It is therefore unclear how speech-cues interact with audiovisual spatial integration mechanisms. Here, we combine two well established psychophysical phenomena, the McGurk effect and the ventriloquist's illusion, to explore this dependency. Our results demonstrate that conflicting spatial cues may not interfere with audiovisual integration of speech, but conflicting speech-cues can impede integration in space. This suggests a direct but asymmetrical influence between ventral 'what' and dorsal 'where' pathways.	[Bishop, Christopher W.; Miller, Lee M.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Miller, Lee M.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Bishop, CW (corresponding author), Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA.	cwbishop@ucdavis.edu			National Institute on Deafness and Other Communication Disorders (NIDCD) [R01-DC008171, 3R01-DC008171-04S1, F31-DC011429]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008171, F31DC011429] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by R01-DC008171 and 3R01-DC008171-04S1 (LMM) and F31-DC011429 (CWB) awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD; http://www.nidcd.nih.gov/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Deafness and Other Communication Disorders or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alsius A, 2005, CURR BIOL, V15, P839, DOI 10.1016/j.cub.2005.03.046; Alsius A, 2007, EXP BRAIN RES, V183, P399, DOI 10.1007/s00221-007-1110-1; Belin P, 2000, NAT NEUROSCI, V3, P965, DOI 10.1038/79890; BERTELSON P, 1994, P INT C SPOK LANG PR; Bishop CW, 2009, J COGNITIVE NEUROSCI, V21, P1790, DOI 10.1162/jocn.2009.21118; Bizley JK, 2007, CEREB CORTEX, V17, P2172, DOI 10.1093/cercor/bhl128; Bizley JK, 2009, HEARING RES, V258, P55, DOI 10.1016/j.heares.2009.06.017; Bizley JK, 2008, BRAIN RES, V1242, P24, DOI 10.1016/j.brainres.2008.02.087; Blauert J., 1996, SPATIAL HEARING REVI; CHERRY EC, 1953, J ACOUST SOC AM, V25; Colin C, 2001, PSYCHOL BELG, V41, P131; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Howard I. P., 1966, HUMAN SPATIAL ORIENT; Jones J. A., 1997, Canadian Acoustics, V25, P13; Jones JA, 2006, EXP BRAIN RES, V174, P588, DOI 10.1007/s00221-006-0634-0; MacDonald J, 2000, PERCEPTION, V29, P1155, DOI 10.1068/p3020; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MEREDITH MA, 1992, EXP BRAIN RES, V88, P181, DOI 10.1007/BF02259139; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Pare M, 2003, PERCEPT PSYCHOPHYS, V65, P553, DOI 10.3758/BF03194582; Recanzone GH, 2003, J NEUROPHYSIOL, V89, P1078, DOI 10.1152/jn.00706.2002; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Senkowski D, 2008, NEUROIMAGE, V43, P379, DOI 10.1016/j.neuroimage.2008.06.046; Shahin AJ, 2009, J ACOUST SOC AM, V125, P1744, DOI 10.1121/1.3075576; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; WARREN DH, 1981, PERCEPT PSYCHOPHYS, V30, P557, DOI 10.3758/BF03202010	32	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24016	10.1371/journal.pone.0024016	http://dx.doi.org/10.1371/journal.pone.0024016			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909378	Green Published, Green Submitted, gold			2022-12-25	WOS:000294680800046
J	Crisafulli, E; Beneventi, C; Bortolotti, V; Kidonias, N; Fabbri, LM; Chetta, A; Clini, EM				Crisafulli, Ernesto; Beneventi, Claudio; Bortolotti, Veronica; Kidonias, Nicoletta; Fabbri, Leonardo M.; Chetta, Alfredo; Clini, Enrico M.			Energy Expenditure at Rest and during Walking in Patients with Chronic Respiratory Failure: A Prospective Two-Phase Case-Control Study	PLOS ONE			English	Article							FAT-FREE MASS; MULTISENSOR ARMBAND; PHYSICAL-ACTIVITIES; COST; PEDOMETER; DISTANCE; DEVICE; ADULTS	Background: Measurements of Energy Expenditure (EE) at rest (REE) and during physical activities are increasing in interest in chronic patients. In this study we aimed at evaluating the validity/reliability of the SenseWear (R) Armband (SWA) device in terms of REE and EE during assisted walking in Chronic Respiratory Failure (CRF) patients receiving long-term oxygen therapy (LTOT). Methodology/Principal Findings: In a two-phase prospective protocol we studied 40 severe patients and 35 age-matched healthy controls. In phase-1 we determined the validity and repeatability of REE measured by SWA (REEa) in comparison with standard calorimetry (REEc). In phase-2 we then assessed EE and Metabolic Equivalents-METs by SWA during the 6-minute walking test while breathing oxygen in both assisted (Aid) or unassisted (No-Aid) modalities. When compared with REEc, REEa was slightly lower in patients (1351 +/- 169 vs 1413 +/- 194 kcal/day respectively, p<0.05), and less repeatable than in healthy controls (0.14 and 0.43 coefficient respectively). COPD patients with CRF patients reported a significant gain with Aid as compared with No-Aid modality in terms of meters walked, perceived symptoms and EE. Conclusions/Significance: SWA provides a feasible and valid method to assess the energy expenditure in CRF patients on LTOT, and it shows that aided walking results in a substantial energy saving in this population.	[Crisafulli, Ernesto; Beneventi, Claudio; Bortolotti, Veronica; Kidonias, Nicoletta; Clini, Enrico M.] Osped Villa Pineta, Dept Pulm Rehabil, Modena, Italy; [Fabbri, Leonardo M.; Clini, Enrico M.] Univ Modena, Dept Oncol Haematol & Pneumol, I-41100 Modena, Italy; [Chetta, Alfredo] Univ Parma, Dept Clin Sci, I-43100 Parma, Italy	Universita di Modena e Reggio Emilia; University of Parma	Crisafulli, E (corresponding author), Osped Villa Pineta, Dept Pulm Rehabil, Modena, Italy.	ecrisafulli@pneumonet.it	Clini, Enrico/ABE-6642-2020; Crisafulli, Ernesto/AAB-9595-2019; Clini, Enrico/A-4496-2017; Fabbri, Leonardo M/I-4055-2012	Clini, Enrico/0000-0002-1515-5094; Crisafulli, Ernesto/0000-0001-7298-7084; Clini, Enrico/0000-0002-1515-5094; Fabbri, Leonardo M/0000-0001-8894-1689; Chetta, Alfredo/0000-0002-0416-5334				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Bedogni G., 2009, MANUALE ANDID VALUTA; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BOUTEN CV, 1994, MED SCI SPORT EXER, V26, P1516; Casanova C, 2011, EUR RESPIR J, V37, P150, DOI 10.1183/09031936.00194909; Chen KY, 1987, J APPL PHYSIOL, V83, P2112; Cole PJ, 2004, J SPORT MED PHYS FIT, V44, P262; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Crisafulli E, 2007, CHEST, V131, P1068, DOI 10.1378/chest.06-2108; DONAHOE M, 1989, AM REV RESPIR DIS, V140, P385, DOI 10.1164/ajrccm/140.2.385; Dwyer TJ, 2009, RESP MED, V103, P1511, DOI 10.1016/j.rmed.2009.04.013; Eggermont LH, 2006, ARCH PHYS MED REHAB, V87, P733, DOI 10.1016/j.apmr.2006.02.008; Engelen MPKJ, 2000, AM J CLIN NUTR, V71, P733, DOI 10.1093/ajcn/71.3.733; Fruin ML, 2004, MED SCI SPORT EXER, V36, P1063, DOI 10.1249/01.MSS.0000128144.91337.38; Global Initiative for Chronic Obstructive Pulmonary Disease, NIH PUBL; Gosker HR, 2002, AM J CLIN NUTR, V76, P113, DOI 10.1093/ajcn/76.1.113; Hill K, 2010, THORAX, V65, P486, DOI 10.1136/thx.2009.128702; Jakicic JM, 2004, MED SCI SPORT EXER, V36, P897, DOI 10.1249/01.MSS.0000126805.32659.43; King GA, 2004, MED SCI SPORT EXER, V36, P1244, DOI 10.1249/01.MSS.0000132379.09364.F8; KNOX AJ, 1988, THORAX, V43, P388, DOI 10.1136/thx.43.5.388; Le Masurier GC, 2003, MED SCI SPORT EXER, V35, P867, DOI 10.1249/01.MSS.0000064996.63632.10; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Malavolti M, 2007, NUTR METAB CARDIOVAS, V17, P338, DOI 10.1016/j.numecd.2005.12.009; Mannix ET, 1999, CHEST, V115, P708, DOI 10.1378/chest.115.3.708; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; Mignault D, 2005, DIABETES CARE, V28, P225, DOI 10.2337/diacare.28.1.225-a; Papazoglou D, 2006, OBESITY, V14, P2217, DOI 10.1038/oby.2006.260; Patel Sanjay A, 2007, COPD, V4, P107, DOI 10.1080/15412550701246658; Pitta F, 2005, AM J RESP CRIT CARE, V171, P972, DOI 10.1164/rccm.200407-855OC; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; SCHOLS AMWJ, 1993, AM REV RESPIR DIS, V147, P1151, DOI 10.1164/ajrccm/147.5.1151; Slinde F, 2003, CLIN NUTR, V22, P159, DOI 10.1054/clnu.2002.0618; SRIDHAR MK, 1994, THORAX, V49, P781, DOI 10.1136/thx.49.8.781; St-Onge M, 2007, AM J CLIN NUTR, V85, P742, DOI 10.1093/ajcn/85.3.742; Steele BG, 2000, CHEST, V117, P1359, DOI 10.1378/chest.117.5.1359; Troosters T, 1999, EUR RESPIR J, V14, P270, DOI 10.1034/j.1399-3003.1999.14b06.x; Tudor-Locke C, 2002, MED SCI SPORT EXER, V34, P2045, DOI 10.1097/00005768-200212000-00027; TURELL DJ, 1964, J APPL PHYSIOL, V19, P946, DOI 10.1152/jappl.1964.19.5.946	39	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23770	10.1371/journal.pone.0023770	http://dx.doi.org/10.1371/journal.pone.0023770			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909356	Green Published, Green Submitted, gold			2022-12-25	WOS:000294680800019
J	Sanders, C; Smith, DP				Sanders, Charcacia; Smith, Dean P.			LUMP Is a Putative Double-Stranded RNA Binding Protein Required for Male Fertility in Drosophila melanogaster	PLOS ONE			English	Article							GERM-LINE; SPERM INDIVIDUALIZATION; CELL-PROLIFERATION; MICRORNA; SPERMATOGENESIS; SPERMIOGENESIS; DISSECTION; MATURATION; DYNAMICS; COMPLEX	In animals, male fertility requires the successful development of motile sperm. During Drosophila melanogaster spermatogenesis, 64 interconnected spermatids descended from a single germline stem cell are resolved into motile sperm in a process termed individualization. Here we identify a putative double-stranded RNA binding protein LUMP that is required for male fertility. lump 1 mutants are male-sterile and lack motile sperm due to defects in sperm individualization. We show that one dsRNA binding domains (dsRBD) is essential for LUMP function in male fertility. These findings reveal LUMP is a novel factor required for late stages of male germline differentiation.	[Sanders, Charcacia] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sanders, C (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	Dean.Smith@utsouthwestern.edu		Smith, Dean/0000-0002-4271-0436	National Institutes of Health (NIH) [R01 GM070684]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011751] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) R01 GM070684 (http://era.nih.gov/commons/index.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CASTRILLON DH, 1993, GENETICS, V135, P489; Cho C, 2001, NAT GENET, V28, P82, DOI 10.1038/ng0501-82; Cox DN, 2000, DEVELOPMENT, V127, P503; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Fabrizio JJ, 1998, DEVELOPMENT, V125, P1833; Fierro-Monti I, 2000, TRENDS BIOCHEM SCI, V25, P241, DOI 10.1016/S0968-0004(00)01580-2; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Fuller MT, 1998, SEMIN CELL DEV BIOL, V9, P433, DOI 10.1006/scdb.1998.0227; Fuller MT, 1993, DEV DROSPHILA MELANO; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; Gerbasi VR, 2011, P NATL ACAD SCI USA, V108, P3204, DOI 10.1073/pnas.1009781108; Ghosh-Roy A, 2005, MOL BIOL CELL, V16, P3107, DOI 10.1091/mbc.E05-02-0103; Ghosh-Roy A, 2004, MOL BIOL CELL, V15, P2470, DOI 10.1091/mbc.E03-11-0848; Gonczy P, 1996, DEVELOPMENT, V122, P2437; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Huh JR, 2004, PLOS BIOL, V2, P43, DOI 10.1371/journal.pbio.0020015; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Kalidas S, 2002, NEURON, V33, P177, DOI 10.1016/S0896-6273(02)00560-3; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Mermall V, 2005, DEV BIOL, V286, P238, DOI 10.1016/j.ydbio.2005.07.028; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nagao A, 2010, RNA, V16, P2503, DOI 10.1261/rna.2270710; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; Noguchi T, 2006, MOL BIOL CELL, V17, P2559, DOI 10.1091/mbc.E06-01-0031; Pirrotta V, 1988, Biotechnology, V10, P437; Raja SJ, 2006, MOL CELL BIOL, V26, P3682; ROBERTSON HM, 1988, GENETICS, V118, P461; ROOSENRUNGE EC, 1952, ANN NY ACAD SCI, V55, P574, DOI 10.1111/j.1749-6632.1952.tb26577.x; Sartain CV, 2011, DEVELOPMENT, V138, P1619, DOI 10.1242/dev.059618; Schmidt A, 1999, GENETICS, V151, P749; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; TOKUYASU KT, 1972, Z ZELLFORSCH MIK ANA, V124, P479, DOI 10.1007/BF00335253; TOKUYASU KT, 1972, Z ZELLFORSCH MIK ANA, V127, P492, DOI 10.1007/BF00306868; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Zhong L, 2007, DEVELOPMENT, V134, P3517, DOI 10.1242/dev.004770	44	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24151	10.1371/journal.pone.0024151	http://dx.doi.org/10.1371/journal.pone.0024151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912621	Green Published, gold, Green Submitted			2022-12-25	WOS:000294678300026
J	Reuland, SN; Goldstein, NB; Partyka, KA; Cooper, DA; Fujita, M; Norris, DA; Shellman, YG				Reuland, Steven N.; Goldstein, Nathaniel B.; Partyka, Katie A.; Cooper, David A.; Fujita, Mayumi; Norris, David A.; Shellman, Yiqun G.			The Combination of BH3-Mimetic ABT-737 with the Alkylating Agent Temozolomide Induces Strong Synergistic Killing of Melanoma Cells Independent of p53	PLOS ONE			English	Article							BH3 MIMETIC ABT-737; METASTATIC MELANOMA; CANCER-THERAPY; APOPTOSIS; NOXA; INHIBITOR; MCL-1; SENSITIVITY; MECHANISMS; PROTEINS	Metastatic melanoma has poor prognosis and is refractory to most conventional chemotherapies. The alkylating agent temozolomide (TMZ) is commonly used in treating melanoma but has a disappointing response rate. Agents that can act cooperatively with TMZ and improve its efficacy are thus highly sought after. The BH3 mimetic ABT-737, which can induce apoptosis by targeting pro-survival Bcl-2 family members, has been found to enhance the efficacy of many conventional chemotherapeutic agents in multiple cancers. We found that combining TMZ and ABT-737 induced strong synergistic apoptosis in multiple human melanoma cell lines. When the drugs were used in combination in a mouse xenograft model, they drastically reduced tumor growth at concentrations where each individual drug had no significant effect. We found that TMZ treatment elevated p53 levels, and that the pro-apoptotic protein Noxa was elevated in TMZ/ABT-737 treated cells. Experiments with shRNA demonstrated that the synergistic effect of TMZ and ABT-737 was largely dependent on Noxa. Experiments with nutlin-3, a p53 inducer, demonstrated that p53 induction was sufficient for synergistic cell death with ABT-737 in a Noxa-dependent fashion. However, p53 was not necessary for TMZ/ABT-737 synergy as demonstrated by a p53-null line, indicating that TMZ and ABT-737 together induce Noxa in a p53-independent fashion. These results demonstrate that targeting anti-apoptotic Bcl-2 members is a promising method for treating metastatic melanoma, and that clinical trials with TMZ and Bcl-2 inhibitors are warranted.	[Reuland, Steven N.; Goldstein, Nathaniel B.; Partyka, Katie A.; Cooper, David A.; Fujita, Mayumi; Norris, David A.; Shellman, Yiqun G.] Univ Colorado Denver, Sch Med, Dept Dermatol, Aurora, CO USA; [Norris, David A.] Dept Vet Affairs Med Ctr, Dermatol Sect, Denver, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Reuland, SN (corresponding author), Univ Colorado Denver, Sch Med, Dept Dermatol, Aurora, CO USA.	yiqun.shellman@ucdenver.edu	Goldstein, Nathaniel/AAN-7503-2020	Shellman, Yiqun/0000-0003-0598-5753; Goldstein, Nathaniel/0000-0001-8814-3767	NIAMS [R01AR26427-18]; Veterans Administration from Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; NIH [5T32AR007411-29]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007411, R01AR026427] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Administration from Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by NIAMS grant R01AR26427-18 to DAN; by a Veterans Administration merit grant from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development to DAN; and by NIH training grant 5T32AR007411-29 to SNR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala S S, 2000, Oncologist, V5, P144, DOI 10.1634/theoncologist.5-2-144; Atallah Ehab, 2005, Curr Treat Options Oncol, V6, P185; Bael TE, 2008, MELANOMA RES, V18, P147, DOI 10.1097/CMR.0b013e3282f2a7ae; Chen M, 2009, MOL CANCER RES, V7, P703, DOI 10.1158/1541-7786.MCR-08-0263; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Clarck JI, 2009, CANCER, V116, P424; Hauck P, 2009, MOL CANCER THER, V8, P883, DOI 10.1158/1535-7163.MCT-08-1118; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Keuling AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006651; La Porta CAM, 2009, CURR CANCER DRUG TAR, V9, P391, DOI 10.2174/156800909788166574; Lestini BJ, 2009, CANCER BIOL THER, V8, P1587, DOI 10.4161/cbt.8.16.8964; Lui P, 2007, CANCER TREAT REV, V33, P665, DOI 10.1016/j.ctrv.2007.06.004; Mhaidat NM, 2007, BRIT J CANCER, V97, P1225, DOI 10.1038/sj.bjc.6604017; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Miller LA, 2009, J INVEST DERMATOL, V129, P964, DOI 10.1038/jid.2008.327; Naumann SC, 2009, BRIT J CANCER, V100, P322, DOI 10.1038/sj.bjc.6604856; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Okumura K, 2008, CLIN CANCER RES, V14, P8132, DOI 10.1158/1078-0432.CCR-08-1665; Qin JZ, 2006, CANCER RES, V66, P9636, DOI 10.1158/0008-5472.CAN-06-0747; Ruth MC, 2006, J INVEST DERMATOL, V126, P862, DOI 10.1038/sj.jid.5700211; Shoemaker AR, 2006, CANCER RES, V66, P8731, DOI 10.1158/0008-5472.CAN-06-0367; Tawbi Hussein A, 2010, Clin Adv Hematol Oncol, V8, P259; Tentori L, 2002, CURR MED CHEM, V9, P1285, DOI 10.2174/0929867023369916; Terzian T, 2010, PIGM CELL MELANOMA R, V23, P781, DOI 10.1111/j.1755-148X.2010.00773.x; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Weber A, 2009, TRANSL ONCOL, V2, P73, DOI 10.1593/tlo.08223; *WELLC TRUST SANG, 2009, RPMI 7951 CAT SOM MU; Wierzbicka-Hainaut E, 2010, MELANOMA RES, V20, P141, DOI 10.1097/CMR.0b013e3283350578; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Zhang L, 2007, DRUG RESIST UPDATE, V10, P207, DOI 10.1016/j.drup.2007.08.002	30	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e24294	10.1371/journal.pone.0024294	http://dx.doi.org/10.1371/journal.pone.0024294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897876	Green Published, Green Submitted, gold			2022-12-25	WOS:000294676900041
J	Vorobieva, NV; Sherbakov, DY; Druzhkova, AS; Stanyon, R; Tsybankov, AA; Vasil'ev, SK; Shunkov, MV; Trifonov, VA; Graphodatsky, AS				Vorobieva, Nadezhda V.; Sherbakov, Dmitry Y.; Druzhkova, Anna S.; Stanyon, Roscoe; Tsybankov, Alexander A.; Vasil'ev, Sergey K.; Shunkov, Mikhail V.; Trifonov, Vladimir A.; Graphodatsky, Alexander S.			Genotyping of Capreolus pygargus Fossil DNA from Denisova Cave Reveals Phylogenetic Relationships between Ancient and Modern Populations	PLOS ONE			English	Article							EUROPEAN ROE DEER; MITOCHONDRIAL; HOMININ	Background: The extant roe deer (Capreolus Gray, 1821) includes two species: the European roe deer (C. capreolus) and the Siberian roe deer (C. pygargus) that are distinguished by morphological and karyotypical differences. The Siberian roe deer occupies a vast area of Asia and is considerably less studied than the European roe deer. Modern systematics of the Siberian roe deer remain controversial with 4 morphological subspecies. Roe deer fossilized bones are quite abundant in Denisova cave (Altai Mountains, South Siberia), where dozens of both extant and extinct mammalian species from modern Holocene to Middle Pleistocene have been retrieved. Methodology/Principal Findings: We analyzed a 629 bp fragment of the mitochondrial control region from ancient bones of 10 Holocene and four Pleistocene Siberian roe deer from Denisova cave as well as 37 modern specimen belonging to populations from Altai, Tian Shan (Kyrgyzstan), Yakutia, Novosibirsk region and the Russian Far East. Genealogical reconstructions indicated that most Holocene haplotypes were probably ancestral for modern roe deer populations of Western Siberia and Tian Shan. One of the Pleistocene haplotypes was possibly ancestral for modern Yakutian populations, and two extinct Pleistocene haplotypes were close to modern roe deer from Tian Shan and Yakutia. Most modern geographical populations (except for West Siberian Plains) are heterogeneous and there is some tentative evidence for structure. However, we did not find any distinct phylogenetic signal characterizing particular subspecies in either modern or ancient samples. Conclusion/Significance: Analysis of mitochondrial DNA from both ancient and modern samples of Siberian roe deer shed new light on understanding the evolutionary history of roe deer. Our data indicate that during the last 50,000 years multiple replacements of populations of the Siberian roe deer took place in the Altai Mountains correlating with climatic changes. The Siberian roe deer represent a complex and heterogeneous species with high migration rates and without evident subspecies structure. Low genetic diversity of the West Siberian Plain population indicates a recent bottleneck or founder effect.	[Vorobieva, Nadezhda V.; Druzhkova, Anna S.; Trifonov, Vladimir A.; Graphodatsky, Alexander S.] Russian Acad Sci, Inst Mol & Cellular Biol, Siberian Branch, Novosibirsk, Russia; [Sherbakov, Dmitry Y.] Russian Acad Sci, Inst Limnol, Siberian Branch, Irkutsk 664003, Russia; [Sherbakov, Dmitry Y.] Irkutsk State Univ, Irkutsk 664003, Russia; [Stanyon, Roscoe] Univ Florence, Dept Evolutionary Biol, Florence, Italy; [Tsybankov, Alexander A.; Vasil'ev, Sergey K.; Shunkov, Mikhail V.] Russian Acad Sci, Inst Archaeol & Ethnog, Siberian Branch, Novosibirsk, Russia	Russian Academy of Sciences; Irkutsk Science Centre of the Russian Academy of Sciences; Russian Academy of Sciences; Limnological Institute SB RAS; Irkutsk State University; University of Florence; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences	Vorobieva, NV (corresponding author), Russian Acad Sci, Inst Mol & Cellular Biol, Siberian Branch, Novosibirsk, Russia.	vlad@mcb.nsc.ru	Sherbakov, Dmitry/ABD-9804-2020; Graphodatsky, Alexander/B-4922-2010; Sherbakov, Dmitry/AAL-5260-2020; Sherbakov, Dmitry Yu/S-4953-2018; Trifonov, Vladimir/E-4907-2012; Vorobieva, Nadezhda/N-6461-2015; Shunkov, Mikhail V./Q-6576-2016; Druzhkova, Anna/N-2011-2015	Graphodatsky, Alexander/0000-0002-8282-1085; Sherbakov, Dmitry/0000-0002-1410-392X; Sherbakov, Dmitry Yu/0000-0002-1410-392X; Trifonov, Vladimir/0000-0003-0454-8359; Shunkov, Mikhail V./0000-0003-1388-2308; Stanyon, Roscoe/0000-0002-7229-1092	Russian Fund for Basic Research [09-04-00056-a, 08-04-00301-a, 09-04-00972]; Russian Academy of Science; Siberian Branch of the Russian Academy of Science; Federal Target Program [02.740.11.0353]	Russian Fund for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Science(Russian Academy of Sciences); Siberian Branch of the Russian Academy of Science(Russian Academy of Sciences); Federal Target Program	The work was supported by research grants of the Russian Fund for Basic Research (09-04-00056-a to A. S. G, 08-04-00301-a to V. A. T and 09-04-00972 to D.Y.S.); MCB program of the Russian Academy of Science (A. S. G.); Integration Program of the Siberian Branch of the Russian Academy of Science (A. S. G.) and Federal Target Program "Scientific and Educational-Scientific Pedagogical Personnel of Innovative Russia" No 02.740.11.0353 (to A. A. T. and M. V. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G.M., 1940, NATURAL HIST CENTRAL, V11, P621; Arkhipov S.A., 1994, GEOLOGICAL HIST PLEI; AS G, 1990, J ZOOL, V69, P101; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Danilkin A.A., 1999, OLENI CERVIDAE; DANILKIN AA, 1992, DISTRIBUTION EUROPEA; Derevianko AP, 2008, ARCHAEOL ETHNOL ANTH, V34, P13, DOI 10.1016/j.aeae.2008.07.002; Derevianko A. P., 1994, DENISOVA CAVE 1; DEREVIANKO AP, 2003, UPPER PALAEOLITHIC S; DEREVIANKO AP, 2010, PROBLEMS ARCHAEOLOGY; DEREVIANKO AP, 2003, PALEOENVIRONMENT PAL, P448; Douzery E, 1997, MOL BIOL EVOL, V14, P1154, DOI 10.1093/oxfordjournals.molbev.a025725; EXCOFFIER L, 1992, GENETICS, V131, P479; Felsenstein J., 1991, PHYLIP PHYLOGENETIC; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Huelsenbeck JP, 1996, TRENDS ECOL EVOL, V11, P152, DOI 10.1016/0169-5347(96)10006-9; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Nylander JAA, 2004, MRMODELTEST V2 0; ORLOVA LA, 2000, PROBLEMS CLIMATE ENV; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Randi E, 1998, HEREDITY, V80, P429, DOI 10.1038/sj.hdy.6883180; Randi E, 2004, MOL ECOL, V13, P3071, DOI 10.1111/j.1365-294X.2004.02279.x; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Sheremet'eva I N, 2010, Genetika, V46, P677; Sheremetyeva IN, 2008, EUR J WILDLIFE RES, V54, P557, DOI 10.1007/s10344-008-0180-0; SOKOLOV VE, 1990, MAMMALIA, V54, P431, DOI 10.1515/mamm.1990.54.3.431; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Xiao CT, 2007, BIOCHEM GENET, V45, P93, DOI 10.1007/s10528-006-9052-z; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2; ZYKINA VS, 2000, PROBLEMS CLIMATE ENV	32	18	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e24045	10.1371/journal.pone.0024045	http://dx.doi.org/10.1371/journal.pone.0024045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897868	gold, Green Published, Green Submitted			2022-12-25	WOS:000294676900032
J	Oike, H; Nagai, K; Fukushima, T; Ishida, N; Kobori, M				Oike, Hideaki; Nagai, Kanji; Fukushima, Tatsunobu; Ishida, Norio; Kobori, Masuko			Feeding Cues and Injected Nutrients Induce Acute Expression of Multiple Clock Genes in the Mouse Liver	PLOS ONE			English	Article							MOLECULAR CIRCADIAN-RHYTHMS; PERIPHERAL CLOCKS; MESSENGER-RNA; ENTRAINMENT; GLUCOSE; TIME; TRANSCRIPTION; SIGNALS; TISSUES; SYSTEM	The circadian clock is closely associated with energy metabolism. The liver clock can rapidly adapt to a new feeding cycle within a few days, whereas the lung clock is gradually entrained over one week. However, the mechanism underlying tissue-specific clock resetting is not fully understood. To characterize the rapid response to feeding cues in the liver clock, we examined the effects of a single time-delayed feeding on circadian rhythms in the liver and lungs of Per2::Luc reporter knockin mice. After adapting to a night-time restricted feeding schedule, the mice were fed according to a 4, 8, or 13 h delayed schedule on the last day. The phase of the liver clock was delayed in all groups with delayed feeding, whereas the lung clock remained unaffected. We then examined the acute response of clock and metabolism-related genes in the liver using focused DNA-microarrays. Clock mutant mice were bred under constant light to attenuate the endogenous circadian rhythm, and gene expression profiles were determined during 24 h of fasting followed by 8 h of feeding. Per2 and Dec1 were significantly increased within 1 h of feeding. Real-time RT-PCR analysis revealed a similarly acute response in hepatic clock gene expression caused by feeding wild type mice after an overnight fast. In addition to Per2 and Dec1, the expression of Per1 increased, and that of Rev-erba decreased in the liver within 1 h of feeding after fasting, whereas none of these clock genes were affected in the lung. Moreover, an intraperitoneal injection of glucose combined with amino acids, but not either alone, reproduced a similar hepatic response. Our findings show that multiple clock genes respond to nutritional cues within 1 h in the liver but not in the lung.	[Oike, Hideaki; Nagai, Kanji; Kobori, Masuko] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan; [Nagai, Kanji; Fukushima, Tatsunobu] Mitsubishi Rayon Co Ltd, Yokohama, Kanagawa, Japan; [Ishida, Norio] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan; [Ishida, Norio] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Mitsubishi Chemical Holdings Corporation; Mitsubishi Rayon Co., Ltd.; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Oike, H (corresponding author), Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan.	oike@affrc.go.jp		Oike, Hideaki/0000-0002-6139-5726	KAKENHI [21700778]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by KAKENHI [21700778; Grant-in-Aid for Young Scientists (B)] to HO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dardente H, 2007, CHRONOBIOL INT, V24, P195, DOI 10.1080/07420520701283693; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; GRANNER D, 1983, NATURE, V305, P549, DOI 10.1038/305549a0; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hirao A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006909; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Hohjoh H, 2007, GENE, V391, P39, DOI 10.1016/j.gene.2006.11.018; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; IYNEDJIAN PB, 1989, P NATL ACAD SCI USA, V86, P7838, DOI 10.1073/pnas.86.20.7838; KATO H, 1984, LIFE SCI, V34, P331, DOI 10.1016/0024-3205(84)90620-9; Kobori M, 2008, J AGR FOOD CHEM, V56, P4004, DOI 10.1021/jf800052y; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Mendoza J, 2007, J NEUROENDOCRINOL, V19, P127, DOI 10.1111/j.1365-2826.2006.01510.x; Miki H, 2003, NEUROREPORT, V14, P1457, DOI 10.1097/00001756-200308060-00010; Nakamura TJ, 2010, STEROIDS, V75, P203, DOI 10.1016/j.steroids.2010.01.007; Oike H, 2011, BIOCHEM BIOPH RES CO, V410, P654, DOI 10.1016/j.bbrc.2011.06.049; Oike H, 2010, BIOCHEM BIOPH RES CO, V402, P7, DOI 10.1016/j.bbrc.2010.09.072; Oishi K, 2002, BIOCHEM BIOPH RES CO, V298, P198, DOI 10.1016/S0006-291X(02)02427-0; Pezuk P, 2010, J BIOL RHYTHM, V25, P432, DOI 10.1177/0748730410385204; Pitts SN, 2003, AM J PHYSIOL-REG I, V285, pR57, DOI 10.1152/ajpregu.00023.2003; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; SAITO M, 1989, J NUTR SCI VITAMINOL, V35, P639, DOI 10.3177/jnsv.35.639; SAITO M, 1981, EXPERIENTIA, V37, P754, DOI 10.1007/BF01967962; Sei H, 2001, NEUROREPORT, V12, P1461, DOI 10.1097/00001756-200105250-00033; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Stephan FK, 1998, PHYSIOL BEHAV, V65, P277, DOI 10.1016/S0031-9384(98)00166-8; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Wu T, 2010, CHRONOBIOL INT, V27, P1, DOI 10.3109/07420520903398625; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	41	44	44	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23709	10.1371/journal.pone.0023709	http://dx.doi.org/10.1371/journal.pone.0023709			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901130	Green Published, gold, Green Submitted			2022-12-25	WOS:000294298000015
J	van den Akker, J; VanBavel, E; van Geel, R; Matlung, HL; Tuna, BG; Janssen, GMC; van Veelen, PA; Boelens, WC; De Mey, JGR; Bakker, ENTP				van den Akker, Jeroen; VanBavel, Ed; van Geel, Remon; Matlung, Hanke L.; Tuna, Bilge Guvenc; Janssen, George M. C.; van Veelen, Peter A.; Boelens, Wilbert C.; De Mey, Jo G. R.; Bakker, Erik N. T. P.			The Redox State of Transglutaminase 2 Controls Arterial Remodeling	PLOS ONE			English	Article							TISSUE-TYPE TRANSGLUTAMINASE; MESENTERIC SMALL ARTERIES; CROSS-LINKING; OXIDATIVE STRESS; RHOA ACTIVATION; S-NITROSYLATION; THIOREDOXIN; MECHANISMS; CELLS; VASOCONSTRICTION	While inward remodeling of small arteries in response to low blood flow, hypertension, and chronic vasoconstriction depends on type 2 transglutaminase (TG2), the mechanisms of action have remained unresolved. We studied the regulation of TG2 activity, its (sub) cellular localization, substrates, and its specific mode of action during small artery inward remodeling. We found that inward remodeling of isolated mouse mesenteric arteries by exogenous TG2 required the presence of a reducing agent. The effect of TG2 depended on its cross-linking activity, as indicated by the lack of effect of mutant TG2. The cell-permeable reducing agent DTT, but not the cell-impermeable reducing agent TCEP, induced translocation of endogenous TG2 and high membrane-bound transglutaminase activity. This coincided with inward remodeling, characterized by a stiffening of the artery. The remodeling could be inhibited by a TG2 inhibitor and by the nitric oxide donor, SNAP. Using a pull-down assay and mass spectrometry, 21 proteins were identified as TG2 cross-linking substrates, including fibronectin, collagen and nidogen. Inward remodeling induced by low blood flow was associated with the upregulation of several anti-oxidant proteins, notably glutathione-S-transferase, and selenoprotein P. In conclusion, these results show that a reduced state induces smooth muscle membrane-bound TG2 activity. Inward remodeling results from the cross-linking of vicinal matrix proteins, causing a stiffening of the arterial wall.	[van den Akker, Jeroen; VanBavel, Ed; Matlung, Hanke L.; Tuna, Bilge Guvenc; Bakker, Erik N. T. P.] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands; [van Geel, Remon; Boelens, Wilbert C.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Biomol Chem 271, NL-6525 ED Nijmegen, Netherlands; [Janssen, George M. C.; van Veelen, Peter A.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Janssen, George M. C.] Netherlands Prote Ctr, Utrecht, Netherlands; [De Mey, Jo G. R.] Maastricht Univ, Dept Pharmacol & Toxicol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University	van den Akker, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	n.t.bakker@amc.uva.nl	Boelens, Wilbert/D-8877-2012; Matlung, Hanke/ABH-5649-2020; Tuna, Bilge Güvenç/O-2215-2014; Tuna, Bilge Guvenc/AAB-5827-2020	Tuna, Bilge Güvenç/0000-0003-1348-1336; Tuna, Bilge Guvenc/0000-0003-1348-1336; De Mey, Jo G. R./0000-0001-6274-8071; Bakker, Erik/0000-0003-2819-5818; van Bavel, Ed/0000-0001-8654-986X; van Veelen, Peter/0000-0002-7898-9408	Netherlands Heart Foundation [NHS.2005.B080, NHS.2001.T038]; Dutch Top Institute Pharma [TIPharma T2-108]; European Union, Marie Curie ITN	Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Top Institute Pharma; European Union, Marie Curie ITN	This work is supported by the Netherlands Heart Foundation (grant NHS.2005.B080 to Jeroen van den Akker and NHS.2001.T038 to Hanke L. Matlung). Ed VanBavel and Jo G. R. De Mey are supported by the Dutch Top Institute Pharma, TIPharma T2-108. Bilge Guvenc Tuna is supported by the European Union, Marie Curie ITN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AESCHLIMANN D, 1991, J BIOL CHEM, V266, P15308; Aeschlimann D, 2000, CONNECT TISSUE RES, V41, P1, DOI 10.3109/03008200009005638; Bakker ENTP, 2005, CIRC RES, V96, P119, DOI 10.1161/01.RES.0000151333.56089.66; Bakker ENTP, 2004, J VASC RES, V41, P174, DOI 10.1159/000077288; Bakker ENTP, 2002, J VASC RES, V39, P12, DOI 10.1159/000048989; Bakker ENTP, 2008, J VASC RES, V45, P271, DOI 10.1159/000113599; Bakker ENTP, 2006, CIRC RES, V99, P86, DOI 10.1161/01.RES.0000229657.83816.a7; Barron JT, 2004, MOL CELL BIOCHEM, V262, P91, DOI 10.1023/B:MCBI.0000038221.44904.a1; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Bernassola F, 1999, ANN NY ACAD SCI, V887, P83, DOI 10.1111/j.1749-6632.1999.tb07924.x; Berndt C, 2007, AM J PHYSIOL-HEART C, V292, pH1227, DOI 10.1152/ajpheart.01162.2006; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Buus CL, 2001, CIRC RES, V89, P180, DOI 10.1161/hh1401.093575; Chen JSK, 1999, INT J BIOCHEM CELL B, V31, P817, DOI 10.1016/S1357-2725(99)00045-X; Chowdhury ZA, 1997, EXP CELL RES, V231, P38, DOI 10.1006/excr.1996.3448; CHUNG SI, 1970, J BIOL CHEM, V245, P681; CONNELLAN JM, 1969, J BIOL CHEM, V244, P3173; Di Niro R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq052; Eftekhari A, 2007, J VASC RES, V44, P471, DOI 10.1159/000106465; Ehrmann J, 2003, VIRCHOWS ARCH, V442, P453, DOI 10.1007/s00428-003-0794-2; Facchiano A, 2009, AMINO ACIDS, V36, P599, DOI 10.1007/s00726-008-0124-8; Faverman L, 2008, FEBS LETT, V582, P1552, DOI 10.1016/j.febslet.2008.03.053; Guilluy C, 2007, J BIOL CHEM, V282, P2918, DOI 10.1074/jbc.M604195200; Hasegawa G, 2003, BIOCHEM J, V373, P793, DOI 10.1042/BJ20021084; Ientile R, 2007, AMINO ACIDS, V33, P385, DOI 10.1007/s00726-007-0517-0; Janiak A, 2006, MOL BIOL CELL, V17, P1606, DOI 10.1091/mbc.E05-06-0549; Janiszewski M, 2005, J BIOL CHEM, V280, P40813, DOI 10.1074/jbc.M509255200; Jeong EM, 2009, FEBS LETT; Johnson KA, 2008, CIRC RES, V102, P529, DOI 10.1161/CIRCRESAHA.107.154260; Koller A, 2006, CIRC RES, V99, P6, DOI 10.1161/01.RES.0000233144.65663.23; Lai TS, 2001, BIOCHEMISTRY-US, V40, P4904, DOI 10.1021/bi002321t; Langille BL, 2005, CIRC RES, V96, P9, DOI 10.1161/01.RES.0000153883.55971.81; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Luciani A, 2009, J IMMUNOL, V183, P2775, DOI 10.4049/jimmunol.0900993; Matlung HL, 2009, AM J PATHOL, V175, P1374, DOI 10.2353/ajpath.2009.090012; Matlung HL, 2010, ATHEROSCLEROSIS; Nemes Z, 2005, PROG EXP TUMOR RES, V38, P19; Park D, 2010, AMINO ACIDS, V39, P619, DOI 10.1007/s00726-010-0500-z; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Piredda L, 1999, FASEB J, V13, P355, DOI 10.1096/fasebj.13.2.355; Pistea A, 2005, AM J PHYSIOL-HEART C, V289, pH2632, DOI 10.1152/ajpheart.00205.2005; Pistea A, 2008, J VASC RES, V45, P10, DOI 10.1159/000109073; Pourageaud F, 1997, AM J PHYSIOL-HEART C, V273, pH1699, DOI 10.1152/ajpheart.1997.273.4.H1699; Rizzoni D, 2003, CIRCULATION, V108, P2230, DOI 10.1161/01.CIR.0000095031.51492.C5; Santhanam L, 2010, CIRC RES, V107, P117, DOI 10.1161/CIRCRESAHA.109.215228; Shin DM, 2004, J BIOL CHEM, V279, P15032, DOI 10.1074/jbc.M308734200; Shin DM, 2008, FASEB J, V22, P2498, DOI 10.1096/fj.07-095455; Siegel M, 2007, PHARMACOL THERAPEUT, V115, P232, DOI 10.1016/j.pharmthera.2007.05.003; SIPPEL TO, 1978, HISTOCHEM J, V10, P597, DOI 10.1007/BF01003140; Soderberg A, 2000, CANCER RES, V60, P2281; Stamnaes J, 2010, J BIOL CHEM; Strom A, 2006, CARDIOVASC RES, V69, P755, DOI 10.1016/j.cardiores.2005.12.001; Thiele M, 2005, ANTIOXID REDOX SIGN, V7, P1234, DOI 10.1089/ars.2005.7.1234; van Hall T, 2006, NAT MED, V12, P417, DOI 10.1038/nm1381; VanBavel E, 2006, CLIN HEMORHEOL MICRO, V34, P35; VanBavel E, 2008, CIRC RES, V102, P507, DOI 10.1161/CIRCRESAHA.108.173013; Verderio EAM, 2009, AMINO ACIDS, V36, P671, DOI 10.1007/s00726-008-0134-6; Waypa GB, 2010, CIRC RES, V106, P526, DOI 10.1161/CIRCRESAHA.109.206334; Wesselman JPM, 2004, J VASC RES, V41, P277, DOI 10.1159/000078826; Wolin MS, 2009, AM J PHYSIOL-HEART C, V296, pH539, DOI 10.1152/ajpheart.01167.2008; World CJ, 2006, J MOL MED-JMM, V84, P997, DOI 10.1007/s00109-006-0109-6; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863; Zhang GY, 2003, J AGR FOOD CHEM, V51, P236, DOI 10.1021/jf020550b	63	44	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23067	10.1371/journal.pone.0023067	http://dx.doi.org/10.1371/journal.pone.0023067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901120	Green Published, gold			2022-12-25	WOS:000294298000005
J	Kim, DK; Kim, JR; Koh, M; Kim, YD; Lee, JM; Chanda, D; Park, SB; Min, JJ; Lee, CH; Park, TS; Choi, HS				Kim, Don-Kyu; Kim, Jung Ran; Koh, Minseob; Kim, Yong Deuk; Lee, Ji-Min; Chanda, Dipanjan; Park, Seung Bum; Min, Jung-Joon; Lee, Chul-Ho; Park, Tae-Sik; Choi, Hueng-Sik			Estrogen-related Receptor gamma (ERR gamma) Is a Novel Transcriptional Regulator of Phosphatidic Acid Phosphatase, LIPIN1, and Inhibits Hepatic Insulin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN NUCLEAR RECEPTOR; SMALL-HETERODIMER-PARTNER; FATTY LIVER-DISEASE; GENE-EXPRESSION; OXIDATIVE-METABOLISM; ADIPOSE-TISSUE; ACTIVATION; RESISTANCE; ALPHA; MUTATION	LIPINs have been reported to perform important roles in the regulation of intracellular lipid levels. Their mutations induce lipodystrophy, myoglobinuria, and inflammatory disorders. Recently, the phosphatidic acid phosphatase function of LIPINs has been associated with the perturbation of hepatic insulin receptor signaling via the diacylglycerol-mediated stimulation of PKC epsilon activity. Here, we report that nuclear estrogen-related receptor (ERR) gamma is a novel transcriptional regulator of LIPIN1. Overexpression of ERR gamma significantly increased LIPIN1 expression in primary hepatocytes, whereas the abolition of ERR gamma gene expression attenuated the expression of LIPIN1. Deletion and mutation analyses of the LIPIN1 promoter showed that ERR gamma exerts its effect on the transcriptional regulation of LIPIN1 via ERRE1 of the LIPIN1 promoter, as confirmed by ChIP assay. We also determined that the gene transcription of LIPIN1 by ERR gamma is controlled by the competition between PGC-1 alpha and small heterodimer partner. Additionally, ERR gamma leads to the induction of hepatic LIPIN1 expression and diacylglycerol production in vivo. Finally, an inverse agonist of ERR gamma, GSK5182, restores the impaired insulin signaling induced by LIPIN1-mediated PKC epsilon activation. Our findings indicate that the selective control of ERR gamma transcriptional activity by its specific inverse agonist could provide a novel therapeutic approach to the amelioration of impaired hepatic insulin signaling induced by LIPIN1-mediated PKC epsilon activation.	[Kim, Don-Kyu; Kim, Yong Deuk; Lee, Ji-Min; Chanda, Dipanjan; Choi, Hueng-Sik] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Kim, Don-Kyu; Kim, Yong Deuk; Lee, Ji-Min; Chanda, Dipanjan; Choi, Hueng-Sik] Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Kim, Jung Ran; Park, Tae-Sik] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Dept Med, Inchon 406840, South Korea; [Koh, Minseob; Park, Seung Bum] Seoul Natl Univ, Dept Chem, Coll Nat Sci, Seoul 151747, South Korea; [Park, Seung Bum] Seoul Natl Univ, Dept Biophys & Chem Biol, Coll Nat Sci, Seoul 151747, South Korea; [Min, Jung-Joon] Chonnam Natl Univ, Sch Med, Dept Nucl Med, Kwangju 501746, South Korea; [Min, Jung-Joon] Chonnam Natl Univ, Sch Med, Dept Microbiol, Kwangju 501746, South Korea; [Min, Jung-Joon] Gwangju Inst Sci & Technol, Bioimaging Res Ctr, Kwangju 500712, South Korea; [Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Res Inst Med Sci, Kwangju 501746, South Korea	Chonnam National University; Chonnam National University; Gachon University; Seoul National University (SNU); Seoul National University (SNU); Chonnam National University; Chonnam National University; Gwangju Institute of Science & Technology (GIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chonnam National University	Choi, HS (corresponding author), Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	Park, Seung Bum/N-1901-2014; Chanda, Dipanjan/AAU-3996-2021	Park, Seung Bum/0000-0003-1753-1433; Chanda, Dipanjan/0000-0003-0685-187X; Koh, Minseob/0000-0003-1935-4776	National Creative Research Initiatives from the Korean Ministry of Education, Science, and Technology [20110018305]; Korea Healthcare Technology RD Project; Ministry for Health, Welfare and Family Affairs, Republic of Korea [A100588]; National Research Foundation of Korea; Ministry of Education, Science and Technology [20100019512]	National Creative Research Initiatives from the Korean Ministry of Education, Science, and Technology; Korea Healthcare Technology RD Project; Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Creative Research Initiatives Grant 20110018305 from the Korean Ministry of Education, Science, and Technology, a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea Grant A100588, and the Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea funded by Ministry of Education, Science and Technology Grant 20100019512.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Chao EYH, 2006, BIOORG MED CHEM LETT, V16, P821, DOI 10.1016/j.bmcl.2005.11.030; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Hentschke M, 2002, BIOCHEM BIOPH RES CO, V299, P872, DOI 10.1016/S0006-291X(02)02753-5; Herzog B, 2007, MOL ENDOCRINOL, V21, P2687, DOI 10.1210/me.2007-0213; Hong H, 1999, J BIOL CHEM, V274, P22618, DOI 10.1074/jbc.274.32.22618; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Ishimoto K, 2009, J BIOL CHEM, V284, P22195, DOI 10.1074/jbc.M109.028753; Jeong BC, 2009, J BIOL CHEM, V284, P14211, DOI 10.1074/jbc.M808345200; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; Lee YS, 2008, BIOCHEM J, V413, P559, DOI 10.1042/BJ20071637; Lee YS, 2007, INT REV CYTOL, V261, P117, DOI 10.1016/S0074-7696(07)61003-1; Mitra MS, 2011, J MOL CELL CARDIOL, V51, P120, DOI 10.1016/j.yjmcc.2011.04.009; Nishigori H, 2001, P NATL ACAD SCI USA, V98, P575, DOI 10.1073/pnas.98.2.575; Pacheco YM, 1998, J CHROMATOGR B, V714, P127, DOI 10.1016/S0378-4347(98)00231-X; Park YY, 2004, MOL ENDOCRINOL, V18, P1082, DOI 10.1210/me.2003-0339; Pearen MA, 2008, ENDOCRINOLOGY, V149, P2853, DOI 10.1210/en.2007-1202; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Razzaque MA, 2004, GENE, V340, P275, DOI 10.1016/j.gene.2004.07.010; Reue K, 2000, J LIPID RES, V41, P1067; Ryu D, 2009, CELL METAB, V9, P240, DOI 10.1016/j.cmet.2009.01.007; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sanyal S, 2004, MOL ENDOCRINOL, V18, P312, DOI 10.1210/me.2003-0165; Sanyal S, 2002, J BIOL CHEM, V277, P1739, DOI 10.1074/jbc.M106140200; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Xie YB, 2009, J BIOL CHEM, V284, P28762, DOI 10.1074/jbc.M109.034165; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhang P, 2008, J LIPID RES, V49, P1519, DOI 10.1194/jlr.M800061-JLR200	43	56	58	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38035	38042		10.1074/jbc.M111.250613	http://dx.doi.org/10.1074/jbc.M111.250613			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911493	Green Published, hybrid			2022-12-25	WOS:000296594200015
J	Kouvidi, K; Berdiaki, A; Nikitovic, D; Katonis, P; Afratis, N; Hascall, VC; Karamanos, NK; Tzanakakis, GN				Kouvidi, Katerina; Berdiaki, Aikaterini; Nikitovic, Dragana; Katonis, Pavlos; Afratis, Nikos; Hascall, Vincent C.; Karamanos, Nikos K.; Tzanakakis, George N.			Role of Receptor for Hyaluronic Acid-mediated Motility (RHAMM) in Low Molecular Weight Hyaluronan (LMWHA)-mediated Fibrosarcoma Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; INDEPENDENT PROSTATE-CANCER; ACTIVATED PROTEIN-KINASE; BINDING-PROTEIN; SIGNALING PATHWAYS; ENDOTHELIAL-CELLS; TUMOR PROGRESSION; CARCINOMA-CELLS; FOCAL ADHESIONS; CD44	Hyaluronan (HA) modulates key cancer cell functions through interaction with its CD44 and receptor for hyaluronic acid-mediated motility (RHAMM) receptors. HA was recently found to regulate the migration of fibrosarcoma cells in a manner specifically dependent on its size. Here, we investigated the effect of HA/RHAMM signaling on the ability of HT1080 fibrosarcoma cells to adhere onto fibronectin. Low molecular weight HA (LMWHA) significantly increased (p <= 0.01) the adhesion capacity of HT1080 cells, which high molecular weight HA inhibited. The ability of HT1080 RHAMM-deficient cells, but not of CD44-deficient ones, to adhere was significantly decreased (p <= 0.001) as compared with control cells. Importantly, the effect of LMWHA on HT1080 cell adhesion was completely attenuated in RHAMM-deficient cells. In contrast, adhesion of RHAMM-deficient cells was not sensitive to high molecular weight HA treatment, which identifies RHAMM as a specific conduit of the LMWHA effect. Western blot and real time-PCR analyses indicated that LMWHA significantly increased RHAMM transcript (p <= 0.05) and protein isoform levels (53%, 95 kDa; 37%, 73 kDa) in fibrosarcoma cells. Moreover, Western blot analyses showed that LMWHA in a RHAMM-dependent manner enhanced basal and adhesion-dependent ERK1/2 and focal adhesion kinase (FAK) phosphorylation in HT1080 cells. Utilization of a specific ERK1/2 inhibitor completely inhibited (p <= 0.001) LMWHA-dependent adhesion, suggesting that ERK1/2 is a downstream effector of LMWHA/RHAMM signaling. Likewise, the utilization of the specific ERK1 inhibitor resulted in a strong down-regulation of FAK activation in HT1080 cells, which identifies ERK1/2 as a FAK upstream activator. In conclusion, our results suggest that RHAMM/HA interaction regulates fibrosarcoma cell adhesion via the activation of FAK and ERK1/2 signaling pathways.	[Kouvidi, Katerina; Berdiaki, Aikaterini; Nikitovic, Dragana; Tzanakakis, George N.] Univ Crete, Sch Med, Dept Histol Embryol, Iraklion 71003, Greece; [Katonis, Pavlos] Univ Crete, Sch Med, Dept Orthopaed, Iraklion 71003, Greece; [Afratis, Nikos; Karamanos, Nikos K.] Univ Patras, Dept Chem, Biochem Lab, GR-26110 Patras, Greece; [Hascall, Vincent C.] Cleveland Clin, Cleveland, OH 44195 USA	University of Crete; University of Crete; University of Patras; Cleveland Clinic Foundation	Tzanakakis, GN (corresponding author), Univ Crete, Sch Med, Dept Histol Embryol, Iraklion 71003, Greece.	tzanakak@med.uoc.gr	Tzanakakis, George N/F-6955-2010; Karamanos, Nikos/A-3616-2008; Nikitovic, Dragana/AAS-6215-2020; afratis, nikos/N-1893-2016; Afratis, Nikolaos/HCI-4508-2022; Tzanakakis, George/ABH-7725-2020	Tzanakakis, George N/0000-0001-5276-4764; Karamanos, Nikos/0000-0003-3618-0288; Nikitovic, Dragana/0000-0003-3882-7399; afratis, nikos/0000-0002-3962-2451; Afratis, Nikolaos/0000-0002-3962-2451; Tzanakakis, George/0000-0001-5276-4764				A-Ayoubi A, 2008, J CELL BIOCHEM, V105, P875, DOI 10.1002/jcb.21889; Ahrens T, 2001, J INVEST DERMATOL, V116, P93, DOI 10.1046/j.1523-1747.2001.00236.x; Akiyama Y, 2001, J NEURO-ONCOL, V53, P115, DOI 10.1023/A:1012297132047; Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Assmann V, 1999, J CELL SCI, V112, P3943; Assmann V, 2001, J PATHOL, V195, P191, DOI 10.1002/path.941; Assmann V, 1998, J CELL SCI, V111, P1685; Berdiaki A, 2009, BBA-GEN SUBJECTS, V1790, P1258, DOI 10.1016/j.bbagen.2009.06.013; Boraldi F, 2003, TISSUE CELL, V35, P37, DOI 10.1016/S0040-8166(02)00101-5; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Chalkiadaki G., 2011, CANC LETT IN PRESS; Cheung WF, 1999, BIOCHEM SOC T, V27, P135, DOI 10.1042/bst0270135; Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B; ENTWISTLE J, 1995, GENE, V163, P233, DOI 10.1016/0378-1119(95)00398-P; Fieber C, 1999, GENE, V226, P41, DOI 10.1016/S0378-1119(98)00566-6; Gao F, 2008, CLIN INVEST MED, V31, pE106, DOI 10.25011/cim.v31i3.3467; Gares S L, 2000, Dev Immunol, V7, P209, DOI 10.1155/2000/94616; Gares SL, 1998, J LEUKOCYTE BIOL, V64, P781, DOI 10.1002/jlb.64.6.781; Gares SL, 1999, SCAND J IMMUNOL, V50, P626; Geiger T, 2010, SEMIN CANCER BIOL, V20, P146, DOI 10.1016/j.semcancer.2010.05.004; Groen AC, 2004, CURR BIOL, V14, P1801, DOI 10.1016/j.cub.2004.10.002; Gust KM, 2009, NEOPLASIA, V11, P956, DOI 10.1593/neo.09694; HALL CL, 1994, J CELL BIOL, V126, P575, DOI 10.1083/jcb.126.2.575; HALL CL, 1995, CELL, V82, P19, DOI 10.1016/0092-8674(95)90048-9; Hall CL, 1996, ONCOGENE, V13, P2213; Hall CL, 2001, MATRIX BIOL, V20, P183, DOI 10.1016/S0945-053X(01)00133-0; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343; Herrera-Gayol A, 2001, INT J EXP PATHOL, V82, P193, DOI 10.1111/j.1365-2613.2001.iep196.x; Hofmann M, 1998, J CELL SCI, V111, P1673; Hus I, 2008, LEUKEMIA, V22, P1007, DOI 10.1038/leu.2008.29; Johnson TR, 2008, MOL CANCER RES, V6, P1639, DOI 10.1158/1541-7786.MCR-08-0052; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; KARAMANOS NK, 1995, ANAL BIOCHEM, V225, P220, DOI 10.1006/abio.1995.1147; Karousou EG, 2004, ELECTROPHORESIS, V25, P2919, DOI 10.1002/elps.200406034; KLEWES L, 1993, BIOCHEM J, V290, P791, DOI 10.1042/bj2900791; Laurich C, 2004, J SURG RES, V122, P70, DOI 10.1016/j.jss.2004.05.018; LESLEY J, 1998, FRONT BIOSCI, V3, P616; Lin SL, 2008, CARCINOGENESIS, V29, P282, DOI 10.1093/carcin/bgm259; Lin SL, 2007, CARCINOGENESIS, V28, P310, DOI 10.1093/carcin/bgl134; Lokeshwar VB, 2000, J BIOL CHEM, V275, P27641; Malavaki CJ, 2008, ANAL BIOCHEM, V374, P213, DOI 10.1016/j.ab.2007.11.006; Matou-Nasri S, 2009, INT J ONCOL, V35, P761, DOI 10.3892/ijo_00000389; Maxwell CA, 2005, CANCER RES, V65, P850; Maxwell CA, 2003, MOL BIOL CELL, V14, P2262, DOI 10.1091/mbc.e02-07-0377; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Meng XN, 2009, BRIT J CANCER, V101, P327, DOI 10.1038/sj.bjc.6605154; Militsopoulou M, 2002, ELECTROPHORESIS, V23, P1104, DOI 10.1002/1522-2683(200204)23:7/8<1104::AID-ELPS1104>3.0.CO;2-1; Mohapatra S, 1996, J EXP MED, V183, P1663, DOI 10.1084/jem.183.4.1663; Nagy JI, 1996, CELL GROWTH DIFFER, V7, P745; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; PIEPKORN M, 1988, J CELL PHYSIOL, V135, P189, DOI 10.1002/jcp.1041350206; Price RD, 2007, J PLAST RECONSTR AES, V60, P1110, DOI 10.1016/j.bjps.2007.03.005; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Rein DT, 2003, J CANCER RES CLIN, V129, P161, DOI 10.1007/s00432-003-0415-0; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SHERMAN L, 1994, CURR OPIN CELL BIOL, V6, P726, DOI 10.1016/0955-0674(94)90100-7; Simpson MA, 2002, J BIOL CHEM, V277, P10050, DOI 10.1074/jbc.M110069200; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Tolg C, 2003, ONCOGENE, V22, P6873, DOI 10.1038/sj.onc.1206811; Tolg C, 2006, J CELL BIOL, V175, P1017, DOI 10.1083/jcb.200511027; Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O; Toole BP, 2002, AM J PATHOL, V161, P745, DOI 10.1016/S0002-9440(10)64232-0; Toole BP, 2008, DRUG RESIST UPDATE, V11, P110, DOI 10.1016/j.drup.2008.04.002; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; TURLEY EA, 1992, CANCER METAST REV, V11, P21, DOI 10.1007/BF00047600; TURLEY EA, 1987, BIOCHEMISTRY-US, V26, P2997, DOI 10.1021/bi00385a007; Twarock S, 2010, J BIOL CHEM, V285, P23274, DOI 10.1074/jbc.M109.093146; Vomastek T, 2007, MOL CELL BIOL, V27, P8296, DOI 10.1128/MCB.00598-07; Wang C, 1998, CLIN CANCER RES, V4, P567; Zhang SW, 1998, J BIOL CHEM, V273, P11342, DOI 10.1074/jbc.273.18.11342; Zlobec I, 2008, GUT, V57, P1413, DOI 10.1136/gut.2007.141192	79	95	98	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38509	38520		10.1074/jbc.M111.275875	http://dx.doi.org/10.1074/jbc.M111.275875			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914806	Green Published, hybrid			2022-12-25	WOS:000296594200065
J	Landry, GJ; Kent, BA; Patton, DF; Jaholkowski, M; Marchant, EG; Mistlberger, RE				Landry, Glenn J.; Kent, Brianne A.; Patton, Danica F.; Jaholkowski, Mark; Marchant, Elliott G.; Mistlberger, Ralph E.			Evidence for Time-of-Day Dependent Effect of Neurotoxic Dorsomedial Hypothalamic Lesions on Food Anticipatory Circadian Rhythms in Rats	PLOS ONE			English	Article							CLOCK-GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; FEEDING SCHEDULES; OSCILLATORS; ENTRAINMENT; PROJECTIONS; LIVER; ORGANIZATION; FOREBRAIN; BEHAVIOR	The dorsomedial hypothalamus (DMH) is a site of circadian clock gene and immediate early gene expression inducible by daytime restricted feeding schedules that entrain food anticipatory circadian rhythms in rats and mice. The role of the DMH in the expression of anticipatory rhythms has been evaluated using different lesion methods. Partial lesions created with the neurotoxin ibotenic acid (IBO) have been reported to attenuate food anticipatory rhythms, while complete lesions made with radiofrequency current leave anticipatory rhythms largely intact. We tested a hypothesis that the DMH and fibers of passage spared by IBO lesions play a time-of-day dependent role in the expression of food anticipatory rhythms. Rats received intra-DMH microinjections of IBO and activity and body temperature (T-b) rhythms were recorded by telemetry during ad-lib food access, total food deprivation and scheduled feeding, with food provided for 4-h/day for 20 days in the middle of the light period and then for 20 days late in the dark period. During ad-lib food access, rats with DMH lesions exhibited a lower amplitude and mean level of light-dark entrained activity and T-b rhythms. During the daytime feeding schedule, all rats exhibited food anticipatory activity and T-b rhythms that persisted during 2 days without food in constant dark. In some rats with partial or total DMH ablation, the magnitude of the anticipatory rhythm was weak relative to most intact rats. When mealtime was shifted to the late night, the magnitude of the food anticipatory activity rhythms in these cases was restored to levels characteristic of intact rats. These results confirm that rats can anticipate scheduled daytime or nighttime meals without the DMH. Improved anticipation at night suggests a modulatory role for the DMH in the expression of food anticipatory activity rhythms during the daily light period, when nocturnal rodents normally sleep.	[Landry, Glenn J.; Kent, Brianne A.; Patton, Danica F.; Jaholkowski, Mark; Marchant, Elliott G.; Mistlberger, Ralph E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Landry, GJ (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.	mistlber@sfu.ca	Landry, Glenn J/L-2133-2015	Landry, Glenn J/0000-0002-6946-3914; Kent, Brianne/0000-0003-0074-028X	Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by the Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; Angeles-Castellanos M, 2004, AM J PHYSIOL-REG I, V286, pR158, DOI 10.1152/ajpregu.00216.2003; Antle MC, 2005, TRENDS NEUROSCI, V28, P145, DOI 10.1016/j.tins.2005.01.003; Antle MC, 2000, J NEUROSCI, V20, P9326; BOULOS Z, 1980, BEHAV BRAIN RES, V1, P39, DOI 10.1016/S0166-4328(80)80049-0; BOULOS Z, 1980, NEUROSCI BIOBEHAV R, V4, P119, DOI 10.1016/0149-7634(80)90010-X; Canteras NS, 2011, BRAIN RES REV, V65, P150, DOI 10.1016/j.brainresrev.2010.09.006; Chou TC, 2003, J NEUROSCI, V23, P10691; CLARKE JD, 1986, PHYSIOL BEHAV, V36, P105, DOI 10.1016/0031-9384(86)90082-X; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Deurveilher S, 2005, NEUROSCIENCE, V130, P165, DOI 10.1016/j.neuroscience.2004.08.030; Escobar C, 2007, EUR J NEUROSCI, V26, P2804, DOI 10.1111/j.1460-9568.2007.05893.x; Feillet CA, 2008, MOL CELL NEUROSCI, V37, P209, DOI 10.1016/j.mcn.2007.09.010; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Hsu JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011802; Landry GJ, 2006, AM J PHYSIOL-REG I, V290, pR1527, DOI 10.1152/ajpregu.00874.2005; Landry GJ, 2007, J BIOL RHYTHM, V22, P467, DOI 10.1177/0748730407307804; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; Minana-Solis MC, 2009, CHRONOBIOL INT, V26, P808, DOI 10.1080/07420520903044240; Mistlberger RE, 2006, CURR BIOL, V16, pR968, DOI 10.1016/j.cub.2006.10.020; Mistlberger RE, 2009, J BIOL RHYTHM, V24, P95, DOI 10.1177/0748730408329573; Mistlberger RE, 2005, BRAIN RES REV, V49, P429, DOI 10.1016/j.brainresrev.2005.01.005; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Moriya T, 2009, EUR J NEUROSCI, V29, P1447, DOI 10.1111/j.1460-9568.2009.06697.x; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Tahara Y, 2010, J BIOL RHYTHM, V25, P9, DOI 10.1177/0748730409352782; Thompson RH, 1996, J COMP NEUROL, V376, P143, DOI 10.1002/(SICI)1096-9861(19961202)376:1<143::AID-CNE9>3.0.CO;2-3; Verwey M, 2007, NEUROSCIENCE, V147, P277, DOI 10.1016/j.neuroscience.2007.04.044; Verwey M, 2009, EUR J NEUROSCI, V30, P1650, DOI 10.1111/j.1460-9568.2009.06960.x; Verwey M, 2009, EUR J NEUROSCI, V29, P2217, DOI 10.1111/j.1460-9568.2009.06766.x; VOGELBAUM MA, 1992, J NEUROSCI, V12, P3619; WATTS AG, 1987, J COMP NEUROL, V258, P204, DOI 10.1002/cne.902580204; Yi CX, 2006, ENDOCRINOLOGY, V147, P283, DOI 10.1210/en.2005-1051	39	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24187	10.1371/journal.pone.0024187	http://dx.doi.org/10.1371/journal.pone.0024187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912674	Green Published, gold, Green Submitted			2022-12-25	WOS:000294686100021
J	Brown, KA; Flynn, DFB; Abram, NK; Ingram, JC; Johnson, SE; Wright, P				Brown, Kerry A.; Flynn, Dan F. B.; Abram, Nicola K.; Ingram, J. Carter; Johnson, Steig E.; Wright, Patricia			Assessing Natural Resource Use by Forest-Reliant Communities in Madagascar Using Functional Diversity and Functional Redundancy Metrics	PLOS ONE			English	Article							ECOSYSTEM SERVICES; PROTECTED AREAS; ASSEMBLY RULES; CONSERVATION; HOUSEHOLDS; LIVELIHOOD; KNOWLEDGE; RICHNESS; COSTS; TREE	Biodiversity plays an integral role in the livelihoods of subsistence-based forest-dwelling communities and as a consequence it is increasingly important to develop quantitative approaches that capture not only changes in taxonomic diversity, but also variation in natural resources and provisioning services. We apply a functional diversity metric originally developed for addressing questions in community ecology to assess utilitarian diversity of 56 forest plots in Madagascar. The use categories for utilitarian plants were determined using expert knowledge and household questionnaires. We used a null model approach to examine the utilitarian (functional) diversity and utilitarian redundancy present within ecological communities. Additionally, variables that might influence fluctuations in utilitarian diversity and redundancy-specifically number of felled trees, number of trails, basal area, canopy height, elevation, distance from village-were analyzed using Generalized Linear Models (GLMs). Eighteen of the 56 plots showed utilitarian diversity values significantly higher than expected. This result indicates that these habitats exhibited a low degree of utilitarian redundancy and were therefore comprised of plants with relatively distinct utilitarian properties. One implication of this finding is that minor losses in species richness may result in reductions in utilitarian diversity and redundancy, which may limit local residents' ability to switch between alternative choices. The GLM analysis showed that the most predictive model included basal area, canopy height and distance from village, which suggests that variation in utilitarian redundancy may be a result of local residents harvesting resources from the protected area. Our approach permits an assessment of the diversity of provisioning services available to local communities, offering unique insights that would not be possible using traditional taxonomic diversity measures. These analyses introduce another tool available to conservation biologists for assessing how future losses in biodiversity will lead to a reduction in natural resources and provisioning services from forests.	[Brown, Kerry A.] Kingston Univ London, Sch Geog Geol & Environm, Surrey, England; [Flynn, Dan F. B.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA; [Abram, Nicola K.] Univ Kent, DICE, Canterbury, Kent, England; [Ingram, J. Carter] Wildlife Conservat Soc, Bronx, NY USA; [Johnson, Steig E.] Univ Calgary, Dept Anthropol, Calgary, AB, Canada; [Wright, Patricia] SUNY Stony Brook, Inst Conservat Trop Environm, Stony Brook, NY 11794 USA	Kingston University; Columbia University; University of Kent; Wildlife Conservation Society; University of Calgary; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Brown, KA (corresponding author), Kingston Univ London, Sch Geog Geol & Environm, Surrey, England.	k.brown@kingston.ac.uk	Flynn, Dan/A-4200-2008; Flynn, Dan/AAT-7028-2020; Brown, Kerry/U-5082-2019; Abram, Nicola/K-2060-2014	Flynn, Dan/0000-0002-2978-5257; Flynn, Dan/0000-0002-2978-5257; Abram, Nicola/0000-0003-1886-7297; BROWN, KERRY/0000-0002-6342-8966; Johnson, Steig/0000-0003-2257-8949	David and Lucile Packard Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	Funding was provided by the David and Lucile Packard Foundation (PCW) (http://www.packard.org/home.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Brown KA, 2009, ENVIRON MANAGE, V44, P136, DOI 10.1007/s00267-008-9257-5; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Byron N, 1999, WORLD DEV, V27, P789, DOI 10.1016/S0305-750X(99)00025-X; Cocks ML, 2008, INT J SUST DEV WORLD, V15, P198, DOI 10.3843/SusDev.15.3:3; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Davidar P, 2008, BIOL CONSERV, V141, P1876, DOI 10.1016/j.biocon.2008.05.004; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Gavin MC, 2007, ECOL ECON, V60, P752, DOI 10.1016/j.ecolecon.2006.01.010; Gavin MC, 2009, J APPL ECOL, V46, P1275, DOI 10.1111/j.1365-2664.2009.01713.x; Griffin JN, 2009, OIKOS, V118, P37, DOI 10.1111/j.1600-0706.2008.16960.x; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Holdaway RJ, 2006, J ECOL, V94, P1092, DOI 10.1111/j.1365-2745.2006.01170.x; Ingram JC, 2005, ENVIRON MANAGE, V35, P779, DOI 10.1007/s00267-004-0079-9; Jones JPG, 2006, ORYX, V40, P168, DOI 10.1017/S0030605306000500; Kistler P., 2003, NATURAL HIST MADAGAS, P123; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Kremen C, 1998, CONSERV BIOL, V12, P549, DOI 10.1046/j.1523-1739.1998.96374.x; Luck GW, 2009, BIOSCIENCE, V59, P223, DOI 10.1525/bio.2009.59.3.7; Mason NWH, 2008, J ANIM ECOL, V77, P285, DOI 10.1111/j.1365-2656.2007.01350.x; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; McElwee PD, 2010, ENVIRON MANAGE, V45, P113, DOI 10.1007/s00267-009-9394-5; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2007, OIKOS, V116, P1422, DOI 10.1111/j.2007.0030-1299.15894.x; Petchey OL, 2007, J ANIM ECOL, V76, P977, DOI 10.1111/j.1365-2656.2007.01271.x; Peters J, 1998, J AGR ENVIRON ETHIC, V11, P17, DOI 10.1023/A:1007796628731; Schwilk DW, 2005, ECOL LETT, V8, P272, DOI 10.1111/j.1461-0248.2004.00720.x; Shaanker RU, 2004, ENVIRON CONSERV, V31, P242, DOI 10.1017/S0376892904001596; Syampungani S, 2009, NAT RESOUR FORUM, V33, P150, DOI 10.1111/j.1477-8947.2009.01218.x; Tabuti JRS, 2003, BIOMASS BIOENERG, V25, P581, DOI 10.1016/S0961-9534(03)00052-7; WEIHER E, 1995, OIKOS, V74, P159, DOI 10.2307/3545686; Yeo-Chang Y, 2009, FOREST ECOL MANAG, V257, P2027, DOI 10.1016/j.foreco.2009.01.054; [No title captured]; [No title captured]; [No title captured]; [No title captured]	41	22	22	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24107	10.1371/journal.pone.0024107	http://dx.doi.org/10.1371/journal.pone.0024107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909413	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000294683900029
J	Castellini, C; Badino, L; Metta, G; Sandini, G; Tavella, M; Grimaldi, M; Fadiga, L				Castellini, Claudio; Badino, Leonardo; Metta, Giorgio; Sandini, Giulio; Tavella, Michele; Grimaldi, Mirko; Fadiga, Luciano			The Use of Phonetic Motor Invariants Can Improve Automatic Phoneme Discrimination	PLOS ONE			English	Article							SPEECH; PERCEPTION	We investigate the use of phonetic motor invariants (MIs), that is, recurring kinematic patterns of the human phonetic articulators, to improve automatic phoneme discrimination. Using a multi-subject database of synchronized speech and lips/tongue trajectories, we first identify MIs commonly associated with bilabial and dental consonants, and use them to simultaneously segment speech and motor signals. We then build a simple neural network-based regression schema (called Audio-Motor Map, AMM) mapping audio features of these segments to the corresponding MIs. Extensive experimental results show that (a) a small set of features extracted from the MIs, as originally gathered from articulatory sensors, are dramatically more effective than a large, state-of-the-art set of audio features, in automatically discriminating bilabials from dentals; (b) the same features, extracted from AMM-reconstructed MIs, are as effective as or better than the audio features, when testing across speakers and coarticulating phonemes; and dramatically better as noise is added to the speech signal. These results seem to support some of the claims of the motor theory of speech perception and add experimental evidence of the actual usefulness of MIs in the more general framework of automated speech recognition.	[Castellini, Claudio; Metta, Giorgio; Tavella, Michele] Univ Genoa, LIRA Lab, Genoa, Italy; [Badino, Leonardo; Metta, Giorgio; Sandini, Giulio; Fadiga, Luciano] Italian Inst Technol, Genoa, Italy; [Grimaldi, Mirko] Salento Univ, CRIL, Lecce, Italy; [Fadiga, Luciano] Univ Ferrara, DSBTA, I-44100 Ferrara, Italy	University of Genoa; Istituto Italiano di Tecnologia - IIT; University of Salento; University of Ferrara	Castellini, C (corresponding author), Univ Genoa, LIRA Lab, Genoa, Italy.	claudio.castellini@dlr.de	Fadiga, Luciano/AAC-7404-2022; Castellini, Claudio/M-8555-2017	Castellini, Claudio/0000-0002-7346-2180; fadiga, luciano/0000-0001-5691-5080; Sandini, Giulio/0000-0003-3324-985X; Grimaldi, Mirko/0000-0002-0940-3645	European Commission [NEST-5010, FP7-IST-250026]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors acknowledge the support of the European Commission project CONTACT (grant agreement NEST-5010) and SIEMPRE (grant agreement number FP7-IST-250026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Brookes M., 1997, VOICEBOX SPEECH PROC, V47; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; D'Ausillo A, 2009, CURR BIOL, V19, P381, DOI 10.1016/j.cub.2009.01.017; Galantucci B, 2006, PSYCHON B REV, V13, P361, DOI 10.3758/BF03193857; GRIMALDI M, 2008, P LANGTECH 2008 ROM; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2011, NEURON, V69, P407, DOI 10.1016/j.neuron.2011.01.019; King S, 2007, J ACOUST SOC AM, V121, P723, DOI 10.1121/1.2404622; Kroger BJ, 2009, SPEECH COMMUN, V51, P793, DOI 10.1016/j.specom.2008.08.002; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Livescu K., 2003, P EUR GEN SWITZ, V4, P2529; Massaro DW, 2008, PSYCHON B REV, V15, P453, DOI 10.3758/PBR.15.2.453; Metta G, 2006, INTERACT STUD, V7, P197, DOI 10.1075/is.7.2.06met; MOLLER MF, 1993, NEURAL NETWORKS, V6, P525, DOI 10.1016/S0893-6080(05)80056-5; Nair V, 2006, ADV NEURAL INFORM PR, P515; Ostendorf M., 1999, P IEEE ASRU WORKSH, P79; PAPCUN G, 1992, J ACOUST SOC AM; Pinto J, 2008, INT CONF ACOUST SPEE, P4449, DOI 10.1109/ICASSP.2008.4518643; PUJOL P, 2003, IEEE T SPEECH AUDIO, V13, P14; RICHARDSON M, 2000, P ICSLP BEIJ CHIN, P131; Richmond K, 2003, COMPUT SPEECH LANG, V17, P153, DOI 10.1016/S0885-2308(03)00005-6; Richmond K, 2007, LECT NOTES ARTIF INT, V4885, P263; ROSE RC, 1996, J ACOUST SOC AM, V99, P153; STEPHENSON TA, 2000, P INT C SPOK LANG PR, P951; TODA T, 2004, P INT C SPOK LANG PR; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Wrench A., 2000, P INT C SPOK LANG PR, P145; Zlokarnik I., 1995, J ACOUST SOC AM, V97, P3246, DOI [10.1121/1.411699, DOI 10.1121/1.411699]	31	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24055	10.1371/journal.pone.0024055	http://dx.doi.org/10.1371/journal.pone.0024055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	817OO	21912661	Green Published, Green Submitted, gold			2022-12-25	WOS:000294683900024
J	Davis, L; Maizels, N				Davis, Luther; Maizels, Nancy			DNA Nicks Promote Efficient and Safe Targeted Gene Correction	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; DOUBLE-STRAND BREAKS; IN-VIVO; HOMING ENDONUCLEASE; HOMOLOGOUS RECOMBINATION; TRANSCRIPTION; PROTEINS; REPAIR; GENERATION; PATHWAY	Targeted gene correction employs a site-specific DNA lesion to promote homologous recombination that eliminates mutation in a disease gene of interest. The double-strand break typically used to initiate correction can also result in genomic instability if deleterious repair occurs rather than gene correction, possibly compromising the safety of targeted gene correction. Here we show that single-strand breaks (nicks) and double-strand breaks both promote efficient gene correction. However, breaks promote high levels of inadvertent but heritable genomic alterations both locally and elsewhere in the genome, while nicks are accompanied by essentially no collateral local mutagenesis, and thus provide a safer approach to gene correction. Defining efficacy as the ratio of gene correction to local deletion, nicks initiate gene correction with 70-fold greater efficacy than do double-strand breaks (29.0 +/- 6.0% and 0.42 +/- 0.03%, respectively). Thus nicks initiate efficient gene correction, with limited local mutagenesis. These results have clear therapeutic implications, and should inform future design of meganucleases for targeted gene correction.	[Davis, Luther; Maizels, Nancy] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA; [Maizels, Nancy] Univ Washington, Dept Biochem, Sch Med, Seattle, WA 98195 USA; [Davis, Luther; Maizels, Nancy] NW Genome Engn Consortium, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Davis, L (corresponding author), Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA.	maizels@u.washington.edu		Davis, Luther/0000-0002-2346-3898	National Institutes of Health [RL1 GM84344, R01 GM41712]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041712, RL1GM084434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health (RL1 GM84344 and R01 GM41712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2011, J MOL CELL BIOL, V3, P4, DOI 10.1093/jmcb/mjq049; Arcangioli B, 1998, EMBO J, V17, P4503, DOI 10.1093/emboj/17.15.4503; Boch J, 2011, NAT BIOTECHNOL, V29, P135, DOI 10.1038/nbt.1767; CERTO MT, 2011, NAT METHODS IN PRESS; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cuozzo C, 2007, PLOS GENET, V3, P1144, DOI 10.1371/journal.pgen.0030110; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Fajardo-Sanchez E, 2008, NUCLEIC ACIDS RES, V36, P2163, DOI 10.1093/nar/gkn059; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; Li H, 2009, NUCLEIC ACIDS RES, V37, P1650, DOI 10.1093/nar/gkp004; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; Niu Y, 2008, J MOL BIOL, V382, P188, DOI 10.1016/j.jmb.2008.07.010; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Olsen PA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-35; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pessach IM, 2011, J ALLERGY CLIN IMMUN, V127, P1344, DOI 10.1016/j.jaci.2011.02.027; Petek LM, 2010, MOL THER, V18, P983, DOI 10.1038/mt.2010.35; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Sanders KL, 2009, NUCLEIC ACIDS RES, V37, P2105, DOI 10.1093/nar/gkp046; Savolainen L, 2009, NUCLEIC ACIDS RES, V37, P405, DOI 10.1093/nar/gkn971; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Smith AM, 2009, P NATL ACAD SCI USA, V106, P5099, DOI 10.1073/pnas.0810588106; Smith GR, 2004, CELL, V117, P146, DOI 10.1016/S0092-8674(04)00338-1; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; STRATHERN JN, 1991, GENETICS, V127, P61; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takeuchi R, 2009, NUCLEIC ACIDS RES, V37, P877, DOI 10.1093/nar/gkn1007; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	35	62	65	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e23981	10.1371/journal.pone.0023981	http://dx.doi.org/10.1371/journal.pone.0023981			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21912657	Green Published, gold, Green Submitted			2022-12-25	WOS:000294683900017
J	Eisenhauer, N; Migunova, VD; Ackermann, M; Ruess, L; Scheu, S				Eisenhauer, Nico; Migunova, Varvara D.; Ackermann, Michael; Ruess, Liliane; Scheu, Stefan			Changes in Plant Species Richness Induce Functional Shifts in Soil Nematode Communities in Experimental Grassland	PLOS ONE			English	Article							BELOW-GROUND BIODIVERSITY; NITROGEN DEPOSITION; FAUNAL ANALYSIS; ELEVATED CO2; DIVERSITY; MECHANISMS; ABUNDANCE; RESPONSES; ECOLOGY; BIOMASS	Background: Changes in plant diversity may induce distinct changes in soil food web structure and accompanying soil feedbacks to plants. However, knowledge of the long-term consequences of plant community simplification for soil animal food webs and functioning is scarce. Nematodes, the most abundant and diverse soil Metazoa, represent the complexity of soil food webs as they comprise all major trophic groups and allow calculation of a number of functional indices. Methodology/Principal Findings: We studied the functional composition of nematode communities three and five years after establishment of a grassland plant diversity experiment (Jena Experiment). In response to plant community simplification common nematode species disappeared and pronounced functional shifts in community structure occurred. The relevance of the fungal energy channel was higher in spring 2007 than in autumn 2005, particularly in species-rich plant assemblages. This resulted in a significant positive relationship between plant species richness and the ratio of fungal-to-bacterial feeders. Moreover, the density of predators increased significantly with plant diversity after five years, pointing to increased soil food web complexity in species-rich plant assemblages. Remarkably, in complex plant communities the nematode community shifted in favour of microbivores and predators, thereby reducing the relative abundance of plant feeders after five years. Conclusions/Significance: The results suggest that species-poor plant assemblages may suffer from nematode communities detrimental to plants, whereas species-rich plant assemblages support a higher proportion of microbivorous nematodes stimulating nutrient cycling and hence plant performance; i.e. effects of nematodes on plants may switch from negative to positive. Overall, food web complexity is likely to decrease in response to plant community simplification and results of this study suggest that this results mainly from the loss of common species which likely alter plant - nematode interactions.	[Eisenhauer, Nico] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Migunova, Varvara D.] KI Skryabin All Russian Inst Helminthol, Moscow, Russia; [Ackermann, Michael; Ruess, Liliane] Humboldt Univ, Inst Biol, Berlin, Germany; [Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany	University of Minnesota System; University of Minnesota Twin Cities; Federal Scientific Centre VIEV; Humboldt University of Berlin; University of Gottingen	Eisenhauer, N (corresponding author), Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA.	nico.eisenhauer@web.de	Eisenhauer, Nico/I-5932-2012; Migunova, Varvara/Q-3899-2018; Scheu, Stefan/H-7049-2015; Eisenhauer, Nico/I-3191-2019	Eisenhauer, Nico/0000-0002-0371-6720; Eisenhauer, Nico/0000-0002-0371-6720	German Science Foundation [FOR 456, Ei 862/1-1]	German Science Foundation(German Research Foundation (DFG))	This work was supported by the German Science Foundation (FOR 456), German Science Foundation (Ei 862/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bezemer TM, 2010, ECOLOGY, V91, P3027, DOI 10.1890/09-2198.1; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; Bongers T, 1998, APPL SOIL ECOL, V10, P239, DOI 10.1016/S0929-1393(98)00123-1; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Chung HG, 2007, GLOBAL CHANGE BIOL, V13, P980, DOI 10.1111/j.1365-2486.2007.01313.x; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; De Deyn GB, 2005, TRENDS ECOL EVOL, V20, P625, DOI 10.1016/j.tree.2005.08.009; De Deyn GB, 2004, OIKOS, V106, P576, DOI 10.1111/j.0030-1299.2004.13265.x; Eisenhauer N, 2010, ECOLOGY, V91, P485, DOI 10.1890/08-2338.1; Eisenhauer N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016055; Eisenhauer N, 2011, SOIL BIOL BIOCHEM, V43, P462, DOI 10.1016/j.soilbio.2010.10.018; Eisenhauer N, 2010, ACTA OECOL, V36, P477, DOI 10.1016/j.actao.2010.06.004; Eisenhauer N, 2009, SOIL BIOL BIOCHEM, V41, P2430, DOI 10.1016/j.soilbio.2009.09.001; *FAO UN, 1997, SOIL MAP WORLD REV L; Ferris H, 2001, APPL SOIL ECOL, V18, P13, DOI 10.1016/S0929-1393(01)00152-4; Ferris H, 2006, J NEMATOL, V38, P3; Gastine A, 2003, APPL SOIL ECOL, V24, P101, DOI 10.1016/S0929-1393(02)00137-3; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hedlund K, 2003, OIKOS, V103, P45, DOI 10.1034/j.1600-0706.2003.12511.x; Hooper DU, 2000, BIOSCIENCE, V50, P1049, DOI 10.1641/0006-3568(2000)050[1049:IBAABB]2.0.CO;2; KLUGE G, 2000, 213 DTSCH WETT; Korthals GW, 2001, FUNCT ECOL, V15, P506, DOI 10.1046/j.0269-8463.2001.00551.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; Lyons KG, 2005, CONSERV BIOL, V19, P1019, DOI 10.1111/j.1523-1739.2005.00106.x; Lyons KG, 2001, ECOL LETT, V4, P358, DOI 10.1046/j.1461-0248.2001.00235.x; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Neher DA, 2006, FRESHWATER NEMATODES: ECOLOGY AND TAXONOMY, P211, DOI 10.1079/9780851990095.0211; Neher DA, 2010, ANNU REV PHYTOPATHOL, V48, P371, DOI 10.1146/annurev-phyto-073009-114439; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; RUESS L, 1995, NEMATOLOGICA, V41, P229, DOI 10.1163/003925995X00198; Ruess L, 2003, NEMATOLOGY, V5, P179, DOI 10.1163/156854103767139662; Ruess L, 2004, NEMATOL MONOGR PERSP, V2, P547; Sabais ACW, 2011, ACTA OECOL, V37, P195, DOI 10.1016/j.actao.2011.02.002; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Schmid B, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P61; Sohlenius B, 2011, NEMATOLOGY, V13, P115, DOI 10.1163/138855410X520945; Spehn EM, 2000, PLANT SOIL, V224, P217, DOI 10.1023/A:1004891807664; Stephan A, 2000, J ECOL, V88, P988, DOI 10.1046/j.1365-2745.2000.00510.x; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Verschoor BC, 2001, PEDOBIOLOGIA, V45, P213, DOI 10.1078/0031-4056-00081; Viketoft M, 2009, ECOLOGY, V90, P90, DOI 10.1890/08-0382.1; Viketoft M, 2011, SOIL BIOL BIOCHEM, V43, P1063, DOI 10.1016/j.soilbio.2011.01.027; Wardle DA, 2006, ECOL LETT, V9, P870, DOI 10.1111/j.1461-0248.2006.00931.x; Wasilewska L., 1989, Zeszyty Problemowe Postepow Nauk Rolniczych, V358, P7; WASILEWSKA L, 1995, APPL SOIL ECOL, V2, P53, DOI 10.1016/0929-1393(94)00037-8; Wasilewska Lucyna, 1997, Ekologia Polska, V45, P719; Williamson WM, 2005, SOIL BIOL BIOCHEM, V37, P1289, DOI 10.1016/j.soilbio.2004.11.025; Yeates GW, 2003, BIOL FERT SOILS, V37, P199, DOI 10.1007/s00374-003-0586-5; YEATES GW, 1993, J NEMATOL, V25, P315; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433	57	64	69	8	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24087	10.1371/journal.pone.0024087	http://dx.doi.org/10.1371/journal.pone.0024087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909412	Green Published, Green Submitted, gold			2022-12-25	WOS:000294683900028
J	Jourdain, E; van Riel, D; Munster, VJ; Kuiken, T; Waldenstrom, J; Olsen, B; Ellstrom, P				Jourdain, Elsa; van Riel, Debby; Munster, Vincent J.; Kuiken, Thijs; Waldenstrom, Jonas; Olsen, Bjorn; Ellstrom, Patrik			The Pattern of Influenza Virus Attachment Varies among Wild Bird Species	PLOS ONE			English	Article							LOWER RESPIRATORY-TRACT; SIALIC-ACID RECEPTORS; A VIRUS; BINDING-SITES; HEMAGGLUTININ; DUCKS; HOST; REPLICATION; SPECIFICITY; INFECTION	The ability to attach to host cells is one of the main determinants of the host range of influenza A viruses. By using virus histochemistry, we investigate the pattern of virus attachment of both a human and an avian influenza virus in colon and trachea sections from 12 wild bird species. We show that significant variations exist, even between closely related avian species, which suggests that the ability of wild birds to serve as hosts for influenza viruses strongly varies among species. These results will prove valuable to assess the possibilities of interspecies transmission of influenza viruses in natural environments and better understand the ecology of influenza.	[Jourdain, Elsa] INRA, UR 346, F-63122 St Genes Champanelle, France; [van Riel, Debby; Kuiken, Thijs] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Munster, Vincent J.] NIAID, Virol Lab, Rocky Mt Labs, Div Intramural Res,NIH, Hamilton, MT 59840 USA; [Waldenstrom, Jonas; Olsen, Bjorn] Linnaeus Univ, Sch Nat Sci, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden; [Olsen, Bjorn; Ellstrom, Patrik] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden	INRAE; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Linnaeus University; Uppsala University	Jourdain, E (corresponding author), INRA, UR 346, F-63122 St Genes Champanelle, France.	elsa.jourdain@clermont.inra.fr	Munster, Vincent/I-7607-2018; Waldenström, Jonas/E-4460-2013	Munster, Vincent/0000-0002-2288-3196; Waldenström, Jonas/0000-0002-1152-4235; Kuiken, Thijs/0000-0001-5501-9049; Olsen, Bjorn/0000-0002-4646-691X; van Riel, Debby/0000-0001-9753-3564	Swedish Research Council (VR); Swedish Research Council Formas; French Fondation pour la Recherche Medicale [SPE20070709608]; National Institutes of Health	Swedish Research Council (VR)(Swedish Research Council); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); French Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was financially supported by the Swedish Research Council (VR) and the Swedish Research Council Formas, the French Fondation pour la Recherche Medicale (reference SPE20070709608) and the Intramural Research Program of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiuk S, 2010, J GEN VIROL, V91, P339, DOI 10.1099/vir.0.016246-0; Brinkman-Van der Linden ECM, 2002, ANAL BIOCHEM, V303, P98, DOI 10.1006/abio.2001.5539; Brown JD, 2009, J VET DIAGN INVEST, V21, P437, DOI 10.1177/104063870902100404; Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09; Ellstrom P, 2008, VACCINE, V26, P4414, DOI 10.1016/j.vaccine.2008.06.027; Ellstrom P, 2009, ARCH VIROL, V154, P1533, DOI 10.1007/s00705-009-0476-8; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gambaryan A, 2005, VIROLOGY, V334, P276, DOI 10.1016/j.virol.2005.02.003; Gambaryan A, 2002, ARCH VIROL, V147, P1197, DOI 10.1007/s00705-002-0796-4; Guo CT, 2007, GLYCOBIOLOGY, V17, P713, DOI 10.1093/glycob/cwm038; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; KIDA H, 1980, INFECT IMMUN, V30, P547; Kimble B, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-365; Kleijn D, 2010, P ROY SOC B-BIOL SCI, V277, P2041, DOI 10.1098/rspb.2010.0026; Kuchipudi Suresh V, 2009, J Mol Genet Med, V3, P143; Liu YH, 2009, AVIAN PATHOL, V38, P263, DOI 10.1080/03079450903055363; Mansfield KG, 2007, AM J PATHOL, V171, P1089, DOI 10.2353/ajpath.2007.070695; Munster VJ, 2010, J VIROL, V84, P7953, DOI 10.1128/JVI.00449-10; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Wan HQ, 2006, VIROLOGY, V346, P278, DOI 10.1016/j.virol.2005.10.035; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; Whitworth D., 2007, WILD BIRDS AVIAN INF; Yamnikova SS, 2003, AVIAN DIS, V47, P1164, DOI 10.1637/0005-2086-47.s3.1164	32	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24155	10.1371/journal.pone.0024155	http://dx.doi.org/10.1371/journal.pone.0024155			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909418	Green Submitted, gold, Green Published			2022-12-25	WOS:000294683900034
J	Biasiolo, M; Sales, G; Lionetti, M; Agnelli, L; Todoerti, K; Bisognin, A; Coppe, A; Romualdi, C; Neri, A; Bortoluzzi, S				Biasiolo, Marta; Sales, Gabriele; Lionetti, Marta; Agnelli, Luca; Todoerti, Katia; Bisognin, Andrea; Coppe, Alessandro; Romualdi, Chiara; Neri, Antonino; Bortoluzzi, Stefania			Impact of Host Genes and Strand Selection on miRNA and miRNA* Expression	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; MICRORNA BIOGENESIS; REGULATORY NETWORKS; TARGET; MECHANISMS; FEATURES	Dysregulation of miRNAs expression plays a critical role in the pathogenesis of genetic, multifactorial disorders and in human cancers. We exploited sequence, genomic and expression information to investigate two main aspects of post-transcriptional regulation in miRNA biogenesis, namely strand selection regulation and expression relationships between intragenic miRNAs and host genes. We considered miRNAs expression profiles, measured in five sizeable microarray datasets, including samples from different normal cell types and tissues, as well as different tumours and disease states. First, the study of expression profiles of "sister" miRNA pairs (miRNA/miRNA*, 5' and 3' strands of the same hairpin precursor) showed that the strand selection is highly regulated since it shows tissue-/cell-/condition-specific modulation. We used information about the direction and the strength of the strand selection bias to perform an unsupervised cluster analysis for the sample classification evidencing that is able to distinguish among different tissues, and sometimes between normal and malignant cells. Then, considering a minimum expression threshold, in few miRNA pairs only one mature miRNA is always present in all considered cell types, whereas the majority of pairs were concurrently expressed in some cell types and alternatively in others. In a significant fraction of concurrently expressed pairs, the major and the minor forms found at comparable levels may contribute to post-transcriptional gene silencing, possibly in a coordinate way. In the second part of the study, the behaved tendency to co-expression of intragenic miRNAs and their "host" mRNA genes was confuted by expression profiles examination, suggesting that the expression profile of a given host gene can hardly be a good estimator of co-transcribed miRNA(s) for post-transcriptional regulatory networks inference. Our results point out the regulatory importance of post-transcriptional phases of miRNAs biogenesis, reinforcing the role of such layer of miRNA biogenesis in miRNA-based regulation of cell activities.	[Biasiolo, Marta; Sales, Gabriele; Bisognin, Andrea; Coppe, Alessandro; Romualdi, Chiara; Bortoluzzi, Stefania] Univ Padua, Dept Biol, Padua, Italy; [Lionetti, Marta; Neri, Antonino] Univ Milan, Dept Pharmacol, Matarelli Fdn, Milan, Italy; [Lionetti, Marta; Agnelli, Luca; Todoerti, Katia] Univ Milan, Dept Med Sci, Osped Maggiore Policlin, Fdn IRCCS Ca Granda,Hematol CTMO 1, Milan, Italy	University of Padua; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Biasiolo, M (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	stefania.bortoluzzi@unipd.it	Agnelli, Luca/H-8238-2012; Neri, Antonino/I-9690-2014; Bortoluzzi, Stefania/G-8211-2011; Romualdi, Chiara/K-1132-2016; Bisognin, Andrea/J-3619-2013; Sales, Gabriele/K-5065-2016	Neri, Antonino/0000-0001-9047-5912; Bortoluzzi, Stefania/0000-0001-8240-3070; Romualdi, Chiara/0000-0003-4792-9047; Bisognin, Andrea/0000-0002-9114-1508; Todoerti, Katia/0000-0001-6687-6871; Agnelli, Luca/0000-0003-0582-6170; Sales, Gabriele/0000-0003-2078-5661	Fondazione Cassa di Risparmio di Padova e Rovigo; University of Padova [CPDR074285/07, 60A06-0033/08, 60A06-1977/09, 60A06-8282/09]; Italian Ministry for University and Research [CHSMEB_002]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [561000]; FIRC	Fondazione Cassa di Risparmio di Padova e Rovigo(Fondazione Cariparo); University of Padova; Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); FIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Fondazione Cassa di Risparmio di Padova e Rovigo (Progetti Eccellenza 2006) to SB and CR; University of Padova (CPDR074285/07, 60A06-0033/08, 60A06-1977/09 and 60A06-8282/09) to SB and CR; Italian Ministry for University and Research (PRIN 2007CHSMEB_002) to SB; Associazione Italiana per la Ricerca sul Cancro (AIRC) Regional Research Program 2008 to SB; AIRC Special Program Molecular Clinical Oncology 561000 (AGIMM) to SB and to AN; LA is recipient of a FIRC fellowship, AB is recipient of a AIRC fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Biasiolo M, 2010, BIOCOMPUT-PAC SYM, P397; Bortoluzzi S, 2011, TRENDS MOL IN PRESS; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Callis TE, 2008, EXP BIOL MED, V233, P131, DOI 10.3181/0709-MR-237; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Fazi F, 2008, CARDIOVASC RES, V79, P553, DOI 10.1093/cvr/cvn151; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Fulci V, 2009, GENE CHROMOSOME CANC, V48, P1069, DOI 10.1002/gcc.20709; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Golan D, 2010, BIOINFORMATICS, V26, P992, DOI 10.1093/bioinformatics/btq077; Hu HY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-413; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Jin WW, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-90; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuhn DE, 2008, METHODS, V44, P47, DOI 10.1016/j.ymeth.2007.09.005; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lionetti M, 2009, BLOOD, V114, pE20, DOI 10.1182/blood-2009-08-237495; Luedde Tom, 2010, Hepatology, V52, P1164, DOI 10.1002/hep.23854; Lutter D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-224; Marti E, 2010, NUCLEIC ACIDS RES, V38, P7219, DOI 10.1093/nar/gkq575; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Polster BJ, 2010, MOL GENET METAB, V101, P292, DOI 10.1016/j.ymgme.2010.07.016; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Ronchetti D, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-37; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xin FX, 2009, BIOINFORMATICS, V25, P430, DOI 10.1093/bioinformatics/btn646; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	42	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23854	10.1371/journal.pone.0023854	http://dx.doi.org/10.1371/journal.pone.0023854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909367	Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800029
J	Reissland, N; Francis, B; Mason, J; Lincoln, K				Reissland, Nadja; Francis, Brian; Mason, James; Lincoln, Karen			Do Facial Expressions Develop before Birth?	PLOS ONE			English	Article								Background: Fetal facial development is essential not only for postnatal bonding between parents and child, but also theoretically for the study of the origins of affect. However, how such movements become coordinated is poorly understood. 4-D ultrasound visualisation allows an objective coding of fetal facial movements. Methodology/Findings: Based on research using facial muscle movements to code recognisable facial expressions in adults and adapted for infants, we defined two distinct fetal facial movements, namely "cry-face-gestalt" and "laughter-gestalt," both made up of up to 7 distinct facial movements. In this conceptual study, two healthy fetuses were then scanned at different gestational ages in the second and third trimester. We observed that the number and complexity of simultaneous movements increased with gestational age. Thus, between 24 and 35 weeks the mean number of co-occurrences of 3 or more facial movements increased from 7% to 69%. Recognisable facial expressions were also observed to develop. Between 24 and 35 weeks the number of co-occurrences of 3 or more movements making up a "cry-face gestalt" facial movement increased from 0% to 42%. Similarly the number of co-occurrences of 3 or more facial movements combining to a "laughter-face gestalt" increased from 0% to 35%. These changes over age were all highly significant. Significance: This research provides the first evidence of developmental progression from individual unrelated facial movements toward fetal facial gestalts. We propose that there is considerable potential of this method for assessing fetal development: Subsequent discrimination of normal and abnormal fetal facial development might identify health problems in utero.	[Reissland, Nadja] Univ Durham, Dept Psychol, Durham DH1 3LE, England; [Francis, Brian] Univ Lancaster, Dept Math & Stat, Lancaster, England; [Mason, James] Univ Durham, Wolfson Res Inst, Stockton On Tees, England; [Lincoln, Karen] James Cook Univ Hosp, Middlesbrough, Cleveland, England	Durham University; Lancaster University; Durham University; James Cook University Hospital	Reissland, N (corresponding author), Univ Durham, Dept Psychol, Durham DH1 3LE, England.	n.n.reissland@durham.ac.uk	Francis, Brian J/A-1953-2011; Reissland, Nadja/B-6079-2008; Mason, James M/D-9904-2011	Francis, Brian J/0000-0001-7926-9085; Reissland, Nadja/0000-0003-4976-7117; Mason, James M/0000-0001-9210-4082	Durham University; Lancaster University; ESRC [RES-576-25-5020]; ESRC [ES/F032242/1] Funding Source: UKRI; Economic and Social Research Council [RES-576-25-5020, ES/F032242/1] Funding Source: researchfish	Durham University; Lancaster University; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Funding was provided by Durham University (http://www.dur.ac.uk) and Lancaster University (http://www.lancs.ac.uk/). The analysis of the data was supported by ESRC grant RES-576-25-5020. (http://www.esrc.ac.uk/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2004, ANAL ORDINAL CATEGOR; [Anonymous], SPSS WIND REL 17; Bosma JF, 1975, NERVOUS SYSTEM, P469; Chetelat-Pele E, 2008, 15 C TRAIT AUT LANG; Crelin E.S., 1969, ANATOMY NEWBORN ATLA; Draganova R, 2005, NEUROIMAGE, V28, P354, DOI 10.1016/j.neuroimage.2005.06.011; Finan DS, 1998, EARLY HUM DEV, V52, P181, DOI 10.1016/S0378-3782(98)00029-2; Flores V, 2005, P SIGGRAPH 2006 ED P, DOI [10.1145/1179295.1179318, DOI 10.1145/1179295.1179318]; Friesen E., 1978, CONSULTING PSYCHOL P, V3, P1; Gingras JL, 2005, ARCH DIS CHILD-FETAL, V90, pF415, DOI 10.1136/adc.2004.062257; Granier-Deferre C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017304; Green JR, 2006, DEV PSYCHOBIOL, V48, P16, DOI 10.1002/dev.20112; Grunau RE, 1998, PAIN, V76, P277, DOI 10.1016/S0304-3959(98)00046-3; Hata T, 2005, J OBSTET GYNAECOL RE, V31, P337, DOI 10.1111/j.1447-0756.2005.00298.x; Hopkins B., 2000, CRYING SIGN SYMPTOM, P176; Humprey T, 1967, 2 S OR SENS PERC, P195; Izard C. E., 1991, PSYCHOL EMOTIONS; Kisilevsky BS, 2011, DEVELOPMENTAL SCI, V14, P214, DOI 10.1111/j.1467-7687.2010.00970.x; Kurjak A, 2006, J PERINAT MED, V34, P56, DOI 10.1515/JPM.2006.007; Kurjak A, 2005, J PERINAT MED, V32, P346; Kurjak A, 2007, AM J OBSTET GYNECOL, V196, P16, DOI 10.1016/j.ajog.2006.06.090; Kurjak A, 2010, J PERINAT MED, V38, P77, DOI [10.1515/JPM.2010.012, 10.1515/jpm.2010.012]; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Morokuma S, 2004, BEHAV BRAIN RES, V153, P459, DOI 10.1016/j.bbr.2004.01.002; Morokuma S, 2007, EARLY HUM DEV, V83, P177, DOI 10.1016/j.earlhumdev.2006.05.012; Oster H., 2005, EMOTIONAL DEV, P261; Oster H, 2007, MONOGRAPH CODI UNPUB; Oster Harriet, 1978, DEV AFFECT, P43, DOI DOI 10.1007/978-1-4684-2616-8_; RINN WE, 1984, PSYCHOL BULL, V95, P52, DOI 10.1037/0033-2909.95.1.52; Salihagic-Kadic A, 2005, ULTRASOUND REV OBSTE, V5, P154; VISSER GHA, 1985, EARLY HUM DEV, V12, P173, DOI 10.1016/0378-3782(85)90180-X; Yan F, 2006, INT J GYNECOL OBSTET, V94, P108, DOI 10.1016/j.ijgo.2006.05.004	32	52	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24081	10.1371/journal.pone.0024081	http://dx.doi.org/10.1371/journal.pone.0024081			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904607	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000294680800053
J	Zheng, J; Ho, B; Mekalanos, JJ				Zheng, Jun; Ho, Brian; Mekalanos, John J.			Genetic Analysis of Anti-Amoebae and Anti-Bacterial Activities of the Type VI Secretion System in Vibrio cholerae	PLOS ONE			English	Article							ENTEROAGGREGATIVE ESCHERICHIA-COLI; CROSS-LINKS ACTIN; PSEUDOMONAS-AERUGINOSA; PROTEIN SECRETION; DICTYOSTELIUM-DISCOIDEUM; EDWARDSIELLA-TARDA; BACTERIAL GENOMES; VIRULENCE; IDENTIFICATION; REQUIRES	A type VI secretion system (T6SS) was recently shown to be required for full virulence of Vibrio cholerae O37 serogroup strain V52. In this study, we systematically mutagenized each individual gene in T6SS locus and characterized their functions based on expression and secretion of the hemolysin co-regulated protein (Hcp), virulence towards amoebae of Dictyostelium discoideum and killing of Escherichia coli bacterial cells. We group the 17 proteins characterized in the T6SS locus into four categories: twelve (VipA, VipB, VCA0109-VCA0115, ClpV, VCA0119, and VasK) are essential for Hcp secretion and bacterial virulence, and thus likely function as structural components of the apparatus; two (VasH and VCA0122) are regulators that are required for T6SS gene expression and virulence; another two, VCA0121 and valine-glycine repeat protein G 3 (VgrG-3), are not essential for Hcp expression, secretion or bacterial virulence, and their functions are unknown; the last group is represented by VCA0118, which is not required for Hcp expression or secretion but still plays a role in both amoebae and bacterial killing and may therefore be an effector protein. We also showed that the clpV gene product is required for Dictyostelium virulence but is less important for killing E. coli. In addition, one vgrG gene (vgrG-2) outside of the T6SS gene cluster was required for bacterial killing but another (vgrG-1) was not. However, a bacterial killing defect was observed when vgrG-1 and vgrG-3 were both deleted. Several genes encoded in the same putative operon as vgrG-1 and vgrG-2 also contribute to virulence toward Dictyostelium but have a smaller effect on bacterial killing. Our results provide new insights into the functional requirements of V. cholerae's T6SS in the context of secretion as well as killing of bacterial and eukaryotic phagocytic cells.	[Zheng, Jun; Ho, Brian; Mekalanos, John J.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Zheng, J (corresponding author), Novartis Inst Trop Dis Pte Ltd, Chromos, Singapore.	john_mekalanos@hms.harvard.edu	Ho, Brian/M-1976-2019; Zheng, Jun/AAN-4698-2020	Ho, Brian/0000-0003-4979-780X; Zheng, Jun/0000-0001-6329-4518	National Institute of Allergy and Infectious Diseases [AI-018045]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI018045, R37AI018045, R01AI018045] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant AI-018045 to JJM from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Aubert DF, 2008, INFECT IMMUN, V76, P1979, DOI 10.1128/IAI.01338-07; Bernard CS, 2011, J BACTERIOL, V193, P2158, DOI 10.1128/JB.00029-11; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Economou A, 2006, MOL MICROBIOL, V62, P308, DOI 10.1111/j.1365-2958.2006.05377.x; Ermolaeva MD, 2000, J MOL BIOL, V301, P27, DOI 10.1006/jmbi.2000.3836; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Fey P, 2007, NAT PROTOC, V2, P1307, DOI 10.1038/nprot.2007.178; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Ishikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006734; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; LINN T, 1990, J BACTERIOL, V172, P1077, DOI 10.1128/jb.172.2.1077-1084.1990; Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Michel-Briand Y, 2002, BIOCHIMIE, V84, P499, DOI 10.1016/S0300-9084(02)01422-0; Miller JH., 1972, EXPT MOL GENETICS; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Miyata ST, 2011, INFECT IMMUN, V79, P2941, DOI 10.1128/IAI.01266-10; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Rubires X, 1997, J BACTERIOL, V179, P7581, DOI 10.1128/jb.179.23.7581-7586.1997; Sandkvist M, 1997, J BACTERIOL, V179, P6994, DOI 10.1128/jb.179.22.6994-7003.1997; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Sheahan KL, 2004, P NATL ACAD SCI USA, V101, P9798, DOI 10.1073/pnas.0401104101; Shrivastava S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002955; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Zheng J, 2005, INFECT IMMUN, V73, P4127, DOI 10.1128/IAI.73.7.4127-4137.2005; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zheng J, 2010, P NATL ACAD SCI USA, V107, P21128, DOI 10.1073/pnas.1014998107	45	135	139	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23876	10.1371/journal.pone.0023876	http://dx.doi.org/10.1371/journal.pone.0023876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909372	Green Submitted, Green Published, gold			2022-12-25	WOS:000294680800034
J	Chen, S; Li, DL; Yuan, WG; Fu, ZK; Xu, FY; Pang, D; Li, DJ				Chen Shuang; Li Dalin; Yuan Weiguang; Fu Zhenkun; Xu Fengyan; Pang Da; Li, Dianjun			Association of CD40 Gene Polymorphisms with Sporadic Breast Cancer in Chinese Han Women of Northeast China	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELLS; EXPRESSION; PATHWAY; OVEREXPRESSION; ANGIOGENESIS; ACTIVATION; C-ERBB-2; ANTIBODY; P53	Background: Breast cancer is a polygenetic disorder with a complex inheritance pattern. Single nucleotide polymorphisms (SNPs), the most common genetic variations, influence not only phenotypic traits, but also interindividual predisposition to disease, treatment outcomes with drugs and disease prognosis. The co-stimulatory molecule CD40 plays a prominent role in immune regulation and homeostasis. Accumulating evidence suggests that CD40 contributes to the pathogenesis of cancer. Here, we set out to test the association between polymorphisms in the CD40 gene and breast carcinogenesis and tumor pathology. Methodology and Principal Findings: Four SNPs (rs1800686, rs1883832, rs4810485 and rs3765459) were genotyped by the polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) method in a case-control study including 591 breast cancer patients and 600 age-matched healthy controls. Differences in the genotypic distribution between breast cancer patients and healthy controls were analyzed by the Chi-square test for trends. Our preliminary data showed a statistically significant association between the four CD40 gene SNPs and sporadic breast cancer risk (additive P = 0.0223, 0.0012, 0.0013 and 0.0279, respectively). A strong association was also found using the dominant, recessive and homozygote comparison genetic models. In the clinical features analysis, significant associations were observed between CD40 SNPs and lymph node metastasis, human epidermal growth factor receptor 2 (C-erbB2), estrogen receptor (ER), progesterone receptor (PR) and tumor protein 53 (P53) statuses. In addition, our haplotype analysis indicated that the haplotype C(rs1883832)G(rs4810485), which was located within the only linkage disequilibrium (LD) block identified, was a protective haplotype for breast cancer, whereas T(rs1883832)T(rs4810485) increased the risk in the studied population, even after correcting the P value for multiple testing (P = 0.0337 and 0.0430, respectively). Conclusions and Significance: Our findings primarily show that CD40 gene polymorphisms contribute to sporadic breast cancer risk and have a significant association with clinicopathological features among Chinese Han women from the Heilongjiang Province.	[Li Dalin; Pang Da] Harbin Med Coll, Dept Surg, Affiliated Hosp 3, Harbin, Peoples R China; [Chen Shuang; Fu Zhenkun; Xu Fengyan; Li, Dianjun] Harbin Med Coll, Dept Immunol, Harbin, Peoples R China; [Chen Shuang; Yuan Weiguang; Pang Da; Li, Dianjun] Harbin Med Coll, Inst Canc Prevent & Treatment, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Chen, S (corresponding author), Harbin Med Coll, Dept Surg, Affiliated Hosp 3, Harbin, Peoples R China.	pangdasir@163.com; dianjunli@163.com			National Natural Science Foundation of China [31070780]; Heilongjiang Province Foundation of Education Department [11522001]; Technology Department, Heilongjiang Province [GB05C402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Province Foundation of Education Department; Technology Department, Heilongjiang Province	This study was supported by a grant from the National Natural Science Foundation of China (31070780), the Heilongjiang Province Foundation of Education Department (11522001) and the Major Project of Technology Department, Heilongjiang Province (GB05C402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Baxendale AJ, 2005, ONCOGENE, V24, P7913, DOI 10.1038/sj.onc.1208929; Beenken SW, 2001, ANN SURG, V233, P630, DOI 10.1097/00000658-200105000-00006; Deregibus MC, 2003, J BIOL CHEM, V278, P18008, DOI 10.1074/jbc.M300711200; Dolen Y, 2010, CYTOKINE, V50, P243, DOI 10.1016/j.cyto.2010.03.010; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Flaxenburg JA, 2004, J IMMUNOL, V172, P7503, DOI 10.4049/jimmunol.172.12.7503; Gomes EM, 2009, CLIN CANCER RES, V15, P1317, DOI 10.1158/1078-0432.CCR-08-1360; HOLLENBAUGH D, 1995, J EXP MED, V182, P33, DOI 10.1084/jem.182.1.33; Jacobson EM, 2007, GENES IMMUN, V8, P205, DOI 10.1038/sj.gene.6364375; Jacobson EM, 2005, ENDOCRINOLOGY, V146, P2684, DOI 10.1210/en.2004-1617; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lee JS, 2007, CANCER BIOL THER, V6, P1114, DOI 10.4161/cbt.6.7.4331; Loskog ASI, 2009, SEMIN IMMUNOL, V21, P301, DOI 10.1016/j.smim.2009.07.001; Melter M, 2000, BLOOD, V96, P3801, DOI 10.1182/blood.V96.12.3801.h8003801_3801_3808; Murugaiyan G, 2007, TRENDS IMMUNOL, V28, P467, DOI 10.1016/j.it.2007.08.010; Pal R, 2011, BREAST CANCER RES TR, V126, P333, DOI 10.1007/s10549-010-0900-5; Purkerson JM, 2005, EUR J IMMUNOL, V35, P2920, DOI 10.1002/eji.200526219; Shimizu C, 2000, J SURG ONCOL, V73, P17, DOI 10.1002/(SICI)1096-9098(200001)73:1<17::AID-JSO5>3.3.CO;2-U; Skibola CF, 2008, BLOOD, V111, P4348, DOI 10.1182/blood-2007-09-112144; Stendahl M, 2006, CLIN CANCER RES, V12, P4614, DOI 10.1158/1078-0432.CCR-06-0248; Tan J, 2002, EMBO J, V21, P643, DOI 10.1093/emboj/21.4.643; Vonderheide RH, 2007, J CLIN ONCOL, V25, P876, DOI 10.1200/JCO.2006.08.3311; Young LS, 1998, IMMUNOL TODAY, V19, P502, DOI 10.1016/S0167-5699(98)01340-1	24	3	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e23762	10.1371/journal.pone.0023762	http://dx.doi.org/10.1371/journal.pone.0023762			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912605	Green Published, gold, Green Submitted			2022-12-25	WOS:000294678300008
J	Czibere, L; Baur, LA; Wittmann, A; Gemmeke, K; Steiner, A; Weber, P; Putz, B; Ahmad, N; Bunck, M; Graf, C; Widner, R; Kuhne, C; Panhuysen, M; Hambsch, B; Rieder, G; Reinheckel, T; Peters, C; Holsboer, F; Landgraf, R; Deussing, JM				Czibere, Ludwig; Baur, Laura A.; Wittmann, Anke; Gemmeke, Katja; Steiner, Andrea; Weber, Peter; Puetz, Benno; Ahmad, Nafees; Bunck, Mirjam; Graf, Cornelia; Widner, Regina; Kuehne, Claudia; Panhuysen, Markus; Hambsch, Boris; Rieder, Gabriele; Reinheckel, Thomas; Peters, Christoph; Holsboer, Florian; Landgraf, Rainer; Deussing, Jan M.			Profiling Trait Anxiety: Transcriptome Analysis Reveals Cathepsin B (Ctsb) as a Novel Candidate Gene for Emotionality in Mice	PLOS ONE			English	Article							SYNAPTOTAGMIN-IV; METALLOTHIONEIN-I/II; MOUSE-BRAIN; WILD-TYPE; DEPRESSION; EXPRESSION; VASOPRESSIN; SYSTEM; MODEL; P2RX7	Behavioral endophenotypes are determined by a multitude of counteracting but precisely balanced molecular and physiological mechanisms. In this study, we aim to identify potential novel molecular targets that contribute to the multigenic trait "anxiety". We used microarrays to investigate the gene expression profiles of different brain regions within the limbic system of mice which were selectively bred for either high (HAB) or low (LAB) anxiety-related behavior, and also show signs of comorbid depression-like behavior. We identified and confirmed sex-independent differences in the basal expression of 13 candidate genes, using tissue from the entire brain, including coronin 7 (Coro7), cathepsin B (Ctsb), muscleblind-like 1 (Mbnl1), metallothionein 1 (Mt1), solute carrier family 25 member 17 (Slc25a17), tribbles homolog 2 (Trib2), zinc finger protein 672 (Zfp672), syntaxin 3 (Stx3), ATP-binding cassette, sub-family A member 2 (Abca2), ectonucleotide pyrophosphatase/phosphodiesterase 5 (Enpp5), high mobility group nucleosomal binding domain 3 (Hmgn3) and pyruvate dehydrogenase beta (Pdhb). Additionally, we confirmed brain region-specific differences in the expression of synaptotagmin 4 (Syt4). Our identification of about 90 polymorphisms in Ctsb suggested that this gene might play a critical role in shaping our mouse model's behavioral endophenotypes. Indeed, the assessment of anxiety-related and depression-like behaviors of Ctsb knock-out mice revealed an increase in depression-like behavior in females. Altogether, our results suggest that Ctsb has significant effects on emotionality, irrespective of the tested mouse strain, making it a promising target for future pharmacotherapy.	[Czibere, Ludwig; Baur, Laura A.; Wittmann, Anke; Gemmeke, Katja; Steiner, Andrea; Weber, Peter; Puetz, Benno; Ahmad, Nafees; Bunck, Mirjam; Graf, Cornelia; Widner, Regina; Kuehne, Claudia; Hambsch, Boris; Holsboer, Florian; Landgraf, Rainer; Deussing, Jan M.] Max Planck Inst Psychiat, Munich, Germany; [Ahmad, Nafees; Graf, Cornelia; Deussing, Jan M.] Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Panhuysen, Markus] Affectis Pharmaceut, Martinsried, Germany; [Rieder, Gabriele] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany; [Reinheckel, Thomas; Peters, Christoph] Univ Freiburg, Fac Biol, Inst Mol Med & Cell Res, Freiburg, Germany	Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Freiburg	Czibere, L (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	czibere@mpipsykl.mpg.de	Deussing, Jan M/ABB-5993-2021; Pütz, Benno/P-2630-2016; Reinheckel, Thomas/AAL-9761-2021	Pütz, Benno/0000-0002-2208-209X; Reinheckel, Thomas/0000-0001-9866-9105; Deussing, Jan/0000-0002-9329-5252; Czibere, Ludwig/0000-0002-7508-5841; Ahmad, Nafees/0000-0002-7436-7644	Bundesministerium fur Bildung und Forschung [FKZ: 01GS08151]; Helmholtz Association within the framework of the Helmholtz Alliance for Mental Health in an Aging Society [HA-215]; Affectis Pharmaceuticals	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Helmholtz Association within the framework of the Helmholtz Alliance for Mental Health in an Aging Society; Affectis Pharmaceuticals	This work was partially supported by the Bundesministerium fur Bildung und Forschung within the framework of NGFN-Plus (FKZ: 01GS08151, http://www.ngfn.de/en/ngfn_plus.html), and by the Initiative and Networking Fund of the Helmholtz Association within the framework of the Helmholtz Alliance for Mental Health in an Aging Society (HA-215, www.neuro-ageing.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Affectis Pharmaceuticals funded the study through the employment of Markus Panhuysen. This author designed and performed the experiments and analyzed the data. Mr. Panhuysen's experience with the MPIP24K microarray platform made him a major participant in study design and evaluation of the MPIP24K microarray experiment.	Bao AM, 2008, BRAIN RES REV, V57, P531, DOI 10.1016/j.brainresrev.2007.04.005; Barden N, 2006, AM J MED GENET B, V141B, P374, DOI 10.1002/ajmg.b.30303; Baulac S, 2008, ARCH NEUROL-CHICAGO, V65, P943, DOI 10.1001/archneur.65.7.943; Beltramini M, 2004, BRAIN RES, V1013, P134, DOI 10.1016/j.brainres.2004.04.010; Beltramini M, 2004, GLIA, V47, P30, DOI 10.1002/glia.20020; BELZUNG C, 2007, NEURAL PLAST; Brudno M, 2004, GENOME RES, V14, P685, DOI 10.1101/gr.2067704; Bunck M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005129; Caglic D, 2009, BIOL CHEM, V390, P175, DOI 10.1515/BC.2009.021; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Copanaki E, 2010, MOL CELL NEUROSCI, V44, P386, DOI 10.1016/j.mcn.2010.04.007; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Deussing JM, 2007, J CEREBR BLOOD F MET, V27, P1476, DOI 10.1038/sj.jcbfm.9600451; Dina C, 2005, AM J MED GENET B, V132B, P104, DOI 10.1002/ajmg.b.30099; Ditzen C, 2010, MOL PSYCHIATR, V15, P702, DOI 10.1038/mp.2008.146; Do MS, 2006, YONSEI MED J, V47, P729, DOI 10.3349/ymj.2006.47.5.729; Dudoit S, 2002, STAT SINICA, V12, P111; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Erhardt A, 2011, MOL PSYCHIATR, V16, P647, DOI 10.1038/mp.2010.41; Erhardt A, 2007, J AFFECT DISORDERS, V101, P159, DOI 10.1016/j.jad.2006.11.016; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Ferguson GD, 1999, J NEUROCHEM, V72, P1821, DOI 10.1046/j.1471-4159.1999.0721821.x; Ferguson GD, 2004, NEUROPHARMACOLOGY, V47, P604, DOI 10.1016/j.neuropharm.2004.05.008; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Gillespie NA, 2004, TWIN RES, V7, P39, DOI 10.1375/13690520460741435; Gimenez-Llort L, 2008, NEUROIMMUNOMODULAT, V15, P331, DOI 10.1159/000156475; Gonda Xenia, 2007, Ann Gen Psychiatry, V6, P23, DOI 10.1186/1744-859X-6-23; GONIK M, BIOL PSYCHIAT UNPUB; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Hambsch B, 2010, J NEUROCHEM, V113, P1240, DOI 10.1111/j.1471-4159.2010.06693.x; Hamilton SP, 2009, DEPRESS ANXIETY, V26, P976, DOI 10.1002/da.20615; Hejjas K, 2009, AM J MED GENET B, V150B, P295, DOI 10.1002/ajmg.b.30799; Hook VYH, 2009, BIOCHEM BIOPH RES CO, V386, P284, DOI 10.1016/j.bbrc.2009.05.131; Jacobi F, 2004, PSYCHOL MED, V34, P597, DOI 10.1017/S0033291703001399; Jansen F, 2010, BEHAV BRAIN RES, V207, P21, DOI 10.1016/j.bbr.2009.09.033; Kageyama K, 2009, ENDOCR J, V56, P335, DOI 10.1507/endocrj.K09E-075; Kessler MS, 2007, EUR J NEUROSCI, V26, P2857, DOI 10.1111/j.1460-9568.2007.05917.x; Ketter Terrence A, 2010, J Clin Psychiatry, V71, pe14, DOI 10.4088/JCP.8125tx11c; Kromer SA, 2005, J NEUROSCI, V25, P4375, DOI 10.1523/JNEUROSCI.0115-05.2005; Landgraf R, 2001, ENDOCR J, V48, P517, DOI 10.1507/endocrj.48.517; Landgraf R, 2007, NEUROSCI BIOBEHAV R, V31, P89, DOI 10.1016/j.neubiorev.2006.07.003; Liebl C, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.001.2009; Littleton JT, 1999, NATURE, V400, P757, DOI 10.1038/23462; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonnstedt I, 2002, STAT SINICA, V12, P31; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; Middeldorp CM, 2005, TWIN RES HUM GENET, V8, P609, DOI 10.1375/183242705774860123; Mosing MA, 2009, DEPRESS ANXIETY, V26, P1004, DOI 10.1002/da.20611; Muigg P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005346; Muller MB, 2003, NEUROPSYCHOPHARMACOL, V28, P1991, DOI 10.1038/sj.npp.1300257; Murgatroyd C, 2006, ANAL BIOCHEM, V348, P160, DOI 10.1016/j.ab.2005.10.004; Murgatroyd C, 2004, J NEUROSCI, V24, P7762, DOI 10.1523/JNEUROSCI.1614-04.2004; Neumann ID, 2000, REGUL PEPTIDES, V96, P31, DOI 10.1016/S0167-0115(00)00197-X; Okajima K, 2008, MOL GENET METAB, V93, P371, DOI 10.1016/j.ymgme.2007.10.135; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Plomin R, 2000, PSYCHOL BULL, V126, P806, DOI 10.1037/0033-2909.126.6.806; Pollack MH, 2005, J CLIN PSYCHIAT, V66, P22; Royer-Zemmour B, 2008, HUM MOL GENET, V17, P3617, DOI 10.1093/hmg/ddn256; Rozen S, 2000, Methods Mol Biol, V132, P365; Rybakin V, 2004, FEBS LETT, V573, P161, DOI 10.1016/j.febslet.2004.07.066; Rybakin V, 2006, J BIOL CHEM, V281, P31070, DOI 10.1074/jbc.M604680200; Sakai H, 2007, J BIOL CHEM, V282, P19692, DOI 10.1074/jbc.M611056200; Schmidt M, 2002, DEV BRAIN RES, V139, P39, DOI 10.1016/S0165-3806(02)00519-9; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Song GH, 2005, ENDOCRINOLOGY, V146, P4825, DOI 10.1210/en.2005-0768; Stahl S, 2007, BBA-PROTEINS PROTEOM, V1774, P1237, DOI 10.1016/j.bbapap.2007.07.004; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Sullivan JM, 2007, NEURON, V54, P493, DOI 10.1016/j.neuron.2007.05.011; Ting JT, 2006, J NEUROSCI, V26, P372, DOI 10.1523/JNEUROSCI.3997-05.2006; Touma C, 2008, PSYCHONEUROENDOCRINO, V33, P839, DOI 10.1016/j.psyneuen.2008.03.013; Visser WF, 2002, BIOCHEM BIOPH RES CO, V299, P494, DOI 10.1016/S0006-291X(02)02663-3; Vorbrodt AW, 2006, J MOL HISTOL, V37, P143, DOI 10.1007/s10735-006-9053-6; Wang QF, 2008, CANCER LETT, V269, P127, DOI 10.1016/j.canlet.2008.04.035; West KL, 2004, MOL CELL BIOL, V24, P3747, DOI 10.1128/MCB.24.9.3747-3756.2004; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zimmermann P, 2008, BIOL PSYCHIAT, V63, P406, DOI 10.1016/j.biopsych.2007.05.020	80	35	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23604	10.1371/journal.pone.0023604	http://dx.doi.org/10.1371/journal.pone.0023604			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897848	gold, Green Published, Green Submitted			2022-12-25	WOS:000294676900011
J	Calame, M; Cachafeiro, M; Philippe, S; Schouwey, K; Tekaya, M; Wanner, D; Sarkis, C; Kostic, C; Arsenijevic, Y				Calame, Maritza; Cachafeiro, Maite; Philippe, Stephanie; Schouwey, Karine; Tekaya, Meriem; Wanner, Dana; Sarkis, Chamsy; Kostic, Corinne; Arsenijevic, Yvan			Retinal Degeneration Progression Changes Lentiviral Vector Cell Targeting in the Retina	PLOS ONE			English	Article							TRANSPLANTED PHOTORECEPTOR PRECURSORS; EFFICIENT GENE-TRANSFER; MOUSE MODEL; TRANSGENE EXPRESSION; NEUROTROPHIC FACTOR; RHO(-/-) MOUSE; IN-VITRO; THERAPY; RAT; TRANSDUCTION	In normal mice, the lentiviral vector (LV) is very efficient to target the RPE cells, but transduces retinal neurons well only during development. In the present study, the tropism of LV has been investigated in the degenerating retina of mice, knowing that the retina structure changes during degeneration. We postulated that the viral transduction would be increased by the alteration of the outer limiting membrane (OLM). Two different LV pseudotypes were tested using the VSVG and the Mokola envelopes, as well as two animal models of retinal degeneration: light-damaged Balb-C and Rhodopsin knockout (Rho-/-) mice. After light damage, the OLM is altered and no significant increase of the number of transduced photoreceptors can be obtained with a LV-VSVG-Rhop-GFP vector. In the Rho-/- mice , an alteration of the OLM was also observed, but the possibility of transducing photoreceptors was decreased, probably by ongoing gliosis. The use of a ubiquitous promoter allows better photoreceptor transduction, suggesting that photoreceptor-specific promoter activity changes during late stages of photoreceptor degeneration. However, the number of targeted photoreceptors remains low. In contrast, LV pseudotyped with the Mokola envelope allows a wide dispersion of the vector into the retina (corresponding to the injection bleb) with preferential targeting of Muller cells, a situation which does not occur in the wildtype retina. Mokola-pseudotyped lentiviral vectors may serve to engineer these glial cells to deliver secreted therapeutic factors to a diseased area of the retina.	[Calame, Maritza; Cachafeiro, Maite; Philippe, Stephanie; Schouwey, Karine; Tekaya, Meriem; Wanner, Dana; Kostic, Corinne; Arsenijevic, Yvan] Univ Lausanne, Jules Gonin Eye Hosp, Serv Ophthalmol, Unit Gene Therapy & Stem Cell Biol, Lausanne, Switzerland; [Sarkis, Chamsy] NewVectys SAS, Paris, France; [Sarkis, Chamsy] Univ Paris 06, INSERM U975, CNRS UMR 7225, Team Biotherapy & Biotechnol,UMR S 975, Paris, France	University of Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Calame, M (corresponding author), Univ Lausanne, Jules Gonin Eye Hosp, Serv Ophthalmol, Unit Gene Therapy & Stem Cell Biol, Lausanne, Switzerland.	yvan.arsenijevic@fa2.ch		Arsenijevic, Yvan/0000-0001-6960-1291; Kostic, Corinne/0000-0003-1006-9733	Fondation Provisu	Fondation Provisu	Fondation Provisu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsen WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012387; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Balaggan KS, 2006, J GENE MED, V8, P275, DOI 10.1002/jgm.845; Bemelmans AP, 2006, PLOS MED, V3, P1892, DOI 10.1371/journal.pmed.0030347; Bemelmans AP, 2005, J GENE MED, V7, P1367, DOI 10.1002/jgm.788; Buch PK, 2008, GENE THER, V15, P849, DOI 10.1038/gt.2008.66; Buch PK, 2006, MOL THER, V14, P700, DOI 10.1016/j.ymthe.2006.05.019; Campbell M, 2006, EXP EYE RES, V83, P484, DOI 10.1016/j.exer.2006.01.032; Campbell M, 2007, EXP EYE RES, V85, P714, DOI 10.1016/j.exer.2007.08.004; Colin A, 2009, GLIA, V57, P667, DOI 10.1002/glia.20795; Dalkara D, 2011, MOL THER; Desclaux M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006227; Dinculescu A, 2005, HUM GENE THER, V16, P649, DOI 10.1089/hum.2005.16.649; Dorrell MI, 2009, J CLIN INVEST, V119, P611, DOI 10.1172/JCI35977; Greenberg KP, 2007, INVEST OPHTH VIS SCI, V48, P1844, DOI 10.1167/iovs.05-1570; Gruter O, 2005, GENE THER; Jones BW, 2003, J COMP NEUROL, V464, P1, DOI 10.1002/cne.10703; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Klimczak RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007467; Kolstad KD, 2010, HUM GENE THER, V21, P571, DOI 10.1089/hum.2009.194; Kong J, 2008, GENE THER, V15, P1311, DOI 10.1038/gt.2008.78; Kostic C, 2003, GENE THER, V10, P818, DOI 10.1038/sj.gt.3301948; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; Pearson RA, 2010, CELL TRANSPLANT, V19, P487, DOI 10.3727/096368909X486057; Pertusa A, 2008, NEUROBIOL AGING, V29, P1366, DOI 10.1016/j.neurobiolaging.2007.02.026; Philippe S, 2006, P NATL ACAD SCI USA, V103, P17684, DOI 10.1073/pnas.0606197103; Pignatelli V, 2004, J COMP NEUROL, V469, P351, DOI 10.1002/cne.11019; Strettoi E, 2002, J NEUROSCI, V22, P5492; Surace EM, 2008, VISION RES, V48, P353, DOI 10.1016/j.visres.2007.07.027; Sweigard JH, 2010, INVEST OPHTH VIS SCI, V51, P2219, DOI 10.1167/iovs.09-4367; Takahashi M, 1999, J VIROL, V73, P7812, DOI 10.1128/JVI.73.9.7812-7816.1999; Tschernutter M, 2005, GENE THER, V12, P694, DOI 10.1038/sj.gt.3302460; Tucker B, 2008, INVEST OPHTH VIS SCI, V49, P1686, DOI 10.1167/iovs.07-1058; Van Adel BA, 2003, HUM GENE THER, V14, P103, DOI 10.1089/104303403321070801; Weber M, 2003, MOL THER, V7, P774, DOI 10.1016/S1525-0016(03)00098-4; West EL, 2008, EXP EYE RES, V86, P601, DOI 10.1016/j.exer.2008.01.004; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365	39	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23782	10.1371/journal.pone.0023782	http://dx.doi.org/10.1371/journal.pone.0023782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901134	Green Published, gold, Green Submitted			2022-12-25	WOS:000294298000019
J	Fedrigo, GV; Campoy, EM; Di Venanzio, G; Colombo, MI; Vescovi, EG				Fedrigo, Griselda V.; Campoy, Emanuel M.; Di Venanzio, Gisela; Isabel Colombo, Maria; Garcia Vescovi, Eleonora			Serratia marcescens Is Able to Survive and Proliferate in Autophagic-Like Vacuoles inside Non-Phagocytic Cells	PLOS ONE			English	Article							SALMONELLA-ENTERICA; EPITHELIAL-CELLS; HOST-CELLS; FLAGELLA; PATHWAY; RAB7; MATURATION; INHIBITORS; PATHOGENS; SURFACES	Serratia marcescens is an opportunistic human pathogen that represents a growing problem for public health, particularly in hospitalized or immunocompromised patients. However, little is known about factors and mechanisms that contribute to S. marcescens pathogenesis within its host. In this work, we explore the invasion process of this opportunistic pathogen to epithelial cells. We demonstrate that once internalized, Serratia is able not only to persist but also to multiply inside a large membrane-bound compartment. This structure displays autophagic-like features, acquiring LC3 and Rab7, markers described to be recruited throughout the progression of antibacterial autophagy. The majority of the autophagic-like vacuoles in which Serratia resides and proliferates are non-acidic and have no degradative properties, indicating that the bacteria are capable to either delay or prevent fusion with lysosomal compartments, altering the expected progression of autophagosome maturation. In addition, our results demonstrate that Serratia triggers a non-canonical autophagic process before internalization. These findings reveal that S. marcescens is able to manipulate the autophagic traffic, generating a suitable niche for survival and proliferation inside the host cell.	[Fedrigo, Griselda V.; Di Venanzio, Gisela; Garcia Vescovi, Eleonora] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Dept Microbiol, Inst Biol Mol & Celular Rosario IBR CONICET, RA-2000 Rosario, Argentina; [Campoy, Emanuel M.; Isabel Colombo, Maria] Univ Nacl Cuyo, CONICET, Fac Ciencias Med, Lab Biol Celular & Mol,Inst Hist & Embriol IHEM, RA-5500 Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Fedrigo, GV (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Dept Microbiol, Inst Biol Mol & Celular Rosario IBR CONICET, RA-2000 Rosario, Argentina.	garciavescovi@ibr.gov.ar	Di Venanzio, Gisela/GYV-3910-2022	Garcia Vescovi, Eleonora/0000-0002-4431-8606; Campoy, Emanuel/0000-0003-0521-6073	Agencia Nacional de Promocion Cientificay Tecnologica [ANPCyT-PICT 2007-02173]; Consejo Nacional de Investigaciones Cientificasy Tecnologicas (CONICET), Argentina [PIP 112-200801-01063]; CONICET; ANPCyT, Argentina	Agencia Nacional de Promocion Cientificay Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificasy Tecnologicas (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT, Argentina(ANPCyT)	E. G. V. and M. I. C. are supported by grants from Agencia Nacional de Promocion Cientificay Tecnologica (ANPCyT-PICT 2007-02173) and from Consejo Nacional de Investigaciones Cientificasy Tecnologicas (CONICET, PIP 112-200801-01063), Argentina. E. G. V. and M. I. C. are career investigators of CONICET, Argentina. G. V. F. has a fellowship from CONICET, and E. C. and G. D. V. have fellowships from ANPCyT, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M, 2009, INFECT IMMUN, V77, P4609, DOI 10.1128/IAI.00301-09; Aguirre A, 2006, J BACTERIOL, V188, P6889, DOI 10.1128/JB.00804-06; Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Alvarez V, 2005, INT J MOL MED, V16, P565; Barchiesi J, 2008, J BACTERIOL, V190, P4951, DOI 10.1128/JB.00195-08; Mestre MB, 2010, AUTOPHAGY, V6, P110, DOI 10.4161/auto.6.1.10698; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Campoy E, 2009, BBA-MOL CELL RES, V1793, P1465, DOI 10.1016/j.bbamcr.2009.03.003; Castelli ME, 2008, J BACTERIOL, V190, P213, DOI 10.1128/JB.01348-07; Drose S, 1997, J EXP BIOL, V200, P1; Giron JA, 2002, MOL MICROBIOL, V44, P361, DOI 10.1046/j.1365-2958.2002.02899.x; Gutierrez MG, 2005, CELL MICROBIOL, V7, P981, DOI 10.1111/j.1462-5822.2005.00527.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Hejazi A, 2000, J HOSP INFECT, V45, P42, DOI 10.1053/jhin.1999.0722; Hertle R, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-16; Ihle NT, 2009, MOL CANCER THER, V8, P1, DOI 10.1158/1535-7163.MCT-08-0801; Inglis TJJ, 2003, INFECT IMMUN, V71, P2280, DOI 10.1128/IAI.71.4.2280-2282.2003; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kageyama S, 2011, MOL BIOL CELL, V22, P2290, DOI 10.1091/mbc.E10-11-0893; Kirov SM, 2004, INFECT IMMUN, V72, P1939, DOI 10.1128/IAI.72.4.1939-1945.2004; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kumar Y, 2009, CELL HOST MICROBE, V5, P593, DOI 10.1016/j.chom.2009.05.014; Kumari S, 2010, CELL RES, V20, P256, DOI 10.1038/cr.2010.19; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Noda T, 2010, AUTOPHAGY, V6, P419, DOI 10.4161/auto.6.3.11419; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Ray K, 2009, NAT REV MICROBIOL, V7, P333, DOI 10.1038/nrmicro2112; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; Roy K, 2009, NATURE, V457, P594, DOI 10.1038/nature07568; Sciara MI, 2008, MOL MICROBIOL, V70, P479, DOI 10.1111/j.1365-2958.2008.06427.x; UMATA T, 1990, J BIOL CHEM, V265, P21940; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967	41	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e24054	10.1371/journal.pone.0024054	http://dx.doi.org/10.1371/journal.pone.0024054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901159	Green Published, Green Submitted, gold			2022-12-25	WOS:000294298000044
J	Giannatselis, H; Calder, M; Watson, AJ				Giannatselis, Holly; Calder, Michele; Watson, Andrew J.			Ouabain Stimulates a Na+/K+-ATPase-Mediated SFK-Activated Signalling Pathway That Regulates Tight Junction Function in the Mouse Blastocyst	PLOS ONE			English	Article							ENDOGENOUS CARDIOTONIC STEROIDS; NA/K-ATPASE; PREIMPLANTATION DEVELOPMENT; EPITHELIAL-CELLS; TROPHECTODERM DIFFERENTIATION; MOLECULAR REGULATION; CARDIAC-GLYCOSIDES; KINASE INHIBITOR; BINDING SITE; EMBRYO	The Na+/K+-ATPase plays a pivotal role during preimplantation development; it establishes a trans-epithelial ionic gradient that facilitates the formation of the fluid-filled blastocyst cavity, crucial for implantation and successful pregnancy. The Na+/K+-ATPase is also implicated in regulating tight junctions and cardiotonic steroid (CTS)-induced signal transduction via SRC. We investigated the expression of SRC family kinase (SFK) members, Src and Yes, during preimplantation development and determined whether SFK activity is required for blastocyst formation. Embryos were collected following super-ovulation of CD1 or MF1 female mice. RT-PCR was used to detect SFK mRNAs encoding Src and Yes throughout preimplantation development. SRC and YES protein were localized throughout preimplantation development. Treatment of mouse morulae with the SFK inhibitors PP2 and SU6656 for 18 hours resulted in a reversible blockade of progression to the blastocyst stage. Blastocysts treated with 10(-3) M ouabain for 2 or 10 minutes and immediately immunostained for phosphorylation at SRC tyr418 displayed reduced phosphorylation while in contrast blastocysts treated with 10(-4) M displayed increased tyr418 fluorescence. SFK inhibition increased and SFK activation reduced trophectoderm tight junction permeability in blastocysts. The results demonstrate that SFKs are expressed during preimplantation development and that SFK activity is required for blastocyst formation and is an important mediator of trophectoderm tight junction permeability.	[Giannatselis, Holly; Calder, Michele; Watson, Andrew J.] Univ Western Ontario, Dept Obstet & Gynaecol, London, ON, Canada; [Giannatselis, Holly; Calder, Michele; Watson, Andrew J.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Giannatselis, Holly; Calder, Michele; Watson, Andrew J.] Childrens Hlth Res Inst, London, ON, Canada; [Giannatselis, Holly; Calder, Michele; Watson, Andrew J.] Lawson Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Giannatselis, H (corresponding author), Univ Western Ontario, Dept Obstet & Gynaecol, London, ON, Canada.	awatson@uwo.ca	Watson, Andrew J/A-5636-2015	Watson, Andrew J/0000-0002-2344-3061	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes of Health Research (CIHR) operating grant to AJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova Olga, 2006, Pathophysiology, V13, P209, DOI 10.1016/j.pathophys.2006.06.001; Alarcon VB, 2010, BIOL REPROD, V83, P347, DOI 10.1095/biolreprod.110.084400; Antolovic R, 2000, HYPERTENS RES, V23, pS93, DOI 10.1291/hypres.23.Supplement_S93; Averina IV, 2006, CELL MOL BIOL, V52, P19, DOI 10.1170/T755; Bagrov AY, 2008, NAT CLIN PRACT NEPHR, V4, P378, DOI 10.1038/ncpneph0848; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Barcroft LC, 1998, J REPROD FERTIL, V114, P327, DOI 10.1530/jrf.0.1140327; Barcroft LC, 2004, MECH DEVELOP, V121, P417, DOI 10.1016/j.mod.2004.04.005; Barcroft LC, 2003, DEV BIOL, V256, P342, DOI 10.1016/S0012-1606(02)00127-6; Bell CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008530; Bell CE, 2009, HUM REPROD, V24, P1373, DOI 10.1093/humrep/dep010; Betts DH, 1998, DEV BIOL, V197, P77, DOI 10.1006/dbio.1998.8874; Betts DH, 1997, MOL REPROD DEV, V46, P114, DOI 10.1002/(SICI)1098-2795(199702)46:2&lt;114::AID-MRD2&gt;3.0.CO;2-T; BIGGERS JD, 1978, J PHYSIOL-LONDON, V280, P319, DOI 10.1113/jphysiol.1978.sp012386; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Cereijido M, 2008, BBA-BIOMEMBRANES, V1778, P770, DOI 10.1016/j.bbamem.2007.09.001; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; Daniel L, 2010, DEV BIOL, V344, P650, DOI 10.1016/j.ydbio.2010.05.490; Duranthon V, 2008, REPRODUCTION, V135, P141, DOI 10.1530/REP-07-0324; Eckert JJ, 2008, BBA-BIOMEMBRANES, V1778, P717, DOI 10.1016/j.bbamem.2007.09.031; Fedorova OV, 2010, BBA-MOL BASIS DIS, V1802, P1230, DOI 10.1016/j.bbadis.2010.03.011; FLEMING TP, 1994, HISTOCHEMISTRY, V101, P1, DOI 10.1007/BF00315824; FLEMING TP, 1992, DEVELOPMENT, P105; Fleming TP, 2000, SEMIN REPROD MED, V18, P185, DOI 10.1055/s-2000-12557; GUALTIERI R, 1992, MOL REPROD DEV, V32, P81, DOI 10.1002/mrd.1080320113; HANKE JH, 1995, INFLAMM RES, V44, P357, DOI 10.1007/BF01797862; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Karni R, 2003, FEBS LETT, V537, P47, DOI 10.1016/S0014-5793(03)00069-3; Karpova LV, 2010, CELL BIOCHEM FUNCT, V28, P135, DOI 10.1002/cbf.1632; Kidder GM, 2005, SEMIN NEPHROL, V25, P352, DOI 10.1016/j.semnephrol.2005.03.011; Li ZC, 2009, J BIOL CHEM, V284, P21066, DOI 10.1074/jbc.M109.013821; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; MacPhee DJ, 2000, DEV BIOL, V222, P486, DOI 10.1006/dbio.2000.9708; Madan P, 2007, J BIOL CHEM, V282, P12127, DOI 10.1074/jbc.M700696200; Nakasato M, 2006, BIOL REPROD, V75, P508, DOI 10.1095/biolreprod.105.047860; Offenberg H, 2000, MOL REPROD DEV, V57, P323, DOI 10.1002/1098-2795(200012)57:4&lt;323::AID-MRD3&gt;3.0.CO;2-5; Oshiro N, 2010, AM J HYPERTENS, V23, P1279, DOI 10.1038/ajh.2010.195; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P3717, DOI 10.1091/mbc.12.12.3717; Rajasekaran SA, 2003, AM J PHYSIOL-CELL PH, V284, pC1497, DOI 10.1152/ajpcell.00355.2002; Rajasekaran SA, 2008, BBA-BIOMEMBRANES, V1778, P757, DOI 10.1016/j.bbamem.2007.11.007; Rajasekaran SA, 2007, AM J PHYSIOL-GASTR L, V292, pG124, DOI 10.1152/ajpgi.00297.2006; Rajasekaran SA, 2009, FRONT BIOSCI-LANDMRK, V14, P2130, DOI 10.2741/3367; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Sabath E, 2008, J CELL SCI, V121, P814, DOI 10.1242/jcs.014878; Schoner W, 2003, ANN NY ACAD SCI, V986, P678, DOI 10.1111/j.1749-6632.2003.tb07282.x; Schoner W, 2008, NEPHROL DIAL TRANSPL, V23, P2723, DOI 10.1093/ndt/gfn325; Schoner W, 2007, AM J CARDIOVASC DRUG, V7, P173, DOI 10.2165/00129784-200707030-00004; Shah OJ, 2002, BIOCHEM J, V366, P57, DOI 10.1042/BJ20020198; Sheth B, 2000, MECH DEVELOP, V97, P93, DOI 10.1016/S0925-4773(00)00416-0; Sophocleous A, 2003, J ENDOCRINOL INVEST, V26, P668, DOI 10.1007/BF03347027; VANWINKLE LJ, 1991, DEV BIOL, V146, P158, DOI 10.1016/0012-1606(91)90456-D; Violette MI, 2006, DEV BIOL, V289, P406, DOI 10.1016/j.ydbio.2005.11.004; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Wang SW, 2004, BRIT J PHARMACOL, V142, P1123, DOI 10.1038/sj.bjp.0705777; Wang Z, 2009, CANCER RES, V69, P6556, DOI 10.1158/0008-5472.CAN-09-0891; WATSON AJ, 1990, DEV BIOL, V141, P104, DOI 10.1016/0012-1606(90)90105-R; WATSON AJ, 1988, DEV BIOL, V126, P80, DOI 10.1016/0012-1606(88)90241-2; Watson AJ, 2004, ANIM REPROD SCI, V82-3, P583, DOI 10.1016/j.anireprosci.2004.04.004; WATSON AJ, 1992, MOL REPROD DEV, V33, P492, DOI 10.1002/mrd.1080330417; Watson AJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD708, DOI 10.2741/Watson; WILEY LM, 1984, DEV BIOL, V105, P330, DOI 10.1016/0012-1606(84)90290-2; WILEY LM, 1990, BIOESSAYS, V12, P67, DOI 10.1002/bies.950120204; Xie ZJ, 2005, FRONT BIOSCI-LANDMRK, V10, P3100, DOI 10.2741/1766; Xie ZJ, 2003, ANN NY ACAD SCI, V986, P497, DOI 10.1111/j.1749-6632.2003.tb07234.x; Xie ZJ, 2001, CELL MOL BIOL, V47, P383; Xu JW, 2009, WORLD J PEDIATR, V5, P140, DOI 10.1007/s12519-009-0028-z; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295; Zheng J, 2011, CARDIOVASC RES, V89, P51, DOI 10.1093/cvr/cvq263	70	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23704	10.1371/journal.pone.0023704	http://dx.doi.org/10.1371/journal.pone.0023704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901128	Green Submitted, Green Published, gold			2022-12-25	WOS:000294298000013
J	Dahlhoff, M; Blutke, A; Wanke, R; Wolf, E; Schneider, MR				Dahlhoff, Maik; Blutke, Andreas; Wanke, Ruediger; Wolf, Eckhard; Schneider, Marlon R.			In Vivo Evidence for Epidermal Growth Factor Receptor (EGFR)-mediated Release of Prolactin from the Pituitary Gland	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE MAMMARY-GLAND; ERBB SIGNALING NETWORK; FACTOR-ALPHA; LOBULOALVEOLAR DEVELOPMENT; KNOCKOUT MICE; ACTIVATION; AMPHIREGULIN; EXPRESSION; EGF; PROLIFERATION	Members of the epidermal growth factor receptor (EGFR/ERBB) system are essential local regulators of mammary gland development and function. Emerging evidence suggests that EGFR signaling may also influence mammary gland activity indirectly by promoting the release of prolactin from the pituitary gland in a MAPK and estrogen receptor-alpha (ER alpha)-dependent manner. Here, we report that overexpression of the EGFR ligand betacellulin (BTC) causes a lactating-like phenotype in the mammary gland of virgin female mice including the major hallmarks of lactogenesis. BTC transgenic (BTC-tg) females showed reduced levels of prolactin in the pituitary gland and increased levels of the hormone in the circulation. Furthermore, treatment of BTC-tg females with bromocriptine, an inhibitor of prolactin secretion, blocked the development of the lactation-like phenotype, suggesting that it is caused by central release of prolactin rather than by local actions of BTC in the mammary gland. Introduction of the antimorphic Egfr allele Wa5 also blocked the appearance of the mammary gland alterations, revealing that the phenotype is EGFR-dependent. We detected an increase in MAPK activity, but unchanged phosphorylation of ER alpha in the pituitary gland of BTC-tg females as compared with control mice. These results provide the first functional evidence in vivo for a role of the EGFR system in regulating mammary gland activity by modulating prolactin release from the pituitary gland.	[Dahlhoff, Maik; Wolf, Eckhard; Schneider, Marlon R.] Ludwig Maximilians Univ Munchen, Gene Ctr, Inst Mol Anim Breeding & Biotechnol, D-81377 Munich, Germany; [Blutke, Andreas; Wanke, Ruediger] Ludwig Maximilians Univ Munchen, Inst Vet Pathol, D-80533 Munich, Germany	University of Munich; University of Munich	Schneider, MR (corresponding author), Ludwig Maximilians Univ Munchen, Gene Ctr, Inst Mol Anim Breeding & Biotechnol, Feodor Lynen Str 25, D-81377 Munich, Germany.	schnder@lmb.uni-muenchen.de	Dahlhoff, Maik/AGH-1182-2022	Wolf, Eckhard/0000-0002-0430-9510; Schneider, Marlon/0000-0002-9570-3491; Dahlhoff, Maik/0000-0001-9189-7631; Wanke, Rudiger/0000-0002-0153-224X				Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Ben-Jonathan N, 2009, ENDOCRINOLOGY, V150, P795, DOI 10.1210/en.2008-0756; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Dahlhoff M, 2010, GASTROENTEROLOGY, V138, P1585, DOI 10.1053/j.gastro.2009.12.045; FAN XM, 1995, ENDOCRINOLOGY, V136, P2284, DOI 10.1210/en.136.5.2284; FINLEY EL, 1994, J ENDOCRINOL, V141, P547, DOI 10.1677/joe.0.1410547; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Kenney NJ, 1996, CELL GROWTH DIFFER, V7, P1769; Lee D, 2004, MAMM GENOME, V15, P525, DOI 10.1007/s00335-004-2384-2; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; MCANDREW J, 1995, ENDOCRINOLOGY, V136, P4479, DOI 10.1210/en.136.10.4479; MURDOCH GH, 1982, NATURE, V300, P192, DOI 10.1038/300192a0; Oakes SR, 2008, J MAMMARY GLAND BIOL, V13, P13, DOI 10.1007/s10911-008-9069-5; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; RUI H, 1994, J BIOL CHEM, V269, P5364; Saito T, 2004, ENDOCRINOLOGY, V145, P4232, DOI 10.1210/en.2004-0401; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Schneider MR, 2005, ENDOCRINOLOGY, V146, P5237, DOI 10.1210/en.2005-0418; SCHONBRUNN A, 1980, J CELL BIOL, V85, P786, DOI 10.1083/jcb.85.3.786; Schroeder JA, 1998, CELL GROWTH DIFFER, V9, P451; Stern DF, 2003, EXP CELL RES, V284, P89, DOI 10.1016/S0014-4827(02)00103-9; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Troyer KL, 2001, J MAMMARY GLAND BIOL, V6, P7, DOI 10.1023/A:1009560330359; VONDERHAAR BK, 1987, J CELL PHYSIOL, V132, P581, DOI 10.1002/jcp.1041320324; Watters JJ, 2000, MOL ENDOCRINOL, V14, P1872, DOI 10.1210/me.14.11.1872; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	32	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39297	39306		10.1074/jbc.M111.243493	http://dx.doi.org/10.1074/jbc.M111.243493			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21914800	Green Published, hybrid			2022-12-25	WOS:000296759800048
J	Dickinson, RJ; Delavaine, L; Cejudo-Marin, R; Stewart, G; Staples, CJ; Didmon, MP; Trinidad, AG; Alonso, A; Pulido, R; Keyse, SM				Dickinson, Robin J.; Delavaine, Laurent; Cejudo-Marin, Rocio; Stewart, Graeme; Staples, Christopher J.; Didmon, Mark P.; Garcia Trinidad, Antonio; Alonso, Andres; Pulido, Rafael; Keyse, Stephen M.			Phosphorylation of the Kinase Interaction Motif in Mitogen-activated Protein (MAP) Kinase Phosphatase-4 Mediates Cross-talk between Protein Kinase A and MAP Kinase Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-SPECIFICITY PHOSPHATASES; TYROSINE-PHOSPHATASE; CATALYTIC ACTIVATION; DIFFERENTIAL REGULATION; INSULIN-RESISTANCE; PTP-SL; CAMP; ERK2; INACTIVATION; ASSOCIATION	MAP kinase phosphatase 4 (DUSP9/MKP-4) plays an essential role during placental development and is one of a subfamily of three closely related cytoplasmic dual-specificity MAPK phosphatases, which includes the ERK-specific enzymes DUSP6/MKP-3 and DUSP7/MKP-X. However, unlike DUSP6/MKP-3, DUSP9/MKP-4 also inactivates the p38 alpha MAP kinase both in vitro and in vivo. Here we demonstrate that inactivation of both ERK1/2 and p38 alpha by DUSP9/MKP-4 is mediated by a conserved arginine-rich kinase interaction motif located within the amino-terminal non-catalytic domain of the protein. Furthermore, DUSP9/MKP-4 is unique among these cytoplasmic MKPs in containing a conserved PKA consensus phosphorylation site 55RRXSer-58 immediately adjacent to the kinase interaction motif. DUSP9/MKP-4 is phosphorylated on Ser-58 by PKA in vitro, and phosphorylation abrogates the binding of DUSP9/MKP-4 to both ERK2 and p38 alpha MAP kinases. In addition, although mutation of Ser-58 to either alanine or glutamic acid does not affect the intrinsic catalytic activity of DUSP9/MKP-4, phospho-mimetic (Ser-58 to Glu) substitution inhibits both the interaction of DUSP9/MKP-4 with ERK2 and p38 alpha in vivo and its ability to dephosphorylate and inactivate these MAP kinases. Finally, the use of a phospho-specific antibody demonstrates that endogenous DUSP9/MKP-4 is phosphorylated on Ser-58 in response to the PKA agonist forskolin and is also modified in placental tissue. We conclude that DUSP9/MKP-4 is a bona fide target of PKA signaling and that attenuation of DUSP9/MKP-4 function can mediate cross-talk between the PKA pathway and MAPK signaling through both ERK1/2 and p38 alpha in vivo.	[Dickinson, Robin J.; Delavaine, Laurent; Stewart, Graeme; Staples, Christopher J.; Didmon, Mark P.; Keyse, Stephen M.] Univ Dundee, CR UK Stress Response Lab, Med Res Inst, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [Cejudo-Marin, Rocio; Pulido, Rafael] Ctr Invest Principe Felipe, Valencia 46013, Spain; [Garcia Trinidad, Antonio; Alonso, Andres] Univ Valladolid, CSIC, Inst Biol & Genet Mol, Valladolid 47003, Spain	University of Dundee; Prince Felipe Research Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid	Keyse, SM (corresponding author), Univ Dundee, CR UK Stress Response Lab, Biomed Res Inst, Ninewells Hosp & Med Sch, Level 5, Dundee DD1 9SY, Scotland.	s.m.keyse@dundee.ac.uk	Alonso, Andrés/L-7523-2014; Keyse, Stephen M./B-9575-2009; Cejudo, Rocio/I-2794-2015	Alonso, Andrés/0000-0001-8674-9378; Keyse, Stephen M./0000-0002-5150-8221; Pulido, Rafael/0000-0001-9100-248X; Cejudo Marin, Rocio/0000-0001-5389-7200; Staples, Christopher/0000-0002-0482-9954	Ministerio de Ciencia e Innovacion [SAF2009-10226]; Generalitat Valenciana [AP-040/10, ACOMP/2010/222]; Instituto de Salud Carlos III (Spain); EU Research Training Network [MRTN-CT-2006-035830]; Cancer Research UK CR-UK [C8227/A12053]; Fondo Europeo de Desarrollo Regional ISCIII-RETICS [RD06/0020/0049]; Cancer Research UK (CR-UK Stress Response Laboratory) [C8227/A12053]; Medical Research Council; Ministerio de Ciencia e Innovacion (Spain) [JC2007-00077]; Cancer Research UK [12053] Funding Source: researchfish	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); EU Research Training Network; Cancer Research UK CR-UK(Cancer Research UK); Fondo Europeo de Desarrollo Regional ISCIII-RETICS; Cancer Research UK (CR-UK Stress Response Laboratory)(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Cancer Research UK(Cancer Research UK)	This work was supported in part by Ministerio de Ciencia e Innovacion Grant SAF2009-10226, Generalitat Valenciana Grants AP-040/10 and ACOMP/2010/222, Instituto de Salud Carlos III (Spain and Fondo Europeo de Desarrollo Regional ISCIII-RETICS RD06/0020/0049), and EU Research Training Network MRTN-CT-2006-035830 (to R. C.-M.). This work was also supported by Cancer Research UK CR-UK Stress Response Laboratory Programme Grant C8227/A12053 (to S. M. K.).; Supported by a Cancer Research UK programme grant (CR-UK Stress Response Laboratory C8227/A12053, to S. M. K.) and a Medical Research Council Ph.D studentship (to C. J. S.).; Supported in part by Ministerio de Ciencia e Innovacion Grant SAF2009-10226. Generalitat Valenciana Grants AP-040/10 and ACOMP/2010/222, Instituto de Salud Carlos III (Spain and Fondo Europeo de Desarrollo Regional ISCIII-RETICS RD06/0020/0049), and EU Research Training Network MRTN-CT-2006-035830. R. C.-M. was also supported in part by Ministerio de Ciencia e Innovacion (Spain) Programa Jose Castillejo Grant JC2007-00077.	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Blanco-Aparicio C, 1999, J CELL BIOL, V147, P1129, DOI 10.1083/jcb.147.6.1129; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Christie GR, 2005, MOL CELL BIOL, V25, P8323, DOI 10.1128/MCB.25.18.8323-8333.2005; Dickinson RJ, 2002, BIOCHEM J, V364, P145, DOI 10.1042/bj3640145; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Dowd S, 1998, J CELL SCI, V111, P3389; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Emanuelli B, 2008, P NATL ACAD SCI USA, V105, P3545, DOI 10.1073/pnas.0712275105; Escamilla-Hernandez R, 2008, MOL ENDOCRINOL, V22, P1842, DOI 10.1210/me.2008-0103; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; James P, 1996, GENETICS, V144, P1425; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Muda M, 1997, J BIOL CHEM, V272, P5141, DOI 10.1074/jbc.272.8.5141; Nika K, 2004, BIOCHEM J, V378, P335, DOI 10.1042/BJ20031244; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Perander M, 2008, BIOCHEM J, V411, P613, DOI 10.1042/BJ20071369; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Staples CJ, 2010, J BIOL CHEM, V285, P25928, DOI 10.1074/jbc.M110.117911; Tarrega C, 2005, J BIOL CHEM, V280, P37885, DOI 10.1074/jbc.M504366200; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Xu HY, 2003, J BIOL CHEM, V278, P30187, DOI 10.1074/jbc.M302010200	31	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38018	38026		10.1074/jbc.M111.255844	http://dx.doi.org/10.1074/jbc.M111.255844			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908610	hybrid, Green Published			2022-12-25	WOS:000296594200013
J	Liu, YN; Tian, XL; Leitner, WW; Aldridge, ME; Zheng, JY; Yu, ZY; Restifo, NP; Weiss, R; Scheiblhofer, S; Xie, C; Sun, R; Cheng, GH; Zeng, G				Liu, Yanan; Tian, Xiaoli; Leitner, Wolfgang W.; Aldridge, Michael E.; Zheng, Junying; Yu, Zhiya; Restifo, Nicholas P.; Weiss, Richard; Scheiblhofer, Sandra; Xie, Chong; Sun, Ren; Cheng, Genhong; Zeng, Gang			Polymeric Structure and Host Toll-like Receptor 4 Dictate Immunogenicity of NY-ESO-1 Antigen in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-SYSTEM; SURFACE CALRETICULIN; TUMOR-ANTIGEN; GENE; IDENTIFICATION; IMMUNOTHERAPY; PROGRESSION; EXPRESSION; TOLERANCE; DANGER	In search of intrinsic factors that contribute to the distinctively strong immunogenicity of a non-mutated cancer/testis antigen, we found that NY-ESO-1 forms polymeric structures through disulfide bonds. NY-ESO-1 binding to immature dendritic cells was dependent on its polymeric structure and involved Toll-like receptor-4 (TLR4) on the surface of immature dendritic cells in mouse and human. Gene gun-delivered plasmid encoding the wild-type NY-ESO-1 readily induced T cell-dependent antibody (Ab) responses in wild-type C57BL/10 mice but not TLR4-knock-out C57BL/10ScNJ mice. Disrupting polymeric structures of NY-ESO-1 by cysteine-to-serine (Cys-to-Ser) substitutions lead to diminished immunogenicity and altered TLR4-dependence in the induced Ab response. To demonstrate its adjuvant effect, NY-ESO-1 was fused with a major mugwort pollen allergen Art v 1 and a tumor-associated antigen, carbonic anhydrase 9. Plasmid DNA vaccines encoding the fusion genes generated robust immune responses against otherwise non-immunogenic targets in mice. Polymeric structure and TLR4 may play important roles in rendering NY-ESO-1 immunogenic and thus serve as a potent molecular adjuvant. NY-ESO-1 thus represents the first example of a cancer/testis antigen that is a also damage-associated molecular pattern.	[Liu, Yanan; Tian, Xiaoli; Aldridge, Michael E.; Zheng, Junying; Xie, Chong; Zeng, Gang] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA; [Leitner, Wolfgang W.] NCI, Dermatol Branch, NIH, Bethesda, MD 20892 USA; [Yu, Zhiya; Restifo, Nicholas P.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA; [Weiss, Richard; Scheiblhofer, Sandra] Salzburg Univ, Dept Mol Biol, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Salzburg University	Zeng, G (corresponding author), 66 128 Ctr Hlth Sci, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	gzeng@mednet.ucla.edu	Weiss, Richard/N-7279-2013; Restifo, Nicholas P/A-5713-2008; Leitner, Wolfgang W/F-5741-2011; Restifo, Nicholas Phillip/M-6549-2019; Restifo, Nicholas Phillip/Z-1614-2019	Weiss, Richard/0000-0003-3185-7253; Leitner, Wolfgang W/0000-0003-3125-5922; Restifo, Nicholas P./0000-0003-4229-4580; Scheiblhofer, Sandra/0000-0003-2867-9054	UCLA; American Cancer Society [RSG-08-070-01-LIB]; NATIONAL CANCER INSTITUTE [R21CA137651, ZIABC010763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056154, R01AI078389] Funding Source: NIH RePORTER	UCLA(University of California System); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the UCLA Gene Medicine Program (to G. Z.) and Research Scholar Award RSG-08-070-01-LIB from the American Cancer Society (to G. Z.).	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Barrow C, 2006, CLIN CANCER RES, V12, P764, DOI 10.1158/1078-0432.CCR-05-1544; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Bauer R, 2003, ALLERGY, V58, P1003, DOI 10.1034/j.1398-9995.2003.00170.x; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Chen DQ, 2005, J BIOL CHEM, V280, P22425, DOI 10.1074/jbc.M413380200; Gnjatic S, 2006, ADV CANCER RES, V95, P1, DOI 10.1016/S0065-230X(06)95001-5; Hartl A, 2004, METHODS, V32, P328, DOI 10.1016/j.ymeth.2003.08.014; Hernandez JM, 2003, CLIN CANCER RES, V9, P1906; Himly M, 2002, FASEB J, V16, P106, DOI 10.1096/fj.02-0472fje; Leitner WW, 2003, NAT MED, V9, P33, DOI 10.1038/nm813; Lethe B, 1998, INT J CANCER, V76, P903, DOI 10.1002/(SICI)1097-0215(19980610)76:6<903::AID-IJC22>3.0.CO;2-1; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; Riker AI, 2000, INT J CANCER, V86, P818, DOI 10.1002/(SICI)1097-0215(20000615)86:6<818::AID-IJC10>3.3.CO;2-N; Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Stoler DL, 1999, P NATL ACAD SCI USA, V96, P15121, DOI 10.1073/pnas.96.26.15121; Watson PA, 2005, CANCER RES, V65, P11565, DOI 10.1158/0008-5472.CAN-05-3441; Zeng G, 2000, J IMMUNOL, V165, P1153, DOI 10.4049/jimmunol.165.2.1153; Zeng G, 2005, INT J CANCER, V114, P268, DOI 10.1002/ijc.20716; Zeng G, 2006, J IMMUNOL, V177, P3582, DOI 10.4049/jimmunol.177.6.3582	22	7	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37077	37084		10.1074/jbc.M111.280123	http://dx.doi.org/10.1074/jbc.M111.280123			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900253	Green Published, hybrid			2022-12-25	WOS:000296542400008
J	Yang, YC; Lin, S; Chang, PC; Lin, HC; Kuo, CC				Yang, Ya-Chin; Lin, Shin; Chang, Po-Chun; Lin, Hsiao-Chun; Kuo, Chung-Chin			Functional Extension of Amino Acid Triads from the Fourth Transmembrane Segment (S4) into Its External Linker in Shaker K+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION CHANNELS; VOLTAGE SENSOR; POTASSIUM CHANNEL; SODIUM-CHANNELS; ELECTROSTATIC INTERACTIONS; CLOSED STATES; STRUCTURAL MODELS; CHARGE MOVEMENT; ACTIVATION; DOMAIN	The highly conserved fourth transmembrane segment (S4) is the primary voltage sensor of the voltage-dependent channel and would move outward upon membrane depolarization. S4 comprises repetitive amino acid triads, each containing one basic (presumably charged and voltage-sensing) followed by two hydrophobic residues. We showed that the triad organization is functionally extended into the S3-4 linker right external to S4 in Shaker K+ channels. The arginine (and lysine) substitutes for the third and the sixth residues (Ala-359 and Met-356, respectively) external to the outmost basic residue (Arg-362) in S4 dramatically and additively stabilize S4 in the resting conformation. Also, Leu-361 and Leu-358 play a very similar role in stabilization of S4 in the resting position, presumably by their hydrophobic side chains. Moreover, the double mutation A359R/E283A leads to a partially extruded position of S4 and consequently prominent closed-state inactivation, suggesting that Glu-283 in S2 may coordinate with the arginines in the extruded S4 upon depolarization. We conclude that the triad organization extends into the S3-4 linker for about six amino acids in terms of their microenvironment. These approximately six residues should retain the same helical structure as S4, and their microenvironment serves as part of the "gating canal" accommodating the extruding S4. Upon depolarization, S4 most likely moves initially as a sliding helix and follows the path that is set by the approximately six residues in the S3-4 linker in the resting state, whereas further S4 translocation could be more like, for example, a paddle, without orderly coordination from the contiguous surroundings.	[Lin, Shin; Chang, Po-Chun; Lin, Hsiao-Chun; Kuo, Chung-Chin] Natl Taiwan Univ, Coll Med, Dept Physiol, Taipei 100, Taiwan; [Yang, Ya-Chin] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan 333, Taiwan; [Yang, Ya-Chin] Chang Gung Univ, Dept Biomed Sci, Tao Yuan 333, Taiwan; [Kuo, Chung-Chin] Natl Taiwan Univ Hosp, Dept Neurol, Taipei 100, Taiwan	National Taiwan University; Chang Gung University; Chang Gung University; National Taiwan University; National Taiwan University Hospital	Kuo, CC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Physiol, 1 Jen Ai Rd,1st Sect, Taipei 100, Taiwan.	chungchinkuo@ntu.edu.tw		Kuo, Chung-Chin/0000-0001-8208-6829	National Science Council, Taiwan [NSC99-2321-B-002-008, NSC99-2311-B-182-001-MY3]; National Health Research Institutes, Taiwan [NHRI-EX100-10006NI]; Chang Gung Hospital, Taiwan [CMRPD170453]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Chang Gung Hospital, Taiwan	This work was supported by National Science Council, Taiwan, Grants NSC99-2321-B-002-008 (to C.-C. K.) and NSC99-2311-B-182-001-MY3 (to Y.-C. Y.). This work was also supported by National Health Research Institutes, Taiwan, Grant NHRI-EX100-10006NI (to C.-C. K.) and Chang Gung Hospital, Taiwan, Medical Research Project CMRPD170453 (to Y.-C. Y.).	Armstrong CM, 2006, P NATL ACAD SCI USA, V103, P17991, DOI 10.1073/pnas.0607603103; Bahring R, 2011, J PHYSIOL-LONDON, V589, P461, DOI 10.1113/jphysiol.2010.191965; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; CATTERALL WA, 1986, TRENDS NEUROSCI, V9, P7, DOI 10.1016/0166-2236(86)90004-4; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; CHAHINE M, 1994, NEURON, V12, P281, DOI 10.1016/0896-6273(94)90271-2; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; Durell SR, 1998, J STRUCT BIOL, V121, P263, DOI 10.1006/jsbi.1998.3962; El-Din TMG, 2010, CHANNELS, V4, P93, DOI 10.4161/chan.4.2.10672; Elinder F, 2001, J GEN PHYSIOL, V118, P1, DOI 10.1085/jgp.118.1.1; Freites JA, 2005, P NATL ACAD SCI USA, V102, P15059, DOI 10.1073/pnas.0507618102; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jogini V, 2007, BIOPHYS J, V93, P3070, DOI 10.1529/biophysj.107.112540; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; PLANELLSCASES R, 1995, P NATL ACAD SCI USA, V92, P9422, DOI 10.1073/pnas.92.20.9422; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Sands ZA, 2007, STRUCTURE, V15, P235, DOI 10.1016/j.str.2007.01.004; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schonherr R, 2002, NEURON, V35, P935, DOI 10.1016/S0896-6273(02)00869-3; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Schoppa NE, 1998, J GEN PHYSIOL, V111, P271, DOI 10.1085/jgp.111.2.271; Schoppa NE, 1998, J GEN PHYSIOL, V111, P295, DOI 10.1085/jgp.111.2.295; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Sokolov S, 2005, NEURON, V47, P183, DOI 10.1016/j.neuron.2005.06.012; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Upadhyay SK, 2009, J PHYSIOL-LONDON, V587, P3851, DOI 10.1113/jphysiol.2009.174730; Wu D, 2010, J GEN PHYSIOL, V135, P595, DOI 10.1085/jgp.201010408; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yang YC, 2007, J PHYSIOL-LONDON, V582, P1059, DOI 10.1113/jphysiol.2007.131490; Yang YC, 2009, J GEN PHYSIOL, V134, P95, DOI 10.1085/jgp.200810158; Yang YC, 2003, J NEUROSCI, V23, P4922; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253; Zhang LY, 2007, P NATL ACAD SCI USA, V104, P8263, DOI 10.1073/pnas.0611007104	55	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37503	37514		10.1074/jbc.M111.237792	http://dx.doi.org/10.1074/jbc.M111.237792			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900243	hybrid, Green Published			2022-12-25	WOS:000296542400049
J	Nasser, MW; Qamri, Z; Deol, YS; Smith, D; Shilo, K; Zou, XH; Ganju, RK				Nasser, Mohd W.; Qamri, Zahida; Deol, Yadwinder S.; Smith, Diane; Shilo, Konstantin; Zou, Xianghong; Ganju, Ramesh K.			Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB2 in Modulating Breast Cancer Growth and Invasion	PLOS ONE			English	Article							CELL-DERIVED FACTOR-1-ALPHA; FOCAL ADHESION KINASE; TUMOR-GROWTH; IN-VIVO; HEPATOCELLULAR-CARCINOMA; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; EXPRESSION; METASTASIS; ACTIVATION	Background: Cannabinoids bind to cannabinoid receptors CB1 and CB2 and have been reported to possess anti-tumorigenic activity in various cancers. However, the mechanisms through which cannabinoids modulate tumor growth are not well known. In this study, we report that a synthetic non-psychoactive cannabinoid that specifically binds to cannabinoid receptor CB2 may modulate breast tumor growth and metastasis by inhibiting signaling of the chemokine receptor CXCR4 and its ligand CXCL12. This signaling pathway has been shown to play an important role in regulating breast cancer progression and metastasis. Methodology/Principal Findings: We observed high expression of both CB2 and CXCR4 receptors in breast cancer patient tissues by immunohistochemical analysis. We further found that CB2-specific agonist JWH-015 inhibits the CXCL12-induced chemotaxis and wound healing of MCF7 overexpressing CXCR4 (MCF7/CXCR4), highly metastatic clone of MDA-MB-231 (SCP2) and NT 2.5 cells (derived from MMTV-neu) by using chemotactic and wound healing assays. Elucidation of the molecular mechanisms using various biochemical techniques and confocal microscopy revealed that JWH-015 treatment inhibited CXCL12-induced P44/P42 ERK activation, cytoskeletal focal adhesion and stress fiber formation, which play a critical role in breast cancer invasion and metastasis. In addition, we have shown that JWH-015 significantly inhibits orthotopic tumor growth in syngenic mice in vivo using NT 2.5 cells. Furthermore, our studies have revealed that JWH-015 significantly inhibits phosphorylation of CXCR4 and its downstream signaling in vivo in orthotopic and spontaneous breast cancer MMTV-PyMT mouse model systems. Conclusions/Significance: This study provides novel insights into the crosstalk between CB2 and CXCR4/CXCL12-signaling pathways in the modulation of breast tumor growth and metastasis. Furthermore, these studies indicate that CB2 receptors could be used for developing innovative therapeutic strategies against breast cancer.	[Nasser, Mohd W.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Nasser, MW (corresponding author), Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.	Ramesh.Ganju@osumc.edu	Shilo, K/AAV-2360-2020; zou, Xianghong/E-4374-2011; Reever, Larson/H-9685-2019; Nasser, Mohd/Y-3355-2019; Shilo, Konstantin/E-4084-2011	Shilo, K/0000-0002-6702-3130; Reever, Larson/0000-0002-5692-4793; 	National Institutes of Health/NCI [R01CA109527]; Department of Defense [W81XWH-11-1-0279, W81XWH-11-1-0275]; NATIONAL CANCER INSTITUTE [R01CA113579, R01CA109527] Funding Source: NIH RePORTER	National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health/NCI Grant R01CA109527 and Department of Defense Grants W81XWH-11-1-0279 and W81XWH-11-1-0275 to RKG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Andre F, 2006, ANN ONCOL, V17, P945, DOI 10.1093/annonc/mdl053; Bachelder RE, 2002, CANCER RES, V62, P7203; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Bendall LJ, 2005, CANCER RES, V65, P3290, DOI 10.1158/0008-5472.CAN-04-3402; Blazquez C, 2006, FASEB J, V20, P2633, DOI 10.1096/fj.06-6638fje; Blot E, 2008, BREAST J, V14, P268, DOI 10.1111/j.1524-4741.2008.00573.x; Cabioglu N, 2007, ANN ONCOL, V18, P1021, DOI 10.1093/annonc/mdm060; Cabioglu N, 2005, CLIN EXP METASTAS, V22, P39, DOI 10.1007/s10585-005-3222-y; Cabioglu N, 2009, ANN ONCOL, V20, P1013, DOI 10.1093/annonc/mdn740; Caffarel MM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-196; Carracedo A, 2006, CANCER CELL, V9, P301, DOI 10.1016/j.ccr.2006.03.005; Casanova ML, 2003, J CLIN INVEST, V111, P43, DOI 10.1172/JCI200316116; Chu QD, 2008, SURG ONCOL CLIN N AM, V17, P421, DOI 10.1016/j.soc.2007.12.006; Chu QYD, 2010, J SURG RES, V159, P689, DOI 10.1016/j.jss.2008.09.020; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Ellert-Miklaszewska A, 2005, CELL SIGNAL, V17, P25, DOI 10.1016/j.cellsig.2004.05.011; Fernandis AZ, 2004, ONCOGENE, V23, P157, DOI 10.1038/sj.onc.1206910; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Galve-Roperh I, 2000, NAT MED, V6, P313, DOI 10.1038/73171; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; GANJU RK, 2011, CXCL12 CXCR4 SIGNALI; Ghosh S, 2006, MOL IMMUNOL, V43, P2169, DOI 10.1016/j.molimm.2006.01.005; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Inngjerdingen M, 2002, BLOOD, V99, P4318, DOI 10.1182/blood.V99.12.4318; Jia W, 2006, MOL CANCER RES, V4, P549, DOI 10.1158/1541-7786.MCR-05-0193; Kogan NM, 2006, MOL PHARMACOL, V70, P51, DOI 10.1124/mol.105.021089; Lee BC, 2004, MOL CANCER RES, V2, P327; Li MZ, 2009, SEMIN CANCER BIOL, V19, P111, DOI 10.1016/j.semcancer.2008.11.001; Liang ZX, 2004, CANCER RES, V64, P4302, DOI 10.1158/0008-5472.CAN-03-3958; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Preet A, 2008, ONCOGENE, V27, P339, DOI 10.1038/sj.onc.1210641; Preet A, 2011, CANCER PREV RES, V4, P65, DOI 10.1158/1940-6207.CAPR-10-0181; Qamri Z, 2009, MOL CANCER THER, V8, P3117, DOI 10.1158/1535-7163.MCT-09-0448; Richmond Ann, 2004, Novartis Found Symp, V256, P74; Sanchez C, 2001, CANCER RES, V61, P5784; Sarfaraz S, 2006, J BIOL CHEM, V281, P39480, DOI 10.1074/jbc.M603495200; Sun CK, 2008, CARCINOGENESIS, V29, P2096, DOI 10.1093/carcin/bgn203; Tamamura H, 2005, EXPERT OPIN THER TAR, V9, P1267, DOI 10.1517/14728222.9.6.1267; Tamamura H, 2003, FEBS LETT, V550, P79, DOI 10.1016/S0014-5793(03)00824-X; Teranishi S, 2009, INVEST OPHTH VIS SCI, V50, P5646, DOI 10.1167/iovs.08-2534; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Ueda Y, 2006, CANCER RES, V66, P5665, DOI 10.1158/0008-5472.CAN-05-3579; van Nimwegen MJ, 2005, CANCER RES, V65, P4698, DOI 10.1158/0008-5472.CAN-04-4126; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Xu XD, 2006, CANCER GENET CYTOGEN, V171, P31, DOI 10.1016/j.cancergencyto.2006.06.014; Zhao M, 2008, BREAST CANCER RES TR, V110, P211, DOI 10.1007/s10549-007-9712-7	53	65	68	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e23901	10.1371/journal.pone.0023901	http://dx.doi.org/10.1371/journal.pone.0023901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915267	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802500017
J	McAdam, PR; Holmes, A; Templeton, KE; Fitzgerald, JR				McAdam, Paul R.; Holmes, Anne; Templeton, Kate E.; Fitzgerald, J. Ross			Adaptive Evolution of Staphylococcus aureus during Chronic Endobronchial Infection of a Cystic Fibrosis Patient	PLOS ONE			English	Article							SMALL-COLONY VARIANTS; PSEUDOMONAS-AERUGINOSA; RESISTANCE; VIRULENCE; SIGMA(B); STRAINS; EXPRESSION; DISEASE; GENOMES; AIRWAYS	The molecular adaptation of Staphylococcus aureus to its host during chronic infection is not well understood. Comparative genome sequencing of 3 S. aureus isolates obtained sequentially over 26 months from the airways of a cystic fibrosis patient, revealed variation in phage content, and genetic polymorphisms in genes which influence antibiotic resistance, and global regulation of virulence. The majority of polymorphisms were isolate-specific suggesting the existence of an heterogeneous infecting population that evolved from a single infecting strain of S. aureus. The genetic variation identified correlated with differences in growth rate, hemolytic activity, and antibiotic sensitivity, implying a profound effect on the ecology of S. aureus. In particular, a high frequency of mutations in loci associated with the alternate transcription factor SigB, were observed. The identification of genes under diversifying selection during long-term infection may inform the design of novel therapeutics for the control of refractory chronic infections.	[McAdam, Paul R.; Holmes, Anne; Fitzgerald, J. Ross] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Easter Bush, Midlothian, Scotland; [McAdam, Paul R.; Holmes, Anne; Fitzgerald, J. Ross] Univ Edinburgh, Royal Dick Sch Vet Studies, Ctr Infect Dis, Easter Bush, Midlothian, Scotland; [Holmes, Anne; Templeton, Kate E.] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	McAdam, PR (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Easter Bush, Midlothian, Scotland.	Ross.Fitzgerald@ed.ac.uk	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592; Templeton, Kate/0000-0001-7414-1277	Medical Research Council UK; Chief Scientist's Office, Scotland; Chief Scientist Office [CZB/4/717] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist's Office, Scotland; Chief Scientist Office	The study was supported by a doctoral training grant from the Medical Research Council UK, and by a grant from the Chief Scientist's Office, Scotland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besier S, 2008, ANTIMICROB AGENTS CH, V52, P2183, DOI 10.1128/AAC.01395-07; Besier S, 2007, J CLIN MICROBIOL, V45, P168, DOI 10.1128/JCM.01510-06; Branger C, 1996, J MED MICROBIOL, V45, P294, DOI 10.1099/00222615-45-4-294; Entenza JM, 2005, INFECT IMMUN, V73, P990, DOI 10.1128/IAI.73.2.990-998.2005; Gao W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000944; Goerke C, 2004, J INFECT DIS, V189, P724, DOI 10.1086/381502; Goerke C, 2010, INT J MED MICROBIOL, V300, P520, DOI 10.1016/j.ijmm.2010.08.003; Gysin C, 2000, PEDIATR PULM, V30, P481, DOI 10.1002/1099-0496(200012)30:6<481::AID-PPUL8>3.3.CO;2-E; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Kahl BC, 2010, INT J MED MICROBIOL, V300, P514, DOI 10.1016/j.ijmm.2010.08.002; Karlsson-Kanth A, 2006, INT J MED MICROBIOL, V296, P229, DOI 10.1016/j.ijmm.2006.01.067; Levdikov VM, 2006, J BIOL CHEM, V281, P11366, DOI 10.1074/jbc.M513015200; Mainz JG, 2009, THORAX, V64, P535, DOI 10.1136/thx.2008.104711; Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10; Meier S, 2007, INFECT IMMUN, V75, P4562, DOI 10.1128/IAI.00392-07; Mitchell G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-33; Moisan FN, 2006, J BACTERIOL, V188, P64, DOI 10.1128/JB.188.1.64-76.2006; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Nagaev I, 2001, MOL MICROBIOL, V40, P433, DOI 10.1046/j.1365-2958.2001.02389.x; Oliver A, 2010, INT J MED MICROBIOL, V300, P563, DOI 10.1016/j.ijmm.2010.08.009; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Prunier AL, 2005, J BACTERIOL, V187, P3455, DOI 10.1128/JB.187.10.3455-3464.2005; Prunier AL, 2003, J INFECT DIS, V187, P1709, DOI 10.1086/374937; Razvi S, 2009, CHEST, V136, P1554, DOI 10.1378/chest.09-0132; Ridder-Schaphorn S, 2007, J CLIN MICROBIOL, V45, P2979, DOI 10.1128/JCM.00855-07; Robinson DA, 2005, LANCET, V365, P1256, DOI 10.1016/S0140-6736(05)74814-5; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Vu-Thien H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-24	32	66	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24301	10.1371/journal.pone.0024301	http://dx.doi.org/10.1371/journal.pone.0024301			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912685	gold, Green Published, Green Submitted			2022-12-25	WOS:000294686100032
J	Hafner-Bratkovic, I; Gaedtke, L; Ondracka, A; Veranic, P; Vorberg, I; Jerala, R				Hafner-Bratkovic, Iva; Gaedtke, Lars; Ondracka, Andrej; Veranic, Peter; Vorberg, Ina; Jerala, Roman			Effect of Hydrophobic Mutations in the H2-H3 Subdomain of Prion Protein on Stability and Conversion In Vitro and In Vivo	PLOS ONE			English	Article							THERMODYNAMIC STABILITY; AMYLOID FORM; CELL-LINES; SCRAPIE; PRPSC; FIBRILS; DISEASE; MUTANT; GENE; GLYCOSYLATION	Prion diseases are fatal neurodegenerative diseases, which can be acquired, sporadic or genetic, the latter being linked to mutations in the gene encoding prion protein. We have recently described the importance of subdomain separation in the conversion of prion protein (PrP). The goal of the present study was to investigate the effect of increasing the hydrophobic interactions within the H2-H3 subdomain on PrP conversion. Three hydrophobic mutations were introduced into PrP. The mutation V209I associated with human prion disease did not alter protein stability or in vitro fibrillization propensity of PrP. The designed mutations V175I and T187I on the other hand increased protein thermal stability. V175I mutant fibrillized faster than wild-type PrP. Conversion delay of T187I was slightly longer, but fluorescence intensity of amyloid specific dye thioflavin T was significantly higher. Surprisingly, cells expressing V209I variant exhibited inefficient proteinase K resistant PrP formation upon infection with 22L strain, which is in contrast to cell lines expressing wild-type, V175I and T187I mPrPs. In agreement with increased ThT fluorescence at the plateau T187I expressing cell lines accumulated an increased amount of the proteinase K-resistant prion protein. We showed that T187I induces formation of thin fibrils, which are absent from other samples. We propose that larger solvent accessibility of I187 in comparison to wild-type and other mutants may interfere with lateral annealing of filaments and may be the underlying reason for increased conversion efficiency.	[Hafner-Bratkovic, Iva; Ondracka, Andrej; Jerala, Roman] Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia; [Gaedtke, Lars] Tech Univ Munich, Inst Virol, Munich, Germany; [Veranic, Peter] Univ Ljubljana, Sch Med, Inst Cell Biol, Ljubljana, Slovenia; [Vorberg, Ina] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Jerala, Roman] Univ Ljubljana, Dept Chem & Chem Technol, Ljubljana 61000, Slovenia; [Jerala, Roman] EN FIST Ctr Excellence, Ljubljana, Slovenia	National Institute of Chemistry - Slovenia; Technical University of Munich; University of Ljubljana; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Ljubljana	Hafner-Bratkovic, I (corresponding author), Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia.	roman.jerala@ki.si	Veranic, Peter/I-6276-2015	Veranic, Peter/0000-0003-1999-9988; Hafner Bratkovic, Iva/0000-0001-5635-931X; Ondracka, Andrej/0000-0003-4193-6027	Slovenian Research Agency; EN-FIST Centre of Excellence; DFG [1277/1-3]; EU; TSEUR	Slovenian Research Agency(Slovenian Research Agency - Slovenia); EN-FIST Centre of Excellence; DFG(German Research Foundation (DFG)); EU(European Commission); TSEUR	The authors acknowledge the financial support from the state budget by the Slovenian Research Agency (IHB, RJ), EN-FIST Centre of Excellence (RJ), DFG 1277/1-3 (IV), the 6th framework EU project, TSEUR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 2006, J MOL BIOL, V358, P580, DOI 10.1016/j.jmb.2006.02.007; Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Atarashi R, 2006, J VIROL, V80, P7854, DOI 10.1128/JVI.00424-06; Barron RM, 2003, J GEN VIROL, V84, P3165, DOI 10.1099/vir.0.19147-0; Beck JA, 2010, HUM MUTAT, V31, pE1551, DOI 10.1002/humu.21281; BESTWICK RK, 1988, P NATL ACAD SCI USA, V85, P5404, DOI 10.1073/pnas.85.15.5404; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Chasseigneaux S, 2006, NEUROSCI LETT, V408, P165, DOI 10.1016/j.neulet.2006.08.008; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; DIRINGER H, 1983, NATURE, V306, P476, DOI 10.1038/306476a0; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Gaspersic J, 2010, FEBS J, V277, P2038, DOI 10.1111/j.1742-4658.2010.07619.x; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Grasbon-Frodl E, 2004, ACTA NEUROPATHOL, V108, P476, DOI 10.1007/s00401-004-0913-4; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Hafner-Bratkovic I, 2008, J NEUROCHEM, V104, P1553, DOI 10.1111/j.1471-4159.2007.05105.x; Hafner-Bratkovic I, 2011, PRION, V5, P56, DOI 10.4161/pri.5.2.16232; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; HOBBS JR, 1963, J PATHOL BACTERIOL, V86, P437, DOI 10.1002/path.1700860218; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kovacs GG, 2002, J NEUROL, V249, P1567, DOI 10.1007/s00415-002-0896-9; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Maas E, 2007, J BIOL CHEM, V282, P18702, DOI 10.1074/jbc.M701309200; Makarava N, 2008, J BIOL CHEM, V283, P15988, DOI 10.1074/jbc.M800562200; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; Pace CN, 1998, J MOL BIOL, V279, P271, DOI 10.1006/jmbi.1998.1760; Polano M, 2009, J MOL BIOL, V393, P1033, DOI 10.1016/j.jmb.2009.08.056; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; SOMERVILLE RA, 1989, J GEN VIROL, V70, P25, DOI 10.1099/0022-1317-70-1-25; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; van der Kamp MW, 2010, J MOL BIOL, V404, P732, DOI 10.1016/j.jmb.2010.09.060; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	44	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24238	10.1371/journal.pone.0024238	http://dx.doi.org/10.1371/journal.pone.0024238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909425	Green Published, Green Submitted, gold			2022-12-25	WOS:000294683900041
J	Brown, CJ; Dastidar, SG; Quah, ST; Lim, A; Chia, B; Verma, CS				Brown, Christopher J.; Dastidar, Shubhra G.; Quah, Soo T.; Lim, Annie; Chia, Brian; Verma, Chandra S.			C-Terminal Substitution of MDM2 Interacting Peptides Modulates Binding Affinity by Distinctive Mechanisms	PLOS ONE			English	Article							SUPPRESSOR TRANSACTIVATION DOMAIN; MOLECULAR-DYNAMICS; IN-VIVO; P53; WATER; PROTEIN; RESTORATION; RECOGNITION; SIMULATIONS; ENTROPY	The complex between the proteins MDM2 and p53 is a promising drug target for cancer therapy. The residues 19-26 of p53 have been biochemically and structurally demonstrated to be a most critical region to maintain the association of MDM2 and p53. Variation of the amino acid sequence in this range obviously alters the binding affinity. Surprisingly, suitable substitutions contiguous to this region of the p53 peptides can yield tightly binding peptides. The peptide variants may differ by a single residue that vary little in their structural conformations and yet are characterized by large differences in their binding affinities. In this study a systematic analysis into the role of single C-terminal mutations of a 12 residue fragment of the p53 transactivation domain (TD) and an equivalent phage optimized peptide (12/1) were undertaken to elucidate their mechanistic and thermodynamic differences in interacting with the N-terminal of MDM2. The experimental results together with atomistically detailed dynamics simulations provide insight into the principles that govern peptide design protocols with regard to protein-protein interactions and peptidomimetic design.	[Brown, Christopher J.; Dastidar, Shubhra G.; Quah, Soo T.] ASTAR, Lab P53, Singapore, Singapore; [Verma, Chandra S.] ASTAR, Bioinformat Inst, Singapore, Singapore; [Lim, Annie; Chia, Brian] ASTAR, Ctr Expt Therapeut, Singapore, Singapore; [Verma, Chandra S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Verma, Chandra S.] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Brown, CJ (corresponding author), ASTAR, Lab P53, Singapore, Singapore.	cjbrown@p53lab.a-star.edu.sg; chandra@bii.a-star.edu.sg			Agency for Science, Technology & Research (A*Star) of Singapore	Agency for Science, Technology & Research (A*Star) of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology & Research (A*Star) of Singapore (http://www.a-star.edu.sg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2009, CELL CYCLE, V8, P2828; Baron R, 2010, J AM CHEM SOC, V132, P12091, DOI 10.1021/ja1050082; Bottger A, 1997, CURR BIOL, V7, P860, DOI 10.1016/S0960-9822(06)00374-5; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dastidar SG, 2008, J AM CHEM SOC, V130, P13514, DOI 10.1021/ja804289g; Dastidar SG, 2010, THEOR CHEM ACC, V125, P621, DOI 10.1007/s00214-009-0682-1; Dastidar SG, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S6; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dickens MP, 2010, SEMIN CANCER BIOL, V20, P10, DOI 10.1016/j.semcancer.2009.10.003; DUNITZ JD, 1994, SCIENCE, V264, P670, DOI 10.1126/science.264.5159.670; Fischer S, 1999, P NATL ACAD SCI USA, V96, P9613, DOI 10.1073/pnas.96.17.9613; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joseph TL, 2010, CELL CYCLE, V9, P1167, DOI 10.4161/cc.9.6.11067; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Macchiarulo A, 2008, J CHEM INF MODEL, V48, P1999, DOI 10.1021/ci800146m; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Pennell S, 2010, STRUCTURE, V18, P1587, DOI 10.1016/j.str.2010.09.014; Popowicz GM, 2008, CELL CYCLE, V7, P2441, DOI 10.4161/cc.6365; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Ward JM, 2010, J AM CHEM SOC, V132, P11058, DOI 10.1021/ja910535j; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; Zidek L, 1999, NAT STRUCT BIOL, V6, P1118; Zondlo SC, 2006, BIOCHEMISTRY-US, V45, P11945, DOI 10.1021/bi060309g	31	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24122	10.1371/journal.pone.0024122	http://dx.doi.org/10.1371/journal.pone.0024122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904608	Green Submitted, Green Published, gold			2022-12-25	WOS:000294680800056
J	Collado, MS; Burns, JC; Meyers, JR; Corwin, JT				Collado, Maria Sol; Burns, Joseph C.; Meyers, Jason R.; Corwin, Jeffrey T.			Variations in Shape-Sensitive Restriction Points Mirror Differences in the Regeneration Capacities of Avian and Mammalian Ears	PLOS ONE			English	Article							HAIR CELL REGENERATION; INNER-EAR; ACOUSTIC TRAUMA; INTRACELLULAR SIGNALS; SENSORY EPITHELIA; CYCLE PROGRESSION; DEPENDENT CONTROL; DEVELOPING ORGAN; GROWTH-FACTORS; CHICK COCHLEA	When inner ear hair cells die, humans and other mammals experience permanent hearing and balance deficits, but non-mammalian vertebrates quickly recover these senses after epithelial supporting cells give rise to replacement hair cells. A postnatal decline in cellular plasticity appears to limit regeneration in mammalian balance organs, where declining proliferation responses are correlated with decreased spreading of supporting cells on artificial and native substrates. By culturing balance epithelia on substrates that differed in flexibility, we assessed spreading effects independent of age, showing a strong correlation between shape change and supporting cell proliferation. Then we made excision wounds in utricles cultured from young and old chickens and mice and compared quantified levels of spreading and proliferation. In utricles from young mice, and both young and old chickens, wounds re-epithelialized in,24 hours, while those in utricles from mature mice took three times longer. More cells changed shape in the fastest healing wounds, which accounted for some differences in the levels of proliferation, but inter-species and age-related differences in shape-sensitive restriction points, i.e., the cellular thresholds for shape changes that promote S-phase, were evident and may be particularly influential in the responses to hair cell losses in vivo.	[Collado, Maria Sol; Burns, Joseph C.; Corwin, Jeffrey T.] Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; [Burns, Joseph C.] Univ Virginia, Sch Med, Dept Biomed Engn, Charlottesville, VA 22908 USA; [Meyers, Jason R.] Univ Virginia, Sch Med, Neurosci Grad Program, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Collado, MS (corresponding author), Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA.	mc4sr@virginia.edu	Meyers, Jason/B-1889-2018; Burns, Joseph/HHD-1604-2022	Meyers, Jason/0000-0002-0456-0115; 	National Institute on Deafness and Other Communication Disorders (NIDCD) [RO1-DC000200]; National Institutes of Health (NIH); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000200] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by RO1-DC000200 from the National Institute on Deafness and Other Communication Disorders (NIDCD), and National Institutes of Health (NIH) awarded to Dr. Corwin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhadriraju K, 2002, EXP CELL RES, V278, P92, DOI 10.1006/excr.2002.5557; Borghi N, 2010, P NATL ACAD SCI USA, V107, P13324, DOI 10.1073/pnas.1002662107; Burns J, 2008, J COMP NEUROL, V511, P396, DOI 10.1002/cne.21849; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chen P, 1999, DEVELOPMENT, V126, P1581; COLLADO MS, 2011, J NEUROSCI IN PRESS; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; COTANCHE DA, 1987, HEARING RES, V30, P181, DOI 10.1016/0378-5955(87)90135-3; COTANCHE DA, 1990, HEARING RES, V46, P29, DOI 10.1016/0378-5955(90)90137-E; Davies D, 2007, EUR J NEUROSCI, V25, P985, DOI 10.1111/j.1460-9568.2007.05355.x; Edge ASB, 2008, CURR OPIN NEUROBIOL, V18, P377, DOI 10.1016/j.conb.2008.10.001; FORGE A, 1993, SCIENCE, V259, P1616, DOI 10.1126/science.8456284; FORSCHER P, 1989, TRENDS NEUROSCI, V12, P468, DOI 10.1016/0166-2236(89)90098-2; Fournier AK, 2008, J CELL SCI, V121, P226, DOI 10.1242/jcs.017012; Gale JE, 2004, CURR BIOL, V14, P526, DOI 10.1016/j.cub.2004.03.002; Goodyear RJ, 1999, J NEUROCYTOL, V28, P851, DOI 10.1023/A:1007070121751; Gu RD, 2007, EUR J NEUROSCI, V25, P1363, DOI 10.1111/j.1460-9568.2007.05414.x; Hooper S, 2006, METHOD ENZYMOL, V406, P625, DOI 10.1016/S0076-6879(06)06049-6; Huang S, 1998, MOL BIOL CELL, V9, P3179, DOI 10.1091/mbc.9.11.3179; Hume CR, 2003, JARO-J ASSOC RES OTO, V4, P422, DOI 10.1007/s10162-002-3008-8; Itano N, 2003, P NATL ACAD SCI USA, V100, P5181, DOI 10.1073/pnas.0531397100; JORGENSEN JM, 1988, NATURWISSENSCHAFTEN, V75, P319, DOI 10.1007/BF00367330; KELLEY MW, 1993, DEVELOPMENT, V119, P1041; Khurana S, 2008, FEBS LETT, V582, P2128, DOI 10.1016/j.febslet.2008.02.040; Kil J, 1997, HEARING RES, V114, P117, DOI 10.1016/S0378-5955(97)00166-4; KULESH DA, 1986, CANCER RES, V46, P2793; Laine H, 2010, DEV BIOL, V337, P134, DOI 10.1016/j.ydbio.2009.10.027; Liu WF, 2007, CIRC RES, V101, pE44, DOI 10.1161/CIRCRESAHA.107.158329; Liu WF, 2006, J CELL BIOL, V173, P431, DOI 10.1083/jcb.200510087; Lowenheim H, 1999, P NATL ACAD SCI USA, V96, P4084, DOI 10.1073/pnas.96.7.4084; Lu ZJ, 2008, DEV NEUROBIOL, V68, P1059, DOI 10.1002/dneu.20635; Mammoto A, 2004, J BIOL CHEM, V279, P26323, DOI 10.1074/jbc.M402725200; MARSH RR, 1990, HEARING RES, V46, P229, DOI 10.1016/0378-5955(90)90004-9; McNeil PL, 2003, P NATL ACAD SCI USA, V100, P4592, DOI 10.1073/pnas.0736739100; Meyers Jason R., 2008, V33, P39; Meyers JR, 2007, J NEUROSCI, V27, P4313, DOI 10.1523/JNEUROSCI.5023-06.2007; Meyers JR, 2003, J NEUROSCI, V23, P4054; Minoda R, 2007, HEARING RES, V232, P44, DOI 10.1016/j.heares.2007.06.005; Montcouquiol M, 2001, J NEUROSCI, V21, P570, DOI 10.1523/JNEUROSCI.21-02-00570.2001; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pennington SR, 2007, J BIOL CHEM, V282, P32112, DOI 10.1074/jbc.M705067200; Pirone DM, 2006, J CELL BIOL, V174, P277, DOI 10.1083/jcb.200510062; Raphael Y, 2002, BRIT MED BULL, V63, P25, DOI 10.1093/bmb/63.1.25; Roca-Cusachs P, 2008, BIOPHYS J, V94, P4984, DOI 10.1529/biophysj.107.116863; Soofi SS, 2009, J STRUCT BIOL, V167, P216, DOI 10.1016/j.jsb.2009.05.005; Stone JS, 2007, INT J DEV BIOL, V51, P633, DOI 10.1387/ijdb.072408js; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Wang YK, 2003, J BIOL CHEM, V278, P21886, DOI 10.1074/jbc.M300092200; Warchol ME, 2007, HEARING RES, V227, P11, DOI 10.1016/j.heares.2006.08.014; Warchol ME, 2002, J NEUROSCI, V22, P2607, DOI 10.1523/JNEUROSCI.22-07-02607.2002; WARCHOL ME, 1993, SCIENCE, V259, P1619, DOI 10.1126/science.8456285; Witte MC, 2001, EUR J NEUROSCI, V14, P829, DOI 10.1046/j.0953-816x.2001.01695.x; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zheng JL, 1997, J NEUROSCI, V17, P216, DOI 10.1523/JNEUROSCI.17-01-00216.1997	55	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23861	10.1371/journal.pone.0023861	http://dx.doi.org/10.1371/journal.pone.0023861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909368	Green Published, Green Submitted, gold			2022-12-25	WOS:000294680800030
J	Hanvesakul, R; Kubal, C; Moore, J; Neil, D; Cook, M; Ball, S; Briggs, D; Moss, P; Cockwell, P				Hanvesakul, Raj; Kubal, Chandrashekhar; Moore, Jason; Neil, Desley; Cook, Mark; Ball, Simon; Briggs, David; Moss, Paul; Cockwell, Paul			KIR and HLA-C Interactions Promote Differential Dendritic Cell Maturation and Is a Major Determinant of Graft Failure following Kidney Transplantation	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; CHRONIC ALLOGRAFT NEPHROPATHY; CHEMOKINE RECEPTOR CCR7; TUBULAR EPITHELIAL-CELLS; NK-CELL; T-CELLS; CLASS-I; LIVER-TRANSPLANTATION; LIGAND INCOMPATIBILITY; RENAL-TRANSPLANTATION	Background: HLA-C is an important ligand for killer immunoglobulin like receptors (KIR) that regulate natural killer (NK) cell function. Based on KIR specificity HLA-C molecules are allocated into two groups, HLA-C1 or HLA-C2; HLA-C2 is more inhibiting to NK cell function than HLA-C1. We studied the clinical importance of HLA-C genotypes on the long-term graft survival of 760 kidney transplants performed at our centre utilising a population based genetic study and cell culture model to define putative mechanisms. Methods and Findings: Genotyping was performed using conventional DNA PCR techniques and correlations made to clinical outcomes. We found that transplant recipients with HLA-C2 had significantly better long-term graft survival than transplant recipients with HLA-C1 (66% versus 44% at 10 years, log-rank p = 0.002, HR = 1.51, 95% CI = 1.16-1.97). In in-vitro NK and dendritic cell (DC) co-culture model we made several key observations that correlated with the population based genetic study. We observed that donor derived NK cells, on activation with IL-15, promoted differential HLA-C genotype dependent DC maturation. In NK-DC co-culture, the possession of HLA-C2 by DC was associated with anti-inflammatory cytokine production (IL-1RA/IL-6), diminished DC maturation (CD86, HLA-DR), and absent CCR7 expression. Conversely, possession of HLA-C1 by DC was associated with pro-inflammatory cytokine synthesis (TNF-alpha, IL-12p40/p70), enhanced DC maturation and up-regulation of CCR7 expression. By immunohistochemistry the presence of donor NK cells was confirmed in pre-transplant kidneys. Conclusions: We propose that after kidney transplantation IL-15 activated donor derived NK cells interact with recipient DC with less activation of indirect allo-reactivity in HLA-C2 positive recipients than HLA-C1 positive recipients; this has implications for long-term graft survival. Early events following kidney transplantation involving NK-DC interaction via KIR and HLA-C immune synapse may have a central role in long-term kidney transplant outcomes.	[Hanvesakul, Raj; Kubal, Chandrashekhar; Moore, Jason; Ball, Simon; Cockwell, Paul] Univ Hosp Birmingham, Renal Inst Birmingham, Birmingham, W Midlands, England; [Neil, Desley] Univ Hosp Birmingham, Dept Pathol, Birmingham, W Midlands, England; [Cook, Mark] Univ Hosp Birmingham, Dept Haematol, Birmingham, W Midlands, England; [Briggs, David] Natl Blood Serv, Dept Histocompatibil & Immunogenet, Birmingham, W Midlands, England; [Moss, Paul] Univ Birmingham, Div Canc Studies, Birmingham, W Midlands, England; [Cockwell, Paul] Univ Birmingham, Div Immun & Infect, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Hanvesakul, R (corresponding author), Univ Hosp Birmingham, Renal Inst Birmingham, Birmingham, W Midlands, England.	rhanvesakul@doctors.org.uk	Kubal, Chandrashekhar/AAX-4744-2021; Moss, Paul/D-1728-2009	Moss, Paul/0000-0002-6895-1967; kubal, chandrashekhar/0000-0003-4043-2943; Cockwell, Paul/0000-0003-1975-266X; Neil, Desley/0000-0001-9800-6811; Briggs, David/0000-0002-6796-7086; Cook, Mark/0000-0001-8647-9208; Ball, Simon/0000-0001-7410-5268	University Hospital Birmingham; Medical Research Council [G0901755, G9818340B] Funding Source: researchfish; MRC [G0901755] Funding Source: UKRI	University Hospital Birmingham; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Grants for this study were provided by the University Hospital Birmingham charitable funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2008, J CLIN INVEST, V118, P1017, DOI 10.1172/JCI32400; [Anonymous], 2004, 2004 ANN REP US ORG; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Baan CC, 1998, CLIN TRANSPLANT, V12, P212; Baan CC, 1999, TRANSPLANTATION, V67, P870, DOI 10.1097/00007890-199903270-00014; Baker RJ, 2001, J IMMUNOL, V167, P7199, DOI 10.4049/jimmunol.167.12.7199; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bestard O, 2008, J AM SOC NEPHROL, V19, P1419, DOI 10.1681/ASN.2007050539; Borg C, 2004, BLOOD, V104, P3267, DOI 10.1182/blood-2004-01-0380; Boros P, 2006, AM J TRANSPLANT, V6, P652, DOI 10.1111/j.1600-6143.2005.01228.x; Brilot F, 2007, J CLIN INVEST, V117, P3316, DOI 10.1172/JCI31751; Carrington M, 2005, J EXP MED, V201, P1069, DOI 10.1084/jem.20042158; Chiossone L, 2007, BLOOD, V109, P3767, DOI 10.1182/blood-2006-07-037846; Coates PTH, 2004, TRANSPLANTATION, V77, P1080, DOI 10.1097/01.TP.0000122183.60680.C9; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Hanvesakul R, 2008, AM J TRANSPLANT, V8, P1931, DOI 10.1111/j.1600-6143.2008.02341.x; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hegde S, 2004, FASEB J, V18, P1439, DOI 10.1096/fj.03-0969fje; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Jacobs R, 2001, EUR J IMMUNOL, V31, P3121, DOI 10.1002/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4; Jevnikar AM, 2008, CLIN J AM SOC NEPHRO, V3, pS56, DOI 10.2215/CJN.03040707; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kellermann SA, 1999, J IMMUNOL, V162, P3859; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kitchens WH, 2006, TRANSPLANTATION, V81, P811, DOI 10.1097/01.tp.0000202844.33794.0e; Knolle PA, 1999, GASTROENTEROLOGY, V116, P1428, DOI 10.1016/S0016-5085(99)70508-1; Kunert K, 2007, TRANSPLANTATION, V84, P1527, DOI 10.1097/01.tp.0000290681.41859.41; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; LaRosa DF, 2007, J IMMUNOL, V178, P7503, DOI 10.4049/jimmunol.178.12.7503; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Maier S, 2001, NAT MED, V7, P557, DOI 10.1038/87880; Mailliard RB, 2003, J IMMUNOL, V171, P2366, DOI 10.4049/jimmunol.171.5.2366; Marcenaro E, 2005, J IMMUNOL, V174, P3992, DOI 10.4049/jimmunol.174.7.3992; Martinez OM, 2005, LIVER TRANSPLANT, V11, P370, DOI 10.1002/lt.20406; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1289, DOI 10.1111/j.1600-6143.2004.00515.x; Mocikat R, 2003, IMMUNITY, V19, P561, DOI 10.1016/S1074-7613(03)00264-4; Moretta A, 2005, CURR OPIN IMMUNOL, V17, P306, DOI 10.1016/j.coi.2005.03.004; Najafian B, 2008, CURR OPIN NEPHROL HY, V17, P149, DOI 10.1097/MNH.0b013e3282f4e514; Najafian N, 2002, J AM SOC NEPHROL, V13, P252, DOI 10.1681/ASN.V131252; Navarro V, 2006, LIVER TRANSPLANT, V12, P652, DOI 10.1002/lt.20680; Nowak I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012381; O'Connell PJ, 2000, J IMMUNOL, V165, P795, DOI 10.4049/jimmunol.165.2.795; Obara H, 2005, AM J TRANSPLANT, V5, P2094, DOI 10.1111/j.1600-6143.2005.00995.x; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Paul LC, 1999, KIDNEY INT, V56, P783, DOI 10.1046/j.1523-1755.1999.00611.x; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070; Sanchez-Sanchez N, 2004, BLOOD, V104, P619, DOI 10.1182/blood-2003-11-3943; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Sayegh MH, 2004, NEW ENGL J MED, V351, P2761, DOI 10.1056/NEJMon043418; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; SivaSai KSR, 1999, TRANSPLANTATION, V67, P1094, DOI 10.1097/00007890-199904270-00002; Strehlau J, 1996, CLIN NEPHROL, V46, P30; Terasaki PI, 2008, TRANSPLANTATION, V86, P377, DOI 10.1097/TP.0b013e31817c4cb8; Tran TH, 2005, TRANSPLANTATION, V80, P1121, DOI 10.1097/01.tp.0000179110.15304.90; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Uehara S, 2005, J IMMUNOL, V175, P3424, DOI 10.4049/jimmunol.175.5.3424; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Weiler M, 1998, J AM SOC NEPHROL, V9, P1194; Weiler M, 2001, J AM SOC NEPHROL, V12, P80, DOI 10.1681/ASN.V12.1.80	66	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23631	10.1371/journal.pone.0023631	http://dx.doi.org/10.1371/journal.pone.0023631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21912600	Green Published, Green Submitted, gold			2022-12-25	WOS:000294680800013
J	Matsushita, N; Endo, Y; Sato, K; Kurumizaka, H; Yamashita, T; Takata, M; Yanagi, S				Matsushita, Nobuko; Endo, Yujiro; Sato, Koichi; Kurumizaka, Hitoshi; Yamashita, Takayuki; Takata, Minoru; Yanagi, Shigeru			Direct Inhibition of TNF-alpha Promoter Activity by Fanconi Anemia Protein FANCD2	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; DOUBLE-STRANDED-RNA; INDUCED APOPTOSIS; INTERFERON-GAMMA; DNA-DAMAGE; IFN-GAMMA; IN-VITRO; CELLS; KINASE	Fanconi anemia (FA), an inherited disease, is associated with progressive bone marrow failure, predisposition to cancer, and genomic instability. Genes corresponding to 15 identified FA complementation groups have been cloned, and each gene product functions in the response to DNA damage induced by cross-linking agents and/or in protection against genome instability. Interestingly, overproduction of inflammatory cytokines such as tumor necrosis factor alpha (TNF-alpha) and aberrant activation of NF-kappa B-dependent transcriptional activity have been observed in FA cells. Here we demonstrated that FANCD2 protein inhibits NF-kappa B activity in its monoubiquitination-dependent manner. Furthermore, we detected a specific association between FANCD2 and an NF-kappa B consensus element in the TNF-alpha promoter by electrophoretic mobility shift assays (EMSA) and chromatin immunoprecipitation (ChIP) assay. Therefore, we propose FANCD2 deficiency promotes transcriptional activity of the TNF-alpha promoter and induces overproduction of TNF-which then sustains prolonged inflammatory responses. These results also suggest that artificial modulation of TNF alpha production could be a promising therapeutic approach to FA.	[Matsushita, Nobuko; Endo, Yujiro; Yanagi, Shigeru] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Mol Biochem, Tokyo, Japan; [Sato, Koichi; Kurumizaka, Hitoshi] Waseda Univ, Struct Biol Lab, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo, Japan; [Takata, Minoru] Kyoto Univ, Ctr Radiat Biol, Lab DNA Damage Signaling, Dept Late Effects Studies, Kyoto 606, Japan; [Yamashita, Takayuki] Gunma Univ, Mol Genet Lab, Inst Mol & Cellular Regulat, Gunma, Japan	Tokyo University of Pharmacy & Life Sciences; Waseda University; Kyoto University; Gunma University	Matsushita, N (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Mol Biochem, Tokyo, Japan.	matsun@ls.toyaku.ac.jp	Yanagi, Shigeru/AAU-9513-2020	Yanagi, Shigeru/0000-0002-1392-8663; Kurumizaka, Hitoshi/0000-0001-7412-3722; Takata, Minoru/0000-0002-4926-3675; Sato, Koichi/0000-0002-0574-774X	Ministry of Education, Science, Sports and Culture of Japan; Uehara Memorial Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [22310119] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan (http://www.jsps.go.jp/english/e-grants/grants.html)(N.M., S.Y., H.K., M.T.). Financial support was also provided by The Uehara Memorial Foundation (http://www.ueharazaidan.com/) (M.T.) and The Takeda Science Foundation (http://www.takeda-sci.or.jp/)(M.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; Bijangi-Vishehsaraei K, 2005, BLOOD, V106, P4124, DOI 10.1182/blood-2005-05-2096; Briot D, 2008, BLOOD, V111, P1913, DOI 10.1182/blood-2007-07-099218; BUTTURINI A, 1994, BLOOD, V84, P1650, DOI 10.1182/blood.V84.5.1650.bloodjournal8451650; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Csonga R, 1998, J IMMUNOL, V160, P273; de Winter JP, 2009, MUTAT RES-FUND MOL M, V668, P11, DOI 10.1016/j.mrfmmm.2008.11.004; Dufour C, 2003, BLOOD, V102, P2053, DOI 10.1182/blood-2003-01-0114; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Kuprash DV, 1999, J IMMUNOL, V162, P4045; Li J, 2007, J CLIN INVEST, V117, P3283, DOI 10.1172/JCI31772; Li XX, 2004, BLOOD, V104, P1204, DOI 10.1182/blood-2004-03-1094; Lyakhovich Alex, 2011, Genome Integr, V2, P4, DOI 10.1186/2041-9414-2-4; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Pang QS, 2002, J BIOL CHEM, V277, P49638, DOI 10.1074/jbc.M209386200; Pang QS, 2001, BLOOD, V97, P1644, DOI 10.1182/blood.V97.6.1644; Pang QS, 2001, EMBO J, V20, P4478, DOI 10.1093/emboj/20.16.4478; Park WH, 2005, J BIOL CHEM, V280, P23593, DOI 10.1074/jbc.M503730200; Ravi D, 2008, MOL CELL BIOCHEM, V308, P193, DOI 10.1007/s11010-007-9628-x; RHOADES KL, 1992, J BIOL CHEM, V267, P22102; ROSSELLI F, 1994, BLOOD, V83, P1216; Ruppitsch W, 1997, HUM GENET, V99, P710, DOI 10.1007/s004390050437; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHULTZ JC, 1993, AM J HEMATOL, V42, P196, DOI 10.1002/ajh.2830420211; Sejas DP, 2007, J IMMUNOL, V178, P5277, DOI 10.4049/jimmunol.178.8.5277; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Udalova IA, 1998, J BIOL CHEM, V273, P21178, DOI 10.1074/jbc.273.33.21178; Vanderwerf SM, 2009, BLOOD, V114, P5290, DOI 10.1182/blood-2009-05-222414; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Venkatraman M, 2005, MOL CARCINOGEN, V44, P51, DOI 10.1002/mc.20116; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Zhang XL, 2007, J CELL SCI, V120, P1572, DOI 10.1242/jcs.003152; Zhang XL, 2004, J BIOL CHEM, V279, P43910, DOI 10.1074/jbc.M403884200	40	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23324	10.1371/journal.pone.0023324	http://dx.doi.org/10.1371/journal.pone.0023324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21912593	Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800008
J	Paape, T; Miyake, T; Takebayashi, N; Wolf, D; Kohn, JR				Paape, Timothy; Miyake, Takashi; Takebayashi, Naoki; Wolf, Diana; Kohn, Joshua R.			Evolutionary Genetics of an S-Like Polymorphism in Papaveraceae with Putative Function in Self-Incompatibility	PLOS ONE			English	Article							PRIMARY STRUCTURAL FEATURES; AMINO-ACID SITES; F-BOX PROTEIN; NATURAL-POPULATIONS; NUCLEOTIDE-SEQUENCE; RECENT SPECIATION; LOCUS; IDENTIFICATION; ARABIDOPSIS; ALLELES	Background: Papaver rhoeas possesses a gametophytic self-incompatibility (SI) system not homologous to any other SI mechanism characterized at the molecular level. Four previously published full length stigmatic S-alleles from the genus Papaver exhibited remarkable sequence divergence, but these studies failed to amplify additional S-alleles despite crossing evidence for more than 60 S-alleles in Papaver rhoeas alone. Methodology/Principal Findings: Using RT-PCR we identified 87 unique putative stigmatic S-allele sequences from the Papaveraceae Argemone munita, Papaver mcconnellii, P. nudicuale, Platystemon californicus and Romneya coulteri. Hand pollinations among two full-sib families of both A. munita and P. californicus indicate a strong correlation between the putative S-genotype and observed incompatibility phenotype. However, we also found more than two S-like sequences in some individuals of A. munita and P. californicus, with two products co-segregating in both full-sib families of P. californicus. Pairwise sequence divergence estimates within and among taxa show Papaver stigmatic S-alleles to be the most variable with lower divergence among putative S-alleles from other Papaveraceae. Genealogical analysis indicates little shared ancestral polymorphism among S-like sequences from different genera. Lack of shared ancestral polymorphism could be due to long divergence times among genera studied, reduced levels of balancing selection if some or all S-like sequences do not function in incompatibility, population bottlenecks, or different levels of recombination among taxa. Preliminary estimates of positive selection find many sites under selective constraint with a few undergoing positive selection, suggesting that self-recognition may depend on amino acid substitutions at only a few sites. Conclusions/Significance: Because of the strong correlation between genotype and SI phenotype, sequences reported here represent either functional stylar S-alleles, tightly linked paralogs of the S-locus or a combination of both. The considerable complexity revealed in this study shows we have much to learn about the evolutionary dynamics of self-incompatibility systems.	[Paape, Timothy] Univ Minnesota, Coll Biol Sci, St Paul, MN 55108 USA; [Miyake, Takashi; Takebayashi, Naoki; Wolf, Diana] Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Takebayashi, Naoki; Wolf, Diana] Univ Alaska, Dept Biol & Wildlife, Fairbanks, AK 99775 USA; [Kohn, Joshua R.] Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of California System; University of California San Diego	Paape, T (corresponding author), Univ Minnesota, Coll Biol Sci, St Paul, MN 55108 USA.	paap0008@umn.edu	Miyake, Takashi/AAN-6409-2020	Miyake, Takashi/0000-0001-6175-5026; Paape, Timothy/0000-0002-3595-2875	University of California; California Desert Research Fund; National Science Foundation [DEB0639984, DEB0640520]; National Institutes of Health National Center for Research Resources [2P20RR016466]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016466] Funding Source: NIH RePORTER	University of California(University of California System); California Desert Research Fund; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Field collections were supported by grants from the University of California Mildred Mathias Research Fund and the California Desert Research Fund to TP. Further support came from the National Science Foundation DEB0639984 to JK, and DEB0640520 to NT and DW and a National Institutes of Health National Center for Research Resources Grant 2P20RR016466 to NT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatty AV, 1936, J HERED, V27, P331, DOI 10.1093/oxfordjournals.jhered.a104242; Bechsgaard JS, 2006, MOL BIOL EVOL, V23, P1741, DOI 10.1093/molbev/msl042; Bilinski P, 2010, THESIS U CALIFORNIA; Bosch M, 2008, J EXP BOT, V59, P481, DOI 10.1093/jxb/erm195; Busch JW, 2008, GENETICS, V178, P2055, DOI 10.1534/genetics.107.083204; Castric V, 2004, MOL ECOL, V13, P2873, DOI 10.1111/j.1365-294X.2004.02267.x; COOK SA, 1962, EVOLUTION, V16, P278, DOI 10.2307/2406277; de Graaf BHJ, 2006, NATURE, V444, P490, DOI 10.1038/nature05311; de Nettancourt D., 1977, INCOMPATIBILITY ANGI; DOEBLEY J, 1990, EVOLUTION, V44, P1097, DOI 10.1111/j.1558-5646.1990.tb03828.x; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; FOOTE HCC, 1994, P NATL ACAD SCI USA, V91, P2265, DOI 10.1073/pnas.91.6.2265; Foxe JP, 2009, P NATL ACAD SCI USA, V106, P5241, DOI 10.1073/pnas.0807679106; Franklin-Tong N, 2003, TRENDS PLANT SCI, V8, P598, DOI 10.1016/j.tplants.2003.10.008; Golz JF, 1999, GENETICS, V152, P1123; Good-Avila SV, 2002, EVOLUTION, V56, P263; Guo YL, 2009, P NATL ACAD SCI USA, V106, P5246, DOI 10.1073/pnas.0808012106; Hagenblad J, 2006, GENETICS, V173, P1057, DOI 10.1534/genetics.106.055780; HANNAN GL, 1981, AM J BOT, V68, P233, DOI 10.2307/2442855; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes AL, 2007, HEREDITY, V99, P364, DOI 10.1038/sj.hdy.6801031; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Hughes AL, 2008, P NATL ACAD SCI USA, V105, P13193, DOI 10.1073/pnas.0807440105; Igic B, 2008, INT J PLANT SCI, V169, P93, DOI 10.1086/523362; Ikeda K, 2004, SEX PLANT REPROD, V16, P235, DOI 10.1007/s00497-003-0200-x; IOERGER TR, 1990, P NATL ACAD SCI USA, V87, P9732, DOI 10.1073/pnas.87.24.9732; IOERGER TR, 1991, SEX PLANT REPROD, V4, P81; JUKES T H, 1969, P21; Kakeda K, 1998, PLANT CELL, V10, P1723, DOI 10.1105/tpc.10.10.1723; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Kohn J. R., 2008, P103, DOI 10.1007/978-3-540-68486-2_5; Kubo K, 2010, SCIENCE, V330, P796, DOI 10.1126/science.1195243; Kurup S, 1998, SEX PLANT REPROD, V11, P192, DOI 10.1007/s004970050141; Kusaba M, 1997, P NATL ACAD SCI USA, V94, P7673, DOI 10.1073/pnas.94.14.7673; Kusaba M, 2001, PLANT CELL, V13, P627, DOI 10.1105/tpc.13.3.627; LANE MD, 1993, HEREDITY, V71, P596, DOI 10.1038/hdy.1993.184; LAWRENCE MJ, 1981, HEREDITY, V47, P53, DOI 10.1038/hdy.1981.58; Mable BK, 2004, NEW PHYTOL, V162, P803, DOI 10.1111/j.1469-8137.2004.01055.x; Mable BK, 2003, HEREDITY, V90, P422, DOI 10.1038/sj.hdy.6800261; Mena-Ali JI, 2007, GENETICS, V177, P501, DOI 10.1534/genetics.107.073775; Miege C, 2001, GENETICS, V159, P811; Miller JS, 2008, EVOLUTION, V62, P1052, DOI 10.1111/j.1558-5646.2008.00358.x; Newbigin E, 2008, PLANT CELL, V20, P2286, DOI 10.1105/tpc.108.060327; Nielsen R, 1998, GENETICS, V148, P929; Paape T, 2008, MOL BIOL EVOL, V25, P655, DOI 10.1093/molbev/msn016; Paetsch M, 2006, HEREDITY, V97, P283, DOI 10.1038/sj.hdy.6800854; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Qiao H, 2004, PLANT CELL, V16, P2307, DOI 10.1105/tpc.104.024919; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Richman AD, 1996, SCIENCE, V273, P1212, DOI 10.1126/science.273.5279.1212; Ride JP, 1999, PLANT MOL BIOL, V39, P927, DOI 10.1023/A:1006178511787; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sakamoto K, 1998, MOL GEN GENET, V258, P397, DOI 10.1007/s004380050747; Sassa H, 2007, GENETICS, V175, P1869, DOI 10.1534/genetics.106.068858; Schierup MH, 2000, GENETICS, V156, P879; Schierup MH, 2001, GENETICS, V158, P387; Schierup MH, 2001, GENETICS, V159, P1833; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Solstad, 2008, THESIS U OSLO; Stone JL, 2004, HEREDITY, V92, P335, DOI 10.1038/sj.hdy.6800425; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TAKAHATA N, 1990, P NATL ACAD SCI USA, V87, P2419, DOI 10.1073/pnas.87.7.2419; Takuno S, 2008, GENETICS, V180, P517, DOI 10.1534/genetics.108.091918; Testa G, 2002, SEX PLANT REPROD, V14, P269, DOI 10.1007/s00497-001-0122-4; Thomas S, 2003, PHILOS T ROY SOC B, V358, P1033, DOI 10.1098/rstb.2003.1288; Thomas SG, 2004, NATURE, V429, P305, DOI 10.1038/nature02540; Turner LM, 2006, MOL BIOL EVOL, V23, P1656, DOI 10.1093/molbev/msl035; Vieira CP, 2002, HEREDITY, V88, P172, DOI 10.1038/sj.hdy.6800024; Walker EA, 1996, PLANT MOL BIOL, V30, P983, DOI 10.1007/BF00020809; Wheeler D, 2007, GENETICS, V177, P2171, DOI 10.1534/genetics.107.076885; Wheeler MJ, 2009, NATURE, V459, P992, DOI 10.1038/nature08027; Wheeler MJ, 2001, NEW PHYTOL, V151, P565, DOI 10.1046/j.0028-646x.2001.00229.x; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wilson DJ, 2006, GENETICS, V172, P1411, DOI 10.1534/genetics.105.044917; Wiuf C, 2000, GENETICS, V155, P451; WOLFE KH, 1989, J MOL EVOL, V29, P208, DOI 10.1007/BF02100204; WRIGHT GM, 1979, HEREDITY, V43, P429, DOI 10.1038/hdy.1979.93; Wright S, 1939, GENETICS, V24, P538; Yang Z, 2000, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Zhou JL, 2003, SEX PLANT REPROD, V16, P165, DOI 10.1007/s00497-003-0185-5	83	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23635	10.1371/journal.pone.0023635	http://dx.doi.org/10.1371/journal.pone.0023635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21912602	Green Published, gold			2022-12-25	WOS:000294680800014
J	Roth, EK; Hirtz, S; Duerr, J; Wenning, D; Eichler, I; Seydewitz, HH; Amaral, MD; Mall, MA				Roth, Eva K.; Hirtz, Stephanie; Duerr, Julia; Wenning, Daniel; Eichler, Irmgard; Seydewitz, Hans H.; Amaral, Margarida D.; Mall, Marcus A.			The K+ Channel Opener 1-EBIO Potentiates Residual Function of Mutant CFTR in Rectal Biopsies from Cystic Fibrosis Patients	PLOS ONE			English	Article							MEDIATED CL-SECRETION; ION-TRANSPORT; NONSENSE MUTATIONS; CHLORIDE SECRETION; CONDUCTANCE; MODULATION; COLON; GENE; BENZIMIDAZOLONES; DEHYDRATION	Background: The identification of strategies to improve mutant CFTR function remains a key priority in the development of new treatments for cystic fibrosis (CF). Previous studies demonstrated that the K+ channel opener 1-ethyl-2-benzimidazolone (1-EBIO) potentiates CFTR-mediated Cl- secretion in cultured cells and mouse colon. However, the effects of 1-EBIO on wild-type and mutant CFTR function in native human colonic tissues remain unknown. Methods: We studied the effects of 1-EBIO on CFTR-mediated Cl- secretion in rectal biopsies from 47 CF patients carrying a wide spectrum of CFTR mutations and 57 age-matched controls. Rectal tissues were mounted in perfused micro-Ussing chambers and the effects of 1-EBIO were compared in control tissues, CF tissues expressing residual CFTR function and CF tissues with no detectable Cl- secretion. Results: Studies in control tissues demonstrate that 1-EBIO activated CFTR-mediated Cl- secretion in the absence of cAMP-mediated stimulation and potentiated cAMP-induced Cl- secretion by 39.266.7% (P, 0.001) via activation of basolateral Ca2+-activated and clotrimazole-sensitive KCNN4 K+ channels. In CF specimens, 1-EBIO potentiated cAMP-induced Cl- secretion in tissues with residual CFTR function by 44.4611.5% (P, 0.001), but had no effect on tissues lacking CFTR-mediated Cl- conductance. Conclusions: We conclude that 1-EBIO potentiates Cl- secretion in native CF tissues expressing CFTR mutants with residual Cl- channel function by activation of basolateral KCNN4 K+ channels that increase the driving force for luminal Cl- exit. This mechanism may augment effects of CFTR correctors and potentiators that increase the number and/or activity of mutant CFTR channels at the cell surface and suggests KCNN4 as a therapeutic target for CF.	[Roth, Eva K.; Hirtz, Stephanie; Duerr, Julia; Mall, Marcus A.] Heidelberg Univ, Div Pediat Pulmonol & Allergy, Heidelberg, Germany; [Roth, Eva K.; Hirtz, Stephanie; Duerr, Julia; Mall, Marcus A.] Heidelberg Univ, Cyst Fibrosis Ctr, Dept Pediat 3, Heidelberg, Germany; [Roth, Eva K.; Hirtz, Stephanie; Duerr, Julia; Mall, Marcus A.] Heidelberg Univ, Translat Lung Res Ctr, Heidelberg, Germany; [Wenning, Daniel] Heidelberg Univ, Dept Pediat 1, Heidelberg, Germany; [Eichler, Irmgard] Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Seydewitz, Hans H.] Univ Freiburg, Dept Pediat & Adolescent Med, Freiburg, Germany; [Amaral, Margarida D.] Natl Inst Hlth Dr Ricardo Jorge, Ctr Human Genet, Lisbon, Portugal; [Amaral, Margarida D.] Univ Lisbon, Fac Sci, Dept Chem & Biochem, Lisbon, Portugal	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Vienna; University of Freiburg; Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade de Lisboa	Roth, EK (corresponding author), Heidelberg Univ, Div Pediat Pulmonol & Allergy, Heidelberg, Germany.	Marcus.Mall@med.uni-heidelberg.de	Amaral, Margarida D/E-5748-2012; Mall, Marcus A./AAA-1498-2022; Duerr, Julia/J-9133-2015	Amaral, Margarida D/0000-0002-0828-8630; Mall, Marcus A./0000-0002-4057-2199; Duerr, Julia/0000-0002-4862-9487	Mukoviszidose e.V.; Deutsche Forschungsgemeinschaft (DFG) [MA 2081/4-1]; FCT - Fundacao para a Ciencia e a Tecnologia, Portugal [PIC/IC/83103/2007]; FEDER - Fundo Europeu de Desenvolvimento Regional, EU	Mukoviszidose e.V.; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); FCT - Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); FEDER - Fundo Europeu de Desenvolvimento Regional, EU	Supported by the Mukoviszidose e.V., the Deutsche Forschungsgemeinschaft (DFG MA 2081/4-1) and PIC/IC/83103/2007 (FCT - Fundacao para a Ciencia e a Tecnologia, Portugal and FEDER - Fundo Europeu de Desenvolvimento Regional, EU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Amaral MD, 2011, CURR DRUG TARGETS, V12, P683; Becq F, 2006, CURR PHARM DESIGN, V12, P471, DOI 10.2174/138161206775474459; Bleich M, 1997, PFLUG ARCH EUR J PHY, V434, P499, DOI 10.1007/s004240050427; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cuthbert AW, 1999, AM J PHYSIOL-CELL PH, V277, pC111, DOI 10.1152/ajpcell.1999.277.1.C111; Cuthbert AW, 2001, BRIT J PHARMACOL, V132, P659, DOI 10.1038/sj.bjp.0703859; De Boeck K, 2006, THORAX, V61, P627, DOI 10.1136/thx.2005.043539; Derichs N, 2010, THORAX, V65, P594, DOI 10.1136/thx.2009.125088; Devor DC, 2000, AM J PHYSIOL-CELL PH, V279, pC461, DOI 10.1152/ajpcell.2000.279.2.C461; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL785, DOI 10.1152/ajplung.1996.271.5.L785; Devor DC, 1997, AM J PHYSIOL-CELL PH, V273, pC531, DOI 10.1152/ajpcell.1997.273.2.C531; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; Du M, 2008, P NATL ACAD SCI USA, V105, P2064, DOI 10.1073/pnas.0711795105; Flores CA, 2007, J PHYSIOL-LONDON, V583, P705, DOI 10.1113/jphysiol.2007.134387; Gonska T, 2009, THORAX, V64, P932, DOI 10.1136/thx.2009.115295; HAMOSH A, 1991, J CLIN INVEST, V88, P1880, DOI 10.1172/JCI115510; Heitzmann D, 2008, PHYSIOL REV, V88, P1119, DOI 10.1152/physrev.00020.2007; Hirtz S, 2004, GASTROENTEROLOGY, V127, P1085, DOI 10.1053/j.gastro.2004.07.006; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kerem E, 2008, LANCET, V372, P719, DOI 10.1016/S0140-6736(08)61168-X; KNOWLES MR, 1995, HUM GENE THER, V6, P445, DOI 10.1089/hum.1995.6.4-445; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; LOHRMANN E, 1995, PFLUG ARCH EUR J PHY, V429, P517, DOI 10.1007/BF00704157; MacVinish LJ, 2001, PFLUG ARCH EUR J PHY, V443, pS127; MacVinish LJ, 1998, J PHYSIOL-LONDON, V510, P237, DOI 10.1111/j.1469-7793.1998.237bz.x; Mall M, 2004, GASTROENTEROLOGY, V126, P32, DOI 10.1053/j.gastro.2003.10.049; Mall M, 2000, AM J PHYSIOL-GASTR L, V278, pG617, DOI 10.1152/ajpgi.2000.278.4.G617; Mall M, 2003, PEDIATR RES, V53, P608, DOI 10.1203/01.PDR.0000057204.51420.DC; Mall M, 2000, AM J RESP CELL MOL, V23, P283, DOI 10.1165/ajrcmb.23.3.4060; Mall M, 2000, BRIT J PHARMACOL, V130, P1884, DOI 10.1038/sj.bjp.0703520; Mall M, 1998, AM J PHYSIOL-GASTR L, V275, pG1274, DOI 10.1152/ajpgi.1998.275.6.G1274; Matos JE, 2007, ACTA PHYSIOL, V189, P251, DOI 10.1111/j.1748-1716.2006.01646.x; Namkung W, 2008, J AM CHEM SOC, V130, P7794, DOI 10.1021/ja8014499; Noone PG, 2001, GASTROENTEROLOGY, V121, P1310, DOI 10.1053/gast.2001.29673; Preston P, 2010, J BIOL CHEM, V285, P7165, DOI 10.1074/jbc.M109.047829; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; Singh S, 2001, J PHARMACOL EXP THER, V296, P600; Sloane PA, 2010, CURR OPIN PULM MED, V16, P591, DOI 10.1097/MCP.0b013e32833f1d00; Vallon V, 2005, P NATL ACAD SCI USA, V102, P17864, DOI 10.1073/pnas.0505860102; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; VEEZE HJ, 1991, GASTROENTEROLOGY, V101, P398, DOI 10.1016/0016-5085(91)90017-F; Verkman AS, 2006, CURR PHARM DESIGN, V12, P2235, DOI 10.2174/138161206777585148; von Hahn T, 2001, CELL PHYSIOL BIOCHEM, V11, P219, DOI 10.1159/000051936; Wallis C, 1997, LANCET, V350, P1001, DOI 10.1016/S0140-6736(97)24040-7; Warth R, 1999, PFLUG ARCH EUR J PHY, V438, P437, DOI 10.1007/s004240051059; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Welsh MJ, 2001, METABOLIC MOL BASES, P5121	53	36	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24445	10.1371/journal.pone.0024445	http://dx.doi.org/10.1371/journal.pone.0024445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909392	Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800089
J	Wallace, E; Dranow, D; Laible, PD; Christensen, J; Nollert, P				Wallace, Ellen; Dranow, David; Laible, Philip D.; Christensen, Jeff; Nollert, Peter			Monoolein Lipid Phases as Incorporation and Enrichment Materials for Membrane Protein Crystallization	PLOS ONE			English	Article							CUBIC PHASES; CRYSTAL-STRUCTURE; MECHANISM; RECEPTOR; DIAGRAM; SYSTEM	The crystallization of membrane proteins in amphiphile-rich materials such as lipidic cubic phases is an established methodology in many structural biology laboratories. The standard procedure employed with this methodology requires the generation of a highly viscous lipidic material by mixing lipid, for instance monoolein, with a solution of the detergent solubilized membrane protein. This preparation is often carried out with specialized mixing tools that allow handling of the highly viscous materials while minimizing dead volume to save precious membrane protein sample. The processes that occur during the initial mixing of the lipid with the membrane protein are not well understood. Here we show that the formation of the lipidic phases and the incorporation of the membrane protein into such materials can be separated experimentally. Specifically, we have investigated the effect of different initial monoolein-based lipid phase states on the crystallization behavior of the colored photosynthetic reaction center from Rhodobacter sphaeroides. We find that the detergent solubilized photosynthetic reaction center spontaneously inserts into and concentrates in the lipid matrix without any mixing, and that the initial lipid material phase state is irrelevant for productive crystallization. A substantial in-situ enrichment of the membrane protein to concentration levels that are otherwise unobtainable occurs in a thin layer on the surface of the lipidic material. These results have important practical applications and hence we suggest a simplified protocol for membrane protein crystallization within amphiphile rich materials, eliminating any specialized mixing tools to prepare crystallization experiments within lipidic cubic phases. Furthermore, by virtue of sampling a membrane protein concentration gradient within a single crystallization experiment, this crystallization technique is more robust and increases the efficiency of identifying productive crystallization parameters. Finally, we provide a model that explains the incorporation of the membrane protein from solution into the lipid phase via a portal lamellar phase.	[Wallace, Ellen; Dranow, David; Christensen, Jeff; Nollert, Peter] Emerald BioStruct, Bainbridge Isl, WA 98110 USA; [Laible, Philip D.] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory	Wallace, E (corresponding author), Emerald BioStruct, Bainbridge Isl, WA 98110 USA.	pnollert@embios.com			NIH [P01 GM075913]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM075913] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the NIH Roadmap grant P01 GM075913. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Briggs J, 1996, J PHYS II, V6, P723, DOI 10.1051/jp2:1996208; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Caffrey M, 2008, CRYST GROWTH DES, V8, P4244, DOI 10.1021/cg800693r; Cherezov V, 2005, J APPL CRYSTALLOGR, V38, P398, DOI 10.1007/S0021889805001640; Cherezov V, 2003, J APPL CRYSTALLOGR, V36, P1372, DOI 10.1107/S002188980301906X; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cherezov V, 2007, FARADAY DISCUSS, V136, P195, DOI 10.1039/b618173b; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Chiu ML, 2000, ACTA CRYSTALLOGR D, V56, P781, DOI 10.1107/S0907444900004716; CZESLIK C, 1995, BIOPHYS J, V68, P1423, DOI 10.1016/S0006-3495(95)80315-2; Deng JP, 2004, ACTA CRYSTALLOGR D, V60, P203, DOI 10.1107/S0907444903024491; DiMagno TJ, 1998, SPECTROCHIM ACTA A, V54, P1247, DOI 10.1016/S1386-1425(98)00074-2; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kors CA, 2009, ACTA CRYSTALLOGR D, V65, P1062, DOI 10.1107/S0907444909029163; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; LANDAU EM, 1993, J AM CHEM SOC, V115, P2102, DOI 10.1021/ja00059a002; Li L, 2010, MICROFLUID NANOFLUID, V8, P789, DOI 10.1007/s10404-009-0512-8; Liu W, 2010, BIOPHYS J, V98, P1539, DOI 10.1016/j.bpj.2009.12.4296; Lopez-Jaramillo FJ, 2003, J CRYST GROWTH, V247, P177, DOI 10.1016/S0022-0248(02)01837-7; LUZZATI V, 1968, NATURE, V220, P485, DOI 10.1038/220485a0; Misquitta Y, 2003, BIOPHYS J, V85, P3084, DOI 10.1016/S0006-3495(03)74727-4; Ng JD, 2003, J STRUCT BIOL, V142, P218, DOI 10.1016/S1047-8477(03)00052-2; Nollert P, 2002, J APPL CRYSTALLOGR, V35, P637, DOI 10.1107/S0021889802012001; Nollert P, 2001, FEBS LETT, V504, P179, DOI 10.1016/S0014-5793(01)02747-8; Nollert P, 2002, METHOD ENZYMOL, V343, P183; Qiu H, 2000, BIOMATERIALS, V21, P223, DOI 10.1016/S0142-9612(99)00126-X; Rouhani S, 2002, BIOPOLYMERS, V66, P300, DOI 10.1002/bip.10310; Rummel G, 1998, J STRUCT BIOL, V121, P82, DOI 10.1006/jsbi.1997.3952; Tsapis N, 2001, BIOPHYS J, V81, P1613, DOI 10.1016/S0006-3495(01)75815-8; Wadsten P, 2006, J MOL BIOL, V364, P44, DOI 10.1016/j.jmb.2006.06.043; Wohri AB, 2008, STRUCTURE, V16, P1003, DOI 10.1016/j.str.2008.06.003; Wohri AB, 2009, BIOCHEMISTRY-US, V48, P9831, DOI 10.1021/bi900545e; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396	35	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24488	10.1371/journal.pone.0024488	http://dx.doi.org/10.1371/journal.pone.0024488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909395	gold, Green Published, Green Submitted			2022-12-25	WOS:000294680800092
J	Ricarte, F; Menjivar, R; Chhun, S; Soreta, T; Oliveira, L; Hsueh, T; Serranilla, M; Gharakhanian, E				Ricarte, Florante; Menjivar, Rosa; Chhun, Surya; Soreta, Tattika; Oliveira, Lisa; Hsueh, Teli; Serranilla, Maribeth; Gharakhanian, Editte			A Genome-Wide Immunodetection Screen in S. cerevisiae Uncovers Novel Genes Involved in Lysosomal Vacuole Function and Morphology	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; RIBOSOMAL-PROTEINS; MEMBRANE-PROTEINS; GLOBAL ANALYSIS; DOWN-REGULATION; LATE ENDOSOMES; YEAST VACUOLE; LATE GOLGI; MUTANTS; FUSION	Vacuoles of yeast Saccharomyces cerevisiae are functionally analogous to mammalian lysosomes. Both are cellular organelles responsible for macromolecular degradation, ion/pH homeostasis, and stress survival. We hypothesized that undefined gene functions remain at post-endosomal stage of vacuolar events and performed a genome-wide screen directed at such functions at the late endosome and vacuole interface - ENV genes. The immunodetection screen was designed to identify mutants that internally accumulate precursor form of the vacuolar hydrolase carboxypeptidase Y (CPY). Here, we report the uncovering and initial characterizations of twelve ENV genes. The small size of the collection and the lack of genes previously identified with vacuolar events are suggestive of the intended exclusive functional interface of the screen. Most notably, the collection includes four novel genes ENV7, ENV9, ENV10, and ENV11, and three genes previously linked to mitochondrial processes -MAM3, PCP1, PPE1. In all env mutants, vesicular trafficking stages were undisturbed in live cells as assessed by invertase and active alpha-factor secretion, as well as by localization of the endocytic fluorescent marker FM4-64 to the vacuole. Several mutants exhibit defects in stress survival functions associated with vacuoles. Confocal fluorescence microscopy revealed the collection to be significantly enriched in vacuolar morphologies suggestive of fusion and fission defects. These include the unique phenotype of lumenal vesicles within vacuoles in the novel env9 Delta mutant and severely fragmented vacuoles upon deletion of GET4, a gene recently implicated in tail anchored membrane protein insertion. Thus, our results establish new gene functions in vacuolar function and morphology, and suggest a link between vacuolar and mitochondrial events.	[Ricarte, Florante; Menjivar, Rosa; Chhun, Surya; Soreta, Tattika; Oliveira, Lisa; Hsueh, Teli; Serranilla, Maribeth; Gharakhanian, Editte] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA	California State University System; California State University Long Beach	Ricarte, F (corresponding author), Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA.	eghara@csulb.edu			National Institutes of Health [1R15GM085794-01A1]; National Science Foundation Research in Undergraduate Institutions (NSF-RUI) [0843569]; NSF [0722757]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM085794, R25GM086262] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Research in Undergraduate Institutions (NSF-RUI)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health Academic Research Enhancement Award (NIH-AREA) (1R15GM085794-01A1), a National Science Foundation Research in Undergraduate Institutions (NSF-RUI) grant (0843569), and an NSF Major Research Instrumentation (MRI) Program grant (0722757) to EG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; BANKAITIS VA, 1986, P NATL ACAD SCI USA, V83, P9075, DOI 10.1073/pnas.83.23.9075; Banuelos MG, 2010, CURR GENET, V56, P121, DOI 10.1007/s00294-009-0285-3; Belyaeva OV, 2005, BIOCHEMISTRY-US, V44, P7035, DOI 10.1021/bi050226k; Berson AE, 1999, BIOCHEM BIOPH RES CO, V259, P533, DOI 10.1006/bbrc.1999.0811; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Bright NA, 1997, J CELL SCI, V110, P2027; Broach JR, 1991, CURR OPIN GENET DEV, V1, P370, DOI 10.1016/S0959-437X(05)80302-8; Bryant NJ, 1998, J CELL BIOL, V142, P651, DOI 10.1083/jcb.142.3.651; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486; Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; Flinn RJ, 2010, CELL CYCLE, V9, P1869, DOI 10.4161/cc.9.10.11679; Fratti RA, 2007, J BIOL CHEM, V282, P13133, DOI 10.1074/jbc.M700584200; FULLER RS, 1988, ANNU REV PHYSIOL, V50, P345, DOI 10.1146/annurev.ph.50.030188.002021; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Gan X, 2002, EUR J BIOCHEM, V269, P5203, DOI 10.1046/j.1432-1033.2002.03226.x; Gharakhanian E, 2011, MOL CELL BIOCHEM, V346, P187, DOI 10.1007/s11010-010-0604-5; GRAHAM TR, 1991, J CELL BIOL, V114, P207, DOI 10.1083/jcb.114.2.207; Guo J, 2006, EMBO REP, V7, P1124, DOI 10.1038/sj.embor.7400813; Gustavsson M, 2008, MOL GENET GENOMICS, V280, P233, DOI 10.1007/s00438-008-0359-9; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hall MN, 2010, ENZYMES STRUCTURE FU; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; HORAZDOVSKY BF, 1995, CURR OPIN CELL BIOL, V7, P544, DOI 10.1016/0955-0674(95)80012-3; Huang J, 2007, CELL CYCLE, V6, P1837, DOI 10.4161/cc.6.15.4511; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jensen LT, 2009, MOL BIOL CELL, V20, P2810, DOI 10.1091/mbc.E08-10-1084; JOHNSON LM, 1987, CELL, V48, P875, DOI 10.1016/0092-8674(87)90084-5; JONES EW, 1977, GENETICS, V85, P23; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; JULIUS D, 1984, CELL, V36, P309, DOI 10.1016/0092-8674(84)90224-1; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Lecompte O, 2002, NUCLEIC ACIDS RES, V30, P5382, DOI 10.1093/nar/gkf693; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Ligos JM, 1998, BIOCHEM BIOPH RES CO, V249, P380, DOI 10.1006/bbrc.1998.9163; Liu XF, 1997, J BIOL CHEM, V272, P11763, DOI 10.1074/jbc.272.18.11763; Lussier M, 1997, GENETICS, V147, P435; Luzio JP, 2007, BIOCHEM SOC T, V35, P1088, DOI 10.1042/BST0351088; Luzio JP, 2005, BIOCHEM SOC SYMP, V72, P77, DOI 10.1042/bss0720077; Luzio JP, 2003, MOL MEMBR BIOL, V20, P141, DOI 10.1080/0968768031000089546; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mijaljica D, 2007, AUTOPHAGY, V3, P417, DOI 10.4161/auto.4441; Mullins C, 2001, BIOESSAYS, V23, P333, DOI 10.1002/bies.1048; Neufeld TP, 2010, CELL CYCLE, V9, P3146, DOI 10.4161/cc.9.16.12781; NOTHWEHR SF, 1994, J BIOL CHEM, V269, P10185; Ostrowicz CW, 2008, AUTOPHAGY, V4, P5, DOI 10.4161/auto.5054; Pathak R, 2004, EUKARYOT CELL, V3, P1627, DOI 10.1128/EC.3.6.1627-1638.2004; Pelham HRB, 2002, CURR OPIN CELL BIOL, V14, P454, DOI 10.1016/S0955-0674(02)00352-6; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Planta RJ, 1998, YEAST, V14, P471, DOI 10.1002/(SICI)1097-0061(19980330)14:5<471::AID-YEA241>3.0.CO;2-U; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; ROBERTS CJ, 1992, J CELL BIOL, V119, P69, DOI 10.1083/jcb.119.1.69; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Santos B, 2000, MOL BIOL CELL, V11, P435, DOI 10.1091/mbc.11.2.435; Schluter C, 2008, MOL BIOL CELL, V19, P1282, DOI 10.1091/mbc.E07-07-0659; Sesaki H, 2003, BIOCHEM BIOPH RES CO, V308, P276, DOI 10.1016/S0006-291X(03)01348-2; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SIKORSKI RS, 1989, GENETICS, V122, P19; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007; Stairs DB, 1998, HUM MOL GENET, V7, P2157, DOI 10.1093/hmg/7.13.2157; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Sturgill TW, 2008, EUKARYOT CELL, V7, P1819, DOI 10.1128/EC.00088-08; Sullivan JA, 2007, MOL BIOL CELL, V18, P2429, DOI 10.1091/mbc.e07-01-0011; Takahashi MK, 2008, MOL CELL BIOCHEM, V311, P121, DOI 10.1007/s11010-008-9703-y; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WADA Y, 1992, J BIOL CHEM, V267, P18671; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Westfall PJ, 2004, SCIENCE, V306, P1511, DOI 10.1126/science.1104879; Wickner W, 2002, EMBO J, V21, P1241, DOI 10.1093/emboj/21.6.1241; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Yang M, 2005, BIOCHEM J, V386, P479, DOI 10.1042/BJ20041582	87	17	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e23696	10.1371/journal.pone.0023696	http://dx.doi.org/10.1371/journal.pone.0023696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912603	Green Submitted, Green Published, gold			2022-12-25	WOS:000294678300006
J	Zhang, YF; Xiao, K; Chandramouli, KH; Xu, Y; Pan, K; Wang, WX; Qian, PY				Zhang, Yi-Fan; Xiao, Kang; Chandramouli, Kondethimmanahalli H.; Xu, Ying; Pan, Ke; Wang, Wen-Xiong; Qian, Pei-Yuan			Acute Toxicity of the Antifouling Compound Butenolide in Non-Target Organisms	PLOS ONE			English	Article							MITOCHONDRIAL APOPTOSIS; BCL-2; ZEBRAFISH; GROWTH; PROTEASOMES; INHIBITION; ACTIVATION; SURVIVAL; CHANNEL; DEATH	Butenolide [5-octylfuran-2(5H)-one] is a recently discovered and very promising anti-marine-fouling compound. In this study, the acute toxicity of butenolide was assessed in several non-target organisms, including micro algae, crustaceans, and fish. Results were compared with previously reported results on the effective concentrations used on fouling (target) organisms. According to OECD's guideline, the predicted no effect concentration (PNEC) was 0.168 mu g l(-1), which was among one of the highest in representative new biocides. Mechanistically, the phenotype of butenolide-treated Danio rerio (zebrafish) embryos was similar to the phenotype of the pro-caspase-3 over-expression mutant with pericardial edema, small eyes, small brains, and increased numbers of apoptotic cells in the bodies of zebrafish embryos. Butenolide also induced apoptosis in HeLa cells, with the activation of c-Jun N-terminal kinases (JNK), Bcl-2 family proteins, and caspases and proteasomes/lysosomes involved in this process. This is the first detailed toxicity and toxicology study on this antifouling compound.	[Zhang, Yi-Fan; Xiao, Kang; Chandramouli, Kondethimmanahalli H.; Xu, Ying; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Collaborat Res Program, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Zhang, YF (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Collaborat Res Program, Hong Kong, Hong Kong, Peoples R China.	boqianpy@ust.hk	Zhang, Yifan/O-9621-2015; Wang, Wen-Xiong/E-7254-2011; Xu, Ying/E-2072-2018	Zhang, Yifan/0000-0002-0629-0200; Wang, Wen-Xiong/0000-0001-9033-0158; Xu, Ying/0000-0003-4658-3283; Qian, Pei-Yuan/0000-0003-4074-9078; Xiao, Kang/0000-0002-7666-2460; Chandramouli, Kondethimmanahalli/0000-0002-0104-1993	King Abdullah University of Science and Technology [SA-C0040/UK-C0016]; Research Grants Council of HKSAR [N_HKUST602/09, AoE/P-04/04-2-II]	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Research Grants Council of HKSAR(Hong Kong Research Grants Council)	This work was supported by an award [SA-C0040/UK-C0016] from the King Abdullah University of Science and Technology (http://www.kaust.edu.sa/) and grants from the Research Grants Council of HKSAR (http://www.ugc.edu.hk/eng/rgc/index.htm) [N_HKUST602/09, AoE/P-04/04-2-II] to PY Qian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antizar-Ladislao B, 2008, ENVIRON INT, V34, P292, DOI 10.1016/j.envint.2007.09.005; Bao VWW, 2011, MAR POLLUT BULL, V62, P1147, DOI 10.1016/j.marpolbul.2011.02.041; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Ceruti S, 2003, MOL PHARMACOL, V63, P1437, DOI 10.1124/mol.63.6.1437; Chambers LD, 2006, SURF COAT TECH, V201, P3642, DOI 10.1016/j.surfcoat.2006.08.129; Choi RCY, 2010, J ALZHEIMERS DIS, V19, P795, DOI 10.3233/JAD-2010-1293; DAVIES PE, 1994, ENVIRON TOXICOL CHEM, V13, P1341, DOI 10.1897/1552-8618(1994)13[1341:SRTPOS]2.0.CO;2; Dejean LM, 2006, BBA-MOL BASIS DIS, V1762, P191, DOI 10.1016/j.bbadis.2005.07.002; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Geis SW, 2000, ENVIRON TOXICOL CHEM, V19, P36, DOI 10.1002/etc.5620190105; Genovese T, 2007, SHOCK, V27, P258, DOI 10.1097/01.shk.0000239775.41022.54; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Kiernan JA., HISTOLOGICAL HISTOCH, VSecond; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li G, 2002, P NATL ACAD SCI USA, V99, P13254, DOI 10.1073/pnas.202355799; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; Miloso M, 2008, CURR MED CHEM, V15, P538, DOI 10.2174/092986708783769731; Ming L, 2006, J BIOL CHEM, V281, P16034, DOI 10.1074/jbc.M513587200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; OECD, 2004, SECT 2 EFF BIOT SYST; Pimentel-Elardo SM, 2010, MAR DRUGS, V8, P373, DOI 10.3390/md8020373; Sachidanandan C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001947; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Thiyagarajan V, 2003, J MAR BIOL ASSOC UK, V83, P83, DOI 10.1017/S0025315403006830h; THOMAS WD, 1970, WEED CONTROL, P27; Tind T, 2009, PEST MANAG SCI, V65, P1257, DOI 10.1002/ps.1819; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; Turk B, 2007, FEBS LETT, V581, P2761, DOI 10.1016/j.febslet.2007.05.038; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Xu Y, 2010, BIORESOURCE TECHNOL, V101, P1331, DOI 10.1016/j.biortech.2009.09.046; Yamada Hisashi, 2007, Bulletin of Fisheries Research Agency, P31; Yamashita M, 2008, J EXP BIOL, V211, P1874, DOI 10.1242/jeb.012690; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yebra DM, 2004, PROG ORG COAT, V50, P75, DOI 10.1016/j.porgcoat.2003.06.001; Yoshikawa E, 2007, RES RISK ASSESSMENT, P107; Zhang YF, 2011, BIOFOULING, V27, P467, DOI 10.1080/08927014.2011.583985; Zhang Y, 2010, J PROTEOME RES, V9, P3146, DOI 10.1021/pr1000384	38	23	25	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23803	10.1371/journal.pone.0023803	http://dx.doi.org/10.1371/journal.pone.0023803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897857	Green Published, gold, Green Submitted			2022-12-25	WOS:000294676900020
J	Barkhuff, WD; Gilk, SD; Whitmarsh, R; Tilley, LD; Hunter, C; Ward, GE				Barkhuff, Whittney Dotzler; Gilk, Stacey D.; Whitmarsh, Ryan; Tilley, Lucas D.; Hunter, Chris; Ward, Gary E.			Targeted Disruption of TgPhIL1 in Toxoplasma gondii Results in Altered Parasite Morphology and Fitness	PLOS ONE			English	Article							GLIDING MOTILITY; CELL INVASION; PROTEIN; IDENTIFICATION; CYTOSKELETON; GLIDEOSOME; COMPONENT; PELLICLE; MORPHOGENESIS; INFECTIVITY	The inner membrane complex (IMC), a series of flattened vesicles at the periphery of apicomplexan parasites, is thought to be important for parasite shape, motility and replication, but few of the IMC proteins that function in these processes have been identified. TgPhIL1, a Toxoplasma gondii protein that was previously identified through photosensitized labeling with 5-[I-125] iodonapthaline-1-azide, associates with the IMC and/or underlying cytoskeleton and is concentrated at the apical end of the parasite. Orthologs of TgPhIL1 are found in other apicomplexans, but the function of this conserved protein family is unknown. As a first step towards determining the function of TgPhIL1 and its orthologs, we generated a T. gondii parasite line in which the single copy of TgPhIL1 was disrupted by homologous recombination. The TgPhIL1 knockout parasites have a distinctly different morphology than wild-type parasites, and normal shape is restored in the knockout background after complementation with the wild-type allele. The knockout parasites are outcompeted in culture by parasites expressing functional TgPhIL1, and they generate a reduced parasite load in the spleen and liver of infected mice. These findings demonstrate a role for TgPhIL1 in the morphology, growth and fitness of T. gondii tachyzoites.	[Barkhuff, Whittney Dotzler; Gilk, Stacey D.; Tilley, Lucas D.; Ward, Gary E.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Whitmarsh, Ryan; Hunter, Chris] Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Vermont; University of Pennsylvania	Barkhuff, WD (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.	Gary.Ward@uvm.edu	Hunter, Christopher/H-1970-2011	Ward, Gary/0000-0003-4138-3055	National Institutes of Health [AI01719, AI42334]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI001719, R01AI042334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI01719 (GEW) and AI42334 (CH), www.nih.gov. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-White BR, 2011, CELL MICROBIOL, V13, P18, DOI 10.1111/j.1462-5822.2010.01514.x; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Brossier F, 2008, EUKARYOT CELL, V7, P664, DOI 10.1128/EC.00331-07; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; DUBREMETZ JF, 1979, CR ACAD SCI D NAT, V288, P623; DUBREMETZ JF, 1978, J ULTRA MOL STRUCT R, V62, P94, DOI 10.1016/S0022-5320(78)90012-6; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Frixione E, 1996, CELL MOTIL CYTOSKEL, V34, P152, DOI 10.1002/(SICI)1097-0169(1996)34:2&lt;152::AID-CM6&gt;3.0.CO;2-D; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gilbert LA, 2007, EUKARYOT CELL, V6, P73, DOI 10.1128/EC.00309-06; Gilk SD, 2006, EUKARYOT CELL, V5, P1622, DOI 10.1128/EC.00114-06; Grigg ME, 2001, J CLIN MICROBIOL, V39, P398, DOI 10.1128/JCM.39.1.398-400.2001; Gubbels MJ, 2006, J CELL SCI, V119, P2236, DOI 10.1242/jcs.02949; Gubbels MJ, 2004, MOL BIOCHEM PARASIT, V137, P99, DOI 10.1016/j.molbiopara.2004.05.007; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; Hu K, 2002, J CELL BIOL, V156, P1039, DOI 10.1083/jcb.200112086; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Khater EI, 2004, J CELL BIOL, V167, P425, DOI 10.1083/jcb.200406068; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Mann T, 2002, J BIOL CHEM, V277, P41240, DOI 10.1074/jbc.M205056200; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; MESSINA M, 1995, GENE, V165, P213, DOI 10.1016/0378-1119(95)00548-K; Milloning G., 1961, J APPL PHYS, V32, P1637; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; Mital J, 2006, CYTOM PART A, V69A, P13, DOI 10.1002/cyto.a.20202; Mital Jeffrey, 2008, V47, P1; Mondragon R, 1996, J EUKARYOT MICROBIOL, V43, P120, DOI 10.1111/j.1550-7408.1996.tb04491.x; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; NICHOLS BA, 1987, J PROTOZOOL, V34, P217, DOI 10.1111/j.1550-7408.1987.tb03162.x; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Santos JM, 2009, INT J PARASITOL, V39, P153, DOI 10.1016/j.ijpara.2008.10.007; Savage DF, 2007, J MOL BIOL, V368, P607, DOI 10.1016/j.jmb.2007.02.070; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Tremp AZ, 2008, J BIOL CHEM, V283, P27604, DOI 10.1074/jbc.M801302200; Turetzky JM, 2010, INT J PARASITOL, V40, P1037, DOI 10.1016/j.ijpara.2010.02.014; Ward GE, 1999, J IMMUNOL METHODS, V230, P11, DOI 10.1016/S0022-1759(99)00109-X; Wichroski MJ, 2002, INFECT IMMUN, V70, P4353, DOI 10.1128/IAI.70.8.4353-4361.2002	42	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23977	10.1371/journal.pone.0023977	http://dx.doi.org/10.1371/journal.pone.0023977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901148	Green Submitted, Green Published, gold			2022-12-25	WOS:000294298000033
J	Huang, HL; Wu, JL; Chen, MHC; Hong, JR				Huang, Hui Ling; Wu, Jen Leih; Chen, Mark Hung Chih; Hong, Jiann Ruey			Aquatic Birnavirus-Induced ER Stress-Mediated Death Signaling Contribute to Downregulation of Bcl-2 Family Proteins in Salmon Embryo Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PANCREATIC NECROSIS VIRUS; HEPATITIS-C VIRUS; NF-KAPPA-B; TRANSLATIONAL CONTROL; RESIDENT KINASE; VIRAL PROTEIN; APOPTOSIS; INFECTION; EXPRESSION	Aquatic birnavirus induces mitochondria-mediated cell death, but whether connects to endoplasmic reticulum (ER) stress is still unknown. In this present, we characterized that IPNV infection triggers ER stress-mediated cell death via PKR/eIF2 alpha phosphorylation signaling for regulating the Bcl-2 family protein expression in fish cells. The IPNV infection can induce ER stress as follows: (1) ER stress sensor ATF6 cleavaged; (2) ER stress marker GRP78 upregulation, and (3) PERK/eIF2 alpha phosphorylation. Then, the IPNV-induced ER stress signals can induce the CHOP expression at early (6 h p.i.) and middle replication (12 h p.i.) stages. Moreover, IPNV-induced CHOP upregulation dramatically correlates to apparently downregulate the Bcl-2 family proteins, Bcl-2, Mcl-1 and Bcl-xL at middle replication stage (12 h p.i.) and produces mitochondria membrane potential (MMP) loss and cell death. Furthermore, with GRP78 synthesis inhibitor momitoxin (VT) and PKR inhibitor 2-aminopurine (2-AP) treatment for blocking GRP78 expression and eIF2 alpha phosphorylation, PKR/PERK may involve in eIF2 alpha phosphorylation/CHOP upregulation pathway that enhances the downstream regulators Bcl-2 family proteins expression and increased cell survival. Taken together, our results suggest that IPNV infection activates PKR/PERK/eIF2 alpha ER stress signals for regulating downstream molecules CHOP upregulation and Bcl-2 family downregulation that led to induce mitochondria-mediated cell death in fish cells, which may provide new insight into RNA virus pathogenesis and disease.	[Huang, Hui Ling; Hong, Jiann Ruey] Natl Cheng Kung Univ, Inst Biotechnol, Lab Mol Virol & Biotechnol, Tainan 70101, Taiwan; [Wu, Jen Leih] Acad Sinica, Inst Cellular & Organism Biol, Lab Marine Mol Biol & Biotechnol, Taipei 115, Taiwan; [Chen, Mark Hung Chih] Hungkuang Univ, Dept Biotechnol, Inst Biotechnol, Bioluminescence Life Image Lab, Taichung, Taiwan	National Cheng Kung University; Academia Sinica - Taiwan; Hungkuang University	Huang, HL (corresponding author), Natl Cheng Kung Univ, Inst Biotechnol, Lab Mol Virol & Biotechnol, Tainan 70101, Taiwan.	zohcchen@pchome.com.tw; jrhong@mail.ncku.edu.tw						Baltzis D, 2004, J VIROL, V78, P12747, DOI 10.1128/JVI.78.23.12747-12761.2004; Bitko V, 2001, J CELL BIOCHEM, V80, P441, DOI 10.1002/1097-4644(20010301)80:3<441::AID-JCB170>3.0.CO;2-C; Chen PC, 2010, FISH SHELLFISH IMMUN, V28, P344, DOI 10.1016/j.fsi.2009.11.014; Chen SP, 2006, VIROLOGY, V347, P379, DOI 10.1016/j.virol.2005.11.052; Cheng GF, 2005, J VIROL, V79, P1379, DOI 10.1128/JVI.79.3.1379-1388.2005; Chiu CL, 2010, APOPTOSIS, V15, P653, DOI 10.1007/s10495-010-0468-x; DELMAS B, 2005, VIRUS TAXONOMY, P561; Dimcheff DE, 2004, J BIOL CHEM, V279, P33782, DOI 10.1074/jbc.M403304200; DOBOS P, 1977, J VIROL, V21, P242, DOI 10.1128/JVI.21.1.242-258.1977; Dobos Peter, 1995, Annual Review of Fish Diseases, V5, P25, DOI 10.1016/0959-8030(95)00003-8; Garner JN, 2003, DEV COMP IMMUNOL, V27, P217, DOI 10.1016/S0145-305X(02)00096-4; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Hong JR, 2008, J FISH DIS, V31, P451, DOI 10.1111/j.1365-2761.2008.00928.x; Hong JiannRuey, 2002, Current Topics in Virology, V2, P151; Hong JR, 2005, J FISH DIS, V28, P133, DOI 10.1111/j.1365-2761.2004.00604.x; Hong JR, 1998, VIROLOGY, V250, P76, DOI 10.1006/viro.1998.9347; Hong JR, 2002, CELL DEATH DIFFER, V9, P113, DOI 10.1038/sj/cdd/4400933; Hong JR, 2002, VIROLOGY, V295, P217, DOI 10.1006/viro.2001.1336; Hong JR, 1999, J VIROL, V73, P5056, DOI 10.1128/JVI.73.6.5056-5063.1999; Hong JR, 1999, VIRUS RES, V63, P75, DOI 10.1016/S0168-1702(99)00060-X; Hwang HJ, 2007, J VIROL, V81, P13816, DOI 10.1128/JVI.02822-06; Isler JA, 2005, J VIROL, V79, P6890, DOI 10.1128/JVI.79.11.6890-6899.2005; Jordan R, 2002, J VIROL, V76, P9588, DOI 10.1128/JVI.76.19.9588-9599.2002; KAIN SR, 1994, BIOTECHNIQUES, V17, P982; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Khatri M, 2006, VIRUS RES, V118, P70, DOI 10.1016/j.virusres.2005.11.015; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li XD, 2005, VIROLOGY, V333, P180, DOI 10.1016/j.virol.2005.01.002; Liu MH, 2006, J VIROL, V80, P3369, DOI 10.1128/JVI.80.7.3369-3377.2006; Madesh M, 2002, J BIOL CHEM, V277, P5651, DOI 10.1074/jbc.M108171200; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Netherton CL, 2004, J VIROL, V78, P10825, DOI 10.1128/JVI.78.19.10825-10828.2004; Newton K, 1998, CURR OPIN GENET DEV, V8, P68, DOI 10.1016/S0959-437X(98)80064-6; NICHOLSON BL, 1974, J VIROL, V14, P180, DOI 10.1128/JVI.14.1.180-182.1974; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Su YC, 2011, APOPTOSIS, V16, P272, DOI 10.1007/s10495-010-0565-x; Sun M, 2004, J VIROL, V78, P5068, DOI 10.1128/JVI.78.10.5068-5078.2004; Szegezdi E, 2003, ANN NY ACAD SCI, V1010, P186, DOI 10.1196/annals.1299.032; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002; Tirosh B, 2005, J VIROL, V79, P2768, DOI 10.1128/JVI.79.5.2768-2779.2005; Wang XD, 2001, GENE DEV, V15, P2922; WEK RC, 1994, TRENDS BIOCHEM SCI, V19, P491, DOI 10.1016/0968-0004(94)90136-8; Wu HC, 2008, FISH SHELLFISH IMMUN, V24, P436, DOI 10.1016/j.fsi.2008.01.001; WU J, 1989, B I ZOOL ACAD SINICA, V26, P201; Wu JL, 1998, J FISH DIS, V21, P215, DOI [10.1111/j.1365-2761.1998.00097.x, 10.1046/j.1365-2761.1998.00097.x]; Yang GH, 2000, TOXICOL APPL PHARM, V162, P207, DOI 10.1006/taap.1999.8842; Yeh TC, 2007, BIOCHEM PHARMACOL, V73, P782, DOI 10.1016/j.bcp.2006.11.027; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	57	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e22935	10.1371/journal.pone.0022935	http://dx.doi.org/10.1371/journal.pone.0022935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901118	Green Submitted, Green Published, gold			2022-12-25	WOS:000294298000003
J	Hult, EF; Tobe, SS; Chang, BSW				Hult, Ekaterina F.; Tobe, Stephen S.; Chang, Belinda S. W.			Molecular Evolution of Ultraspiracle Protein (USP/RXR) in Insects	PLOS ONE			English	Article							LIGAND-BINDING DOMAIN; RETINOID-X-RECEPTOR; DETECTING POSITIVE SELECTION; DROSOPHILA ECDYSONE-RECEPTOR; CODON-SUBSTITUTION MODELS; CELL CLUSTER FORMATION; AMINO-ACID SITES; NUCLEAR RECEPTOR; CRYSTAL-STRUCTURE; JUVENILE-HORMONE	Ultraspiracle protein/retinoid X receptor (USP/RXR) is a nuclear receptor and transcription factor which is an essential component of a heterodimeric receptor complex with the ecdysone receptor (EcR). In insects this complex binds ecdysteroids and plays an important role in the regulation of growth, development, metamorphosis and reproduction. In some holometabolous insects, including Lepidoptera and Diptera, USP/RXR is thought to have experienced several important shifts in function. These include the acquisition of novel ligand-binding properties and an expanded dimerization interface with EcR. In light of these recent hypotheses, we implemented codon-based likelihood methods to investigate if the proposed shifts in function are reflected in changes in site-specific evolutionary rates across functional and structural motifs in insect USP/RXR sequences, and if there is any evidence for positive selection at functionally important sites. Our results reveal evidence of positive selection acting on sites within the loop connecting helices H1 and H3, the ligand-binding pocket, and the dimer interface in the holometabolous lineage leading to the Lepidoptera/Diptera/Trichoptera. Similar analyses conducted using EcR sequences did not indicate positive selection. However, analyses allowing for variation across sites demonstrated elevated non-synonymous/synonymous rate ratios (d(N)/d(S)), suggesting relaxed constraint, within the dimerization interface of both USP/RXR and EcR as well as within the coactivator binding groove and helix H12 of USP/RXR. Since the above methods are based on the assumption that d(S) is constant among sites, we also used more recent models which relax this assumption and obtained results consistent with traditional random-sites models. Overall our findings support the evolution of novel function in USP/RXR of more derived holometabolous insects, and are consistent with shifts in structure and function which may have increased USP/RXR reliance on EcR for cofactor recruitment. Moreover, these findings raise important questions regarding hypotheses which suggest the independent activation of USP/RXR by its own ligand.	[Hult, Ekaterina F.; Tobe, Stephen S.; Chang, Belinda S. W.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Chang, Belinda S. W.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Chang, Belinda S. W.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Hult, EF (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	belinda.chang@utoronto.ca	Tobe, Stephen S./A-1445-2008		Natural Sciences and Engineering Council of Canada (NSERC)	Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by Natural Sciences and Engineering Council of Canada (NSERC) Discovery grants (SST and BSWC) and an Early Researcher Award to BSWC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Ponce D, 2009, GENOME RES, V19, P234, DOI 10.1101/gr.084038.108; Baker KD, 2003, CELL, V113, P731, DOI 10.1016/S0092-8674(03)00420-3; Barchuk AR, 2008, J INSECT PHYSIOL, V54, P1035, DOI 10.1016/j.jinsphys.2008.04.006; Bernardi F, 2009, DEV BIOL, V328, P541, DOI 10.1016/j.ydbio.2009.01.013; Billas IML, 2003, NATURE, V426, P91, DOI 10.1038/nature02112; Billas IML, 2001, J BIOL CHEM, V276, P7465, DOI 10.1074/jbc.M008926200; Bonneton F, 2006, INSECT MOL BIOL, V15, P351, DOI 10.1111/j.1365-2583.2006.00654.x; Bonneton F, 2003, MOL BIOL EVOL, V20, P541, DOI 10.1093/molbev/msg054; Bonneton F, 2008, INSECT BIOCHEM MOLEC, V38, P416, DOI 10.1016/j.ibmb.2007.10.006; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brothers DJ, 1999, ZOOL SCR, V28, P233, DOI 10.1046/j.1463-6409.1999.00003.x; Bulmer MS, 2006, MOL BIOL EVOL, V23, P317, DOI 10.1093/molbev/msj037; BUNING J, 1993, INT J INSECT MORPHOL, V22, P237, DOI 10.1016/0020-7322(93)90013-Q; Carmichael JA, 2005, J BIOL CHEM, V280, P22258, DOI 10.1074/jbc.M500661200; Carney GE, 2000, GENETICS, V154, P1203; Castro LR, 2005, MOL PHYLOGENET EVOL, V34, P469, DOI 10.1016/j.ympev.2004.11.005; Chen CY, 2008, MOL PHYLOGENET EVOL, V47, P637, DOI 10.1016/j.ympev.2007.12.026; Clayton GM, 2001, P NATL ACAD SCI USA, V98, P1549, DOI 10.1073/pnas.041611298; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Fang F, 2005, FEBS J, V272, P1577, DOI 10.1111/j.1742-4658.2005.04578.x; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gao TP, 2009, ANN ENTOMOL SOC AM, V102, P588, DOI 10.1603/008.102.0402; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall BL, 1998, DEVELOPMENT, V125, P4709; Hayward DC, 1999, DEV GENES EVOL, V209, P564, DOI 10.1007/s004270050290; Hayward DC, 2003, J INSECT PHYSIOL, V49, P1135, DOI 10.1016/j.jinsphys.2003.08.007; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Hirai M, 2002, MOL CELL ENDOCRINOL, V189, P201, DOI 10.1016/S0303-7207(01)00604-9; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; HUEBNER E, 1975, TISSUE CELL, V7, P535, DOI 10.1016/0040-8166(75)90025-7; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Irles P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-206; Iwema T, 2007, EMBO J, V26, P3770, DOI 10.1038/sj.emboj.7601810; Iwema T, 2009, MOL BIOL EVOL, V26, P753, DOI 10.1093/molbev/msn302; Jones G, 1997, P NATL ACAD SCI USA, V94, P13499, DOI 10.1073/pnas.94.25.13499; Jones G, 2006, FEBS J, V273, P4983, DOI 10.1111/j.1742-4658.2006.05498.x; Kelleher ES, 2009, GENETICS, V181, P1451, DOI 10.1534/genetics.108.099044; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kristensen NP, 1999, EUR J ENTOMOL, V96, P237; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; Li YP, 2007, J BIOL CHEM, V282, P37605, DOI 10.1074/jbc.M704595200; Maestro O, 2005, MOL CELL ENDOCRINOL, V238, P27, DOI 10.1016/j.mce.2005.04.004; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Martin D, 2006, J INSECT PHYSIOL, V52, P410, DOI 10.1016/j.jinsphys.2005.12.002; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Nielsen R, 1998, GENETICS, V148, P929; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Nowickyj SM, 2008, P NATL ACAD SCI USA, V105, P9540, DOI 10.1073/pnas.0712132105; Nozawa M, 2009, P NATL ACAD SCI USA, V106, P6700, DOI 10.1073/pnas.0901855106; ORO AE, 1990, NATURE, V347, P298, DOI 10.1038/347298a0; ORO AE, 1992, DEVELOPMENT, V115, P449; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Raikhel A.S., 2005, P433; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHARP PM, 1995, PHILOS T R SOC B, V349, P241, DOI 10.1098/rstb.1995.0108; Smadja C, 2009, MOL BIOL EVOL, V26, P2073, DOI 10.1093/molbev/msp116; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan A, 2008, MOL CELL ENDOCRINOL, V291, P42, DOI 10.1016/j.mce.2008.05.006; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tocchini-Valentini GD, 2009, J BIOL CHEM, V284, P1938, DOI 10.1074/jbc.M805692200; Trauner J, 2007, DEV GENES EVOL, V217, P13, DOI 10.1007/s00427-006-0114-3; VALLE D, 1993, MEM I OSWALDO CRUZ, V88, P1, DOI 10.1590/S0074-02761993000100005; Wang SF, 2000, MOL CELL BIOL, V20, P3870, DOI 10.1128/MCB.20.11.3870-3879.2000; Weller SJ, 1992, MOL PHYLOGENET EVOL, V1, P312, DOI 10.1016/1055-7903(92)90007-4; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1006/clad.2000.0147, 10.1111/j.1096-0031.2001.tb00115.x]; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1; Wiens M, 2003, J EXP BIOL, V206, P3261, DOI 10.1242/jeb.00541; Wozniak M, 2004, INSECT BIOCHEM MOLEC, V34, P1147, DOI 10.1016/j.ibmb.2004.07.006; Wu DD, 2009, MOL BIOL EVOL, V26, P2333, DOI 10.1093/molbev/msp139; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Xu JJ, 2010, J INSECT PHYSIOL, V56, P1471, DOI 10.1016/j.jinsphys.2010.04.004; Xu Y, 2002, EUR J BIOCHEM, V269, P6026, DOI 10.1046/j.1432-1033.2002.03293.x; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Yang ZH, 2009, P NATL ACAD SCI USA, V106, pE95, DOI 10.1073/pnas.0904550106; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Yeates DK, 1999, ANNU REV ENTOMOL, V44, P397, DOI 10.1146/annurev.ento.44.1.397; Zhu JS, 2003, P NATL ACAD SCI USA, V100, P13338, DOI 10.1073/pnas.2234416100; Zhu JS, 2003, P NATL ACAD SCI USA, V100, P544, DOI 10.1073/pnas.0235695100	93	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23416	10.1371/journal.pone.0023416	http://dx.doi.org/10.1371/journal.pone.0023416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901121	Green Submitted, Green Published, gold			2022-12-25	WOS:000294298000006
J	Irvin, MR; Wineinger, NE; Rice, TK; Pajewski, NM; Kabagambe, EK; Gu, CC; Pankow, J; North, KE; Wilk, JB; Freedman, BI; Franceschini, N; Broeckel, U; Tiwari, HK; Arnett, DK				Irvin, Marguerite R.; Wineinger, Nathan E.; Rice, Treva K.; Pajewski, Nicholas M.; Kabagambe, Edmond K.; Gu, Charles C.; Pankow, Jim; North, Kari E.; Wilk, Jemma B.; Freedman, Barry I.; Franceschini, Nora; Broeckel, Uli; Tiwari, Hemant K.; Arnett, Donna K.			Genome-Wide Detection of Allele Specific Copy Number Variation Associated with Insulin Resistance in African Americans from the HyperGEN Study	PLOS ONE			English	Article							GLUCOSE-HOMEOSTASIS; DIABETES-MELLITUS; ADMIXTURE; MODEL; POLYMORPHISMS; POPULATIONS; MECHANISMS; THERAPIES; DISEASE; COMPLEX	African Americans have been understudied in genome wide association studies of diabetes and related traits. In the current study, we examined the joint association of single nucleotide polymorphisms (SNPs) and copy number variants (CNVs) with fasting insulin and an index of insulin resistance (HOMA-IR) in the HyperGEN study, a family based study with proband ascertainment for hypertension. This analysis is restricted to 1,040 African Americans without diabetes. We generated allele specific CNV genotypes at 872,243 autosomal loci using Birdsuite, a freely available multi-stage program. Joint tests of association for SNPs and CNVs were performed using linear mixed models adjusting for covariates and familial relationships. Our results highlight SNPs associated with fasting insulin and HOMA-IR (rs6576507 and rs8026527, 3.7*10(-7)<= P <= 1.1*10(-5)) near ATPase, class V, type 10A (ATP10A), and the L Type voltage dependent calcium channel (CACNA1D, rs1401492, P <= 5.2*10(-6)). ATP10A belongs to a family of aminophospholipid-transporting ATPases and has been associated with type 2 diabetes in mice. CACNA1D has been linked to pancreatic beta cell generation in mice. The two most significant copy variable markers (rs10277702 and rs361367; P<2.0*10(-4)) were in the beta variable region of the T-cell receptor gene (TCRVB). Human and mouse TCR has been shown to mimic insulin and its receptor and could contribute to insulin resistance. Our findings differ from genome wide association studies of fasting insulin and other diabetes related traits in European populations, highlighting the continued need to investigate unique genetic influences for understudied populations such as African Americans.	[Irvin, Marguerite R.; Kabagambe, Edmond K.; Arnett, Donna K.] Univ Alabama, Dept Epidemiol, Birmingham, AL 35294 USA; [Wineinger, Nathan E.; Tiwari, Hemant K.] Univ Alabama, Dept Biostat, Birmingham, AL 35294 USA; [Rice, Treva K.; Gu, Charles C.] Washington Univ, Div Biostat, St Louis, MO USA; [Pajewski, Nicholas M.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Pankow, Jim] Univ Minnesota, Dept Epidemiol, St Paul, MN 55108 USA; [North, Kari E.; Franceschini, Nora] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [North, Kari E.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Wilk, Jemma B.] Boston Univ, Dept Neurol, Boston, MA 02215 USA; [Freedman, Barry I.] Wake Forest Sch Med, Dept Internal Med Nephrol, Winston Salem, NC USA; [Broeckel, Uli] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Boston University; Wake Forest University; Medical College of Wisconsin	Irvin, MR (corresponding author), Univ Alabama, Dept Epidemiol, Birmingham, AL 35294 USA.	irvinr@uab.edu	Pajewski, Nicholas/J-1096-2019; Gu, C. Charles/A-7934-2010	Pankow, James/0000-0001-7076-483X; Gu, C. Charles/0000-0002-8527-8145; Rice, Treva/0000-0001-7452-2600	National Institutes of Health [T32NS054584, T32HL079888, NHLBI R01 HL55673]; NHLBI [HL54471, HL54515, HL54472, HL54496, HL54473, HL54495, HL54509]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL054472, U01HL054495, U01HL054509, U10HL054509, U10HL054515, U01HL054473, U01HL054471, U10HL054495, U10HL054473, U10HL054496, R01HL055673, T32HL079888, U10HL054471, U01HL054496, U10HL054472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS054584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by National Institutes of Health grants T32NS054584, T32HL079888 and NHLBI R01 HL55673 and cooperative agreements (U10) with NHLBI: HL54471, HL54515 (UT); HL54472, HL54496 (MN); HL54473 (DCC); HL54495 (AL); HL54509 (NC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; ALLAUZEN S, 1995, J IMMUNOL METHODS, V183, P27, DOI 10.1016/0022-1759(95)00020-B; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Brooks-Worrell B, 2011, CLIN CHEM, V57, P158, DOI 10.1373/clinchem.2010.148270; Centers for Disease Control and Prevention, 2008, NAT DIAB FACT SHEET; Chandalia M, 2007, J DIABETES COMPLICAT, V21, P143, DOI 10.1016/j.jdiacomp.2006.11.003; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Cooper-DeHoff RM, 2009, J AM COLL CARDIOL, V53, pS28, DOI 10.1016/j.jacc.2008.10.037; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Dai B., 2008, IME4 LINEAR MIXED EF; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Deng HW, 2001, GENETICS, V159, P1319; Dhar MS, 2004, J NUTR, V134, P799, DOI 10.1093/jn/134.4.799; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Dreja T, 2010, DIABETOLOGIA, V53, P309, DOI 10.1007/s00125-009-1576-4; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Elbein SC, 2007, CURR OPIN CLIN NUTR, V10, P415, DOI 10.1097/MCO.0b013e3281e2c99a; Elbein Steven C, 2009, J Diabetes Sci Technol, V3, P685; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Freedman BI, 2005, DIABETOLOGIA, V48, P661, DOI 10.1007/s00125-005-1679-5; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Halder Indrani, 2003, Human Genomics, V1, P52; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Hong KW, 2010, J HUM HYPERTENS, V24, P367, DOI 10.1038/jhh.2009.86; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Johnson JD, 2010, ADV EXP MED BIOL, V654, P447, DOI 10.1007/978-90-481-3271-3_19; Kent WJ, 2005, GENOME RES, V15, P737, DOI 10.1101/gr.3694705; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Koriyama H, 2010, J ATHEROSCLER THROMB, V17, P1054, DOI 10.5551/jat.4291; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; LAAKSO M, 1993, AM J EPIDEMIOL, V137, P959, DOI 10.1093/oxfordjournals.aje.a116768; Lambert CA, 2009, COLD SH Q B, V74, P395, DOI 10.1101/sqb.2009.74.053; Lewis JP, 2008, DIABETES, V57, P2220, DOI 10.2337/db07-1319; Maneka N, 2010, CURR OPIN LIPIDOL, V21, P44, DOI 10.1097/MOL.0b013e328334fdb6; Martinelli DC, 2007, CELL CYCLE, V6, P2650, DOI 10.4161/cc.6.21.4877; McCarroll SA, 2008, HUM MOL GENET, V17, pR135, DOI 10.1093/hmg/ddn282; Namkung Y, 2001, J CLIN INVEST, V108, P1015, DOI 10.1172/JCI13310; Neal J Matthew, 2008, Endocr Pract, V14, P1006; Palmer ND, 2008, DIABETES, V57, P1093, DOI 10.2337/db07-1169; Palmer ND, 2011, DIABETES, V60, P662, DOI 10.2337/db10-0134; Pevsner J, 2009, METHODS MOL BIOL, V537, P277, DOI 10.1007/978-1-59745-251-9_14; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Reimann M, 2007, HORM METAB RES, V39, P853, DOI 10.1055/s-2007-993152; Root-Bernstein R, 2009, J MOL RECOGNIT, V22, P177, DOI 10.1002/jmr.930; Salanti G, 2010, AM J EPIDEMIOL, V171, P1155, DOI 10.1093/aje/kwq059; Salanti G, 2009, AM J EPIDEMIOL, V170, P537, DOI 10.1093/aje/kwp145; Schwarz PEH, 2006, HORM METAB RES, V38, P460, DOI 10.1055/s-2006-947839; WATERS KM, 2010, PLOS GENET, P6; Williams RR, 2000, ANN EPIDEMIOL, V10, P389, DOI 10.1016/S1047-2797(00)00063-6; Zeno SA, 2010, METAB SYNDR RELAT D, V8, P149, DOI 10.1089/met.2009.0053; Zhang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014511; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	52	35	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e24052	10.1371/journal.pone.0024052	http://dx.doi.org/10.1371/journal.pone.0024052			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901158	Green Published, Green Submitted, gold			2022-12-25	WOS:000294298000043
J	Lemieux, ME; Cheng, ZM; Zhou, Q; White, R; Cornell, J; Kung, AL; Rebel, VI				Lemieux, Madeleine E.; Cheng, Ziming; Zhou, Qing; White, Ruth; Cornell, John; Kung, Andrew L.; Rebel, Vivienne I.			Inactivation of a Single Copy of Crebbp Selectively Alters Pre-mRNA Processing in Mouse Hematopoietic Stem Cells	PLOS ONE			English	Article							ADULT BONE-MARROW; BINDING-PROTEIN; GENE-EXPRESSION; SELF-RENEWAL; GLUCOCORTICOID-RECEPTOR; FETAL LIVER; TRANSCRIPTIONAL ACTIVATION; P300; DIFFERENTIATION; LEUKEMIA	Global expression analysis of fetal liver hematopoietic stem cells (FL HSCs) revealed the presence of unspliced pre-mRNA for a number of genes in normal FL HSCs. In a subset of these genes, Crebbp(+/-) FL HSCs had less unprocessed pre-mRNA without a corresponding reduction in total mRNA levels. Among the genes thus identified were the key regulators of HSC function Itga4, Msi2 and Tcf4. A similar but much weaker effect was apparent in Ep300(+/-) FL HSCs, indicating that, in this context as in others, the two paralogs are not interchangeable. As a group, the down-regulated intronic probe sets could discriminate adult HSCs from more mature cell types, suggesting that the underlying mechanism is regulated with differentiation stage and is active in both fetal and adult hematopoiesis. Consistent with increased myelopoiesis in Crebbp hemizygous mice, targeted reduction of CREBBP abundance by shRNA in the multipotent EML cell line triggered spontaneous myeloid differentiation in the absence of the normally required inductive signals. In addition, differences in protein levels between phenotypically distinct EML subpopulations were better predicted by taking into account not only the total mRNA signal but also the amount of unspliced message present. CREBBP thus appears to selectively influence the timing and degree of pre-mRNA processing of genes essential for HSC regulation and thereby has the potential to alter subsequent cell fate decisions in HSCs.	[Lemieux, Madeleine E.; Kung, Andrew L.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Lemieux, Madeleine E.; Rebel, Vivienne I.] Harvard Univ, Sch Med, Boston, MA USA; [Cheng, Ziming; Zhou, Qing; Rebel, Vivienne I.] Univ Texas Hlth Sci Ctr San Antonio, GCCRI, San Antonio, TX 78229 USA; [White, Ruth] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA; [Cornell, John] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Rebel, Vivienne I.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Texas System; University of Texas Health San Antonio; Oregon Health & Science University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Lemieux, ME (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	rebel@uthscsa.edu	Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020	Kung, Andrew L/0000-0002-9091-488X; Rebel, Vivienne/0000-0002-3862-3903; Lemieux, Madeleine/0000-0001-6355-8691	Greehey Children's Cancer Research Institute/University of Texas Health Science Center in San Antonio (UTHSCSA); National Cancer Institute-Cancer Center [2P30 CA054174-17]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER	Greehey Children's Cancer Research Institute/University of Texas Health Science Center in San Antonio (UTHSCSA); National Cancer Institute-Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported with funding from the Greehey Children's Cancer Research Institute/University of Texas Health Science Center in San Antonio (UTHSCSA) and a National Cancer Institute-Cancer Center Support Grant (2P30 CA054174-17) for the UTHSCSA Flow Cytometry Core. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almlof T, 1998, BIOCHEMISTRY-US, V37, P9586, DOI 10.1021/bi973029x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arroyo AG, 1999, IMMUNITY, V11, P555, DOI 10.1016/S1074-7613(00)80131-4; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Bex F, 1998, MOL CELL BIOL, V18, P2392, DOI 10.1128/MCB.18.4.2392; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Bowman TV, 2006, STEM CELLS, V24, P662, DOI 10.1634/stemcells.2005-0552; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Byun JS, 2009, P NATL ACAD SCI USA, V106, P19292, DOI 10.1073/pnas.0905469106; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chuck AS, 1996, HUM GENE THER, V7, P743, DOI 10.1089/hum.1996.7.6-743; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Finstad SL, 2007, J VIROL, V81, P7274, DOI 10.1128/JVI.00250-07; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Goodman RH, 2000, GENE DEV, V14, P1553; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hauses M, 1998, J BIOL CHEM, V273, P31844, DOI 10.1074/jbc.273.48.31844; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jiang X, 2004, J BIOL CHEM, V279, P38480, DOI 10.1074/jbc.M403948200; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Karlsson G, 2007, J EXP MED, V204, P467, DOI 10.1084/jem.20060465; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; Kung AL, 2000, GENE DEV, V14, P272; LANG KM, 1987, MOL CELL BIOL, V7, P3428, DOI 10.1128/MCB.7.10.3428; Liu Z, 1999, MOL CELL ENDOCRINOL, V153, P183, DOI 10.1016/S0303-7207(99)00036-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McManus KJ, 2006, PLOS COMPUT BIOL, V2, P1271, DOI 10.1371/journal.pcbi.0020139; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Nam DK, 2002, P NATL ACAD SCI USA, V99, P6152, DOI 10.1073/pnas.092140899; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Partanen M, 1999, INT J DEV BIOL, V43, P487; Piao Y, 2001, GENOME RES, V11, P1553, DOI 10.1101/gr.185501; Pritsker M, 2005, P NATL ACAD SCI USA, V102, P14290, DOI 10.1073/pnas.0502132102; R Development Core Team, 2009, R FDN STAT COMP; Ramos YF, NUCL ACIDS RES, V38, P5396; Rebel VI, 1996, BLOOD, V87, P3500, DOI 10.1182/blood.V87.8.3500.bloodjournal8783500; Rebel VI, 1996, EXP HEMATOL, V24, P638; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rozen S, 2000, Methods Mol Biol, V132, P365; Schor IE, 2009, P NATL ACAD SCI USA, V106, P4325, DOI 10.1073/pnas.0810666106; Schwarze U, 1999, AM J HUM GENET, V65, P336, DOI 10.1086/302512; Shimazu T, 2007, J BIOL CHEM, V282, P4470, DOI 10.1074/jbc.M609745200; Song HW, 2007, DIFFERENTIATION, V75, P519, DOI 10.1111/j.1432-0436.2006.00155.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suh HC, 2006, BLOOD, V107, P4308, DOI 10.1182/blood-2005-06-2216; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Sun Y, 2006, NUCLEIC ACIDS RES, V34, P6314, DOI 10.1093/nar/gkl914; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; Testa U, 2004, LEUKEMIA, V18, P1864, DOI 10.1038/sj.leu.2403472; Tliba O, 2008, AM J RESP CELL MOL, V38, P463, DOI 10.1165/rcmb.2007-0226OC; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; TSAI S, 1994, GENE DEV, V8, P2831, DOI 10.1101/gad.8.23.2831; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; von Lindern M, 1999, BLOOD, V94, P550, DOI 10.1182/blood.V94.2.550.414k39_550_559; von Mikecz A, 2000, J CELL BIOL, V150, P265, DOI 10.1083/jcb.150.1.265; Voulgarelis M, 2004, EUR J CLIN INVEST, V34, P690, DOI 10.1111/j.1365-2362.2004.01417.x; Webb CF, 1998, J IMMUNOL, V160, P4747; Weishaupt H, 2010, BLOOD, V115, P247, DOI 10.1182/blood-2009-07-235176; Wessely O, 1997, EMBO J, V16, P267, DOI 10.1093/emboj/16.2.267; WILLMAN CL, 1993, SCIENCE, V259, P968, DOI 10.1126/science.8438156; Yamamoto H, 1999, ONCOGENE, V18, P1495, DOI 10.1038/sj.onc.1202427; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Ye ZJ, 2005, P NATL ACAD SCI USA, V102, P18461, DOI 10.1073/pnas.0509314102; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	87	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e24153	10.1371/journal.pone.0024153	http://dx.doi.org/10.1371/journal.pone.0024153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901164	Green Published, Green Submitted, gold			2022-12-25	WOS:000294298000049
J	Shulman, LM; Sofer, D; Manor, Y; Mendelson, E; Balanant, J; Salvati, AL; Delpeyroux, F; Fiore, L				Shulman, Lester M.; Sofer, Danit; Manor, Yossi; Mendelson, Ella; Balanant, Jean; Salvati, Anna Laura; Delpeyroux, Francis; Fiore, Lucia			Antiviral Activity of 3(2H)- and 6-Chloro-3(2H)-Isoflavenes against Highly Diverged, Neurovirulent Vaccine-Derived, Type2 Poliovirus Sewage Isolates	PLOS ONE			English	Article							ENVIRONMENTAL SURVEILLANCE; SUBSTITUTED FLAVANOIDS; ORAL POLIOVACCINE; INFECTION; POLIOMYELITIS; ERADICATION; CIRCULATION; ISOFLAVENES; STRAIN	Background: Substituted flavanoids interfere with uncoating of Enteroviruses including Sabin-2 polio vaccine strains. However flavanoid resistant and dependent, type-2 polio vaccine strains (minimally-diverged), emerged during in vitro infections. Between 1998-2009, highly-diverged (8 to >15%) type-2, aVDPV(2)s, from two unrelated persistent infections were periodically isolated from Israeli sewage. Aim: To determine whether highly evolved aVDPV(2)s derived from persistent infections retained sensitivity to isoflavenes. Methods: Sabin-2 and ten aVDPV(2) isolates from two independent Israeli sources were titered on HEp2C cells in the presence and absence of 3(2H)-Isoflavene and 6-chloro-3(2H)-Isoflavene. Neurovirulence of nine aVDPV(2)s was measured in PVR-Tg-21 transgenic mice. Differences were related to unique amino acid substitutions within capsid proteins. Principal Findings: The presence of either flavanoid inhibited viral titers of Sabin-2 and nine of ten aVDPV(2)s by one to two log(10). The tenth aVDPV(2), which had unique amino acid substitution distant from the isoflavene-binding pocket but clustered at the three-and five-fold axies of symmetry between capsomeres, was unaffected by both flavanoids. Genotypic neurovirulence attenuation sites in the 5'UTR and VP1 reverted in all aVDPV(2)s and all reacquired a full neurovirulent phenotype except one with amino acid substitutions flanking the VP1 site. Conclusion: Both isoflavenes worked equally well against Sabin 2 and most of the highly-diverged, Israeli, aVDPV(2)s isolates. Thus, functionality of the hydrophobic pocket may be unaffected by selective pressures exerted during persistent poliovirus infections. Amino acid substitutions at sites remote from the drug-binding pocket and adjacent to a neurovirulence attenuation site may influence flavanoid antiviral activity, and neurovirulence, respectively.	[Shulman, Lester M.; Sofer, Danit; Manor, Yossi; Mendelson, Ella] Chaim Sheba Med Ctr, Publ Hlth Serv Israel Minist Hlth, Cent Virol Lab, IL-52621 Tel Hashomer, Israel; [Shulman, Lester M.; Mendelson, Ella] Tel Aviv Univ, Sackler Fac Med, Dept Epidemiol & Prevent Med, Ramat Gan, Israel; [Balanant, Jean; Delpeyroux, Francis] Inst Pasteur, Paris, France; [Balanant, Jean; Delpeyroux, Francis] INSERM U994, Paris, France; [Salvati, Anna Laura; Fiore, Lucia] Ist Super Sanita, Natl Ctr Immunobiol Res & Evaluat CRIVIB, I-00161 Rome, Italy	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Istituto Superiore di Sanita (ISS)	Shulman, LM (corresponding author), Chaim Sheba Med Ctr, Publ Hlth Serv Israel Minist Hlth, Cent Virol Lab, IL-52621 Tel Hashomer, Israel.	lester.shulman@sheba.health.gov.il	Delpeyroux, Francis/H-8838-2016; Shulman, Lester M./AAU-4372-2021; DELPEYROUX, Francis/ABA-5429-2021	Delpeyroux, Francis/0000-0002-4895-823X; Shulman, Lester M./0000-0002-6385-894X; DELPEYROUX, Francis/0000-0002-4895-823X	Israel Ministry of Health; Institut Pasteur [PTR-276, ACIP A-06-2007]	Israel Ministry of Health; Institut Pasteur(European Commission)	The Israel Ministry of Health funded all expenses for the studies involving the molecular characterization of the aVDPV isolates and the antiviral effects of the isoflavenes. Grants from the Institut Pasteur (Transversal Research Project PTR-276 and ACIP A-06-2007) funded the expenses for evaluation of neurovirulence attenuation of the aVDPV isolates in PVR-TG21 mice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomqvist S, 2004, J VIROL, V78, P4876, DOI 10.1128/JVI.78.9.4876-4883.2004; BURALI C, 1987, EUR J MED CHEM, V22, P119, DOI 10.1016/0223-5234(87)90005-5; Buttinelli G, 2003, J GEN VIROL, V84, P1215, DOI 10.1099/vir.0.18974-0; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1002; Collett MS, 2008, ANTIVIR RES, V79, P179, DOI 10.1016/j.antiviral.2008.04.002; CONTI C, 1990, ANTIMICROB AGENTS CH, V34, P460, DOI 10.1128/AAC.34.3.460; Conti Cinzia, 2005, Antiviral Chemistry & Chemotherapy, V16, P267; De Palma AM, 2008, EMERG INFECT DIS, V14, P545, DOI 10.3201/eid1404.070439; Ehrenfeld E, 2008, LANCET, V371, P1385, DOI 10.1016/S0140-6736(08)60597-8; Ehrenfeld E, 2009, EXPERT REV VACCINES, V8, P899, DOI [10.1586/erv.09.49, 10.1586/ERV.09.49]; GENOVESE D, 1995, ANTIVIR RES, V27, P123, DOI 10.1016/0166-3542(95)00088-4; Jenkins HE, 2010, NEW ENGL J MED, V362, P2360, DOI 10.1056/NEJMoa0910074; John T J, 1972, Indian Pediatr, V9, P252; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Kapp D, 2003, LANCET, V362, P1631, DOI 10.1016/S0140-6736(03)14826-X; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Korotkova EA, 2003, J VIROL, V77, P12460, DOI 10.1128/JVI.77.23.12460-12465.2003; Lentz KN, 1997, STRUCTURE, V5, P961, DOI 10.1016/S0969-2126(97)00249-9; MACADAM AJ, 1993, VIROLOGY, V192, P18, DOI 10.1006/viro.1993.1003; MacLennan C, 2004, LANCET, V363, P1509, DOI 10.1016/S0140-6736(04)16150-3; Manor Y, 2007, APPL ENVIRON MICROB, V73, P5954, DOI 10.1128/AEM.02537-06; Manor Y, 1999, J CLIN MICROBIOL, V37, P1670, DOI 10.1128/JCM.37.6.1670-1675.1999; *MMWR, 2007, MMWR-MORBID MORTAL W, V56, P996; *MMWR T, 2002, MMWR-MORBID MORTAL W, V51, P369; Paul Y, 2004, VACCINE, V22, P4144, DOI 10.1016/j.vaccine.2004.04.032; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; RACANIELLO VR, 2001, VIROLOGY, P685; Roberts L, 2009, SCIENCE, V323, P702, DOI [10.1126/science.323.5915.702, 10.1126/science.323.5915.705]; Roivainen M, 2010, EURO SURVEILL, V15; Salvati AL, 2004, ANTIMICROB AGENTS CH, V48, P2233, DOI 10.1128/AAC.48.6.2233-2243.2004; Samba E, 2004, NEW ENGL J MED, V350, P645, DOI 10.1056/NEJMp038210; Shulman LM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000069; Shulman LM, 2006, ISR MED ASSOC J, V8, P312; Shulman LM, 2009, SCIENCE, V324, P334, DOI 10.1126/science.324.5925.334b; Shulman LM, 2000, J CLIN MICROBIOL, V38, P3729, DOI 10.1128/JCM.38.10.3729-3734.2000; SHULMAN LM, 2009, ADV DETECTION VIRAL, P111; Smyth M, 2003, ARCH VIROL, V148, P1225, DOI 10.1007/s00705-002-0974-4; SUPERTI F, 1989, ANTIVIR RES, V11, P247, DOI 10.1016/0166-3542(89)90034-X; Tait S, 2006, ANTIVIR RES, V72, P252, DOI 10.1016/j.antiviral.2006.07.003; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Yang CF, 2005, J VIROL, V79, P12623, DOI 10.1128/JVI.79.20.12623-12634.2005	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e18360	10.1371/journal.pone.0018360	http://dx.doi.org/10.1371/journal.pone.0018360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21904594	gold, Green Submitted, Green Published			2022-12-25	WOS:000291006500003
J	Astle, MV; Hannan, KM; Ng, PY; Lee, RS; George, AJ; Hsu, AK; Haupt, Y; Hannan, RD; Pearson, RB				Astle, M. V.; Hannan, K. M.; Ng, P. Y.; Lee, R. S.; George, A. J.; Hsu, A. K.; Haupt, Y.; Hannan, R. D.; Pearson, R. B.			AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy	ONCOGENE			English	Article						PI3K; AKT; stress; senescence; p53; mTOR	ONCOGENE-INDUCED SENESCENCE; HUMAN-DIPLOID FIBROBLASTS; HEMATOPOIETIC STEM-CELLS; RAS-INDUCED SENESCENCE; RIBOSOMAL-PROTEIN L11; CELLULAR SENESCENCE; HUMAN CANCER; PREMATURE SENESCENCE; TRANSLATIONAL CONTROL; SIGNALING PATHWAY	The phosphatidylinositol 3-kinase (PI3K)/AKT and RAS oncogenic signalling modules are frequently mutated in sporadic human cancer. Although each of these pathways has been shown to play critical roles in driving tumour growth and proliferation, their activation in normal human cells can also promote cell senescence. Although the mechanisms mediating RAS-induced senescence have been well characterised, those controlling PI3K/AKT-induced senescence are poorly understood. Here we show that PI3K/AKT pathway activation in response to phosphatase and tensin homolog (PTEN) knockdown, mutant PI3K, catalytic, alpha polypeptide (PIK3CA) or activated AKT expression, promotes accumulation of p53 and p21, increases cell size and induces senescence-associated beta-galactosidase activity. We demonstrate that AKT-induced senescence is p53-dependent and is characterised by mTORC1-dependent regulation of p53 translation and stabilisation of p53 protein following nucleolar localisation and inactivation of MDM2. The underlying mechanisms of RAS and AKT-induced senescence appear to be distinct, demonstrating that different mediators of senescence may be deregulated during transformation by specific oncogenes. Unlike RAS, AKT promotes rapid proliferative arrest in the absence of a hyperproliferative phase or DNA damage, indicating that inactivation of the senescence response is critical at the early stages of PI3K/AKT-driven tumourigenesis. Furthermore, our data imply that chronic activation of AKT signalling provides selective pressure for the loss of p53 function, consistent with observations that PTEN or PIK3CA mutations are significantly associated with p53 mutation in a number of human tumour types. Importantly, the demonstration that mTORC1 is an essential mediator of AKT-induced senescence raises the possibility that targeting mTORC1 in tumours with activated PI3K/AKT signalling may exert unexpected detrimental effects due to inactivation of a senescence brake on potential cancer-initiating cells. Oncogene (2012) 31, 1949-1962; doi:10.1038/onc.2011.394; published online 12 September 2011	[Pearson, R. B.] Peter MacCallum Canc Ctr, Prot Chem Lab, Growth Control & Differentiat Program, Trescowthick Res Labs, Melbourne, Vic 8006, Australia; [George, A. J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [George, A. J.; Haupt, Y.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Hsu, A. K.] Peter MacCallum Canc Ctr, Hematol Immunol Translat Res Lab, Trescowthick Res Labs, Melbourne, Vic 8006, Australia; [Hannan, R. D.; Pearson, R. B.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Haupt, Y.; Hannan, R. D.; Pearson, R. B.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; University of Queensland; University of Melbourne; Peter Maccallum Cancer Center; Monash University; University of Melbourne	Pearson, RB (corresponding author), Peter MacCallum Canc Ctr, Prot Chem Lab, Growth Control & Differentiat Program, Trescowthick Res Labs, Locked Bag 1,ABeckett St, Melbourne, Vic 8006, Australia.	rick.pearson@petermac.org	Pearson, Richard Bruce/I-1451-2013	Pearson, Richard Bruce/0000-0001-5919-5090; Haupt, Ygal/0000-0001-5925-0096; George, Amee/0000-0002-0265-4476; Hannan, Ross/0000-0002-2166-4493; Hannan, Katherine/0000-0003-4186-8167	National Health and Medical Research Council (NHMRC) of Australia [166908, 251688, 509087, 400116]; Cancer Council Victoria	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria)	We acknowledge the Victorian Centre for Functional Genomics for the use of equipment and advice. This work was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia to RDH (NHMRC Nos. 166908 and 251688) and to RBP (NHMRC Nos. 509087 and 400116) and from Cancer Council Victoria to RBP. RDH and RBP are NHMRC Senior Research Fellows. We thank Professor Stephen Jane and Loretta Cerruti for assistance with retrovirus production.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Andjelkovic T, 2011, TRANSL RES, V157, P19, DOI 10.1016/j.trsl.2010.09.004; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bellodi C, 2010, EMBO J, V29, P1865, DOI 10.1038/emboj.2010.83; Benanti JA, 2004, MOL CELL BIOL, V24, P2842, DOI 10.1128/MCB.24.7.2842-2852.2004; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Bhatt AP, 2010, BLOOD, V115, P4455, DOI 10.1182/blood-2009-10-251082; Brachmann S, 2009, CURR OPIN CELL BIOL, V21, P194, DOI 10.1016/j.ceb.2008.12.011; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Catasus L, 2009, MODERN PATHOL, V22, P522, DOI 10.1038/modpathol.2009.5; Chan JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001754; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Cristiano BE, 2006, CANCER RES, V66, P11718, DOI 10.1158/0008-5472.CAN-06-1968; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Ferbeyre G, 2000, GENE DEV, V14, P2015; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Gorgoulis VG, 2010, CURR OPIN CELL BIOL, V22, P816, DOI 10.1016/j.ceb.2010.07.013; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hannan KM, 2011, IUBMB LIFE, V63, P79, DOI 10.1002/iub.428; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Huot TJ, 2002, MOL CELL BIOL, V22, P8135, DOI 10.1128/MCB.22.23.8135-8143.2002; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Kim JS, 2007, MOL CELL BIOL, V27, P662, DOI 10.1128/MCB.00537-06; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Leontieva OV, 2010, AGING, V31, P31; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mavrakis KJ, 2008, GENE DEV, V22, P2178, DOI 10.1101/gad.1690808; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Meek DW, 2003, MOL CANCER RES, V1, P1017; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Moral M, 2009, CANCER RES, V69, P1099, DOI 10.1158/0008-5472.CAN-08-3240; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Oki E, 2005, CANCER LETT, V227, P33, DOI 10.1016/j.canlet.2004.12.006; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Ouellette MM, 1999, BIOCHEM BIOPH RES CO, V254, P795, DOI 10.1006/bbrc.1998.0114; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Puzio-Kuter AM, 2009, GENE DEV, V23, P675, DOI 10.1101/gad.1772909; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Solomon B, 2009, J THORAC ONCOL, V4, P787, DOI 10.1097/JTO.0b013e3181a74dba; Tremain R, 2000, ONCOGENE, V19, P1698, DOI 10.1038/sj.onc.1203471; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wolyniec K, 2009, ONCOGENE, V28, P2502, DOI 10.1038/onc.2009.101; Xu Z, 2011, J BIOL CHEM, V286, P21401, DOI 10.1074/jbc.M110.198630; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	95	165	172	3	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2012	31	15					1949	1962		10.1038/onc.2011.394	http://dx.doi.org/10.1038/onc.2011.394			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	926CW	21909130	Green Published, hybrid			2022-12-25	WOS:000302809900007
J	Mohamed, JS; Hajira, A; Li, ZL; Paulin, D; Boriek, AM				Mohamed, Junaith S.; Hajira, Ameena; Li, Zhenlin; Paulin, Denise; Boriek, Aladin M.			Desmin Regulates Airway Smooth Muscle Hypertrophy through Early Growth-responsive Protein-1 and MicroRNA-26a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; CARDIAC-HYPERTROPHY; KINASE 3-BETA; EGR-1 EXPRESSION; MOUSE MODEL; GENE; PHOSPHORYLATION; TRANSCRIPTION; CELLS; DIFFERENTIATION	Bronchial biopsies of asthmatic patients show a negative correlation between desmin expression in airway smooth muscle cell (ASMC) and airway hyperresponsiveness. We previously showed that desmin is an intracellular load-bearing protein, which influences airway compliance, lung recoil, and airway contractile responsiveness (Shardonofsky, F. R., Capetanaki, Y., and Boriek, A. M. (2006) Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L890-L896). These results suggest that desmin may play an important role in ASMC homeostasis. Here, we report that ASMCs of desmin null mice (ASMCs(Des-/-)) show hypertrophy and up-regulation microRNA-26a (miR-26a). Knockdown of miR-26a in ASMCs(Des-/-) inhibits hypertrophy, whereas enforced expression of miR-26a in ASMCs(Des-/-) induces hypertrophy. We identify that Egr1 (early growth responsive protein-1) activates miR-26a promoter via enhanced phosphorylation of Erk1/2 in ASMCs(Des-/-). We show glycogen synthase kinase-3 beta (GSK-3 beta) as a target gene of miR-26a. Moreover, induction of ASMCs(Des-/-) hypertrophy by the Erk-1/2/Egr-1/miR-26a/GSK-3 beta pathway is consistent in human recombinant ASMCs, which stably suppresses 90% endogenous desmin expression. Overall, our data demonstrate a novel role for desmin as an anti-hypertrophic protein necessary for ASMC homeostasis and identifies desmin as a novel regulator of microRNA.	[Mohamed, Junaith S.; Hajira, Ameena; Boriek, Aladin M.] Baylor Coll Med, Dept Med, Sect Pulm Crit Care & Sleep Med, Houston, TX 77030 USA; [Li, Zhenlin; Paulin, Denise] Univ Paris 06, UR4, F-75005 Paris, France	Baylor College of Medicine; UDICE-French Research Universities; Sorbonne Universite	Boriek, AM (corresponding author), Baylor Coll Med, Dept Med, Sect Pulm Crit Care & Sleep Med, Houston, TX 77030 USA.	boriek@bcm.edu	Li, Zhenlin/E-3937-2016; Mohamed, Junaith/AAC-4050-2020	LI, Zhenlin/0000-0002-3706-4505	National Science Foundation; Keck Foundation	National Science Foundation(National Science Foundation (NSF)); Keck Foundation(W.M. Keck Foundation)	This work was supported by the National Science Foundation and the Keck Foundation.	Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Badorff C, 2002, J CLIN INVEST, V109, P373, DOI 10.1172/JCI200213779; Baron V, 2003, ONCOGENE, V22, P4194, DOI 10.1038/sj.onc.1206560; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Bentley JK, 2009, AM J PHYSIOL-LUNG C, V296, pL176, DOI 10.1152/ajplung.90376.2008; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Calogero A, 2001, CLIN CANCER RES, V7, P2788; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Costa ML, 2004, BRAZ J MED BIOL RES, V37, P1819, DOI 10.1590/S0100-879X2004001200007; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Deng H, 2008, J BIOL CHEM, V283, P10198, DOI 10.1074/jbc.M800624200; EBINA M, 1993, AM REV RESPIR DIS, V148, P720, DOI 10.1164/ajrccm/148.3.720; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Halayko AJ, 1996, AM J PHYSIOL-LUNG C, V270, pL1040, DOI 10.1152/ajplung.1996.270.6.L1040; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Hays SR, 2005, THORAX, V60, P226, DOI 10.1136/thx.2004.028340; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Huang RP, 1997, INT J CANCER, V72, P102, DOI 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; KAPANCI Y, 1992, J HISTOCHEM CYTOCHEM, V40, P1955, DOI 10.1177/40.12.1333502; Kramer EL, 2009, AM J RESP CELL MOL, V41, P415, DOI 10.1165/rcmb.2008-0470OC; LEVIN WJ, 1994, CHEST, V106, pS372, DOI 10.1378/chest.106.6.372S; Liu CT, 1996, CRIT REV ONCOGENESIS, V7, P101, DOI 10.1615/CritRevOncog.v7.i1-2.70; Liu LX, 2000, BLOOD, V96, P1772, DOI 10.1182/blood.V96.5.1772.h8001772_1772_1781; Liu MY, 1999, AM J PHYSIOL-LUNG C, V277, pL667, DOI 10.1152/ajplung.1999.277.4.L667; MOHAMED JS, 2011, FASEB J IN PRESS; Mohamed JS, 2010, J BIOL CHEM, V285, P29336, DOI 10.1074/jbc.M110.101147; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Ogawa H, 2011, CLIN EXP ALLERGY, V41, P104, DOI 10.1111/j.1365-2222.2010.03564.x; PARK S, 1986, J BIOL CHEM, V261, P5734; PARKER PJ, 1983, EUR J BIOCHEM, V130, P227; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; RAUSCHER FJ, 1993, ADV EXP MED BIOL, V348, P23; Regamey N, 2008, AM J RESP CRIT CARE, V177, P837, DOI 10.1164/rccm.200707-977OC; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Roth M, 2004, NEW ENGL J MED, V351, P560, DOI 10.1056/NEJMoa021660; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Shardonofsky FR, 2006, AM J PHYSIOL-LUNG C, V290, pL890, DOI 10.1152/ajplung.00397.2005; Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6; Slats AM, 2008, J ALLERGY CLIN IMMUN, V121, P1196, DOI 10.1016/j.jaci.2008.02.017; Terzano C, 2003, Eur Rev Med Pharmacol Sci, V7, P9; Vyas DR, 2002, AM J PHYSIOL-CELL PH, V283, pC545, DOI 10.1152/ajpcell.00049.2002; Williams AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005889; Yamada M, 2005, J HISTOCHEM CYTOCHEM, V53, P735, DOI 10.1369/jhc.4A6483.2005; Yang Y, 2000, J CLIN INVEST, V106, P1321, DOI 10.1172/JCI8893	49	24	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43394	43404		10.1074/jbc.M111.235127	http://dx.doi.org/10.1074/jbc.M111.235127			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21903578	hybrid, Green Published			2022-12-25	WOS:000298351300059
J	Wong, VW; Paterno, J; Sorkin, M; Glotzbach, JP; Levi, K; Januszyk, M; Rustad, KC; Longaker, MT; Gurtner, GC				Wong, Victor W.; Paterno, Josemaria; Sorkin, Michael; Glotzbach, Jason P.; Levi, Kemal; Januszyk, Michael; Rustad, Kristine C.; Longaker, Michael T.; Gurtner, Geoffrey C.			Mechanical force prolongs acute inflammation via T-cell-dependent pathways during scar formation	FASEB JOURNAL			English	Article						wound healing; mechanotransduction; fibrosis; microarray	POSTBURN HYPERTROPHIC SCAR; FOCAL ADHESION KINASE; GENE-EXPRESSION; SKIN FIBROSIS; DERMAL FIBROBLASTS; RENAL FIBROSIS; SCLEROTIC SKIN; ANIMAL-MODEL; MECHANOTRANSDUCTION; ACTIVATION	Mechanical force significantly modulates both inflammation and fibrosis, yet the fundamental mechanisms that regulate these interactions remain poorly understood. Here we performed microarray analysis to compare gene expression in mechanically loaded wounds vs. unloaded control wounds in an established murine hypertrophic scar (HTS) model. We identified 853 mechanically regulated genes (false discovery rate <2) at d 14 postinjury, a subset of which were enriched for T-cell-regulated pathways. To substantiate the role of T cells in scar mechanotransduction, we applied the HTS model to T-cell-deficient mice and wild-type mice. We found that scar formation in T-cell-deficient mice was reduced by almost 9-fold (P < 0.001) with attenuated epidermal (by 2.6-fold, P < 0.01) and dermal (3.9-fold, P < 0.05) proliferation. Mechanical stimulation was highly associated with sustained T-cell-dependent Th2 cytokine (IL-4 and IL-13) and chemokine (MCP-1) signaling. Further, T-cell-deficient mice failed to recruit systemic inflammatory cells such as macrophages or monocytic fibroblast precursors in response to mechanical loading. These findings indicate that T-cell-regulated fibrogenic pathways are highly mechanoresponsive and suggest that mechanical forces induce a chronic-like inflammatory state through immune-dependent activation of both local and systemic cell populations.-Wong, V. W., Paterno, J., Sorkin, M., Glotzbach, J. P., Levi, K., Januszyk, M., Rustad, K. C., Longaker, M. T., Gurtner, G. C. Mechanical force prolongs acute inflammation via T-cell-dependent pathways during scar formation. FASEB J. 25, 4498-4510 (2011). www.fasebj.org	[Wong, Victor W.; Paterno, Josemaria; Sorkin, Michael; Glotzbach, Jason P.; Januszyk, Michael; Rustad, Kristine C.; Longaker, Michael T.; Gurtner, Geoffrey C.] Stanford Univ, Dept Surg, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA; [Levi, Kemal] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Gurtner, GC (corresponding author), Stanford Univ, Dept Surg, Hagey Lab Pediat Regenerat Med, 257 Campus Dr,GK-201, Stanford, CA 94305 USA.	ggurtner@stanford.edu	Glotzbach, Jason P./O-4394-2019	Glotzbach, Jason P./0000-0002-8002-9422; Levi, Kemal/0000-0001-9760-166X				Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6; Alenzi FQB, 2004, BRIT J BIOMED SCI, V61, P99, DOI 10.1080/09674845.2004.11732652; Aliprantis AO, 2007, P NATL ACAD SCI USA, V104, P2827, DOI 10.1073/pnas.0700021104; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Boyce DE, 2001, BRIT J PLAST SURG, V54, P511, DOI 10.1054/bjps.2001.3638; Brown CE, 2007, J IMMUNOL, V179, P3332, DOI 10.4049/jimmunol.179.5.3332; Castagnoli C, 1997, BURNS, V23, P565, DOI 10.1016/S0305-4179(97)00070-3; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Davison SP, 2007, PLAST RECONSTR SURG, V119, P110, DOI 10.1097/01.prs.0000244846.11400.68; Distler JHW, 2009, RHEUMATOLOGY, V48, P98, DOI 10.1093/rheumatology/ken401; Distler JHW, 2006, ARTHRITIS RHEUM-US, V54, P214, DOI 10.1002/art.21497; Eckes B, 2006, J INVEST DERM SYMP P, V11, P66, DOI 10.1038/sj.jidsymp.5650003; Ferreira AM, 2006, J INVEST DERMATOL, V126, P1900, DOI 10.1038/sj.jid.5700302; Ferretti M, 2006, J IMMUNOL, V177, P8757, DOI 10.4049/jimmunol.177.12.8757; Gawronska-Kozak B, 2006, WOUND REPAIR REGEN, V14, P265, DOI 10.1111/j.1743-6109.2006.00121.x; Gawronska-Kozak B, 2011, MATRIX BIOL, V30, P290, DOI 10.1016/j.matbio.2011.04.004; Gieni RS, 2008, J CELL BIOCHEM, V104, P1964, DOI 10.1002/jcb.21364; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gurtner G. C., 2011, ANN SURG, DOI [10.1097/SLA.0b013e31822b8b2f, DOI 10.1097/SLA.0B013E31822B8B2F]; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Iniguez MA, 1999, J IMMUNOL, V163, P111; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Kessler-Becker D, 2004, BIOCHEM J, V379, P351, DOI 10.1042/BJ20031371; Lakos G, 2006, PATHOBIOLOGY, V73, P224, DOI 10.1159/000098208; Lin Y, 1997, J IMMUNOL, V158, P5658; Lindahl GE, 2002, J BIOL CHEM, V277, P6153, DOI 10.1074/jbc.M108966200; Lionetti V, 2005, CURR OPIN CRIT CARE, V11, P82, DOI 10.1097/00075198-200502000-00013; Makino A, 2007, BIORHEOLOGY, V44, P221; MATTANA J, 1995, AM J PATHOL, V147, P529; Mecklenburg L, 2005, EXP DERMATOL, V14, P797, DOI 10.1111/j.1600-0625.2005.00362.x; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Morisugi T, 2010, J BIOCHEM, V147, P633, DOI 10.1093/jb/mvp210; Morrison J, 2000, LAB INVEST, V80, P881, DOI 10.1038/labinvest.3780092; Niedermeier M, 2009, P NATL ACAD SCI USA, V106, P17892, DOI 10.1073/pnas.0906070106; Ogawa R, 2008, MED HYPOTHESES, V71, P493, DOI 10.1016/j.mehy.2008.05.020; Ostergaard HL, 2005, IMMUNOL RES, V31, P267, DOI 10.1385/IR:31:3:267; Paddock HN, 2003, J BURN CARE REHABIL, V24, P371, DOI 10.1097/01.BCR.0000095508.96754.E0; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Paterno J, 2011, WOUND REPAIR REGEN, V19, P49, DOI 10.1111/j.1524-475X.2010.00643.x; Pignata C, 2009, ADV EXP MED BIOL, V665, P195; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Shynlova O, 2008, J IMMUNOL, V181, P1470, DOI 10.4049/jimmunol.181.2.1470; Simon BA, 2006, AM J PHYSIOL-LUNG C, V291, pL851, DOI 10.1152/ajplung.00463.2005; Simonian PL, 2006, J IMMUNOL, V177, P4436, DOI 10.4049/jimmunol.177.7.4436; Strieter RM, 2007, J CLIN INVEST, V117, P549, DOI 10.1172/JCI30562; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tapmeier TT, 2010, KIDNEY INT, V78, P351, DOI 10.1038/ki.2010.177; Tredget EE, 2006, J INTERF CYTOK RES, V26, P179, DOI 10.1089/jir.2006.26.179; Tsou R, 2000, J BURN CARE REHABIL, V21, P541, DOI 10.1097/00004630-200021060-00012; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wada T, 2007, KIDNEY INT, V72, P269, DOI 10.1038/sj.ki.5002325; WALLACE VA, 1994, EUR J IMMUNOL, V24, P1463, DOI 10.1002/eji.1830240634; Wang JF, 2007, WOUND REPAIR REGEN, V15, P113, DOI 10.1111/j.1524-475X.2006.00192.x; Wang JF, 2007, J INTERF CYTOK RES, V27, P921, DOI 10.1089/jir.2007.0008; Wang JF, 2007, WOUND REPAIR REGEN, V15, P530, DOI 10.1111/j.1524-475X.2007.00261.x; Wang JF, 2011, WOUND REPAIR REGEN, V19, P274, DOI 10.1111/j.1524-475X.2011.00672.x; Wang Z, 2006, J CELL PHYSIOL, V206, P510, DOI 10.1002/jcp.20486; Wittmann M, 2006, CURR OPIN ALLERGY CL, V6, P329, DOI 10.1097/01.all.0000244792.95615.3a; Wong VW, 2011, TISSUE ENG PT A, V17, P631, DOI [10.1089/ten.tea.2010.0298, 10.1089/ten.TEA.2010.0298]; Wu J, 2004, J TRAUMA, V57, P1276, DOI 10.1097/01.TA.0000108997.49513.DC; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yamamoto T, 2004, ARCH DERMATOL RES, V295, P453, DOI 10.1007/s00403-003-0439-y; Yamamoto T, 2001, J INVEST DERMATOL, V117, P999, DOI 10.1046/j.0022-202x.2001.01509.x; Yang DY, 2007, PLAST RECONSTR SURG, V119, P104, DOI 10.1097/01.prs.0000244828.80490.62; Yano S, 2004, J INVEST DERMATOL, V122, P783, DOI 10.1111/j.0022-202X.2004.22328.x; Zeisberg M, 2001, CURR OPIN NEPHROL HY, V10, P315, DOI 10.1097/00041552-200105000-00004	73	83	106	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4498	4510		10.1096/fj.10-178087	http://dx.doi.org/10.1096/fj.10-178087			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21911593				2022-12-25	WOS:000298138100040
J	Bartolommei, G; Tadini-Buoninsegni, F; Moncelli, MR; Gemma, S; Camodeca, C; Butini, S; Campiani, G; Lewis, D; Inesi, G				Bartolommei, Gianluca; Tadini-Buoninsegni, Francesco; Moncelli, Maria Rosa; Gemma, Sandra; Camodeca, Caterina; Butini, Stefania; Campiani, Giuseppe; Lewis, David; Inesi, Giuseppe			The Ca2+-ATPase (SERCA1) Is Inhibited by 4-Aminoquinoline Derivatives through Interference with Catalytic Activation by Ca2+, Whereas the ATPase E-2 State Remains Functional	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTENT ANTIMALARIAL AGENTS; SARCOPLASMIC-RETICULUM; PLASMODIUM-FALCIPARUM; CALCIUM-PUMP; INNOVATIVE PHARMACOPHORE; CLOTRIMAZOLE SCAFFOLD; CYCLOPIAZONIC ACID; PROSTATE-CANCER; IN-VITRO; BINDING	Several clotrimazole (CLT) and 4-aminoquinoline derivatives were synthesized and found to exhibit in vitro antiplasmodial activity with IC50 ranging from nM to mu M values. We report here that some of these compounds produce inhibition of rabbit sarcoplasmic reticulum Ca2+-ATPase (SERCA1) with IC50 values in the mu M range. The highest affinity for the Ca2+-ATPase was observed with NF1442 (N-((3-chlorophenyl)(4-((4-(7-chloroquinolin-4-yl) piperazin-1-yl)methyl)phenyl)methyl)-7-chloro-4-aminoquinoline) and NF1058 (N-((3-chlorophenyl)(4-(pyrrolidin-1-ylmethyl)phenyl)methyl)-7-chloro-4-aminoquinoline), yielding IC50 values of 1.3 and 8.0 mu M as demonstrated by measurements of steady state ATPase activity as well as single cycle charge transfer. Characterization of sequential reactions comprising the ATPase catalytic and transport cycle then demonstrated that NF1058, and similarly CLT, interferes with the mechanism of Ca2+ binding and Ca2+-dependent enzyme activation (E-2 to E-1.Ca-2 transition) required for formation of phosphorylated intermediate by ATP utilization. On the other hand, Ca2+ independent phosphoenzyme formation by utilization of P-i (i.e. reverse of the hydrolytic reaction in the absence of Ca2+) was not inhibited by NF1058 or CLT. Comparative experiments showed that the high affinity inhibitor thapsigargin interferes not only with Ca2+ binding and phosphoenzyme formation with ATPbut also with phosphoenzyme formation by utilization of P-i even though this reaction does not require Ca2+. It is concluded that NF1058 and CLT inhibit SERCA by stabilization of an E-2 state that, as opposed to that obtained with thapsigargin, retains the functional ability to form E-2-P by reacting with P-i.	[Bartolommei, Gianluca; Tadini-Buoninsegni, Francesco; Moncelli, Maria Rosa] Univ Florence, Dept Chem Ugo Schiff, I-50019 Sesto Fiorentino, Florence, Italy; [Gemma, Sandra; Camodeca, Caterina; Butini, Stefania; Campiani, Giuseppe] Univ Siena, European Res Ctr Drug Discovery & Dev, I-53100 Siena, Italy; [Gemma, Sandra; Camodeca, Caterina; Butini, Stefania; Campiani, Giuseppe] Univ Siena, Dept Pharmaceut & Appl Chem, I-53100 Siena, Italy; [Lewis, David; Inesi, Giuseppe] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA	University of Florence; University of Siena; University of Siena; California Pacific Medical Center; California Pacific Medical Center Research Institute	Tadini-Buoninsegni, F (corresponding author), Univ Florence, Dept Chem Ugo Schiff, Via Lastruccia 3, I-50019 Sesto Fiorentino, Florence, Italy.	francesco.tadini@unifi.it	Gemma, Sandra/D-3568-2009; butini, stefania/D-9954-2015; Tadini-Buoninsegni, Francesco/CAJ-5745-2022	Gemma, Sandra/0000-0002-8313-2417; butini, stefania/0000-0002-8471-0880; Camodeca, Caterina/0000-0002-8676-7311; TADINI-BUONINSEGNI, Francesco/0000-0001-5594-2554; Campiani, Giuseppe/0000-0001-5295-9529	National Institutes of Health [RO301-69830]; Ministero dell'Istruzione, dell'Universita e della Ricerca; Ente Cassa di Risparmio di Firenze; Monte dei Paschi di Siena; NatSynDrugs	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Monte dei Paschi di Siena; NatSynDrugs	This work was supported, in whole or in part, by National Institutes of Health Grant RO301-69830 (NHBLI). This work was also supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN2008), the Ente Cassa di Risparmio di Firenze, Monte dei Paschi di Siena and NatSynDrugs.	ANDERSEN JP, 1995, FEBS LETT, V359, P101, DOI 10.1016/0014-5793(95)00019-6; Andrews S, 2010, J MED CHEM, V53, P916, DOI 10.1021/jm900972u; Arnou B, 2011, BIOCHEM SOC T, V39, P823, DOI 10.1042/BST0390823; Avellanal M, 1998, J CARDIOVASC PHARM, V32, P845, DOI 10.1097/00005344-199811000-00022; Bartolommei G, 2006, J BIOL CHEM, V281, P9547, DOI 10.1074/jbc.M510550200; Bartolommei G, 2008, BIOPHYS J, V95, P1813, DOI 10.1529/biophysj.108.133546; Berman MC, 2003, BIOCHEMISTRY-US, V42, P3556, DOI 10.1021/bi026071n; Bilmen JG, 2001, EUR J BIOCHEM, V268, P6318, DOI 10.1046/j.0014-2956.2001.02589.x; Brugnara C, 1996, J CLIN INVEST, V97, P1227, DOI 10.1172/JCI118537; Campiani G, 2008, Italy patent, Patent No. [WO2008/101891, 2008101891]; de Meis L, 1974, Biochemistry, V13, P2057, DOI 10.1021/bi00707a009; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Denmeade SR, 2005, CANCER BIOL THER, V4, P14; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V290, P178, DOI 10.1016/0005-2736(72)90062-4; Gemma S, 2009, J MED CHEM, V52, P502, DOI 10.1021/jm801352s; Gemma Sandra, 2007, Bioorg Med Chem Lett, V17, P3535, DOI 10.1016/j.bmcl.2007.04.077; Gemma S, 2008, J MED CHEM, V51, P1278, DOI 10.1021/jm701247k; Gemma S, 2007, J MED CHEM, V50, P595, DOI 10.1021/jm061429p; INESI G, 1988, METHOD ENZYMOL, V157, P154; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; INESI G, 1980, J BIOL CHEM, V255, P3025; Kaplan J.H., 2004, HDB ATPASES BIOCH CE, P63; Krishna S, 2001, J BIOL CHEM, V276, P10782, DOI 10.1074/jbc.M010554200; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; Michelangeli F, 2011, BIOCHEM SOC T, V39, P789, DOI 10.1042/BST0390789; MOORE GA, 1987, FEBS LETT, V224, P331, DOI 10.1016/0014-5793(87)80479-9; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Pintschovius J, 1999, BIOPHYS J, V76, P814, DOI 10.1016/S0006-3495(99)77245-0; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Saliba KJ, 1998, T ROY SOC TROP MED H, V92, P666, DOI 10.1016/S0035-9203(98)90805-7; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; Sohoel H, 2006, BIOORGAN MED CHEM, V14, P2810, DOI 10.1016/j.bmc.2005.12.001; Strock C, 1998, J BIOL CHEM, V273, P15104, DOI 10.1074/jbc.273.24.15104; Tadini-Buoninsegni F, 2008, ARCH BIOCHEM BIOPHYS, V476, P75, DOI 10.1016/j.abb.2008.02.031; Tadini-Buoninsegni F, 2006, J BIOL CHEM, V281, P37720, DOI 10.1074/jbc.M606040200; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Tiffert T, 2000, P NATL ACAD SCI USA, V97, P331, DOI 10.1073/pnas.97.1.331; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Witzke A, 2010, BIOCHEMISTRY-US, V49, P4524, DOI 10.1021/bi1004014; Yatime L, 2009, BBA-BIOENERGETICS, V1787, P207, DOI 10.1016/j.bbabio.2008.12.019; YU X, 1995, J BIOL CHEM, V270, P4361, DOI 10.1074/jbc.270.9.4361	46	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38383	38389		10.1074/jbc.M111.287276	http://dx.doi.org/10.1074/jbc.M111.287276			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914795	hybrid, Green Published			2022-12-25	WOS:000296594200052
J	Luque, B; Lacasa, L; Ballesteros, FJ; Robledo, A				Luque, Bartolo; Lacasa, Lucas; Ballesteros, Fernando J.; Robledo, Alberto			Feigenbaum Graphs: A Complex Network Perspective of Chaos	PLOS ONE			English	Article							TIME-SERIES; VISIBILITY GRAPH	The recently formulated theory of horizontal visibility graphs transforms time series into graphs and allows the possibility of studying dynamical systems through the characterization of their associated networks. This method leads to a natural graph-theoretical description of nonlinear systems with qualities in the spirit of symbolic dynamics. We support our claim via the case study of the period-doubling and band-splitting attractor cascades that characterize unimodal maps. We provide a universal analytical description of this classic scenario in terms of the horizontal visibility graphs associated with the dynamics within the attractors, that we call Feigenbaum graphs, independent of map nonlinearity or other particulars. We derive exact results for their degree distribution and related quantities, recast them in the context of the renormalization group and find that its fixed points coincide with those of network entropy optimization. Furthermore, we show that the network entropy mimics the Lyapunov exponent of the map independently of its sign, hinting at a Pesin-like relation equally valid out of chaos.	[Luque, Bartolo; Lacasa, Lucas] Univ Politecn Madrid, ETSI Aeronaut, Dept Matemat Aplicada & Estadist, Madrid, Spain; [Ballesteros, Fernando J.] Univ Valencia, Observ Astron, Valencia, Spain; [Robledo, Alberto] Univ Carlos III Madrid, Dept Matemat, Madrid, Spain; [Robledo, Alberto] Univ Nacl Autonoma Mexico, Inst Fis, Mexico City 01000, DF, Mexico	Universidad Politecnica de Madrid; University of Valencia; Universidad Carlos III de Madrid; Universidad Nacional Autonoma de Mexico	Luque, B (corresponding author), Univ Politecn Madrid, ETSI Aeronaut, Dept Matemat Aplicada & Estadist, Madrid, Spain.	lucas.lacasa@upm.es	Roselló, Fernando J Ballesteros/G-9761-2012; Luque, Bartolo/B-3646-2018	Roselló, Fernando J Ballesteros/0000-0003-1053-8384; Luque, Bartolo/0000-0002-0396-4396; Lacasa, Lucas/0000-0003-3057-0357	Ministerio de Educacion y Ciencia (MEC); Comunidad de Madrid (Spain) [FIS2009-13690, S2009ESP-1691]; MEC [AYA2006-14056]; MEC (Spain); CONACyT; DGAPA-UNAM (Mexican agencies)	Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Comunidad de Madrid (Spain)(Comunidad de Madrid); MEC(European Commission); MEC (Spain)(Spanish Government); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-UNAM (Mexican agencies)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	BL and LL acknowledge financial support from the Ministerio de Educacion y Ciencia (MEC) and Comunidad de Madrid (Spain) through projects FIS2009-13690 and S2009ESP-1691. FJB acknowledges support from MEC through project AYA2006-14056, and AR acknowledges support from MEC (Spain) and CONACyT and DGAPA-UNAM (Mexican agencies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bollobas B., 1998, MODERN GRAPH THEORY; CRUTCHFIELD JP, 1982, PHYS REP, V92, P45, DOI 10.1016/0370-1573(82)90089-8; Donner RV, 2011, INT J BIFURCAT CHAOS, V21, P1019, DOI 10.1142/S0218127411029021; Donner RV, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/033025; Elsner JB, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039129; FEIGENBAUM MJ, 1978, J STAT PHYS, V19, P25, DOI 10.1007/BF01020332; Gao ZK, 2009, CHAOS, V19, DOI 10.1063/1.3227736; Gutin G, 2011, PHYSICA A, V390, P2421, DOI 10.1016/j.physa.2011.02.031; Hao B., 1998, APPL SYMBOLIC DYNAMI; Kyriakopoulos F, 2007, LECT NOTES COMPUT SC, V4488, P625; Lacasa L, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30001; Lacasa L, 2008, P NATL ACAD SCI USA, V105, P4972, DOI 10.1073/pnas.0709247105; Lacasa L, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036120; Luque B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046103; Marvel SA, 2009, CHAOS, V19, DOI 10.1063/1.3247089; MILNOR J, 1988, LECT NOTES MATH, V1342, P465; Newman MEJ, 1999, PHYS LETT A, V263, P341, DOI 10.1016/S0375-9601(99)00757-4; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Peitgen H.O., 1992, CHAOS FRACTALS NEW F; Radicchi F, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.148701; Robledo A, 1999, PHYS REV LETT, V83, P2289, DOI 10.1103/PhysRevLett.83.2289; Schroeder M, 1991, FRACTALS CHAOS POWER; SCHUSTER HG, 1988, DETERMINISTIC CHAOS; Shao ZG, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3308505; Song C, 2006, NAT PHYS, P2; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Xu X, 2008, P NATL ACAD SCI USA, V105, P50; Yang Y, 2009, PHYSICA A, V388, P4431, DOI 10.1016/j.physa.2009.07.016; Zhang J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238701	33	71	71	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e22411	10.1371/journal.pone.0022411	http://dx.doi.org/10.1371/journal.pone.0022411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915254	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802500006
J	Panigaj, M; Glier, H; Wildova, M; Holada, K				Panigaj, Martin; Glier, Hana; Wildova, Marcela; Holada, Karel			Expression of Prion Protein in Mouse Erythroid Progenitors and Differentiating Murine Erythroleukemia Cells	PLOS ONE			English	Article							HEXAMETHYLENE BISACETAMIDE; GENE-EXPRESSION; IRON UPTAKE; DEXAMETHASONE; SUPPRESSION; ACTIVATION; DEFICIENT; LAMININ; CDNA; PRPC	Prion diseases have been observed to deregulate the transcription of erythroid genes, and prion protein knockout mice have demonstrated a diminished response to experimental anemia. To investigate the role of the cellular prion protein (PrPC) in erythropoiesis, we studied the protein's expression on mouse erythroid precursors in vivo and utilized an in vitro model of the erythroid differentiation of murine erythroleukemia cells (MEL) to evaluate the effect of silencing PrPC through RNA interference. The expression of PrPC and selected differentiation markers was analyzed by quantitative multicolor flow cytometry, western blot analysis and quantitative RT-PCR. The silencing of PrPC expression in MEL cells was achieved by expression of shRNAmir from an integrated retroviral vector genome. The initial upregulation of PrPC expression in differentiating erythroid precursors was detected both in vivo and in vitro, suggesting PrPC's importance to the early stages of differentiation. The upregulation was highest on early erythroblasts (16200 +/- 3700 PrPC / cell) and was followed by the gradual decrease of PrPC level with the precursor's maturation reaching 470 +/- 230 PrPC / cell on most mature CD71 2 Ter119(+) small precursors. Interestingly, the downregulation of PrPC protein with maturation of MEL cells was not accompanied by the decrease of PrP mRNA. The stable expression of anti-Prnp shRNAmir in MEL cells led to the efficient (> 80%) silencing of PrPC levels. Cell growth, viability, hemoglobin production and the transcription of selected differentiation markers were not affected by the downregulation of PrPC. In conclusion, the regulation of PrPC expression in differentiating MEL cells mimics the pattern detected on mouse erythroid precursors in vivo. Decrease of PrPC protein expression during MEL cell maturation is not regulated on transcriptional level. The efficient silencing of PrPC levels, despite not affecting MEL cell differentiation, enables created MEL lines to be used for studies of PrPC cellular function.	[Panigaj, Martin; Glier, Hana; Wildova, Marcela; Holada, Karel] Charles Univ Prague, Inst Microbiol & Immunol, Fac Med 1, Prague, Czech Republic	Charles University Prague	Panigaj, M (corresponding author), Charles Univ Prague, Inst Microbiol & Immunol, Fac Med 1, Prague, Czech Republic.	Karel.Holada@LF1.cuni.cz	Panigaj, Martin/G-6492-2013; Holada, Karel/J-7043-2017; Panigaj, Martin/M-3898-2019	Holada, Karel/0000-0002-3768-2629; Panigaj, Martin/0000-0002-0940-8737	Czech Science Foundation [GACR 310/08/0878]; Grant Agency of Charles University: [GAUK 86408, GAUK 203429, SVV-2010-260506]; Ministry of Education of the Czech Republic [MSM0021620806]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of Charles University:; Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by Czech Science Foundation: project GACR 310/08/0878; Grant Agency of Charles University: projects GAUK 86408, GAUK 203429 and SVV-2010-260506; and by Ministry of Education of the Czech Republic: project MSM0021620806. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown AR, 2007, BIOCHEM BIOPH RES CO, V364, P366, DOI 10.1016/j.bbrc.2007.10.015; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chen J, 2002, ONCOGENE, V21, P1859, DOI 10.1038/sj.onc.1205003; Christensen HM, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-11; Chute JP, 2010, MOL ENDOCRINOL, V24, P1, DOI 10.1210/me.2009-0332; CLARKE MF, 1988, MOL CELL BIOL, V8, P884, DOI 10.1128/MCB.8.2.884; Dodelet VC, 1998, BLOOD, V91, P1556, DOI 10.1182/blood.V91.5.1556.1556_1556_1561; FIBACH E, 1977, CANCER RES, V37, P440; Ford MJ, 2002, NEUROSCIENCE, V111, P533, DOI 10.1016/S0306-4522(01)00603-0; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gougoumas DD, 2001, EXP CELL RES, V264, P408, DOI 10.1006/excr.2001.5151; Gougoumas DD, 2007, J CELL PHYSIOL, V211, P551, DOI 10.1002/jcp.20969; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Griffiths RE, 2007, BLOOD, V110, P4518, DOI 10.1182/blood-2007-04-085183; Holada K, 2000, BRIT J HAEMATOL, V110, P472, DOI 10.1046/j.1365-2141.2000.02158.x; Holada K, 2007, TRANSFUSION, V47, P2223, DOI 10.1111/j.1537-2995.2007.01451.x; Hyman T, 2001, EXP HEMATOL, V29, P563, DOI 10.1016/S0301-472X(01)00616-6; KANEDA T, 1985, P NATL ACAD SCI USA, V82, P5020, DOI 10.1073/pnas.82.15.5020; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARKS PA, 1989, ENVIRON HEALTH PERSP, V80, P181, DOI 10.2307/3430743; Mattern J, 2007, CANCER BIOL THER, V6, P1345, DOI 10.4161/cbt.6.9.4765; Miele G, 2001, NAT MED, V7, P361, DOI 10.1038/85515; Nicolas O, 2009, BRAIN RES REV, V61, P170, DOI 10.1016/j.brainresrev.2009.06.002; OSBORNE HB, 1982, CANCER RES, V42, P513; Otsuka Y, 2008, JPN J VET RES, V56, P75; Panigaj M, 2011, TRANSFUSION, V51, P1012, DOI 10.1111/j.1537-2995.2010.02924.x; Petrak J, 2007, EXP HEMATOL, V35, P193, DOI 10.1016/j.exphem.2006.10.007; Pfeifer A, 2006, J CLIN INVEST, V116, P3204, DOI 10.1172/JCI29236; Risitano AM, 2003, EXP HEMATOL, V31, P65, DOI 10.1016/S0301-472X(02)01011-1; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; Roucou X, 2004, J NEUROSCI RES, V75, P153, DOI 10.1002/jnr.10864; Schroder B, 2002, ACTA VIROL, V46, P159; Singh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016804; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006115; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004468; Tilly G, 2003, BIOCHEM BIOPH RES CO, V305, P548, DOI 10.1016/S0006-291X(03)00805-2; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103; Zivny JH, 2008, BLOOD CELL MOL DIS, V40, P302, DOI 10.1016/j.bcmd.2007.09.009	40	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24599	10.1371/journal.pone.0024599	http://dx.doi.org/10.1371/journal.pone.0024599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912705	Green Submitted, Green Published, gold			2022-12-25	WOS:000294686100051
J	Collier, IE; Legant, W; Marmer, B; Lubman, O; Saffarian, S; Wakatsuki, T; Elson, E; Goldberg, GI				Collier, Ivan E.; Legant, Wesley; Marmer, Barry; Lubman, Olga; Saffarian, Saveez; Wakatsuki, Tetsuro; Elson, Elliot; Goldberg, Gregory I.			Diffusion of MMPs on the Surface of Collagen Fibrils: The Mobile Cell Surface - Collagen Substratum Interface	PLOS ONE			English	Article							C-TERMINAL DOMAIN; REPRESSOR-OPERATOR INTERACTION; HUMAN FIBROBLAST COLLAGENASE; IV COLLAGENASE; COMPLEX-FORMATION; TISSUE INHIBITOR; MATRIX METALLOPROTEINASES; INTERSTITIAL COLLAGENASE; PROTEIN TRANSLOCATION; DRIVEN MECHANISMS	Remodeling of the extracellular matrix catalyzed by MMPs is central to morphogenetic phenomena during development and wound healing as well as in numerous pathologic conditions such as fibrosis and cancer. We have previously demonstrated that secreted MMP-2 is tethered to the cell surface and activated by MT1-MMP/TIMP-2-dependent mechanism. The resulting cell-surface collagenolytic complex (MT1-MMP)(2)/TIMP-2/MMP-2 can initiate (MT1-MMP) and complete (MMP-2) degradation of an underlying collagen fibril. The following question remained: What is the mechanism of substrate recognition involving the two structures of relatively restricted mobility, the cell surface enzymatic complex and a collagen fibril embedded in the ECM? Here we demonstrate that all the components of the complex are capable of processive movement on a surface of the collagen fibril. The mechanism of MT1-MMP movement is a biased diffusion with the bias component dependent on the proteolysis of its substrate, not adenosine triphosphate (ATP) hydrolysis. It is similar to that of the MMP-1 Brownian ratchet we described earlier. In addition, both MMP-2 and MMP-9 as well as their respective complexes with TIMP-1 and -2 are capable of Brownian diffusion on the surface of native collagen fibrils without noticeable dissociation while the dimerization of MMP-9 renders the enzyme immobile. Most instructive is the finding that the inactivation of the enzymatic activity of MT1-MMP has a detectable negative effect on the cell force developed in miniaturized 3D tissue constructs. We propose that the collagenolytic complex (MT1-MMP)(2)/TIMP-2/MMP-2 represents a Mobile Cell Surface - Collagen Substratum Interface. The biological implications of MT1-MMP acting as a molecular ratchet tethered to the cell surface in complex with MMP-2 suggest a new mechanism for the role of spatially regulated peri-cellular proteolysis in cell-matrix interactions.	[Collier, Ivan E.; Marmer, Barry; Goldberg, Gregory I.] Washington Univ, Sch Med, Div Dermatol, Dept Med, St Louis, MO 63110 USA; [Elson, Elliot; Goldberg, Gregory I.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Lubman, Olga] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Legant, Wesley] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Saffarian, Saveez] Univ Utah, Dept Phys, Salt Lake City, UT 84112 USA; [Wakatsuki, Tetsuro] Med Coll Wisconsin, Dept Physiol, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Pennsylvania; Utah System of Higher Education; University of Utah; Medical College of Wisconsin	Collier, IE (corresponding author), Washington Univ, Sch Med, Div Dermatol, Dept Med, St Louis, MO 63110 USA.	goldberg@DOM.wustl.edu		Wakatsuki, Tetsuro/0000-0002-2175-1132	NIAMS, NIH [R01AR040618]; NCI, NIH [R01CA123363]; NATIONAL CANCER INSTITUTE [R01CA123363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040618] Funding Source: NIH RePORTER	NIAMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the grants R01AR040618 from NIAMS, NIH and R01CA123363 from NCI, NIH to GG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam G., 1968, STRUCTURAL CHEM MOL; Aiken A, 2010, BBA-MOL CELL RES, V1803, P121, DOI 10.1016/j.bbamcr.2009.07.002; AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Bertini I, 2009, J BIOL CHEM, V284, P12821, DOI 10.1074/jbc.M809627200; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Burton K, 1999, MOL BIOL CELL, V10, P3745, DOI 10.1091/mbc.10.11.3745; CARTER SB, 1967, NATURE, V213, P256, DOI 10.1038/213256a0; Cary LA, 1996, J CELL SCI, V109, P1787; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; Collier IE, 2001, BIOPHYS J, V81, P2370, DOI 10.1016/S0006-3495(01)75883-3; COOPER A, 1970, BIOCHEM J, V118, P355, DOI 10.1042/bj1180355; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Dittrich PS, 2001, APPL PHYS B-LASERS O, V73, P829, DOI 10.1007/sO03400100737; Eggeling C, 1998, ANAL CHEM, V70, P2651, DOI 10.1021/ac980027p; Elson EL, 1999, BIOCHEM SOC SYMP, V65, P299; Falconi M, 2003, J COMPUT AID MOL DES, V17, P837, DOI 10.1023/B:JCAM.0000021883.44532.75; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; FRIDMAN R, 1992, J BIOL CHEM, V267, P15398; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; GOLDBERG GI, 1989, P NATL ACAD SCI USA, V86, P8207, DOI 10.1073/pnas.86.21.8207; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; ILLC D, 1995, NATURE, V377, P539; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2008, J BIOL CHEM, V283, P13053, DOI 10.1074/jbc.M709327200; JACOBSON K, 1987, ANNU REV PHYSIOL, V49, P163, DOI 10.1146/annurev.ph.49.030187.001115; Jervis EJ, 1997, J BIOL CHEM, V272, P24016, DOI 10.1074/jbc.272.38.24016; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kinoshita T, 1998, J BIOL CHEM, V273, P16098, DOI 10.1074/jbc.273.26.16098; KOLODNEY MS, 1993, J BIOL CHEM, V268, P23850; KREIS T, GUIDEBOOK EXTRACELLU; Kruger A, 2010, BBA-MOL CELL RES, V1803, P95, DOI 10.1016/j.bbamcr.2009.09.016; Lehti K, 2002, J BIOL CHEM, V277, P8440, DOI 10.1074/jbc.M109128200; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Libson AM, 2000, TISSUE INHIBITORS OF METALLOPROTEINASES IN DEVELOPMENT AND DISEASE, PROCEEDINGS, P91; MAGDE D, 1978, BIOPOLYMERS, V17, P361, DOI 10.1002/bip.1978.360170208; Mai J, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011102; Marquez JP, 2005, BIOPHYS J, V88, P765, DOI 10.1529/biophysj.104.040808; Marquez JP, 2005, BIOPHYS J, V88, P778, DOI 10.1529/biophysj.104.041947; Marquez JP, 2009, TISSUE ENG PART C-ME, V15, P181, DOI 10.1089/ten.tec.2008.0347; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; MURPHY G, 1992, J BIOL CHEM, V267, P9612; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagy A, 2005, BIOPHYS J, V89, P2077, DOI 10.1529/biophysj.104.052779; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Orgel JPRO, 2001, STRUCTURE, V9, P1061, DOI 10.1016/S0969-2126(01)00669-4; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Patterson ML, 2001, FEBS LETT, V503, P158, DOI 10.1016/S0014-5793(01)02723-5; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; PETERSEN NO, 1982, P NATL ACAD SCI-BIOL, V79, P5327, DOI 10.1073/pnas.79.17.5327; PETERSEN NO, 1986, METHOD ENZYMOL, V130, P454; Pingoud A, 1997, EUR J BIOCHEM, V246, P1, DOI 10.1111/j.1432-1033.1997.t01-6-00001.x; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Rosenblum G, 2007, STRUCTURE, V15, P1227, DOI 10.1016/j.str.2007.07.019; Rosenblum G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011043; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Saffarian S, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041909; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; SAFFARIAN SC, 2004, BROWNIAN RATCHET DRI, P1; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SELTZER JL, 1989, J BIOL CHEM, V264, P19583; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; Sun J, 2003, BIOPHYS J, V84, P3317, DOI 10.1016/S0006-3495(03)70056-3; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Tanford C., 1961, PHYS CHEM MACROMOLEC; Tiktopulo EI, 1998, BIOCHEMISTRY-US, V37, P8147, DOI 10.1021/bi980360n; Tochowicz A, 2011, J BIOL CHEM, V286, P7587, DOI 10.1074/jbc.M110.178434; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; Viadiu H, 2000, MOL CELL, V5, P889, DOI 10.1016/S1097-2765(00)80329-9; Wagenseil JE, 2003, J BIOMECH ENG-T ASME, V125, P719, DOI 10.1115/1.1614818; Wakatsuki T, 2000, BIOPHYS J, V79, P2353, DOI 10.1016/S0006-3495(00)76481-2; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6948, DOI 10.1021/bi00527a029; WU H, 1990, P NATL ACAD SCI USA, V87, P5888, DOI 10.1073/pnas.87.15.5888; YURCHENKO PD, EXTRACELLULAR MATRIX; Zahalak GI, 2000, BIOPHYS J, V79, P2369, DOI 10.1016/S0006-3495(00)76482-4	92	54	54	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24029	10.1371/journal.pone.0024029	http://dx.doi.org/10.1371/journal.pone.0024029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21912660	Green Published, gold			2022-12-25	WOS:000294683900021
J	Contreras, V; Friday, AJ; Morrison, JK; Hao, E; Keiper, BD				Contreras, Vince; Friday, Andrew J.; Morrison, J. Kaitlin; Hao, Enhui; Keiper, Brett D.			Cap-Independent Translation Promotes C. elegans Germ Cell Apoptosis through Apaf-1/CED-4 in a Caspase-Dependent Mechanism	PLOS ONE			English	Article							INTERNAL RIBOSOME ENTRY; INITIATION-FACTOR 4G; SITE-MEDIATED TRANSLATION; CAENORHABDITIS-ELEGANS; PROTEIN-SYNTHESIS; EUKARYOTIC TRANSLATION; MESSENGER-RNAS; MAMMALIAN-CELLS; DEATH INHIBITOR; GENETIC-CONTROL	Apoptosis is a natural process during animal development for the programmed removal of superfluous cells. During apoptosis general protein synthesis is reduced, but the synthesis of cell death proteins is enhanced. Selective translation has been attributed to modification of the protein synthesis machinery to disrupt cap-dependent mRNA translation and induce a cap-independent mechanism. We have previously shown that disruption of the balance between cap-dependent and cap-independent C. elegans eIF4G isoforms (IFG-1 p170 and p130) by RNA interference promotes apoptosis in developing oocytes. Germ cell apoptosis was accompanied by the appearance of the Apaf-1 homolog, CED-4. Here we show that IFG-1 p170 is a native substrate of the worm executioner caspase, CED-3, just as mammalian eIF4GI is cleaved by caspase-3. Loss of Bcl-2 function (ced-9ts) in worms induced p170 cleavage in vivo, coincident with extensive germ cell apoptosis. Truncation of IFG-1 occurred at a single site that separates the cap-binding and ribosome-associated domains. Site-directed mutagenesis indicated that CED-3 processes IFG-1 at a non-canonical motif, TTTD(456). Coincidentally, the recognition site was located 65 amino acids downstream of the newly mapped IFG-1 p130 start site suggesting that both forms support cap-independent initiation. Genetic evidence confirmed that apoptosis induced by loss of ifg-1 p170 mRNA was caspase (ced-3) and apoptosome (ced-4/Apaf-1) dependent. These findings support a new paradigm in which modal changes in protein synthesis act as a physiological signal to initiate cell death, rather than occur merely as downstream consequences of the apoptotic event.	[Contreras, Vince; Friday, Andrew J.; Morrison, J. Kaitlin; Hao, Enhui; Keiper, Brett D.] E Carolina Univ, Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Contreras, V (corresponding author), E Carolina Univ, Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27858 USA.	keiperb@ecu.edu		Keiper, Brett/0000-0002-8621-9825	National Science Foundation [MCB-0321017, MCB-0842475]; East Carolina University; Direct For Biological Sciences [0842475] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); East Carolina University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants MCB-0321017 and MCB-0842475 from the National Science Foundation to BDK, as well as a 2009 Research Development Award from East Carolina University Research and Graduate Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri A, 2001, DEVELOPMENT, V128, P3899; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Baum JS, 2005, SEMIN CELL DEV BIOL, V16, P245, DOI 10.1016/j.semcdb.2004.12.008; Bradley CA, 2002, J BIOL CHEM, V277, P12559, DOI 10.1074/jbc.M111134200; Bushell M, 2000, CELL DEATH DIFFER, V7, P628, DOI 10.1038/sj.cdd.4400699; Bushell M, 1999, FEBS LETT, V451, P332, DOI 10.1016/S0014-5793(99)00614-6; Chan SL, 2000, J BIOL CHEM, V275, P17925, DOI 10.1074/jbc.C000146200; Clemens MJ, 2000, CELL DEATH DIFFER, V7, P603, DOI 10.1038/sj.cdd.4400695; Clemens MJ, 1998, ONCOGENE, V17, P2921, DOI 10.1038/sj.onc.1202227; Contreras V, 2008, CELL DEATH DIFFER, V15, P1232, DOI 10.1038/cdd.2008.46; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; Creagh EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005055; Crittenden SL, 2003, PHILOS T ROY SOC B, V358, P1359, DOI 10.1098/rstb.2003.1333; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fraser AG, 1999, CANCER METAST REV, V18, P285, DOI 10.1023/A:1006329509169; FROMONTRACINE M, 1993, NUCLEIC ACIDS RES, V21, P1683, DOI 10.1093/nar/21.7.1683; Galvin BD, 2011, P NATL ACAD SCI USA, V108, P1998, DOI 10.1073/pnas.1018805108; Gan WN, 1998, J BIOL CHEM, V273, P5006, DOI 10.1074/jbc.273.9.5006; Graber TE, 2007, MOL BIOSYST, V3, P825, DOI 10.1039/b708867a; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Henderson MA, 2009, J CELL SCI, V122, P1529, DOI 10.1242/jcs.046771; Hengartner Michael O., 1997, V33, P383; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Henis-Korenblit S, 2002, P NATL ACAD SCI USA, V99, P5400, DOI 10.1073/pnas.082102499; Henis-Korenblit S, 2000, MOL CELL BIOL, V20, P496, DOI 10.1128/MCB.20.2.496-506.2000; Holcik M, 2000, TRENDS GENET, V16, P469, DOI 10.1016/S0168-9525(00)02106-5; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hubbard E Jane Albert, 2005, WormBook, P1; Hundsdoerfer P, 2005, P NATL ACAD SCI USA, V102, P13421, DOI 10.1073/pnas.0506536102; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; Keiper BD, 1999, DEV BIOL, V206, P1, DOI 10.1006/dbio.1998.9131; Keiper BD, 1999, INT J BIOCHEM CELL B, V31, P37, DOI 10.1016/S1357-2725(98)00130-7; Kritikou EA, 2006, GENE DEV, V20, P2279, DOI 10.1101/gad.384506; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lee SH, 2006, EMBO J, V25, P4008, DOI 10.1038/sj.emboj.7601268; Marissen WE, 1998, MOL CELL BIOL, V18, P7565, DOI 10.1128/MCB.18.12.7565; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Nevins TA, 2003, J BIOL CHEM, V278, P3572, DOI 10.1074/jbc.M206781200; Satoh S, 1999, BIOCHEM J, V342, P65, DOI 10.1042/0264-6021:3420065; Scott CE, 1999, J CELL PHYSIOL, V181, P147, DOI 10.1002/(SICI)1097-4652(199910)181:1<147::AID-JCP15>3.0.CO;2-M; Shaham S, 1999, GENETICS, V153, P1655; Shaham S, 1996, CELL, V86, P201, DOI 10.1016/S0092-8674(00)80092-6; Sherrill KW, 2004, J BIOL CHEM, V279, P29066, DOI 10.1074/jbc.M402727200; Taylor RC, 2007, J BIOL CHEM, V282, P15011, DOI 10.1074/jbc.M611051200; Thornberry NA, 1997, BRIT MED BULL, V53, P478; Warnakulasuriyarachchi D, 2004, J BIOL CHEM, V279, P17148, DOI 10.1074/jbc.M308737200; Xue D, 1996, GENE DEV, V10, P1073, DOI 10.1101/gad.10.9.1073; Xue D, 1997, NATURE, V390, P305, DOI 10.1038/36889; YUAN JY, 1992, DEVELOPMENT, V116, P309; Zhou BB, 1998, P NATL ACAD SCI USA, V95, P6785, DOI 10.1073/pnas.95.12.6785; Zullig S, 2007, CURR BIOL, V17, P994, DOI 10.1016/j.cub.2007.05.024	53	13	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24444	10.1371/journal.pone.0024444	http://dx.doi.org/10.1371/journal.pone.0024444			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909434	Green Published, gold, Green Submitted			2022-12-25	WOS:000294683900050
J	Hou, Y; Lou, A				Hou, Yan; Lou, Anru			Population Genetic Diversity and Structure of a Naturally Isolated Plant Species, Rhodiola dumulosa (Crassulaceae)	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; HABITAT FRAGMENTATION; CLIMATE-CHANGE; WESTERN ALPS; DISTANCE; INFERENCE; RANGE; AFLP; DIFFERENTIATION; CONSEQUENCES	Aims: Rhodiola dumulosa (Crassulaceae) is a perennial diploid species found in high-montane areas. It is distributed in fragmented populations across northern, central and northwestern China. In this study, we aimed to (i) measure the genetic diversity of this species and that of its populations; (ii) describe the genetic structure of these populations across the entire distribution range in China; and (iii) evaluate the extent of gene flow among the naturally fragmented populations. Methods: Samples from 1089 individuals within 35 populations of R. dumulosa were collected, covering as much of the entire distribution range of this species within China as possible. Population genetic diversity and structure were analyzed using AFLP molecular markers. Gene flow among populations was estimated according to the level of population differentiation. Important Findings: The total genetic diversity of R. dumulosa was high but decreased with increasing altitude. Population-structure analysis indicated that the most closely related populations were geographically restricted and occurred in close proximity to each other. A significant isolation-by-distance pattern, caused by the naturally fragmented population distribution, was observed. At least two distinct gene pools were found in the 35 sampled populations, one composed of populations in northern China and the other composed of populations in central and northwestern China. The calculation of Nei's gene diversity index revealed that the genetic diversity in the northern China pool (0.1972) was lower than that in the central and northwestern China pool (0.2216). The populations were significantly isolated, and gene flow was restricted throughout the entire distribution. However, gene flow among populations on the same mountain appears to be unrestricted, as indicated by the weak genetic isolation among these populations.	[Hou, Yan; Lou, Anru] Beijing Normal Univ, Coll Life Sci, State Key Lab Earth Surface Proc & Resource, Beijing 100875, Peoples R China	Beijing Normal University	Hou, Y (corresponding author), Beijing Normal Univ, Coll Life Sci, State Key Lab Earth Surface Proc & Resource, Beijing 100875, Peoples R China.	louanru@bnu.edu.cn			National Natural Science Foundation of China [30770356]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30770356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2008, MOL ECOL, V17, P5177, DOI 10.1111/j.1365-294X.2008.03971.x; [Anonymous], 1997, TFPGA TOOLS POPULATI; BALLAL SR, 1994, CAN J BOT, V72, P1311, DOI 10.1139/b94-160; Beatty GE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-29; Beck JB, 2008, MOL ECOL, V17, P902, DOI 10.1111/j.1365-294X.2007.03615.x; Bossuyt B, 2007, CONSERV BIOL, V21, P832, DOI 10.1111/j.1523-1739.2006.00645.x; Cardoso SRS, 2005, BIODIVERS CONSERV, V14, P1047, DOI 10.1007/s10531-004-8409-z; [陈克霞 CHEN KeXia], 2008, [生态学报, Acta Ecologica Sinica], V28, P2480; Chen XY, 2000, ACTA ECOL SIN, V20, P884; de la Torre A, 2008, FOREST ECOL MANAG, V255, P334, DOI 10.1016/j.foreco.2007.09.058; Dubreuil M, 2008, AM J BOT, V95, P577, DOI 10.3732/ajb.2007320; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Felsenstein J, 2008, PHYLIP PHYLOGENY INF; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Honnay O, 2005, NEW PHYTOL, V166, P723, DOI 10.1111/j.1469-8137.2005.01352.x; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kuss P, 2008, J PLANT ECOL, V1, P149, DOI 10.1093/jpe/rtn009; LV YL, 2009, GENETIC DIVERSITY AN; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Medrano M, 2008, ANN BOT-LONDON, V102, P183, DOI 10.1093/aob/mcn086; MENG QW, 2007, INTRASPECIES GENETIC; Mu Yong, 2007, Zhiwu Shengtai Xuebao, V31, P528; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; NEI M, 1978, GENETICS, V89, P583; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Parisod C, 2008, BOT HELV, V118, P1, DOI 10.1007/s00035-008-0825-3; Parisod C, 2007, MOL ECOL, V16, P2755, DOI 10.1111/j.1365-294X.2007.03315.x; Parisod C, 2010, ANN BOT-LONDON, V105, P655, DOI 10.1093/aob/mcq014; Prentice HC, 2006, J ECOL, V94, P87, DOI 10.1111/j.1365-2745.2005.01054.x; Pritchard JK, 2000, GENETICS, V155, P945; PROBER SM, 1990, AUST J BOT, V38, P79, DOI 10.1071/BT9900079; ROHLF F, 2000, NTSYS NUMERICAL TAXO; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schaal BA, 1998, MOL ECOL, V7, P465, DOI 10.1046/j.1365-294x.1998.00318.x; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; UHL CH, 1952, EVOLUTION, V6, P81, DOI 10.2307/2405505; Van Geert A, 2008, CONSERV GENET, V9, P845, DOI 10.1007/s10592-007-9409-9; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; VEKEMANS X, 2002, AFLP SURV VERSION 1; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wesche K, 2006, PLANT SPEC BIOL, V21, P155, DOI 10.1111/j.1442-1984.2006.00161.x; Wright S, 1943, GENETICS, V28, P114; Yao XH, 2007, NEW PHYTOL, V176, P472, DOI 10.1111/j.1469-8137.2007.02175.x; Yeh F.C., 1997, POPGENE VERSION 1 31; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x; Zhu L, 2010, J PLANT ECOL, V3, P219, DOI 10.1093/jpe/rtq024; Zhu Y, 2009, BIOCHEM SYST ECOL, V37, P589, DOI 10.1016/j.bse.2009.10.007	54	33	38	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24497	10.1371/journal.pone.0024497	http://dx.doi.org/10.1371/journal.pone.0024497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909437	Green Published, gold, Green Submitted			2022-12-25	WOS:000294683900053
J	Gao, C; Shi, Q; Tian, C; Chen, C; Han, J; Zhou, W; Zhang, BY; Jiang, HY; Zhang, J; Dong, XP				Gao, Chen; Shi, Qi; Tian, Chan; Chen, Cao; Han, Jun; Zhou, Wei; Zhang, Bao-Yun; Jiang, Hui-Ying; Zhang, Jin; Dong, Xiao-Ping			The Epidemiological, Clinical, and Laboratory Features of Sporadic Creutzfeldt-Jakob Disease Patients in China: Surveillance Data from 2006 to 2010	PLOS ONE			English	Article								Background: Creutzfeldt-Jakob disease (CJD) is a rare, rapidly progressive fatal central nervous system disorder, which consists of three main catalogues: sporadic, familial, and iatrogenic CJD. Methodology/Principal Findings: In China, the surveillance for CJD started in 2006, covering 12 provincial Centers for Disease Control and Prevention (CDCs) and 15 hospitals. From 2006 to 2010, 624 suspected patients were referred to China CJD surveillance. The epidemiological, clinical and laboratory features of sporadic CJD (sCJD) were analysed. Both groups of probable and possible sCJD showed highest incidences in the population of 60 to 69 year-olds. The most common presenting symptoms were progressive dementia and mental-related symptoms (neurological symptoms including sleeping turbulence, depression, anxiety and stress). Among the four main clinical manifestations, myoclonus was more frequently observed in the probable sCJD patients. About 2/3 of probable sCJD cases showed positive 14-3-3 in CSF and/or periodic sharp wave complexes (PSWC) in electroencephalography (EEG). The presence of myoclonus was significantly closely related with the appearance of PSWC in EEG. Polymorphisms of codon 129 in PRNP of the notified cases revealed a highly predominant M129M genotype in Han Chinese. Among 23 genetic human prion diseases, ten were D178N/M129M Fatal familial insomnia (FFI) and five were T188K genetic CJD (gCJD), possibly indicating a special distribution of gCJD-related mutations in Han Chinese. Conclusion: From the period of 2006 to 2010, 261 patients were diagnosed as sCJD and 23 patients were diagnosed as genetic human prion diseases in China. The epidemiological, clinical and laboratory analysis data were consistent with the characteristics of sporadic CJD, which provide insight into the features of CJD in China.	[Gao, Chen; Shi, Qi; Tian, Chan; Chen, Cao; Han, Jun; Zhou, Wei; Zhang, Bao-Yun; Jiang, Hui-Ying; Zhang, Jin; Dong, Xiao-Ping] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Gao, C (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	dongxp238@sina.com	Chen, Cao/CAF-1246-2022	Chen, Cao/0000-0002-5193-9283	China Mega-Project for Infectious Disease [2009ZX10004-101, 2008ZX10004-008]; SKLID (State Key Laboratory for Infectious Disease Prevention and Control) [2008SKLID102, 2008SKLID202]; National Basic Research Program of China (973 Program) [2007CB310505]; Chinese National Natural Science Foundation [30800975]; China CDC Young Scientist Foundation [2009A104]	China Mega-Project for Infectious Disease; SKLID (State Key Laboratory for Infectious Disease Prevention and Control); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China CDC Young Scientist Foundation	This work was supported by the China Mega-Project for Infectious Disease (2009ZX10004-101, 2008ZX10004-008), SKLID (State Key Laboratory for Infectious Disease Prevention and Control) Development Grant (2008SKLID102, 2008SKLID202), National Basic Research Program of China (973 Program) (2007CB310505), Chinese National Natural Science Foundation Grants (30800975) and China CDC Young Scientist Foundation (2009A104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahantes JC, 2007, EUR J EPIDEMIOL, V22, P457, DOI 10.1007/s10654-007-9146-x; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Gao C, 2010, BIOMED ENVIRON SCI, V23, P158, DOI 10.1016/S0895-3988(10)60046-3; Heinemann U, 2007, BRAIN, V130, P1350, DOI 10.1093/brain/awm063; Hou Xingsheng, 2002, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V16, P105; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; Ladogana A, 2005, NEUROLOGY, V64, P1592, DOI 10.1212/01.WNL.0000160118.26865.11; Shi Qi, 2009, Cases J, V2, P7820, DOI 10.1186/1757-1626-2-7820; Shi Q, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-360; Shi XH, 2010, INFECT GENET EVOL, V10, P292, DOI 10.1016/j.meegid.2010.01.007; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Ye Jing, 2008, J Med Case Rep, V2, P331, DOI 10.1186/1752-1947-2-331; Zerr I, 2009, BRAIN, V132, P2659, DOI 10.1093/brain/awp191	13	46	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24231	10.1371/journal.pone.0024231	http://dx.doi.org/10.1371/journal.pone.0024231			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904617	gold, Green Published, Green Submitted			2022-12-25	WOS:000294680800069
J	Garcia-Arriaza, J; Najera, JL; Gomez, CE; Tewabe, N; Sorzano, COS; Calandra, T; Roger, T; Esteban, M				Garcia-Arriaza, Juan; Luis Najera, Jose; Gomez, Carmen E.; Tewabe, Nolawit; Sorzano, Carlos Oscar S.; Calandra, Thierry; Roger, Thierry; Esteban, Mariano			A Candidate HIV/AIDS Vaccine (MVA-B) Lacking Vaccinia Virus Gene C6L Enhances Memory HIV-1-Specific T-Cell Responses	PLOS ONE			English	Article							POXVIRUS VECTORS MVA; RNA HELICASE DDX3; HIV-1 DNA VACCINE; PHASE-I TRIAL; IMMUNE-RESPONSES; WESTERN RESERVE; ANKARA MVA; VIRULENCE FACTOR; RHESUS-MONKEYS; VIRAL LOAD	The vaccinia virus (VACV) C6 protein has sequence similarities with the poxvirus family Pox_A46, involved in regulation of host immune responses, but its role is unknown. Here, we have characterized the C6 protein and its effects in virus replication, innate immune sensing and immunogenicity in vivo. C6 is a 18.2 kDa protein, which is expressed early during virus infection and localizes to the cytoplasm of infected cells. Deletion of the C6L gene from the poxvirus vector MVA-B expressing HIV-1 Env, Gag, Pol and Nef antigens from clade B (MVA-B Delta C6L) had no effect on virus growth kinetics; therefore C6 protein is not essential for virus replication. The innate immune signals elicited by MVA-B Delta C6L in human macrophages and monocyte-derived dendritic cells (moDCs) are characterized by the up-regulation of the expression of IFN-beta and IFN-alpha/beta-inducible genes. In a DNA prime/MVA boost immunization protocol in mice, flow cytometry analysis revealed that MVA-B Delta C6L enhanced the magnitude and polyfunctionality of the HIV-1-specific CD4(+) and CD8(+) T-cell memory immune responses, with most of the HIV-1 responses mediated by the CD8(+) T-cell compartment with an effector phenotype. Significantly, while MVA-B induced preferentially Env- and Gag-specific CD8(+) T-cell responses, MVA-B Delta C6L induced more Gag-Pol-Nef-specific CD8(+) T-cell responses. Furthermore, MVA-B Delta C6L enhanced the levels of antibodies against Env in comparison with MVA-B. These findings revealed that C6 can be considered as an immunomodulator and that deleting C6L gene in MVA-B confers an immunological benefit by enhancing IFN-beta-dependent responses and increasing the magnitude and quality of the T-cell memory immune responses to HIV-1 antigens. Our observations are relevant for the improvement of MVA vectors as HIV-1 vaccines.	[Garcia-Arriaza, Juan; Luis Najera, Jose; Gomez, Carmen E.; Tewabe, Nolawit; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain; [Sorzano, Carlos Oscar S.] CSIC, Ctr Nacl Biotecnol, Biocomp Unit, Madrid, Spain; [Calandra, Thierry; Roger, Thierry] CHU Vaudois, Dept Med, Infect Dis Serv, Lausanne, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Garcia-Arriaza, J (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain.	mesteban@cnb.csic.es	Gomez, Carmen Elena/K-1940-2014; Roger, Thierry/G-2007-2012; GARCIA-ARRIAZA, JUAN/Q-6243-2017; NAJERA, Jose Luis/W-8177-2019; Sorzano, Carlos Oscar S S./F-2639-2016; Franzeck, Fabian C/B-5055-2011; Calandra, Thierry/D-9017-2015; Esteban, Mariano/ABG-5375-2020; S. Sorzano, Carlos Oscar/ABE-4884-2021	Gomez, Carmen Elena/0000-0002-5414-7935; Roger, Thierry/0000-0002-9358-0109; GARCIA-ARRIAZA, JUAN/0000-0002-5167-5724; Sorzano, Carlos Oscar S S./0000-0002-9473-283X; Calandra, Thierry/0000-0003-3051-1285; Esteban, Mariano/0000-0003-0846-2827; S. Sorzano, Carlos Oscar/0000-0002-9473-283X; Najera, jose Luis/0000-0001-7798-3330	Ministry of Science and Innovation [SAF2008-02036]; Foundation Botin of Spain; Swiss National Science Foundation [310000-114073/1, 310030-118266]; Santos Suarez Foundation;  [FIPSE-360731/09]	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Foundation Botin of Spain; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Santos Suarez Foundation; 	This investigation was supported by grants from FIPSE-360731/09, the Ministry of Science and Innovation (SAF2008-02036), Foundation Botin of Spain, the Swiss National Science Foundation (310000-114073/1 and 310030-118266), and the Santos Suarez Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud S, 2010, CLIN VACCINE IMMUNOL, V17, P1124, DOI 10.1128/CVI.00008-10; Addo MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000321; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Amara RR, 2005, VIROLOGY, V343, P246, DOI 10.1016/j.virol.2005.08.027; Amara RR, 2002, J VIROL, V76, P7625, DOI 10.1128/JVI.76.15.7625-7631.2002; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Assarsson E, 2008, P NATL ACAD SCI USA, V105, P2140, DOI 10.1073/pnas.0711573105; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Bart PA, 2008, VACCINE, V26, P3153, DOI 10.1016/j.vaccine.2008.03.083; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chen RAJ, 2006, J GEN VIROL, V87, P1451, DOI 10.1099/vir.0.81736-0; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Chung CS, 2006, J VIROL, V80, P2127, DOI 10.1128/JVI.80.5.2127-2140.2006; Clark RH, 2006, J GEN VIROL, V87, P29, DOI 10.1099/vir.0.81417-0; Climent N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019644; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Dondi E, 2001, J BIOL CHEM, V276, P47004, DOI 10.1074/jbc.M104316200; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Esteban M, 2009, HUM VACCINES, V5, P867, DOI 10.4161/hv.9693; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Girgis NM, 2011, J VIROL, V85, P2547, DOI 10.1128/JVI.01474-10; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Gomez CE, 2009, VACCINE, V27, P3165, DOI 10.1016/j.vaccine.2009.03.049; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; Gonzalez JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-59; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000128; Guerra S, 2007, J VIROL, V81, P8707, DOI 10.1128/JVI.00444-07; Guerra S, 2010, J VIROL, V84, P8141, DOI 10.1128/JVI.00749-10; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hess C, 2004, LANCET, V363, P863, DOI 10.1016/S0140-6736(04)15735-8; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Kalverda AP, 2009, J MOL BIOL, V385, P843, DOI 10.1016/j.jmb.2008.09.048; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; MIYAHIRA Y, 1995, J IMMUNOL METHODS, V181, P45, DOI 10.1016/0022-1759(94)00327-S; Mooij P, 2008, J VIROL, V82, P2975, DOI 10.1128/JVI.02216-07; Najera JL, 2006, J VIROL, V80, P6033, DOI 10.1128/JVI.02108-05; Northfield JW, 2007, J VIROL, V81, P5759, DOI 10.1128/JVI.00045-07; Oda S, 2009, STRUCTURE, V17, P1528, DOI 10.1016/j.str.2009.09.005; Oseroff C, 2008, J IMMUNOL, V180, P7193, DOI 10.4049/jimmunol.180.11.7193; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Peters BS, 2007, VACCINE, V25, P2120, DOI 10.1016/j.vaccine.2006.11.016; Ramanathan VD, 2009, AIDS RES HUM RETROV, V25, P1107, DOI 10.1089/aid.2009.0096; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Rehm KE, 2011, VACCINE, V29, P3276, DOI 10.1016/j.vaccine.2011.02.023; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robinson HL, 2007, AIDS RES HUM RETROV, V23, P1555, DOI 10.1089/aid.2007.0165; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Staib C, 2005, J GEN VIROL, V86, P1997, DOI 10.1099/vir.0.80646-0; UZE G, 1994, J MOL BIOL, V243, P245, DOI 10.1006/jmbi.1994.1651; Vasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008816; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Zhang LL, 2009, J PROTEOME RES, V8, P4311, DOI 10.1021/pr900491n; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	73	60	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24244	10.1371/journal.pone.0024244	http://dx.doi.org/10.1371/journal.pone.0024244			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909386	Green Published, gold			2022-12-25	WOS:000294680800071
J	Li, Y; Shen, CX; Ji, YN; Feng, Y; Ma, GS; Liu, NF				Li, Yang; Shen, Chengxing; Ji, Yanan; Feng, Yi; Ma, Genshan; Liu, Naifeng			Clinical Implication of Coronary Tortuosity in Patients with Coronary Artery Disease	PLOS ONE			English	Article							CAROTID-ARTERY; HEART-DISEASE; SHEAR-STRESS; ATHEROSCLEROSIS; KINKING	Background: Coronary tortuosity (CT) is a common coronary angiography finding. The exact pathogenesis, clinical implication and long-term prognosis of CT are not fully understood. The purpose of this study is to investigate the clinical characteristics of CT in patients with suspected coronary artery disease(CAD) in a Chinese population. Methods: A total of 1010 consecutive patients underwent coronary angiography with complaints of chest pain or related symptoms were included in the present study (544 male, mean age: 64611 years). CT was defined by the finding of >= 3 bends (defined as >= 45 degrees change in vessel direction) along main trunk of at least one artery in systole and in diastole. Patients with or without CAD were further divided into CT-positive and CT-negative groups, all patients were followed up for the incidence of major adverse cardiovascular events (MACE) for 2 to 4 years. Results: The prevalence of CT was 39.1% in this patient cohort and incidence of CT was significantly higher in female patients than that in male patients (OR = 2.603, 95% CI 1.897, 3.607, P<0.001). CT was positively correlated with essential hypertension (OR = 1.533, 95% CI 1.131, 2.076, P = 0.006) and negatively correlated with CAD (OR = 0.755, 95% CI 0.574, 0.994, P = 0.045). MACE during follow up was similar between CAD patients with or without CT. Conclusions: CT is more often seen in females and positively correlated with hypertension and negatively correlated with coronary atherosclerosis.	[Li, Yang; Shen, Chengxing; Ji, Yanan; Feng, Yi; Ma, Genshan; Liu, Naifeng] Southeast Univ, Dept Cardiol, Zhongda Hosp, Nanjing, Peoples R China	Southeast University - China	Li, Y (corresponding author), Southeast Univ, Dept Cardiol, Zhongda Hosp, Nanjing, Peoples R China.	liunf@seu.edu.cn	Liu, Nai-feng/AAM-7836-2020		Jiangsu Key Laboratory of Medicine-high technology platform for molecular biological diagnosis and treatment of severe diseases, Jiangsu Provincial People's Hospital [KF200940]	Jiangsu Key Laboratory of Medicine-high technology platform for molecular biological diagnosis and treatment of severe diseases, Jiangsu Provincial People's Hospital	This work was supported in part by the Open Project Program of the Jiangsu Key Laboratory of Medicine-high technology platform for molecular biological diagnosis and treatment of severe diseases, Jiangsu Provincial People's Hospital (no. KF200940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Del Corso L, 1998, ANGIOLOGY, V49, P361, DOI 10.1177/000331979804900505; GERTZ SD, 1990, AM J CARDIOL, V66, P1368, DOI 10.1016/0002-9149(90)91170-B; Groves Samuel S, 2009, W V Med J, V105, P14; Han HC, 2007, J BIOMECH, V40, P3672, DOI 10.1016/j.jbiomech.2007.06.018; HUTCHINS GM, 1977, AM HEART J, V94, P196, DOI 10.1016/S0002-8703(77)80280-9; Jackson ZS, 2005, ARTERIOSCL THROM VAS, V25, P957, DOI 10.1161/01.ATV.0000161277.46464.11; Jakob M, 1996, CATHETER CARDIO DIAG, V38, P25; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Pancera P, 2000, J INTERN MED, V248, P7, DOI 10.1046/j.1365-2796.2000.00611.x; Satish G, 2008, CIRCULATION, V117, pE477, DOI 10.1161/CIRCULATIONAHA.107.739839; Sho E, 2004, J VASC SURG, V39, P601, DOI 10.1016/j.jvs.2003.10.058; Smedby O, 1996, ANN BIOMED ENG, V24, P474, DOI 10.1007/BF02648109; Thygesen K, 2007, EUR HEART J, V28, P2525; Turgut O, 2007, INT J CARDIOVAS IMAG, V23, P671, DOI 10.1007/s10554-006-9186-4; Wang Li-jun, 2008, Zhonghua Wai Ke Za Zhi, V46, P1658; Zegers ES, 2007, NETH HEART J, V15, P191, DOI 10.1007/BF03085979; Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423	20	48	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24232	10.1371/journal.pone.0024232	http://dx.doi.org/10.1371/journal.pone.0024232			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904618	gold, Green Submitted, Green Published			2022-12-25	WOS:000294680800070
J	Bajc, M; Cas, M; Ballian, D; Kunovac, S; Zubic, G; Grubesic, M; Zhelev, P; Paule, L; Grebenc, T; Kraigher, H				Bajc, Marko; Cas, Miran; Ballian, Dalibor; Kunovac, Sasa; Zubic, Goran; Grubesic, Marijan; Zhelev, Petar; Paule, Ladislav; Grebenc, Tine; Kraigher, Hojka			Genetic Differentiation of the Western Capercaillie Highlights the Importance of South-Eastern Europe for Understanding the Species Phylogeography	PLOS ONE			English	Article							WINTER HABITAT SELECTION; POPULATION-GROWTH; TETRAO-UROGALLUS; MAXIMUM-LIKELIHOOD; GLACIAL REFUGIA; MUTATION-RATE; DNA; FOREST; PATTERNS; RATES		[Bajc, Marko; Cas, Miran; Grebenc, Tine; Kraigher, Hojka] Slovenian Forestry Inst, Ljubljana, Slovenia; [Ballian, Dalibor; Kunovac, Sasa] Fac Forestry, Sarajevo, Bosnia & Herceg; [Zubic, Goran] Municipal Kupres, Republic Of Srpska, Bosnia & Herceg; [Grubesic, Marijan] Univ Zagreb, Fac Forestry, Zagreb 41000, Croatia; [Zhelev, Petar] Univ Forestry, Sofia, Bulgaria; [Paule, Ladislav] Tech Univ, Fac Forestry, Zvolen, Slovakia	Slovenian Forestry Institute; University of Zagreb; University of Forestry - Bulgaria; Technical University Zvolen	Bajc, M (corresponding author), Slovenian Forestry Inst, Ljubljana, Slovenia.	hojka.kraigher@gozdis.si	Paule, Ladislav/K-5373-2012; Grebenc, Tine/V-1571-2019; Zhelev, Petar/ABG-4248-2020	Paule, Ladislav/0000-0002-5097-7472; Grebenc, Tine/0000-0003-4035-8587; Zhelev, Petar/0000-0002-4273-3400	Slovenian Research Agency (Ministry of Higher Education, Science and Technology of the Republic of Slovenia) [P4-0107]; Ministry for Agriculture, Forestry and Food; National Science Fund of Bulgaria [BS-106];  [V4-0492]	Slovenian Research Agency (Ministry of Higher Education, Science and Technology of the Republic of Slovenia)(Slovenian Research Agency - Slovenia); Ministry for Agriculture, Forestry and Food; National Science Fund of Bulgaria(National Science Fund of Bulgaria); 	The study was financed by the Slovenian Research Agency (on behalf of the Ministry of Higher Education, Science and Technology of the Republic of Slovenia) through the Research programme Forest Biology, Ecology and Technology (P4-0107) and a goal research project V4-0492, co-financed by the Ministry for Agriculture, Forestry and Food of RS. P. Zhelev was supported by National Science Fund of Bulgaria within a bilateral project with Slovakia (BS-106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic M, 2006, UGROZENE VRSTE DIVLJ; ADAMIC M, 1987, ECOLOGY CAPERCAILLIE; Angelstam P., 2004, Ecological Bulletins, V51, P427; Anic I., 2009, SUMAR LIST, V3, P135; [Anonymous], 2005, PHYLIP PHYLOGENY INF; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Babik W, 2005, MOL ECOL, V14, P2475, DOI 10.1111/j.1365-294X.2005.02605.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Blanco-Fontao B, 2010, J ORNITHOL, V151, P269, DOI 10.1007/s10336-009-0452-9; Boev Zlatozar, 2002, Acta Zoologica Cracoviensia, V45, P263; Bollmann K, 2005, FOREST ECOL MANAG, V215, P307, DOI 10.1016/j.foreco.2005.05.019; Brito PH, 2005, MOL ECOL, V14, P3077, DOI 10.1111/j.1365-294X.2005.02663.x; Cas M., 2001, Gozdarski Vestnik, V59, P411; CAS M, 2002, GROUSE NEWS, V24, P10; CAS M, 2006, FLUCTUATION CAPERCAI; CAS M, 2007, CLIMATE CHANGE IMPAC, P99; CAS M, 1998, ZBORNIK GOZDARSTVA L, V57, P5; Cas M, 2010, SUMAR LIST, V134, P487; CHAKRABORTY R, 1990, AM J HUM GENET, V47, P87; COOPER SJB, 1995, MOL ECOL, V4, P49, DOI 10.1111/j.1365-294X.1995.tb00191.x; Deffontaine V, 2005, MOL ECOL, V14, P1727, DOI 10.1111/j.1365-294X.2005.02506.x; DEJUANA E, 1994, HDB BIRDS WORLD, V2, P376; Denver DR, 2000, SCIENCE, V289, P2342, DOI 10.1126/science.289.5488.2342; Drovetski SV, 2002, SYST BIOL, V51, P930, DOI 10.1080/10635150290156033; Drovetski SV, 2003, J BIOGEOGR, V30, P1173, DOI 10.1046/j.1365-2699.2003.00920.x; Olivier D, 2007, CONSERV GENET, V8, P513, DOI 10.1007/s10592-006-9165-2; EIBERLE K, 1984, SCHWEIZ JAGD ZTG, V11, P28; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frenzel B., 1992, LATE PLEISTOCENE HOL; Fu YX, 1997, GENETICS, V147, P915; GACIC D, 2009, SUMARSTVO, V61, P155; Gonzalez MA, 2010, J ORNITHOL, V151, P901, DOI 10.1007/s10336-010-0528-6; Grimm V, 2000, WILDLIFE BIOL, V6, P219, DOI 10.2981/wlb.2000.019; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hedrick PW, 2010, CONSERV GENET, V11, P615, DOI 10.1007/s10592-009-9999-5; Heyer E, 2001, AM J HUM GENET, V69, P1113, DOI 10.1086/324024; Horvath MB, 2005, J AVIAN BIOL, V36, P84, DOI 10.1111/j.0908-8857.2005.03370.x; Huntley B., 1983, ATLAS PRESENT POLLEN; Klaus S., 1994, Gibier Faune Sauvage, V11, P57; Krystufek B, 2007, MOL ECOL, V16, P1221, DOI 10.1111/j.1365-294X.2007.03235.x; Kuhner MK, 1998, GENETICS, V149, P429; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; KUHNER MK, 1995, GENETICS, V140, P1421; Kutnar L., 2009, Zbornik Gozdarstva in Lesarstva, P33; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liukkonen-Anttila T, 2004, ANN ZOOL FENN, V41, P619; Lucchini V, 2001, MOL PHYLOGENET EVOL, V20, P149, DOI 10.1006/mpev.2001.0943; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Matvejev S., 1991, NARAVNI TIPI PREDELO; MATVEJEV SD, 1957, GODISNJAK I NAUCNA I, P5; Mila B, 2000, P ROY SOC B-BIOL SCI, V267, P1033, DOI 10.1098/rspb.2000.1107; MONMONIER MS, 1973, GEOGR ANAL, V5, P245; Nei M., 1987, MOL EVOLUTIONARY GEN; Petrov IK, 2008, ACTA ZOOL BULGAR, P35; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PRICE TD, 1984, NATURE, V309, P787, DOI 10.1038/309787a0; Quevedo M, 2006, WILDLIFE BIOL, V12, P267, DOI 10.2981/0909-6396(2006)12[267:HSBCCT]2.0.CO;2; RADOVIC D, 2003, GROUSE TETRAONIDAE R, P97; RAGUZ D, 2006, FOREST PROTECTION WO, P169; Randi E, 2003, MOL ECOL, V12, P2201, DOI 10.1046/j.1365-294X.2003.01899.x; REYNOLDS J, 1983, GENETICS, V105, P767; Rodriguez-Munoz R, 2007, CONSERV GENET, V8, P659, DOI 10.1007/s10592-006-9212-z; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; ROLSTAD J, 1987, OECOLOGIA, V72, P389, DOI 10.1007/BF00377569; Sachot S, 2003, BIOL CONSERV, V112, P373, DOI 10.1016/S0006-3207(02)00334-8; Sandercock BK, 2011, J ANIM ECOL, V80, P244, DOI 10.1111/j.1365-2656.2010.01769.x; Schneider S, 1999, GENETICS, V152, P1079; Segelbacher G, 2003, MOL ECOL, V12, P1773, DOI 10.1046/j.1365-294X.2003.01873.x; Segelbacher G, 2002, MOL ECOL, V11, P1669, DOI 10.1046/j.1365-294X.2002.01565.x; Segelbacher G, 2007, J ORNITHOL, V148, pS269, DOI 10.1007/s10336-007-0153-1; SLATKIN M, 1995, GENETICS, V139, P457; STORCH I, 1993, ECOGRAPHY, V16, P351, DOI 10.1111/j.1600-0587.1993.tb00224.x; STORCH I, 1993, OECOLOGIA, V95, P257, DOI 10.1007/BF00323498; Storch I., 2007, GROUSE STATUS SURVEY; Sumegi P, 2002, QUATERN INT, V91, P53, DOI 10.1016/S1040-6182(01)00102-1; Suter W, 2002, CONSERV BIOL, V16, P778, DOI 10.1046/j.1523-1739.2002.01129.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002; Willis KJ, 2000, QUATERNARY RES, V53, P203, DOI 10.1006/qres.1999.2119; ZUBIC G, 2009, B FACULTY FORESTRY, V100, P71	92	23	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23602	10.1371/journal.pone.0023602	http://dx.doi.org/10.1371/journal.pone.0023602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897847	Green Published, Green Submitted, gold			2022-12-25	WOS:000294676900010
J	Bakthavatchalu, V; Dey, S; Xu, Y; Noel, T; Jungsuwadee, P; Holley, AK; Dhar, SK; Batinic-Haberle, I; St Clair, DK				Bakthavatchalu, V.; Dey, S.; Xu, Y.; Noel, T.; Jungsuwadee, P.; Holley, A. K.; Dhar, S. K.; Batinic-Haberle, I.; St Clair, D. K.			Manganese superoxide dismutase is a mitochondrial fidelity protein that protects Pol gamma against UV-induced inactivation	ONCOGENE			English	Article						fidelity gene; polymerase gamma; p53; MnSOD; oxidative/nitrative stresses; (MnTE)-T-III-2-PyP5+	DNA-POLYMERASE GAMMA; BASE EXCISION-REPAIR; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; OXIDATIVE STRESS; HUMAN SKIN; P53 PROTEIN; MOUSE KERATINOCYTES; SUNLIGHT EXPOSURE; ACCESSORY SUBUNIT; B IRRADIATION	Manganese superoxide dismutase is a nuclear encoded primary antioxidant enzyme localized exclusively in the mitochondrial matrix. Genotoxic agents, such as ultraviolet (UV) radiation, generates oxidative stress and cause mitochondrial DNA (mtDNA) damage. The mtDNA polymerase (Pol gamma), a major constituent of nucleoids, is responsible for the replication and repair of the mitochondrial genome. Recent studies suggest that the mitochondria contain fidelity proteins and MnSOD constitutes an integral part of the nucleoid complex. However, it is not known whether or how MnSOD participates in the mitochondrial repair processes. Using skin tissue from C57BL/6 mice exposed to UVB radiation, we demonstrate that MnSOD has a critical role in preventing mtDNA damage by protecting the function of Pol gamma. Quantitative-PCR analysis shows an increase in mtDNA damage after UVB exposure. Immunofluorescence and immunoblotting studies demonstrate p53 translocation to the mitochondria and interaction with Pol gamma after UVB exposure. The mtDNA immunoprecipitation assay with Pol gamma and p53 antibodies in p53(+/+) and p53(-/-) mice demonstrates an interaction between MnSOD, p53 and Pol gamma. The results suggest that these proteins form a complex for the repair of UVB-associated mtDNA damage. The data also demonstrate that UVB exposure injures the mtDNA D-loop in a p53-dependent manner. Using MnSOD-deficient mice we demonstrate that UVB-induced mtDNA damage is MnSOD dependent. Exposure to UVB results in nitration and inactivation of Pol gamma, which is prevented by addition of the MnSOD mimetic (MnTE)-T-III-2-PyP5+. These results demonstrate for the first time that MnSOD is a fidelity protein that maintains the activity of Pol gamma by preventing UVB-induced nitration and inactivation of Pol gamma. The data also demonstrate that MnSOD has a role along with p53 to prevent mtDNA damage. Oncogene (2012) 31, 2129-2139; doi:10.1038/onc.2011.407; published online 12 September 2011	[Bakthavatchalu, V.; Xu, Y.; Noel, T.; Jungsuwadee, P.; Holley, A. K.; Dhar, S. K.; St Clair, D. K.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Dey, S.] Proctor & Gamble, Cincinnati, OH USA; [Jungsuwadee, P.] Husson Univ, Dept Pharmacol & Toxicol, Bangor, ME USA; [Batinic-Haberle, I.] Duke Univ, Med Ctr, Durham, NC USA	University of Kentucky; Procter & Gamble; Duke University	St Clair, DK (corresponding author), Univ Kentucky, Grad Ctr Toxicol, 1095 VA Dr,HSRB 454, Lexington, KY 40536 USA.	dstcl00@uky.edu	Jungsuwadee, Paiboon/AAE-4038-2020	Jungsuwadee, Paiboon/0000-0002-5430-6887	National Institutes of Health [RO1CA073599-11]; NATIONAL CANCER INSTITUTE [R01CA073599, R01CA049797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health (RO1CA073599-11). The National Cancer Institute CA 073599.	Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Aitken GR, 2007, CLIN EXP DERMATOL, V32, P722, DOI 10.1111/j.1365-2230.2007.02474.x; Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Bakhanashvili M, 2008, CELL DEATH DIFFER, V15, P1865, DOI 10.1038/cdd.2008.122; Batinic-Haberle I, 1999, INORG CHEM, V38, P4011, DOI 10.1021/ic990118k; Batinic-Haberle I, 2010, ANTIOXID REDOX SIGN, V13, P877, DOI 10.1089/ars.2009.2876; Batinic-Haberle IR, 2010, HDB PORPHYRIN SCI 2, P291; Berg RJW, 1996, P NATL ACAD SCI USA, V93, P274, DOI 10.1073/pnas.93.1.274; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Birch-Machin MA, 1998, J INVEST DERMATOL, V110, P149, DOI 10.1046/j.1523-1747.1998.00099.x; Bogenhagen DF, 2001, PROG NUCLEIC ACID RE, V68, P257; BOLDEN A, 1977, J BIOL CHEM, V252, P3351; Bonifacino J.S., 2001, CURR PROTOC MOL BIOL, V10; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Carrodeguas JA, 1999, MOL CELL BIOL, V19, P4039; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; Decraene D, 2004, J INVEST DERMATOL, V122, P484, DOI 10.1046/j.0022-202X.2004.22215.x; Esworthy RS, 1997, ARCH BIOCHEM BIOPHYS, V340, P59, DOI 10.1006/abbi.1997.9901; Ferrer-Sueta G, 1999, CHEM RES TOXICOL, V12, P442, DOI 10.1021/tx980245d; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; GRAY H, 1992, J BIOL CHEM, V267, P5835; Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805; Graziewicz MA, 2002, NUCLEIC ACIDS RES, V30, P2817, DOI 10.1093/nar/gkf392; HALL PA, 1993, ONCOGENE, V8, P203; Harbottle A, 2006, BRIT J CANCER, V94, P1887, DOI 10.1038/sj.bjc.6603178; Heyne K, 2004, FEBS LETT, V578, P198, DOI 10.1016/j.febslet.2004.10.099; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HUBSCHER U, 1979, P NATL ACAD SCI USA, V76, P2316, DOI 10.1073/pnas.76.5.2316; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Kienhofer J, 2009, FASEB J, V23, P2034, DOI 10.1096/fj.08-113571; Kovalenko O.A., 2009, CURR PROTOC HUM GENE, V62; Krishnan KJ, 2004, J INVEST DERMATOL, V123, P1020, DOI 10.1111/j.0022-202X.2004.23457.x; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kulawiec Mariola, 2009, J Carcinog, V8, P8, DOI 10.4103/1477-3163.50893; Lebedeva MA, 2009, BBA-BIOENERGETICS, V1787, P328, DOI 10.1016/j.bbabio.2009.01.004; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523; LI G, 1995, CANCER RES, V55, P2070; Li G, 1997, AM J PATHOL, V150, P1457; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4; LIU M, 1994, CARCINOGENESIS, V15, P1089, DOI 10.1093/carcin/15.6.1089; Longley Matthew J, 2002, Methods Mol Biol, V197, P245, DOI 10.1385/1-59259-284-8:245; Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244; Maglio DHG, 2005, PHOTODERMATOL PHOTO, V21, P311, DOI 10.1111/j.1600-0781.2005.00185.x; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mihara Motohiro, 2003, Methods Mol Biol, V234, P203; O'Brien KM, 2004, J BIOL CHEM, V279, P51817, DOI 10.1074/jbc.M405958200; Ouhtit A, 2000, AM J PATHOL, V156, P201, DOI 10.1016/S0002-9440(10)64720-7; Ozden O, 2011, AGING-US, V3, P102, DOI 10.18632/aging.100291; Ray AJ, 2000, J INVEST DERMATOL, V115, P674, DOI 10.1046/j.1523-1747.2000.00092.x; Renzing J, 1996, J CELL SCI, V109, P1105; Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100; Stuart JA, 2004, FASEB J, V18, P595, DOI 10.1096/fj.03-0890fje; Taanman JW, 2010, METHODS, V51, P374, DOI 10.1016/j.ymeth.2010.03.002; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tron VA, 1998, AM J PATHOL, V153, P579, DOI 10.1016/S0002-9440(10)65600-3; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Van Remmen H, 1999, ARCH BIOCHEM BIOPHYS, V363, P91, DOI 10.1006/abbi.1998.1060; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Waster PK, 2009, J INVEST DERMATOL, V129, P1769, DOI 10.1038/jid.2008.421; WEISIGER RA, 1973, J BIOL CHEM, V248, P3582; Wu SY, 2010, PHOTOCHEM PHOTOBIOL, V86, P389, DOI 10.1111/j.1751-1097.2009.00682.x; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200; Zhao YF, 2001, CANCER RES, V61, P6082; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835; Zhao YF, 2002, ONCOGENE, V21, P3836, DOI 10.1038/sj.onc.1205477	75	42	43	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2012	31	17					2129	2139		10.1038/onc.2011.407	http://dx.doi.org/10.1038/onc.2011.407			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	934BS	21909133	Green Accepted			2022-12-25	WOS:000303415900002
J	Xu, Z; Prigent, S; Deslys, JP; Rezaei, H				Xu, Zhou; Prigent, Stephanie; Deslys, Jean-Philippe; Rezaei, Human			Dual Conformation of H2H3 Domain of Prion Protein in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCRAPIE PRION; SACCHAROMYCES-CEREVISIAE; PODOSPORA-ANSERINA; APLYSIA CPEB; YEAST; PROPAGATION; BRAIN; OLIGOMERIZATION; IDENTIFICATION; ORGANIZATION	The concept of prion is applied to protein modules that share the ability to switch between at least two conformational states and transmit one of these through intermolecular interaction and change of conformation. Although much progress has been achieved through the understanding of prions from organisms such as Saccharomyces cerevisiae, Podospora anserina, or Aplysia californica, the criteria that qualify a protein module as a prion are still unclear. In addition, the functionality of known prion domains fails to provide clues to understand the first identified prion, the mammalian infectious prion protein, PrP. To address these issues, we generated mammalian cellular models of expression of the C-terminal two helices of PrP, H2 and H3, which have been hypothesized, among other models, to hold the replication and conversion properties of the infectious PrP. We found that the H2H3 domain is an independent folding unit that undergoes glycosylations and glycosylphosphatidylinositol anchoring similar to full-length PrP. Surprisingly, in some conditions the normally folded H2H3 was able to systematically go through a conversion process and generate insoluble proteinase K-resistant aggregates. This structural switch involves the assembly of amyloid structures that bind thioflavin S and oligomers that are reactive to A11 antibody, which specifically detects protein oligomers from neurological disorders. Overall, we show that H2H3 is a conformational switch in a cellular context and is thus suggested to be a candidate for the conversion domain of PrP.	[Prigent, Stephanie; Rezaei, Human] Inst Natl Rech Agron Virol & Immunol Mol, Equipe Biol Physicochim Prions, F-78350 Jouy En Josas, France; [Xu, Zhou; Deslys, Jean-Philippe] CEA, Inst Emerging Dis & Innovat Therapies, SEPIA, F-92260 Fontenay Aux Roses, France	INRAE; CEA; UDICE-French Research Universities; Universite Paris Saclay	Rezaei, H (corresponding author), Inst Natl Rech Agron Virol & Immunol Mol, Equipe Biol Physicochim Prions, F-78350 Jouy En Josas, France.	human.rezaei@jouy.inra.fr	Xu, Zhou/F-8513-2011	Xu, Zhou/0000-0001-9468-1406				Adrover M, 2010, J BIOL CHEM, V285, P21004, DOI 10.1074/jbc.M110.111815; Balguerie A, 2003, EMBO J, V22, P2071, DOI 10.1093/emboj/cdg213; Baron GS, 2011, BIOCHEMISTRY-US, V50, P4479, DOI 10.1021/bi2003907; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Cancellotti E, 2007, BBA-MOL BASIS DIS, V1772, P673, DOI 10.1016/j.bbadis.2006.10.013; Chakroun N, 2010, FASEB J, V24, P3222, DOI 10.1096/fj.09-153924; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; CHRISTOFINIS GJ, 1968, J PATHOL BACTERIOL, V95, P377, DOI 10.1002/path.1700950204; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; DEARMOND SJ, 1985, CELL, V41, P221, DOI 10.1016/0092-8674(85)90076-5; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Demart S, 1999, BIOCHEM BIOPH RES CO, V265, P652, DOI 10.1006/bbrc.1999.1730; Derkatch IL, 1996, GENETICS, V144, P1375; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; HAMMOND DN, 1990, BRAIN RES, V512, P190, DOI 10.1016/0006-8993(90)90626-M; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Kascsak R, 2010, J BIOL CHEM, V285, pLE5, DOI 10.1074/jbc.L109.088831; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kimura Y, 2003, CELL STRUCT FUNCT, V28, P187; Krammer C, 2009, P NATL ACAD SCI USA, V106, P462, DOI 10.1073/pnas.0811571106; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; Masison DC, 1997, P NATL ACAD SCI USA, V94, P12503, DOI 10.1073/pnas.94.23.12503; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Speare JO, 2010, EMBO J, V29, P782, DOI 10.1038/emboj.2009.392; Su HW, 2007, J BIOL CHEM, V282, P9883, DOI 10.1074/jbc.M606754200; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Xu Z., 2011, FASEB J IN PRESS	42	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40060	40068		10.1074/jbc.M111.275255	http://dx.doi.org/10.1074/jbc.M111.275255			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21911495	Green Published, hybrid			2022-12-25	WOS:000296925700038
J	Hassinen, A; Pujol, FM; Kokkonen, N; Pieters, C; Kihlstrom, M; Korhonen, K; Kellokumpu, S				Hassinen, Antti; Pujol, Francois M.; Kokkonen, Nina; Pieters, Caroline; Kihlstrom, Minna; Korhonen, Kati; Kellokumpu, Sakari			Functional Organization of Golgi N- and O-Glycosylation Pathways Involves pH-dependent Complex Formation That Is Impaired in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; FLUORESCENT PROTEIN; LIVING CELLS; GLYCOSYLTRANSFERASES; GLYCANS; LOCALIZATION; GALACTOSYLTRANSFERASE; ACETYLGLUCOSAMINE; IDENTIFICATION; RECOGNITION	Glycosylation is one of the most common modifications of proteins and lipids and also a major source of biological diversity in eukaryotes. It is critical for many basic cellular functions and recognition events that range from protein folding to cell signaling, immunological defense, and the development of multicellular organisms. Glycosylation takes place mainly in the endoplasmic reticulum and Golgi apparatus and involves dozens of functionally distinct glycosidases and glycosyltransferases. How the functions of these enzymes, which act sequentially and often competitively, are coordinated to faithfully synthesize a vast array of different glycan structures is currently unclear. Here, we investigate the supramolecular organization of the Golgi N- and O-glycosylation pathways in live cells using a FRET flow cytometric quantification approach. We show that the enzymes form enzymatically active homo- and/or heteromeric complexes within each pathway. However, no complexes composed of enzymes that operate in different pathways, were detected, which suggests that the pathways are physically distinct. In addition, we show that complex formation is mediated almost exclusively by the catalytic domains of the interacting enzymes. Our data also suggest that the heteromeric complexes are functionally more important than enzyme homomers. Heteromeric complex formation was found to be dependent on Golgi acidity, markedly impaired in acidification-defective cancer cells, and required for the efficient synthesis of cell surface glycans. Collectively, the results emphasize that the Golgi glycosylation pathways are functionally organized into complexes that are important for glycan synthesis.	[Kellokumpu, Sakari] Univ Oulu, Dept Biochem, FIN-90014 Oulu, Finland; Univ Oulu, Finnish Glycosci Grad Sch, FIN-90014 Oulu, Finland	Finland National Institute for Health & Welfare; University of Oulu; University of Oulu	Kellokumpu, S (corresponding author), Univ Oulu, Dept Biochem, Rm MN212-1,POB 3000, FIN-90014 Oulu, Finland.	sakari.kellokumpu@oulu.fi		Kihlstrom, Minna/0000-0002-3180-4875; Kokkonen, Nina/0000-0003-0913-4892; Hassinen, Antti/0000-0001-9491-2868	Academy of Finland; Finnish Glycoscience Graduate School	Academy of Finland(Academy of Finland); Finnish Glycoscience Graduate School	This work was supported by The Academy of Finland (to S. K.) and the Finnish Glycoscience Graduate School (to A. H.).	Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; BERGER EG, 1978, EUR J BIOCHEM, V90, P213, DOI 10.1111/j.1432-1033.1978.tb12593.x; BERGER EG, 1981, J HISTOCHEM CYTOCHEM, V29, P364, DOI 10.1177/29.3.6787115; Bieberich E, 2002, BIOCHEMISTRY-US, V41, P11479, DOI 10.1021/bi0259958; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Campbell BJ, 2001, GLYCOBIOLOGY, V11, P385, DOI 10.1093/glycob/11.5.385; de Graffenried CL, 2004, CURR OPIN CELL BIOL, V16, P356, DOI 10.1016/j.ceb.2004.06.007; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; DUNPHY WG, 1985, CELL, V40, P463, DOI 10.1016/0092-8674(85)90161-8; Fahrenkrug J, 2009, BIOCHEMISTRY-US, V48, P5142, DOI 10.1021/bi900249n; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; GERBER AC, 1979, EUR J BIOCHEM, V93, P453, DOI 10.1111/j.1432-1033.1979.tb12843.x; Giraudo CG, 2003, J BIOL CHEM, V278, P40262, DOI 10.1074/jbc.M305455200; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hansske B, 2002, J CLIN INVEST, V109, P725, DOI 10.1172/JCI200214010; Hart Gerald W., 1992, Current Opinion in Cell Biology, V4, P1017, DOI 10.1016/0955-0674(92)90134-X; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Holappa K, 2001, J HISTOCHEM CYTOCHEM, V49, P259, DOI 10.1177/002215540104900213; Huang HH, 2010, J CELL BIOL, V190, P893, DOI 10.1083/jcb.201004102; Jungmann J, 1998, EMBO J, V17, P423, DOI 10.1093/emboj/17.2.423; KELLOKUMPU S, 1988, SCIENCE, V242, P1308, DOI 10.1126/science.2461589; Kokkonen N, 2004, J BIOL CHEM, V279, P39982, DOI 10.1074/jbc.M406698200; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Legaigneur P, 2001, J BIOL CHEM, V276, P21608, DOI 10.1074/jbc.M100860200; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NILSSON T, 1993, FEBS LETT, V330, P1, DOI 10.1016/0014-5793(93)80906-B; Nilsson T, 2009, FEBS LETT, V583, P3764, DOI 10.1016/j.febslet.2009.10.064; Opat AS, 2000, J BIOL CHEM, V275, P11836, DOI 10.1074/jbc.275.16.11836; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Rivinoja A, 2006, J CELL PHYSIOL, V208, P167, DOI 10.1002/jcp.20653; Rivinoja A, 2009, J CELL PHYSIOL, V220, P144, DOI 10.1002/jcp.21744; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Thyrock A, 2010, BIOCHEM BIOPH RES CO, V396, P679, DOI 10.1016/j.bbrc.2010.04.161; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Varki A., 2008, ESSENTIALS GLYCOBIOL; YAMASHITA K, 1987, CANCER RES, V47, P3451; Young WW, 2004, J MEMBRANE BIOL, V198, P1, DOI 10.1007/s00232-004-0656-5; Zeng Y, 2009, NAT METHODS, V6, P207, DOI [10.1038/NMETH.1305, 10.1038/nmeth.1305]	42	88	90	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38329	38340		10.1074/jbc.M111.277681	http://dx.doi.org/10.1074/jbc.M111.277681			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911486	hybrid, Green Published			2022-12-25	WOS:000296594200046
J	Mitsui, K; Koshimura, Y; Yoshikawa, Y; Matsushita, M; Kanazawa, H				Mitsui, Keiji; Koshimura, Yuri; Yoshikawa, Yuriko; Matsushita, Masafumi; Kanazawa, Hiroshi			The Endosomal Na+/H+ Exchanger Contributes to Multivesicular Body Formation by Regulating the Recruitment of ESCRT-0 Vps27p to the Endosomal Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; FUNCTIONAL EXPRESSION; FYVE DOMAIN; H+-ATPASE; YEAST; PH; COMPARTMENT; MACHINERY; MUTANTS; BIOGENESIS	Multivesicular bodies (MVBs) are late endosomal compartments containing luminal vesicles (MVB vesicles) that are formed by inward budding of the endosomal membrane. In budding yeast, MVBs are an important cellular mechanism for the transport of membrane proteins to the vacuolar lumen. This process requires a class E subset of vacuolar protein sorting (VPS) genes. VPS44 (allelic to NHX1) encodes an endosome-localized Na+/H+ exchanger. The function of the VPS44 exchanger in the context of vacuolar protein transport is largely unknown. Using a cell-free MVB formation assay system, we demonstrated that Nhx1p is required for the efficient formation of MVB vesicles in the late endosome. The recruitment of Vps27p, a class E Vps protein, to the endosomal membrane was dependent on Nhx1p activity and was enhanced by an acidic pH at the endosomal surface. Taken together, we propose that Nhx1p contributes to MVB formation by the recruitment of Vps27p to the endosomal membrane, possibly through Nhx1p antiporter activity.	[Mitsui, Keiji; Koshimura, Yuri; Yoshikawa, Yuriko; Matsushita, Masafumi; Kanazawa, Hiroshi] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan	Osaka University	Mitsui, K (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, Machikaneyama Cho 1-1, Toyonaka, Osaka 5600043, Japan.	mitsui8@bio.sci.osaka-u.ac.jp; kanazawa@bio.sci.osaka-u.ac.jp			Japanese Ministry of Education, Science, Sports, Technology, and Culture	Japanese Ministry of Education, Science, Sports, Technology, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid from the Japanese Ministry of Education, Science, Sports, Technology, and Culture.	Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Attaphitaya S, 1999, J BIOL CHEM, V274, P4383, DOI 10.1074/jbc.274.7.4383; Baird NR, 1999, J BIOL CHEM, V274, P4377, DOI 10.1074/jbc.274.7.4377; BANKAITIS VA, 1986, P NATL ACAD SCI USA, V83, P9075, DOI 10.1073/pnas.83.23.9075; BIANCHINI L, 1994, J EXP BIOL, V196, P337; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brachmann CB, 1998, YEAST, V14, P115; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Fukura N, 2010, J MEMBRANE BIOL, V234, P149, DOI 10.1007/s00232-010-9242-9; Gu F, 2000, J BIOL CHEM, V275, P8154, DOI 10.1074/jbc.275.11.8154; He J, 2009, PROTEINS, V76, P852, DOI 10.1002/prot.22392; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; KANAZAWA H, 1979, P NATL ACAD SCI USA, V76, P1126, DOI 10.1073/pnas.76.3.1126; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Maranda B, 2001, J BIOL CHEM, V276, P18540, DOI 10.1074/jbc.M011577200; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Mitsui K, 2010, BIOCHEM J, V432, P343, DOI 10.1042/BJ20100796; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; Nass R, 1998, J BIOL CHEM, V273, P21054, DOI 10.1074/jbc.273.33.21054; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Nelson N, 2000, J EXP BIOL, V203, P89; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Numata M, 2001, J BIOL CHEM, V276, P17387, DOI 10.1074/jbc.M101319200; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Ohgaki R, 2011, BIOCHEMISTRY-US, V50, P443, DOI 10.1021/bi101082e; Ohgaki R, 2010, MOL BIOL CELL, V21, P1293, DOI 10.1091/mbc.E09-09-0767; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Rieder SE, 1996, MOL BIOL CELL, V7, P985, DOI 10.1091/mbc.7.6.985; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; TSE CM, 1993, J BIOL CHEM, V268, P11917; Ungermann C, 1999, P NATL ACAD SCI USA, V96, P11194, DOI 10.1073/pnas.96.20.11194; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836	51	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37625	37638		10.1074/jbc.M111.260612	http://dx.doi.org/10.1074/jbc.M111.260612			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21896492	Green Published, hybrid			2022-12-25	WOS:000296542400060
J	Koberl, M; Muller, H; Ramadan, EM; Berg, G				Koeberl, Martina; Mueller, Henry; Ramadan, Elshahat M.; Berg, Gabriele			Desert Farming Benefits from Microbial Potential in Arid Soils and Promotes Diversity and Plant Health	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; COMMUNITY STRUCTURE; BACTERIAL; RHIZOSPHERE	Background: To convert deserts into arable, green landscapes is a global vision, and desert farming is a strong growing area of agriculture world-wide. However, its effect on diversity of soil microbial communities, which are responsible for important ecosystem services like plant health, is still not known. Methodology/Principal Findings: We studied the impact of long-term agriculture on desert soil in one of the most prominent examples for organic desert farming in Sekem (Egypt). Using a polyphasic methodological approach to analyse microbial communities in soil as well as associated with cultivated plants, drastic effects caused by 30 years of agriculture were detected. Analysing bacterial fingerprints, we found statistically significant differences between agricultural and native desert soil of about 60%. A pyrosequencing-based analysis of the 16S rRNA gene regions showed higher diversity in agricultural than in desert soil (Shannon diversity indices: 11.21/7.90), and displayed structural differences. The proportion of Firmicutes in field soil was significantly higher (37%) than in the desert (11%). Bacillus and Paenibacillus play the key role: they represented 96% of the antagonists towards phytopathogens, and identical 16S rRNA sequences in the amplicon library and for isolates were detected. The proportion of antagonistic strains was doubled in field in comparison to desert soil (21.6%/12.4%); disease-suppressive bacteria were especially enriched in plant roots. On the opposite, several extremophilic bacterial groups, e.g., Acidimicrobium, Rubellimicrobium and Deinococcus-Thermus, disappeared from soil after agricultural use. The N-fixing Herbaspirillum group only occurred in desert soil. Soil bacterial communities were strongly driven by the a-biotic factors water supply and pH. Conclusions/Significance: After long-term farming, a drastic shift in the bacterial communities in desert soil was observed. Bacterial communities in agricultural soil showed a higher diversity and a better ecosystem function for plant health but a loss of extremophilic bacteria. Interestingly, we detected that indigenous desert microorganisms promoted plant health in desert agro-ecosystems.	[Koeberl, Martina; Mueller, Henry; Berg, Gabriele] Graz Univ Technol, Inst Environm Biotechnol, A-8010 Graz, Austria; [Ramadan, Elshahat M.] SEKEM, Fac Agr, Cairo, Egypt; [Ramadan, Elshahat M.] Heliopolis Univ, Cairo, Egypt	Graz University of Technology; Egyptian Knowledge Bank (EKB); Heliopolis University	Koberl, M (corresponding author), Graz Univ Technol, Inst Environm Biotechnol, A-8010 Graz, Austria.	gabriele.berg@TUGraz.at		Berg, Gabriele/0000-0001-9423-3101; Koberl, Martina/0000-0001-8146-8315	EU-Egypt [C2/S1/190]	EU-Egypt	This project was funded by the EU-Egypt Innovation Fund (C2/S1/190). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Angel R, 2010, ISME J, V4, P553, DOI 10.1038/ismej.2009.136; Barot S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001248; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Battistuzzi FU, 2009, MOL BIOL EVOL, V26, P335, DOI 10.1093/molbev/msn247; Ben-David EA, 2011, FEMS MICROBIOL ECOL, V76, P492, DOI 10.1111/j.1574-6941.2011.01075.x; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Berg G, 2002, APPL ENVIRON MICROB, V68, P3328, DOI 10.1128/AEM.68.7.3328-3338.2002; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CARUSO T, 2011, ISME J IN PRESS; Cary SC, 2010, NAT REV MICROBIOL, V8, P129, DOI 10.1038/nrmicro2281; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Clery D, 2011, SCIENCE, V331, P136, DOI 10.1126/science.331.6014.136; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crowder DW, 2010, NATURE, V466, P109, DOI 10.1038/nature09183; de los Rios A, 2010, INT MICROBIOL, V13, P79, DOI 10.2436/20.1501.01.113; Emmert EAB, 1999, FEMS MICROBIOL LETT, V171, P1, DOI 10.1111/j.1574-6968.1999.tb13405.x; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Hansel CM, 2008, APPL ENVIRON MICROB, V74, P1620, DOI 10.1128/AEM.01787-07; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Kropfa S, 2004, J MICROBIOL METH, V57, P187, DOI 10.1016/j.mimet.2004.01.002; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Leps J, 2003, MULTIVARIATE ANAL EC; Luske B, 2009, CARBON SEQUESTRATION; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; McKay DL, 2006, PHYTOTHER RES, V20, P519, DOI 10.1002/ptr.1900; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Milling A, 2004, PLANT SOIL, V266, P23; Niraula NP, 2010, APPL MICROBIOL BIOT, V87, P1187, DOI 10.1007/s00253-010-2675-3; Othman AA, 2004, MICROBIOL RES, V159, P285, DOI 10.1016/j.micres.2004.05.004; Pereira AC, 2010, BRAZ J BIOL, V70, P969, DOI 10.1590/S1519-69842010000500008; Pointing SB, 2009, P NATL ACAD SCI USA, V106, P19964, DOI 10.1073/pnas.0908274106; Rademaker JLW, 1997, DNA MARKERS, P151; *REUT, 2007, EG PLAN GREEN SAH DE; Saul-Tcherkas V, 2011, MICROB ECOL, V61, P64, DOI 10.1007/s00248-010-9763-x; Schieffer A., 2009, TRANSITION STUDIES R, V15, P713, DOI [DOI 10.1007/S11300-008-0040-3, 10.1007/s11300-008-0040-3]; Schmid F, 2011, APPL ENVIRON MICROB, V77, P2188, DOI 10.1128/AEM.02187-10; Schwieger F, 1998, APPL ENVIRON MICROB, V64, P4870; Shannon CE, 1997, M D COMPUT, V14, P306; Shaw LJ, 2006, ENVIRON MICROBIOL, V8, P1867, DOI 10.1111/j.1462-2920.2006.01141.x; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; STOCKER S, 2011, SNOWMAN HIG IN PRESS; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Zachow C, 2008, MICROB ECOL, V55, P119, DOI 10.1007/s00248-007-9257-7	47	141	146	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24452	10.1371/journal.pone.0024452	http://dx.doi.org/10.1371/journal.pone.0024452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912695	gold, Green Published, Green Submitted			2022-12-25	WOS:000294686100042
J	Lee, MR; Gallen, CL; Zhang, XC; Hodgkinson, CA; Goldman, D; Stein, EA; Barr, CS				Lee, Mary R.; Gallen, Courtney L.; Zhang, Xiaochu; Hodgkinson, Colin A.; Goldman, David; Stein, Elliot A.; Barr, Christina S.			Functional Polymorphism of the Mu-Opioid Receptor Gene (OPRM1) Influences Reinforcement Learning in Humans	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; A118G POLYMORPHISM; DOPAMINE NEURONS; STRESS-RESPONSE; ASSOCIATION; BINDING	Previous reports on the functional effects (i.e., gain or loss of function), and phenotypic outcomes (e. g., changes in addiction vulnerability and stress response) of a commonly occurring functional single nucleotide polymorphism (SNP) of the mu-opioid receptor (OPRM1 A118G) have been inconsistent. Here we examine the effect of this polymorphism on implicit reward learning. We used a probabilistic signal detection task to determine whether this polymorphism impacts response bias to monetary reward in 63 healthy adult subjects: 51 AA homozygotes and 12 G allele carriers. OPRM1 AA homozygotes exhibited typical responding to the rewarded response-that is, their bias to the rewarded stimulus increased over time. However, OPRM1 G allele carriers exhibited a decline in response to the rewarded stimulus compared to the AA homozygotes. These results extend previous reports on the heritability of performance on this task by implicating a specific polymorphism. Through comparison with other studies using this task, we suggest a possible mechanism by which the OPRM1 polymorphism may confer reduced response to natural reward through a dopamine-mediated decrease during positive reinforcement learning.	[Lee, Mary R.; Gallen, Courtney L.; Zhang, Xiaochu; Stein, Elliot A.] Natl Inst Drug Abuse, Intramural Res Program, Baltimore, MD USA; [Hodgkinson, Colin A.; Goldman, David; Barr, Christina S.] NIAAA, Intramural Res Program, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Lee, MR (corresponding author), Natl Inst Drug Abuse, Intramural Res Program, Baltimore, MD USA.	leemary@mail.nih.gov	Zhang, Xiaochu/AEW-0582-2022; Zhang, Xiaochu/AAG-8768-2022; Zhang, Xiaochu/O-9592-2014; Goldman, David/F-9772-2010; Majid, Salma/AAT-2616-2020	Zhang, Xiaochu/0000-0002-7541-0130; Goldman, David/0000-0002-1724-5405; Majid, Salma/0000-0002-1724-5405; Hodgkinson, Colin/0000-0002-5365-8119	National Institute on Drug Abuse; National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000301, ZIAAA000311] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Intramural Research Programs of the National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr CS, 2008, P NATL ACAD SCI USA, V105, P5277, DOI 10.1073/pnas.0710225105; Barr CS, 2007, ARCH GEN PSYCHIAT, V64, P369, DOI 10.1001/archpsyc.64.3.369; Barr CS, 2010, BIOL PSYCHIAT, V67, P78, DOI 10.1016/j.biopsych.2009.07.026; Beck AT., 1996, BECK DEPRESSION INVE; Beyer A, 2004, J NEUROCHEM, V89, P553, DOI 10.1111/j.1471-4159.2004.02340.x; Bond C, 1998, P NATL ACAD SCI USA, V95, P9608, DOI 10.1073/pnas.95.16.9608; Chefer VI, 2009, EUR J NEUROSCI, V30, P272, DOI 10.1111/j.1460-9568.2009.06827.x; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Dreher JC, 2008, P NATL ACAD SCI USA, V105, P15106, DOI [10.1073/pnas.0802127105, 10.1073/pnas.0805517106]; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hernandez-Avila CA, 2003, AM J MED GENET B, V118B, P60, DOI 10.1002/ajmg.b.10054; Hodgkinson CA, 2008, ALCOHOL ALCOHOLISM, V43, P505, DOI 10.1093/alcalc/agn032; Jocham G, 2009, J NEUROSCI, V29, P3695, DOI 10.1523/JNEUROSCI.5195-08.2009; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Johnstone V, 2000, J EXP ANAL BEHAV, V73, P275, DOI 10.1901/jeab.2000.73-275; Kroslak T, 2007, J NEUROCHEM, V103, P77, DOI 10.1111/j.1471-4159.2007.04738.x; Krugel LK, 2009, P NATL ACAD SCI USA, V106, P17951, DOI 10.1073/pnas.0905191106; Le Merrer J, 2009, PHYSIOL REV, V89, P1379, DOI 10.1152/physrev.00005.2009; Mague SD, 2010, DRUG ALCOHOL DEPEN, V108, P172, DOI 10.1016/j.drugalcdep.2009.12.016; Mague SD, 2009, P NATL ACAD SCI USA, V106, P10847, DOI 10.1073/pnas.0901800106; Mathon DS, 2005, EUR J NEUROSCI, V21, P2883, DOI 10.1111/j.1460-9568.2005.04123.x; Mathon DS, 2005, NEUROSCIENCE, V130, P359, DOI 10.1016/j.neuroscience.2004.10.002; Miller GM, 2004, MOL PSYCHIATR, V9, P99, DOI 10.1038/sj.mp.4001378; Niikura K, 2010, TRENDS PHARMACOL SCI, V31, P299, DOI 10.1016/j.tips.2010.04.003; Pang GSY, 2009, PHARMACOGENOMICS, V10, P1101, DOI [10.2217/pgs.09.63, 10.2217/PGS.09.63]; Pizzagalli DA, 2005, BIOL PSYCHIAT, V57, P319, DOI 10.1016/j.biopsych.2004.11.026; Pizzagalli DA, 2008, PSYCHOPHARMACOLOGY, V196, P221, DOI 10.1007/s00213-007-0957-y; Pizzagalli DA, 2007, BEHAV RES THER, V45, P2742, DOI 10.1016/j.brat.2007.07.013; Pizzagalli DA, 2008, J PSYCHIATR RES, V43, P76, DOI 10.1016/j.jpsychires.2008.03.001; Santesso DL, 2009, HUM BRAIN MAPP, V30, P1963, DOI 10.1002/hbm.20642; Tan EC, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-32; Van Ree JM, 2000, EUR J PHARMACOL, V405, P89, DOI 10.1016/S0014-2999(00)00544-6; Way BM, 2009, P NATL ACAD SCI USA, V106, P15079, DOI 10.1073/pnas.0812612106; Wechsler D., 1999, WECHSLER ABBREVIATED; Zhang Y, 2005, J BIOL CHEM, V280, P32618, DOI 10.1074/jbc.M504942200; Zhou ZF, 2008, NATURE, V452, P997, DOI 10.1038/nature06858; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	39	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24203	10.1371/journal.pone.0024203	http://dx.doi.org/10.1371/journal.pone.0024203			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912675	gold, Green Published, Green Submitted			2022-12-25	WOS:000294686100022
J	Bernard, KE; Parkes, TL; Merritt, TJS				Bernard, Kristine E.; Parkes, Tony L.; Merritt, Thomas J. S.			A Model of Oxidative Stress Management: Moderation of Carbohydrate Metabolizing Enzymes in SOD1-Null Drosophila melanogaster	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PENTOSE-PHOSPHATE PATHWAY; ZINC SUPEROXIDE-DISMUTASE; LIFE-SPAN EXTENSION; STARVATION RESISTANCE; GLUTATHIONE-REDUCTASE; NULL MUTATION; MALIC ENZYME; GENE; NADH	The response to oxidative stress involves numerous genes and mutations in these genes often manifest in pleiotropic ways that presumably reflect perturbations in ROS-mediated physiology. The Drosophila melanogaster SOD1-null allele (cSODn108) is proposed to result in oxidative stress by preventing superoxide breakdown. In SOD1-null flies, oxidative stress management is thought to be reliant on the glutathione-dependent antioxidants that utilize NADPH to cycle between reduced and oxidized form. Previous studies suggest that SOD1-null Drosophila rely on lipid catabolism for energy rather than carbohydrate metabolism. We tested these connections by comparing the activity of carbohydrate metabolizing enzymes, lipid and triglyceride concentration, and steady state NADPH: NADP+ in SOD1-null and control transgenic rescue flies. We find a negative shift in the activity of carbohydrate metabolizing enzymes in SOD1-nulls and the NADP+-reducing enzymes were found to have significantly lower activity than the other enzymes assayed. Little evidence for the catabolism of lipids as preferential energy source was found, as the concentration of lipids and triglycerides were not significantly lower in SOD1-nulls compared with controls. Using a starvation assay to impact lipids and triglycerides, we found that lipids were indeed depleted in both genotypes when under starvation stress, suggesting that oxidative damage was not preventing the catabolism of lipids in SOD1-null flies. Remarkably, SOD1-nulls were also found to be relatively resistant to starvation. Age profiles of enzyme activity, triglyceride and lipid concentration indicates that the trends observed are consistent over the average lifespan of the SOD1-nulls. Based on our results, we propose a model of physiological response in which organisms under oxidative stress limit the production of ROS through the down-regulation of carbohydrate metabolism in order to moderate the products exiting the electron transport chain.	[Bernard, Kristine E.] Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada; [Parkes, Tony L.] Nipissing Univ, Dept Biol & Chem, N Bay, ON, Canada; [Merritt, Thomas J. S.] Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada	Laurentian University; Nipissing University; Laurentian University	Bernard, KE (corresponding author), Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada.	tmerritt@laurentian.ca			NSERC [341466-07, 298518-08]; Canada Research Chairs [950-215763]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs(Canada Research ChairsCGIAR)	This work was supported by NSERC Discovery Grants to T.J.S. Merritt (341466-07) and T. L. Parkes (298518-08) (http://www.nserc-crsng.gc.ca/professors-professeurs/grants-subs/dgigp-psigp_eng.asp), and by a Canada Research Chairs Grant to T.J.S. Merritt (950-215763) (http://www.chairs-chaires.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer H, 2002, J BIOL CHEM, V277, P17457, DOI 10.1074/jbc.M200636200; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; CAMPBELL SD, 1986, GENETICS, V112, P205; CAVENER DR, 1981, P NATL ACAD SCI-BIOL, V78, P4444, DOI 10.1073/pnas.78.7.4444; Chaudhuri A, 2007, J NEUROSCI, V27, P2457, DOI 10.1523/JNEUROSCI.4239-06.2007; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; Curtis C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r262; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Dhalla NS, 2000, CARDIOVASC RES, V47, P446, DOI 10.1016/S0008-6363(00)00078-X; Duttaroy A, 2003, GENETICS, V165, P2295; Eanes WF, 2006, P NATL ACAD SCI USA, V103, P19413, DOI 10.1073/pnas.0607095104; GEER BW, 1979, BIOCHEM GENET, V17, P867, DOI 10.1007/BF00504309; GEER BW, 1979, BIOCHEM GENET, V17, P881, DOI 10.1007/BF00504310; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Harshman LG, 1999, J EVOLUTION BIOL, V12, P370, DOI 10.1046/j.1420-9101.1999.00024.x; Ja WW, 2009, P NATL ACAD SCI USA, V106, P18633, DOI 10.1073/pnas.0908016106; Juhnke H, 1996, MOL GEN GENET, V252, P456, DOI 10.1007/BF02173011; Kabil H, 2007, BIOGERONTOLOGY, V8, P201, DOI 10.1007/s10522-006-9065-3; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; Legan SK, 2008, J BIOL CHEM, V283, P32492, DOI 10.1074/jbc.M805832200; Mailloux RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000690; Marron MT, 2003, J INSECT PHYSIOL, V49, P261, DOI 10.1016/S0022-1910(02)00287-1; Merritt TJS, 2009, GENETICS, V182, P565, DOI 10.1534/genetics.109.100677; Merritt TJS, 2006, GENETICS, V172, P293, DOI 10.1534/genetics.105.047035; Merritt TJS, 2005, GENETICS, V171, P1707, DOI 10.1534/genetics.105.048249; Missirlis F, 2003, BIOL CHEM, V384, P463, DOI 10.1515/BC.2003.052; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Parkes TL, 1998, GENOME, V41, P642; PARKES TL, 1993, GENOME, V36, P1007, DOI 10.1139/g93-134; Paul A, 2007, MECH AGEING DEV, V128, P706, DOI 10.1016/j.mad.2007.10.013; PHILLIPS JP, 1989, P NATL ACAD SCI USA, V86, P2761, DOI 10.1073/pnas.86.8.2761; Piazza N, 2009, BIOGERONTOLOGY, V10, P637, DOI 10.1007/s10522-008-9210-2; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Rion S, 2007, J EVOLUTION BIOL, V20, P1655, DOI 10.1111/j.1420-9101.2007.01405.x; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ruan HY, 2008, P NATL ACAD SCI USA, V105, P7506, DOI 10.1073/pnas.0711127105; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; Singh R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002682; Slekar KH, 1996, J BIOL CHEM, V271, P28831, DOI 10.1074/jbc.271.46.28831; SOHAL RS, 1990, MECH AGEING DEV, V56, P223, DOI 10.1016/0047-6374(90)90084-S; SOHAL RS, 1995, J BIOL CHEM, V270, P15671, DOI 10.1074/jbc.270.26.15671; Strub BR, 2008, GENOME, V51, P409, DOI 10.1139/G08-023; Tong WH, 2007, BIOMETALS, V20, P549, DOI 10.1007/s10534-006-9047-6; Tsuzuki T, 2007, CANCER SCI, V98, P465, DOI 10.1111/j.1349-7006.2007.00409.x; Turner BJ, 2009, NEUROBIOL DIS, V34, P511, DOI 10.1016/j.nbd.2009.03.005; Vermeulen CJ, 2006, J INSECT PHYSIOL, V52, P910, DOI 10.1016/j.jinsphys.2006.05.014; Wang PY, 2009, P NATL ACAD SCI USA, V106, P9262, DOI 10.1073/pnas.0904115106; Wicks S, 2009, FREE RADICAL BIO MED, V46, P176, DOI 10.1016/j.freeradbiomed.2008.09.036; WISE EM, 1964, P NATL ACAD SCI USA, V52, P1255, DOI 10.1073/pnas.52.5.1255; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zhan M, 2007, GENOME RES, V17, P1236, DOI 10.1101/gr.6216607; Zou S, 2000, P NATL ACAD SCI USA, V97, P13726, DOI 10.1073/pnas.260496697	60	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24518	10.1371/journal.pone.0024518	http://dx.doi.org/10.1371/journal.pone.0024518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909438	gold, Green Submitted, Green Published			2022-12-25	WOS:000294683900054
J	Kaneb, HM; Sharp, PS; Rahmani-Kondori, N; Wells, DJ				Kaneb, Hannah M.; Sharp, Paul S.; Rahmani-Kondori, Nazanin; Wells, Dominic J.			Metformin Treatment Has No Beneficial Effect in a Dose-Response Survival Study in the SOD1(G93A) Mouse Model of ALS and Is Harmful in Female Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ACTIVATED PROTEIN-KINASE; MOTOR UNIT LOSS; DISEASE PROGRESSION; HUNTINGTONS-DISEASE; ENDOTHELIAL-CELLS; FAMILIAL ALS; MECHANISM; MITOCHONDRIA; DYSFUNCTION	Background: Amyotrophic Lateral Sclerosis (ALS) is a devastating neurological disorder characterized by selective degeneration of upper and lower motor neurons. The primary triggers for motor neuron degeneration are unknown but inflammation, oxidative stress and mitochondrial defects have been identified as potential contributing factors. Metformin is an anti-type II diabetes drug that has anti-inflammatory and anti-oxidant properties, can bring about mitochondrial biogenesis and has been shown to attenuate pathology in mouse models of Huntington's disease and multiple sclerosis. We therefore hypothesized that it might increase survival in the SOD1(G93A) murine model of ALS. Methodology/Principal Findings: Treatment of male and female SOD1(G93A) mice (n = >= 6 per sex) with 2 mg/ml metformin in the drinking water from 35 days, resulted in a significant increase in motor unit survival, as measured by in vivo electrophysiology at 100 days, in male EDL muscles (24+/-2 vs. 14+/-2 motor units, p<0.005) and female TA muscles (21+/-1 vs. 15+/-2 motor units, P = 0.0134). We therefore continued to test the effect of 0.5, 2 and 5 mg/ml metformin in the drinking water from 35 days on disease onset and progression (identified by twice weekly determination of weight and neurological score) as well as survival in male and female SOD1(G93A) mice (n = >= 14 per sex). Results for all groups were compared using Kaplan-Meier time to event analyses. In this survival study, metformin was unable to reduce pathology at any dose and had an unexpected dose-dependent negative effect on the onset of neurological symptoms (P = 0.0236) and on disease progression (P = 0.0362) in female mice. Conclusions/Significance: This study suggests that metformin is a poor candidate for clinical trial in ALS patients and that the possibility of harmful effects of metformin in female ALS patients with type II diabetes should be investigated.	[Kaneb, Hannah M.; Sharp, Paul S.; Rahmani-Kondori, Nazanin] Univ London Imperial Coll Sci Technol & Med, Wolfson Neurosci Labs, Fac Med, London, England; [Kaneb, Hannah M.; Rahmani-Kondori, Nazanin; Wells, Dominic J.] Univ London Royal Vet Coll, Dept Vet Basic Sci, London, England; [Sharp, Paul S.] Univ Sheffield, Acad Neurol Unit, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England	Imperial College London; University of London; University of London Royal Veterinary College; University of Sheffield	Kaneb, HM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Wolfson Neurosci Labs, Fac Med, Hammersmith Hosp Campus, London, England.	dwells@rvc.ac.uk		Wells, Dominic/0000-0002-1425-6344	Medical Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded by a Medical Research Council Doctoral Training Account Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Beal MF, 2004, NAT REV NEUROSCI, V5, P373, DOI 10.1038/nrn1386; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Chen YM, 2009, P NATL ACAD SCI USA, V106, P3907, DOI 10.1073/pnas.0807991106; CHENGYUN Z, 2004, ANN NEUROL, V56, P564; Cho YM, 2011, DIABETOLOGIA, V54, P219, DOI 10.1007/s00125-010-1986-3; Choi CI, 2008, J NEUROL SCI, V268, P40, DOI 10.1016/j.jns.2007.10.024; Cozzolino M, 2008, ANTIOXID REDOX SIGN, V10, P405, DOI 10.1089/ars.2007.1760; Dadon-Nachum M, 2011, J MOL NEUROSCI, V43, P470, DOI 10.1007/s12031-010-9467-1; Dandona P, 2004, J CLIN ENDOCR METAB, V89, P5043, DOI 10.1210/jc.2004-0436; Duffy LM, 2011, NEUROPATH APPL NEURO, V37, P336, DOI 10.1111/j.1365-2990.2011.01166.x; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Ferri A, 2006, P NATL ACAD SCI USA, V103, P13860, DOI 10.1073/pnas.0605814103; Gill A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006489; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; Groeneveld GJ, 2004, BRAIN RES, V1021, P128, DOI 10.1016/j.brainres.2004.06.024; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hegedus J, 2008, J PHYSIOL-LONDON, V586, P3337, DOI 10.1113/jphysiol.2007.149286; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Jawaid A, 2010, EUR J NEUROL, V17, P733, DOI 10.1111/j.1468-1331.2009.02923.x; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Lin HZ, 2000, NAT MED, V6, P998, DOI 10.1038/79697; Lincecum JM, 2010, NAT GENET, V42, P392, DOI 10.1038/ng.557; Ludolph Albert C, 2009, Ther Adv Neurol Disord, V2, P319, DOI 10.1177/1756285609336399; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Lutz C., 2009, WORKING ALS MICE GUI; Ma TC, 2007, NEUROSCI LETT, V411, P98, DOI 10.1016/j.neulet.2006.10.039; Mansfield R, 2003, FERTIL STERIL, V79, P956, DOI 10.1016/S0015-0282(02)04925-7; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; Ouslimani N, 2005, METABOLISM, V54, P829, DOI 10.1016/j.metabol.2005.01.029; Papadimitriou D, 2010, NEUROBIOL DIS, V37, P493, DOI 10.1016/j.nbd.2009.10.005; Parkhouse WS, 2008, AMYOTROPH LATERAL SC, V9, P24, DOI 10.1080/17482960701725646; Rice S, 2009, ENDOCRINOLOGY, V150, P4794, DOI 10.1210/en.2009-0540; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Sharp PS, 2008, NEUROBIOL DIS, V30, P42, DOI 10.1016/j.nbd.2007.12.002; Sharp PS, 2005, NEUROSCIENCE, V130, P897, DOI 10.1016/j.neuroscience.2004.09.069; Srividhya S, 2002, J Biochem Mol Biol Biophys, V6, P379, DOI 10.1080/1025814021000024280; STADELMANN C, 2011, CURR OPIN NEUROL; Traynor BJ, 2006, NEUROLOGY, V67, P20, DOI 10.1212/01.wnl.0000223353.34006.54; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	46	62	64	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24189	10.1371/journal.pone.0024189	http://dx.doi.org/10.1371/journal.pone.0024189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909419	gold, Green Accepted, Green Published			2022-12-25	WOS:000294683900035
J	Murray, EJ; Morse, SS				Murray, Eleanor J.; Morse, Stephen S.			Seasonal Oscillation of Human Infection with Influenza A/H5N1 in Egypt and Indonesia	PLOS ONE			English	Article							H5N1 AVIAN INFLUENZA; A VIRUS H5N1; RELATIVE-HUMIDITY; RISK-FACTORS; TRANSMISSION; SURVIVAL; EPIDEMIOLOGY; SURVEILLANCE; TEMPERATURE; OUTBREAKS	As of June 22, 2011, influenza A/H5N1 has caused a reported 329 deaths and 562 cases in humans, typically attributed to contact with infected poultry. Influenza H5N1 has been described as seasonal. Although several studies have evaluated environmental risk factors for H5N1 in poultry, none have considered seasonality of H5N1 in humans. In addition, temperature and humidity are suspected to drive influenza in temperate regions, but drivers in the tropics are unknown, for H5N1 as well as other influenza viruses. An analysis was conducted to determine whether human H5N1 cases occur seasonally in association with changes in temperature, precipitation and humidity. Data analyzed were H5N1 human cases in Indonesia (n = 135) and Egypt (n = 50), from January 1, 2005 (Indonesia) or 2006 (Egypt) through May 1, 2008 obtained from WHO case reports, and average daily weather conditions obtained from NOAA's National Climatic Data Center. Fourier time series analysis was used to determine seasonality of cases and associations between weather conditions and human H5N1 incidence. Human H5N1 cases in Indonesia occurred with a period of 1.67 years/cycle (p<0.05) and in Egypt, a period of 1.18 years/cycle (p congruent to 0.10). Human H5N1 incidence in Egypt, but not Indonesia, was strongly associated with meteorological variables (kappa(2)>= 0.94) and peaked in Egypt when precipitation was low, and temperature, absolute humidity and relative humidity were moderate compared to the average daily conditions in Egypt. Weather conditions coinciding with peak human H5N1 incidence in Egypt suggest that human infection may be occurring primarily via droplet transmission from close contact with infected poultry.	[Murray, Eleanor J.; Morse, Stephen S.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Columbia University	Murray, EJ (corresponding author), Harvard Univ, Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	emurray@hsph.harvard.edu	Murray, Eleanor/I-6996-2019	Murray, Eleanor/0000-0003-0043-4901	USAID EPT/"PREDICT'' (US Agency for International Development) [GHN-A-009-00010-00]; Arts & Letters Foundation	USAID EPT/"PREDICT'' (US Agency for International Development)(United States Agency for International Development (USAID)); Arts & Letters Foundation	SSM is supported by USAID EPT/"PREDICT'' (US Agency for International Development, www.usaid.gov, grant number: USAID Cooperative Agreement GHN-A-009-00010-00) and the Arts & Letters Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Abdelwhab EM, 2011, EPIDEMIOL INFECT, V139, P647, DOI 10.1017/S0950268810003122; Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; ANDREWS DWK, 1991, ECONOMETRICA, V59, P817, DOI 10.2307/2938229; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Bi P, 2007, J INFECTION, V55, P551, DOI 10.1016/j.jinf.2007.07.004; Bloomfield P., 2000, FOURIER ANAL TIME SE, P261; *CDCP, 2010, KEY FACTS INFL FLU F; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Chiu SS, 2002, NEW ENGL J MED, V347, P2097, DOI 10.1056/NEJMoa020546; Crighton EJ, 2001, BMC HEALTH SERV RES, V1, DOI 10.1186/1472-6963-1-7; Doraisingham S, 1981, Ann Acad Med Singap, V10, P69; Dosseh A, 2000, AM J TROP MED HYG, V62, P639, DOI 10.4269/ajtmh.2000.62.639; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; El Zanaty F, 2007, AVIAN INFLUENZA SURV; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; FARIED S, 2006, KAPB STUDY POULTRY R; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; GORDON A, 2009, EMERG INFECT DIS MAR; Nguyen HLK, 2007, J INFECTION, V55, P58, DOI 10.1016/j.jinf.2006.12.001; HARPER GJ, 1961, J HYG-CAMBRIDGE, V59, P479, DOI 10.1017/S0022172400039176; *HONG KONG DEP HLT, 2006, WHAT EMPL ENT SHOULD; Huai Y, 2008, EMERG INFECT DIS, V14, P1819, DOI 10.3201/eid1411.080509; Huntington E, 1920, ECOLOGY, V1, P6, DOI 10.2307/1929252; Jensen ES, 2004, EUR J EPIDEMIOL, V19, P181, DOI 10.1023/B:EJEP.0000017659.80903.5f; Kaoud H. A., 2008, International Journal of Poultry Science, V7, P72; Khalenkov A, 2008, J VIROL METHODS, V149, P180, DOI 10.1016/j.jviromet.2008.01.001; Kleinbaum D.G., 2008, APPL REGRESSION ANAL; Lawrence MG, 2005, B AM METEOROL SOC, V86, P225, DOI 10.1175/BAMS-86-2-225; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; MINH PQ, 2009, PREV VET MED; Montgomery D. C, 2012, INTRO LINEAR REGRESS, V5th, P289; Morse SS, 2006, SCIENCE, V314, P929, DOI 10.1126/science.1135823; *PANDEMICFLU GOV, PAND PLANN ASS; RAO BL, 1993, B WORLD HEALTH ORGAN, V71, P177; *SAS I INC, 2003, PROD DOC SPECTRA PRO; Sedyaningsih ER, 2008, ANN ACAD MED SINGAP, V37, P482; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; SIEGEL AF, 1980, J AM STAT ASSOC, V75, P345, DOI 10.2307/2287456; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; SUNGU M, 1991, PAPUA NEW GUINEA MED, V34, P199; Tarantola A, 2010, EUROSURVEILLANCE, V15, P8; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; THAWATSUPHA P, 1997, J HEALTH SCI, V6, P668; Thompson PN, 2008, PREV VET MED, V86, P139, DOI 10.1016/j.prevetmed.2008.03.011; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Tiensin T, 2007, AVIAN DIS, V51, P182, DOI 10.1637/7635-042806R.1; Tiwari A, 2006, AVIAN DIS, V50, P284, DOI 10.1637/7453-101205R.1; Treanor J, 2004, NEW ENGL J MED, V350, P218, DOI 10.1056/NEJMp038238; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Vong S, 2008, EMERG INFECT DIS, V14, P1303, DOI 10.3201/eid1408.070912; Wallace J., 2006, ATMOSPHERIC SCI INTR, V2nd; Ward M, 2008, VET RES COMMUN, V32, P627, DOI 10.1007/s11259-008-9064-8; White T, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e73; *WHO, 2010, WKLY EPIDEMIOL REC, V7, P49; *WHO, 2008, WHO SIT UPD AV INFL; Williams RAJ, 2008, T ROY SOC TROP MED H, V102, P471, DOI 10.1016/j.trstmh.2008.01.016; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121; YUPIANA Y, 2010, INT J INFECT DI 0714	63	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24042	10.1371/journal.pone.0024042	http://dx.doi.org/10.1371/journal.pone.0024042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909409	Green Submitted, gold, Green Published			2022-12-25	WOS:000294683900022
J	Lu, CY; Wu, J; Wang, HH; Wang, S; Diao, N; Wang, FF; Gao, Y; Chen, JZ; Shao, LY; Weng, XH; Zhang, Y; Zhang, WH				Lu, Chanyi; Wu, Jing; Wang, Honghai; Wang, Sen; Diao, Ni; Wang, Feifei; Gao, Yan; Chen, Jiazhen; Shao, Lingyun; Weng, Xinhua; Zhang, Ying; Zhang, Wenhong			Novel Biomarkers Distinguishing Active Tuberculosis from Latent Infection Identified by Gene Expression Profile of Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							T-CELLS; CONTACT INVESTIGATIONS; IMMUNE-RESPONSES; IFN-GAMMA; MYCOBACTERIUM; PROGRESSION; DIAGNOSIS; ATP10C; IP-10; INTERLEUKIN-2	Background: Humans infected with Mycobacterium tuberculosis (MTB) can delete the pathogen or otherwise become latent infection or active disease. However, the factors influencing the pathogen clearance and disease progression from latent infection are poorly understood. This study attempted to use a genome-wide transcriptome approach to identify immune factors associated with MTB infection and novel biomarkers that can distinguish active disease from latent infection. Methodology/Principal Findings: Using microarray analysis, we comprehensively determined the transcriptional difference in purified protein derivative (PPD) stimulated peripheral blood mononuclear cells (PBMCs) in 12 individuals divided into three groups: TB patients (TB), latent TB infection individuals (LTBI) and healthy controls (HC) (n = 4 per group). A transcriptional profiling of 506 differentially expressed genes could correctly group study individuals into three clusters. Moreover, 55-and 229-transcript signatures for tuberculosis infection (TB& LTBI) and active disease (TB) were identified, respectively. The validation study by quantitative real-time PCR (qPCR) performed in 83 individuals confirmed the expression patterns of 81% of the microarray identified genes. Decision tree analysis indicated that three genes of CXCL10, ATP10A and TLR6 could differentiate TB from LTBI subjects. Additional validation was performed to assess the diagnostic ability of the three biomarkers within 36 subjects, which yielded a sensitivity of 71% and specificity of 89%. Conclusions/Significance: The transcription profiles of PBMCs induced by PPD identified distinctive gene expression patterns associated with different infectious status and provided new insights into human immune responses to MTB. Furthermore, this study indicated that a combination of CXCL10, ATP10A and TLR6 could be used as novel biomarkers for the discrimination of TB from LTBI.	[Lu, Chanyi; Wu, Jing; Wang, Sen; Diao, Ni; Wang, Feifei; Gao, Yan; Chen, Jiazhen; Shao, Lingyun; Weng, Xinhua; Zhang, Ying; Zhang, Wenhong] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China; [Lu, Chanyi; Wu, Jing; Wang, Honghai] Fudan Univ, Sch Life Sci, Inst Genet, SKLGE, Shanghai 200433, Peoples R China; [Zhang, Ying] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Zhang, Wenhong] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Fudan University	Lu, CY (corresponding author), Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China.	pharmlife2002@yahoo.com; zhangwenhong@fudan.edu.cn	吴, 晶/D-3782-2013; Wu, Jing/GQI-1843-2022	Wu, Jing/0000-0002-1224-0912	Shanghai Science and Technology Development Funds [10XD1400900, 10QA1401100]; National Natural Science Foundation of China [30901277]; Key Technologies Research and Development Program for Infectious Diseases of China [2008ZX10003003, 2009ZX10004-104]; Key Project of Science and Technology of Shanghai [10411955000]	Shanghai Science and Technology Development Funds; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technologies Research and Development Program for Infectious Diseases of China; Key Project of Science and Technology of Shanghai	This study was supported in part by research grants from the Shanghai Science and Technology Development Funds (10XD1400900, 10QA1401100) and National Natural Science Foundation of China (30901277), Key Technologies Research and Development Program for Infectious Diseases of China (2008ZX10003003, 2009ZX10004-104) and the Key Project of Science and Technology of Shanghai (10411955000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IMO, 2010, PEDIATR INFECT DIS J, V29, P439, DOI 10.1097/INF.0b013e3181cb45da; Altet-Gomez N, 2010, EUROPEAN RESP J; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; BEADLING C, 1993, P NATL ACAD SCI USA, V90, P2719, DOI 10.1073/pnas.90.7.2719; Beadling Carol, 2002, Med Immunol, V1, P2, DOI 10.1186/1476-9433-1-2; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Booth V, 2002, BIOCHEMISTRY-US, V41, P10418, DOI 10.1021/bi026020q; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Cardona PJ, 2004, EUR RESPIR J, V24, P1044, DOI 10.1183/09031936.04.00072604; Chang JS, 2006, J IMMUNOL, V176, P3010, DOI 10.4049/jimmunol.176.5.3010; Chee CBE, 2009, EUR J CLIN MICROBIOL, V28, P667, DOI 10.1007/s10096-008-0670-8; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Chen JZ, 2009, MICROBES INFECT, V11, P876, DOI 10.1016/j.micinf.2009.05.008; Chen X, 2010, MOL CELL BIOCHEM, V342, P71, DOI 10.1007/s11010-010-0470-1; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Dhar MS, 2004, J NUTR, V134, P799, DOI 10.1093/jn/134.4.799; Dheda K, 2010, RESPIROLOGY, V15, P433, DOI 10.1111/j.1440-1843.2010.01739.x; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Herzing LBK, 2001, AM J HUM GENET, V68, P1501, DOI 10.1086/320616; Huang J, 2010, J CLIN INVEST, V120, P223, DOI 10.1172/JCI38012; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Jereb J, 2003, INT J TUBERC LUNG D, V7, pS384; Lawn SD, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/980594; Li L, 2008, BLOOD, V111, P5629, DOI 10.1182/blood-2008-02-139899; Lighter J, 2009, INT J TUBERC LUNG D, V13, P731; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Maertzdorf J, 2010, GENES IMMUN; Marais B, 2010, LANCET; Marin ND, 2010, TUBERCULOSIS, V90, P252, DOI 10.1016/j.tube.2010.05.003; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Meguro M, 2001, NAT GENET, V28, P19, DOI 10.1038/ng0501-19; MEYERSON M, 2005, MOL DIAGNOSTICS CLIN, P121; Mistry R, 2007, J INFECT DIS, V195, P357, DOI 10.1086/510397; MURAGUCHI A, 1985, J EXP MED, V161, P181, DOI 10.1084/jem.161.1.181; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Shao LY, 2008, AIDS, V22, P2241, DOI 10.1097/QAD.0b013e3283117f18; Siawaya JFD, 2007, INT J INFECT DIS, V11, P289, DOI 10.1016/j.ijid.2007.02.001; STERN JB, 1986, SCIENCE, V233, P203, DOI 10.1126/science.3523754; Stop TB Partnership, 2008, STOP TB PARTN; Sutherland JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012365; Thuong Nguyen Thuy Thuong, 2008, PLoS Pathog, V4, pe1000229, DOI 10.1371/journal.ppat.1000229; UCHIYAMA T, 1985, J CLIN INVEST, V76, P446, DOI 10.1172/JCI111992; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Weng YM, 1998, J BIOL CHEM, V273, P18288, DOI 10.1074/jbc.273.29.18288; Wilkinson KA, 2010, EUR J IMMUNOL, V40, P2139, DOI 10.1002/eji.201040731; World Health Organization, 2010, GLOB TUB CONTR; Wu B, 2007, J IMMUNOL, V178, P3688, DOI 10.4049/jimmunol.178.6.3688; Yuen MF, 2007, HEPATOLOGY, V46, P1695, DOI 10.1002/hep.21939; Zhang S, 2010, CLIN VACCINE IMMUNOL, V17, P1985, DOI 10.1128/CVI.00294-10	55	56	59	6	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24290	10.1371/journal.pone.0024290	http://dx.doi.org/10.1371/journal.pone.0024290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904626	Green Published, Green Submitted, gold			2022-12-25	WOS:000294680800080
J	Neely, GG; Keene, AC; Duchek, P; Chang, EC; Wang, QP; Aksoy, YA; Rosenzweig, M; Costigan, M; Woolf, CJ; Garrity, PA; Penninger, JM				Neely, G. Gregory; Keene, Alex C.; Duchek, Peter; Chang, Elaine C.; Wang, Qiao-Ping; Aksoy, Yagiz Alp; Rosenzweig, Mark; Costigan, Michael; Woolf, Clifford J.; Garrity, Paul A.; Penninger, Josef M.			TrpA1 Regulates Thermal Nociception in Drosophila	PLOS ONE			English	Article							TEMPERATURE PREFERENCE; ADULT DROSOPHILA; MUSHROOM BODY; PAIN; COLD; CONTRIBUTES; BEHAVIOR; NEURONS; FLY	Pain is a significant medical concern and represents a major unmet clinical need. The ability to perceive and react to tissue-damaging stimuli is essential in order to maintain bodily integrity in the face of environmental danger. To prevent damage the systems that detect noxious stimuli are therefore under strict evolutionary pressure. We developed a high-throughput behavioral method to identify genes contributing to thermal nociception in the fruit fly and have reported a large-scale screen that identified the Ca2+ channel straightjacket (stj) as a conserved regulator of thermal nociception. Here we present the minimal anatomical and neuronal requirements for Drosophila to avoid noxious heat in our novel behavioral paradigm. Bioinformatics analysis of our whole genome data set revealed 23 genes implicated in Ca2+ signaling that are required for noxious heat avoidance. One of these genes, the conserved thermoreceptor TrpA1, was confirmed as a bona fide "pain'' gene in both adult and larval fly nociception paradigms. The nociceptive function of TrpA1 required expression within the Drosophila nervous system, specifically within nociceptive multi-dendritic (MD) sensory neurons. Therefore, our analysis identifies the channel TRPA1 as a conserved regulator of nociception.	[Neely, G. Gregory; Wang, Qiao-Ping; Aksoy, Yagiz Alp] Garvan Inst Med Res, Neurosci Program, Sydney, NSW, Australia; [Neely, G. Gregory; Duchek, Peter; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria; [Keene, Alex C.] NYU, Dept Biol, New York, NY 10003 USA; [Chang, Elaine C.; Rosenzweig, Mark; Garrity, Paul A.] Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02254 USA; [Costigan, Michael; Woolf, Clifford J.] Childrens Hosp Boston, Program Neurobiol, Boston, MA USA; [Costigan, Michael; Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Garvan Institute of Medical Research; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); New York University; Brandeis University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Neely, GG (corresponding author), Garvan Inst Med Res, Neurosci Program, Sydney, NSW, Australia.	g.neely@garvan.org.au	Wang, Qiaoping/I-5993-2013; Penninger, Josef M/I-6860-2013; Woolf, Clifford/A-9784-2010; Aksoy, Yagiz Alp/E-5853-2012; Aksoy, Yagiz/GRY-0536-2022; Neely, Greg/AAB-4642-2020; neely, graham/A-6511-2011	Penninger, Josef M/0000-0002-8194-3777; Neely, Greg/0000-0002-1957-9732; Aksoy, Yagiz Alp/0000-0003-3301-8648; Garrity, Paul/0000-0002-8274-6564	Institute of Molecular Biotechnology; Austrian Ministry of Sciences; Austrian Academy of Sciences, Genome Research in Austria (AustroMouse); European Union European Research Council; National Institutes of Health (NIH) National Research Service [1 F32GM086207-01]; NIH [NS039518, NS038253, NS044232]; Marie Curie Incoming International Fellowship; EuroThymaide; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM086207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232, R01NS039518, R01NS038253, R37NS039518] Funding Source: NIH RePORTER	Institute of Molecular Biotechnology; Austrian Ministry of Sciences; Austrian Academy of Sciences, Genome Research in Austria (AustroMouse); European Union European Research Council(European Research Council (ERC)European Commission); National Institutes of Health (NIH) National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie Incoming International Fellowship(European Commission); EuroThymaide(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	JP is supported by grants from Institute of Molecular Biotechnology, the Austrian Ministry of Sciences, the Austrian Academy of Sciences, Genome Research in Austria (AustroMouse), and European Union European Research Council Advanced Grant. AK is supported by National Institutes of Health (NIH) National Research Service Award 1 F32GM086207-01. CW is supported by NIH NS039518 and NS038253. GN was supported by a Marie Curie Incoming International Fellowship and EuroThymaide. PG is supported by NIH NS044232. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; del Camino D, 2010, J NEUROSCI, V30, P15165, DOI 10.1523/JNEUROSCI.2580-10.2010; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Gioia A, 2009, J COMP PHYSIOL A, V195, P777, DOI 10.1007/s00359-009-0455-2; Glauser DA, 2011, GENETICS, V188, P91, DOI 10.1534/genetics.111.127100; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Helme RD, 2001, CLIN GERIATR MED, V17, P417, DOI 10.1016/S0749-0690(05)70078-1; Hong ST, 2008, NATURE, V454, P771, DOI 10.1038/nature07090; Hsueh YP, 2006, CURR MED CHEM, V13, P1915, DOI 10.2174/092986706777585040; Jung JY, 2004, J BIOL CHEM, V279, P7048, DOI 10.1074/jbc.M311448200; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Neely GG, 2010, CELL, V143, P628, DOI 10.1016/j.cell.2010.09.047; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang HB, 2005, NEURON, V46, P9, DOI 10.1016/j.neuron.2005.03.011; Woolf CJ, 2010, NAT MED, V16, P1241, DOI 10.1038/nm.2230; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Xu SY, 2006, GENES BRAIN BEHAV, V5, P602, DOI 10.1111/j.1601-183X.2006.00213.x; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194	35	104	112	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24343	10.1371/journal.pone.0024343	http://dx.doi.org/10.1371/journal.pone.0024343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909389	Green Submitted, gold, Green Published			2022-12-25	WOS:000294680800085
J	Schulte, J; Sepp, KJ; Wu, CH; Hong, PY; Littleton, JT				Schulte, Joost; Sepp, Katharine J.; Wu, Chaohong; Hong, Pengyu; Littleton, J. Troy			High-Content Chemical and RNAi Screens for Suppressors of Neurotoxicity in a Huntington's Disease Model	PLOS ONE			English	Article							CELL-CELL INTERACTIONS; MUTANT HUNTINGTIN; AXONAL-TRANSPORT; MOUSE MODEL; DROSOPHILA; NEURODEGENERATION; EXPRESSION; PATHOGENESIS; SIROLIMUS; PROTEINS	To identify Huntington's Disease therapeutics, we conducted high-content small molecule and RNAi suppressor screens using a Drosophila primary neural culture Huntingtin model. Drosophila primary neurons offer a sensitive readout for neurotoxicty, as their neurites develop dysmorphic features in the presence of mutant polyglutamine-expanded Huntingtin compared to nonpathogenic Huntingtin. By tracking the subcellular distribution of mRFP-tagged pathogenic Huntingtin and assaying neurite branch morphology via live-imaging, we identified suppressors that could reduce Huntingtin aggregation and/or prevent the formation of dystrophic neurites. The custom algorithms we used to quantify neurite morphologies in complex cultures provide a useful tool for future high-content screening approaches focused on neurodegenerative disease models. Compounds previously found to be effective aggregation inhibitors in mammalian systems were also effective in Drosophila primary cultures, suggesting translational capacity between these models. However, we did not observe a direct correlation between the ability of a compound or gene knockdown to suppress aggregate formation and its ability to rescue dysmorphic neurites. Only a subset of aggregation inhibitors could revert dysmorphic cellular profiles. We identified lkb1, an upstream kinase in the mTOR/Insulin pathway, and four novel drugs, Camptothecin, OH-Camptothecin, 18 beta-Glycyrrhetinic acid, and Carbenoxolone, that were strong suppressors of mutant Huntingtin-induced neurotoxicity. Huntingtin neurotoxicity suppressors identified through our screen also restored viability in an in vivo Drosophila Huntington's Disease model, making them attractive candidates for further therapeutic evaluation.	[Schulte, Joost; Sepp, Katharine J.; Littleton, J. Troy] MIT, Dept Brain & Cognit Sci, Dept Biol, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Wu, Chaohong; Hong, Pengyu] Brandeis Univ, Dept Comp Sci, Natl Ctr Behav Genom, Waltham, MA USA	Massachusetts Institute of Technology (MIT); Northwell Health; Brandeis University	Schulte, J (corresponding author), MIT, Dept Brain & Cognit Sci, Dept Biol, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	jschulte@mit.edu	Hong, Pengyu/AAE-6736-2020	Littleton, J. Troy/0000-0001-5576-2887; Hong, Pengyu/0000-0002-3177-2754	NIH;  [R01 EB007042]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040296, R01NS043244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants to JTL and R01 EB007042 to PH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2005, P NATL ACAD SCI USA, V102, P3777, DOI 10.1073/pnas.0500055102; Ambegaokar SS, 2010, NEUROBIOL DIS, V40, P29, DOI 10.1016/j.nbd.2010.05.026; [Anonymous], 1932, STAT METHODS RES WOR; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Auluck PK, 2002, NAT MED, V8, P1185, DOI 10.1038/nm1102-1185; Banovic D, 2010, NEURON, V66, P724, DOI 10.1016/j.neuron.2010.05.020; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Bradford J, 2010, J BIOL CHEM, V285, P10653, DOI 10.1074/jbc.M109.083287; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chin PC, 2004, J NEUROCHEM, V90, P595, DOI 10.1111/j.1471-4159.2004.02530.x; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; DIFIGLIA M, 1997, SCIENCE; Doumanis J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007275; Fleming A, 2011, NAT CHEM BIOL, V7, P9, DOI 10.1038/NCHEMBIO.500; Fu XA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002009; Gayan J, 2008, GENET EPIDEMIOL, V32, P445, DOI 10.1002/gepi.20317; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gu XF, 2005, NEURON, V46, P433, DOI 10.1016/j.neuron.2005.03.025; Gu XF, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-8; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Halliday GM, 1998, EXP NEUROL, V154, P663, DOI 10.1006/exnr.1998.6919; Hardie DG, 2006, GASTROENTEROLOGY, V131, P973, DOI 10.1053/j.gastro.2006.07.032; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Hertzberg R, 1990, J BIOL CHEM; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Ju TC, 2011, J CELL BIOL, V194, P209, DOI 10.1083/jcb.201105010; Juszczak GR, 2009, PROG NEURO-PSYCHOPH, V33, P181, DOI 10.1016/j.pnpbp.2008.12.014; Kao TC, 2009, J AGR FOOD CHEM, V57, P754, DOI 10.1021/jf802864k; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Kluza J, 2004, ONCOGENE, V23, P7018, DOI 10.1038/sj.onc.1207936; Kretzschmar D, 2005, GLIA, V49, P59, DOI 10.1002/glia.20098; Kuypers DRJ, 2005, DRUG SAFETY, V28, P153, DOI 10.2165/00002018-200528020-00006; Lang-Rollin ICJ, 2003, J NEUROSCI, V23, P11015; Lee JH, 2006, CELL DEATH DIFFER, V13, P1110, DOI 10.1038/sj.cdd.4401790; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Letavernier E, 2007, CLIN J AM SOC NEPHRO, V2, P326, DOI 10.2215/CJN.03751106; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Li Z, 1999, HUM MOL GENET, V8, P1807, DOI 10.1093/hmg/8.9.1807; Lim KL, 2010, EXPERT OPIN DRUG DIS, V5, P165, DOI 10.1517/17460440903527675; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Min KT, 1999, SCIENCE, V284, P1985, DOI 10.1126/science.284.5422.1985; Morrisett JD, 2002, J LIPID RES, V43, P1170, DOI 10.1194/jlr.M100392-JLR200; Nopoulos PC, 2010, NEUROBIOL DIS, V40, P544, DOI 10.1016/j.nbd.2010.07.014; O'Kane CJ, 2011, DROSOPHILA MODEL ORG; Maroto JP, 2011, J CLIN ONCOL, V29, P1750, DOI 10.1200/JCO.2010.29.2235; Paulsen JS, 2010, BRAIN RES BULL, V82, P201, DOI 10.1016/j.brainresbull.2010.04.003; Pham PTT, 2004, TRANSPLANTATION, V77, P1215, DOI 10.1097/01.TP.0000118413.92211.B6; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; REIPERT S, 1995, EXP CELL RES, V221, P281, DOI 10.1006/excr.1995.1376; Robertson AL, 2010, CURR MED CHEM, V17, P3058; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Roze E, 2008, CURR OPIN NEUROL, V21, P497, DOI 10.1097/WCO.0b013e328304b692; Sapp E, 1999, J NEUROPATH EXP NEUR, V58, P165, DOI 10.1097/00005072-199902000-00006; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Schulte J, 2010, J NEUROSCI, V30, P5189, DOI 10.1523/JNEUROSCI.5823-09.2010; Sepp KJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000111; Shaw R, 2005, SCIENCE; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021108; Tamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004262; Thomas CJ, 2004, BIOORGAN MED CHEM, V12, P1585, DOI 10.1016/j.bmc.2003.11.036; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; van Veelen W, 2011, LONG WINDING ROAD RA; Wang J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-1; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Williams R, 2006, NAT REV NEUROSCI, V7, P831, DOI 10.1038/nrn2029; Wu CH, 2010, NEUROINFORMATICS, V8, P83, DOI 10.1007/s12021-010-9067-9; Yamamoto A, 2006, J CELL BIOL; Zhang S, 2010, GENETICS, V184, P1165, DOI 10.1534/genetics.109.112516; Zhang S, 2009, DIS MODEL MECH, V2, P247, DOI 10.1242/dmm.000653; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	78	41	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23841	10.1371/journal.pone.0023841	http://dx.doi.org/10.1371/journal.pone.0023841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909362	gold, Green Published, Green Submitted			2022-12-25	WOS:000294680800025
J	Sohara, E; Rai, T; Yang, SS; Ohta, A; Naito, S; Chiga, M; Nomura, N; Lin, SH; Vandewalle, A; Ohta, E; Sasaki, S; Uchida, S				Sohara, Eisei; Rai, Tatemitsu; Yang, Sung-Sen; Ohta, Akihito; Naito, Shotaro; Chiga, Motoko; Nomura, Naohiro; Lin, Shih-Hua; Vandewalle, Alain; Ohta, Eriko; Sasaki, Sei; Uchida, Shinichi			Acute Insulin Stimulation Induces Phosphorylation of the Na-Cl Cotransporter in Cultured Distal mpkDCT Cells and Mouse Kidney	PLOS ONE			English	Article							SODIUM-CHLORIDE COTRANSPORTER; BLOOD-PRESSURE; CONVOLUTED TUBULE; DIETARY SALT; HYPERTENSION; ALDOSTERONE; KINASES; SPAK; SGK1; HYPERKALEMIA	The NaCl cotransporter (NCC) is essential for sodium reabsorption at the distal convoluted tubules (DCT), and its phosphorylation increases its transport activity and apical membrane localization. Although insulin has been reported to increase sodium reabsorption in the kidney, the linkage between insulin and NCC phosphorylation has not yet been investigated. This study examined whether insulin regulates NCC phosphorylation. In cultured mpkDCT cells, insulin increased phosphorylation of STE20/SPS1-related proline-alanine-rich kinase (SPAK) and NCC in a dose-dependent manner. This insulin-induced phosphorylation of NCC was suppressed in WNK4 and SPAK knockdown cells. In addition, Ly294002, a PI3K inhibitor, decreased the insulin effect on SPAK and NCC phosphorylation, indicating that insulin induces phosphorylation of SPAK and NCC through PI3K and WNK4 in mpkDCT cells. Moreover, acute insulin administration to mice increased phosphorylation of oxidative stress-responsive kinase-1 (OSR1), SPAK and NCC in the kidney. Time-course experiments in mpkDCT cells and mice suggested that SPAK is upstream of NCC in this insulin-induced NCC phosphorylation mechanism, which was confirmed by the lack of insulin-induced NCC phosphorylation in SPAK knockout mice. Moreover, insulin administration to WNK4 hypomorphic mice did not increase phosphorylation of OSR1, SPAK and NCC in the kidney, suggesting that WNK4 is also involved in the insulin-induced OSR1, SPAK and NCC phosphorylation mechanism in vivo. The present results demonstrated that insulin is a potent regulator of NCC phosphorylation in the kidney, and that WNK4 and SPAK are involved in this mechanism of NCC phosphorylation by insulin.	[Sohara, Eisei; Rai, Tatemitsu; Ohta, Akihito; Naito, Shotaro; Chiga, Motoko; Nomura, Naohiro; Ohta, Eriko; Sasaki, Sei; Uchida, Shinichi] Tokyo Med & Dent Univ, Grad Sch Med, Dept Nephrol, Tokyo, Japan; [Yang, Sung-Sen; Lin, Shih-Hua] Tri Serv Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Vandewalle, Alain] INSERM, U773, Paris, France; [Vandewalle, Alain] Univ Paris 07, Paris, France	Tokyo Medical & Dental University (TMDU); Tri-Service General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Sohara, E (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Nephrol, Tokyo, Japan.	esohara.kid@tmd.ac.jp	Rai, Tatemitsu/K-7165-2019; Uchida, Shinichi/D-1111-2013	Nomura, Naohiro/0000-0002-6998-1922	Ministry of Education, Culture, Sports, Science and Technology of Japan [22790783]; Japan Society for the Promotion of Science [22249032, 20249047]; Japan-Taiwan Joint Research Program for Interchange Association Japan; Salt Science Research Foundation [1026]; Takeda Science Foundation [2032]; Kanae Foundation for the Promotion of Medical Science; Nakajima Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan-Taiwan Joint Research Program for Interchange Association Japan; Salt Science Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Kanae Foundation for the Promotion of Medical Science; Nakajima Foundation	This study was supported in part by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grants-in-Aid for Scientific Research on Creative Scientific Research from the Japan Society for the Promotion of Science (22249032), Grant-in-Aid for Scientific Research (A) from the Japan Society for the Promotion of Science (20249047), Grant-in-Aid for Young Scientists (B and start-up) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (22790783), the Japan-Taiwan Joint Research Program for Interchange Association Japan (no number), the Salt Science Research Foundation (# 1026), Takeda Science Foundation (2032), Kanae Foundation for the Promotion of Medical Science (no number), and The Nakajima Foundation (no number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Achard JM, 2001, CLIN EXP PHARMACOL P, V28, P1048, DOI 10.1046/j.1440-1681.2001.03575.x; Chen J, 2009, LANCET, V373, P829, DOI 10.1016/S0140-6736(09)60144-6; Chiga M, 2008, KIDNEY INT, V74, P1403, DOI 10.1038/ki.2008.451; DEFRONZO RA, 1976, J CLIN INVEST, V58, P83, DOI 10.1172/JCI108463; DEFRONZO RA, 1975, J CLIN INVEST, V55, P845, DOI 10.1172/JCI107996; Diepens RJW, 2004, AM J PHYSIOL-RENAL, V286, pF483, DOI 10.1152/ajprenal.00231.2003; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; GORDON RD, 1986, HYPERTENSION, V8, P93, DOI 10.1161/01.HYP.8.2.93; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kim GH, 1998, P NATL ACAD SCI USA, V95, P14552, DOI 10.1073/pnas.95.24.14552; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lee IH, 2007, J BIOL CHEM, V282, P29866, DOI 10.1074/jbc.M701923200; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; Naito S, 2011, CLIN EXP NEPHROL, V15, P195, DOI 10.1007/s10157-010-0378-9; Ohta A, 2009, HUM MOL GENET, V18, P3978, DOI 10.1093/hmg/ddp344; Pedersen NB, 2010, KIDNEY INT, V78, P160, DOI 10.1038/ki.2010.130; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Ring AM, 2007, P NATL ACAD SCI USA, V104, P4025, DOI 10.1073/pnas.0611728104; Rozansky DJ, 2009, J CLIN INVEST, V119, P2601, DOI 10.1172/JCI38323; San-Cristobal P, 2009, P NATL ACAD SCI USA, V106, P4384, DOI 10.1073/pnas.0813238106; Sandberg MB, 2007, AM J PHYSIOL-RENAL, V293, pF662, DOI 10.1152/ajprenal.00064.2007; SCHAMBELAN M, 1981, KIDNEY INT, V19, P716, DOI 10.1038/ki.1981.72; Sohara E, 2006, P NATL ACAD SCI USA, V103, P14217, DOI 10.1073/pnas.0602331103; Song J, 2006, AM J PHYSIOL-RENAL, V290, pF1055, DOI 10.1152/ajprenal.00108.2005; Talati G, 2010, BIOCHEM BIOPH RES CO, V393, P844, DOI 10.1016/j.bbrc.2010.02.096; Tiwari S, 2007, AM J PHYSIOL-RENAL, V293, pF178, DOI 10.1152/ajprenal.00447.2006; Uzu T, 2006, J HYPERTENS, V24, P1627, DOI 10.1097/01.hjh.0000239299.71001.77; Vallon V, 2009, AM J PHYSIOL-RENAL, V297, pF704, DOI 10.1152/ajprenal.00030.2009; Vitari AC, 2004, BIOCHEM J, V378, P257, DOI 10.1042/BJ20031692; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009; Yang SS, 2010, J AM SOC NEPHROL, V21, P1868, DOI 10.1681/ASN.2009121295	33	70	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24277	10.1371/journal.pone.0024277	http://dx.doi.org/10.1371/journal.pone.0024277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909387	gold, Green Published, Green Submitted			2022-12-25	WOS:000294680800076
J	Su, JM; Wang, YS; Li, YY; Li, RZ; Li, Q; Wu, YY; Quan, FS; Liu, J; Guo, ZK; Zhang, Y				Su, Jianmin; Wang, Yongsheng; Li, Yanyan; Li, Ruizhe; Li, Qian; Wu, Yongyan; Quan, Fusheng; Liu, Jun; Guo, Zekun; Zhang, Yong			Oxamflatin Significantly Improves Nuclear Reprogramming, Blastocyst Quality, and In Vitro Development of Bovine SCNT Embryos	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; PLURIPOTENT STEM-CELLS; FULL-TERM DEVELOPMENT; ADULT SOMATIC-CELLS; GENE-EXPRESSION; CLONED EMBRYOS; MINIATURE PIG; CLONING EFFICIENCY; DNA METHYLATION; TRICHOSTATIN-A	Aberrant epigenetic nuclear reprogramming results in low somatic cloning efficiency. Altering epigenetic status by applying histone deacetylase inhibitors (HDACi) enhances developmental potential of somatic cell nuclear transfer (SCNT) embryos. The present study was carried out to examine the effects of Oxamflatin, a novel HDACi, on the nuclear reprogramming and development of bovine SCNT embryos in vitro. We found that Oxamflatin modified the acetylation status on H3K9 and H3K18, increased total and inner cell mass (ICM) cell numbers and the ratio of ICM: trophectoderm (TE) cells, reduced the rate of apoptosis in SCNT blastocysts, and significantly enhanced the development of bovine SCNT embryos in vitro. Furthermore, Oxamflatin treatment suppressed expression of the pro-apoptotic gene Bax and stimulated expression of the anti-apoptotic gene Bcl-XL and the pluripotency-related genes OCT4 and SOX2 in SCNT blastocysts. Additionally, the treatment also reduced the DNA methylation level of satellite I in SCNT blastocysts. In conclusion, Oxamflatin modifies epigenetic status and gene expression, increases blastocyst quality, and subsequently enhances the nuclear reprogramming and developmental potential of SCNT embryos.	[Su, Jianmin; Wang, Yongsheng; Li, Yanyan; Li, Ruizhe; Li, Qian; Wu, Yongyan; Quan, Fusheng; Liu, Jun; Zhang, Yong] NW A&F Univ, Coll Vet Med, Minist Agr, Key Lab Anim Reprod Physiol & Embryo Technol, Yangling, Shaanxi, Peoples R China; [Guo, Zekun] NW A&F Univ, Coll Life Sci, Dept Biochem & Mol Biol, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China	Zhang, Y (corresponding author), NW A&F Univ, Coll Vet Med, Minist Agr, Key Lab Anim Reprod Physiol & Embryo Technol, Yangling, Shaanxi, Peoples R China.	jianminsu@163.com; zhangylab@gmail.com	Zhang, Yong/K-7945-2016; Wu, Yongyan/AAH-1471-2019	Zhang, Yong/0000-0001-8642-4071; Wu, Yongyan/0000-0003-1669-3860; Su, Jianmin/0000-0001-7353-1265	National Key Project for Production of Transgenic Livestock, PR China [2008ZX08007-004]	National Key Project for Production of Transgenic Livestock, PR China	This work was supported by the National Key Project for Production of Transgenic Livestock, PR China (No.2008ZX08007-004; http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aston KI, 2010, CELL REPROGRAM, V12, P23, DOI 10.1089/cell.2009.0042; Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Beebe LFS, 2009, CLONING STEM CELLS, V11, P477, DOI 10.1089/clo.2009.0029; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Beyhan Z, 2007, MOL REPROD DEV, V74, P18, DOI 10.1002/mrd.20618; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; Costa-Borges N, 2010, CELL REPROGRAM, V12, P437, DOI 10.1089/cell.2009.0108; Cui XS, 2011, CELL REPROGRAM, V13, P179, DOI 10.1089/cell.2010.0060; Dai XP, 2010, J BIOL CHEM, V285, P31002, DOI 10.1074/jbc.M110.136085; Das ZC, 2010, CELL REPROGRAM, V12, P95, DOI 10.1089/cell.2009.0068; Ding X, 2008, THERIOGENOLOGY, V70, P622, DOI 10.1016/j.theriogenology.2008.04.042; Dong GE, 2010, AM J PHYSIOL-RENAL, V298, pF293, DOI 10.1152/ajprenal.00410.2009; Fahrudin M, 2002, REPRODUCTION, V124, P813, DOI 10.1530/rep.0.1240813; Farin PW, 2006, THERIOGENOLOGY, V65, P178, DOI 10.1016/j.theriogenology.2005.09.022; Galli C, 2003, NATURE, V424, P635, DOI 10.1038/424635a; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hardy K, 1997, MOL HUM REPROD, V3, P919, DOI 10.1093/molehr/3.10.919; Himaki T, 2010, ANIM SCI J, V81, P558, DOI 10.1111/j.1740-0929.2010.00772.x; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Iager AE, 2008, CLONING STEM CELLS, V10, P371, DOI 10.1089/clo.2007.0002; Im GS, 2006, MOL REPROD DEV, V73, P1094, DOI 10.1002/mrd.20455; Jeon K, 2008, ANIM REPROD SCI, V108, P319, DOI 10.1016/j.anireprosci.2007.09.003; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Kim YB, 1999, ONCOGENE, V18, P2461, DOI 10.1038/sj.onc.1202564; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Lee BC, 2005, NATURE, V436, P641, DOI 10.1038/436641a; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li J, 2008, THERIOGENOLOGY, V70, P800, DOI 10.1016/j.theriogenology.2008.05.046; Li ZY, 2006, DEV BIOL, V293, P439, DOI 10.1016/j.ydbio.2006.02.016; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maalouf WE, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-11; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Meng QG, 2009, CLONING STEM CELLS, V11, P203, DOI 10.1089/clo.2008.0072; Miyoshi K, 2010, CELL REPROGRAM, V12, P67, DOI 10.1089/cell.2009.0032; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Ono T, 2010, BIOL REPROD, V83, P929, DOI 10.1095/biolreprod.110.085282; Park SY, 2007, MOL REPROD DEV, V74, P582, DOI 10.1002/mrd.20641; Rybouchkin A, 2006, BIOL REPROD, V74, P1083, DOI 10.1095/biolreprod.105.047456; Shi LH, 2008, DEV DYNAM, V237, P640, DOI 10.1002/dvdy.21450; Shi W, 2003, BIOL REPROD, V69, P301, DOI 10.1095/biolreprod.102.012112; Shin T, 2002, NATURE, V415, P859, DOI 10.1038/nature723; Su JM, 2011, THERIOGENOLOGY, V75, P1346, DOI 10.1016/j.theriogenology.2010.11.045; TAKAHASHI Y, 1992, THERIOGENOLOGY, V37, P963, DOI 10.1016/0093-691X(92)90096-A; Van Thuan N, 2009, REPRODUCTION, V138, P309, DOI 10.1530/REP-08-0299; VanSoom A, 1996, MOL REPROD DEV, V45, P171, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;171::AID-MRD10&gt;3.0.CO;2-4; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wang YS, 2011, REPROD DOMEST ANIM, V46, P404, DOI 10.1111/j.1439-0531.2010.01679.x; Wang YS, 2011, THERIOGENOLOGY, V75, P819, DOI 10.1016/j.theriogenology.2010.10.022; Wang YS, 2011, CELL REPROGRAM, V13, P297, DOI 10.1089/cell.2010.0098; Wee G, 2007, REPRODUCTION, V134, P781, DOI 10.1530/REP-07-0338; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Woods GL, 2003, SCIENCE, V301, P1063, DOI 10.1126/science.1086743; Xiong YN, 2005, CANCER RES, V65, P2684, DOI 10.1158/0008-5472.CAN-04-2843; Yamanaka K, 2009, J REPROD DEVELOP, V55, P638, DOI 10.1262/jrd.20245; Yang FK, 2007, REPRODUCTION, V133, P219, DOI 10.1530/rep.1.01206; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155; Yu Y, 2007, REPRODUCTION, V133, P947, DOI 10.1530/REP-06-0358; Zhang YH, 2007, CLONING STEM CELLS, V9, P357, DOI 10.1089/clo.2006.0090; Zhao JG, 2010, CELL REPROGRAM, V12, P75, DOI 10.1089/cell.2009.0038; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313	69	65	69	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e23805	10.1371/journal.pone.0023805	http://dx.doi.org/10.1371/journal.pone.0023805			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912607	gold, Green Submitted, Green Published			2022-12-25	WOS:000294678300010
J	Constante, M; Grunberg, R; Isalan, M				Constante, Marco; Gruenberg, Raik; Isalan, Mark			A Biobrick Library for Cloning Custom Eukaryotic Plasmids	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; MUTANT LOX SITES; MAMMALIAN-CELLS; SACCHAROMYCES-CEREVISIAE; RECOMBINANT PROTEINS; SYNTHETIC BIOLOGY; INTEGRATION; PURIFICATION; PEPTIDE; EXPRESSION	Researchers often require customised variations of plasmids that are not commercially available. Here we demonstrate the applicability and versatility of standard synthetic biological parts (biobricks) to build custom plasmids. For this purpose we have built a collection of 52 parts that include multiple cloning sites (MCS) and common protein tags, protein reporters and selection markers, amongst others. Importantly, most of the parts are designed in a format to allow fusions that maintain the reading frame. We illustrate the collection by building several model contructs, including concatemers of protein binding-site motifs, and a variety of plasmids for eukaryotic stable cloning and chromosomal insertion. For example, in 3 biobrick iterations, we make a cerulean-reporter plasmid for cloning fluorescent protein fusions. Furthermore, we use the collection to implement a recombinase-mediated DNA insertion (RMDI), allowing chromosomal site-directed exchange of genes. By making one recipient stable cell line, many standardised cell lines can subsequently be generated, by fluorescent fusion-gene exchange. We propose that this biobrick collection may be distributed peer-to-peer as a stand-alone library, in addition to its distribution through the Registry of Standard Biological Parts (http://partsregistry.org/).	[Constante, Marco] CRG, EMBL CRG Syst Biol Res Unit, Barcelona, Spain; UPF, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University	Constante, M (corresponding author), CRG, EMBL CRG Syst Biol Res Unit, Barcelona, Spain.	marco.constante@crg.es	Grünberg, Raik/A-1839-2011	Grünberg, Raik/0000-0001-9532-6043; Constante, Marco/0000-0002-7448-5552; Isalan, Mark/0000-0002-4652-0365	Portuguese Fundacao para a Ciencia e Tecnologia (FCT); Human Frontiers Science Program; European Research Council [FP7-ERC-201249-ZINC-HUBS]; Ministerio de Ciencia e Innovacion [MICINN BFU2010-17953]; MEC-EMBL	Portuguese Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and Technology); Human Frontiers Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); MEC-EMBL	MC has a PhD fellowship from the Portuguese Fundacao para a Ciencia e Tecnologia (FCT). RG has a postdoctoral fellowship from the Human Frontiers Science Program. MI is funded by the European Research Council, FP7-ERC-201249-ZINC-HUBS, Ministerio de Ciencia e Innovacion grant MICINN BFU2010-17953, and the MEC-EMBL agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; ALBERT H, 1995, PLANT J, V7, P649, DOI 10.1046/j.1365-313X.1995.7040649.x; Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Araki K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf102; Arkin A, 2008, NAT BIOTECHNOL, V26, P771, DOI 10.1038/nbt0708-771; Bartles JR, 1998, J CELL BIOL, V143, P107, DOI 10.1083/jcb.143.1.107; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Cilley CD, 1997, RNA, V3, P57; Clontech, 2005, LIV COL FLUOR PROT V, P18; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; FUKUSHIGE S, 1992, P NATL ACAD SCI USA, V89, P7905, DOI 10.1073/pnas.89.17.7905; Galdzicki M, PLOS ONE; GHATTAS IR, 1991, MOL CELL BIOL, V11, P5848, DOI 10.1128/MCB.11.12.5848; Goodman C, 2008, NAT CHEM BIOL, V4, P13, DOI 10.1038/nchembio0108-13; Grunberg R, 2010, NUCLEIC ACIDS RES, V38, P2645, DOI 10.1093/nar/gkq152; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; KARKHANIS YD, 1971, BIOCHEMISTRY-US, V10, P317; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Knight T., 2003, IDEMPOTENT VECTOR DE; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; McKeown L, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-15; Migliaccio AR, 2000, GENE, V256, P197, DOI 10.1016/S0378-1119(00)00353-X; Peccoud J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002671; Phillips I, 2006, DSPACE; REARDON JE, 1989, J BIOL CHEM, V264, P19039; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rouilly V, 2007, BMC SYS BIOL S1, V1, pP79; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Skerra A, 1999, BIOMOL ENG, V16, P79, DOI 10.1016/S1050-3862(99)00033-9; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; VALEGARD K, 1994, NATURE, V371, P623, DOI 10.1038/371623a0; Venkatesan A, 2001, MOL CELL BIOL, V21, P2826, DOI 10.1128/MCB.21.8.2826-2837.2001; Ward TH, 2006, METHOD BIOCHEM ANAL, V47, P305; Weeding E, 2010, BRIEF BIOINFORM, pbbq002; Zhang GH, 1996, BIOCHEM BIOPH RES CO, V227, P707, DOI 10.1006/bbrc.1996.1573; Zhao X, 2000, CLONTECHNIQUES, VXV, P29	47	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23685	10.1371/journal.pone.0023685	http://dx.doi.org/10.1371/journal.pone.0023685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901127	Green Published, Green Submitted, gold			2022-12-25	WOS:000294298000012
J	Fan, H; Chen, L; Zhang, F; Quan, Y; Su, X; Qiu, X; Zhao, Z; Kong, KL; Dong, S; Song, Y; Chan, THM; Guan, XY				Fan, H.; Chen, L.; Zhang, F.; Quan, Y.; Su, X.; Qiu, X.; Zhao, Z.; Kong, K. L.; Dong, S.; Song, Y.; Chan, T. H. M.; Guan, X-Y			MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma	ONCOGENE			English	Article						DNMT3B; MTSS1; cell cycle; methylation; TSG; HCC	DE-NOVO METHYLATION; PERICENTROMERIC SATELLITE REGIONS; CANCER CELL-LINES; HUMAN HEPATOCARCINOGENESIS; BLADDER-CANCER; BREAST-CANCER; MESSENGER-RNA; CYCLIN-B; EXPRESSION; DNMT3B	DNA methyltransferase 3B (DNMT3B) mediates gene silencing via epigenetic mechanisms during hepatocellular carcinoma (HCC) progression. We aimed to identify novel targets of DNMT3B and their potential regulatory mechanisms in HCC. Metastasis suppressor 1 (MTSS1) was one of the DNMT3B targets and selected for further study. DNMT3B overexpression was detected in 81.25% of clinical HCC specimens and was negatively associated with MTSS1 in HCC cells and clinical samples. The underlying mechanism by which DNMT3B silences MTSS1 was studied using a combination of methylation-specific polymerase chain reaction (PCR) and bisulfite genome sequencing, chromatin immunoprecipitation-PCR and luciferase reporter assays. We found that the MTSS1 promoter region was sparsely methylated, and the methylation inhibitors failed to abolish DNMT3B-mediated MTSS1 silencing. DNMT3B protein bound directly to the 5'-flanking region (-865/-645) of the MTSS1 gene to inhibit its transcription. The functional role of MTSS1 was investigated using in vitro and in vivo tumorigenicity assays. As a result, MTSS1 exerted tumor suppressor effects and arrested cells in the G2/M phase, but not the G1/S phase of the cell cycle when it was depleted or overexpressed in HCC cells. Taken together, MTSS1, a novel target of DNMT3B, is repressed by DNMT3B via a DNA methylation-independent mechanism. MTSS1 was further characterized as a novel tumor suppressor gene in HCC. These findings highlight how DNMT3B regulates MTSS1, and such data may be useful for the development of new treatment options for HCC. Oncogene (2012) 31, 2298-2308; doi:10.1038/onc.2011.411; published online 12 September 2011	[Fan, H.; Zhang, F.; Quan, Y.; Su, X.; Qiu, X.] Southeast Univ, Sch Med, Key Lab Dev Genes & Human Dis, Minist Educ,Dept Med Genet & Dev Biol, Nanjing 210009, Peoples R China; [Chen, L.; Chan, T. H. M.; Guan, X-Y] Univ Hong Kong, State Key Lab Liver Canc, Pokfulam, Hong Kong, Peoples R China; [Chen, L.; Zhao, Z.; Kong, K. L.; Dong, S.; Song, Y.; Chan, T. H. M.; Guan, X-Y] Univ Hong Kong, Dept Clin Oncol, Pokfulam, Hong Kong, Peoples R China; [Chen, L.; Guan, X-Y] Sun Yat Sen Univ, State Key Lab Oncol So China, Dept Clin Oncol, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China	Southeast University - China; University of Hong Kong; University of Hong Kong; Sun Yat Sen University	Fan, H (corresponding author), Southeast Univ, Sch Med, Key Lab Dev Genes & Human Dis, Minist Educ,Dept Genet & Dev Biol, Nanjing 210009, Peoples R China.	fanh@seu.edu.cn; xyguan@hkucc.hku.hk	Guan, Xin-Yuan/A-3639-2009; /A-3639-2009	Guan, Xin-Yuan/0000-0002-4485-6017; /0000-0003-1874-9805	National Natural Science Foundation of China [30971605]; HKU Li Ka Shing Faculty of Medicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); HKU Li Ka Shing Faculty of Medicine	This work was supported by The National Natural Science Foundation of China, No. 30971605, and in part by the Dr Cheng Yu Tung Fellowships 2007/08 under the HKU Li Ka Shing Faculty of Medicine. We are grateful to Professor Dianqing WU in UConn Health Center USA for providing siRNA expression vector. We are also grateful to Dr Stephanie Ma in Department of Pathology in University of Hong Kong for helping in MTSS1 antibody.	Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Baylin SB, 1998, ADV CANCER RES, V72, P141; Beaulieu N, 2002, J BIOL CHEM, V277, P28176, DOI 10.1074/jbc.M204734200; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Chang DC, 2003, J BIOL CHEM, V278, P37865, DOI 10.1074/jbc.M306376200; Chang HC, 2006, CANCER RES, V66, P8413, DOI 10.1158/0008-5472.CAN-06-0685; Chen LL, 2010, J CLIN INVEST, V120, P1178, DOI 10.1172/JCI40665; Choi MS, 2003, HUM PATHOL, V34, P11, DOI 10.1053/hupa.2003.5; Claus R, 2003, ONCOGENE, V22, P6489, DOI 10.1038/sj.onc.1206814; Cross FR, 2005, MOL BIOL CELL, V16, P2129, DOI 10.1091/mbc.E04-10-0897; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Girault I, 2003, CLIN CANCER RES, V9, P4415; Gowher H, 2002, J BIOL CHEM, V277, P20409, DOI 10.1074/jbc.M202148200; Huang Xiu-yan, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P915, DOI 10.3760/cma.j.issn.1007-3418.2010.12.008; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Jun Xu, 2005, Acta Genetica Sinica, V32, P1115; Kanai Y, 2007, CARCINOGENESIS, V28, P2434, DOI 10.1093/carcin/bgm206; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Lee YG, 2002, NEOPLASIA, V4, P291, DOI 10.1038/sj.neo.7900231; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Liu K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-428; Ma S, 2007, HUM PATHOL, V38, P1201, DOI 10.1016/j.humpath.2007.01.004; McGarvey KM, 2007, CANCER RES, V67, P5097, DOI 10.1158/0008-5472.CAN-06-2029; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Nixdorf S, 2004, CANCER LETT, V215, P209, DOI 10.1016/j.canlet.2004.05.002; Oh BK, 2007, INT J MOL MED, V20, P65; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Parr C, 2009, EUR J CANCER, V45, P1673, DOI 10.1016/j.ejca.2009.02.019; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Robertson KD, 2000, NUCLEIC ACIDS RES, V28, P2108, DOI 10.1093/nar/28.10.2108; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Roll JD, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-15; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Saito Y, 2002, P NATL ACAD SCI USA, V99, P10060, DOI 10.1073/pnas.152121799; Saito Y, 2001, HEPATOLOGY, V33, P561, DOI 10.1053/jhep.2001.22507; Shafiei F, 2008, ONCOGENE, V27, P2602, DOI 10.1038/sj.onc.1210917; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; Simao TDA, 2006, HUM EXP TOXICOL, V25, P515, DOI 10.1191/0960327106het649oa; Takeshima H, 2006, J BIOCHEM, V139, P503, DOI 10.1093/jb/mvj044; Tao Q, 2002, HUM MOL GENET, V11, P2091, DOI 10.1093/hmg/11.18.2091; Utikal J, 2006, INT J CANCER, V119, P2287, DOI 10.1002/ijc.22106; Wang J, 2007, CANCER RES, V67, P10647, DOI 10.1158/0008-5472.CAN-07-1337; Weisenberger DJ, 2004, MOL CANCER RES, V2, P62	48	49	56	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	18					2298	2308		10.1038/onc.2011.411	http://dx.doi.org/10.1038/onc.2011.411			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	936SR	21909138				2022-12-25	WOS:000303610800005
J	Lu, C; Zhu, X; Willingham, MC; Cheng, SY				Lu, C.; Zhu, X.; Willingham, M. C.; Cheng, S-Y			Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma	ONCOGENE			English	Article						thyroid hormone; follicular thyroid carcinoma; animal model; protein kinase B/AKT; PTEN	BETA-CATENIN; GENETIC ALTERATIONS; RECEPTOR-BETA; PHOSPHATIDYLINOSITOL 3-KINASE; METASTATIC SPREAD; TRANSFORMING GENE; PROTEIN-KINASE; GROWTH-FACTOR; PATHWAY; CANCER	Thyroid cancers are the most common malignancy of the endocrine system in humans. To understand the molecular genetic events underlying thyroid carcinogenesis, we have generated a mouse model that spontaneously develops follicular thyroid carcinoma similar to human thyroid cancer (Thrb(PV/PV) mouse). This mutant mouse harbors a dominant-negative mutated thyroid hormone receptor beta (denoted PV). The PV mutation was identified in a patient with resistance to thyroid hormone (TH). Thrb(PV/PV) mice exhibit highly elevated serum thyroid-stimulating hormone levels and increased TH. We have previously shown that thyroid-stimulating hormone is required, but not sufficient to induce metastatic follicular thyroid cancer in Thrb(PV/PV) mice. However, whether the elevated TH also contributes to the thyroid carcinogenesis of Thrb(PV/PV) mice was not elucidated. To understand the role of TH in thyroid carcinogenesis, we blocked the production of TH by treating Thrb(PV/PV) mice with propylthiouracil (Thrb(PV/PV)-PTU mice) and compared the development of thyroid cancer in Thrb(PV/PV)-PTU and untreated ThrbPV/PV mice. We found that thyroid tumor growth was reduced by similar to 42% in Thrb(PV/PV)-PTU mice as compared with Thrb(PV/PV) mice. Analysis by bromodeoxyuridine-nuclear labeling showed decreased incorporation of bromodeoxyuridine in thyroid tumor cells of Thrb(PV/PV)-PTU mice, indicative of decreased tumor cell proliferation. However, cleaved-caspase 3 staining showed no apparent changes in apoptosis of tumor cells in Thrb(PV/PV)-PTU mice. Molecular studies identified a marked attenuation of the PI3K-AKT-beta-catenin signaling pathway that led to decreased protein levels of cyclin D2, thereby decreasing tumor cell proliferation in Thrb(PV/PV)-PTU mice. Furthermore, matrix metalloproteinase-2, a downstream target of beta-catenin and a key regulator during tumor invasion and metastasis, was also decreased. Thus, the present study uncovers a critical role of TH in promoting the thyroid carcinogenesis of Thrb(PV/PV) mice via membrane signaling events. Importantly, these findings suggest that anti-thyroid drugs could be considered as possible therapeutic agents of thyroid cancer. Oncogene (2012) 31, 2007-2016; doi: 10.1038/onc.2011.390; published online 12 September 2011	[Lu, C.; Zhu, X.; Cheng, S-Y] NCI, Mol Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Willingham, M. C.] Wake Forest Univ, Dept Pathol, Winston Salem, NC 27109 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Wake Forest University	Cheng, SY (corresponding author), NCI, Mol Biol Lab, Ctr Canc Res, 37 Convent Dr,Room 5128, Bethesda, MD 20892 USA.	chengs@mail.nih.gov			National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011191] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of National Institutes of Health, National Cancer Institute, Center for Cancer Research.	Abbosh PH, 2005, THYROID, V15, P551, DOI 10.1089/thy.2005.15.551; Antico-Arciuch VG, 2010, ONCOGENE, V29, P5678, DOI 10.1038/onc.2010.308; Bergh JJ, 2005, ENDOCRINOLOGY, V146, P2864, DOI 10.1210/en.2005-0102; Boelaert K, 2003, J CLIN ENDOCR METAB, V88, P2341, DOI 10.1210/jc.2002-021113; Cao X, 2005, MOL ENDOCRINOL, V19, P102, DOI 10.1210/me.2004-0093; Castellone MD, 2009, CANCER RES, V69, P1867, DOI 10.1158/0008-5472.CAN-08-1982; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Cole AM, 2010, CANCER RES, V70, P8149, DOI 10.1158/0008-5472.CAN-10-0315; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Davis FB, 2004, CIRC RES, V94, P1500, DOI 10.1161/01.RES.0000130784.90237.4a; Davis PJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE1238, DOI 10.1152/ajpendo.00480.2009; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Furumoto H, 2005, MOL CELL BIOL, V25, P124, DOI 10.1128/MCB.25.1.124-135.2005; Furuya F, 2006, P NATL ACAD SCI USA, V103, P1780, DOI 10.1073/pnas.0510849103; Furuya F, 2007, CARCINOGENESIS, V28, P2451, DOI 10.1093/carcin/bgm174; Glinskii AB, 2009, CELL CYCLE, V8, P3562, DOI 10.4161/cc.8.21.9963; Guigon CJ, 2008, MOL CELL BIOL, V28, P4598, DOI 10.1128/MCB.02192-07; Guigon CJ, 2010, ENDOCRINOLOGY, V151, P5528, DOI 10.1210/en.2010-0475; Guigon CJ, 2009, MOL CELL ENDOCRINOL, V308, P63, DOI 10.1016/j.mce.2009.01.007; Hou P, 2007, CLIN CANCER RES, V13, P1161, DOI 10.1158/1078-0432.CCR-06-1125; Kaneshige M, 2000, P NATL ACAD SCI USA, V97, P13209, DOI 10.1073/pnas.230285997; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim CS, 2007, CARCINOGENESIS, V28, P932, DOI 10.1093/carcin/bgl231; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lin HY, 2007, STEROIDS, V72, P180, DOI 10.1016/j.steroids.2006.11.014; Lin HY, 2009, AM J PHYSIOL-CELL PH, V296, pC980, DOI 10.1152/ajpcell.00305.2008; Lu CX, 2011, AM J CANCER RES, V1, P1; Lu CX, 2011, STEROIDS, V76, P885, DOI 10.1016/j.steroids.2011.03.016; Lu CX, 2010, ENDOCRINOLOGY, V151, P1929, DOI 10.1210/en.2009-1017; Mousa SA, 2006, INT ANGIOL, V25, P407; Nikiforov YE, 2004, ENDOCR PATHOL, V15, P319, DOI 10.1385/EP:15:4:319; Nikiforova MN, 2009, THYROID, V19, P1351, DOI 10.1089/thy.2009.0240; ONO S, 1991, J CLIN ENDOCR METAB, V73, P990, DOI 10.1210/jcem-73-5-990; PARRILLA R, 1991, J CLIN INVEST, V88, P2123, DOI 10.1172/JCI115542; Puxeddu E, 2011, CURR OPIN ONCOL, V23, P13, DOI 10.1097/CCO.0b013e328340cf94; Rego-Iraeta A, 2009, THYROID, V19, P333, DOI 10.1089/thy.2008.0210; Rowlands TM, 2004, CELL CYCLE, V3, P145; Saji M, 2010, MOL CELL ENDOCRINOL, V321, P20, DOI 10.1016/j.mce.2009.10.016; Sassolas G, 2009, EUR J ENDOCRINOL, V160, P71, DOI 10.1530/EJE-08-0624; Sipos JA, 2010, CLIN ONCOL-UK, V22, P395, DOI 10.1016/j.clon.2010.05.004; Sonderegger S, 2010, ENDOCRINOLOGY, V151, P211, DOI 10.1210/en.2009-0557; Suzuki H, 2002, THYROID, V12, P963, DOI 10.1089/105072502320908295; Verga Falzacappa C, 2007, J MOL ENDOCRINOL, V38, P221, DOI DOI 10.1677/JME.1.02166; Weinberger PM, 2007, ARCH OTOLARYNGOL, V133, P503, DOI 10.1001/archotol.133.5.503; Xing MZ, 2010, THYROID, V20, P697, DOI 10.1089/thy.2010.1646; Yalcin M, 2010, THYROID, V20, P281, DOI 10.1089/thy.2009.0249; Ying H, 2008, ONCOGENE, V27, P823, DOI 10.1038/sj.onc.1210680; Ying H, 2003, CANCER RES, V63, P5274; Ying H, 2006, J CLIN INVEST, V116, P2972, DOI 10.1172/JCI28598	50	14	15	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	16					2007	2016		10.1038/onc.2011.390	http://dx.doi.org/10.1038/onc.2011.390			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	928TP	21909131	Green Accepted			2022-12-25	WOS:000303008600002
J	Sznee, K; Dekker, JP; Dame, RT; van Roon, H; Wuite, GJL; Frese, RN				Sznee, Kinga; Dekker, Jan P.; Dame, Remus T.; van Roon, Henny; Wuite, Gijs J. L.; Frese, Raoul N.			Jumping Mode Atomic Force Microscopy on Grana Membranes from Spinach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II SUPERCOMPLEXES; LIGHT-HARVESTING ANTENNA; THYLAKOID MEMBRANES; PHOTOSYNTHETIC APPARATUS; MOLECULAR ARCHITECTURE; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; ATP SYNTHASE; TAPPING-MODE; ORGANIZATION	The thylakoid membrane system is a complex membrane system that organizes and reorganizes itself to provide plants optimal chemical energy from sunlight under different and varying environmental conditions. Grana membranes are part of this system and contain the light-driven water-splitting enzyme Photosystem II (PSII) and light-harvesting antenna complexes. Here, we present a direct visualization of PSII complexes within grana membranes from spinach. By means of jumping mode atomic force microscopy in liquid, minimal forces were applied between the scanning tip and membrane or protein, allowing complexes to be imaged with high detail. We observed four different packing arrangements of PSII complexes, which occur primarily as dimers: co-linear crystalline rows, nanometric domains of straight or skewed rows, and disordered domains. Upon storing surface-adhered membranes at low temperature prior to imaging, large-scale reorganizations of supercomplexes between PSII and light-harvesting complex II could be induced. The highest resolution images show the existence of membrane domains without obvious topography extending beyond supercomplexes. These observations illustrate the possibility for diffusion of proteins and smaller molecules within these densely packed membranes.	[Sznee, Kinga; Dekker, Jan P.; Dame, Remus T.; van Roon, Henny; Wuite, Gijs J. L.; Frese, Raoul N.] Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Frese, RN (corresponding author), Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands.	r.n.frese@vu.nl	Dame, Remus T./E-1941-2014; Dame, Remus/AAT-2989-2020; Dame, Remus/A-8570-2008	Dame, Remus T./0000-0001-9863-1692; Dame, Remus/0000-0001-9863-1692; wuite, gijs/0000-0002-5706-043X; frese, raoul/0000-0001-8243-9954	Netherlands Organization for Scientific Research (NWO); Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported in part by the Netherlands Organization for Scientific Research (NWO).r Supported by a Netherlands Organization for Scientific Research Vidi grant. To whom correspondence should be addressed. E-mail: r.n.frese@vu.nl.	Bahatyrova S, 2004, NATURE, V430, P1058, DOI 10.1038/nature02823; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Boekema EJ, 2000, J MOL BIOL, V301, P1123, DOI 10.1006/jmbi.2000.4037; Boekema EJ, 1999, BIOCHEMISTRY-US, V38, P2233, DOI 10.1021/bi9827161; Buzhynskyy N, 2007, EMBO REP, V8, P51, DOI 10.1038/sj.embor.7400858; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Daum B, 2010, PLANT CELL, V22, P1299, DOI 10.1105/tpc.109.071431; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DUNAHAY TG, 1984, BIOCHIM BIOPHYS ACTA, V764, P179, DOI 10.1016/0005-2728(84)90027-6; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Frese RN, 2008, BIOPHYS J, V94, P640, DOI 10.1529/biophysj.107.116913; Goncalves RP, 2005, J STRUCT BIOL, V152, P221, DOI 10.1016/j.jsb.2005.10.002; Goncalves RP, 2007, J MOL BIOL, V369, P413, DOI 10.1016/j.jmb.2007.03.063; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Kirchhoff H, 2002, BIOCHEMISTRY-US, V41, P4872, DOI 10.1021/bi011650y; Kirchhoff H, 2008, PLANT PHYSIOL, V146, P1571, DOI 10.1104/pp.107.115170; Kirchhoff H, 2008, BIOCHEMISTRY-US, V47, P431, DOI 10.1021/bi7017877; Kirchhoff H, 2007, BIOCHEMISTRY-US, V46, P11169, DOI 10.1021/bi700748y; Kouril R, 2012, BBA-BIOENERGETICS, V1817, P2, DOI 10.1016/j.bbabio.2011.05.024; Kouril R, 2011, BBA-BIOENERGETICS, V1807, P368, DOI 10.1016/j.bbabio.2010.11.007; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Magis GJ, 2010, BBA-BIOMEMBRANES, V1798, P637, DOI 10.1016/j.bbamem.2009.12.018; Moller C, 1999, BIOPHYS J, V77, P1150, DOI 10.1016/S0006-3495(99)76966-3; Moreno-Herrero F, 2000, SURF SCI, V453, P152, DOI 10.1016/S0039-6028(00)00341-1; Moreno-Herrero F, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.031915; Moreno-Herrero F, 2002, APPL PHYS LETT, V81, P2620, DOI 10.1063/1.1509856; Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Nield J, 2002, J BIOL CHEM, V277, P15006, DOI 10.1074/jbc.M110549200; Nield J, 2006, BBA-BIOENERGETICS, V1757, P353, DOI 10.1016/j.bbabio.2006.03.019; Ruban AV, 2003, NATURE, V421, P648, DOI 10.1038/nature01344; Scheuring S, 2006, J MOL BIOL, V358, P83, DOI 10.1016/j.jmb.2006.01.085; Scheuring S, 2005, SCIENCE, V309, P484, DOI 10.1126/science.1110879; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; SEMENOVA GA, 1995, CAN J BOT, V73, P1676, DOI 10.1139/b95-181; Staehelin LA, 2003, PHOTOSYNTH RES, V76, P185, DOI 10.1023/A:1024994525586; van Roon H, 2000, PHOTOSYNTH RES, V64, P155, DOI 10.1023/A:1006476213540; Yakushevska AE, 2003, BIOCHEMISTRY-US, V42, P608, DOI 10.1021/bi027109z; Yakushevska AE, 2001, EUR J BIOCHEM, V268, P6020, DOI 10.1046/j.0014-2956.2001.02505.x; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	41	32	32	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39164	39171		10.1074/jbc.M111.284844	http://dx.doi.org/10.1074/jbc.M111.284844			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21911498	Green Published, hybrid			2022-12-25	WOS:000296759800035
J	Tang, GQ; Deshpande, AP; Patel, SS				Tang, Guo-Qing; Deshpande, Aishwarya P.; Patel, Smita S.			Transcription Factor-dependent DNA Bending Governs Promoter Recognition by the Mitochondrial RNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SC-MTTFB; PROTEIN; INITIATION; BINDING; PURIFICATION; SPECIFICITY; COMPLEXES	Promoter recognition is the first and the most important step during gene expression. Our studies of the yeast (Saccharomyces cerevisiae) mitochondrial (mt) transcription machinery provide mechanistic understandings on the basic problem of how the mt RNA polymerase (RNAP) with the help of the initiation factor discriminates between promoter and non-promoter sequences. We have used fluorescence-based approaches to quantify DNA binding, bending, and opening steps by the core mtRNAP subunit (Rpo41) and the transcription factor (Mtf1). Our results show that promoter recognition is not achieved by tight and selective binding to the promoter sequence. Instead, promoter recognition is achieved by an induced-fit mechanism of transcription factor-dependent differential conformational changes in the promoter and non-promoter DNAs. While Rpo41 induces a slight bend upon binding both the DNAs, addition of the Mtf1 results in severe bending of the promoter and unbending of the non-promoter DNA. Only the sharply bent DNA results in the catalytically active open complex. Such an induced-fit mechanism serves three purposes: 1) assures catalysis at promoter sites, 2) prevents RNA synthesis at non-promoter sites, and 3) provides a conformational state at the non-promoter sites that would aid in facile translocation to scan for specific sites.	[Tang, Guo-Qing; Deshpande, Aishwarya P.; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Patel, SS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	patelss@umdnj.edu			National Institutes of Health [GM51966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051966, R37GM051966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported, in whole or in part, by National Institutes of Health Grant GM51966 (to S. S. P.).	Albright RA, 1998, P NATL ACAD SCI USA, V95, P3431, DOI 10.1073/pnas.95.7.3431; Bandwar RP, 2002, J MOL BIOL, V324, P63, DOI 10.1016/S0022-2836(02)01034-3; Bartlett MS, 2005, CURR OPIN MICROBIOL, V8, P677, DOI 10.1016/j.mib.2005.10.016; BISWAS TK, 1986, J BIOL CHEM, V261, P3927; BISWAS TK, 1990, P NATL ACAD SCI USA, V87, P9338, DOI 10.1073/pnas.87.23.9338; BISWAS TK, 1990, J BIOL CHEM, V265, P19053; BISWAS TK, 1987, J BIOL CHEM, V262, P13690; BISWAS TK, 1985, P NATL ACAD SCI USA, V82, P1954, DOI 10.1073/pnas.82.7.1954; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Coulombre B, 1999, MICROBIOL MOL BIOL R, V63, P457, DOI 10.1128/MMBR.63.2.457-478.1999; DIFFLEY JFX, 1992, J BIOL CHEM, V267, P3368; DIFFLEY JFX, 1991, P NATL ACAD SCI USA, V88, P7864, DOI 10.1073/pnas.88.17.7864; ERIE DA, 1994, SCIENCE, V266, P1562, DOI 10.1126/science.7985026; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; HEUMANN H, 1988, EMBO J, V7, P4379, DOI 10.1002/j.1460-2075.1988.tb03336.x; JANG SH, 1991, J BIOL CHEM, V266, P22671; JenJacobson L, 1997, BIOPOLYMERS, V44, P153; Jiang HY, 2011, NUCLEIC ACIDS RES, V39, P5119, DOI 10.1093/nar/gkr103; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kim H, 2012, NUCLEIC ACIDS RES, V40, P371, DOI 10.1093/nar/gkr736; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; LEVENS D, 1981, J BIOL CHEM, V256, P1474; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; Matsunaga M, 2004, PROTEIN EXPRES PURIF, V35, P126, DOI 10.1016/j.pep.2003.12.022; Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200; MCALLISTER WT, 1993, CELL MOL BIOL RES, V39, P385; Nagaich AK, 1997, J BIOL CHEM, V272, P14842, DOI 10.1074/jbc.272.23.14842; Paratkar S, 2010, J BIOL CHEM, V285, P3949, DOI 10.1074/jbc.M109.050732; PerezMartin J, 1997, ANNU REV MICROBIOL, V51, P593, DOI 10.1146/annurev.micro.51.1.593; Post CB, 1995, BIOCHEMISTRY-US, V34, P15881, DOI 10.1021/bi00049a001; Record M. T., 1996, ESCHERICHIA COLI RNA; REZNIKOFF WS, 1985, ANNU REV GENET, V19, P355, DOI 10.1146/annurev.genet.19.1.355; Rippe K, 1997, J MOL BIOL, V270, P125, DOI 10.1006/jmbi.1997.1079; Rivetti C, 1999, EMBO J, V18, P4464, DOI 10.1093/emboj/18.16.4464; Savkina M, 2010, J BIOL CHEM, V285, P3957, DOI 10.1074/jbc.M109.051003; SCHINKEL AH, 1988, NUCLEIC ACIDS RES, V16, P9147, DOI 10.1093/nar/16.19.9147; SCHINKEL AH, 1988, EMBO J, V7, P3255, DOI 10.1002/j.1460-2075.1988.tb03192.x; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; SHADEL GS, 1995, MOL CELL BIOL, V15, P2101; Shutt TE, 2010, P NATL ACAD SCI USA, V107, P12133, DOI 10.1073/pnas.0910581107; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; Soppa J, 1999, MOL MICROBIOL, V31, P1295, DOI 10.1046/j.1365-2958.1999.01273.x; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4936, DOI 10.1021/bi0522910; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4947, DOI 10.1021/bi052292s; Tang GQ, 2009, J BIOL CHEM, V284, P5514, DOI 10.1074/jbc.M807880200; Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X; Wang H, 2003, P NATL ACAD SCI USA, V100, P14822, DOI 10.1073/pnas.2433654100; WINKLER FK, 1993, EMBO J, V12, P1781, DOI 10.1002/j.1460-2075.1993.tb05826.x; XU BJ, 1992, NUCLEIC ACIDS RES, V20, P1053, DOI 10.1093/nar/20.5.1053; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	54	24	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38805	38813		10.1074/jbc.M111.261966	http://dx.doi.org/10.1074/jbc.M111.261966			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911502	Green Published, hybrid			2022-12-25	WOS:000296594200091
J	Hatton, O; Phillips, LK; Vaysberg, M; Hurwich, J; Krams, SM; Martinez, OM				Hatton, Olivia; Phillips, Lori K.; Vaysberg, Maria; Hurwich, Jordan; Krams, Sheri M.; Martinez, Olivia M.			Syk Activation of Phosphatidylinositol 3-Kinase/Akt Prevents HtrA2-dependent Loss of X-linked Inhibitor of Apoptosis Protein (XIAP) to Promote Survival of Epstein-Barr Virus plus (EBV plus ) B Cell Lymphomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; SPLEEN TYROSINE KINASE; NON-HODGKIN-LYMPHOMA; SERINE-PROTEASE; SIGNAL-TRANSDUCTION; THERAPEUTIC TARGET; ANTIGEN RECEPTOR; SURFACE-IMMUNOGLOBULIN; AKT PHOSPHORYLATION; MEDIATED APOPTOSIS	B cell lymphoma survival requires tonic or ligand-independent signals through activation of Syk by the B cell receptor. The Epstein-Barr virus (EBV) protein latent membrane 2a (LMP2a), a mimic of the B cell receptor, provides constitutive survival signals for latently infected cells through Syk activation; however, the precise downstream mechanisms coordinating this survival response in EBV+ B cell lymphomas remain to be elucidated. Herein, we assess the mechanism of Syk survival signaling in EBV+ B cell lymphomas from post-transplant lymphoproliferative disorder (PTLD) to discover virally controlled therapeutic targets involved in lymphomagenesis and tumor progression. Using small molecule inhibition and siRNA strategies, we show that Syk inhibition reduces proliferation and induces apoptosis of PTLD-derived EBV+ B cell lines. Syk inhibition also reduces autocrine IL-10 production. Although Syk inhibition attenuates signaling through both the PI3K/Akt and Erk pathways, only PI3K/Akt inhibition causes apoptosis of PTLD-derived cell lines. Loss of the endogenous caspase inhibitor XIAP is observed after Syk or PI3K/Akt inhibition. The loss of XIAP and apoptosis that results from Syk or PI3K/Akt inhibition is reversed by inhibition of the mitochondrial protease HtrA2. Thus, Syk drives EBV+ B cell lymphoma survival through PI3K/Akt activation, which prevents the HtrA2-dependent loss of XIAP. Syk, Akt, and XIAP antagonists may present potential new therapeutic strategies for PTLD through targeting of EBV-driven survival signals.	[Hatton, Olivia; Phillips, Lori K.; Vaysberg, Maria; Krams, Sheri M.; Martinez, Olivia M.] Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; [Hatton, Olivia; Phillips, Lori K.; Vaysberg, Maria; Hurwich, Jordan; Krams, Sheri M.; Martinez, Olivia M.] Stanford Univ, Sch Med, Dept Surg, Div Transplantat, Stanford, CA 94305 USA	Stanford University; Stanford University	Martinez, OM (corresponding author), 1201 Welch Rd,MSLS P312, Stanford, CA 94305 USA.	omm@stanford.edu		, Olivia/0000-0002-2798-0251; Krams, Sheri/0000-0002-6049-5119	National Institutes of Health [AI41769]; Stanford Graduate Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041769, R21AI041769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Graduate Fellowship(Stanford University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI41769 (to O. M. M.).; Recipient of a Stanford Graduate Fellowship.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Beatty PR, 1997, J IMMUNOL, V158, P4045; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Buchner M, 2010, BLOOD, V115, P4497, DOI 10.1182/blood-2009-07-233692; Buchner M, 2009, CANCER RES, V69, P5424, DOI 10.1158/0008-5472.CAN-08-4252; BURKHARDT AL, 1992, J VIROL, V66, P5161, DOI 10.1128/JVI.66.8.5161-5167.1992; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chan SM, 2004, NAT MED, V10, P1390, DOI 10.1038/nm1139; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Dykstra ML, 2001, IMMUNITY, V14, P57, DOI 10.1016/S1074-7613(01)00089-9; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Fruehling S, 1997, VIROLOGY, V235, P241, DOI 10.1006/viro.1997.8690; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; Gauld SB, 2002, SCIENCE, V296, P1641, DOI 10.1126/science.1071546; Gobessi S, 2009, LEUKEMIA, V23, P686, DOI 10.1038/leu.2008.346; Gottschalk S, 2005, ANNU REV MED, V56, P29, DOI 10.1146/annurev.med.56.082103.104727; Green D R, 1998, Results Probl Cell Differ, V24, P45; Gururajan M, 2007, J IMMUNOL, V178, P111, DOI 10.4049/jimmunol.178.1.111; Gururajan M, 2006, J IMMUNOL, V176, P5715, DOI 10.4049/jimmunol.176.10.5715; Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936; Klupsch K, 2006, CELL DEATH DIFFER, V13, P2157, DOI 10.1038/sj.cdd.4401955; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lambert SL, 2007, J IMMUNOL, V179, P8225, DOI 10.4049/jimmunol.179.12.8225; Lindsley CW, 2010, CURR TOP MED CHEM, V10, P458, DOI 10.2174/156802610790980602; LONGNECKER R, 1991, J VIROL, V65, P3681, DOI 10.1128/JVI.65.7.3681-3692.1991; Longnecker R, 1996, TRENDS MICROBIOL, V4, P38; Mancao C, 2007, BLOOD, V110, P3715, DOI 10.1182/blood-2007-05-090142; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matskova L, 2001, J VIROL, V75, P10941, DOI 10.1128/JVI.75.22.10941-10949.2001; Meffre E, 2002, P NATL ACAD SCI USA, V99, P11334, DOI 10.1073/pnas.172369999; Merchant M, 2000, J VIROL, V74, P9115, DOI 10.1128/JVI.74.19.9115-9124.2000; MILLER CL, 1995, IMMUNITY, V2, P155, DOI 10.1016/S1074-7613(95)80040-9; MILLER CL, 1994, P NATL ACAD SCI USA, V91, P772, DOI 10.1073/pnas.91.2.772; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Morrison JA, 2005, J VIROL, V79, P2375, DOI 10.1128/JVI.79.4.2375-2382.2005; Nepomuceno RR, 2003, CANCER RES, V63, P4472; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Portis T, 2004, ONCOGENE, V23, P8619, DOI 10.1038/sj.onc.1207905; Portis T, 2002, FRONT BIOSCI-LANDMRK, V7, pD414, DOI 10.2741/portis; Quiroga MP, 2009, BLOOD, V114, P1029, DOI 10.1182/blood-2009-03-212837; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Scholle F, 2000, J VIROL, V74, P10681, DOI 10.1128/JVI.74.22.10681-10689.2000; Shin H, 2003, BIOCHEM J, V373, P965, DOI 10.1042/BJ20030583; Snow AL, 2001, J IMMUNOL, V167, P5404, DOI 10.4049/jimmunol.167.9.5404; Snow AL, 2007, AM J TRANSPLANT, V7, P271, DOI 10.1111/j.1600-6143.2006.01650.x; Srinivasula SM, 2003, J BIOL CHEM, V278, P31469, DOI 10.1074/jbc.C300240200; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Uckun FM, 2010, BRIT J HAEMATOL, V149, P508, DOI 10.1111/j.1365-2141.2010.08106.x; van Loo G, 2002, CELL DEATH DIFFER, V9, P1031, DOI 10.1038/sj.cdd.4401088; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yang L, 2007, J BIOL CHEM, V282, P10981, DOI 10.1074/jbc.M700445200; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Young RM, 2009, BLOOD, V113, P2508, DOI 10.1182/blood-2008-05-158618	68	36	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37368	37378		10.1074/jbc.M111.255125	http://dx.doi.org/10.1074/jbc.M111.255125			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21908615	Green Published, hybrid			2022-12-25	WOS:000296542400037
J	Tran, SL; Puhar, A; Ngo-Camus, M; Ramarao, N				Tran, Seav-Ly; Puhar, Andrea; Ngo-Camus, Maud; Ramarao, Nalini			Trypan Blue Dye Enters Viable Cells Incubated with the Pore-Forming Toxin HlyII of Bacillus cereus	PLOS ONE			English	Article							HEMOLYSIN-II; STAPHYLOCOCCUS-AUREUS; PLASMA-MEMBRANE; ALPHA-TOXIN; MACROPHAGES; VIRULENCE; APOPTOSIS; ADHESION; REPAIR; INHA1	Trypan blue is a dye that has been widely used for selective staining of dead tissues or cells. Here, we show that the pore-forming toxin HlyII of Bacillus cereus allows trypan blue staining of macrophage cells, despite the cells remaining viable and metabolically active. These findings suggest that the dye enters viable cells through the pores. To our knowledge, this is the first demonstration that trypan blue may enter viable cells. Consequently, the use of trypan blue staining as a marker of vital status should be interpreted with caution. The blue coloration does not necessarily indicate cell lysis, but may rather indicate pore formation in the cell membranes and more generally increased membrane permeability.	[Tran, Seav-Ly; Ngo-Camus, Maud; Ramarao, Nalini] INRA, Unite MICALIS, UMR 1319, Guyancourt, France; [Puhar, Andrea] Inst Pasteur, INSERM, U786, Unite PMM, F-75724 Paris, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tran, SL (corresponding author), Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada.	nalini.ramarao@jouy.inra.fr	Rama Rao, Nalini/GRR-7800-2022	Puhar, Andrea/0000-0002-9915-002X; Tran, Seav-ly/0000-0001-7014-6601				Andreeva ZI, 2007, BBA-BIOMEMBRANES, V1768, P253, DOI 10.1016/j.bbamem.2006.11.004; Andreeva ZI, 2006, PROTEIN EXPRES PURIF, V47, P186, DOI 10.1016/j.pep.2005.10.030; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Auger S, 2009, APPL ENVIRON MICROB, V75, P6616, DOI 10.1128/AEM.00155-09; Baida G, 1999, FEMS MICROBIOL LETT, V180, P7, DOI 10.1016/S0378-1097(99)00455-3; Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Bischofberger M, 2009, CURR OPIN CELL BIOL, V21, P589, DOI 10.1016/j.ceb.2009.04.003; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Brillard J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-183; Cadot C, 2010, J CLIN MICROBIOL, V48, P1358, DOI 10.1128/JCM.02123-09; Draeger A, 2011, BIOCHEM PHARMACOL, V81, P703, DOI 10.1016/j.bcp.2010.12.027; Gilois N, 2007, PROTEOMICS, V7, P1719, DOI 10.1002/pmic.200600502; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Guillemet E, 2010, J BACTERIOL, V192, P286, DOI 10.1128/JB.00264-09; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Miles G, 2002, PROTEIN SCI, V11, P1813, DOI 10.1110/ps.0204002; Ramarao N, 2005, CELL MICROBIOL, V7, P1357, DOI 10.1111/j.1462-5822.2005.00562.x; Ramarao N, 2006, MICROBES INFECT, V8, P1483, DOI 10.1016/j.micinf.2006.01.005; Steinthorsdottir V, 2000, MICROB PATHOGENESIS, V28, P45, DOI 10.1006/mpat.1999.0323; Tran SL, 2011, CELL MICROBIOL, V13, P92, DOI 10.1111/j.1462-5822.2010.01522.x; Tran SL, 2010, J BACTERIOL, V192, P2638, DOI 10.1128/JB.01315-09; Walev I, 2001, FASEB J, V15, P237, DOI 10.1096/fj.01-0572fje; Zwaferink H, 2008, J IMMUNOL, V180, P4116, DOI 10.4049/jimmunol.180.6.4116	25	91	91	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e22876	10.1371/journal.pone.0022876	http://dx.doi.org/10.1371/journal.pone.0022876			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21909398	Green Published, gold, Green Submitted			2022-12-25	WOS:000294689200002
J	Van Zeebroeck, G; Kimpe, M; Vandormael, P; Thevelein, JM				Van Zeebroeck, Griet; Kimpe, Marlies; Vandormael, Patrick; Thevelein, Johan M.			A Split-Ubiquitin Two-Hybrid Screen for Proteins Physically Interacting with the Yeast Amino Acid Transceptor Gap1 and Ammonium Transceptor Mep2	PLOS ONE			English	Article							KINASE-A PATHWAY; SACCHAROMYCES-CEREVISIAE; PSEUDOHYPHAL GROWTH; CELL-WALL; PERMEASE; ACTIVATION; TREHALASE; CAMP; TOPOLOGY; GENES	Several nutrient permeases have been identified in yeast, which combine a transport and receptor function, and are called transceptors. The Gap1 general amino acid permease and the Mep2 ammonium permease mediate rapid activation by amino acids and by ammonium, respectively, of the protein kinase A (PKA) pathway in nitrogen-starved cells. Their mode of action is not well understood. Both proteins are subject to complex controls governing their intracellular trafficking. Using a split-ubiquitin yeast two-hybrid screen with Gap1 or Mep2 as bait, we identified proteins putatively interacting with Gap1 and/or Mep2. They are involved in glycosylation, the secretory pathway, sphingolipid biosynthesis, cell wall biosynthesis and other processes. For several candidate interactors, determination of transport and signaling capacity, as well as localization of Gap1 or Mep2 in the corresponding deletion strains, confirmed a functional interaction with Gap1 and/or Mep2. Also common interacting proteins were identified. Transport and signaling were differentially affected in specific deletion strains, clearly separating the two functions of the transceptors and confirming that signaling does not require transport. We identified two new proteins, Bsc6 and Yir014w, that affect trafficking or downregulation of Gap1. Deletion of EGD2, YNL024c or SPC2 inactivates Gap1 transport and signaling, while its plasma membrane level appears normal.. Vma4 is required for Mep2 expression, while Gup1 appears to be required for proper distribution of Mep2 over the plasma membrane. Some of the interactions were confirmed by GST pull-down assay, using the C-terminal tail of Gap1 or Mep2 expressed in E. coli. Our results reveal the effectiveness of split-ubiquitin two-hybrid screening for identification of proteins functionally interacting with membrane proteins. They provide several candidate proteins involved in the transport and signaling function or in the complex trafficking control of the Gap1 and Mep2 transceptors.	[Van Zeebroeck, Griet; Kimpe, Marlies; Vandormael, Patrick; Thevelein, Johan M.] KULeuven, Inst Bot & Microbiol, Mol Cell Biol Lab, Flanders, Belgium; [Van Zeebroeck, Griet; Kimpe, Marlies; Vandormael, Patrick; Thevelein, Johan M.] Vlaams Inst Biotechnol, Dept Mol Microbiol, Flanders, Belgium	KU Leuven	Van Zeebroeck, G (corresponding author), KULeuven, Inst Bot & Microbiol, Mol Cell Biol Lab, Flanders, Belgium.	johan.thevelein@mmbio.vib-kuleuven.be	Thevelein, Johan M./A-7897-2013; Thevelein, Johan M./AAK-4203-2021	Thevelein, Johan M./0000-0002-2626-0180; 	FWO post-doctoral fellowship; FWO PhD fellowship; Fund for Scientific Research - Flanders, Interuniversity Attraction Poles Network [P6/14]; Research Fund of the KULeuven (Concerted Research Actions)	FWO post-doctoral fellowship(FWO); FWO PhD fellowship(FWO); Fund for Scientific Research - Flanders, Interuniversity Attraction Poles Network(Belgian Federal Science Policy OfficeFWO); Research Fund of the KULeuven (Concerted Research Actions)	This work was supported by an FWO post-doctoral fellowship to GVZ and an FWO PhD fellowship to MK, and by grants from the Fund for Scientific Research - Flanders, Interuniversity Attraction Poles Network P6/14, and the Research Fund of the KULeuven (Concerted Research Actions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APP H, 1989, J BIOL CHEM, V264, P17583; Bahn YS, 2008, EUKARYOT CELL, V7, P2017, DOI 10.1128/EC.00323-08; Boeckstaens M, 2007, MOL MICROBIOL, V64, P534, DOI 10.1111/j.1365-2958.2007.05681.x; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Chung NJ, 2001, J BIOL CHEM, V276, P35614, DOI 10.1074/jbc.M105653200; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; DURNEZ P, 1994, YEAST, V10, P1049, DOI 10.1002/yea.320100807; Eisenkolb M, 2002, MOL BIOL CELL, V13, P4414, DOI 10.1091/mbc.E02-02-0116; Ferreira C, 2006, FEMS YEAST RES, V6, P1027, DOI 10.1111/j.1567-1364.2006.00110.x; Ferreira C, 2008, BBA-BIOMEMBRANES, V1778, P2648, DOI 10.1016/j.bbamem.2008.08.011; Gilstring CF, 2000, J BIOL CHEM, V275, P31488, DOI 10.1074/jbc.M005047200; Giots F, 2003, MOL MICROBIOL, V47, P1163, DOI 10.1046/j.1365-2958.2003.03365.x; Hein C, 1997, MOL MICROBIOL, V24, P607, DOI 10.1046/j.1365-2958.1997.3771735.x; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; HIRIMBUREGAMA K, 1992, J GEN MICROBIOL, V138, P2035, DOI 10.1099/00221287-138-10-2035; HO MN, 1993, J BIOL CHEM, V268, P221; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; JAUNIAUX JC, 1990, EUR J BIOCHEM, V190, P39, DOI 10.1111/j.1432-1033.1990.tb15542.x; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Kihara A, 2008, J BIOL CHEM, V283, P11199, DOI 10.1074/jbc.M708993200; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Lauwers E, 2006, TRAFFIC, V7, P1045, DOI 10.1111/j.1600-0854.2006.00445.x; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; Marini AM, 2000, MOL MICROBIOL, V38, P552, DOI 10.1046/j.1365-2958.2000.02151.x; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; Navarre C, 2000, EMBO J, V19, P2515, DOI 10.1093/emboj/19.11.2515; Nikawa J, 1997, BBA-LIPID LIPID MET, V1348, P173, DOI 10.1016/S0005-2760(97)00103-3; Popova Y, 2010, P NATL ACAD SCI USA, V107, P2890, DOI 10.1073/pnas.0906546107; Risinger AL, 2006, MOL BIOL CELL, V17, P4411, DOI 10.1091/mbc.E06-06-0506; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Rubio-Texeira M, 2007, FEBS LETT, V581, P541, DOI 10.1016/j.febslet.2007.01.019; Rubio-Texeira M, 2006, MOL BIOL CELL, V17, P3031, DOI 10.1091/mbc.E05-07-0669; Rutherford JC, 2008, MOL BIOL CELL, V19, P3028, DOI 10.1091/mbc.E08-01-0033; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; Thevelein JM, 2009, MOL BIOL EVOL, V26, P2407, DOI 10.1093/molbev/msp168; UNO I, 1983, J BIOL CHEM, V258, P867; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; Van Zeebroeck G, 2009, NAT CHEM BIOL, V5, P45, DOI 10.1038/nchembio.132; VANDENBOL M, 1990, MOL GEN GENET, V222, P393, DOI 10.1007/BF00633845; VANDERVAART JM, 1995, J BACTERIOL, V177, P3104, DOI 10.1128/jb.177.11.3104-3110.1995; WERNERWASHBURNE M, 1987, MOL CELL BIOL, V7, P2568, DOI 10.1128/MCB.7.7.2568; Zhang F, 2008, MOL CELL BIOL, V28, P6796, DOI 10.1128/MCB.00800-08	50	19	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24275	10.1371/journal.pone.0024275	http://dx.doi.org/10.1371/journal.pone.0024275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912684	Green Published, gold, Green Submitted			2022-12-25	WOS:000294686100031
J	Dreij, K; Chaudhry, QA; Jernstrom, B; Morgenstern, R; Hanke, M				Dreij, Kristian; Chaudhry, Qasim Ali; Jernstrom, Bengt; Morgenstern, Ralf; Hanke, Michael			A Method for Efficient Calculation of Diffusion and Reactions of Lipophilic Compounds in Complex Cell Geometry	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; REGION DIOL EPOXIDES; GLUTATHIONE CONJUGATION; MEMBRANES; TRANSFERASES; METABOLISM; ACTIVATION; TOPOTECAN; BINDING; FATE	A general description of effects of toxic compounds in mammalian cells is facing several problems. Firstly, most toxic compounds are hydrophobic and partition phenomena strongly influence their behaviour. Secondly, cells display considerable heterogeneity regarding the presence, activity and distribution of enzymes participating in the metabolism of foreign compounds i.e. bioactivation/biotransformation. Thirdly, cellular architecture varies greatly. Taken together, complexity at several levels has to be addressed to arrive at efficient in silico modelling based on physicochemical properties, metabolic preferences and cell characteristics. In order to understand the cellular behaviour of toxic foreign compounds we have developed a mathematical model that addresses these issues. In order to make the system numerically treatable, methods motivated by homogenization techniques have been applied. These tools reduce the complexity of mathematical models of cell dynamics considerably thus allowing to solve efficiently the partial differential equations in the model numerically on a personal computer. Compared to a compartment model with well-stirred compartments, our model affords a more realistic representation. Numerical results concerning metabolism and chemical solvolysis of a polycyclic aromatic hydrocarbon carcinogen show good agreement with results from measurements in V79 cell culture. The model can easily be extended and refined to include more reactants, and/or more complex reaction chains, enzyme distribution etc, and is therefore suitable for modelling cellular metabolism involving membrane partitioning also at higher levels of complexity.	[Dreij, Kristian; Jernstrom, Bengt; Morgenstern, Ralf] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Chaudhry, Qasim Ali; Hanke, Michael] Royal Inst Technol, Sch Comp Sci & Commun, Stockholm, Sweden	Karolinska Institutet; Royal Institute of Technology	Dreij, K (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	kristian.dreij@ki.se	Morgenstern, Ralf/GZH-0158-2022; Dreij, Kristian/I-6083-2012; Chaudhry, Qasim Ali/N-9317-2015	Dreij, Kristian/0000-0001-8445-4293; Chaudhry, Qasim Ali/0000-0002-2568-4600	Swedish Research Council; Higher Education Commission (HEC) Pakistan	Swedish Research Council(Swedish Research CouncilEuropean Commission); Higher Education Commission (HEC) Pakistan(Higher Education Commission of Pakistan)	These studies were supported by the Swedish Research Council. QAC acknowledges the support given by Higher Education Commission (HEC) Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababou R, 2005, P COMS MULT C 2005 P, P193; Allen JI, 2004, J MOL HISTOL, V35, P697; [Anonymous], 1985, BIOACTIVATION FOREIG; Barhoumi R, 2000, TOXICOL SCI, V53, P264, DOI 10.1093/toxsci/53.2.264; Bensoussan A., 1978, Asymptotic analysis for periodic structures; Blum A, 2003, PROG NUCLEIC ACID RE, V75, P173, DOI 10.1016/S0079-6603(03)75006-5; Caruso G, 2005, IEE P SYST BIOL, V152, P119, DOI 10.1049/ip-syb:20050019; Cheung SYA, 2008, MATH BIOSCI, V213, P119, DOI 10.1016/j.mbs.2008.03.008; COMSOL AB Stockholm, 2007, COMS MULT 3 3; COOPER CS, 1980, CARCINOGENESIS, V1, P1075, DOI 10.1093/carcin/1.12.1075; Dreij K, 2005, CHEM RES TOXICOL, V18, P655, DOI 10.1021/tx0497090; Dreij K, 2002, CHEM RES TOXICOL, V15, P825, DOI 10.1021/tx025519i; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Endy D, 2001, NATURE, V409, P391, DOI 10.1038/35053181; Evans ND, 2005, INT J ADAPT CONTROL, V19, P395, DOI 10.1002/acs.856; Evans ND, 2004, MATH BIOSCI, V189, P185, DOI 10.1016/j.mbs.2004.01.007; Fan J, 2010, FEBS LETT, V584, P1678, DOI 10.1016/j.febslet.2009.10.051; Gillespie DT, 2009, J PHYS CHEM B, V113, P1640, DOI 10.1021/jp806431b; Godfrey K, 1983, COMPARTMENT MODELS T; Goel P, 2006, MULTISCALE MODEL SIM, V5, P1045, DOI 10.1137/060660783; GROVER PL, 1986, XENOBIOTICA, V16, P915, DOI 10.3109/00498258609038974; Halmos PR., 1954, MEASURE THEORY; Hanke M, 2007, P EUR COMS C 2007 GR, P40; Hanke M, 2007, 20076 TRITACSCNA ROY; Harvey R. G., 1991, POLYCYCLIC AROMATIC; Holz M, 2001, ADV DRUG DELIVER REV, V48, P249, DOI 10.1016/S0169-409X(01)00118-1; Hornung U., 1997, HOMOGENIZATION POROU, V6; ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V; ISLAM NB, 1988, CHEM RES TOXICOL, V1, P398, DOI 10.1021/tx00006a012; JACQUEZ JA, 1996, COMPARTMENTAL ANAL B; Jerina D, 1991, BIOL REACTIVE INTERM; JERNSTROM B, 1982, CARCINOGENESIS, V3, P861, DOI 10.1093/carcin/3.8.861; JERNSTROM B, 1984, CARCINOGENESIS, V5, P199, DOI 10.1093/carcin/5.2.199; Jernstrom B, 1996, CARCINOGENESIS, V17, P1491, DOI 10.1093/carcin/17.7.1491; Jikov V. V., 1994, HOMOGENIZATION DIFFE; JOHNSON JE, 1979, MECH AGEING DEV, V10, P405, DOI 10.1016/0047-6374(79)90022-8; LEO A, 1971, CHEM REV, V71, P525, DOI 10.1021/cr60274a001; MACKAY D, 1991, ENVIRON SCI TECHNOL, V25, P427, DOI 10.1021/es00015a008; Makino N, 2004, BBA-GEN SUBJECTS, V1673, P149, DOI 10.1016/j.bbagen.2004.04.011; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Moreno L, 1991, 9144 SWED NUCL FUEL; Olmstead AW, 2005, AQUAT TOXICOL, V75, P253, DOI 10.1016/j.aquatox.2005.08.007; Oz M, 2006, PHARMACOL THERAPEUT, V111, P114, DOI 10.1016/j.pharmthera.2005.09.009; Persson L, 1993, HOMOGENIZATION METHO; Petzold L., 1983, IMACS T SCI COMPUT, P65; Pfeilschifter J, 2000, NEWS PHYSIOL SCI, V15, P11; Puchalka J, 2004, BIOPHYS J, V86, P1357, DOI 10.1016/S0006-3495(04)74207-1; Srivastava SK, 1999, ARCH BIOCHEM BIOPHYS, V371, P340, DOI 10.1006/abbi.1999.1475; Stella L, 2007, J BIOL CHEM, V282, P6372, DOI 10.1074/jbc.M609906200; Sundberg K, 2002, CHEM RES TOXICOL, V15, P170, DOI 10.1021/tx015546t; Sundberg K, 1997, CHEM RES TOXICOL, V10, P1221, DOI 10.1021/tx970099w; Tacka KA, 2004, CHEM RES TOXICOL, V17, P1434, DOI 10.1021/tx0498760; Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y; The MathWorks Inc, 2018, MATLAB 2018A; TOWNSEND KMS, 1990, INT J RADIAT BIOL, V58, P499, DOI 10.1080/09553009014551841; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; US EPA, 1996, EPA540R95128; VANDERKOOI JM, 1974, BIOCHEMISTRY-US, V13, P4000, DOI 10.1021/bi00716a028; Verkman AS, 2002, TRENDS BIOCHEM SCI, V27, P27, DOI 10.1016/S0968-0004(01)02003-5; Wang XY, 1999, PROG LIPID RES, V38, P309, DOI 10.1016/S0163-7827(99)00008-9; Zhao ZH, 2011, COMPUT GEOTECH, V38, P113, DOI 10.1016/j.compgeo.2010.10.001	61	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23128	10.1371/journal.pone.0023128	http://dx.doi.org/10.1371/journal.pone.0023128			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21912588	Green Published, gold			2022-12-25	WOS:000294680800004
J	Kobayashi, DT; Olson, RJ; Sly, L; Swanson, CJ; Chung, B; Naryshkin, N; Narasimhan, J; Bhattacharyya, A; Mullenix, M; Chen, KS				Kobayashi, Dione T.; Olson, Rory J.; Sly, Laurel; Swanson, Chad J.; Chung, Brett; Naryshkin, Nikolai; Narasimhan, Jana; Bhattacharyya, Anuradha; Mullenix, Michael; Chen, Karen S.			Utility of Survival Motor Neuron ELISA for Spinal Muscular Atrophy Clinical and Preclinical Analyses	PLOS ONE			English	Article							INCREASES SMN EXPRESSION; VALPROIC ACID INCREASES; MOUSE MODEL; PROTEIN-LEVELS; MESSENGER-RNA; SINGLE NUCLEOTIDE; IN-VITRO; GENE; PHENOTYPE; IDENTIFICATION	Objectives: Genetic defects leading to the reduction of the survival motor neuron protein (SMN) are a causal factor for Spinal Muscular Atrophy (SMA). While there are a number of therapies under evaluation as potential treatments for SMA, there is a critical lack of a biomarker method for assessing efficacy of therapeutic interventions, particularly those targeting upregulation of SMN protein levels. Towards this end we have engaged in developing an immunoassay capable of accurately measuring SMN protein levels in blood, specifically in peripheral blood mononuclear cells (PBMCs), as a tool for validating SMN protein as a biomarker in SMA. Methods: A sandwich enzyme-linked immunosorbent assay (ELISA) was developed and validated for measuring SMN protein in human PBMCs and other cell lysates. Protocols for detection and extraction of SMN from transgenic SMA mouse tissues were also developed. Results: The assay sensitivity for human SMN is 50 pg/mL. Initial analysis reveals that PBMCs yield enough SMN to analyze from blood volumes of less than 1 mL, and SMA Type I patients' PBMCs show similar to 90% reduction of SMN protein compared to normal adults. The ELISA can reliably quantify SMN protein in human and mouse PBMCs and muscle, as well as brain, and spinal cord from a mouse model of severe SMA. Conclusions: This SMN ELISA assay enables the reliable, quantitative and rapid measurement of SMN in healthy human and SMA patient PBMCs, muscle and fibroblasts. SMN was also detected in several tissues in a mouse model of SMA, as well as in wildtype mouse tissues. This SMN ELISA has general translational applicability to both preclinical and clinical research efforts.	[Kobayashi, Dione T.; Swanson, Chad J.; Chung, Brett; Chen, Karen S.] Spinal Muscular Atrophy Fdn, New York, NY 10106 USA; [Olson, Rory J.; Mullenix, Michael] Enzo Life Sci Inc, Ann Arbor, MI USA; [Sly, Laurel] PharmOptima LLC, Portage, MI USA; [Naryshkin, Nikolai; Narasimhan, Jana; Bhattacharyya, Anuradha] PTC Therapeut Inc, S Plainfield, NJ USA		Kobayashi, DT (corresponding author), Spinal Muscular Atrophy Fdn, New York, NY 10106 USA.	dkobayashi@smafoundation.org		kobayashi, dione/0000-0002-5541-7175	SMA Foundation	SMA Foundation	The development and testing of the SMN ELISA was funded solely by the SMA Foundation, a non-profit charity focused on accelerating therapies for SMA. DK, BC, KS are employees of the funding organization and are co-authors involved in the study design, data analysis, decision to publish, and preparation of the manuscript. RJO and MM are employees and shareholders of Enzo Life Sciences Inc. NN, JN, and AB are employees of PTC Therapeutics Inc. LS is an employee of PharmOptima. These authors were also involved in the study design, data analysis, decision to publish, and preparation of the manuscript.	Andreassi C, 2004, EUR J HUM GENET, V12, P59, DOI 10.1038/sj.ejhg.5201102; Andreassi C, 2001, HUM MOL GENET, V10, P2841, DOI 10.1093/hmg/10.24.2841; Angelozzi C, 2008, J MED GENET, V45, P29, DOI 10.1136/jmg.2007.051177; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Azzouz M, 2004, J CLIN INVEST, V114, P1726, DOI 10.1172/JCI200422922; Battaglia G, 1997, HUM MOL GENET, V6, P1961, DOI 10.1093/hmg/6.11.1961; Brichta L, 2003, HUM MOL GENET, V12, P2481, DOI 10.1093/hmg/ddg256; Butchbach MER, 2010, HUM MOL GENET, V19, P454, DOI 10.1093/hmg/ddp510; Chang HC, 2004, NEUROCHEM INT, V45, P1107, DOI 10.1016/j.neuint.2004.04.005; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Araujo APDC, 2009, J PEDIATR-US, V155, P292, DOI 10.1016/j.jpeds.2009.01.071; El-Khodor BF, 2008, EXP NEUROL, V212, P29, DOI 10.1016/j.expneurol.2008.02.025; ElsasserBeile U, 1995, PEDIATR ALLERGY IMMU, V6, P170, DOI 10.1111/j.1399-3038.1995.tb00278.x; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Frugier T, 2002, CURR OPIN GENET DEV, V12, P294, DOI 10.1016/S0959-437X(02)00301-5; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; Garbes L, 2009, HUM MOL GENET, V18, P3645, DOI 10.1093/hmg/ddp313; Grzeschik SM, 2005, ANN NEUROL, V58, P194, DOI 10.1002/ana.20548; Hahnen E, 2006, J NEUROCHEM, V98, P193, DOI 10.1111/j.1471-4159.2006.03868.x; Hastings ML, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000208; Hendrickson BC, 2009, J MED GENET, V46, P641, DOI 10.1136/jmg.2009.066969; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Jarecki J, 2005, HUM MOL GENET, V14, P2003, DOI 10.1093/hmg/ddi205; Kolb SJ, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-6; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson MA, 2008, DEV DYNAM, V237, P2268, DOI 10.1002/dvdy.21642; Lorson MA, 2011, TRANSGENIC RES, V20, P1293, DOI 10.1007/s11248-011-9496-8; Man NT, 2008, NEUROLOGY, V71, P1757, DOI 10.1212/01.wnl.0000313038.34337.b1; Mattis VB, 2006, HUM GENET, V120, P589, DOI 10.1007/s00439-006-0245-7; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Park GH, 2010, J NEUROSCI, V30, P12005, DOI 10.1523/JNEUROSCI.2208-10.2010; Park GH, 2010, CURR NEUROL NEUROSCI, V10, P108, DOI 10.1007/s11910-010-0095-5; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; Patrizi AL, 1999, EUR J HUM GENET, V7, P301, DOI 10.1038/sj.ejhg.5200286; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; PEARN J, 1980, LANCET, V1, P919; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Piepers S, 2011, J NEUROL NEUROSUR PS, V82, P850, DOI 10.1136/jnnp.2009.200253; Riessland M, 2010, HUM MOL GENET, V19, P1492, DOI 10.1093/hmg/ddq023; Rudnik-Schoneborn S, 2010, MUSCLE NERVE, V42, P144, DOI 10.1002/mus.21654; Singh J, 2008, ACS CHEM BIOL, V3, P711, DOI 10.1021/cb800120t; Singh NK, 2006, MOL CELL BIOL, V26, P1333, DOI 10.1128/MCB.26.4.1333-1346.2006; Sproule DM, 2011, J CHILD NEUROL, V26, P309, DOI 10.1177/0883073810380457; Sumner CJ, 2006, NEUROLOGY, V66, P1067, DOI 10.1212/01.wnl.0000201929.56928.13; Sumner CJ, 2003, ANN NEUROL, V54, P647, DOI 10.1002/ana.10743; Williams JH, 2009, J NEUROSCI, V29, P7633, DOI 10.1523/JNEUROSCI.0950-09.2009; Wishart TM, 2010, HUM MOL GENET, V19, P4216, DOI 10.1093/hmg/ddq340	52	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24269	10.1371/journal.pone.0024269	http://dx.doi.org/10.1371/journal.pone.0024269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904622	Green Submitted, Green Published, gold			2022-12-25	WOS:000294680800075
J	Nazer, E; Sanchez, DO				Nazer, Ezequiel; Sanchez, Daniel O.			Nucleolar Accumulation of RNA Binding Proteins Induced by ActinomycinD Is Functional in Trypanosoma cruzi and Leishmania mexicana but Not in T. brucei	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNAS; DYNAMICS; INTERFERENCE; LOCALIZATION; GRANULES; STRESS; SYSTEM; P53; SR	We have recently shown in T. cruzi that a group of RNA Binding Proteins (RBPs), involved in mRNA metabolism, are accumulated into the nucleolus in response to Actinomycin D (ActD) treatment. In this work, we have extended our analysis to other members of the trypanosomatid lineage. In agreement with our previous study, the mechanism seems to be conserved in L. mexicana, since both endogenous RBPs and a transgenic RBP were relocalized to the nucleolus in parasites exposed to ActD. In contrast, in T. brucei, neither endogenous RBPs (TbRRM1 and TbPABP2) nor a transgenic RBP from T. cruzi were accumulated into the nucleolus under such treatment. Interestingly, when a transgenic TbRRM1 was expressed in T. cruzi and the parasites exposed to ActD, TbRRM1 relocated to the nucleolus, suggesting that it contains the necessary sequence elements to be targeted to the nucleolus. Together, both experiments demonstrate that the mechanism behind nucleolar localization of RBPs, which is present in T. cruzi and L. mexicana, is not functional in T. brucei, suggesting that it has been lost or retained differentially during the evolution of the trypanosomatid lineage.	[Nazer, Ezequiel; Sanchez, Daniel O.] UNSAM CONICET, Inst Tecnol Chascomu, Inst Invest Biotecnol, San Martin, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Nazer, E (corresponding author), UNSAM CONICET, Inst Tecnol Chascomu, Inst Invest Biotecnol, San Martin, Buenos Aires, Argentina.	dsanchez@unsam.edu.ar		sanchez, daniel/0000-0002-5427-7764	National Agency for Promotion of Science and Technology, (ANPCyT, Argentina) [PICT 2007- 624]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina)	National Agency for Promotion of Science and Technology, (ANPCyT, Argentina)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by National Agency for Promotion of Science and Technology, (ANPCyT, Argentina. PICT 2007- 624 to DOS) and by the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali GS, 2003, PLANT J, V36, P883, DOI 10.1046/j.1365-313X.2003.01932.x; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Brown JWS, 2005, NUCLEIC ACIDS RES, V33, pD633, DOI 10.1093/nar/gki052; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Lima TDD, 2010, EUKARYOT CELL, V9, P1484, DOI 10.1128/EC.00148-10; DaRocha WD, 2004, MOL BIOCHEM PARASIT, V133, P175, DOI 10.1016/j.molbiopara.2003.10.005; Gorgoni Barbara, 2004, Briefings in Functional Genomics & Proteomics, V3, P125, DOI 10.1093/bfgp/3.2.125; Karni-Schmidt O, 2008, J CELL SCI, V121, P4098, DOI 10.1242/jcs.030098; KELLY JM, 1992, NUCLEIC ACIDS RES, V20, P3963, DOI 10.1093/nar/20.15.3963; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; Koroleva OA, 2009, PLANT SIGNAL BEHAV, V4, P1148, DOI 10.4161/psb.4.12.9906; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Krieger MA, 1999, MEM I OSWALDO CRUZ, V94, P165, DOI 10.1590/S0074-02761999000700021; Lee MGS, 1997, ANNU REV MICROBIOL, V51, P463, DOI 10.1146/annurev.micro.51.1.463; Lye LF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001161; Manger ID, 1998, MOL BIOCHEM PARASIT, V97, P1, DOI 10.1016/S0166-6851(98)00118-2; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Mishra KK, 2003, EUKARYOT CELL, V2, P1009, DOI 10.1128/EC.2.5.1009-1017.2003; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Nazer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019920; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; Rolin S, 1998, MOL BIOCHEM PARASIT, V93, P251, DOI 10.1016/S0166-6851(98)00046-2; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Sakashita E, 2010, NUCLEUS-PHILA, V1, P367, DOI 10.4161/nucl.1.4.12683; Schwede A, 2009, NUCLEIC ACIDS RES, V37, P5511, DOI 10.1093/nar/gkp571; Sydorskyy Y, 2010, MOL CELL BIOL, V30, P4452, DOI 10.1128/MCB.00335-10; Tillemans V, 2005, PLANT J, V41, P567, DOI 10.1111/j.1365-313X.2004.02321.x; Ullu E, 2004, CELL MICROBIOL, V6, P509, DOI 10.1111/j.1462-5822.2004.00399.x; VANHAMME L, 1995, MICROBIOL REV, V59, P223, DOI 10.1128/MMBR.59.2.223-240.1995; Wesierska-Gadek J, 2003, ANN NY ACAD SCI, V1010, P266, DOI 10.1196/annals.1299.046	35	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24184	10.1371/journal.pone.0024184	http://dx.doi.org/10.1371/journal.pone.0024184			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904613	gold, Green Published, Green Submitted			2022-12-25	WOS:000294680800063
J	O'Leary, J; Osborne, LR				O'Leary, Jennifer; Osborne, Lucy R.			Global Analysis of Gene Expression in the Developing Brain of Gtf2ird1 Knockout Mice	PLOS ONE			English	Article							WILLIAMS-BEUREN-SYNDROME; TFII-I FAMILY; SUPRAVALVULAR AORTIC-STENOSIS; ATYPICAL 7Q11.23 DELETION; TRANSCRIPTION FACTORS; POINT MUTATIONS; BINDING; BEN; MEMBER; IDENTIFICATION	Background: Williams-Beuren Syndrome (WBS) is a neurodevelopmental disorder caused by a hemizygous deletion of a 1.5 Mb region on chromosome 7q11.23 encompassing 26 genes. One of these genes, GTF2IRD1, codes for a putative transcription factor that is expressed throughout the brain during development. Genotype-phenotype studies in patients with atypical deletions of 7q11.23 implicate this gene in the neurological features of WBS, and Gtf2ird1 knockout mice show reduced innate fear and increased sociability, consistent with features of WBS. Multiple studies have identified in vitro target genes of GTF2IRD1, but we sought to identify in vivo targets in the mouse brain. Methodology/Principal Findings: We performed the first in vivo microarray screen for transcriptional targets of Gtf2ird1 in brain tissue from Gtf2ird1 knockout and wildtype mice at embryonic day 15.5 and at birth. Changes in gene expression in the mutant mice were moderate (0.5 to 2.5 fold) and of candidate genes with altered expression verified using real-time PCR, most were located on chromosome 5, within 10 Mb of Gtf2ird1. siRNA knock-down of Gtf2ird1 in two mouse neuronal cell lines failed to identify changes in expression of any of the genes identified from the microarray and subsequent analysis showed that differences in expression of genes on chromosome 5 were the result of retention of that chromosome region from the targeted embryonic stem cell line, and so were dependent upon strain rather than Gtf2ird1 genotype. In addition, specific analysis of genes previously identified as direct in vitro targets of GTF2IRD1 failed to show altered expression. Conclusions/Significance: We have been unable to identify any in vivo neuronal targets of GTF2IRD1 through genome-wide expression analysis, despite widespread and robust expression of this protein in the developing rodent brain.	[O'Leary, Jennifer; Osborne, Lucy R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Osborne, Lucy R.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto	O'Leary, J (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	lucy.osborne@utoronto.ca			Canadian Institutes of Health Research [MOP-77720]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by a grant (MOP-77720) from the Canadian Institutes of Health Research to LRO (www.cihr.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonell A, 2010, J MED GENET, V47, P312, DOI 10.1136/jmg.2009.071712; Bayarsaihan D, 2003, GENE EXPR PATTERNS, V3, P579, DOI 10.1016/S1567-133X(03)00118-2; Bayarsaihan D, 2000, P NATL ACAD SCI USA, V97, P7342, DOI 10.1073/pnas.97.13.7342; Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/089892900561940; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Botta A, 1999, J MED GENET, V36, P478; Calvo S, 2001, MOL CELL BIOL, V21, P8490, DOI 10.1128/MCB.21.24.8490-8503.2001; Caraveo G, 2006, SCIENCE, V314, P122, DOI 10.1126/science.1127815; Chimge NO, 2008, P NATL ACAD SCI USA, V105, P9006, DOI 10.1073/pnas.0803051105; Chimge NO, 2007, J EXP ZOOL PART B, V308B, P209, DOI 10.1002/jez.b.21129; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; Dai L, 2009, AM J MED GENET A, V149A, P302, DOI 10.1002/ajmg.a.32652; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Enkhmandakh B, 2009, P NATL ACAD SCI USA, V106, P181, DOI 10.1073/pnas.0811531106; Ferrero GB, 2010, EUR J HUM GENET, V18, P33, DOI 10.1038/ejhg.2009.108; Gagliardi C, 2003, J MED GENET, V40, P526, DOI 10.1136/jmg.40.7.526; Heller R, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e99; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; Howald C, 2006, J MED GENET, V43, P266, DOI 10.1136/jmg.2005.034009; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Issa LL, 2006, DEV BIOL, V293, P104, DOI 10.1016/j.ydbio.2006.01.019; Jackson TA, 2005, J BIOL CHEM, V280, P29856, DOI 10.1074/jbc.M500335200; Kedmi M, 2007, PHYSIOL GENOMICS, V28, P213, DOI 10.1152/physiolgenomics.00155.2006; Klein-Tasman BP, 2003, DEV NEUROPSYCHOL, V23, P269, DOI 10.1207/S15326942DN231&2_12; Ku MC, 2005, MOL CELL BIOL, V25, P7144, DOI 10.1128/MCB.25.16.7144-7157.2005; Lazebnik MB, 2008, J BIOL CHEM, V283, P11078, DOI 10.1074/jbc.C800049200; Leyfer OT, 2006, AM J MED GENET B, V141B, P615, DOI 10.1002/ajmg.b.30344; Li DY, 1997, HUM MOL GENET, V6, P1021, DOI 10.1093/hmg/6.7.1021; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Mervis CB, 2000, BRAIN COGNITION, V44, P604, DOI 10.1006/brcg.2000.1232; Morris CA, 2003, AM J MED GENET A, V123A, P45, DOI 10.1002/ajmg.a.20496; Noyes HA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-361; O'Mahoney JV, 1998, MOL CELL BIOL, V18, P6641, DOI 10.1128/MCB.18.11.6641; OSBORNE LR, 2011, NEUROCONSTRUCTIVISM; Osborne LR, 2010, AM J MED GENET C, V154C, P209, DOI 10.1002/ajmg.c.30257; Palmer SJ, 2007, GENE EXPR PATTERNS, V7, P396, DOI 10.1016/j.modgep.2006.11.008; Palmer SJ, 2010, J BIOL CHEM, V285, P4715, DOI 10.1074/jbc.M109.086660; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; Proulx E, 2010, J NEURODEV DISORD, V2, P99, DOI 10.1007/s11689-010-9044-5; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Ring C, 2002, GENE DEV, V16, P820, DOI 10.1101/gad.963802; Rodger J, 1998, J NEUROCHEM, V71, P666; Schalkwyk LC, 2007, GENES BRAIN BEHAV, V6, P299, DOI 10.1111/j.1601-183X.2007.00304.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stromme P, 2002, J CHILD NEUROL, V17, P269, DOI 10.1177/088307380201700406; Tai C, 2011, HIPPOCAMPUS, V21, P958, DOI 10.1002/hipo.20807; Tassabehji M, 2005, SCIENCE, V310, P1184, DOI 10.1126/science.1116142; Tassabehji M, 1997, HUM MOL GENET, V6, P1029, DOI 10.1093/hmg/6.7.1029; Thompson PD, 2007, FEBS LETT, V581, P1233, DOI 10.1016/j.febslet.2007.02.040; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tussie-Luna MI, 2001, P NATL ACAD SCI USA, V98, P7789, DOI 10.1073/pnas.141222298; Valor LM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001303; Vullhorst D, 2005, J BIOL CHEM, V280, P31722, DOI 10.1074/jbc.M500593200; Vullhorst D, 2003, J BIOL CHEM, V278, P8370, DOI 10.1074/jbc.M209361200; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Young EJ, 2008, GENES BRAIN BEHAV, V7, P224, DOI 10.1111/j.1601-183X.2007.00343.x	57	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23868	10.1371/journal.pone.0023868	http://dx.doi.org/10.1371/journal.pone.0023868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909369	Green Submitted, Green Published, gold			2022-12-25	WOS:000294680800031
J	Kelley, JL; Morrell, LJ; Inskip, C; Krause, J; Croft, DP				Kelley, Jennifer L.; Morrell, Lesley J.; Inskip, Chloe; Krause, Jens; Croft, Darren P.			Predation Risk Shapes Social Networks in Fission-Fusion Populations	PLOS ONE			English	Article							PAN-TROGLODYTES-VERUS; GROUP-SIZE; ECOLOGICAL DETERMINANTS; ANTIPREDATOR BEHAVIOR; POECILIA-RETICULATA; TRINIDADIAN GUPPY; DYNAMICS; TRANSMISSION; FAMILIARITY; EVOLUTION	Predation risk is often associated with group formation in prey, but recent advances in methods for analysing the social structure of animal societies make it possible to quantify the effects of risk on the complex dynamics of spatial and temporal organisation. In this paper we use social network analysis to investigate the impact of variation in predation risk on the social structure of guppy shoals and the frequency and duration of shoal splitting (fission) and merging (fusion) events. Our analyses revealed that variation in the level of predation risk was associated with divergent social dynamics, with fish in high-risk populations displaying a greater number of associations with overall greater strength and connectedness than those from low-risk sites. Temporal patterns of organisation also differed according to predation risk, with fission events more likely to occur over two short time periods (5 minutes and 20 minutes) in low-predation fish and over longer time scales (> 1.5 hours) in high-predation fish. Our findings suggest that predation risk influences the fine-scale social structure of prey populations and that the temporal aspects of organisation play a key role in defining social systems.	[Kelley, Jennifer L.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Morrell, Lesley J.] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Inskip, Chloe] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NZ, Kent, England; [Krause, Jens] Leibniz Inst Biol & Ecol Fishes, Berlin, Germany; [Krause, Jens] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England; [Croft, Darren P.] Univ Exeter, Dept Psychol, Exeter EX4 4RJ, Devon, England	University of Western Australia; University of Hull; University of Kent; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Leeds; University of Exeter	Kelley, JL (corresponding author), Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia.	jennifer.kelley@uwa.edu.au	Krause, Jens/J-4381-2013; Croft, Darren P/B-5503-2009; Kelley, Jennifer L./H-5177-2014; Morrell, Lesley J/A-4311-2008	Krause, Jens/0000-0002-1289-2857; Croft, Darren P/0000-0001-6869-5097; Kelley, Jennifer L./0000-0002-8223-7241; Morrell, Lesley J/0000-0003-0256-7871	Universities of Western Australia and New South Wales; Association for the Study of Animal Behaviour; Fisheries Society of the British Isles; NERC [NE/D011035/1] Funding Source: UKRI; Natural Environment Research Council [NE/D011035/1] Funding Source: researchfish	Universities of Western Australia and New South Wales; Association for the Study of Animal Behaviour; Fisheries Society of the British Isles; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	JLK was supported by the Universities of Western Australia and New South Wales. The Association for the Study of Animal Behaviour and the Fisheries Society of the British Isles funded the project through their small research grants programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Barthelemy M, 2005, PHYSICA A, V346, P34, DOI 10.1016/j.physa.2004.08.047; Benjamini Y, 2001, ANN STAT, V29, P1165; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; BOESCH C, 1991, BEHAVIOUR, V117, P221, DOI 10.1163/156853991X00544; Borgatti S.P., 2002, NETDRAW GRAPH VISUAL; Botham MS, 2008, ECOLOGY, V89, P3174, DOI 10.1890/07-0490.1; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; CARACO T, 1975, AM NAT, V109, P343, DOI 10.1086/283001; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; Chaverri G, 2010, BEHAV ECOL SOCIOBIOL, V64, P1619, DOI 10.1007/s00265-010-0975-3; CLUTTONBROCK TH, 1977, J ZOOL, V183, P1, DOI 10.1111/j.1469-7998.1977.tb04171.x; Connor RC, 2000, CETACEAN SOCIETIES, P91; Corner LAL, 2003, PREV VET MED, V59, P147, DOI 10.1016/S0167-5877(03)00075-8; Corner LAL, 2002, NEW ZEAL VET J, V50, P154, DOI 10.1080/00480169.2002.36302; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; Couzin ID, 2009, CURR BIOL, V19, pR633, DOI 10.1016/j.cub.2009.05.034; Croft DP, 2009, BEHAV ECOL SOCIOBIOL, V63, P1495, DOI 10.1007/s00265-009-0802-x; Croft DP, 2006, BEHAV ECOL SOCIOBIOL, V59, P644, DOI 10.1007/s00265-005-0091-y; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Croft DP, 2003, OIKOS, V100, P429, DOI 10.1034/j.1600-0706.2003.12023.x; Croft DP, 2004, P ROY SOC B-BIOL SCI, V271, pS516, DOI 10.1098/rsbl.2004.0206; Croft DP, 2005, OECOLOGIA, V143, P211, DOI 10.1007/s00442-004-1796-8; CROOK JH, 1966, NATURE, V210, P1200, DOI 10.1038/2101200a0; Cumming GS, 2010, DIVERS DISTRIB, V16, P414, DOI 10.1111/j.1472-4642.2010.00651.x; Darden SK, 2009, P ROY SOC B-BIOL SCI, V276, P2651, DOI 10.1098/rspb.2009.0087; Drewe JA, 2010, P ROY SOC B-BIOL SCI, V277, P633, DOI 10.1098/rspb.2009.1775; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Foley R, 2009, PHILOS T R SOC B, V364, P3267, DOI 10.1098/rstb.2009.0136; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Griffiths SW, 1997, ANIM BEHAV, V53, P945, DOI 10.1006/anbe.1996.0315; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Henzi SP, 2009, BEHAV ECOL SOCIOBIOL, V63, P1015, DOI 10.1007/s00265-009-0720-y; Hill RA, 1998, J ZOOL, V245, P447, DOI 10.1111/j.1469-7998.1998.tb00119.x; HINDE RA, 1976, MAN, V11, P1, DOI 10.2307/2800384; Hoppitt W, 2011, AM J PRIMATOL, V73, P834, DOI 10.1002/ajp.20920; Jacoby DMP, 2010, BEHAV ECOL, V21, P808, DOI 10.1093/beheco/arq061; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Karczmarski L, 2005, BEHAV ECOL, V16, P675, DOI 10.1093/beheco/ari028; Kelley JL, 2003, ANIM BEHAV, V65, P655, DOI 10.1006/anbe.2003.2076; Krause J, 2007, BEHAV ECOL SOCIOBIOL, V62, P15, DOI 10.1007/s00265-007-0445-8; Krause J, 2002, LIVING GROUPS; Krause S, 2009, BEHAV ECOL SOCIOBIOL, V63, P1089, DOI 10.1007/s00265-009-0746-1; Krob J, 2008, ECOLOGY SOCIAL EVOLU; Kruuk H., 1972, P1; Kummer H., 1971, PRIMATE SOC GROUP TE; Lehmann J, 2004, BEHAV ECOL SOCIOBIOL, V56, P207, DOI 10.1007/s00265-004-0781-x; Lehmann J, 2009, OIKOS, V118, P379, DOI 10.1111/j.1600-0706.2008.16382.x; Liley NR., 1975, FUNCTION EVOLUTION B, P118; Lusseau D, 2006, J ANIM ECOL, V75, P14, DOI 10.1111/j.1365-2656.2005.01013.x; MAGURRAN AE, 1995, ADV STUD BEHAV, V24, P155, DOI 10.1016/S0065-3454(08)60394-0; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Patriquin KJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P899, DOI 10.1007/s00265-010-0905-4; Pike TW, 2008, P ROY SOC B-BIOL SCI, V275, P2515, DOI 10.1098/rspb.2008.0744; Pitcher T.J., 1983, British Freshwater Fisheries Conference Proceedings, V3, P220; Ramos-Fernandez G, 2006, BEHAV ECOL SOCIOBIOL, V60, P536, DOI 10.1007/s00265-006-0197-x; Reader SM, 2003, ANIM BEHAV, V66, P729, DOI 10.1006/anbe.2003.2252; Rodd FH, 1997, ECOLOGY, V78, P405; Rodgers GM, 2011, PUBLIC LIB SCI ONE, V6; Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011170; Rubenstein DI., 1986, ECOLOGICAL ASPECTS S; SAKURA O, 1994, INT J PRIMATOL, V15, P167, DOI 10.1007/BF02735272; Schurch R, 2010, PHILOS T R SOC B, V365, P4089, DOI 10.1098/rstb.2010.0177; SEGHERS BH, 1974, EVOLUTION, V28, P486, DOI 10.1111/j.1558-5646.1974.tb00774.x; Sih A, 2009, BEHAV ECOL SOCIOBIOL, V63, P975, DOI 10.1007/s00265-009-0725-6; Smith JE, 2008, ANIM BEHAV, V76, P619, DOI 10.1016/j.anbehav.2008.05.001; Sueur C, 2010, J EXP BIOL, V213, P1338, DOI 10.1242/jeb.039016; Swaney W, 2001, ANIM BEHAV, V62, P591, DOI 10.1006/anbe.2001.1788; SYMINGTON MM, 1988, BEHAVIOUR, V105, P117; VANSCHAIK CP, 1983, BEHAVIOUR, V87, P120, DOI 10.1163/156853983X00147; Vonhof MJ, 2004, ANIM BEHAV, V68, P507, DOI 10.1016/j.anbehav.2003.08.025; Ward AJW, 2003, FISH FISH, V4, P348, DOI 10.1046/j.1467-2979.2003.00135.x; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Wey TW, 2010, ANIM BEHAV, V79, P1343, DOI 10.1016/j.anbehav.2010.03.008; WHITEHEAD H, 1995, BEHAV ECOL, V6, P199, DOI 10.1093/beheco/6.2.199; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6; Whitehead H., 2008, ANAL ANIMAL SOC; Whitehead H, 2007, COMMUN STAT-SIMUL C, V36, P1233, DOI 10.1080/03610910701569531; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Wiszniewski J, 2009, ANIM BEHAV, V77, P1449, DOI 10.1016/j.anbehav.2009.02.025; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018; Wittemyer G, 2009, P ROY SOC B-BIOL SCI, V276, P3513, DOI 10.1098/rspb.2009.0941; WRONA FJ, 1991, AM NAT, V137, P186, DOI 10.1086/285153	89	68	69	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24280	10.1371/journal.pone.0024280	http://dx.doi.org/10.1371/journal.pone.0024280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912627	Green Published, gold, Green Submitted			2022-12-25	WOS:000294678300035
J	Johnson, RD; Schauerte, JA; Wisser, KC; Gafni, A; Steel, DG				Johnson, Robin D.; Schauerte, Joseph A.; Wisser, Kathleen C.; Gafni, Ari; Steel, Duncan G.			Direct Observation of Single Amyloid-beta(1-40) Oligomers on Live Cells: Binding and Growth at Physiological Concentrations	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; ALZHEIMERS-DISEASE; NEUROBLASTOMA-CELLS; DEPENDENT MECHANISM; MEMBRANE-BINDING; OXIDATIVE STRESS; PLASMA-MEMBRANE; NMDA-RECEPTORS; LIPID-BILAYERS; ION CHANNELS	Understanding how amyloid-beta peptide interacts with living cells on a molecular level is critical to development of targeted treatments for Alzheimer's disease. Evidence that oligomeric A beta interacts with neuronal cell membranes has been provided, but the mechanism by which membrane binding occurs and the exact stoichiometry of the neurotoxic aggregates remain elusive. Physiologically relevant experimentation is hindered by the high A beta concentrations required for most biochemical analyses, the metastable nature of A beta aggregates, and the complex variety of A beta species present under physiological conditions. Here we use single molecule microscopy to overcome these challenges, presenting direct optical evidence that small A beta(1-40) oligomers bind to living neuroblastoma cells at physiological A beta concentrations. Single particle fluorescence intensity measurements indicate that cell-bound A beta species range in size from monomers to hexamers and greater, with the majority of bound oligomers falling in the dimer-to-tetramer range. Furthermore, while low-molecular weight oligomeric species do form in solution, the membrane-bound oligomer size distribution is shifted towards larger aggregates, indicating either that bound A beta oligomers can rapidly increase in size or that these oligomers cluster at specific sites on the membrane. Calcium indicator studies demonstrate that small oligomer binding at physiological concentrations induces only mild, sporadic calcium leakage. These findings support the hypothesis that small oligomers are the primary A beta species that interact with neurons at physiological concentrations.	[Johnson, Robin D.; Schauerte, Joseph A.; Wisser, Kathleen C.; Gafni, Ari; Steel, Duncan G.] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA; [Gafni, Ari] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Steel, Duncan G.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Steel, Duncan G.] Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Johnson, RD (corresponding author), Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA.	johnsoro@umich.edu			NIA [R21-AG027370]; University of Michigan [NIGMS T32 GM07863, NIGMS GM008270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863, T32GM008270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG027370] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIA R21-AG027370, the University of Michigan Medical Scientist Training Program (NIGMS T32 GM07863), and a University of Michigan Molecular Biophysics Training Grant (NIGMS GM008270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Bateman DA, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-29; Bateman DA, 2009, BIOPHYS J, V96, P4260, DOI 10.1016/j.bpj.2009.01.056; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Burli T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011507; Capone R, 2009, NEUROTOX RES, V16, P1, DOI 10.1007/s12640-009-9033-1; Chafekar SM, 2008, BBA-MOL BASIS DIS, V1782, P523, DOI 10.1016/j.bbadis.2008.06.003; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Crouch PJ, 2008, INT J BIOCHEM CELL B, V40, P181, DOI 10.1016/j.biocel.2007.07.013; Davis DG, 1999, J NEUROPATH EXP NEUR, V58, P376, DOI 10.1097/00005072-199904000-00008; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Ding H, 2009, BIOPHYS J, V97, P912, DOI 10.1016/j.bpj.2009.05.035; Gao Q, 2008, TOXICOL IN VITRO, V22, P837, DOI 10.1016/j.tiv.2007.12.017; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Kawahara M, 1997, BIOPHYS J, V73, P67, DOI 10.1016/S0006-3495(97)78048-2; Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Kulikov AV, 2007, B EXP BIOL MED+, V144, P626, DOI 10.1007/s10517-007-0390-6; Lacowicz J.R., 1999, PRINCIPLES FLUORESCE; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McLean CA, 1999, ANN NEUROL, V155, P853; Nag S, 2010, BIOPHYS J, V99, P1969, DOI 10.1016/j.bpj.2010.07.020; Nicholson AM, 2009, J NEUROSCI, V29, P4640, DOI 10.1523/JNEUROSCI.0862-09.2009; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Poomthavorn P, 2009, ENDOCR-RELAT CANCER, V16, P991, DOI 10.1677/ERC-08-0340; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Schauerte JA, 2010, BIOCHEMISTRY-US, V49, P3031, DOI 10.1021/bi901444w; Sepulveda FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011820; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Simakova O, 2007, J NEUROSCI, V27, P13719, DOI 10.1523/JNEUROSCI.3006-07.2007; Simakova O, 2006, BIOCHEMISTRY-US, V45, P5907, DOI 10.1021/bi060148g; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Williamson R, 2008, FASEB J, V22, P1552, DOI 10.1096/fj.07-9766com; Wong PT, 2009, J MOL BIOL, V386, P81, DOI 10.1016/j.jmb.2008.11.060	49	32	32	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23970	10.1371/journal.pone.0023970	http://dx.doi.org/10.1371/journal.pone.0023970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901146	gold, Green Submitted, Green Published			2022-12-25	WOS:000294298000031
J	Tjeldhorn, L; Iversen, N; Sandvig, K; Bergan, J; Sandset, PM; Skretting, G				Tjeldhorn, Lena; Iversen, Nina; Sandvig, Kirsten; Bergan, Jonas; Sandset, Per Morten; Skretting, Grethe			Protein C Mutation (A267T) Results in ER Retention and Unfolded Protein Response Activation	PLOS ONE			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; IMPAIRED SECRETION; QUALITY-CONTROL; DEFICIENCY; MUTANT; STRESS; DOMAIN; PROTEASOME; APOPTOSIS	Background: Protein C (PC) deficiency is associated with a high risk of venous thrombosis. Recently, we identified the PC-A267T mutation in a patient with PC deficiency and revealed by in vitro studies decreased intracellular and secreted levels of the mutant. The aim of the present study was to characterize the underlying mechanism(s). Methodology/Principal Findings: CHO-K1 cells stably expressing the wild-type (PC-wt) or the PC mutant were generated. In order to examine whether the PC mutant was subjected to increased intracellular degradation, the cells were treated with several inhibitors of various degradation pathways and pulse-chase experiments were performed. Protein-chaperone complexes were analyzed by treating the cells with a cross-linker followed by Western blotting (WB). Expression levels of the immunoglobulin-binding protein (BiP) and the phosphorylated eukaryotic initiation factor 2 alpha (P-eIF2 alpha), both common ER stress markers, were determined by WB to examine if the mutation induced ER stress and unfolded protein response (UPR) activation. We found no major differences in the intracellular degradation between the PC variants. The PC mutant was retained in the endoplasmic reticulum (ER) and had increased association with the Grp-94 and calreticulin chaperones. Retention of the PC-A267T in ER resulted in UPR activation demonstrated by increased expression levels of the ER stress markers BiP and P-eIF2 alpha and caused also increased apoptotic activity in CHO-K1 cells as evidenced by elevated levels of DNA fragmentation. Conclusions/Significance: The reduced intracellular level and impaired secretion of the PC mutant were due to retention in ER. In contrast to other PC mutations, retention of the PC-A267T in ER resulted in minor increased proteasomal degradation, rather it induced ER stress, UPR activation and apoptosis.	[Tjeldhorn, Lena; Sandset, Per Morten; Skretting, Grethe] Oslo Univ Hosp, Dept Haematol, Oslo, Norway; [Sandvig, Kirsten; Bergan, Jonas] Oslo Univ Hosp, Dept Biochem, Inst Canc Res, Oslo, Norway; [Tjeldhorn, Lena; Sandset, Per Morten] Univ Oslo, Inst Clin Med, Fac Med, Clin Specialized Med & Surg, Oslo, Norway; [Sandvig, Kirsten; Bergan, Jonas] Univ Oslo, Inst Clin Med, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Sandvig, Kirsten; Bergan, Jonas] Univ Oslo, Fac Math & Nat Sci, Dept Mol Biosci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Tjeldhorn, L (corresponding author), Oslo Univ Hosp, Dept Haematol, Oslo, Norway.	grethe.skretting@medisin.uio.no	Sandset, Per Morten/J-8141-2019	Sandset, Per Morten/0000-0001-5556-8099; Bergan, Jonas/0000-0003-4267-8904	Norwegian South-Eastern Health Authority	Norwegian South-Eastern Health Authority	This study was financially supported by grants from the Norwegian South-Eastern Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio G, 2009, INT J BIOCHEM CELL B, V41, P2511, DOI 10.1016/j.biocel.2009.08.006; Arbini AA, 1996, BLOOD, V87, P5085, DOI 10.1182/blood.V87.12.5085.bloodjournal87125085; D'Ursi P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S11; Dahlback B, 2003, J THROMB HAEMOST, V1, P1525, DOI 10.1046/j.1538-7836.2003.00299.x; Enjolras N, 2004, J THROMB HAEMOST, V2, P1143, DOI 10.1111/j.1538-7836.2004.00756.x; Fayadat L, 2000, J BIOL CHEM, V275, P15948, DOI 10.1074/jbc.M905763199; Gelsthorpe ME, 2008, J BIOL CHEM, V283, P8229, DOI 10.1074/jbc.M708735200; Griffin JH, 2007, J THROMB HAEMOST, V5, P73, DOI 10.1111/j.1538-7836.2007.02491.x; GRIFFIN JH, 1981, J CLIN INVEST, V68, P1370, DOI 10.1172/JCI110385; Hashimoto Y, 2003, AM J PATHOL, V163, P101, DOI 10.1016/S0002-9440(10)63634-6; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Katsumi A, 1996, BLOOD, V87, P4164, DOI 10.1182/blood.V87.10.4164.bloodjournal87104164; Lind B, 2002, THROMB HAEMOSTASIS, V88, P632; Lind B, 2001, BRIT J HAEMATOL, V113, P642, DOI 10.1046/j.1365-2141.2001.02809.x; Liu Y, 2009, HUM MOL GENET, V18, P2622, DOI 10.1093/hmg/ddp196; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Mulugeta S, 2005, AM J RESP CELL MOL, V32, P521, DOI 10.1165/rcmb.2005-0009OC; Naito M, 2003, CIRC RES, V92, P865, DOI 10.1161/01.RES.0000069020.87627.7D; Nakahara M, 2004, THROMB HAEMOSTASIS, V92, P1284, DOI 10.1160/TH04-07-0403; Nishio M, 2008, THROMB HAEMOSTASIS, V100, P405, DOI 10.1160/TH08-04-0252; Nishitsuji K, 2009, AM J PATHOL, V174, P957, DOI 10.2353/ajpath.2009.080480; Park SY, 2010, BIOCHEM BIOPH RES CO, V391, P1449, DOI 10.1016/j.bbrc.2009.12.090; Rebello G, 2004, P NATL ACAD SCI USA, V101, P6617, DOI 10.1073/pnas.0401529101; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Sorensen S, 2006, J BIOL CHEM, V281, P468, DOI 10.1074/jbc.M507071200; SUGAHARA Y, 1994, THROMB HAEMOSTASIS, V72, P814; SUGAHARA Y, 1992, BLOOD, V80, P126; Susuki S, 2009, J BIOL CHEM, V284, P8312, DOI 10.1074/jbc.M809354200; Tjeldhorn L, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-67; Tokunaga F, 1996, J BIOCHEM, V120, P360; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Tsuda H, 2006, THROMB RES, V117, P323, DOI 10.1016/j.thromres.2005.02.017; Uchio N, 2007, FEBS J, V274, P5619, DOI 10.1111/j.1742-4658.2007.06085.x; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vollrath D, 2006, EXP EYE RES, V82, P1030, DOI 10.1016/j.exer.2005.10.007; Vu D, 2008, HAEMATOLOGICA, V93, P224, DOI 10.3324/haematol.11868; Wakabayashi S, 2000, J BIOCHEM-TOKYO, V128, P201, DOI 10.1093/oxfordjournals.jbchem.a022742; Yam GHF, 2007, BIOCHEM BIOPH RES CO, V360, P375, DOI 10.1016/j.bbrc.2007.06.048; Zhou RF, 2006, J THROMB HAEMOST, V4, P1154, DOI 10.1111/j.1538-7836.2006.01913.x	40	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e24009	10.1371/journal.pone.0024009	http://dx.doi.org/10.1371/journal.pone.0024009			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901152	Green Published, gold, Green Submitted			2022-12-25	WOS:000294298000037
J	Grepin, R; Guyot, M; Jacquin, M; Durivault, J; Chamorey, E; Sudaka, A; Serdjebi, C; Lacarelle, B; Scoazec, JY; Negrier, S; Simonnet, H; Pages, G				Grepin, R.; Guyot, M.; Jacquin, M.; Durivault, J.; Chamorey, E.; Sudaka, A.; Serdjebi, C.; Lacarelle, B.; Scoazec, J-Y; Negrier, S.; Simonnet, H.; Pages, G.			Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines	ONCOGENE			English	Article						angiogenesis; bevacizumab; CXCL cytokines; VEGF	PHASE-II TRIAL; TUMOR-GROWTH; IN-VITRO; CANCER; INTERLEUKIN-8; CHEMOKINES; RECEPTORS; ERLOTINIB; ANGIOGENESIS; COMBINATION	The anti-VEGF targeted antibody bevacizumab (BVZ) has been approved for treating renal cell carcinomas (RCCs). Although BVZ increases the progression-free survival of patients with metastatic RCC, the effect on overall survival is poor. To gain insight into the limited efficacy of BVZ on overall survival, we analyzed patient samples of RCC for angiogenic factors that may participate in escape from anti-VEGF therapy. Our study shows that the level of vascular endothelial growth factor (VEGF) in tumors was increased compared with normal tissue. The level of interleukin-8/CXCL8, a pro-angiogenic member of the CXCL family of cytokines, was also increased in tumors. These observations gave us a good reason to analyze the combined effects of BVZ and anti-CXCL8 antibodies on tumor growth. Surprisingly, we report that BVZ accelerates the growth of RCC in nude mice with in vivo selection of tumor cells with an increased growth capacity. Downregulation of receptor tyrosine phosphatase-kappa, a phosphatase implicated in EGF receptor regulation, may partly explain this phenomenon. Modification of the vascular network and development of lymphatic vessels through VEGF-C production and compensatory production of pro-angiogenic CXCL cytokines were also observed. The apparent normalization of the vascular network prompted us to associate BVZ with the chemotherapeutic agent paclitaxel. While efficient in vitro, paclitaxel did not reverse the anti-VEGF effects in vivo. Anti-CXCL8-targeting antibodies were promising as they decreased intra-tumor VEGF production; decreased the pro-angiogenic CXCL/anti-angiogenic CXCL ratio and did not induce lymphangiogenesis. These observations hold clinical implication as they highlight putative markers implicated in escape from BVZ treatment. They also recommend proceeding with caution in the use of anti-VEGF therapy alone for treatment of RCC. Oncogene (2012) 31, 1683-1694; doi:10.1038/onc.2011.360; published online 12 September 2011	[Pages, G.] Univ Nice Sophia Antipolis, CNRS, UMR 6543, IBDC,Ctr Antoine Lacassagne, F-06189 Nice, France; [Chamorey, E.; Sudaka, A.] Ctr Antoine Lacassagne, Dept Stat EC, F-06054 Nice, France; [Chamorey, E.; Sudaka, A.] Ctr Antoine Lacassagne, Dept Anatomopathol AS, F-06054 Nice, France; [Serdjebi, C.; Lacarelle, B.] Univ Marseille, UFR Pharm, Lab Pharmacocinet, Marseille, France; [Scoazec, J-Y] Fac Laennec, IFR62, INSERM, UMR S865, Lyon, France; [Negrier, S.] Ctr Leon Berard, F-69373 Lyon, France; [Simonnet, H.] Fac Med Grange Blanche, UMR 5201, Lille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; UNICANCER; Centre Antoine Lacassagne; UNICANCER; Centre Antoine Lacassagne; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Pages, G (corresponding author), Univ Nice Sophia Antipolis, CNRS, UMR 6543, IBDC,Ctr Antoine Lacassagne, 33 Ave Valombrose, F-06189 Nice, France.	gpages@unice.fr	Pages, Gilles/N-7135-2017; lacarelle, bruno/C-5585-2015; Chamorey, Emmanuel/AGO-9982-2022	lacarelle, bruno/0000-0002-7122-5851; Durivault, Jerome/0000-0002-8228-2915	National Institute of Cancer (INCA); French Association for Cancer Research (ARC) [4932]; Roche France	National Institute of Cancer (INCA)(Institut National du Cancer (INCA) France); French Association for Cancer Research (ARC); Roche France(Roche Holding)	We thank Dr Marc Colombel (patients' informed consent), Dr Jean Claude Chambard (lentivirus expressing the luciferase gene), Dr Elodie Delaplanche (biopsy management), Dr Florence Mege-Lechevallier (anatomo-pathology determination), Ms Cendrine Dubaud (animal studies) and Dr M Christiane Brahimi-Horn (careful reading of the manuscript). Financial support: Contract VEGFIL from the National Institute of Cancer (INCA), the French Association for Cancer Research (ARC, contract no. 4932) and Roche France.	Bertini R, 2004, P NATL ACAD SCI USA, V101, P11791, DOI 10.1073/pnas.0402090101; Bieche I, 2007, ENDOCR-RELAT CANCER, V14, P1039, DOI 10.1677/erc.1.01301; Cao Y, 2008, CANCER RES, V68, P8667, DOI 10.1158/0008-5472.CAN-08-2614; Cascone T, 2011, J CLIN INVEST, V121, P1313, DOI 10.1172/JCI42405; Cervi D, 2008, BLOOD, V111, P1201, DOI 10.1182/blood-2007-04-084798; Cohen EEW, 2009, LANCET ONCOL, V10, P247, DOI 10.1016/S1470-2045(09)70002-6; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2010, J CLIN ONCOL, V28, P2144, DOI 10.1200/JCO.2009.26.7849; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Hainsworth JD, 2007, CLIN GENITOURIN CANC, V5, P427, DOI 10.3816/CGC.2007.n.030; Hainsworth JD, 2007, J CLIN ONCOL, V25, P1747, DOI 10.1200/JCO.2006.09.3047; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim JY, 2008, MOL CELL PROTEOMICS, V7, P431, DOI 10.1074/mcp.M700194-MCP200; Kopetz S, 2010, J CLIN ONCOL, V28, P453, DOI 10.1200/JCO.2009.24.8252; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Levashova ZB, 2007, J AM SOC NEPHROL, V18, P2359, DOI 10.1681/ASN.2006040380; Lubner SJ, 2010, J CLIN ONCOL, V28, P3491, DOI 10.1200/JCO.2010.28.4075; Merritt WM, 2008, J NATL CANCER I, V100, P359, DOI 10.1093/jnci/djn024; Mestas J, 2005, J IMMUNOL, V175, P5351, DOI 10.4049/jimmunol.175.8.5351; Milanini J, 1998, J BIOL CHEM, V273, P18165, DOI 10.1074/jbc.273.29.18165; Oliver G, 2010, DEVELOPMENT, V137, P363, DOI 10.1242/dev.035360; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pillai MM, 2006, BLOOD, V107, P3520, DOI 10.1182/blood-2005-10-4285; Quatrale AE, 2011, FRONT BIOSCI-LANDMRK, V16, P1962, DOI 10.2741/3833; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Xu L, 2009, CANCER RES, V69, P7905, DOI 10.1158/0008-5472.CAN-09-2099; Xu YR, 2005, J BIOL CHEM, V280, P42694, DOI 10.1074/jbc.M507722200; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491	37	40	46	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	13					1683	1694		10.1038/onc.2011.360	http://dx.doi.org/10.1038/onc.2011.360			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	918EF	21909141				2022-12-25	WOS:000302231400007
J	Chateau, A; van Schaik, W; Six, A; Aucher, W; Fouet, A				Chateau, Alice; van Schaik, Willem; Six, Anne; Aucher, Willy; Fouet, Agnes			CodY regulation is required for full virulence and heme iron acquisition in Bacillus anthracis	FASEB JOURNAL			English	Article						anthrax; capsule; toxin; dissemination	GRAM-POSITIVE BACTERIA; TOXIN GENE-EXPRESSION; CAPSULE SYNTHESIS; STREPTOCOCCUS-PNEUMONIAE; PROTEIN; ATXA; GROWTH; TRANSACTIVATOR; IDENTIFICATION; TRANSCRIPTION	Capsule and toxin are the major virulence factors of Bacillus anthracis. The B. anthracis pleiotropic regulator CodY activates toxin gene expression by post-translationally regulating the accumulation of the global regulator AtxA. However, the role of CodY on B. anthracis capsulation and virulence of encapsulated strains has been unknown. The role of CodY in B. anthracis virulence was studied in mouse and guinea pig models. Spore outgrowth and dissemination of the vegetative cells was followed in mice by bioluminescent imaging. We also determined the state of capsulation and the iron requirement for growth of the codY mutant. In all models tested, the codY mutant strain was strongly attenuated compared to the wildtype strain and, in mice, also compared to the atxA strain. The disruption of codY did not affect either ex vivo or in vivo capsulation, whereas atxA deletion affected ex vivo capsulation only. The disruption of codY led to a delayed initiation of dissemination but similar kinetics of subsequent spread of the bacilli. The codY mutant cannot grow on heme iron as sole iron source, whereas the parental and complemented strains can. The lack of CodY-mediated transcription weakens virulence by controlling iron acquisition and synthesis of toxin, but without modifying capsulation.-Chateau, A., van Schaik, W., Six, A., Aucher, W., Fouet, A. CodY regulation is required for full virulence and heme iron acquisition in Bacillus anthracis. FASEB J. 25, 4445-4456 (2011). www.fasebj.org	[Fouet, Agnes] Inst Cochin Barrier & Pathogens, INSERM, U1016, F-75014 Paris, France; [Chateau, Alice; van Schaik, Willem; Six, Anne; Aucher, Willy; Fouet, Agnes] Inst Pasteur, Unite Toxines & Pathogenie Bacteriennes, F-75015 Paris, France; [Chateau, Alice; Six, Anne; Fouet, Agnes] Inst Pasteur, Lab Pathogenie Toxi Infect Bacteriennes, F-75015 Paris, France; [Fouet, Agnes] CNRS, UMR 8104, Paris, France; [van Schaik, Willem] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Fouet, Agnes] Univ Paris 05, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Utrecht University; Utrecht University Medical Center; UDICE-French Research Universities; Universite Paris Cite	Fouet, A (corresponding author), Inst Cochin Barrier & Pathogens, INSERM, U1016, Rm 206,22 Rue Mechain, F-75014 Paris, France.	agnes.fouet@inserm.fr	CHATEAU, Alice/AAU-7791-2021	van Schaik, Willem/0000-0001-5832-0988; Fouet, Agnes/0000-0001-7715-9157; CHATEAU, Alice/0000-0002-7288-4744	Direction Generale de l'Armement; EMBO; Agence Nationale de la Recherche [ANR-09-MIEN-010-02]	Direction Generale de l'Armement; EMBO(European Molecular Biology Organization (EMBO)); Agence Nationale de la Recherche(French National Research Agency (ANR))	The authors thank M. Haustant for technical assistance. Financial support was provided by a fellowship from the Direction Generale de l'Armement (A.C.) and an EMBO Long Term Fellowship (W.V.S.) and by the Agence Nationale de la Recherche, ANR-09-MIEN-010-02.	Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; Berthier M, 1996, LANCET, V347, P828, DOI 10.1016/S0140-6736(96)90901-0; Bertin M, 2010, RES MICROBIOL, V161, P249, DOI 10.1016/j.resmic.2010.03.003; Bourgogne A, 2003, INFECT IMMUN, V71, P2736, DOI 10.1128/IAI.71.5.2736-2743.2003; Brossier F, 2002, INFECT IMMUN, V70, P661; Candela T, 2005, J BACTERIOL, V187, P7765, DOI 10.1128/JB.187.22.7765-7772.2005; Candela T, 2005, MOL MICROBIOL, V57, P717, DOI 10.1111/j.1365-2958.2005.04718.x; Carlson PE, 2010, MOL MICROBIOL, V75, P900, DOI 10.1111/j.1365-2958.2009.07025.x; Carlson PE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006988; Caymaris S, 2010, MOL MICROBIOL, V78, P344, DOI 10.1111/j.1365-2958.2010.07339.x; Cendrowski S, 2004, MOL MICROBIOL, V51, P407, DOI 10.1046/j.1365-2958.2003.03861.x; Chiang C, 2011, J BACTERIOL, V193, P52, DOI 10.1128/JB.01656-09; DAI ZH, 1995, MOL MICROBIOL, V16, P1171, DOI 10.1111/j.1365-2958.1995.tb02340.x; Daou N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000675; Davison S, 2005, J BACTERIOL, V187, P6742, DOI 10.1128/JB.187.19.6742-6749.2005; Drysdale M, 2004, J BACTERIOL, V186, P307, DOI 10.1128/JB.186.2.307-315.2004; Duguid J. P., 1951, J PATHOL BACTERIOL, V63, P675; Dumetz F, 2011, AM J PATHOL, V178, P2523, DOI 10.1016/j.ajpath.2011.02.027; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Fouet A, 2006, CURR OPIN MICROBIOL, V9, P160, DOI 10.1016/j.mib.2006.02.009; Fouet A, 1996, INFECT IMMUN, V64, P4928, DOI 10.1128/IAI.64.12.4928-4932.1996; Fouet A, 2010, RES MICROBIOL, V161, P735, DOI 10.1016/j.resmic.2010.09.006; Fouet A, 2009, MOL ASPECTS MED, V30, P374, DOI 10.1016/j.mam.2009.07.001; Gat O, 2008, MOL MICROBIOL, V70, P983, DOI 10.1111/j.1365-2958.2008.06460.x; Gimenez AP, 2004, J IMMUNOL, V173, P521, DOI 10.4049/jimmunol.173.1.521; Glomski IJ, 2007, PLOS PATHOG, V3, P699, DOI 10.1371/journal.ppat.0030076; Glomski IJ, 2007, INFECT IMMUN, V75, P4754, DOI 10.1128/IAI.00575-07; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Guignot J, 1997, FEMS MICROBIOL LETT, V147, P203, DOI 10.1111/j.1574-6968.1997.tb10242.x; Hendriksen WT, 2008, J BACTERIOL, V190, P590, DOI 10.1128/JB.00917-07; Honsa ES, 2011, BIOMETALS, V24, P533, DOI 10.1007/s10534-011-9413-x; Hotta K, 2010, MICROBIOL-SGM, V156, P1918, DOI 10.1099/mic.0.039404-0; Jones MB, 2010, VIRULENCE, V1, P72, DOI 10.4161/viru.1.2.10752; Kern JW, 2008, MOL MICROBIOL, V68, P504, DOI 10.1111/j.1365-2958.2008.06169.x; KOEHLER TM, 1994, J BACTERIOL, V176, P586, DOI 10.1128/jb.176.3.586-595.1994; Lee JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020777; Lemos JA, 2008, J BACTERIOL, V190, P5291, DOI 10.1128/JB.00288-08; MAKINO S, 1989, J BACTERIOL, V171, P722, DOI 10.1128/jb.171.2.722-730.1989; Malke H, 2007, J MED MICROBIOL, V56, P707, DOI 10.1099/jmm.0.46984-0; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mignot T, 2003, MOL MICROBIOL, V47, P917, DOI 10.1046/j.1365-2958.2003.03345.x; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Namy O, 1999, FEMS MICROBIOL LETT, V173, P297, DOI 10.1111/j.1574-6968.1999.tb13517.x; PEZARD C, 1993, J GEN MICROBIOL, V139, P2459, DOI 10.1099/00221287-139-10-2459; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; Preisz H., 1909, Z IMMUNITAT FORSCH, V5, P341; REED L. J., 1938, AMER JOUR HYG, V27, P493; RISTROPH JD, 1983, INFECT IMMUN, V39, P483, DOI 10.1128/IAI.39.1.483-486.1983; Saile E, 2002, J BACTERIOL, V184, P370, DOI 10.1128/JB.184.2.370-380.2002; Scorpio A, 2007, ANTIMICROB AGENTS CH, V51, P215, DOI 10.1128/AAC.00706-06; SIRARD JC, 1994, J BACTERIOL, V176, P5188, DOI 10.1128/jb.176.16.5188-5192.1994; Skaar EP, 2006, J BACTERIOL, V188, P1071, DOI 10.1128/JB.188.3.1071-1080.2006; SMITH H, 1955, BRIT J EXP PATHOL, V36, P323; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; Stauff DL, 2009, MOL MICROBIOL, V72, P763, DOI 10.1111/j.1365-2958.2009.06684.x; Stenz L, 2011, FEMS IMMUNOL MED MIC, V62, P123, DOI 10.1111/j.1574-695X.2011.00812.x; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; Strauch MA, 2005, MICROBIOL-SGM, V151, P1751, DOI 10.1099/mic.0.27803-0; Tarlovsky Y, 2010, J BACTERIOL, V192, P3503, DOI 10.1128/JB.00054-10; TRIEUCUOT P, 1991, GENE, V106, P21, DOI 10.1016/0378-1119(91)90561-O; TRIEUCUOT P, 1987, MICROBIOL SCI, V4, P263; Tsvetanova B, 2007, MOL MICROBIOL, V63, P644, DOI 10.1111/j.1365-2958.2006.05543.x; Uchida I, 1997, MOL MICROBIOL, V23, P1229, DOI 10.1046/j.1365-2958.1997.3041667.x; UCHIDA I, 1993, J BACTERIOL, V175, P5329, DOI 10.1128/JB.175.17.5329-5338.1993; Unge A, 1999, APPL ENVIRON MICROB, V65, P813; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; van Schaik W, 2009, INFECT IMMUN, V77, P4437, DOI 10.1128/IAI.00716-09; VIETRI NJ, 1995, GENE, V152, P1, DOI 10.1016/0378-1119(94)00662-C; Welkos S. L., 1991, BACILLUS ANTHRACIS M, V10, P183; Wilson AC, 2009, MOL MICROBIOL, V72, P109, DOI 10.1111/j.1365-2958.2009.06627.x; Wilson MK, 2010, BIOMETALS, V23, P129, DOI 10.1007/s10534-009-9272-x	76	32	32	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2011	25	12					4445	4456		10.1096/fj.11-188912	http://dx.doi.org/10.1096/fj.11-188912			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21911592				2022-12-25	WOS:000298138100035
J	Chen, YN; Shen, A; Rider, PJ; Yu, Y; Wu, KL; Mu, YX; Hao, Q; Liu, YL; Gong, H; Zhu, Y; Liu, FY; Wu, JG				Chen, Yanni; Shen, Ao; Rider, Paul J.; Yu, Yi; Wu, Kailang; Mu, Yongxin; Hao, Qian; Liu, Yingle; Gong, Hao; Zhu, Ying; Liu, Fenyong; Wu, Jianguo			A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication	FASEB JOURNAL			English	Article						chronic infection; liver disease; hepatocellular carcinoma; viral infection; miR-122; therapeutic agent	IDENTIFICATION	Regulated gene expression and progeny production are essential for persistent and chronic infection by human pathogens, such as hepatitis B virus (HBV), which affects >400 million people worldwide and is a major cause of liver disease. In this study, we provide the first direct evidence that a liver-specific microRNA, miR-122, binds to a highly conserved HBV pregenomic RNA sequence via base-pairing interactions and inhibits HBV gene expression and replication. The miR-122 target sequence is located at the coding region of the mRNA for the viral polymerase and the 3' untranslated region of the mRNA for the core protein. In cultured cells, HBV gene expression and replication reduces with increased expression of miR-122, and the expression of miR-122 decreases in the presence of HBV infection and replication. Furthermore, analyses of clinical samples demonstrated an inverse linear correlation in vivo between the miR-122 level and the viral loads in the peripheral blood mononuclear cells of HBV-positive patients. Our results suggest that miR-122 may down-regulate HBV replication by binding to the viral target sequence, contributing to the persistent/chronic infection of HBV, and that HBV-induced modulation of miR-122 expression may represent a mechanism to facilitate viral pathogenesis.-Chen, Y., Shen, A., Rider, P. J., Yu, Y., Wu, K., Mu, Y., Hao, Q, Liu, Y., Gong, H., Zhu, Y., Liu, F., Wu, J. A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication. FASEB J. 25, 4511-4521 (2011). www.fasebj.org	[Shen, Ao; Rider, Paul J.; Gong, Hao; Liu, Fenyong] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Chen, Yanni; Shen, Ao; Yu, Yi; Wu, Kailang; Mu, Yongxin; Hao, Qian; Liu, Yingle; Zhu, Ying; Liu, Fenyong; Wu, Jianguo] Wuhan Univ, Wuhan Inst Biotechnol, Chinese French Liver Dis Res Inst, State Key Lab Virol,Zhongnan Hosp, Wuhan 430072, Peoples R China; [Chen, Yanni; Shen, Ao; Yu, Yi; Wu, Kailang; Mu, Yongxin; Hao, Qian; Liu, Yingle; Zhu, Ying; Liu, Fenyong; Wu, Jianguo] Wuhan Univ, Wuhan Inst Biotechnol, Chinese French Liver Dis Res Inst, Coll Life Sci,Zhongnan Hosp, Wuhan 430072, Peoples R China	University of California System; University of California Berkeley; Wuhan University; Wuhan University	Liu, FY (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.	liu_fy@berkeley.edu; jwu@whu.edu.cn	mu, yongxin/G-1882-2014	mu, yongxin/0000-0002-5569-5255; Wu, Jianguo/0000-0002-8326-2895; SHEN, AO/0000-0002-1559-3895	National Mega Project on Major Infectious Diseases Prevention and Treatment [2008ZX10002-009]; National Basic Research Program of China (973 Program) [2011CB504800, 2012CB518900]; National Mega Project on Major Drug Development [2009ZX09301-012]; Major State Basic Research Development Program of China [2005CB522901, 2007CB512803]; National Natural Science Foundation of China [30730001, 81171525, 30570070, 31100128, 81030031]; Program for Changjiang Scholars and Innovative Research Team in Universities [IRT0745]; U.S. National Institutes of Health [AI041927, AI050468, DE014842]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041927, R01AI050468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Mega Project on Major Infectious Diseases Prevention and Treatment; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Mega Project on Major Drug Development; Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in Universities(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors are indebted to Gerry Abenes, Naresh Sunkara, and Ed Yang for technical assistance and valuable suggestions. This work has been supported by research grants from the National Mega Project on Major Infectious Diseases Prevention and Treatment (2008ZX10002-009), National Basic Research Program of China (973 Program; 2011CB504800 and 2012CB518900), National Mega Project on Major Drug Development (2009ZX09301-012), Major State Basic Research Development Program of China (2005CB522901 and 2007CB512803), National Natural Science Foundation of China (30730001, 81171525, 30570070, 31100128, and 81030031), and Program for Changjiang Scholars and Innovative Research Team in Universities (IRT0745). This research has been supported by grants from the U.S. National Institutes of Health (AI041927, AI050468, and DE014842).	Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Belongia E A, 2008, NIH Consens State Sci Statements, V25, P1; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Fu HJ, 2005, FEBS LETT, V579, P3849, DOI 10.1016/j.febslet.2005.05.064; GANEM D, 1987, ANNU REV BIOCHEM, V56, P651, DOI 10.1146/annurev.biochem.56.1.651; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Jackson Richard J, 2007, Sci STKE, V2007, pre1, DOI 10.1126/stke.3672007re1; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Ramezani A, 2008, J GASTROEN HEPATOL, V23, P1716, DOI 10.1111/j.1440-1746.2008.05482.x; Seegar C., 2007, FIELDS VIROLOGY, P2978; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Sullivan CS, 2005, MOL CELL, V20, P3, DOI 10.1016/j.molcel.2005.09.012; Tan AT, 2008, J VIROL, V82, P10986, DOI 10.1128/JVI.01124-08; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Wu KL, 2005, VIRUS RES, V112, P100, DOI 10.1016/j.virusres.2005.04.001	33	141	154	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4511	4521		10.1096/fj.11-187781	http://dx.doi.org/10.1096/fj.11-187781			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21903935	Green Published			2022-12-25	WOS:000298138100041
J	Garnett, JP; Hickman, E; Burrows, R; Hegyi, P; Tiszlavicz, L; Cuthbert, AW; Fong, PY; Gray, MA				Garnett, James P.; Hickman, Emma; Burrows, Rachel; Hegyi, Peter; Tiszlavicz, Laszlo; Cuthbert, Alan W.; Fong, Peying; Gray, Michael A.			Novel Role for Pendrin in Orchestrating Bicarbonate Secretion in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-expressing Airway Serous Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRACHEAL SUBMUCOSAL GLANDS; BRONCHIAL EPITHELIAL-CELLS; CILIARY BEAT FREQUENCY; SYNDROME GENE PDS; CL-/HCO3-EXCHANGE; MUCUS SECRETION; FUNCTIONAL-CHARACTERIZATION; SULFATE TRANSPORTER; CHLORIDE SECRETION; LIQUID SECRETION	In most HCO3--secreting epithelial tissues, SLC26 Cl-/HCO3- transporters work in concert with the cystic fibrosis transmembrane conductance regulator (CFTR) to regulate the magnitude and composition of the secreted fluid, a process that is vital for normal tissue function. By contrast, CFTR is regarded as the only exit pathway for HCO3- in the airways. Here we show that Cl-/HCO3- anion exchange makes a major contribution to transcellular HCO3- transport in airway serous cells. Real-time measurement of intracellular pH from polarized cultures of human Calu-3 cells demonstrated cAMP/PKA-activated Cl--dependent HCO3- transport across the luminal membrane via CFTR-dependent coupled Cl-/HCO3- anion exchange. The pharmacological and functional profile of the luminal anion exchanger was consistent with SLC26A4 (pendrin), which was shown to be expressed by quantitative RT-PCR, Western blot, and immunofluorescence. Pendrin-mediated anion exchange activity was confirmed by shRNA pendrin knockdown (KD), which markedly reduced cAMP-activated Cl-/HCO3- exchange. To establish the relative roles of CFTR and pendrin in net HCO3- secretion, transepithelial liquid secretion rate and liquid pH were measured in wild type, pendrin KD, and CFTR KD cells. cAMP/PKA increased the rate and pH of the secreted fluid. Inhibiting CFTR reduced the rate of liquid secretion but not the pH, whereas decreasing pendrin activity lowered pH with little effect on volume. These results establish that CFTR predominately controls the rate of liquid secretion, whereas pendrin regulates the composition of the secreted fluid and identifies a critical role for this anion exchanger in transcellular HCO3- secretion in airway serous cells.	[Gray, Michael A.] Newcastle Univ, Epithelial Res Grp, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Hickman, Emma; Burrows, Rachel] Novartis Horsham Res Ctr, Novartis Inst Biomed Res, Horsham RH12 5AB, W Sussex, England; [Hegyi, Peter] Univ Szeged, Dept Med, H-6701 Szeged, Hungary; [Tiszlavicz, Laszlo] Univ Szeged, Dept Pathol, H-6701 Szeged, Hungary; [Cuthbert, Alan W.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Fong, Peying] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66505 USA	Newcastle University - UK; Novartis; Szeged University; Szeged University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Kansas State University	Gray, MA (corresponding author), Newcastle Univ, Epithelial Res Grp, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	m.a.gray@ncl.ac.uk	Fong, Peying/AAU-3774-2021; Garnett, James/O-7093-2014	Garnett, James/0000-0002-4767-020X; Talbot, Rachel/0000-0001-9085-9318; GRAY, MICHAEL/0000-0002-6774-6283	Biotechnology and Biological Sciences Research Council [BBS/S/M/2006/13134]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council-Industrial Collaborative PhD. Studentship Award BBS/S/M/2006/13134 (to J. P. G.).	Allen DB, 1997, ARCH SURG-CHICAGO, V132, P991; Babu PBR, 2004, BIOCHEM BIOPH RES CO, V319, P1132, DOI 10.1016/j.bbrc.2004.05.101; Ballard ST, 1999, AM J PHYSIOL-LUNG C, V277, pL694, DOI 10.1152/ajplung.1999.277.4.L694; Ballard ST, 2004, J PHYSIOL-LONDON, V556, P1, DOI 10.1113/jphysiol.2003.052779; Bertrand CA, 2009, J GEN PHYSIOL, V133, P421, DOI 10.1085/jgp.200810097; BHASKAR KR, 1991, AM J PHYSIOL, V261, pG827, DOI 10.1152/ajpgi.1991.261.5.G827; Chang MH, 2009, J BIOL CHEM, V284, P28306, DOI 10.1074/jbc.M109.001669; Chen EYT, 2010, AM J PHYSIOL-LUNG C, V299, pL542, DOI 10.1152/ajplung.00180.2010; Chen WY, 2009, BIOL REPROD, V80, P115, DOI 10.1095/biolreprod.108.068528; Cho HJ, 2010, AM J PHYSIOL-LUNG C, V299, pL124, DOI 10.1152/ajplung.00049.2010; Choi JY, 2009, J CLIN INVEST, V119, P1189, DOI 10.1172/JCI37284; Clary-Meinesz C, 1998, EUR RESPIR J, V11, P330, DOI 10.1183/09031936.98.11020330; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Cobb BR, 2002, AM J PHYSIOL-LUNG C, V282, pL12, DOI 10.1152/ajplung.2002.282.1.L12; Derand R, 2004, BRIT J PHARMACOL, V141, P698, DOI 10.1038/sj.bjp.0705597; Devor DC, 1999, J GEN PHYSIOL, V113, P743, DOI 10.1085/jgp.113.5.743; Dorwart MR, 2008, PHYSIOLOGY, V23, P104, DOI 10.1152/physiol.00037.2007; Dossena S, 2006, CELL PHYSIOL BIOCHEM, V17, P245, DOI 10.1159/000094137; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; Garcia MAS, 2009, J CLIN INVEST, V119, P2613, DOI 10.1172/JCI38662; HOLMA P, 1989, SCI TOTAL ENVIRON, V84, P71, DOI 10.1016/0048-9697(89)90371-9; Illek B, 1997, AM J PHYSIOL-LUNG C, V272, pL752, DOI 10.1152/ajplung.1997.272.4.L752; Inglis SK, 2002, J PHYSIOL-LONDON, V538, P527, DOI 10.1113/jphysiol.2001.012806; Irokawa T, 2004, AM J PHYSIOL-LUNG C, V287, pL784, DOI 10.1152/ajplung.00124.2004; Ishiguro H, 2002, J PHYSIOL-LONDON, V539, P175, DOI 10.1113/jphysiol.2001.012490; Joo NS, 2010, J CLIN INVEST, V120, P3161, DOI 10.1172/JCI43466; Joo NS, 2002, J BIOL CHEM, V277, P28167, DOI 10.1074/jbc.M202712200; Khansaheb M, 2011, AM J PHYSIOL-LUNG C, V300, pL370, DOI 10.1152/ajplung.00372.2010; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Ko SBH, 2002, EMBO J, V21, P5662, DOI 10.1093/emboj/cdf580; Krouse ME, 2004, AM J PHYSIOL-LUNG C, V287, pL1274, DOI 10.1152/ajplung.00036.2004; Lee MC, 1998, AM J PHYSIOL-LUNG C, V274, pL450, DOI 10.1152/ajplung.1998.274.3.L450; Lee RJ, 2010, J CLIN INVEST, V120, P3137, DOI 10.1172/JCI42992; Loffing J, 2000, AM J PHYSIOL-CELL PH, V279, pC1016, DOI 10.1152/ajpcell.2000.279.4.C1016; Lohi H, 2002, J BIOL CHEM, V277, P14246, DOI 10.1074/jbc.M111802200; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; MacVinish LJ, 2007, BRIT J PHARMACOL, V150, P1055, DOI 10.1038/sj.bjp.0707175; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Muchekehu RW, 2010, J PHYSIOL-LONDON, V588, P2329, DOI 10.1113/jphysiol.2010.187237; Nakao I, 2008, J IMMUNOL, V180, P6262, DOI 10.4049/jimmunol.180.9.6262; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; Pedemonte N, 2007, J IMMUNOL, V178, P5144, DOI 10.4049/jimmunol.178.8.5144; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; Quinton PM, 2001, NAT MED, V7, P292, DOI 10.1038/85429; Rakonczay Z, 2008, J CELL PHYSIOL, V214, P442, DOI 10.1002/jcp.21220; Royaux IE, 2000, ENDOCRINOLOGY, V141, P839, DOI 10.1210/en.141.2.839; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Satoh H, 1998, J BIOL CHEM, V273, P12307, DOI 10.1074/jbc.273.20.12307; Schmid A, 2010, J BIOL CHEM, V285, P29998, DOI 10.1074/jbc.M110.113621; Scott DA, 1999, NAT GENET, V21, P440, DOI 10.1038/7783; Scott DA, 2000, AM J PHYSIOL-CELL PH, V278, pC207, DOI 10.1152/ajpcell.2000.278.1.C207; Shcheynikov N, 2006, J GEN PHYSIOL, V127, P511, DOI 10.1085/jgp.200509392; Shcheynikov N, 2008, J PHYSIOL-LONDON, V586, P3813, DOI 10.1113/jphysiol.2008.154468; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; SIMCHOWITZ L, 1985, J CLIN INVEST, V76, P1079, DOI 10.1172/JCI112061; Simpson JE, 2005, AM J PHYSIOL-GASTR L, V288, pG1241, DOI 10.1152/ajpgi.00493.2004; Singh AK, 2010, AM J PHYSIOL-CELL PH, V298, pC1057, DOI 10.1152/ajpcell.00454.2009; SMITH JJ, 1992, J CLIN INVEST, V89, P1148, DOI 10.1172/JCI115696; Sohma Y, 2000, J MEMBRANE BIOL, V176, P77, DOI 10.1007/s002320001077; Song YL, 2006, AM J PHYSIOL-CELL PH, V290, pC741, DOI 10.1152/ajpcell.00379.2005; Stewart AK, 2007, AM J PHYSIOL-CELL PH, V292, pC909, DOI 10.1152/ajpcell.00265.2006; Stewart AK, 2009, AM J PHYSIOL-GASTR L, V296, pG1307, DOI 10.1152/ajpgi.90697.2008; Thiagarajah JR, 2004, FASEB J, V18, P875, DOI 10.1096/fj.03-1248fje; Wall SM, 2008, CURR OPIN NEPHROL HY, V17, P18, DOI 10.1097/MNH.0b013e3282f29086; Wheat VJ, 2000, AM J PHYSIOL-CELL PH, V279, pC62, DOI 10.1152/ajpcell.2000.279.1.C62; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015	70	73	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41069	41082		10.1074/jbc.M111.266734	http://dx.doi.org/10.1074/jbc.M111.266734			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21914796	Green Published, hybrid			2022-12-25	WOS:000297315400066
J	Sun, JW; He, HF; Xiong, Y; Lu, S; Shen, JL; Cheng, AN; Chang, WC; Hou, MF; Lancaster, JM; Kim, M; Yang, SY				Sun, Jianwei; He, Huifang; Xiong, Yin; Lu, Shuang; Shen, Junling; Cheng, Anna; Chang, Wei-Chiao; Hou, Ming-Feng; Lancaster, Johnathan M.; Kim, Minjung; Yang, Shengyu			Fascin Protein Is Critical for Transforming Growth Factor beta Protein-induced Invasion and Filopodia Formation in Spindle-shaped Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE BREAST-CANCER; TGF-BETA; PROGNOSTIC-SIGNIFICANCE; METASTASIS; ACTIN; CARCINOMA; EXPRESSION; MIGRATION; MOTILITY; RECEPTOR	Fascin, an actin-bundling protein overexpressed in all carcinomas, has been associated with poor prognosis, shorter survival, and more metastatic diseases. It is believed that fascin facilitates tumor metastasis by promoting the formation of invasive membrane protrusions. However, the mechanisms by which fascin is overexpressed in tumors are not clear. TGF beta is a cytokine secreted by tumor and mesenchymal cells and promotes metastasis in many late stage tumors. The pro-metastasis mechanisms of TGF beta remain to be fully elucidated. Here we demonstrated that TGF beta induced fascin expression in spindleshaped tumor cells through the canonical Smad-dependent pathway. Fascin was critical for TGF beta-promoted filopodia formation, migration, and invasion in spindle tumor cells. More importantly, fascin expression significantly correlates with TGF beta 1 and TGF beta receptor I levels in a cohort of primary breast tumor samples. Our results indicate that elevated TGF beta level in the tumor microenvironment may be responsible for fascin overexpression in some of the metastatic tumors. Our data also suggest that fascin could play a central role in TGF beta-promoted tumor metastasis.	[Sun, Jianwei; He, Huifang; Lu, Shuang; Shen, Junling; Cheng, Anna; Kim, Minjung; Yang, Shengyu] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Comprehens Melanoma Res Ctr, Tampa, FL 33612 USA; [Sun, Jianwei; He, Huifang; Lu, Shuang; Shen, Junling; Cheng, Anna; Yang, Shengyu] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA; [Xiong, Yin; Lancaster, Johnathan M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Womens Oncol, Tampa, FL 33612 USA; [Kim, Minjung] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Shen, Junling] Qingdao Agr Univ, Qingdao 266109, Peoples R China; [Chang, Wei-Chiao; Hou, Ming-Feng] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung 807, Taiwan	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Qingdao Agricultural University; Kaohsiung Medical University	Yang, SY (corresponding author), 12902 Magnolia Dr,SRB-2, Tampa, FL 33612 USA.	shengyu.yang@moffitt.org	Yang, Shengyu/I-9531-2012	Yang, Shengyu/0000-0002-7933-6118; Kim, Minjung/0000-0002-5682-6640; Chang, Wei-Chiao/0000-0002-8573-5924	American Cancer Society [IRG-93-032-16]; Donald A. Adams Comprehensive Melanoma Research Center; Miles for Moffitt Foundation Center; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Donald A. Adams Comprehensive Melanoma Research Center; Miles for Moffitt Foundation Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by an Institutional Research Grant from the American Cancer Society (IRG-93-032-16), a Career Development Award from the Donald A. Adams Comprehensive Melanoma Research Center, and a Milestone Award from Miles for Moffitt Foundation Center (to S. Y.).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Bakin AV, 2004, MOL BIOL CELL, V15, P4682, DOI 10.1091/mbc.E04-04-0353; Bros M, 2003, J IMMUNOL, V171, P1825, DOI 10.4049/jimmunol.171.4.1825; Buck MB, 2004, CLIN CANCER RES, V10, P491, DOI 10.1158/1078-0432.CCR-0320-03; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Goncharuk VN, 2002, J CUTAN PATHOL, V29, P430, DOI 10.1034/j.1600-0560.2002.290708.x; Grothey A, 2000, ONCOGENE, V19, P4864, DOI 10.1038/sj.onc.1203838; Hagedorn HG, 2001, INT J ONCOL, V18, P669; Hashimoto Y, 2005, CLIN CANCER RES, V11, P2597, DOI 10.1158/1078-0432.CCR-04-1378; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Hashimoto Y, 2004, ONCOLOGY-BASEL, V67, P262, DOI 10.1159/000081327; Hashimoto Y, 2007, MOL BIOL CELL, V18, P4591, DOI 10.1091/mbc.E07-02-0157; Hashimoto Y, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-241; Hashimoto Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005130; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Kang YB, 2006, J CELL BIOCHEM, V98, P1380, DOI 10.1002/jcb.20928; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Massague J, 2000, GENE DEV, V14, P627; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Moustakas A, 1999, J CELL SCI, V112, P1169; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pelosi G, 2003, LUNG CANCER-J IASLC, V42, P203, DOI 10.1016/S0169-5002(03)00294-0; Puppa G, 2007, BRIT J CANCER, V96, P1118, DOI 10.1038/sj.bjc.6603690; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Romano LA, 2000, DEV BIOL, V223, P91, DOI 10.1006/dbio.2000.9750; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; STOLER AB, 1993, J CELL BIOL, V122, P1103, DOI 10.1083/jcb.122.5.1103; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; Yoder BJ, 2005, CLIN CANCER RES, V11, P186	42	46	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38865	38875		10.1074/jbc.M111.270413	http://dx.doi.org/10.1074/jbc.M111.270413			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21914811	hybrid, Green Published			2022-12-25	WOS:000296759800005
J	Antonaki, A; Demetriades, C; Polyzos, A; Banos, A; Vatsellas, G; Lavigne, MD; Apostolou, E; Mantouvalou, E; Papadopoulou, D; Mosialos, G; Thanos, D				Antonaki, Athina; Demetriades, Constantinos; Polyzos, Alexander; Banos, Aggelos; Vatsellas, Giannis; Lavigne, Matthieu D.; Apostolou, Effie; Mantouvalou, Eva; Papadopoulou, Deppie; Mosialos, George; Thanos, Dimitris			Genomic Analysis Reveals a Novel Nuclear Factor-kappa B (NF-kappa B)-binding Site in Alu-repetitive Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-BINDING; CHROMATIN; ACTIVATION; RECRUITMENT; OCCUPANCY; DYNAMICS; INSIGHTS; INNATE; IMPACT	The transcription factor NF-kappa B is a critical regulator of immune responses. To determine how NF-kappa B builds transcriptional control networks, we need to obtain a topographic map of the factor bound to the genome and correlate it with global gene expression. We used a ChIP cloning technique and identified novel NF-kappa B target genes in response to virus infection. We discovered that most of the NF-kappa B-bound genomic sites deviate from the consensus and are located away from conventional promoter regions. Remarkably, we identified a novel abundant NF-kappa B-binding site residing in specialized Alu-repetitive elements having the potential for long range transcription regulation, thus suggesting that in addition to its known role, NF-kappa B has a primate-specific function and a role in human evolution. By combining these data with global gene expression profiling of virus-infected cells, we found that most of the sites bound by NF-kappa B in the human genome do not correlate with changes in gene expression of the nearby genes and they do not appear to function in the context of synthetic promoters. These results demonstrate that repetitive elements interspersed in the human genome function as common target sites for transcription factors and may play an important role in expanding the repertoire of binding sites to engage new genes into regulatory networks.	[Demetriades, Constantinos; Mosialos, George] Aristotle Univ Thessaloniki, Dept Biol, Thessaloniki 54124, Greece; [Antonaki, Athina; Polyzos, Alexander; Banos, Aggelos; Vatsellas, Giannis; Lavigne, Matthieu D.; Apostolou, Effie; Mantouvalou, Eva; Papadopoulou, Deppie; Thanos, Dimitris] Acad Athens, Inst Mol Biol Genet & Biotechnol, Biomed Res Fdn, Athens 11527, Greece	Aristotle University of Thessaloniki; Academy of Athens	Mosialos, G (corresponding author), Aristotle Univ Thessaloniki, Dept Biol, Univ Campus, Thessaloniki 54124, Greece.	gmosialo@bio.auth.gr; thanos@bioacademy.gr	Apostolou, Effie/AAG-1559-2020; Demetriades, Constantinos/AAD-3600-2021; Thanos, Dimitris/AAE-5720-2019; Demetriades, Constantinos/E-7444-2015; cheng, yong/I-4270-2012	Demetriades, Constantinos/0000-0001-7813-7726; Demetriades, Constantinos/0000-0001-7813-7726; Lavigne, Matthieu/0000-0003-1543-8745	European Union [LSHC-CT-2005-018704]; Greek Secretariat for Research and Technology	European Union(European Commission); Greek Secretariat for Research and Technology(Greek Ministry of Development-GSRT)	This work was supported by the Sixth Research Framework Programme of the European Union (MRC-RTN TAF CHROMATIN and INCA, LSHC-CT-2005-018704) and by the Greek Secretariat for Research and Technology (Program PENED 2001, PENED 2003, co-financed by E.U.-European Social Fund (75%) and GSRT (25%)).	Agelopoulos M, 2006, EMBO J, V25, P4843, DOI 10.1038/sj.emboj.7601364; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Beckett D, 2009, P NATL ACAD SCI USA, V106, P22035, DOI 10.1073/pnas.0912300107; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Hasler J, 2007, CELL MOL LIFE SCI, V64, P1793, DOI 10.1007/s00018-007-7084-0; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Jurka J, 2004, CURR OPIN GENET DEV, V14, P603, DOI 10.1016/j.gde.2004.08.008; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Koutroubas G, 2008, MOL CELL BIOL, V28, P926, DOI 10.1128/MCB.01344-07; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Linnell J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh042; Lomvardas S, 2002, CELL, V110, P261, DOI 10.1016/S0092-8674(02)00822-X; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Nolis IK, 2009, P NATL ACAD SCI USA, V106, P20222, DOI 10.1073/pnas.0902454106; Pan YP, 2010, TRENDS GENET, V26, P75, DOI 10.1016/j.tig.2009.12.003; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Polak P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-133; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; Topalidou I, 2003, EMBO REP, V4, P872, DOI 10.1038/sj.embor.embor931; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Udalova IA, 2002, P NATL ACAD SCI USA, V99, P8167, DOI 10.1073/pnas.102674699; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; White RB, 2006, BIOCHEM BIOPH RES CO, V346, P479, DOI 10.1016/j.bbrc.2006.05.145; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002	48	45	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38768	38782		10.1074/jbc.M111.234161	http://dx.doi.org/10.1074/jbc.M111.234161			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21896491	Green Published, hybrid			2022-12-25	WOS:000296594200088
J	Zhang, Q; Xiao, H; Chai, SC; Hoang, QQ; Lu, H				Zhang, Qi; Xiao, Hui; Chai, Sergio C.; Hoang, Quyen Q.; Lu, Hua			Hydrophilic Residues Are Crucial for Ribosomal Protein L11 (RPL11) Interaction with Zinc Finger Domain of MDM2 and p53 Protein Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIAMOND-BLACKFAN ANEMIA; CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; NUCLEOLAR PROTEIN; HUMAN 5Q-SYNDROME; ONCOPROTEIN MDM2; MOUSE MODEL; DNA-DAMAGE; PATHWAY; DEGRADATION	Ribosomal protein L11 (RPL11) has been shown to activate p53 by binding to MDM2 and negating its p53 suppression activity in response to ribosomal stress. Although a mutation at Cys-305 within the zinc finger domain of MDM2 has been shown to drastically impair MDM2 interaction with RPL11 and thus escapes the inhibition by this ribosomal protein, it still remains elusive whether RPL11 inactivates MDM2 via direct action on this zinc finger domain and what is the chemical nature of this specific interaction. To define the roles of the MDM2 zinc finger in association with RPL11, we conducted hydrogen-deuterium exchange mass spectrometry, computational modeling, circular dichroism, and mutational analyses of the zinc finger domain of MDM2 and human RPL11. Our study reveals that RPL11 forms a stable complex with MDM2 in vitro through direct contact with its zinc finger. This binding is disrupted by single mutations of non-cysteine amino acids within the zinc finger domain of MDM2. Basic residues in RPL11 are crucial for the stable binding and RPL11 suppression of MDM2 activity toward p53. These results provide the first line of evidence for the specific interaction between RPL11 and the zinc finger of MDM2 via hydrophilic residues as well as a molecular foundation for better understanding RPL11 inhibition of MDM2 function.	[Zhang, Qi; Chai, Sergio C.; Hoang, Quyen Q.; Lu, Hua] Indiana Univ, Sch Med, Simon Canc Ctr, Dept Biochem & Mol Biol, Indianapolis, IN 46032 USA; [Xiao, Hui] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Yeshiva University; Albert Einstein College of Medicine	Lu, H (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	hualu@iupui.edu	Zhang, Qi/I-1049-2012	Chai, Sergio/0000-0002-8257-8599	National Institutes of Health from NCI [CA127724, CA095441, CA129828]; NATIONAL CANCER INSTITUTE [R01CA095441, R01CA127724, R01CA129828] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019891, S10RR019352] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA127724, CA095441, and CA129828 from NCI (to H. L.).	BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Barkic M, 2009, MOL CELL BIOL, V29, P2489, DOI 10.1128/MCB.01588-08; Barlow JL, 2010, NAT MED, V16, P59, DOI 10.1038/nm.2063; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakraborty A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004152; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Cmejla R, 2009, HUM MUTAT, V30, P321, DOI 10.1002/humu.20874; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Devlin EE, 2010, BLOOD, V116, P2826, DOI 10.1182/blood-2010-03-275776; Ebert B, 2011, SEMIN HEMATOL, V48, P73, DOI 10.1053/j.seminhematol.2011.01.003; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng ZH, 2010, TRENDS CELL BIOL, V20, P427, DOI 10.1016/j.tcb.2010.03.004; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Ge JP, 2010, MOL CELL BIOL, V30, P413, DOI 10.1128/MCB.01128-09; Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Komrokji RS, 2010, HEMATOL ONCOL CLIN N, V24, P377, DOI 10.1016/j.hoc.2010.02.013; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Lindstrom MS, 2010, PLOS ONE, V5, pA116, DOI 10.1371/journal.pone.0009578; Llanos S, 2010, CELL CYCLE, V9, P4005, DOI 10.4161/cc.9.19.13299; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Pellagatti A, 2010, BLOOD, V115, P2721, DOI 10.1182/blood-2009-12-259705; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Sieff CA, 2010, BRIT J HAEMATOL, V148, P611, DOI 10.1111/j.1365-2141.2009.07993.x; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Sun XX, 2010, J BIOL CHEM, V285, P25812, DOI 10.1074/jbc.M109.098442; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Yu GW, 2006, PROTEIN SCI, V15, P384, DOI 10.1110/ps.051927306; Yu WS, 2011, NUCLEIC ACIDS RES, V39, P2234, DOI 10.1093/nar/gkq1117; Zakharov SD, 1998, P NATL ACAD SCI USA, V95, P4282, DOI 10.1073/pnas.95.8.4282; Zeng XY, 1999, MOL CELL BIOL, V19, P3257; Zhang F, 2006, J BIOL CHEM, V281, P30036, DOI 10.1074/jbc.M604674200; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P6544, DOI 10.1093/nar/gkq536; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	62	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38264	38274		10.1074/jbc.M111.277012	http://dx.doi.org/10.1074/jbc.M111.277012			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21903592	Green Published, hybrid			2022-12-25	WOS:000296594200040
J	Liu, X; Zhang, H; Wang, XJ; Li, LF; Su, XD				Liu, Xiang; Zhang, Heng; Wang, Xiao-Jun; Li, Lan-Fen; Su, Xiao-Dong			Get Phases from Arsenic Anomalous Scattering: de novo SAD Phasing of Two Protein Structures Crystallized in Cacodylate Buffer	PLOS ONE			English	Article							HEAVY-ATOM DERIVATIVES; ACTIVE-SITE; MECHANISM; POWER; MAD; P40(PHOX); SIGNAL	The crystal structures of two proteins, a putative pyrazinamidase/nicotinamidase from the dental pathogen Streptococcus mutans (SmPncA) and the human caspase-6 (Casp6), were solved by de novo arsenic single-wavelength anomalous diffraction (As-SAD) phasing method. Arsenic (As), an uncommonly used element in SAD phasing, was covalently introduced into proteins by cacodylic acid, the buffering agent in the crystallization reservoirs. In SmPncA, the only cysteine was bound to dimethylarsinoyl, which is a pentavalent arsenic group (As (V)). This arsenic atom and a protein-bound zinc atom both generated anomalous signals. The predominant contribution, however, was from the As anomalous signals, which were sufficient to phase the SmPncA structure alone. In Casp6, four cysteines were found to bind cacodyl, a trivalent arsenic group (As (III)), in the presence of the reducing agent, dithiothreitol (DTT), and arsenic atoms were the only anomalous scatterers for SAD phasing. Analyses and discussion of these two As-SAD phasing examples and comparison of As with other traditional heavy atoms that generate anomalous signals, together with a few arsenic-based de novo phasing cases reported previously strongly suggest that As is an ideal anomalous scatterer for SAD phasing in protein crystallography.	[Liu, Xiang] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr BIOPIC, Beijing 100871, Peoples R China	Peking University; Peking University	Liu, X (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	xdsu@pku.edu.cn	zhang, heng/E-9997-2012; zhang, heng/O-2665-2013	zhang, heng/0000-0003-1112-7149	National Basic Research Program of China 973 [2011CB911103]; Peking University [2006AA02A317]	National Basic Research Program of China 973(National Basic Research Program of China); Peking University(Peking University)	National Basic Research Program of China 973 (No. 2011CB911103 to XDS), National High Technology, 863 Program (2006AA02A317), and 985 and 211 grants from Peking University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bentley R, 2002, MICROBIOL MOL BIOL R, V66, P250, DOI 10.1128/MMBR.66.2.250-271.2002; Brooks MA, 2009, ACTA CRYSTALLOGR D, V65, P421, DOI 10.1107/S0907444909005484; Chin KH, 2007, PROTEINS, V69, P665, DOI 10.1002/prot.21501; Dauter Miroslawa, 2007, Methods Mol Biol, V364, P149; Dauter Z, 2005, PROG BIOPHYS MOL BIO, V89, P153, DOI 10.1016/j.pbiomolbio.2004.09.004; Dauter Z, 1999, J MOL BIOL, V289, P83, DOI 10.1006/jmbi.1999.2743; Dauter Z, 2002, ACTA CRYSTALLOGR D, V58, P494, DOI 10.1107/S090744490200118X; Dauter Z, 2001, STRUCTURE, V9, pR21, DOI 10.1016/S0969-2126(01)00565-2; Dawson A, 2006, MOL MICROBIOL, V61, P1457, DOI 10.1111/j.1365-2958.2006.05332.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dodson E, 2003, ACTA CRYSTALLOGR D, V59, P1958, DOI 10.1107/S0907444903020936; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fyfe PK, 2009, ANGEW CHEM INT EDIT, V48, P9176, DOI 10.1002/anie.200903407; Girard E, 2003, ACTA CRYSTALLOGR D, V59, P1914, DOI 10.1107/S0907444903020511; Girard E, 2002, ACTA CRYSTALLOGR D, V58, P1, DOI 10.1107/S0907444901016444; Greenwald J, 1999, BIOCHEMISTRY-US, V38, P8892, DOI 10.1021/bi9907173; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HENDRICKSON WA, 1981, NATURE, V290, P107, DOI 10.1038/290107a0; Honbou K, 2007, EMBO J, V26, P1176, DOI 10.1038/sj.emboj.7601561; Honbou K, 2006, ACTA CRYSTALLOGR F, V62, P1018, DOI 10.1107/S1744309106036256; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kenyon EM, 2001, TOXICOLOGY, V160, P227, DOI 10.1016/S0300-483X(00)00458-3; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; MCCALDON P, 1988, PROTEINS, V4, P99, DOI 10.1002/prot.340040204; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Peterson MR, 1996, J SYNCHROTRON RADIAT, V3, P24, DOI 10.1107/S0909049595013288; Ramagopal UA, 2003, ACTA CRYSTALLOGR D, V59, P868, DOI 10.1107/S0907444903005663; Retailleau P, 2003, ACTA CRYSTALLOGR D, V59, P887, DOI 10.1107/S0907444903003512; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shepard W, 1998, STRUCT FOLD DES, V6, P849, DOI 10.1016/S0969-2126(98)00087-2; Silvaggi NR, 2007, J AM CHEM SOC, V129, P7114, DOI 10.1021/ja070481n; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; TSAO DHH, 1991, BIOCHEMISTRY-US, V30, P4565, DOI 10.1021/bi00232a029; Walden H, 2010, ACTA CRYSTALLOGR D, V66, P352, DOI 10.1107/S0907444909038207; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Wang XJ, 2010, EMBO REP, V11, P841, DOI 10.1038/embor.2010.141; WHITFORD D, 2005, AMINO ACID BUILDING, P19; Zwart PH, 2005, CCP4 NEWSLETTER, V43	43	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24227	10.1371/journal.pone.0024227	http://dx.doi.org/10.1371/journal.pone.0024227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912678	Green Published, Green Submitted, gold			2022-12-25	WOS:000294686100025
J	Satyanarayana, S; Nair, SA; Chadha, SS; Shivashankar, R; Sharma, G; Yadav, S; Mohanty, S; Kamineni, V; Wilson, NC; Harries, AD; Dewan, PK				Satyanarayana, Srinath; Nair, Sreenivas Achutan; Chadha, Sarabjit Singh; Shivashankar, Roopa; Sharma, Geetanjali; Yadav, Subhash; Mohanty, Subrat; Kamineni, Vishnuvardhan; Wilson, Nevin Charles; Harries, Anthony David; Dewan, Puneet Kumar			From Where Are Tuberculosis Patients Accessing Treatment in India? Results from a Cross-Sectional Community Based Survey of 30 Districts	PLOS ONE			English	Article							CARE	Background: Tuberculosis (TB) notification in India by the Revised National TB Control Programme (RNTCP) provides information on TB patients registered for treatment from the programme. There is limited information about the proportion of patients treated for TB outside RNTCP and where these patients access their treatment. Objectives: To estimate the proportion of patients accessing TB treatment outside the RNTCP and to identify their basic demographic characteristics. Methods: A cross sectional community-based survey in 30 districts. Patients were identified through a door-to-door survey and interviewed using a semi-structured questionnaire. Results: Of the estimated 75,000 households enumerated, 73,249 households (97.6%) were visited. Of the 371,174 household members, 761 TB patients were identified (similar to 205 cases per 100,000 populations). Data were collected from 609 (80%) TB patients of which 331 [54% (95% CI: 42-66%)] were determined to be taking treatment 'under DOTS/RNTCP'. The remaining 278 [46% (95% CI: 34-57%)] were on treatment from 'outside DOTS/RNTCP' sources and hence were unlikely to be part of the TB notification system. Patients who were accessing treatment from 'outside DOTS/RNTCP' were more likely to be patients from rural areas [adjusted Odds Ratio (aOR) 2.5, 95% CI (1.2-5.3)] and whose TB was diagnosed in a non-government health facility (aOR 14.0, 95% CI 7.9-24.9). Conclusions: This community-based survey found that nearly half of self-reported TB patients were missed by TB notification system in these districts. The study highlights the need for 1) Reviewing and revising the scope of the TB notification system, 2) Strengthening and monitoring health care delivery systems with periodic assessment of the reach and utilisation of the RNTCP services especially among rural communities, 3) Advocacy, communication and social mobilisation activities focused at rural communities with low household incomes and 4) Inclusive involvement of all health-care providers, especially providers of poor rural communities.	[Satyanarayana, Srinath; Nair, Sreenivas Achutan; Chadha, Sarabjit Singh; Sharma, Geetanjali; Yadav, Subhash; Mohanty, Subrat; Kamineni, Vishnuvardhan; Wilson, Nevin Charles] The Union, Int Union TB & Lung Dis, SE Asia Reg Off, New Delhi, India; [Satyanarayana, Srinath; Harries, Anthony David] The Union, Ctr Operat Res, Paris, France; [Shivashankar, Roopa] CCDC, New Delhi, India; [Harries, Anthony David] London Sch Hyg & Trop Med, London WC1, England; [Dewan, Puneet Kumar] WHO, India Country Off, New Delhi, India	University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Satyanarayana, S (corresponding author), The Union, Int Union TB & Lung Dis, SE Asia Reg Off, New Delhi, India.	ssrinath@theunion.org	yadav, subhash/AAD-1512-2019	yadav, subhash/0000-0002-6297-544X; Nair, Sreenivas/0000-0002-2586-6797; Satyanarayana, Srinath/0000-0002-5420-2551; Wilson, Nevin/0000-0002-0191-8855	Global Fund Round 9 India TB Project; International Union Against Tuberculosis and Lung Disease, South-East Asia Regional Office; Global Fund Grant	Global Fund Round 9 India TB Project; International Union Against Tuberculosis and Lung Disease, South-East Asia Regional Office; Global Fund Grant	This study was conducted as a part of the baseline survey for the advocacy, communications and social mobilization activities under the Global Fund Round 9 India TB Project. The funds for this study were provided by The International Union Against Tuberculosis and Lung Disease, South-East Asia Regional Office, from the Global Fund Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*CENTR TUB DIV, 2010, UN ACC TB CAR PRACT; *CENTR TUB DIV, 2011, TUB IND ANN REP REV; Central Tuberculosis Division, 2005, TECHN OP GUID TUB CO; Charles N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012379; Dewan PK, 2006, BMJ-BRIT MED J, V332, P574, DOI 10.1136/bmj.38738.473252.7C; Hazarika I, 2011, J GLOB INFECT DIS, V3, P19, DOI 10.4103/0974-777X.77291; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; IIPS, 2007, IND NAT FAM HLTH SUR, V1; Jaggarajamma K, 2009, Indian J Tuberc, V56, P185; Lal SS, 2011, INT J TUBERC LUNG D, V15, P97; Ministry of Health and Family Welfare, 2002, NAT HLTH POL; Pinto LM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-357; *PRIC WAT COOP, 2007, HLTH CARE IND EM MAR; Sachdeva KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022061; Selvam JM, 2007, INT J TUBERC LUNG D, V11, P161; Singh V, 2002, TROP MED INT HEALTH, V7, P693, DOI 10.1046/j.1365-3156.2002.00909.x; [Stop TB Partnership World Health Organization], 2006, GLOB PLAN STOP TB 20; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; UN Statistics Division, 2011, MILL DEV GOALS IND; Vandan N, 2009, PUBLIC HEALTH, V123, P484, DOI 10.1016/j.puhe.2009.05.004; Vandan Nimisha, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P1072; Wells WA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018964; *WHO, 2005, ADDR POV TUB CONTR O; *WHO, 2010, WHO REP GLOB TUB; *WHO, 2009, 2 STOP TB WHO	25	98	98	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24160	10.1371/journal.pone.0024160	http://dx.doi.org/10.1371/journal.pone.0024160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912669	Green Published, Green Submitted, gold			2022-12-25	WOS:000294686100016
J	Ying, MY; Huang, XT; Zhao, HJ; Wu, YH; Wan, FS; Huang, CH; Jie, KM				Ying, Muying; Huang, Xiaotian; Zhao, Haijun; Wu, Yuehao; Wan, Fusheng; Huang, Chunhong; Jie, Kemin			Comprehensively Surveying Structure and Function of RING Domains from Drosophila melanogaster	PLOS ONE			English	Article							E3 UBIQUITIN LIGASES; NITRIC-OXIDE; U-BOX; CONJUGATING ENZYMES; PROTEIN-SEQUENCE; IN-VIVO; FINGER; COMPLEX; P53; FAMILY	Using a complete set of RING domains from Drosophila melanogaster, all the solved RING domains and cocrystal structures of RING-containing ubiquitin-ligases (RING-E3) and ubiquitin-conjugating enzyme (E2) pairs, we analyzed RING domains structures from their primary to quarternary structures. The results showed that: i) putative orthologs of RING domains between Drosophila melanogaster and the human largely occur (118/139, 84.9%); ii) of the 118 orthologous pairs from Drosophila melanogaster and the human, 117 pairs (117/118, 99.2%) were found to retain entirely uniform domain architectures, only Iap2/Diap2 experienced evolutionary expansion of domain architecture; iii) 4 evolutionary structurally conserved regions (SCRs) are responsible for homologous folding of RING domains at the superfamily level; iv) besides the conserved Cys/His chelating zinc ions, 6 equivalent residues (4 hydrophobic and 2 polar residues) in the SCRs possess good-consensus and conservation-these 4 SCRs function in the structural positioning of 6 equivalent residues as determinants for RING-E3 catalysis; v) members of these RING proteins located nucleus, multiple subcellular compartments, membrane protein and mitochondrion are respectively 42 (42/139, 30.2%), 71 (71/139, 51.1%), 22 (22/139, 15.8%) and 4 (4/139, 2.9%); vi) CG15104 (Topors) and CG1134 (Mul1) in C3HC4, and CG3929 (Deltex) in C3H2C3 seem to display broader E2s binding profiles than other RING-E3s; vii) analyzing intermolecular interfaces of E2/RING-E3 complexes indicate that residues directly interacting with E2s are all from the SCRs in RING domains. Of the 6 residues, 2 hydrophobic ones contribute to constructing the conserved hydrophobic core, while the 2 hydrophobic and 2 polar residues directly participate in E2/RING-E3 interactions. Based on sequence and structural data, SCRs, conserved equivalent residues and features of intermolecular interfaces were extracted, highlighting the presence of a nucleus for RING domain fold and formation of catalytic core in which related residues and regions exhibit preferential evolutionary conservation.	[Ying, Muying; Wan, Fusheng; Huang, Chunhong; Jie, Kemin] Nanchang Univ, Dept Mol Biol & Biochem, Basic Med Coll, Nanchang, Peoples R China; [Huang, Xiaotian] Nanchang Univ, Dept Med Microbiol, Basic Med Coll, Nanchang, Peoples R China; [Zhao, Haijun] Southeast Univ, Dept Gynecol & Obstet, ZhongDa Hosp, Nanjing, Peoples R China; [Wu, Yuehao] Acad Agr Sci Jiangxi, Nanchang, Peoples R China	Nanchang University; Nanchang University; Southeast University - China	Ying, MY (corresponding author), Nanchang Univ, Dept Mol Biol & Biochem, Basic Med Coll, Nanchang, Peoples R China.	yingmuying@ncu.edu.cn	Ying, Muying/V-7902-2019	Ying, Muying/0000-0002-3600-5060	National Natural Science Foundation of China [30660010]; Science and Technology Foundation of Jiangxi Province; Science and Technology Foundation of the Education Department of Jiangxi Province [323]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province); Science and Technology Foundation of the Education Department of Jiangxi Province	This work was supported by the National Natural Science Foundation of China (No. 30660010), the Science and Technology Foundation of Jiangxi Province (2008) and the Science and Technology Foundation of the Education Department of Jiangxi Province 323, (2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Nabi AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012464; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Aravind L, 2000, CURR BIOL, V10, pR132, DOI 10.1016/S0960-9822(00)00398-5; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; ASSEMAT K, 1995, PROTEIN SCI, V4, P2510, DOI 10.1002/pro.5560041207; Bocock JP, 2010, TRAFFIC, V11, P756, DOI 10.1111/j.1600-0854.2010.01060.x; Carbone A, 2008, ONCOLOGIST, V13, P577, DOI 10.1634/theoncologist.2008-0036; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105; Chang TS, 2004, FREE RADICAL BIO MED, V37, P521, DOI 10.1016/j.freeradbiomed.2004.05.006; Chen DS, 2009, DEVELOPMENT, V136, P4133, DOI 10.1242/dev.039032; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Dominguez C, 2004, STRUCTURE, V12, P633, DOI 10.1016/j.str.2004.03.004; Dreyer J, 2004, J NEUROSCI, V24, P10454, DOI 10.1523/JNEUROSCI.2265-04.2004; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Duprez E, 1999, J CELL SCI, V112, P381; Engelen S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000267; Espinosa A, 2008, EXP CELL RES, V314, P3605, DOI 10.1016/j.yexcr.2008.09.011; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hasegawa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013590; Hill EE, 2002, J MOL BIOL, V322, P205, DOI 10.1016/S0022-2836(02)00653-8; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Huang Y, 2000, BIOCHEM BIOPH RES CO, V270, P717, DOI 10.1006/bbrc.2000.2510; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Jain AK, 2009, CELL CYCLE, V8, P3668, DOI 10.4161/cc.8.22.9979; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Konagurthu AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010048; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; LESPINET O, 2002, ROLE LINEAGE SPECIFI, P1048; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Liao W, 2008, CURR BIOL, V18, P641, DOI 10.1016/j.cub.2008.04.017; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Marteijn JA, 2009, LEUKEMIA, V23, P1480, DOI 10.1038/leu.2009.57; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Mercier P, 2007, PROTEIN SCI, V16, P602, DOI 10.1110/ps.062358007; Minakawa M, 2008, BIOL PHARM BULL, V31, P2223, DOI 10.1248/bpb.31.2223; Natarajan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005898; Nikoh N, 1997, J MOL EVOL, V45, P97, DOI 10.1007/PL00006208; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Omwancha J, 2006, ENDOCRINE, V29, P363, DOI 10.1385/ENDO:29:2:363; Paiardini A, 2004, PROTEIN SCI, V13, P2992, DOI 10.1110/ps.04938104; Pang CNI, 2008, NUCLEIC ACIDS RES, V36, P578, DOI 10.1093/nar/gkm1070; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pringa E, 2001, J BIOL CHEM, V276, P19617, DOI 10.1074/jbc.M100192200; Qu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001085; Rajendra R, 2004, J BIOL CHEM, V279, P36440, DOI 10.1074/jbc.C400300200; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salonen J, 2009, MOL CELL ENDOCRINOL, V307, P205, DOI 10.1016/j.mce.2009.03.015; Santonico E, 2010, ONCOGENE, V29, P5604, DOI 10.1038/onc.2010.294; Seeberger LC, 2009, EXPERT REV NEUROTHER, V9, P929, DOI [10.1586/ern.09.64, 10.1586/ERN.09.64]; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Soundararajan V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009391; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Su ZX, 2006, GENOME RES, V16, P182, DOI 10.1101/gr.4197006; Sughra K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012683; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Sun Y, 2003, CANCER BIOL THER, V2, P623; Suzuki A, 2008, CANCER SCI, V99, P986, DOI 10.1111/j.1349-7006.2008.00779.x; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; Vander Kooi CW, 2006, BIOCHEMISTRY-US, V45, P121, DOI 10.1021/bi051787e; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wang HL, 2011, CELL RES, V21, P700, DOI 10.1038/cr.2011.44; Wang W, 2005, GENOME RES, V15, P1258, DOI 10.1101/gr.3929705; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Wei Dongping, 2010, Genes Cancer, V1, P700, DOI 10.1177/1947601910382776; Winkler GS, 2004, J MOL BIOL, V337, P157, DOI 10.1016/j.jmb.2004.01.031; Xia LX, 2010, CELL, V143, P978, DOI 10.1016/j.cell.2010.11.022; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Yang YL, 2005, CANCER CELL, V7, P547, DOI 10.1016/j.ccr.2005.04.029; YIN Q, 2009, NAT STRUCT IN PRESS; Ying MY, 2009, GENE, V447, P72, DOI 10.1016/j.gene.2009.07.021; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zhou Y, 2008, CELL SIGNAL, V20, P942, DOI 10.1016/j.cellsig.2008.01.010	88	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e23863	10.1371/journal.pone.0023863	http://dx.doi.org/10.1371/journal.pone.0023863			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912646	Green Published, gold, Green Submitted			2022-12-25	WOS:000294686100006
J	Serviddio, G; Giudetti, AM; Bellanti, F; Priore, P; Rollo, T; Tamborra, R; Siculella, L; Vendemiale, G; Altomare, E; Gnoni, GV				Serviddio, Gaetano; Giudetti, Anna M.; Bellanti, Francesco; Priore, Paola; Rollo, Tiziana; Tamborra, Rosanna; Siculella, Luisa; Vendemiale, Gianluigi; Altomare, Emanuele; Gnoni, Gabriele V.			Oxidation of Hepatic Carnitine Palmitoyl Transferase-I (CPT-I) Impairs Fatty Acid Beta-Oxidation in Rats Fed a Methionine-Choline Deficient Diet	PLOS ONE			English	Article							HUMAN NONALCOHOLIC STEATOHEPATITIS; CONJUGATED LINOLEIC ACIDS; LIVER-DISEASE; INSULIN-RESISTANCE; MITOCHONDRIAL DYSFUNCTION; RESPIRATORY-CHAIN; GENE-EXPRESSION; ATP HOMEOSTASIS; MODEL; METABOLISM	There is growing evidence that mitochondrial dysfunction, and more specifically fatty acid beta-oxidationimpairment, is involved in the pathophysiology of non-alcoholic steatohepatitis (NASH). The goal of the present study was to achieve more understanding on the modification/s of carnitinepalmitoyltransferase-I (CPT-I), the rate-limiting enzyme of the mitochondrial fatty acid beta-oxidation, duringsteatohepatitis. A high fat/methionine-choline deficient (MCD) diet, administered for 4 weeks, was used to induce NASH in rats. We demonstrated that CPT-lactivitydecreased, to the same extent, both in isolated liver mitochondria and in digitonin-permeabilized hepatocytes from MCD-diet fed rats. At the same time, the rate of total fatty acid oxidation to CO2 and ketone bodies, measured in isolated hepatocytes, was significantly lowered in treated animalswhen compared to controls. Finally, an increase in CPT-I mRNA abundance and protein content, together with a high level of CPT-I protein oxidation was observed in treated rats. A posttranslational modification of rat CPT-I during steatohepatitishas been here discussed.	[Serviddio, Gaetano; Bellanti, Francesco; Rollo, Tiziana; Tamborra, Rosanna; Vendemiale, Gianluigi; Altomare, Emanuele] Univ Foggia, Ctr Study Liver Dis, Inst Internal Med, Dept Med & Occupat Sci, Foggia, Italy; [Giudetti, Anna M.; Priore, Paola; Siculella, Luisa; Gnoni, Gabriele V.] Univ Salento, Lab Biochem & Mol Biol, Dept Biol & Environm Sci & Technol, Lecce, Italy; [Vendemiale, Gianluigi] IRCCS Casa Sollievo Sofferenza, Foggia, Italy	University of Foggia; University of Salento; IRCCS Casa Sollievo Della Sofferenza	Serviddio, G (corresponding author), Univ Foggia, Ctr Study Liver Dis, Inst Internal Med, Dept Med & Occupat Sci, Foggia, Italy.	gabriele.gnoni@unisalento.it	Giudetti, Anna Maria/ABF-4049-2021; serviddio, gaetano/C-7629-2011	serviddio, gaetano/0000-0002-6424-7841; Siculella, Luisa/0000-0002-6890-3674; BELLANTI, Francesco/0000-0002-8196-7373; GIUDETTI, ANNA MARIA/0000-0002-9204-040X	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) FUNDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; Caldwell SH, 1999, J HEPATOL, V31, P430, DOI 10.1016/S0168-8278(99)80033-6; Cong WN, 2008, LIFE SCI, V82, P983, DOI 10.1016/j.lfs.2008.01.022; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; Day CP, 2002, BEST PRACT RES CL GA, V16, P663, DOI 10.1053/bega.2002.0333; Dey A, 2007, HEPATOLOGY, V45, P1355, DOI 10.1002/hep.21603; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; Fromenty B, 2004, DIABETES METAB, V30, P121, DOI 10.1016/S1262-3636(07)70098-8; Geelen MJH, 2005, ANAL BIOCHEM, V347, P1, DOI 10.1016/j.ab.2005.03.032; GHOSHAL AK, 1993, LAB INVEST, V68, P255; Giudetti AM, 2005, EUR J NUTR, V44, P33, DOI 10.1007/s00394-004-0489-8; Giudetti AM, 2003, J LIPID RES, V44, P2135, DOI 10.1194/jlr.M300237-JLR200; Giudetti AM, 2006, BBA-MOL CELL BIOL L, V1761, P484, DOI 10.1016/j.bbalip.2006.03.021; Grattagliano I, 2008, EUR J CLIN INVEST, V38, P523, DOI 10.1111/j.1365-2362.2008.01963.x; Kashfi K, 2011, BIOCHEM SOC T, V39, P833, DOI 10.1042/BST0390833; Kohjima M, 2007, INT J MOL MED, V20, P351; Leclercq IA, 2007, LAB INVEST, V87, P56, DOI 10.1038/labinvest.3700489; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Merrill GF, 1998, J APPL PHYSIOL, V85, P1909, DOI 10.1152/jappl.1998.85.5.1909; Nakamuta M, 2005, INT J MOL MED, V16, P631; Namikawa C, 2004, J HEPATOL, V40, P781, DOI 10.1016/j.jhep.2004.01.028; Otogawa K, 2007, AM J PATHOL, V170, P967, DOI 10.2353/ajpath.2007.060441; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Poli G, 2008, MOL ASPECTS MED, V29, P67, DOI 10.1016/j.mam.2007.09.016; Priore P, 2007, BBA-MOL CELL BIOL L, V1771, P1299, DOI 10.1016/j.bbalip.2007.08.005; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Serviddio G, 2008, GUT, V57, P957, DOI 10.1136/gut.2007.147496; Serviddio G, 2008, EUR J CLIN INVEST, V38, P245, DOI 10.1111/j.1365-2362.2008.01936.x; Serviddio G, 2006, J HEPATOL, V44, pS263, DOI 10.1016/S0168-8278(06)80716-6; Serviddio G, 2008, MOL ASPECTS MED, V29, P22, DOI 10.1016/j.mam.2007.09.014; SLATER TF, 1984, BIOCHEM J, V222, P1; TERAMOTO K, 1993, TRANSPLANTATION, V55, P737, DOI 10.1097/00007890-199304000-00010; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P4544, DOI 10.1073/pnas.89.10.4544	36	87	88	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24084	10.1371/journal.pone.0024084	http://dx.doi.org/10.1371/journal.pone.0024084			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909411	gold, Green Published, Green Submitted			2022-12-25	WOS:000294683900027
J	Kanji, A; Hasan, Z; Tanveer, M; Mahboob, R; Jafri, S; Hasan, R				Kanji, Akbar; Hasan, Zahra; Tanveer, Mehnaz; Mahboob, Raunaq; Jafri, Sana; Hasan, Rumina			Presence of RD149 Deletions in M. tuberculosis Central Asian Strain1 Isolates Affect Growth and TNF alpha Induction in THP-1 Monocytes	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; HUMAN MACROPHAGES; PULMONARY TUBERCULOSIS; GRANULOMA-FORMATION; DISEASE SEVERITY; GENE-EXPRESSION; INFECTION; MICE; APOPTOSIS; CYTOKINE	Central Asian Strain 1 (CAS1) is the prevalent Mycobacterium tuberculosis genogroup in South Asia. CAS1 strains carry deletions in RD149 and RD152 regions. Significance of these deletions is as yet unknown. We compared CAS1 strains with RD149 and concurrent RD149-RD152 deletions with CAS1 strains without deletions and with the laboratory reference strain, M. tuberculosis H37Rv for growth and for induction of TNF alpha, IL6, CCL2 and IL10 in THP-1 cells. Growth of CAS1 strains with deletions was slower in broth (RD149; p = 0.024 and RD149-RD152; p = 0.025) than that of strains without deletions. CAS1 strains with RD149 deletion strains further showed reduced intracellular growth (p = 0.013) in THP-1 cells as compared with strains without deletions, and also as compared with H37Rv (p = 0.007) and with CAS1 RD149-RD152 deletion strains (p = 0.029). All CAS1 strains induced higher levels of TNFa and IL10 secretion in THP-1 cells than H37Rv. Additionally, CAS1 strains with RD149 deletions induced more TNF alpha secretion than those without deletions (p = 0.013). CAS1 RD149 deletion strains from extrapulmonary sources showed more rapid growth and induced lower levels of TNF alpha and IL6 secretion in THP-1 cells than isolates from pulmonary sources. This data suggests that presence of RD149 reduces growth and increases the induction of TNF alpha in host cells by CAS1 strains. Differences observed for extrapulmonary strains may indicate an adaptation which increases potential for dissemination and tropism outside the lung. Overall, we hypothesise that RD149 deletions generate genetic diversity within strains and impact interactions of CAS1 strains with host cells with important clinical consequences.	[Kanji, Akbar; Hasan, Zahra; Tanveer, Mehnaz; Mahboob, Raunaq; Jafri, Sana; Hasan, Rumina] Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan	Aga Khan University	Kanji, A (corresponding author), Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan.	rumina.hasan@aku.edu	Hasan, Zahra/AAF-2191-2020; Hasan, Zahra/F-5111-2015; Hasan, Rumina/F-4420-2015	Hasan, Zahra/0000-0001-7580-372X; 	University Research Council; Aga Khan University, Karachi, Pakistan; Bennenden Healthcare Society, UK; HEC/MoST/USAID; Juma Research Laboratories, of the Aga Khan University Hospital, Karachi	University Research Council; Aga Khan University, Karachi, Pakistan; Bennenden Healthcare Society, UK; HEC/MoST/USAID(United States Agency for International Development (USAID)); Juma Research Laboratories, of the Aga Khan University Hospital, Karachi	This study was supported by a University Research Council grant, The Aga Khan University, Karachi, Pakistan; partly by the Bennenden Healthcare Society, UK and in part through a grant from the Joint Pakistan-US Academic and Research Program HEC/MoST/USAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. Rabia Hussain from Department of Pathology and Microbiology, AKU, Pakistan for advice at the initial stage of this work, Mr. Iqbal Azam, Community Health Sciences, AKU, and Pakistan for statistical support. We thank the faculty and staff of the Clinical Microbiology, especially Mr. Tanveer Ahsan, Mr. Khalid Wahab, Ms. Muniba Islam and Ms. Mussarat Ashraf and Juma Research Laboratories, of the Aga Khan University Hospital, Karachi for their support in this study.	Aarestrup FM, 2000, INT J LEPROSY, V68, P156; Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; Banu S, 2004, J CLIN MICROBIOL, V42, P674, DOI 10.1128/JCM.42.2.674-682.2004; Bean AGD, 1999, J IMMUNOL, V162, P3504; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; Constant P, 2002, J BIOL CHEM, V277, P38148, DOI 10.1074/jbc.M206538200; Espitia C, 1999, MICROBIOL-UK, V145, P3487, DOI 10.1099/00221287-145-12-3487; Garcia de Viedma D, 2005, J INFECT DIS, V192, P2059, DOI 10.1086/498245; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Goyal M, 1997, J CLIN MICROBIOL, V35, P647, DOI 10.1128/JCM.35.3.647-651.1997; Hasan Z, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-78; Hasan Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008459; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; IDIGORAS P, 1995, EUR J CLIN MICROBIOL, V14, P6, DOI 10.1007/BF02112611; Jamil B, 2007, TUBERCULOSIS, V87, P279, DOI 10.1016/j.tube.2007.03.004; Janulionis E, 2005, INFECT IMMUN, V73, P2595, DOI 10.1128/IAI.73.5.2595-2601.2005; Kanji A, 2011, J INFECT DEV COUNTR, V5, P106, DOI 10.3855/jidc.1112; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kipnis A, 2003, IMMUNOLOGY, V109, P547, DOI 10.1046/j.1365-2567.2003.01680.x; Lasunskaia E, 2010, MICROBES INFECT, V12, P467, DOI 10.1016/j.micinf.2010.02.008; Manca C, 1999, J IMMUNOL, V162, P6740; Monahan IM, 2001, MICROBIOL-SGM, V147, P459, DOI 10.1099/00221287-147-2-459; Mootoo Amanda, 2009, Inflammation & Allergy Drug Targets, V8, P53; Murray PJ, 1999, INFECT IMMUN, V67, P3087, DOI 10.1128/IAI.67.6.3087-3095.1999; Newton SM, 2006, P NATL ACAD SCI USA, V103, P15594, DOI 10.1073/pnas.0604283103; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; REDDY MV, 1994, TUBERCLE LUNG DIS, V75, P127, DOI 10.1016/0962-8479(94)90041-8; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Russell DG, 2011, IMMUNOL REV, V240, P252, DOI 10.1111/j.1600-065X.2010.00984.x; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Sola C, 2001, EMERG INFECT DIS, V7, P390; Tanveer M, 2009, T ROY SOC TROP MED H, V103, P581, DOI 10.1016/j.trstmh.2009.03.014; Tanveer M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-171; Them S, 2007, INT J TUBERC LUNG D, V11, P1087; Theus SA, 2005, J INFECT DIS, V191, P453, DOI 10.1086/425936; Theus SA, 2004, INFECT IMMUN, V72, P1169, DOI 10.1128/IAI.72.2.1169-1173.2004; Thwaites G, 2008, J CLIN MICROBIOL, V46, P1363, DOI 10.1128/JCM.02180-07; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Warren RM, 2000, MOL MICROBIOL, V37, P1405, DOI 10.1046/j.1365-2958.2000.02090.x; Wong KC, 2007, CLIN VACCINE IMMUNOL, V14, P1279, DOI 10.1128/CVI.00190-07; Yang ZH, 2005, AM J RESP CRIT CARE, V171, P1436, DOI 10.1164/rccm.200408-1147OC; Zhang M, 1999, J INFECT DIS, V179, P1213, DOI 10.1086/314738	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24178	10.1371/journal.pone.0024178	http://dx.doi.org/10.1371/journal.pone.0024178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904612	gold, Green Submitted, Green Published			2022-12-25	WOS:000294680800062
J	Vandenbroucke, V; Croubels, S; Martel, A; Verbrugghe, E; Goossens, J; Van Deun, K; Boyen, F; Thompson, A; Shearer, N; De Backer, P; Haesebrouck, F; Pasmans, F				Vandenbroucke, Virginie; Croubels, Siska; Martel, An; Verbrugghe, Elin; Goossens, Joline; Van Deun, Kim; Boyen, Filip; Thompson, Arthur; Shearer, Neil; De Backer, Patrick; Haesebrouck, Freddy; Pasmans, Frank			The Mycotoxin Deoxynivalenol Potentiates Intestinal Inflammation by Salmonella Typhimurium in Porcine Ileal Loops	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; CELL LINES IPEC-1; IN-VITRO; FUNCTIONAL-ANALYSIS; EPITHELIAL-CELLS; T-2 TOXIN; EXPRESSION; CACO-2; FOOD; PIGS	Background and Aims: Both deoxynivalenol (DON) and nontyphoidal salmonellosis are emerging threats with possible hazardous effects on both human and animal health. The objective of this study was to examine whether DON at low but relevant concentrations interacts with the intestinal inflammation induced by Salmonella Typhimurium. Methodology: By using a porcine intestinal ileal loop model, we investigated whether intake of low concentrations of DON interacts with the early intestinal inflammatory response induced by Salmonella Typhimurium. Results: A significant higher expression of IL-12 and TNF alpha and a clear potentiation of the expression of IL-1 beta, IL-8, MCP-1 and IL-6 was seen in loops co-exposed to 1 mu g/mL of DON and Salmonella Typhimurium compared to loops exposed to Salmonella Typhimurium alone. This potentiation coincided with a significantly enhanced Salmonella invasion in and translocation over the intestinal epithelial IPEC-J2 cells, exposed to non-cytotoxic concentrations of DON for 24 h. Exposure of Salmonella Typhimurium to 0.250 mu g/mL of DON affected the bacterial gene expression level of a limited number of genes, however none of these expression changes seemed to give an explanation for the increased invasion and translocation of Salmonella Typhimurium and the potentiated inflammatory response in combination with DON. Conclusion: These data imply that the intake of low and relevant concentrations of DON renders the intestinal epithelium more susceptible to Salmonella Typhimurium with a subsequent potentiation of the inflammatory response in the gut.	[Vandenbroucke, Virginie; Croubels, Siska; Goossens, Joline; De Backer, Patrick] Univ Ghent, Fac Vet Med, Dept Pharmacol Toxicol & Biochem, Merelbeke, Belgium; [Martel, An; Verbrugghe, Elin; Van Deun, Kim; Boyen, Filip; Haesebrouck, Freddy; Pasmans, Frank] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Thompson, Arthur; Shearer, Neil] Inst Food Res, Norwich, Norfolk, England	Ghent University; Ghent University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Vandenbroucke, V (corresponding author), Univ Ghent, Fac Vet Med, Dept Pharmacol Toxicol & Biochem, Merelbeke, Belgium.	Virginie.vandenbroucke@ugent.be	Haesebrouck, Freddy/M-3857-2014; Vandenbroucke, Virginie/F-6106-2011; Pasmans, Frank/D-3667-2014; Martel, An/D-3713-2014; Boyen, Filip/AAF-6109-2020	Haesebrouck, Freddy/0000-0002-1709-933X; Boyen, Filip/0000-0002-4777-6880; Croubels, Siska/0000-0001-6357-3517	Institute for the Promotion of Innovation in Science Technology in Flanders (IWT Flanders), Brussels, Belgium [070574]; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044404] Funding Source: researchfish; BBSRC [BBS/E/F/00044404] Funding Source: UKRI	Institute for the Promotion of Innovation in Science Technology in Flanders (IWT Flanders), Brussels, Belgium(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Institute for the Promotion of Innovation in Science Technology in Flanders (IWT Flanders), Brussels, Belgium (project 070574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond GW, 1996, VET CLIN N AM-FOOD A, V12, P707, DOI 10.1016/S0749-0720(15)30394-7; [Anonymous], 2006, OFFICIAL J EUROPEAN; [Anonymous], 2004, EUROSURVEILLANCE MON, V9; Blanc-Potard AB, 1999, J BACTERIOL, V181, P998, DOI 10.1128/JB.181.3.998-1004.1999; Bohm J, 1992, Arch Tierernahr, V42, P95; Bony S, 2006, TOXICOL LETT, V166, P67, DOI 10.1016/j.toxlet.2006.04.010; Bottalico A, 2002, EUR J PLANT PATHOL, V108, P611, DOI 10.1023/A:1020635214971; Bouhet S, 2005, VET IMMUNOL IMMUNOP, V108, P199, DOI 10.1016/j.vetimm.2005.08.010; Boyen F, 2009, LAB ANIM-UK, V43, P46, DOI 10.1258/la.2007.007084; Boyen F, 2008, VET MICROBIOL, V130, P1, DOI 10.1016/j.vetmic.2007.12.017; Centers for Disease Control and Prevention (CDC), 2009, MMWR-MORBID MORTAL W, V59, P418; Danicke S, 2010, FOOD CHEM TOXICOL, V48, P2154, DOI 10.1016/j.fct.2010.05.022; De Walle JV, 2008, TOXICOL LETT, V177, P205, DOI 10.1016/j.toxlet.2008.01.018; Diesing AK, 2011, TOXICOL LETT, V200, P8, DOI 10.1016/j.toxlet.2010.10.006; Donne E, 2005, VET MICROBIOL, V107, P205, DOI 10.1016/j.vetmic.2005.01.027; Doyle E, 2009, WHITE PAPER HUMAN IL; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gonzalez-Osnaya L, 2011, FOOD CHEM, V124, P156, DOI 10.1016/j.foodchem.2010.06.002; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Higashide W, 2002, CELL MICROBIOL, V4, P357, DOI 10.1046/j.1462-5822.2002.00196.x; Jess T, 2011, GUT, V60, P318, DOI 10.1136/gut.2010.223396; Kasuga F, 1998, MYCOPATHOLOGIA, V142, P161, DOI 10.1023/A:1006923808748; Kolf-Clauw M, 2009, TOXICOL IN VITRO, V23, P1580, DOI 10.1016/j.tiv.2009.07.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundberg U, 1999, J BACTERIOL, V181, P3433, DOI 10.1128/JB.181.11.3433-3437.1999; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Maresca M, 2002, J NUTR, V132, P2723, DOI 10.1093/jn/132.9.2723; Maresca M, 2008, TOXICOL APPL PHARM, V228, P84, DOI 10.1016/j.taap.2007.11.013; Maresca M, 2010, TOXICON, V56, P282, DOI 10.1016/j.toxicon.2010.04.016; Mbandi E, 2006, J FOOD PROTECT, V69, P1334, DOI 10.4315/0362-028X-69.6.1334; Nagy G, 2006, INFECT IMMUN, V74, P5914, DOI 10.1128/IAI.00619-06; Niewold TA, 2005, VET IMMUNOL IMMUNOP, V105, P317, DOI 10.1016/j.vetimm.2005.02.010; Obremski K, 2008, POL J VET SCI, V11, P339; Pinton P, 2010, J NUTR, V140, P1956, DOI 10.3945/jn.110.123919; Pinton P, 2009, TOXICOL APPL PHARM, V237, P41, DOI 10.1016/j.taap.2009.03.003; RHOADS JM, 1994, AM J PHYSIOL, V266, pG828, DOI 10.1152/ajpgi.1994.266.5.G828; Rothkotter HJ, 2002, HUM EXP TOXICOL, V21, P533, DOI 10.1191/0960327102ht293oa; Rozen S, 2000, Methods Mol Biol, V132, P365; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Schothorst RC, 2004, TOXICOL LETT, V153, P133, DOI 10.1016/j.toxlet.2004.04.045; Sergent T, 2006, TOXICOL LETT, V164, P167, DOI 10.1016/j.toxlet.2005.12.006; Tukel C, 2006, FEMS IMMUNOL MED MIC, V46, P320, DOI 10.1111/j.1574-695X.2006.00051.x; Turner PC, 2008, ENVIRON HEALTH PERSP, V116, P21, DOI 10.1289/ehp.10663; Van De Walle J, 2010, TOXICOL IN VITRO, V24, P1890, DOI 10.1016/j.tiv.2010.07.008; Van de Walle J, 2010, TOXICOL APPL PHARM, V245, P291, DOI 10.1016/j.taap.2010.03.012; Vandenbroucke V, 2009, VET RES, V40, DOI 10.1051/vetres/2009045; Volf J, 2007, ZOONOSES PUBLIC HLTH, V54, P286, DOI 10.1111/j.1863-2378.2007.01064.x; Volf J, 2010, VET MICROBIOL, V146, P105, DOI 10.1016/j.vetmic.2010.04.031; Wray CWA, 2000, SALMONELLA INFECTION; YOKOSEKI T, 1995, MICROBIOL-SGM, V141, P1715, DOI 10.1099/13500872-141-7-1715	50	76	85	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23871	10.1371/journal.pone.0023871	http://dx.doi.org/10.1371/journal.pone.0023871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909370	Green Submitted, Green Published, gold			2022-12-25	WOS:000294680800032
J	Vera, M; Martinez, P; Poisa-Beiro, L; Figueras, A; Novoa, B				Vera, Manuel; Martinez, Paulino; Poisa-Beiro, Laura; Figueras, Antonio; Novoa, Beatriz			Genomic Organization, Molecular Diversification, and Evolution of Antimicrobial Peptide Myticin-C Genes in the Mussel (Mytilus galloprovincialis)	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; SOMATIC HYPERMUTATION; IMMUNOGLOBULIN GENES; DIVERSITY; DISCOVERY; OYSTER; IDENTIFICATION; RECOMBINATION; RECOGNITION; GENERATION	Myticin-C is a highly variable antimicrobial peptide associated to immune response in Mediterranean mussel (Mytilus galloprovincialis). In this study, we tried to ascertain the genetic organization and the mechanisms underlying myticin-C variation and evolution of this gene family. We took advantage of the large intron size variation to find out the number of myticin-C genes. Using fragment analysis a maximum of four alleles was detected per individual at both introns in a large mussel sample suggesting a minimum of two myticin-C genes. The transmission pattern of size variants in two full-sib families was also used to ascertain the number of myticin-C genes underlying the variability observed. Results in both families were in accordance with two myticin-C genes organized in tandem. A more detailed analysis of myticin-C variation was carried out by sequencing a large sample of complementary (cDNA) and genomic DNA (gDNA) in 10 individuals. Two basic sequences were detected at most individuals and several sequences were constituted by combination of two different basic sequences, strongly suggesting somatic recombination or gene conversion. Slight within-basic sequence variation detected in all individuals was attributed to somatic mutation. Such mutations were more frequently at the C-terminal domain and mostly determined non-synonymous substitutions. The mature peptide domain showed the highest variation both in the whole cDNA and in the basic-sequence samples, which is in accordance with the pathogen recognition function associated to this domain. Although most tests suggested neutrality for myticin-C variation, evidence indicated positive selection in the mature peptide and C-terminal region. Three main highly supported clusters were observed when reconstructing phylogeny on basic sequences, meiotic recombination playing a relevant role on myticin-C evolution. This study demonstrates that mechanisms to generate molecular variation similar to that observed in vertebrates are also operating in molluscs.	[Vera, Manuel; Martinez, Paulino] Univ Santiago de Compostela, Fac Vet, Dept Genet, Lugo, Spain; [Poisa-Beiro, Laura; Figueras, Antonio; Novoa, Beatriz] CSIC, Inst Invest Marinas, Vigo, Spain	Universidade de Santiago de Compostela; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Vera, M (corresponding author), Univ Santiago de Compostela, Fac Vet, Dept Genet, Lugo, Spain.	paulino.martinez@usc.es	Figueras, Antonio/AAB-8921-2019; Figueras, Antonio/B-5133-2015; Gómez, ACUIGEN/ABD-5337-2020; Vera, Manuel/B-7429-2012; Martínez, Paulino/K-8636-2014; Novoa, Beatriz/K-3785-2014	Figueras, Antonio/0000-0002-0617-0030; Figueras, Antonio/0000-0002-0617-0030; Vera, Manuel/0000-0003-1584-6140; Martínez, Paulino/0000-0001-8438-9305; Novoa, Beatriz/0000-0003-4888-8419	Spanish Ministerio de Ciencia e Innovation [AGL2008-05111/ACU]	Spanish Ministerio de Ciencia e Innovation(Spanish Government)	This work has been funded by the project AGL2008-05111/ACU from the Spanish Ministerio de Ciencia e Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; APROMAR, 2010, AC MAR PEC ESP; Balseiro P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023140; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; BRACK C, 1978, CELL, V15, P1, DOI 10.1016/0092-8674(78)90078-8; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Charlet M, 1996, J BIOL CHEM, V271, P21808, DOI 10.1074/jbc.271.36.21808; Costa MM, 2009, DEV COMP IMMUNOL, V33, P162, DOI 10.1016/j.dci.2008.08.005; Diz AP, 2008, MAR BIOL, V154, P277, DOI 10.1007/s00227-008-0921-3; Dorner T, 1998, EUR J IMMUNOL, V28, P3384; Du Pasquier L, 2006, IMMUNOL LETT, V104, P2, DOI 10.1016/j.imlet.2005.11.022; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; Gestal C, 2007, GENE, V406, P134, DOI 10.1016/j.gene.2007.07.030; Gueguen Y, 2003, GENE, V303, P139, DOI 10.1016/S0378-1119(02)01149-6; Hagger JA, 2008, MAR POLLUT BULL, V56, P1111, DOI 10.1016/j.marpolbul.2008.03.040; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HUDSON RR, 1985, GENETICS, V111, P147; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Janeway C., 2001, IMMUNOBIOLOGY, V5th; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; JONES HD, 1992, J EXP MAR BIOL ECOL, V155, P213, DOI 10.1016/0022-0981(92)90064-H; KOCKS C, 1989, ANNU REV IMMUNOL, V7, P537, DOI 10.1146/annurev.iy.07.040189.002541; Kurata S, 2006, MOL DIVERS, V10, P599, DOI 10.1007/s11030-006-9032-6; Lee WH, 2005, EUR J IMMUNOL, V35, P1220, DOI 10.1002/eji.200425615; Leonard PM, 2001, GENE, V269, P155, DOI 10.1016/S0378-1119(01)00444-9; Li HH, 2002, IMMUNOL REV, V190, P53, DOI 10.1034/j.1600-065X.2002.19005.x; Lubet P., 1959, Revues des Travaux Inst Peches Marit, V23, P387; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; MEYHOFER E, 1985, MAR BIOL, V85, P137, DOI 10.1007/BF00397432; Mitta G, 2000, DEV COMP IMMUNOL, V24, P381, DOI 10.1016/S0145-305X(99)00084-1; Nei M, 1987, MOL EVOLUTIONARY GEN; Norman RS, 1988, J EXP MAR BIOL ECOL, V120, P171; Nylander J. A. A., 2004, MRMODELTEST V2; O'Leary NA, 2006, GENE, V371, P75, DOI 10.1016/j.gene.2005.11.028; Padhi A, 2008, PEPTIDES, V29, P1094, DOI 10.1016/j.peptides.2008.03.007; Pallavicini A, 2008, DEV COMP IMMUNOL, V32, P213, DOI 10.1016/j.dci.2007.05.008; Papavasiliou FN, 2002, CELL, V109, pS35, DOI 10.1016/S0092-8674(02)00706-7; Paul W. E., 2003, FUNDAMENTAL IMMUNOLO, V5th; POTTS WK, 1993, TRENDS GENET, V9, P408, DOI 10.1016/0168-9525(93)90103-O; Prado-Alvarez M, 2009, FISH SHELLFISH IMMUN, V26, P72, DOI 10.1016/j.fsi.2008.03.002; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozen S, 2000, Methods Mol Biol, V132, P365; SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0; Schmitt P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-23; Schulenburg H, 2007, MOL IMMUNOL, V44, P3338, DOI 10.1016/j.molimm.2007.02.019; Song LS, 2006, MAR BIOTECHNOL, V8, P161, DOI 10.1007/s10126-005-0126-4; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanguy A, 2004, GENE, V338, P121, DOI 10.1016/j.gene.2004.05.019; Tanguy A, 2008, GENE, V408, P27, DOI 10.1016/j.gene.2007.10.021; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang LL, 2009, FISH SHELLFISH IMMUN, V26, P744, DOI 10.1016/j.fsi.2009.03.002; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Yamaguchi Y, 2002, J IMMUNOL, V169, P2516, DOI 10.4049/jimmunol.169.5.2516; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069	58	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24041	10.1371/journal.pone.0024041	http://dx.doi.org/10.1371/journal.pone.0024041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904604	Green Submitted, Green Published, gold			2022-12-25	WOS:000294680800050
J	Nowsheen, S; Bonner, JA; LoBuglio, AF; Trummell, H; Whitley, AC; Dobelbower, MC; Yang, ES				Nowsheen, Somaira; Bonner, James A.; LoBuglio, Albert F.; Trummell, Hoa; Whitley, Alexander C.; Dobelbower, Michael C.; Yang, Eddy S.			Cetuximab Augments Cytotoxicity with Poly (ADP-Ribose) Polymerase Inhibition in Head and Neck Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SQUAMOUS-CELL CARCINOMA; DEPENDENT PROTEIN-KINASE; POLY(ADP-RIBOSE) POLYMERASE; HUMAN-PAPILLOMAVIRUS; RADIATION RESPONSE; REPAIR; EGFR; SURVIVAL; THERAPY	Overexpression of the epidermal growth factor receptor (EGFR) is a hallmark of head and neck cancers and confers increased resistance and inferior survival rates. Despite targeted agents against EGFR, such as cetuximab (C225), almost half of treated patients fail this therapy, necessitating novel therapeutic strategies. Poly (ADP-Ribose) polymerase (PARP) inhibitors (PARPi) have gained recent attention due to their unique selectivity in killing tumors with defective DNA repair. In this study, we demonstrate that C225 enhances cytotoxicity with the PARPi ABT-888 in UM-SCC1, UM-SCC6, and FaDu head and neck cancer cells. The mechanism of increased susceptibility to C225 and PARPi involves C225-mediated reduction of non-homologous end-joining (NHEJ)- and homologous recombination (HR)-mediated DNA double strand break (DSB) repair, the subsequent persistence of DNA damage, and activation of the intrinsic apoptotic pathway. By generating a DSB repair deficiency, C225 can render head and neck tumor cells susceptible to PARP inhibition. The combination of C225 and the PARPi ABT-888 can thus be an innovative treatment strategy to potentially improve outcomes in head and neck cancer patients. Furthermore, this strategy may also be feasible for other EGFR overexpressing tumors, including lung and brain cancers.	[Nowsheen, Somaira; Bonner, James A.; Trummell, Hoa; Whitley, Alexander C.; Dobelbower, Michael C.; Yang, Eddy S.] Univ Alabama Birmingham, Med Sch Birmingham, Ctr Comprehens Canc, Dept Radiat Oncol, Birmingham, AL 35233 USA; [Yang, Eddy S.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Yang, Eddy S.] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL USA; [LoBuglio, Albert F.] Univ Alabama Birmingham, Med Sch Birmingham, Ctr Comprehens Canc, Dept Radiat Oncol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Nowsheen, S (corresponding author), Univ Alabama Birmingham, Med Sch Birmingham, Ctr Comprehens Canc, Dept Radiat Oncol, Birmingham, AL 35233 USA.	eyang@uab.edu			University of Alabama at Birmingham School of Medicine; Center for Clinical and Translational Science (CCTS); NIH National Center for Research Resources [5UL1 RR025777-04]; Comprehensive Cancer Center; Department of Radiation Oncology at the University of Alabama at Birmingham School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025777] Funding Source: NIH RePORTER	University of Alabama at Birmingham School of Medicine; Center for Clinical and Translational Science (CCTS); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Comprehensive Cancer Center; Department of Radiation Oncology at the University of Alabama at Birmingham School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the State of Alabama Investment Pool for Action (IMPACT) Award from the University of Alabama at Birmingham School of Medicine, the Center for Clinical and Translational Science (CCTS) and the Council of Center Directors (COCD) Translational Research Intramural Pilot Grant Program (grant number 5UL1 RR025777-04) from the NIH National Center for Research Resources, and developmental support from the Comprehensive Cancer Center and Department of Radiation Oncology at the University of Alabama at Birmingham School of Medicine (to E.S.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JM, 2007, CLIN CANCER RES, V13, P3033, DOI 10.1158/1078-0432.CCR-06-2872; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Ang KK, 2002, CANCER RES, V62, P7350; BAKER SR, 1985, LARYNGOSCOPE, V95, P43; Bandyopadhyay D, 1998, J BIOL CHEM, V273, P1568, DOI 10.1074/jbc.273.3.1568; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Bonner JA, 2000, J CLIN ONCOL, V18, p47S; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Bryant HE, 2006, NUCLEIC ACIDS RES, V34, P1685, DOI 10.1093/nar/gkl108; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chinnaiyan P, 2005, CANCER RES, V65, P3328, DOI 10.1158/0008-5472.CAN-04-3547; Chung CH, 2006, J CLIN ONCOL, V24, P4170, DOI 10.1200/JCO.2006.07.2587; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dittmann K, 2010, FEBS LETT, V584, P3878, DOI 10.1016/j.febslet.2010.08.005; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Efimova EV, 2010, CANCER RES, V70, P6277, DOI 10.1158/0008-5472.CAN-09-4224; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feng ZH, 2004, J BIOL CHEM, V279, P28574, DOI 10.1074/jbc.M404137200; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Golding SE, 2009, CANCER BIOL THER, V8, P730, DOI 10.4161/cbt.8.8.7927; Hegan DC, 2010, P NATL ACAD SCI USA, V107, P2201, DOI 10.1073/pnas.0904783107; Huang SM, 2000, CLIN CANCER RES, V6, P2166; Inbar-Rozensal D, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2445; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kumar B, 2007, INT J RADIAT ONCOL, V69, pS109, DOI 10.1016/j.ijrobp.2007.05.072; Kummar S, 2009, J CLIN ONCOL, V27, P2705, DOI 10.1200/JCO.2008.19.7681; Li LP, 2008, CANCER RES, V68, P9141, DOI 10.1158/0008-5472.CAN-08-1127; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Moyer JD, 1997, CANCER RES, V57, P4838; Niu G, 2010, CLIN CANCER RES, V16, P2095, DOI 10.1158/1078-0432.CCR-09-2495; PANG E, 2010, INT J RAD ONCOL BIOL; RANGAN SRS, 1972, CANCER, V29, P117, DOI 10.1002/1097-0142(197201)29:1<117::AID-CNCR2820290119>3.0.CO;2-R; Rodemann HP, 2007, INT J RADIAT BIOL, V83, P781, DOI 10.1080/09553000701769970; Rottenberg S, 2008, P NATL ACAD SCI USA, V105, P17079, DOI 10.1073/pnas.0806092105; Saleh MN, 1999, CANCER BIOTHER RADIO, V14, P451, DOI 10.1089/cbr.1999.14.451; Sisk EA, 2002, HEAD NECK-J SCI SPEC, V24, P841, DOI 10.1002/hed.10146; TORRES MA, 2010, INVEST NEW DRUGS; Voldborg BR, 1997, ANN ONCOL, V8, P1197, DOI 10.1023/A:1008209720526; Wang H, 2010, CANCER RES, V70, P6258, DOI 10.1158/0008-5472.CAN-09-4713; Yang ES, 2009, J CLIN INVEST, V119, P1124, DOI 10.1172/JCI34051; Zhang YD, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-39	45	50	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24148	10.1371/journal.pone.0024148	http://dx.doi.org/10.1371/journal.pone.0024148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912620	gold, Green Published, Green Submitted			2022-12-25	WOS:000294678300025
J	Thoene-Reineke, C; Rumschussel, K; Schmerbach, K; Krikov, M; Wengenmayer, C; Godes, M; Mueller, S; Villringer, A; Steckelings, U; Namsolleck, P; Unger, T				Thoene-Reineke, Christa; Rumschuessel, Kay; Schmerbach, Kristin; Krikov, Maxim; Wengenmayer, Christina; Godes, Michael; Mueller, Susanne; Villringer, Arno; Steckelings, Ulrike; Namsolleck, Pawel; Unger, Thomas			Prevention and Intervention Studies with Telmisartan, Ramipril and Their Combination in Different Rat Stroke Models	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; ANGIOTENSIN-II; CONVERTING-ENZYME; CARDIOVASCULAR EVENTS; CENTRAL RESPONSES; HIGH-RISK; IN-VITRO; IMPROVES; CANDESARTAN; MORTALITY	Objectives: The effects of AT1 receptor blocker, telmisartan, and the ACE inhibitor, ramipril, were tested head-to head and in combination on stroke prevention in hypertensive rats and on potential neuroprotection in acute cerebral ischemia in normotensive rats. Methods: Prevention study: Stroke-prone spontaneously hypertensive rats (SHR-SP) were subjected to high salt and randomly assigned to 4 groups: (1) untreated (NaCl, n = 24), (2) telmisartan (T; n = 27), (3) ramipril (R; n = 27) and (4) telmisartan +ramipril (T+R; n = 26). Drug doses were selected to keep blood pressure (BP) at 150 mmHg in all groups. Neurological signs and stroke incidence at 50% mortality of untreated SHR-SP were investigated. Intervention study: Normotensive Wistar rats were treated s.c. 5 days prior to middle cerebral artery occlusion (MCAO) for 90 min with reperfusion. Groups (n = 10 each): (1) sham, (2) vehicle (V; 0,9% NaCl), (3) T (0,5 mg/kg once daily), (4) R (0,01 mg/kg twice daily), (5) R (0,1 mg/kg twice daily) or (6) T (0,5 mg/kg once daily) plus R (0,01 mg/kg twice daily). Twenty-four and 48 h after MCAO, neurological outcome (NO) was determined. Forty-eight h after MCAO, infarct volume by MRI, neuronal survival, inflammation factors and neurotrophin receptor (TrkB) were analysed. Results: Stroke incidence was reduced, survival was prolonged and neurological outcome was improved in all treated SHR-SP with no differences between treated groups. In the acute intervention study, T and T+R, but not R alone, improved NO, reduced infarct volume, inflammation (TNF alpha), and induced TrkB receptor and neuronal survival in comparison to V. Conclusions: T, R or T+R had similar beneficial effects on stroke incidence and NO in hypertensive rats, confirming BP reduction as determinant factor in stroke prevention. In contrast, T and T+R provided superior neuroprotection in comparison to R alone in normotensive rats with induced cerebral ischemia.	[Thoene-Reineke, Christa; Rumschuessel, Kay; Schmerbach, Kristin; Krikov, Maxim; Wengenmayer, Christina; Godes, Michael; Steckelings, Ulrike; Namsolleck, Pawel; Unger, Thomas] Charite, CCR, Inst Pharmacol, D-13353 Berlin, Germany; [Thoene-Reineke, Christa] Charite, Forsch Einrichtung Expt Med, D-13353 Berlin, Germany; [Mueller, Susanne] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany; [Villringer, Arno] MPI Kognit & Neurowissensch, Leipzig, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Thoene-Reineke, C (corresponding author), Charite, CCR, Inst Pharmacol, D-13353 Berlin, Germany.	christa.thoene-reineke@charite.de; thomas.unger@charite.de		Steckelings, Ulrike Muscha/0000-0002-5430-4275; Mueller, Susanne/0000-0002-5053-2211; Villringer, Arno/0000-0003-2604-2404	Charite - Universitatsmedizin Berlin; Boehringer Ingelheim Pharma GmbH Co. KG; Boehringer Ingelheim Pharma	Charite - Universitatsmedizin Berlin; Boehringer Ingelheim Pharma GmbH Co. KG(Boehringer Ingelheim); Boehringer Ingelheim Pharma(Boehringer Ingelheim)	This project was financed by grants of the Charite - Universitatsmedizin Berlin and Boehringer Ingelheim Pharma GmbH & Co. KG (Dr. Christine Teutsch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thomas Unger has received research grants from and has been on the speakers' bureau of Boehringer Ingelheim Pharma. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Baker SA, 2005, BRAIN RES, V1039, P177, DOI 10.1016/j.brainres.2005.01.052; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dai WJ, 1999, STROKE, V30, P2391, DOI 10.1161/01.STR.30.11.2391; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Dienert HC, 2008, LANCET NEUROL, V7, P875, DOI 10.1016/S1474-4422(08)70198-4; Faure S, 2006, J HYPERTENS, V24, P2255, DOI 10.1097/01.hjh.0000249704.34607.4c; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gates MA, 2000, NEUROSCIENCE, V98, P437, DOI 10.1016/S0306-4522(00)00106-8; Gohlke P, 2002, J HYPERTENS, V20, P909, DOI 10.1097/00004872-200205000-00026; Gohlke P, 2001, J PHARMACOL EXP THER, V298, P62; GOHLKE P, 1989, J PHARMACOL EXP THER, V249, P609; Groth W, 2003, J HYPERTENS, V21, P2175, DOI 10.1097/00004872-200311000-00028; Hosomi N, 2005, NEUROSCIENCE, V134, P225, DOI 10.1016/j.neuroscience.2005.03.054; Huber K, 2000, J NEUROSCI RES, V59, P372, DOI 10.1002/(SICI)1097-4547(20000201)59:3<372::AID-JNR11>3.3.CO;2-6; Iwai M, 2004, CIRCULATION, V110, P843, DOI 10.1161/01.CIR.0000138848.58269.80; Krikov M, 2008, J HYPERTENS, V26, P544, DOI 10.1097/HJH.0b013e3282f2dac9; Li J, 2005, FASEB J, V19, P617, DOI 10.1096/fj.04-2960fje; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; Lou M, 2004, J CEREBR BLOOD F MET, V24, P536, DOI 10.1097/00004647-200405000-00008; Maier CM, 2001, J NEUROSURG, V94, P90, DOI 10.3171/jns.2001.94.1.0090; Mochizuki S, 2004, CARDIOVASC DRUG THER, V18, P305, DOI 10.1023/B:CARD.0000041250.00079.84; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Onal MZ, 1997, STROKE, V28, P1060, DOI 10.1161/01.STR.28.5.1060; Ravati A, 1999, EUR J PHARMACOL, V373, P21, DOI 10.1016/S0014-2999(99)00211-3; Schabitz WR, 1999, STROKE, V30, P427, DOI 10.1161/01.STR.30.2.427; Schmerbach K, 2008, BRAIN RES, V1208, P225, DOI 10.1016/j.brainres.2008.02.032; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; Thone-Reineke C, 2003, CLIN SCI, V104, P79; Turnbull F, 2003, LANCET, V362, P1527; Unger T, 2007, AM J CARDIOL, V100, p25J, DOI 10.1016/j.amjcard.2007.05.011; Walther T, 2002, FASEB J, V16, P169, DOI 10.1096/fj.01-0601com; Xu JH, 2005, J HYPERTENS, V23, P2277, DOI 10.1097/01.hjh.0000189868.48290.d8; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	34	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23646	10.1371/journal.pone.0023646	http://dx.doi.org/10.1371/journal.pone.0023646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901125	gold, Green Published, Green Submitted			2022-12-25	WOS:000294298000010
J	Bindu, S; Pal, C; Dey, S; Goyal, M; Alam, A; Iqbal, MS; Dutta, S; Sarkar, S; Kumar, R; Maity, P; Bandyopadhyay, U				Bindu, Samik; Pal, Chinmay; Dey, Sumanta; Goyal, Manish; Alam, Athar; Iqbal, Mohd Shameel; Dutta, Shubham; Sarkar, Souvik; Kumar, Rahul; Maity, Pallab; Bandyopadhyay, Uday			Translocation of Heme Oxygenase-1 to Mitochondria Is a Novel Cytoprotective Mechanism against Non-steroidal Anti-inflammatory Drug-induced Mitochondrial Oxidative Stress, Apoptosis, and Gastric Mucosal Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; HYDROGEN-PEROXIDE; REACTIVE-OXYGEN; GENE-EXPRESSION; CELL-DEATH; IRON-METABOLISM; CARBON-MONOXIDE; HUMAN MONOCYTES; PROTECTIVE ROLE; HEPATOMA-CELLS	The mechanism of action of heme oxygenase-1 (HO-1) in mitochondrial oxidative stress (MOS)-mediated apoptotic tissue injury was investigated. MOS-mediated gastric mucosal apoptosis and injury were introduced in rat by indomethacin, a non-steroidal anti-inflammatory drug. Here, we report that HO-1 was not only induced but also translocated to mitochondria during gastric mucosal injury to favor repair mechanisms. Furthermore, mitochondrial translocation of HO-1 resulted in the prevention of MOS and mitochondrial pathology as evident from the restoration of the complex I-driven mitochondrial respiratory control ratio and transmembrane potential. Mitochondrial translocation of HO-1 also resulted in time-dependent inhibition of apoptosis. We searched for the plausible mechanisms responsible for HO-1 induction and mitochondrial localization. Free heme, the substrate for HO-1, was increased inside mitochondria during gastric injury, and mitochondrial entry of HO-1 decreased intramitochondrial free heme content, suggesting that a purpose of mitochondrial translocation of HO-1 is to detoxify accumulated heme. Heme may activate nuclear translocation of NF-E2-related factor 2 to induce HO-1 through reactive oxygen species generation. Electrophoretic mobility shift assay and chromatin immunoprecipitation studies indicated nuclear translocation of NF-E2-related factor 2 and its binding to HO-1 promoter to induce HO-1 expression during gastric injury. Inhibition of HO-1 by zinc protoporphyrin aggravated the mucosal injury and delayed healing. Zinc protoporphyrin further reduced the respiratory control ratio and transmembrane potential and enhanced MOS and apoptosis. In contrast, induction of HO-1 by cobalt protoporphyrin reduced MOS, corrected mitochondrial dysfunctions, and prevented apoptosis and gastric injury. Thus, induction and mitochondrial localization of HO-1 are a novel cytoprotective mechanism against MOS-mediated apoptotic tissue injury.	[Bindu, Samik; Pal, Chinmay; Dey, Sumanta; Goyal, Manish; Alam, Athar; Iqbal, Mohd Shameel; Dutta, Shubham; Sarkar, Souvik; Kumar, Rahul; Maity, Pallab; Bandyopadhyay, Uday] Indian Inst Chem Biol, Dept Infect Dis & Immunol, Kolkata 700032, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bandyopadhyay, U (corresponding author), Indian Inst Chem Biol, Dept Infect Dis & Immunol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	ubandyo_1964@yahoo.com	Dutta, Shubham/ABA-2754-2020; Maity, Pallab/L-3896-2017; Goyal, Manish/O-2183-2015; Alam, Athar/B-3642-2010; Iqbal, Mohd Shameel/AAD-9641-2021	Dutta, Shubham/0000-0001-8484-0717; Maity, Pallab/0000-0001-9769-3533; Goyal, Manish/0000-0003-2383-5409; Iqbal, Mohd Shameel/0000-0002-0353-3561; Bindu, Samik/0000-0003-1416-2003	Council of Scientific and Industrial Research, New Delhi	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by grants from the Council of Scientific and Industrial Research, New Delhi.	Aburaya M, 2006, J BIOL CHEM, V281, P33422, DOI 10.1074/jbc.M602074200; ADAMS SS, 1958, NATURE, V181, P773, DOI 10.1038/181773b0; Agarwal A, 2000, J AM SOC NEPHROL, V11, P965, DOI 10.1681/ASN.V115965; Akamatsu Y, 2004, FASEB J, V18, P771, DOI 10.1096/fj.03-0921fje; ALAM J, 1989, J BIOL CHEM, V264, P6371; Andreadi CK, 2006, MOL PHARMACOL, V69, P1033, DOI 10.1124/mol.105.018374; APPLEGATE LA, 1991, CANCER RES, V51, P974; Bailey SM, 2002, FREE RADICAL BIO MED, V32, P11, DOI 10.1016/S0891-5849(01)00769-9; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Bandyopadhyay U, 2002, LIFE SCI, V71, P2845, DOI 10.1016/S0024-3205(02)02143-4; Bayir H, 2008, CRIT CARE, V12, DOI 10.1186/cc6779; Becker JC, 2003, BIOCHEM BIOPH RES CO, V312, P507, DOI 10.1016/j.bbrc.2003.10.146; Beckman JD, 2011, J BIOL CHEM, V286, P3194, DOI 10.1074/jbc.M110.148726; Belcher JD, 2010, ANTIOXID REDOX SIGN, V12, P233, DOI 10.1089/ars.2009.2822; Benallaoua M, 2007, ARTHRITIS RHEUM, V56, P2585, DOI 10.1002/art.22749; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; BRITTON RS, 1987, CHEM PHYS LIPIDS, V45, P207, DOI 10.1016/0009-3084(87)90066-1; Campanella A, 2004, HUM MOL GENET, V13, P2279, DOI 10.1093/hmg/ddh232; Campanella A, 2009, HUM MOL GENET, V18, P1, DOI 10.1093/hmg/ddn308; Chan KH, 2011, CLIN SCI, V120, P493, DOI 10.1042/CS20100508; Chattopadhyay I, 2006, FREE RADICAL BIO MED, V40, P1397, DOI 10.1016/j.freeradbiomed.2005.12.016; Chen K, 2000, J NEUROCHEM, V75, P304, DOI 10.1046/j.1471-4159.2000.0750304.x; Converso DP, 2006, FASEB J, V20, P1236, DOI 10.1096/fj.05-4204fje; Corsi B, 2002, J BIOL CHEM, V277, P22430, DOI 10.1074/jbc.M105372200; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Duchen MR, 2004, DIABETES, V53, pS96, DOI 10.2337/diabetes.53.2007.S96; Farombi EO, 2008, FOOD CHEM TOXICOL, V46, P1279, DOI 10.1016/j.fct.2007.09.095; Ferreira A, 2008, J MOL MED, V86, P1097, DOI 10.1007/s00109-008-0368-5; Fornai M, 2011, PHARMACOL RES, V63, P59, DOI 10.1016/j.phrs.2010.10.013; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gomes AS, 2010, EUR J PHARMACOL, V642, P140, DOI 10.1016/j.ejphar.2010.05.023; GONZALEZFLECHA B, 1993, J CLIN INVEST, V91, P456, DOI 10.1172/JCI116223; GOPINATHAN V, 1994, FEBS LETT, V349, P197, DOI 10.1016/0014-5793(94)00666-0; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Guha M, 2007, J PINEAL RES, V43, P372, DOI 10.1111/j.1600-079X.2007.00488.x; Guha M, 2006, FASEB J, V20, P1224, DOI 10.1096/fj.05-5338fje; Guo JS, 2003, WORLD J GASTROENTERO, V9, P1767, DOI 10.3748/wjg.v9.i8.1767; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Han ZS, 2009, J PHARMACOL EXP THER, V329, P94, DOI 10.1124/jpet.108.145557; Hira S, 2007, IUBMB LIFE, V59, P542, DOI 10.1080/15216540701225941; Hou WH, 2010, HEPATOLOGY, V51, P1494, DOI 10.1002/hep.23401; Hoye AT, 2008, ACCOUNTS CHEM RES, V41, P87, DOI 10.1021/ar700135m; Inoue K, 2008, SHOCK, V29, P252, DOI 10.1097/shk.0b013e3180cab913; Ishikawa M, 2005, FREE RADICAL BIO MED, V38, P1344, DOI 10.1016/j.freeradbiomed.2005.01.021; Jacob M, 2001, ALIMENT PHARM THER, V15, P1837, DOI 10.1046/j.1365-2036.2001.01095.x; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kim JY, 2009, CARDIOVASC RES, V82, P550, DOI 10.1093/cvr/cvp072; Kim NH, 2006, J BIOCHEM MOL BIOL, V39, P452; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Laine L, 1996, Gastrointest Endosc Clin N Am, V6, P489; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lang D, 2005, INT IMMUNOL, V17, P155, DOI 10.1093/intimm/dxh196; Lawson TE, 2011, WOUND REPAIR REGEN, V19, P241, DOI 10.1111/j.1524-475X.2010.00661.x; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Li XL, 2008, J IMMUNOL, V180, P6933, DOI 10.4049/jimmunol.180.10.6933; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lithgow T, 2000, FEBS LETT, V476, P22, DOI 10.1016/S0014-5793(00)01663-X; Liu XM, 2005, J BIOL CHEM, V280, P872, DOI 10.1074/jbc.M410413200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAINES MD, 1981, BIOCHIM BIOPHYS ACTA, V673, P339, DOI 10.1016/0304-4165(81)90465-7; Maity P, 2003, MOL CELL BIOCHEM, V253, P329, DOI 10.1023/A:1026040723669; Maity P, 2008, J BIOL CHEM, V283, P14391, DOI 10.1074/jbc.M800414200; Maity P, 2009, J PINEAL RES, V46, P314, DOI 10.1111/j.1600-079X.2009.00663.x; Maity P, 2009, J BIOL CHEM, V284, P3058, DOI 10.1074/jbc.M805329200; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Maricic N, 1999, BRIT J PHARMACOL, V128, P1659, DOI 10.1038/sj.bjp.0702966; Missirlis F, 2006, P NATL ACAD SCI USA, V103, P5893, DOI 10.1073/pnas.0601471103; Morse D, 2009, FREE RADICAL BIO MED, V47, P1, DOI 10.1016/j.freeradbiomed.2009.04.007; Musumba C, 2009, ALIMENT PHARM THER, V30, P517, DOI 10.1111/j.1365-2036.2009.04086.x; Nagababu E, 2004, ANTIOXID REDOX SIGN, V6, P967, DOI 10.1089/1523086042259823; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Pae Hyun-Ock, 2009, Immune Netw, V9, P12, DOI 10.4110/in.2009.9.1.12; Pal C, 2010, FREE RADICAL BIO MED, V49, P258, DOI 10.1016/j.freeradbiomed.2010.04.013; Porto BN, 2007, J BIOL CHEM, V282, P24430, DOI 10.1074/jbc.M703570200; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Rousou AJ, 2004, AM J PHYSIOL-HEART C, V287, pH1967, DOI 10.1152/ajpheart.00338.2004; Rushworth SA, 2006, BIOCHEM BIOPH RES CO, V341, P1007, DOI 10.1016/j.bbrc.2006.01.065; SAHNI SK, 1991, EXP MOL PATHOL, V55, P55, DOI 10.1016/0014-4800(91)90018-S; Sammut IA, 1998, BRIT J PHARMACOL, V125, P1437, DOI 10.1038/sj.bjp.0702212; Santambrogio P, 2007, J HISTOCHEM CYTOCHEM, V55, P1129, DOI 10.1369/jhc.7A7273.2007; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Shi ZH, 2010, ANTIOXID REDOX SIGN, V13, P783, DOI 10.1089/ars.2009.3018; Shibuya A, 2010, BIOCHEM BIOPH RES CO, V398, P581, DOI 10.1016/j.bbrc.2010.06.124; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; Srivastava P, 1996, INT J BIOCHEM CELL B, V28, P1071, DOI 10.1016/1357-2725(96)00030-1; Sugiyama K, 1997, P NATL ACAD SCI USA, V94, P796, DOI 10.1073/pnas.94.3.796; Suttner DM, 1999, FASEB J, V13, P1800, DOI 10.1096/fasebj.13.13.1800; SWIFT GL, 1992, DIGESTION, V53, P88, DOI 10.1159/000200975; Takagi T, 2009, J PHARMACOL EXP THER, V331, P255, DOI 10.1124/jpet.109.152702; Takahashi T, 2006, DRUG DEVELOP RES, V67, P130, DOI 10.1002/ddr.20073; Turkseven S, 2007, J CELL BIOCHEM, V100, P815, DOI 10.1002/jcb.21138; Ueda K, 2008, AM J PHYSIOL-GASTR L, V295, pG460, DOI 10.1152/ajpgi.00204.2007	99	75	78	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39387	39402		10.1074/jbc.M111.279893	http://dx.doi.org/10.1074/jbc.M111.279893			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21908612	Green Published, hybrid			2022-12-25	WOS:000296759800057
J	Cipolla, A; D'Amico, S; Barumandzadeh, R; Matagne, A; Feller, G				Cipolla, Alexandre; D'Amico, Salvino; Barumandzadeh, Roya; Matagne, Andre; Feller, Georges			Stepwise Adaptations to Low Temperature as Revealed by Multiple Mutants of Psychrophilic alpha-Amylase from Antarctic Bacterium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD ADAPTATION; ALTEROMONAS-HALOPLANCTIS; THERMODYNAMIC STABILITY; STRUCTURAL-ANALYSIS; CITRATE SYNTHASE; ENZYMES; PROTEIN; ENVIRONMENTS; INHIBITOR; INSIGHTS	The mutants Mut5 and Mut5CC from a psychrophilic alpha-amylase bear representative stabilizing interactions found in the heat-stable porcine pancreatic alpha-amylase but lacking in the cold-active enzyme from an Antarctic bacterium. From an evolutionary perspective, these mutants can be regarded as structural intermediates between the psychrophilic and the mesophilic enzymes. We found that these engineered interactions improve all the investigated parameters related to protein stability as follows: compactness; kinetically driven stability; thermodynamic stability; resistance toward chemical denaturation, and the kinetics of unfolding/refolding. Concomitantly to this improved stability, both mutants have lost the kinetic optimization to low temperature activity displayed by the parent psychrophilic enzyme. These results provide strong experimental support to the hypothesis assuming that the disappearance of stabilizing interactions in psychrophilic enzymes increases the amplitude of concerted motions required by catalysis and the dynamics of active site residues at low temperature, leading to a higher activity.	[Feller, Georges] Univ Liege, Inst Chem B6A, Ctr Prot Engn, Biochem Lab, B-4000 Liege, Belgium; [Barumandzadeh, Roya; Matagne, Andre] Univ Liege, Ctr Prot Engn, Labs Enzymol & Prot Folding, B-4000 Liege, Belgium	University of Liege; University of Liege	Feller, G (corresponding author), Univ Liege, Inst Chem B6A, Ctr Prot Engn, Biochem Lab, B-4000 Liege, Belgium.	gfeller@ulg.ac.be			Fonds de la Recherche Scientifique-Fonds; National de la Recherche Scientifique; Belgium Fonds de la Recherche Fondamentale et Collective [2.4535.08, 2.4530.09]; Belgian Program of Interuniversity Attraction Poles [P6/19]; Institut Polaire Francais	Fonds de la Recherche Scientifique-Fonds; National de la Recherche Scientifique; Belgium Fonds de la Recherche Fondamentale et Collective(Fonds de la Recherche Scientifique - FNRS); Belgian Program of Interuniversity Attraction Poles; Institut Polaire Francais	This work was supported by the Fonds de la Recherche Scientifique-Fonds, National de la Recherche Scientifique, Belgium Fonds de la Recherche Fondamentale et Collective Contracts 2.4535.08 (to G. F.) and 2.4530.09 (to A. M.) and the Belgian Program of Interuniversity Attraction Poles initiated by the Federal Office for Scientific, Technical and Cultural Affaires P6/19.; We thank H. Bichoff (Bayer AG, Germany) for the kind gift of acarbose. The support of the Institut Polaire Francais was also appreciated.	Aghajari N, 1998, STRUCTURE, V6, P1503, DOI 10.1016/S0969-2126(98)00149-X; Aghajari N, 1998, PROTEIN SCI, V7, P564, DOI 10.1002/pro.5560070304; Aghajari N, 2002, PROTEIN SCI, V11, P1435, DOI 10.1110/ps.0202602; Bae E, 2004, J BIOL CHEM, V279, P28202, DOI 10.1074/jbc.M401865200; Bell GS, 2002, EUR J BIOCHEM, V269, P6250, DOI 10.1046/j.1432-1033.2002.03344.x; Casanueva A, 2010, TRENDS MICROBIOL, V18, P374, DOI 10.1016/j.tim.2010.05.002; Collins T, 2006, ANAL BIOCHEM, V352, P299, DOI 10.1016/j.ab.2006.01.035; Coquelle N, 2007, J MOL BIOL, V374, P547, DOI 10.1016/j.jmb.2007.09.049; D'Amico S, 2000, GENE, V253, P95, DOI 10.1016/S0378-1119(00)00229-8; D'Amico S, 2006, J MOL BIOL, V358, P1296, DOI 10.1016/j.jmb.2006.03.004; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; D'Amico S, 2003, J MOL BIOL, V332, P981, DOI 10.1016/j.jmb.2003.07.014; D'Amico S, 2003, J BIOL CHEM, V278, P7891, DOI 10.1074/jbc.M212508200; D'Amico S, 2002, J BIOL CHEM, V277, P46110, DOI 10.1074/jbc.M207253200; D'Amico S, 2001, J BIOL CHEM, V276, P25791, DOI 10.1074/jbc.M102741200; D'Amico S, 2009, ANAL BIOCHEM, V385, P389, DOI 10.1016/j.ab.2008.11.016; Da Lage JL, 2004, CELL MOL LIFE SCI, V61, P97, DOI 10.1007/s00018-003-3334-y; Deming JW, 2002, CURR OPIN MICROBIOL, V5, P301, DOI 10.1016/S1369-5274(02)00329-6; Feller G, 1999, BIOCHEMISTRY-US, V38, P4613, DOI 10.1021/bi982650+; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; FELLER G, 1994, EUR J BIOCHEM, V222, P441, DOI 10.1111/j.1432-1033.1994.tb18883.x; Feller G, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/32/323101; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Fields PA, 1998, P NATL ACAD SCI USA, V95, P11476, DOI 10.1073/pnas.95.19.11476; Gerday C, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, pXV; Gianese G, 2002, PROTEINS, V47, P236, DOI 10.1002/prot.10084; Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; Luke KA, 2007, FEBS J, V274, P4023, DOI 10.1111/j.1742-4658.2007.05955.x; Margesin R., 2008, PSYCHROPHILES BIODIV; MATOUSCHEK A, 1994, PROTEIN ENG, V7, P1089, DOI 10.1093/protein/7.9.1089; Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905; Perl D, 1998, NAT STRUCT BIOL, V5, P229, DOI 10.1038/nsb0398-229; Privalov Peter L., 1992, P83; QIAN MX, 1994, BIOCHEMISTRY-US, V33, P6284, DOI 10.1021/bi00186a031; Rodrigues DF, 2008, APPL ENVIRON MICROB, V74, P1677, DOI 10.1128/AEM.02000-07; Roulling F., 2011, EXTREMOPHILES HDB, P891; Russell RJM, 1998, STRUCTURE, V6, P351, DOI 10.1016/S0969-2126(98)00037-9; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P1648, DOI 10.1021/bi00405a039; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; Smalas A O, 2000, Biotechnol Annu Rev, V6, P1, DOI 10.1016/S1387-2656(00)06018-X; Tehei M, 2004, EMBO REP, V5, P66, DOI 10.1038/sj.embor.7400049; Tronelli D, 2007, FEBS J, V274, P4595, DOI 10.1111/j.1742-4658.2007.05988.x; VUILLARD L, 1995, BIOCHEM J, V305, P337, DOI 10.1042/bj3050337	44	21	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38348	38355		10.1074/jbc.M111.274423	http://dx.doi.org/10.1074/jbc.M111.274423			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900238	Green Published, hybrid			2022-12-25	WOS:000296594200048
J	Devlin, CM; Lahm, T; Hubbard, WC; Van Demark, M; Wang, KC; Wu, X; Bielawska, A; Obeid, LM; Ivan, M; Petrache, I				Devlin, Cecilia M.; Lahm, Tim; Hubbard, Walter C.; Van Demark, Mary; Wang, Kevin C.; Wu, Xue; Bielawska, Alicja; Obeid, Lina M.; Ivan, Mircea; Petrache, Irina			Dihydroceramide-based Response to Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR; HIF-ALPHA; PROLYL 4-HYDROXYLASES; CERAMIDE SYNTHASE; C-ELEGANS; DESATURASE; HYDROXYLATION; APOPTOSIS; STRESS; INVOLVEMENT	To understand the mechanisms of ceramide-based responses to hypoxia, we performed a mass spectrometry-based survey of ceramide species elicited by a wide range of hypoxic conditions (0.2-5% oxygen). We describe a rapid, time-dependent, marked up-regulation of dihydroceramides (DHCs) in mammalian cells and in the lungs of hypoxic rats. The increase affected all DHC species and was proportional with the depth and duration of hypoxia, ranging from 2-(1 h) to 10-fold (24 h), with complete return to normal after 1 h of reoxygenation at the expense of increased ceramides. We demonstrate that a DHC-based response to hypoxia occurs in a hypoxia-inducible factor-independent fashion and is catalyzed by theDHCdesaturase (DEGS) in the de novo ceramide pathway. Both the impact of hypoxia on DHC molecular species and its inhibitory effect on cell proliferation were reproduced by knockdown of DEGS1 or DEGS2 by siRNA during normoxia. Conversely, overexpression of DEGS1 or DEGS2 attenuated the DHC accumulation and increased cell proliferation during hypoxia. Based on the amplitude and kinetics of DHC accumulation, the enzymatic desaturation of DHCs fulfills the criteria of an oxygen sensor across physiological hypoxic conditions, regulating the balance between biologically active components of ceramide metabolism.	[Ivan, Mircea; Petrache, Irina] Indiana Univ, Dept Med, Indianapolis, IN 46202 USA; [Wu, Xue; Ivan, Mircea] Indiana Univ, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Lahm, Tim; Petrache, Irina] RL Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; [Hubbard, Walter C.] Johns Hopkins Univ, Dept Med, Baltimore, MD 21286 USA; [Bielawska, Alicja; Obeid, Lina M.] Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Johns Hopkins University; Medical University of South Carolina	Ivan, M (corresponding author), Indiana Univ, Dept Med, 980 W Walnut St,Walther Hall C225, Indianapolis, IN 46202 USA.	mivan@iupui.edu; ipetrach@iupui.edu	Ivan, Mircea/A-8109-2012; Wu, Xue/AAJ-9340-2020; Lahm, Tim/AAF-7162-2020; Petrache, Irina/AAZ-9648-2020	Wu, Xue/0000-0002-0511-9436; obeid, lina/0000-0002-0734-0847; Ivan, Mircea/0000-0003-3424-6642	National Institutes of Health [RO1HL077328, 1 S10 RR16798]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016798] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA029249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1HL077328 (to I. P.) and 1 S10 RR16798 (to W. C. H. for funding the API4000 LC-MS/MS system).	Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Bhuiyan MIH, 2010, BIOL PHARM BULL, V33, P11, DOI 10.1248/bpb.33.11; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Broadwater JA, 2002, J BIOL CHEM, V277, P15613, DOI 10.1074/jbc.M200231200; Buist PH, 2004, NAT PROD REP, V21, P249, DOI 10.1039/b302094k; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cogolludo A, 2009, CARDIOVASC RES, V82, P296, DOI 10.1093/cvr/cvn349; Crowder CM, 2009, SCIENCE, V324, P343, DOI 10.1126/science.1173278; Cuzzocrea S, 2008, J PHARMACOL EXP THER, V327, P45, DOI 10.1124/jpet.108.139808; Dobrowsky RT, 2001, METHOD CELL BIOL, V66, P135; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; GAROFALO O, 1988, J NEUROCHEM, V51, P172, DOI 10.1111/j.1471-4159.1988.tb04851.x; Geeraert L, 1997, BIOCHEM J, V327, P125, DOI 10.1042/bj3270125; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Idkowiak-Baldys J, 2010, BIOCHEM J, V427, P265, DOI 10.1042/BJ20091589; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kang MS, 2010, CELL SIGNAL, V22, P610, DOI 10.1016/j.cellsig.2009.11.015; KENDLER A, 1992, J NEUROSCI RES, V31, P205, DOI 10.1002/jnr.490310202; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Liu J, 2000, AM J PHYSIOL-CELL PH, V278, pC144, DOI 10.1152/ajpcell.2000.278.1.C144; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Munoz-Olaya JM, 2008, CHEMMEDCHEM, V3, P946, DOI 10.1002/cmdc.200700325; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Noureddine L, 2008, PROSTAG OTH LIPID M, V86, P49, DOI 10.1016/j.prostaglandins.2008.02.003; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Ryan HE, 2000, CANCER RES, V60, P4010; Signorelli P, 2009, CANCER LETT, V282, P238, DOI 10.1016/j.canlet.2009.03.020; Stiban J, 2006, APOPTOSIS, V11, P773, DOI 10.1007/s10495-006-5882-8; Szulc ZM, 2006, BIOORGAN MED CHEM, V14, P7083, DOI 10.1016/j.bmc.2006.07.016; Ward JPT, 2008, BBA-BIOENERGETICS, V1777, P1, DOI 10.1016/j.bbabio.2007.10.010; Ye JB, 2009, CURR MOL MED, V9, P411, DOI 10.2174/156652409788167096	40	50	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38069	38078		10.1074/jbc.M111.297994	http://dx.doi.org/10.1074/jbc.M111.297994			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914808	hybrid, Green Published			2022-12-25	WOS:000296594200019
J	Posch, G; Pabst, M; Brecker, L; Altmann, F; Messner, P; Schaffer, C				Posch, Gerald; Pabst, Martin; Brecker, Lothar; Altmann, Friedrich; Messner, Paul; Schaeffer, Christina			Characterization and Scope of S-layer Protein O-Glycosylation in Tannerella forsythia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LC-ESI-MS; CELL-WALL POLYMER; STRUCTURAL-CHARACTERIZATION; NONREDUCTIVE RELEASE; LINKED GLYCANS; OLIGOSACCHARIDES; GLYCOPROTEINS; SURFACE; SYSTEM; IDENTIFICATION	Cell surface glycosylation is an important element in defining the life of pathogenic bacteria. Tannerella forsythia is a Gram-negative, anaerobic periodontal pathogen inhabiting the subgingival plaque biofilms. It is completely covered by a two-dimensional crystalline surface layer (S-layer) composed of two glycoproteins. Although the S-layer has previously been shown to delay the bacterium's recognition by the innate immune system, we characterize here the S-layer protein O-glycosylation as a potential virulence factor. The T. forsythia S-layer glycan was elucidated by a combination of electrospray ionization-tandem mass spectrometry and nuclear magnetic resonance spectroscopy as an oligosaccharide with the structure 4-Me-beta-ManpNAcCONH(2)-(1 -> 3)-[Pse5Am7Gc-(2 -> 4)-]-beta-ManpNAcA-(1 -> 4)-[4-Me-alpha-Galp-(1 -> 2)-]-alpha-Fucp-(1 -> 4)-[-alpha-Xylp-(1 -> 3)-]-beta-GlcpA-(1 -> 3)-[-beta-Digp-(1 -> 2)-]-alpha-Galp, which is O-glycosidically linked to distinct serine and threonine residues within the three-amino acid motif (D)(S/T)(A/I/L/M/T/V) on either S-layer protein. This S-layer glycan obviously impacts the life style of T. forsythia because increased biofilm formation of an UDP-N-acetylmannosaminuronic acid dehydrogenase mutant can be correlated with the presence of truncated S-layer glycans. We found that several other proteins of T. forsythia are modified with that specific oligosaccharide. Proteomics identified two of them as being among previously classified antigenic outer membrane proteins that are up-regulated under biofilm conditions, in addition to two predicted antigenic lipoproteins. Theoretical analysis of the S-layer O-glycosylation of T. forsythia indicates the involvement of a 6.8-kb gene locus that is conserved among different bacteria from the Bacteroidetes phylum. Together, these findings reveal the presence of a protein O-glycosylation system in T. forsythia that is essential for creating a rich glycoproteome pinpointing a possible relevance for the virulence of this bacterium.	[Posch, Gerald; Messner, Paul; Schaeffer, Christina] Univ Nat Resources & Appl Life Sci Vienna, Dept NanoBiotechnol, Vienna Inst BioTechnol, A-1190 Vienna, Austria; [Pabst, Martin; Altmann, Friedrich] Univ Nat Resources & Appl Life Sci Vienna, Dept Chem, Vienna Inst BioTechnol, A-1190 Vienna, Austria; [Brecker, Lothar] Univ Vienna, Inst Organ Chem, A-1090 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Vienna	Schaffer, C (corresponding author), Univ Nat Resources & Appl Life Sci Vienna, Dept NanoBiotechnol, Vienna Inst BioTechnol, Muthgasse 11, A-1190 Vienna, Austria.	christina.schaeffer@boku.ac.at	Pabst, Martin/GOH-1766-2022; Schäffer, Christina/V-3404-2018; Messner, Paul/Q-5345-2017	Pabst, Martin/0000-0001-9897-0723; Schäffer, Christina/0000-0003-1613-7258; Messner, Paul/0000-0002-3246-5801; Altmann, Friedrich/0000-0002-0112-7877	Austrian Science Fund [P20605-B20, P21954-B20, P20745-B11]; Austrian Science Fund (FWF) [P 20745, P 21954, P 20605] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund projects P20605-B20 and P21954-B20 (to C. S.) and P20745-B11 (to P. M.).	ANUMULA KR, 1994, ANAL BIOCHEM, V220, P275, DOI 10.1006/abio.1994.1338; Beck JD, 2000, PERIODONTOL 2000, V23, P110, DOI 10.1034/j.1600-0757.2000.2230111.x; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; Calo D, 2010, APPL ENVIRON MICROB, V76, P5684, DOI 10.1128/AEM.00681-10; Castric P, 2001, J BIOL CHEM, V276, P26479, DOI 10.1074/jbc.M102685200; Chai WG, 1997, GLYCOBIOLOGY, V7, P861, DOI 10.1093/glycob/7.6.861; DiGiandomenico A, 2002, MOL MICROBIOL, V46, P519, DOI 10.1046/j.1365-2958.2002.03171.x; Fletcher CM, 2007, P NATL ACAD SCI USA, V104, P2413, DOI 10.1073/pnas.0608797104; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Hart C, 2003, ELECTROPHORESIS, V24, P588, DOI 10.1002/elps.200390069; Honma K, 2007, MICROB PATHOGENESIS, V42, P156, DOI 10.1016/j.micpath.2007.01.003; Hsu KL, 2006, NAT CHEM BIOL, V2, P153, DOI 10.1038/nchembio767; Huang YP, 2001, ANAL CHEM, V73, P6063, DOI 10.1021/ac015534c; Kiss E, 2001, MOL PLANT MICROBE IN, V14, P1395, DOI 10.1094/MPMI.2001.14.12.1395; Knirel YA, 2003, ADV CARBOHYD CHEM BI, V58, P371, DOI 10.1016/S0065-2318(03)58007-6; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SW, 2006, GENE, V371, P102, DOI 10.1016/j.gene.2005.11.027; Li XJ, 2000, CLIN MICROBIOL REV, V13, P547, DOI 10.1128/CMR.13.4.547-558.2000; Marsh PD, 2011, PERIODONTOL 2000, V55, P16, DOI 10.1111/j.1600-0757.2009.00339.x; Messner P, 2008, CARBOHYD RES, V343, P1934, DOI 10.1016/j.carres.2007.12.025; Pabst M, 2008, ANAL CHEM, V80, P7534, DOI 10.1021/ac801024r; Pabst M, 2007, ANAL CHEM, V79, P5051, DOI 10.1021/ac070363i; Pabst M, 2010, CARBOHYD RES, V345, P1389, DOI 10.1016/j.carres.2010.02.017; Pabst M, 2009, ANAL BIOCHEM, V384, P263, DOI 10.1016/j.ab.2008.09.041; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Petersen BO, 2008, CARBOHYD RES, V343, P1346, DOI 10.1016/j.carres.2008.03.029; Pham TK, 2010, PROTEOMICS, V10, P3130, DOI 10.1002/pmic.200900448; Ristl Robin, 2011, Int J Microbiol, V2011, DOI 10.1155/2011/127870; Roy S, 2010, J BACTERIOL, V192, P2285, DOI 10.1128/JB.00079-10; Sabet M, 2003, MICROBIOL-SGM, V149, P3617, DOI 10.1099/mic.0.26535-0; Sakakibara J, 2007, MICROBIOL-SGM, V153, P866, DOI 10.1099/mic.0.29275-0; Schaffer C, 2000, EUR J BIOCHEM, V267, P5482, DOI 10.1046/j.1432-1327.2000.01610.x; Schoenhofen IC, 2006, GLYCOBIOLOGY, V16, p8C, DOI 10.1093/glycob/cwl010; Sekot G, 2011, J DENT RES, V90, P109, DOI 10.1177/0022034510384622; Sharma A, 1998, INFECT IMMUN, V66, P5703, DOI 10.1128/IAI.66.12.5703-5710.1998; Sharma A, 2010, PERIODONTOL 2000, V54, P106, DOI 10.1111/j.1600-0757.2009.00332.x; Sleytr UB, 2002, BIOPOLYMERS, P285; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Steindl C, 2005, CARBOHYD RES, V340, P2290, DOI 10.1016/j.carres.2005.07.005; Steiner K, 2007, J BACTERIOL, V189, P2590, DOI 10.1128/JB.01592-06; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Taylor AM, 2006, PROTEOMICS, V6, P2936, DOI 10.1002/pmic.200500331; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Veith PD, 2009, J PROTEOME RES, V8, P4279, DOI 10.1021/pr900372c; Veith PD, 2002, BIOCHEM J, V363, P105, DOI 10.1042/0264-6021:3630105; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Wang L, 2010, PLANTA MED, V76, P909, DOI 10.1055/s-0029-1240842; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Wuhrer M, 2011, MASS SPECTROM REV, V30, P664, DOI 10.1002/mas.20337; Zarschler K, 2010, GLYCOBIOLOGY, V20, P787, DOI 10.1093/glycob/cwq035; Zeleny R, 2006, PLANTA, V224, P222, DOI 10.1007/s00425-005-0206-8	53	60	60	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38714	38724		10.1074/jbc.M111.284893	http://dx.doi.org/10.1074/jbc.M111.284893			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911490	hybrid, Green Published			2022-12-25	WOS:000296594200083
J	Leppa, E; Linden, AM; Vekovischeva, OY; Swinny, JD; Rantanen, V; Toppila, E; Hoger, H; Sieghart, W; Wulff, P; Wisden, W; Korpi, ER				Leppa, Elli; Linden, Anni-Maija; Vekovischeva, Olga Y.; Swinny, Jerome D.; Rantanen, Ville; Toppila, Esko; Hoeger, Harald; Sieghart, Werner; Wulff, Peer; Wisden, William; Korpi, Esa R.			Removal of GABA(A) Receptor gamma 2 Subunits from Parvalbumin Neurons Causes Wide-Ranging Behavioral Alterations	PLOS ONE			English	Article							HARMALINE-INDUCED TREMOR; PREPULSE INHIBITION DEFICITS; BENZODIAZEPINE-SITE LIGANDS; GREEN FLUORESCENT PROTEIN; MORRIS WATER MAZE; POSITIVE INTERNEURONS; KNOCKOUT MICE; AMINOBUTYRIC-ACID; PREFRONTAL CORTEX; TRANSGENIC MICE	We investigated the behavioral significance of fast synaptic inhibition by alpha beta gamma 2-type GABA(A) receptors on parvalbumin (Pv) cells. The GABA(A) receptor gamma 2 subunit gene was selectively inactivated in Pv-positive neurons by Cre/loxP recombination. The resulting Pv-Delta gamma 2 mice were relatively healthy in the first postnatal weeks; but then as Cre started to be expressed, the mice progressively developed wide-ranging phenotypic alterations including low body weight, motor deficits and tremor, decreased anxiety levels, decreased pain sensitivity and deficient prepulse inhibition of the acoustic startle reflex and impaired spatial learning. Nevertheless, the deletion was not lethal, and mice did not show increased mortality even after one year. Autoradiography with t-butylbicyclophosphoro[S-35]thionate suggested an increased amount of GABA(A) receptors with only alpha and beta subunits in central nervous system regions that contained high levels of parvalbumin neurons. Using BACtransgenesis, we reduced some of the Pv-Delta gamma 2 phenotype by selectively re-expressing the wild-type gamma 2 subunit back into some Pv cells (reticular thalamic neurons and cerebellar Pv-positive neurons). This produced less severe impairments of motor skills and spatial learning compared with Pv-Delta gamma 2 mice, but all other deficits remained. Our results reveal the widespread significance of fast GABAergic inhibition onto Pv-positive neurons for diverse behavioral modalities, such as motor coordination, sensorimotor integration, emotional behavior and nociception.	[Leppa, Elli; Linden, Anni-Maija; Vekovischeva, Olga Y.; Korpi, Esa R.] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Swinny, Jerome D.] Univ Oxford, Dept Pharmacol, Anat Neuropharmacol Unit, MRC, Oxford OX1 3QT, England; [Swinny, Jerome D.] Univ Portsmouth, Sch Pharm & Biomed Sci, Inst Biomed & Biomol Sci, Portsmouth, Hants, England; [Rantanen, Ville] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Rantanen, Ville] Univ Helsinki, Inst Biomed Biochem & Dev Biol, Helsinki, Finland; [Toppila, Esko] Finnish Inst Occupat Hlth, Helsinki, Finland; [Hoeger, Harald] Med Univ Vienna, Div Lab Anim Sci & Genet, Core Unit Biomed Res, Himberg, Austria; [Sieghart, Werner] Med Univ Vienna, Ctr Brain Res, Dept Biochem & Mol Biol, Vienna, Austria; [Wulff, Peer; Wisden, William] Univ Heidelberg, Dept Clin Neurobiol, Heidelberg, Germany	University of Helsinki; University of Oxford; University of Portsmouth; University of Helsinki; University of Helsinki; Finnish Institute of Occupational Health; Medical University of Vienna; Medical University of Vienna; Ruprecht Karls University Heidelberg	Leppa, E (corresponding author), Univ Helsinki, Inst Biomed, Helsinki, Finland.	w.wisden@imperial.ac.uk; esa.korpi@helsinki.fi	Wisden, William/A-4071-2011; Sieghart, Werner/A-4877-2013	Wisden, William/0000-0003-4743-0334; Sieghart, Werner/0000-0002-0443-0302; Swinny, Jerome/0000-0002-8194-5481; Rantanen, Ville/0000-0002-0105-7071; Korpi, Esa R./0000-0003-0683-4009; Linden, Anni-Maija/0000-0003-1573-8051	Finnish Graduate School of Neuroscience; Academy of Finland; Sigrid Juselius Foundation; Volkswagen Foundation [I/78 554]; Deutsche Forschungsgemeinschaft [WI 1951/2]; Medical Research Council [G0601498]; MRC [G0601498] Funding Source: UKRI	Finnish Graduate School of Neuroscience; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Finnish Graduate School of Neuroscience (EL), the Academy of Finland (ERK), the Sigrid Juselius Foundation (ERK), the Volkswagen Foundation I/78 554 (ERK & WW), the Deutsche Forschungsgemeinschaft WI 1951/2 (PW & WW), and the Medical Research Council G0601498 (PW & WW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711; BAKSHI VP, 1994, J PHARMACOL EXP THER, V271, P787; Bradford AM, 2010, PSYCHOPHARMACOLOGY, V212, P155, DOI 10.1007/s00213-010-1938-0; Brody SA, 2004, MOL PSYCHIATR, V9, P35, DOI 10.1038/sj.mp.4001404; CAGGIULA AR, 1995, PSYCHOPHARMACOLOGY, V122, P301, DOI 10.1007/BF02246552; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Chandra D, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-30; Chiu C, 2008, ANN NEUROL, V64, P284, DOI 10.1002/ana.21440; Cone RD, 2001, INT J OBESITY, V25, pS63, DOI 10.1038/sj.ijo.0801913; Cope DW, 2004, NEUROPHARMACOLOGY, V47, P17, DOI 10.1016/j.neuropharm.2004.03.007; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; Dougherty KJ, 2009, NEUROSCIENCE, V163, P909, DOI 10.1016/j.neuroscience.2009.06.055; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Fahey JM, 1999, PHARMACOL BIOCHEM BE, V62, P103, DOI 10.1016/S0091-3057(98)00145-2; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Florian C, 2004, BEHAV BRAIN RES, V154, P365, DOI 10.1016/j.bbr.2004.03.003; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Haerich P, 2005, PHYSIOL BEHAV, V86, P103, DOI 10.1016/j.physbeh.2005.06.024; Halonen LM, 2009, NEUROCHEM INT, V55, P389, DOI 10.1016/j.neuint.2009.04.008; Heinke B, 2004, J PHYSIOL-LONDON, V560, P249, DOI 10.1113/jphysiol.2004.070540; Heldt SA, 2004, NEUROPSYCHOPHARMACOL, V29, P1610, DOI 10.1038/sj.npp.1300468; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; Hong LE, 2007, AM J PSYCHIAT, V164, P61, DOI 10.1176/appi.ajp.164.1.61; Iivonen H, 2003, BEHAV BRAIN RES, V141, P207, DOI 10.1016/S0166-4328(02)00369-8; Jinno S, 2004, J COMP NEUROL, V477, P188, DOI 10.1002/cne.20246; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; Kittler JT, 2000, MOL CELL NEUROSCI, V16, P440, DOI 10.1006/mcne.2000.0882; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Korpi ER, 1999, EUR J NEUROSCI, V11, P233, DOI 10.1046/j.1460-9568.1999.00421.x; Korpi ER, 2002, NEUROSCIENCE, V109, P733, DOI 10.1016/S0306-4522(01)00527-9; Lee K, 2010, ENDOCRINOLOGY, V151, P4428, DOI 10.1210/en.2010-0314; Leppa E, 2005, NEUROPHARMACOLOGY, V48, P469, DOI 10.1016/j.neuropharm.2004.11.007; Leppa E, 2011, EUR J PHARMACOL, V666, P111, DOI 10.1016/j.ejphar.2011.05.011; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2001, AM J PSYCHIAT, V158, P1411, DOI 10.1176/appi.ajp.158.9.1411; Linden AM, 2008, J PHARMACOL EXP THER, V327, P277, DOI 10.1124/jpet.108.142083; Linden AM, 2007, J PHARMACOL EXP THER, V323, P924, DOI 10.1124/jpet.107.129544; Linden AM, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00003; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; LLINAS R, 1973, EXP BRAIN RES, V18, P69; LLINAS R, 1986, J PHYSIOL-LONDON, V376, P163, DOI 10.1113/jphysiol.1986.sp016147; Lorez Matthias, 2000, Journal of Physiology (Cambridge), V527, P11, DOI 10.1111/j.1469-7793.2000.t01-1-00011.x; LUDDENS H, 1995, J NEUROSCI, V15, P6957; Ludewig K, 2003, BIOL PSYCHIAT, V54, P121, DOI 10.1016/S0006-3223(02)01925-X; Makela R, 1997, MOL PHARMACOL, V52, P380, DOI 10.1124/mol.52.3.380; MAKSAY G, 1986, MOL PHARMACOL, V30, P321; McDonald AJ, 2004, J COMP NEUROL, V473, P137, DOI 10.1002/cne.20101; Mehta H, 2003, BEHAV BRAIN RES, V145, P31, DOI 10.1016/S0166-4328(03)00094-9; Meyer AH, 2002, J NEUROSCI, V22, P7055; MILNER TE, 1995, J NEUROPHYSIOL, V73, P2568, DOI 10.1152/jn.1995.73.6.2568; Morris BJ, 2005, CURR OPIN PHARMACOL, V5, P101, DOI 10.1016/j.coph.2004.08.008; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Ogris W, 2004, BIOCHEM PHARMACOL, V68, P1621, DOI 10.1016/j.bcp.2004.07.020; Pratt JA, 2008, BRIT J PHARMACOL, V153, pS465, DOI 10.1038/bjp.2008.24; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; Reddy DS, 1998, PSYCHOPHARMACOLOGY, V137, P391; Rotaru DC, 2005, J COMP NEUROL, V490, P220, DOI 10.1002/cne.20661; Saarelainen KS, 2008, J NEUROCHEM, V105, P338, DOI 10.1111/j.1471-4159.2007.05136.x; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; SEEBURG PH, 1990, COLD SH Q B, V55, P29; Shen QY, 2010, BIOL PSYCHIAT, V68, P512, DOI 10.1016/j.biopsych.2010.04.024; Sinkkonen ST, 2004, NEUROCHEM INT, V44, P539, DOI 10.1016/j.neuint.2003.08.008; SIVILOTTI L, 1994, J NEUROPHYSIOL, V72, P169, DOI 10.1152/jn.1994.72.1.169; Spooren W, 2004, PSYCHOPHARMACOLOGY, V175, P99, DOI 10.1007/s00213-004-1785-y; Stevenson A, 1995, MOL PHARMACOL, V48, P965; STORB U, 1986, J EXP MED, V164, P627, DOI 10.1084/jem.164.2.627; Swerdlow NR, 2008, PSYCHOPHARMACOLOGY, V199, P331, DOI 10.1007/s00213-008-1072-4; TAFT WC, 1984, P NATL ACAD SCI-BIOL, V81, P3118, DOI 10.1073/pnas.81.10.3118; Takahashi H, 1999, EUR NEUROPSYCHOPHARM, V9, P317, DOI 10.1016/S0924-977X(98)00051-0; Tepper JM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00150; Vekovischeva OY, 2004, GENES BRAIN BEHAV, V3, P253, DOI 10.1111/j.1601-1848.2004.00075.x; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; Wang CZ, 2008, NEUROPSYCHOPHARMACOL, V33, P2442, DOI 10.1038/sj.npp.1301647; WISDEN W, 1992, J NEUROSCI, V12, P1040; WISDEN W, 1994, IN SITU HYBRIDIZATIO, P9; Wisden W, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.029.2009; Woodruff AR, 2007, J NEUROSCI, V27, P553, DOI 10.1523/JNEUROSCI.3686-06.2007; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Wulff P, 2007, NAT NEUROSCI, V10, P923, DOI 10.1038/nn1927; Wulff P, 2009, NAT NEUROSCI, V12, P1042, DOI 10.1038/nn.2348; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106; Yamashita M, 2006, NEUROPSYCHOPHARMACOL, V31, P2132, DOI 10.1038/sj.npp.1301009; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Zeilhofer HU, 2009, J MOL MED, V87, P465, DOI 10.1007/s00109-009-0454-3	89	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24159	10.1371/journal.pone.0024159	http://dx.doi.org/10.1371/journal.pone.0024159			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912668	Green Submitted, Green Published, gold			2022-12-25	WOS:000294686100015
J	Li, R; Wen, R; Banzon, T; Maminishkis, A; Miller, SS				Li, Rong; Wen, Rong; Banzon, Tina; Maminishkis, Arvydas; Miller, Sheldon S.			CNTF Mediates Neurotrophic Factor Secretion and Fluid Absorption in Human Retinal Pigment Epithelium	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INTRACELLULAR SIGNALING PATHWAYS; MACULAR DEGENERATION; RAT RETINA; FACTOR-RECEPTOR; OUTER SEGMENTS; TGF-BETA; PHOTOTRANSDUCTION MACHINERY; ROD PHOTORECEPTORS; GENE-TRANSFER	Ciliary neurotrophic factor (CNTF) protects photoreceptors and regulates their phototransduction machinery, but little is known about CNTF's effects on retinal pigment epithelial (RPE) physiology. Therefore, we determined the expression and localization of CNTF receptors and the physiological consequence of their activation in primary cultures of human fetal RPE (hfRPE). Cultured hfRPE express CNTF, CT1, and OsM and their receptors, including CNTFR alpha, LIFR beta, gp130, and OsMR beta, all localized mainly at the apical membrane. Exogenous CNTF, CT1, or OsM induces STAT3 phosphorylation, and OsM also induces the phosphorylation of ERK1/2 (p44/42 MAP kinase). CNTF increases RPE survivability, but not rates of phagocytosis. CNTF increases secretion of NT3 to the apical bath and decreases that of VEGF, IL8, and TGF beta 2. It also significantly increases fluid absorption (J(V)) across intact monolayers of hfRPE by activating CFTR chloride channels at the basolateral membrane. CNTF induces profound changes in RPE cell biology, biochemistry, and physiology, including the increase in cell survival, polarized secretion of cytokines/neurotrophic factors, and the increase in steady-state fluid absorption mediated by JAK/STAT3 signaling. In vivo, these changes, taken together, could serve to regulate the microenvironment around the distal retinal/RPE/Bruch's membrane complex and provide protection against neurodegenerative disease.	[Li, Rong; Banzon, Tina; Maminishkis, Arvydas; Miller, Sheldon S.] NEI, NIH, Bethesda, MD 20892 USA; [Wen, Rong] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Bascom Palmer Eye Institute; University of Miami	Li, R (corresponding author), NEI, NIH, Bethesda, MD 20892 USA.	millers@nei.nih.gov		Maminishkis, Arvydas/0000-0003-3345-3375	National Institutes of Health [R01-EY018586]; NATIONAL EYE INSTITUTE [ZIAEY000419, R01EY018586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Intramural Research Program of the National Institutes of Health (SSM, RL, TB and AM) and National Institutes of Health grant R01-EY018586 (RW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adijanto J, 2009, J GEN PHYSIOL, V133, P603, DOI 10.1085/jgp.200810169; ADLER R, 1979, SCIENCE, V204, P1434, DOI 10.1126/science.451576; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Beltran WA, 2005, MOL VIS, V11, P232; Beltran WA, 2003, INVEST OPHTH VIS SCI, V44, P3642, DOI 10.1167/iovs.02-0763; Bhutto IA, 2006, EXP EYE RES, V82, P99, DOI 10.1016/j.exer.2005.05.007; Cayouette M, 1997, HUM GENE THER, V8, P423, DOI 10.1089/hum.1997.8.4-423; Cayouette M, 1998, J NEUROSCI, V18, P9282; Chong NHV, 1999, INVEST OPHTH VIS SCI, V40, P1298; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; Do Rhee K, 2010, ADV EXP MED BIOL, V664, P647, DOI 10.1007/978-1-4419-1399-9_74; Dunker N, 2001, DEVELOPMENT, V128, P1933; Dunker N, 2000, EUR J BIOCHEM, V267, P6982, DOI 10.1046/j.1432-1327.2000.01825.x; Dutt K, 2010, IN VITRO CELL DEV-AN, V46, P635, DOI 10.1007/s11626-010-9319-x; EDELMAN JL, 1991, INVEST OPHTH VIS SCI, V32, P3033; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Folk JC, 2010, NEW ENGL J MED, V363, P1648, DOI 10.1056/NEJMct1000495; Fuhrmann S, 1998, J COMP NEUROL, V400, P244; Glazer Liane Clamen, 2002, Ophthalmol Clin North Am, V15, P93, DOI 10.1016/S0896-1549(01)00011-6; GRANT MB, 1990, CURR EYE RES, V9, P323, DOI 10.3109/02713689008999620; Grisanti S, 2008, PROG RETIN EYE RES, V27, P372, DOI 10.1016/j.preteyeres.2008.05.002; HAMILTON WK, 1989, OPHTHALMOLOGY, V96, P1755; Harada T, 2000, NEURON, V26, P533, DOI 10.1016/S0896-6273(00)81185-X; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hertle D, 2008, CELL TISSUE RES, V334, P7, DOI 10.1007/s00441-008-0651-3; HUGHES BA, 1984, J GEN PHYSIOL, V83, P875, DOI 10.1085/jgp.83.6.875; JIANG CW, 1993, SCIENCE, V262, P424, DOI 10.1126/science.8211164; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kalb R, 2005, TRENDS NEUROSCI, V28, P5, DOI 10.1016/j.tins.2004.11.003; Kanda A, 2008, BRIT J OPHTHALMOL, V92, P448, DOI 10.1136/bjo.2007.131581; Kvanta A, 1996, INVEST OPHTH VIS SCI, V37, P1929; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Li R, 2007, INVEST OPHTH VIS SCI, V48, P5722, DOI 10.1167/iovs.07-0327; Li R, 2009, INVEST OPHTH VIS SCI, V50, P5988, DOI 10.1167/iovs.09-3591; Li R, 2009, AM J PHYSIOL-CELL PH, V297, pC1452, DOI 10.1152/ajpcell.00255.2009; Li YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009495; LINDSAY RM, 1994, PROG BRAIN RES, V103, P3; Maminishkis A, 2002, INVEST OPHTH VIS SCI, V43, P3555; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Mata NL, 2010, CURR OPIN OPHTHALMOL, V21, P190, DOI 10.1097/ICU.0b013e32833866c8; MILLER SS, 1982, P NATL ACAD SCI-BIOL, V79, P2111, DOI 10.1073/pnas.79.6.2111; Miller SS, 2010, ENCY EYE, V4, P89; Miyajima A, 2000, CYTOKINE GROWTH F R, V11, P177, DOI 10.1016/S1359-6101(00)00003-4; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; MOLDAY RS, 1987, J CELL BIOL, V105, P2589, DOI 10.1083/jcb.105.6.2589; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; Nowak JZ, 2006, PHARMACOL REP, V58, P353; Nussenblatt RB, 2007, AM J OPHTHALMOL, V144, P618, DOI 10.1016/j.ajo.2007.06.025; Parapuram SK, 2009, INVEST OPHTH VIS SCI, V50, P5965, DOI 10.1167/iovs.09-3621; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Peterson WM, 2000, J NEUROSCI, V20, P4081; Rhee KD, 2003, MOL VIS, V9, P715; Sahel J, 2010, DEV OPHTHALMOL, V47, P160, DOI 10.1159/000320079; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Seydewitz V, 2004, INVEST OPHTH VIS SCI, V45, P655, DOI 10.1167/iovs.03-0182; Shams Naveed, 2006, Ophthalmol Clin North Am, V19, P335; Shi G, 2008, INVEST OPHTH VIS SCI, V49, P4620, DOI 10.1167/iovs.08-1816; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Song Y, 2003, INVEST OPHTH VIS SCI, V44, P4069, DOI 10.1167/iovs.02-1130; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STAHL N, 1994, J NEUROBIOL, V25, P1454, DOI 10.1002/neu.480251111; Standiford Theodore J., 1993, Regional Immunology, V5, P134; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Talcott KE, 2011, INVEST OPHTH VIS SCI, V52, P2219, DOI 10.1167/iovs.10-6479; Valter K, 2003, BRAIN RES, V985, P169, DOI 10.1016/S0006-8993(03)03130-5; Vinores SA, 2001, HISTOL HISTOPATHOL, V16, P1061, DOI 10.14670/HH-16.1061; Vives-Bauza C, 2008, J BIOL CHEM, V283, P24770, DOI 10.1074/jbc.M800706200; Wahlin K, 2004, MOL VIS, V10, P366; Wahlin KJ, 2000, INVEST OPHTH VIS SCI, V41, P927; Wahlin KJ, 2001, EXP EYE RES, V73, P693, DOI 10.1006/exer.2001.1078; Walsh N, 2001, EXP EYE RES, V72, P495, DOI 10.1006/exer.2000.0984; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856; WEN R, 1995, J NEUROSCI, V15, P7377; Wen R, 1998, CURR EYE RES, V17, P494, DOI 10.1076/ceyr.17.5.494.5186; Wen R, 2008, ADV EXP MED BIOL, V613, P407, DOI 10.1007/978-0-387-74904-4_48; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; WONG V, 1993, EUR J NEUROSCI, V5, P466, DOI 10.1111/j.1460-9568.1993.tb00513.x; Xia X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018282; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598	81	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e23148	10.1371/journal.pone.0023148	http://dx.doi.org/10.1371/journal.pone.0023148			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912637	Green Published, Green Submitted			2022-12-25	WOS:000294686100002
J	Meireles, AM; Dzhindzhev, NS; Ohkura, H				Meireles, Ana M.; Dzhindzhev, Nikola S.; Ohkura, Hiroyuki			Kebab: Kinetochore and EB1 Associated Basic Protein That Dynamically Changes Its Localisation during Drosophila Mitosis	PLOS ONE			English	Article							PLUS-END-TRACKING; MICROTUBULE ATTACHMENT; CENP-A; COMPLEX; REQUIRES; CENTROMERE; SPINDLE; SIGNAL	Microtubule plus ends are dynamic ends that interact with other cellular structures. Microtubule plus end tracking proteins are considered to play important roles in the regulation of microtubule plus ends. Recent studies revealed that EB1 is the central regulator for microtubule plus end tracking proteins by recruiting them to microtubule plus ends through direct interaction. Here we report the identification of a novel Drosophila protein, which we call Kebab (kinetochore and EB1 associated basic protein), through in vitro expression screening for EB1-interacting proteins. Kebab fused to GFP shows a novel pattern of dynamic localisation in mitosis. It localises to kinetochores weakly in metaphase and accumulates progressively during anaphase. In telophase, it associates with microtubules in central-spindle and centrosomal regions. The localisation to kinetochores depends on microtubules. The protein has a domain most similar to the atypical CH domain of Ndc80, and a coiled-coil domain. The interaction with EB1 is mediated by two SxIP motifs but is not required for the localisation. Depletion of Kebab in cultured cells by RNA interference did not show obvious defects in mitotic progression or microtubule organisation. Generation of mutants lacking the kebab gene indicated that Kebab is dispensable for viability and fertility.	[Meireles, Ana M.; Dzhindzhev, Nikola S.; Ohkura, Hiroyuki] Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Meireles, AM (corresponding author), Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	h.ohkura@ed.ac.uk		Dzhindzhev, Nikola/0000-0001-9866-3600; Ohkura, Hiroyuki/0000-0003-4059-431X	Wellcome Trust [081849]	Wellcome Trust(Wellcome TrustEuropean Commission)	This study is funded by The Wellcome Trust (081849; www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Ashburner M., 2004, DROSOPHILA LAB HDB; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; CASSIMERIS L, 1993, CELL MOTIL CYTOSKEL, V26, P275, DOI 10.1002/cm.970260402; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Dzhindzhev NS, 2005, J CELL SCI, V118, P3781, DOI 10.1242/jcs.02504; Ferrand A, 2009, BIOL CELL, V101, P221, DOI 10.1042/BC20080060; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Gu C, 2006, NEURON, V52, P803, DOI 10.1016/j.neuron.2006.10.022; Hanisch A, 2006, EMBO J, V25, P5504, DOI 10.1038/sj.emboj.7601426; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; King RW, 1997, SCIENCE, V277, P973, DOI 10.1126/science.277.5328.973; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Lagana A, 2010, NAT CELL BIOL, V12, P1186, DOI 10.1038/ncb2129; Lee LA, 2005, DEV CELL, V8, P435, DOI 10.1016/j.devcel.2004.12.008; Lustig KD, 1997, METHOD ENZYMOL, V283, P83; Meireles M, 2009, J CELL BIOL, V184, P777, DOI 10.1083/jcb.200811102; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Rogers SL, 2004, CURR BIOL, V14, P1827, DOI 10.1016/j.cub.2004.09.078; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Slep KC, 2010, CURR OPIN CELL BIOL, V22, P88, DOI 10.1016/j.ceb.2009.10.009; SU LK, 1995, CANCER RES, V55, P2972; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Tirnauer JS, 2002, MOL BIOL CELL, V13, P4308, DOI 10.1091/mbc.e02-04-0236; Vaughan KT, 2005, J CELL BIOL, V171, P197, DOI 10.1083/jcb.200509150; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186	40	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24174	10.1371/journal.pone.0024174	http://dx.doi.org/10.1371/journal.pone.0024174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912673	Green Published, gold, Green Submitted			2022-12-25	WOS:000294686100020
J	Timofeyeva, NA; Koval, VV; Ishchenko, AA; Saparbaev, MK; Fedorova, OS				Timofeyeva, Nadezhda A.; Koval, Vladimir V.; Ishchenko, Alexander A.; Saparbaev, Murat K.; Fedorova, Olga S.			Lys98 Substitution in Human AP Endonuclease 1 Affects the Kinetic Mechanism of Enzyme Action in Base Excision and Nucleotide Incision Repair Pathways	PLOS ONE			English	Article							HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE; DNA-REPAIR; ESCHERICHIA-COLI; EXOCYCLIC ADDUCT; SITE; CLEAVAGE; MUTAGENESIS; IDENTIFICATION; DEOXYRIBOSE; PRODUCTS	Human apurinic/apyrimidinic endonuclease 1 (APE1) is a key enzyme in the base excision repair (BER) and nucleotide incision repair (NIR) pathways. We recently analyzed the conformational dynamics and kinetic mechanism of wild-type (wt) protein, in a stopped-flow fluorescence study. In this study, we investigated the mutant enzyme APE1K98A using the same approach. Lys98 was known to hydrogen bond to the carboxyl group of Asp70, a residue implicated in binding the divalent metal ion. Our data suggested that the conformational selection and induced fit occur during the enzyme action. We expanded upon the evidence that APE1 can pre-exist in two conformations. The isomerization of an enzyme-product complex in the BER process and the additional isomerization stage of enzyme-substrate complex in the NIR process were established for APE1K98A. These stages had not been registered for the wtAPE1. We found that the K98A substitution resulted in a 12-fold reduction of catalytic constant of 59-phosphodiester bond hydrolysis in (3-hydroxytetrahydrofuran-2yl) methyl phosphate (F, tetrahydrofuran) containing substrate, and in 200-fold reduction in 5,6-dihydrouridine (DHU) containing substrate. Thus, the K98A substitution influenced NIR more than BER. We demonstrated that the K98A mutation influenced the formation of primary unspecific enzyme-substrate complex in a complicated manner, depending on the Mg2+ concentration and pH. This mutation obstructed the induced fit of enzyme in the complex with undamaged DNA and F-containing DNA and appreciably decreased the stability of primary complex upon interaction of enzyme with DNA, containing the natural apurinic/apyrimidinic (AP) site. Furthermore, it significantly delayed the activation of the less active form of enzyme during NIR and slowed down the conformational conversion of the complex of enzyme with the cleavage product of DHU-substrate. Our data revealed that APE1 uses the same active site to catalyze the cleavage of DHU- and AP-substrates.	[Timofeyeva, Nadezhda A.; Koval, Vladimir V.; Fedorova, Olga S.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia; [Ishchenko, Alexander A.; Saparbaev, Murat K.] Univ Paris 11, Inst Cancerol Gustave Roussy, CNRS, UMR8200, Villejuif, France	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Fedorova, OS (corresponding author), Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia.	fedorova@niboch.nsc.ru	Timofeyeva, Nadya/AAE-9249-2021; Ishchenko, Alexander/D-4133-2013; Saparbaev, Murat K/N-3225-2015; Fedorova, Olga S./E-1291-2013; Koval, Vladimir/G-3489-2013; Fedorova, Olga/ABE-6637-2020; Saparbaev, Murat/AAC-5478-2020	Timofeyeva, Nadya/0000-0002-3618-4257; Ishchenko, Alexander/0000-0002-0488-8858; Saparbaev, Murat K/0000-0002-4630-1074; Fedorova, Olga S./0000-0002-4001-7187; Koval, Vladimir/0000-0002-2577-2184; Fedorova, Olga/0000-0002-4001-7187; Saparbaev, Murat/0000-0002-4630-1074	Russian Foundation for Basic Research [10-04-00070]; Siberian Branch of the Russian Academy of Sciences [28, 48]; Russian Ministry of Education and Science [NSh-3185.2010.4, 02.740.11.0079, 02.740.11.5012]; Fondation de France [00012091]; Centre National de la Recherche Scientifique [PICS N5479-Russie]; Fondation pour la Recherche Medicale; Electricite de France [RB 2010]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Siberian Branch of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); Fondation de France(Fondation de France); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Electricite de France	This work was supported by grants from the Russian Foundation for Basic Research (10-04-00070), the Siberian Branch of the Russian Academy of Sciences (28, 48), from the Russian Ministry of Education and Science (NSh-3185.2010.4, 02.740.11.0079 and 02.740.11.5012) to N.A.T., V. V. K, O.S.F., and by grants from Fondation de France 00012091 to A. A. I. and Centre National de la Recherche Scientifique (http://www.cnrs.fr) [PICS N5479-Russie], Fondation pour la Recherche Medicale (http://www.frm.org) [EQUIPES FRM 2007], Electricite de France (http://www.edf.fr) Contrat Radioprotection [RB 2010] to M. K. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILLY V, 1989, BIOCHEM J, V259, P761, DOI 10.1042/bj2590761; BARZILAY G, 1995, NUCLEIC ACIDS RES, V23, P1544, DOI 10.1093/nar/23.9.1544; BARZILAY G, 1995, NAT STRUCT BIOL, V2, P561, DOI 10.1038/nsb0795-561; Beernink PT, 2001, J MOL BIOL, V307, P1023, DOI 10.1006/jmbi.2001.4529; Bhagwat M, 1996, BIOCHEMISTRY-US, V35, P659, DOI 10.1021/bi9522662; BOITEUX S, 1982, BIOCHEMISTRY-US, V21, P6746, DOI 10.1021/bi00269a020; Burrows CJ, 1998, CHEM REV, V98, P1109, DOI 10.1021/cr960421s; Daviet S, 2007, DNA REPAIR, V6, P8, DOI 10.1016/j.dnarep.2006.08.001; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; Fasman G.D, 1975, HDB BIOCH MOL BIOL N, V1; FURLONG EA, 1986, BIOCHEMISTRY-US, V25, P4344, DOI 10.1021/bi00363a025; Gelin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012241; Gorman MA, 1997, EMBO J, V16, P6548, DOI 10.1093/emboj/16.21.6548; Gros L, 2004, NUCLEIC ACIDS RES, V32, P73, DOI 10.1093/nar/gkh165; Gros L, 2002, ONCOGENE, V21, P8905, DOI 10.1038/sj.onc.1206005; Hang B, 1996, P NATL ACAD SCI USA, V93, P13737, DOI 10.1073/pnas.93.24.13737; Hang B, 1997, BIOCHEMISTRY-US, V36, P15411, DOI 10.1021/bi971367s; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Ishchenko AA, 2006, P NATL ACAD SCI USA, V103, P2564, DOI 10.1073/pnas.0508582103; Ishchenko AA, 2004, BIOCHEMISTRY-US, V43, P15210, DOI 10.1021/bi049214+; Ishchenko AA, 2003, NUCLEIC ACIDS RES, V31, P6344, DOI 10.1093/nar/gkg812; Izumi T, 1999, J MOL BIOL, V287, P47, DOI 10.1006/jmbi.1999.2573; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Krokan HE, 1997, BIOCHEM J, V325, P1; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; Maher RL, 2007, J BIOL CHEM, V282, P30577, DOI 10.1074/jbc.M704341200; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Oezguen N, 2007, PROTEINS, V68, P313, DOI 10.1002/prot.21397; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P5519, DOI 10.1093/nar/19.20.5519; Sambrook J, 2001, MOL CLONING LAB MANU; Timofeyeva NA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P273, DOI 10.1134/S0006297911020155; Timofeyeva NA, 2009, J BIOMOL STRUCT DYN, V26, P637, DOI 10.1080/07391102.2009.10507278	36	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24063	10.1371/journal.pone.0024063	http://dx.doi.org/10.1371/journal.pone.0024063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21912662	Green Published, gold, Green Submitted			2022-12-25	WOS:000294683900025
J	von Hahn, T; Schulze, A; Wust, IC; Heidrich, B; Becker, T; Steinmann, E; Helfritz, FA; Rohrmann, K; Urban, S; Manns, MP; Pietschmann, T; Ciesek, S				von Hahn, Thomas; Schulze, Andreas; Wust, Ivan Chicano; Heidrich, Benjamin; Becker, Thomas; Steinmann, Eike; Helfritz, Fabian A.; Rohrmann, Katrin; Urban, Stephan; Manns, Michael P.; Pietschmann, Thomas; Ciesek, Sandra			The Novel Immunosuppressive Protein Kinase C Inhibitor Sotrastaurin Has No Pro-Viral Effects on the Replication Cycle of Hepatitis B or C Virus	PLOS ONE			English	Article							INFECTION; AEB071; CELLS; GENE; PKC; HBV	The pan-protein kinase C (PKC) inhibitor sotrastaurin (AEB071) is a novel immunosuppressant currently in phase II trials for immunosuppression after solid organ transplantation. Besides T-cell activation, PKC affects numerous cellular processes that are potentially important for the replication of hepatitis B virus (HBV) and hepatitis C virus (HCV), major blood-borne pathogens prevalent in solid organ transplant recipients. This study uses state of the art virological assays to assess the direct, non-immune mediated effects of sotrastaurin on HBV and HCV. Most importantly, sotrastaurin had no pro-viral effect on either HBV or HCV. In the presence of high concentrations of sotrastaurin, well above those used clinically and close to levels where cytotoxic effects become detectable, there was a reduction of HCV and HBV replication. This reduction is very likely due to cytotoxic and/or anti-proliferative effects rather than direct anti-viral activity of the drug. Replication cycle stages other than genome replication such as viral cell entry and spread of HCV infection directly between adjacent cells was clearly unaffected by sotrastaurin. These data support the evaluation of sotrastaurin in HBV and/or HCV infected transplant recipients.	[von Hahn, Thomas; Wust, Ivan Chicano; Heidrich, Benjamin; Rohrmann, Katrin; Manns, Michael P.; Ciesek, Sandra] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany; [Schulze, Andreas; Urban, Stephan] Univ Heidelberg Hosp, Dept Infect Dis, Otto Meyerhof Zentrum, Heidelberg, Germany; [Becker, Thomas; Helfritz, Fabian A.] Hannover Med Sch, Dept Visceral & Transplant Surg, D-3000 Hannover, Germany; [Steinmann, Eike; Pietschmann, Thomas; Ciesek, Sandra] Ctr Expt & Clin Infect Res, Div Expt Virol, TWINCORE, Hannover, Germany	Hannover Medical School; Ruprecht Karls University Heidelberg; Hannover Medical School	von Hahn, T (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany.	ciesek.sandra@mh-hannover.de	Pietschmann, Thomas/E-9241-2015; Ciesek, Sandra/AAO-4719-2020	Pietschmann, Thomas/0000-0001-5138-6239; Ciesek, Sandra/0000-0002-1802-7565; Steinmann, Eike/0000-0002-3654-9965	Deutsche Forschungsgemeinschaft [HA4393/2-1, Ci171/2-1]; Novartis	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Novartis(Novartis)	This work was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de) HA4393/2-1 to TH and Ci171/2-1 to SC and DFG "Open Access Publication". While several of the authors are recipients of grants from Novartis, none of these grants funded any of the research presented in this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldick CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001086; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brown RS, 2005, NATURE, V436, P973, DOI 10.1038/nature04083; Ciesek S, 2010, GASTROENTEROLOGY, V138, P1875, DOI 10.1053/j.gastro.2010.02.004; Ciesek S, 2009, HEPATOLOGY, V50, P1638, DOI 10.1002/hep.23281; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Evenou JP, 2009, J PHARMACOL EXP THER, V330, P792, DOI 10.1124/jpet.109.153205; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Huskey J, 2011, NAT REV NEPHROL, V7, P156, DOI 10.1038/nrneph.2010.192; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Kang-Park S, 2001, BIOCHEM BIOPH RES CO, V283, P303, DOI 10.1006/bbrc.2001.4767; KEKULE AS, 1993, NATURE, V361, P742, DOI 10.1038/361742a0; Kovarik JM, 2011, TRANSPLANTATION, V91, P317, DOI 10.1097/TP.0b013e318203860d; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Manicassamy S, 2009, CURR OPIN INVEST DR, V10, P1225; Mee CJ, 2010, GASTROENTEROLOGY, V138, P1134, DOI 10.1053/j.gastro.2009.11.047; Murakami Y, 2009, ANTIVIR RES, V83, P112, DOI 10.1016/j.antiviral.2009.03.008; Nomura-Takigawa Y, 2006, J GEN VIROL, V87, P1935, DOI 10.1099/vir.0.81701-0; Schulze A, 2010, J VIROL, V84, P1989, DOI 10.1128/JVI.01902-09; Skvara H, 2008, J CLIN INVEST, V118, P3151, DOI 10.1172/JCI35636; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; Stockl L, 2003, ONCOGENE, V22, P2604, DOI 10.1038/sj.onc.1206320; TURKASPA R, 1986, P NATL ACAD SCI USA, V83, P1627, DOI 10.1073/pnas.83.6.1627; VALLETPICHARD A, 2011, J HEPATOL	25	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24142	10.1371/journal.pone.0024142	http://dx.doi.org/10.1371/journal.pone.0024142			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909416	Green Published, gold, Green Submitted			2022-12-25	WOS:000294683900032
J	Harley, KG; Huen, K; Schall, RA; Holland, NT; Bradman, A; Barr, DB; Eskenazi, B				Harley, Kim G.; Huen, Karen; Schall, Raul Aguilar; Holland, Nina T.; Bradman, Asa; Barr, Dana Boyd; Eskenazi, Brenda			Association of Organophosphate Pesticide Exposure and Paraoxonase with Birth Outcome in Mexican-American Women	PLOS ONE			English	Article							SERUM PARAOXONASE; OXIDATIVE STRESS; DEVELOPMENTAL NEUROTOXICITY; PRENATAL EXPOSURE; ENZYME-ACTIVITY; PON1; POLYMORPHISMS; CHLORPYRIFOS; PREGNANCY; GENE	Background: Epidemiologic studies suggest that maternal organophosphorus (OP) pesticide exposure is associated with poorer fetal growth, but findings are inconsistent. We explored whether paraoxonase (PON1), a key enzyme involved in detoxification of OPs, could be an effect modifier in this association. Methods: The study population included 470 pregnant women enrolled in the CHAMACOS Study, a longitudinal cohort study of mothers and children living in an agricultural region of California. We analyzed urine samples collected from mothers twice during pregnancy for dialkyl phosphate (DAP) metabolites of OP pesticides. We analyzed maternal and fetal (cord) blood samples for PON1 genotype (PON1(192) and PON1(-108)) and enzyme activity (paraoxonase and arylesterase). Infant birth weight, head circumference, and gestational age were obtained from medical records. Results: Infants' PON1 genotype and activity were associated with birth outcome, but mothers' were not. Infants with the susceptible PON1(-108TT) genotype had shorter gestational age (beta = -0.5 weeks, 95% Confidence Interval (CI): -0.9, 0.0) and smaller head circumference (beta = -0.4 cm, 95% CI: -0.7, 0.0) than those with the PON1(-108CC) genotype. Infants' arylesterase and paraoxonase activity were positively associated with gestational age. There was some evidence of effect modification with DAPs: maternal DAP concentrations were associated with shorter gestational age only among infants of the susceptible PON1(-108TT) genotype (p-value(interaction) = 0.09). However, maternal DAP concentrations were associated with larger birth weight (p-value(interaction) = 0.06) and head circumference (p-value(interaction) <0.01) in infants with non-susceptible genotypes. Conclusions: Infants whose PON1 genotype and enzyme activity levels suggested that they might be more susceptible to the effects of OP pesticide exposure had decreased fetal growth and length of gestation. PON1 may be another factor contributing to preterm or low birth weight birth.	[Harley, Kim G.; Huen, Karen; Schall, Raul Aguilar; Holland, Nina T.; Bradman, Asa; Eskenazi, Brenda] Univ Calif Berkeley, Sch Publ Hlth, Ctr Environm Res & Childrens Hlth, Berkeley, CA 94720 USA; [Barr, Dana Boyd] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	University of California System; University of California Berkeley; Emory University; Rollins School Public Health	Harley, KG (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Ctr Environm Res & Childrens Hlth, Berkeley, CA 94720 USA.	kharley@berkeley.edu	Barr, Dana B/E-2276-2013; Barr, Dana B/E-6369-2011	Huen, Karen/0000-0003-3604-2096	National Institute of Environmental Health Sciences [PO1 ES009605, RO1 ES012503]; U.S. Environmental Protection Agency [RD 826709-01-1]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES009605, R01ES012503] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U.S. Environmental Protection Agency(United States Environmental Protection Agency); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by PO1 ES009605 and RO1 ES012503 from the National Institute of Environmental Health Sciences (www.niehs.gov) and RD 826709-01-1 from the U.S. Environmental Protection Agency (epa.gov/ncer/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviram M, 2004, FREE RADICAL BIO MED, V37, P1304, DOI 10.1016/j.freeradbiomed.2004.06.030; Barr DB, 2010, SCI TOTAL ENVIRON, V408, P790, DOI 10.1016/j.scitotenv.2009.10.007; Berkowitz GS, 2004, ENVIRON HEALTH PERSP, V112, P388, DOI 10.1289/ehp.6414; Bradman A, 2005, ENVIRON HEALTH PERSP, V113, P1802, DOI 10.1289/ehp.7894; Bravo R, 2002, J ANAL TOXICOL, V26, P245, DOI 10.1093/jat/26.5.245; Breslin WJ, 1996, FUND APPL TOXICOL, V29, P119, DOI 10.1006/faat.1996.0013; CHANDA SM, 1995, J TOXICOL ENV HEALTH, V44, P189, DOI 10.1080/15287399509531954; Chen DF, 2004, EPIDEMIOLOGY, V15, P466, DOI 10.1097/01.ede.0000129509.59912.b2; Connelly PW, 2008, J LIPID RES, V49, P245, DOI 10.1194/jlr.D700022-JLR200; Costa LG, 2003, ANNU REV MED, V54, P371, DOI 10.1146/annurev.med.54.101601.152421; Costa LG, 2003, BIOMARKERS, V8, P1, DOI 10.1080/13547500210148315; Deakin S, 2003, BIOCHEM J, V372, P643, DOI 10.1042/BJ20021670; Deakin SP, 2004, CLIN SCI, V107, P435, DOI 10.1042/CS20040187; Eskenazi B, 2004, ENVIRON HEALTH PERSP, V112, P1116, DOI 10.1289/ehp.6789; ESKENAZI B, 2010, ENV HLTH PERSPECT; Furlong CE, 2010, CHEM-BIOL INTERACT, V187, P355, DOI 10.1016/j.cbi.2010.03.033; Furlong CE, 2006, PHARMACOGENET GENOM, V16, P183; Holland N, 2006, ENVIRON HEALTH PERSP, V114, P985, DOI 10.1289/ehp.8540; HUEN K, ENV MOL MUT IN PRESS; Huen K, 2009, CLIN CHIM ACTA, V402, P67, DOI 10.1016/j.cca.2008.12.019; KEILY T, 2004, PESTICIDES IND SALES; Kujiraoka T, 2000, J LIPID RES, V41, P1358; Lawlor DA, 2006, PAEDIATR PERINAT EP, V20, P244, DOI 10.1111/j.1365-3016.2006.00716.x; Li HL, 2003, J MOL MED, V81, P766, DOI 10.1007/s00109-003-0481-4; Li WF, 2000, PHARMACOGENETICS, V10, P767, DOI 10.1097/00008571-200012000-00002; Maurissen JPJ, 2000, TOXICOL SCI, V57, P250, DOI 10.1093/toxsci/57.2.250; Min J, 2006, REPROD TOXICOL, V22, P418, DOI 10.1016/j.reprotox.2006.01.003; Moreno-Banda G, 2009, SCI TOTAL ENVIRON, V407, P5478, DOI 10.1016/j.scitotenv.2009.06.033; MUTO MA, 1992, VET HUM TOXICOL, V34, P498; Qiao D, 2002, ENVIRON HEALTH PERSP, V110, P1097, DOI 10.1289/ehp.021101097; RICHTER RJ, 2004, CURRENT PROTOCOLS TO; ROY AC, 1994, GYNECOL OBSTET INVES, V38, P10, DOI 10.1159/000292435; Ryckman KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009040; SPYKER JM, 1977, J TOXICOL ENV HEALTH, V3, P989, DOI 10.1080/15287397709529633; Srivastava M. K., 1996, Indian Journal of Experimental Biology, V34, P329; Stoltz DA, 2008, J CLIN INVEST, V118, P3123, DOI 10.1172/JCI35147; Weerasekera G, 2009, J ENVIRON MONITOR, V11, P1345, DOI 10.1039/b821841b; Whyatt RM, 2004, ENVIRON HEALTH PERSP, V112, P1125, DOI 10.1289/ehp.6641; Wolff MS, 2007, PEDIATR RES, V61, P243, DOI 10.1203/pdr.0b013e31802d77f0	39	67	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23923	10.1371/journal.pone.0023923	http://dx.doi.org/10.1371/journal.pone.0023923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904599	gold, Green Published, Green Submitted			2022-12-25	WOS:000294680800042
J	Wang, Y; Ballar, P; Zhong, YW; Zhang, XB; Liu, C; Zhang, YJ; Monteiro, MJ; Li, J; Fang, SY				Wang, Yang; Ballar, Petek; Zhong, Yongwang; Zhang, Xuebao; Liu, Chao; Zhang, Ying-Jiu; Monteiro, Mervyn J.; Li, Jun; Fang, Shengyun			SVIP Induces Localization of p97/VCP to the Plasma and Lysosomal Membranes and Regulates Autophagy	PLOS ONE			English	Article							UBIQUITIN LIGASE; PROTEIN; ATPASE; ER; DEGRADATION; RETROTRANSLOCATION; COMPLEX; GP78	The small p97/VCP-interacting protein (SVIP) functions as an inhibitor of the endoplasmic reticulum (ER)-associated degradation (ERAD) pathway. Here we show that overexpression of SVIP in HeLa cells leads to localization of p97/VCP at the plasma membrane, intracellular foci and juxtanuclear vacuoles. The p97/VCP-positive vacuolar structures colocalized or associated with LC3 and lamp1, suggesting that SVIP may regulate autophagy. In support of this possibility, knockdown of SVIP diminished, whereas overexpression of SVIP enhanced LC3 lipidation. Surprisingly, knockdown of SVIP reduced the levels of p62 protein at least partially through downregulation of its mRNA, which was accompanied by a decrease in starvation-induced formation of p62 bodies. Overexpression of SVIP, on the other hand, increased the levels of p62 protein and enhanced starvation-activated autophagy as well as promoted sequestration of polyubiquitinated proteins and p62 in autophagosomes. These results suggest that SVIP plays a regulatory role in p97 subcellular localization and is a novel regulator of autophagy.	[Wang, Yang; Zhang, Ying-Jiu] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China; [Wang, Yang; Ballar, Petek; Zhong, Yongwang; Liu, Chao; Monteiro, Mervyn J.; Fang, Shengyun] Univ Maryland, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Fang, Shengyun] Univ Maryland, Dept Physiol, Baltimore, MD 21201 USA; [Zhang, Xuebao; Li, Jun] Vanderbilt Univ, Dept Neurol, Nashville, TN USA	Jilin University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Vanderbilt University	Wang, Y (corresponding author), Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China.	sfang@umaryland.edu	Fang, Shengyun/H-3802-2011; Monteiro, Mervyn J/H-3813-2011; Zhong, Yongwang/A-2527-2012; Kirmizibayrak, Petek Ballar/Y-6869-2018	Kirmizibayrak, Petek Ballar/0000-0002-6189-1818; Fang, Shengyun/0000-0001-7280-5463	National Institutes of Health [5R01GM069967]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is funded by a grant from the National Institutes of Health (5R01GM069967) to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Ballar P, 2011, INT J BIOCHEM CELL B, V43, P613, DOI 10.1016/j.biocel.2010.12.021; Ding QX, 2003, J NEUROCHEM, V86, P489, DOI 10.1046/j.1471-4159.2003.01885.x; Haines Dale S, 2010, Genes Cancer, V1, P753; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kawakami T, 2009, NEPHROL DIAL TRANSPL, V24, P2665, DOI 10.1093/ndt/gfp215; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Nagahama M, 2003, MOL BIOL CELL, V14, P262, DOI 10.1091/mbc.02-07-0115; Naidu MD, 2010, J RADIAT RES, V51, P393, DOI 10.1269/jrr.09077; Noda T, 2009, CELL DEATH DIFFER, V16, P984, DOI 10.1038/cdd.2009.54; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Rothenberg C, 2010, HUM MOL GENET, V19, P3219, DOI 10.1093/hmg/ddq231; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Vij N, 2008, J CELL MOL MED, V12, P2511, DOI 10.1111/j.1582-4934.2008.00462.x; Yang H, 2007, EXP CELL RES, V313, P538, DOI 10.1016/j.yexcr.2006.10.031; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	30	16	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24478	10.1371/journal.pone.0024478	http://dx.doi.org/10.1371/journal.pone.0024478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909394	Green Submitted, Green Published, gold			2022-12-25	WOS:000294680800091
J	Carlsson, MA; Bisch-Knaden, S; Schapers, A; Mozuraitis, R; Hansson, BS; Janz, N				Carlsson, Mikael A.; Bisch-Knaden, Sonja; Schaepers, Alexander; Mozuraitis, Raimondas; Hansson, Bill S.; Janz, Niklas			Odour Maps in the Brain of Butterflies with Divergent Host-Plant Preferences	PLOS ONE			English	Article							MOTH SPODOPTERA-LITTORALIS; ANTENNAL LOBE; MANDUCA-SEXTA; OLFACTORY-BULB; SPHINX MOTH; SPATIAL REPRESENTATION; GLOMERULAR ACTIVITY; LEAF VOLATILES; APIS-MELLIFERA; FLORAL SCENTS	Butterflies are believed to use mainly visual cues when searching for food and oviposition sites despite that their olfactory system is morphologically similar to their nocturnal relatives, the moths. The olfactory ability in butterflies has, however, not been thoroughly investigated. Therefore, we performed the first study of odour representation in the primary olfactory centre, the antennal lobes, of butterflies. Host plant range is highly variable within the butterfly family Nymphalidae, with extreme specialists and wide generalists found even among closely related species. Here we measured odour evoked Ca2+ activity in the antennal lobes of two nymphalid species with diverging host plant preferences, the specialist Aglais urticae and the generalist Polygonia c-album. The butterflies responded with stimulus-specific combinations of activated glomeruli to single plant-related compounds and to extracts of host and non-host plants. In general, responses were similar between the species. However, the specialist A. urticae responded more specifically to its preferred host plant, stinging nettle, than P. c-album. In addition, we found a species-specific difference both in correlation between responses to two common green leaf volatiles and the sensitivity to these compounds. Our results indicate that these butterflies have the ability to detect and to discriminate between different plant-related odorants.	[Carlsson, Mikael A.; Schaepers, Alexander; Janz, Niklas] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Bisch-Knaden, Sonja; Hansson, Bill S.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany; [Mozuraitis, Raimondas] Royal Inst Technol, Dept Chem, Stockholm, Sweden; [Mozuraitis, Raimondas] Nat Res Ctr, Inst Ecol, Lab Chem & Behav Ecol, Vilnius, Lithuania	Stockholm University; Max Planck Society; Royal Institute of Technology; Nature Research Center - Lithuania	Carlsson, MA (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	mikael.carlsson@zoologi.su.se	Hansson, Bill S/G-2774-2013; Janz, Niklas/B-1756-2010	Hansson, Bill S/0000-0002-4811-1223; Janz, Niklas/0000-0002-6379-7905; Schapers, Alexander/0000-0002-3187-3555; /0000-0002-1719-2294	Swedish Research Council; Stockholm University Faculty of Science; Royal Swedish Academy of Science; Max Planck Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm University Faculty of Science; Royal Swedish Academy of Science; Max Planck Society(Max Planck SocietyFoundation CELLEX)	The project was financed by The Swedish Research Council (NJ), the Stockholm University Faculty of Science (NJ), the Royal Swedish Academy of Science (MAC), and the Max Planck Society (BSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERY PR, 1988, BIOL J LINN SOC, V33, P95, DOI 10.1111/j.1095-8312.1988.tb00446.x; Andersson S, 2003, J CHEM ECOL, V29, P2319, DOI 10.1023/A:1026278531806; Andersson S, 2003, CHEMOECOLOGY, V13, P13, DOI 10.1007/s000490300001; Angioy AM, 2003, CHEM SENSES, V28, P279, DOI 10.1093/chemse/28.4.279; Braby MF, 2006, ZOOL J LINN SOC-LOND, V147, P238; Brower AVZ, 2000, P ROY SOC B-BIOL SCI, V267, P1201, DOI 10.1098/rspb.2000.1129; Carlsson MA, 2003, CHEM SENSES, V28, P269, DOI 10.1093/chemse/28.4.269; Carlsson MA, 2002, CHEM SENSES, V27, P231, DOI 10.1093/chemse/27.3.231; Carlsson MA, 2007, CHEM SENSES, V32, P433, DOI 10.1093/chemse/bjm009; CHRISTENSEN TA, 1987, J COMP PHYSIOL A, V160, P553, DOI 10.1007/BF00611929; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dupuy F, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-28; Elbert G, 1993, SCHMETTERLINGE BADEN; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Galizia CG, 1998, EUR J NEUROSCI, V10, P2964, DOI 10.1111/j.1460-9568.1998.00303.x; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; Hamback PA, 2007, P NATL ACAD SCI USA, V104, P8368, DOI 10.1073/pnas.0611462104; HANSSON BS, 1992, SCIENCE, V256, P1313, DOI 10.1126/science.1598574; Hansson BS, 2003, J COMP PHYSIOL A, V189, P301, DOI 10.1007/s00359-003-0403-5; HANSSON BS, 1995, EXPERIENTIA, V51, P1003, DOI 10.1007/BF01946910; Ikeura H, 2010, BIOCHEM SYST ECOL, V38, P1199, DOI 10.1016/j.bse.2010.12.007; Janz N, 2003, OIKOS, V100, P493, DOI 10.1034/j.1600-0706.2003.12290.x; Janz N, 1997, P ROY SOC B-BIOL SCI, V264, P701, DOI 10.1098/rspb.1997.0100; Janz N, 2001, EVOLUTION, V55, P783, DOI 10.1554/0014-3820(2001)055[0783:EDOHPS]2.0.CO;2; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Johnson BA, 2004, J COMP NEUROL, V480, P234, DOI 10.1002/cne.20335; Kazawa T, 2009, CELL TISSUE RES, V336, P119, DOI 10.1007/s00441-009-0756-3; Masante-Roca I, 2005, J EXP BIOL, V208, P1147, DOI 10.1242/jeb.01508; Meijerink J, 2003, J COMP NEUROL, V467, P11, DOI 10.1002/cne.10914; NYLIN S, 1988, OIKOS, V53, P381, DOI 10.2307/3565539; Nylin S, 2000, J INSECT BEHAV, V13, P469, DOI 10.1023/A:1007839200323; Omura H, 2009, CHEMOECOLOGY, V19, P227, DOI 10.1007/s00049-009-0024-8; ROSPARS JP, 1992, CELL TISSUE RES, V270, P205, DOI 10.1007/BF00328007; ROSPARS JP, 1983, J COMP NEUROL, V220, P80, DOI 10.1002/cne.902200108; Sachse S, 2003, EUR J NEUROSCI, V18, P2119, DOI 10.1046/j.1460-9568.2003.02931.x; Schoonhoven LM, 2005, INSECT PLANT BIOL, Vxvii, P421; Utz S, 2005, CELL TISSUE RES, V320, P149, DOI 10.1007/s00441-004-1059-3; Utz S, 2007, DEV NEUROBIOL, V67, P764, DOI 10.1002/dneu.20381; Valentincic T, 2005, CHEM SENSES, V30, pI312, DOI 10.1093/chemse/bjh240; Varela N, 2009, CELL TISSUE RES, V337, P513, DOI 10.1007/s00441-009-0839-1; VISSER JH, 1978, ENTOMOL EXP APPL, V24, P738, DOI 10.1007/BF02385130; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wahlberg N, 2006, SYST BIOL, V55, P703, DOI 10.1080/10635150600913235; Wahlberg N, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-92; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Youngentob SL, 2006, BEHAV NEUROSCI, V120, P1337, DOI 10.1037/0735-7044.120.6.1337; Zhang QH, 1999, J CHEM ECOL, V25, P1923, DOI 10.1023/A:1020994119019	51	20	24	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e24025	10.1371/journal.pone.0024025	http://dx.doi.org/10.1371/journal.pone.0024025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901154	Green Published, gold			2022-12-25	WOS:000294298000039
J	Wang, CM; Liu, P; Yi, CX; Gu, KY; Sun, F; Li, L; Lo, LC; Liu, XK; Feng, F; Lin, G; Cao, SY; Hong, Y; Yin, ZC; Yue, GH				Wang, Chun Ming; Liu, Peng; Yi, Chengxin; Gu, Keyu; Sun, Fei; Li, Lei; Lo, Loong Chueng; Liu, Xiaokun; Feng, Felicia; Lin, Grace; Cao, Suying; Hong, Yan; Yin, Zhongchao; Yue, Gen Hua			A First Generation Microsatellite- and SNP-Based Linkage Map of Jatropha	PLOS ONE			English	Article							ASIAN SEA-BASS; CURCAS L.; MARKERS; GENOME; BIOFUEL; OIL; SSR; IDENTIFICATION; PLANT	Jatropha curcas is a potential plant species for biodiesel production. However, its seed yield is too low for profitable production of biodiesel. To improve the productivity, genetic improvement through breeding is essential. A linkage map is an important component in molecular breeding. We established a first-generation linkage map using a mapping panel containing two backcross populations with 93 progeny. We mapped 506 markers (216 microsatellites and 290 SNPs from ESTs) onto 11 linkage groups. The total length of the map was 1440.9 cM with an average marker space of 2.8 cM. Blasting of 222 Jatropha ESTs containing polymorphic SSR or SNP markers against EST-databases revealed that 91.0%, 86.5% and 79.2% of Jatropha ESTs were homologous to counterparts in castor bean, poplar and Arabidopsis respectively. Mapping 192 orthologous markers to the assembled whole genome sequence of Arabidopsis thaliana identified 38 syntenic blocks and revealed that small linkage blocks were well conserved, but often shuffled. The first generation linkage map and the data of comparative mapping could lay a solid foundation for QTL mapping of agronomic traits, marker-assisted breeding and cloning genes responsible for phenotypic variation.	[Wang, Chun Ming; Liu, Peng; Sun, Fei; Li, Lei; Lo, Loong Chueng; Feng, Felicia; Lin, Grace; Cao, Suying; Yue, Gen Hua] Natl Univ Singapore, Temasek Life Sci Lab, Mol Populat Genet Grp, Singapore 117548, Singapore; [Yi, Chengxin; Lo, Loong Chueng; Hong, Yan] Joil Pte Ltd, Singapore, Singapore; [Gu, Keyu; Yin, Zhongchao] Natl Univ Singapore, Temasek Life Sci Lab, Mol Plant Pathol Grp, Singapore 117548, Singapore; [Liu, Xiaokun; Hong, Yan] Natl Univ Singapore, Temasek Life Sci Lab, Plant Biotechnol Grp, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Wang, CM (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Mol Populat Genet Grp, Singapore 117548, Singapore.	genhua@tll.org.sg	Lin, Grace XL/F-9883-2011; Yue, GH/F-4801-2015; Hong, Yan/D-5106-2014	Lin, Grace XL/0000-0003-0867-3827; Yue, GH/0000-0002-3537-2248; Hong, Yan/0000-0002-2954-8788; Wang, Chunming/0000-0003-3780-8065	Joil Pte Ltd, Singapore; Temasek Life Sciences Laboratory, Singapore	Joil Pte Ltd, Singapore; Temasek Life Sciences Laboratory, Singapore	This project is financially supported by Joil Pte Ltd, Singapore and the internal fund of the Temasek Life Sciences Laboratory, Singapore. Three people (Yang Hong, Chengxin Yi and Loong Chueng Lo) from Joil Pte Ltd were involved in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brown JR, 2008, COMP GENOMICS BASIC; Carvalho CR, 2008, PLANT SCI, V174, P613, DOI 10.1016/j.plantsci.2008.03.010; Dear PH, 1997, GENOME MAPPING PRACT; Dekkers JCM, 2002, NAT REV GENET, V3, P22, DOI 10.1038/nrg701; Fairless D, 2007, NATURE, V449, P652, DOI 10.1038/449652a; Ganal MW, 2009, CURR OPIN PLANT BIOL, V12, P211, DOI 10.1016/j.pbi.2008.12.009; Goldstein D, 1999, MICROSATELLITES EVOL; Green P, 1990, DOCUMENTATION CRI MA; Gu KY, 2011, PLANT SCI, V180, P642, DOI 10.1016/j.plantsci.2011.01.007; Guimaraes Elcio P., 2007, MARKER ASSISTED SELE; Harushima Y, 1998, GENETICS, V148, P479; Hayashi M, 2001, DNA RES, V8, P301, DOI 10.1093/dnares/8.6.301; Hu XS, 2004, THEOR APPL GENET, V109, P996, DOI 10.1007/s00122-004-1705-x; Hwang TY, 2009, DNA RES, V16, P213, DOI 10.1093/dnares/dsp010; Jain S, 2010, RENEW SUST ENERG REV, V14, P3140, DOI 10.1016/j.rser.2010.07.047; Joachim H, 1996, PHYS NUT JATROPHA CU; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li F, 2009, DNA RES, V16, P311, DOI 10.1093/dnares/dsp020; Meksem K, 2005, HANDBOOK OF PLANT GENOME MAPPING: GENETIC AND PHYSICAL MAPPING, P1, DOI 10.1002/3527603514; Openshaw K, 2000, BIOMASS BIOENERG, V19, P1, DOI 10.1016/S0961-9534(00)00019-2; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; Sato S, 2011, DNA RES, V18, P65, DOI 10.1093/dnares/dsq030; Schuster SC, 2008, NATURE, P200; Shah S, 2005, BIORESOURCE TECHNOL, V96, P121, DOI 10.1016/j.biortech.2004.02.026; Sun QB, 2008, CROP SCI, V48, P1865, DOI 10.2135/cropsci2008.02.0074; Wang CM, 2007, GENETICS, V175, P907, DOI 10.1534/genetics.106.059972; Wang CM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-174; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Xia JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-356; Xia Z, 2007, DNA RES, V14, P257, DOI 10.1093/dnares/dsm027; Ye J, 2009, PLANT BIOTECHNOL J, V7, P964, DOI 10.1111/j.1467-7652.2009.00457.x; Yi CX, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-259; Yue GH, 2000, MOL ECOL, V9, P1007, DOI 10.1046/j.1365-294x.2000.00939-10.x; Zhang Y, 2007, ACTA BIOCH BIOPH SIN, V39, P787, DOI 10.1111/j.1745-7270.2007.00334.x	37	41	47	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23632	10.1371/journal.pone.0023632	http://dx.doi.org/10.1371/journal.pone.0023632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901124	gold, Green Published, Green Submitted			2022-12-25	WOS:000294298000009
J	Cornish, AJ; Gartner, K; Yang, H; Peters, JW; Hegg, EL				Cornish, Adam J.; Gaertner, Katrin; Yang, Hui; Peters, John W.; Hegg, Eric L.			Mechanism of Proton Transfer in [FeFe]-Hydrogenase from Clostridium pasteurianum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-ONLY HYDROGENASE; ACTIVE-SITE; IRON HYDROGENASE; H-CLUSTER; COORDINATION; INHIBITION; MATURATION; REDUCTION; TRANSPORT; OXYGEN	[FeFe]-Hydrogenases are complex metalloproteins that catalyze the reversible reduction of protons to molecular hydrogen utilizing a unique diiron subcluster bridged to a [4Fe4S] subcluster. Extensive studies have concentrated on the nature and catalytic activity of the active site, yet relatively little information is available concerning the mechanism of proton transport that is required for this activity. Previously, structural characterization of [FeFe]-hydrogenase from Clostridium pasteurianum indicated a potential proton transport pathway involving four residues (Cys-299, Glu-279, Ser-319, and Glu-282) that connect the active site to the enzyme surface. Here, we demonstrate that substitution of any of these residues resulted in a drastic reduction in hydrogenase activity relative to the native enzyme, supporting the importance of these residues in catalysis. Inhibition studies of native and amino acid-substituted enzymes revealed that Zn2+ specifically blocked proton transfer by binding to Glu-282, confirming the role of this residue in the identified pathway. In addition, all four of these residues are strictly conserved, suggesting that they may form a proton transport pathway that is common to all [FeFe]-hydrogenases.	[Cornish, Adam J.; Gaertner, Katrin; Yang, Hui; Hegg, Eric L.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Peters, John W.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Peters, John W.] Montana State Univ, Astrobiol Biogeocatalysis Res Ctr, Bozeman, MT 59717 USA	Michigan State University; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Hegg, EL (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	erichegg@msu.edu		Peters, John/0000-0001-9117-9568	Air Force Office of Scientific Research [FA9550-05-1-0365]; United States Department of Energy Great Lakes Bioenergy Research Center (Biological and Environmental Research Office of Science) [DE-FC02-07ER64494]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); United States Department of Energy Great Lakes Bioenergy Research Center (Biological and Environmental Research Office of Science)(United States Department of Energy (DOE))	This work was supported by Air Force Office of Scientific Research Grant FA9550-05-1-0365 and by the United States Department of Energy Great Lakes Bioenergy Research Center (Biological and Environmental Research Office of Science Grant DE-FC02-07ER64494).	ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bethel RD, 2010, ANGEW CHEM INT EDIT, V49, P8567, DOI 10.1002/anie.201003747; Chang YH, 2007, J BIOL CHEM, V282, P34306, DOI 10.1074/jbc.M706336200; Cukierman S, 2006, BBA-BIOENERGETICS, V1757, P876, DOI 10.1016/j.bbabio.2005.12.001; Czech I, 2011, FEBS LETT, V585, P225, DOI 10.1016/j.febslet.2010.11.052; Dementin S, 2004, J BIOL CHEM, V279, P10508, DOI 10.1074/jbc.M312716200; English CM, 2009, DALTON T, P9970, DOI 10.1039/b913426n; Faxen K, 2006, BBA-BIOENERGETICS, V1757, P388, DOI 10.1016/j.bbabio.2006.05.010; FERNANDEZ VM, 1989, EUR J BIOCHEM, V185, P449, DOI 10.1111/j.1432-1033.1989.tb15135.x; Florin L, 2001, J BIOL CHEM, V276, P6125, DOI 10.1074/jbc.M008470200; Fontecilla-Camps JC, 2009, NATURE, V460, P814, DOI 10.1038/nature08299; Frey M, 2002, CHEMBIOCHEM, V3, P153, DOI 10.1002/1439-7633(20020301)3:2/3<153::AID-CBIC153>3.0.CO;2-B; Fujii M, 2009, GENES CELLS, V14, P457, DOI 10.1111/j.1365-2443.2009.01282.x; Ghirardi ML, 2007, ANNU REV PLANT BIOL, V58, P71, DOI 10.1146/annurev.arplant.58.032806.103848; Goldet G, 2009, J AM CHEM SOC, V131, P14979, DOI [10.1021/ja905388j, 10.1021/ja905388i]; Hong G, 2011, BBA-BIOENERGETICS, V1807, P510, DOI 10.1016/j.bbabio.2011.01.011; KAMACHI T, 1995, J MOL CATAL A-CHEM, V96, P329, DOI 10.1016/1381-1169(94)00057-3; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lautier T, 2011, FARADAY DISCUSS, V148, P385, DOI 10.1039/c004099c; Liebgott PP, 2010, NAT CHEM BIOL, V6, P63, DOI [10.1038/NCHEMBIO.276, 10.1038/nchembio.276]; Marshall MJ, 2008, ENVIRON MICROBIOL, V10, P125, DOI 10.1111/j.1462-2920.2007.01438.x; Moulis JM, 1995, BIOCHEMISTRY-US, V34, P16781, DOI 10.1021/bi00051a028; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; NAGLE JF, 1978, P NATL ACAD SCI USA, V75, P298, DOI 10.1073/pnas.75.1.298; Nicolet Y, 2000, TRENDS BIOCHEM SCI, V25, P138, DOI 10.1016/S0968-0004(99)01536-4; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2001, J AM CHEM SOC, V123, P1596, DOI 10.1021/ja0020963; Ozawa K, 2001, BIOSCI BIOTECH BIOCH, V65, P185, DOI 10.1271/bbb.65.185; Pandey AS, 2008, J AM CHEM SOC, V130, P4533, DOI 10.1021/ja711187e; Peters JW, 1999, CURR OPIN STRUC BIOL, V9, P670, DOI 10.1016/S0959-440X(99)00028-7; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Schultz BE, 2001, ANNU REV BIOPH BIOM, V30, P23, DOI 10.1146/annurev.biophys.30.1.23; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Shepard EM, 2010, P NATL ACAD SCI USA, V107, P10448, DOI 10.1073/pnas.1001937107; Silakov A, 2009, PHYS CHEM CHEM PHYS, V11, P6592, DOI 10.1039/b905841a; Stripp ST, 2009, P NATL ACAD SCI USA, V106, P17331, DOI 10.1073/pnas.0905343106; Takahashi E, 2006, J BIOL CHEM, V281, P4413, DOI 10.1074/jbc.M511359200; TAKAHASHI E, 1991, FEBS LETT, V283, P140, DOI 10.1016/0014-5793(91)80572-K; Vannucci AK, 2010, DALTON T, V39, P3050, DOI 10.1039/b921067a; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Whitehead SJ, 2009, BBA-BIOENERGETICS, V1787, P1276, DOI 10.1016/j.bbabio.2009.06.001; Wright JA, 2009, CHEM COMMUN, P5719, DOI 10.1039/b912499c; Xu JC, 2005, P NATL ACAD SCI USA, V102, P6795, DOI 10.1073/pnas.0408117102; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	46	84	84	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38341	38347		10.1074/jbc.M111.254664	http://dx.doi.org/10.1074/jbc.M111.254664			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900241	hybrid, Green Published			2022-12-25	WOS:000296594200047
J	Hirano, T; Serve, O; Yagi-Utsumi, M; Takemoto, E; Hiromoto, T; Satoh, T; Mizushima, T; Kato, K				Hirano, Takashi; Serve, Olivier; Yagi-Utsumi, Maho; Takemoto, Emi; Hiromoto, Takeshi; Satoh, Tadashi; Mizushima, Tsunehiro; Kato, Koichi			Conformational Dynamics of Wild-type Lys-48-linked Diubiquitin in Solution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; 26 S PROTEASOME; POLYUBIQUITIN CHAINS; LYS48-LINKED TETRAUBIQUITIN; INTERDOMAIN MOBILITY; CRYSTAL-STRUCTURE; BINDING DOMAINS; PROTEIN; NMR; MODEL	Proteasomal degradation is mediated through modification of target proteins by Lys-48-linked polyubiquitin (polyUb) chain, which interacts with several binding partners in this pathway through hydrophobic surfaces on individual Ub units. However, the previously reported crystal structures of Lys-48-linked diUb exhibit a closed conformation with sequestered hydrophobic surfaces. NMR studies on mutated Lys-48-linked diUb indicated a pH-dependent conformational equilibrium between closed and open states with the predominance of the former under neutral conditions (90% at pH 6.8). To address the question of how Ub-binding proteins can efficiently access the sequestered hydrophobic surfaces of Ub chains, we revisited the conformational dynamics of Lys-48-linked diUb in solution using wild-type diUb and cyclic forms of diUb in which the Ub units are connected through two Lys-48-mediated isopeptide bonds. Our newly determined crystal structure of wild-type diUb showed an open conformation, whereas NMR analyses of cyclic Lys-48-linked diUb in solution revealed that its structure resembled the closed conformation observed in previous crystal structures. Comparison of a chemical shift of wild-type diUb with that of monomeric Ub and cyclic diUb, which mimic the open and closed states, respectively, with regard to the exposure of hydrophobic surfaces to the solvent indicates that wild-type Lys-48-linked diUb in solution predominantly exhibits the open conformation (75% at pH 7.0), which becomes more populated upon lowering pH. The intrinsic properties of Lys-48-linked Ub chains to adopt the open conformation may be advantageous for interacting with Ub-binding proteins.	[Hirano, Takashi; Serve, Olivier; Yagi-Utsumi, Maho; Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Hirano, Takashi; Serve, Olivier; Yagi-Utsumi, Maho; Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Hirano, Takashi; Serve, Olivier; Yagi-Utsumi, Maho; Takemoto, Emi; Hiromoto, Takeshi; Satoh, Tadashi; Mizushima, Tsunehiro; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4678603, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Nagoya City University	Kato, K (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	kkatonmr@ims.ac.jp	Satoh, Tadashi/M-5157-2017	Satoh, Tadashi/0000-0002-4493-4978; Mizushima, Tsunehiro/0000-0002-6631-2889; Yagi-Utsumi, Maho/0000-0001-8144-740X; Serve, Olivier/0000-0002-0199-8453; Kato, Koichi/0000-0001-7187-9612	Ministry of Education, Culture, Sports, Science, and Technology [20107004, 21370050]; Grants-in-Aid for Scientific Research [20107004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas 20107004, Grant-in-aid for Scientific Research (B) 21370050, the Targeted Proteins Research Program, and the Nanotechnology Network Project from the Ministry of Education, Culture, Sports, Science, and Technology.	Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; COOK WJ, 1994, J MOL BIOL, V236, P601, DOI 10.1006/jmbi.1994.1169; COOK WJ, 1992, J BIOL CHEM, V267, P16467; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fujiwara K, 2004, J BIOL CHEM, V279, P4760, DOI 10.1074/jbc.M309448200; Goddard T.D., 1993, SPARKY VERSION 3 0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Moont G, 1999, PROTEINS, V35, P364, DOI 10.1002/(SICI)1097-0134(19990515)35:3<364::AID-PROT11>3.0.CO;2-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Phillips CL, 2001, ACTA CRYSTALLOGR D, V57, P341, DOI 10.1107/S090744490001800X; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Ryabov Y, 2006, PROTEINS, V63, P787, DOI 10.1002/prot.20917; Ryabov YE, 2007, J AM CHEM SOC, V129, P3315, DOI 10.1021/ja067667r; Satoh T, 2010, BIOCHEM BIOPH RES CO, V400, P329, DOI 10.1016/j.bbrc.2010.08.057; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Trempe JF, 2010, ACTA CRYSTALLOGR F, V66, P994, DOI 10.1107/S1744309110027600; Valafar H, 2004, J MAGN RESON, V167, P228, DOI 10.1016/j.jmr.2003.12.012; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Wang X, 2008, PROTEIN SCI, V17, P899, DOI 10.1110/ps.073395108; Yao TT, 2000, J BIOL CHEM, V275, P36862, DOI 10.1074/jbc.M006050200; Zhang NX, 2009, MOL CELL, V35, P280, DOI 10.1016/j.molcel.2009.06.010; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	38	45	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37496	37502		10.1074/jbc.M111.256354	http://dx.doi.org/10.1074/jbc.M111.256354			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900242	Green Published, hybrid			2022-12-25	WOS:000296542400048
J	Nam, EA; Zhao, RX; Cortez, D				Nam, Edward A.; Zhao, Runxiang; Cortez, David			Analysis of Mutations That Dissociate G(2) and Essential S Phase Functions of Human Ataxia Telangiectasia-mutated and Rad3-related (ATR) Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY EMBRYONIC LETHALITY; PIK-RELATED KINASES; DNA-DAMAGE; CATALYTIC SUBUNIT; SECKEL-SYNDROME; HEAT REPEATS; CANCER-CELLS; IN-VITRO; CHECKPOINT; PHOSPHORYLATION	ATR (ataxia telangiectasia-mutated and Rad3-related) contains 16 conserved candidate autophosphorylation sites that match its preferred S/TQ consensus. To determine whether any is functionally important, we mutated the 16 candidate residues to alanine in a single cDNA to create a 16A-ATR mutant. The 16A-ATR mutant maintains kinase and G(2) checkpoint activities. However, it fails to rescue the essential function of ATR in maintaining cell viability and fails to promote replication recovery from a transient exposure to replication stress. Further analysis identified T1566A/T1578A/T1589A (3A-ATR) as critical mutations causing this separation of function activity. Secondary structure predictions indicate that these residues occur in a region between ATRHEAT repeats 31R and 32R that aligns with regions of ATM and DNA-PK containing regulatory autophosphorylation sites. Although this region is important for ATR function, the 3A-ATR residues do not appear to be sites of autophosphorylation. Nevertheless, our analysis identifies an important regulatory region of ATR that is shared among the PI3K-related protein kinase family. Furthermore, our data indicate that the essential function of ATR for cell viability is linked to its function in promoting proper replication in the context of replication stress and is independent of G(2) checkpoint activity.	[Zhao, Runxiang; Cortez, David] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Nam, Edward A.] Vanderbilt Univ, Dept Canc Biol, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 613 Light Hall, Nashville, TN 37232 USA.	david.cortez@vanderbilt.edu			National Institutes of Health [R01CA102729]; Vanderbilt-Ingram Cancer Center (National Institutes of Health through the NCI) [CA06485]; Vanderbilt Center in Molecular Toxicology (National Institutes of Health through the NIEHS) [P30ES000267]; NATIONAL CANCER INSTITUTE [R01CA102729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Ingram Cancer Center (National Institutes of Health through the NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt Center in Molecular Toxicology (National Institutes of Health through the NIEHS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA102729 (to D. C.). This work was also supported by the Vanderbilt-Ingram Cancer Center (National Institutes of Health Grant CA06485 through the NCI) and the Vanderbilt Center in Molecular Toxicology (National Institutes of Health Grant P30ES000267 through the NIEHS).	Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, J BIOL CHEM, V280, P31390, DOI 10.1074/jbc.M504961200; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Dobbs TA, 2010, DNA REPAIR, V9, P1307, DOI 10.1016/j.dnarep.2010.09.019; Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fang Y, 2004, EMBO J, V23, P3164, DOI 10.1038/sj.emboj.7600315; Furuya K, 2004, GENE DEV, V18, P1154, DOI 10.1101/gad.291104; Gohler T, 2011, J CELL BIOL, V192, P219, DOI 10.1083/jcb.201008076; Jardim MJ, 2009, MOL BIOL CELL, V20, P3801, DOI 10.1091/mbc.E09-04-0303; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Kozlov SV, 2011, J BIOL CHEM, V286, P9107, DOI 10.1074/jbc.M110.204065; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Lewis KA, 2005, CANCER RES, V65, P7091, DOI 10.1158/0008-5472.CAN-05-1019; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Mordes DA, 2008, CELL CYCLE, V7, P2809, DOI 10.4161/cc.7.18.6689; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Nam EA, 2011, J BIOL CHEM, V286, P28707, DOI 10.1074/jbc.M111.248914; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Paciotti V, 2001, MOL CELL BIOL, V21, P3913, DOI 10.1128/MCB.21.12.3913-3925.2001; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Williams DR, 2008, STRUCTURE, V16, P468, DOI 10.1016/j.str.2007.12.014; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	59	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37320	37327		10.1074/jbc.M111.276113	http://dx.doi.org/10.1074/jbc.M111.276113			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21908846	hybrid, Green Published			2022-12-25	WOS:000296542400032
J	Ogura, K; Yahiro, K; Tsutsuki, H; Nagasawa, S; Yamasaki, S; Moss, J; Noda, M				Ogura, Kohei; Yahiro, Kinnosuke; Tsutsuki, Hiroyasu; Nagasawa, Sayaka; Yamasaki, Shinji; Moss, Joel; Noda, Masatoshi			Characterization of Cholix Toxin-induced Apoptosis in HeLa Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATING FACTOR; CYTOCHROME-C; VIBRIO-CHOLERAE; PROTEINS; ACTIVATION; MECHANISMS; CLEAVAGE; CASPASE; GENE; TRANSLATION	Cholix toxin (Cholix) is a novel ADP-ribosylating cytotoxin produced by Vibrio cholerae, which utilizes eukaryotic elongation factor 2 as a substrate and acts by a mechanism similar to that of diphtheria toxin and Pseudomonas exotoxin A. First it was found that Cholix-treated HeLa cells exhibited caspase-dependent apoptosis, whereas intestinal cells such as Caco-2, HCT116, and RKO did not. Here we investigated Cholix-induced cell death signaling pathways in HeLa cells. Cholix-induced cytochrome c release into cytosol was initiated by specific conformational changes of pro-apoptotic Bak associated with Bax. Silencing of bak/bax genes or bak gene alone using siRNA significantly suppressed cytochrome c release and caspase-7 activation, but not activation of caspases-3 and -9. Although pretreatment with a caspase-8 inhibitor (Z-IETD-FMK) reduced Cholix-induced cytochrome c release and activation of caspases-3, -7, and -9, cytotoxicity was not decreased. Pretreatment with Z-YVAD-FMK, which inhibits caspase-1, -4, and -5, suppressed not only cytochrome c release, activation of caspase-3, -7, -8, or -9, and PARP cleavage, but also cytotoxicity, indicating that caspase-1, -4, and -5 activation is initiated at an early stage of Cholix-induced apoptosis and promotes caspase-8 activation. These results show that the inflammatory caspases (caspase-1, -4, and -5) and caspase-8 are responsible for both mitochondrial signals and other caspase activation. In conclusion, we showed that Cholix-induced caspase activation plays an essential role in generation of apoptotic signals, which are mediated by both mitochondria-dependent and -independent pathways.	[Ogura, Kohei; Yahiro, Kinnosuke; Tsutsuki, Hiroyasu; Nagasawa, Sayaka; Noda, Masatoshi] Chiba Univ, Grad Sch Med, Dept Mol Infectiol, Chuo Ku, Chiba, Japan; [Nagasawa, Sayaka] Chiba Univ, Grad Sch Med, Dept Legal Med, Chuo Ku, Chiba, Japan; [Yamasaki, Shinji] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka 5988531, Japan; [Moss, Joel] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA	Chiba University; Chiba University; Osaka Metropolitan University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Yahiro, K (corresponding author), Chiba Univ, Grad Sch Med, Dept Mol Infectiol, Chuo Ku, 1-8-1 Inohana, Chiba, Japan.	yahirok@faculty.chiba-u.jp		Yahiro, Kinnosuke/0000-0002-9813-0780	Japan Science and Technology Agency; National Institutes of Health, National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000659] Funding Source: NIH RePORTER	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants-in-aid for Scientific Research for Young Scientists (B) of Japan and Improvement of Research Environment for Young Researchers from Japan Science and Technology Agency.; Supported by the Intramural Research Program, National Institutes of Health, National Heart, Lung, and Blood Institute.	Adams KW, 2007, J BIOL CHEM, V282, P6192, DOI 10.1074/jbc.M610643200; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Bian ZM, 2009, INVEST OPHTH VIS SCI, V50, P6006, DOI 10.1167/iovs.09-3628; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Chen M, 2007, J BIOL CHEM, V282, P33888, DOI 10.1074/jbc.M702969200; Chen Y, 2007, INFECT IMMUN, V75, P2645, DOI 10.1128/IAI.01317-06; Chiu CC, 2009, J VET MED SCI, V71, P1, DOI 10.1292/jvms.71.1; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Du X, 2010, MOL CELL BIOL, V30, P3444, DOI 10.1128/MCB.00813-09; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; HUGHES JM, 1978, ANN INTERN MED, V88, P602, DOI 10.7326/0003-4819-88-5-602; Jenkins CE, 2004, J BIOL CHEM, V279, P37201, DOI 10.1074/jbc.M405594200; Jorgensen R, 2008, J BIOL CHEM, V283, P10671, DOI 10.1074/jbc.M710008200; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Krumschnabel G, 2009, CELL DEATH DIFFER, V16, P195, DOI 10.1038/cdd.2008.170; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; McDonnell MA, 2003, CELL DEATH DIFFER, V10, P1005, DOI 10.1038/sj.cdd.4401271; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; MORRIS JG, 1985, NEW ENGL J MED, V312, P343, DOI 10.1056/NEJM198502073120604; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; PETERSON JW, 1989, SCIENCE, V245, P857, DOI 10.1126/science.2549637; Petsaris O, 2010, J MED MICROBIOL, V59, P1260, DOI 10.1099/jmm.0.021014-0; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Purdy AE, 2010, ENV MICROBIOL REP, V2, P198, DOI 10.1111/j.1758-2229.2010.00139.x; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Roy V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015753; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Yahiro K, 2010, MICROB PATHOGENESIS, V49, P153, DOI 10.1016/j.micpath.2010.05.007; Yamamuro A, 2011, J PHARMACOL SCI, V115, P239, DOI 10.1254/jphs.10217SC; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhao Y, 2010, J CELL PHYSIOL, V225, P316, DOI 10.1002/jcp.22276; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	41	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37207	37215		10.1074/jbc.M111.246504	http://dx.doi.org/10.1074/jbc.M111.246504			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21903588	hybrid, Green Published			2022-12-25	WOS:000296542400021
J	Rivera, PC; Di Cola, V; Martinez, JJ; Gardenal, CN; Chiaraviglio, M				Rivera, Paula C.; Di Cola, Valeria; Martinez, Juan J.; Gardenal, Cristina N.; Chiaraviglio, Margarita			Species Delimitation in the Continental Forms of the Genus Epicrates (Serpentes, Boidae) Integrating Phylogenetics and Environmental Niche Models	PLOS ONE			English	Article							BOA-CONSTRICTOR; DISTRIBUTIONS; NUCLEAR; PHYLOGEOGRAPHY; ECOLOGY	Until recently, the genus Epicrates (Boidae) presented only one continental species, Epicrates cenchria, distributed in Central and South America, but after a taxonomic revision using morphologic characters five species were recognized: E. cenchria, E. crassus, E. maurus, E. assisi, and E. alvarezi. We analyzed two independent data sets, environmental niche models and phylogeny based on molecular information, to explore species delimitation in the continental species of this genus. Our results indicated that the environmental requirements of the species are different; therefore there are not evidences of ecological interchangeability among them. There is a clear correlation between species distributions and the major biogeographic regions of Central and South America. Their overall distribution reveals that allopatry or parapatry is the general pattern. These evidences suggest that habitat isolation prevents or limits gene exchange among them. The phylogenetic reconstruction showed that the continental Epicrates are monophyletic, being E. alvarezi the sister species for the remaining two clades: E. crassus - E. assisi, and E. maurus - E. cenchria. The clade grouping the continental Epicrates is the sister taxon of the genus Eunectes and not of the Caribbean Epicrates clade, indicating that the genus is paraphyletic. There is a non-consistent pattern in niche evolution among continental Epicrates. On the contrary, a high variation and abrupt shifts in environmental variables are shown when ancestral character states were reconstructed on the sequence-based tree. The degree of genetic and ecological divergence among continental Epicrates and the phylogenetic analyses support the elevation to full species of E. cenchria, E. crassus, E. maurus, E. assisi, and E. alvarezi.	[Rivera, Paula C.; Di Cola, Valeria; Chiaraviglio, Margarita] Univ Nacl Cordoba, Lab Biol Comportamiento, Fac Ciencias Exactas Fis & Nat, RA-5000 Cordoba, Argentina; [Rivera, Paula C.; Martinez, Juan J.; Gardenal, Cristina N.] Univ Nacl Cordoba, Catedra Genet Poblac & Evoluc, Fac Ciencias Exactas Fis & Nat, RA-5000 Cordoba, Argentina	National University of Cordoba; National University of Cordoba	Rivera, PC (corresponding author), Univ Nacl Cordoba, Lab Biol Comportamiento, Fac Ciencias Exactas Fis & Nat, RA-5000 Cordoba, Argentina.	riverapauc@yahoo.com.ar		Chiaraviglio, Margarita/0000-0003-4044-6288; Di Cola, Valeria/0000-0003-2925-8366	Consejo Nacional de Investigaciones Cientificas y Tecnologicas of Argentina (CONICET)	Consejo Nacional de Investigaciones Cientificas y Tecnologicas of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	V. D. and J. J. M. are Fellows and P. C. R. and C. N. G. are Career Investigators of the Consejo Nacional de Investigaciones Cientificas y Tecnologicas of Argentina (CONICET). V. D. and J. J. M. are doctoral students of the Doctorado de Ciencias Biologicas, Universidad Nacional de Cordoba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez B.B., 2002, ATLAS ANFIBIOS REPTI; AMARAL A, 1954, MEM I BUTANTAN, V26, P227; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Barrio-Amoros Cesar L., 2008, Check List, V4, P244; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Bruford Michael W., 1992, P225; Burbrink FT, 2005, MOL PHYLOGENET EVOL, V34, P167, DOI 10.1016/j.ympev.2004.08.017; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; CABRERA A.L., 1973, SERIE BIOL MONOGRAFI, V13; Cei Jose M., 1993, Museo Regionale di Scienze Naturali Monografie (Turin), V14, P1; Chippaux J.-F., 1987, Faune Tropicale, V27, P1; de Avila Pires Teresa C.S., 2005, Bulletin of the Biological Society of Washington, V13, P25, DOI 10.2988/0097-0298(2005)13[25:R]2.0.CO;2; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; DELEMA T, 2002, REPTEIS RIO GRANDE S; Di Cola V, 2008, AMPHIBIA-REPTILIA, V29, P299, DOI 10.1163/156853808785112138; Duellman W.E., 2005, CUSCO AMAZONICO THE; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; FROST DR, 1990, HERPETOLOGICA, V46, P87; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Giraudo A.R., 2001, DIVERSIDAD SERPIENTE; Goloboff P, 2008, CLADISTICS, V24, P91; Gorzula S., 1999, SCI GUAIANAE, V8, pxviii+270+32; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; MANTEL N, 1967, CANCER RES, V27, P209; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; MATZ G, 2004, SITULA, V10, P2; McDiarmid RW, 1999, SNAKES SPECIES WORLD, V1; Moreno A.G., 1988, MUSEO REGIONALE SCI, V6, P6; Noonan BP, 2006, MOL PHYLOGENET EVOL, V40, P347, DOI 10.1016/j.ympev.2006.03.010; Nosil P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001907; Passos P, 2008, HERPETOL MONOGR, V22, P1; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; REATI GJ, 1996, BIODIVERSIDAD PROVIN, V1, P239; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saint KM, 1998, MOL PHYLOGENET EVOL, V10, P259, DOI 10.1006/mpev.1998.0515; Scrocchi G. J., 2006, SERPIENTES NOROESTE; Slowinski JB, 2002, MOL PHYLOGENET EVOL, V24, P194, DOI 10.1016/S1055-7903(02)00239-7; Smith G.R., 1992, OCC PAPERS MUS ZOOL, V28, P99; Stockman AK, 2007, MOL ECOL, V16, P3374, DOI 10.1111/j.1365-294X.2007.03389.x; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Tipton B.L, 2005, SNAKES AM CHECKLIST; WALLER T, 1995, DISTRIBUCION CONSERV; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2008, SYST BIOL, V57, P420, DOI 10.1080/10635150802166053	50	20	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e22199	10.1371/journal.pone.0022199	http://dx.doi.org/10.1371/journal.pone.0022199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912634	Green Published, Green Submitted, gold			2022-12-25	WOS:000294686100001
J	Skalsky, RL; Cullen, BR				Skalsky, Rebecca L.; Cullen, Bryan R.			Reduced Expression of Brain-Enriched microRNAs in Glioblastomas Permits Targeted Regulation of a Cell Death Gene	PLOS ONE			English	Article							HUMAN CYTOMEGALOVIRUS; STEM-CELLS; MALIGNANT GLIOMA; CANCER; TUMORS; DIFFERENTIATION; RECEPTOR; THERAPY; PROLIFERATION; SIGNATURE	Glioblastoma is a highly aggressive malignant tumor involving glial cells in the human brain. We used high-throughput sequencing to comprehensively profile the small RNAs expressed in glioblastoma and non-tumor brain tissues. MicroRNAs (miRNAs) made up the large majority of small RNAs, and we identified over 400 different cellular pre-miRNAs. No known viral miRNAs were detected in any of the samples analyzed. Cluster analysis revealed several miRNAs that were significantly down-regulated in glioblastomas, including miR-128, miR-124, miR-7, miR-139, miR-95, and miR-873. Post-transcriptional editing was observed for several miRNAs, including the miR-376 family, miR-411, miR-381, and miR-379. Using the deep sequencing information, we designed a lentiviral vector expressing a cell suicide gene, the herpes simplex virus thymidine kinase (HSV-TK) gene, under the regulation of a miRNA, miR-128, that was found to be enriched in non-tumor brain tissue yet down-regulated in glioblastomas, Glioblastoma cells transduced with this vector were selectively killed when cultured in the presence of ganciclovir. Using an in vitro model to recapitulate expression of brain-enriched miRNAs, we demonstrated that neuronally differentiated SH-SY5Y cells transduced with the miRNA-regulated HSV-TK vector are protected from killing by expression of endogenous miR-128. Together, these results provide an in-depth analysis of miRNA dysregulation in glioblastoma and demonstrate the potential utility of these data in the design of miRNA-regulated therapies for the treatment of brain cancers.	[Skalsky, Rebecca L.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA; Duke Univ, Med Ctr, Ctr Virol, Durham, NC USA	Duke University; Duke University	Skalsky, RL (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA.	culle002@mc.duke.edu	Xie, Huangming/B-2260-2012	Skalsky, Rebecca/0000-0003-2967-9478	Pediatric Brain Tumor Foundation [1B, 14-P3836637]; NIH [T342-CA009111]	Pediatric Brain Tumor Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by Proj 1B, Sub#14-P3836637 from the Pediatric Brain Tumor Foundation (http://www.pbtfus.org/medcomm/research/). Rebecca Skalsky was supported by NIH training grant T342-CA009111. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltinger C, 1999, P NATL ACAD SCI USA, V96, P8699, DOI 10.1073/pnas.96.15.8699; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Cobbs CS, 2002, CANCER RES, V62, P3347; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Crawford JR, 2009, J NEURO-ONCOL, V95, P49, DOI 10.1007/s11060-009-9908-2; Crawford JR, 2009, J CLIN VIROL, V46, P37, DOI 10.1016/j.jcv.2009.05.011; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Evangelisti C, 2009, FASEB J, V23, P4276, DOI 10.1096/fj.09-134965; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gabriely G, 2011, CANCER RES, V71, P3563, DOI 10.1158/0008-5472.CAN-10-3568; Godlewski J, 2010, CELL DEATH DIFFER, V17, P221, DOI 10.1038/cdd.2009.71; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Gottwein E, 2010, J VIROL, V84, P5229, DOI 10.1128/JVI.00202-10; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; IM HI, NAT NEUROSCI, V13, P1120; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kelly EJ, 2009, MOL THER, V17, P409, DOI 10.1038/mt.2008.288; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MAGILL ST, P NATL ACAD SCI US, V107, P20382; Maginnis MS, 2009, SEMIN CANCER BIOL, V19, P261, DOI 10.1016/j.semcancer.2009.02.013; MARTI E, NUCL ACIDS RES, V38, P7219; MESEGUER S, J BIOL CHEM, V286, P4150; Mitchell DA, 2008, NEURO-ONCOLOGY, V10, P10, DOI 10.1215/15228517-2007-035; MOOLTEN FL, 1986, CANCER RES, V46, P5276; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Pang JCS, 2009, ACTA NEUROPATHOL, V117, P599, DOI 10.1007/s00401-009-0525-0; Pulkkanen KJ, 2005, MOL THER, V12, P585, DOI 10.1016/j.ymthe.2005.07.357; Rainov NG, 2003, CANCER J, V9, P180, DOI 10.1097/00130404-200305000-00006; Ronen R, 2010, BIOINFORMATICS, V26, P2615, DOI 10.1093/bioinformatics/btq493; Scheurer ME, 2008, ACTA NEUROPATHOL, V116, P79, DOI 10.1007/s00401-008-0359-1; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Umbach JL, 2009, J VIROL, V83, P10677, DOI 10.1128/JVI.01185-09; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu CX, 2009, MOL THER, V17, P2058, DOI 10.1038/mt.2009.225; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Zhang Y, 2009, J MOL MED, V87, P43, DOI 10.1007/s00109-008-0403-6	62	147	152	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24248	10.1371/journal.pone.0024248	http://dx.doi.org/10.1371/journal.pone.0024248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912681	Green Published, Green Submitted, gold			2022-12-25	WOS:000294686100028
J	Badr, G; Lefevre, EA; Mohany, M				Badr, Gamal; Lefevre, Eric A.; Mohany, Mohamed			Thymoquinone Inhibits the CXCL12-Induced Chemotaxis of Multiple Myeloma Cells and Increases Their Susceptibility to Fas-Mediated Apoptosis	PLOS ONE			English	Article							STROMAL-DERIVED FACTOR-1-ALPHA; CHEMOKINE RECEPTORS; HEMATOPOIETIC PROGENITORS; SURFACE TRAFFICKING; CANCER CELLS; CXCR4; EXPRESSION; ACTIVATION; THERAPY; MECHANISM	In multiple myeloma (MM), malignant plasma cells reside in the bone marrow, where they accumulate in close contact with stromal cells. The mechanisms responsible for the chemotaxis of malignant plasma cells are still poorly understood. Thus, we investigated the mechanisms involved in the chemotaxis of MDN and XG2 MM cell lines. Both cell lines strongly expressed CCR9, CXCR3 and CXCR4 chemokine receptors but only migrated toward CXCL12. Activation of CXCR4 by CXCL12 resulted in the association of CXCR4 with CD45 and activation of PLC beta 3, AKT, RhoA, I kappa B alpha and ERK1/2. Using siRNA-silencing techniques, we showed CD45/CXCR4 association is essential for CXCL12-induced migration of MM cells. Thymoquinone (TQ), the major active component of the medicinal herb Nigella sativa Linn, has been described as a chemopreventive and chemotherapeutic compound. TQ treatment strongly inhibited CXCL12-mediated chemotaxis in MM cell lines as well as primary cells isolated from MM patients, but not normal PBMCs. Moreover, TQ significantly down-regulated CXCR4 expression and CXCL12-mediated CXCR4/CD45 association in MM cells. Finally, TQ also induced the relocalization of cytoplasmic Fas/CD95 to the membrane of MM cells and increased CD95-mediated apoptosis by 80%. In conclusion, we demonstrate the potent anti-myeloma activity of TQ, providing a rationale for further clinical evaluation.	[Badr, Gamal; Mohany, Mohamed] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Badr, Gamal] Assiut Univ, Fac Sci, Dept Zool, Assiut, Egypt; [Lefevre, Eric A.] AFRC, Inst Anim Hlth, Newbury RG16 0NN, Berks, England	King Saud University; Egyptian Knowledge Bank (EKB); Assiut University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Badr, G (corresponding author), King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia.	badr73@yahoo.com	Mohany, Mohamed/M-9898-2013; Badr, Gamal/I-4891-2014	Badr, Gamal/0000-0002-6157-7319	King Saud University, Saudi Arabia [NPAR3-(3)]	King Saud University, Saudi Arabia(King Saud University)	This work was supported by the Deanship of Scientific Research (http://dsrs.ksu.edu.sa/english/default.aspx), King Saud University, Saudi Arabia, Project number NPAR3-(3) and through a collaboration with the Biotechnology and Biological Sciences Research Council (BBSRC, http://www.bbsrc.ac.uk) & the Institute for Animal Health (IAH, http://www.iah.bbsrc.ac.uk), UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2006, EXP HEMATOL, V34, P1289, DOI 10.1016/j.exphem.2006.06.017; Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Augstein P, 2002, BIOCHEM BIOPH RES CO, V290, P443, DOI 10.1006/bbrc.2001.6215; Badary OA, 2001, CANCER DETECT PREV, V25, P362; Badr G, 2005, J IMMUNOL, V175, P302, DOI 10.4049/jimmunol.175.1.302; Bendall LJ, 2005, CANCER RES, V65, P3290, DOI 10.1158/0008-5472.CAN-04-3402; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Bhowmick NA, 2003, P NATL ACAD SCI USA, V100, P15548, DOI 10.1073/pnas.2536483100; Broek IV, 2003, BRIT J CANCER, V88, P855, DOI 10.1038/sj.bjc.6600833; Chan CC, 2003, OPHTHALMOLOGY, V110, P421, DOI 10.1016/S0161-6420(02)01737-2; Fernandis AZ, 2003, J BIOL CHEM, V278, P9536, DOI 10.1074/jbc.M211803200; Floridi F, 2003, J NEUROIMMUNOL, V135, P38, DOI 10.1016/S0165-5728(02)00432-0; Fulton AM, 2009, CURR ONCOL REP, V11, P125, DOI 10.1007/s11912-009-0019-1; Gali-Muhtasib H, 2004, INT J ONCOL, V25, P857; Gali-Muhtasib H, 2008, CANCER RES, V68, P5609, DOI 10.1158/0008-5472.CAN-08-0884; Gali-Muhtasib H, 2006, INT J BIOCHEM CELL B, V38, P1249, DOI 10.1016/j.biocel.2005.10.009; Gali-Muhtasib HU, 2004, ANTI-CANCER DRUG, V15, P389, DOI 10.1097/00001813-200404000-00012; Helferman MJ, 2010, ANTICANCER RES, V30, P73; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hideshima T, 2002, MOL CANCER THER, V1, P539; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hussain T, 2005, INT J CANCER, V113, P660, DOI 10.1002/ijc.20629; Ishii Y, 2006, CANCER GENET CYTOGEN, V167, P131, DOI 10.1016/j.cancergencyto.2006.01.002; Jakobsen CH, 2008, J LIPID RES, V49, P2089, DOI 10.1194/jlr.M700389-JLR200; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kakinuma T, 2006, J LEUKOCYTE BIOL, V79, P639, DOI 10.1189/jlb.1105633; Kaseb AO, 2007, CANCER RES, V67, P7782, DOI 10.1158/0008-5472.CAN-07-1483; Koshiba T, 2000, CLIN CANCER RES, V6, P3530; Kyle RA, 2007, BRIT J HAEMATOL, V139, P730, DOI 10.1111/j.1365-2141.2007.06873.x; Kyle RA, 2009, CLIN LYMPHOMA MYELOM, V9, P278, DOI 10.3816/CLM.2009.n.056; Ladas EJ, 2004, J CLIN ONCOL, V22, P517, DOI 10.1200/JCO.2004.03.086; Li F, 2010, BRIT J PHARMACOL, V161, P541, DOI 10.1111/j.1476-5381.2010.00874.x; Menu E, 2006, HAEMATOLOGICA, V91, P605; Moller C, 2003, LEUKEMIA, V17, P203, DOI 10.1038/sj.leu.2402717; Nowakowski GS, 2005, BLOOD, V106, P2276, DOI 10.1182/blood-2005-05-1858; Oliveira DM, 2003, GENESIS, V36, P203, DOI 10.1002/gene.10212; Popik W, 2002, J VIROL, V76, P4709, DOI 10.1128/JVI.76.10.4709-4722.2002; Puthier D, 1999, EUR J IMMUNOL, V29, P3945, DOI 10.1002/(SICI)1521-4141(199912)29:12<3945::AID-IMMU3945>3.0.CO;2-O; Ravindran J, 2010, BIOCHEM PHARMACOL, V79, P1640, DOI 10.1016/j.bcp.2010.01.023; Roepke M, 2007, CANCER BIOL THER, V6, P160, DOI 10.4161/cbt.6.2.3575; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Rosner D, 2006, AM J PATHOL, V168, P2054, DOI 10.2353/ajpath.2006.050473; Shivtiel S, 2008, J EXP MED, V205, P2381, DOI 10.1084/jem.20080072; Shoieb AM, 2003, INT J ONCOL, V22, P107; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; Sun YX, 2003, J CELL BIOCHEM, V89, P462, DOI 10.1002/jcb.10522; Trentin L, 2007, BRIT J HAEMATOL, V138, P594, DOI 10.1111/j.1365-2141.2007.06686.x; Uchida D, 2003, EXP CELL RES, V290, P289, DOI 10.1016/S0014-4827(03)00344-6; Worthen DR, 1998, ANTICANCER RES, V18, P1527; Zannettino ACW, 2005, CANCER RES, V65, P1700, DOI 10.1158/0008-5472.CAN-04-1687; Zeelenberg IS, 2003, CANCER RES, V63, P3833; ZHANG XG, 1994, BLOOD, V83, P3654	53	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e23741	10.1371/journal.pone.0023741	http://dx.doi.org/10.1371/journal.pone.0023741			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21912642	Green Published, gold, Green Submitted			2022-12-25	WOS:000294683900008
J	Danielsen, SA; Cekaite, L; Agesen, TH; Sveen, A; Nesbakken, A; Thiis-Evensen, E; Skotheim, RI; Lind, GE; Lothe, RA				Danielsen, Stine A.; Cekaite, Lina; Agesen, Trude H.; Sveen, Anita; Nesbakken, Arild; Thiis-Evensen, Espen; Skotheim, Rolf I.; Lind, Guro E.; Lothe, Ragnhild A.			Phospholipase C Isozymes Are Deregulated in Colorectal Cancer - Insights Gained from Gene Set Enrichment Analysis of the Transcriptome	PLOS ONE			English	Article							GENOME-WIDE EXPRESSION; COLON-CANCER; PATHWAYS; PTEN; PROLIFERATION; INSTABILITY; CARCINOMAS; MUTATIONS	Colorectal cancer (CRC) is one of the most common cancer types in developed countries. To identify molecular networks and biological processes that are deregulated in CRC compared to normal colonic mucosa, we applied Gene Set Enrichment Analysis to two independent transcriptome datasets, including a total of 137 CRC and ten normal colonic mucosa samples. Eighty-two gene sets as described by the Kyoto Encyclopedia of Genes and Genomes database had significantly altered gene expression in both datasets. These included networks associated with cell division, DNA maintenance, and metabolism. Among signaling pathways with known changes in key genes, the "Phosphatidylinositol signaling network", comprising part of the PI3K pathway, was found deregulated. The downregulated genes in this pathway included several members of the Phospholipase C protein family, and the reduced expression of two of these, PLCD1 and PLCE1, were successfully validated in CRC biopsies (n = 70) and cell lines (n = 19) by quantitative analyses. The repression of both genes was found associated with KRAS mutations (P = 0.005 and 0.006, respectively), and we observed that microsatellite stable carcinomas with reduced PLCD1 expression more frequently had TP53 mutations (P = 0.002). Promoter methylation analyses of PLCD1 and PLCE1 performed in cell lines and tumor biopsies revealed that methylation of PLCD1 can contribute to reduced expression in 40% of the microsatellite instable carcinomas. In conclusion, we have identified significantly deregulated pathways in CRC, and validated repression of PLCD1 and PLCE1 expression. This illustrates that the GSEA approach may guide discovery of novel biomarkers in cancer.	[Danielsen, Stine A.; Cekaite, Lina; Agesen, Trude H.; Sveen, Anita; Skotheim, Rolf I.; Lind, Guro E.; Lothe, Ragnhild A.] Oslo Univ Hosp, Inst Canc Res, Dept Canc Prevent, Oslo, Norway; [Danielsen, Stine A.; Cekaite, Lina; Agesen, Trude H.; Sveen, Anita; Nesbakken, Arild; Skotheim, Rolf I.; Lind, Guro E.; Lothe, Ragnhild A.] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Nesbakken, Arild] Oslo Univ Hosp, Dept Gastrointestinal Surg, Oslo, Norway; [Thiis-Evensen, Espen] Oslo Univ Hosp, Dept Organ Transplantat Gastroenterol & Nephrol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Danielsen, SA (corresponding author), Oslo Univ Hosp, Inst Canc Res, Dept Canc Prevent, Oslo, Norway.	Ragnhild.A.Lothe@rr-research.no	Skotheim, Rolf I./H-6192-2017; Pillay, Nischalan/F-9536-2012	Skotheim, Rolf I./0000-0002-5609-4048; Sveen, Anita/0000-0001-8219-6251; Lothe, Ragnhild A./0000-0002-1693-1032	Norwegian Cancer Society [PR-2006-0442]; Research Council at Rikshospitalet-Radiumhospitalet Health Enterprise; South-Eastern Norway Regional Health Authority [RAL: PR-2009-093]; Norwegian Foundation for Health and Rehabilitation [ETE: HF-52015/002];  [GEL: PR-2008-0163];  [RIS: PR-2007-0166]	Norwegian Cancer Society(Norwegian Cancer Society); Research Council at Rikshospitalet-Radiumhospitalet Health Enterprise; South-Eastern Norway Regional Health Authority; Norwegian Foundation for Health and Rehabilitation; ; 	This study was funded by grants from the Norwegian Cancer Society (http://www.kreftforeningen.no/english) (RAL: no. PR-2006-0442, including PhD grants to SAD and THA; GEL: PR-2008-0163; RIS: PR-2007-0166), by a grant from the Research Council at Rikshospitalet-Radiumhospitalet Health Enterprise (RAL: including a PhD grant to AS), by a grant from the South-Eastern Norway Regional Health Authority (http://www.helse-sorost.no/omoss/english/Sider/page.aspx) (RAL: PR-2009-093, including postdoc grant to LC), and grant from the Norwegian Foundation for Health and Rehabilitation (http://www.extrastiftelsen.no/) through the EXTRA funds (ETE: HF-52015/002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agesen TH, 2011, GENES IMMUN, V12, P653, DOI 10.1038/gene.2011.43; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berg M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013978; Bunney TD, 2009, ADV ENZYME REGUL, V49, P54, DOI 10.1016/j.advenzreg.2009.01.004; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Danielsen SA, 2008, HUM MUTAT, V29, pE252, DOI 10.1002/humu.20860; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Distaso A, 2008, INT J BIOL SCI, V4, P368; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fu L, 2007, CANCER RES, V67, P10720, DOI 10.1158/0008-5472.CAN-07-2411; Fukami K, 2002, J BIOCHEM, V131, P293, DOI 10.1093/oxfordjournals.jbchem.a003102; Fukami K, 2010, PROG LIPID RES, V49, P429, DOI 10.1016/j.plipres.2010.06.001; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hahne F, 2008, USE R, P1, DOI 10.1007/978-0-387-77240-0_1; Heijink DM, 2011, ONCOGENE, V30, P2026, DOI 10.1038/onc.2010.578; Hu XT, 2009, ONCOGENE, V28, P2466, DOI 10.1038/onc.2009.92; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaproth-Joslin KA, 2008, BIOCHEM J, V415, P439, DOI 10.1042/BJ20080233; Kleivi K, 2004, CANCER GENET CYTOGEN, V155, P119, DOI 10.1016/j.cancergencyto.2004.03.014; Lind GE, 2011, ONCOGENE, V30, P3967, DOI 10.1038/onc.2011.109; Lind GE, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-13; Maglietta R, 2010, J BIOMED INFORM, V43, P397, DOI 10.1016/j.jbi.2009.09.005; Nannini M, 2009, CANCER TREAT REV, V35, P201, DOI 10.1016/j.ctrv.2008.10.006; NOMOTO K, 1995, MOL CARCINOGEN, V12, P146, DOI 10.1002/mc.2940120306; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Rebecchi MJ, 2009, ADV ENZYME REGUL, V49, P59, DOI 10.1016/j.advenzreg.2009.01.009; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Sillars-Hardebol AH, 2010, TUMOR BIOL, V31, P89, DOI 10.1007/s13277-009-0012-1; Sorli SC, 2005, ONCOGENE, V24, P90, DOI 10.1038/sj.onc.1208168; Stallings JD, 2008, J BIOL CHEM, V283, P13992, DOI 10.1074/jbc.M800752200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sveen A, 2011, GENOME MED, V3, DOI 10.1186/gm248; Wang X., 2011, MED ONCOL; Wang XL, 2008, HEPATO-GASTROENTEROL, V55, P2039; WARBURG O, 1956, SCIENCE, V124, P269; Xiang TX, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12726; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241	38	40	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24419	10.1371/journal.pone.0024419	http://dx.doi.org/10.1371/journal.pone.0024419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909432	Green Submitted, Green Published, gold			2022-12-25	WOS:000294683900048
J	Evers, MM; Pepers, BA; van Deutekom, JCT; Mulders, SAM; den Dunnen, JT; Aartsma-Rus, A; van Ommen, GJB; van Roon-Mom, WMC				Evers, Melvin M.; Pepers, Barry A.; van Deutekom, Judith C. T.; Mulders, Susan A. M.; den Dunnen, Johan T.; Aartsma-Rus, Annemieke; van Ommen, Gert-Jan B.; van Roon-Mom, Willeke M. C.			Targeting Several CAG Expansion Diseases by a Single Antisense Oligonucleotide	PLOS ONE			English	Article							ALLELE-SELECTIVE INHIBITION; NORMAL HUNTINGTIN FUNCTION; MACHADO-JOSEPH-DISEASE; MUTANT HUNTINGTIN; NEURODEGENERATIVE DISEASE; MUSCULAR-DYSTROPHY; RNA INTERFERENCE; BINDING PROTEIN; REPEAT LENGTH; POLYGLUTAMINE	To date there are 9 known diseases caused by an expanded polyglutamine repeat, with the most prevalent being Huntington's disease. Huntington's disease is a progressive autosomal dominant neurodegenerative disorder for which currently no therapy is available. It is caused by a CAG repeat expansion in the HTT gene, which results in an expansion of a glutamine stretch at the N-terminal end of the huntingtin protein. This polyglutamine expansion plays a central role in the disease and results in the accumulation of cytoplasmic and nuclear aggregates. Here, we make use of modified 2'-O-methyl phosphorothioate (CUG)n triplet-repeat antisense oligonucleotides to effectively reduce mutant huntingtin transcript and protein levels in patient-derived Huntington's disease fibroblasts and lymphoblasts. The most effective antisense oligonucleotide, (CUG)(7), also reduced mutant ataxin-1 and ataxin-3 mRNA levels in spinocerebellar ataxia 1 and 3, respectively, and atrophin-1 in dentatorubral-pallidoluysian atrophy patient derived fibroblasts. This antisense oligonucleotide is not only a promising therapeutic tool to reduce mutant huntingtin levels in Huntington's disease but our results in spinocerebellar ataxia and dentatorubral-pallidoluysian atrophy cells suggest that this could also be applicable to other polyglutamine expansion disorders as well.	[Evers, Melvin M.; Pepers, Barry A.; den Dunnen, Johan T.; Aartsma-Rus, Annemieke; van Ommen, Gert-Jan B.; van Roon-Mom, Willeke M. C.] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands; [van Deutekom, Judith C. T.; Mulders, Susan A. M.] Prosensa Therapeut BV, Leiden, Netherlands; [den Dunnen, Johan T.] Leiden Univ, Med Ctr, Leiden Genome Technol Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; BioMarin Pharmaceutical Inc.; Prosensa; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Evers, MM (corresponding author), Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands.	w.vanroon@lumc.nl	dunnen, johan den/ABH-4228-2020; van Roon-Mom, Willeke/Y-3039-2018	dunnen, johan den/0000-0002-6304-1710; van Roon-Mom, Willeke/0000-0002-3035-0533; Evers, Melvin/0000-0003-2920-5854	Center for Biomedical Genetics (The Netherlands); Agentschap NL (The Netherlands)	Center for Biomedical Genetics (The Netherlands)(Netherlands Government); Agentschap NL (The Netherlands)(Netherlands Government)	The research in this study was financed by the Center for Biomedical Genetics (The Netherlands) and Agentschap NL (The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2002, NEUROMUSCULAR DISORD, V12, pS71, DOI 10.1016/S0960-8966(02)00086-X; Alves S, 2010, HUM MOL GENET, V19, P2380, DOI 10.1093/hmg/ddq111; ANDREW SE, 1993, AM J HUM GENET, V53, P1118; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; *CLINICALTRIALS, 2009, SAF TOL ACT STUD ISI; Crespo-Barreto J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001021; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; de Mezer M, 2011, NUCLEIC ACIDS RES, V39, P3852, DOI 10.1093/nar/gkq1323; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Gagnon KT, 2010, BIOCHEMISTRY-US, V49, P10166, DOI 10.1021/bi101208k; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hu JX, 2011, BIOL CHEM, V392, P315, DOI 10.1515/BC.2011.045; Hu JX, 2009, ANN NY ACAD SCI, V1175, P24, DOI 10.1111/j.1749-6632.2009.04975.x; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031; Lombardi MS, 2009, EXP NEUROL, V217, P312, DOI 10.1016/j.expneurol.2009.03.004; Manto MU, 2005, CEREBELLUM, V4, P2, DOI 10.1080/14734220510007914; Matilla-Duenas A, 2008, CEREBELLUM, V7, P106, DOI 10.1007/s12311-008-0009-0; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; McNeil SM, 1997, HUM MOL GENET, V6, P775, DOI 10.1093/hmg/6.5.775; METCALF DJ, 2010, EXP NEUROL; Molla M, 2009, P NATL ACAD SCI USA, V106, P17095, DOI 10.1073/pnas.0907112106; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Mulders SAM, 2009, P NATL ACAD SCI USA, V106, P13915, DOI 10.1073/pnas.0905780106; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Padiath QS, 2005, AM J MED GENET B, V133B, P124, DOI 10.1002/ajmg.b.30088; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; RANEN NG, 1995, AM J HUM GENET, V57, P593; Rao DD, 2009, CANCER GENE THER, V16, P807, DOI 10.1038/cgt.2009.53; Riess O, 2008, CEREBELLUM, V7, P125, DOI 10.1007/s12311-008-0013-4; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Robberecht W, 2000, J NEUROL, V247, P2; ROONMOM WMC, 2002, MOL BRAIN RES, V109, P1; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sah DWY, 2011, J CLIN INVEST, V121, P500, DOI 10.1172/JCI45130; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Scholefield J, 2010, TRENDS GENET, V26, P29, DOI 10.1016/j.tig.2009.11.005; Schols L, 2004, LANCET NEUROL, V3, P443, DOI 10.1016/S1474-4422(04)00816-6; Seo H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000238; Shen Y, 2009, CELL MOL LIFE SCI, V66, P437, DOI 10.1007/s00018-008-8403-9; Shen YG, 2007, J BIOL CHEM, V282, P5037, DOI 10.1074/jbc.M610274200; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; van Bilsen PHJ, 2008, HUM GENE THER, V19, P710, DOI 10.1089/hum.2007.116; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zhang S, 2009, DIS MODEL MECH, V2, P247, DOI 10.1242/dmm.000653; Zhang Y, 2009, J NEUROCHEM, V108, P82, DOI 10.1111/j.1471-4159.2008.05734.x	67	71	78	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24308	10.1371/journal.pone.0024308	http://dx.doi.org/10.1371/journal.pone.0024308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909428	gold, Green Published, Green Submitted			2022-12-25	WOS:000294683900044
J	Hirama, T; Yamaguchi, T; Miyazawa, H; Tanaka, T; Hashikita, G; Kishi, E; Tachi, Y; Takahashi, S; Kodama, K; Egashira, H; Yokote, A; Kobayashi, K; Nagata, M; Ishii, T; Nemoto, M; Tanaka, M; Fukunaga, K; Morita, S; Kanazawa, M; Hagiwara, K				Hirama, Takashi; Yamaguchi, Takefumi; Miyazawa, Hitoshi; Tanaka, Tomoaki; Hashikita, Giichi; Kishi, Etsuko; Tachi, Yoshimi; Takahashi, Shun; Kodama, Keiji; Egashira, Hiroshi; Yokote, Akemi; Kobayashi, Kunihiko; Nagata, Makoto; Ishii, Toshiaki; Nemoto, Manabu; Tanaka, Masahiko; Fukunaga, Koichi; Morita, Satoshi; Kanazawa, Minoru; Hagiwara, Koichi			Prediction of the Pathogens That Are the Cause of Pneumonia by the Battlefield Hypothesis	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; REAL-TIME PCR; RISK-FACTORS; GUIDELINES; ETIOLOGY; MANAGEMENT; INFECTION; ADULTS; DIAGNOSIS; VIRUS	Commensal organisms are frequent causes of pneumonia. However, the detection of these organisms in the airway does not mean that they are the causative pathogens; they may exist merely as colonizers. In up to 50% cases of pneumonia, the causative pathogens remain unidentified, thereby hampering targeting therapies. In speculating on the role of a commensal organism in pneumonia, we devised the battlefield hypothesis. In the "pneumonia battlefield,'' the organism-to-human cell number ratio may be an index for the pathogenic role of the organism. Using real-time PCR reactions for sputum samples, we tested whether the hypothesis predicts the results of bacteriological clinical tests for 4 representative commensal organisms: Streptococcus pneumoniae, Haemophilus influenzae, Pseudomonas spp., and Moraxella catarrhalis. The cutoff value for the organism-to-human cell number ratio, above which the pathogenic role of the organism was suspected, was set up for each organism using 224 sputum samples. The validity of the cutoff value was then tested in a prospective study that included 153 samples; the samples were classified into 3 groups, and each group contained 93%, 7%, and 0% of the samples from pneumonia, in which the pathogenic role of Streptococcus pneumoniae was suggested by the clinical tests. The results for Haemophilus influenzae, Pseudomonas spp., and Moraxella catarrhalis were 100%, 0%, and 0%, respectively. The battlefield hypothesis enabled legitimate interpretation of the PCR results and predicted pneumonia in which the pathogenic role of the organism was suggested by the clinical test. The PCR reactions based on the battlefield hypothesis may help to promote targeted therapies for pneumonia. The prospective observatory study described in the current report had been registered to the University Hospital Medical Information Network (UMIN) registry before its initiation, where the UMIN is a registry approved by the International Committee of Medical Journal Editors (ICMJE). The UMIN registry number was UMIN000001118: A prospective study for the investigation of the validity of cutoff values established for the HIRA-TAN system (April 9, 2008).	[Hirama, Takashi; Yamaguchi, Takefumi; Miyazawa, Hitoshi; Tanaka, Tomoaki; Kodama, Keiji; Egashira, Hiroshi; Yokote, Akemi; Nagata, Makoto; Kanazawa, Minoru; Hagiwara, Koichi] Saitama Med Univ, Dept Resp Med, Moroyama, Saitama, Japan; [Hashikita, Giichi; Kishi, Etsuko; Tachi, Yoshimi; Takahashi, Shun] Saitama Med Univ, Cent Lab, Moroyama, Saitama, Japan; [Kodama, Keiji] Saitama Med Univ, Dept Gen Internal Med, Moroyama, Saitama, Japan; [Kobayashi, Kunihiko] Saitama Med Univ, Dept Resp Med, Int Med Ctr, Hidaka, Saitama, Japan; [Ishii, Toshiaki] Tsurugashima Ikenodai Hosp, Tsurugashima, Saitama, Japan; [Nemoto, Manabu] Saitama Med Univ, Int Med Ctr, Dept Emergency & Acute Med, Hidaka, Saitama, Japan; [Tanaka, Masahiko] Kan Etsu Hosp, Tsurugashima, Saitama, Japan; [Fukunaga, Koichi] Saitama Social Insurance Hosp, Saitama, Japan; [Morita, Satoshi] Yokohama City Univ, Med Ctr, Dept Biostat & Epidemiol, Kanagawa, Japan	Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; Yokohama City University	Hirama, T (corresponding author), Saitama Med Univ, Dept Resp Med, Moroyama, Saitama, Japan.	hagiwark@saitama-med.ac.jp	Fukunaga, Koichi/R-5338-2019	Hirama, Takashi/0000-0002-9390-5057	Japan Society for the Promotion of Science [21790784]; Saitama Medical University [09-01, 21-2-2-06]; Ochiai Memorial Foundation; Ministry of Health, Labor and Welfare, Japan [H22-Nanchi-Ippan-005, H20-Nanchi-Ippan-023]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Saitama Medical University(Saitama Medical University); Ochiai Memorial Foundation; Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work is supported in part by a Grant-in-Aid for Young Scientists (B) (No. 21790784) from the Japan Society for the Promotion of Science, in part by the Saitama Medical University Internal Grant 09-01 (No. 21-2-2-06) from Saitama Medical University, in part by the Grant-in-Aid from Ochiai Memorial Foundation, and in part by the Grants-in-Aid for Health and Labor Science (Nos. H22-Nanchi-Ippan-005 and H20-Nanchi-Ippan-023) from the Ministry of Health, Labor and Welfare, Japan. No other external funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; *FRENCH SOC INF DI, 2001, MED MALADIES INFECT, V31, P357; Herer B, 2001, EUR RESPIR J, V18, P157, DOI 10.1183/09031936.01.99097901; Hoo GWS, 2005, CHEST, V128, P2778, DOI 10.1378/chest.128.4.2778; Ioanas M, 2003, EUR RESPIR J, V22, P876, DOI 10.1183/09031936.03.00045903; Leroy O, 2003, CHEST, V123, P2034, DOI 10.1378/chest.123.6.2034; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Luna CM, 2000, CHEST, V118, P1344, DOI 10.1378/chest.118.5.1344; Mandell LA, 2000, CLIN INFECT DIS, V31, P422, DOI 10.1086/313965; Masterton RG, 2008, J ANTIMICROB CHEMOTH, V62, P5, DOI 10.1093/jac/dkn162; MILLER DL, 1963, AM REV RESPIR DIS, V88, P473; Miyashita N, 2001, CHEST, V119, P1295, DOI 10.1378/chest.119.4.1295-a; Miyashita N, 2006, INTERNAL MED, V45, P419, DOI 10.2169/internalmedicine.45.1691; Morozumi M, 2006, J CLIN MICROBIOL, V44, P1440, DOI 10.1128/JCM.44.4.1440-1446.2006; Park DR, 2001, J INFECT DIS, V184, P268, DOI 10.1086/322040; Ruiz-Gonzalez A, 1999, AM J MED, V106, P385, DOI 10.1016/S0002-9343(99)00050-9; Scott JAG, 2000, LANCET, V355, P1225, DOI 10.1016/S0140-6736(00)02089-4; Seifert HS, 2006, EVOLUTION OF MICROBIAL PATHOGENS, pXI; Spilker T, 2004, J CLIN MICROBIOL, V42, P2074, DOI 10.1128/JCM.42.5.2074-2079.2004; Takahashi T, 2006, J CLIN MICROBIOL, V44, P1029, DOI 10.1128/JCM.44.3.1029-1039.2006; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; WAKEFIELD AE, 1990, LANCET, V336, P451, DOI 10.1016/0140-6736(90)92008-6; Watanabe Akira, 2007, Journal of Infection and Chemotherapy, V13, P332, DOI 10.1007/s10156-007-0562-3; Watanabe A, 2008, INTERNAL MED, V47, P245, DOI 10.2169/internalmedicine.47.0577; Wattanathum A, 2003, CHEST, V123, P1512, DOI 10.1378/chest.123.5.1512; Woodhead M, 2005, EUR RESPIR J, V26, P1138, DOI 10.1183/09031936.05.00055705	28	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24474	10.1371/journal.pone.0024474	http://dx.doi.org/10.1371/journal.pone.0024474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909436	Green Published, gold, Green Submitted			2022-12-25	WOS:000294683900052
J	Young, RL; Malcolm, KC; Kret, JE; Caceres, SM; Poch, KR; Nichols, DP; Taylor-Cousar, JL; Saavedra, MT; Randell, SH; Vasil, ML; Burns, JL; Moskowitz, SM; Nick, JA				Young, Robert L.; Malcolm, Kenneth C.; Kret, Jennifer E.; Caceres, Silvia M.; Poch, Katie R.; Nichols, David P.; Taylor-Cousar, Jennifer L.; Saavedra, Milene T.; Randell, Scott H.; Vasil, Michael L.; Burns, Jane L.; Moskowitz, Samuel M.; Nick, Jerry A.			Neutrophil Extracellular Trap (NET)-Mediated Killing of Pseudomonas aeruginosa: Evidence of Acquired Resistance within the CF Airway, Independent of CFTR	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; RECOMBINANT HUMAN DNASE; GROUP-A STREPTOCOCCUS; PULMONARY-FUNCTION; YOUNG-CHILDREN; NONOPSONIC PHAGOCYTOSIS; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-TREATMENT; GENETIC ADAPTATION; HUMAN-GRANULOCYTES	The inability of neutrophils to eradicate Pseudomonas aeruginosa within the cystic fibrosis (CF) airway eventually results in chronic infection by the bacteria in nearly 80 percent of patients. Phagocytic killing of P. aeruginosa by CF neutrophils is impaired due to decreased cystic fibrosis transmembrane conductance regulator (CFTR) function and virulence factors acquired by the bacteria. Recently, neutrophil extracellular traps (NETs), extracellular structures composed of neutrophil chromatin complexed with granule contents, were identified as an alternative mechanism of pathogen killing. The hypothesis that NET-mediated killing of P. aeruginosa is impaired in the context of the CF airway was tested. P. aeruginosa induced NET formation by neutrophils from healthy donors in a bacterial density dependent fashion. When maintained in suspension through continuous rotation, P. aeruginosa became physically associated with NETs. Under these conditions, NETs were the predominant mechanism of killing, across a wide range of bacterial densities. Peripheral blood neutrophils isolated from CF patients demonstrated no impairment in NET formation or function against P. aeruginosa. However, isogenic clinical isolates of P. aeruginosa obtained from CF patients early and later in the course of infection demonstrated an acquired capacity to withstand NET-mediated killing in 8 of 9 isolates tested. This resistance correlated with development of the mucoid phenotype, but was not a direct result of the excess alginate production that is characteristic of mucoidy. Together, these results demonstrate that neutrophils can kill P. aeruginosa via NETs, and in vitro this response is most effective under non-stationary conditions with a low ratio of bacteria to neutrophils. NET-mediated killing is independent of CFTR function or bacterial opsonization. Failure of this response in the context of the CF airway may occur, in part, due to an acquired resistance against NET-mediated killing by CF strains of P. aeruginosa.	[Young, Robert L.; Malcolm, Kenneth C.; Kret, Jennifer E.; Caceres, Silvia M.; Poch, Katie R.; Nichols, David P.; Taylor-Cousar, Jennifer L.; Saavedra, Milene T.; Nick, Jerry A.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Nichols, David P.; Taylor-Cousar, Jennifer L.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Young, Robert L.; Taylor-Cousar, Jennifer L.; Saavedra, Milene T.; Nick, Jerry A.] Univ Colorado, Denver Sch Med, Dept Med, Div Pulm Sci & Crit Care Med, Aurora, CO USA; [Nichols, David P.] Univ Colorado, Denver Sch Med, Dept Pediat, Aurora, CO USA; [Randell, Scott H.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC USA; [Vasil, Michael L.] Univ Colorado, Denver Sch Med, Dept Microbiol, Aurora, CO USA; [Burns, Jane L.] Univ Washington, Sch Med, Dept Pediat, Seattle Childrens Hosp,Div Pediat Infect Dis, Seattle, WA 98195 USA; [Moskowitz, Samuel M.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Moskowitz, Samuel M.] Harvard Univ, Sch Med, Boston, MA USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of North Carolina; University of North Carolina Chapel Hill; University of Colorado System; University of Colorado Anschutz Medical Campus; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Young, RL (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO USA.	rlyoung630@gmail.com		Nichols, David/0000-0001-8611-7960	Cystic Fibrosis Foundation [YOUNG08Q0]; Rebecca Runyon Bryan Chair for Cystic Fibrosis; Max and Yetta Karasik Foundation; National Institutes of Health (NIH) [1R01HL090991, R37AI15940, P30DK065988]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Rebecca Runyon Bryan Chair for Cystic Fibrosis; Max and Yetta Karasik Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support for this work was provided by the Cystic Fibrosis Foundation (YOUNG08Q0), the Rebecca Runyon Bryan Chair for Cystic Fibrosis, the Max and Yetta Karasik Foundation, the National Institutes of Health (NIH) 1R01HL090991 to JAN, NIH R37AI15940 to MLV, and NIH P30DK065988 to SHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2008, MOL MED, V14, P36, DOI 10.2119/2007-00081.Adib-Conquy; Alghamdi AS, 2005, BIOL REPROD, V73, P1174, DOI 10.1095/biolreprod.105.045666; Avdi NJ, 2001, J BIOL CHEM, V276, P2189, DOI 10.1074/jbc.M007527200; BAYER AS, 1991, INFECT IMMUN, V59, P302, DOI 10.1128/IAI.59.1.302-308.1991; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Bergsson G, 2009, J IMMUNOL, V183, P543, DOI 10.4049/jimmunol.0803959; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Bonvillain RW, 2010, FREE RADICAL BIO MED, V49, P1872, DOI 10.1016/j.freeradbiomed.2010.09.012; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075; CABRAL DA, 1987, PEDIATR RES, V22, P429, DOI 10.1203/00006450-198710000-00013; Chmiel JF, 2003, RESPIR RES, V4, DOI 10.1186/1465-9921-4-8; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; *CLIN TRIALS GOV, 2010, EFF PULM INF CYST FI; Comeau AM, 2004, PEDIATRICS, V113, P1573, DOI 10.1542/peds.113.6.1573; Cystic Fibrosis Foundation, 2021, PAT REG 2020 ANN DAT; DAI YL, 1994, THORAX, V49, P867, DOI 10.1136/thx.49.9.867; Dakin CJ, 2002, AM J RESP CRIT CARE, V165, P904, DOI 10.1164/ajrccm.165.7.2010139; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Frederiksen B, 1997, PEDIATR PULM, V23, P330, DOI 10.1002/(SICI)1099-0496(199705)23:5<330::AID-PPUL4>3.0.CO;2-O; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Bass JIF, 2010, J IMMUNOL, V184, P6386, DOI 10.4049/jimmunol.0901640; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; HAMMER MC, 1981, J LAB CLIN MED, V98, P938; HASLETT C, 1985, AM J PATHOL, V119, P101; Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7; Hayes E, 2011, ARCH IMMUNOL THER EX, V59, P97, DOI 10.1007/s00005-011-0113-6; Heale JP, 2001, J INFECT DIS, V183, P1214, DOI 10.1086/319685; HENRY RL, 1992, PEDIATR PULM, V12, P158, DOI 10.1002/ppul.1950120306; Hill D, 2005, J CLIN MICROBIOL, V43, P5085, DOI 10.1128/JCM.43.10.5085-5090.2005; HIRSCH JG, 1958, J EXP MED, V108, P925, DOI 10.1084/jem.108.6.925; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Jesaitis AJ, 2003, J IMMUNOL, V171, P4329, DOI 10.4049/jimmunol.171.8.4329; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Konstan MW, 2007, J PEDIATR-US, V151, P134, DOI 10.1016/j.jpeds.2007.03.006; Kosorok MR, 2001, PEDIATR PULM, V32, P277, DOI 10.1002/ppul.2009.abs; Lauth X, 2009, J INNATE IMMUN, V1, P202, DOI 10.1159/000203645; LEIJH PCJ, 1979, IMMUNOLOGY, V37, P453; Lippolis JD, 2006, VET IMMUNOL IMMUNOP, V113, P248, DOI 10.1016/j.vetimm.2006.05.004; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Makam M, 2009, P NATL ACAD SCI USA, V106, P5779, DOI 10.1073/pnas.0813410106; Martinelli S, 2004, J BIOL CHEM, V279, P44123, DOI 10.1074/jbc.M405883200; McKeon DJ, 2010, EUR RESPIR J, V35, P1264, DOI 10.1183/09031936.00089709; Mena A, 2008, J BACTERIOL, V190, P7910, DOI 10.1128/JB.01147-08; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Moraes TJ, 2006, AM J RESP CELL MOL, V34, P364, DOI 10.1165/rcmb.2005-0146OC; Moriceau S, 2010, J INNATE IMMUN, V2, P260, DOI 10.1159/000295791; Morris MR, 2005, CLIN EXP IMMUNOL, V142, P68, DOI [10.1111/j.1365-2249.2005.02893.x, 10.1111/j.1365-2249.2005.02893.X]; Mulcahy H, 2010, ENVIRON MICROBIOL, V12, P1621, DOI 10.1111/j.1462-2920.2010.02208.x; Nixon GM, 2001, J PEDIATR-US, V138, P699, DOI 10.1067/mpd.2001.112897; O'Donnell AE, 1998, CHEST, V113, P1329, DOI 10.1378/chest.113.5.1329; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; OGLE JW, 1987, J INFECT DIS, V155, P119, DOI 10.1093/infdis/155.1.119; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Painter RG, 2008, J LEUKOCYTE BIOL, V83, P1345, DOI 10.1189/jlb.0907658; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Painter RG, 2010, J LEUKOCYTE BIOL, V87, P933, DOI 10.1189/jlb.1009655; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Parad RB, 1999, INFECT IMMUN, V67, P4744, DOI 10.1128/IAI.67.9.4744-4750.1999; Parks QM, 2009, J MED MICROBIOL, V58, P492, DOI 10.1099/jmm.0.005728-0; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Quan JM, 2001, J PEDIATR-US, V139, P813, DOI 10.1067/mpd.2001.118570; Rau MH, 2010, ENVIRON MICROBIOL, V12, P1643, DOI 10.1111/j.1462-2920.2010.02211.x; Rubin BK, 2007, PAEDIATR RESPIR REV, V8, P4, DOI 10.1016/j.prrv.2007.02.004; Schaedel C, 2002, PEDIATR PULM, V33, P483, DOI 10.1002/ppul.10100; Sheils CA, 1996, AM J PATHOL, V148, P919; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sontag MK, 2005, J PEDIATR-US, V147, pS83, DOI 10.1016/j.jpeds.2005.08.005; Stick SM, 2009, J PEDIATR-US, V155, P623, DOI 10.1016/j.jpeds.2009.05.005; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Tirouvanziam R, 2008, P NATL ACAD SCI USA, V105, P4335, DOI 10.1073/pnas.0712386105; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Van Ziffle JA, 2009, BLOOD, V114, P4871, DOI 10.1182/blood-2009-05-220806; Vasil M L, 1987, Antibiot Chemother (1971), V39, P264; von Kockritz-Blickwede M, 2009, BLOOD, V114, P5245, DOI 10.1182/blood-2009-08-240713; Walker TS, 2005, INFECT IMMUN, V73, P3693, DOI 10.1128/IAI.73.6.3693-3701.2005; Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96	86	144	149	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e23637	10.1371/journal.pone.0023637	http://dx.doi.org/10.1371/journal.pone.0023637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909403	Green Submitted, Green Published, gold			2022-12-25	WOS:000294683900006
J	Rebelato, E; Abdulkader, F; Curi, R; Carpinelli, AR				Rebelato, Eduardo; Abdulkader, Fernando; Curi, Rui; Carpinelli, Angelo Rafael			Control of the Intracellular Redox State by Glucose Participates in the Insulin Secretion Mechanism	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; INTACT ISLETS; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE ACTIVITY; OXIDATIVE STRESS; NADPH OXIDASE; RAT ISLETS; LANGERHANS; CHANNELS; METABOLISM; EXOCYTOSIS	Background: Production of reactive oxygen species (ROS) due to chronic exposure to glucose has been associated with impaired beta cell function and diabetes. However, physiologically, beta cells are well equipped to deal with episodic glucose loads, to which they respond with a fine tuned glucose-stimulated insulin secretion (GSIS). In the present study, a systematic investigation in rat pancreatic islets about the changes in the redox environment induced by acute exposure to glucose was carried out. Methodology/Principal Findings: Short term incubations were performed in isolated rat pancreatic islets. Glucose dose- and time-dependently reduced the intracellular ROS content in pancreatic islets as assayed by fluorescence in a confocal microscope. This decrease was due to activation of pentose-phosphate pathway (PPP). Inhibition of PPP blunted the redox control as well as GSIS in a dose-dependent manner. The addition of low doses of ROS scavengers at high glucose concentration acutely improved beta cell function. The ROS scavenger N-acetyl-L-cysteine increased the intracellular calcium response to glucose that was associated with a small decrease in ROS content. Additionally, the presence of the hydrogen peroxide-specific scavenger catalase, in its membrane-permeable form, nearly doubled glucose metabolism. Interestingly, though an increase in GSIS was also observed, this did not match the effect on glucose metabolism. Conclusions: The control of ROS content via PPP activation by glucose importantly contributes to the mechanisms that couple the glucose stimulus to insulin secretion. Moreover, we identified intracellular hydrogen peroxide as an inhibitor of glucose metabolism intrinsic to rat pancreatic islets. These findings suggest that the intracellular adjustment of the redox environment by glucose plays an important role in the mechanism of GSIS.	[Rebelato, Eduardo; Abdulkader, Fernando; Curi, Rui; Carpinelli, Angelo Rafael] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil	Universidade de Sao Paulo	Rebelato, E (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil.	rebelato@icb.usp.br	Abdulkader, Fernando/R-6892-2018; Curi, Rui/C-9351-2012; Carpinelli, Angelo R/G-8566-2011	Abdulkader, Fernando/0000-0002-4273-1608; Carpinelli, Angelo R/0000-0002-0781-4934	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AMMON HPT, 1980, DIABETES, V29, P830, DOI 10.2337/diabetes.29.10.830; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; Bulteau AL, 2003, BIOCHEMISTRY-US, V42, P14846, DOI 10.1021/bi0353979; CARPINELLI AR, 1980, J ENDOCRINOL INVEST, V3, P365, DOI 10.1007/BF03349372; CHATHAM JC, 1989, EUR J BIOCHEM, V184, P657, DOI 10.1111/j.1432-1033.1989.tb15063.x; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Gier B, 2009, J CLIN INVEST, V119, P3246, DOI 10.1172/JCI38817; Goldstein BJ, 2005, DIABETES, V54, P311, DOI 10.2337/diabetes.54.2.311; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Krippeit-Drews P, 1999, J PHYSIOL-LONDON, V514, P471, DOI 10.1111/j.1469-7793.1999.471ae.x; Lacraz G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006500; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; LARRABEE MG, 1989, J BIOL CHEM, V264, P15875; LARRABEE MG, 1990, BIOCHEM J, V272, P127, DOI 10.1042/bj2720127; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; MALAISSE WJ, 1979, DIABETOLOGIA, V16, P331, DOI 10.1007/BF01223623; Martens GA, 2005, J BIOL CHEM, V280, P20389, DOI 10.1074/jbc.M411869200; Martens GA, 2007, ANTIOXID REDOX SIGN, V9, P309, DOI 10.1089/ars.2006.1466; Morgan D, 2007, DIABETOLOGIA, V50, P359, DOI 10.1007/s00125-006-0462-6; Morgan D, 2009, ENDOCRINOLOGY, V150, P2197, DOI 10.1210/en.2008-1149; NAKAZAKI M, 1995, DIABETES, V44, P878, DOI 10.2337/diabetes.44.8.878; Oliveira HR, 1999, AM J PHYSIOL-CELL PH, V276, pC507, DOI 10.1152/ajpcell.1999.276.2.C507; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Quesada I, 1999, DIABETES, V48, P2390, DOI 10.2337/diabetes.48.12.2390; Ravier MA, 1999, DIABETES, V48, P2374, DOI 10.2337/diabetes.48.12.2374; REBELATO E, 2009, METABOLISM; Reinbothe TM, 2009, MOL ENDOCRINOL, V23, P893, DOI 10.1210/me.2008-0306; ROBINSON JP, 1988, J LEUKOCYTE BIOL, V43, P304, DOI 10.1002/jlb.43.4.304; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Syed I, 2011, AM J PHYSIOL-REG I, V300, pR756, DOI 10.1152/ajpregu.00786.2010; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; Tian WN, 1999, AM J PHYSIOL-CELL PH, V276, pC1121, DOI 10.1152/ajpcell.1999.276.5.C1121; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; VERSPOHL EJ, 1979, ENDOCRINOLOGY, V105, P1269, DOI 10.1210/endo-105-5-1269; Zhang AY, 2006, HYPERTENSION, V47, P74, DOI 10.1161/01.HYP.0000196727.53300.62; Zhang Q, 2008, PHILOS T R SOC A, V366, P3503, DOI 10.1098/rsta.2008.0110; Zhang ZY, 2010, FASEB J, V24, P1497, DOI 10.1096/fj.09-136572	41	39	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24507	10.1371/journal.pone.0024507	http://dx.doi.org/10.1371/journal.pone.0024507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909396	Green Submitted, gold, Green Published			2022-12-25	WOS:000294680800093
J	Stoger, R; Genereux, DP; Hagerman, RJ; Hagerman, PJ; Tassone, F; Laird, CD				Stoeger, Reinhard; Genereux, Diane P.; Hagerman, Randi J.; Hagerman, Paul J.; Tassone, Flora; Laird, Charles D.			Testing the FMR1 Promoter for Mosaicism in DNA Methylation among CpG Sites, Strands, and Cells in FMR1-Expressing Males with Fragile X Syndrome	PLOS ONE			English	Article							HAIRPIN-BISULFITE PCR; MESSENGER-RNA; CGG-REPEAT; FULL MUTATION; RETT-SYNDROME; PREMUTATION CARRIERS; ELEVATED LEVELS; TRANSCRIPTION; EXPRESSION; GENE	Variability among individuals in the severity of fragile X syndrome (FXS) is influenced by epigenetic methylation mosaicism, which may also be common in other complex disorders. The epigenetic signal of dense promoter DNA methylation is usually associated with gene silencing, as was initially reported for FMR1 alleles in individuals with FXS. A paradox arose when significant levels of FMR1 mRNA were reported for some males with FXS who had been reported to have predominately methylated alleles. We have used hairpin-bisufite PCR, validated with molecular batch-stamps and barcodes, to collect and assess double-stranded DNA methylation patterns from these previously studied males. These patterns enable us to distinguish among three possible forms of methylation mosaicism, any one of which could explain FMR1 expression in these males. Our data indicate that cryptic inter-cell mosaicism in DNA methylation can account for the presence of FMR1 mRNA in some individuals with FXS.	[Stoeger, Reinhard; Genereux, Diane P.; Laird, Charles D.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Laird, Charles D.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Hagerman, Randi J.; Hagerman, Paul J.; Tassone, Flora] Univ Calif Davis, Med Ctr, Med Invest Neurodev Disorders Inst, Sacramento, CA 95817 USA; [Hagerman, Randi J.] Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA; [Hagerman, Paul J.; Tassone, Flora] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Stoeger, Reinhard] Univ Nottingham, Sch Biosci, Nottingham NG7 2RD, Leics, England	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Nottingham	Stoger, R (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	reinhard.stoger@nottingham.ac.uk; cdlaird@u.washington.edu		Stoger, Reinhard/0000-0002-2301-0805; Genereux, Diane/0000-0001-5770-0989	National Institutes of Health (NIH) [HD002274, GM077464, T32 HG 00035]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077464] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (NIH) grants HD002274, GM077464 and NIH Genome Training Grant T32 HG 00035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Beilina A, 2004, HUM MOL GENET, V13, P543, DOI 10.1093/hmg/ddh053; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Braunschweig D, 2004, HUM MOL GENET, V13, P1275, DOI 10.1093/hmg/ddh142; Burden AF, 2005, J BIOL CHEM, V280, P14413, DOI 10.1074/jbc.M413836200; Coffee B, 2009, AM J HUM GENET, V85, P503, DOI 10.1016/j.ajhg.2009.09.007; Crawford DC, 2002, AM J MED GENET, V110, P226, DOI 10.1002/ajmg.10427; Dahl C, 2007, CLIN CHEM, V53, P790, DOI 10.1373/clinchem.2006.080762; deGraaff E, 1996, AM J MED GENET, V64, P302, DOI 10.1002/(SICI)1096-8628(19960809)64:2<302::AID-AJMG14>3.0.CO;2-J; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Hagerman PJ, 2008, J MED GENET, V45, P498, DOI 10.1136/jmg.2008.059055; Hagerman RJ, 2008, CURR PEDIATR REV, V4, P40, DOI 10.2174/157339608783565770; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; Kenneson A, 2001, HUM MOL GENET, V10, P1449, DOI 10.1093/hmg/10.14.1449; Kumari D, 2001, J BIOL CHEM, V276, P4357, DOI 10.1074/jbc.M009629200; LAIRD C, 1987, TRENDS GENET, V3, P274, DOI 10.1016/0168-9525(87)90268-X; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Loesch DZ, 2004, MENT RETARD DEV D R, V10, P31, DOI 10.1002/mrdd.20006; MCCONKIEROSELL A, 1993, AM J HUM GENET, V53, P800; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Mila M, 1996, J MED GENET, V33, P338, DOI 10.1136/jmg.33.4.338; Miner BE, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh132; Pesso R, 2000, PRENATAL DIAG, V20, P611, DOI 10.1002/1097-0223(200008)20:8<611::AID-PD881>3.0.CO;2-M; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Primerano B, 2002, RNA, V8, P1482, DOI 10.1017/s1355838202020642; Sandberg G, 1997, NUCLEIC ACIDS RES, V25, P2883, DOI 10.1093/nar/25.14.2883; Scala E, 2007, AM J MED GENET A, V143A, P2775, DOI 10.1002/ajmg.a.32002; Singal R, 2001, BLOOD, V98, P3441, DOI 10.1182/blood.V98.12.3441; Stoger R, 1997, HUM MOL GENET, V6, P1791, DOI 10.1093/hmg/6.11.1791; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Tassone F, 2000, AM J MED GENET, V94, P232, DOI 10.1002/1096-8628(20000918)94:3<232::AID-AJMG9>3.0.CO;2-H; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tassone F, 2001, J MED GENET, V38, P453, DOI 10.1136/jmg.38.7.453; Tassone F, 2007, RNA, V13, P555, DOI 10.1261/rna.280807	35	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23648	10.1371/journal.pone.0023648	http://dx.doi.org/10.1371/journal.pone.0023648			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909353	Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800016
J	Kang, J; Goodman, B; Zheng, YX; Tantin, D				Kang, Jinsuk; Goodman, Ben; Zheng, Yixian; Tantin, Dean			Dynamic Regulation of Oct1 during Mitosis by Phosphorylation and Ubiquitination	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; MITOTIC PHOSPHORYLATION; CELL-CYCLE; QUANTITATIVE PHOSPHOPROTEOMICS; OXIDATIVE STRESS; SPINDLE; DOMAIN; CYTOKINESIS; ACTIVATION; MECHANISM	Background: Transcription factor Oct1 regulates multiple cellular processes. It is known to be phosphorylated during the cell cycle and by stress, however the upstream kinases and downstream consequences are not well understood. One of these modified forms, phosphorylated at S335, lacks the ability to bind DNA. Other modification states besides phosphorylation have not been described. Methodology/Principal Findings: We show that Oct1 is phosphorylated at S335 in the Oct1 DNA binding domain during M-phase by the NIMA-related kinase Nek6. Phospho-Oct1 is also ubiquitinated. Phosphorylation excludes Oct1 from mitotic chromatin. Instead, Oct1(pS335) concentrates at centrosomes, mitotic spindle poles, kinetochores and the midbody. Oct1 siRNA knockdown diminishes the signal at these locations. Both Oct1 ablation and overexpression result in abnormal mitoses. S335 is important for the overexpression phenotype, implicating this residue in mitotic regulation. Oct1 depletion causes defects in spindle morphogenesis in Xenopus egg extracts, establishing a mitosis-specific function of Oct1. Oct1 colocalizes with lamin B1 at the spindle poles and midbody. At the midbody, both proteins are mutually required to correctly localize the other. We show that phospho-Oct1 is modified late in mitosis by non-canonical K11-linked polyubiquitin chains. Ubiquitination requires the anaphase-promoting complex, and we further show that the anaphase-promoting complex large subunit APC1 and Oct1(pS335) interact. Conclusions/Significance: These findings reveal mechanistic coupling between Oct1 phosphorylation and ubquitination during mitotic progression, and a role for Oct1 in mitosis.	[Kang, Jinsuk; Tantin, Dean] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA; [Goodman, Ben; Zheng, Yixian] Carnegie Inst Sci, Dept Embryol, HHMI, Baltimore, MD 21210 USA	Utah System of Higher Education; University of Utah; Carnegie Institution for Science; Howard Hughes Medical Institute	Kang, J (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA.	dean.tantin@path.utah.edu			American Cancer Society [GMC-115196]; National Cancer Institute [1R21CA141009]; NATIONAL CANCER INSTITUTE [R21CA141009] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the American Cancer Society (GMC-115196) and National Cancer Institute (1R21CA141009) to D.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Fan WH, 2002, J BIOL CHEM, V277, P8061, DOI 10.1074/jbc.M110225200; Goodman B, 2010, J BIOL CHEM, V285, P35238, DOI 10.1074/jbc.M110.140749; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hansen DV, 2002, ONCOGENE, V21, P6209, DOI 10.1038/sj.onc.1205824; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Imai S, 1997, MOL BIOL CELL, V8, P2407, DOI 10.1091/mbc.8.12.2407; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kanai M, 2003, MOL CELL BIOL, V23, P2451, DOI 10.1128/MCB.23.7.2451-2462.2003; Kang JS, 2009, TRENDS BIOCHEM SCI, V34, P491, DOI 10.1016/j.tibs.2009.06.003; Kang JS, 2009, GENE DEV, V23, P208, DOI 10.1101/gad.1750709; Ma L, 2009, NAT CELL BIOL, V11, P246, DOI 10.1038/ncb1832; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Malhas AN, 2009, J CELL BIOL, V184, P45, DOI 10.1083/jcb.200804155; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Nie J, 1998, FEBS LETT, V424, P27, DOI 10.1016/S0014-5793(98)00131-8; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Parvin JD, 2009, ENVIRON MOL MUTAGEN, V50, P649, DOI 10.1002/em.20475; Pereira AL, 2006, MOL BIOL CELL, V17, P4526, DOI 10.1091/mbc.E06-07-0579; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; ROBERTS SB, 1991, SCIENCE, V253, P1022, DOI 10.1126/science.1887216; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sebastiano V, 2010, DEVELOPMENT, V137, P3551, DOI 10.1242/dev.047027; SEGIL N, 1991, SCIENCE, V254, P1814, DOI 10.1126/science.1684878; Shakya A, 2011, J BIOL CHEM, V286, P450, DOI 10.1074/jbc.M110.174045; Shakya A, 2009, NAT CELL BIOL, V11, P320, DOI 10.1038/ncb1840; TANAKA M, 1992, CELL, V68, P755, DOI 10.1016/0092-8674(92)90150-B; Tang H, 1999, IMMUNITY, V11, P517, DOI 10.1016/S1074-7613(00)80127-2; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Wang RH, 2004, P NATL ACAD SCI USA, V101, P17108, DOI 10.1073/pnas.0407585101; Wang VEH, 2004, MOL CELL BIOL, V24, P1022, DOI 10.1128/MCB.24.3.1022-1032.2004; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Yokoyama H, 2008, J CELL BIOL, V180, P867, DOI 10.1083/jcb.200706189	39	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23872	10.1371/journal.pone.0023872	http://dx.doi.org/10.1371/journal.pone.0023872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897860	Green Published, Green Submitted, gold			2022-12-25	WOS:000294676900024
J	Llach, A; Molina, CE; Alvarez-Lacalle, E; Tort, L; Benitez, R; Hove-Madsen, L				Llach, Anna; Molina, Cristina E.; Alvarez-Lacalle, Enrique; Tort, Lluis; Benitez, Raul; Hove-Madsen, Leif			Detection, Properties, and Frequency of Local Calcium Release from the Sarcoplasmic Reticulum in Teleost Cardiomyocytes	PLOS ONE			English	Article							TROUT ATRIAL MYOCYTES; RABBIT VENTRICULAR MYOCYTES; RAINBOW-TROUT; CA2+ RELEASE; EARLY AFTERDEPOLARIZATION; NA+/CA2+ EXCHANGE; CARDIAC MYOCYTES; HEART-MUSCLE; SUDDEN-DEATH; CONTRACTION	Calcium release from the sarcoplasmic reticulum (SR) plays a central role in the regulation of cardiac contraction and rhythm in mammals and humans but its role is controversial in teleosts. Since the zebrafish is an emerging model for studies of cardiovascular function and regeneration we here sought to determine if basic features of SR calcium release are phylogenetically conserved. Confocal calcium imaging was used to detect spontaneous calcium release (calcium sparks and waves) from the SR. Calcium sparks were detected in 16 of 38 trout atrial myocytes and 6 of 15 ventricular cells. The spark amplitude was 1.45 +/- 0.03 times the baseline fluorescence and the time to half maximal decay of sparks was 27 +/- 3 ms. Spark frequency was 0.88 sparks mu m(-1) min(-1) while calcium waves were 8.5 times less frequent. Inhibition of SR calcium uptake reduced the calcium transient (F/F-0) from 1.77 +/- 0.17 to 1.12 +/- 0.18 (p = 0.002) and abolished calcium sparks and waves. Moreover, elevation of extracellular calcium from 2 to 10 mM promoted early and delayed afterdepolarizations (from 0.6 +/- 0.3 min(-1) to 8.1 +/- 2.0 min(-1), p = 0.001), demonstrating the ability of SR calcium release to induce afterdepolarizations in the trout heart. Calcium sparks of similar width and duration were also observed in zebrafish ventricular myocytes. In conclusion, this is the first study to consistently report calcium sparks in teleosts and demonstrate that the basic features of calcium release through the ryanodine receptor are conserved, suggesting that teleost cardiac myocytes is a relevant model to study the functional impact of abnormal SR function.	[Llach, Anna; Molina, Cristina E.; Hove-Madsen, Leif] CSIC, Cardiovasc Res Ctr, Barcelona, Spain; [Llach, Anna; Molina, Cristina E.; Hove-Madsen, Leif] Hosp Santa Creu & Sant Pau, IIB St Pau, Barcelona, Spain; [Tort, Lluis] Univ Autonoma Barcelona, Dept Biol Celular Fisiol & Inmunol, E-08193 Barcelona, Spain; [Alvarez-Lacalle, Enrique; Benitez, Raul] Univ Politecn Cataluna, Dept Ingn Sistemas Automat & Informat Ind, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Universitat Politecnica de Catalunya	Llach, A (corresponding author), CSIC, Cardiovasc Res Ctr, Barcelona, Spain.	lhove@csic-iccc.org	Alvarez-Lacalle, Enrique/ADA-6394-2022; Llach Martinez, Ana/M-6691-2016; Molina, Cristina E./E-4536-2013; Alvarez Lacalle, Enrique/M-1031-2014; Benítez, Raúl/AGO-5018-2022; Tort, Lluis/H-5650-2011	Alvarez-Lacalle, Enrique/0000-0001-6824-6857; Llach Martinez, Ana/0000-0002-7486-1079; Molina, Cristina E./0000-0003-3094-1568; Alvarez Lacalle, Enrique/0000-0001-6824-6857; Benítez, Raúl/0000-0002-8782-9406; Llach, Anna/0000-0002-4352-2920; Hove-Madsen, Leif/0000-0001-5493-3998; Tort, Lluis/0000-0002-3907-722X	Spanish Ministry of Science and Technology [SAF2007-60174, CNIC2007-12]; Instituto de Salud Carlos III [REDINSCOR RD06-0003]	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was funded by grants from the Spanish Ministry of Science and Technology (SAF2007-60174 and CNIC2007-12) and a Network grant from Instituto de Salud Carlos III (REDINSCOR RD06-0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGIBAY JA, 1988, J PHYSIOL-LONDON, V401, P201, DOI 10.1113/jphysiol.1988.sp017158; Barriga M, 2010, EUR HEART J, V31, P895; BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; BENITEZ R, 2010, METHOD DETECTING LOC; Bers D.M., 2001, EXCITATION CONTRACTI, V2nd ed.; Brette F, 2008, BIOCHEM BIOPH RES CO, V374, P143, DOI 10.1016/j.bbrc.2008.06.109; Burashnikov A, 2003, CIRCULATION, V107, P2355, DOI 10.1161/01.CIR.0000065578.00869.7C; CANNELL MB, 1995, SCIENCE, V268, P1045, DOI 10.1126/science.7754384; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; ELSAYED MF, 1989, AM J PHYSIOL, V257, pR599, DOI 10.1152/ajpregu.1989.257.3.R599; FABIATO A, 1982, FED PROC, V41, P2238; FISCHMEISTER R, 1983, BIOPHYS J, V41, P341, DOI 10.1016/S0006-3495(83)84445-2; Gillis TE, 2000, AM J PHYSIOL-REG I, V279, pR1707, DOI 10.1152/ajpregu.2000.279.5.R1707; HORDOF AJ, 1978, CIRCULATION, V57, P223, DOI 10.1161/01.CIR.57.2.223; Hove-Madsen L, 2000, AM J PHYSIOL-REG I, V279, pR1856, DOI 10.1152/ajpregu.2000.279.5.R1856; Hove-Madsen L, 1999, PFLUG ARCH EUR J PHY, V438, P545, DOI 10.1007/s004240051074; Hove-Madsen L, 2004, CIRCULATION, V110, P1358, DOI 10.1161/01.CIR.0000141296.59876.87; Hove-Madsen L, 2003, AM J PHYSIOL-REG I, V284, pR1330, DOI 10.1152/ajpregu.00404.2002; Hove-Madsen L, 1998, AM J PHYSIOL-REG I, V275, pR2070, DOI 10.1152/ajpregu.1998.275.6.R2070; Hove-Madsen L, 1998, AM J PHYSIOL-REG I, V275, pR2061, DOI 10.1152/ajpregu.1998.275.6.R2061; Hove-Madsen L, 2001, PFLUG ARCH EUR J PHY, V441, P701, DOI 10.1007/s004240000470; Hove-Madsen L, 2001, AM J PHYSIOL-REG I, V281, pR1902, DOI 10.1152/ajpregu.2001.281.6.R1902; Hove-Madsen L, 2006, CARDIOVASC RES, V72, P292, DOI 10.1016/j.cardiores.2006.07.020; HOVEMADSEN L, 1993, CIRC RES, V73, P820, DOI 10.1161/01.RES.73.5.820; HOVEMADSEN L, 1989, J COMP PHYSIOL B, V159, P61, DOI 10.1007/BF00692684; HOVEMADSEN L, 1992, J EXP BIOL, V167, P47; Huang JB, 2006, AM J PHYSIOL-CELL PH, V290, pC1572, DOI 10.1152/ajpcell.00226.2005; Huang JB, 2005, AM J PHYSIOL-CELL PH, V288, pC195, DOI 10.1152/ajpcell.00183.2004; Huang J, 2008, AM J PHYSIOL-CELL PH, V294, pC516, DOI 10.1152/ajpcell.00417.2007; Huang J, 2007, AM J PHYSIOL-CELL PH, V293, pC1906, DOI 10.1152/ajpcell.00241.2007; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2002, CIRC RES, V91, P218, DOI 10.1161/01.RES.0000028455.36940.5E; Molina CE, 2007, AM J PHYSIOL-REG I, V292, pR388, DOI 10.1152/ajpregu.00499.2005; NABAUER M, 1989, AM J PHYSIOL, V256, pH916, DOI 10.1152/ajpheart.1989.256.3.H916; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; SANTER RM, 1974, CELL TISSUE RES, V151, P395; Schlotthauer K, 2000, CIRC RES, V87, P774, DOI 10.1161/01.RES.87.9.774; Sedarat F, 2000, AM J PHYSIOL-HEART C, V279, pH202, DOI 10.1152/ajpheart.2000.279.1.H202; Sheehan KA, 2006, J PHYSIOL-LONDON, V572, P799, DOI 10.1113/jphysiol.2005.103267; Shiels HA, 2005, AM J PHYSIOL-REG I, V288, pR1756, DOI 10.1152/ajpregu.00510.2004; Shiels HA, 2004, AM J PHYSIOL-REG I, V286, pR659, DOI 10.1152/ajpregu.00521.2003; Shiels HA, 2002, J EXP BIOL, V205, P3631; Vornanen M, 1999, J EXP BIOL, V202, P1763; Vornanen M, 1998, J EXP BIOL, V201, P533; Zhang P.C., 2010, AM J PHYSL REGUL INT; ZHOU JT, 1992, PACE, V15, P2164, DOI 10.1111/j.1540-8159.1992.tb03041.x	46	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23708	10.1371/journal.pone.0023708	http://dx.doi.org/10.1371/journal.pone.0023708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897853	Green Submitted, Green Published, gold			2022-12-25	WOS:000294676900016
J	Barauna, VG; Campos, LCG; Miyakawa, AA; Krieger, JE				Barauna, Valerio Garrone; Gastalho Campos, Luciene Cristina; Miyakawa, Ayumi Aurea; Krieger, Jose Eduardo			ACE as a Mechanosensor to Shear Stress Influences the Control of Its Own Regulation via Phosphorylation of Cytoplasmic Ser(1270)	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; ENDOTHELIAL-CELLS; SIGNAL-TRANSDUCTION; NITRIC-OXIDE; EXPRESSION; ACTIVATION; INHIBITORS; JNK; MECHANOTRANSDUCTION; ATHEROSCLEROSIS	Objectives: We tested whether angiotensin converting enzyme (ACE) and phosphorylation of Ser(1270) are involved in shear-stress (SS)-induced downregulation of the enzyme. Methods and Results: Western blotting analysis showed that SS (18 h, 15 dyn/cm(2)) decreases ACE expression and phosphorylation as well as p-JNK inhibition in human primary endothelial cells (EC). CHO cells expressing wild-type ACE (wt-ACE) also displayed SS-induced decrease in ACE and p-JNK. Moreover, SS decreased ACE promoter activity in wt-ACE, but had no effect in wild type CHO or CHO expressing ACE without either the extra-or the intracellular domains, and decreased less in CHO expressing a mutated ACE at Ser(1270) compared to wt-ACE (13 vs. 40%, respectively). The JNK inhibitor (SP600125, 18 h), in absence of SS, also decreased ACE promoter activity in wt-ACE. Finally, SS-induced inhibition of ACE expression and phosphorylation in EC was counteracted by simultaneous exposure to an ACE inhibitor. Conclusions: ACE displays a key role on its own downregulation in response to SS. This response requires both the extra- and the intracellular domains and ACE Ser(1270), consistent with the idea that the extracellular domain behaves as a mechanosensor while the cytoplasmic domain elicits the downstream intracellular signaling by phosphorylation on Ser(1270).	[Barauna, Valerio Garrone; Gastalho Campos, Luciene Cristina; Miyakawa, Ayumi Aurea; Krieger, Jose Eduardo] Univ Sao Paulo, Sch Med, Heart Inst InCor, Lab Genet & Mol Cardiol, Sao Paulo, Brazil	Universidade de Sao Paulo	Barauna, VG (corresponding author), Univ Sao Paulo, Sch Med, Heart Inst InCor, Lab Genet & Mol Cardiol, Sao Paulo, Brazil.	ayumi.miyakawa@incor.usp.br; krieger@incor.usp.br	Miyakawa, Ayumi A/M-4343-2015; Barauna, Valerio Jau/A-6115-2013; Campos, Luciene C/L-7603-2015; Pereira, Alexandre/HHN-1038-2022; Krieger, Jose E/C-3117-2011; Campos, Luciene/Y-3562-2019	Miyakawa, Ayumi A/0000-0003-3911-3259; Campos, Luciene C/0000-0002-5962-661X; Krieger, Jose E/0000-0001-5464-1792; Campos, Luciene/0000-0002-5962-661X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [01/00009-0, 03/14115-2, 06/52053-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [480120/2007-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP: 01/00009-0) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq: 480120/2007-2). L. C. G. C. and V. G. B. are recipients of fellowships from FAPESP (03/14115-2, 06/52053-7, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann A, 1998, BRIT J PHARMACOL, V124, P291, DOI 10.1038/sj.bjp.0701836; Bader M, 2008, J MOL MED, V86, P615, DOI 10.1007/s00109-008-0336-0; Bassaneze V, 2009, STEM CELLS DEV; Cheng C, 2007, ATHEROSCLEROSIS, V195, P225, DOI 10.1016/j.atherosclerosis.2006.11.019; Cheng M, 2008, CLIN BIOMECH, V23, pS96, DOI 10.1016/j.clinbiomech.2008.06.003; Chien S, 2006, BIORHEOLOGY, V43, P95; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Coates D, 2003, INT J BIOCHEM CELL B, V35, P769, DOI 10.1016/S1357-2725(02)00309-6; Dandona P, 2007, J HUM HYPERTENS, V21, P20, DOI 10.1038/sj.jhh.1002101; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dzau VJ, 2001, HYPERTENSION, V37, P1047, DOI 10.1161/01.HYP.37.4.1047; Fleming I, 2006, CIRC RES, V98, P887, DOI 10.1161/01.RES.0000217340.40936.53; Fleming I, 2005, PHYSIOLOGY, V20, P91, DOI 10.1152/physiol.00003.2005; Fukuhara M, 2000, HYPERTENSION, V35, P353, DOI 10.1161/01.HYP.35.1.353; Campos LCG, 2009, CARDIOVASC RES, V83, P140, DOI 10.1093/cvr/cvp108; Hahn C, 2009, CIRC RES, V104, P995, DOI 10.1161/CIRCRESAHA.108.186486; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Kohlstedt K, 2005, HYPERTENSION, V45, P126, DOI 10.1161/01.HYP.0000150159.48992.11; Kohlstedt K, 2004, CIRC RES, V94, P60, DOI 10.1161/01.RES.0000107195.13573.E4; Kohlstedt K, 2002, CIRC RES, V91, P749, DOI 10.1161/01.RES.0000038114.17939.C8; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LEHTONEN JYA, 1995, BIOPHYS J, V68, P1888, DOI 10.1016/S0006-3495(95)80366-8; MALEK A, 1992, AM J PHYSIOL, V263, pC389, DOI 10.1152/ajpcell.1992.263.2.C389; Marcic B, 2000, J BIOL CHEM, V275, P16110, DOI 10.1074/jbc.M909490199; Miyakawa AA, 2004, PHYSIOL GENOMICS, V17, P107, DOI 10.1152/physiolgenomics.00169.2003; Osto E, 2008, CIRCULATION, V118, P2073, DOI 10.1161/CIRCULATIONAHA.108.765032; Pang S, 2001, BIOCHEM J, V358, P185, DOI 10.1042/0264-6021:3580185; Pertrini CM, 2003, BRAZ J MED BIOL RES, V36, P1175, DOI 10.1590/S0100-879X2003000900005; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4; Richter Y, 2006, CIRCULATION, V113, P2679, DOI 10.1161/CIRCULATIONAHA.106.632687; Rieder MJ, 1997, CIRC RES, V80, P312, DOI 10.1161/01.RES.80.3.312; Ryan MJ, 2004, CIRC RES, V94, P1, DOI 10.1161/01.RES.0000112961.57831.87; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Sumara G, 2005, CELL MOL LIFE SCI, V62, P2487, DOI 10.1007/s00018-005-5253-6; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; VANHOUTTE PM, 1993, J CARDIOVASC PHARM, V22, pS10, DOI 10.1097/00005344-199322005-00003; Verna L, 2006, ARTERIOSCL THROM VAS, V26, P1344, DOI 10.1161/01.ATV.0000222152.83069.3f	39	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e22803	10.1371/journal.pone.0022803	http://dx.doi.org/10.1371/journal.pone.0022803			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901117	Green Submitted, gold, Green Published			2022-12-25	WOS:000294298000002
J	Blanchet, E; Bertrand, C; Annicotte, JS; Schlernitzauer, A; Pessemesse, L; Levin, J; Fouret, G; Feillet-Coudray, C; Bonafos, B; Fajas, L; Cabello, G; Wrutniak-Cabello, C; Casas, F				Blanchet, Emilie; Bertrand, Christelle; Annicotte, Jean Sebastien; Schlernitzauer, Audrey; Pessemesse, Laurence; Levin, Jonathan; Fouret, Gilles; Feillet-Coudray, Christine; Bonafos, Beatrice; Fajas, Lluis; Cabello, Gerard; Wrutniak-Cabello, Chantal; Casas, Francois			Mitochondrial T3 receptor p43 regulates insulin secretion and glucose homeostasis	FASEB JOURNAL			English	Article						thyroid hormone; mitochondria	THYROID-HORMONE-RECEPTOR; BETA-CELL FUNCTION; MYOBLAST DIFFERENTIATION; C-ERB; RESPIRATORY-CHAIN; EXPRESSION; ALPHA; OVEREXPRESSION; IDENTIFICATION; PROTEIN	Thyroid hormone is a major determinant of energy expenditure and a key regulator of mitochondrial activity. We have previously identified a mitochondrial triiodothyronine receptor (p43) that acts as a mitochondrial transcription factor of the organelle genome, which leads, in vitro and in vivo, to a stimulation of mitochondrial biogenesis. Here we generated mice specifically lacking p43 to address its physiological influence. We found that p43 is required for normal glucose homeostasis. The p43(-/-) mice had a major defect in insulin secretion both in vivo and in isolated pancreatic islets and a loss of glucose-stimulated insulin secretion. Moreover, a high-fat/high-sucrose diet elicited more severe glucose intolerance than that recorded in normal animals. In addition, we observed in p43(-/-) mice both a decrease in pancreatic islet density and in the activity of complexes of the respiratory chain in isolated pancreatic islets. These dysfunctions were associated with a down-regulation of the expression of the glucose transporter Glut2 and of Kir6.2, a key component of the K(ATP) channel. Our findings establish that p43 is an important regulator of glucose homeostasis and pancreatic beta-cell function and provide evidence for the first time of a physiological role for a mitochondrial endocrine receptor.-Blanchet, E., Bertrand, C., Annicotte, J. S., Schlernitzauer, A., Pessemesse, L., Levin, J., Fouret, G., Feillet-Coudray, C., Bonafos, B., Fajas, L., Cabello, G., Wrutniak-Cabello, C., Casas, F. Mitochondrial T3 receptor p43 regulates insulin secretion and glucose homeostasis. FASEB J. 26, 40-50 (2012). www.fasebj.org	[Bertrand, Christelle; Schlernitzauer, Audrey; Pessemesse, Laurence; Levin, Jonathan; Fouret, Gilles; Feillet-Coudray, Christine; Bonafos, Beatrice; Wrutniak-Cabello, Chantal; Casas, Francois] Univ Montpellier 1, INRA, Dynam Musculaire & Metab UMR866, F-34060 Montpellier, France; [Bertrand, Christelle; Schlernitzauer, Audrey; Pessemesse, Laurence; Levin, Jonathan; Fouret, Gilles; Feillet-Coudray, Christine; Bonafos, Beatrice; Wrutniak-Cabello, Chantal; Casas, Francois] Univ Montpellier 2, F-34095 Montpellier 5, France; [Blanchet, Emilie; Annicotte, Jean Sebastien; Fajas, Lluis; Cabello, Gerard] Univ Montpellier 1, Inst Rech Clin Montreal, Inst Rech Cancerol Montpellier, Inst Natl Sante & Rech Med INSERM U896, F-34060 Montpellier, France	INRAE; Universite de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Casas, F (corresponding author), Univ Montpellier 1, INRA, Dynam Musculaire & Metab UMR866, 2 Pl Viala, F-34060 Montpellier, France.	casasf@supagro.inra.fr	Levin, Jonathan/N-3189-2018; BERTRAND-GADAY, Christelle/ABA-8619-2021; Annicotte, Jean-Sébastien/H-4641-2018; Coll, Lluis Fajas/C-8567-2014	BERTRAND-GADAY, Christelle/0000-0003-0461-2402; Annicotte, Jean-Sébastien/0000-0002-2109-4849; Francois, Casas/0000-0002-5535-8195; Fajas, Lluis/0000-0002-1283-9503	Institut National de la Recherche Agronomique; ANR MitHyCal; Societe Francophone du Diabete-Novartis	Institut National de la Recherche Agronomique; ANR MitHyCal(French National Research Agency (ANR)); Societe Francophone du Diabete-Novartis	The authors are grateful to J. Samarut (ENS, Lyon, France) for providing plasmid alpha 8BS, T. Lamonerie (ENS, Lyon, France) for vector pT102, and L. Lecam (Institut de Genetique Moleculaire de Montpellier, Montpellier, France) for ES cells. The authors thank the animal staff for animal care. This work was supported by grants from the Institut National de la Recherche Agronomique, ANR MitHyCal, and Societe Francophone du Diabete-Novartis.	Annicotte JS, 2009, NAT CELL BIOL, V11, P1017, DOI 10.1038/ncb1915; Annicotte JS, 2003, MOL CELL BIOL, V23, P6713, DOI 10.1128/MCB.23.19.6713-6724.2003; ANTIN PB, 1991, DEV BIOL, V143, P111, DOI 10.1016/0012-1606(91)90058-B; BARIS O, 2007, FEBS ADV LECT SERIES, P14; BRENT GA, 1991, ANNU REV PHYSIOL, V53, P17, DOI 10.1146/annurev.ph.53.030191.000313; Casas F, 1999, MOL CELL BIOL, V19, P7913; Casas F, 2006, MOL ENDOCRINOL, V20, P749, DOI 10.1210/me.2005-0074; Casas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005631; Casas F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002501; CassarMalek I, 1996, J BIOL CHEM, V271, P11392, DOI 10.1074/jbc.271.19.11392; Chassande O, 1997, MOL ENDOCRINOL, V11, P1278, DOI 10.1210/me.11.9.1278; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Crunkhorn S, 2008, THYROID, V18, P227, DOI 10.1089/thy.2007.0249; Fajas L, 2004, J CLIN INVEST, V113, P1288, DOI 10.1172/JCI200418555; FORREST D, 1990, EMBO J, V9, P1519, DOI 10.1002/j.1460-2075.1990.tb08270.x; Grandemange S, 2005, CANCER RES, V65, P4282, DOI 10.1158/0008-5472.CAN-04-3652; HODIN RA, 1989, SCIENCE, V244, P76, DOI 10.1126/science.2539642; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Koenig R., 1988, P NATL ACAD SCI USA, V85, P531; LAZAR MA, 1988, MOL ENDOCRINOL, V2, P893, DOI 10.1210/mend-2-10-893; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Maechler P, 2010, ADV EXP MED BIOL, V654, P193, DOI 10.1007/978-90-481-3271-3_9; MITSUHASHI T, 1988, P NATL ACAD SCI USA, V85, P5804, DOI 10.1073/pnas.85.16.5804; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; Seyer P, 2006, J CELL PHYSIOL, V207, P75, DOI 10.1002/jcp.20539; Seyer P, 2011, EXP CELL RES, V317, P2059, DOI 10.1016/j.yexcr.2011.05.020; Taylor SI, 1999, CELL, V97, P9, DOI 10.1016/S0092-8674(00)80709-6; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; Wharton DC., 1967, METHOD ENZYMOL, P245; Williams GR, 2000, MOL CELL BIOL, V20, P8329, DOI 10.1128/MCB.20.22.8329-8342.2000; WRUTNIAK C, 1995, J BIOL CHEM, V270, P16347, DOI 10.1074/jbc.270.27.16347; Wrutniak-Cabello C, 2001, J MOL ENDOCRINOL, V26, P67, DOI 10.1677/jme.0.0260067	37	35	38	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2012	26	1					40	50		10.1096/fj.11-186841	http://dx.doi.org/10.1096/fj.11-186841			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21914860				2022-12-25	WOS:000299202200006
J	Wenzel, UA; Bank, E; Florian, C; Forster, S; Zimara, N; Steinacker, J; Klinger, M; Reiling, N; Ritter, U; van Zandbergen, G				Wenzel, Ulf Alexander; Bank, Elena; Florian, Christian; Foerster, Sabine; Zimara, Nicole; Steinacker, Jochen; Klinger, Matthias; Reiling, Norbert; Ritter, Uwe; van Zandbergen, Ger			Leishmania major parasite stage-dependent host cell invasion and immune evasion	FASEB JOURNAL			English	Article						human macrophages; neutrophils; amastigotes; promastigotes; axenic culture; endocytosis and phagocytosis	AXENIC AMASTIGOTES; GENE-EXPRESSION; MACROPHAGES; DONOVANI; PROMASTIGOTES; INFECTION; LIPOPHOSPHOGLYCAN; CHOLESTEROL; TEMPERATURE; CULTIVATION	Leishmania pathogenesis is primarily studied using the disease-inducing promastigote stage of Leishmania major. Despite many efforts, all attempts so far have failed to culture the disease-relevant multiplying amastigote stage of L. major. Here, we established a stably growing axenic L. major amastigote culture system that was characterized genetically, morphologically, and by stage-specific DsRed protein expression. We found parasite stage-specific disease development in resistant C57BL/6 mice. Human neutrophils, as first host cells for promastigotes, do not take up amastigotes. In human macrophages, we observed an amastigote-specific complement receptor 3-mediated, endocytotic entry mechanism, whereas promastigotes are taken up by complement receptor 1-mediated phagocytosis. Promastigote infection of macrophages induced the inflammatory mediators TNF, CCL3, and CCL4, whereas amastigote infection was silent and resulted in significantly increased parasite numbers: from 7.1 +/- 1.4 (after 3 h) to 20.1 +/- 7.9 parasites/cell (after 96 h). Our study identifies Leishmania stage-specific disease development, host cell preference, entry mechanism, and immune evasion. Since the amastigote stage is the disease-propagating form found in the infected mammalian host, the newly developed L. major axenic cultures will serve as an important tool in better understanding the amastigote-driven immune response in leishmaniasis.-Wenzel, U. A., Bank, E., Florian, C., Forster, S., Zimara, N., Steinacker, J., Klinger, M., Reiling, N., Ritter, U., van Zandbergen, G. Leishmania major parasite stage-dependent host cell invasion and immune evasion. FASEB J. 26, 29-39 (2012). www.fasebj.org	[Bank, Elena; Foerster, Sabine; van Zandbergen, Ger] Fed Inst Vaccines & Biomed, Div Immunol, Paul Ehrlich Inst, D-63225 Langen, Germany; [Wenzel, Ulf Alexander; Bank, Elena; Steinacker, Jochen; van Zandbergen, Ger] Univ Clin Ulm, Inst Med Microbiol & Hyg, Ulm, Germany; [Wenzel, Ulf Alexander] Univ Gothenburg, Dept Microbiol & Immunol, Sahlgrenska Acad, Mucosal Immunobiol & Vaccine Ctr MIVAC, Gothenburg, Sweden; [Florian, Christian; Zimara, Nicole; Ritter, Uwe] Univ Regensburg, Dept Immunol, Regensburg, Germany; [Klinger, Matthias] Univ Lubeck, Inst Anat, Lubeck, Germany; [Reiling, Norbert] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Microbial Interface Biol, Borstel, Germany	Paul Ehrlich Institute; Ulm University; University of Gothenburg; University of Regensburg; University of Lubeck; Forschungszentrum Borstel	van Zandbergen, G (corresponding author), Fed Inst Vaccines & Biomed, Div Immunol, Paul Ehrlich Inst, Paul Ehrlich Str 51-59, D-63225 Langen, Germany.	ger.zandbergen@pei.de	van Zandbergen, Ger/M-1571-2013; Reiling, Norbert/D-6796-2013; Förster, Sabine/I-4714-2012; Steinacker, Juergen M. M/E-6876-2015	Reiling, Norbert/0000-0001-6673-4291; Steinacker, Juergen M. M/0000-0001-8901-9450	German Research Foundation [VA204 2-1, ZA533 5-1, ZA533 7-1, SFB 415-C7]; Bundesministerium fur Bildung und Forschung [01KI0784]	German Research Foundation(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	The authors thank S. Diebold, S. Moller, L. Dost, and K. Strele for excellent technical help. The authors thank Dr. G. Schonian (Charite, Humboldt University, Berlin, Germany) for helping to establish the ITS1 analyses and Dr. G. Spath (Institute Pasteur, Paris, France) for kindly providing the anti-LPG antibody WIC79.3. This research is supported in part by grants from the German Research Foundation (VA204 2-1, ZA533 5-1, and ZA533 7-1 to G.V.Z.; and SFB 415-C7 to N.R.) and the Bundesministerium fur Bildung und Forschung, Project 01KI0784, WP D (to N.R.).	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; BATES PA, 1992, PARASITOLOGY, V105, P193, DOI 10.1017/S0031182000074102; BERMAN JD, 1981, AM J TROP MED HYG, V30, P318, DOI 10.4269/ajtmh.1981.30.318; BOGDAN C, 1990, EUR J IMMUNOL, V20, P1131, DOI 10.1002/eji.1830200528; Bogdan C, 2000, J EXP MED, V191, P2121, DOI 10.1084/jem.191.12.2121; Charmoy M, 2007, J LEUKOCYTE BIOL, V82, P288, DOI 10.1189/jlb.0706440; Cohen-Freue G, 2007, INT J PARASITOL, V37, P1077, DOI 10.1016/j.ijpara.2007.04.011; Courret N, 2002, J CELL SCI, V115, P2303; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; DOYLE PS, 1991, EXP PARASITOL, V73, P326, DOI 10.1016/0014-4894(91)90104-5; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; GLASER TA, 1991, MOL BIOCHEM PARASIT, V45, P337, DOI 10.1016/0166-6851(91)90102-C; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Gupta N, 2001, TRENDS PARASITOL, V17, P150, DOI 10.1016/S1471-4922(00)01811-0; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Lauer S, 2000, EMBO J, V19, P3556, DOI 10.1093/emboj/19.14.3556; Leifso K, 2007, MOL BIOCHEM PARASIT, V152, P35, DOI 10.1016/j.molbiopara.2006.11.009; Lodge R, 2005, CLIN IMMUNOL, V114, P256, DOI 10.1016/j.clim.2004.07.018; MEDINAACOSTA E, 1989, MOL BIOCHEM PARASIT, V37, P263, DOI 10.1016/0166-6851(89)90158-8; Misslitz A, 2000, MOL BIOCHEM PARASIT, V107, P251, DOI 10.1016/S0166-6851(00)00195-X; Mizbani A, 2009, VACCINE, V28, P53, DOI 10.1016/j.vaccine.2009.09.114; Mordue DG, 1999, J EXP MED, V190, P1783, DOI 10.1084/jem.190.12.1783; Nasereddin A, 2010, ACTA TROP, V113, P72, DOI 10.1016/j.actatropica.2009.09.009; Neumann J, 2010, FASEB J, V24, P4599, DOI 10.1096/fj.10-160994; Ouakad M, 2007, PARASITOL RES, V101, P473, DOI 10.1007/s00436-007-0491-1; Ribeiro-Gomes FL, 2007, J IMMUNOL, V179, P3988, DOI 10.4049/jimmunol.179.6.3988; Ritter U, 2002, PARASITE IMMUNOL, V24, P295, DOI 10.1046/j.1365-3024.2002.00467.x; Rupp J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006020; Saar Y, 1998, MOL BIOCHEM PARASIT, V95, P9, DOI 10.1016/S0166-6851(98)00062-0; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Spath GF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000381; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; Weiss R, 2007, VACCINE, V25, P25, DOI 10.1016/j.vaccine.2006.07.044; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; ZENIAN A, 1979, J CELL SCI, V39, P187; Zhang WW, 1997, P NATL ACAD SCI USA, V94, P8807, DOI 10.1073/pnas.94.16.8807; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	41	34	34	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2012	26	1					29	39		10.1096/fj.11-184895	http://dx.doi.org/10.1096/fj.11-184895			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21908716				2022-12-25	WOS:000299202200005
J	Neniskyte, U; Neher, JJ; Brown, GC				Neniskyte, Urte; Neher, Jonas J.; Brown, Guy C.			Neuronal Death Induced by Nanomolar Amyloid beta Is Mediated by Primary Phagocytosis of Neurons by Microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; NITRIC-OXIDE; PHOSPHOLIPID ASYMMETRY; APOPTOTIC LYMPHOCYTES; IN-VITRO; PHOSPHATIDYLSERINE; BRAIN; EXPRESSION; PEPTIDE; PROTEIN	Alzheimer disease is characterized by neuronal loss and brain plaques of extracellular amyloid beta (A beta), but the means by which A beta may induce neuronal loss is not entirely clear. Although high concentrations of A beta (mu M) can induce direct toxicity to neurons, we find that low concentration (nM) induce neuronal loss through a microglia-mediated mechanism. In mixed neuronal-glial cultures from rat cerebellum, 250 nM A beta 1-42 (added as monomers, oligomers or fibers) induced about 30% loss of neurons between 2 and 3 days. This neuronal loss occurred without any increase in neuronal apoptosis or necrosis, and no neuronal loss occurred with A beta 42-1. A beta greatly increased the phagocytic capacity of microglia and induced phosphatidylserine exposure (an "eat-me" signal) on neuronal processes. Blocking exposed phosphatidylserine by adding annexin V or an antibody to phosphatidylserine or inhibiting microglial phagocytosis by adding either cytochalasin D (to block actin polymerization) or cyclo( RGDfV) (to block vitronectin receptors) significantly prevented neuronal loss. Loss of neuronal synapses occurred in parallel with loss of cell bodies and was also prevented by blocking phagocytosis. Inhibition of phagocytosis prevented neuronal loss with no increase in neuronal death, even after 7 days, suggesting that microglial phagocytosis was the primary cause of neuronal death induced by nanomolar A beta	[Neniskyte, Urte; Neher, Jonas J.; Brown, Guy C.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge	Neniskyte, U (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	us230@cam.ac.uk	Brown, Guy C./HHC-1102-2022; Neher, Jonas/AAQ-4927-2021; Neniskyte, Urte/AAI-2217-2021	Neher, Jonas/0000-0003-1346-8924; Neniskyte, Urte/0000-0001-7645-703X; Brown, Guy/0000-0002-3610-1730	Wellcome Trust [RG50995]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grant RG50995.	Abdul HM, 2005, BBA-MOL BASIS DIS, V1741, P140, DOI 10.1016/j.bbadis.2004.12.002; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Balasubramanian K, 2007, J BIOL CHEM, V282, P18357, DOI 10.1074/jbc.M700202200; BIANCA VD, 1999, J BIOL CHEM, V274, P15493; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Calissano P, 2009, Commun Integr Biol, V2, P163; Cappai R, 2008, NEUROCHEM RES, V33, P526, DOI 10.1007/s11064-007-9469-8; Ciccotosto GD, 2011, NEUROBIOL AGING, V32, P235, DOI 10.1016/j.neurobiolaging.2009.02.018; Cizas P, 2010, ARCH BIOCHEM BIOPHYS, V496, P84, DOI 10.1016/j.abb.2010.02.001; De Simone R, 2003, J NEUROPATH EXP NEUR, V62, P208, DOI 10.1093/jnen/62.2.208; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Gleiss B, 2002, FEBS LETT, V519, P153, DOI 10.1016/S0014-5793(02)02743-6; Haubner R, 1996, J AM CHEM SOC, V118, P7461, DOI 10.1021/ja9603721; Hellstrom-Lindahl E, 2009, NEUROCHEM INT, V55, P243, DOI 10.1016/j.neuint.2009.03.007; Jana M, 2008, J IMMUNOL, V181, P7254, DOI 10.4049/jimmunol.181.10.7254; Jekabsone A, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-24; Kao AW, 2011, P NATL ACAD SCI USA, V108, P4441, DOI 10.1073/pnas.1100650108; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Kinsner A, 2005, J NEUROCHEM, V95, P1132, DOI 10.1111/j.1471-4159.2005.03422.x; Krahling S, 1999, CELL DEATH DIFFER, V6, P183, DOI 10.1038/sj.cdd.4400473; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lange MLB, 2008, NEUROBIOL DIS, V29, P456, DOI 10.1016/j.nbd.2007.11.004; Lange MLB, 2010, NEUROBIOL DIS, V38, P104, DOI 10.1016/j.nbd.2010.01.004; Lee G, 2002, PEPTIDES, V23, P1249, DOI 10.1016/S0196-9781(02)00060-8; Liao MQ, 2007, FEBS LETT, V581, P1161, DOI 10.1016/j.febslet.2007.02.026; Maezawa I, 2011, J BIOL CHEM, V286, P3693, DOI 10.1074/jbc.M110.135244; McArthur S, 2010, J IMMUNOL, V185, P6317, DOI 10.4049/jimmunol.1001095; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Morgan K, 2011, NEUROPATH APPL NEURO, V37, P353, DOI 10.1111/j.1365-2990.2011.01181.x; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; OSENSAND A, 1993, NATURE, V364, P445, DOI 10.1038/364445a0; OYLER GA, 1991, P NATL ACAD SCI USA, V88, P5247, DOI 10.1073/pnas.88.12.5247; Perry G, 1998, SCIENCE, V282, P1268; Raina A K, 2000, Prog Cell Cycle Res, V4, P235; Raymond A, 2009, J CELL BIOCHEM, V106, P957, DOI 10.1002/jcb.22076; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; SHENG JG, 1995, NEUROPATH APPL NEURO, V21, P290, DOI 10.1111/j.1365-2990.1995.tb01063.x; Simakova O, 2007, J NEUROSCI, V27, P13719, DOI 10.1523/JNEUROSCI.3006-07.2007; Sondag CM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-1; Steinerman JR, 2008, ARCH NEUROL-CHICAGO, V65, P906, DOI 10.1001/archneur.65.7.906; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Styren SD, 1998, J COMP NEUROL, V396, P511; Tyurina YY, 2007, J BIOL CHEM, V282, P8498, DOI 10.1074/jbc.M606950200; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; VandenEijnde SM, 1997, CELL DEATH DIFFER, V4, P311, DOI 10.1038/sj.cdd.4400241; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; Weldon DT, 1998, J NEUROSCI, V18, P2161; Wilkinson B, 2006, J BIOL CHEM, V281, P20842, DOI 10.1074/jbc.M600627200; Witting A, 2000, J NEUROCHEM, V75, P1060, DOI 10.1046/j.1471-4159.2000.0751060.x; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Xie Z, 2002, J NEUROSCI, V22, P3484	56	139	144	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39904	39913		10.1074/jbc.M111.267583	http://dx.doi.org/10.1074/jbc.M111.267583			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21903584	Green Published, hybrid			2022-12-25	WOS:000296925700024
J	Champ, S; Puvirajesinghe, TM; Perrody, E; Menouni, R; Genevaux, P; Ansaldi, M				Champ, Stephanie; Puvirajesinghe, Tania M.; Perrody, Elsa; Menouni, Rachid; Genevaux, Pierre; Ansaldi, Mireille			Chaperone-assisted Excisive Recombination, a Solitary Role for DnaJ (Hsp40) Chaperone in Lysogeny Escape	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; HEAT-SHOCK PROTEINS; RESPONSE REGULATOR INHIBITOR; ESCHERICHIA-COLI; BACTERIOPHAGE-LAMBDA; J-DOMAIN; IN-VIVO; REPLICATION PROTEINS; MOLECULAR CHAPERONE; NUCLEOTIDE-SEQUENCE	Temperate bacteriophage lytic development is intrinsically related to the stress response in particular at the DNA replication and virion maturation steps. Alternatively, temperate phages become lysogenic and integrate their genome into the host chromosome. Under stressful conditions, the prophage resumes a lytic development program, and the phage DNA is excised before being replicated. The KplE1 defective prophage of Escherichia coli K12 constitutes a model system because it is fully competent for integrative as well as excisive recombination and presents an atypical recombination module, which is conserved in various phage genomes. In this work, we identified the host-encoded stress-responsive molecular chaperone DnaJ (Hsp40) as an active participant in KplE1 prophage excision. We first show that the recombination directionality factor TorI of KplE1 specifically interacts with DnaJ. In addition, we found that DnaJ dramatically enhances both TorI binding to its DNA target and excisive recombination in vitro. Remarkably, such stimulatory effect by DnaJ was performed independently of its DnaK chaperone partner and did not require a functional DnaJ J-domain. Taken together, our results underline a novel and unsuspected functional interaction between the generic host stress-regulated chaperone and temperate bacteriophage lysogenic development.	[Champ, Stephanie; Puvirajesinghe, Tania M.; Menouni, Rachid; Ansaldi, Mireille] Aix Marseille Univ, Lab Chim Bacterienne, Inst Microbiol Mediterranee, CNRS UPR9043, F-13402 Marseille 20, France; [Perrody, Elsa; Genevaux, Pierre] Univ Toulouse 3, Lab Microbiol & Genet Mol, CNRS UMR 5100, F-31062 Toulouse 9, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Ansaldi, M (corresponding author), Aix Marseille Univ, Lab Chim Bacterienne, Inst Microbiol Mediterranee, CNRS UPR9043, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	ansaldi@ifr88.cnrs-mrs.fr	Genevaux, Pierre/A-4851-2015; Puvirajesinghe, Tania/AAD-9137-2020	Puvirajesinghe, Tania/0000-0002-8304-9824; GENEVAUX, Pierre/0000-0001-7539-3126; ANSALDI, Mireille/0000-0002-2878-0702	CNRS; French Research Ministry (Ministere de l'Education Nationale de la Recherche et de la Technologie); National Research Agency [ANR-08-BLAN-0122-01]	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Research Ministry (Ministere de l'Education Nationale de la Recherche et de la Technologie)(Ministry of Research, France); National Research Agency(French National Research Agency (ANR))	This work was supported by CNRS, the French Research Ministry (Ministere de l'Education Nationale de la Recherche et de la Technologie), and National Research Agency Grant ANR-08-BLAN-0122-01 (to M. A. and P. G.).	Abbani M, 2005, J MOL BIOL, V347, P11, DOI 10.1016/j.jmb.2005.01.019; ABREMSKI K, 1982, J BIOL CHEM, V257, P9658; Ansaldi M, 1996, ANAL BIOCHEM, V234, P110, DOI 10.1006/abio.1996.0060; Ansaldi M, 2004, P NATL ACAD SCI USA, V101, P9423, DOI 10.1073/pnas.0401927101; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Campbell A. M., 1996, ESCHERICHIA COLI SAL, P2041; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Casjens S, 2004, J MOL BIOL, V339, P379, DOI 10.1016/j.jmb.2004.03.068; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Clark AJ, 2001, J MOL BIOL, V311, P657, DOI 10.1006/jmbi.2001.4868; ElAntak L, 2005, J BIOL CHEM, V280, P36802, DOI 10.1074/jbc.M507409200; FRIEDMAN DI, 1984, MICROBIOL REV, V48, P299, DOI 10.1128/MMBR.48.4.299-325.1984; GAITANARIS GA, 1994, MOL MICROBIOL, V14, P861, DOI 10.1111/j.1365-2958.1994.tb01322.x; Genevaux P, 2003, J VIROL, V77, P10706, DOI 10.1128/JVI.77.19.10706-10713.2003; Genevaux P, 2002, GENETICS, V162, P1045; Genevaux P, 2001, J BACTERIOL, V183, P5747, DOI 10.1128/JB.183.19.5747-5750.2001; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Georgopoulos C, 2006, GENETICS, V174, P1699, DOI 10.1534/genetics.104.68262; GEORGOPOULOS CP, 1977, MOL GEN GENET, V151, P35, DOI 10.1007/BF00446910; GOTTESMAN S, 1980, J MOL BIOL, V138, P503, DOI 10.1016/S0022-2836(80)80015-5; Gur E, 2005, FEBS LETT, V579, P1935, DOI 10.1016/j.febslet.2005.01.084; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Huang W, 2007, CHINESE J STRUC CHEM, V26, P594; KAWASAKI Y, 1990, MOL GEN GENET, V220, P277; KAWASAKI Y, 1992, J BIOL CHEM, V267, P11520; LEBOWITZ JH, 1985, P NATL ACAD SCI USA, V82, P3988, DOI 10.1073/pnas.82.12.3988; Lewis JA, 2001, NUCLEIC ACIDS RES, V29, P2205, DOI 10.1093/nar/29.11.2205; LIBEREK K, 1990, J BIOL CHEM, V265, P3022; Mayer MP, 2005, REV PHYSIOL BIOCH P, V153, P1, DOI 10.1007/s10254-004-0025-5; Maynard ND, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001017; Mumm JP, 2006, EMBO J, V25, P4586, DOI 10.1038/sj.emboj.7601325; Nakamura A, 2007, P NATL ACAD SCI USA, V104, P18484, DOI 10.1073/pnas.0705623104; Nash H, 1996, ESCHERICHIA COLI SAL, P2363; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; OSIPIUK J, 1993, J BIOL CHEM, V268, P4821; Panis G, 2007, J BIOL CHEM, V282, P21798, DOI 10.1074/jbc.M701827200; Panis G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001149; Panis G, 2010, VIROLOGY, V404, P41, DOI 10.1016/j.virol.2010.04.027; Perales-Calvo J, 2010, J BIOL CHEM, V285, P34231, DOI 10.1074/jbc.M110.144642; Rokney A, 2008, MOL MICROBIOL, V68, P29, DOI 10.1111/j.1365-2958.2008.06119.x; Sakr S, 2010, J BIOL CHEM, V285, P23504, DOI 10.1074/jbc.M110.133058; Sam MD, 2002, J MOL BIOL, V324, P791, DOI 10.1016/S0022-2836(02)01150-6; SELL SM, 1990, J BACTERIOL, V172, P4827, DOI 10.1128/jb.172.9.4827-4835.1990; Shi YY, 2005, BIOCHEMISTRY-US, V44, P1683, DOI 10.1021/bi0480943; Srinivasan A, 1997, MOL CELL BIOL, V17, P4761, DOI 10.1128/MCB.17.8.4761; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Sullivan CS, 2001, VIROLOGY, V287, P1, DOI 10.1006/viro.2001.1038; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; VANDERVIES SM, 1994, NATURE, V368, P654, DOI 10.1038/368654a0; WALL D, 1994, J BIOL CHEM, V269, P5446; WICKNER SH, 1979, COLD SPRING HARB SYM, V43, P303, DOI 10.1101/SQB.1979.043.01.037; Xiao A, 2010, ARCH VIROL, V155, P1021, DOI 10.1007/s00705-010-0691-3; Zylicz M, 1998, P NATL ACAD SCI USA, V95, P15259, DOI 10.1073/pnas.95.26.15259; ZYLICZ M, 1989, EMBO J, V8, P1601, DOI 10.1002/j.1460-2075.1989.tb03544.x; ZYLICZ M, 1993, PHILOS T ROY SOC B, V339, P271, DOI 10.1098/rstb.1993.0025	57	9	10	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38876	38885		10.1074/jbc.M111.281865	http://dx.doi.org/10.1074/jbc.M111.281865			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21908845	Green Published, hybrid			2022-12-25	WOS:000296759800006
J	Earley, KW; Poethig, RS				Earley, Keith W.; Poethig, R. Scott			Binding of the Cyclophilin 40 Ortholog SQUINT to Hsp90 Protein Is Required for SQUINT Function in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL CIS/TRANS ISOMERASES; PLANT DEVELOPMENT; SACCHAROMYCES-CEREVISIAE; IMMUNOPHILIN CHAPERONES; CATALYTIC MECHANISM; THALIANA; DOMAIN; SITE; COMPLEXES; ARGONAUTE1	SQN (SQUINT) is the Arabidopsis ortholog of the immunophilin CyP40 (cyclophilin 40) and promotes microRNA activity by promoting the activity of AGO1. In animals and Saccharomyces cerevisiae, CyP40 promotes protein activity in association with the protein chaperone Hsp90. To determine whether CyP40 also acts in association with Hsp90 in plants, we examined the interaction between SQN and Hsp90 in vitro and tested the importance of this interaction for the function of SQN in planta. We found that SQN interacts with cytoplasmic Hsp90 proteins but not with Hsp90 proteins localized to chloroplasts, mitochondria, or the endoplasmic reticulum. The interaction between SQN and Hsp90 in vitro requires the MEEVD domain of Hsp90, as well as several conserved amino acids within the tetratricopeptide repeat domain of SQN. Amino acid substitutions that disrupt the interaction between SQN and Hsp90 in vitro also impair the activity of SQN in planta. Our results indicate that the interaction between CyP40 and Hsp90 is conserved in plants and that this interaction is essential for the function of CyP40.	[Earley, Keith W.; Poethig, R. Scott] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Poethig, RS (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	spoethig@sas.upenn.edu	Poethig, R. Scott/J-7009-2015	Poethig, R. Scott/0000-0001-6592-5862	National Institutes of Health [R01GM051893]; NIGMS [F32GM084591]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084591, R01GM051893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM051893 (to R. S. P.) and National Research Service Award Postdoctoral Fellowship F32GM084591 from NIGMS (to K. W. E.).	Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Berardini TZ, 2001, SCIENCE, V291, P2405, DOI 10.1126/science.1057144; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Braaten D, 1997, J VIROL, V71, P2107, DOI 10.1128/JVI.71.3.2107-2113.1997; Cao DS, 2003, PLANT J, V33, P107, DOI 10.1046/j.1365-313X.2003.016011.x; Carrello A, 1999, J BIOL CHEM, V274, P2682, DOI 10.1074/jbc.274.5.2682; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davis TL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000439; Dorfman T, 1996, J VIROL, V70, P5751, DOI 10.1128/JVI.70.9.5751-5757.1996; Duina AA, 1996, YEAST, V12, P943, DOI 10.1002/(SICI)1097-0061(199608)12:10<943::AID-YEA997>3.0.CO;2-3; Duina AA, 1998, J BIOL CHEM, V273, P10819, DOI 10.1074/jbc.273.18.10819; Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713; Earley K, 2010, SILENCE, V1, P15, DOI [10.1186/1758-907X-1-15, DOI 10.1186/1758-907X-1-15]; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Geisler M, 2004, MOL BIOL CELL, V15, P3393, DOI 10.1091/mbc.E03-11-0831; Geisler M, 2007, TRENDS PLANT SCI, V12, P465, DOI 10.1016/j.tplants.2007.08.015; Howard BR, 2003, NAT STRUCT BIOL, V10, P475, DOI 10.1038/nsb927; Huai Q, 2002, P NATL ACAD SCI USA, V99, P12037, DOI 10.1073/pnas.192206699; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Iki T, 2010, MOL CELL, V39, P282, DOI 10.1016/j.molcel.2010.05.014; Ishiguro S, 2002, EMBO J, V21, P898, DOI 10.1093/emboj/21.5.898; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Johnston M, 2010, MOL BIOL CELL, V21, P1462, DOI 10.1091/mbc.E09-10-0885; Kamphausen T, 2002, PLANT J, V32, P263, DOI 10.1046/j.1365-313X.2002.01420.x; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Mayr C, 2000, J BIOL CHEM, V275, P34140, DOI 10.1074/jbc.M005251200; Meiri D, 2009, PLANT J, V59, P387, DOI 10.1111/j.1365-313X.2009.03878.x; Moparthi SB, 2009, PROTEIN SCI, V18, P475, DOI 10.1002/pro.28; OwensGrillo JK, 1996, J BIOL CHEM, V271, P13468, DOI 10.1074/jbc.271.23.13468; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pirkl F, 2001, J MOL BIOL, V308, P795, DOI 10.1006/jmbi.2001.4595; Prassinos C, 2008, PLANT MOL BIOL, V67, P323, DOI 10.1007/s11103-008-9322-8; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Ratajczak T, 2003, CURR TOP MED CHEM, V3, P1348, DOI 10.2174/1568026033451934; Ratajczak T, 1996, J BIOL CHEM, V271, P2961, DOI 10.1074/jbc.271.6.2961; Ratajczak T, 2009, INT J BIOCHEM CELL B, V41, P1652, DOI 10.1016/j.biocel.2009.03.006; Romano P, 2005, NEW PHYTOL, V166, P753, DOI 10.1111/j.1469-8137.2005.01373.x; Sangster TA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000648; Smith MR, 2009, P NATL ACAD SCI USA, V106, P5424, DOI 10.1073/pnas.0812729106; Smyczynski C, 2006, J BIOL CHEM, V281, P25475, DOI 10.1074/jbc.M601815200; Taylor P, 2001, STRUCTURE, V9, P431, DOI 10.1016/S0969-2126(01)00603-7; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vittorioso P, 1998, MOL CELL BIOL, V18, P3034, DOI 10.1128/MCB.18.5.3034; Ward BK, 2002, J BIOL CHEM, V277, P40799, DOI 10.1074/jbc.M207097200; Wu GS, 2010, PLANT CELL, V22, P3295, DOI 10.1105/tpc.110.078360; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Yurchenko V, 2002, J BIOL CHEM, V277, P22959, DOI 10.1074/jbc.M201593200; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	56	48	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38184	38189		10.1074/jbc.M111.290130	http://dx.doi.org/10.1074/jbc.M111.290130			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908611	hybrid, Green Published			2022-12-25	WOS:000296594200032
J	Takatsu, H; Baba, K; Shima, T; Umino, H; Kato, U; Umeda, M; Nakayama, K; Shin, HW				Takatsu, Hiroyuki; Baba, Keiko; Shima, Takahiro; Umino, Hiroyuki; Kato, Utako; Umeda, Masato; Nakayama, Kazuhisa; Shin, Hye-Won			ATP9B, a P4-ATPase (a Putative Aminophospholipid Translocase), Localizes to the trans-Golgi Network in a CDC50 Protein-independent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PLASMA-MEMBRANE; ADP-RIBOSYLATION FACTORS; P-TYPE ATPASES; PHOSPHOLIPID TRANSLOCATION; SUBCELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; BETA-SUBUNIT; EXPRESSION; ASYMMETRY; PHOSPHATIDYLSERINE	Type IV P-type ATPases (P4-ATPases) are putative phospholipid flippases that translocate phospholipids from the exoplasmic (lumenal) to the cytoplasmic leaflet of lipid bilayers and are believed to function in complex with CDC50 proteins. In Saccharomyces cerevisiae, five P4-ATPases are localized to specific cellular compartments and are required for vesicle-mediated protein transport from these compartments, suggesting a role for phospholipid translocation in vesicular transport. The human genome encodes 14 P4-ATPases and three CDC50 proteins. However, the subcellular localization of human P4-ATPases and their interactions with CDC50 proteins are poorly understood. Here, we show that class 5 (ATP10A, ATP10B, and ATP10D) and class 6 (ATP11A, ATP11B, and ATP11C) P4-ATPases require CDC50 proteins, primarily CDC50A, for their exit from the endoplasmic reticulum (ER) and final subcellular localization. In contrast, class 2 P4-ATPases (ATP9A and ATP9B) are able to exit the ER in the absence of exogenous CDC50 expression: ATP9B, but not ATP11B, was able to exit the ER despite depletion of CDC50 proteins by RNAi. Although ATP9A and ATP9B show a high overall sequence similarity, ATP9A localizes to endosomes and the trans-Golgi network (TGN), whereas ATP9B localizes exclusively to the TGN. A chimeric ATP9 protein in which the N-terminal cytoplasmic region of ATP9A was replaced with the corresponding region of ATP9B was localized exclusively to the Golgi. These results indicate that ATP9B is able to exit the ER and localize to the TGN independently of CDC50 proteins and that this protein contains a Golgi localization signal in its N-terminal cytoplasmic region.	[Takatsu, Hiroyuki; Shin, Hye-Won] Kyoto Univ, Career Path Promot Unit Young Life Scientists, Sakyo Ku, Kyoto 6068501, Japan; [Baba, Keiko; Shima, Takahiro; Umino, Hiroyuki; Nakayama, Kazuhisa; Shin, Hye-Won] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Kato, Utako; Umeda, Masato] Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Kyoto 6158530, Japan	Kyoto University; Kyoto University; Kyoto University	Shin, HW (corresponding author), Kyoto Univ, Career Path Promot Unit Young Life Scientists, Sakyo Ku, Kyoto 6068501, Japan.	shin@cp.kyoto-u.ac.jp	Nakayama, Kazuhisa/ABF-2924-2020; Shin, Hye-Won/P-5398-2018	Shin, Hye-Won/0000-0002-9138-9554; Nakayama, Kazuhisa/0000-0001-7701-7183	Ministry of Education, Culture, Sports, Science and Technology of Japan; Special Coordination Fund for Promoting Science and Technology; Targeted Proteins Research Program; Takeda Science Foundation; Inamori Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Fund for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Inamori Foundation	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Special Coordination Fund for Promoting Science and Technology; the Targeted Proteins Research Program; the Takeda Science Foundation; and the Inamori Foundation.	Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Graham TR, 2004, TRENDS CELL BIOL, V14, P670, DOI 10.1016/j.tcb.2004.10.008; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Kain R, 1998, J BIOL CHEM, V273, P981, DOI 10.1074/jbc.273.2.981; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; Katoh Y, 2004, ONCOL REP, V12, P939; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lopez-Marques RL, 2010, MOL BIOL CELL, V21, P791, DOI 10.1091/mbc.E09-08-0656; Nishimoto-Morita K, 2009, J BIOL CHEM, V284, P10583, DOI 10.1074/jbc.M900847200; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OPDENKAMP JAF, 1979, ANNU REV BIOCHEM, V48, P47, DOI 10.1146/annurev.bi.48.070179.000403; Osada N, 2007, GENE, V392, P151, DOI 10.1016/j.gene.2006.11.021; Paterson JK, 2006, BIOCHEMISTRY-US, V45, P5367, DOI 10.1021/bi052359b; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Prezant TR, 1996, MICROBIOL-SGM, V142, P3407, DOI 10.1099/13500872-142-12-3407; Riekhof WR, 2009, BBA-MOL CELL BIOL L, V1791, P620, DOI 10.1016/j.bbalip.2009.02.013; Ruaud AF, 2009, TRAFFIC, V10, P88, DOI 10.1111/j.1600-0854.2008.00844.x; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; SCHRIER SL, 1992, BLOOD, V79, P782; Shin HW, 2005, J CELL SCI, V118, P4039, DOI 10.1242/jcs.02524; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Williamson P, 2002, BBA-MOL CELL BIOL L, V1585, P53, DOI 10.1016/S1388-1981(02)00324-4; Xu P, 2007, ACTA BIOCH BIOPH SIN, V39, P739, DOI 10.1111/j.1745-7270.2007.00342.x; Yamamoto H, 2010, MOL BIOL CELL, V21, P2746, DOI 10.1091/mbc.E10-01-0074; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	41	83	96	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38159	38167		10.1074/jbc.M111.281006	http://dx.doi.org/10.1074/jbc.M111.281006			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914794	hybrid, Green Published			2022-12-25	WOS:000296594200029
J	Huang, B; Li, T; Alonso-Gonzalez, L; Gorre, R; Keatley, S; Green, A; Turner, P; Kallingappa, PK; Verma, V; Oback, B				Huang, Ben; Li, Tong; Alonso-Gonzalez, Lucia; Gorre, Ruben; Keatley, Sarah; Green, Andria; Turner, Pavla; Kallingappa, Prasanna Kumar; Verma, Vinod; Oback, Bjoern			A Virus-Free Poly-Promoter Vector Induces Pluripotency in Quiescent Bovine Cells under Chemically Defined Conditions of Dual Kinase Inhibition	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GROUND-STATE; CLONING EFFICIENCY; NUCLEAR TRANSFER; ANIMAL-MODELS; IPS CELLS; GENERATION; FIBROBLASTS; LINES; MICE	Authentic induced pluripotent stem cells (iPSCs), capable of giving rise to all cell types of an adult animal, are currently only available in mouse. Here, we report the first generation of bovine iPSC-like cells following transfection with a novel virus-free poly-promoter vector. This vector contains the bovine cDNAs for OCT4, SOX2, KLF4 and c-MYC, each controlled by its own independent promoter. Bovine fibroblasts were cultured without feeders in a chemically defined medium containing leukaemia inhibitory factor (LIF) and inhibitors of MEK1/2 and glycogen synthase kinase-3 signaling ('2i'). Non-invasive real-time kinetic profiling revealed a different response of bovine vs human and mouse cells to culture in 2i/LIF. In bovine, 2i was necessary and sufficient to induce the appearance of tightly packed alkaline phosphatase-positive iPSC-like colonies. These colonies formed in the absence of DNA synthesis and did not expand after passaging. Following transfection, non-proliferative primary colonies expressed discriminatory markers of pluripotency, including endogenous iPSC factors, CDH1, DPPA3, NANOG, SOCS3, ZFP42, telomerase activity, Tra-1-60/81 and SSEA-3/4, but not SSEA-1. This indicates that they had initiated a self-sustaining pluripotency programme. Bovine iPSC-like cells maintained a normal karyotype and differentiated into derivatives of all three germ layers in vitro and in teratomas. Our study demonstrates that conversion into induced pluripotency can occur in quiescent cells, following a previously undescribed route of direct cell reprogramming. This identifies a major species-specific barrier for generating iPSCs and provides a chemically defined screening platform for factors that induce proliferation and maintain pluripotency of embryo-derived pluripotent stem cells in livestock.	[Huang, Ben; Li, Tong; Keatley, Sarah; Green, Andria; Turner, Pavla; Kallingappa, Prasanna Kumar; Oback, Bjoern] Ruakura Res Ctr, Hamilton, New Zealand; [Li, Tong] Guangxi Univ, Anim Reprod Inst, Nanning 530004, Peoples R China; [Alonso-Gonzalez, Lucia] Univ Otago, Childrens Canc Res Grp, Dept Paediat, Christchurch, New Zealand; [Gorre, Ruben] Trenzyme GmbH, Constance, Germany; [Verma, Vinod] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	Guangxi University; University of Otago; National University of Singapore	Huang, B (corresponding author), Ruakura Res Ctr, Hamilton, New Zealand.	bjorn.oback@agresearch.co.nz	Oback, Björn/C-7897-2012	Oback, Björn/0000-0001-7279-4565; Turner, Pavla/0000-0001-7195-4491	New Zealand Foundation for Research, Science and Technology [C10X0303, C10X0805, C10X1002]; AgResearch [AR_C 13214]	New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); AgResearch	This work was partly funded by contracts C10X0303, C10X0805 and C10X1002 from the New Zealand Foundation for Research, Science and Technology (http://www.frst.govt.nz/). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It was also partly funded by contract AR_C 13214 and a postdoctoral fellowship (to BH) from AgResearch (www.agresearch.co.nz).	Allen JE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000217; Araki R, 2010, STEM CELLS, V28, P213, DOI 10.1002/stem.282; Bao L, 2011, CELL RES, V21, P600, DOI 10.1038/cr.2011.6; Baxter J, 2004, EMBO J, V23, P4462, DOI 10.1038/sj.emboj.7600414; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; BERNSTINE EG, 1973, P NATL ACAD SCI USA, V70, P3899, DOI 10.1073/pnas.70.12.3899; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Dharmadhikari AS, 2008, AM J RESP CELL MOL, V39, P503, DOI 10.1165/rcmb.2008-0154TR; Doerfler W, 1997, TRENDS BIOTECHNOL, V15, P297, DOI 10.1016/S0167-7799(97)01061-5; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Guo G, 2010, DEVELOPMENT, V137, P3185, DOI 10.1242/dev.052753; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Honda A, 2010, J BIOL CHEM, V285, P31362, DOI 10.1074/jbc.M110.150540; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Keefer CL, 2007, ANIM REPROD SCI, V98, P147, DOI 10.1016/j.anireprosci.2006.10.009; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lee B, 1999, P NATL ACAD SCI USA, V96, P3981, DOI 10.1073/pnas.96.7.3981; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Meilinger D, 2009, EMBO REP, V10, P1259, DOI 10.1038/embor.2009.201; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Misica-Turner PA, 2007, BIOL REPROD, V76, P268, DOI 10.1095/biolreprod.106.050922; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy K, 2011, STEM CELL REV REP, V7, P693, DOI 10.1007/s12015-011-9239-5; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Oback B, 2003, CLONING STEM CELLS, V5, P243, DOI 10.1089/153623003772032763; Oback B, 2003, CLONING STEM CELLS, V5, P3, DOI 10.1089/153623003321512111; OBACK B, 2010, ENCY BIOTECHNOLOGY A, P167; Oback B, 2009, REPROD FERT DEVELOP, V21, P83, DOI 10.1071/RD08212; Oback Bjorn, 2002, Cloning and Stem Cells, V4, P169, DOI 10.1089/153623002320253337; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Renard JP, 2007, THERIOGENOLOGY, V68, pS196, DOI 10.1016/j.theriogenology.2007.05.060; Roberts S, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-24; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Skvorak KJ, 2009, J INHERIT METAB DIS, V32, P229, DOI 10.1007/s10545-009-1086-z; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tchakoute VL, 2006, P NATL ACAD SCI USA, V103, P5971, DOI 10.1073/pnas.0601385103; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tomioka I, 2010, GENES CELLS, V15, P959, DOI 10.1111/j.1365-2443.2010.01437.x; Trees AJ, 2000, PARASITOLOGY, V120, pS133, DOI 10.1017/S0031182099005788; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wells DN, 2003, THERIOGENOLOGY, V59, P45, DOI 10.1016/S0093-691X(02)01273-6; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	90	57	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24501	10.1371/journal.pone.0024501	http://dx.doi.org/10.1371/journal.pone.0024501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912700	Green Published, Green Submitted, gold			2022-12-25	WOS:000294686100047
J	Wang, Q; Huang, JH; Zhang, XM; Wu, B; Liu, XY; Shen, ZY				Wang, Qi; Huang, Jianhua; Zhang, Xinmin; Wu, Bin; Liu, Xiaoyu; Shen, Ziyin			The Spatial Association of Gene Expression Evolves from Synchrony to Asynchrony and Stochasticity with Age	PLOS ONE			English	Article							LIFE-SPAN; CAENORHABDITIS-ELEGANS; CALORIE RESTRICTION; TRANSCRIPTIONAL PROFILE; DROSOPHILA-MELANOGASTER; DNA-DAMAGE; C-ELEGANS; RESVERATROL; LONGEVITY; STRESS	For multicellular organisms, different tissues coordinate to integrate physiological functions, although this systematically and gradually declines in the aging process. Therefore, an association exists between tissue coordination and aging, and investigating the evolution of tissue coordination with age is of interest. In the past decade, both common and heterogeneous aging processes among tissues were extensively investigated. The results on spatial association of gene changes that determine lifespan appear complex and paradoxical. To reconcile observed commonality and heterogeneity of gene changes among tissues and to address evolution feature of tissue coordination with age, we introduced a new analytical strategy to systematically analyze genome-wide spatio-temporal gene expression profiles. We first applied the approach to natural aging process in three species (Rat, Mouse and Drosophila) and then to anti-aging process in Mouse. The results demonstrated that temporal gene expression alteration in different tissues experiences a progressive association evolution from spatial synchrony to asynchrony and stochasticity with age. This implies that tissue coordination gradually declines with age. Male mice showed earlier spatial asynchrony in gene expression than females, suggesting that male animals are more prone to aging than females. The confirmed anti-aging interventions (resveratrol and caloric restriction) enhanced tissue coordination, indicating their underlying anti-aging mechanism on multiple tissue levels. Further, functional analysis suggested asynchronous DNA/protein damage accumulation as well as asynchronous repair, modification and degradation of DNA/protein in tissues possibly contributes to asynchronous and stochastic changes of tissue microenvironment. This increased risk for a variety of age-related diseases such as neurodegeneration and cancer that eventually accelerate organismal aging and death. Our study suggests a novel molecular event occurring in aging process of multicellular species that may represent an intrinsic molecular mechanism of aging.	[Wang, Qi; Huang, Jianhua; Zhang, Xinmin; Wu, Bin; Shen, Ziyin] Fudan Univ, Huashan Hosp, Shanghai 200433, Peoples R China; [Wang, Qi] Natl Engn Ctr Biochip, Shanghai, Peoples R China; [Liu, Xiaoyu] Tongji Univ, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China	Fudan University; Tongji University	Wang, Q (corresponding author), Fudan Univ, Huashan Hosp, Shanghai 200433, Peoples R China.	wtq_flying@hotmail.com; ziyinshen@126.com			National Basic Research Program in China [2007CB507400, 2010CB530402]; National Natural Science Foundation of China [30873319, 30901888]	National Basic Research Program in China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program in China (NO. 2007CB507400, and NO. 2010CB530402), and partially supported by the Project of National Natural Science Foundation of China (NO. 30873319, and NO. 30901888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Barger JL, 2003, EXP GERONTOL, V38, P1343, DOI 10.1016/j.exger.2003.10.017; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; Golden TR, 2004, AGING CELL, V3, P111, DOI 10.1111/j.1474-9728.2004.00095.x; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; Newlands S, 1998, GENE DEV, V12, P2748, DOI 10.1101/gad.12.17.2748; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161; Shimokawa I, 2008, MOL CELLS, V26, P427; Tower John, 2009, Journal of Biology (London), V8, P38, DOI 10.1186/jbiol141; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Wick G, 2000, VACCINE, V18, P1567, DOI 10.1016/S0264-410X(99)00489-2; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zhan M, 2007, GENOME RES, V17, P1236, DOI 10.1101/gr.6216607	39	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24076	10.1371/journal.pone.0024076	http://dx.doi.org/10.1371/journal.pone.0024076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912663	gold, Green Published			2022-12-25	WOS:000294686100011
J	Kirschner, MB; Kao, SC; Edelman, JJ; Armstrong, NJ; Vallely, MP; van Zandwijk, N; Reid, G				Kirschner, Michaela B.; Kao, Steven C.; Edelman, J. James; Armstrong, Nicola J.; Vallely, Michael P.; van Zandwijk, Nico; Reid, Glen			Haemolysis during Sample Preparation Alters microRNA Content of Plasma	PLOS ONE			English	Article							CIRCULATING MICRORNAS; POTENTIAL BIOMARKER; EXPRESSION; CANCER; SERUM; PCR; DIAGNOSIS; IDENTIFICATION; MECHANISM; TARGETS	The presence of cell-free microRNAs (miRNAs) has been detected in a range of body fluids. The miRNA content of plasma/serum in particular has been proposed as a potential source of novel biomarkers for a number of diseases. Nevertheless, the quantification of miRNAs from plasma or serum is made difficult due to inefficient isolation and lack of consensus regarding the optimal reference miRNA. The effect of haemolysis on the quantification and normalisation of miRNAs in plasma has not been investigated in great detail. We found that levels of miR-16, a commonly used reference gene, showed little variation when measured in plasma samples from healthy volunteers or patients with malignant mesothelioma or coronary artery disease. Including samples with evidence of haemolysis led to variation in miR-16 levels and consequently decreased its ability to serve as a reference. The levels of miR-16 and miR-451, both present in significant levels in red blood cells, were proportional to the degree of haemolysis. Measurements of the level of these miRNAs in whole blood, plasma, red blood cells and peripheral blood mononuclear cells revealed that the miRNA content of red blood cells represents the major source of variation in miR-16 and miR-451 levels measured in plasma. Adding lysed red blood cells to non-haemolysed plasma allowed a cut-off level of free haemoglobin to be determined, below which miR-16 and miR-451 levels displayed little variation between individuals. In conclusion, increases in plasma miR-16 and miR-451 are caused by haemolysis. In the absence of haemolysis the levels of both miR-16 and miR-451 are sufficiently constant to serve as normalisers.	[Kirschner, Michaela B.; Kao, Steven C.; van Zandwijk, Nico; Reid, Glen] Univ Sydney, Bernie Banton Ctr, ADRI, Sydney, NSW 2006, Australia; [Kao, Steven C.] Concord Hosp, Dept Med Oncol, Concord, Australia; [Edelman, J. James; Vallely, Michael P.] Univ Sydney, Cardiothorac Surg Unit, Royal Prince Alfred Hosp, Baird Inst,Fac Med, Sydney, NSW 2006, Australia; [Armstrong, Nicola J.] Univ New S Wales, Canc Res Program, Garvan Inst Med Res, Sydney, NSW, Australia; [Armstrong, Nicola J.] Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia	University of Sydney; Concord Repatriation General Hospital; University of Sydney; Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney	Kirschner, MB (corresponding author), Univ Sydney, Bernie Banton Ctr, ADRI, Sydney, NSW 2006, Australia.	glen.reid@sydney.edu.au	Armstrong, Nicola J./AAF-3045-2021; van Zandwijk, Nico/E-4177-2012; Kirschner, Michaela/D-2214-2015	Armstrong, Nicola J./0000-0002-4477-293X; van Zandwijk, Nico/0000-0002-8405-9688; Kirschner, Michaela/0000-0001-7444-9829; Reid, Glen/0000-0001-6465-5223	Asbestos Diseases Research Foundation; Asbestos Research Fund	Asbestos Diseases Research Foundation; Asbestos Research Fund	This work was in part supported through funding from the Asbestos Diseases Research Foundation and a grant from the Asbestos Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121; Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Andreasen D, 2010, METHODS, V50, pS6, DOI 10.1016/j.ymeth.2010.01.006; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bruchova H, 2007, EXP HEMATOL, V35, P1657, DOI 10.1016/j.exphem.2007.08.021; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Choong ML, 2007, EXP HEMATOL, V35, P551, DOI 10.1016/j.exphem.2006.12.002; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hanson EK, 2009, ANAL BIOCHEM, V387, P303, DOI 10.1016/j.ab.2009.01.037; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; TURCHINOVICH A, 2011, NUCL ACIDS RES; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; WANG K, 2010, NUCL ACIDS RES; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wong CH, 2006, PLAST RECONSTR SURG, V117, P1206, DOI 10.1097/01.prs.0000200070.66604.1e; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104; Zhu Weizhu, 2009, BMC Res Notes, V2, P89, DOI 10.1186/1756-0500-2-89	53	379	397	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24145	10.1371/journal.pone.0024145	http://dx.doi.org/10.1371/journal.pone.0024145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909417	Green Submitted, Green Published, gold			2022-12-25	WOS:000294683900033
J	Wessman, M; Forsblom, C; Kaunisto, MA; Soderlund, J; Ilonen, J; Sallinen, R; Hiekkalinna, T; Parkkonen, M; Maxwell, AP; Tarnow, L; Parving, HH; Hadjadj, S; Marre, M; Peltonen, L; Groop, PH				Wessman, Maija; Forsblom, Carol; Kaunisto, Mari A.; Soderlund, Jenny; Ilonen, Jorma; Sallinen, Riitta; Hiekkalinna, Tero; Parkkonen, Maija; Maxwell, Alexander P.; Tarnow, Lise; Parving, Hans-Henrik; Hadjadj, Samy; Marre, Michel; Peltonen, Leena; Groop, Per-Henrik		FinnDiane Study Grp	Novel Susceptibility Locus at 22q11 for Diabetic Nephropathy in Type 1 Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; STAGE RENAL-DISEASE; AFRICAN-AMERICANS; LINKAGE ANALYSIS; COMPLEX TRAITS; CHROMOSOME 3Q; SCAN; POPULATION; GENES; POLYMORPHISMS	Background: Diabetic nephropathy (DN) affects about 30% of patients with type 1 diabetes (T1D) and contributes to serious morbidity and mortality. So far only the 3q21-q25 region has repeatedly been indicated as a susceptibility region for DN. The aim of this study was to search for new DN susceptibility loci in Finnish, Danish and French T1D families. Methods and Results: We performed a genome-wide linkage study using 384 microsatellite markers. A total of 175 T1D families were studied, of which 94 originated from Finland, 46 from Denmark and 35 from France. The whole sample set consisted of 556 individuals including 42 sib-pairs concordant and 84 sib-pairs discordant for DN. Two-point and multi-point non-parametric linkage analyses were performed using the Analyze package and the MERLIN software. A novel DN locus on 22q11 was identified in the joint analysis of the Finnish, Danish and French families by genome-wide multipoint non-parametric linkage analysis using the Kong and Cox linear model (NPL(pairs) LOD score 3.58). Nominal or suggestive evidence of linkage to this locus was also detected when the three populations were analyzed separately. Suggestive evidence of linkage was found to six additional loci in the Finnish and French sample sets. Conclusions: This study identified a novel DN locus at chromosome 22q11 with significant evidence of linkage to DN. Our results suggest that this locus may be of importance in European populations. In addition, this study supports previously indicated DN loci on 3q21-q25 and 19q13.	[Wessman, Maija; Forsblom, Carol; Kaunisto, Mari A.; Soderlund, Jenny; Sallinen, Riitta; Parkkonen, Maija; Groop, Per-Henrik] Biomedicum Helsinki, Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland; [Wessman, Maija; Kaunisto, Mari A.; Hiekkalinna, Tero; Peltonen, Leena] Univ Helsinki, Biomedicum Helsinki, Res Program Mol Med, Helsinki, Finland; [Wessman, Maija; Kaunisto, Mari A.; Hiekkalinna, Tero; Peltonen, Leena] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Forsblom, Carol; Soderlund, Jenny; Parkkonen, Maija; Groop, Per-Henrik] Univ Helsinki, Cent Hosp, Dept Med, Div Nephrol, Helsinki, Finland; [Ilonen, Jorma] Univ Eastern Finland, Dept Clin Microbiol, Kuopio, Finland; [Ilonen, Jorma] Univ Turku, Immunogenet Lab, Turku, Finland; [Hiekkalinna, Tero; Peltonen, Leena] Natl Inst Hlth & Welf, Unit Publ Hlth Genom, Helsinki, Finland; [Maxwell, Alexander P.] Queens Univ Belfast, Nephrol Res Grp, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Tarnow, Lise] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Parving, Hans-Henrik] Univ Copenhagen, Rigshosp, Dept Med Endocrinol, DK-2100 Copenhagen, Denmark; [Parving, Hans-Henrik] Aarhus Univ, Fac Hlth Sci, Aarhus, Denmark; [Hadjadj, Samy] CHU Poitiers, Serv Med Interne Endocrinol & Malad Metab, INSERM, Ctr Invest Clin,CIC0802, Poitiers, France; [Hadjadj, Samy] Univ Poitiers, Poitiers, France; [Marre, Michel] Bichat Claude Bernard Univ Hosp, Dept Endocrinol Diabetol & Nutr, Paris, France; [Peltonen, Leena] Wellcome Trust Sanger Inst, Dept Human Genet, Hingston, England	Folkhalsan Research Center; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Eastern Finland; University of Turku; Finland National Institute for Health & Welfare; Queens University Belfast; Steno Diabetes Center; Rigshospitalet; University of Copenhagen; Aarhus University; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Wellcome Trust Sanger Institute	Wessman, M (corresponding author), Biomedicum Helsinki, Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland.	maija.wessman@helsinki.fi; per-henrik.groop@helsinki.fi	Alhenc-Gelas, Francois/F-9511-2017	Sallinen, Riitta/0000-0003-4252-0197; Bridoux, Frank/0000-0002-2005-8424; Rosengard-Barlund, Milla/0000-0001-5469-3517; Hiekkalinna, Tero/0000-0002-3345-2981; Kaunisto, Mari/0000-0002-6946-9195; Marre, Michel/0000-0002-3071-1837; Maxwell, Alexander P./0000-0002-6110-7253; Lakka, Timo/0000-0002-9199-2871; Ilonen, Jorma/0000-0002-9973-2062; WEEKERS, Laurent/0000-0002-3151-4640; Tarnow, Lise/0000-0002-8735-966X	Academy of Finland [214335, 124280]; Sigrid Juselius Foundation; Diabetes Research Foundation; Medicinska Understodforeningen Liv och Halsa r.f.; Folkhalsan Research Foundation; Helsinki University Central Hospital; Wilhelm and Else Stockmann Foundation; Danish Diabetes Association; Sehested Hansen Foundation; Association Francaise des Diabetiques; INSERM (Institut National de la Sante et de la Recherche Medicale); Societe Francaise d'Hypertension Arterielle; European Union [QLG2-CT2001-01 669]; Association Diabete et Risque Vasculaire (Paris, France); Public Health Agency [STL/3714/07] Funding Source: researchfish	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Diabetes Research Foundation; Medicinska Understodforeningen Liv och Halsa r.f.; Folkhalsan Research Foundation; Helsinki University Central Hospital; Wilhelm and Else Stockmann Foundation; Danish Diabetes Association; Sehested Hansen Foundation; Association Francaise des Diabetiques; INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Societe Francaise d'Hypertension Arterielle; European Union(European Commission); Association Diabete et Risque Vasculaire (Paris, France); Public Health Agency	This study was funded by the Academy of Finland (214335, 124280 to MW), the Sigrid Juselius Foundation, the Diabetes Research Foundation (to MW), the Medicinska Understodforeningen Liv och Halsa r.f., the Folkhalsan Research Foundation, the Research Funds of the Helsinki University Central Hospital, the Wilhelm and Else Stockmann Foundation, the Danish Diabetes Association, the Sehested Hansen Foundation, the GENESIS France Belgium by grants from the Association Francaise des Diabetiques, INSERM (Institut National de la Sante et de la Recherche Medicale), Societe Francaise d'Hypertension Arterielle, European Union (Euragedic Project; QLG2-CT2001-01 669), and Association Diabete et Risque Vasculaire (Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2004, AM J HUM GENET, V74, P403, DOI 10.1086/381713; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Akkina S, 2011, TRANSL RES, V157, P236, DOI 10.1016/j.trsl.2011.01.011; ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496; Anttila V, 2008, AM J HUM GENET, V82, P1051, DOI 10.1016/j.ajhg.2008.03.003; BORCHJOHNSEN K, 1992, KIDNEY INT, V41, P719, DOI 10.1038/ki.1992.112; Bowden DW, 2004, KIDNEY INT, V66, P1517, DOI 10.1111/j.1523-1755.2004.00915.x; Chistiakov DA, 2004, DIABETES RES CLIN PR, V66, P79, DOI 10.1016/j.diabres.2004.02.011; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; Freedman BI, 2007, CLIN J AM SOC NEPHRO, V2, P1306, DOI 10.2215/CJN.02560607; Gaffen Sarah L, 2009, Curr Rheumatol Rep, V11, P365; Hadjadj S, 2004, DIABETES CARE, V27, P2661, DOI 10.2337/diacare.27.11.2661; Harjutsalo V, 2004, DIABETES, V53, P2449, DOI 10.2337/diabetes.53.9.2449; He B, 2009, AM J HUM GENET, V84, P5, DOI 10.1016/j.ajhg.2008.11.012; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hermann R, 2003, TISSUE ANTIGENS, V62, P162, DOI 10.1034/j.1399-0039.2003.00071.x; Hiekkalinna T, 2005, TWIN RES HUM GENET, V8, P16, DOI 10.1375/twin.8.1.16; Huang B, 2002, ACTA NEUROPATHOL, V103, P415, DOI 10.1007/s00401-001-0479-3; Igo RP, 2011, AM J NEPHROL, V33, P381, DOI 10.1159/000326763; Kang HS, 2010, HISTOL HISTOPATHOL, V25, P1481, DOI 10.14670/HH-25.1481; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kim JH, 2006, DIABETES, V55, P843, DOI 10.2337/diabetes.55.03.06.db05-1013; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; KROLEWSKI AS, 1985, AM J MED, V78, P785, DOI 10.1016/0002-9343(85)90284-0; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Maeda Shiro, 2008, Ther Adv Cardiovasc Dis, V2, P363, DOI 10.1177/1753944708094768; McDermid HE, 2002, AM J HUM GENET, V70, P1077, DOI 10.1086/340363; McDonough CW, 2011, KIDNEY INT, V79, P563, DOI 10.1038/ki.2010.467; McKnight AJ, 2006, J AM SOC NEPHROL, V17, P831, DOI 10.1681/ASN.2005050493; Moczulski DK, 1998, DIABETES, V47, P1164, DOI 10.2337/diabetes.47.7.1164; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Nyholt DR, 2005, AM J HUM GENET, V77, P500, DOI 10.1086/444510; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Osterholm AM, 2007, KIDNEY INT, V71, P140, DOI 10.1038/sj.ki.5001933; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Pezzolesi MG, 2009, DIABETES, V58, P1403, DOI 10.2337/db08-1514; Pociot F, 2010, DIABETES, V59, P1561, DOI 10.2337/db10-0076; Quinn M, 1996, DIABETOLOGIA, V39, P940; Rogus JJ, 2008, DIABETES, V57, P2519, DOI 10.2337/db07-1086; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saraheimo M, 2003, DIABETOLOGIA, V46, P1402, DOI 10.1007/s00125-003-1194-5; Saraheimo M, 2008, DIABETES CARE, V31, P1165, DOI 10.2337/dc07-2306; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SEAQUIST ER, 1989, NEW ENGL J MED, V320, P1161, DOI 10.1056/NEJM198905043201801; Tanaka N, 2003, DIABETES, V52, P2848, DOI 10.2337/diabetes.52.11.2848; Tuomilehto J, 1999, DIABETOLOGIA, V42, P655, DOI 10.1007/s001250051212; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; Wiltshire S, 2002, AM J HUM GENET, V71, P1175, DOI 10.1086/342976; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	52	8	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24053	10.1371/journal.pone.0024053	http://dx.doi.org/10.1371/journal.pone.0024053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909410	Green Submitted, Green Published, gold			2022-12-25	WOS:000294683900023
J	Garcia-Garcera, M; Gigli, E; Sanchez-Quinto, F; Ramirez, O; Calafell, F; Civit, S; Lalueza-Fox, C				Garcia-Garcera, Marc; Gigli, Elena; Sanchez-Quinto, Federico; Ramirez, Oscar; Calafell, Francesc; Civit, Sergi; Lalueza-Fox, Carles			Fragmentation of Contaminant and Endogenous DNA in Ancient Samples Determined by Shotgun Sequencing; Prospects for Human Palaeogenomics	PLOS ONE			English	Article							GENOME SEQUENCE; CAVE; PALEOGENOMICS; REMAINS	Background: Despite the successful retrieval of genomes from past remains, the prospects for human palaeogenomics remain unclear because of the difficulty of distinguishing contaminant from endogenous DNA sequences. Previous sequence data generated on high-throughput sequencing platforms indicate that fragmentation of ancient DNA sequences is a characteristic trait primarily arising due to depurination processes that create abasic sites leading to DNA breaks. Methodology/Principals Findings: To investigate whether this pattern is present in ancient remains from a temperate environment, we have 454-FLX pyrosequenced different samples dated between 5,500 and 49,000 years ago: a bone from an extinct goat (Myotragus balearicus) that was treated with a depurinating agent (bleach), an Iberian lynx bone not subjected to any treatment, a human Neolithic sample from Barcelona (Spain), and a Neandertal sample from the El Sidron site (Asturias, Spain). The efficiency of retrieval of endogenous sequences is below 1% in all cases. We have used the non-human samples to identify human sequences (0.35 and 1.4%, respectively), that we positively know are contaminants. Conclusions: We observed that bleach treatment appears to create a depurination-associated fragmentation pattern in resulting contaminant sequences that is indistinguishable from previously described endogenous sequences. Furthermore, the nucleotide composition pattern observed in 59 and 39 ends of contaminant sequences is much more complex than the flat pattern previously described in some Neandertal contaminants. Although much research on samples with known contaminant histories is needed, our results suggest that endogenous and contaminant sequences cannot be distinguished by the fragmentation pattern alone.	[Garcia-Garcera, Marc; Gigli, Elena; Sanchez-Quinto, Federico; Ramirez, Oscar; Calafell, Francesc; Lalueza-Fox, Carles] CSIC UPF, Inst Biol Evolut, Barcelona, Spain; [Civit, Sergi] Univ Barcelona, Dept Bioestadist, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of Barcelona	Garcia-Garcera, M (corresponding author), CSIC UPF, Inst Biol Evolut, Barcelona, Spain.	carles.lalueza@upf.edu	Ramirez, Oscar/E-7293-2012; civit-vives, sergi/N-4287-2015; Sánchez-Quinto, Federico/AAV-8927-2020; LALUEZA-FOX, CARLES/AAG-5341-2020; Calafell, Francesc/C-8595-2014	Ramirez, Oscar/0000-0001-5164-6790; civit-vives, sergi/0000-0002-2511-4579; Sánchez-Quinto, Federico/0000-0002-0201-6204; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Calafell, Francesc/0000-0002-1083-9438; Garcia-Garcera, Marc/0000-0001-6408-7561	Ministerio de Innovacion y Ciencia from Spain [BFU2009-06974]	Ministerio de Innovacion y Ciencia from Spain	CL-F, OR and SC are supported by a grant from the Ministerio de Innovacion y Ciencia from Spain (BFU2009-06974). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blow MJ, 2008, GENOME RES, V18, P1347, DOI 10.1101/gr.076091.108; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Cooper A, 2000, SCIENCE, V289, P1139; Fortea J, 2008, J HUM EVOL, V55, P353, DOI 10.1016/j.jhevol.2008.03.005; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; Helgason A, 2007, J MOL EVOL, V65, P92, DOI 10.1007/s00239-006-0259-8; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Lalueza-Fox C, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-70; LINDAHL T, 1993, NATURE, V365, P700, DOI 10.1038/365700a0; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Orlando L, GEN RES IN PRESS; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Ramirez O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005670; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rodriguez R, MOL ECOL IN PRESS; Sampietro ML, 2007, P ROY SOC B-BIOL SCI, V274, P2161, DOI 10.1098/rspb.2007.0465; Sampietro ML, 2006, MOL BIOL EVOL, V23, P1801, DOI 10.1093/molbev/msl047; Vives Sergi, 2008, BMC Res Notes, V1, P40, DOI 10.1186/1756-0500-1-40; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175	28	39	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24161	10.1371/journal.pone.0024161	http://dx.doi.org/10.1371/journal.pone.0024161			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904610	Green Published, Green Submitted, gold			2022-12-25	WOS:000294680800059
J	Marreddy, RKR; Pinto, JPC; Wolters, JC; Geertsma, ER; Fusetti, F; Permentier, HP; Kuipers, OP; Kok, J; Poolman, B				Marreddy, Ravi K. R.; Pinto, Joao P. C.; Wolters, Justina C.; Geertsma, Eric R.; Fusetti, Fabrizia; Permentier, Hjalmar P.; Kuipers, Oscar P.; Kok, Jan; Poolman, Bert			The Response of Lactococcus lactis to Membrane Protein Production	PLOS ONE			English	Article							CONTROLLED GENE-EXPRESSION; ABC TRANSPORTER OPUA; DNA-MICROARRAY DATA; ESCHERICHIA-COLI; TRANSCRIPTOME ANALYSIS; STRINGENT RESPONSE; QUALITY-CONTROL; ACID BACTERIA; STRESS; SYSTEM	Background: The biogenesis of membrane proteins is more complex than that of water-soluble proteins, and recombinant expression of membrane proteins in functional form and in amounts high enough for structural and functional studies is often problematic. To better engineer cells towards efficient protein production, we set out to understand and compare the cellular consequences of the overproduction of both classes of proteins in Lactococcus lactis, employing a combined proteomics and transcriptomics approach. Methodology and Findings: Highly overproduced and poorly expressed membrane proteins both resulted in severe growth defects, whereas amplified levels of a soluble substrate receptor had no effect. In addition, membrane protein overproduction evoked a general stress response (upregulation of various chaperones and proteases), which is probably due to accumulation of misfolded protein. Notably, upon the expression of membrane proteins a cell envelope stress response, controlled by the two-component regulatory CesSR system, was observed. Conclusions: The physiological response of L. lactis to the overproduction of several membrane proteins was determined and compared to that of a soluble protein, thus offering better understanding of the bottlenecks related to membrane protein production and valuable knowledge for subsequent strain engineering.	[Marreddy, Ravi K. R.; Wolters, Justina C.; Geertsma, Eric R.; Fusetti, Fabrizia; Permentier, Hjalmar P.; Poolman, Bert] Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Netherlands Prote Ctr, Groningen, Netherlands; [Marreddy, Ravi K. R.; Wolters, Justina C.; Geertsma, Eric R.; Fusetti, Fabrizia; Permentier, Hjalmar P.; Poolman, Bert] Univ Groningen, Zernike Inst Adv Mat, Groningen, Netherlands; [Pinto, Joao P. C.; Kuipers, Oscar P.; Kok, Jan] Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Marreddy, RKR (corresponding author), Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Netherlands Prote Ctr, Groningen, Netherlands.	b.poolman@rug.n1	Permentier, Hjalmar P/H-4190-2016; Institute, Zernike/W-7033-2019; Kuipers, Oscar/B-6752-2009; Marreddy, RaviKanthReddy/Q-5680-2018; Poolman, Bert/D-1882-2012; Kok, Jan/C-9972-2012	Permentier, Hjalmar P/0000-0001-7317-8887; Kuipers, Oscar/0000-0001-5596-7735; Marreddy, RaviKanthReddy/0000-0003-0425-406X; Geertsma, Eric R./0000-0002-2789-5444	Netherlands Proteomics Centre; European Membrane Protein Consortium European Drug Initiative for Channels and Transporters; Netherlands Science Foundation	Netherlands Proteomics Centre; European Membrane Protein Consortium European Drug Initiative for Channels and Transporters; Netherlands Science Foundation(Netherlands Organization for Scientific Research (NWO))	This research was supported by the Netherlands Proteomics Centre, the European Membrane Protein Consortium European Drug Initiative for Channels and Transporters, and the Netherlands Science Foundation; Chemical Sciences Top Subsidy to BP; grant number 700-56-302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer NH, 2003, PROTEOMICS, V3, P786, DOI 10.1002/pmic.200300416; Biemans-Oldehinkel E, 2003, EMBO J, V22, P5983, DOI 10.1093/emboj/cdg581; Biemans-Oldehinkel E, 2006, P NATL ACAD SCI USA, V103, P10624, DOI 10.1073/pnas.0603871103; Bonander N, 2005, PROTEIN SCI, V14, P1729, DOI 10.1110/ps.051435705; Bonander N, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-10; Budin-Verneuil A, 2005, PROTEOMICS, V5, P4794, DOI 10.1002/pmic.200401327; Budin-Verneuil A, 2007, PROTEOMICS, V7, P2038, DOI 10.1002/pmic.200600773; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Dressaire C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-343; EATON T, 1993, J GEN MICROBIOL, V139, P3253, DOI 10.1099/00221287-139-12-3253; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; GASSON MJ, 1983, J BACTERIOL, V154, P1; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; Gitton C, 2005, APPL ENVIRON MICROB, V71, P7152, DOI 10.1128/AEM.71.11.7152-7163.2005; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; Guedon E, 2005, MICROBIOL-SGM, V151, P3895, DOI 10.1099/mic.0.28186-0; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Junge F, 2008, CELL MOL LIFE SCI, V65, P1729, DOI 10.1007/s00018-008-8067-5; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Katzen F, 2009, TRENDS BIOTECHNOL, V27, P455, DOI 10.1016/j.tibtech.2009.05.005; Kilstrup M, 1997, APPL ENVIRON MICROB, V63, P1826, DOI 10.1128/AEM.63.5.1826-1837.1997; Kleerebezem M, 1997, APPL ENVIRON MICROB, V63, P4581, DOI 10.1128/AEM.63.11.4581-4584.1997; Kuipers OP, 2002, ANTON LEEUW INT J G, V82, P113, DOI 10.1023/A:1020691801251; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Kunji ERS, 2003, BBA-BIOMEMBRANES, V1610, P97, DOI 10.1016/S0005-2736(02)00712-5; Lewinson O, 2008, J MOL BIOL, V377, P62, DOI 10.1016/j.jmb.2007.12.059; Linares DM, 2010, J MOL BIOL, V401, P45, DOI 10.1016/j.jmb.2010.06.002; Llull D, 2004, APPL ENVIRON MICROB, V70, P5398, DOI 10.1128/AEM.70.9.5398-5406.2004; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Long AD, 2001, J BIOL CHEM, V276, P19937, DOI 10.1074/jbc.M010192200; Mahmood NABN, 2009, J BIOL CHEM, V284, P14368, DOI 10.1074/jbc.M901238200; Marreddy RKR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010317; Martinez B, 2007, MOL MICROBIOL, V64, P473, DOI 10.1111/j.1365-2958.2007.05668.x; Massey-Gendel E, 2009, PROTEIN SCI, V18, P372, DOI 10.1002/pro.39; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Monne M, 2005, PROTEIN SCI, V14, P3048, DOI 10.1110/ps.051689905; Morello E, 2008, J MOL MICROB BIOTECH, V14, P48, DOI 10.1159/000106082; Mulligan C, 2009, P NATL ACAD SCI USA, V106, P1778, DOI 10.1073/pnas.0809979106; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Palmfeldt J, 2004, PROTEOMICS, V4, P3881, DOI 10.1002/pmic.200400858; PINTO JP, 2011, PLOS ONE; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Rallu F, 1996, ANTON LEEUW INT J G, V70, P243, DOI 10.1007/BF00395935; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; STEEN A, 2010, MOL CELL PROTEOMICS, DOI DOI 10.1074/MCP.M000052-MCP201; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Surade S, 2006, PROTEIN SCI, V15, P2178, DOI 10.1110/ps.062312706; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; van Bloois E, 2008, FEBS LETT, V582, P1419, DOI 10.1016/j.febslet.2008.02.082; van der Heide T, 2000, P NATL ACAD SCI USA, V97, P7102, DOI 10.1073/pnas.97.13.7102; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; van Hijum SAFT, 2003, BIOINFORMATICS, V19, P1580, DOI 10.1093/bioinformatics/btg203; VANASSELDONK M, 1993, J BACTERIOL, V175, P1637, DOI 10.1128/JB.175.6.1637-1644.1993; Varmanen P, 2000, MICROBIOL-UK, V146, P1447, DOI 10.1099/00221287-146-6-1447; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657	68	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24060	10.1371/journal.pone.0024060	http://dx.doi.org/10.1371/journal.pone.0024060			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904605	Green Submitted, Green Published, gold			2022-12-25	WOS:000294680800051
J	Pang, B; Zheng, X; Diao, BW; Cui, ZG; Zhou, HJ; Gao, SY; Kan, B				Pang, Bo; Zheng, Xiao; Diao, Baowei; Cui, Zhigang; Zhou, Haijian; Gao, Shouyi; Kan, Biao			Whole Genome PCR Scanning Reveals the Syntenic Genome Structure of Toxigenic Vibrio cholerae Strains in the O1/O139 Population	PLOS ONE			English	Article							FRAGMENT LENGTH POLYMORPHISM; 7TH PANDEMIC CLONE; GENETIC DIVERSITY; RIBOSOMAL-RNA; CHLAMYDOMONAS-EUGAMETOS; MOLECULAR ANALYSIS; ESCHERICHIA-COLI; EL-TOR; O1; BANGLADESH	Vibrio cholerae is commonly found in estuarine water systems. Toxigenic O1 and O139 V. cholerae strains have caused cholera epidemics and pandemics, whereas the nontoxigenic strains within these serogroups only occasionally lead to disease. To understand the differences in the genome and clonality between the toxigenic and nontoxigenic strains of V. cholerae serogroups O1 and O139, we employed a whole genome PCR scanning (WGPScanning) method, an rrn operon-mediated fragment rearrangement analysis and comparative genomic hybridization (CGH) to analyze the genome structure of different strains. WGPScanning in conjunction with CGH revealed that the genomic contents of the toxigenic strains were conservative, except for a few indels located mainly in mobile elements. Minor nucleotide variation in orthologous genes appeared to be the major difference between the toxigenic strains. rrn operon-mediated rearrangements were infrequent in El Tor toxigenic strains tested using I-CeuI digested pulsed-field gel electrophoresis (PFGE) analysis and PCR analysis based on flanking sequence of rrn operons. Using these methods, we found that the genomic structures of toxigenic El Tor and O139 strains were syntenic. The nontoxigenic strains exhibited more extensive sequence variations, but toxin coregulated pilus positive (TCP+) strains had a similar structure. TCP+ nontoxigenic strains could be subdivided into multiple lineages according to the TCP type, suggesting the existence of complex intermediates in the evolution of toxigenic strains. The data indicate that toxigenic O1 El Tor and O139 strains were derived from a single lineage of intermediates from complex clones in the environment. The nontoxigenic strains with non-El Tor type TCP may yet evolve into new epidemic clones after attaining toxigenic attributes.	[Pang, Bo; Zheng, Xiao; Diao, Baowei; Cui, Zhigang; Zhou, Haijian; Gao, Shouyi; Kan, Biao] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Pang, B (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	kanbiao@icdc.cn			Ministry of Science and Technology, People's Republic of China [2009CB522604]; Ministry of Science and Technology [2008ZX10004-008, 2008ZX10004-009]; Ministry of Health, People's Republic of China	Ministry of Science and Technology, People's Republic of China(Ministry of Science and Technology, China); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health, People's Republic of China	This work was supported by the National Basic Research Priorities Program 2009CB522604 from the Ministry of Science and Technology, People's Republic of China, and by the Priority Project on Infectious Disease Control and Prevention 2008ZX10004-008 and 2008ZX10004-009 from the Ministry of Science and Technology and the Ministry of Health, People's Republic of China (URL of funders: www.most.gov.cn, www.moh.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT MJ, 1993, LANCET, V342, P387, DOI 10.1016/0140-6736(93)92811-7; Ben Zakour NL, 2008, J BACTERIOL, V190, P6302, DOI 10.1128/JB.01984-07; Beres SB, 2004, P NATL ACAD SCI USA, V101, P11833, DOI 10.1073/pnas.0404163101; Boyd EF, 2002, MICROBIOL-SGM, V148, P1655, DOI 10.1099/00221287-148-6-1655; Byun R, 1999, INFECT IMMUN, V67, P1116, DOI 10.1128/IAI.67.3.1116-1124.1999; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; COLWELL RR, 1984, VIBRIOS ENV, V9; Cooper KLF, 2006, FOODBORNE PATHOG DIS, V3, P51, DOI 10.1089/fpd.2006.3.51; Dziejman M, 2002, P NATL ACAD SCI USA, V99, P1556, DOI 10.1073/pnas.042667999; Faruque SM, 2007, P NATL ACAD SCI USA, V104, P5151, DOI 10.1073/pnas.0700365104; Faruque SM, 2004, P NATL ACAD SCI USA, V101, P2123, DOI 10.1073/pnas.0308485100; Faruque SM, 1997, J CLIN MICROBIOL, V35, P2299, DOI 10.1128/JCM.35.9.2299-2306.1997; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; GAUTHIER A, 1991, CURR GENET, V19, P43, DOI 10.1007/BF00362086; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Heilpern AJ, 2003, J BACTERIOL, V185, P1037, DOI 10.1128/JB.185.3.1037-1044.2003; Jiang SC, 2000, APPL ENVIRON MICROB, V66, P148, DOI 10.1128/AEM.66.1.148-153.2000; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; KARAOLIS DKR, 1995, J BACTERIOL, V177, P3191, DOI 10.1128/jb.177.11.3191-3198.1995; Lan RT, 1998, MICROBIOL-UK, V144, P1213, DOI 10.1099/00221287-144-5-1213; Lan RT, 2002, J CLIN MICROBIOL, V40, P172, DOI 10.1128/JCM.40.1.172-181.2002; Liu GW, 2006, VACCINE, V24, P1749, DOI 10.1016/j.vaccine.2005.09.059; LIU SL, 1993, P NATL ACAD SCI USA, V90, P6874, DOI 10.1073/pnas.90.14.6874; Liu WQ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-290; MARSHALL P, 1991, GENE, V104, P241, DOI 10.1016/0378-1119(91)90256-B; Mukhopadhyay AK, 2001, J BACTERIOL, V183, P4737, DOI 10.1128/JB.183.16.4737-4746.2001; Nair GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002; Nandi S, 2003, MICROBIOL-SGM, V149, P89, DOI 10.1099/mic.0.25599-0; Ohnishi M, 2002, P NATL ACAD SCI USA, V99, P17043, DOI 10.1073/pnas.262441699; Ooka T, 2009, GENOME RES, V19, P1809, DOI 10.1101/gr.089615.108; Pang B, 2007, J BACTERIOL, V189, P4837, DOI 10.1128/JB.01959-06; RAMAMURTHY T, 1993, LANCET, V341, P703, DOI 10.1016/0140-6736(93)90480-5; Singh DV, 2001, APPL ENVIRON MICROB, V67, P910, DOI 10.1128/AEM.67.2.910-921.2001; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Zo YG, 2002, P NATL ACAD SCI USA, V99, P12409, DOI 10.1073/pnas.192426499	35	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24267	10.1371/journal.pone.0024267	http://dx.doi.org/10.1371/journal.pone.0024267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904621	Green Submitted, Green Published, gold			2022-12-25	WOS:000294680800074
J	Hunyadi, A; Chuang, DW; Danko, B; Chiang, MY; Lee, CL; Wang, HC; Wu, CC; Chang, FR; Wu, YC				Hunyadi, Attila; Chuang, Da-Wei; Danko, Balazs; Chiang, Michael Y.; Lee, Chia-Lin; Wang, Hui-Chun; Wu, Chin-Chung; Chang, Fang-Rong; Wu, Yang-Chang			Direct Semi-Synthesis of the Anticancer Lead-Drug Protoapigenone from Apigenin, and Synthesis of Further New Cytotoxic Protoflavone Derivatives	PLOS ONE			English	Article							CANCER; FLAVONOIDS; GROWTH; CHEMOPREVENTION; CELLS	Protoapigenone, a natural flavonoid possessing an unusual p-quinol moiety on its B-ring, is a novel prospective anticancer agent with low toxicity that is currently in development. The first economical, one-step synthesis of protoapigenone from apigenin is described on up to gram scale. 13 new 1'-O-alkylflavone analogs were also synthesized, either from apigenin or beta-naphthoflavone. The in vitro cytotoxic activity of each compound was tested on six human cancer cell lines (HepG2, Hep3B, Ca9-22, A549, MCF-7 and MDA-MB-231). In the case of 1'-O-alkyl-protoapigenone derivatives, structure-activity relationships were found depending on the side-chain, and protoapigenone 1'-O-butyl ether was found to exert significantly stronger activity against three of the cell lines (Hep3B, MCF-7 and MDA-MB-231) than its non-substituted analog, protoapigenone itself. In contrast to this, all beta-naphthoflavone derivatives bearing the same pharmacophore on their B-ring showed decreased cytotoxic activities when substituted with an O-alkyl side-chain at position 1', comparing to that of the non-substituted compound.	[Hunyadi, Attila; Danko, Balazs] Univ Szeged, Inst Pharmacognosy, Szeged, Hungary; [Chiang, Michael Y.] Natl Sun Yat Sen Univ, Dept Chem, Kaohsiung 80424, Taiwan; [Lee, Chia-Lin; Wu, Yang-Chang] China Med Univ, Coll Chinese Med, Grad Inst Integrated Med, Taichung, Taiwan; [Chang, Fang-Rong] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chang, Fang-Rong] Kaohsiung Med Univ, Coll Pharm, Res & Dev Ctr Chinese Herbal Med & New Drugs, Kaohsiung, Taiwan; [Wu, Yang-Chang] China Med Univ Hosp, Nat Med Prod Res Ctr, Taichung, Taiwan; [Hunyadi, Attila; Chuang, Da-Wei; Wang, Hui-Chun; Wu, Chin-Chung; Chang, Fang-Rong; Wu, Yang-Chang] Kaohsiung Med Univ, Grad Inst Nat Prod, Kaohsiung, Taiwan	Szeged University; National Sun Yat Sen University; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Medical University	Hunyadi, A (corresponding author), Univ Szeged, Inst Pharmacognosy, Szeged, Hungary.	aaronfrc@kmu.edu.tw; yachwu@mail.cmu.edu.tw	Wu, Yang-Chang/C-5682-2009; Lee, Chia-Lin/P-2038-2015; Wang, Hui-Chun/C-5680-2009	Wu, Yang-Chang/0000-0001-7815-2686; Lee, Chia-Lin/0000-0002-5949-1989; Wang, Hui-Chun/0000-0003-1414-1595; Hunyadi, Attila/0000-0003-0074-3472; Chang, Fang-Rong/0000-0003-2549-4193; Wu, Chin-Chung/0000-0003-4203-4084	Department of Health, Executive Yuan, Taiwan [DOH99-TD-C-111-002]; National Science Council of Taiwan; National Sun Yat-Sen University-Kaohsiung Medical University Joint Research Center; New Hungary Development Plan [TAMOP-4.2.2-08/1-2008-0013]; Zoltan Magyary postdoctoral fellowship (EEA and Norway) [104/2009]	Department of Health, Executive Yuan, Taiwan; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Sun Yat-Sen University-Kaohsiung Medical University Joint Research Center; New Hungary Development Plan; Zoltan Magyary postdoctoral fellowship (EEA and Norway)	This work was supported by the Department of Health, Executive Yuan, Taiwan (DOH99-TD-C-111-002), the National Science Council of Taiwan, the National Sun Yat-Sen University-Kaohsiung Medical University Joint Research Center for YCW, the New Hungary Development Plan (TAMOP-4.2.2-08/1-2008-0013), and by the Zoltan Magyary postdoctoral fellowship (EEA and Norway Grants, 104/2009) for AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang HL, 2008, CANCER LETT, V267, P85, DOI 10.1016/j.canlet.2008.03.007; Chang HL, 2008, J PHARMACOL EXP THER, V325, P841, DOI 10.1124/jpet.107.135442; Chiu CC, 2009, DNA CELL BIOL, V28, P501, DOI 10.1089/dna.2009.0852; Di Carlo G, 1999, LIFE SCI, V65, P337, DOI 10.1016/S0024-3205(99)00120-4; Favaro G, 2007, J FLUORESC, V17, P707, DOI 10.1007/s10895-007-0222-0; Felpin FX, 2007, TETRAHEDRON LETT, V48, P409, DOI 10.1016/j.tetlet.2006.11.073; Hamamoto H, 2002, CHEM-EUR J, V8, P5377, DOI 10.1002/1521-3765(20021202)8:23<5377::AID-CHEM5377>3.0.CO;2-H; Kale A, 2008, PHYTOTHER RES, V22, P567, DOI 10.1002/ptr.2283; Kanadaswami C, 2005, IN VIVO, V19, P895; KHOKHRINA TA, 1973, KHIM PRIRODNYK SOEDI, P802; Le Marchand L, 2002, BIOMED PHARMACOTHER, V56, P296, DOI 10.1016/S0753-3322(02)00186-5; Li YL, 2007, MINI-REV MED CHEM, V7, P663; Lin AS, 2007, J MED CHEM, V50, P3921, DOI 10.1021/jm070363a; Lin AS, 2005, PLANTA MED, V71, P867, DOI 10.1055/s-2005-871292; Liu LZ, 2005, MOL PHARMACOL, V68, P635, DOI 10.1124/mol.105.011254; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Patel D, 2007, INT J ONCOL, V30, P233; Quideau S, 2008, SYNLETT, P467, DOI 10.1055/s-2008-1032094; Wagner H, 1976, TETRAHEDRON LETT, V17, P1799, DOI [10.1016/S0040-4039(00)93787-0, DOI 10.1016/S0040-4039(00)93787-0]; Wells G, 2003, J MED CHEM, V46, P532, DOI 10.1021/jm020984y; Zhdankin VV, 2009, ARKIVOC, P1, DOI 10.3998/ark.5550190.0010.101	21	19	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e23922	10.1371/journal.pone.0023922	http://dx.doi.org/10.1371/journal.pone.0023922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912610	gold, Green Published, Green Submitted			2022-12-25	WOS:000294678300013
J	Gustafsson, SB; Palmqvist, R; Henriksson, ML; Dahlin, AM; Edin, S; Jacobsson, SOP; Oberg, A; Fowler, CJ				Gustafsson, Sofia B.; Palmqvist, Richard; Henriksson, Maria L.; Dahlin, Anna M.; Edin, Sofia; Jacobsson, Stig O. P.; Oberg, Ake; Fowler, Christopher J.			High Tumour Cannabinoid CB1 Receptor Immunoreactivity Negatively Impacts Disease-Specific Survival in Stage II Microsatellite Stable Colorectal Cancer	PLOS ONE			English	Article							COLON-CANCER; ENDOCANNABINOID SYSTEM; PRECANCEROUS LESIONS; EXPERIMENTAL COLITIS; ULCERATIVE-COLITIS; CELL-GROWTH; MOUSE COLON; EXPRESSION; APOPTOSIS; CARCINOMA	Background: There is good evidence in the literature that the cannabinoid system is disturbed in colorectal cancer. In the present study, we have investigated whether CB1 receptor immunoreactive intensity (CB1IR intensity) is associated with disease severity and outcome. Methodology/Principal Findings: CB1IR was assessed in formalin-fixed, paraffin-embedded specimens collected with a consecutive intent during primary tumour surgical resection from a series of cases diagnosed with colorectal cancer. Tumour centre (n = 483) and invasive front (n = 486) CB1IR was scored from 0 (absent) to 3 (intense staining) and the data was analysed as a median split i.e. CB1IR <2 and >= 2. In microsatellite stable, but not microsatellite instable tumours (as adjudged on the basis of immunohistochemical determination of four mismatch repair proteins), there was a significant positive association of the tumour grade with the CB1IR intensity. The difference between the microsatellite stable and instable tumours for this association of CB1IR was related to the CpG island methylation status of the cases. Cox proportional hazards regression analyses indicated a significant contribution of CB1IR to disease-specific survival in the microsatellite stable tumours when adjusting for tumour stage. For the cases with stage II microsatellite stable tumours, there was a significant effect of both tumour centre and front CB1IR upon disease specific survival. The 5 year probabilities of event-free survival were: 8565 and 66+/-8%; tumour interior, 86+/-4% and 63+/-8% for the CB1IR<2 and CB1IR >= 2 groups, respectively. Conclusions/Significance: The level of CB1 receptor expression in colorectal cancer is associated with the tumour grade in a manner dependent upon the degree of CpG hypermethylation. A high CB1IR is indicative of a poorer prognosis in stage II microsatellite stable tumour patients.	[Gustafsson, Sofia B.; Jacobsson, Stig O. P.; Fowler, Christopher J.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Palmqvist, Richard; Henriksson, Maria L.; Dahlin, Anna M.; Edin, Sofia] Umea Univ, Dept Med Biosci, Umea, Sweden; [Oberg, Ake] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden	Umea University; Umea University; Umea University	Gustafsson, SB (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden.	cf@pharm.umu.se	Fowler, Christopher J./M-6313-2019	Fowler, Christopher J./0000-0002-6658-7874; Dahlin, Anna/0000-0002-6754-2571	Swedish Science Council [12158]; Swedish Cancer Society [CAN2008/856, CAN2010/437]; Medical Faculty, Umea University	Swedish Science Council; Swedish Cancer Society(Swedish Cancer Society); Medical Faculty, Umea University	The authors thank the Swedish Science Council (Grant no. 12158, medicine, C.J. Fowler); the Swedish Cancer Society (Grant no. CAN2008/856, R. Palmqvist; Grant no. CAN2010/437, C.J. Fowler); and the Research Funds of the Medical Faculty, Umea University (C.J. Fowler) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton JC, 2012, HIPPOCAMPUS, V22, P643, DOI 10.1002/hipo.20946; Bab I, 2008, BRIT J PHARMACOL, V153, P182, DOI 10.1038/sj.bjp.0707593; Bedoya F, 2009, ONCOLOGY-BASEL, V76, P435, DOI 10.1159/000217263; Borner C, 2007, J LEUKOCYTE BIOL, V81, P336, DOI 10.1189/jlb.0306224; Burry RW, 2000, J HISTOCHEM CYTOCHEM, V48, P163, DOI 10.1177/002215540004800201; Chung SC, 2009, EUR J CANCER, V45, P174, DOI 10.1016/j.ejca.2008.10.010; Cianchi F, 2008, CLIN CANCER RES, V14, P7691, DOI 10.1158/1078-0432.CCR-08-0799; Compton CC, 2004, CA-CANCER J CLIN, V54, P295, DOI 10.3322/canjclin.54.6.295; Cudaback E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008702; D'Argenio G, 2006, FASEB J, V20, P568, DOI 10.1096/fj.05-4943fje; Dahlin AM, 2010, CLIN CANCER RES, V16, P1845, DOI 10.1158/1078-0432.CCR-09-2594; Engel MA, 2010, J PHYSIOL PHARMACOL, V61, P89; Forssell J, 2007, CLIN CANCER RES, V13, P1472, DOI 10.1158/1078-0432.CCR-06-2073; Fowler CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015205; Fowler CJ, 2010, CURR TOP MED CHEM, V10, P814; Freimuth N, 2010, J PHARMACOL EXP THER, V332, P336, DOI 10.1124/jpet.109.157735; Grimsey NL, 2010, BIOCHEM PHARMACOL, V80, P1050, DOI 10.1016/j.bcp.2010.06.007; Guindon J, 2009, CNS NEUROL DISORD-DR, V8, P403, DOI 10.2174/187152709789824660; Gustafsson SB, 2009, CANCER CHEMOTH PHARM, V63, P691, DOI 10.1007/s00280-008-0788-5; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; Horne AW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003969; Hsieh C, 1999, J NEUROCHEM, V73, P493, DOI 10.1046/j.1471-4159.1999.0730493.x; Izzo AA, 2008, J MOL MED, V86, P89, DOI 10.1007/s00109-007-0248-4; Izzo AA, 2010, PHARMACOL THERAPEUT, V126, P21, DOI 10.1016/j.pharmthera.2009.12.005; Jass JR, 2007, SURG ONCOL, V16, pS7, DOI 10.1016/j.suronc.2007.10.039; Jo Won-Seok, 2006, Cancer Biomarkers, V2, P51; Jorissen RN, 2008, CLIN CANCER RES, V14, P8061, DOI 10.1158/1078-0432.CCR-08-1431; Kimball ES, 2006, AM J PHYSIOL-GASTR L, V291, pG364, DOI 10.1152/ajpgi.00407.2005; Koller FL, 2010, CARCINOGENESIS, V31, P1010, DOI 10.1093/carcin/bgq044; Kunos G, 2008, AM J PHYSIOL-GASTR L, V294, pG1101, DOI 10.1152/ajpgi.00057.2008; Ligresti A, 2003, GASTROENTEROLOGY, V125, P677, DOI 10.1016/S0016-5085(03)00881-3; Linsalata M, 2010, ANTICANCER RES, V30, P2583; Lorincz A, 2008, J NEUROSCI, V28, P9083, DOI 10.1523/JNEUROSCI.2494-08.2008; Marquez L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006893; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; McIntosh HH, 1998, MOL BRAIN RES, V53, P163, DOI 10.1016/S0169-328X(97)00294-5; Michalski CW, 2008, INT J CANCER, V122, P742, DOI 10.1002/ijc.23114; Prall F, 2007, HISTOPATHOLOGY, V50, P151, DOI 10.1111/j.1365-2559.2006.02551.x; Rousseau B, 2010, CANCER J, V16, P202, DOI 10.1097/PPO.0b013e3181ddc5bf; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Santoro A, 2009, INT J CANCER, V125, P996, DOI 10.1002/ijc.24483; Scavone JL, 2010, BRAIN RES, V1312, P18, DOI 10.1016/j.brainres.2009.11.023; Shinto E, 2005, HISTOPATHOLOGY, V47, P25, DOI 10.1111/j.1365-2559.2005.02162.x; Storr M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009453; Storr MA, 2008, J MOL MED, V86, P925, DOI 10.1007/s00109-008-0359-6; Todaro M, 2008, CELL DEATH DIFFER, V15, P762, DOI 10.1038/sj.cdd.4402305; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Wang DZ, 2008, CANCER RES, V68, P6468, DOI 10.1158/0008-5472.CAN-08-0896; Wright K, 2005, GASTROENTEROLOGY, V129, P437, DOI 10.1053/j.gastro.2005.05.026; Xu XD, 2006, CANCER GENET CYTOGEN, V171, P31, DOI 10.1016/j.cancergencyto.2006.06.014; Zlobec I, 2009, WORLD J GASTROENTERO, V15, P5898, DOI 10.3748/wjg.15.5898	51	34	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23003	10.1371/journal.pone.0023003	http://dx.doi.org/10.1371/journal.pone.0023003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901119	Green Submitted, Green Published, gold			2022-12-25	WOS:000294298000004
J	Legrand, B; Giudice, E; Nicolas, A; Delalande, O; Le Rumeur, E				Legrand, Baptiste; Giudice, Emmanuel; Nicolas, Aurelie; Delalande, Olivier; Le Rumeur, Elisabeth			Computational Study of the Human Dystrophin Repeats: Interaction Properties and Molecular Dynamics	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; DUCHENNE MUSCULAR-DYSTROPHY; EMPIRICAL FORCE-FIELD; ROD DOMAIN; LIPID-BINDING; 3-DIMENSIONAL STRUCTURES; STABILITY PROPERTIES; CRYSTAL-STRUCTURE; SPECTRIN REPEAT; BETA-SPECTRIN	Dystrophin is a large protein involved in the rare genetic disease Duchenne muscular dystrophy (DMD). It functions as a mechanical linker between the cytoskeleton and the sarcolemma, and is able to resist shear stresses during muscle activity. In all, 75% of the dystrophin molecule consists of a large central rod domain made up of 24 repeat units that share high structural homology with spectrin-like repeats. However, in the absence of any high-resolution structure of these repeats, the molecular basis of dystrophin central domain's functions has not yet been deciphered. In this context, we have performed a computational study of the whole dystrophin central rod domain based on the rational homology modeling of successive and overlapping tandem repeats and the analysis of their surface properties. Each tandem repeat has very specific surface properties that make it unique. However, the repeats share enough electrostatic-surface similarities to be grouped into four separate clusters. Molecular dynamics simulations of four representative tandem repeats reveal specific flexibility or bending properties depending on the repeat sequence. We thus suggest that the dystrophin central rod domain is constituted of seven biologically relevant sub-domains. Our results provide evidence for the role of the dystrophin central rod domain as a scaffold platform with a wide range of surface features and biophysical properties allowing it to interact with its various known partners such as proteins and membrane lipids. This new integrative view is strongly supported by the previous experimental works that investigated the isolated domains and the observed heterogeneity of the severity of dystrophin related pathologies, especially Becker muscular dystrophy.	[Legrand, Baptiste; Giudice, Emmanuel; Nicolas, Aurelie; Delalande, Olivier; Le Rumeur, Elisabeth] Univ Rennes 1, Rennes, France; [Legrand, Baptiste; Nicolas, Aurelie; Delalande, Olivier; Le Rumeur, Elisabeth] CNRS, Fac Med, Equipe RMN ILP, UMR 6026, Rennes, France; [Giudice, Emmanuel] CNRS, Equipe SDM, UMR 6026, Rennes, France; [Legrand, Baptiste; Giudice, Emmanuel; Nicolas, Aurelie; Delalande, Olivier; Le Rumeur, Elisabeth] Univ Europeenne Bretagne, Rennes, France	Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Bretagne Occidentale	Legrand, B (corresponding author), CNRS INPL, Lab Chim Phys Macromol, UMR 7568, Nancy, France.	elisabeth.lerumeur@univ-rennes1.fr	Giudice, Emmanuel/AFT-2595-2022; Nicolas, Aurélie/AAE-9832-2019; Legrand, Baptiste/ABB-2552-2021	Nicolas, Aurélie/0000-0002-6960-9362; GIUDICE, Emmanuel/0000-0001-7209-7890; Legrand, Baptiste/0000-0001-8931-7757	Association Francaise contre les Myopathies; Rennes Metropole; French Ministry of Research; CNRS	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Rennes Metropole(Region Bretagne); French Ministry of Research(Ministry of Research, FranceEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by "Association Francaise contre les Myopathies", Rennes Metropole, French Ministry of Research and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann KJ, 1998, J BIOL CHEM, V273, P28419, DOI 10.1074/jbc.273.43.28419; Baines AJ, 2010, TRANSFUS CLIN BIOL, V17, P95, DOI 10.1016/j.tracli.2010.06.008; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banks GB, 2008, CURR TOP DEV BIOL, V84, P431, DOI 10.1016/S0070-2153(08)00609-1; BEGGS AH, 1991, AM J HUM GENET, V49, P54; Blomberg N, 1999, PROTEINS, V37, P379, DOI 10.1002/(SICI)1097-0134(19991115)37:3<379::AID-PROT6>3.0.CO;2-K; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Broderick MJF, 2005, ADV PROTEIN CHEM, V70, P203, DOI 10.1016/S0065-3233(04)70007-8; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Czogalla A, 2008, BBA-BIOMEMBRANES, V1778, P2612, DOI 10.1016/j.bbamem.2008.07.020; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; Davis L, 2009, J BIOL CHEM, V284, P6982, DOI 10.1074/jbc.M809245200; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; DeLano WL, 2002, PYMOL USERS MANUAL; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Efremov RG, 2007, CURR MED CHEM, V14, P393, DOI 10.2174/092986707779941050; Ervasti JM, 2007, BBA-MOL BASIS DIS, V1772, P108, DOI 10.1016/j.bbadis.2006.05.010; FELSENSTEIN J, 1987, J MOL EVOL, V26, P123, DOI 10.1007/BF02111286; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Gabdoulline RR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-373; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ipsaro JJ, 2010, BLOOD, V115, P4843, DOI 10.1182/blood-2010-01-261396; Ipsaro JJ, 2010, BLOOD, V115, P4093, DOI 10.1182/blood-2009-11-255604; Ipsaro JJ, 2009, BLOOD, V113, P5385, DOI 10.1182/blood-2008-10-184358; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KAHANA E, 1994, J MOL BIOL, V235, P1271, DOI 10.1006/jmbi.1994.1080; KAHANA E, 1995, BIOCHEMISTRY-US, V34, P8110, DOI 10.1021/bi00025a017; Kaspar RW, 2009, CIRC-CARDIOVASC GENE, V2, P544, DOI 10.1161/CIRCGENETICS.109.867242; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1990, J BIOL CHEM, V265, P4560; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Kusunoki H, 2004, STRUCTURE, V12, P645, DOI 10.1016/j.str.2004.02.022; La-Borde PJ, 2010, BIOCHEM BIOPH RES CO, V392, P490, DOI 10.1016/j.bbrc.2010.01.046; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le Rumeur E, 2010, BBA-PROTEINS PROTEOM, V1804, P1713, DOI 10.1016/j.bbapap.2010.05.001; Legardinier S, 2008, BBA-PROTEINS PROTEOM, V1784, P672, DOI 10.1016/j.bbapap.2007.12.014; Legardinier S, 2009, J MOL BIOL, V389, P546, DOI 10.1016/j.jmb.2009.04.025; Li HY, 2002, BIOCHEMISTRY-US, V41, P13868, DOI 10.1021/bi020417c; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mehboob S, 2003, BIOCHEMISTRY-US, V42, P14702, DOI 10.1021/bi0353833; Menhart N, 2006, BBA-PROTEINS PROTEOM, V1764, P993, DOI 10.1016/j.bbapap.2006.03.017; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Mirijanian DT, 2007, J MOL BIOL, V365, P523, DOI 10.1016/j.jmb.2006.10.003; Mirza A, 2010, BBA-PROTEINS PROTEOM, V1804, P1796, DOI 10.1016/j.bbapap.2010.03.009; Nakamura A, 2009, NEUROPATHOLOGY, V29, P494, DOI 10.1111/j.1440-1789.2009.01028.x; OHLENDIECK K, 1991, FEBS LETT, V283, P230, DOI 10.1016/0014-5793(91)80595-T; Pascual J, 1997, J MOL BIOL, V273, P740, DOI 10.1006/jmbi.1997.1344; Petrey D, 2005, MOL CELL, V20, P811, DOI 10.1016/j.molcel.2005.12.005; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Pyrkov TV, 2009, BIOINFORMATICS, V25, P1201, DOI 10.1093/bioinformatics/btp111; Richter S, 2008, NUCLEIC ACIDS RES, V36, pW276, DOI 10.1093/nar/gkn181; Rybakova IN, 2006, J BIOL CHEM, V281, P9996, DOI 10.1074/jbc.M513121200; Saadat L, 2006, BBA-PROTEINS PROTEOM, V1764, P943, DOI 10.1016/j.bbapap.2006.02.012; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Stabach PR, 2009, BLOOD, V113, P5377, DOI 10.1182/blood-2008-10-184291; Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976; Wade RC, 2001, INT J QUANTUM CHEM, V83, P122, DOI 10.1002/qua.1204; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WINDER SJ, 1995, FEBS LETT, V369, P27, DOI 10.1016/0014-5793(95)00398-S; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Ylanne Jari, 2001, Cell Mol Biol Lett, V6, P234; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zhang Y, 2009, CURR OPIN STRUC BIOL, V19, P145, DOI 10.1016/j.sbi.2009.02.005	75	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23819	10.1371/journal.pone.0023819	http://dx.doi.org/10.1371/journal.pone.0023819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901138	Green Published, gold, Green Submitted			2022-12-25	WOS:000294298000023
J	Ferrer, T; Cordero-Morales, JF; Arias, M; Ficker, E; Medovoy, D; Perozo, E; Tristani-Firouzi, M				Ferrer, Tania; Cordero-Morales, Julio F.; Arias, Marcelo; Ficker, Eckhard; Medovoy, David; Perozo, Eduardo; Tristani-Firouzi, Martin			Molecular Coupling in the Human ether-a-go-go-related gene-1 (hERG1) K+ Channel Inactivation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNEL; HUMAN INWARD RECTIFIER; C-TYPE INACTIVATION; CARDIAC-ARRHYTHMIA; SELECTIVITY FILTER; ALPHA-HELIX; ACTIVATION; MECHANISM; DYNAMICS; LINKER	Emerging evidence suggests that K+ channel inactivation involves coupling between residues in adjacent regions of the channel. Human ether-a-go-go-related gene-1 (hERG1) K+ channels undergo a fast inactivation gating process that is crucial for maintaining electrical stability in the heart. The molecular mechanisms that drive inactivation in hERG1 channels are unknown. Using alanine scanning mutagenesis, we show that a pore helix residue (Thr-618) that points toward the S5 segment is critical for normal inactivation gating. Amino acid substitutions at position 618 modulate the free energy of inactivation gating, causing enhanced or reduced inactivation. Mutation of an S5 residue that is predicted to be adjacent to Thr-618 (W568L) abolishes inactivation and alters ion selectivity. The introduction of the Thr-618-equivalent residue in Kv1.5 enhances inactivation. Molecular dynamic simulations of the Kv1.2 tetramer reveal van der Waals coupling between hERG1 618- and 568-equivalent residues and a significant increase in interaction energies when threonine is introduced at the 618-equivalent position. We propose that coupling between the S5 segment and pore helix may participate in the inactivation process in hERG1 channels.	[Tristani-Firouzi, Martin] Univ Utah, Sch Med, PCMC, Div Pediat Cardiol, Salt Lake City, UT 84113 USA; [Ferrer, Tania; Arias, Marcelo; Tristani-Firouzi, Martin] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA; [Cordero-Morales, Julio F.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Ficker, Eckhard] Case Western Reserve Univ, Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA; [Medovoy, David; Perozo, Eduardo] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California San Francisco; Case Western Reserve University; MetroHealth System; University of Chicago	Tristani-Firouzi, M (corresponding author), Univ Utah, Sch Med, PCMC, Div Pediat Cardiol, Suite 1500,100 N Mario Capecchi Way, Salt Lake City, UT 84113 USA.	mfirouzi@cvrti.utah.edu		Cordero Morales, Julio/0000-0002-6505-5403	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009412] Funding Source: NIH RePORTER; NIBIB NIH HHS [T32 EB009412] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Clarke CE, 2006, J PHYSIOL-LONDON, V573, P291, DOI 10.1113/jphysiol.2006.108332; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P319, DOI 10.1038/nsmb1070; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gajewski C, 2011, P NATL ACAD SCI USA, V108, P3240, DOI 10.1073/pnas.1017097108; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang M, 2005, J PHYSIOL-LONDON, V569, P75, DOI 10.1113/jphysiol.2005.093682; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jogini V, 2007, BIOPHYS J, V93, P3070, DOI 10.1529/biophysj.107.112540; Ju PC, 2009, J BIOL CHEM, V284, P1000, DOI 10.1074/jbc.M806400200; Liu J, 2002, J GEN PHYSIOL, V120, P723, DOI 10.1085/jgp.20028687; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Panyi G, 2006, J GEN PHYSIOL, V128, P547, DOI 10.1085/jgp.200609644; Perrin MJ, 2008, MOL PHARMACOL, V74, P1443, DOI 10.1124/mol.108.049056; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piper DR, 2008, CELL PHYSIOL BIOCHEM, V21, P37, DOI 10.1159/000113745; Piper DR, 2005, J BIOL CHEM, V280, P7206, DOI 10.1074/jbc.M411042200; Piper DR, 2003, P NATL ACAD SCI USA, V100, P10534, DOI 10.1073/pnas.1832721100; Rasmusson RL, 1998, CIRC RES, V82, P739, DOI 10.1161/01.RES.82.7.739; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Stefani E, 1998, METHOD ENZYMOL, V293, P300; STUHMER W, 1992, METHOD ENZYMOL, V207, P319; Torres AM, 2003, J BIOL CHEM, V278, P42136, DOI 10.1074/jbc.M212824200; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Waight AB, 2010, NAT STRUCT MOL BIOL, V17, P31, DOI 10.1038/nsmb.1740; Wang HZ, 2002, CANCER RES, V62, P4843; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Zhang M, 2004, J GEN PHYSIOL, V124, P703, DOI 10.1085/jgp.200409119; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	41	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39091	39099		10.1074/jbc.M111.292060	http://dx.doi.org/10.1074/jbc.M111.292060			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21908602	Green Published, hybrid			2022-12-25	WOS:000296759800028
J	Suttisansanee, U; Lau, K; Lagishetty, S; Rao, KN; Swaminathan, S; Sauder, JM; Burley, SK; Honek, JF				Suttisansanee, Uthaiwan; Lau, Kelvin; Lagishetty, Satyanarayana; Rao, Krishnamurthy N.; Swaminathan, Subramanyam; Sauder, J. Michael; Burley, Stephen K.; Honek, John F.			Structural Variation in Bacterial Glyoxalase I Enzymes INVESTIGATION OF THE METALLOENZYME GLYOXALASE I FROM CLOSTRIDIUM ACETOBUTYLICUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITE PLASMODIUM-FALCIPARUM; ACTIVE-SITE STRUCTURE; ESCHERICHIA-COLI; IMMUNOCHEMICAL CHARACTERIZATION; CRYSTALLOGRAPHIC ANALYSIS; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; GENE DUPLICATION; METAL-BINDING; PROTEIN	The glyoxalase system catalyzes the conversion of toxic, metabolically produced alpha-ketoaldehydes, such as methylglyoxal, into their corresponding nontoxic 2-hydroxycarboxylic acids, leading to detoxification of these cellular metabolites. Previous studies on the first enzyme in the glyoxalase system, glyoxalase I (GlxI), from yeast, protozoa, animals, humans, plants, and Gram-negative bacteria, have suggested two metal activation classes, Zn2+ and non-Zn2+ activation. Here, we report a biochemical and structural investigation of the GlxI from Clostridium acetobutylicum, which is the first GlxI enzyme from Gram-positive bacteria that has been fully characterized as to its three-dimensional structure and its detailed metal specificity. It is a Ni2+/Co2+-activated enzyme, in which the active site geometry forms an octahedral coordination with one metal atom, two water molecules, and four metal-binding ligands, although its inactive Zn2+-bound form possesses a trigonal bipyramidal geometry with only one water molecule liganded to the metal center. This enzyme also possesses a unique dimeric molecular structure. Unlike other small homodimeric GlxI where two active sites are located at the dimeric interface, the C. acetobutylicum dimeric GlxI enzyme also forms two active sites but each within single subunits. Interestingly, even though this enzyme possesses a different dimeric structure from previously studied GlxI, its metal activation characteristics are consistent with properties of other GlxI. These findings indicate that metal activation profiles in this class of enzyme hold true across diverse quaternary structure arrangements.	[Sauder, J. Michael; Burley, Stephen K.] Eli Lilly & Co, San Diego, CA 92121 USA; [Suttisansanee, Uthaiwan; Lau, Kelvin; Honek, John F.] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada; [Lagishetty, Satyanarayana; Rao, Krishnamurthy N.; Swaminathan, Subramanyam] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Eli Lilly; University of Waterloo; United States Department of Energy (DOE); Brookhaven National Laboratory	Burley, SK (corresponding author), Eli Lilly & Co, San Diego, CA 92121 USA.	sburley@sgxpharma.com; jhonek@uwaterloo.ca	Suttisansanee, Uthaiwan/GRR-1655-2022; Lau, Kelvin/M-2639-2019	Lau, Kelvin/0000-0002-9040-7597; Sauder, J Michael/0000-0002-0254-4955; Honek, John/0000-0002-4035-4538; Lagishetty, Satya/0000-0002-5329-1257; Suttisansanee, Uthaiwan/0000-0001-5887-6329; Burley, Stephen K./0000-0002-2487-9713	National Institutes of Health from NIGMS [GM074945]; Department of Energy [DEAC02-98CH10886]; Brookhaven National Laboratory; Natural Sciences and Engineering Research Council of Canada; University of Waterloo (Ontario, Canada); Government of Thailand; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074945] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); Brookhaven National Laboratory(United States Department of Energy (DOE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Waterloo (Ontario, Canada); Government of Thailand; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074945 (U54 Award) from NIGMS (to the New York-Structural Genomix Research Consortium under Department of Energy Prime Contract DEAC02-98CH10886 with Brookhaven National Laboratory; principal investigator, S. K. B.). This work was also supported by the Natural Sciences and Engineering Research Council of Canada, University of Waterloo (Ontario, Canada), and the Government of Thailand.	Akoachere M, 2005, BIOL CHEM, V386, P41, DOI 10.1515/BC.2005.006; Ariza A, 2006, MOL MICROBIOL, V59, P1239, DOI 10.1111/j.1365-2958.2006.05022.x; ARONSSON AC, 1978, BIOCHEM BIOPH RES CO, V81, P1235, DOI 10.1016/0006-291X(78)91268-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergdoll M, 1998, PROTEIN SCI, V7, P1661, DOI 10.1002/pro.5560070801; Bobik TA, 2004, APPL MICROBIOL BIOT, V63, P682, DOI 10.1007/s00253-003-1474-5; Bobik TA, 2003, ANAL BIOANAL CHEM, V375, P344, DOI 10.1007/s00216-002-1696-x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROPHY PM, 1990, INT J PARASITOL, V20, P259, DOI 10.1016/0020-7519(90)90109-Z; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cameron AD, 1997, EMBO J, V16, P3386, DOI 10.1093/emboj/16.12.3386; Cameron AD, 1999, BIOCHEMISTRY-US, V38, P13480, DOI 10.1021/bi990696c; Chen ZY, 2004, PHYTOPATHOLOGY, V94, P938, DOI 10.1094/PHYTO.2004.94.9.938; CLIFFE EE, 1961, BIOCHEM J, V79, P475, DOI 10.1042/bj0790475; Clugston SL, 1997, GENE, V186, P103, DOI 10.1016/S0378-1119(96)00691-9; Clugston SL, 1998, BIOCHEMISTRY-US, V37, P8754, DOI 10.1021/bi972791w; Clugston SL, 2004, BIOCHEM J, V377, P309, DOI 10.1042/BJ20030271; Clugston SL, 1998, J MOL EVOL, V47, P230, DOI 10.1007/PL00006380; COOPER RA, 1984, ANNU REV MICROBIOL, V38, P49, DOI 10.1146/annurev.mi.38.100184.000405; Danshiftsoodol N, 2006, J MOL BIOL, V360, P398, DOI 10.1016/j.jmb.2006.05.017; Davidson G, 2000, INORG CHEM, V39, P2962, DOI 10.1021/ic0001208; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Deswal R, 1998, PHYTOCHEMISTRY, V49, P2245, DOI 10.1016/S0031-9422(98)00334-3; DESWAL R, 1991, FEBS LETT, V282, P277, DOI 10.1016/0014-5793(91)80494-N; Feierberg I, 1999, FEBS LETT, V453, P90, DOI 10.1016/S0014-5793(99)00703-6; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; FRENCH FA, 1958, CANCER RES, V18, P172; Frickel EM, 2001, J BIOL CHEM, V276, P1845, DOI 10.1074/jbc.M005760200; Gasteiger E, 2001, Curr Issues Mol Biol, V3, P47; Greig N, 2006, BIOCHEM J, V400, P217, DOI 10.1042/BJ20060882; He MM, 2000, BIOCHEMISTRY-US, V39, P8719, DOI 10.1021/bi000856g; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HUNT JB, 1985, ANAL BIOCHEM, V146, P150, DOI 10.1016/0003-2697(85)90409-9; Inoue Y, 1995, Adv Microb Physiol, V37, P177, DOI 10.1016/S0065-2911(08)60146-0; Iozef R, 2003, FEBS LETT, V554, P284, DOI 10.1016/S0014-5793(03)01146-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kino K, 2007, BIOCHEM BIOPH RES CO, V352, P351, DOI 10.1016/j.bbrc.2006.11.016; LESLIE AGW, 1987, ACTA CRYSTALLOGR A, V43, P134, DOI 10.1107/S0108767387099720; Liyanage H, 2001, APPL ENVIRON MICROB, V67, P2004, DOI 10.1128/AEM.67.5.2004-2010.2001; MARMSTAL E, 1979, BIOCHEM J, V183, P23, DOI 10.1042/bj1830023; Martin TW, 2002, STRUCTURE, V10, P933, DOI 10.1016/S0969-2126(02)00778-5; Martins AM, 2001, EUR J BIOCHEM, V268, P3930, DOI 10.1046/j.1432-1327.2001.02304.x; McCall KA, 2000, ANAL BIOCHEM, V284, P307, DOI 10.1006/abio.2000.4706; McCarthy AA, 2001, STRUCTURE, V9, P637, DOI 10.1016/S0969-2126(01)00622-0; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; O'Young J, 2007, ARCH BIOCHEM BIOPHYS, V459, P20, DOI 10.1016/j.abb.2006.11.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oya T, 1999, J BIOL CHEM, V274, P18492, DOI 10.1074/jbc.274.26.18492; PAPOULIS A, 1995, BIOCHEMISTRY-US, V34, P648, DOI 10.1021/bi00002a032; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pfister T, 2000, J VIROL, V74, P334, DOI 10.1128/JVI.74.1.334-343.2000; RICHARD JP, 1991, BIOCHEMISTRY-US, V30, P4581, DOI 10.1021/bi00232a031; Richter U, 2001, J AM CHEM SOC, V123, P6973, DOI 10.1021/ja0105966; Ridderstrom M, 1996, BIOCHEM J, V314, P463; Saint-Jean AP, 1998, BIOCHEMISTRY-US, V37, P10345, DOI 10.1021/bi980868q; Sambrook J, 2001, MOL CLONING LAB MANU; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SELLIN S, 1983, J BIOL CHEM, V258, P2091; Sukdeo N, 2004, BIOCHEM J, V384, P111, DOI 10.1042/BJ20041006; Sukdeo N, 2007, BBA-PROTEINS PROTEOM, V1774, P756, DOI 10.1016/j.bbapap.2007.04.005; Takatsume Y, 2004, ARCH MICROBIOL, V181, P371, DOI 10.1007/s00203-004-0666-4; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Vander Jagt DL, 2003, CHEM-BIOL INTERACT, V143, P341, DOI 10.1016/S0009-2797(02)00212-0; VANDERJAGT DL, 1975, J MED CHEM, V18, P1155, DOI 10.1021/jm00245a025; Vickers TJ, 2004, P NATL ACAD SCI USA, V101, P13186, DOI 10.1073/pnas.0402918101; VINCE R, 1971, J MED CHEM, V14, P402, DOI 10.1021/jm00287a006	66	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38367	38374		10.1074/jbc.M111.251603	http://dx.doi.org/10.1074/jbc.M111.251603			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914803	Green Published, hybrid			2022-12-25	WOS:000296594200050
J	Shioya, K; Michaux, C; Kuenne, C; Hain, T; Verneuil, N; Budin-Verneuil, A; Hartsch, T; Hartke, A; Giard, JC				Shioya, Kouki; Michaux, Charlotte; Kuenne, Carsten; Hain, Torsten; Verneuil, Nicolas; Budin-Verneuil, Aurelie; Hartsch, Thomas; Hartke, Axel; Giard, Jean-Christophe			Genome-Wide Identification of Small RNAs in the Opportunistic Pathogen Enterococcus faecalis V583	PLOS ONE			English	Article							NONCODING RNAS; PROTEIN; STRESS; GLS24; TRANSLATION; DEGRADATION; EXPRESSION; PREDICTION; PHYSIOLOGY; MECHANISM	Small RNA molecules (sRNAs) are key mediators of virulence and stress inducible gene expressions in some pathogens. In this work we identify sRNAs in the Gram positive opportunistic pathogen Enterococcus faecalis. We characterized 11 sRNAs by tiling microarray analysis, 5' and 3' RACE-PCR, and Northern blot analysis. Six sRNAs were specifically expressed at exponential phase, two sRNAs were observed at stationary phase, and three were detected during both phases. Searches of putative functions revealed that three of them (EFA0080_EFA0081 and EFB0062_EFB0063 on pTF1 and pTF2 plasmids, respectively, and EF0408_EF04092 located on the chromosome) are similar to antisense RNA involved in plasmid addiction modules. Moreover, EF1097_EF1098 shares strong homologies with tmRNA (bi-functional RNA acting as both a tRNA and an mRNA) and EF2205_EF2206 appears homologous to 4.5S RNA member of the Signal Recognition Particle (SRP) ribonucleoprotein complex. In addition, proteomic analysis of the DEF3314_EF3315 sRNA mutant suggests that it may be involved in the turnover of some abundant proteins. The expression patterns of these transcripts were evaluated by tiling array hybridizations performed with samples from cells grown under eleven different conditions some of which may be encountered during infection. Finally, distribution of these sRNAs among genome sequences of 54 E. faecalis strains was assessed. This is the first experimental genome-wide identification of sRNAs in E. faecalis and provides impetus to the understanding of gene regulation in this important human pathogen.	[Shioya, Kouki; Michaux, Charlotte; Verneuil, Nicolas; Budin-Verneuil, Aurelie; Hartke, Axel; Giard, Jean-Christophe] Univ Caen, Lab Microbiol Environm, ICORE IFR146, USC INRA 2017,EA956, F-14032 Caen, France; [Kuenne, Carsten; Hain, Torsten] Univ Giessen, Inst Med Microbiol, Giessen, Germany; [Hartsch, Thomas] Genedata AG, Basel, Switzerland	INRAE; Universite de Caen Normandie; Justus Liebig University Giessen	Shioya, K (corresponding author), Univ Caen, Lab Microbiol Environm, ICORE IFR146, USC INRA 2017,EA956, F-14032 Caen, France.	jean-christophe.giard@unicaen.fr		giard, jean-christophe/0000-0001-8588-2732; Kuenne, Carsten/0000-0001-8013-5906; BUDIN-VERNEUIL, Aurelie/0000-0002-1173-251X; Michaux, Charlotte/0000-0003-1089-7846; Verneuil, Nicolas/0000-0002-9080-6627	Ministere de l'Enseignement Superieur et de la Recherche; Agence Nationale de la Recherche [ANR-08-PATH-008-01]; Region of Lower Normandy (CRBN)	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Region of Lower Normandy (CRBN)	CM is funded by a thesis grant awarded by the Ministere de l'Enseignement Superieur et de la Recherche. This study was supported by grants of the "Agence Nationale de la Recherche'' in the frame of the transnational ERA-NET PathoGenoMics program (ANR-08-PATH-008-01), and by the Region of Lower Normandy (CRBN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Budin-Verneuil A, 2005, PROTEOMICS, V5, P4794, DOI 10.1002/pmic.200401327; Cao Y, 2009, BIOINFORMATION, V3, P364, DOI 10.6026/97320630003364; DHEROUEL AF, 2011, NUCL ACIDS RES; Dulebohn D, 2007, BIOCHEMISTRY-US, V46, P4681, DOI 10.1021/bi6026055; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; GERDES K, 1990, MOL MICROBIOL, V4, P1807, DOI 10.1111/j.1365-2958.1990.tb02029.x; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; Giard JC, 2002, FEMS MICROBIOL LETT, V206, P235, DOI 10.1111/j.1574-6968.2002.tb11015.x; Giard JC, 2001, ELECTROPHORESIS, V22, P2947, DOI 10.1002/1522-2683(200108)22:14&lt;2947::AID-ELPS2947&gt;3.0.CO;2-K; Giard JC, 2000, J BACTERIOL, V182, P4512, DOI 10.1128/JB.182.16.4512-4520.2000; Hayes CS, 2010, FEBS LETT, V584, P413, DOI 10.1016/j.febslet.2009.11.023; Keiler KC, 2007, CURR OPIN MICROBIOL, V10, P169, DOI 10.1016/j.mib.2007.03.014; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Kumar R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-350; Landt SG, 2008, MOL MICROBIOL, V68, P600, DOI 10.1111/j.1365-2958.2008.06172.x; Livny J, 2007, CURR OPIN MICROBIOL, V10, P96, DOI 10.1016/j.mib.2007.03.005; Livny J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003197; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; McBride SM, 2009, J BACTERIOL, V191, P3392, DOI 10.1128/JB.00031-09; Mraheil MA, 2010, MICROB BIOTECHNOL, V3, P658, DOI 10.1111/j.1751-7915.2010.00171.x; Nielsen JS, 2010, NUCLEIC ACIDS RES, V38, P907, DOI 10.1093/nar/gkp1081; Ogier JC, 2008, INT J FOOD MICROBIOL, V126, P291, DOI 10.1016/j.ijfoodmicro.2007.08.017; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Perez N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007668; Repoila F, 2009, BIOL CELL, V101, P117, DOI 10.1042/BC20070137; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sharma CM, 2009, CURR OPIN MICROBIOL, V12, P536, DOI 10.1016/j.mib.2009.07.006; Shepard BD, 2002, INFECT IMMUN, V70, P4344, DOI 10.1128/IAI.70.8.4344-4352.2002; Smith C, 2010, NUCLEIC ACIDS RES, V38, pW373, DOI 10.1093/nar/gkq316; Storz G, 2004, CURR OPIN MICROBIOL, V7, P140, DOI 10.1016/j.mib.2004.02.015; Sun XG, 2002, NUCLEIC ACIDS RES, V30, P3662, DOI 10.1093/nar/gkf508; Teng F, 2005, J INFECT DIS, V191, P472, DOI 10.1086/427191; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Trevino J, 2010, MICROBIOL-SGM, V156, P1342, DOI 10.1099/mic.0.036558-0; Tsui HCT, 2010, J BACTERIOL, V192, P264, DOI 10.1128/JB.01204-09; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Vebo HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012489; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weaver KE, 2007, CURR OPIN MICROBIOL, V10, P110, DOI 10.1016/j.mib.2007.03.002; Weaver KE, 2009, MICROBIOL-SGM, V155, P2930, DOI 10.1099/mic.0.030932-0	46	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e23948	10.1371/journal.pone.0023948	http://dx.doi.org/10.1371/journal.pone.0023948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912655	Green Submitted, Green Published, gold			2022-12-25	WOS:000294686100010
J	Zhao, J; Yang, TH; Huang, YX; Holme, P				Zhao, Jing; Yang, Ting-Hong; Huang, Yongxu; Holme, Petter			Ranking Candidate Disease Genes from Gene Expression and Protein Interaction: A Katz-Centrality Based Approach	PLOS ONE			English	Article							ONSET ALZHEIMER-DISEASE; NETWORK PROPERTIES; ASSOCIATION; IDENTIFICATION; PRIORITIZATION; POLYMORPHISM; MICROARRAYS; MODEL	Many diseases have complex genetic causes, where a set of alleles can affect the propensity of getting the disease. The identification of such disease genes is important to understand the mechanistic and evolutionary aspects of pathogenesis, improve diagnosis and treatment of the disease, and aid in drug discovery. Current genetic studies typically identify chromosomal regions associated specific diseases. But picking out an unknown disease gene from hundreds of candidates located on the same genomic interval is still challenging. In this study, we propose an approach to prioritize candidate genes by integrating data of gene expression level, protein-protein interaction strength and known disease genes. Our method is based only on two, simple, biologically motivated assumptions-that a gene is a good disease-gene candidate if it is differentially expressed in cases and controls, or that it is close to other disease-gene candidates in its protein interaction network. We tested our method on 40 diseases in 58 gene expression datasets of the NCBI Gene Expression Omnibus database. On these datasets our method is able to predict unknown disease genes as well as identifying pleiotropic genes involved in the physiological cellular processes of many diseases. Our study not only provides an effective algorithm for prioritizing candidate disease genes but is also a way to discover phenotypic interdependency, cooccurrence and shared pathophysiology between different disorders.	[Zhao, Jing; Yang, Ting-Hong] Logist Engn Univ, Dept Math, Chongqing, Peoples R China; [Huang, Yongxu] Univ Pittsburgh, Dept Hlth Policy & Management, Pittsburgh, PA USA; [Holme, Petter] Umea Univ, Dept Phys, IceLab, Umea, Sweden; [Holme, Petter] Sungkyunkwan Univ, Dept Energy Sci, Suwon, South Korea; [Holme, Petter] Chinese Acad Sci, Kavli Inst Theoret Phys China, Beijing, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Umea University; Sungkyunkwan University (SKKU); Chinese Academy of Sciences	Zhao, J (corresponding author), Logist Engn Univ, Dept Math, Chongqing, Peoples R China.	zhaojanne@gmail.com; petter.holme@physics.umu.se	Holme, Petter/A-7646-2008; Zhao, Jing/S-3581-2019	Holme, Petter/0000-0003-2156-1096; Zhao, Jing/0000-0002-2439-2876	National Natural Science Foundation of China [10971227]; Swedish Research Council; National Research Foundation of Korea; Ministry of Education, Science and Technology [R31-2008-10029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by National Natural Science Foundation of China (10971227) (ZJ); the Swedish Research Council and the World Class University program through National Research Foundation of Korea funded by Ministry of Education, Science and Technology R31-2008-10029 (PH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Azizi Z, 2010, ALZ DIS ASSOC DIS, V24, P204, DOI 10.1097/WAD.0b013e3181a7c8fd; Barrenas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008090; Chavali S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-78; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011; Dermitzakis ET, 2008, NAT GENET, V40, P492, DOI 10.1038/ng0508-492; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gezen-Ak D, 2007, TOHOKU J EXP MED, V212, P275, DOI 10.1620/tjem.212.275; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Halaschek-Wiener J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006641; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hochstrasser T, 2010, EXP GERONTOL, V45, P70, DOI 10.1016/j.exger.2009.10.005; Janciauskiene SM, 2009, NEUROBIOL AGING, V30, P1504, DOI 10.1016/j.neurobiolaging.2007.08.025; JENSEN LJ, NUCL ACIDS RES, V37, pD412; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karni S, 2009, J COMPUT BIOL, V16, P181, DOI 10.1089/cmb.2008.05TT; Katz L., 1953, PSYCHOMETRIKA, V18, P39, DOI [DOI 10.1007/BF02289026, 10.1007/BF02289026]; Kauwe JSK, 2010, AM J MED GENET B, V153B, P955, DOI 10.1002/ajmg.b.31053; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kong LN, 2005, ACTA PHARMACOL SIN, V26, P666, DOI 10.1111/j.1745-7254.2005.00129.x; Leicht EA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026120; Liu CC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S25; Liu HC, 2008, J BIOMED INFORM, V41, P570, DOI 10.1016/j.jbi.2007.11.005; Lu LY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046122; Meltzer PS, 2001, CURR OPIN GENET DEV, V11, P258, DOI 10.1016/S0959-437X(00)00187-8; Mohammadi A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-12; Nagai Yasuo, 2004, Nihon Yakurigaku Zasshi, V124, P135; Navlakha S, 2010, BIOINFORMATICS, V26, P1057, DOI 10.1093/bioinformatics/btq076; Nitsch D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005526; Noverstern N, 2008, AM J RESP CELL MOL, V38, P324, DOI 10.1165/rcmb.2007-0151OC; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Power JHT, 2008, ACTA NEUROPATHOL, V115, P611, DOI 10.1007/s00401-008-0373-3; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Ruan XG, 2008, J BIOMED INFORM, V41, P530, DOI 10.1016/j.jbi.2007.11.006; Sakamoto KM, 2002, MOL GENET METAB, V77, P44, DOI 10.1016/S1096-7192(02)00146-4; Wharton SB, 2005, NEUROSCI LETT, V383, P33, DOI 10.1016/j.neulet.2005.04.019; Wheeler D.L., 2005, NUCLEIC ACIDS RES, V35, pD5; Zhao J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-311; Zhao J, 2010, BRIEF BIOINFORM, V11, P417, DOI 10.1093/bib/bbp063; Zimmer DB, 2005, CELL MOL BIOL, V51, P201, DOI 10.1170/T620; Zuchner S, 2008, ANN HUM GENET, V72, P725, DOI 10.1111/j.1469-1809.2008.00474.x; KEGG PATHWAY ALZHEIM; KEGG PATHWAY TYPE 2	45	46	48	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24306	10.1371/journal.pone.0024306	http://dx.doi.org/10.1371/journal.pone.0024306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912686	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000294686100033
J	Konow, N; Bellwood, DR				Konow, Nicolai; Bellwood, David R.			Evolution of High Trophic Diversity Based on Limited Functional Disparity in the Feeding Apparatus of Marine Angelfishes (f. Pomacanthidae)	PLOS ONE			English	Article							PREY CAPTURE KINEMATICS; REEF FISHES; HERBIVOROUS FISHES; LARGEMOUTH BASS; TELEOST FISHES; LABRID FISHES; PERCIFORMES; MECHANICS; FAMILY; MORPHOLOGY	The use of biting to obtain food items attached to the substratum is an ecologically widespread and important mode of feeding among aquatic vertebrates, which rarely has been studied. We did the first evolutionary analyses of morphology and motion kinematics of the feeding apparatus in Indo-Pacific members of an iconic family of biters, the marine angelfishes (f. Pomacanthidae). We found clear interspecific differences in gut morphology that clearly reflected a wide range of trophic niches. In contrast, feeding apparatus morphology appeared to be conserved. A few unusual structural innovations enabled angelfishes to protrude their jaws, close them in the protruded state, and tear food items from the substratum at a high velocity. Only one clade, the speciose pygmy angelfishes, showed functional departure from the generalized and clade-defining grab-and-tearing feeding pattern. By comparing the feeding kinematics of angelfishes with wrasses and parrotfishes (f. Labridae) we showed that grab-and-tearing is based on low kinematics disparity. Regardless of its restricted disparity, the grab-and-tearing feeding apparatus has enabled angelfishes to negotiate ecological thresholds: Given their widely different body sizes, angelfishes can access many structurally complex benthic surfaces that other biters likely are unable to exploit. From these surfaces, angelfishes can dislodge sturdy food items from their tough attachments. Angelfishes thus provide an intriguing example of a successful group that appears to have evolved considerable trophic diversity based on an unusual yet conserved feeding apparatus configuration that is characterized by limited functional disparity.	James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia; James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia	James Cook University; James Cook University	Konow, N (corresponding author), Brown Univ, Providence, RI 02912 USA.	nkonow@brown.edu			Danish Research Agency [642-00-0229]; Australian Coral Reef Society; Australian Research Council	Danish Research Agency; Australian Coral Reef Society; Australian Research Council(Australian Research Council)	Danish Research Agency www.fnu.dk, #642-00-0229 to NK. Australian Coral Reef Society www.acrs.com.au, 2001 research fellowship to NK. Australian Research Council, www.arc.gov.au, to DRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affonso PRAD, 2005, GENETICA, V123, P227, DOI 10.1007/s10709-004-3214-x; ALEXANDER RM, 1967, J ZOOL, V151, P43; Alfaro ME, 2005, AM NAT, V165, pE140, DOI 10.1086/429564; ALLEN G, 1981, BUTTERFLY ANGELFISHE; Allen G.R., 1998, GUIDE ANGELFISHES BU; Bellwood David R., 1994, Records of the Australian Museum Supplement, V20, P1; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Bellwood DR, 2004, MOL PHYLOGENET EVOL, V33, P140, DOI 10.1016/j.ympev.2004.04.015; Bellwood DR, 2003, PALEOBIOLOGY, V29, P71, DOI 10.1666/0094-8373(2003)029<0071:OAEOHI>2.0.CO;2; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bowen BW, 2006, J HERED, V97, P1, DOI 10.1093/jhered/esj006; BURGESS WE, 1974, PAC SCI, V28, P57; Choat JH, 2004, MAR BIOL, V145, P445, DOI 10.1007/s00227-004-1341-7; Chung KC, 1998, J ZOOL, V246, P215, DOI 10.1017/S0952836998010103; Clements KD, 2009, FUNCT ECOL, V23, P79, DOI 10.1111/j.1365-2435.2008.01524.x; Collar DC, 2006, EVOLUTION, V60, P2575; Cooper WJ, 2010, PLOS ONE, V5, pA38, DOI 10.1371/journal.pone.0009551; Cooper WJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-24; Cowman PF, 2009, MOL PHYLOGENET EVOL, V52, P621, DOI 10.1016/j.ympev.2009.05.015; Debelius H., 2003, ANGELFISHES COMPREHE; Eagle JV, 2001, MAR ECOL PROG SER, V214, P253, DOI 10.3354/meps214253; Elliott JP, 2003, J FISH BIOL, V63, P1598, DOI 10.1111/j.1095-8649.2003.00272.x; Ferry-Graham LA, 2002, MAR BIOL, V141, P819, DOI 10.1007/s00227-002-0882-x; Ferry-Graham LA, 2001, J EXP ZOOL, V290, P88, DOI 10.1002/jez.1038; Ferry-Graham LA, 2001, J MORPHOL, V248, P120, DOI 10.1002/jmor.1024; Ferry-Graham LA, 2010, J MORPHOL, V271, P271, DOI [10.1002/jmol.10796, 10.1002/jmor.10796]; FERRYGRAHAM LA, 2001, J EXPT MARINE BIOL E, P167; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; Froese R., 2012, FISHBASE; Galis F, 1996, J EVOLUTION BIOL, V9, P641, DOI 10.1046/j.1420-9101.1996.9050641.x; GREGORY WK, 1933, AM PHILOS SOC, V23, P1; Horn M.H., 1989, Oceanography and Marine Biology an Annual Review, V27, P167; HOURIGAN TF, 1989, ENVIRON BIOL FISH, V24, P105, DOI 10.1007/BF00001281; HOWE JC, 1993, J FISH BIOL, V43, P593; Hulsey CD, 2006, EVOLUTION, V60, P2096, DOI 10.1111/j.0014-3820.2006.tb01847.x; HULSEY DC, 2002, P ROY SOC LOND B BIO, V269, P317, DOI DOI 10.1098/RSPB.2001.1874; Konow N, 2005, J EXP BIOL, V208, P1421, DOI 10.1242/jeb.01552; KONOW N, BIOL BUTTER IN PRESS; KONOW N, 2008, INTEGRATIVE COMP BIO; Konow N, 2008, INTEGR COMP BIOL, V48, P246, DOI 10.1093/icb/icn045; Konow N, 2008, BIOL J LINN SOC, V93, P545, DOI 10.1111/j.1095-8312.2007.00893.x; LAUDER GV, 1982, AM ZOOL, V22, P275; LIEM KF, 1980, AM ZOOL, V20, P295; LIEM KF, 1973, SYST ZOOL, V22, P425, DOI 10.2307/2412950; LIEM KF, 1980, ENV PHYSL FISHES, P299; Mantyka CS, 2007, MAR ECOL PROG SER, V352, P177, DOI 10.3354/meps07055; Martinez-Diaz SF, 1999, J FISH BIOL, V55, P692, DOI 10.1006/jfbi.1999.1023; MOTTA PJ, 1984, COPEIA, P1; MOTTA PJ, 1988, ENVIRON BIOL FISH, V22, P39, DOI 10.1007/BF00000543; MOTTA PJ, 1982, J MORPHOL, V174, P283, DOI 10.1002/jmor.1051740305; Nemeth DH, 1997, J EXP BIOL, V200, P2155; NORTON SF, 1993, J EXP BIOL, V176, P11; Parnell NF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-122; PerezEspana H, 1996, J FISH BIOL, V48, P807, DOI 10.1111/j.1095-8649.1996.tb01477.x; Price SA, 2010, EVOLUTION, V64, P3057, DOI 10.1111/j.1558-5646.2010.01036.x; PURCELL SW, 1993, ENVIRON BIOL FISH, V37, P139, DOI 10.1007/BF00000589; Pyle R. L., 2003, SYSTEMATIC TREATMENT; PYLE RL, 1994, ENVIRON BIOL FISH, V41, P127; RANDALL JE, 1965, ECOLOGY, V46, P255, DOI 10.2307/1936328; Rice AN, 2005, J EXP BIOL, V208, P3503, DOI 10.1242/jeb.01779; Sass GG, 2002, ENVIRON BIOL FISH, V65, P441, DOI 10.1023/A:1021108519634; Smol JP, 2007, P NATL ACAD SCI USA, V104, P12395, DOI 10.1073/pnas.0702777104; Streelman JT, 2002, EVOLUTION, V56, P961; VIAL CI, 1990, REV CHIL HIST NAT, V63, P247; Wainwright PC, 2005, INTEGR COMP BIOL, V45, P256, DOI 10.1093/icb/45.2.256; Wainwright PC, 2004, BIOL J LINN SOC, V82, P1, DOI 10.1111/j.1095-8312.2004.00313.x; WAINWRIGHT PC, 1995, J EXP BIOL, V198, P1161; WAINWRIGHT PC, ECOLOGICAL MORPHOLOG; Wainwright PC, 2007, ANNU REV ECOL EVOL S, V38, P381, DOI 10.1146/annurev.ecolsys.38.091206.095706; WESTNEAT MW, 1989, J MORPHOL, V202, P129, DOI 10.1002/jmor.1052020202; Westneat MW, 2005, P ROY SOC B-BIOL SCI, V272, P993, DOI 10.1098/rspb.2004.3013; WESTNEAT MW, 1990, J MORPHOL, V205, P269, DOI 10.1002/jmor.1052050304; WESTNEAT MW, 1994, ZOOMORPHOLOGY, V114, P103, DOI 10.1007/BF00396643; Zar JH, 1999, BIOSTATISTICAL ANAL	74	29	29	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24113	10.1371/journal.pone.0024113	http://dx.doi.org/10.1371/journal.pone.0024113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909414	Green Published, gold, Green Accepted			2022-12-25	WOS:000294683900030
J	Tsai, YS; Aguan, K; Pal, NR; Chung, IF				Tsai, Yu-Shuen; Aguan, Kripamoy; Pal, Nikhil R.; Chung, I-Fang			Identification of Single- and Multiple-Class Specific Signature Genes from Gene Expression Profiles by Group Marker Index	PLOS ONE			English	Article							CELL LUNG-CANCER; TRANSCRIPTION FACTOR; FEATURE-SELECTION; MEMBRANE-PROTEIN; CLASSIFICATION; ACTIN; PREDICTION; LEUKEMIA; METASTASIS; DISCOVERY	Informative genes from microarray data can be used to construct prediction model and investigate biological mechanisms. Differentially expressed genes, the main targets of most gene selection methods, can be classified as single-and multiple-class specific signature genes. Here, we present a novel gene selection algorithm based on a Group Marker Index (GMI), which is intuitive, of low-computational complexity, and efficient in identification of both types of genes. Most gene selection methods identify only single-class specific signature genes and cannot identify multiple-class specific signature genes easily. Our algorithm can detect de novo certain conditions of multiple-class specificity of a gene and makes use of a novel non-parametric indicator to assess the discrimination ability between classes. Our method is effective even when the sample size is small as well as when the class sizes are significantly different. To compare the effectiveness and robustness we formulate an intuitive template-based method and use four well-known datasets. We demonstrate that our algorithm outperforms the template-based method in difficult cases with unbalanced distribution. Moreover, the multiple-class specific genes are good biomarkers and play important roles in biological pathways. Our literature survey supports that the proposed method identifies unique multiple-class specific marker genes (not reported earlier to be related to cancer) in the Central Nervous System data. It also discovers unique biomarkers indicating the intrinsic difference between subtypes of lung cancer. We also associate the pathway information with the multiple-class specific signature genes and cross-reference to published studies. We find that the identified genes participate in the pathways directly involved in cancer development in leukemia data. Our method gives a promising way to find genes that can involve in pathways of multiple diseases and hence opens up the possibility of using an existing drug on other diseases as well as designing a single drug for multiple diseases.	[Tsai, Yu-Shuen; Chung, I-Fang] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Aguan, Kripamoy] NE Hill Univ, Dept Biotechnol & Bioinformat, Shillong, Meghalaya, India; [Pal, Nikhil R.] Indian Stat Inst, Elect & Commun Sci Unit, Kolkata 700035, W Bengal, India; [Chung, I-Fang] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; North Eastern Hill University; Indian Statistical Institute; Indian Statistical Institute Kolkata; National Yang Ming Chiao Tung University	Tsai, YS (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan.	nikhil@isical.ac.in; ifchung@ym.edu.tw			National Science Council (NSC) [NSC100-2221-E-010-011, NSC99-2627-B-010-009]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	This work is supported by National Science Council (NSC) (NSC100-2221-E-010-011 and NSC99-2627-B-010-009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatha G, 2001, CANCER LETT, V173, P139, DOI 10.1016/S0304-3835(01)00674-7; Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; [Anonymous], 2010, R LANG ENV STAT COMP; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Atz ME, 2007, PSYCHIAT GENET, V17, P55, DOI 10.1097/YPG.0b013e328012d850; Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; BISHOPRIC NH, 1992, J BIOL CHEM, V267, P25535; Bruserud O, 2002, LEUKEMIA RES, V26, P515, DOI 10.1016/S0145-2126(01)00165-5; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Campbell DH, 1996, INT J CANCER, V68, P485, DOI 10.1002/(SICI)1097-0215(19961115)68:4<485::AID-IJC14>3.0.CO;2-4; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Cerisano V, 2004, ONCOGENE, V23, P5664, DOI 10.1038/sj.onc.1207741; Chiarini F, 2009, CANCER RES, V69, P3520, DOI 10.1158/0008-5472.CAN-08-4884; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; Depaz IM, 2005, J NEUROSCI RES, V81, P253, DOI 10.1002/jnr.20563; Dilley WG, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-9; Downing JR, 1999, BRIT J HAEMATOL, V106, P296, DOI 10.1046/j.1365-2141.1999.01377.x; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Fernandez-Chacon R, 2000, J NEUROSCI, V20, P7941; Fiancette R, 2009, LEUKEMIA, V23, P1196, DOI 10.1038/leu.2009.36; Gerlitz G, 2010, J CELL SCI, V123, P2207, DOI 10.1242/jcs.058271; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Han CF, 2009, J IMMUNOL, V182, P2986, DOI 10.4049/jimmunol.0802002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huerta Edmundo Bonilla, 2008, Genomics Proteomics & Bioinformatics, V6, P61, DOI 10.1016/S1672-0229(08)60021-2; Hulshizer R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-240; Ishii H, 1999, P NATL ACAD SCI USA, V96, P3928, DOI 10.1073/pnas.96.7.3928; Jirapech-Umpai T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-148; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kostyukova AS, 2005, BIOCHEMISTRY-US, V44, P4905, DOI 10.1021/bi047468p; Kuroda K, 2010, CANCER SCI, V101, P46, DOI 10.1111/j.1349-7006.2009.01351.x; Lan MS, 2009, FASEB J, V23, P2024, DOI 10.1096/fj.08-125971; Li LP, 2001, BIOINFORMATICS, V17, P1131, DOI 10.1093/bioinformatics/17.12.1131; LINIAL M, 1989, NEURON, V2, P1265, DOI 10.1016/0896-6273(89)90311-5; Liu Q, 2010, J CELL SCI, V123, P1116, DOI 10.1242/jcs.058958; Liu WD, 2006, BIOCHEM J, V397, P169, DOI 10.1042/BJ20051669; Liu XX, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-76; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Martins L, 2002, J CLIN ENDOCR METAB, V87, P4806, DOI 10.1210/jc.2002-020094; Martoglio AM, 2000, MOL MED, V6, P750, DOI 10.1007/BF03402191; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; MENGUBAS K, 1994, LEUKEMIA, V8, P1718; Mukhopadhyay NK, 2005, J CELL MOL MED, V9, P387, DOI 10.1111/j.1582-4934.2005.tb00364.x; Nadano D, 2002, BBA-GENE STRUCT EXPR, V1577, P430, DOI 10.1016/S0167-4781(02)00445-1; Nahar R, 2009, CELL CYCLE, V8, P3874, DOI 10.4161/cc.8.23.10035; Niijima S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-543; Ocak S, 2010, ONCOGENE, V29, P6331, DOI 10.1038/onc.2010.362; Ooi CH, 2003, BIOINFORMATICS, V19, P37, DOI 10.1093/bioinformatics/19.1.37; Opgen-Rhein R, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1252; Pal NR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-5; Patel AM, 1996, ONCOGENE, V12, P31; PAVLIDIS P, 2001, GENOME BIOL, V0002; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; REN WZ, 1994, MOL BRAIN RES, V22, P173, DOI 10.1016/0169-328X(94)90045-0; Rocchi A, 2010, J CLIN INVEST, V120, P668, DOI 10.1172/JCI36667; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Salagierski M, 2010, PROSTATE, V70, P70, DOI 10.1002/pros.21040; Scotlandi K, 2000, CANCER RES, V60, P5134; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Sun L, 1999, P NATL ACAD SCI USA, V96, P680, DOI 10.1073/pnas.96.2.680; Tavor S, 2008, LEUKEMIA, V22, P2151, DOI 10.1038/leu.2008.238; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; Tian T, 2007, CANCER SCI, V98, P1265, DOI 10.1111/j.1349-7006.2007.00514.x; Tsai YS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-425; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Alphen RJ, 2009, BRIT J CANCER, V100, P228, DOI 10.1038/sj.bjc.6604801; Wang MS, 1997, ONCOGENE, V14, P2767, DOI 10.1038/sj.onc.1201245; Watanabe H, 2006, ONCOGENE, V25, P470, DOI 10.1038/sj.onc.1209068; Yamashita N, 2006, J NEUROSCI, V26, P13357, DOI 10.1523/JNEUROSCI.4276-06.2006; Yap CT, 2005, CELL MOTIL CYTOSKEL, V60, P153, DOI 10.1002/cm.20053; Yoshimura A, 2003, GENE CHROMOSOME CANC, V37, P159, DOI 10.1002/gcc.10205; Yousef M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-144; Yousef M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-337; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zhang LB, 2004, J BIOL CHEM, V279, P2053, DOI 10.1074/jbc.M310357200; Zhou X, 2007, BIOINFORMATICS, V23, P1106, DOI 10.1093/bioinformatics/btm036; Zuber V, 2009, BIOINFORMATICS, V25, P2700, DOI 10.1093/bioinformatics/btp460; Zweidler-McKay PA, 2005, BLOOD, V106, P3898, DOI 10.1182/blood-2005-01-0355	86	26	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24259	10.1371/journal.pone.0024259	http://dx.doi.org/10.1371/journal.pone.0024259			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909426	Green Published, gold, Green Submitted			2022-12-25	WOS:000294683900042
J	Ahmed, S; Komori, M; Tsuji-Ueno, S; Suzuki, M; Kosaku, A; Miyamoto, K; Nishigaki, K				Ahmed, Shamim; Komori, Manabu; Tsuji-Ueno, Sachika; Suzuki, Miho; Kosaku, Akinori; Miyamoto, Kiyoshi; Nishigaki, Koichi			Genome Profiling (GP) Method Based Classification of Insects: Congruence with That of Classical Phenotype-Based One	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; DNA; IDENTIFICATION; TAXONOMY; PHYLOGENY; TOOL	Background: Ribosomal RNAs have been widely used for identification and classification of species, and have produced data giving new insights into phylogenetic relationships. Recently, multilocus genotyping and even whole genome sequencing-based technologies have been adopted in ambitious comparative biology studies. However, such technologies are still far from routine-use in species classification studies due to their high costs in terms of labor, equipment and consumables. Methodology/Principal Findings: Here, we describe a simple and powerful approach for species classification called genome profiling (GP). The GP method composed of random PCR, temperature gradient gel electrophoresis (TGGE) and computer-aided gel image processing is highly informative and less laborious. For demonstration, we classified 26 species of insects using GP and 18S rDNA-sequencing approaches. The GP method was found to give a better correspondence to the classical phenotype-based approach than did 18S rDNA sequencing employing a congruence value. To our surprise, use of a single probe in GP was sufficient to identify the relationships between the insect species, making this approach more straightforward. Conclusion/Significance: The data gathered here, together with those of previous studies show that GP is a simple and powerful method that can be applied for actually universally identifying and classifying species. The current success supported our previous proposal that GP-based web database can be constructible and effective for the global identification/classification of species.	[Ahmed, Shamim; Komori, Manabu; Tsuji-Ueno, Sachika; Suzuki, Miho; Nishigaki, Koichi] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan; [Kosaku, Akinori] Dokkyo Med Univ, Clin Sci Lab, Mibu, Tochigi, Japan; [Miyamoto, Kiyoshi] Dokkyo Med Univ, Lab Med Sci, Mibu, Tochigi, Japan	Saitama University; Dokkyo Medical University; Dokkyo Medical University	Ahmed, S (corresponding author), Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan.	koichi@fms.saitama-u.ac.jp						Ahmed S, 2007, INT J BIOL LIFE SCI, V3, P82; [Anonymous], ON WEB GP; Bard JBL, 2005, J ANAT, V206, P1, DOI 10.1111/j.0021-8782.2005.00376.x; Biyani M, 2001, ELECTROPHORESIS, V22, P23; Clark BR, 2009, PHILOS T R SOC A, V367, P953, DOI 10.1098/rsta.2008.0190; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Futakami M, 2007, J BIOCHEM, V141, P675, DOI 10.1093/jb/mvm074; Futakami M, 2007, CHEM LETT, V36, P358, DOI 10.1246/cl.2007.358; Godfray HCJ, 2004, PHILOS T R SOC B, V359, P559, DOI 10.1098/rstb.2003.1457; Hamano K, 1996, NIPPON KAGAKU KAISHI, P54, DOI 10.1246/nikkashi.1996.54; Hatakeyama Yoshinori, 2008, Journal of Insect Biotechnology and Sericology, V77, P1; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; Hutchison CA, 2007, NUCLEIC ACIDS RES, V35, P6227, DOI 10.1093/nar/gkm688; Jobson JD, APPL MULTIVARIATE DA, V2; Kjer KM, 2004, SYST BIOL, V53, P506, DOI 10.1080/10635150490445922; Kouduka M, 2007, INT J PLANT GENOMICS, V2007, P1; Kouduka M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-135; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Maidak BL, 1996, NUCLEIC ACIDS RES, V24, P82, DOI 10.1093/nar/24.1.82; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Naimuddin M, 2000, GENE, V261, P243, DOI 10.1016/S0378-1119(00)00502-3; Nishigaki K, 2000, J BIOCHEM, V128, P107, DOI 10.1093/oxfordjournals.jbchem.a022719; NISHIGAKI K, 1984, J BIOCHEM-TOKYO, V95, P627, DOI 10.1093/oxfordjournals.jbchem.a134651; NISHIGAKI K, 1991, CHEM LETT, P1097, DOI 10.1246/cl.1991.1097; SAKUMA Y, 1994, J BIOCHEM-TOKYO, V116, P736, DOI 10.1093/oxfordjournals.jbchem.a124589; WANG H, 1993, NUCLEIC ACIDS RES, V21, P4153, DOI 10.1093/nar/21.17.4153; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wartell RM, 1998, J CHROMATOGR A, V806, P169, DOI 10.1016/S0021-9673(98)00149-6; Watanabe T, 2002, GENOME BIOL, V3; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1006/clad.2000.0147, 10.1111/j.1096-0031.2001.tb00115.x]; Yamamoto M, 2006, EXTREMOPHILES, V10, P421, DOI 10.1007/s00792-006-0516-1	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23963	10.1371/journal.pone.0023963	http://dx.doi.org/10.1371/journal.pone.0023963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21912611	Green Submitted, Green Published, gold			2022-12-25	WOS:000294680800044
J	Babona-Pilipos, R; Droujinine, IA; Popovic, MR; Morshead, CM				Babona-Pilipos, Robart; Droujinine, Ilia A.; Popovic, Milos R.; Morshead, Cindi M.			Adult Subependymal Neural Precursors, but Not Differentiated Cells, Undergo Rapid Cathodal Migration in the Presence of Direct Current Electric Fields	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; PROGENITOR CELLS; STEM-CELLS; IN-VIVO; HIPPOCAMPAL-NEURONS; SUBVENTRICULAR ZONE; EPITHELIAL-CELLS; NERVOUS-SYSTEM; NEURITE GROWTH; MOUSE BRAIN	Background: The existence of neural stem and progenitor cells (together termed neural precursor cells) in the adult mammalian brain has sparked great interest in utilizing these cells for regenerative medicine strategies. Endogenous neural precursors within the adult forebrain subependyma can be activated following injury, resulting in their proliferation and migration toward lesion sites where they differentiate into neural cells. The administration of growth factors and immunomodulatory agents following injury augments this activation and has been shown to result in behavioural functional recovery following stroke. Methods and Findings: With the goal of enhancing neural precursor migration to facilitate the repair process we report that externally applied direct current electric fields induce rapid and directed cathodal migration of pure populations of undifferentiated adult subependyma-derived neural precursors. Using time-lapse imaging microscopy in vitro we performed an extensive single-cell kinematic analysis demonstrating that this galvanotactic phenomenon is a feature of undifferentiated precursors, and not differentiated phenotypes. Moreover, we have shown that the migratory response of the neural precursors is a direct effect of the electric field and not due to chemotactic gradients. We also identified that epidermal growth factor receptor (EGFR) signaling plays a role in the galvanotactic response as blocking EGFR significantly attenuates the migratory behaviour. Conclusions: These findings suggest direct current electric fields may be implemented in endogenous repair paradigms to promote migration and tissue repair following neurotrauma.	[Babona-Pilipos, Robart; Popovic, Milos R.; Morshead, Cindi M.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Droujinine, Ilia A.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Popovic, Milos R.] Toronto Rehabil Inst, Lyndhurst Ctr, Toronto, ON, Canada; [Morshead, Cindi M.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Morshead, Cindi M.] Univ Toronto, Dept Rehabil Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University of Toronto	Babona-Pilipos, R (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	cindi.morshead@utoronto.ca		Popovic, Milos R/0000-0002-2837-2346	Natural Sciences and Engineering Research Council of Canada [249669, 482986]; Heart and Stroke Foundation of Canada [485508]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	The authors thank the following sources of funding: Natural Sciences and Engineering Research Council of Canada (grant #249669, http://www.nserc-crsng.gc.ca/), Natural Sciences and Engineering Research Council of Canada (grant #482986, http://www.nserc-crsng.gc.ca/), Heart and Stroke Foundation of Canada (grant #485508, http://www.heartandstroke.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Ariza CA, 2010, STEM CELL REV REP, V6, P585, DOI 10.1007/s12015-010-9171-0; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; BORGENS RB, 1995, DEV DYNAM, V203, P456, DOI 10.1002/aja.1002030408; Cantrell DA, 2001, J CELL SCI, V114, P1439; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Craig CG, 1996, J NEUROSCI, V16, P2649; DAVENPORT RW, 1993, J NEUROBIOL, V24, P89, DOI 10.1002/neu.480240108; Erlandsson A, 2006, CURR OPIN MOL THER, V8, P331; Erlandsson A, 2011, EXP NEUROL, V230, P48, DOI 10.1016/j.expneurol.2010.05.018; Fang KS, 1999, J CELL SCI, V112, P1967; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; HINKLE L, 1981, J PHYSIOL-LONDON, V314, P121, DOI 10.1113/jphysiol.1981.sp013695; HOTARY KB, 1992, DEVELOPMENT, V114, P985; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402; Komitova M, 2005, STROKE, V36, P1278, DOI 10.1161/01.STR.0000166197.94147.59; Li L, 2008, STEM CELLS, V26, P2193, DOI 10.1634/stemcells.2007-1022; Matos MA, 2010, BIOTECHNOL PROGR, V26, P664, DOI 10.1002/btpr.389; MCCAIG CD, 1990, J CELL SCI, V95, P605; MCCAIG CD, 1986, J PHYSIOL-LONDON, V375, P55, DOI 10.1113/jphysiol.1986.sp016105; Meng XT, 2011, EXP NEUROL, V227, P210, DOI 10.1016/j.expneurol.2010.11.002; Moyer JD, 1997, CANCER RES, V57, P4838; Nishimura KY, 1996, J CELL SCI, V109, P199; Okano J, 2000, J BIOL CHEM, V275, P30934, DOI 10.1074/jbc.M004112200; Pu J, 2007, J CELL SCI, V120, P3395, DOI 10.1242/jcs.002774; Rajnicek AM, 1998, DEV BIOL, V203, P412, DOI 10.1006/dbio.1998.9039; RAJNICEK AM, 1992, EXP PHYSIOL, V77, P229, DOI 10.1113/expphysiol.1992.sp003580; Rajnicek AM, 2006, J CELL SCI, V119, P1736, DOI 10.1242/jcs.02897; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Rodgers EE, 2002, INT J DEV NEUROSCI, V20, P187, DOI 10.1016/S0736-5748(02)00047-3; Sato MJ, 2007, BIOSYSTEMS, V88, P261, DOI 10.1016/j.biosystems.2006.06.008; Sato MJ, 2009, P NATL ACAD SCI USA, V106, P6667, DOI 10.1073/pnas.0809974106; Song B, 2004, J CELL SCI, V117, P4681, DOI 10.1242/jcs.01341; Song B, 2002, P NATL ACAD SCI USA, V99, P13577, DOI 10.1073/pnas.202235299; SORENSEN E, 1978, SCAND J CLIN LAB INV, V38, P203, DOI 10.3109/00365517809108412; Yao L, 2008, J CELL PHYSIOL, V216, P527, DOI 10.1002/jcp.21431; Yao L, 2011, TISSUE ENG PART B-RE, V17, P143, DOI [10.1089/ten.teb.2010.0561, 10.1089/ten.TEB.2010.0561]; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhao M, 1999, MOL BIOL CELL, V10, P1259, DOI 10.1091/mbc.10.4.1259; Zhao M, 1996, J CELL SCI, V109, P1405; Zhao M, 2002, FASEB J, V16, P857, DOI 10.1096/fj.01-0811fje; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009	46	53	55	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23808	10.1371/journal.pone.0023808	http://dx.doi.org/10.1371/journal.pone.0023808			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909360	Green Published, Green Submitted, gold			2022-12-25	WOS:000294680800023
J	Cai, XY; Qin, ZD; Wen, B; Xu, SH; Wang, Y; Lu, Y; Wei, LH; Wang, CC; Li, SL; Huang, XQ; Jin, L; Li, H; Consortium, G				Cai, Xiaoyun; Qin, Zhendong; Wen, Bo; Xu, Shuhua; Wang, Yi; Lu, Yan; Wei, Lanhai; Wang, Chuanchao; Li, Shilin; Huang, Xingqiu; Jin, Li; Li, Hui; Consortium, Genographic			Human Migration through Bottlenecks from Southeast Asia into East Asia during Last Glacial Maximum Revealed by Y Chromosomes	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; GENETIC-STRUCTURE; DEMIC DIFFUSION; POPULATIONS; ORIGIN; DIVERSITY; HIMALAYAS; INFERENCE; NETWORKS; INDIA	Molecular anthropological studies of the populations in and around East Asia have resulted in the discovery that most of the Y-chromosome lineages of East Asians came from Southeast Asia. However, very few Southeast Asian populations had been investigated, and therefore, little was known about the purported migrations from Southeast Asia into East Asia and their roles in shaping the genetic structure of East Asian populations. Here, we present the Y-chromosome data from 1,652 individuals belonging to 47 Mon-Khmer (MK) and Hmong-Mien (HM) speaking populations that are distributed primarily across Southeast Asia and extend into East Asia. Haplogroup O3a3b-M7, which appears mainly in MK and HM, indicates a strong tie between the two groups. The short tandem repeat network of O3a3b-M7 displayed a hierarchical expansion structure (annual ring shape), with MK haplotypes being located at the original point, and the HM and the Tibeto-Burman haplotypes distributed further away from core of the network. Moreover, the East Asian dominant haplogroup O3a3c1-M117 shows a network structure similar to that of O3a3b-M7. These patterns indicate an early unidirectional diffusion from Southeast Asia into East Asia, which might have resulted from the genetic drift of East Asian ancestors carrying these two haplogroups through many small bottle-necks formed by the complicated landscape between Southeast Asia and East Asia. The ages of O3a3b-M7 and O3a3c1-M117 were estimated to be approximately 19 thousand years, followed by the emergence of the ancestors of HM lineages out of MK and the unidirectional northward migrations into East Asia.	[Cai, Xiaoyun; Qin, Zhendong; Wen, Bo; Wang, Yi; Lu, Yan; Wei, Lanhai; Wang, Chuanchao; Li, Shilin; Jin, Li; Li, Hui] Fudan Univ, Sch Life Sci, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Cai, Xiaoyun; Qin, Zhendong; Wen, Bo; Wang, Yi; Lu, Yan; Wei, Lanhai; Wang, Chuanchao; Li, Shilin; Jin, Li; Li, Hui] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Xu, Shuhua; Jin, Li] Chinese Acad Sci, Shanghai Inst Biol Sci, Max Planck Soc Partner Inst Comp Biol, Shanghai, Peoples R China; [Huang, Xingqiu] Guangxi Univ Nationalities, Inst Ethnol & Anthropol, Nanning, Guangxi, Peoples R China; [Jin, Li] China Med City, Inst Hlth Sci, Taizhou, Jiangsu, Peoples R China	Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Guangxi Minzu University	Cai, XY (corresponding author), Fudan Univ, Sch Life Sci, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China.	lihui.fudan@gmail.com	Balanovsky, Oleg/G-1549-2014; Xu, Shuhua/AAH-7620-2020; Cooper, Alan/E-8171-2012; Li, Hui/A-2014-2010; Wang, Chuan-Chao/B-2975-2011; Wen, Bo/P-5332-2019; Wei, Lan-Hai/R-6876-2018; Jin, Li/C-1468-2009; Santos, Fabrício Rodrigues/H-2370-2011; XU, SHUHUA/D-5345-2009; Wang, Chuan-Chao/AGY-2940-2022; Jin, Li/M-5063-2019; Haak, Wolfgang/C-2362-2014; Comas, David/D-5382-2014	Xu, Shuhua/0000-0002-1975-1002; Cooper, Alan/0000-0002-7738-7851; Wang, Chuan-Chao/0000-0001-9628-0307; Wen, Bo/0000-0003-0394-7366; Wei, Lan-Hai/0000-0003-3119-7400; Jin, Li/0000-0002-4546-2415; Santos, Fabrício Rodrigues/0000-0001-9088-1750; XU, SHUHUA/0000-0002-1975-1002; Wang, Chuan-Chao/0000-0003-4630-5232; Haak, Wolfgang/0000-0003-2475-2007; Comas, David/0000-0002-5075-0956; Quintana-Murci, Lluis/0000-0003-2429-6320; mele, marta/0000-0001-8874-6453; Matisoo-Smith, Elizabeth/0000-0002-3500-8307; Royyuru, Ajay/0000-0003-4440-4755	Genographic Project to Fudan University; National Geographic Society, International Business Machines; Waitt Family Foundation; National Natural Science Foundation of China [39993420, 30890034]; 863 Program [2007AA02Z312]; Shanghai Leading Academic Discipline Project (B111); Science and Technology Commission of Shanghai Municipality; Center for Evolutionary Biology; Natural Science Foundation of Shanghai [10ZR1402200]; Shanghai Commission of Education Research Innovation [11zz04]; Shanghai professional development funding [2010001]	Genographic Project to Fudan University; National Geographic Society, International Business Machines(National Geographic Society); Waitt Family Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Program(National High Technology Research and Development Program of China); Shanghai Leading Academic Discipline Project (B111)(Shanghai Leading Academic Discipline Project); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Center for Evolutionary Biology; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Commission of Education Research Innovation; Shanghai professional development funding	This study was supported by the Genographic Project to Fudan University funded by the National Geographic Society, International Business Machines, and the Waitt Family Foundation. LJ was also supported by the National Natural Science Foundation of China (39993420, 30890034), 863 Program (2007AA02Z312), Shanghai Leading Academic Discipline Project (B111), the Science and Technology Commission of Shanghai Municipality, and the Center for Evolutionary Biology. HL was supported by the Natural Science Foundation of Shanghai (10ZR1402200), Shanghai Commission of Education Research Innovation Key Project (11zz04), and Shanghai professional development funding (2010001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Feng H, 2007, GEN HIST YAO NATL; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Forster P, 1996, AM J HUM GENET, V59, P935; Gayden T, 2007, AM J HUM GENET, V80, P884, DOI 10.1086/516757; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kumar V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-47; Lewis M. P., ETHNOLOGUE LANGUAGES; Li DN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002168; Li H, 2005, GENETICS STRUCTURE A; Li H, 2007, AM J PHYS ANTHROPOL, V134, P481, DOI 10.1002/ajpa.20690; Li H, 2007, HUM GENET, V122, P383, DOI 10.1007/s00439-007-0407-2; Li H, 2007, AM J HUM GENET, V81, P842, DOI 10.1086/521201; Li H, 2009, ANN HUM GENET, V73, P335, DOI 10.1111/j.1469-1809.2009.00517.x; Li H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-146; Liang M, 2006, STUDIES LANGUAGES LI, V26, P8; Reddy BM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001141; Sagart L., 2005, PEOPLING E ASIA PUTT, P1; Sahoo S, 2006, P NATL ACAD SCI USA, V103, P843, DOI 10.1073/pnas.0507714103; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Shi H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-45; Stumpf MPH, 2001, SCIENCE, V291, P1738, DOI 10.1126/science.291.5509.1738; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Thanseem I, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-42; van Driem G, 2008, ROUTLEDGE STUD EARLY, V5, P219; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Wen B, 2004, AM J HUM GENET, V74, P856, DOI 10.1086/386292; Wen B, 2004, Y CHROMOSOME MTDNA V; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Yu G, 2001, CHINESE SCI BULL, V46, P364, DOI 10.1007/BF03183264; Zhang F, 2007, PHILOS T R SOC B, V362, P987, DOI 10.1098/rstb.2007.2028; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	40	55	62	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24282	10.1371/journal.pone.0024282	http://dx.doi.org/10.1371/journal.pone.0024282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904623	Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800077
J	Avey, MT; Hoeschele, M; Moscicki, MK; Bloomfield, LL; Sturdy, CB				Avey, Marc T.; Hoeschele, Marisa; Moscicki, Michele K.; Bloomfield, Laurie L.; Sturdy, Christopher B.			Neural Correlates of Threat Perception: Neural Equivalence of Conspecific and Heterospecific Mobbing Calls Is Learned	PLOS ONE			English	Article							BLACK-CAPPED CHICKADEES; ALARM CALLS; POECILE-ATRICAPILLUS; GENE-EXPRESSION; SONGBIRD FOREBRAIN; ZENK EXPRESSION; ZEBRA FINCHES; DISCRIMINATION; PREDATORS; EXPOSURE	Songbird auditory areas (i.e., CMM and NCM) are preferentially activated to playback of conspecific vocalizations relative to heterospecific and arbitrary noise [1-2]. Here, we asked if the neural response to auditory stimulation is not simply preferential for conspecific vocalizations but also for the information conveyed by the vocalization. Black-capped chickadees use their chick-a-dee mobbing call to recruit conspecifics and other avian species to mob perched predators [3]. Mobbing calls produced in response to smaller, higher-threat predators contain more "D" notes compared to those produced in response to larger, lower-threat predators and thus convey the degree of threat of predators [4]. We specifically asked whether the neural response varies with the degree of threat conveyed by the mobbing calls of chickadees and whether the neural response is the same for actual predator calls that correspond to the degree of threat of the chickadee mobbing calls. Our results demonstrate that, as degree of threat increases in conspecific chickadee mobbing calls, there is a corresponding increase in immediate early gene (IEG) expression in telencephalic auditory areas. We also demonstrate that as the degree of threat increases for the heterospecific predator, there is a corresponding increase in IEG expression in the auditory areas. Furthermore, there was no significant difference in the amount IEG expression between conspecific mobbing calls or heterospecific predator calls that were the same degree of threat. In a second experiment, using hand-reared chickadees without predator experience, we found more IEG expression in response to mobbing calls than corresponding predator calls, indicating that degree of threat is learned. Our results demonstrate that degree of threat corresponds to neural activity in the auditory areas and that threat can be conveyed by different species signals and that these signals must be learned.	[Avey, Marc T.; Sturdy, Christopher B.] Univ Alberta, Dept Psychol, Ctr Neurosci, Edmonton, AB, Canada; [Bloomfield, Laurie L.] Algoma Univ, Dept Psychol, Sault Ste Marie, ON, Canada	University of Alberta; Algoma University	Avey, MT (corresponding author), Univ Alberta, Dept Psychol, Ctr Neurosci, Edmonton, AB, Canada.	csturdy@ualberta.ca	Sturdy, Christopher B/A-4407-2009; Hoeschele, Marisa/R-6198-2018; Hoeschele, Marisa/R-2176-2019	Hoeschele, Marisa/0000-0002-2102-0882; Hoeschele, Marisa/0000-0002-2102-0882; Avey, Marc/0000-0002-8696-3232; Sturdy, Christopher/0000-0003-2721-3770	Natural Sciences and Engineering Research Council of Canada; Alberta Ingenuity Fund New Faculty Grant; Canada Foundation; University of Alberta; Alberta Ingenuity Fund	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Ingenuity Fund New Faculty Grant; Canada Foundation; University of Alberta(University of Alberta); Alberta Ingenuity Fund	C.B.S. was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant and a Discovery Accelerator Supplement, an Alberta Ingenuity Fund New Faculty Grant, Canada Foundation for Innovation New Opportunities Fund Award and Infrastructure Operating Grants (IOF), as well as start-up and partner funding from the University of Alberta. M.T.A, M.H., M.K.M., and L.L.B. were supported by the Natural Sciences and Engineering Research Council of Canada and Alberta Ingenuity Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avey MT, 2008, BEHAV BRAIN RES, V188, P201, DOI 10.1016/j.bbr.2007.10.034; Avey MT, 2008, BEHAV PROCESS, V77, P149, DOI 10.1016/j.beproc.2007.12.004; Avey MT, 2005, BEHAV BRAIN RES, V165, P247, DOI 10.1016/j.bbr.2005.07.002; Bailey DJ, 2006, NEUROSCI LETT, V401, P86, DOI 10.1016/j.neulet.2006.02.076; Baker MC, 2002, WILSON BULL, V114, P510, DOI 10.1676/0043-5643(2002)114[0510:MCOBCC]2.0.CO;2; Bloomfield LL, 2008, BEHAV PROCESS, V77, P166, DOI 10.1016/j.beproc.2007.08.003; Charrier I, 2004, CAN J ZOOL, V82, P769, DOI 10.1139/Z04-045; EVANS CS, 1993, ANIM BEHAV, V46, P23, DOI 10.1006/anbe.1993.1158; FICKEN MS, 1977, AUK, V94, P156; Gentner TQ, 2001, J NEUROBIOL, V46, P48, DOI 10.1002/1097-4695(200101)46:1<48::AID-NEU5>3.0.CO;2-3; Good P.I., 2001, RESAMPLING METHODS P; Griffin AS, 2004, LEARN BEHAV, V32, P131; Holschuh CI, 2005, J RAPTOR RES, V39, P134; Hurd CR, 1996, BEHAV ECOL SOCIOBIOL, V38, P287, DOI 10.1007/s002650050244; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Marler P, 2004, ANN NY ACAD SCI, V1016, P31, DOI 10.1196/annals.1298.034; Mello CV, 2004, ANN NY ACAD SCI, V1016, P263, DOI 10.1196/annals.1298.021; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Phillmore LS, 2003, BEHAV BRAIN RES, V147, P125, DOI 10.1016/S0166-4328(03)00155-4; Pinaud R, 2008, J BIOSCIENCES, V33, P145, DOI 10.1007/s12038-008-0030-y; Templeton CN, 2007, P NATL ACAD SCI USA, V104, P5479, DOI 10.1073/pnas.0605183104; Templeton CN, 2005, SCIENCE, V308, P1934, DOI 10.1126/science.1108841; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062; Zuberbuhler K, 1999, ETHOLOGY, V105, P477, DOI 10.1046/j.1439-0310.1999.00396.x	24	31	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23844	10.1371/journal.pone.0023844	http://dx.doi.org/10.1371/journal.pone.0023844			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21909363	Green Published, gold			2022-12-25	WOS:000294676900022
J	Adam, TC; Schmitt, RJ; Holbrook, SJ; Brooks, AJ; Edmunds, PJ; Carpenter, RC; Bernardi, G				Adam, Thomas C.; Schmitt, Russell J.; Holbrook, Sally J.; Brooks, Andrew J.; Edmunds, Peter J.; Carpenter, Robert C.; Bernardi, Giacomo			Herbivory, Connectivity, and Ecosystem Resilience: Response of a Coral Reef to a Large-Scale Perturbation	PLOS ONE			English	Article							PHASE-SHIFTS; CLIMATE-CHANGE; SEAGRASS BEDS; FISH; RECOVERY; COMMUNITIES; MANGROVES; IMPACTS; MOOREA; DISTURBANCES	Coral reefs world-wide are threatened by escalating local and global impacts, and some impacted reefs have shifted from coral dominance to a state dominated by macroalgae. Therefore, there is a growing need to understand the processes that affect the capacity of these ecosystems to return to coral dominance following disturbances, including those that prevent the establishment of persistent stands of macroalgae. Unlike many reefs in the Caribbean, over the last several decades, reefs around the Indo-Pacific island of Moorea, French Polynesia have consistently returned to coral dominance following major perturbations without shifting to a macroalgae-dominated state. Here, we present evidence of a rapid increase in populations of herbivorous fishes following the most recent perturbation, and show that grazing by these herbivores has prevented the establishment of macroalgae following near complete loss of coral on offshore reefs. Importantly, we found the positive response of herbivorous fishes to increased benthic primary productivity associated with coral loss was driven largely by parrotfishes that initially recruit to stable nursery habitat within the lagoons before moving to offshore reefs later in life. These results underscore the importance of connectivity between the lagoon and offshore reefs for preventing the establishment of macroalgae following disturbances, and indicate that protecting nearshore nursery habitat of herbivorous fishes is critical for maintaining reef resilience.	[Adam, Thomas C.; Schmitt, Russell J.; Holbrook, Sally J.; Brooks, Andrew J.] Univ Calif Santa Barbara, Inst Marine Sci, Coastal Res Ctr, Santa Barbara, CA 93106 USA; [Schmitt, Russell J.; Holbrook, Sally J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Edmunds, Peter J.; Carpenter, Robert C.] Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA; [Bernardi, Giacomo] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; California State University System; California State University Northridge; University of California System; University of California Santa Cruz	Adam, TC (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Coastal Res Ctr, Santa Barbara, CA 93106 USA.	adam@lifesci.ucsb.edu	Bernardi, Giacomo/F-6346-2011	Bernardi, Giacomo/0000-0002-8249-4678; Edmunds, Peter/0000-0002-9039-9347	National Science Foundation [OCE 10-26851]; Gordon and Betty Moore Foundation	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	Funding for this work was provided by the National Science Foundation (OCE 10-26851 and earlier awards) and the Gordon and Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Alongi DM, 2008, ESTUAR COAST SHELF S, V76, P1, DOI 10.1016/j.ecss.2007.08.024; Aronson RB, 1997, PALEOBIOLOGY, V23, P326, DOI 10.1017/S0094837300019710; Aubanel A, 1999, OCEAN COAST MANAGE, V42, P419, DOI 10.1016/S0964-5691(99)00023-X; Bellwood DR, 2011, CORAL REEFS, V30, P549, DOI 10.1007/s00338-011-0738-2; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; CARPENTER RC, 1990, MAR BIOL, V104, P79, DOI 10.1007/BF01313160; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; de Loma TL, 2008, PAC SCI, V62, P431, DOI 10.2984/1534-6188(2008)62[431:AFFAIO]2.0.CO;2; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Dorenbosch M, 2005, MAR ECOL PROG SER, V302, P63, DOI 10.3354/meps302063; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Gates RD, 1999, AM ZOOL, V39, P30; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Graham NAJ, 2011, ECOL LETT, V14, P341, DOI 10.1111/j.1461-0248.2011.01592.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; JACKSON JBC, 1992, AM ZOOL, V32, P719; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kulbicki M, 2005, CYBIUM, V29, P235; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; Lenihan HS, 2008, MAR ECOL PROG SER, V370, P127, DOI 10.3354/meps07622; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2005, CORAL REEFS, V24, P230, DOI 10.1007/s00338-004-0471-1; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211; Mumby PJ, 2008, J APPL ECOL, V45, P854, DOI 10.1111/j.1365-2664.2008.01459.x; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Nagelkerken I, 2001, MAR ECOL PROG SER, V214, P225, DOI 10.3354/meps214225; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pandolfi JM, 2006, ECOL LETT, V9, P818, DOI 10.1111/j.1461-0248.2006.00933.x; Penin L, 2007, CR BIOL, V330, P171, DOI 10.1016/j.crvi.2006.12.003; Pratchett MS, 2011, CORAL REEFS, V30, P183, DOI 10.1007/s00338-010-0678-2; Rogers CS, 2006, MAR ECOL PROG SER, V306, P103, DOI 10.3354/meps306103; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schmitt RJ, 2000, ECOLOGY, V81, P3479, DOI 10.1890/0012-9658(2000)081[3479:HLROCR]2.0.CO;2; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Shulman MJ, 1996, CORAL REEFS, V15, P231, DOI 10.1007/s003380050048; Smith LD, 2008, CORAL REEFS, V27, P197, DOI 10.1007/s00338-007-0311-1; Steneck RS, 2009, CORAL REEFS, V28, P367, DOI 10.1007/s00338-009-0470-3; Trapon Melanie L., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/807625; Unsworth RKF, 2010, CONSERV LETT, V3, P63, DOI 10.1111/j.1755-263X.2010.00101.x; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wilson SK, 2010, J EXP BIOL, V213, P894, DOI 10.1242/jeb.037895; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	58	210	213	2	186	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23717	10.1371/journal.pone.0023717	http://dx.doi.org/10.1371/journal.pone.0023717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901131	Green Published, gold			2022-12-25	WOS:000294298000016
J	Vasovcak, P; Pavlikova, K; Sedlacek, Z; Skapa, P; Kouda, M; Hoch, J; Krepelova, A				Vasovcak, Peter; Pavlikova, Kristyna; Sedlacek, Zdenek; Skapa, Petr; Kouda, Martin; Hoch, Jiri; Krepelova, Anna			Molecular Genetic Analysis of 103 Sporadic Colorectal Tumours in Czech Patients	PLOS ONE			English	Article							MISMATCH REPAIR DEFICIENCY; APC MUTATIONS; MICROSATELLITE INSTABILITY; SOMATIC MUTATION; BRAF MUTATION; BETA-CATENIN; HUMAN BREAST; CANCER RISK; POLYPOSIS; MYH	The Czech Republic has one of the highest incidences of colorectal cancer (CRC) in Europe. To evaluate whether sporadic CRCs in Czech patients have specific mutational profiles we analysed somatic genetic changes in known CRC genes (APC, KRAS, TP53, CTNNB1, MUTYH and BRAF, loss of heterozygosity (LOH) at the APC locus, microsatellite instability (MSI), and methylation of the MLH1 promoter) in 103 tumours from 102 individuals. The most frequently mutated gene was APC (68.9% of tumours), followed by KRAS (31.1%), TP53 (27.2%), BRAF (8.7%) and CTNNB1 (1.9%). Heterozygous germline MUTYH mutations in 2 patients were unlikely to contribute to the development of their CRCs. LOH at the APC locus was found in 34.3% of tumours, MSI in 24.3% and MLH1 methylation in 12.7%. Seven tumours (6.9%) were without any changes in the genes tested. The analysis yielded several findings possibly specific for the Czech cohort. Somatic APC mutations did not cluster in the mutation cluster region (MCR). Tumours with MSI but no MLH1 methylation showed earlier onset and more severe mutational profiles compared to MSI tumours with MLH1 methylation. TP53 mutations were predominantly located outside the hot spots, and transitions were underrepresented. Our analysis supports the observation that germline MUTYH mutations are rare in Czech individuals with sporadic CRCs. Our findings suggest the influence of specific ethnic genetic factors and/or lifestyle and dietary habits typical for the Czech population on the development of these cancers.	[Vasovcak, Peter; Pavlikova, Kristyna; Sedlacek, Zdenek; Krepelova, Anna] Charles Univ Prague, Dept Biol & Med Genet, Fac Med 2, Prague, Czech Republic; [Vasovcak, Peter; Pavlikova, Kristyna; Sedlacek, Zdenek; Skapa, Petr; Kouda, Martin; Hoch, Jiri; Krepelova, Anna] Univ Hosp Motol, Prague, Czech Republic; [Skapa, Petr] Charles Univ Prague, Dept Pathol & Mol Med, Fac Med 2, Prague, Czech Republic; [Kouda, Martin; Hoch, Jiri] Charles Univ Prague, Dept Surg, Fac Med 2, Prague, Czech Republic	Charles University Prague; Motol University Hospital; Charles University Prague; Charles University Prague	Vasovcak, P (corresponding author), Charles Univ Prague, Dept Biol & Med Genet, Fac Med 2, Prague, Czech Republic.	pevas78@hotmail.com	Markova, Kristyna/ABB-1765-2021; Škapa, Petr/W-4830-2018; Krepelova, Anna/AAP-8124-2020	Markova, Kristyna/0000-0002-0520-3494; Škapa, Petr/0000-0002-7722-3718; 	Ministry of Health of the Czech Republic [MZOFNM2005]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	Funding was provided by grant MZOFNM2005, Ministry of Health of the Czech Republic (http://www.mzcr.cz/En/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Aretz S, 2010, DTSCH ARZTEBL INT, V107, P163, DOI 10.3238/arztebl.2010.0163; Berg KD, 2000, J MOL DIAGN, V2, P20, DOI 10.1016/S1525-1578(10)60611-3; BIGGS PJ, 1993, MUTAGENESIS, V8, P275, DOI 10.1093/mutage/8.4.275; Bodmer WF, 2006, J HUM GENET, V51, P391, DOI 10.1007/s10038-006-0373-x; Center MM, 2009, CANCER EPIDEM BIOMAR, V18, P1688, DOI 10.1158/1055-9965.EPI-09-0090; de la Chapelle A, 2010, J CLIN ONCOL, V28, P3380, DOI 10.1200/JCO.2009.27.0652; de Vogel S, 2009, ANN ONCOL, V20, P1216, DOI 10.1093/annonc/mdn782; Deng GR, 2004, CLIN CANCER RES, V10, P191, DOI 10.1158/1078-0432.CCR-1118-3; Dofkova M, 2001, PUBLIC HEALTH NUTR, V4, P999, DOI 10.1079/PHN2001169; Domingo E, 2004, GENE CHROMOSOME CANC, V39, P138, DOI 10.1002/gcc.10310; Farrington SM, 2005, AM J HUM GENET, V77, P112, DOI 10.1086/431213; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Huang J, 1996, P NATL ACAD SCI USA, V93, P9049, DOI 10.1073/pnas.93.17.9049; Isidro Gloria, 2004, Hum Mutat, V24, P353, DOI 10.1002/humu.9282; Jackson MA, 2006, TOXICOL SCI, V90, P400, DOI 10.1093/toxsci/kfj101; Jenkins MA, 2006, CANCER EPIDEM BIOMAR, V15, P312, DOI 10.1158/1055-9965.EPI-05-0793; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kazerouni N, 2001, FOOD CHEM TOXICOL, V39, P423, DOI 10.1016/S0278-6915(00)00158-7; Kim YH, 2010, ANN SURG ONCOL, V17, P1435, DOI 10.1245/s10434-009-0888-4; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kitaeva MN, 1997, CANCER RES, V57, P4478; Knai C, 2007, ECON HUM BIOL, V5, P392, DOI 10.1016/j.ehb.2007.08.002; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lamlum H, 1999, NAT MED, V5, P1071, DOI 10.1038/12511; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Lubbe SJ, 2009, J CLIN ONCOL, V27, P3975, DOI 10.1200/JCO.2008.21.6853; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Oliveira C, 2007, ONCOGENE, V26, P158, DOI 10.1038/sj.onc.1209758; Pardini B, 2008, MUTAT RES-FUND MOL M, V638, P146, DOI 10.1016/j.mrfmmm.2007.09.008; Peterlongo P, 2005, INT J CANCER, V114, P505, DOI 10.1002/ijc.20767; Phillips DH, 1999, MUTAT RES-GEN TOX EN, V443, P139, DOI 10.1016/S1383-5742(99)00016-2; Poulsen MLM, 2008, CURR GENOMICS, V9, P420, DOI 10.2174/138920208785699562; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Pritchard CC, 2011, GUT, V60, P116, DOI 10.1136/gut.2009.206250; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Samowitz WS, 2007, MOL CANCER RES, V5, P165, DOI 10.1158/1541-7786.MCR-06-0398; Samowitz WS, 2009, CANCER CAUSE CONTROL, V20, P1763, DOI 10.1007/s10552-009-9410-3; Smith G, 2002, P NATL ACAD SCI USA, V99, P9433, DOI 10.1073/pnas.122612899; Sparks AB, 1998, CANCER RES, V58, P1130; Sugimura T, 2004, CANCER SCI, V95, P290, DOI 10.1111/j.1349-7006.2004.tb03205.x; Sulova M, 2007, EUR J CANCER, V43, P1617, DOI 10.1016/j.ejca.2007.04.010; Thibodeau SN, 1998, CANCER RES, V58, P1713; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	51	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e24114	10.1371/journal.pone.0024114	http://dx.doi.org/10.1371/journal.pone.0024114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901162	Green Submitted, gold, Green Published			2022-12-25	WOS:000294298000047
J	Lopez-Legentil, S; Song, B; Bosch, M; Pawlik, JR; Turon, X				Lopez-Legentil, Susanna; Song, Bongkeun; Bosch, Manel; Pawlik, Joseph R.; Turon, Xavier			Cyanobacterial Diversity and a New Acaryochloris-Like Symbiont from Bahamian Sea-Squirts	PLOS ONE			English	Article							ASCIDIAN TRIDIDEMNUM-SOLIDUM; OXYGENIC PHOTOSYNTHETIC PROKARYOTE; VERTICAL TRANSMISSION; CHLOROPHYLL-D; RYUKYU ARCHIPELAGO; DIPLOSOMA ASCIDIACEA; SEXUAL REPRODUCTION; ALGAL SYMBIONTS; PROCHLORON; DNA	Symbiotic interactions between ascidians (sea-squirts) and microbes are poorly understood. Here we characterized the cyanobacteria in the tissues of 8 distinct didemnid taxa from shallow-water marine habitats in the Bahamas Islands by sequencing a fragment of the cyanobacterial 16S rRNA gene and the entire 16S-23S rRNA internal transcribed spacer region (ITS) and by examining symbiont morphology with transmission electron (TEM) and confocal microscopy (CM). As described previously for other species, Trididemnum spp. mostly contained symbionts associated with the Prochloron-Synechocystis group. However, sequence analysis of the symbionts in Lissoclinum revealed two unique clades. The first contained a novel cyanobacterial clade, while the second clade was closely associated with Acaryochloris marina. CM revealed the presence of chlorophyll d (chl d) and phycobiliproteins (PBPs) within these symbiont cells, as is characteristic of Acaryochloris species. The presence of symbionts was also observed by TEM inside the tunic of both the adult and larvae of L. fragile, indicating vertical transmission to progeny. Based on molecular phylogenetic and microscopic analyses, Candidatus Acaryochloris bahamiensis nov. sp. is proposed for this symbiotic cyanobacterium. Our results support the hypothesis that photosymbiont communities in ascidians are structured by host phylogeny, but in some cases, also by sampling location.	[Lopez-Legentil, Susanna] Univ Barcelona, Dept Anim Biol Invertebrates, Barcelona, Spain; [Song, Bongkeun; Pawlik, Joseph R.] Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28401 USA; [Bosch, Manel] Univ Barcelona, Sci & Tech Serv Confocal Microscopy, Barcelona, Spain; [Turon, Xavier] Ctr Adv Studies Blanes, Spanish Natl Res Council, Blanes, Girona, Spain	University of Barcelona; University of North Carolina; University of North Carolina Wilmington; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Lopez-Legentil, S (corresponding author), Univ Barcelona, Dept Anim Biol Invertebrates, Barcelona, Spain.	slopez@ub.edu	Turon, Xavier/J-9211-2012; Pawlik, Joseph R/I-5718-2012; Bosch, Manel/S-4390-2018; Lopez-Legentil, Susanna/B-8194-2008	Turon, Xavier/0000-0002-9229-5541; Bosch, Manel/0000-0001-5870-6346; Lopez-Legentil, Susanna/0000-0001-8737-6729; Pawlik, Joseph/0000-0002-8559-8456	European Community [FP7-PEOPLE-2010-RG 277038]; Linnean Society and the Systematics Association; Spanish Government [CTM2010-17755]; US National Science Foundation [OCE 0550468]	European Community(European Commission); Linnean Society and the Systematics Association; Spanish Government(Spanish GovernmentEuropean Commission); US National Science Foundation(National Science Foundation (NSF))	This research was funded by the Marie Curie International Reintegration Grant FP7-PEOPLE-2010-RG 277038 (within the 7th European Community Framework Program), by a Systematics Research grant from the Linnean Society and the Systematics Association, and by the Spanish Government project CTM2010-17755. Use of the UNOLS Research Vessel Walton Smith was funded by a grant from the US National Science Foundation (OCE 0550468 to JRP). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAK RPM, 1981, MAR ECOL PROG SER, V6, P43, DOI 10.3354/meps006043; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; COX G, 1986, NEW PHYTOL, V104, P429, DOI 10.1111/j.1469-8137.1986.tb02910.x; COX GC, 1985, MAR BIOL, V89, P149, DOI 10.1007/BF00392886; DUCLAUX G, 1988, Vie et Milieu, V38, P145; Eldredge L. G., 1967, Micronesica, V2, P161; Erwin PM, 2008, MOL ECOL, V17, P2937, DOI 10.1111/j.1365-294X.2008.03808.x; Erwin PM, 2007, J MAR BIOL ASSOC UK, V87, P1683, DOI 10.1017/S0025315407058213; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Groepler W, 2003, HELGOLAND MAR RES, V57, P139, DOI 10.1007/s10152-003-0152-4; HERNANDEZMARINE M, 1990, PHYCOLOGIA, V29, P275, DOI 10.2216/i0031-8884-29-3-275.1; Hirose E, 2001, ZOOL SCI, V18, P723, DOI 10.2108/zsj.18.723; Hirose E, 2005, MAR BIOL, V146, P677, DOI 10.1007/s00227-004-1469-5; Hirose E, 2000, ZOOL SCI, V17, P233, DOI 10.2108/zsj.17.233; Hirose E, 2006, J MAR BIOL ASSOC UK, V86, P175, DOI 10.1017/S0025315406013002; Hirose E, 2004, ENDOCYT CELL RES, V15, P51; HIROSE E, 1992, HIYOSHI REV NAT SCI, V11, P5; Hirose E, 2006, ZOOL SCI, V23, P669, DOI 10.2108/zsj.23.669; Hirose E, 2009, BACTERIOL RES DEV, P161; Hirose E, 2009, EUR J PHYCOL, V44, P365, DOI 10.1080/09670260802710269; Hirose E, 2009, ZOOL SCI, V26, P362, DOI 10.2108/zsj.26.362; Hirose E, 2008, ZOOL SCI, V25, P1261, DOI 10.2108/zsj.25.1261; Hirose E, 2008, ZOOL SCI, V25, P1205, DOI 10.2108/zsj.25.1205; Hirose E, 2006, ZOOL SCI, V23, P435, DOI 10.2108/zsj.23.435; Hirose E, 2007, MAR BIOL, V150, P359, DOI 10.1007/s00227-006-0378-1; Hirose M, 2009, ZOOL SCI, V26, P564, DOI 10.2108/zsj.26.564; HOLTON RW, 1990, J PHYCOL, V26, P358; Hu Q, 1999, BBA-BIOENERGETICS, V1412, P250, DOI 10.1016/S0005-2728(99)00067-5; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iteman I, 2000, MICROBIOL-SGM, V146, P1275, DOI 10.1099/00221287-146-6-1275; Jobb G, 2008, TREEFINDER VERSION O; Kojima A, 2010, ZOOL SCI, V27, P124, DOI 10.2108/zsj.27.124; KOTT P, 1982, Micronesica, V18, P95; KOTT P, 1984, B MAR SCI, V34, P308; KOTT P, 1980, Memoirs of the Queensland Museum, V20, P1; Kott Patricia, 2001, Memoirs of the Queensland Museum, V47, P1; Kuhl M, 2005, NATURE, V433, P820, DOI 10.1038/433820a; Kuhl M, 2002, CELL OR EX, V4, P273; LAFARGUE F, 1979, ANN I OCEANOGR PARIS, V55, P163; Larkum AWD, 2005, TRENDS PLANT SCI, V10, P355, DOI 10.1016/j.tplants.2005.06.005; LARKUM AWD, 1987, MAR BIOL, V95, P1, DOI 10.1007/BF00447479; LEWIN R A, 1977, Phycologia, V16, P217, DOI 10.2216/i0031-8884-16-2-217.1; LEWIN R A, 1975, Phycologia, V14, P149, DOI 10.2216/i0031-8884-14-3-149.1; Lopez-Legentil S, 2005, ZOOL SCR, V34, P3, DOI 10.1111/j.1463-6409.2005.00167.x; Lopez-Legentil S, 2008, MOL ECOL, V17, P1840, DOI 10.1111/j.1365-294X.2008.03667.x; Lopez-Legentil S, 2006, BIOL J LINN SOC, V88, P203, DOI 10.1111/j.1095-8312.2006.00614.x; Manning WM, 1943, J BIOL CHEM, V151, P1; Marquardt J, 2000, ARCH MICROBIOL, V174, P181, DOI 10.1007/s002030000194; Martinez-Garcia M, 2007, ENVIRON MICROBIOL, V9, P521, DOI 10.1111/j.1462-2920.2006.01170.x; Martinez-Garcia M, 2011, MICROB ECOL, V61, P13, DOI 10.1007/s00248-010-9694-6; Martinez-Garcia M, 2010, FEMS MICROBIOL ECOL, V71, P387, DOI 10.1111/j.1574-6941.2009.00816.x; Miller SR, 2005, P NATL ACAD SCI USA, V102, P850, DOI 10.1073/pnas.0405667102; Miyashita H, 2003, J PHYCOL, V39, P1247, DOI 10.1111/j.0022-3646.2003.03-158.x; Miyashita H, 1996, NATURE, V383, P402, DOI 10.1038/383402a0; MONNIOT C, 1994, B MAR SCI, V54, P71; MONNIOT F, 1984, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V6, P885; Monniot Francoise, 1992, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V14, P565; Munchhoff J, 2007, ENVIRON MICROBIOL, V9, P890, DOI 10.1111/j.1462-2920.2006.01209.x; Murakami A, 2004, SCIENCE, V303, P1633, DOI 10.1126/science.1095459; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Oka AT, 2005, ZOOL SCI, V22, P367, DOI 10.2108/zsj.22.367; OLSON RR, 1986, BIOL BULL, V170, P62, DOI 10.2307/1541381; Palenik B, 1996, J PHYCOL, V32, P638, DOI 10.1111/j.0022-3646.1996.00638.x; PARRY DL, 1984, PHYCOLOGIA, V23, P503, DOI 10.2216/i0031-8884-23-4-503.1; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Shimada A, 2003, PHYCOLOGIA, V42, P193, DOI 10.2216/i0031-8884-42-2-193.1; Stefaniak Lauren, 2009, Aquatic Invasions, V4, P29, DOI 10.3391/ai.2009.4.1.3; Steindler L, 2005, APPL ENVIRON MICROB, V71, P4127, DOI 10.1128/AEM.71.7.4127-4131.2005; Swingley WD, 2005, APPL ENVIRON MICROB, V71, P8606, DOI 10.1128/AEM.71.12.8606-8610.2005; SYBESMA J, 1981, MAR ECOL PROG SER, V6, P53, DOI 10.3354/meps006053; Tait E, 2007, J EXP MAR BIOL ECOL, V342, P138, DOI 10.1016/j.jembe.2006.10.024; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarjuelo I, 2004, MOL ECOL, V13, P3125, DOI 10.1111/j.1365-294X.2004.02306.x; Tarjuelo I, 2001, MAR BIOL, V139, P455; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Thacker RW, 2005, INTEGR COMP BIOL, V45, P369, DOI 10.1093/icb/45.2.369; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TURON X, 1987, ESTUDIO ASCIDIAS COS; TURON X, 1991, ALGOLOGICAL STUDIES, V64, P249; Usher KM, 2007, ANNU REV ECOL EVOL S, V38, P255, DOI 10.1146/annurev.ecolsys.38.091206.095641; Usher KM, 2004, SYMBIOSIS, V36, P183; VANDUYL FC, 1981, MAR ECOL PROG SER, V6, P35; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Yokobori S, 2006, MOL PHYLOGENET EVOL, V40, P8, DOI 10.1016/j.ympev.2005.11.025	87	37	37	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23938	10.1371/journal.pone.0023938	http://dx.doi.org/10.1371/journal.pone.0023938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21915246	Green Published, gold			2022-12-25	WOS:000294251800042
J	Guo, LW; Gao, LQ; Rothschild, J; Su, B; Gelman, IH				Guo, Li-Wu; Gao, Lingqiu; Rothschild, Julian; Su, Bing; Gelman, Irwin H.			Control of Protein Kinase C Activity, Phorbol Ester-induced Cytoskeletal Remodeling, and Cell Survival Signals by the Scaffolding Protein SSeCKS/GRAVIN/AKAP12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; GROWTH-FACTOR RECEPTOR; INDUCED APOPTOSIS; ONCOGENIC TRANSFORMATION; BINDING PROTEIN; SMOOTH-MUSCLE; CYCLIN-D; IN-VIVO; SUBSTRATE; SSECKS	The product of the SSeCKS/GRAVIN/AKAP12 gene ("SSeCKS") is a major protein kinase (PK) C substrate that exhibits tumor-and metastasis-suppressing activity likely through its ability to scaffold multiple signaling mediators such as PKC, PKA, cyclins, calmodulin, and Src. Although SSeCKS and PKC alpha bind phosphatidylserine, we demonstrate that phosphatidylserine-independent binding of PKC by SSeCKS is facilitated by two homologous SSeCKS motifs, EG(I/V)(T/S)-XWXSFK(K/R)(M/L)VTP(K/R)K(K/R)X(K/R)XXXEXXXE(E/D) (amino acids 592-620 and 741-769). SSeCKS binding to PKC alpha decreased kinase activity and was dependent on the two PKC-binding motifs. SSeCKS scaffolding of PKC was increased in confluent cell cultures, correlating with significantly increased SSeCKS protein levels and decreased PKC alpha activity, suggesting a role for SSeCKS in suppressing PKC activation during contact inhibition. SSeCKS-null mouse embryo fibroblasts displayed increased relative basal and phorbol ester (phorbol 12-myristate 13-acetate)-induced PKC activity but were defective in phorbol 12-myristate 13-acetate-induced actin cytoskeletal reorganization and cell shape change; these responses could be rescued by the forced expression of full-length SSeCKS but not by an SSeCKS variant deleted of its PKC-binding domains. Finally, the PKC binding sites in SSeCKS were required to restore cell rounding and/or decreased apoptosis in phorbol ester-treated LNCaP, LNCaP-C4-2, and MAT-LyLu prostate cancer cells. Thus, PKC-mediated remodeling of the actin cytoskeleton is likely regulated by the ability of SSeCKS to control PKC signaling and activity through a direct scaffolding function.	[Guo, Li-Wu; Gao, Lingqiu; Rothschild, Julian; Su, Bing; Gelman, Irwin H.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Gelman, IH (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA.	irwin.gelman@roswellpark.org			National Institutes of Health [CA94108, CA116430]; Comprehensive Cancer Center from the NCI [P30-CA016056]; United States Department of Defense [PC074228, PC101210]; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA094108, R01CA116430, R55CA094108] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comprehensive Cancer Center from the NCI; United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA94108 and CA116430 (to I. H. G.) and Comprehensive Cancer Center Grant P30-CA016056 from the NCI.; Supported by United States Department of Defense Grants PC074228 and PC101210.	Akakura S, 2008, CANCER RES, V68, P5096, DOI 10.1158/0008-5472.CAN-07-5619; Akakura S, 2010, CELL CYCLE, V9, P4656, DOI 10.4161/cc.9.23.13974; BAE VL, 1994, INT J CANCER, V58, P721, DOI 10.1002/ijc.2910580517; Benavides F, 2011, CELL CYCLE, V10, P268, DOI 10.4161/cc.10.2.14469; Bogatcheva NV, 2003, AM J PHYSIOL-LUNG C, V285, pL415, DOI 10.1152/ajplung.00364.2001; Bu Y, 2007, J BIOL CHEM, V282, P26725, DOI 10.1074/jbc.M702885200; Chapline C, 1996, J BIOL CHEM, V271, P6417, DOI 10.1074/jbc.271.11.6417; Chapline C, 1998, J BIOL CHEM, V273, P19482, DOI 10.1074/jbc.273.31.19482; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; Diviani D, 2001, J CELL SCI, V114, P1431; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Garcia-Bermejo ML, 2002, J BIOL CHEM, V277, P645, DOI 10.1074/jbc.M107639200; Garzotto M, 1998, CANCER RES, V58, P2260; Gelman IH, 1998, CELL MOTIL CYTOSKEL, V41, P1; Gelman IH, 2002, FRONT BIOSCI-LANDMRK, V7, pD1782, DOI 10.2741/gelman; Gelman Irwin H, 2010, Genes Cancer, V1, P1147, DOI 10.1177/1947601910392984; Gonzalez-Guerrico AM, 2005, J BIOCHEM MOL BIOL, V38, P639; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Henttu P, 1998, BIOCHEM BIOPH RES CO, V244, P167, DOI 10.1006/bbrc.1998.8238; Ho A, 2001, CANCER RES, V61, P474; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; Hornia A, 1999, MOL CELL BIOL, V19, P7672; HYATT SL, 1994, CELL GROWTH DIFFER, V5, P495; IGARASHI K, 1995, J BIOL CHEM, V270, P29075, DOI 10.1074/jbc.270.49.29075; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Kazanietz MG, 2000, MOL CARCINOGEN, V28, P5, DOI 10.1002/(SICI)1098-2744(200005)28:1<5::AID-MC2>3.0.CO;2-G; Koren R, 2004, ONCOL REP, V11, P321; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Leitges M, 2007, BIOCHEM SOC T, V35, P1018, DOI 10.1042/BST0351018; Lin XY, 2000, MOL CELL BIOL, V20, P7259, DOI 10.1128/MCB.20.19.7259-7272.2000; Lin XY, 1996, J BIOL CHEM, V271, P28430, DOI 10.1074/jbc.271.45.28430; Lin XY, 2002, BIOCHEM BIOPH RES CO, V290, P1368, DOI 10.1006/bbrc.2002.6357; Medkova M, 1998, BIOCHEMISTRY-US, V37, P4892, DOI 10.1021/bi972495j; Moissoglu K, 2003, J BIOL CHEM, V278, P47946, DOI 10.1074/jbc.M302720200; Nauert JB, 1997, CURR BIOL, V7, P52, DOI 10.1016/S0960-9822(06)00027-3; Nelson PJ, 1999, J CELL SCI, V112, P361; Nelson PJ, 1997, MOL CELL BIOCHEM, V175, P233, DOI 10.1023/A:1006836003758; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Piontek J, 2003, J BIOL CHEM, V278, P38970, DOI 10.1074/jbc.M306749200; SELKIRK JK, 1971, CANCER RES, V31, P27; SINGER HA, 1990, J PHARMACOL EXP THER, V252, P1068; Stebbins EG, 2001, J BIOL CHEM, V276, P29644, DOI 10.1074/jbc.M101044200; Stewart JR, 2005, MOL CANCER THER, V4, P726, DOI 10.1158/1535-7163.MCT-05-0013; Streb JW, 2004, J BIOL CHEM, V279, P56014, DOI 10.1074/jbc.M408828200; Su B, 2006, CANCER RES, V66, P5599, DOI 10.1158/0008-5472.CAN-05-4123; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; Turbedsky K, 1997, BIOCHEMISTRY-US, V36, P2063, DOI 10.1021/bi9624651; VENEMA RC, 1993, BIOCHEM J, V294, P401, DOI 10.1042/bj2940401; Weber LP, 2000, BIOCHEM J, V352, P573, DOI 10.1042/0264-6021:3520573; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Xia W, 2001, CANCER RES, V61, P5644; Yamazaki Kosuke, 1995, In Vivo (Attiki), V9, P427; Yan XH, 2009, EXP CELL RES, V315, P1247, DOI 10.1016/j.yexcr.2008.12.026; YOUNG CYF, 1994, ONCOL RES, V6, P203	55	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38356	38366		10.1074/jbc.M111.258830	http://dx.doi.org/10.1074/jbc.M111.258830			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21903576	Green Published, hybrid			2022-12-25	WOS:000296594200049
J	Kobayashi, Y; Horie, M; Tomonaga, K; Suzuki, Y				Kobayashi, Yuki; Horie, Masayuki; Tomonaga, Keizo; Suzuki, Yoshiyuki			No Evidence for Natural Selection on Endogenous Borna-Like Nucleoprotein Elements after the Divergence of Old World and New World Monkeys	PLOS ONE			English	Article							DISEASE VIRUS; MAXIMUM-LIKELIHOOD; PHYLOGENETIC TREES; MAMMALIAN GENOMES; DNA-SEQUENCES; SUBSTITUTION; EVOLUTION; RATES; INFECTION; BIOLOGY	Endogenous Borna-like nucleoprotein (EBLNs) elements were recently discovered as non-retroviral RNA virus elements derived from bornavirus in the genomes of various animals. Most of EBLNs appeared to be defective, but some of primate EBLN-1 to -4, which appeared to be originated from four independent integrations of bornavirus nucleoprotein (N) gene, have retained an open reading frame (ORF) for more than 40 million years. It was therefore possible that primate EBLNs have encoded functional proteins during evolution. To examine this possibility, natural selection operating on all ORFs of primate EBLN-1 to -4 was examined by comparing the rates of synonymous and nonsynonymous substitutions. The expected number of premature termination codons in EBLN-1 generated after the divergence of Old World and New World monkeys under the selective neutrality was also examined by the Monte Carlo simulation. As a result, natural selection was not identified for the entire region as well as parts of ORFs in the pairwise analysis of primate EBLN-1 to -4 and for any branch of the phylogenetic trees for EBLN-1 to -4 after the divergence of Old World and New World monkeys. Computer simulation also indicated that the absence of premature termination codon in the present-day EBLN-1 does not necessarily support the maintenance of function after the divergence of Old World and New World monkeys. These results suggest that EBLNs have not generally encoded functional proteins after the divergence of Old World and New World monkeys.	[Kobayashi, Yuki; Suzuki, Yoshiyuki] Nagoya City Univ, Grad Sch Nat Sci, Aichi, Japan; [Horie, Masayuki; Tomonaga, Keizo] Osaka Univ, Res Inst Microbial Dis BIKEN, Osaka, Japan; [Horie, Masayuki; Tomonaga, Keizo] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 606, Japan	Nagoya City University; Osaka University; Kyoto University	Kobayashi, Y (corresponding author), Nagoya City Univ, Grad Sch Nat Sci, Aichi, Japan.	yossuzuk@nsc.nagoya-cu.ac.jp		Horie, Masayuki/0000-0003-4682-7698	JSPS [21.4991]; Grants-in-Aid for Scientific Research [09J04991] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Y.K. was supported by a JSPS Research Fellowship for Young Scientists (21.4991) (http://www.jsps.go.jp/j-pd/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyi VA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001030; Creevey CJ, 2003, BIOINFORMATICS, V19, P1726, DOI 10.1093/bioinformatics/btg225; de la Torre JC, 2002, FRONT BIOSCI-LANDMRK, V7, pD569, DOI 10.2741/torre; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Geib T, 2003, J VIROL, V77, P4283, DOI 10.1128/JVI.77.7.4283-4290.2003; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Han K, 2007, SCIENCE, V316, P238, DOI 10.1126/science.1139462; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Jordan I, 2001, REV MED VIROL, V11, P37, DOI 10.1002/rmv.300; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Nei M., 2000, MOL EVOLUTION PHYLOG; PAMILO P, 1993, MOL BIOL EVOL, V10, P271; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Rauer M, 2004, J VIROL, V78, P3621, DOI 10.1128/JVI.78.7.3621-3632.2004; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Suzuki Y, 2001, MOL BIOL EVOL, V18, P2179, DOI 10.1093/oxfordjournals.molbev.a003764; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomonaga K, 2002, MICROBES INFECT, V4, P491, DOI 10.1016/S1286-4579(02)01564-2; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yi SJ, 2002, MOL BIOL EVOL, V19, P2191, DOI 10.1093/oxfordjournals.molbev.a004043	28	17	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24403	10.1371/journal.pone.0024403	http://dx.doi.org/10.1371/journal.pone.0024403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912690	Green Published, Green Submitted, gold			2022-12-25	WOS:000294686100037
J	Kuo, PC; Huang, JH; Liu, MD				Kuo, Pei-Chun; Huang, Jiun-Hau; Liu, Ming-Der			Avian Influenza Risk Perception and Preventive Behavior among Traditional Market Workers and Shoppers in Taiwan: Practical Implications for Prevention	PLOS ONE			English	Article							H5N1 VIRUS-INFECTION; KNOWLEDGE; POULTRY; COMMUNITY; ATTITUDES; EVOLUTION; OUTBREAK; CHINA; BIRDS	Background: Avian influenza (AI) can be highly pathogenic and fatal. Preventive behavior such as handwashing and wearing face masks has been recommended. However, little is known about what psychosocial factors might influence people's decision to adopt such preventive behavior. This study aims to explore risk perception and other factors associated with handwashing and wearing face masks to prevent AI. Methodology/Principal Findings: An interviewer-administered survey was conducted among 352 traditional market workers and shoppers in Taiwan between December 2009 and January 2010. Factors associated with the recommended AI preventive behavior (i.e., when in a traditional market, wearing a face mask and also washing hands after any contact with poultry) included: having correct knowledge about the fatality rate of AI (adjusted odds ratio [AOR] = 4.18), knowing of severe cases of AI (AOR = 2.13), being informed of local AI outbreaks (AOR = 2.24), living in northeastern Taiwan (AOR = 6.01), having a senior high-school education (AOR = 3.33), and having a university or higher education (AOR = 6.86). Gender interactive effect was also found among participants with a senior high-school education, with males being less likely to engage in the recommended AI preventive behavior than their female counterparts (AOR = 0.34). Conclusions/Significance: Specific information concerning AI risk perception was associated with the recommended AI preventive behavior. In particular, having correct knowledge about the fatality rate of AI and being informed of severe cases and local outbreaks of AI were linked to increased AI preventive behavior. These findings underscore the importance of transparency in dealing with epidemic information. These results also have practical implications for prevention and policy-making to more effectively promote the recommended AI preventive behavior in the public.	[Kuo, Pei-Chun; Huang, Jiun-Hau] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Policy & Management, Taipei 10764, Taiwan; [Huang, Jiun-Hau] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Liu, Ming-Der] Hungkuang Univ, Coll Gen Educ, Taichung, Taiwan	National Taiwan University; National Taiwan University; Hungkuang University	Kuo, PC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Policy & Management, Taipei 10764, Taiwan.	jhuang@ntu.edu.tw		HUANG, JIUN-HAU/0000-0002-4569-0629	National Science Council, Taiwan [NSC 98-2621-M-002-021-, NSC 99-2621-M-002-010-, NSC 100-2621-M-002-010-]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by grants from the National Science Council, Taiwan (NSC 98-2621-M-002-021-, NSC 99-2621-M-002-010-, and NSC 100-2621-M-002-010-) to JHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate R, 2006, EMERG INFECT DIS, V12, P1762, DOI 10.3201/eid1211.060671; Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; [Anonymous], 1974, Health Education Monograph, V2, P324; Barennes H, 2007, EMERG INFECT DIS, V13, P1126, DOI 10.3201/eid1307.061197; Becker MH, 1974, HLTH BELIEF MODEL PE; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; *BUR AN PLANT HLTH, 2008, AV INFL OUTBR LUZH D; Cairncross S, 2003, TROP MED INT HEALTH, V8, P677, DOI 10.1046/j.1365-3156.2003.01096.x; Cheng MC, 2010, AVIAN DIS, V54, P109, DOI 10.1637/8960-061709-Reg.1; Di Giuseppe G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-36; Edirne T, 2011, INT J PUBLIC HEALTH, V56, P163, DOI 10.1007/s00038-010-0131-x; Fielding R, 2005, EMERG INFECT DIS, V11, P677, DOI 10.3201/eid1105.041225; Fung ICH, 2007, INT J ENVIRON HEAL R, V17, P161, DOI 10.1080/09603120701254276; Hsu JL, 2008, POULTRY SCI, V87, P1526, DOI 10.3382/ps.2008-00105; Hsu J.L., 2002, INT REV RETAIL DISTR, V12, P423, DOI DOI 10.1080/09593960210151180; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Korteweg C, 2010, BIOCHEM CELL BIOL, V88, P575, DOI 10.1139/O10-017; Lau JTF, 2008, INFECTION, V36, P434, DOI [10.1007/s15010-008-7277-y, 10.1007/s15010-008-7277-Y]; Leung GM, 2005, CLIN INFECT DIS, V40, P1713, DOI 10.1086/429923; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Liao QY, 2011, INT J BEHAV MED, V18, P93, DOI 10.1007/s12529-010-9123-8; Liao QY, 2009, RISK ANAL, V29, P416, DOI 10.1111/j.1539-6924.2008.01157.x; Monto AS, 2005, NEW ENGL J MED, V352, P323, DOI 10.1056/NEJMp048343; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; *TAIW CTR DIS CONT, 2011, PREV BEH AV INFL; van der Sande M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002618; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WHO, 2006, QUEST ANSW AV INFL S; *WHO, 2004, ADV PEOPL LIV AR AFF; *WHO, 2005, 10 CONC AV INFL BEC; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA	31	31	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24157	10.1371/journal.pone.0024157	http://dx.doi.org/10.1371/journal.pone.0024157			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	817PK	21912667	Green Published, Green Submitted, gold			2022-12-25	WOS:000294686100014
J	Ferreira, PE; Holmgren, G; Veiga, MI; Uhlen, P; Kaneko, A; Gil, JP				Ferreira, Pedro Eduardo; Holmgren, Gabrielle; Veiga, Maria Isabel; Uhlen, Per; Kaneko, Akira; Gil, Jose Pedro			PfMDR1: Mechanisms of Transport Modulation by Functional Polymorphisms	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; IN-VIVO SELECTION; ARTEMETHER-LUMEFANTRINE; CHLOROQUINE RESISTANCE; P-GLYCOPROTEIN; MEFLOQUINE RESISTANCE; SUBSTRATE-SPECIFICITY; DISRUPT INTERACTIONS; COMBINATION THERAPY; NUCLEOTIDE-BINDING	ATP-Binding Cassette (ABC) transporters are efflux pumps frequently associated with multidrug resistance in many biological systems, including malaria. Antimalarial drug-resistance involves an ABC transporter, PfMDR1, a homologue of P-glycoprotein in humans. Twenty years of research have shown that several single nucleotide polymorphisms in pfmdr1 modulate in vivo and/or in vitro drug susceptibility. The underlying physiological mechanism of the effect of these mutations remains unclear. Here we develop structural models for PfMDR1 in different predicted conformations, enabling the study of transporter motion. Such analysis of functional polymorphisms allows determination of their potential role in transport and resistance. The bacterial MsbA ABC pump is a PfMDR1 homologue. MsbA crystals in different conformations were used to create PfMDR1 models with Modeller software. Sequences were aligned with ClustalW and analysed by Ali2D revealing a high level of secondary structure conservation. To validate a potential drug binding pocket we performed antimalarial docking simulations. Using aminoquinoline as probe drugs in PfMDR1 mutated parasites we evaluated the physiology underlying the mechanisms of resistance mediated by PfMDR1 polymorphisms. We focused on the analysis of well known functional polymorphisms in PfMDR1 amino acid residues 86, 184, 1034, 1042 and 1246. Our structural analysis suggested the existence of two different biophysical mechanisms of PfMDR1 drug resistance modulation. Polymorphisms in residues 86/184/1246 act by internal allosteric modulation and residues 1034 and 1042 interact directly in a drug pocket. Parasites containing mutated PfMDR1 variants had a significant altered aminoquinoline susceptibility that appears to be dependent on the aminoquinoline lipophobicity characteristics as well as vacuolar efflux by PfCRT. We previously described the in vivo selection of PfMDR1 polymorphisms under antimalarial drug pressure. Now, together with recent PfMDR1 functional reports, we contribute to the understanding of the specific structural role of these polymorphisms in parasite antimalarial drug response.	[Ferreira, Pedro Eduardo; Holmgren, Gabrielle; Veiga, Maria Isabel] Karolinska Inst, Dept Med, Malaria Res Lab, Stockholm, Sweden; [Ferreira, Pedro Eduardo; Kaneko, Akira] Karolinska Inst, Inst Microbiol Tumour & Cell Biol, Stockholm, Sweden; Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Ferreira, Pedro Eduardo; Veiga, Maria Isabel; Gil, Jose Pedro] Univ Algarve, Ctr Mol & Struct Biomed, Inst Biotechnol & Bioengn, Drug Resistance & Pharmacogenet Grp, Faro, Portugal; [Gil, Jose Pedro] Karolinska Inst, Dept Physiol & Pharmacol, Unit Pharmacogenet, Stockholm, Sweden; [Gil, Jose Pedro] SUNY Binghamton, Dept Biol Sci, Harpur Coll Arts & Sci, Binghamton, NY USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Universidade do Algarve; Karolinska Institutet; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Ferreira, PE (corresponding author), Karolinska Inst, Dept Med, Malaria Res Lab, Stockholm, Sweden.	pedro.ferreira@gmail.com	Ferreira, Pedro/Q-6748-2016; Gil, José Pedro/AAB-6169-2020; Ferreira, Pedro/G-1717-2012; Veiga, Maria Isabel/H-9922-2018; Ferreira, Pedro/AAD-4309-2020; Ferreira, Pedro/HDO-1346-2022	Ferreira, Pedro/0000-0002-2682-7722; Ferreira, Pedro/0000-0002-2682-7722; Veiga, Maria Isabel/0000-0002-2205-8102; Ferreira, Pedro/0000-0002-2682-7722; Gil, Jose Pedro/0000-0002-6107-9379; Uhlen, Per/0000-0003-1446-1062; , Akira/0000-0003-2411-3352	Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia e Ensino Superior, Portugal - MCES [SFRH/BD/28368/2006, SFRH/BD/28393/2006]; Swedish Research Council [2005-6682]; Ake Wiberg's Foundation; Fredrik and Ingrid Thuring's Foundation; EDCTP [IP.2007.31060.002]; Styrelsen for Internationellt Utvecklingssamarbete (SIDA) [SWE-2009-165]	Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia e Ensino Superior, Portugal - MCES(Portuguese Foundation for Science and Technology); Swedish Research Council(Swedish Research CouncilEuropean Commission); Ake Wiberg's Foundation; Fredrik and Ingrid Thuring's Foundation; EDCTP; Styrelsen for Internationellt Utvecklingssamarbete (SIDA)	PEF and MIV are recipients of PhD grants from Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia e Ensino Superior, Portugal - MCES (ref. SFRH/BD/28368/2006 and ref. SFRH/BD/28393/2006, respectively). This study was supported by the Swedish Research Council (2005-6682), Ake Wiberg's Foundation (PU), Fredrik and Ingrid Thuring's Foundation (PU), EDCTP project IP.2007.31060.002 (JPG) and Styrelsen for Internationellt Utvecklingssamarbete (SIDA) - (SWE-2009-165) (JPG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basco LK, 2002, AM J TROP MED HYG, V66, P667, DOI 10.4269/ajtmh.2002.66.667; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bray PG, 1996, MOL PHARMACOL, V50, P1559; Brown NP, 1998, BIOINFORMATICS, V14, P380, DOI 10.1093/bioinformatics/14.4.380; Buchaklian AH, 2004, BIOCHEMISTRY-US, V43, P8600, DOI 10.1021/bi0497751; Carrier I, 2008, FEBS J, V275, P3312, DOI 10.1111/j.1742-4658.2008.06479.x; Chaiyaroj SC, 1999, AM J TROP MED HYG, V61, P780, DOI 10.4269/ajtmh.1999.61.780; Chavchich M, 2010, ANTIMICROB AGENTS CH, V54, P2455, DOI 10.1128/AAC.00947-09; CHEN N, 2010, ANTIMICROB AGENTS CH; Chen NH, 2002, J INFECT DIS, V185, P405, DOI 10.1086/338470; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dalmas O, 2005, J BIOL CHEM, V280, P36857, DOI 10.1074/jbc.M503266200; Dokomajilar C, 2006, ANTIMICROB AGENTS CH, V50, P1893, DOI 10.1128/AAC.50.5.1893-1895.2006; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Duraisingh MT, 2000, MOL BIOCHEM PARASIT, V108, P13, DOI 10.1016/S0166-6851(00)00201-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOOTE SJ, 1989, CELL, V57, P921, DOI 10.1016/0092-8674(89)90330-9; Gowda DC, 1999, PARASITOL TODAY, V15, P147, DOI 10.1016/S0169-4758(99)01412-X; Holland I. B., 2003, ABC PROTEINS BACTERI; Holmgren G, 2006, INFECT GENET EVOL, V6, P309, DOI 10.1016/j.meegid.2005.09.001; Holmgren G, 2007, INFECT GENET EVOL, V7, P562, DOI 10.1016/j.meegid.2007.03.005; Jiang HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002484; KAJIJI S, 1993, BIOCHEMISTRY-US, V32, P4185, DOI 10.1021/bi00067a005; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Lekostaj JK, 2008, MOL BIOCHEM PARASIT, V157, P107, DOI 10.1016/j.molbiopara.2007.09.008; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2005, BIOCHEMISTRY-US, V44, P10250, DOI 10.1021/bi050705j; Loo TW, 2004, J BIOL CHEM, V279, P38395, DOI 10.1074/jbc.M405623200; Lopes Dinora, 2002, Malar J, V1, P12, DOI 10.1186/1475-2875-1-12; Marsh K, 1998, LANCET, V352, P924, DOI 10.1016/S0140-6736(05)61510-3; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Noedl H, 2005, ANTIMICROB AGENTS CH, V49, P3575, DOI 10.1128/AAC.49.8.3575-3577.2005; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nsobya SL, 2007, ANTIMICROB AGENTS CH, V51, P3023, DOI 10.1128/AAC.00012-07; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Price RN, 1999, ANTIMICROB AGENTS CH, V43, P2943, DOI 10.1128/AAC.43.12.2943; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Rohrbach P, 2006, EMBO J, V25, P3000, DOI 10.1038/sj.emboj.7601203; Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106; SAFA AR, 1990, P NATL ACAD SCI USA, V87, P7225, DOI 10.1073/pnas.87.18.7225; SALI A, 1995, CURR OPIN BIOTECH, V6, P437, DOI 10.1016/0958-1669(95)80074-3; Sanchez CP, 2008, MOL MICROBIOL, V70, P786, DOI 10.1111/j.1365-2958.2008.06413.x; Sanchez CP, 2005, BIOCHEMISTRY-US, V44, P9862, DOI 10.1021/bi050061f; Sanchez CP, 2004, BIOCHEMISTRY-US, V43, P16365, DOI 10.1021/bi048241x; SCHINKEL AH, 1993, J BIOL CHEM, V268, P7474; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SHEN DW, 1986, SCIENCE, V232, P643, DOI 10.1126/science.3457471; Siarheyeva A, 2009, BIOCHEM J, V419, P317, DOI 10.1042/BJ20081364; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; Sisowath C, 2007, TROP MED INT HEALTH, V12, P736, DOI 10.1111/j.1365-3156.2007.01843.x; Sisowath C, 2009, J INFECT DIS, V199, P750, DOI 10.1086/596738; Sutherland CJ, 2002, AM J TROP MED HYG, V67, P578, DOI 10.4269/ajtmh.2002.67.578; Taguchi Y, 1997, BIOCHEMISTRY-US, V36, P8883, DOI 10.1021/bi970553v; THOMPSON MA, 4 0 1; Trape JF, 1998, CR ACAD SCI III-VIE, V321, P689, DOI 10.1016/S0764-4469(98)80009-7; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; White NJ, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P301; *WHO, 2001, WHOCDSRBM200135; WILSON CM, 1989, SCIENCE, V244, P1184, DOI 10.1126/science.2658061; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Zalis MG, 1998, AM J TROP MED HYG, V58, P630, DOI 10.4269/ajtmh.1998.58.630	68	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e23875	10.1371/journal.pone.0023875	http://dx.doi.org/10.1371/journal.pone.0023875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21912647	gold, Green Published, Green Submitted			2022-12-25	WOS:000294683900010
J	Colantonio, AD; Epeldegui, M; Jesiak, M; Jachimowski, L; Blom, B; Uittenbogaart, CH				Colantonio, Arnaud D.; Epeldegui, Marta; Jesiak, Maria; Jachimowski, Loes; Blom, Bianca; Uittenbogaart, Christel H.			IFN-alpha Is Constitutively Expressed in the Human Thymus, but Not in Peripheral Lymphoid Organs	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PLASMACYTOID DENDRITIC CELLS; INTERFERON-PRODUCING CELLS; MX-HOMOLOGOUS PROTEIN; INFLUENZA-VIRUS; T-CELL; DIFFERENTIAL TROPISM; HIV-1 INFECTION; GENE-EXPRESSION; IN-VIVO	Type I interferons have been typically studied for their effects in the context of bacterial or viral infections. However in this report, we provide evidence that Interferon-alpha (IFN-alpha) expressing cells are present in the thymus in the absence of infection. We show that pDC express the highest level of IFN-a and that MxA, which is exclusively expressed after engagement of the type I IFN receptor by IFN-alpha/beta, is expressed in normal fetal and post-natal thymus, but not in the periphery. The highest level of MxA is expressed in mature thymocytes and pDC located in the medulla and at the cortico-medullary junction. The anti-microbial peptide LL-37, which is expressed in the thymus, when complexed with eukaryotic nucleic acids, induces the secretion of IFN-alpha by thymic pDC. This results in the upregulation of MxA expression in responsive thymocytes. We propose that the secretion of IFN-alpha in the thymus may function to regulate the rate of T cell development and modulate the requirements for the selection of developing T cells.	[Colantonio, Arnaud D.; Epeldegui, Marta; Jesiak, Maria; Uittenbogaart, Christel H.] Univ Calif Los Angeles, David E Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Uittenbogaart, Christel H.] Univ Calif Los Angeles, Dept Pediat, David E Geffen Sch Med, Los Angeles, CA 90024 USA; [Uittenbogaart, Christel H.] Univ Calif Los Angeles, UCLA AIDS Inst, David E Geffen Sch Med, Los Angeles, CA 90024 USA; [Uittenbogaart, Christel H.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, David E Geffen Sch Med, Los Angeles, CA 90024 USA; [Jachimowski, Loes; Blom, Bianca] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Amsterdam; Academic Medical Center Amsterdam	Colantonio, AD (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, New England Primate Res Ctr, Southborough, MA 01772 USA.	uittenbo@ucla.edu			National Institutes of Health (University of California Los Angeles, Center for AIDS Research) [AI 080564, AI 52002, AI 28697]; University of California; National Institutes of Health [T32-AR-053463, T32-CA-009120]; NATIONAL CANCER INSTITUTE [T32CA009120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080564, R01AI052002, R21AI052002, P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR053463] Funding Source: NIH RePORTER	National Institutes of Health (University of California Los Angeles, Center for AIDS Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of California(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institutes of Health (AI 080564, AI 52002, and AI 28697 (University of California Los Angeles, Center for AIDS Research), a Dissertation Award from the University of California: Universitywide AIDS Research Program (UARP) currently known as California HIV/AIDS Research Program (to AC), and National Institutes of Health Training grants T32-AR-053463 and T32-CA-009120 (to ME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Baron ML, 2008, J IMMUNOL, V180, P7134, DOI 10.4049/jimmunol.180.11.7134; Bendriss-Vermare N, 2001, J CLIN INVEST, V107, P835, DOI 10.1172/JCI11734; Berkowitz RD, 1998, J VIROL, V72, P10108, DOI 10.1128/JVI.72.12.10108-10117.1998; Binder D, 1997, J EXP MED, V185, P517, DOI 10.1084/jem.185.3.517; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Cheney IW, 2002, J VIROL, V76, P11148, DOI 10.1128/JVI.76.21.11148-11154.2002; Chieux V, 1998, J VIROL METHODS, V70, P183, DOI 10.1016/S0166-0934(97)00177-8; FERBAS JJ, 1994, J IMMUNOL, V152, P4649; Fong L, 2002, J VIROL, V76, P11033, DOI 10.1128/JVI.76.21.11033-11041.2002; Foster GR, 2000, EUR J IMMUNOL, V30, P3228, DOI 10.1002/1521-4141(200011)30:11<3228::AID-IMMU3228>3.0.CO;2-B; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Grandvaux N, 2002, CURR OPIN INFECT DIS, V15, P259, DOI 10.1097/00001432-200206000-00008; Gurney KB, 2004, J IMMUNOL, V173, P7269, DOI 10.4049/jimmunol.173.12.7269; Gurney KB, 2006, CLIN VACCINE IMMUNOL, V13, P1237, DOI 10.1128/CVI.00184-06; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Hanabuchi S, 2010, J IMMUNOL, V184, P2999, DOI 10.4049/jimmunol.0804106; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; HORISBERGER MA, 1983, P NATL ACAD SCI-BIOL, V80, P1910, DOI 10.1073/pnas.80.7.1910; Ito T, 2001, J IMMUNOL, V166, P2961, DOI 10.4049/jimmunol.166.5.2961; JAMIESON BD, 1995, J VIROL, V69, P6259, DOI 10.1128/JVI.69.10.6259-6264.1995; Jamieson BD, 1997, J VIROL, V71, P8245, DOI 10.1128/JVI.71.11.8245-8253.1997; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Keir ME, 2002, J IMMUNOL, V168, P325, DOI 10.4049/jimmunol.168.1.325; KHAN NUD, 1990, IMMUNOLOGY, V71, P230; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Kitchen SG, 1997, J VIROL, V71, P6928, DOI 10.1128/JVI.71.9.6928-6934.1997; Kochs G, 1998, METHODS, V15, P255, DOI 10.1006/meth.1998.0629; Kochs G, 2002, P NATL ACAD SCI USA, V99, P3153, DOI 10.1073/pnas.052430399; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lin Q, 1998, J EXP MED, V187, P79, DOI 10.1084/jem.187.1.79; LINDENMANN J, 1964, P SOC EXP BIOL MED, V116, P506, DOI 10.3181/00379727-116-29292; Martin-Gayo E, 2010, BLOOD, V115, P5366, DOI 10.1182/blood-2009-10-248260; Meager A, 2006, PLOS MED, V3, P1152, DOI 10.1371/journal.pmed.0030289; Mibayashi M, 2002, MICROBIOL IMMUNOL, V46, P29, DOI 10.1111/j.1348-0421.2002.tb02673.x; Numajiri A, 2006, J INTERF CYTOK RES, V26, P214, DOI 10.1089/jir.2006.26.214; Pedroza-Martins L, 1998, J VIROL, V72, P9441, DOI 10.1128/JVI.72.12.9441-9452.1998; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Res PCM, 1999, BLOOD, V94, P2647, DOI 10.1182/blood.V94.8.2647.420k06_2647_2657; Schmidlin H, 2006, BLOOD, V108, P3792, DOI 10.1182/blood-2006-02-004978; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9; Strasser A, 2008, IMMUNOL CELL BIOL, V86, P57, DOI 10.1038/sj.icb.7100141; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; Uittenbogaart CH, 1996, AIDS, V10, pF9, DOI 10.1097/00002030-199606001-00001; Vandenabeele S, 2001, BLOOD, V97, P1733, DOI 10.1182/blood.V97.6.1733; VONWUSSOW P, 1990, EUR J IMMUNOL, V20, P2015, DOI 10.1002/eji.1830200920; VONWUSSOW P, 1990, AIDS, V4, P119, DOI 10.1097/00002030-199002000-00004; Yonezawa A, 2003, J VIROL, V77, P3777, DOI 10.1128/JVI.77.6.3777-3784.2003; Zheng SJ, 2003, IMMUNOL RES, V28, P295, DOI 10.1385/IR:28:3:295	52	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24252	10.1371/journal.pone.0024252	http://dx.doi.org/10.1371/journal.pone.0024252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904619	Green Published, Green Submitted, gold			2022-12-25	WOS:000294680800072
J	Hsieh, YH; Ma, S; Hernandez, JXV; Lee, VJ; Lim, WY				Hsieh, Ying-Hen; Ma, Stefan; Velasco Hernandez, Jorge X.; Lee, Vernon J.; Lim, Wei Yen			Early Outbreak of 2009 Influenza A (H1N1) in Mexico Prior to Identification of pH1N1 Virus	PLOS ONE			English	Article							A/H1N1; NUMBER	Background: In the aftermath of the global spread of 2009 influenza A (pH1N1) virus, still very little is known of the early stages of the outbreak in Mexico during the early months of the year, before the virus was identified. Methodology/Main Findings: We fit a simple mathematical model, the Richards model, to the number of excess laboratory-confirmed influenza cases in Mexico and Mexico City during the first 15 weeks in 2009 over the average influenza case number of the previous five baseline years of 2004-2008 during the same period to ascertain the turning point (or the peak incidence) of a wave of early influenza infections, and to estimate the transmissibility of the virus during these early months in terms of its basic reproduction number. The results indicate that there may have been an early epidemic in Mexico City as well as in all of Mexico during February/March. Based on excess influenza cases, the estimated basic reproduction number R-0 for the early outbreak was 1.59 (0.55 to 2.62) for Mexico City during weeks 5-9, and 1.25 (0.76, 1.74) for all of Mexico during weeks 5-14. Conclusions: We established the existence of an early epidemic in Mexico City and in all of Mexico during February/March utilizing the routine influenza surveillance data, although the location of seeding is unknown. Moreover, estimates of R-0 as well as the time of peak incidence (the turning point) for Mexico City and all of Mexico indicate that the early epidemic in Mexico City in February/March had been more transmissible (larger R-0) and peaked earlier than the rest of the country. Our conclusion lends support to the possibility that the virus could have already spread to other continents prior to the identification of the virus and the reporting of lab-confirmed pH1N1 cases in North America in April.	[Hsieh, Ying-Hen] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Hsieh, Ying-Hen] China Med Univ, Ctr Infect Dis Educ & Res, Taichung, Taiwan; [Ma, Stefan; Lim, Wei Yen] Minist Hlth Singapore, Epidemiol & Dis Control Div, Singapore, Singapore; [Velasco Hernandez, Jorge X.] Inst Mexicano Petr, Programa Matemat Aplicadas & Computac, Mexico City, DF, Mexico; [Velasco Hernandez, Jorge X.] Natl Polytech Inst, Interdisciplinary Ctr Res & Studies Environm & De, Dept Biociencias & Ingn, Mexico City, DF, Mexico; [Lee, Vernon J.] Singapore Armed Forces, Headquarters Med Corps, Singapore, Singapore; [Lee, Vernon J.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore	China Medical University Taiwan; China Medical University Taiwan; Ministry of Health-Singapore; Instituto Mexicano del Petroleo; Instituto Politecnico Nacional - Mexico; National University of Singapore	Hsieh, YH (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.	hsieh@mail.cmu.edu.tw	Hsieh, Ying-Hen/E-9685-2010; Velasco-Hernandez, Jorge/A-5391-2008	Velasco-Hernandez, Jorge/0000-0002-5604-7719	NSC [97-2118-M-039-004, 97-2314-B-039-013-MY3, 97-2115-M-039-002-MY3]; CMU [97 323]; NIMBioS through NSF [EF-0832-858]; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	NSC(Ministry of Science and Technology, Taiwan); CMU; NIMBioS through NSF; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	YHH is funded by grants (NSC 97-2118-M-039-004, 97-2314-B-039-013-MY3, 97-2115-M-039-002-MY3) and (CMU 97 323). JXVH acknowledges partial support from NIMBioS through NSF grant (EF-0832-858). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P481; [Anonymous], 2010, LACRONICA       0113; Avila E, 2010, UNIVERSAL       0428; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Boelle PY, 2009, EURO SURVEILL, V14; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Chao DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014555; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Colizza Vittoria, 2009, PLoS Curr, V1, pRRN1129; Comite Nacional de Vigilancia Epidemiologica, 2006, MAN PROC NOT SEM CAS; Cruz-Pacheco G, 2009, EUROSURVEILLANCE, V14; de Silva UC, 2009, EUROSURVEILLANCE, V14, P11; Fajardo-Dolci GE, 2009, SALUD PUBLICA MEXICO, V51, P361; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hsieh YH, 2006, EMERG INFECT DIS, V12, P122, DOI 10.3201/eid1201.050396; Hsieh YH, 2004, EMERG INFECT DIS, V10, P1165, DOI 10.3201/eid1006.031023; Hsieh YH, 2008, SERIES CONT APPL MAT, V11; Hsieh YH, 2009, TROP MED INT HEALTH, V16, P1; Hsieh Ying-Hen, 2010, BMC Res Notes, V3, P283, DOI 10.1186/1756-0500-3-283; Hsieh YH, 2010, INFLUENZA OTHER RESP, V4, P187, DOI 10.1111/j.1750-2659.2010.00147.x; Hsieh YH, 2009, AM J TROP MED HYG, V80, P66, DOI 10.4269/ajtmh.2009.80.66; Kelly HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011341; Lipsitch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006895; Lopez-Cervantes M, 2010, REV DIGITAL U, V11; McBryde ES, 2009, EUROSURVEILLANCE, V14, P45; Munayco CV, 2009, EUROSURVEILLANCE, V14, P6; Nishiura H, 2009, EUROSURVEILLANCE, V14, P1; Nishiura H, 2009, NEW ZEAL MED J, V122, P73; Peacey M, 2010, EMERG INFECT DIS; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Secretaria de Salud Mexico, 2006, MAN VIG EP INFL; Tena G, 2010, GRIPE H1N1 SE GESTO; US Centers for Disease Control, 2009, CDC BRIEF PUBL HLTH; Velasco-Hernandez JX, LEITE MCA M IN PRESS; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; WHO, 2009, SUMM REP HIGH LEV CO; World Health Organization, 2009, WORLD NOW START 2009; Yang JR, 2009, J CLIN MICROBIOL, V47, P3714, DOI 10.1128/JCM.01646-09	42	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23853	10.1371/journal.pone.0023853	http://dx.doi.org/10.1371/journal.pone.0023853			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909366	gold, Green Published			2022-12-25	WOS:000294680800028
J	van den Biggelaar, M; Bouwens, EAM; Voorberg, J; Mertens, K				van den Biggelaar, Maartje; Bouwens, Eveline A. M.; Voorberg, Jan; Mertens, Koen			Storage of Factor VIII Variants with Impaired von Willebrand Factor Binding in Weibel-Palade Bodies in Endothelial Cells	PLOS ONE			English	Article							COAGULATION-FACTOR-VIII; MILD HEMOPHILIA-A; RELEASABLE POOL; BLOOD; DOMAIN; FVIII; VWF; DESMOPRESSIN; TRAFFICKING; MECHANISMS	Background: Point mutations resulting in reduced factor VIII (FVIII) binding to von Willebrand factor (VWF) are an important cause of mild/moderate hemophilia A. Treatment includes desmopressin infusion, which concomitantly increases VWF and FVIII plasma levels, apparently from storage pools containing both proteins. The source of these VWF/FVIII co-storage pools and the mechanism of granule biogenesis are not fully understood. Methodology/Principal Findings: We studied intracellular trafficking of FVIII variants implicated in mild/moderate hemophilia A together with VWF in HEK293 cells and primary endothelial cells. The role of VWF binding was addressed using FVIII variants displaying reduced VWF interaction. Binding studies using purified FVIII proteins revealed moderate (Arg2150His, Del2201, Pro2300Ser) to severe (Tyr1680Phe, Ser2119Tyr) VWF binding defects. Expression studies in HEK293 cells and primary endothelial cells revealed that all FVIII variants were present within VWF-containing organelles. Quantitative studies showed that the relative amount of FVIII storage was independent of various mutations. Substantial amounts of FVIII variants are co-stored in VWF-containing storage organelles, presumably by virtue of their ability to interact with VWF at low pH. Conclusions: Our data suggest that the potential of FVIII co-storage with VWF is not affected in mild/moderate hemophilia A caused by reduced FVIII/VWF interaction in the circulation. These data support the hypothesis that Weibel-Palade bodies comprise the desmopressin-releasable FVIII storage pool in vivo.	[van den Biggelaar, Maartje; Bouwens, Eveline A. M.; Voorberg, Jan; Mertens, Koen] Sanquin Res, Dept Plasma Prot, Amsterdam, Netherlands; [van den Biggelaar, Maartje; Bouwens, Eveline A. M.; Mertens, Koen] Univ Utrecht, Dept Pharmaceut, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Voorberg, Jan] Univ Amsterdam, Landsteiner Lab AMC & Sanquin, Amsterdam, Netherlands	Utrecht University; University of Amsterdam	van den Biggelaar, M (corresponding author), Sanquin Res, Dept Plasma Prot, Amsterdam, Netherlands.	m.vandenbiggelaar@sanquin.nl		Voorberg, Jan/0000-0003-4585-2621				Bierings R, 2007, J THROMB HAEMOST, V5, P2512, DOI 10.1111/j.1538-7836.2007.02768.x; Borchiellini A, 1996, BLOOD, V88, P2951, DOI 10.1182/blood.V88.8.2951.bloodjournal8882951; d'Oiron R, 2004, BLOOD, V103, P155, DOI 10.1182/blood-2003-04-1321; d'Oiron R, 2003, J THROMB HAEMOST S1, V1, pOC214; de Leeuw HPJC, 1999, THROMB HAEMOSTASIS, V82, P1177, DOI 10.1055/s-0037-1614349; De Meyer SF, 2006, BLOOD, V107, P4728, DOI 10.1182/blood-2005-09-3605; de Wit TR, 2003, ARTERIOSCL THROM VAS, V23, P755, DOI 10.1161/01.ATV.0000069847.72001.E8; DONATH MJSH, 1995, J BIOL CHEM, V270, P3648, DOI 10.1074/jbc.270.8.3648; Erent A, 2007, J PHYSIOL-LONDON, V583, P195, DOI 10.1113/jphysiol.2007.132993; Follenzi A, 2008, J CLIN INVEST, V118, P935, DOI 10.1172/JCI32748; Fribourg C, 2006, BIOCHEMISTRY-US, V45, P10777, DOI 10.1021/bi060451h; Haberichter SL, 2009, BLOOD, V113, P2873, DOI 10.1182/blood-2009-01-199844; Haberichter SL, 2006, PEDIATR BLOOD CANCER, V46, P547, DOI 10.1002/pbc.20658; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; Jacquemin M, 2003, J THROMB HAEMOST, V1, P456, DOI 10.1046/j.1538-7836.2003.00088.x; Jacquemin M, 2000, BLOOD, V96, P958, DOI 10.1182/blood.V96.3.958.015k13_958_965; Jacquemin M, 2006, BLOOD, V108, P515, DOI 10.1182/blood-2005-11-4571; Kaufman RJ, 2003, J THROMB HAEMOST, V1, P2472, DOI 10.1111/j.1538-7836.2003.00540.x; Kumaran V, 2005, J THROMB HAEMOST, V3, P2022, DOI 10.1111/j.1538-7836.2005.01508.x; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; Lethagen S, 2003, SEMIN THROMB HEMOST, V29, P101, DOI 10.1055/s-2003-37944; LEYTE A, 1991, J BIOL CHEM, V266, P740; Mannucci PM, 2000, HAEMOPHILIA, V6, P60; MANNUCCI PM, 1975, BRIT J HAEMATOL, V30, P81, DOI 10.1111/j.1365-2141.1975.tb00521.x; Mannucci PM, 2001, NEW ENGL J MED, V344, P1773, DOI 10.1056/NEJM200106073442307; Michaux G, 2006, DEV CELL, V10, P223, DOI 10.1016/j.devcel.2005.12.012; Modderman PW, 1998, BIOCHEM J, V336, P153, DOI 10.1042/bj3360153; Montgomery RR, 2000, J PEDIAT HEMATOL ONC, V22, P269, DOI 10.1097/00043426-200005000-00017; Rich RL, 2007, J MOL RECOGNIT, V20, P300, DOI 10.1002/jmr.862; Rosenberg JB, 1998, J CLIN INVEST, V101, P613, DOI 10.1172/JCI1250; Rosenberg JB, 2000, ARTERIOSCL THROM VAS, V20, P2689, DOI 10.1161/01.ATV.20.12.2689; Sadler JE, 2009, J THROMB HAEMOST, V7, P24, DOI 10.1111/j.1538-7836.2009.03375.x; Shi QZ, 2010, BLOOD, V116, P3049, DOI 10.1182/blood-2010-03-272419; Shovlin Claire L, 2010, PLoS One, V5, pe9154, DOI 10.1371/journal.pone.0009154; Spiegel PC, 2004, J BIOL CHEM, V279, P53691, DOI 10.1074/jbc.M409389200; Thompson AR, 2003, SEMIN THROMB HEMOST, V29, P11, DOI 10.1055/s-2003-37935; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Van den Biggelaar M, 2007, J THROMB HAEMOST, V5, P2235, DOI 10.1111/j.1538-7836.2007.02737.x; van den Biggelaar M, 2009, HAEMATOL-HEMATOL J, V94, P670, DOI 10.3324/haematol.13427; van den Biggelaar M, 2009, BLOOD, V113, P3102, DOI 10.1182/blood-2008-05-159699; Wilcox DA, 2003, J THROMB HAEMOST, V1, P2477, DOI 10.1111/j.1538-7836.2003.00534.x; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Yarovoi HV, 2003, BLOOD, V102, P4006, DOI 10.1182/blood-2003-05-1519	43	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24163	10.1371/journal.pone.0024163	http://dx.doi.org/10.1371/journal.pone.0024163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909383	Green Submitted, gold, Green Published			2022-12-25	WOS:000294680800060
J	Kirchhoff, NT; Rough, KM; Nowak, BF				Kirchhoff, Nicole T.; Rough, Kirsty M.; Nowak, Barbara F.			Moving Cages Further Offshore: Effects on Southern Bluefin Tuna, T. maccoyii, Parasites, Health and Performance	PLOS ONE			English	Article							THUNNUS-MACCOYII; CARDICOLA-FORSTERI; BLOOD-FLUKE; AQUACULTURE; CASTELNAU; AUSTRALIA; STRESS; SALMON	The effects of offshore aquaculture on SBT health (particularly parasitic infections and haematology) and performance were the main aim of this study. Two cohorts of ranched Southern Bluefin tuna (SBT) (Thunnus maccoyii) were monitored throughout the commercial season, one maintained in the traditional near shore tuna farming zone and one maintained further offshore. SBT maintained offshore had reduced mortality, increased condition index at week 6 post transfer, reduced blood fluke and sealice loads, and haematological variables such as haemoglobin or lysozyme equal to or exceeding near shore maintained fish. The offshore cohort had no Cardicola forsteri and a 5% prevalence of Caligus spp., compared to a prevalence of 85% for Cardicola forsteri and 55% prevalence for Caligus spp. near shore at 6 weeks post transfer. This study is the first of its kind to examine the effects of commercial offshore sites on farmed fish parasites, health and performance.	[Kirchhoff, Nicole T.; Nowak, Barbara F.] Univ Tasmania, Natl Ctr Marine Conservat & Resource Sustainabil, Launceston, Tas 7250, Australia; [Rough, Kirsty M.] Australian So Bluefin Tuna Ind Assoc, Port Lincoln, SA, Australia	University of Tasmania	Kirchhoff, NT (corresponding author), Univ Tasmania, Natl Ctr Marine Conservat & Resource Sustainabil, Launceston, Tas 7250, Australia.	Nicole.Kirchhoff@utas.edu.au	Nowak, Barbara/J-7261-2014; Kirchhoff, Nicole/B-2732-2012	Nowak, Barbara/0000-0002-0347-643X; 	Australian Government; Commonwealth and state-based fisheries [2008/228]; FRDC	Australian Government(Australian GovernmentCGIAR); Commonwealth and state-based fisheries; FRDC	The Fisheries Research and Development Corporation (FRDC), which obtains funding from the Australian Government and contributions revenue from the Commonwealth and state-based fisheries, provided funding for this project under the project name: 2008/228 Maintaining SBT High Health Status Understanding SBT parasites and investigating ways to mitigate their influence on SBT production. While the authors received funding from FRDC, FRDC does not control any project outcomes and all information acquired during this project is public, therefore adheres to all PloS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken HM, 2006, AQUACULTURE, V254, P40, DOI 10.1016/j.aquaculture.2005.10.013; Aiken HM, 2008, FISH SHELLFISH IMMUN, V25, P66, DOI 10.1016/j.fsi.2007.12.010; BROWN BA, 1984, HEMATOLOGY PRINCIPLE, P29; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Carrington AC, 2007, FISH SHELLFISH IMMUN, V23, P781, DOI 10.1016/j.fsi.2007.02.006; Cribb TH, 2000, T ROY SOC SOUTH AUST, V124, P117; CRIBB TH, 2011, INT J PARAS IN PRESS; *ERA, 2009, EC STRAT OFFSH AQ RE; Gatica MC, 2010, ARCH MED VET, V42, P73, DOI 10.4067/S0301-732X2010000100010; Hayward CJ, 2009, J FISH DIS, V32, P101, DOI 10.1111/j.1365-2761.2008.01010.x; HAYWARD CJ, 2011, AQUACULTURE IN PRESS; Hayward CJ, 2008, DIS AQUAT ORGAN, V79, P57, DOI 10.3354/dao01890; Hayward CJ, 2010, VET PARASITOL, V173, P107, DOI 10.1016/j.vetpar.2010.06.007; HERZFELD M, 2008, SARDI RES REPORT SER, V342; Hobday A. J., 2008, IMPLICATIONS CLIMATE; JONES EM, 2010, THESIS FLINDERS U AU; Kirchhoff NT, 2011, AQUACULTURE, V315, P207, DOI 10.1016/j.aquaculture.2011.02.036; KIRCHHOFF NT, 2011, J FISH BIOL IN PRESS; Nowak BF, 2004, B EUR ASSOC FISH PAT, V24, P45; NOWAK BF, 2009, 2006225 FRFDC; *OATP, 2007, INT WORKSH OFFSH AQ; Porter-Smith R, 2004, MAR GEOL, V211, P1, DOI 10.1016/j.margeo.2004.05.031; REDDING JM, 1983, T AM FISH SOC, V112, P800, DOI 10.1577/1548-8659(1983)112<800:IOASOO>2.0.CO;2; Reiczigel J., 2005, QUANTITATIVE PARASIT; Svane I, 2008, J EXP MAR BIOL ECOL, V363, P110, DOI 10.1016/j.jembe.2008.06.028; Urbinati EC, 2004, AQUACULTURE, V229, P389, DOI 10.1016/S0044-8486(03)00350-8; Watts M, 2002, J FISH DIS, V25, P191, DOI 10.1046/j.1365-2761.2002.00342.x; Yano T., 1992, TECHNIQUES FISH IMMU, P131	28	29	29	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23705	10.1371/journal.pone.0023705	http://dx.doi.org/10.1371/journal.pone.0023705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901129	gold, Green Submitted, Green Published			2022-12-25	WOS:000294298000014
J	Martin, C; Passilly-Degrace, P; Gaillard, D; Merlin, JF; Chevrot, M; Besnard, P				Martin, Celine; Passilly-Degrace, Patricia; Gaillard, Dany; Merlin, Jean-Francois; Chevrot, Michael; Besnard, Philippe			The Lipid-Sensor Candidates CD36 and GPR120 Are Differentially Regulated by Dietary Lipids in Mouse Taste Buds: Impact on Spontaneous Fat Preference	PLOS ONE			English	Article							ACID; EXPRESSION; RECEPTORS; SECRETION; GUSTDUCIN	Background: Recent studies in rodents and humans suggest that the chemoreception of long-chain fatty acids (LCFA) in oral cavity is involved in the spontaneous preference for fatty foods and might contribute to the obesity risk. CD36 and GPR120 are LCFA receptors identified in rodent taste bud cells. The fact that CD36 or GPR120 gene inactivation leads to a decrease in the preference for lipids raises the question of the respective role(s) played by these gustatory lipid-sensor candidates. Methodology/Principal Findings: Using a combination of biochemical, nutritional and behavioural studies in wild-type, CD36(+/-) and CD36(-/-) mice, it was found that: 1 degrees) CD36 and GPR120 display different diurnal rhythms in the gustatory circumvallate papillae, CD36 mRNA levels being down-regulated during the dark period in contrast to GPR120, 2 degrees) this change is due to food intake and strictly dependent of the presence of lipids in the diet, 3 degrees) CD36 protein levels are also rapidly but transiently decreased by the food intake, a two-fold drop in CD36 protein levels being found 1 h after refeeding, followed by a progressive return to the pre-prandial values, 4 degrees) this down-regulation, which has a post-transcriptional origin, seems sufficient to alter the spontaneous fat preference, independently to change in the GPR120 gene expression. Conclusions/Significance: In contrast to GPR120, CD36 appears to be a food-sensitive lipid sensor in the gustatory circumvallate papillae. Lipid-mediated change in lingual CD36 expression might modulate the motivation for fat during a meal, initially high and then gradually decreasing secondary to the food intake. This short-term lipid-mediated effect is reminiscent of sensory-specific satiety. These findings, which highlight the role played by CD36 in the oro-sensory perception of dietary lipids, raise the possibility of novel pharmacological strategies to modify attraction for fatty foods and decrease obesity risks.	[Martin, Celine; Passilly-Degrace, Patricia; Gaillard, Dany; Merlin, Jean-Francois; Chevrot, Michael; Besnard, Philippe] Univ Bourgogne, INSERM, U866, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Martin, C (corresponding author), Univ Bourgogne, INSERM, U866, Dijon, France.	pbesnard@u-bourgogne.fr	Passilly-Degrace, Patricia/AAF-5903-2021	Gaillard, Dany/0000-0002-6875-025X	French Research Agency (ANR); Vitagora cluster; Burgundy Council; Centre National Interprofessionnel de l'Economie Laitiere (CNIEL)	French Research Agency (ANR)(French National Research Agency (ANR)); Vitagora cluster; Burgundy Council(Region Bourgogne-Franche-Comte); Centre National Interprofessionnel de l'Economie Laitiere (CNIEL)	This work was supported by the French Research Agency (ANR) and the Vitagora cluster (SensoFAT project to P. B.) and by the Burgundy Council and Centre National Interprofessionnel de l'Economie Laitiere (CNIEL) (HumanFATaste project to P. B.). C. M. and M. C. are fellows of ANR and Ministere de l'Enseignement Superieur et de la Recherche, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie AGS, 1996, J MEMBRANE BIOL, V153, P75, DOI 10.1007/s002329900111; Bray GA, 2004, PHYSIOL BEHAV, V83, P549, DOI 10.1016/j.physbeh.2004.08.039; CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; El-Yassimi A, 2008, J BIOL CHEM, V283, P12949, DOI 10.1074/jbc.M707478200; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Fukuwatari T, 1997, FEBS LETT, V414, P461, DOI 10.1016/S0014-5793(97)01055-7; Gaillard D, 2008, FASEB J, V22, P1458, DOI 10.1096/fj.07-8415com; Gilbertson TA, 1998, ANN NY ACAD SCI, V855, P165, DOI 10.1111/j.1749-6632.1998.tb10560.x; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Martin C, 2011, PHYSIOL BEHAV, V105, P36, DOI 10.1016/j.physbeh.2011.02.029; Matsumura S, 2007, BIOMED RES-TOKYO, V28, P49, DOI 10.2220/biomedres.28.49; Mattes RD, 2009, ANNU REV NUTR, V29, P305, DOI 10.1146/annurev-nutr-080508-141108; Passilly-Degrace P, 2009, RESULTS PROBL CELL D, V47, P221, DOI 10.1007/400_2008_7; Rac ME, 2007, MOL MED, V13, P288, DOI 10.2119/2006-00088.Rac; Sclafani A, 2007, AM J PHYSIOL-REG I, V293, pR1823, DOI 10.1152/ajpregu.00211.2007; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Simons PJ, 2011, ACTA HISTOCHEM, V113, P839, DOI 10.1016/j.acthis.2010.08.006; Stewart JE, 2010, BRIT J NUTR, V104, P145, DOI 10.1017/S0007114510000267; Thi TTT, 2011, J BIOL CHEM, V286, P25201, DOI 10.1074/jbc.M111.233551	26	113	118	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e24014	10.1371/journal.pone.0024014	http://dx.doi.org/10.1371/journal.pone.0024014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901153	Green Published, Green Submitted, gold			2022-12-25	WOS:000294298000038
J	Vissers, YM; Blanc, F; Skov, PS; Johnson, PE; Rigby, NM; Przybylski-Nicaise, L; Bernard, H; Wal, JM; Ballmer-Weber, B; Zuidmeer-Jongejan, L; Szepfalusi, Z; Ruinemans-Koerts, J; Jansen, APH; Savelkoul, HFJ; Wichers, HJ; Mackie, AR; Mills, CEN; Adel-Patient, K				Vissers, Yvonne M.; Blanc, Fany; Skov, Per Stahl; Johnson, Phil E.; Rigby, Neil M.; Przybylski-Nicaise, Laetitia; Bernard, Herve; Wal, Jean-Michel; Ballmer-Weber, Barbara; Zuidmeer-Jongejan, Laurian; Szepfalusi, Zsolt; Ruinemans-Koerts, Janneke; Jansen, Ad P. H.; Savelkoul, Huub F. J.; Wichers, Harry J.; Mackie, Alan R.; Mills, Clare E. N.; Adel-Patient, Karine			Effect of Heating and Glycation on the Allergenicity of 2S Albumins (Ara h 2/6) from Peanut	PLOS ONE			English	Article							T-CELL RESPONSES; LIPID TRANSFER PROTEIN; IGE-BINDING EPITOPES; IN-VITRO ASSAY; MAILLARD REACTION; MAJOR ALLERGEN; B-CELL; REACTIVITY; DIGESTION; CHILDREN	Background: Peanut allergy is one of the most common and severe food allergies, and processing is known to influence the allergenicity of peanut proteins. We aimed to establish the effect of heating and glycation on the IgE-binding properties and biological activity of 2S albumins (Ara h 2/6) from peanut. Methodology/Principal Findings: Native Ara h 2/6 was purified from raw peanuts and heated in solution (15 min, 110 degrees C) in the presence or absence of glucose. Ara h 2 and 6 were also purified from roasted peanut. Using PBMC and sera from peanut-allergic patients, the cellular proliferative potency and IgE reactivity (reverse EAST inhibition) and functionality (basophil degranulation capacity) of allergens were assessed. Heating Ara h 2/6 at 110 degrees C resulted in extensive denaturation, hydrolysis and aggregation of the protein, whilst Ara h 2 and 6 isolated from roasted peanut retained its native conformation. Allergen stimulation of PBMC induced proliferation and Th2 cytokine secretion which was unaffected by thermal processing. Conversely, IgE reactivity and functionality of Ara h 2/6 was decreased by heating. Whilst heating-glycation further reduced the IgE binding capacity of the proteins, it moderated their loss of histamine releasing capacity. Ara h 2 and 6 purified from roasted peanut demonstrated the same IgE reactivity as unheated, native Ara h 2/6. Conclusions/Significance: Although no effect of processing on T-cell reactivity was observed, heat induced denaturation reduced the IgE reactivity and subsequent functionality of Ara h 2/6. Conversely, Ara h 2 and 6 purified from roasted peanut retained the structure and IgE reactivity/functionality of the native protein which may explain the allergenic potency of this protein. Through detailed molecular study and allergenicity assessment approaches, this work then gives new insights into the effect of thermal processing on structure/allergenicity of peanut proteins.	[Vissers, Yvonne M.; Wichers, Harry J.] Univ Wageningen & Res Ctr, Food Chem Grp, Wageningen, Netherlands; [Blanc, Fany; Przybylski-Nicaise, Laetitia; Bernard, Herve; Wal, Jean-Michel; Adel-Patient, Karine] INRA, Dept Alimentat Humaine, Unite Immunoallergie Alimentaire UR496, Jouy En Josas, France; [Skov, Per Stahl] RefLab ApS, Copenhagen, Denmark; [Johnson, Phil E.; Rigby, Neil M.; Mackie, Alan R.; Mills, Clare E. N.] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Ballmer-Weber, Barbara] Univ Zurich Hosp, Dept Dermatol, Allergy Unit, CH-8091 Zurich, Switzerland; [Zuidmeer-Jongejan, Laurian] Univ Amsterdam, Acad Med Ctr, Lab Allergy Res, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Szepfalusi, Zsolt] Med Univ Vienna, Dept Pediat, Vienna, Austria; [Ruinemans-Koerts, Janneke] Rijnstate Hosp, Dept Clin Chem & Haematol, Arnhem, Netherlands; [Jansen, Ad P. H.] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, NL-6525 ED Nijmegen, Netherlands; [Vissers, Yvonne M.; Savelkoul, Huub F. J.; Wichers, Harry J.] Univ Wageningen & Res Ctr, Cell Biol & Immunol Grp, Wageningen, Netherlands	Wageningen University & Research; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Zurich; University Zurich Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Medical University of Vienna; Rijnstate Hospital; Radboud University Nijmegen; Wageningen University & Research	Vissers, YM (corresponding author), Univ Wageningen & Res Ctr, Cell Biol & Immunol Grp, Wageningen, Netherlands.	Karine.Adel-Patient@cea.fr	Mackie, Alan/B-3753-2015; Savelkoul, Huub FJ/F-6026-2012; Jansen, A.P.H./L-4408-2015; Mackie, Alan/N-7780-2018	Mackie, Alan/0000-0002-5681-0593; Mackie, Alan/0000-0002-5681-0593; Zuidmeer-Jongejan, Laurian/0000-0003-3245-5555; Szepfalusi, Zsolt/0000-0003-4852-3102; BLANC, Fany/0000-0003-2366-9826; Wichers, HJ/0000-0002-8030-7090	EU [51400]; Biological and Biotechnological Sciences Research Council in the UK; Biotechnology and Biological Sciences Research Council [BBS/E/F/00041800] Funding Source: researchfish	EU(European Commission); Biological and Biotechnological Sciences Research Council in the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work described was carried out under the EU FP6 project "The Prevalence, Cost and Basis of Food Allergy Across Europe'', EuroPrevall (Contract No. 51400). ENCM, PEJ and NR were also supported by the institute strategic programme grant to IFR from the Biological and Biotechnological Sciences Research Council in the UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barre A, 2005, IMMUNOL LETT, V100, P153, DOI 10.1016/j.imlet.2005.03.014; Bernard H, 2007, J AGR FOOD CHEM, V55, P9663, DOI 10.1021/jf071424g; Bernard H, 2003, ALLERGY, V58, P1285, DOI 10.1046/j.1398-9995.2003.00300.x; Bernard H, 2009, ANAL BIOANAL CHEM, V395, P139, DOI 10.1007/s00216-009-2842-5; Beyer K, 2003, J ALLERGY CLIN IMMUN, V112, P202, DOI 10.1067/mai.2003.1621; Beyer KB, 2001, J ALLERGY CLIN IMMUN, V107, P1077, DOI 10.1067/mai.2001.115480; Blanc F, 2009, CLIN EXP ALLERGY, V39, P1277, DOI 10.1111/j.1365-2222.2009.03294.x; Bohle B, 2006, CLIN REV ALLERG IMMU, V30, P97, DOI 10.1385/CRIAI:30:2:97; Brockow K, 2009, ANAL BIOANAL CHEM, V395, P17, DOI 10.1007/s00216-009-2939-x; Chung SY, 2001, J AGR FOOD CHEM, V49, P3911, DOI 10.1021/jf001186o; Davis PJ, 1998, ALLERGY, V53, P102, DOI 10.1111/j.1398-9995.1998.tb04975.x; EFSA (European Food Safety Authority), 2004, EFSA J, V32, P1; Ehn BM, 2004, J AGR FOOD CHEM, V52, P1398, DOI 10.1021/jf0304371; Flinterman AE, 2007, CLIN EXP ALLERGY, V37, P1221, DOI 10.1111/j.1365-2222.2007.02764.x; Flinterman AE, 2008, J ALLERGY CLIN IMMUN, V121, P737, DOI 10.1016/j.jaci.2007.11.039; Gabrielsson S, 1997, CLIN EXP ALLERGY, V27, P808, DOI 10.1046/j.1365-2222.1997.560878.x; Gruber P, 2004, J AGR FOOD CHEM, V52, P4002, DOI 10.1021/jf035458+; Gruber P, 2005, J AGR FOOD CHEM, V53, P2289, DOI 10.1021/jf048398w; Hilmenyuk T, 2010, IMMUNOLOGY, V129, P437, DOI 10.1111/j.1365-2567.2009.03199.x; Ilchmann A, 2010, J ALLERGY CLIN IMMUN, V125, P175, DOI 10.1016/j.jaci.2009.08.013; Jensen LB, 2008, CLIN EXP ALLERGY, V38, P1969, DOI 10.1111/j.1365-2222.2008.03129.x; Jeurink PV, 2008, CRYOBIOLOGY, V57, P91, DOI 10.1016/j.cryobiol.2008.06.002; Johnson PE, 2010, MOL NUTR FOOD RES, V54, P1701, DOI 10.1002/mnfr.201000006; Koppelman SJ, 1999, J BIOL CHEM, V274, P4770, DOI 10.1074/jbc.274.8.4770; Koppelman SJ, 2005, CLIN EXP ALLERGY, V35, P490, DOI 10.1111/j.1365-2222.2005.02204.x; Lehmann K, 2006, BIOCHEM J, V395, P463, DOI 10.1042/BJ20051728; Maleki SJ, 2000, J ALLERGY CLIN IMMUN, V106, P763, DOI 10.1067/mai.2000.109620; Maleki SJ, 2000, J IMMUNOL, V164, P5844, DOI 10.4049/jimmunol.164.11.5844; Marsh J, 2008, MOL NUTR FOOD RES, V52, pS272, DOI 10.1002/mnfr.200700524; Mills ENC, 2009, BIOCHEMISTRY-US, V48, P12081, DOI 10.1021/bi901328f; Mondoulet L, 2005, J AGR FOOD CHEM, V53, P4547, DOI 10.1021/jf050091p; Morisawa Y, 2009, CLIN EXP ALLERGY, V39, P918, DOI 10.1111/j.1365-2222.2009.03203.x; Naegeli H, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4862; Nakamura A, 2006, J AGR FOOD CHEM, V54, P9529, DOI 10.1021/jf061070d; Sampson HA, 2003, PEDIATRICS, V111, P1601; Sancho AI, 2005, ALLERGY, V60, P1262, DOI 10.1111/j.1398-9995.2005.00876.x; Scheurer S, 2004, J ALLERGY CLIN IMMUN, V114, P900, DOI 10.1016/j.jaci.2004.06.017; Schimek EM, 2005, J ALLERGY CLIN IMMUN, V116, P1327, DOI 10.1016/j.jaci.2005.09.007; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; Shreffler WG, 2005, J ALLERGY CLIN IMMUN, V116, P893, DOI 10.1016/j.jaci.2005.06.033; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Stanley JS, 1997, ARCH BIOCHEM BIOPHYS, V342, P244, DOI 10.1006/abbi.1997.9998; Suhr M, 2004, MOL NUTR FOOD RES, V48, P390, DOI 10.1002/mnfr.200400028; Turcanu V, 2008, CLIN EXP ALLERGY, V38, P1132, DOI 10.1111/j.1365-2222.2008.03016.x; Turcanu VH, 2005, J ALLERGY CLIN IMMUN, V115, pS62; van Wijk F, 2004, CLIN EXP ALLERGY, V34, P1422, DOI 10.1111/j.1365-2222.2004.02062.x; Venter C, 2010, ALLERGY, V65, P103, DOI 10.1111/j.1398-9995.2009.02176.x; Vissers YM, 2011, FEMS IMMUNOL MED MIC, V61, P28, DOI 10.1111/j.1574-695X.2010.00741.x; Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x	49	70	76	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23998	10.1371/journal.pone.0023998	http://dx.doi.org/10.1371/journal.pone.0023998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901150	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000294298000035
J	Das, S; Rericha, EC; Bagorda, A; Parent, CA				Das, Satarupa; Rericha, Erin C.; Bagorda, Anna; Parent, Carole A.			Direct Biochemical Measurements of Signal Relay during Dictyostelium Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; COLLECTIVE CELL-MIGRATION; CYCLIC 3',5'-AMP RELAY; CHEMOATTRACTANT RECEPTOR; MEDIATED ACTIVATION; ADENYLYL-CYCLASE; DOWN-REGULATION; CAMP RECEPTOR; INDUCED PHOSPHORYLATION; DISCOIDEUM	Upon starvation, individual Dictyostelium discoideum cells enter a developmental program that leads to collective migration and the formation of a multicellular organism. The process is mediated by extracellular cAMP binding to the G protein-coupled cAMP receptor 1, which initiates a signaling cascade leading to the activation of adenylyl cyclase A (ACA), the synthesis and secretion of additional cAMP, and an autocrine and paracrine activation loop. The release of cAMP allows neighboring cells to polarize and migrate directionally and form characteristic chains of cells called streams. We now report that cAMP relay can be measured biochemically by assessing ACA, ERK2, and TORC2 activities at successive time points in development after stimulating cells with subsaturating concentrations of cAMP. We also find that the activation profiles of ACA, ERK2, and TORC2 change in the course of development, with later developed cells showing a loss of sensitivity to the relayed signal. We examined mutants in PKA activity that have been associated with precocious development and find that this loss in responsiveness occurs earlier in these mutants. Remarkably, we show that this loss in sensitivity correlates with a switch in migration patterns as cells transition from streams to aggregates. We propose that as cells proceed through development, the cAMP-induced desensitization and down-regulation of cAMP receptor 1 impacts the sensitivities of chemotactic signaling cascades leading to changes in migration patterns.	[Das, Satarupa; Bagorda, Anna; Parent, Carole A.] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Rericha, Erin C.] Univ Maryland, Inst Res Elect & Appl Phys, College Pk, MD 20742 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland College Park	Parent, CA (corresponding author), NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, 37 Convent Dr,Bldg 37,Rm 2066, Bethesda, MD 20892 USA.	parentc@mail.nih.gov		Das, Satarupa/0000-0002-4217-9972	National Institutes of Health NCI of the Center for Cancer Research; Burroughs Wellcome fund; NATIONAL CANCER INSTITUTE [ZIABC010418] Funding Source: NIH RePORTER	National Institutes of Health NCI of the Center for Cancer Research; Burroughs Wellcome fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health NCI Intramural Research Program of the Center for Cancer Research.; Recipient of a Career Award at the Scientific Interface from the Burroughs Wellcome fund.	Aubry L, 1999, ANNU REV CELL DEV BI, V15, P469, DOI 10.1146/annurev.cellbio.15.1.469; Bader S, 2007, BIOCHEM J, V402, P153, DOI 10.1042/BJ20061153; Bagorda A, 2009, J CELL SCI, V122, P3907, DOI 10.1242/jcs.051987; BRENNER M, 1984, DEV BIOL, V101, P136, DOI 10.1016/0012-1606(84)90124-6; Brzostowski JA, 2001, TRENDS BIOCHEM SCI, V26, P291, DOI 10.1016/S0968-0004(01)01804-7; Brzostowski JA, 2006, MOL BIOL CELL, V17, P4220, DOI 10.1091/mbc.E06-05-0376; Cai HQ, 2010, J CELL BIOL, V190, P233, DOI 10.1083/jcb.201001129; CATERINA MJ, 1995, J BIOL CHEM, V270, P4418, DOI 10.1074/jbc.270.9.4418; CATERINA MJ, 1995, J BIOL CHEM, V270, P8667, DOI 10.1074/jbc.270.15.8667; Charest PG, 2010, DEV CELL, V18, P737, DOI 10.1016/j.devcel.2010.03.017; Chen MY, 1997, GENE DEV, V11, P3218, DOI 10.1101/gad.11.23.3218; Comer FI, 2006, MOL BIOL CELL, V17, P357, DOI 10.1091/mbc.E05-08-0781; DEVREOTES PN, 1979, J CELL BIOL, V80, P300, DOI 10.1083/jcb.80.2.300; DINAUER MC, 1980, J CELL BIOL, V86, P545, DOI 10.1083/jcb.86.2.545; DINAUER MC, 1980, J CELL BIOL, V86, P537, DOI 10.1083/jcb.86.2.537; Garcia GL, 2008, J MICROSC-OXFORD, V231, P529, DOI 10.1111/j.1365-2818.2008.02066.x; Garcia GL, 2009, MOL BIOL CELL, V20, P3295, DOI 10.1091/mbc.E09-03-0223; HERELD D, 1994, J BIOL CHEM, V269, P7036; JOHNSON RL, 1991, BIOCHEMISTRY-US, V30, P6982, DOI 10.1021/bi00242a025; JOHNSON RL, 1992, J BIOL CHEM, V267, P4600; JOHNSON RL, 1993, GENE DEV, V7, P273, DOI 10.1101/gad.7.2.273; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; Kriebel PW, 2008, J CELL BIOL, V183, P949, DOI 10.1083/jcb.200808105; LACOMBE ML, 1986, J BIOL CHEM, V261, P6811; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laub MT, 1998, MOL BIOL CELL, V9, P3521, DOI 10.1091/mbc.9.12.3521; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Lee S, 1999, MOL BIOL CELL, V10, P2829, DOI 10.1091/mbc.10.9.2829; Luttrell Louis M., 2006, V332, P3; Maeda M, 1996, J BIOL CHEM, V271, P3351; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; Mann SKO, 1997, DEV BIOL, V183, P208, DOI 10.1006/dbio.1996.8499; McCann CP, 2010, J CELL SCI, V123, P1724, DOI 10.1242/jcs.060137; McMains VC, 2008, AGEING RES REV, V7, P234, DOI 10.1016/j.arr.2008.04.003; Nitta N, 2007, J IMMUNOL METHODS, V320, P155, DOI 10.1016/j.jim.2006.12.010; PARENT CA, 1995, J BIOL CHEM, V270, P22693, DOI 10.1074/jbc.270.39.22693; Sawai S, 2005, NATURE, V433, P323, DOI 10.1038/nature03228; Serge A, 2011, INTEGR BIOL-UK, V3, P675, DOI 10.1039/c0ib00121j; Shaulsky G, 1998, DEVELOPMENT, V125, P691; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Thomason PA, 1999, J BIOL CHEM, V274, P27379, DOI 10.1074/jbc.274.39.27379; VANHAASTERT PJM, 1987, J BIOL CHEM, V262, P7700; VANHAASTERT PJM, 1994, BIOCHEM J, V303, P539, DOI 10.1042/bj3030539; WANG M, 1988, DEV BIOL, V128, P72, DOI 10.1016/0012-1606(88)90268-0; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; WU LJ, 1995, J CELL BIOL, V129, P1667, DOI 10.1083/jcb.129.6.1667; Xiao Z, 1999, J BIOL CHEM, V274, P1440, DOI 10.1074/jbc.274.3.1440; Zhang H, 2003, EUKARYOT CELL, V2, P62, DOI 10.1128/EC.2.1.62-75.2003; Zhang N, 2001, MOL BIOL CELL, V12, P3204, DOI 10.1091/mbc.12.10.3204	50	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38649	38658		10.1074/jbc.M111.284182	http://dx.doi.org/10.1074/jbc.M111.284182			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911494	hybrid, Green Published			2022-12-25	WOS:000296594200077
J	Xue, L; Aihara, E; Wang, TC; Montrose, MH				Xue, Lin; Aihara, Eitaro; Wang, Timothy C.; Montrose, Marshall H.			Trefoil Factor 2 Requires Na/H Exchanger 2 Activity to Enhance Mouse Gastric Epithelial Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/H+ EXCHANGER; TARGETED DISRUPTION; BARRIER HOMEOSTASIS; MUCOSAL RESTITUTION; RABBIT PARIETAL; ACID-SECRETION; CELL-MIGRATION; MUCOUS CELLS; SURFACE PH; IN-VIVO	Trefoil factor (TFF) peptides are pivotal for gastric restitution after surface epithelial damage, but TFF cellular targets that promote cell migration are poorly understood. Conversely, Na/H exchangers (NHE) are often implicated in cellular migration but have a controversial role in gastric restitution. Using intravital microscopy to create microscopic lesions in the mouse gastric surface epithelium and directly measure epithelial restitution, we evaluated whether TFFs and NHE isoforms share a common pathway to promote epithelial repair. Blocking Na/H exchange (luminal 10 mu M 5-(N-ethyl-N-isopropyl) amiloride or 25 mu M HOE694) slows restitution 72-83% in wild-type or NHE1(-/-) mice. In contrast, HOE694 has no effect on the intrinsically defective gastric restitution in NHE2(-/-) mice or TFF2(-/-) mice. In TFF2(-/-) mice, NHE2 protein is reduced 23%, NHE2 remains localized to apical membranes of surface epithelium, and NHE1 protein amount or localization is unchanged. The action of topical rat TFF3 to accelerate restitution in TFF2(-/-) mice was inhibited by AMD3100 (CXCR4 receptor antagonist). Furthermore, rat TFF3 did not rescue restitution when NHE2 was inhibited [TFF2(-/-) mice +HOE694, or NHE2(-/-) mice]. HOE694 had no effect on pH at the juxtamucosal surface before or after damage. We conclude that functional NHE2, but not NHE1, is essential for mouse gastric epithelial restitution and that TFFs activate epithelial repair via NHE2.	[Xue, Lin; Aihara, Eitaro; Montrose, Marshall H.] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [Wang, Timothy C.] Columbia Univ, Med Ctr, Div Digest & Liver Dis, New York, NY 10032 USA	University System of Ohio; University of Cincinnati; Columbia University	Montrose, MH (corresponding author), Univ Cincinnati, Dept Mol & Cellular Physiol, ML 0576,231 Albert Sabin Way, Cincinnati, OH 45267 USA.	mhm@uc.edu		Wang, Timothy/0000-0001-5730-3019	National Institutes of Health [DK54940, DK060758, DK050594]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054940, R01DK060758, R01DK050594, R37DK050594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54940 (to M. H. M.), DK060758 (to T. C. W.) and DK050594 (Dr. Gary E. Shull).	Babyatsky MW, 1996, GASTROENTEROLOGY, V110, P489, DOI 10.1053/gast.1996.v110.pm8566596; Bachmann O, 1998, AM J PHYSIOL-GASTR L, V275, pG1085, DOI 10.1152/ajpgi.1998.275.5.G1085; Baumgartner HK, 2002, J PHYSIOL-LONDON, V544, P871, DOI 10.1113/jphysiol.2002.024620; Behne MJ, 2002, J BIOL CHEM, V277, P47399, DOI 10.1074/jbc.M204759200; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; Boivin GP, 2000, COMPARATIVE MED, V50, P511; Chu JS, 2002, AM J PHYSIOL-CELL PH, V283, pC358, DOI 10.1152/ajpcell.01380.2000; Chu SY, 1999, J CLIN INVEST, V103, P605, DOI 10.1172/JCI5217; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; Demitrack ES, 2010, AM J PHYSIOL-GASTR L, V299, pG255, DOI 10.1152/ajpgi.00037.2010; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Dubeykovskaya Z, 2009, J BIOL CHEM, V284, P3650, DOI 10.1074/jbc.M804935200; Farrell JJ, 2002, J CLIN INVEST, V109, P193, DOI 10.1172/JCI200212529; Furukawa O, 1999, J PHARMACOL EXP THER, V288, P620; Guan YF, 2011, AM J PHYSIOL-CELL PH, V300, pC1404, DOI 10.1152/ajpcell.00270.2010; Hagen SJ, 2004, AM J PHYSIOL-GASTR L, V286, pG596, DOI 10.1152/ajpgi.00390.2002; Hoffmann W, 2005, CELL MOL LIFE SCI, V62, P2932, DOI 10.1007/s00018-005-5481-9; Ilic D, 2007, AM J PATHOL, V170, P2055, DOI 10.2353/ajpath.2007.061277; JEFFREY GP, 1994, GASTROENTEROLOGY, V106, P336, DOI 10.1016/0016-5085(94)90590-8; Joutsi T, 1996, DIGEST DIS SCI, V41, P2187, DOI 10.1007/BF02071399; Kirchhoff P, 2003, AM J PHYSIOL-GASTR L, V285, pG1242, DOI 10.1152/ajpgi.00165.2003; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Klein M, 2000, J GEN PHYSIOL, V115, P599, DOI 10.1085/jgp.115.5.599; LACY ER, 1984, LAB INVEST, V51, P573; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; Moeser AJ, 2008, AM J PHYSIOL-GASTR L, V295, pG791, DOI 10.1152/ajpgi.00538.2007; Moeser AJ, 2006, AM J PHYSIOL-GASTR L, V291, pG885, DOI 10.1152/ajpgi.00380.2005; Musch MW, 2009, J PHARMACOL EXP THER, V330, P818, DOI 10.1124/jpet.109.151910; Nowak P, 2004, INT J MOL MED, V14, P175; Park SL, 2010, BRAIN RES, V1366, P189, DOI 10.1016/j.brainres.2010.09.077; Pizzonia JH, 1998, AM J PHYSIOL-RENAL, V275, pF510, DOI 10.1152/ajprenal.1998.275.4.F510; Rossmann H, 2001, AM J PHYSIOL-GASTR L, V281, pG447, DOI 10.1152/ajpgi.2001.281.2.G447; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Starodub OT, 2008, AM J PHYSIOL-CELL PH, V294, pC223, DOI 10.1152/ajpcell.00395.2006; Stock C, 2005, J PHYSIOL-LONDON, V567, P225, DOI 10.1113/jphysiol.2005.088344; Stock C, 2008, EUR J CELL BIOL, V87, P591, DOI 10.1016/j.ejcb.2008.01.007; STUARTTILLEY A, 1994, AM J PHYSIOL, V266, pC559, DOI 10.1152/ajpcell.1994.266.2.C559; Stuwe L, 2007, J PHYSIOL-LONDON, V585, P351, DOI 10.1113/jphysiol.2007.145185; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; THIM L, 1995, BIOCHEMISTRY-US, V34, P4757, DOI 10.1021/bi00014a033; Xue L, 2010, GUT, V59, P1184, DOI 10.1136/gut.2009.205625; Yanaka A, 2002, AM J PHYSIOL-GASTR L, V282, pG866, DOI 10.1152/ajpgi.00150.2001; YU FH, 1993, J BIOL CHEM, V268, P25536	43	43	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38375	38382		10.1074/jbc.M111.268219	http://dx.doi.org/10.1074/jbc.M111.268219			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900251	hybrid, Green Published			2022-12-25	WOS:000296594200051
J	Chandran, S; Li, H; Dong, WX; Krasinska, K; Adams, C; Alexandrova, L; Chien, A; Hallows, KR; Bhalla, V				Chandran, Sindhu; Li, Hui; Dong, Wuxing; Krasinska, Karolina; Adams, Chris; Alexandrova, Ludmila; Chien, Allis; Hallows, Kenneth R.; Bhalla, Vivek			Neural Precursor Cell-expressed Developmentally Down-regulated Protein 4-2 (Nedd4-2) Regulation by 14-3-3 Protein Binding at Canonical Serum and Glucocorticoid Kinase 1 (SGK1) Phosphorylation Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; UBIQUITIN LIGASE NEDD4-2; SODIUM-CHANNEL; FUNCTIONAL REGULATION; SURFACE EXPRESSION; LIDDLES-SYNDROME; ENAC REGULATION; ALDOSTERONE; INHIBITION; DEGRADATION	Regulation of epithelial Na+ channel (ENaC)-mediated transport in the distal nephron is a critical determinant of blood pressure in humans. Aldosterone via serum and glucocorticoid kinase 1 (SGK1) stimulates ENaC by phosphorylation of the E3 ubiquitin ligase Nedd4-2, which induces interaction with 14-3-3 proteins. However, the mechanisms of SGK1- and 14-3-3-mediated regulation of Nedd4-2 are unclear. There are three canonical SGK1 target sites on Nedd4-2 that overlap phosphorylation-dependent 14-3-3 interaction motifs. Two of these are termed "minor," and one is termed " major," based on weak or strong binding to 14-3-3 proteins, respectively. By mass spectrometry, we found that aldosterone significantly stimulates phosphorylation of a minor, relative to the major, 14-3-3 binding site on Nedd4-2. Phosphorylation-deficient minor site Nedd4-2 mutants bound less 14-3-3 than did wild-type (WT) Nedd4-2, and minor site Nedd4-2 mutations were sufficient to inhibit SGK1 stimulation of ENaC cell surface expression. As measured by pulse-chase and cycloheximide chase assays, a major binding site Nedd4-2 mutant had a shorter cellular half-life than WT Nedd4-2, but this property was not dependent on binding to 14-3-3. Additionally, a dimerization-deficient 14-3-3 epsilon mutant failed to bind Nedd4-2. We conclude that whereas phosphorylation at the Nedd4-2 major site is important for interaction with 14-3-3 dimers, minor site phosphorylation by SGK1 may be the relevant molecular switch that stabilizes Nedd4-2 interaction with 14-3-3 and thus promotes ENaC cell surface expression. We also propose that major site phosphorylation promotes cellular Nedd4-2 protein stability, which potentially represents a novel form of regulation for turnover of E3 ubiquitin ligases.	[Chandran, Sindhu; Dong, Wuxing; Bhalla, Vivek] Stanford Univ, Div Nephrol, Dept Med, Sch Med, Palo Alto, CA 94304 USA; [Li, Hui; Hallows, Kenneth R.] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Sch Med, Pittsburgh, PA 15261 USA; [Krasinska, Karolina; Adams, Chris; Alexandrova, Ludmila; Chien, Allis] Stanford Univ, Mass Spectrometry Facil, Stanford, CA 94305 USA	Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University	Bhalla, V (corresponding author), Stanford Univ, Div Nephrol, Dept Med, Sch Med, 780 Welch Rd,Suite 106, Palo Alto, CA 94304 USA.	vbhalla@stanford.edu	Chandran, Sindhu/AAE-6783-2021	Chandran, Sindhu/0000-0003-4547-3381; Hallows, Kenneth/0000-0002-2964-2440; Bhalla, Vivek/0000-0002-5420-9657; Chien, Allis/0000-0002-4805-2243	National Institutes of Health [T32 DK007357-26, R01 DK075048, K08 DK071648]; National Kidney Foundation [YIB787]; National Center for Research Resources [S10RR027425]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK071648, R01DK075048, R03DK083613, T32DK007357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 DK007357-26 (to S. C.), R01 DK075048 (to K. R. H), and K08 DK071648 (to V. B.). This work was also supported by National Kidney Foundation Young Investigator Grant YIB787 (to V. B.) and by National Center for Research Resources Award S10RR027425 (to the Stanford University Mass Spectrometry Facility).	Abriel H, 1999, J PHYSIOL-LONDON, V516, P31, DOI 10.1111/j.1469-7793.1999.031aa.x; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Edinger RS, 2009, J BIOL CHEM, V284, P150, DOI 10.1074/jbc.M807358200; Flores SY, 2005, J AM SOC NEPHROL, V16, P2279, DOI 10.1681/ASN.2004100828; Hallows KR, 2010, J BIOL CHEM, V285, P21671, DOI 10.1074/jbc.M109.084731; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Itani OA, 2005, AM J PHYSIOL-RENAL, V289, pF334, DOI 10.1152/ajprenal.00394.2004; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Lee IH, 2007, J BIOL CHEM, V282, P29866, DOI 10.1074/jbc.M701923200; Liang XB, 2008, J BIOL CHEM, V283, P27418, DOI 10.1074/jbc.M803687200; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; Liang XB, 2010, MOL BIOL CELL, V21, P2024, DOI 10.1091/mbc.E10-01-0042; Malik B, 2005, AM J PHYSIOL-RENAL, V289, pF107, DOI 10.1152/ajprenal.00179.2002; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Michlig S, 2005, J BIOL CHEM, V280, P38264, DOI 10.1074/jbc.M506308200; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4	31	38	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37830	37840		10.1074/jbc.M111.293233	http://dx.doi.org/10.1074/jbc.M111.293233			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900244	Green Published, hybrid			2022-12-25	WOS:000296542400077
J	Floquet, C; Rousset, JP; Bidou, L				Floquet, Celia; Rousset, Jean-Pierre; Bidou, Laure			Readthrough of Premature Termination Codons in the Adenomatous Polyposis Coli Gene Restores Its Biological Activity in Human Cancer Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; NONSENSE MUTATIONS; READ-THROUGH; APC GENE; AMINOGLYCOSIDE; CARCINOMA; LINES; TUMORIGENESIS; SPECIFICITY; GENTAMICIN	The APC tumor suppressor gene is frequently mutated in human colorectal cancer, with nonsense mutations accounting for 30% of all mutations in this gene. Reintroduction of the WT APC gene into cancer cells generally reduces tumorigenicity or induces apoptosis. In this study, we explored the possibility of using drugs to induce premature termination codon (PTC) readthrough (aminoglycosides, negamycin), as a means of reactivating endogenous APC. By quantifying the readthrough of 11 nonsense mutations in APC, we were able to identify those giving the highest levels of readthrough after treatment. For these mutations, we demonstrated that aminoglycoside or negamycin treatment led to a recovery of the biological activity of APC in cancer cell lines, and showed that the level of APC activity was proportional to the level of induced readthrough. These findings show that treatment with readthrough inducers should be considered as a potential strategy for treating cancers caused by nonsense mutations APC gene. They also provide a rational basis for identifying mutations responsive to readthrough inducers.	[Floquet, Celia; Rousset, Jean-Pierre; Bidou, Laure] CNRS, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Floquet, Celia; Rousset, Jean-Pierre] Univ Paris 11, Orsay, France; [Bidou, Laure] Univ Paris 06, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Floquet, C (corresponding author), CNRS, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France.	laure.bidou@igmors.u-psud.fr		Bidou, Laure/0000-0002-3973-4058	Association pour la Recherche sur le Cancer (ARC) [5016]; Association Francaise contre les Myopathies [13986]; French Ministry of Education and Research; Ligue Nationale Contre le Cancer	Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); French Ministry of Education and Research; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by funds from the Association pour la Recherche sur le Cancer (ARC No. 5016 to JPR) and Association Francaise contre les Myopathies (contract 13986). CF was funded in part by the French Ministry of Education and Research and in part by a fellowship from the Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allamand V, 2008, J GENE MED, V10, P217, DOI 10.1002/jgm.1140; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Arakawa M, 2003, J BIOCHEM, V134, P751, DOI 10.1093/jb/mvg203; Aurino S, 2006, Acta Myol, V25, P5; Bidou L, 2004, GENE THER, V11, P619, DOI 10.1038/sj.gt.3302211; Bidou L, 2000, RNA, V6, P952, DOI 10.1017/S1355838200000443; BURKE JF, 1985, NUCLEIC ACIDS RES, V13, P6265, DOI 10.1093/nar/13.17.6265; Cassan M, 2001, BMC Mol Biol, V2, P3, DOI 10.1186/1471-2199-2-3; DEXTER DL, 1981, AM J MED, V71, P949, DOI 10.1016/0002-9343(81)90312-0; FEARON K, 1994, J BIOL CHEM, V269, P17802; FENG YX, 1990, P NATL ACAD SCI USA, V87, P8860, DOI 10.1073/pnas.87.22.8860; FLOQUET C, 2010, NUCL ACIDS RES; GRODEN J, 1995, CANCER RES, V55, P1531; Howard MT, 2000, ANN NEUROL, V48, P164, DOI 10.1002/1531-8249(200008)48:2<164::AID-ANA5>3.3.CO;2-2; Howard MT, 2004, ANN NEUROL, V55, P422, DOI 10.1002/ana.20052; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Kramer EB, 2010, RNA, V16, P1797, DOI 10.1261/rna.2201210; Laurent-Puig P, 1998, NUCLEIC ACIDS RES, V26, P269, DOI 10.1093/nar/26.1.269; Linde L, 2008, TRENDS GENET, V24, P552, DOI 10.1016/j.tig.2008.08.010; Lynch SR, 2001, J MOL BIOL, V306, P1037, DOI 10.1006/jmbi.2000.4420; Manuvakhova M, 2000, RNA, V6, P1044, DOI 10.1017/S1355838200000716; MARTIN R, 1993, BIOCHEM SOC T, V21, P846, DOI 10.1042/bst0210846; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Oh JH, 1999, INT J CANCER, V81, P902, DOI 10.1002/(SICI)1097-0215(19990611)81:6<902::AID-IJC11>3.0.CO;2-T; Rowe SM, 2009, BIODRUGS, V23, P165, DOI 10.2165/00063030-200923030-00003; Salas-Marco J, 2005, J MOL BIOL, V348, P801, DOI 10.1016/j.jmb.2005.03.025; Schroeder SJ, 2007, ANTIMICROB AGENTS CH, V51, P4462, DOI 10.1128/AAC.00455-07; Sermet-Gaudelus I, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-5; Yang CM, 2007, P NATL ACAD SCI USA, V104, P15394, DOI 10.1073/pnas.0610878104; YANG LY, 1990, CANCER RES, V50, P3218; Zilberberg A, 2010, GUT, V59, P496, DOI 10.1136/gut.2008.169805; Zingman LV, 2007, CLIN PHARMACOL THER, V81, P99, DOI 10.1038/sj.clpt.6100012	33	40	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24125	10.1371/journal.pone.0024125	http://dx.doi.org/10.1371/journal.pone.0024125			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909382	Green Submitted, gold, Green Published			2022-12-25	WOS:000294680800057
J	Kembel, SW; Eisen, JA; Pollard, KS; Green, JL				Kembel, Steven W.; Eisen, Jonathan A.; Pollard, Katherine S.; Green, Jessica L.			The Phylogenetic Diversity of Metagenomes	PLOS ONE			English	Article							COMMUNITY STRUCTURE; BACTERIAL; PATTERNS; GENOMICS; TAXONOMY; ECOLOGY; SPACE	Phylogenetic diversity-patterns of phylogenetic relatedness among organisms in ecological communities-provides important insights into the mechanisms underlying community assembly. Studies that measure phylogenetic diversity in microbial communities have primarily been limited to a single marker gene approach, using the small subunit of the rRNA gene (SSU-rRNA) to quantify phylogenetic relationships among microbial taxa. In this study, we present an approach for inferring phylogenetic relationships among microorganisms based on the random metagenomic sequencing of DNA fragments. To overcome challenges caused by the fragmentary nature of metagenomic data, we leveraged fully sequenced bacterial genomes as a scaffold to enable inference of phylogenetic relationships among metagenomic sequences from multiple phylogenetic marker gene families. The resulting metagenomic phylogeny can be used to quantify the phylogenetic diversity of microbial communities based on metagenomic data sets. We applied this method to understand patterns of microbial phylogenetic diversity and community assembly along an oceanic depth gradient, and compared our findings to previous studies of this gradient using SSU-rRNA gene and metagenomic analyses. Bacterial phylogenetic diversity was highest at intermediate depths beneath the ocean surface, whereas taxonomic diversity (diversity measured by binning sequences into taxonomically similar groups) showed no relationship with depth. Phylogenetic diversity estimates based on the SSU-rRNA gene and the multi-gene metagenomic phylogeny were broadly concordant, suggesting that our approach will be applicable to other metagenomic data sets for which corresponding SSU-rRNA gene sequences are unavailable. Our approach opens up the possibility of using metagenomic data to study microbial diversity in a phylogenetic context.	[Kembel, Steven W.; Green, Jessica L.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA; [Eisen, Jonathan A.] Univ Calif Davis, Univ Calif Davis Genome Ctr, Dept Evolut & Ecol & Med Microbiol & Immunol, Davis, CA 95616 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Gladstone Inst, Inst Human Genet, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Div Biostat, San Francisco, CA 94143 USA; [Green, Jessica L.] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Oregon; University of California System; University of California Davis; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The Santa Fe Institute	Kembel, SW (corresponding author), Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA.	skembel@uoregon.edu	Eisen, Jonathan A./H-2706-2019	Eisen, Jonathan A./0000-0002-0159-2197; Kembel, Steven/0000-0001-5224-0952	Gordon and Betty Moore Foundation [1660]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This study was supported by grant #1660 from the Gordon and Betty Moore Foundation as part of the project iSEEM ('Integrating Statistical, Ecological, and Evolutionary Approaches to Metagenomics'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger JH, 2005, INT J SYST EVOL MICR, V55, P1021, DOI 10.1099/ijs.0.63510-0; Berger SA, 2011, BIOINFORMATICS, V27, P2068, DOI 10.1093/bioinformatics/btr320; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Cadotte MW, 2010, ECOL LETT, V13, P96, DOI 10.1111/j.1461-0248.2009.01405.x; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Eisen JA, 2007, PLOS BIOL, V5, P384, DOI 10.1371/journal.pbio.0050082; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hewson I, 2006, LIMNOL OCEANOGR, V51, P1274, DOI 10.4319/lo.2006.51.3.1274; Horner-Devine MC, 2006, ECOLOGY, V87, pS100, DOI 10.1890/0012-9658(2006)87[100:PCAOIB]2.0.CO;2; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kembel SW, 2009, ECOL LETT, V12, P949, DOI 10.1111/j.1461-0248.2009.01354.x; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li WLS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008487; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Rokas A, 2009, TRENDS ECOL EVOL, V24, P192, DOI 10.1016/j.tree.2008.11.004; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stark M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-461; Temperton B, 2009, ISME J, V3, P792, DOI 10.1038/ismej.2009.32; Treusch AH, 2009, ISME J, V3, P1148, DOI 10.1038/ismej.2009.60; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Wu DY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002566; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	46	65	66	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23214	10.1371/journal.pone.0023214	http://dx.doi.org/10.1371/journal.pone.0023214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21912589	Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800005
J	Lei, H; Reisenman, CE; Wilson, CH; Gabbur, P; Hildebrand, JG				Lei, Hong; Reisenman, Carolina E.; Wilson, Caroline H.; Gabbur, Prasad; Hildebrand, John G.			Spiking Patterns and Their Functional Implications in the Antennal Lobe of the Tobacco Hornworm Manduca sexta	PLOS ONE			English	Article							OLFACTORY LOCAL INTERNEURONS; PROJECTION NEURONS; SPHINX MOTH; IN-VIVO; ELECTROPHYSIOLOGICAL PROPERTIES; RESPONSE CHARACTERISTICS; DEVELOPMENTAL-CHANGES; PHEROMONE BLEND; CALCIUM CURRENT; ODOR RESPONSES	Bursting as well as tonic firing patterns have been described in various sensory systems. In the olfactory system, spontaneous bursts have been observed in neurons distributed across several synaptic levels, from the periphery, to the olfactory bulb (OB) and to the olfactory cortex. Several in vitro studies indicate that spontaneous firing patterns may be viewed as "fingerprints" of different types of neurons that exhibit distinct functions in the OB. It is still not known, however, if and how neuronal burstiness is correlated with the coding of natural olfactory stimuli. We thus conducted an in vivo study to probe this question in the OB equivalent structure of insects, the antennal lobe (AL) of the tobacco hornworm Manduca sexta. We found that in the moth's AL, both projection (output) neurons (PNs) and local interneurons (LNs) are spontaneously active, but PNs tend to produce spike bursts while LNs fire more regularly. In addition, we found that the burstiness of PNs is correlated with the strength of their responses to odor stimulation - the more bursting the stronger their responses to odors. Moreover, the burstiness of PNs was also positively correlated with the spontaneous firing rate of these neurons, and pharmacological reduction of bursting resulted in a decrease of the neurons' responsiveness. These results suggest that neuronal burstiness reflects a physiological state of these neurons that is directly linked to their response characteristics.	[Lei, Hong; Reisenman, Carolina E.; Hildebrand, John G.] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA; [Wilson, Caroline H.] Univ Alaska Anchorage, Dept Biol, Anchorage, AK USA; [Gabbur, Prasad] Univ Arizona, Dept Comp Sci, Tucson, AZ 85721 USA	University of Arizona; University of Alaska System; University of Alaska Anchorage; University of Arizona	Lei, H (corresponding author), Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA.	hlei@neurobio.arizona.edu	Lei, Hong/ABH-1356-2020	Lei, Hong/0000-0002-5619-3097	National Institute on Deafness and other Communication Disorders (NIDCD) [DC312990, DC006368]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002751, F31DC006368] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by The National Institute on Deafness and other Communication Disorders (NIDCD) (http://www.nidcd.nih.gov/) grants (DC312990 to Dr. Hildebrand; DC006368 to Dr. Wilson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobkov YV, 2007, J NEUROPHYSIOL, V97, P1052, DOI 10.1152/jn.01111.2006; Cang JH, 2003, J NEUROSCI, V23, P4108; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; CHRISTENSEN TA, 1987, J COMP PHYSIOL A, V160, P553, DOI 10.1007/BF00611929; Christensen TA, 1998, J NEUROSCI, V18, P5999; CHRISTENSEN TA, 1989, ARCH INSECT BIOCHEM, V10, P281, DOI 10.1002/arch.940100404; CHRISTENSEN TA, 1993, J COMP PHYSIOL A, V173, P385, DOI 10.1007/BF00193512; Dolzer J, 2001, J EXP BIOL, V204, P2781; Hamilton KA, 2005, NEUROSCIENCE, V133, P819, DOI 10.1016/j.neuroscience.2005.03.008; HANSSON BS, 1994, J COMP PHYSIOL A, V175, P547, DOI 10.1007/BF00199476; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; Heinbockel T, 2004, J COMP PHYSIOL A, V190, P1023, DOI 10.1007/s00359-004-0559-7; Heinbockel T, 1999, J COMP NEUROL, V409, P1; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Huang J, 2010, NEURON, V67, P1021, DOI 10.1016/j.neuron.2010.08.025; Husch A, 2009, J NEUROPHYSIOL, V102, P2834, DOI 10.1152/jn.00627.2009; Husch A, 2009, J NEUROSCI, V29, P716, DOI 10.1523/JNEUROSCI.3677-08.2009; Ji H, 2006, NEUROSCIENCE, V140, P623, DOI 10.1016/j.neuroscience.2006.02.020; KAISSLING KE, 1989, ARCH INSECT BIOCHEM, V10, P273, DOI 10.1002/arch.940100403; KANZAKI R, 1989, J COMP PHYSIOL A, V165, P427, DOI 10.1007/BF00611233; Khawaled R, 1999, PFLUG ARCH EUR J PHY, V438, P314, DOI 10.1007/s004240050915; King JR, 2000, J NEUROSCI, V20, P2391; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; LAURENT G, 1993, J NEUROPHYSIOL, V69, P1484, DOI 10.1152/jn.1993.69.5.1484; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; Lei H, 2002, NAT NEUROSCI, V5, P557, DOI 10.1038/nn859; Lei Hong, 2009, Journal of Biology (London), V8, P21, DOI 10.1186/jbiol120; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; MACLEOD NK, 1976, EXP BRAIN RES, V25, P267; Mercer AR, 2002, J NEUROPHYSIOL, V87, P2664, DOI 10.1152/jn.2002.87.6.2664; Mercer AR, 2002, J NEUROPHYSIOL, V87, P2650, DOI 10.1152/jn.2002.87.6.2650; Mwilaria EK, 2008, CHEM SENSES, V33, P267, DOI 10.1093/chemse/bjm085; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Ro H, 2007, J COMP NEUROL, V500, P658, DOI 10.1002/cne.21194; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; ROSPARS JP, 1992, CELL TISSUE RES, V270, P205, DOI 10.1007/BF00328007; Sadek MM, 2002, J EXP BIOL, V205, P1363; Seki Y, 2010, J NEUROPHYSIOL, V104, P1007, DOI 10.1152/jn.00249.2010; SELCHOW KI, 1998, THESIS U ARIZONA; Shinomoto S, 2003, NEURAL COMPUT, V15, P2823, DOI 10.1162/089976603322518759; STARRATT AN, 1979, Z NATURFORSCH C, V34, P9; SUN XJ, 1993, CHEM SENSES, V18, P355, DOI 10.1093/chemse/18.4.355; Suzuki N, 2006, J NEUROSCI, V26, P11938, DOI 10.1523/JNEUROSCI.3473-06.2006; Toporikova N, 2009, J NEUROPHYSIOL, V102, P2273, DOI 10.1152/jn.00282.2009; Tripathy SJ, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/neuro.03.001.2010; TUMLINSON JH, 1994, J CHEM ECOL, V20, P579, DOI 10.1007/BF02059599; TUMLINSON JH, 1989, ARCH INSECT BIOCHEM, V10, P255, DOI 10.1002/arch.940100402; Varela N, 2011, J EXP BIOL, V214, P637, DOI 10.1242/jeb.047316	48	21	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23382	10.1371/journal.pone.0023382	http://dx.doi.org/10.1371/journal.pone.0023382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897842	Green Published, Green Submitted, gold			2022-12-25	WOS:000294676900005
J	Borralho, PM; Simoes, AES; Gomes, SE; Lima, RT; Carvalho, T; Ferreira, DMS; Vasconcelos, MH; Castro, RE; Rodrigues, CMP				Borralho, Pedro M.; Simoes, Andre E. S.; Gomes, Sofia E.; Lima, Raquel T.; Carvalho, Tania; Ferreira, Duarte M. S.; Vasconcelos, Maria H.; Castro, Rui E.; Rodrigues, Cecilia M. P.			miR-143 Overexpression Impairs Growth of Human Colon Carcinoma Xenografts in Mice with Induction of Apoptosis and Inhibition of Proliferation	PLOS ONE			English	Article							NF-KAPPA-B; MICRORNA EXPRESSION; DOWN-REGULATION; ERK5; CELLS; ACCUMULATION; PROGRESSION; SIGNATURE; TARGETS; AND-145	Background: MicroRNAs (miRNAs) are aberrantly expressed in human cancer and involved in the (dys) regulation of cell survival, proliferation, differentiation and death. Specifically, miRNA-143 (miR-143) is down-regulated in human colon cancer. In the present study, we evaluated the role of miR-143 overexpression on the growth of human colon carcinoma cells xenografted in nude mice (immunodeficient mouse strain: N:NIH(s) II-nu/nu). Methodology/Principal Findings: HCT116 cells with stable miR-143 overexpression (Over-143) and control (Empty) cells were subcutaneously injected into the flanks of nude mice, and tumor growth was evaluated over time. Tumors arose, 14 days after tumor cell implantation, and the experiment was ended at 40 days after implantation. miR-143 was confirmed to be significantly overexpressed in Over-143 versus Empty xenografts, by TaqMan(R) Real-time PCR (p<0.05). Importantly, Over-143 xenografts displayed slower tumor growth compared to Empty xenografts from 23 until 40 days in vivo (p<0.05), with final volumes of 928+/-338 and 2512+/-387 mm(3), respectively. Evaluation of apoptotic proteins showed that Over-143 versus Empty xenografts displayed reduced Bcl-2 levels, and increased caspase-3 activation and PARP cleavage (p<0.05). In addition, the incidence of apoptotic tumor cells, assessed by TUNEL, was increased in Over-143 versus Empty xenografts (p<0.01). Finally, Over-143 versus Empty xenografts displayed significantly reduced NF-kappa B activation and ERK5 levels and activation (p<0.05), as well as reduced proliferative index, evaluated by Ki-67 immunohistochemistry (p<0.01). Conclusions: Our results suggest that reduced tumor volume in Over-143 versus Empty xenografts may result from increased apoptosis and decreased proliferation induced by miR-143. This reinforces the relevance of miR-143 in colon cancer, indicating an important role in the control of in vivo tumor progression, and suggesting that miR-143 may constitute a putative novel therapeutic tool for colon cancer treatment that warrants further investigation.	[Borralho, Pedro M.; Simoes, Andre E. S.; Gomes, Sofia E.; Ferreira, Duarte M. S.; Castro, Rui E.; Rodrigues, Cecilia M. P.] Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, P-1699 Lisbon, Portugal; [Lima, Raquel T.; Vasconcelos, Maria H.] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Canc Drug Resistance Grp, Oporto, Portugal; [Carvalho, Tania] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Lima, Raquel T.] Univ Porto CEQUIMED UP, Ctr Med Chem, Oporto, Portugal; [Carvalho, Tania] Ctr Lisboa, Inst Portugues Oncol Francisco Gentil, Ctr Invest Patobiol Mol, Lisbon, Portugal; [Vasconcelos, Maria H.] Univ Porto, Fac Pharm, Dept Biol Sci, P-4100 Oporto, Portugal; [Rodrigues, Cecilia M. P.] Univ Lisbon, Fac Pharm, Dept Biochem & Human Biol, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade do Porto; Instituto Gulbenkian de Ciencia; Universidade do Porto; Portuguese Institute of Oncology; Universidade do Porto; Universidade de Lisboa	Borralho, PM (corresponding author), Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, P-1699 Lisbon, Portugal.	cmprodrigues@ff.ul.pt	Ferreira, Duarte M Sacramento/E-4270-2012; Lima, Raquel T./J-7374-2013; Castro, Rui E/AAG-4179-2021; iMed.ULisboa, CellFun/A-4244-2014; Rodrigues, Cecilia MP/M-3572-2013; Simões, André/E-6393-2015; gomes, sofia/I-9436-2016; Borralho, Pedro M/C-2727-2011; Carvalho, Tânia/GNM-6203-2022; Castro, Rui E/I-2975-2013; Vasconcelos, M. Helena/J-9547-2013; Carvalho, Tânia/X-2873-2019	Ferreira, Duarte M Sacramento/0000-0001-5940-7102; Lima, Raquel T./0000-0002-5838-9659; Castro, Rui E/0000-0002-7417-0091; Rodrigues, Cecilia MP/0000-0002-4829-754X; Simões, André/0000-0002-0489-6356; gomes, sofia/0000-0003-3624-1933; Borralho, Pedro M/0000-0003-4488-7240; Castro, Rui E/0000-0002-7417-0091; Carvalho, Tânia/0000-0002-5283-5013; Vasconcelos, M. Helena/0000-0002-7801-4643	FCT; Portuguese Foundation for Science and Technology [PTDC/SAU-GMG/099161/2008, SFRH/BPD/65212/2009, SFRH/BPD/68787/2010, SFRH/BD/60521/2009]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This study was supported by FCT, the Portuguese Foundation for Science and Technology, through grant PTDC/SAU-GMG/099161/2008 (to C. M. P. R.), postdoctoral fellowships SFRH/BPD/65212/2009 (to P. M. B.) and SFRH/BPD/68787/2010 (to R. T. L.), and PhD fellowship SFRH/BD/60521/2009 (to D. M. S. F). Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2010, CANCER GENE THER, V17, P398, DOI 10.1038/cgt.2009.88; Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Akao Y, 2006, ONCOL REP, V16, P845; Akao Y, 2009, LEUKEMIA RES, V33, P1530, DOI 10.1016/j.leukres.2009.04.019; Aranha MM, 2007, EUR J CLIN INVEST, V37, P416, DOI 10.1111/j.1365-2362.2007.01801.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borralho PM, 2007, BBA-MOL BASIS DIS, V1772, P40, DOI 10.1016/j.bbadis.2006.09.005; Borralho PM, 2009, FEBS J, V276, P6689, DOI 10.1111/j.1742-4658.2009.07383.x; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Cude K, 2007, J CELL BIOL, V177, P253, DOI 10.1083/jcb.200609166; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garaude J, 2006, J IMMUNOL, V177, P7607, DOI 10.4049/jimmunol.177.11.7607; Gayet J, 2001, ONCOGENE, V20, P5025, DOI 10.1038/sj.onc.1204611; Girio A, 2007, CELL SIGNAL, V19, P1964, DOI 10.1016/j.cellsig.2007.05.005; Gokhale A, 2010, J CANCER RES THER, V6, P521, DOI 10.4103/0973-1482.77072; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Letzen BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010480; Li Z, 2008, TOXICOL IN VITRO, V22, P1749, DOI 10.1016/j.tiv.2008.08.001; Lima RT, 2011, EUR J CANCER, V47, P163, DOI 10.1016/j.ejca.2010.11.005; Lin TX, 2009, J UROLOGY, V181, P1372, DOI 10.1016/j.juro.2008.10.149; Longley DB, 2004, CLIN CANCER RES, V10, P3562, DOI 10.1158/1078-0432.CCR-03-0532; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Michael MZ, 2003, MOL CANCER RES, V1, P882; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Navarro A, 2011, J SURG ONCOL, V103, P411, DOI 10.1002/jso.21847; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Pearson G, 2001, J BIOL CHEM, V276, P7927, DOI 10.1074/jbc.M009764200; Pekow JR, 2012, INFLAMM BOWEL DIS, V18, P94, DOI 10.1002/ibd.21742; Sakamoto K, 2009, CLIN CANCER RES, V15, P2248, DOI 10.1158/1078-0432.CCR-08-1383; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Voboril R, 2004, J SURG RES, V120, P178, DOI 10.1016/j.jss.2003.11.023; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Wijnhoven BPL, 2010, BRIT J SURG, V97, P853, DOI 10.1002/bjs.7000; Wu BL, 2011, WORLD J GASTROENTERO, V17, P79, DOI 10.3748/wjg.v17.i1.79; Zhang H, 2010, ONCOL REP, V24, P1363, DOI 10.3892/or_00000994	48	89	96	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23787	10.1371/journal.pone.0023787	http://dx.doi.org/10.1371/journal.pone.0023787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901135	gold, Green Published, Green Submitted			2022-12-25	WOS:000294298000020
J	Zhu, XH; Wang, Y; Zhang, HX; Liu, X; Chen, T; Yang, RF; Shi, YL; Cao, WC; Li, P; Ma, QJ; Zhai, Y; He, FC; Zhou, GQ; Cao, C				Zhu, Xiaohui; Wang, Yan; Zhang, Hongxing; Liu, Xuan; Chen, Ting; Yang, Ruifu; Shi, Yuling; Cao, Wuchun; Li, Ping; Ma, Qingjun; Zhai, Yun; He, Fuchu; Zhou, Gangqiao; Cao, Cheng			Genetic Variation of the Human alpha-2-Heremans-Schmid Glycoprotein (AHSG) Gene Associated with the Risk of SARS-CoV Infection	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; SYNDROME CORONAVIRUS INFECTION; SYNDROME (SARS)-ASSOCIATED CORONAVIRUS; MANNOSE-BINDING LECTIN; HEALTH-CARE WORKERS; NUCLEOCAPSID PROTEIN; ALPHA-2-HS GLYCOPROTEIN; POLYMORPHISM; SUSCEPTIBILITY; FETUIN	Genetic background may play an important role in the process of SARS-CoV infection and SARS development. We found several proteins that could interact with the nucleocapsid protein of the SARS coronavirus (SARS-CoV). alpha-2-Heremans-Schmid Glycoprotein (AHSG), which is required for macrophage deactivation by endogenous cations, is associated with inflammatory regulation. Cytochrome P450 Family 3A (CYP4F3A) is an v-oxidase that inactivates Leukotriene B4 (LTB4) in human neutrophils and the liver. We investigated the association between the polymorphisms of these two inflammation-associated genes and SARS development. The linkage disequilibrium (LD) maps of these two genes were built with Haploview using data on CHB+JPT (version 2) from the HapMap. A total of ten tag SNPs were selected and genotyped. In the Guangzhou cohort study, after adjusting for age and sex, two AHSG SNPs and one CYP4F3 SNP were found to be associated with SARS susceptibility: rs2248690 (adjusted odds ratio [AOR] 2.42; 95% confidence interval [CI] 1.30-4.51); rs4917 (AOR 1.84; 95% CI 1.02-3.34); and rs3794987 (AOR 2.01; 95% CI 1.10-3.68). To further validate the association, the ten tag SNPs were genotyped in the Beijing cohort. After adjusting for age and sex, only rs2248690 (AOR, 1.63; 95% CI, 1.30-2.04) was found to be associated with SARS susceptibility. The combined analysis of the two studies confirmed tag SNP rs2248690 in AHSG as a susceptibility variant (AOR 1.70; 95% CI 1.37-2.09). The statistical analysis of the rs2248690 genotype data among the patients and healthy controls in the HCW cohort, who were all similarly exposed to the SARS virus, also supported the findings. Further, the SNP rs2248690 affected the transcriptional activity of the AHSG promoter and thus regulated the AHSG serum level. Therefore, our study has demonstrated that the AA genotype of rs2268690, which leads to a higher AHSG serum concentration, was significantly associated with protection against SARS development.	[Zhu, Xiaohui; Wang, Yan; Liu, Xuan; Chen, Ting; Li, Ping; Ma, Qingjun; Cao, Cheng] Beijing Inst Biotechnol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Zhang, Hongxing; Zhai, Yun; He, Fuchu; Zhou, Gangqiao] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China; [Yang, Ruifu; Cao, Wuchun] Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Shi, Yuling] PLA, Gen Hosp Guangzhou Command, Guangzhou, Guangdong, Peoples R China; [Wang, Yan] PLA, Gen Hosp Beijing Command, Guangzhou, Guangdong, Peoples R China; [Zhang, Hongxing; Zhai, Yun; He, Fuchu; Zhou, Gangqiao] Natl Engn Res Ctr Prot Drugs, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Zhu, XH (corresponding author), Beijing Inst Biotechnol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	zhougq114@gmail.com; caoc@nic.bmi.ac.cn	Cao, Cheng/GNP-6156-2022		China High-Tech Program (863 program) [2007AA022204]; National Programs on Infectious Disease [2008ZX10004-009]	China High-Tech Program (863 program)(National High Technology Research and Development Program of China); National Programs on Infectious Disease	This work was supported by the China High-Tech Program (863 program) 2007AA022204 and Grant 2008ZX10004-009 from the National Programs on Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUSHEL P, 1995, ONCOGENE, V10, P1361; Chan VSF, 2006, NAT GENET, V38, P38, DOI 10.1038/ng1698; Chang WT, 2004, EMERG INFECT DIS, V10, P1117, DOI 10.3201/eid1006.030972; Che XY, 2004, EMERG INFECT DIS, V10, P1947, DOI 10.3201/eid1011.040516; Chong WP, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-82; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; He J, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-106; Ho KY, 2004, J INFECT DIS, V189, P642, DOI 10.1086/381558; Inoue M, 2008, DIABETES RES CLIN PR, V79, P164, DOI 10.1016/j.diabres.2007.08.005; Ip WKE, 2005, J INFECT DIS, V191, P1697, DOI 10.1086/429631; JEZEQUEL M, 1988, CLIN CHIM ACTA, V176, P49, DOI 10.1016/0009-8981(88)90173-8; KALABAY L, 1992, Orvosi Hetilap, V133, P1553; KALABAY L, 1991, ANN HEMATOL, V63, P264, DOI 10.1007/BF01698376; Kannan S, 2002, MED HYPOTHESES, V59, P261, DOI 10.1016/S0306-9877(02)00213-X; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; LEBRETON JP, 1979, J CLIN INVEST, V64, P1118, DOI 10.1172/JCI109551; Li W, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016945, 10.1371/journal.pone.0021082]; Lin Marie, 2003, BMC Med Genet, V4, P9, DOI 10.1186/1471-2350-4-9; Liu X, 2004, CLIN DIAGN LAB IMMUN, V11, P227, DOI 10.1128/CDLI.11.1.227-228.2004; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Ng MW, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-50; Ng MHL, 2004, J INFECT DIS, V190, P515, DOI 10.1086/421523; Ombrellino M, 2001, SHOCK, V15, P181, DOI 10.1097/00024382-200115030-00004; Osawa M, 1997, HUM GENET, V99, P18; Osawa M, 2005, HUM GENET, V116, P146, DOI 10.1007/s00439-004-1222-7; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Sato H, 2007, INTERNAL MED, V46, P1685, DOI 10.2169/internalmedicine.46.6269; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shi YL, 2003, J CLIN MICROBIOL, V41, P5781, DOI 10.1128/JCM.41.12.5781-5782.2003; Tang NLS, 2007, NAT GENET, V39, P690, DOI 10.1038/ng0607-692; Wang HC, 1998, P NATL ACAD SCI USA, V95, P14429, DOI 10.1073/pnas.95.24.14429; Wilder-Smith A, 2005, EMERG INFECT DIS, V11, P1142, DOI 10.3201/eid1107.041165; Xiong P, 2008, INT J IMMUNOGENET, V35, P69, DOI 10.1111/j.1744-313X.2007.00741.x; Yasui F, 2008, J IMMUNOL, V181, P6337, DOI 10.4049/jimmunol.181.9.6337; Zhang HX, 2005, J INFECT DIS, V192, P1355, DOI 10.1086/491479; Zhao JC, 2007, J VIROL, V81, P6079, DOI 10.1128/JVI.02568-06; Zhi LT, 2007, NAT GENET, V39, P691, DOI [10.1038/ng0607-692, 10.1038/ng0607-691]; Zhou B, 2008, J VIROL, V82, P6962, DOI 10.1128/JVI.00133-08; Zhu MS, 2004, IMMUNOL LETT, V92, P237, DOI 10.1016/j.imlet.2004.01.001	40	18	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23730	10.1371/journal.pone.0023730	http://dx.doi.org/10.1371/journal.pone.0023730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21904596	Green Published, Green Submitted, gold			2022-12-25	WOS:000294121300089
J	Papakosta, M; Dalle, C; Haythornthwaite, A; Cao, LS; Stevens, EB; Burgess, G; Russell, R; Cox, PJ; Phillips, SC; Grimm, C				Papakosta, Marianthi; Dalle, Carine; Haythornthwaite, Alison; Cao, Lishuang; Stevens, Edward B.; Burgess, Gillian; Russell, Rachel; Cox, Peter J.; Phillips, Stephen C.; Grimm, Christian			The Chimeric Approach Reveals That Differences in the TRPV1 Pore Domain Determine Species-specific Sensitivity to Block of Heat Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANILLOID RECEPTOR TRPV1; ION-CHANNEL; MOLECULAR-BASIS; IN-VIVO; ANTAGONISTS; TURRET	The capsaicin-, heat-, and proton-activated ion channel TRPV1, a member of the transient receptor potential cation channel family is a polymodal nociceptor. For almost a decade, TRPV1 has been explored by the pharmaceutical industry as a potential target for example for pain conditions. Antagonists which block TRPV1 activation by capsaicin, heat, and protons were developed by a number of pharmaceutical companies. The unexpected finding of hyperthermia as an on-target side effect in clinical studies using polymodal TRPV1 antagonists has prompted companies to search for ways to circumvent hyperthermia, for example by the development of modality-selective antagonists. The significant lack of consistency of the pharmacology of many TRPV1 antagonists across different species has been a further obstacle. JYL-1421 for example was shown to block capsaicin and heat responses in human and monkey TRPV1 while it was largely ineffective in blocking heat responses in rat TRPV1. These findings suggested structural dissimilarities between different TRPV1 species relevant for small compound antagonism for example of heat activation. Using a chimeric approach (human and rat TRPV1) in combination with a novel FLIPR-based heat activation assay and patch-clamp electrophysiology we have identified the pore region as being strongly linked to the observed species differences. We demonstrate that by exchanging the pore domains JYL-1421, which is modality-selective in rat can be made modality-selective in human TRPV1 and vice-versa.	[Papakosta, Marianthi; Dalle, Carine; Cao, Lishuang; Stevens, Edward B.; Burgess, Gillian; Cox, Peter J.; Phillips, Stephen C.; Grimm, Christian] Pfizer Global Res & Dev, Pain Res Unit, Sandwich CT13 9NJ, Kent, England; [Russell, Rachel] Pfizer Global Res & Dev, Primary Pharmacol Grp, Sandwich CT13 9NJ, Kent, England; [Haythornthwaite, Alison] Nan Technol GmbH, D-80636 Munich, Germany	Pfizer; Pfizer	Papakosta, M (corresponding author), Pfizer Global Res & Dev, Pain Res Unit, Sandwich CT13 9NJ, Kent, England.	thouli23@yahoo.co.uk; christian_grimm@yahoo.de	Grimm, Christian/ABF-9121-2020	Grimm, Christian/0000-0002-0177-5559	Pfizer Ltd. Global RD	Pfizer Ltd. Global RD	This work was supported by Pfizer Ltd. Global R&D.	Aneiros E, 2011, EMBO J, V30, P994, DOI 10.1038/emboj.2011.19; Baez-Nieto D, 2011, ADV EXP MED BIOL, V704, P469, DOI 10.1007/978-94-007-0265-3_26; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Chung MK, 2011, ADV EXP MED BIOL, V704, P615, DOI 10.1007/978-94-007-0265-3_33; Clapham DE, 2003, PHARMACOL REV, V55, P591, DOI 10.1124/pr.55.4.6; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Garami A, 2010, J NEUROSCI, V30, P1435, DOI 10.1523/JNEUROSCI.5150-09.2010; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; Hanazawa T., 2006, PCT Int. Appl., Patent No. 2006097817; Jakab B, 2005, EUR J PHARMACOL, V517, P35, DOI 10.1016/j.ejphar.2005.05.002; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Khairatkar-Joshi N, 2009, TRENDS MOL MED, V15, P14, DOI 10.1016/j.molmed.2008.11.004; Kym PR, 2009, BIOCHEM PHARMACOL, V78, P211, DOI 10.1016/j.bcp.2009.02.014; Lazar J, 2009, EXPERT OPIN DRUG DIS, V4, P159, DOI 10.1517/17460440802681300; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reubish DS, 2009, BIOTECHNIQUES, V47, pIII, DOI 10.2144/000113198; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Wang Y, 2002, MOL PHARMACOL, V62, P947, DOI 10.1124/mol.62.4.947; Wong GY, 2009, BRAIN RES REV, V60, P267, DOI 10.1016/j.brainresrev.2008.12.006; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yao J, 2010, P NATL ACAD SCI USA, V107, pE125, DOI 10.1073/pnas.1008272107; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	30	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39663	39672		10.1074/jbc.M111.273581	http://dx.doi.org/10.1074/jbc.M111.273581			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21911503	Green Published, hybrid			2022-12-25	WOS:000296759800083
J	Bahaie, NS; Kang, BN; Frenzel, EM; Hosseinkhani, MR; Ge, XN; Greenberg, Y; Ha, SG; Demetriou, M; Rao, SP; Sriramarao, P				Bahaie, Nooshin S.; Kang, Bit Na; Frenzel, Elizabeth M.; Hosseinkhani, M. Reza; Ge, Xiao Na; Greenberg, Yana; Ha, Sung Gil; Demetriou, Michael; Rao, Savita P.; Sriramarao, P.			N-Glycans Differentially Regulate Eosinophil and Neutrophil Recruitment during Allergic Airway Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE ORGANIZATION; NECROSIS-FACTOR-ALPHA; ADHESION MOLECULE; BIOLOGICAL FUNCTIONS; EPITHELIAL-CELLS; BONE-MARROW; L-SELECTIN; ASTHMA; GLYCOSYLATION; MICE	Allergic airway inflammation, including asthma, is usually characterized by the predominant recruitment of eosinophils. However, neutrophilia is also prominent during severe exacerbations. Cell surface-expressed glycans play a role in leukocyte trafficking and recruitment during inflammation. Here, the involvement of UDP-N-acetylglucosamine:alpha-6-D-mannoside beta 1,6-N-acetylglucosaminyltransferase V (MGAT5)-modified N-glycans in eosinophil and neutrophil recruitment during allergic airway inflammation was investigated. Allergen-challenged Mgat5-deficient (Mgat5(-/-)) mice exhibited significantly attenuated airway eosinophilia and inflammation (decreased Th2 cytokines, mucus production) compared with WT counterparts, attributable to decreased rolling, adhesion, and survival of Mgat5(-/-) eosinophils. Interestingly, allergen-challenged Mgat5(-/-) mice developed airway neutrophilia and increased airway reactivity with persistent elevated levels of proinflammatory cytokines (IL-17A, TNF alpha, IFN gamma)). This increased neutrophil recruitment was also observed in LPS- and thioglycollate (TG)-induced inflammation in Mgat5(-/-) mice. Furthermore, there was significantly increased recruitment of infused Mgat5(-/-) neutrophils compared with WT neutrophils in the peritoneal cavity of TG-exposed WT mice. Mgat5(-/-) neutrophils demonstrated enhanced adhesion to P-selectin as well as increased migration toward keratinocyte-derived chemokine compared with WT neutrophils in vitro along with increased calcium mobilization upon activation and expression of elevated levels of CXCR2, which may contribute to the increased neutrophil recruitment. These data indicate an important role for MGAT5-modified N-glycans in differential regulation of eosinophil and neutrophil recruitment during allergic airway inflammation.	[Bahaie, Nooshin S.; Kang, Bit Na; Frenzel, Elizabeth M.; Hosseinkhani, M. Reza; Ge, Xiao Na; Greenberg, Yana; Ha, Sung Gil; Rao, Savita P.; Sriramarao, P.] Univ Minnesota, Lab Allerg Dis & Inflammat, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Sriramarao, P.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Demetriou, Michael] Univ Calif Irvine, Inst Immunol, Dept Neurol Microbiol & Mol Genet, Irvine, CA 92697 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Irvine	Sriramarao, P (corresponding author), Univ Minnesota, Lab Allerg Dis & Inflammat, Dept Vet & Biomed Sci, 1971 Commonwealth Ave, St Paul, MN 55108 USA.	psrao@umn.edu		Demetriou, Michael/0000-0002-2224-7798; Rao, Srirama/0000-0001-9082-1029	National Institutes of Health [AI35796, U19-AI70535, HL0793041, AI053331]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI035796, R01AI053331, U19AI070535, R01AI035796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI35796, U19-AI70535, and HL0793041 (to P. Sriramarao) and AI053331 (to Michael Demetriou).	Abbitt KB, 2009, J LEUKOCYTE BIOL, V85, P55, DOI 10.1189/jlb.0507305; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Broide DH, 2002, AM J PHYSIOL-LUNG C, V282, pL259, DOI 10.1152/ajplung.00214.2001; COMBADIERE C, 1995, J BIOL CHEM, V270, P16491, DOI 10.1074/jbc.270.28.16491; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dennis JW, 2002, BBA-GEN SUBJECTS, V1573, P414, DOI 10.1016/S0304-4165(02)00411-7; Deshpande DA, 2004, AM J RESP CELL MOL, V31, P36, DOI 10.1165/rcmb.2003-0313OC; Dong L, 2008, J ASTHMA, V45, P648, DOI 10.1080/02770900802126941; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Eynott PR, 2002, EUR J PHARMACOL, V452, P123, DOI 10.1016/S0014-2999(02)02237-9; Fahy John V, 2009, Proc Am Thorac Soc, V6, P256, DOI 10.1513/pats.200808-087RM; FEIKEN E, 1995, J INVEST DERMATOL, V105, P120, DOI 10.1111/1523-1747.ep12313429; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Ge XN, 2010, J IMMUNOL, V185, P1205, DOI 10.4049/jimmunol.1000039; Granovsky M, 2000, NAT MED, V6, P306; Grigorian A, 2009, IMMUNOL REV, V230, P232, DOI 10.1111/j.1600-065X.2009.00796.x; Gu JG, 2009, BIOL PHARM BULL, V32, P780, DOI 10.1248/bpb.32.780; Gu NB, 2010, AM J PHYSIOL-LUNG C, V298, pL290, DOI 10.1152/ajplung.90612.2008; Guo HB, 2009, GLYCOBIOLOGY, V19, P547, DOI 10.1093/glycob/cwp023; Janik ME, 2010, BBA-GEN SUBJECTS, V1800, P545, DOI 10.1016/j.bbagen.2010.03.013; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Lee SU, 2007, J BIOL CHEM, V282, P33725, DOI 10.1074/jbc.M704839200; Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702; Louahed J, 2001, BLOOD, V97, P1035, DOI 10.1182/blood.V97.4.1035; MARLEY SB, 1994, INFECT IMMUN, V62, P4304, DOI 10.1128/IAI.62.10.4304-4309.1994; Miller M, 2001, J IMMUNOL, V167, P2292, DOI 10.4049/jimmunol.167.4.2292; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; MIYAKE K, 1991, J CELL BIOL, V114, P557, DOI 10.1083/jcb.114.3.557; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Monteseirin J, 2009, J INVEST ALLERG CLIN, V19, P340; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Nocker RET, 1999, INT ARCH ALLERGY IMM, V119, P45, DOI 10.1159/000024174; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Rao SP, 2007, J IMMUNOL, V179, P7800, DOI 10.4049/jimmunol.179.11.7800; Simon SI, 2009, CLIN EXP PHARMACOL P, V36, P217, DOI 10.1111/j.1440-1681.2008.05083.x; Sperandio M, 2009, IMMUNOL REV, V230, P97, DOI 10.1111/j.1600-065X.2009.00795.x; SRIRAMARAO P, 1994, J IMMUNOL, V153, P4238; Sriramarao P, 2000, BLOOD, V95, P592, DOI 10.1182/blood.V95.2.592; SUZUKI H, 1994, J BIOL CHEM, V269, P18263; Suzuki T, 1996, AM J RESP CRIT CARE, V153, P1405, DOI 10.1164/ajrccm.153.4.8616573; Tanino Y, 2010, J IMMUNOL, V184, P2677, DOI 10.4049/jimmunol.0903274; Taube C, 2003, CHEST, V123, p410S, DOI 10.1378/chest.123.3_suppl.410S; Thomas PS, 2001, IMMUNOL CELL BIOL, V79, P132, DOI 10.1046/j.1440-1711.2001.00980.x; Tomkinson A, 2001, AM J RESP CRIT CARE, V163, P721, DOI 10.1164/ajrccm.163.3.2005010; Zuberi RI, 2009, J IMMUNOL, V183, P3971, DOI 10.4049/jimmunol.0901604	51	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38231	38241		10.1074/jbc.M111.279554	http://dx.doi.org/10.1074/jbc.M111.279554			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911487	hybrid, Green Published			2022-12-25	WOS:000296594200037
J	Newell-Caito, JL; Laha, M; Tharp, AC; Creamer, JI; Xu, H; Maddur, AA; Tans, G; Bock, PE				Newell-Caito, Jennifer L.; Laha, Malabika; Tharp, Anthony C.; Creamer, Jonathan I.; Xu, Hong; Maddur, Ashoka A.; Tans, Guido; Bock, Paul E.			Notecarin D Binds Human Factor V and Factor V-a with High Affinity in the Absence of Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-PATHWAY INHIBITOR; NOTECHIS-SCUTATUS-SCUTATUS; COAGULATION FACTOR-XA; ACTIVATED PROTEIN-C; PEPTIDE CHLOROMETHYL KETONES; REGULATORY EXOSITE I; BOVINE FACTOR-V; PROTHROMBINASE COMPLEX; THROMBIN GENERATION; PHOSPHOLIPID-VESICLES	Notecarin D (NotD) is a prothrombin (ProT) activator in the venom of the tiger snake, Notechis scutatus, and a factor Xa (FXa) homolog. NotD binds specifically to the FXa binding site expressed on factor V (FV) upon activation to factor Va (FVa) by thrombin. NotD active site-labeled with 5-fluorescein ([5F]FFR-NotD) binds FV and FVa with remarkably high affinity in the absence of phospholipids (K-D 12 and <= 0.01 nM, respectively). In the presence of membranes, the affinity of [5F]FFR-NotD for FVa is similar, but increased similar to 55-fold for FV. Binding of FXa active site-labeled with Oregon Green to FV and FVa in the presence of phospholipids is similar to 5,000- and similar to 80-fold weaker than [5F]FFR-NotD, respectively. NotD reports FVa and not FV binding by a 3-fold increase in tripeptide substrate hydrolysis, demonstrating allosteric regulation by FVa. The NotD.FVa.membrane complex activates ProT with K-m(app) similar to prothrombinase, and similar to 85-fold weaker without membranes. Active site-blocked NotD exhibits potent anticoagulant activity in plasma thrombin generation assays, representing inhibition of productive prothrombinase assembly and possible disruption of FXa inhibition by the tissue factor pathway inhibitor. The results show that high affinity binding of NotD to FVa is membrane-independent, unlike the strict membrane dependence of FXa for high affinity FVa binding.	[Newell-Caito, Jennifer L.; Laha, Malabika; Tharp, Anthony C.; Creamer, Jonathan I.; Xu, Hong; Maddur, Ashoka A.; Bock, Paul E.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Tans, Guido] Univ Maastricht, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6200 MD Maastricht, Netherlands	Vanderbilt University; Maastricht University	Bock, PE (corresponding author), C3321A Med Ctr N, Nashville, TN 37232 USA.	paul.bock@vanderbilt.edu			National Institutes of Health from the NHLBI [HL038779]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038779, R01HL038779] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL038779 (to P. E. B.) from the NHLBI.	Anderson PJ, 2000, J BIOL CHEM, V275, P16435, DOI 10.1074/jbc.M001255200; Baugh RJ, 1998, J BIOL CHEM, V273, P4378, DOI 10.1074/jbc.273.8.4378; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; BILLY D, 1995, J BIOL CHEM, V270, P26883, DOI 10.1074/jbc.270.45.26883; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; BOCK PE, 1993, METHOD ENZYMOL, V222, P478; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BOCK PE, 1992, J BIOL CHEM, V267, P14974; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; BOSKOVIC DS, 1990, J BIOL CHEM, V265, P10497; BROAD AJ, 1979, TOXICON, V17, P661, DOI 10.1016/0041-0101(79)90245-9; BROZE GJ, 1988, BLOOD, V71, P335; BROZE GJ, 1995, ANNU REV MED, V46, P103, DOI 10.1146/annurev.med.46.1.103; Buddai SK, 2010, J BIOL CHEM, V285, P5212, DOI 10.1074/jbc.M109.049833; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; Bukys MA, 2005, J BIOL CHEM, V280, P27393, DOI 10.1074/jbc.M503435200; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; Dharmawardana KR, 1999, J BIOL CHEM, V274, P18635, DOI 10.1074/jbc.274.26.18635; Dharmawardana KR, 1998, BIOCHEMISTRY-US, V37, P13143, DOI 10.1021/bi9812165; Duckers C, 2008, BLOOD, V112, P3615, DOI 10.1182/blood-2008-06-162453; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; FRANCIS B, 1993, TOXICON, V31, P447, DOI 10.1016/0041-0101(93)90180-Q; GUINTO ER, 1984, J BIOL CHEM, V259, P3986; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; HIGGINS DL, 1983, J BIOL CHEM, V258, P6503; HUANG ZF, 1993, J BIOL CHEM, V268, P26950; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; JOBIN F, 1966, NATURE, V211, P873, DOI 10.1038/211873b0; Kalafatis M, 2003, J BIOL CHEM, V278, P33550, DOI 10.1074/jbc.M303153200; KANE WH, 1981, J BIOL CHEM, V256, P1002; Kravtsov DV, 2009, BLOOD, V114, P452, DOI 10.1182/blood-2009-02-203604; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P8977; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lu G, 2004, J BIOL CHEM, V279, P17241, DOI 10.1074/jbc.M312827200; Lu YF, 1996, BIOCHEMISTRY-US, V35, P8201, DOI 10.1021/bi960281g; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; Mann KG, 2003, BLOOD, V101, P20, DOI 10.1182/blood-2002-01-0290; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; Nicolaes GAF, 2010, J BIOL CHEM, V285, P22888, DOI 10.1074/jbc.M110.131029; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Page MJ, 2005, J THROMB HAEMOST, V3, P2401, DOI 10.1111/j.1538-7836.2005.01456.x; Panizzi P, 2006, J BIOL CHEM, V281, P1169, DOI 10.1074/jbc.M507955200; Petersen LC, 1996, EUR J BIOCHEM, V235, P310, DOI 10.1111/j.1432-1033.1996.0310f.x; Pierre LS, 2005, MOL BIOL EVOL, V22, P1853, DOI 10.1093/molbev/msi181; PRYZDIAL ELG, 1991, J BIOL CHEM, V266, P8969; Rao VS, 2003, BIOCHEM J, V369, P635, DOI 10.1042/BJ20020889; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Rezaie AR, 2004, J BIOL CHEM, V279, P48262, DOI 10.1074/jbc.M409964200; ROSING J, 1986, J BIOL CHEM, V261, P4224; ROSING J, 1980, J BIOL CHEM, V255, P274; Rudolph AE, 2001, J BIOL CHEM, V276, P5123, DOI 10.1074/jbc.M006961200; Salzman, 2001, HEMOSTASIS THROMBOSI, P157; Segers K, 2007, J BIOL CHEM, V282, P33915, DOI 10.1074/jbc.M701123200; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Talbot K, 2010, BBA-PROTEINS PROTEOM, V1804, P723, DOI 10.1016/j.bbapap.2009.11.011; TANS G, 1985, J BIOL CHEM, V260, P9366; Thorelli E, 1998, THROMB HAEMOSTASIS, V80, P92, DOI 10.1055/s-0037-1615145; Tibballs J, 1998, ANAESTH INTENS CARE, V26, P529, DOI 10.1177/0310057X9802600510; Tibballs J, 1998, ANAESTH INTENS CARE, V26, P536; TIBBALLS J, 1991, MED J AUSTRALIA, V154, P275, DOI 10.5694/j.1326-5377.1991.tb121091.x; Toso R, 2006, J BIOL CHEM, V281, P8773, DOI 10.1074/jbc.M511419200; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; YE J, 1995, BIOCHEMISTRY-US, V34, P6448, DOI 10.1021/bi00019a026; Yegneswaran S, 2003, J BIOL CHEM, V278, P33312, DOI 10.1074/jbc.M305906200	70	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38286	38297		10.1074/jbc.M111.247122	http://dx.doi.org/10.1074/jbc.M111.247122			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911491	Green Published, hybrid			2022-12-25	WOS:000296594200042
J	Stoll, EA; Cheung, W; Mikheev, AM; Sweet, IR; Bielas, JH; Zhang, J; Rostomily, RC; Horner, PJ				Stoll, Elizabeth A.; Cheung, Willy; Mikheev, Andrei M.; Sweet, Ian R.; Bielas, Jason H.; Zhang, Jing; Rostomily, Robert C.; Horner, Philip J.			Aging Neural Progenitor Cells Have Decreased Mitochondrial Content and Lower Oxidative Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; COMPLEX-I INHIBITION; SUBVENTRICULAR ZONE; DOPAMINERGIC NEUROTOXICITY; AGED RATS; MUTATIONS; BRAIN; MICE; P53; DNA	Although neurogenesis occurs in discrete areas of the adult mammalian brain, neural progenitor cells (NPCs) produce fewer new neurons with age. To characterize the molecular changes that occur during aging, we performed a proteomic comparison between primary-cultured NPCs from the young adult and aged mouse forebrain. This analysis yielded changes in proteins necessary for cellular metabolism. Mitochondrial quantity and oxygen consumption rates decrease with aging, although mitochondrial DNA in aged NPCs does not have increased mutation rates. In addition, aged cells are resistant to the mitochondrial inhibitor rotenone and proliferate in response to lowered oxygen conditions. These results demonstrate that aging NPCs display an altered metabolic phenotype, characterized by a coordinated shift in protein expression, subcellular structure, and metabolic physiology.	[Stoll, Elizabeth A.; Horner, Philip J.] Univ Washington, Neurobiol & Behav Program, Seattle, WA 98109 USA; [Cheung, Willy] Univ Washington, Dept Comp Sci, Seattle, WA 98109 USA; [Mikheev, Andrei M.; Rostomily, Robert C.] Univ Washington, Dept Neurol Surg, Seattle, WA 98109 USA; [Sweet, Ian R.] Univ Washington, Dept Med, Seattle, WA 98109 USA; [Sweet, Ian R.] Univ Washington, Diabet Endocrine Res Ctr, Seattle, WA 98109 USA; [Bielas, Jason H.] Univ Washington, Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Bielas, Jason H.; Zhang, Jing] Univ Washington, Dept Pathol, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Horner, PJ (corresponding author), 815 Mercer St, Seattle, WA 98109 USA.	phorner@uw.edu	Horner, Philip J./AAF-7012-2021	Rostomily, Robert/0000-0003-1431-162X	National Institutes of Health [AG029406, NSO46724, DK17047]; University of Washington [NIH T32 HDO7183-28]; University of Washington Retirement Association; American Foundation for Aging Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG029406, R21AG038305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington(University of Washington); University of Washington Retirement Association; American Foundation for Aging Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG029406 (to R. C. R. and P. J. H.) NSO46724 (to P. J. H.), and DK17047 (to I. R. S. and the Diabetes Endocrinology Research Center).; Supported by the University of Washington Developmental Biology Training Grant (NIH T32 HDO7183-28), the University of Washington Retirement Association Fellowship in Aging Biology, and the American Foundation for Aging Research.	Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Caporaso GL, 2003, MOL CELL NEUROSCI, V23, P693, DOI 10.1016/S1044-7431(03)00103-9; Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105; Dani MA, 2010, MED HYPOTHESES, V74, P1021, DOI 10.1016/j.mehy.2010.01.005; Dienel GA, 2006, NEUROCHEM INT, V48, P586, DOI 10.1016/j.neuint.2006.01.004; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; Hajieva P, 2009, J NEUROCHEM, V110, P118, DOI 10.1111/j.1471-4159.2009.06114.x; Jablonska B, 2007, J CELL BIOL, V179, P1231, DOI 10.1083/jcb.200702031; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mclaughlin P, 2006, GLIA, V53, P567, DOI 10.1002/glia.20294; Medrano S, 2009, NEUROBIOL AGING, V30, P483, DOI 10.1016/j.neurobiolaging.2007.07.016; Mikheev AM, 2009, AGING CELL, V8, P499, DOI 10.1111/j.1474-9726.2009.00494.x; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Petit A, 2007, P NATL ACAD SCI USA, V104, P17837, DOI 10.1073/pnas.0703240104; Popa-Wagner A, 2007, ACTA NEUROPATHOL, V113, P277, DOI 10.1007/s00401-006-0164-7; Radad K, 2008, TOXICOL IN VITRO, V22, P68, DOI 10.1016/j.tiv.2007.08.015; Richardson JR, 2007, TOXICOL SCI, V95, P196, DOI 10.1093/toxsci/kfl133; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; ROSE SPR, 1967, BIOCHEM J, V102, P33, DOI 10.1042/bj1020033; Sheng HM, 2009, CURR MED CHEM, V16, P1561, DOI 10.2174/092986709788186255; Siwak-Tapp CT, 2007, NEUROBIOL LEARN MEM, V88, P249, DOI 10.1016/j.nlm.2007.05.001; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P661, DOI 10.1089/152091502320798303; Trifunovic A, 2006, BBA-BIOENERGETICS, V1757, P611, DOI 10.1016/j.bbabio.2006.03.003; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; WARBURG O, 1956, SCIENCE, V124, P269; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Yu DS, 2002, CHEM RES TOXICOL, V15, P832, DOI 10.1021/tx010177m	38	52	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38592	38601		10.1074/jbc.M111.252171	http://dx.doi.org/10.1074/jbc.M111.252171			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900249	Green Published, hybrid			2022-12-25	WOS:000296594200072
J	Davies, C; Hogarth, LA; Dietrich, PA; Bachmann, PS; Mackenzie, KL; Hall, AG; Lock, RB				Davies, Carwyn; Hogarth, Linda A.; Dietrich, Philipp A.; Bachmann, Petra S.; Mackenzie, Karen L.; Hall, Andrew G.; Lock, Richard B.			p53-independent Epigenetic Repression of the p21(WAF1) Gene in T-cell Acute Lymphoblastic Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE INHIBITOR GENES; DNA METHYLATION; P53 MUTATIONS; EXPRESSION; APOPTOSIS; CANCER; INACTIVATION; PROMOTER; PATHWAY; HYPERMETHYLATION	The p53 protein is a primary mediator of cellular apoptosis and growth arrest after exposure to DNA-damaging agents. Previous work has shown that the majority of childhood acute lymphoblastic leukemia (ALL) cases express a wild type p53 gene, although the functionality of the p53 pathway has rarely been validated. In the present study, the integrity of the p53 pathway was investigated in a panel of ALL cell lines and xenografts established from direct patient explants in immune-deficient mice. A focused real-time quantitative reverse transcription PCR array of known p53-regulated genes identified p21(WAF1) (CDKN1A) as the highest ranked gene to be differentially expressed between B-cell precursor (BCP)-ALL and T-ALL xenografts following exposure to the DNA-damaging drug etoposide. Lack of p21(WAF1) induction was observed in six of seven T-ALL xenograft lines, as well as primary T-ALL cells following irradiation exposure, despite an otherwise functional p53 response. Repression of p21(WAF1) in T-ALL cells was associated with decreased acetylated H3K9 localized at its promoter compared with BCP-ALL cells, together with increased CpG methylation within the first exon and intron. Although the histone deacetylase inhibitor vorinostat failed to induce p21(WAF1) in T-ALL samples, the combination of vorinostat and the demethylating agent decitabine reactivated expression of the silenced p21(WAF1) gene in the Molt-4 T-ALL cell line. Considering the known anti-apoptotic function of p21(WAF1), our findings have significant implications for the responses of T-versus BCP-ALL cells to chemotherapeutic drugs that induce p21(WAF1).	[Davies, Carwyn; Dietrich, Philipp A.; Bachmann, Petra S.; Mackenzie, Karen L.; Lock, Richard B.] Univ New S Wales, Childrens Canc Inst Australia Med Res, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; [Hogarth, Linda A.; Hall, Andrew G.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Children's Cancer Institute; Children's Medical Research Institute - Australia; University of New South Wales Sydney; Newcastle University - UK	Lock, RB (corresponding author), Univ New S Wales, Childrens Canc Inst Australia Med Res, Lowy Canc Res Ctr, POB 81, Randwick, NSW 2031, Australia.	rlock@ccia.unsw.edu.au	Lock, Richard/G-4253-2013; MacKenzie, Karen/N-5849-2019; Mackenzie, Karen/F-1310-2011	Lock, Richard/0000-0002-3436-9071; MacKenzie, Karen/0000-0003-2996-1617	Children's Cancer Institute Australia for Medical Research; Australian National Health and Medical Research Council; JGW Patterson Foundation (Newcastle upon Tyne, UK)	Children's Cancer Institute Australia for Medical Research; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); JGW Patterson Foundation (Newcastle upon Tyne, UK)	This work was supported by the Children's Cancer Institute Australia for Medical Research, a senior research fellowship (to R. B. L.) from the Australian National Health and Medical Research Council, an Australian postgraduate award (to C. D.), a university postgraduate award (to P. S. B.) and the JGW Patterson Foundation (Newcastle upon Tyne, UK) (to L. A. H.). The Children's Cancer Institute Australia for Medical Research is affiliated with the University of New South Wales and Sydney Children's Hospital.	Allan LA, 2000, MOL CELL BIOL, V20, P1291, DOI 10.1128/MCB.20.4.1291-1298.2000; Bachmann PS, 2007, CANCER RES, V67, P4482, DOI 10.1158/0008-5472.CAN-06-4244; Bachmann PS, 2010, BLOOD, V116, P3013, DOI 10.1182/blood-2010-05-284968; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Blau O, 1997, LEUKEMIA RES, V21, P721, DOI 10.1016/S0145-2126(97)80032-X; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Brown JM, 1999, CANCER RES, V59, P1391; Chang PY, 2006, MOL CANCER RES, V4, P101, DOI 10.1158/1541-7786.MCR-05-0259; Chen B, 2000, CANCER RES, V60, P3290; Chim CS, 2005, AM J HEMATOL, V80, P282, DOI 10.1002/ajh.20503; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Crescenzi E, 2008, CLIN CANCER RES, V14, P1877, DOI 10.1158/1078-0432.CCR-07-4298; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HOLLANDER MC, 1993, J BIOL CHEM, V268, P24385; Holleman A, 2003, BLOOD, V102, P4541, DOI 10.1182/blood-2002-11-3612; Irving J, 2009, HAEMATOL-HEMATOL J, V94, P870, DOI 10.3324/haematol.2008.000414; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Javelaud D, 2002, J BIOL CHEM, V277, P37949, DOI 10.1074/jbc.M204497200; Jung C, 2003, CLIN CANCER RES, V9, P6052; Kimura AP, 2004, MOL ENDOCRINOL, V18, P1018, DOI 10.1210/me.2003-0468; Lazzarini R, 2008, CLIN CANCER RES, V14, P5099, DOI 10.1158/1078-0432.CCR-08-0255; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Liem NLM, 2004, BLOOD, V103, P3905, DOI 10.1182/blood-2003-08-2911; Lock RB, 2002, BLOOD, V99, P4100, DOI 10.1182/blood.V99.11.4100; Mahyar-Roemer M, 2001, ONCOGENE, V20, P3387, DOI 10.1038/sj.onc.1204440; Majid S, 2008, CANCER RES, V68, P2736, DOI 10.1158/0008-5472.CAN-07-2290; Marks DI, 1996, BLOOD, V87, P1155, DOI 10.1182/blood.V87.3.1155.bloodjournal8731155; Meng L, 2003, PLANT MOL BIOL, V53, P327, DOI 10.1023/B:PLAN.0000006942.00464.e3; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Min DJ, 2006, APOPTOSIS, V11, P1977, DOI 10.1007/s10495-006-0081-1; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Peterson LF, 2007, BLOOD, V109, P4392, DOI 10.1182/blood-2006-03-012575; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Rokudai S, 2009, J BIOL CHEM, V284, P237, DOI 10.1074/jbc.M805101200; Roman-Gomez J, 2002, BLOOD, V99, P2291, DOI 10.1182/blood.V99.7.2291; Scott SA, 2004, LEUKEMIA RES, V28, P1293, DOI 10.1016/j.leukres.2004.03.019; Shen LL, 2002, BLOOD, V100, P3432, DOI 10.1182/blood-2002-07-1990; Shin JY, 2000, CANCER RES, V60, P262; SHIOHARA M, 1994, BLOOD, V84, P3781, DOI 10.1182/blood.V84.11.3781.bloodjournal84113781; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tian H, 2000, CANCER RES, V60, P679; WADA M, 1993, BLOOD, V82, P3163; Watanabe M, 2010, J VIROL, V84, P6966, DOI 10.1128/JVI.00073-10; WATTEL E, 1994, BLOOD, V84, P3148, DOI 10.1182/blood.V84.9.3148.3148; Ying JM, 2004, BLOOD, V103, P743, DOI 10.1182/blood-2003-09-3193; Zhang W, 1995, CLIN CANCER RES, V1, P1051; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003	54	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37639	37650		10.1074/jbc.M111.272336	http://dx.doi.org/10.1074/jbc.M111.272336			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21903579	Green Published, hybrid			2022-12-25	WOS:000296542400061
J	Singh, SK; Roberts, SA; McDevitt, SF; Weichsel, A; Wildner, GF; Grass, GB; Rensing, C; Montfort, WR				Singh, Satish K.; Roberts, Sue A.; McDevitt, Sylvia F.; Weichsel, Andrzej; Wildner, Guenter F.; Grass, Gregor B.; Rensing, Christopher; Montfort, William R.			Crystal Structures of Multicopper Oxidase CueO Bound to Copper(I) and Silver(I) FUNCTIONAL ROLE OF A METHIONINE-RICH SEQUENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; RESISTANCE PROTEIN; MOLECULAR-MECHANISMS; ANGSTROM RESOLUTION; COPRINUS-CINEREUS; FULL COMPLEMENT; CUPROUS OXIDASE; LACCASE; SITE; HOMEOSTASIS	The multicopper oxidase CueO oxidizes toxic Cu(I) and is required for copper homeostasis in Escherichia coli. Like many proteins involved in copper homeostasis, CueO has a methionine-rich segment that is thought to be critical for copper handling. How such segments function is poorly understood. Here, we report the crystal structure of CueO at 1.1 angstrom with the 45-residue methionine-rich segment fully resolved, revealing an N-terminal helical segment with methionine residues juxtaposed for Cu(I) ligation and a C-terminal highly mobile segment rich in methionine and histidine residues. We also report structures of CueO with a C500S mutation, which leads to loss of the T1 copper, and CueO with six methionines changed to serine. Soaking C500S CueO crystals with Cu(I), or wild-type CueO crystals with Ag(I), leads to occupancy of three sites, the previously identified substrate-binding site and two new sites along the methionine-rich helix, involving methionines 358, 362, 368, and 376. Mutation of these residues leads to a similar to 4-fold reduction in k(cat) for Cu(I) oxidation. Ag(I), which often appears with copper in nature, strongly inhibits CueO oxidase activities in vitro and compromises copper tolerance in vivo, particularly in the absence of the complementary copper efflux cus system. Together, these studies demonstrate a role for the methionine-rich insert of CueO in the binding and oxidation of Cu(I) and highlight the interplay among cue and cus systems in copper and silver homeostasis.	[Singh, Satish K.; Roberts, Sue A.; Weichsel, Andrzej; Wildner, Guenter F.; Montfort, William R.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA; [Rensing, Christopher] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA; [McDevitt, Sylvia F.] Skidmore Coll, Dept Biol, Saratoga Springs, NY 12866 USA; [Grass, Gregor B.] Bundeswehr Inst Microbiol, D-80937 Munich, Germany	University of Arizona; University of Arizona; Skidmore College; Bundeswehr Institute of Microbiology (IMB)	Montfort, WR (corresponding author), 1041 E Lowell St, Tucson, AZ 85721 USA.	montfort@email.arizona.edu	Singh, Satish/G-4401-2012; Rensing, Christopher/D-3947-2011; Grass, Gregor/A-9981-2009	Rensing, Christopher/0000-0002-5012-7953; Grass, Gregor/0000-0002-8002-7718	National Institutes of Health [HL062969]; International Copper Association; Department of Energy, Office of Biological and Environmental Research; Biomedical Technology Program; NIGMS; United States Department of Energy [W-31-109-Eng-38]; National Institutes of Health, National Center for Research Resources [RR07707]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Copper Association; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Biomedical Technology Program; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL062969 (to W. R. M.) and grants from the International Copper Association (to G. B. G. and C. R.). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the U.S. Dept. of Energy, Office of Basic Energy Sciences, and at Argonne National Laboratory.; The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the NIGMS. Diffraction data were also measured at BioCARS Sector 14, Advanced Photon Source, Argonne National Laboratory, supported by the United States Department of Energy under Contract W-31-109-Eng-38. BioCARS is supported by the National Institutes of Health, National Center for Research Resources Grant RR07707.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Bagai I, 2008, BIOCHEMISTRY-US, V47, P11408, DOI 10.1021/bi801638m; CHA JS, 1991, P NATL ACAD SCI USA, V88, P8915, DOI 10.1073/pnas.88.20.8915; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; COOKSEY DA, 1994, FEMS MICROBIOL REV, V14, P381, DOI 10.1016/0168-6445(94)90056-6; Djoko KY, 2010, J AM CHEM SOC, V132, P2005, DOI 10.1021/ja9091903; Ducros V, 2001, ACTA CRYSTALLOGR D, V57, P333, DOI 10.1107/S0907444900013779; Ducros V, 1998, NAT STRUCT BIOL, V5, P310, DOI 10.1038/nsb0498-310; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandes AS, 2007, J INORG BIOCHEM, V101, P849, DOI 10.1016/j.jinorgbio.2007.01.013; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Franke S, 2001, MICROBIOL-SGM, V147, P965, DOI 10.1099/00221287-147-4-965; Galli I, 2004, J BIOL INORG CHEM, V9, P90, DOI 10.1007/s00775-003-0501-4; Garavaglia S, 2004, J MOL BIOL, V342, P1519, DOI 10.1016/j.jmb.2004.07.100; Grass G, 2001, BIOCHEM BIOPH RES CO, V286, P902, DOI 10.1006/bbrc.2001.5474; Grass G, 2001, J BACTERIOL, V183, P2145, DOI 10.1128/JB.183.6.2145-2147.2001; Hakulinen N, 2002, NAT STRUCT BIOL, V9, P601, DOI 10.1038/nsb823; Kataoka K, 2007, J MOL BIOL, V373, P141, DOI 10.1016/j.jmb.2007.07.041; Kosman DJ, 2010, J BIOL INORG CHEM, V15, P15, DOI 10.1007/s00775-009-0590-9; Lee SM, 2002, BIOCHEM BIOPH RES CO, V295, P616, DOI 10.1016/S0006-291X(02)00726-X; Li X, 2007, BIOCHEM BIOPH RES CO, V354, P21, DOI 10.1016/j.bbrc.2006.12.116; Loftin IR, 2005, BIOCHEMISTRY-US, V44, P10533, DOI 10.1021/bi050827b; Loftin IR, 2007, PROTEIN SCI, V16, P2287, DOI 10.1110/ps.073021307; Loftin IR, 2009, J BIOL INORG CHEM, V14, P905, DOI 10.1007/s00775-009-0503-y; Lok CN, 2008, J PROTEOME RES, V7, P2351, DOI 10.1021/pr700646b; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musci G, 1996, J BIOL CHEM, V271, P1972, DOI 10.1074/jbc.271.4.1972; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Outten FW, 2000, J BIOL CHEM, V275, P31024, DOI 10.1074/jbc.M006508200; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Peariso K, 2003, J AM CHEM SOC, V125, P342, DOI 10.1021/ja028935y; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Roberts SA, 2003, J BIOL CHEM, V278, P31958, DOI 10.1074/jbc.M302963200; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0; Singh SK, 2004, J BACTERIOL, V186, P7815, DOI 10.1128/JB.186.22.7815-7817.2004; Solomon EI, 2008, DALTON T, P3921, DOI 10.1039/b800799c; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Stout JE, 2003, INFECT CONT HOSP EP, V24, P563, DOI 10.1086/502251; Stoyanov JV, 2003, FEBS LETT, V546, P391, DOI 10.1016/S0014-5793(03)00640-9; Stoyanov JV, 2001, MOL MICROBIOL, V39, P502, DOI 10.1046/j.1365-2958.2001.02264.x; Vachette P, 2002, J BIOL CHEM, V277, P40823, DOI 10.1074/jbc.M207188200; Wernimont AK, 2003, J BIOL INORG CHEM, V8, P185, DOI 10.1007/s00775-002-0404-9	47	70	72	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37849	37857		10.1074/jbc.M111.293589	http://dx.doi.org/10.1074/jbc.M111.293589			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21903583	Green Published, hybrid			2022-12-25	WOS:000296542400079
J	Liszczak, G; Arnesen, T; Marmorstein, R				Liszczak, Glen; Arnesen, Thomas; Marmorstein, Ronen			Structure of a Ternary Naa50p (NAT5/SAN) N-terminal Acetyltransferase Complex Reveals the Molecular Basis for Substrate-specific Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PROTEIN; YEAST; MECHANISM; IDENTIFICATION; EXPRESSION; HARD1; NATA; SAN	The co-translational modification of N-terminal acetylation is ubiquitous among eukaryotes and has been reported to have a wide range of biological effects. The human N-terminal acetyltransferase (NAT) Naa50p (NAT5/SAN) acetylates the alpha-amino group of proteins containing an N-terminal methionine residue and is essential for proper sister chromatid cohesion and chromosome condensation. The elevated activity of NATs has also been correlated with cancer, making these enzymes attractive therapeutic targets. We report the x-ray crystal structure of Naa50p bound to a native substrate peptide fragment and CoA. We found that the peptide backbone of the substrate is anchored to the protein through a series of backbone hydrogen bonds with the first methionine residue specified through multiple van der Waals contacts, together creating an alpha-amino methionine-specific pocket. We also employed structure-based mutagenesis; the results support the importance of the alpha-amino methionine-specific pocket of Naa50p and are consistent with the proposal that conserved histidine and tyrosine residues play important catalytic roles. Superposition of the ternary Naa50p complex with the peptide-bound Gcn5 histone acetyltransferase revealed that the two enzymes share a Gcn5-related N-acetyltransferase fold but differ in their respective substrate-binding grooves such that Naa50p can accommodate only an alpha-amino substrate and not a side chain lysine substrate that is acetylated by lysine acetyltransferase enzymes such as Gcn5. The structure of the ternary Naa50p complex also provides the first molecular scaffold for the design of NAT-specific small molecule inhibitors with possible therapeutic applications.	[Liszczak, Glen; Marmorstein, Ronen] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Liszczak, Glen; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Arnesen, Thomas] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; [Arnesen, Thomas] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway	The Wistar Institute; University of Pennsylvania; University of Bergen; University of Bergen; Haukeland University Hospital	Marmorstein, R (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	marmor@wistar.org	Arnesen, Thomas/J-7139-2017; Arnesen, Thomas/Q-8117-2019	Arnesen, Thomas/0000-0002-3005-147X; Arnesen, Thomas/0000-0002-3005-147X	National Institutes of Health [GM060293, GM071339, CA010815]; Research Council of Norway; Norwegian Cancer Society; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060293, T32GM071339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM060293 (to R. M.) and Training Grant GM071339 (to G. L.). This work was also supported by the Research Council of Norway and the Norwegian Cancer Society (to T. A.).; We acknowledge the use of the Wistar Proteomics Core facility, which is supported in part by National Institutes of Health Grant CA010815. We also acknowledge Mike Brent, Marc Holbert, and Rolf Sternglanz for helpful discussions.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnesen T, 2006, ONCOGENE, V25, P4350, DOI 10.1038/sj.onc.1209469; Arnesen T, 2006, GENE, V371, P291, DOI 10.1016/j.gene.2005.12.008; Arnesen T, 2005, BIOCHEM J, V386, P433, DOI 10.1042/BJ20041071; Arnesen T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001074; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Braman J, 1996, Methods Mol Biol, V57, P31; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evjenth R, 2009, J BIOL CHEM, V284, P31122, DOI 10.1074/jbc.M109.001347; Forte GMA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001073; Furdas SD, 2011, BIOORGAN MED CHEM, V19, P3678, DOI 10.1016/j.bmc.2011.01.063; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Hickman AB, 1999, CELL, V97, P361, DOI 10.1016/S0092-8674(00)80745-X; Hodawadekar SC, 2007, ONCOGENE, V26, P5528, DOI 10.1038/sj.onc.1210619; Hou FJ, 2007, J CELL BIOL, V177, P587, DOI 10.1083/jcb.200701043; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Lim JH, 2006, CANCER RES, V66, P10677, DOI 10.1158/0008-5472.CAN-06-3171; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pimenta-Marques A, 2008, DEV BIOL, V323, P197, DOI 10.1016/j.ydbio.2008.08.021; Polevoda B, 2003, BIOCHEM BIOPH RES CO, V308, P1, DOI 10.1016/S0006-291X(03)01316-0; Ren TT, 2008, CANCER LETT, V264, P83, DOI 10.1016/j.canlet.2008.01.028; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Seo JH, 2010, CANCER RES, V70, P4422, DOI 10.1158/0008-5472.CAN-09-3258; Starheim Kristian K, 2009, BMC Proc, V3 Suppl 6, pS3, DOI 10.1186/1753-6561-3-S6-S3; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Van Damme P., 2011, MOL CELL PROTEOMICS, V10; Vetting MW, 2008, PROTEIN SCI, V17, P1781, DOI 10.1110/ps.035899.108; Williams BC, 2003, CURR BIOL, V13, P2025, DOI 10.1016/j.cub.2003.11.018; Wu J, 2011, BIOORG CHEM, V39, P53, DOI 10.1016/j.bioorg.2010.11.003; Yu M, 2009, CANCER INVEST, V27, P978, DOI 10.3109/07357900902769723	37	70	71	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					37002	37010		10.1074/jbc.M111.282863	http://dx.doi.org/10.1074/jbc.M111.282863			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21900231	Green Published, hybrid			2022-12-25	WOS:000296538300078
J	Chen, HY; Chen, CC; Fang, CS; Hsieh, YT; Lin, MH; Shu, JC				Chen, Hong-Yi; Chen, Chien-Cheng; Fang, Chun-Sheng; Hsieh, Yi-Ting; Lin, Mei-Hui; Shu, Jwu-Ching			Vancomycin Activates sigma(B) in Vancomycin-Resistant Staphylococcus aureus Resulting in the Enhancement of Cytotoxicity	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEINS; SUBINHIBITORY CONCENTRATIONS; ALLELIC REPLACEMENT; MODULATES VIRULENCE; GENE-EXPRESSION; TRANSCRIPTION; ANTIBIOTICS; ISOLATE; STRAIN; SIGB	The alternative transcription factor sigma(B) is responsible for transcription in Staphylococcus aureus during the stress response. Many virulence-associated genes are directly or indirectly regulated by sigma(B). We hypothesized that treatment with antibiotics may act as an environmental stressor that induces sigma(B) activity in antibiotic-resistant strains. Several antibiotics with distinct modes of action, including ampicillin (12 mu g/ml), vancomycin (16 or 32 mu g/ml), chloramphenicol (15 mu g/ml), ciprofloxacin (0.25 mu g/ml), and sulfamethoxazole/trimethoprim (SXT, 0.8 mu g/ml), were investigated for their ability to activate this transcription factor. We were especially interested in the stress response in vancomycin-resistant S. aureus (VRSA) strains treated with vancomycin. The transcription levels of selected genes associated with virulence were also measured. Real-time quantitative reverse transcription PCR was employed to evaluate gene transcription levels. Contact hemolytic and cytotoxicity assays were used to evaluate cell damage following antibiotic treatment. Antibiotics that target the cell wall (vancomycin and ampicillin) and SXT induced sigma(B) activity in VRSA strains. Expression of sigma(B)-regulated virulence genes, including hla and fnbA, was associated with the vancomycin-induced sigma(B) activity in VRSA strains and the increase in cytotoxicity upon vancomycin treatment. These effects were not observed in the sigB-deficient strain but were observed in the complemented strain. We demonstrate that sub-minimum inhibitory concentration (sub-MIC) levels of antibiotics act as environmental stressors and activate the stress response sigma factor, sigma(B). The improper use of antibiotics may alter the expression of virulence factors through the activation of sigma(B) in drug-resistant strains of S. aureus and lead to worse clinical outcomes.	[Chen, Hong-Yi; Fang, Chun-Sheng; Hsieh, Yi-Ting; Lin, Mei-Hui; Shu, Jwu-Ching] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Chen, Chien-Cheng] Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Lin, Mei-Hui; Shu, Jwu-Ching] Chang Gung Univ, Res Ctr Pathogen Bacteria, Tao Yuan, Taiwan	Chang Gung University; National Kaohsiung Normal University; Chang Gung University	Chen, HY (corresponding author), Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan.	shujc@mail.cgu.edu.tw	FANG, Chunsheng/GLQ-7250-2022	Shu, Jwu-Ching/0000-0003-4862-6056; Lin, Mei-Hui/0000-0002-3498-9377; Chen, Hong-Yi/0000-0002-0457-9895	National Science Council of the Republic of China (Taiwan) [NSC96-2320-B-182-014-MY3]; Chang Gung Memorial Hospital, Taoyuan, Taiwan [CMRPD160411tilde3]	National Science Council of the Republic of China (Taiwan)(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taoyuan, Taiwan(Chang Gung Memorial Hospital)	This work was supported by the National Science Council of the Republic of China (Taiwan) (grant number NSC96-2320-B-182-014-MY3); and Research Program for Chang Gung Memorial Hospital (grant numbers CMRPD160411 similar to 3), Taoyuan 333, Taiwan. The funder's website: http://web1.nsc.gov.tw/mp.aspx?mp=7 and http://www.cgmh.org.tw/eng2002/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Becker K, 1998, J CLIN MICROBIOL, V36, P2548, DOI 10.1128/JCM.36.9.2548-2553.1998; Bernardo K, 2004, ANTIMICROB AGENTS CH, V48, P546, DOI 10.1128/AAC.48.2.546-555.2004; BERNHEIMER AW, 1988, METHOD ENZYMOL, V165, P213; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P565; Cheung AL, 1999, INFECT IMMUN, V67, P1331, DOI 10.1128/IAI.67.3.1331-1337.1999; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; CLSI, 2018, METHODS DILUTION ANT; Flannagan SE, 2003, ANTIMICROB AGENTS CH, V47, P3954, DOI 10.1128/AAC.47.12.3954-3959.2003; Gerber M, 2008, J MED MICROBIOL, V57, P776, DOI 10.1099/jmm.0.47739-0; Gertz S, 1999, MOL GEN GENET, V261, P558, DOI 10.1007/s004380051001; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Hsueh PR, 2010, INT J ANTIMICROB AG, V36, P307, DOI 10.1016/j.ijantimicag.2010.06.035; Jaruratanasirikul Sutep, 2010, Journal of the Medical Association of Thailand, V93, P172; Jones RN, 2006, CLIN INFECT DIS, V42, pS13, DOI 10.1086/491710; Koszczol C, 2006, J ANTIMICROB CHEMOTH, V58, P564, DOI 10.1093/jac/dkl291; Li DM, 2005, ANTIMICROB AGENTS CH, V49, P916, DOI 10.1128/AAC.49.3.916-924.2005; Lin TP, 1999, J BACTERIOL, V181, P5060, DOI 10.1128/JB.181.16.5060-5067.1999; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz U, 2008, MICROBES INFECT, V10, P217, DOI 10.1016/j.micinf.2007.11.006; LORIAN V, 1993, J ANTIMICROB CHEMOTH, V31, P137, DOI 10.1093/jac/31.suppl_D.137; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nielsen JS, 2011, ARCH MICROBIOL, V193, P23, DOI 10.1007/s00203-010-0641-1; Ohlsen K, 1998, ANTIMICROB AGENTS CH, V42, P2817, DOI 10.1128/AAC.42.11.2817; Pane-Farre J, 2006, INT J MED MICROBIOL, V296, P237, DOI 10.1016/j.ijmm.2005.11.011; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Sinha B, 2000, INFECT IMMUN, V68, P6871, DOI 10.1128/IAI.68.12.6871-6878.2000; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; van Schaik W, 2005, CURR OPIN BIOTECH, V16, P218, DOI 10.1016/j.copbio.2005.01.008; VANN JM, 1988, MICROB PATHOGENESIS, V4, P443, DOI 10.1016/0882-4010(88)90029-0; Vaudaux P, 2002, INFECT IMMUN, V70, P5428, DOI 10.1128/IAI.70.10.5428-5437.2002; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956	36	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24472	10.1371/journal.pone.0024472	http://dx.doi.org/10.1371/journal.pone.0024472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912698	Green Submitted, Green Published, gold			2022-12-25	WOS:000294686100045
J	Fekete, T; Rubin, D; Carlson, JM; Mujica-Parodi, LR				Fekete, Tomer; Rubin, Denis; Carlson, Joshua M.; Mujica-Parodi, Lilianne R.			The NIRS Analysis Package: Noise Reduction and Statistical Inference	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; TIME-SERIES ANALYSIS; ADULT HEAD MODEL; LIGHT-PROPAGATION; BRAIN; FMRI; SIGNAL; DYNAMICS; BOLD	Near infrared spectroscopy (NIRS) is a non-invasive optical imaging technique that can be used to measure cortical hemodynamic responses to specific stimuli or tasks. While analyses of NIRS data are normally adapted from established fMRI techniques, there are nevertheless substantial differences between the two modalities. Here, we investigate the impact of NIRS-specific noise; e.g., systemic (physiological), motion-related artifacts, and serial autocorrelations, upon the validity of statistical inference within the framework of the general linear model. We present a comprehensive framework for noise reduction and statistical inference, which is custom-tailored to the noise characteristics of NIRS. These methods have been implemented in a public domain MATLAB toolbox, the NIRS Analysis Package (NAP). Finally, we validate NAP using both simulated and actual data, showing marked improvement in the detection power and reliability of NIRS.	[Fekete, Tomer; Carlson, Joshua M.; Mujica-Parodi, Lilianne R.] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Rubin, Denis] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Fekete, T (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	lmujicaparodi@gmail.com		Rubin, Denis/0000-0002-0483-9458; Mujica-Parodi, Lilianne Rivka/0000-0002-3752-5519; Fekete, Tomer/0000-0003-3164-125X	Office of Naval Research [N000140410051]; National Science Foundation [0954643]; Div Of Chem, Bioeng, Env, & Transp Sys [0954643] Funding Source: National Science Foundation	Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported by the Office of Naval Research, Grant#N000140410051 (LRMP) and the National Science Foundation, Grant#0954643 (LRMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chul J, 2009, NEUROIMAGE, V44, P428, DOI 10.1016/j.neuroimage.2008.08.036; Cope M, 1988, Adv Exp Med Biol, V222, P183; Cui X, 2010, NEUROIMAGE, V49, P3039, DOI 10.1016/j.neuroimage.2009.11.050; FEKETE T, STAND ALONE ME UNPUB; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Fukui Y, 2003, APPL OPTICS, V42, P2881, DOI 10.1364/AO.42.002881; Gabbay M, 2000, NEUROIMAGE, V11, P313, DOI 10.1006/nimg.2000.0547; GRATTON G, 1995, PSYCHOPHYSIOLOGY, V32, P292, DOI 10.1111/j.1469-8986.1995.tb02958.x; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Izzetoglu M, 2005, IEEE T BIO-MED ENG, V52, P934, DOI 10.1109/TBME.2005.845243; JOBSIS FF, 1977, ACTA NEUROL SCAND, V56, P452; Kantz H., 2004, NONLINEAR TIME SERIE; KEOGH E, ONLINE ALGORITHM SEG; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Lindquist MA, 2009, NEUROIMAGE, V45, pS187, DOI 10.1016/j.neuroimage.2008.10.065; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; Okada E, 2003, APPL OPTICS, V42, P2915, DOI 10.1364/AO.42.002915; Okada E, 2003, APPL OPTICS, V42, P2906, DOI 10.1364/AO.42.002906; RADULESCU AR, POWER SPECT IN PRESS; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sato H, 2006, NEUROIMAGE, V33, P580, DOI 10.1016/j.neuroimage.2006.06.028; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tolkunov D, 2010, NEUROIMAGE, V50, P72, DOI 10.1016/j.neuroimage.2009.12.021; Wilcox T, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852551; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263; Zhang YH, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852552	31	84	84	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24322	10.1371/journal.pone.0024322	http://dx.doi.org/10.1371/journal.pone.0024322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912687	Green Submitted, Green Published, gold			2022-12-25	WOS:000294686100034
J	Collyer, ML; Heilveil, JS; Stockwell, CA				Collyer, Michael L.; Heilveil, Jeffrey S.; Stockwell, Craig A.			Contemporary Evolutionary Divergence for a Protected Species following Assisted Colonization	PLOS ONE			English	Article							WHITE SANDS PUPFISH; RECENTLY ESTABLISHED POPULATIONS; CYPRINODON-TULAROSA; GAMBUSIA-AFFINIS; PHENOTYPIC CHANGE; MODERN LIFE; CONSERVATION; RATES; MICROEVOLUTION; MORPHOMETRICS	Background: Contemporary evolution following assisted colonization may increase the probability of persistence for refuge populations established as a bet-hedge for protected species. Such refuge populations are considered "genetic replicates" that might be used for future re-colonization in the event of a catastrophe in the native site. Although maladaptive evolutionary divergence of captive populations is well recognized, evolutionary divergence of wild refuge populations may also occur on contemporary time scales. Thus, refuge populations may lose their "value" as true genetic replicates of the native population. Here, we show contemporary evolutionary divergence in body shape in an approximately 30-year old refuge population of the protected White Sands pupfish (Cyprinodon tularosa) resulting in a body-shape mismatch with its native environment. Methodology/Principal Findings: Geometric morphometic data were collected from C. tularosa cultures raised in experimental mesocosms. Cultures were initiated with fish from the two native populations, plus hybrids, in high or low salinity treatments representing the salinities of the two native habitats. We found that body shape was heritable and that shape variation due to phenotypic plasticity was small compared to shape variation due to population source. C. tularosa from the high salinity population retained slender body shapes and fish from the low salinity population retained deep body shapes, irrespective of mesocosm salinity. These data suggest that the observed divergence of a recently established pupfish population was not explained by plasticity. An analysis of microsatellite variation indicated that no significant genetic drift occurred in the refuge population, further supporting the adaptive nature of changes in body shape. These lines of evidence suggest that body shape divergence of the refuge population reflects a case of contemporary evolution (over a 30-year period). Conclusions/Significance: These results suggest assisted colonization can introduce novel, and/or relaxed selection, and lead to unintended evolutionary divergence.	[Collyer, Michael L.; Heilveil, Jeffrey S.; Stockwell, Craig A.] N Dakota State Univ, Dept Biol Sci, Fargo, ND 58105 USA; [Collyer, Michael L.] Western Kentucky Univ, Dept Biol, Bowling Green, KY 42101 USA; [Heilveil, Jeffrey S.] SUNY Coll Oneonta, Dept Biol, Oneonta, NY 13820 USA	North Dakota State University Fargo; Western Kentucky University; State University of New York (SUNY) System	Collyer, ML (corresponding author), N Dakota State Univ, Dept Biol Sci, Fargo, ND 58105 USA.	Craig.Stockwell@ndsu.edu		Stockwell, Craig/0000-0001-7882-8674	DOD [DACA87-00-H-0014]; North Dakota EPA-STAR EPSCoR; US Environmental Protection Agency [U-91597601-1]	DOD(United States Department of Defense); North Dakota EPA-STAR EPSCoR; US Environmental Protection Agency(United States Environmental Protection Agency)	This research was funded by DOD Legacy Resource Program Grant no. DACA87-00-H-0014 administered by H. Reiser and J. Dye, (CES/CEV, Holloman AFB) to CAS, a North Dakota EPA-STAR EPSCoR Grant to CAS and a US Environmental Protection Agency Science to Achieve Results (STAR) graduate fellowship (U-91597601-1) to MLC. However, external funding for this study is not currently available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; BEDRICK EJ, 1994, BIOMETRICS, V50, P226, DOI 10.2307/2533213; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Burg TM, 2002, CONSERV GENET, V3, P197, DOI 10.1023/A:1015229529868; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Clegg SM, 2008, EVOLUTION, V62, P2393, DOI 10.1111/j.1558-5646.2008.00437.x; Collyer ML, 2007, ECOL RES, V22, P902, DOI 10.1007/s11284-007-0385-9; Collyer ML, 2005, COPEIA, P1, DOI 10.1643/CG-03-303R1; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frankham R, 2008, MOL ECOL, V17, P325, DOI 10.1111/j.1365-294X.2007.03399.x; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; Gordon SP, 2009, AM NAT, V174, P34, DOI 10.1086/599300; Hendrickson DA, 1001, BATTLE EXTINCTION NA, P283; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Iyengar A, 2004, MOL ECOL NOTES, V4, P191, DOI 10.1111/j.1471-8286.2004.00615.x; Kinnison MT, 2008, MOL ECOL, V17, P405, DOI 10.1111/j.1365-294X.2007.03495.x; Kinnison MT, 2001, GENETICA, V112, P145, DOI 10.1023/A:1013375419520; Koike H, 2008, ANIM CONSERV, V11, P321, DOI 10.1111/j.1469-1795.2008.00187.x; Langerhans RB, 2009, J EVOLUTION BIOL, V22, P1057, DOI 10.1111/j.1420-9101.2009.01716.x; Langerhans RB, 2004, EVOLUTION, V58, P2305, DOI 10.1111/j.0014-3820.2004.tb01605.x; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Miller RR, SW NATURALIST, V19, P365; Miller RR, 1948, CYPRINODONT FISHES D; MINCKLEY WL, 1995, BIOL CONSERV, V72, P297, DOI 10.1016/0006-3207(94)00091-4; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Pittenger JS, 1999, SOUTHWEST NAT, V44, P157; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 2004, TPSSPLIN SOFTWARE VE; ROHLF FJ, 2004, TPSRELW SOFTWARE VER; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Stockwell CA, 1998, EVOLUTION, V52, P1856, DOI 10.1111/j.1558-5646.1998.tb02264.x; Stockwell CA, 1998, ANIM CONSERV, V1, P213, DOI 10.1111/j.1469-1795.1998.tb00031.x; Stockwell CA, 1999, ANIM CONSERV, V2, P103, DOI 10.1111/j.1469-1795.1999.tb00055.x; TURNER BJ, 1974, EVOLUTION, V28, P281, DOI 10.1111/j.1558-5646.1974.tb00748.x; Vogel S., 1994, LIFE MOVING FLUIDS P; WEBB PW, 1994, MECHANICS AND PHYSIOLOGY OF ANIMAL SWIMMING, P45; Wilcox JL, 2006, ANIM CONSERV, V9, P316, DOI 10.1111/j.1469-1795.2006.00039.x; Wright S, 1931, GENETICS, V16, P0097	44	15	15	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e22310	10.1371/journal.pone.0022310	http://dx.doi.org/10.1371/journal.pone.0022310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909348	Green Published, Green Submitted, gold			2022-12-25	WOS:000294680800001
J	Howard, S; Deroo, T; Fujita, Y; Itasaki, N				Howard, Sara; Deroo, Tom; Fujita, Yasuyuki; Itasaki, Nobue			A Positive Role of Cadherin in Wnt/beta-Catenin Signalling during Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							CELL-CELL ADHESION; TUMOR-SUPPRESSOR PROTEIN; FACTOR SCATTER FACTOR; BETA-CATENIN; TYROSINE PHOSPHORYLATION; WNT PATHWAY; N-CADHERIN; DEPENDENT TRANSCRIPTION; NUCLEAR TRANSLOCATION; ADHERENS JUNCTIONS	The Wnt/beta-catenin signalling pathway shares a key component, beta-catenin, with the cadherin-based adhesion system. The signalling function of beta-catenin is conferred by a soluble cytoplasmic pool that is unstable in the absence of a Wnt signal, whilst the adhesion function is based on a cadherin-bound, stable pool at the membrane. The cadherin complex is dynamic, allowing for cell-cell rearrangements such as epithelial-mesenchymal transition (EMT), where the complex turns over through internalisation. Potential interplay between the two pools remains poorly understood, but cadherins are generally considered negative regulators of Wnt signalling because they sequester cytoplasmic beta-catenin. Here we explore how cellular changes at EMT affect the signalling capacity of beta-catenin using two models of EMT: hepatocyte growth factor (HGF) treatment of MDCK cells, and gastrulation in embryonic development. We show that EMT not only provides a pool of signalling-competent beta-catenin following internalisation of cadherin, but also significantly facilitates activation of the Wnt pathway in response to both Wnt signals and exogenous beta-catenin. We further demonstrate that availability of beta-catenin in the cytoplasm does not necessarily correlate with Wnt/beta-catenin pathway activity, since blocking endocytosis or depleting endogenous cadherin abolishes pathway activation despite the presence of beta-catenin in the cytoplasm. Lastly we present data suggesting that cadherins are required for augmented activation of the Wnt/beta-catenin pathway in vivo. This suggests that cadherins play a crucial role in beta-catenin-dependent transcription.	[Howard, Sara; Deroo, Tom; Itasaki, Nobue] MRC Natl Inst Med Res, London, England; [Fujita, Yasuyuki] UCL, MRC Lab Mol Cell Biol, London, England; [Fujita, Yasuyuki] UCL, Dept Cell & Dev Biol, Cell Biol Unit, London, England; [Fujita, Yasuyuki] Hokkaido Univ, Inst Med Genet, Div Mol Oncol, Sapporo, Hokkaido, Japan	MRC National Institute for Medical Research; MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London; Hokkaido University	Howard, S (corresponding author), MRC Natl Inst Med Res, London, England.	nobue.itasaki@ucd.ie	Fujita, Yasuyuki/A-4324-2012	Itasaki, Nobue/0000-0003-0587-9141	Medical Research Council of Great Britain; Medical Research Council [MC_CF12266] Funding Source: researchfish	Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Bialucha CU, 2007, J CELL BIOL, V178, P575, DOI 10.1083/jcb.200612022; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Brault V, 2001, DEVELOPMENT, V128, P1253; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Caca K, 1999, CELL GROWTH DIFFER, V10, P369; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Chapman DL, 2003, MECH DEVELOP, V120, P837, DOI 10.1016/S0925-4773(03)00066-2; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chapman SC, 2004, DEV DYNAM, V229, P668, DOI 10.1002/dvdy.10491; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Cohen D, 2007, MOL BIOL CELL, V18, P2203, DOI 10.1091/mbc.E07-02-0095; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Curtis MW, 2008, CELL COMMUN ADHES, V15, P365, DOI 10.1080/15419060802460748; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Delva E, 2009, TRAFFIC, V10, P259, DOI 10.1111/j.1600-0854.2008.00862.x; Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009; Dunty WC, 2008, DEVELOPMENT, V135, P85, DOI 10.1242/dev.009266; Eger A, 2004, ONCOGENE, V23, P2672, DOI 10.1038/sj.onc.1207416; Eger A, 2000, J CELL BIOL, V148, P173, DOI 10.1083/jcb.148.1.173; Espada J, 1999, J CELL BIOL, V146, P967, DOI 10.1083/jcb.146.5.967; Fagotto F, 1996, J CELL BIOL, V132, P1105, DOI 10.1083/jcb.132.6.1105; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Harris TJC, 2005, TRENDS CELL BIOL, V15, P234, DOI 10.1016/j.tcb.2005.03.002; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Hendriksen J, 2008, J CELL SCI, V121, P1793, DOI 10.1242/jcs.025536; Herzig M, 2007, ONCOGENE, V26, P2290, DOI 10.1038/sj.onc.1210029; Hiscox S, 1999, BIOCHEM BIOPH RES CO, V261, P406, DOI 10.1006/bbrc.1999.1002; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; HUME CR, 1993, DEVELOPMENT, V119, P1147; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kamei T, 1999, ONCOGENE, V18, P6776, DOI 10.1038/sj.onc.1203114; Kim KS, 1998, EXP CELL RES, V245, P79, DOI 10.1006/excr.1998.4238; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Kuphal F, 2006, EXP CELL RES, V312, P457, DOI 10.1016/j.yexcr.2005.11.007; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; LI Y, 1994, IN VITRO CELL DEV-AN, V30A, P105; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Maher MT, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-5; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Monga SPS, 2002, CANCER RES, V62, P2064; Moriyama A, 2007, GENESIS, V45, P90, DOI 10.1002/dvg.20268; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Nakashima A, 2006, FRONT BIOSCI-LANDMRK, V11, P1667, DOI 10.2741/1912; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Orsulic S, 1999, J CELL SCI, V112, P1237; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Papkoff J, 1998, BIOCHEM BIOPH RES CO, V247, P851, DOI 10.1006/bbrc.1998.8888; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Peruzzi B, 2006, P NATL ACAD SCI USA, V103, P14531, DOI 10.1073/pnas.0606850103; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Potempa S, 1998, MOL BIOL CELL, V9, P2185, DOI 10.1091/mbc.9.8.2185; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Sadot E, 1998, P NATL ACAD SCI USA, V95, P15339, DOI 10.1073/pnas.95.26.15339; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Szeto DR, 2004, DEVELOPMENT, V131, P3751, DOI 10.1242/dev.01236; Tominaga J, 2008, GENES CELLS, V13, P67, DOI 10.1111/j.1365-2443.2007.01149.x; van de Wetering M, 2001, CANCER RES, V61, P278; VANVEELEN W, 2011, GUT             0209; Wang Q, 2010, ONCOGENE, V29, P128, DOI 10.1038/onc.2009.302; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wirtz-Peitz F, 2009, CURR OPIN GENET DEV, V19, P350, DOI 10.1016/j.gde.2009.04.011; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zeng G, 2006, EXP CELL RES, V312, P3620, DOI 10.1016/j.yexcr.2006.08.003; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	87	138	144	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23899	10.1371/journal.pone.0023899	http://dx.doi.org/10.1371/journal.pone.0023899			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909376	Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800038
J	Imperati, D; Colcombe, S; Kelly, C; Di Martino, A; Zhou, J; Castellanos, FX; Milham, MP				Imperati, Davide; Colcombe, Stan; Kelly, Clare; Di Martino, Adriana; Zhou, Juan; Castellanos, F. Xavier; Milham, Michael P.			Differential Development of Human Brain White Matter Tracts	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; HUMAN CEREBRAL-CORTEX; AGE-RELATED-CHANGES; GRAY-MATTER; INTERNAL CAPSULE; YOUNG ADULTHOOD; DIFFUSION; MICROSTRUCTURE; ADOLESCENCE; TRACTOGRAPHY	Neuroscience is increasingly focusing on developmental factors related to human structural and functional connectivity. Unfortunately, to date, diffusion-based imaging approaches have only contributed modestly to these broad objectives, despite the promise of diffusion-based tractography. Here, we report a novel data-driven approach to detect similarities and differences among white matter tracts with respect to their developmental trajectories, using 64-direction diffusion tensor imaging. Specifically, using a cross-sectional sample comprising 144 healthy individuals (7 to 48 years old), we applied k-means cluster analysis to separate white matter voxels based on their age-related trajectories of fractional anisotropy. Optimal solutions included 5-, 9- and 14-clusters. Our results recapitulate well-established tracts (e.g., internal and external capsule, optic radiations, corpus callosum, cingulum bundle, cerebral peduncles) and subdivisions within tracts (e.g., corpus callosum, internal capsule). For all but one tract identified, age-related trajectories were curvilinear (i.e., inverted 'U-shape'), with age-related increases during childhood and adolescence followed by decreases in middle adulthood. Identification of peaks in the trajectories suggests that age-related losses in fractional anisotropy occur as early as 23 years of age, with mean onset at 30 years of age. Our findings demonstrate that data-driven analytic techniques may be fruitfully applied to extant diffusion tensor imaging datasets in normative and neuropsychiatric samples.	[Imperati, Davide; Kelly, Clare; Di Martino, Adriana; Zhou, Juan; Castellanos, F. Xavier; Milham, Michael P.] NYU, Phyllis Green & Randolph Cowen Inst Pediat Neuros, Ctr Child Study, Langone Med Ctr, New York, NY 10012 USA; [Colcombe, Stan; Castellanos, F. Xavier; Milham, Michael P.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA	New York University; NYU Langone Medical Center; Nathan Kline Institute for Psychiatric Research	Imperati, D (corresponding author), NYU, Phyllis Green & Randolph Cowen Inst Pediat Neuros, Ctr Child Study, Langone Med Ctr, New York, NY 10012 USA.	mmilham@nki.rfmh.org	Milham, Michael P./Y-3160-2019; Di Martino, Adriana/X-5030-2019; Milham, Michael P/K-9501-2014; Kelly, Clare/H-4629-2016; Di Martino, Adriana/L-2497-2014; Castellanos, Francisco Xavier/K-1892-2014	Kelly, Clare/0000-0001-8253-357X; Castellanos, Francisco Xavier/0000-0001-9192-9437; Zhou, Juan/0000-0002-0180-8648; Colcombe, Stan/0000-0001-5051-2491; Di Martino, Adriana/0000-0001-6927-290X	National Institute of Mental Health [R01MH081218, R01MH083246]; Stavros Niarchos Foundation; Leon Levy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083246, R01MH081218] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Stavros Niarchos Foundation; Leon Levy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health grants (R01MH081218; R01MH083246); Stavros Niarchos Foundation grant to FC; Leon Levy Foundation grant to MM; and gifts from Joseph Healy, Linda and Richard Schaps, and Jill and Bob Smith to FC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER L, 2004, ADULT ADHD CLIN DIAF; ANDERSSON JLR, NON LINEAR REGISTRAT; Ashtari M, 2007, NEUROIMAGE, V35, P501, DOI 10.1016/j.neuroimage.2006.10.047; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bellec P, 2010, NEUROIMAGE, V51, P1126, DOI 10.1016/j.neuroimage.2010.02.082; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Colibazzi T, 2008, HUM BRAIN MAPP, V29, P1302, DOI 10.1002/hbm.20466; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Ffytche DH, 2005, PHILOS T R SOC B, V360, P767, DOI 10.1098/rstb.2005.1621; First MB, 2002, PSYCHOPATHOLOGY, V35, P67, DOI 10.1159/000065121; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Giorgio A, 2008, NEUROIMAGE, V39, P52, DOI 10.1016/j.neuroimage.2007.07.043; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; GUEVARA P, 2010, NEUROIMAGE; HEWITT W, 1961, J ANAT, V95, P191; HOPTMAN MJ, 1994, PSYCHOL BULL, V116, P195, DOI 10.1037/0033-2909.116.2.195; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kelly C, 2010, EUR J NEUROSCI, V32, P383, DOI 10.1111/j.1460-9568.2010.07279.x; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; LAMANTIA AS, 1990, J NEUROSCI, V10, P2156; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; LeBihan D, 1995, NMR BIOMED, V8, P375, DOI 10.1002/nbm.1940080711; MacQueen J, 1967, P 5 BERKELEY S MATH, V1, DOI DOI 10.1007/S11665-016-2173-6; Margulies DS, 2010, MAGN RESON MATER PHY, V23, P289, DOI 10.1007/s10334-010-0228-5; Michielse S, 2010, NEUROIMAGE, V52, P1190, DOI 10.1016/j.neuroimage.2010.05.019; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Peng HL, 2007, MAGN RESON IMAGING, V25, P147, DOI 10.1016/j.mri.2006.10.013; Peng HL, 2009, NEUROIMAGE, V46, P967, DOI 10.1016/j.neuroimage.2009.03.046; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Qiu DQ, 2008, NEUROIMAGE, V41, P223, DOI 10.1016/j.neuroimage.2008.02.023; Raj A, 2011, NEUROIMAGE, V54, P396, DOI 10.1016/j.neuroimage.2010.07.040; RAKIC P, 1988, J NEUROSCI, V8, P3670; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Raz N, 2000, MICROSC RES TECHNIQ, V51, P85, DOI 10.1002/1097-0029(20001001)51:1<85::AID-JEMT9>3.0.CO;2-0; ROSS ED, 1980, NEUROLOGY, V30, P59, DOI 10.1212/WNL.30.1.59; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Salat DH, 2005, ANN NY ACAD SCI, V1064, P37, DOI 10.1196/annals.1340.009; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Schmithorst VJ, 2002, RADIOLOGY, V222, P212, DOI 10.1148/radiol.2221010626; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sosnovik DE, 2009, CIRC-CARDIOVASC IMAG, V2, P206, DOI 10.1161/CIRCIMAGING.108.815050; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; THOMSEN C, 1987, ACTA RADIOL, V28, P353; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Westlye L.T., 2009, CEREB CORTEX; YAKOVLEV P I, 1954, Trans Am Neurol Assoc, V13, P53; Zielinski BA, 2010, P NATL ACAD SCI USA, V107, P18191, DOI 10.1073/pnas.1003109107; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	70	53	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23437	10.1371/journal.pone.0023437	http://dx.doi.org/10.1371/journal.pone.0023437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909351	Green Published, Green Submitted, gold			2022-12-25	WOS:000294680800011
J	Ji, LN; Chauhan, V; Flory, MJ; Chauhan, A				Ji, Lina; Chauhan, Ved; Flory, Michael J.; Chauhan, Abha			Brain Region-Specific Decrease in the Activity and Expression of Protein Kinase A in the Frontal Cortex of Regressive Autism	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CAMP-PHOSPHODIESTERASE INHIBITOR; HOMEOBOX-TRANSCRIPTION-FACTOR; RADIAL-ARM MAZE; NEUROTROPHIC FACTOR; MOUSE MODEL; RAT-BRAIN; MEMORY; ROLIPRAM; ENGRAILED-2	Autism is a severe neurodevelopmental disorder that is characterized by impaired language, communication, and social skills. In regressive autism, affected children first show signs of normal social and language development but eventually lose these skills and develop autistic behavior. Protein kinases are essential in G-protein-coupled, receptor-mediated signal transduction and are involved in neuronal functions, gene expression, memory, and cell differentiation. We studied the activity and expression of protein kinase A (PKA), a cyclic AMP-dependent protein kinase, in postmortem brain tissue samples from the frontal, temporal, parietal, and occipital cortices, and the cerebellum of individuals with regressive autism; autistic subjects without a clinical history of regression; and age-matched developmentally normal control subjects. The activity of PKA and the expression of PKA (C-alpha), a catalytic subunit of PKA, were significantly decreased in the frontal cortex of individuals with regressive autism compared to control subjects and individuals with non-regressive autism. Such changes were not observed in the cerebellum, or the cortices from the temporal, parietal, and occipital regions of the brain in subjects with regressive autism. In addition, there was no significant difference in PKA activity or expression of PKA (C-alpha) between non-regressive autism and control groups. These results suggest that regression in autism may be associated, in part, with decreased PKA-mediated phosphorylation of proteins and abnormalities in cellular signaling.	[Ji, Lina; Chauhan, Ved; Flory, Michael J.; Chauhan, Abha] NYS Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA; [Ji, Lina] Nanjing Univ, Coll Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China	Nanjing University	Ji, LN (corresponding author), NYS Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA.	abha.chauhan@opwdd.ny.gov	Ji, Lina/H-5326-2013		Department of Defense [AS073224P2]; Autism Research Institute; Autism Collaboration; NYS Office of People with Developmental Disabilities	Department of Defense(United States Department of Defense); Autism Research Institute; Autism Collaboration; NYS Office of People with Developmental Disabilities	This work was supported by funds from Department of Defense Autism Spectrum Disorders Research Program AS073224P2, Autism Research Institute, Autism Collaboration (autism.org), and NYS Office of People with Developmental Disabilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 2008, PROG BRAIN RES, V169, P97, DOI 10.1016/S0079-6123(07)00006-4; ALCAZAR A, 1986, INT J DEV NEUROSCI, V4, P525, DOI 10.1016/0736-5748(86)90005-5; ANDERSON GM, 1990, ANN NY ACAD SCI, V600, P331, DOI 10.1111/j.1749-6632.1990.tb16893.x; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Benayed R, 2005, AM J HUM GENET, V77, P851, DOI 10.1086/497705; Blaschke RJ, 2000, GENOMICS, V64, P187, DOI 10.1006/geno.2000.6116; Blokland A, 2006, CURR PHARM DESIGN, V12, P2511, DOI 10.2174/138161206777698855; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; Braun NN, 2007, NEUROREPORT, V18, P1841, DOI 10.1097/WNR.0b013e3282f16dca; Cheh MA, 2006, BRAIN RES, V1116, P166, DOI 10.1016/j.brainres.2006.07.086; Deogracias R, 2004, MOL CELL NEUROSCI, V26, P470, DOI 10.1016/j.mcn.2004.03.007; Egawa T, 1997, JPN J PHARMACOL, V75, P275, DOI 10.1254/jjp.75.275; FLEISCHHACKER WW, 1992, NEUROPSYCHOBIOLOGY, V26, P59, DOI 10.1159/000118897; FOGUET M, 1993, EMBO J, V12, P903, DOI 10.1002/j.1460-2075.1993.tb05731.x; Galter D, 2000, J NEUROSCI RES, V61, P295, DOI 10.1002/1097-4547(20000801)61:3<295::AID-JNR7>3.0.CO;2-4; Gharani N, 2004, MOL PSYCHIATR, V9, P474, DOI 10.1038/sj.mp.4001498; Goldberg WA, 2003, J AUTISM DEV DISORD, V33, P607, DOI 10.1023/B:JADD.0000005998.47370.ef; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Goodwin SF, 1997, J NEUROSCI, V17, P8817; Hamada H, 2003, CHILD NERV SYST, V19, P152, DOI 10.1007/s00381-002-0713-x; Hansen RL, 2008, AMBUL PEDIATR, V8, P25, DOI 10.1016/j.ambp.2007.08.006; Hjerrild M, 2004, FEBS LETT, V568, P55, DOI 10.1016/j.febslet.2004.05.009; Horiuchi J, 2008, P NATL ACAD SCI USA, V105, P20976, DOI 10.1073/pnas.0810119105; Hranilovic D, 2008, COLLEGIUM ANTROPOL, V32, P75; Hranilovic D, 2009, J NEURAL TRANSM, V116, P493, DOI 10.1007/s00702-009-0192-2; Kanes SJ, 2007, NEUROSCIENCE, V144, P239, DOI 10.1016/j.neuroscience.2006.09.026; Karege F, 2004, J AFFECT DISORDERS, V79, P187, DOI 10.1016/S0165-0327(02)00463-9; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; Li W, 1996, LEARN MEMORY, V2, P320, DOI 10.1101/lm.2.6.320; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; Lord C, 2004, J CHILD PSYCHOL PSYC, V45, P936, DOI 10.1111/j.1469-7610.2004.t01-1-00287.x; Luyster R, 2005, DEV NEUROPSYCHOL, V27, P311, DOI 10.1207/s15326942dn2703_2; McLachlan CS, 2007, ARCH NEUROL-CHICAGO, V64, P456, DOI 10.1001/archneur.64.3.456; Micheau J, 1999, CELL MOL LIFE SCI, V55, P534, DOI 10.1007/s000180050312; Morgan R, 2006, FEBS LETT, V580, P2531, DOI 10.1016/j.febslet.2006.04.053; Nagakura A, 2002, BRIT J PHARMACOL, V135, P1783, DOI 10.1038/sj.bjp.0704629; Nguyen PV, 2003, PROG NEUROBIOL, V71, P401, DOI 10.1016/j.pneurobio.2003.12.003; Nie T, 2007, J NEUROSCI, V27, P10278, DOI 10.1523/JNEUROSCI.1602-07.2007; Ozonoff S, 2005, AUTISM, V9, P461, DOI 10.1177/1362361305057880; Parkes J D, 1984, Adv Neurol, V40, P563; Perazzona B, 2004, J NEUROSCI, V24, P8823, DOI 10.1523/JNEUROSCI.4542-03.2004; Rice Catherine, 2009, Morbidity and Mortality Weekly Report, V58, P1; Rose GM, 2005, CURR PHARM DESIGN, V11, P3329, DOI 10.2174/138161205774370799; Rutten K, 2007, PSYCHOPHARMACOLOGY, V192, P275, DOI 10.1007/s00213-006-0697-4; SASAKI H, 1995, EUR J PHARMACOL, V282, P71, DOI 10.1016/0014-2999(95)00278-S; SASAKI H, 1995, LIFE SCI, V56, pPL443, DOI 10.1016/0024-3205(95)00218-U; Sebeo J, 2009, J NEUROSCI, V29, P9778, DOI 10.1523/JNEUROSCI.2613-09.2009; Sen B, 2010, GENES BRAIN BEHAV, V9, P248, DOI 10.1111/j.1601-183X.2009.00556.x; Siuciak JA, 2007, PSYCHOPHARMACOLOGY, V192, P415, DOI 10.1007/s00213-007-0727-x; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; STEFANATOS GA, 1995, J AM ACAD CHILD PSY, V34, P1107, DOI 10.1097/00004583-199508000-00022; Stefanatos GA, 2008, NEUROPSYCHOL REV, V18, P305, DOI 10.1007/s11065-008-9073-y; Tardito D, 2000, NEUROPSYCHOPHARMACOL, V23, P216, DOI 10.1016/S0893-133X(99)00161-X; Tardito D, 2002, EUR NEUROPSYCHOPHARM, V12, P483, DOI 10.1016/S0924-977X(02)00072-X; Tardito D, 2001, EUR NEUROPSYCHOPHARM, V11, P221, DOI 10.1016/S0924-977X(01)00088-8; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; TURNER RS, 1984, P NATL ACAD SCI-BIOL, V81, P3143, DOI 10.1073/pnas.81.10.3143; WACHTEL H, 1983, NEUROPHARMACOLOGY, V22, P267, DOI 10.1016/0028-3908(83)90239-3; Wang LF, 2008, AM J MED GENET B, V147B, P434, DOI 10.1002/ajmg.b.30623; Yang L, 2008, EXP NEUROL, V211, P311, DOI 10.1016/j.expneurol.2007.02.010; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zhang HT, 2000, PSYCHOPHARMACOLOGY, V150, P311, DOI 10.1007/s002130000414; Zhang HT, 2005, PSYCHOPHARMACOLOGY, V179, P613, DOI 10.1007/s00213-004-2085-2	65	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23751	10.1371/journal.pone.0023751	http://dx.doi.org/10.1371/journal.pone.0023751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909354	Green Submitted, gold, Green Published			2022-12-25	WOS:000294680800017
J	Wang, XY; Chao, W; Saini, M; Potash, MJ				Wang, Xingyu; Chao, Wei; Saini, Manisha; Potash, Mary Jane			A Common Path to Innate Immunity to HIV-1 Induced by Toll-Like Receptor Ligands in Primary Human Macrophages	PLOS ONE			English	Article							MONOCYTE-DERIVED MACROPHAGES; PATTERN-RECOGNITION RECEPTORS; VIRUS TYPE-1 INFECTION; MYCOBACTERIUM-TUBERCULOSIS; GENE-EXPRESSION; DOWN-REGULATION; INHIBITS HIV-1; REPLICATION; INDUCTION; LIPOPOLYSACCHARIDE	Toll-like receptors (TLR) represent the best characterized receptor family transducing innate immune responses, the first line of defense against microbial invaders. This study was designed to investigate whether responses through TLR inhibit HIV-1 replication in its primary target cells. Primary human macrophages and lymphocytes from several different donors and HIV-1 infection in tissue culture were used exclusively in this work. We report that ligands of three different TLR: LPS, R848, and double stranded RNA, induce a common antiviral response in macrophages as assayed by measurement of HIV-1 p24 protein, gag DNA, and entry into cells. HIV-1 infection is arrested after efficient entry but prior to reverse transcription. TLR-ligand activated cells secrete antiviral factors that induce a similar restriction. HIV-1 infection of lymphocytes is not affected by exposure to TLR ligands or to antiviral factors secreted by activated macrophages. TBK1, but neither NF-kappa B nor JAK-STAT activity, is required in macrophages to mount this antiviral response; the combination of p38 MAPK and JNK are partially required for induction of antiviral activity. Based on transcriptional induction and inhibition, the TLR-linked antiviral activity is different from APOBEC3 A or G, interferon-beta, NAMPT, or p21(Cip1). The cell-type specificity, site of action, and requirement for signaling intermediates suggest that the TLR-linked antiviral activity is novel.	[Wang, Xingyu; Chao, Wei; Saini, Manisha; Potash, Mary Jane] Columbia Univ, St Lukes Roosevelt Hosp Ctr, Div Mol Virol, Med Ctr, New York, NY USA	Columbia University; Mount Sinai St. Luke's; Mount Sinai West	Wang, XY (corresponding author), Tongji Univ, Sch Med, Ctr Immunol, Shanghai 200092, Peoples R China.	mjp6@columbia.edu			United States Public Health Service [R01 NS 39391, R01 NS 43110]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043110] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by United States Public Health Service grants R01 NS 39391 and R01 NS 43110 to MJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arfi V, 2009, J VIROL, V83, P7524, DOI 10.1128/JVI.00429-09; Bergamaschi A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-31; Bergamaschi A, 2009, J VIROL, V83, P12253, DOI 10.1128/JVI.01395-09; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brichacek B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012831; Cavrois Marielle, 2004, Methods Mol Biol, V263, P333; Chowdhury IH, 1996, J VIROL, V70, P5336, DOI 10.1128/JVI.70.8.5336-5345.1996; Cremer I, 2000, J IMMUNOL, V164, P1582, DOI 10.4049/jimmunol.164.3.1582; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Fantuzzi L, 2003, J LEUKOCYTE BIOL, V74, P719, DOI 10.1189/jlb.0403175; Franchin G, 2000, J IMMUNOL, V164, P2592, DOI 10.4049/jimmunol.164.5.2592; Goletti D, 2004, J INFECT DIS, V189, P624, DOI 10.1086/381554; Hori K, 1999, AIDS, V13, P751, DOI 10.1097/00002030-199905070-00003; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KORNBLUTH RS, 1989, J EXP MED, V169, P1137, DOI 10.1084/jem.169.3.1137; Mancino G, 1997, J INFECT DIS, V175, P1531, DOI 10.1086/516494; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Mogensen TH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-54; Mosoian A, 2010, P NATL ACAD SCI USA, V107, P10178, DOI 10.1073/pnas.0914870107; OZATO K, 2002, BIOTECHNIQUES S, V66, P72; POLI G, 1990, P NATL ACAD SCI USA, V87, P782, DOI 10.1073/pnas.87.2.782; Skott P, 2002, ORAL DIS, V8, P160, DOI 10.1034/j.1601-0825.2002.01807.x; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; STANDIFORD TJ, 1993, AM J RESP CELL MOL, V9, P192, DOI 10.1165/ajrcmb/9.2.192; Van den Bergh R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-53; Vazquez N, 2005, J VIROL, V79, P4479, DOI 10.1128/JVI.79.7.4479-4491.2005; Verani A, 2002, J IMMUNOL, V168, P6388, DOI 10.4049/jimmunol.168.12.6388; Wahl SM, 2006, J LEUKOCYTE BIOL, V80, P973, DOI 10.1189/jlb.0306130; Zhou Y, 2010, IMMUNOLOGY, V131, P40, DOI 10.1111/j.1365-2567.2010.03270.x	31	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24193	10.1371/journal.pone.0024193	http://dx.doi.org/10.1371/journal.pone.0024193			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904615	Green Submitted, gold, Green Published			2022-12-25	WOS:000294680800066
J	Zhang, RH; Pan, XL; Huang, ZH; Weber, GF; Zhang, GX				Zhang, Rihua; Pan, Xiaolin; Huang, Zuhu; Weber, Georg F.; Zhang, Guoxin			Osteopontin Enhances the Expression and Activity of MMP-2 via the SDF-1/CXCR4 Axis in Hepatocellular Carcinoma Cell Lines	PLOS ONE			English	Article							METASTASIS; INVASION; CXCR4; MOBILIZATION; INFLAMMATION; ACTIVATION	Background and Aims: Osteopontin, SDF-1 alpha, and MMP-2 are important secreted molecules involved in the pathophysiology of human hepatocellular carcinoma (HCC). This study investigates the effect of the SDF-1 alpha/CXCR4 axis on expression and activity of MMP-2 induced by osteopontin. Methods: The expression of CXCR4, SDF-1 alpha, MMP-2 and their associated cellular signaling cascades, involving Akt and MAP Kinases, were determined by Western blotting. The activities of MMP-2 and MMP-9 were assayed by gel zymography. The role of the osteopontin receptors integrin alpha(v)beta(3) and CD44v6 was evaluated using neutralizing antibodies. We also established CXCR4-deficient SMMC7721 cell lines by transfection with miRNA-CXCR4 plasmids and determined cell invasion activity in a transwell assay. Results: In comparison with untreated cells, recombinant human osteopontin (rhOPN) up-regulated CXCR4, SDF-1 alpha, and MMP-2 expression about 5-, 4-, and 6-fold on the protein levels through binding to integrin alpha(v)beta(3) and CD44v6 in hepatocellular carcinoma cells (SMMC7721 and HepG2). Inhibition of the SDF-1 alpha/CXCR4 axis down-regulated the rhOPN-induced MMP-2 expression and activity. rhOPN also activated Akt, p38 and JNK. Down-regulation of CXCR4 decreased the rhOPN-induced invasion in SMMC7721 cells. Conclusion: These results indicate that rhOPN up-regulates MMP-2 through the SDF-1 alpha/CXCR4 axis, mediated by binding to integrin alpha(v)beta(3) and CD44v6 and activating the PI-3K/Akt and JNK pathways in HepG2 and SMMC7721 cells. Therefore, the osteopontin-SDF-1 alpha/CXCR4-MMP-2 system may be a new therapeutic target for treating HCC progression.	[Zhang, Rihua; Pan, Xiaolin; Zhang, Guoxin] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Peoples R China; [Huang, Zuhu] Nanjing Med Univ, Affiliated Hosp 1, Dept Infect Dis, Nanjing, Peoples R China; [Weber, Georg F.] Univ Cincinnati, Coll Pharm, Acad Hlth Ctr, Cincinnati, OH 45267 USA	Nanjing Medical University; Nanjing Medical University; University System of Ohio; University of Cincinnati	Zhang, RH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Peoples R China.	guoxinz@njmu.edu.cn			National Natural Science Foundation of China [81072032, 30770992]; Social Development Funds of Jiangsu Province; Jiangsu Health Department, China [B52007070, H200702]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Development Funds of Jiangsu Province; Jiangsu Health Department, China	This work was supported by grants from National Natural Science Foundation of China (No. 81072032 and 30770992), and Social Development Funds of Jiangsu Province and from Jiangsu Health Department, China (No. B52007070 and H200702). GW is founder and CEO of MetaMol Theranostics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brakora KA, 2004, GYNECOL ONCOL, V93, P361, DOI 10.1016/j.ygyno.2004.01.050; Budhu AS, 2005, ONCOLOGY-BASEL, V69, P23, DOI 10.1159/000086628; Clark IM, 1990, METHODS MOL BIOL; El-Tanani MK, 2008, FRONT BIOSCI, V13, P4276, DOI 10.2741/3004; Gaviraghi M, 2010, BIOSCI REP; Gazitt Y, 2004, LEUKEMIA, V18, P1, DOI 10.1038/sj.leu.2403173; Hong IK, 2005, EXP MOL MED, V37, P230, DOI 10.1038/emm.2005.31; Hu T, 2009, CLIN EXP PHARMACOL P, V36, P626, DOI 10.1111/j.1440-1681.2008.05124.x; Jakobsen LP, 2009, EXP MOL MED, V41, P77, DOI 10.3858/emm.2009.41.2.010; Janowski M, 2009, CELL ADHES MIGR, V3, P243, DOI 10.4161/cam.3.3.8260; Jaszczynska-Nowinka K, 2009, EUR J GYNAECOL ONCOL, V30, P124; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; Kang Y, 2010, PLOS ONE, V5, P113; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Lai CF, 2006, CIRC RES, V98, P1479, DOI 10.1161/01.RES.0000227550.00426.60; Levicar N, 2003, ACTA NEUROCHIR, V145, P825, DOI 10.1007/s00701-003-0097-z; Lin HM, 2007, ONCOL REP, V17, P1541; Liu H, 2008, CELL MOL IMMUNOL, V5, P373, DOI 10.1038/cmi.2008.46; McKenna GJ, 2002, AM J SURG, V183, P588, DOI 10.1016/S0002-9610(02)00833-4; Mi ZY, 2009, MOL THER, V17, P153, DOI 10.1038/mt.2008.235; Morimoto J, 2010, CURR DRUG TARGETS, V11, P494, DOI 10.2174/138945010790980321; Ogawa K, 2009, PATHOL INT, V59, P605, DOI 10.1111/j.1440-1827.2009.02416.x; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; Philip S, 2004, GLYCOCONJUGATE J, V21, P429, DOI 10.1007/s10719-004-5533-7; Qin LX, 2002, WORLD J GASTROENTERO, V8, P385, DOI 10.3748/wjg.v8.i3.385; Ramaiah SK, 2008, TOXICOL SCI, V103, P4, DOI 10.1093/toxsci/kfm246; Rogers CD, 2006, CANCER BIOL THER, V5, P1383, DOI 10.4161/cbt.5.10.3323; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Song G, 2009, J CELL MOL MED, V13, P1706, DOI 10.1111/j.1582-4934.2008.00540.x; Takafuji V, 2007, ONCOGENE, V26, P6361, DOI 10.1038/sj.onc.1210463; Tiveron MC, 2008, CURR OPIN NEUROBIOL, V18, P237, DOI 10.1016/j.conb.2008.06.004; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang L, 2010, CANCER LETT, V297, P42, DOI 10.1016/j.canlet.2010.04.022; Xiang ZL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-176; Yan W, 2010, NEURO-ONCOLOGY, V12, P765, DOI 10.1093/neuonc/noq006; Ye S, 2006, CARDIOVASC RES, V69, P636, DOI 10.1016/j.cardiores.2005.07.015	37	47	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23831	10.1371/journal.pone.0023831	http://dx.doi.org/10.1371/journal.pone.0023831			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909361	Green Published, Green Submitted, gold			2022-12-25	WOS:000294680800024
J	Griesser, M; Ma, Q; Webber, S; Bowgen, K; Sumpter, DJT				Griesser, Michael; Ma, Qi; Webber, Simone; Bowgen, Katharine; Sumpter, David J. T.			Understanding Animal Group-Size Distributions	PLOS ONE			English	Article							HOUSE SPARROWS; POWER-LAW; DYNAMICS; FISH; POPULATION; PATTERNS; MODELS; FLOCKS; HERD	One of the most striking aspects of animal groups is their remarkable variation in size, both within and between species. While a number of mechanistic models have been proposed to explain this variation, there are few comprehensive datasets against which these models have been tested. In particular, we only vaguely understand how environmental factors and behavioral activities affect group-size distributions. Here we use observations of House sparrows (Passer domesticus) to investigate the factors determining group-size distribution. Over a wide range of conditions, we observed that animal group sizes followed a single parameter distribution known as the logarithmic distribution. This single parameter is the mean group size experienced by a randomly chosen individual (including the individual itself). For sparrows, the experienced mean group size, and hence the distribution, was affected by four factors: morning temperature, place, behavior and the degree of food spillage. Our results further indicate that the sparrows regulate the mean group size they experience, either by groups splitting more or merging less when local densities are high. We suggest that the mean experienced group size provides a simple but general tool for assessing the ecology and evolution of grouping.	[Griesser, Michael; Bowgen, Katharine] Uppsala Univ, Dept Ecol & Evolut, Uppsala, Sweden; [Griesser, Michael] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Griesser, Michael] Univ Bern, Inst Evolut & Ecol, Bern, Switzerland; [Ma, Qi; Sumpter, David J. T.] Uppsala Univ, Dept Math, S-75238 Uppsala, Sweden; [Webber, Simone] Univ Birmingham, Ctr Ornithol, Birmingham, W Midlands, England	Uppsala University; Swedish University of Agricultural Sciences; University of Bern; Uppsala University; University of Birmingham	Griesser, M (corresponding author), Uppsala Univ, Dept Ecol & Evolut, Uppsala, Sweden.	michael.griesser@iee.unibe.ch	Griesser, Michael/J-6042-2019; Bowgen, Katharine M/GPP-2876-2022; Griesser, Michael/E-4340-2012; Griesser, Michael/J-4542-2012	Bowgen, Katharine M/0000-0002-2414-8021; Griesser, Michael/0000-0002-2220-2637	Swedish Natural Research Council; Stiftelsen for Zoologisk Forskning; C. F. Lilljewalchs Resestipendium; The Swedish Royal Academy of Sciences; Helge Ax:son Johnson Stiftelsen	Swedish Natural Research Council(Swedish Research Council); Stiftelsen for Zoologisk Forskning; C. F. Lilljewalchs Resestipendium; The Swedish Royal Academy of Sciences; Helge Ax:son Johnson Stiftelsen	This study was funded by the Swedish Natural Research Council (DS, MG), the Stiftelsen for Zoologisk Forskning (MG), C. F. Lilljewalchs Resestipendium (MG), The Swedish Royal Academy of Sciences (MG) and Helge Ax:son Johnson Stiftelsen (MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anderson TR., 2006, BIOL UBIQUITOUS HOUS; Aviles L, 1998, AM NAT, V152, P403, DOI 10.1086/286178; BARNARD CJ, 1981, ANIM BEHAV, V29, P543, DOI 10.1016/S0003-3472(81)80117-0; BARNARD CJ, 1980, BEHAVIOUR, V74, P114, DOI 10.1163/156853980X00348; Biro D, 2006, CURR BIOL, V16, P2123, DOI 10.1016/j.cub.2006.08.087; Bonabeau E, 1999, P NATL ACAD SCI USA, V96, P4472, DOI 10.1073/pnas.96.8.4472; BONABEAU E, 1995, PHYS REV E, V51, pR5220, DOI 10.1103/PhysRevE.51.R5220; Brown C. R., 1996, COLONIALITY CLIFF SW; CARACO T, 1980, AM NAT, V115, P262, DOI 10.1086/283558; COHEN JE, 1972, THEOR POPUL BIOL, V3, P119, DOI 10.1016/0040-5809(72)90022-6; Edwards AM, 2008, J ANIM ECOL, V77, P1212, DOI 10.1111/j.1365-2656.2008.01428.x; Gerard JF, 2002, BIOL BULL, V202, P275, DOI 10.2307/1543479; Giraldeau LA, 1999, TRENDS ECOL EVOL, V14, P102, DOI 10.1016/S0169-5347(98)01542-0; GUERON S, 1995, MATH BIOSCI, V128, P243, DOI 10.1016/0025-5564(94)00074-A; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Jarman P., 1982, P323; Johnson CA, 2004, BEHAV ECOL, V15, P412, DOI 10.1093/beheco/arh026; Jovani R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001992; Krause J, 2002, LIVING GROUPS; Ma Q, 2011, J THEOR BIOL, V283, P35, DOI 10.1016/j.jtbi.2011.04.031; MORGAN BJT, 1976, ADV APPL PROBAB, V8, P30, DOI 10.2307/1426021; Niwa HS, 1998, J THEOR BIOL, V195, P351, DOI 10.1006/jtbi.1998.0801; Niwa HS, 2004, J THEOR BIOL, V228, P347, DOI 10.1016/j.jtbi.2004.01.011; Niwa HS, 2003, J THEOR BIOL, V224, P451, DOI 10.1016/S0022-5193(03)00192-9; Okubo A., 1986, Advances in Biophysics, V22, P1, DOI 10.1016/0065-227X(86)90003-1; SIBLY RM, 1983, ANIM BEHAV, V31, P947, DOI 10.1016/S0003-3472(83)80250-4; Sjoberg M, 2000, ECOL LETT, V3, P90, DOI 10.1046/j.1461-0248.2000.00113.x; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Treherne JE, 1981, ANIMAL BEHAV, V28; Weimerskirch H, 2001, NATURE, V413, P697, DOI 10.1038/35099670	32	24	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e23438	10.1371/journal.pone.0023438	http://dx.doi.org/10.1371/journal.pone.0023438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912596	gold, Green Submitted, Green Published			2022-12-25	WOS:000294678300004
J	Darcy, JL; Lynch, RC; King, AJ; Robeson, MS; Schmidt, SK				Darcy, John L.; Lynch, Ryan C.; King, Andrew J.; Robeson, Michael S.; Schmidt, Steven K.			Global Distribution of Polaromonas Phylotypes - Evidence for a Highly Successful Dispersal Capacity	PLOS ONE			English	Article							COMMUNITY COMPOSITIONS; RAST SERVER; BIOGEOGRAPHY; DIVERSITY; BACTERIA; ICE; ELEVATION; INFERENCE; EVOLUTION; SEQUENCE	Bacteria from the genus Polaromonas are dominant phylotypes in clone libraries and culture collections from polar and high-elevation environments. Although Polaromonas has been found on six continents, we do not know if the same phylotypes exist in all locations or if they exhibit genetic isolation by distance patterns. To examine their biogeographic distribution, we analyzed all available, long-read 16S rRNA gene sequences of Polaromonas phylotypes from glacial and periglacial environments across the globe. Using genetic isolation by geographic distance analyses, including Mantel tests and Mantel correlograms, we found that Polaromonas phylotypes are globally distributed showing weak isolation by distance patterns at global scales. More focused analyses using discrete, equally sampled distances classes, revealed that only two distance classes (out of 12 total) showed significant spatial structuring. Overall, our analyses show that most Polaromonas phylotypes are truly globally distributed, but that some, as yet unknown, environmental variable may be selecting for unique phylotypes at a minority of our global sites. Analyses of aerobiological and genomic data suggest that Polaromonas phylotypes are globally distributed as dormant cells through high-elevation air currents; Polaromonas phylotypes are common in air and snow samples from high altitudes, and a glacial-ice metagenome and the two sequenced Polaromonas genomes contain the gene hipA, suggesting that Polaromonas can form dormant cells.	[Darcy, John L.; Lynch, Ryan C.; King, Andrew J.; Robeson, Michael S.; Schmidt, Steven K.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Darcy, JL (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	Steve.Schmidt@Colorado.edu	King, Andrew/C-3810-2012; Schmidt, Steven K/G-2771-2010; Robeson, Michael Scott/J-5211-2019	King, Andrew/0000-0002-1348-7984; Schmidt, Steven K/0000-0002-9175-2085; Robeson, Michael Scott/0000-0001-7119-6301	NSF [MCB-0455606, DEB-0922267]; University of Colorado; National Park Service; National Geographic Committee for Research and Exploration; Direct For Biological Sciences [0922306] Funding Source: National Science Foundation; Division Of Environmental Biology [0921940, 0922267] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); University of Colorado; National Park Service; National Geographic Committee for Research and Exploration(National Geographic Society); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was funded by the NSF Microbial Observatories Program (MCB-0455606) and NSF grant DEB-0922267. Expedition funding was from a Faculty Fellowship to S.K.S. (University of Colorado), a National Park Service fellowship to B.-L.C. and the National Geographic Committee for Research and Exploration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bell T, 2005, SCIENCE, V308, P1884, DOI 10.1126/science.1111318; Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15; BLACK DS, 1994, J BACTERIOL, V176, P4081, DOI 10.1128/JB.176.13.4081-4091.1994; Bowman JP, 2003, APPL ENVIRON MICROB, V69, P2463, DOI 10.1128/AEM.69.5.2463-2483.2003; Brinkmeyer R, 2003, APPL ENVIRON MICROB, V69, P6610, DOI 10.1128/AEM.69.11.6610-6619.2003; Cheng SM, 2007, FEMS MICROBIOL ECOL, V59, P318, DOI 10.1111/j.1574-6941.2006.00267.x; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; FAHLGREN C, 2010, AEROBIOLOGIA, V104, P285; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Foght J, 2004, MICROB ECOL, V47, P329, DOI 10.1007/s00248-003-1036-5; Freeman KR, 2009, P NATL ACAD SCI USA, V106, P18315, DOI 10.1073/pnas.0907303106; Furrer R., 2007, FIELDS TOOLS SPATIAL; Harrison JJ, 2005, MICROBIOL-SGM, V151, P3181, DOI 10.1099/mic.0.27794-0; Hervas A, 2009, FEMS MICROBIOL ECOL, V67, P219, DOI 10.1111/j.1574-6941.2008.00617.x; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Irgens RL, 1996, INT J SYST BACTERIOL, V46, P822, DOI 10.1099/00207713-46-3-822; Jeon CO, 2003, P NATL ACAD SCI USA, V100, P13591, DOI 10.1073/pnas.1735529100; King AJ, 2008, SOIL BIOL BIOCHEM, V40, P2605, DOI 10.1016/j.soilbio.2008.06.026; King AJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1055; Lanoil B, 2009, ENVIRON MICROBIOL, V11, P609, DOI 10.1111/j.1462-2920.2008.01831.x; Legendre P, 1998, NUMERICAL ECOLOGY; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Ley RE, 2004, BIOGEOCHEMISTRY, V68, P313, DOI 10.1023/B:BIOG.0000031032.58611.d0; Liu YQ, 2007, CHINESE SCI BULL, V52, P2350, DOI 10.1007/s11434-007-0360-4; Liu YQ, 2009, EXTREMOPHILES, V13, P411, DOI 10.1007/s00792-009-0227-5; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MADDISON W.P., 2001, MESQUITE MODULAR SYS; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Mattes TE, 2008, APPL ENVIRON MICROB, V74, P6405, DOI 10.1128/AEM.00197-08; Meyer AF, 2004, APPL ENVIRON MICROB, V70, P483, DOI 10.1128/AEM.70.1.483-489.2004; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Nemergut DR, 2007, MICROB ECOL, V53, P110, DOI 10.1007/s00248-006-9144-7; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Oline DK, 2006, MICROB ECOL, V52, P480, DOI 10.1007/s00248-006-9101-5; Osborne TH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-205; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Polz MF, 2006, PHILOS T R SOC B, V361, P2009, DOI 10.1098/rstb.2006.1928; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R Core Development Team, 2008, R LANG ENV STAT COMP; Robeson MS, 2011, P NATL ACAD SCI USA, V108, P4406, DOI 10.1073/pnas.1012678108; Rodrigues DF, 2009, ISME J, V3, P658, DOI 10.1038/ismej.2009.25; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sattin SR, 2009, J MICROBIOL, V47, P673, DOI 10.1007/s12275-009-0194-7; Schmidt SK, 2008, P ROY SOC B-BIOL SCI, V275, P2793, DOI 10.1098/rspb.2008.0808; Schmidt SK, 2011, P ROY SOC B-BIOL SCI, V278, P702, DOI 10.1098/rspb.2010.1254; Schmidt SK, 2009, EXTREMOPHILES, V13, P807, DOI 10.1007/s00792-009-0268-9; Simon C, 2009, APPL ENVIRON MICROB, V75, P7519, DOI 10.1128/AEM.00946-09; Sizova M, 2007, INT J SYST EVOL MICR, V57, P616, DOI 10.1099/ijs.0.64350-0; Skidmore M, 2005, APPL ENVIRON MICROB, V71, P6986, DOI 10.1128/AEM.71.11.6986-6997.2005; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Staley JT, 1999, ANNU REV MICROBIOL, V53, P189, DOI 10.1146/annurev.micro.53.1.189; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Yagi JM, 2009, ENVIRON MICROBIOL, V11, P2253, DOI 10.1111/j.1462-2920.2009.01947.x; Zhang XF, 2008, MICROB ECOL, V55, P476, DOI 10.1007/s00248-007-9293-3; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	59	90	92	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23742	10.1371/journal.pone.0023742	http://dx.doi.org/10.1371/journal.pone.0023742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897856	Green Submitted, gold, Green Published			2022-12-25	WOS:000294676900019
J	Gao, JM; Cai, QL; Lu, J; Jha, HC; Robertson, ES				Gao, Jianming; Cai, Qiliang; Lu, Jie; Jha, Hem Chandra; Robertson, Erle S.			Upregulation of Cellular Bcl-2 by the KSHV Encoded RTA Promotes Virion Production	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; EPSTEIN-BARR-VIRUS; TRANSCRIPTION ACTIVATOR RTA; POLYADENYLATED NUCLEAR-RNA; BINDING PROTEIN-ALPHA; RBP-J-KAPPA; KAPOSIS-SARCOMA; MEDIATED TRANSACTIVATION; LYTIC REPLICATION; GENE-EXPRESSION	Apoptosis of virus infected cells can restrict or dampen full blown virus propagation and this can serve as a protective mechanism against virus infection. Consequently, viruses can also delay programmed cell death by enhancing the expression of anti-apoptotic proteins. Human Bcl-2 is expressed on the surface of the mitochondrial membrane and functions as the regulator of the delicate balance between cell survival and apoptosis. In this report, we showed that the replication and transcription activator (RTA) encoded by KSHV ORF 50, a key regulator for KSHV reactivation from latent to lytic infection, upregulates the mRNA and protein levels of Bcl-2 in 293 cells, and TPA-induced KSHV-infected cells. Further analysis revealed that upregulation of the cellular Bcl-2 promoter by RTA is dose-dependent and acts through targeting of the CCN(9)GG motifs within the Bcl-2 promoter. The Bcl-2 P2 but not the P1 promoter is primarily responsive to RTA. The results of ChIP confirmed the direct interaction of RTA protein with the CCN(9)GG motifs. Knockdown of cellular Bcl-2 by lentivirus-delivered small hairpin RNA (shRNA) resulted in increased cell apoptosis and decreased virion production in KSHV-infected cells. These findings provide an insight into another mechanism by which KSHV utilizes the intrinsic apoptosis signaling pathways for prolonging the survival of lytically infected host cells to allow for maximum production of virus progeny.	[Gao, Jianming; Cai, Qiliang; Lu, Jie; Jha, Hem Chandra; Robertson, Erle S.] Univ Penn, Dept Microbiol, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Gao, Jianming; Cai, Qiliang; Lu, Jie; Jha, Hem Chandra; Robertson, Erle S.] Univ Penn, Tumor Virol Program, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Gao, Jianming] Three Gorges Univ, Sch Med, Dept Pathophysiol, Yichang, Hubei, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; China Three Gorges University	Gao, JM (corresponding author), Univ Penn, Dept Microbiol, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA.	erle@mail.med.upenn.edu	Lu, Jie/B-8362-2012; Jha, Hem Chandra/T-2293-2019	Jha, Hem Chandra/0000-0002-9698-4547	National Cancer Institute [5R01CA091792-08, 5R01CA108461-05, 1R01CA137894-01, 1R01CA138434-01A209]; National Institute of Allergy and Infectious Diseases [5R01AI067037-04]; National Institute of Dental and Craniofacial Research [5R01DE017338-03]; NATIONAL CANCER INSTITUTE [R01CA138434, R01CA108461, R01CA091792, R01CA137894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017338] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	National Cancer Institute 5R01CA091792-08, 5R01CA108461-05, 1R01CA137894-01 and 1R01CA138434-01A209; National Institute of Allergy and Infectious Diseases 5R01AI067037-04 and National Institute of Dental and Craniofacial Research 5R01DE017338-03 (to ESR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; BOSHOFF C, 1995, NAT MED, V1, P1274, DOI 10.1038/nm1295-1274; Bourgarel-Rey V, 2009, BIOCHEM PHARMACOL, V78, P1148, DOI 10.1016/j.bcp.2009.06.025; Bowser BS, 2002, J VIROL, V76, P12574, DOI 10.1128/JVI.76.24.12574-12583.2002; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Brychtova S, 2000, NEOPLASMA, V47, P143; Byun H, 2002, MOL CELLS, V14, P185; Cai QI, 2006, J VIROL, V80, P7965, DOI 10.1128/JVI.00689-06; Cam M, 2010, CELL DEATH DIFFER, V17, P655, DOI 10.1038/cdd.2009.147; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen LW, 2005, J VIROL, V79, P9635, DOI 10.1128/JVI.79.15.9635-9650.2005; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cotter MA, 1999, VIROLOGY, V264, P254, DOI 10.1006/viro.1999.9999; Davis DA, 2001, BLOOD, V97, P3244, DOI 10.1182/blood.V97.10.3244; Deng HY, 2000, J GEN VIROL, V81, P3043, DOI 10.1099/0022-1317-81-12-3043; Deng HY, 2002, J VIROL, V76, P8252, DOI 10.1128/JVI.76.16.8252-8264.2002; Dittmer D, 1998, J VIROL, V72, P8309, DOI 10.1128/JVI.72.10.8309-8315.1998; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; Flanagan AM, 2008, CELL DEATH DIFFER, V15, P580, DOI 10.1038/sj.cdd.4402292; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Gonzalez CM, 2006, J VIROL, V80, P3062, DOI 10.1128/JVI.80.6.3062-3070.2006; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; GRUFFAT H, 1994, NUCLEIC ACIDS RES, V22, P1172, DOI 10.1093/nar/22.7.1172; Haque M, 2003, J VIROL, V77, P6761, DOI 10.1128/JVI.77.12.6761-6768.2003; Haque M, 2000, J VIROL, V74, P2867, DOI 10.1128/JVI.74.6.2867-2875.2000; Harada N, 1998, LEUKEMIA, V12, P1817, DOI 10.1038/sj.leu.2401168; Harima Y, 1998, J CANCER RES CLIN, V124, P503, DOI 10.1007/s004320050206; He ZH, 2010, J VIROL, V84, P2047, DOI 10.1128/JVI.01984-09; HIGASHIYAMA M, 1995, ANTICANCER RES, V15, P503; Jenner RG, 2001, J VIROL, V75, P891, DOI 10.1128/JVI.75.2.891-902.2001; Junn HJ, 2010, BIOCHEM BIOPH RES CO, V396, P861, DOI 10.1016/j.bbrc.2010.05.008; Lan K, 2005, J VIROL, V79, P7453, DOI 10.1128/JVI.79.12.7453-7465.2005; Leiter U, 2000, ARCH DERMATOL RES, V292, P225, DOI 10.1007/s004030050479; Liang YY, 2004, J VIROL, V78, P6818, DOI 10.1128/JVI.78.13.6818-6826.2004; Liu YH, 2008, VIROLOGY, V380, P264, DOI 10.1016/j.virol.2008.08.011; Lu J, 2009, J VIROL, V83, P7129, DOI 10.1128/JVI.00397-09; Lukac DM, 1998, VIROLOGY, V252, P304, DOI 10.1006/viro.1998.9486; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; Masa SR, 2008, VIROLOGY, V371, P14, DOI 10.1016/j.virol.2007.08.023; Miller G, 1997, J VIROL, V71, P314, DOI 10.1128/JVI.71.1.314-324.1997; Moore PS, 2001, PHILOS T R SOC B, V356, P499, DOI 10.1098/rstb.2000.0777; Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739; Nakamura H, 2003, J VIROL, V77, P4205, DOI 10.1128/JVI.77.7.4205-4220.2003; OHMORI T, 1993, BIOCHEM BIOPH RES CO, V192, P30, DOI 10.1006/bbrc.1993.1377; Ohtsuki Yuji, 1999, Medical Electron Microscopy, V32, P94, DOI 10.1007/s007950050014; Onyshchenko MI, 2009, NUCLEIC ACIDS RES, V37, P7570, DOI 10.1093/nar/gkp840; Rimessi P, 2001, J VIROL, V75, P7161, DOI 10.1128/JVI.75.15.7161-7174.2001; Sakakibara S, 2001, J VIROL, V75, P6894, DOI 10.1128/JVI.75.15.6894-6900.2001; Sarid R, 1998, J VIROL, V72, P1005, DOI 10.1128/JVI.72.2.1005-1012.1998; Seaman WT, 2003, VIROLOGY, V310, P72, DOI 10.1016/S0042-6822(03)00095-3; Sharp TV, 2002, J VIROL, V76, P802, DOI 10.1128/JVI.76.2.802-816.2002; Song MJ, 2003, J VIROL, V77, P9451, DOI 10.1128/JVI.77.17.9451-9462.2003; Song MJ, 2002, J VIROL, V76, P5000, DOI 10.1128/JVI.76.10.5000-5013.2002; Song MJ, 2001, J VIROL, V75, P3129, DOI 10.1128/JVI.75.7.3129-3140.2001; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; Ueda K, 2002, J VIROL, V76, P12044, DOI 10.1128/JVI.76.23.12044-12054.2002; Wang SE, 2003, J VIROL, V77, P600, DOI 10.1128/JVI.77.1.600-623.2003; Wang SZ, 2001, J VIROL, V75, P11961, DOI 10.1128/JVI.75.24.11961-11973.2001; Wang SZE, 2003, J VIROL, V77, P9590, DOI 10.1128/JVI.77.17.9590-9612.2003; Wang XD, 2010, J MED CHEM, V53, P4390, DOI 10.1021/jm100445e; Wang Y, 2007, VIROLOGY, V359, P19, DOI 10.1016/j.virol.2006.09.032; Wang YCJ, 1998, J VIROL METHODS, V73, P219, DOI 10.1016/S0166-0934(98)00068-8; Wen HJ, 2009, J GEN VIROL, V90, P944, DOI 10.1099/vir.2008.006817-0; Wong EL, 2006, J VIROL, V80, P1385, DOI 10.1128/JVI.80.3.1385-1392.2006; Yang ZL, 2007, J VIROL, V81, P6294, DOI 10.1128/JVI.02648-06; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; YOUNG RL, 1993, MOL CELL BIOL, V13, P3686, DOI 10.1128/MCB.13.6.3686; Yu YM, 1999, J GEN VIROL, V80, P83, DOI 10.1099/0022-1317-80-1-83	71	13	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23892	10.1371/journal.pone.0023892	http://dx.doi.org/10.1371/journal.pone.0023892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901143	Green Published, Green Submitted, gold			2022-12-25	WOS:000294298000028
J	Grieve, AG; Daniels, RD; Sanchez-Heras, E; Hayes, MJ; Moss, SE; Matter, K; Lowe, M; Levine, TP				Grieve, Adam G.; Daniels, Rachel D.; Sanchez-Heras, Elena; Hayes, Matthew J.; Moss, Stephen E.; Matter, Karl; Lowe, Martin; Levine, Timothy P.			Lowe Syndrome Protein OCRL1 Supports Maturation of Polarized Epithelial Cells	PLOS ONE			English	Article							INOSITOL POLYPHOSPHATE 5-PHOSPHATASE; TRANS-GOLGI NETWORK; TRANSCRIPTION FACTOR ZONAB/DBPA; APICAL JUNCTIONAL COMPLEX; TIGHT JUNCTION; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PLASMA-MEMBRANE; PARACELLULAR PERMEABILITY; MORPHOGENESIS; DOMAIN	Mutations in the inositol polyphosphate 5-phosphatase OCRL1 cause Lowe Syndrome, leading to cataracts, mental retardation and renal failure. We noted that cell types affected in Lowe Syndrome are highly polarized, and therefore we studied OCRL1 in epithelial cells as they mature from isolated individual cells into polarized sheets and cysts with extensive communication between neighbouring cells. We show that a proportion of OCRL1 targets intercellular junctions at the early stages of their formation, co-localizing both with adherens junctional components and with tight junctional components. Correlating with this distribution, OCRL1 forms complexes with junctional components alpha-catenin and zonula occludens (ZO)-1/2/3. Depletion of OCRL1 in epithelial cells growing as a sheet inhibits maturation; cells remain flat, fail to polarize apical markers and also show reduced proliferation. The effect on shape is reverted by re-expressed OCRL1 and requires the 5'-phosphatase domain, indicating that down-regulation of 5-phosphorylated inositides is necessary for epithelial development. The effect of OCRL1 in epithelial maturation is seen more strongly in 3-dimensional cultures, where epithelial cells lacking OCRL1 not only fail to form a central lumen, but also do not have the correct intracellular distribution of ZO-1, suggesting that OCRL1 functions early in the maturation of intercellular junctions when cells grow as cysts. A role of OCRL1 in junctions of polarized cells may explain the pattern of organs affected in Lowe Syndrome.	[Grieve, Adam G.; Daniels, Rachel D.; Sanchez-Heras, Elena; Hayes, Matthew J.; Moss, Stephen E.; Matter, Karl; Levine, Timothy P.] UCL Inst Ophthalmol, Dept Cell Biol, London, England; [Lowe, Martin] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of London; University College London; University of Manchester	Grieve, AG (corresponding author), Hubrecht Inst Stem Cell Res & Dev Biol, Utrecht, Netherlands.	tim.levine@ucl.ac.uk	Matter, Karl/C-4880-2008	Matter, Karl/0000-0001-8026-7220; Levine, Timothy/0000-0002-7231-0775	Lowe Syndrome Trust (UK); Wellcome Trust [084678/78/Z/08/z]; Biotechnology and Biological Sciences Research Council [BB/H002294/1] Funding Source: researchfish; BBSRC [BB/H002294/1] Funding Source: UKRI	Lowe Syndrome Trust (UK); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Lowe Syndrome Trust (UK), and by the Wellcome Trust (grant #084678/78/Z/08/z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aijaz S, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-49; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Astle MV, 2006, IUBMB LIFE, V58, P451, DOI 10.1080/15216540600871159; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Benais-Pont G, 2003, J CELL BIOL, V160, P729, DOI 10.1083/jcb.200211047; Choudhury R, 2005, MOL BIOL CELL, V16, P3467, DOI 10.1091/mbc.E05-02-0120; Choudhury R, 2009, J BIOL CHEM, V284, P9965, DOI 10.1074/jbc.M807442200; Coon BG, 2009, HUM MOL GENET, V18, P4478, DOI 10.1093/hmg/ddp407; Cui SS, 2010, AM J PHYSIOL-RENAL, V298, pF335, DOI 10.1152/ajprenal.00453.2009; Curtis MW, 2008, CELL COMMUN ADHES, V15, P365, DOI 10.1080/15419060802460748; Dambournet D, 2011, NAT CELL BIOL, V13, P981, DOI 10.1038/ncb2279; Devaux J, 2008, J CELL BIOL, V183, P909, DOI 10.1083/jcb.200808034; Dressman MA, 2000, J HISTOCHEM CYTOCHEM, V48, P179, DOI 10.1177/002215540004800203; El Kadhi KB, 2011, CURR BIOL, V21, P1074, DOI 10.1016/j.cub.2011.05.030; El Sayegh TY, 2007, MOL BIOL CELL, V18, P3026, DOI 10.1091/mbc.E06-12-1159; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Faucherre A, 2003, HUM MOL GENET, V12, P2449, DOI 10.1093/hmg/ddg250; Gao L, 2004, J BIOL CHEM, V279, P41557, DOI 10.1074/jbc.M403723200; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; HANZEL D, 1991, EMBO J, V10, P2363, DOI 10.1002/j.1460-2075.1991.tb07775.x; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hayes MJ, 2008, BIOCH BIOPHYS ACTA; Hellsten E, 2002, BIOL REPROD, V66, P1522, DOI 10.1095/biolreprod66.5.1522; Horikoshi Y, 2009, J CELL SCI, V122, P1595, DOI 10.1242/jcs.043174; Hyvola N, 2006, EMBO J, V25, P3750, DOI 10.1038/sj.emboj.7601274; Insall RH, 2001, DEV CELL, V1, P743, DOI 10.1016/S1534-5807(01)00086-7; Ivanov AI, 2005, BIOESSAYS, V27, P356, DOI 10.1002/bies.20203; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; JEFFERSON AB, 1995, J BIOL CHEM, V270, P9370, DOI 10.1074/jbc.270.16.9370; Kavanagh E, 2006, J CELL SCI, V119, P5098, DOI 10.1242/jcs.03297; Lee DBN, 2006, AM J PHYSIOL-RENAL, V290, pF20, DOI 10.1152/ajprenal.00052.2005; Lichter-Konecki U, 2006, MOL GENET METAB, V89, P121, DOI 10.1016/j.ymgme.2006.04.005; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Liu JL, 2007, MOL BIOL CELL, V18, P4483, DOI 10.1091/mbc.E07-05-0461; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; McCrea HJ, 2008, BIOCHEM BIOPH RES CO, V369, P493, DOI 10.1016/j.bbrc.2008.02.067; Noakes CJ, 2011, MOL BIOL CELL, V22, P606, DOI 10.1091/mbc.E10-08-0730; Nowak RB, 2009, J CELL BIOL, V186, P915, DOI 10.1083/jcb.200905065; OJAKIAN GK, 1988, J CELL BIOL, V107, P2377, DOI 10.1083/jcb.107.6.2377; Pirruccello M, 2011, NAT STRUCT MOL BIOL, V18, P789, DOI 10.1038/nsmb.2071; Ponting CP, 2006, BIOINFORMATICS, V22, P1031, DOI 10.1093/bioinformatics/btl022; Rajasekaran AK, 1996, J CELL BIOL, V132, P451, DOI 10.1083/jcb.132.3.451; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; Sourisseau T, 2006, MOL CELL BIOL, V26, P2387, DOI 10.1128/MCB.26.6.2387-2398.2006; Straub BK, 2003, J CELL SCI, V116, P4985, DOI 10.1242/jcs.00815; Suchy SF, 2002, AM J HUM GENET, V71, P1420, DOI 10.1086/344517; Swan LE, 2010, P NATL ACAD SCI USA, V107, P3511, DOI 10.1073/pnas.0914658107; Terry SJ, 2011, NAT CELL BIOL, V13, P159, DOI 10.1038/ncb2156; Ungewickell AJ, 1999, P NATL ACAD SCI USA, V96, P13342, DOI 10.1073/pnas.96.23.13342; van Zeijl L, 2007, J CELL BIOL, V177, P881, DOI 10.1083/jcb.200610144; VEGASALAS DE, 1988, J CELL BIOL, V107, P1717, DOI 10.1083/jcb.107.5.1717; Weber KL, 2007, J CELL SCI, V120, P3625, DOI 10.1242/jcs.011445; Williams C, 2007, J CELL SCI, V120, P3941, DOI 10.1242/jcs.014423; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Yeaman C, 2004, J CELL SCI, V117, P559, DOI 10.1242/jcs.00893; Zhang JK, 2005, J CELL SCI, V118, P5549, DOI 10.1242/jcs.02639; Zhang XL, 1998, J BIOL CHEM, V273, P1574, DOI 10.1074/jbc.273.3.1574	60	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e24044	10.1371/journal.pone.0024044	http://dx.doi.org/10.1371/journal.pone.0024044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901156	Green Published, gold, Green Submitted			2022-12-25	WOS:000294298000041
J	Kumar, S; Dey, D; Hasan, G				Kumar, Satish; Dey, Debleena; Hasan, Gaiti			Patterns of Gene Expression in Drosophila InsP(3) Receptor Mutant Larvae Reveal a Role for InsP(3) Signaling in Carbohydrate and Energy Metabolism	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; MICROARRAY ANALYSIS; MELANOGASTER; STARVATION; PATHWAYS; DYNAMICS; ONTOLOGY; NEURONS; FLIGHT; CELLS	Background: The Inositol 1,4,5-trisphosphate receptor (InsP(3)R) is an InsP(3) gated intracellular Ca2+-release channel. Characterization of Drosophila mutants for the InsP(3)R has demonstrated that InsP(3)-mediated Ca2+ release is required in Drosophila larvae for growth and viability. Methodology/Principal Findings: To understand the molecular basis of these growth defects a genome wide microarray analysis has been carried out with larval RNA obtained from a strong InsP(3)R mutant combination in which 1504 independent genes were differentially regulated with a log(2) of fold change of 1 or more and P<0.05. This was followed by similar transcript analyses from InsP(3)R mutants where growth defects were either suppressed by introduction of a dominant suppressor or rescued by ectopic expression of an InsP(3)R transgene in the Drosophila insulin like peptide-2 (Dilp2) producing cells. Conclusions/Significance: These studies show that expression of transcripts related to carbohydrate and amine metabolism is altered in InsP(3) receptor mutant larvae. Moreover, from a comparative analysis of genes that are regulated in the suppressed and rescued conditions with the mutant condition, it appears that the organism could use different combinations of pathways to restore a 'normal' growth state.	[Kumar, Satish; Dey, Debleena; Hasan, Gaiti] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Kumar, S (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	gaiti@ncbs.res.in	Hasan, Gaiti/I-5851-2015; Hasan, Gaiti/P-4107-2019	Hasan, Gaiti/0000-0001-7194-383X; Hasan, Gaiti/0000-0001-7194-383X	University Grants Commission; Department of Biotechnology; National Centre for Biological Sciences, Tata Institute of Fundamental Research	University Grants Commission(University Grants Commission, India); Department of Biotechnology; National Centre for Biological Sciences, Tata Institute of Fundamental Research	This work was supported by research fellowships from the University Grants Commission (http://www.ugc.ac.in) to Satish Kumar and the Department of Biotechnology (http://dbtindia.nic.in/index.asp) to Debleena Dey. The project was supported financially by grants from the Department of Biotechnology (http://dbtindia.nic.in/index.asp), and the National Centre for Biological Sciences, Tata Institute of Fundamental Research(http://www.ncbs.res.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006652; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banerjee S, 2006, J NEUROSCI, V26, P8278, DOI 10.1523/JNEUROSCI.1231-06.2006; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bina S, 2010, EMBO REP, V11, P201, DOI 10.1038/embor.2010.1; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cai XJ, 2008, MOL BIOL EVOL, V25, P1357, DOI 10.1093/molbev/msn077; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fernandez-Ayala DJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008549; Fujikawa K, 2009, GENE, V446, P11, DOI 10.1016/j.gene.2009.06.017; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Gershman B, 2007, PHYSIOL GENOMICS, V29, P24, DOI 10.1152/physiolgenomics.00061.2006; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Joshi R, 2004, GENETICS, V166, P225, DOI 10.1534/genetics.166.1.225; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; KurzikDumke U, 1996, GENE, V171, P163, DOI 10.1016/0378-1119(95)00885-3; Lorentzos P, 2003, GENET TEST, V7, P135, DOI 10.1089/109065703322146821; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Sanyal S, 2005, GENETICS, V169, P737, DOI 10.1534/genetics.104.031930; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Venkatesh K, 1997, CURR BIOL, V7, P500, DOI 10.1016/S0960-9822(06)00221-1; Venkatesh K, 2001, GENETICS, V158, P309; Venkiteswaran G, 2009, P NATL ACAD SCI USA, V106, P10326, DOI 10.1073/pnas.0902982106; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	32	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e24105	10.1371/journal.pone.0024105	http://dx.doi.org/10.1371/journal.pone.0024105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901161	Green Published, gold, Green Submitted			2022-12-25	WOS:000294298000046
J	Wang, ZF; Lin, S; Li, JLJ; Xu, ZH; Yao, H; Zhu, X; Xie, D; Shen, Z; Sze, J; Li, K; Lu, G; Chan, DTM; Poon, WS; Kung, HF; Lin, MCM				Wang, Zifeng; Lin, Sheng; Li, Julia Jun; Xu, Zhenhua; Yao, Hong; Zhu, Xiao; Xie, Dan; Shen, Zan; Sze, Johnny; Li, Kui; Lu, Gang; Chan, Danny Tat-Ming; Poon, Wai Sang; Kung, Hsiang-fu; Lin, Marie Chia-mi			MYC Protein Inhibits Transcription of the MicroRNA Cluster MC-let-7a-1 similar to let-7d via Noncanonical E-box	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; C-MYC; TUMOR SUPPRESSORS; PROMOTES TRANSFORMATION; DOWN-REGULATION; LET-7 MICRORNA; IN-VITRO; CANCER; EXPRESSION; LIN28	The human microRNA cluster MC-let-7a-1 similar to let-7d, with three members let-7a-1, let-7f-1, and let-7d, is an important cluster of the let-7 family. These microRNAs play critical roles in regulating development and carcinogenesis. Therefore, precise control of MC-let-7a-1 similar to let-7d level is critical for cellular functions. In this study, we first showed that the expression of these three members was significantly reduced in human hepatocellular carcinoma HepG2 cells as compared with the immortalized human liver L02 cells. We demonstrated that the MC-let-7a-1 similar to let-7d cluster was encoded by a single polycistronic transcript driven by a 10-kb upstream promoter, with two MYC-binding sites. Importantly, MYC inhibited MC-let-7a-1 similar to let-7d promoter activity via binding to the noncanonical E-box 3 downstream of the transcription start sites, whereas it enhanced promoter activity by binding to the canonical E-box 2 upstream of the transcription start sites. We found that although the binding affinity of MYC to E-box 2 was stronger than E-box 3, the binding quantum of MYC to E-box 3 was significantly higher in cancerous HepG2 cells as compared with the noncancerous L02 cells. In addition, forced expression of let-7 could reverse the MYC-mediated cell proliferation. These findings suggested that in L02 cells with a low level of MYC, MYC binds mainly to E-box 2 to enhance MC-let-7a-1 similar to let-7d expression. However, in HepG2 cells with an elevated MYC, the extra MYC could bind to E-box 3 to suppress the transcription of MC-let-7a-1 similar to let-7d and thus enable HepG2 cells to maintain a high level of MYC and a low level of let-7 microRNAs simultaneously.	[Wang, Zifeng; Lin, Sheng; Li, Kui; Kung, Hsiang-fu] Sun Yat Sen Univ, Lab Integrated Biosci, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Sheng; Li, Julia Jun; Xu, Zhenhua; Sze, Johnny; Lu, Gang; Chan, Danny Tat-Ming; Poon, Wai Sang; Lin, Marie Chia-mi] Chinese Univ Hong Kong, Dept Surg, Brain Tumour Ctr, Shatin, Hong Kong, Peoples R China; [Lin, Sheng; Li, Julia Jun; Xu, Zhenhua; Sze, Johnny; Lu, Gang; Chan, Danny Tat-Ming; Poon, Wai Sang; Lin, Marie Chia-mi] Chinese Univ Hong Kong, Dept Surg, Div Neurosurg, Shatin, Hong Kong, Peoples R China; [Yao, Hong] Kunming Med Univ, Kunming, Peoples R China; [Zhu, Xiao] Guangdong Med Coll, Inst Biochem & Mol Biol, Key Lab Mol Diag, Dongguan, Peoples R China; [Xie, Dan; Kung, Hsiang-fu] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Shen, Zan] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Oncol, Shanghai 200030, Peoples R China; [Kung, Hsiang-fu] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China	Sun Yat Sen University; Chinese University of Hong Kong; Chinese University of Hong Kong; Kunming Medical University; Guangdong Medical University; Sun Yat Sen University; Shanghai Jiao Tong University; Chinese University of Hong Kong	Kung, HF (corresponding author), Sun Yat Sen Univ, Lab Integrated Biosci, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	hkung@cuhk.edu.hk; mcllin@surgery.cuhk.edu.hk	Lin, Sheng/AAC-9465-2022; Poon, Wai S/HGD-3084-2022; Poon, Wai Sang/F-1558-2011		National Basic Research Program of China (973 Program) [2010CB529400, 2010CB912800]; National Natural Science Foundation of China [81001023]; Research Grants Council of Hong Kong [467109]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by National Basic Research Program of China (973 Program) Grants 2010CB529400 and 2010CB912800, National Natural Science Foundation of China Grant PC: 81001023, and Research Grants Council of Hong Kong Grant 467109.	Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Bortolin-Cavaille ML, 2009, NUCLEIC ACIDS RES, V37, P3464, DOI 10.1093/nar/gkp205; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Diao S, 2010, PROTEOMICS, V10, P3723, DOI 10.1002/pmic.201000050; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kawaji H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r40; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; Lan FF, 2011, INT J CANCER, V128, P319, DOI 10.1002/ijc.25336; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu LG, 2009, EUR J CANCER, V45, P2212, DOI 10.1016/j.ejca.2009.05.003; LUSCHER B, 1990, GENE DEV, V4, P2025, DOI 10.1101/gad.4.12a.2025; Ricarte JCM, 2009, TRANSL ONCOL, V2, P236, DOI 10.1593/tlo.09151; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Muller DW, 2008, ONCOGENE, V27, P6698, DOI 10.1038/onc.2008.282; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Shimizu S, 2010, J HEPATOL, V52, P698, DOI 10.1016/j.jhep.2009.12.024; Simile MM, 2004, CARCINOGENESIS, V25, P333, DOI 10.1093/carcin/bgh014; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Wu YF, 2002, ONCOGENE, V21, P1518, DOI 10.1038/sj.onc.1205208; Xia HP, 2010, BIOCHEM BIOPH RES CO, V391, P535, DOI 10.1016/j.bbrc.2009.11.093; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang HH, 2007, WORLD J GASTROENTERO, V13, P2883, DOI 10.3748/wjg.v13.i20.2883; Zhu YM, 2010, WORLD J GASTROENTERO, V16, P3325, DOI 10.3748/wjg.v16.i26.3325	60	54	57	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39703	39714		10.1074/jbc.M111.293126	http://dx.doi.org/10.1074/jbc.M111.293126			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21903590	Green Published, hybrid			2022-12-25	WOS:000296925700004
J	McKenney, RJ; Weil, SJ; Scherer, J; Vallee, RB				McKenney, Richard J.; Weil, Sarah J.; Scherer, Julian; Vallee, Richard B.			Mutually Exclusive Cytoplasmic Dynein Regulation by NudE-Lis1 and Dynactin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE PLUS ENDS; TUG-OF-WAR; INTERMEDIATE CHAIN; ASPERGILLUS-NIDULANS; NEURONAL MIGRATION; LISSENCEPHALY GENE; NUCLEAR MIGRATION; BINDING DOMAIN; LIS1; NUDEL	Cytoplasmic dynein is responsible for a wide range of cellular roles. How this single motor protein performs so many functions has remained a major outstanding question for many years. Part of the answer is thought to lie in the diversity of dynein regulators, but how the effects of these factors are coordinated in vivo remains unexplored. We previously found NudE to bind dynein through its light chain 8 (LC8) and intermediate chain (IC) subunits (1), the latter of which also mediates the dynein-dynactin interaction (2). We report here that NudE and dynactin bind to a common region within the IC, and compete for this site. We find LC8 to bind to a novel sequence within NudE, without detectably affecting the dynein-NudE interaction. We further find that commonly used dynein inhibitory reagents have broad effects on the interaction of dynein with its regulatory factors. Together these results reveal an unanticipated mechanism for preventing dual regulation of individual dynein molecules, and identify the IC as a nexus for regulatory interactions within the dynein complex.	[McKenney, Richard J.; Weil, Sarah J.; Scherer, Julian; Vallee, Richard B.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University	Vallee, RB (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Columbia Univ Phys & Surg Bldg,Room 15-409 630 W, New York, NY 10032 USA.	rv2025@columbia.edu			National Institutes of Health [GM47434, HD40182]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047434, R37GM047434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM47434 and HD40182 (to R. B. V.).	Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Bolhy S, 2011, J CELL BIOL, V192, P855, DOI 10.1083/jcb.201007118; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Grabham PW, 2007, J NEUROSCI, V27, P5823, DOI 10.1523/JNEUROSCI.1135-07.2007; Guo J, 2006, MOL BIOL CELL, V17, P680, DOI 10.1091/mbc.E05-04-0360; Hebbar S, 2008, J CELL BIOL, V182, P1063, DOI 10.1083/jcb.200803071; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Kim H, 2007, J CELL BIOL, V176, P641, DOI 10.1083/jcb.200608128; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Liang Y, 2007, MOL BIOL CELL, V18, P2656, DOI 10.1091/mbc.E06-04-0345; Lightcap CM, 2008, J BIOL CHEM, V283, P27314, DOI 10.1074/jbc.M800758200; Lightcap CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006025; MA S, 1995, MOL BIOL CELL, V6, P899; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Mesngon MT, 2006, J NEUROSCI, V26, P2132, DOI 10.1523/JNEUROSCI.5095-05.2006; Moore JK, 2009, P NATL ACAD SCI USA, V106, P5147, DOI 10.1073/pnas.0810828106; Myers KR, 2007, J NEUROSCI RES, V85, P2640, DOI 10.1002/jnr.21213; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Paschal B. M., 1991, METHOD ENZYMOL, V196, P192; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Rapali P, 2011, FEBS J, V278, P2980, DOI 10.1111/j.1742-4658.2011.08254.x; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Roghi C, 1999, J CELL SCI, V112, P4673; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; SCHROER TA, 1991, J CELL BIOL, V115, P1309, DOI 10.1083/jcb.115.5.1309; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Siller KH, 2008, DEV BIOL, V319, P1, DOI 10.1016/j.ydbio.2008.03.018; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Steffen W, 1997, MOL BIOL CELL, V8, P2077, DOI 10.1091/mbc.8.10.2077; Steffen W, 1996, J STRUCT BIOL, V117, P227, DOI 10.1006/jsbi.1996.0087; Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vaughan KT, 1999, J CELL SCI, V112, P1437; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; Vaughan PS, 2001, J BIOL CHEM, V276, P26171, DOI 10.1074/jbc.M102649200; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Wang SS, 2011, J BIOL CHEM, V286, P587, DOI 10.1074/jbc.M110.181578; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; Yi J., 2011, J CELL BIOL IN PRESS; Zhang J, 2003, MOL BIOL CELL, V14, P1479, DOI 10.1091/mbc.E02-08-0516; Zhang J, 2010, J CELL SCI, V123, P3596, DOI 10.1242/jcs.075259; Zylkiewicz E, 2011, J CELL BIOL, V192, P433, DOI 10.1083/jcb.201011142	65	72	73	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39615	39622		10.1074/jbc.M111.289017	http://dx.doi.org/10.1074/jbc.M111.289017			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21911489	Green Published, hybrid			2022-12-25	WOS:000296759800078
J	Paul, S; Dansithong, W; Jog, SP; Holt, I; Mittal, S; Brook, JD; Morris, GE; Comai, L; Reddy, S				Paul, Sharan; Dansithong, Warunee; Jog, Sonali P.; Holt, Ian; Mittal, Saloni; Brook, J. David; Morris, Glenn E.; Comai, Lucio; Reddy, Sita			Expanded CUG Repeats Dysregulate RNA Splicing by Altering the Stoichiometry of the Muscleblind 1 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; MYOTONIC-DYSTROPHY; TRIPLET-REPEAT; CHLORIDE CHANNEL; BINDING PROTEIN; STEADY-STATE; CTG REPEAT; GENE; MBNL1; IDENTIFICATION	To understand the role of the splice regulator muscleblind 1 (MBNL1) in the development of RNA splice defects in myotonic dystrophy I (DM1), we purified RNA-independent MBNL1 complexes from normal human myoblasts and examined the behavior of these complexes in DM1 myoblasts. Antibodies recognizing MBNL1 variants (MBNL1(CUG)), which can sequester in the toxic CUG RNA foci that develop in DM1 nuclei, were used to purifyMBNL1(CUG) complexes from normal myoblasts. In normal myoblasts, MBNL1(CUG) bind 10 proteins involved in remodeling ribonucleoprotein complexes including hnRNP H, H2, H3, F, A2/B1, K, L, DDX5, DDX17, and DHX9. Of these proteins, only MBNL1(CUG) colocalizes extensively with DM1 CUG foci (> 80% of foci) with its partners being present in < 10% of foci. Importantly, the stoichiometry of MBNL1(CUG) complexes is altered in DM1 myoblasts, demonstrating an increase in the steady state levels of nine of its partner proteins. These changes are recapitulated by the expression of expanded CUG repeat RNA in Cos7 cells. Altered stoichiometry of MBNL1(CUG) complexes results from aberrant protein synthesis or stability and is unlinked to PKC alpha function. Modeling these changes in normal myoblasts demonstrates that increased levels of hnRNP H, H2, H3, F, and DDX5 independently dysregulate splicing in overlapping RNA subsets. Thus expression of expanded CUG repeats alters the stoichiometry of MBNL1(CUG) complexes to allow both the reinforcement and expansion of RNA processing defects.	[Comai, Lucio] Univ So Calif, Inst Med Genet, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Paul, Sharan; Dansithong, Warunee; Jog, Sonali P.; Reddy, Sita] Univ So Calif, Inst Med Genet, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Holt, Ian; Morris, Glenn E.] Robert Jones & Agnes Hunt Orthoped Hosp, Wolfson Ctr Inherited Neuromuscular Dis, Oswestry SY10 7AG, Shrops, England; [Holt, Ian; Morris, Glenn E.] Keele Univ, Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England; [Mittal, Saloni; Brook, J. David] Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England	University of Southern California; University of Southern California; Keele University; University of Nottingham	Comai, L (corresponding author), Univ So Calif, Inst Med Genet, Dept Mol Microbiol & Immunol, 2250 Alcazar St,CSA 240, Los Angeles, CA 90033 USA.	comai@usc.edu; sitaredd@usc.edu	Comai, Lucio/H-9524-2019; Comai, Lucio/L-5905-2019	Comai, Lucio/0000-0003-3109-1841; Brook, John David/0000-0002-5946-6740	National Institutes of Health [5R01NS050861, 1R01NS060839]; Medical Research Council [G0802629] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050861, R01NS060839] Funding Source: NIH RePORTER; MRC [G0802629] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01NS050861 and 1R01NS060839. This work was also supported by a gift from Don Hauschnecht.	BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Dansithong W, 2011, EMBO REP, V12, P735, DOI 10.1038/embor.2011.86; Dansithong W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003968; Dhaenens CM, 2008, EXP NEUROL, V210, P467, DOI 10.1016/j.expneurol.2007.11.020; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Fox JT, 2009, J BIOL CHEM, V284, P31085, DOI 10.1074/jbc.M109.035576; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Fuller-Pace FV, 2008, BIOCHEM SOC T, V36, P609, DOI 10.1042/BST0360609; Guha M, 2009, MOL BIOL CELL, V20, P4107, DOI 10.1091/mbc.E09-04-0296; Harper PS, 2001, MYOTONIC DYSTROPHY; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Holt I, 2007, GENES CELLS, V12, P1035, DOI 10.1111/j.1365-2443.2007.01112.x; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Li H, 2010, J BIOL CHEM, V285, P17789, DOI 10.1074/jbc.M109.082057; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Millevoi S, 2009, NUCLEIC ACIDS RES, V37, P4672, DOI 10.1093/nar/gkp470; Mulders SAM, 2009, P NATL ACAD SCI USA, V106, P13915, DOI 10.1073/pnas.0905780106; Naarmann IS, 2010, RNA, V16, P2189, DOI 10.1261/rna.2211110; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Torgersen ML, 2007, J BIOL CHEM, V282, P16317, DOI 10.1074/jbc.M610886200; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Van Dusen CM, 2010, MOL CELL BIOL, V30, P2552, DOI 10.1128/MCB.00230-09; Warf MB, 2009, P NATL ACAD SCI USA, V106, P18551, DOI 10.1073/pnas.0903234106; Warf MB, 2009, P NATL ACAD SCI USA, V106, P9203, DOI 10.1073/pnas.0900342106; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601	38	45	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38427	38438		10.1074/jbc.M111.255224	http://dx.doi.org/10.1074/jbc.M111.255224			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900255	Green Published, hybrid			2022-12-25	WOS:000296594200057
J	Ning, B; Liu, G; Liu, YY; Su, XF; Anderson, GJ; Zheng, X; Chang, Y; Guo, MZ; Liu, YF; Zhao, YL; Nie, GJ				Ning, Bo; Liu, Gang; Liu, Yuanyuan; Su, Xiufen; Anderson, Gregory J.; Zheng, Xin; Chang, Yanzhong; Guo, Mingzhou; Liu, Yuanfang; Zhao, Yuliang; Nie, Guangjun			5-Aza-2 '-deoxycytidine Activates Iron Uptake and Heme Biosynthesis by Increasing c-Myc Nuclear Localization and Binding to the E-boxes of Transferrin Receptor 1 (TfR1) and Ferrochelatase (Fech) Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; ACUTE MYELOID-LEUKEMIA; MYELODYSPLASTIC SYNDROMES; DNA-METHYLATION; TERMINAL DIFFERENTIATION; ERYTHROLEUKEMIA-CELLS; EPIGENETIC REGULATION; ERYTHROID PRECURSORS; TARGET GENES; FACTOR EKLF	The hypomethylating agent 5-aza-2'-deoxycytidine (5-aza-CdR) and its derivatives have been successfully used for the treatment of myelodysplastic syndromes, and they frequently improve the anemia that usually accompanies these disorders. However, the molecular mechanisms underlying this action remain poorly understood. In this study, we used two erythroid models, murine erythroid leukemia cells and erythroid burst-forming unit-derived erythroblasts, to show that 5-aza-CdR induced erythroid differentiation and increased the expression of transferrin receptor 1 (TfR1) and ferrochelatase (Fech), thereby increasing iron uptake and heme biosynthesis. We have identified new regulatory E-boxes that lie outside of CpG islands in the TfR1 and Fech promoters, and the methylation status of these sites can be altered by 5-aza-CdR treatment. This in turn altered the binding of the transcription factor c-Myc to these promoter elements. Furthermore, 5-aza-CdR promoted the nuclear translocation of c-Myc and its binding to Max to form functional complexes. The coordinated actions of 5-aza-CdR on the methylation status of the target genes and in stimulating the nuclear translocation of c-Myc provide new molecular insights in to the regulation of E-boxes and explain, at least in part, the increased erythroid response to 5-aza-CdR treatment.	[Ning, Bo; Liu, Gang; Zhao, Yuliang; Nie, Guangjun] Chinese Acad Sci, Key Lab Biol Effects Nanomat & Nanosafety, Natl Ctr Nanosci & Technol, Beijing 100190, Peoples R China; [Liu, Yuanyuan; Su, Xiufen] Jilin Univ, Affiliated Hosp 1, Changchun 130021, Jilin Province, Peoples R China; [Anderson, Gregory J.] Queensland Inst Med Res, Iron Metab Lab, Brisbane, Qld 4092, Australia; [Zheng, Xin; Chang, Yanzhong] Hebei Normal Univ, Coll Life Sci, Lab Mol Iron Metab, Shijiazhuang 050016, Hebei Province, Peoples R China; [Guo, Mingzhou] Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol & Hepatol, Beijing 100853, Peoples R China; [Ning, Bo; Liu, Yuanfang] Peking Univ, Dept Chem Biol & Appl Chem, Coll Chem & Mol Engn, Beijing 100190, Peoples R China; [Ning, Bo; Liu, Gang] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Jilin University; QIMR Berghofer Medical Research Institute; Hebei Normal University; Chinese People's Liberation Army General Hospital; Peking University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Nie, GJ (corresponding author), Chinese Acad Sci, Key Lab Biol Effects Nanomat & Nanosafety, Natl Ctr Nanosci & Technol, 11 Zhongguancun Beiyitiao, Beijing 100190, Peoples R China.	niegj@nanoctr.cn	Anderson, Gregory J/G-4148-2013; Nie, Guangjun/A-9954-2011; liu, yuanyuan/GWZ-5838-2022	Anderson, Gregory J/0000-0002-8814-5866; nie, guangjun/0000-0001-5040-9793	National Basic Research Program of China (973 program) [2012CB934000, 2011CB933400, 2010CB912802]; National Natural Science Foundation of China [30900278, 10979011]; National Health and Medical Research Council of Australia; Chinese Academy of Science	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Chinese Academy of Science(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China (973 program) Grants 2012CB934000, 2011CB933400, and 2010CB912802 and National Natural Science Foundation of China Grants 30900278 and 10979011.; Recipient of a Senior Research Fellowship from the National Health and Medical Research Council of Australia.; Supported by the Chinese Academy of Science Hundred Talents Program.	Angst E, 2010, PANCREAS, V39, P675, DOI 10.1097/MPA.0b013e3181c8b476; Aul C, 1998, HAEMATOLOGICA, V83, P71; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Bowen H, 2002, J BIOL CHEM, V277, P34997, DOI 10.1074/jbc.M204232200; CHRISTMAN JK, 1980, J CELL BIOL, V86, P366, DOI 10.1083/jcb.86.2.366; CREUSOT F, 1982, J BIOL CHEM, V257, P2041; CROSSLEY M, 1994, J BIOL CHEM, V269, P15440; Dang CV, 1999, MOL CELL BIOL, V19, P1; Daskalakis M, 2002, BLOOD, V100, P2957, DOI 10.1182/blood.V100.8.2957; Fandy TE, 2009, BLOOD, V114, P2764, DOI 10.1182/blood-2009-02-203547; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; GUSELLA JF, 1980, BLOOD, V56, P481; Hofmann WK, 2005, ANNU REV MED, V56, P1, DOI 10.1146/annurev.med.56.082103.104704; HUMPHRIES RK, 1985, J CLIN INVEST, V75, P547, DOI 10.1172/JCI111731; Jadersten M, 2010, EXP CELL RES, V316, P1390, DOI 10.1016/j.yexcr.2010.02.043; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KOTKOW KJ, 1995, MOL CELL BIOL, V15, P4640; LASKEY JD, 1986, J CELL PHYSIOL, V129, P185, DOI 10.1002/jcp.1041290209; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mills KI, 2009, BLOOD, V114, P1063, DOI 10.1182/blood-2008-10-187203; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; Okazaki F, 2010, CANCER RES, V70, P6238, DOI 10.1158/0008-5472.CAN-10-0184; OSHIRO S, 1994, J BIOCHEM-TOKYO, V115, P849, DOI 10.1093/oxfordjournals.jbchem.a124428; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Perini G, 2005, P NATL ACAD SCI USA, V102, P12117, DOI 10.1073/pnas.0409097102; PERKINS AC, 1995, NATURE, V375, P318; PINTO A, 1984, BLOOD, V64, P922; PONKA P, 1985, J BIOL CHEM, V260, P4717; Ponka P, 1997, BLOOD, V89, P1; Quintas-Cardama A, 2010, NAT REV CLIN ONCOL, V7, P433, DOI 10.1038/nrclinonc.2010.87; Schmelz K, 2005, LEUKEMIA, V19, P103, DOI 10.1038/sj.leu.2403552; Sinclair P. R., 2001, CURRENT PROTOCOLS TO, P831; Soriano AO, 2007, BLOOD, V110, P2302, DOI 10.1182/blood-2007-03-078576; Sridhar K, 2009, BLOOD, V114, P4847, DOI 10.1182/blood-2009-08-236422; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tefferi A, 2009, NEW ENGL J MED, V361, P1872, DOI 10.1056/NEJMra0902908; Valdez BC, 2010, LEUKEMIA RES, V34, P364, DOI 10.1016/j.leukres.2009.08.014; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676	43	17	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37196	37206		10.1074/jbc.M111.258129	http://dx.doi.org/10.1074/jbc.M111.258129			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21903580	hybrid, Green Published			2022-12-25	WOS:000296542400020
J	von der Malsburg, A; Abutbul-Ionita, I; Haller, O; Kochs, G; Danino, D				von der Malsburg, Alexander; Abutbul-Ionita, Inbal; Haller, Otto; Kochs, Georg; Danino, Dganit			Stalk Domain of the Dynamin-like MxA GTPase Protein Mediates Membrane Binding and Liposome Tubulation via the Unstructured L4 Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH ENDOPLASMIC-RETICULUM; ANTIVIRAL ACTIVITY; BHK CELLS; OLIGOMERIZATION; ACTIVATION; FAMILY; PHOSPHOINOSITIDES; PHOSPHOLIPIDS; CONSTRICTION; ENDOCYTOSIS	The human MxA protein is an interferon-induced large GTPase with antiviral activity against a wide range of viruses, including influenza viruses. Recent structural data demonstrated that MxA oligomerizes into multimeric filamentous or ring-like structures by virtue of its stalk domain. Here, we show that negatively charged lipid membranes support MxA self-assembly. Like dynamin, MxA assembled around spherical liposomes inducing liposome tubulation. Cryo-transmission electron microscopy revealed that MxA oligomers around liposomes have a "T-bar" shape similar to dynamin. Moreover, biochemical assays indicated that the unstructured L4 loop of the MxA stalk serves as the lipid-binding moiety, and mutational analysis of L4 revealed that a stretch of four lysine residues is critical for binding. The orientation of the MxA molecule within the membrane-associated oligomer is in agreement with the proposed topology of MxA oligomers based on crystallographic data. Although oligomerization of wild-type MxA around liposomes led to the creation of helically decorated tubes similar to those formed by dynamin, this lipid interaction did not stimulate GTPase activity, in sharp contrast to the assembly-stimulated nucleotide hydrolysis observed with dynamin. Moreover, MxA readily self-assembles into rings at physiological conditions, as opposed to dynamin which self-assembles only at low salt conditions or onto lipids. Thus, the present results indicate that the oligomeric structures formed by MxA critically differ from those of dynamin.	[von der Malsburg, Alexander; Haller, Otto; Kochs, Georg] Univ Freiburg, Dept Virol, Inst Microbiol, D-79104 Freiburg, Germany; [Abutbul-Ionita, Inbal; Danino, Dganit] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel	University of Freiburg; Technion Israel Institute of Technology	Kochs, G (corresponding author), Hermann Herder Str 11, D-79104 Freiburg, Germany.	georg.kochs@uniklinik-freiburg.de; dganitd@techunix.technion.ac.il	Danino, Dganit/D-6832-2016	Danino, Dganit/0000-0002-9782-4940; Ionita, Inbal/0000-0001-7359-0142	German-Israeli-Research Foundation [GIF-841/04]; Deutsche Forschungsgemeinschaft [Ko1579/8-1]; Israel Science Foundation [ISF-530/03]	German-Israeli-Research Foundation(German-Israeli Foundation for Scientific Research and Development); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Israel Science Foundation(Israel Science Foundation)	This work was supported by German-Israeli-Research Foundation Grant GIF-841/04 (to D. D., O. H., and G. K.), Deutsche Forschungsgemeinschaft Grant Ko1579/8-1 (to G. K.), Israel Science Foundation Grant ISF-530/03 (to D. D.). and by financial support to the Russell Berrie Nanotechnology Institute (RBNI) for the cryo-TEM experiments.	Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; Allan D, 1996, MOL MEMBR BIOL, V13, P81, DOI 10.3109/09687689609160580; Barylko B, 1998, J BIOL CHEM, V273, P3791, DOI 10.1074/jbc.273.6.3791; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; BERNASCONI D, 1995, J INTERF CYTOK RES, V15, P47, DOI 10.1089/jir.1995.15.47; BROTHERUS J, 1977, BIOCHIM BIOPHYS ACTA, V486, P243, DOI 10.1016/0005-2760(77)90020-0; Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Danino D, 2001, CURR OPIN CELL BIOL, V13, P454, DOI 10.1016/S0955-0674(00)00236-2; Danino D, 2001, COLLOID SURFACE A, V183, P113, DOI 10.1016/S0927-7757(01)00543-X; Di Paolo C, 1999, J BIOL CHEM, V274, P32071, DOI 10.1074/jbc.274.45.32071; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Haller O, 2010, J BIOL CHEM, V285, P28419, DOI 10.1074/jbc.R110.145839; He B, 2010, MOL BIOL CELL, V21, P610, DOI 10.1091/mbc.E09-05-0440; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Kochs G, 2002, J BIOL CHEM, V277, P14172, DOI 10.1074/jbc.M200244200; Kochs G, 2005, METHOD ENZYMOL, V404, P632, DOI 10.1016/S0076-6879(05)04055-3; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Low HH, 2010, CURR OPIN STRUC BIOL, V20, P791, DOI 10.1016/j.sbi.2010.09.011; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Reichelt M, 2004, TRAFFIC, V5, P772, DOI 10.1111/j.1600-0854.2004.00219.x; RICHTER MF, 1995, J BIOL CHEM, V270, P13512, DOI 10.1074/jbc.270.22.13512; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Schumacher B, 1998, J BIOL CHEM, V273, P28365, DOI 10.1074/jbc.273.43.28365; SCHWEMMLE M, 1995, J BIOL CHEM, V270, P13518, DOI 10.1074/jbc.270.22.13518; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; TUMA PL, 1993, J BIOL CHEM, V268, P17240; van der Bliek AM, 2010, DEV CELL, V18, P687, DOI [10.1016/j.devcel.2010.05.001, 10.1016/j.devce1.2010.05.001]; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	45	52	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37858	37865		10.1074/jbc.M111.249037	http://dx.doi.org/10.1074/jbc.M111.249037			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900240	Green Published, hybrid			2022-12-25	WOS:000296542400080
J	Chen, CJ; Lee, PI; Chang, SC; Huang, YC; Chiu, CH; Hsieh, YC; Chang, SC; Chang, FY; Lee, JJ; Su, SC; Shen, GH; Chuang, YC; Chen, YS; Liu, JW; Lin, TY				Chen, Chih-Jung; Lee, Ping-Ing; Chang, Shih-Cheng; Huang, Yhu-Chering; Chiu, Cheng-Hsun; Hsieh, Yu-Chia; Chang, Shang-Chwen; Chang, Feng-Yee; Lee, Jen-Jyh; Su, Shey-Chiang; Shen, Gwan-Han; Chuang, Yin-Ching; Chen, Yao-Shen; Liu, Jien-Wei; Lin, Tzou-Yien			Seroprevalence and Severity of 2009 Pandemic Influenza A H1N1 in Taiwan	PLOS ONE			English	Article							VIRUS-INFECTIONS; SURVEILLANCE; PREVALENCE; ANTIBODIES; ENGLAND; ILLNESS; CANADA; RISK	Background: This study is to determine the seroprevalence of the pandemic influenza A H1N1 virus (pH1N1) in Taiwan before and after the 2009 pandemic, and to estimate the relative severity of pH1N1 infections among different age groups. Methodology/Principal Findings: A total of 1544 and 1558 random serum samples were collected from the general population in Taiwan in 2007 and 2010, respectively. Seropositivity was defined by a hemagglutination inhibition titer to pH1N1 (A/Taiwan/126/09) >= 1:40. The seropositivity rate of pH1N1 among the unvaccinated subjects and national surveillance data were used to compare the proportion of infections that led to severe diseases and fatalities among different age groups. The overall seroprevalence of pH1N1 was 0.91% (95% confidence interval [CI] 0.43-1.38) in 2007 and significantly increased to 29.9% (95% CI 27.6-32.2) in 2010 (p<0.0001), with the peak attack rate (55.4%) in 10-17 year-old adolescents, the lowest in elderly >= 65 years (14.1%). The overall attack rates were 20.6% (188/912) in unvaccinated subjects. Among the unvaccinated but infected populations, the estimated attack rates of severe cases per 100,000 infections were significantly higher in children aged 0-5 years (54.9 cases, odds ratio [OR] 4.23, 95% CI 3.04-5.90) and elderly >= 65years (22.4 cases, OR 2.76, 95% CI 1.99-3.83) compared to adolescents aged 10-17 years (13.0 cases). The overall case-fatality rate was 0.98 per 100,000 infections without a significant difference in different age groups. Conclusions/Significance: Pre-existing immunity against pH1N1 was rarely identified in Taiwanese at any age in 2007. Young children and elderly - the two most lower seroprotection groups showed the greatest vulnerability to clinical severity after the pH1N1 infections. These results imply that both age groups should have higher priority for immunization in the coming flu season.	[Chen, Chih-Jung; Huang, Yhu-Chering; Chiu, Cheng-Hsun; Hsieh, Yu-Chia; Lin, Tzou-Yien] Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan; [Chen, Chih-Jung; Huang, Yhu-Chering; Chiu, Cheng-Hsun; Hsieh, Yu-Chia; Lin, Tzou-Yien] Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Lee, Ping-Ing] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Lee, Ping-Ing] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chang, Shih-Cheng] Chang Gung Univ, Res Ctr Emerging Viral Infect, Tao Yuan, Taiwan; [Chang, Shih-Cheng] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Chen, Chih-Jung; Chang, Shih-Cheng; Huang, Yhu-Chering; Chiu, Cheng-Hsun; Hsieh, Yu-Chia; Lin, Tzou-Yien] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Chang, Shang-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chang, Feng-Yee] Ctr Dis Control, Taipei, Taiwan; [Lee, Jen-Jyh] Hualien & Tzu Chi Univ, Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Hualien, Taiwan; [Su, Shey-Chiang] Mackay Mem Hosp, Dept Internal Med, Div Infect Dis, Hsinchu, Taiwan; [Shen, Gwan-Han] Taichung Vet Gen Hosp, Dept Internal Med, Div Resp & Crit Care Med, Taichung, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med, Div Infect Dis, Tainan, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med, Div Infect Dis, Liouying, Taiwan; [Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Div Infect Dis & Clin Microbiol, Kaohsiung, Taiwan; [Chen, Yao-Shen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Liu, Jien-Wei] Chang Gung Univ Kaohsiung, Chang Gung Univ Med Coll, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chang Gung University; Chang Gung University; Chang Gung University; National Taiwan University; National Taiwan University Hospital; Centers For Disease Control - Taiwan; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Mackay Memorial Hospital; Taichung Veterans General Hospital; Chi Mei Hospital; Chi Mei Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung University	Chen, CJ (corresponding author), Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan.	pidlin@adm.cgmh.org.tw		CHANG, SHAN-CHWEN/0000-0001-6505-4139; LEE, PING-ING/0000-0002-7299-2825	Taiwan Center for Disease Control [DOH99-DC-1101]; Chang Gung Memorial Hospital [CMRPG 490111]	Taiwan Center for Disease Control; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The study was supported by a grant from Taiwan Center for Disease Control (DOH99-DC-1101) and partly supported by a grant from Chang Gung Memorial Hospital (CMRPG 490111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson WE, 2010, EUROSURVEILLANCE, V15; Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Chang SC, 2010, CLIN INFECT DIS, V51, P1465, DOI 10.1086/657406; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; *EUR CTR DIS PREV, 2009, EUR SURVEILL, V14; *EUR CTR DIS PREV, 2009, EURO SURVEILL, V14; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Huang WT, 2010, EUROSURVEILLANCE, V15, P2; Hung IFN, 2010, CLIN INFECT DIS, V51, P274, DOI 10.1086/653940; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Janjua NZ, 2010, CLIN INFECT DIS, V51, P1017, DOI 10.1086/656586; Johns MC, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010722, 10.1371/journal.pone.0015801]; Jordan H. T., 2009, Morbidity and Mortality Weekly Report, V58, P470; Kendal AP, 1982, CONCEPTS PROCEDURES; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; McVernon J, 2010, EURO SURVEILL, V15, pii; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Skowronski DM, 2010, CAN MED ASSOC J, V182, P1851, DOI 10.1503/cmaj.100910; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Tilston NL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-650; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization, 2009, WORLD NOW START 2009; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Wu UI, 2010, CLIN INFECT DIS, V51, P1223, DOI 10.1086/656922; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601	32	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24440	10.1371/journal.pone.0024440	http://dx.doi.org/10.1371/journal.pone.0024440			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909433	Green Submitted, gold, Green Published			2022-12-25	WOS:000294683900049
J	Colpitts, TM; Barthel, S; Wang, PH; Fikrig, E				Colpitts, Tonya M.; Barthel, Sebastian; Wang, Penghua; Fikrig, Erol			Dengue Virus Capsid Protein Binds Core Histones and Inhibits Nucleosome Formation in Human Liver Cells	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; WEST-NILE; NUCLEAR-LOCALIZATION; JAPANESE ENCEPHALITIS; LYTIC INFECTION; REPAIR PROTEINS; FLAVIVIRUS; TRANSCRIPTION; CHROMATIN; HERPES-SIMPLEX-VIRUS-1	Dengue virus (DENV) is a member of the Flaviviridae and a globally (re) emerging pathogen that causes serious human disease. There is no specific antiviral or vaccine for dengue virus infection. Flavivirus capsid (C) is a structural protein responsible for gathering the viral RNA into a nucleocapsid that forms the core of a mature virus particle. Flaviviral replication is known to occur in the cytoplasm yet a large portion of capsid protein localizes to the nucleus during infection. The reasons for the nuclear presences of capsid are not completely understood. Here, we expressed mature DENV C in a tandem affinity purification assay to identify potential binding partners in human liver cells. DENV C targeted the four core histones, H2A, H2B, H3 and H4. DENV C bound recombinant histones in solution and colocalized with histones in the nucleus and cytoplasm of liver cells during DENV infection. We show that DENV C acts as a histone mimic, forming heterodimers with core histones, binding DNA and disrupting nucleosome formation. We also demonstrate that DENV infection increases the amounts of core histones in livers cells, which may be a cellular response to C binding away the histone proteins. Infection with DENV additionally alters levels of H2A phosphorylation in a time-dependent manner. The interactions of C and histones add an interesting new role for the presence of C in the nucleus during DENV infection.	[Colpitts, Tonya M.; Wang, Penghua; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA; [Fikrig, Erol] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Barthel, Sebastian] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany	Yale University; Howard Hughes Medical Institute; Yale University; Eberhard Karls University of Tubingen	Colpitts, TM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.	erol.fikrig@yale.edu	wang, Penghua/AAL-4011-2020	Colpitts, Tonya/0000-0003-3915-1554	National Institutes of Health [UO1 AI070343, T32 AI07404]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007404, U01AI070343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was generously supported by National Institutes of Health grants UO1 AI070343 and T32 AI07404. EF is an investigator with the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENTS G, 1995, P NATL ACAD SCI USA, V92, P11170, DOI 10.1073/pnas.92.24.11170; Bhuvanakantham R, 2009, BIOCHEM BIOPH RES CO, V389, P63, DOI 10.1016/j.bbrc.2009.08.108; BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cote-Martin A, 2008, J VIROL, V82, P1271, DOI 10.1128/JVI.01405-07; Franca RFD, 2010, EXP MOL PATHOL, V89, P321, DOI 10.1016/j.yexmp.2010.07.007; Forsman A, 2008, J PROTEOME RES, V7, P2309, DOI 10.1021/pr700769e; Garcia-Robles I, 2005, VIROLOGY, V332, P329, DOI 10.1016/j.virol.2004.09.036; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Hunt TA, 2007, CELL MICROBIOL, V9, P2756, DOI 10.1111/j.1462-5822.2007.01046.x; Hwang JW, 2007, VIROLOGY, V367, P334, DOI 10.1016/j.virol.2007.05.037; Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003; Jorba N, 2008, J GEN VIROL, V89, P520, DOI 10.1099/vir.0.83387-0; Kent JR, 2004, J VIROL, V78, P10178, DOI 10.1128/JVI.78.18.10178-10186.2004; Kiermayr S, 2004, J VIROL, V78, P8078, DOI 10.1128/JVI.78.15.8078-8084.2004; Knipe D., 2001, FIELDS VIROLOGY, V4th, P991; KORNBERG RD, 1992, ANNU REV CELL BIOL, V8, P563, DOI 10.1146/annurev.cellbio.8.1.563; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lilley CE, 2005, P NATL ACAD SCI USA, V102, P5844, DOI 10.1073/pnas.0501916102; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Manzur KL, 2003, NAT STRUCT BIOL, V10, P187, DOI 10.1038/nsb898; Marino-Ramirez L, 2005, EXPERT REV PROTEOMIC, V2, P719, DOI 10.1586/14789450.2.5.719; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005; NETSAWANG J, VIRUS RES, V147, P275; NG ML, 1983, ARCH VIROL, V78, P177; *PAHO, PAHO NUMB REP CAS DE; Poon APW, 2006, P NATL ACAD SCI USA, V103, P9993, DOI 10.1073/pnas.0604142103; Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0; Shah I, 2008, SCAND J INFECT DIS, V40, P993, DOI 10.1080/00365540802209027; Speck SH, 1997, TRENDS MICROBIOL, V5, P399, DOI 10.1016/S0966-842X(97)01129-3; Wang HC, 2008, P NATL ACAD SCI USA, V105, P20758, DOI 10.1073/pnas.0811233106; Wei H, 2010, BBA-GENE REGUL MECH, V1799, P296, DOI 10.1016/j.bbagrm.2009.08.007; Wilkinson DE, 2004, J VIROL, V78, P4783, DOI 10.1128/JVI.78.9.4783-4796.2004; Wilkinson DE, 2006, J CELL SCI, V119, P2695, DOI 10.1242/jcs.02981; Yang MR, 2008, CELL MICROBIOL, V10, P165, DOI 10.1111/j.1462-5822.2007.01027.x; Zhirnov OP, 1997, VIROLOGY, V235, P302, DOI 10.1006/viro.1997.8700	41	63	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24365	10.1371/journal.pone.0024365	http://dx.doi.org/10.1371/journal.pone.0024365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909430	Green Published, gold, Green Submitted			2022-12-25	WOS:000294683900046
J	Serrano-Sanchez, JA; Marti-Trujillo, S; Lera-Navarro, A; Dorado-Garcia, C; Gonzalez-Henriquez, JJ; Sanchis-Moysi, J				Serrano-Sanchez, Jose A.; Marti-Trujillo, Sara; Lera-Navarro, Angela; Dorado-Garcia, Cecilia; Gonzalez-Henriquez, Juan J.; Sanchis-Moysi, Joaquin			Associations between Screen Time and Physical Activity among Spanish Adolescents	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; RISK-FACTORS; CARDIOVASCULAR-DISEASE; ACTIVITY QUESTIONNAIRE; CHILDRENS TELEVISION; METABOLIC RISK; MEDIA USE; BODY-FAT; YOUTH; OBESITY	Background: Excessive time in front of a single or several screens could explain a displacement of physical activity. The present study aimed at determining whether screen-time is associated with a reduced level of moderate to vigorous physical activity (MVPA) in Spanish adolescents living in favorable environmental conditions. Methodology/Principal Findings: A multi-stage stratified random sampling method was used to select 3503 adolescents (12-18 years old) from the school population of Gran Canaria, Spain. MVPA, screen-time in front of television, computer, video game console and portable console was assessed in the classroom by fulfilling a standardized questionnaire. Bivariate and multivariate logistic regression analyses adjusted by a set of social-environmental variables were carried out. Forty-six percent of girls (95% CI +/- 2.3%) and 26% of boys (95% CI +/- 2.1%) did not meet the MVPA recommendations for adolescents. Major gender differences were observed in the time devoted to vigorous PA, video games and the total time spent on screen-based activities. Boys who reported 4 hours.week(-1) or more to total screen-time showed a 64% (OR = 0.61, 95% CI, 0.44-0.86) increased risk of failing to achieve the recommended adolescent MVPA level. Participation in organized physical activities and sports competitions were more strongly associated with MVPA than screen-related behaviors. Conclusions/Significance: No single screen-related behavior explained the reduction of MVPA in adolescents. However, the total time accumulated through several screen-related behaviors was negatively associated with MVPA level in boys. This association could be due to lower availability of time for exercise as the time devoted to sedentary screen-time activities increases. Participation in organized physical activities seems to counteract the negative impact of excessive time in front of screens on physical activity.	[Serrano-Sanchez, Jose A.; Marti-Trujillo, Sara; Dorado-Garcia, Cecilia; Sanchis-Moysi, Joaquin] Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain; [Gonzalez-Henriquez, Juan J.] Univ Las Palmas Gran Canaria, Dept Math, Las Palmas Gran Canaria, Spain; [Lera-Navarro, Angela] Univ A Coruna, Dept Phys Educ, La Coruna, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria; Universidade da Coruna	Serrano-Sanchez, JA (corresponding author), Univ Las Palmas Gran Canaria, Dept Phys Educ, Campus Univ Tafira S-N, Las Palmas Gran Canaria, Spain.	jserrano@def.ulpgc.es	Dorado García, Cecilia/ABC-2792-2021; Serrano-Sanchez, Jose A/L-3691-2014; González-Henríquez, Juan José jjgh/K-8808-2014; SANCHIS-MOYSI, JOAQUIN/H-7017-2015; Henríquez, Juan José González/AAZ-7810-2020; Sanchis-Moysi, Joaquin/B-5561-2012; Cecilia, Dorado-Garcia/B-4586-2010	Serrano-Sanchez, Jose A/0000-0002-4868-8751; González-Henríquez, Juan José jjgh/0000-0002-0622-5580; SANCHIS-MOYSI, JOAQUIN/0000-0001-6602-7087; Henríquez, Juan José González/0000-0002-0622-5580; Cecilia, Dorado-Garcia/0000-0001-6616-6810	Cabildo of Gran Canaria [35/03/22034]	Cabildo of Gran Canaria	This work was supported by Cabildo of Gran Canaria (contract n<SUP>o</SUP> 35/03/22034)(www.grancanaria.es). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2007, EUR J CARDIOV PREV R, V14, P660, DOI 10.1097/HJR.0b013e3280c284c5; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], J SCH HLTH; [Anonymous], 2004, YOUNG PEOPLES HLTH C; Ara I, 2006, INT J OBESITY, V30, P1062, DOI 10.1038/sj.ijo.0803303; Ara I, 2004, INT J OBESITY, V28, P1585, DOI 10.1038/sj.ijo.0802754; Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Bengoechea EG, 2010, RES Q EXERCISE SPORT, V81, P7, DOI 10.1080/02701367.2010.10599623; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Berkey CS, 2003, PEDIATRICS, V111, P836, DOI 10.1542/peds.111.4.836; Biddle S. J., 2003, Medicine & Science in Sports & Exercise, V35, pS178, DOI 10.1097/00005768-200305001-00987; BIDDLE SJ, 1998, YOUNG ACT YOUNG PEOP; Biddle SJH, 2004, J R SOC PROMO HEALTH, V124, P29, DOI 10.1177/146642400312400110; Borzekowski DLG, 2001, J AM DIET ASSOC, V101, P42, DOI 10.1016/S0002-8223(01)00012-8; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Caride J. T., 2005, CUADERNOS PEDAGOGIA, V349, P64; Cavill N, 2001, PEDIATR EXERC SCI, V13, P12, DOI 10.1123/pes.13.1.12; DALY LE, 2000, INTERPRETATIONS USES, P109; Department of Health & Aging, 2004, AUSTR PHYS ACT REC 1; Dowda M, 2001, ARCH PEDIAT ADOL MED, V155, P711, DOI 10.1001/archpedi.155.6.711; Ekelund U, 2006, PLOS MED, V3, P2449, DOI 10.1371/journal.pmed.0030488; Elgar FJ, 2005, PUBLIC HEALTH, V119, P518, DOI 10.1016/j.puhe.2004.10.011; Feldman DE, 2003, ARCH PEDIAT ADOL MED, V157, P797, DOI 10.1001/archpedi.157.8.797; Ferreira I, 2007, OBES REV, V8, P129, DOI 10.1111/j.1467-789X.2006.00264.x; Gordon-Larsen P, 2004, AM J PREV MED, V27, P277, DOI 10.1016/j.amepre.2004.07.006; Gordon-Larsen P, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e83; GORELY T, 2007, INT J PEDIATR OBES, P1; Gortmaker SL, 1999, ARCH PEDIAT ADOL MED, V153, P409, DOI 10.1001/archpedi.153.4.409; Hager RL, 2006, J ADOLESCENT HEALTH, V39, P656, DOI 10.1016/j.jadohealth.2006.04.020; Hardy LL, 2007, PREV MED, V45, P71, DOI 10.1016/j.ypmed.2007.03.014; Hardy LL, 2006, AUST NZ J PUBL HEAL, V30, P534, DOI 10.1111/j.1467-842X.2006.tb00782.x; Hardy LL, 2010, ARCH PEDIAT ADOL MED, V164, P643, DOI 10.1001/archpediatrics.2010.88; Brodersen NH, 2007, BRIT J SPORT MED, V41, P140, DOI 10.1136/bjsm.2006.031138; Hernandez B, 2000, SALUD PUBLICA MEXICO, V42, P315, DOI 10.1590/S0036-36342000000400006; Jago R, 2005, INT J OBESITY, V29, P557, DOI 10.1038/sj.ijo.0802969; KARACA A, 2010, ANN HUM BIOL, P37; LOGSTRUP S, 2001, CHILDREN YOUNG PEOPL; Manios Y, 2004, AM J HUM BIOL, V16, P639, DOI 10.1002/ajhb.20075; Marshall SJ, 2006, J ADOLESCENCE, V29, P333, DOI 10.1016/j.adolescence.2005.08.016; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; MARSHALL SJ, 2002, MED SCI SPORTS EXERC, V34, P129, DOI DOI 10.1097/00005768-200205001-01827; Martinez-Gomez D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-274; Martinez-Gomez D, 2010, REV ESP CARDIOL, V63, P277, DOI 10.1016/S0300-8932(10)70086-5; Matheson DM, 2004, AM J CLIN NUTR, V79, P1088; Melkevik O, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-46; Mota J, 2002, INT J BEHAV MED, V9, P111, DOI 10.1207/S15327558IJBM0902_03; Nagelkerke NJD, 1992, MAXIMUM LIKELIHOOD E; Okely AD, 2001, MED SCI SPORT EXER, V33, P1899, DOI 10.1097/00005768-200111000-00015; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Parsons TJ, 2008, EUR J CLIN NUTR, V62, P1355, DOI 10.1038/sj.ejcn.1602884; Pate RR, 2009, BRIT J SPORT MED, V43, P14, DOI 10.1136/bjsm.2008.055517; Pate R.R., 1994, HLTH FITNESS PHYS ED, P215; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Pate RR, 2007, AM J PREV MED, V33, P276, DOI 10.1016/j.amepre.2007.06.005; Pate RR, 2006, CIRCULATION, V114, P1214, DOI 10.1161/CIRCULATIONAHA.106.177052; *PUBL HLTH AG CAN, 2002, CAN PHYS ACT GUID FA; Rey-Lopez JP, 2010, PREV MED, V51, P50, DOI 10.1016/j.ypmed.2010.03.013; Rey-Lopez JP, 2008, NUTR METAB CARDIOVAS, V18, P242, DOI 10.1016/j.numecd.2007.07.008; Robinson TN, 1998, JAMA-J AM MED ASSOC, V279, P959, DOI 10.1001/jama.279.12.959; Robinson TN, 2001, PEDIATR CLIN N AM, V48, P1017, DOI 10.1016/S0031-3955(05)70354-0; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Saar M, 2007, PERCEPT MOTOR SKILL, V105, P559, DOI 10.2466/PMS.105.2.559-562; SALLIS JF, 1994, PEDIATR EXERC SCI, V6, P302; Santos MP, 2005, ANN BEHAV MED, V30, P21, DOI 10.1207/s15324796abm3001_3; Sardinha LB, 2008, DIABETES CARE, V31, P569, DOI 10.2337/dc07-1286; Slinde F, 2003, MED SCI SPORT EXER, V35, P1923, DOI 10.1249/01.MSS.0000093608.95629.85; Spanier PA, 2006, CAN J PUBLIC HEALTH, V97, P255, DOI 10.1007/BF03405599; *SPSS INC, 2006, STAT PACK SOC SCI BA; Tammelin T, 2007, MED SCI SPORT EXER, V39, P1067, DOI 10.1249/mss.0b13e318058a603; Taveras EM, 2007, PEDIATRICS, V119, pE314, DOI 10.1542/peds.2005-2974; Torsheim T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-324; Tsai HJ, 2007, J ASTHMA, V44, P397, DOI 10.1080/02770900701364304; Vandewater EA, 2004, J ADOLESCENCE, V27, P71, DOI 10.1016/j.adolescence.2003.10.003; Vicente-Rodriguez G, 2008, NUTRITION, V24, P654, DOI 10.1016/j.nut.2008.03.011; World Health Organization, 2006, PROM PHYS ACT SCH IM; [No title captured]	77	61	62	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24453	10.1371/journal.pone.0024453	http://dx.doi.org/10.1371/journal.pone.0024453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	817OO	21909435	gold, Green Published			2022-12-25	WOS:000294683900051
J	Yu, CC; Hu, Y; Duan, JH; Yuan, W; Wang, C; Xu, HY; Yang, XD				Yu, Chenchen; Hu, Yan; Duan, Jinhong; Yuan, Wei; Wang, Chen; Xu, Haiyan; Yang, Xian-Da			Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells In Vitro	PLOS ONE			English	Article							PLGA-PEG NANOPARTICLES; TARGETED DELIVERY; FOLATE RECEPTOR; MUC1; THERAPY; VIVO; NANOTECHNOLOGY; EXPRESSION	MUC1 protein is an attractive target for anticancer drug delivery owing to its overexpression in most adenocarcinomas. In this study, a reported MUC1 protein aptamer is exploited as the targeting agent of a nanoparticle-based drug delivery system. Paclitaxel (PTX) loaded poly (lactic-co-glycolic-acid) (PLGA) nanoparticles were formulated by an emulsion/evaporation method, and MUC1 aptamers (Apt) were conjugated to the particle surface through a DNA spacer. The aptamer conjugated nanoparticles (Apt-NPs) are about 225.3 nm in size with a stable in vitro drug release profile. Using MCF-7 breast cancer cell as a MUC1-overexpressing model, the MUC1 aptamer increased the uptake of nanoparticles into the target cells as measured by flow cytometry. Moreover, the PTX loaded Apt-NPs enhanced in vitro drug delivery and cytotoxicity to MUC1(+) cancer cells, as compared with non-targeted nanoparticles that lack the MUC1 aptamer (P<0.01). The behavior of this novel aptamer-nanoparticle bioconjugates suggests that MUC1 aptamers may have application potential in targeted drug delivery towards MUC1-overexpressing tumors.	[Yu, Chenchen; Hu, Yan; Duan, Jinhong; Xu, Haiyan; Yang, Xian-Da] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Yu, Chenchen; Hu, Yan; Duan, Jinhong; Xu, Haiyan; Yang, Xian-Da] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yuan, Wei] Chinese Acad Med Sci, Peking Union Med Coll, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Wang, Chen; Yang, Xian-Da] Natl Ctr Nanosci & Technol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China	Yu, CC (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China.	ayangmd@gmail.com	Prow, Tarl W/A-4764-2010	Prow, Tarl W/0000-0003-2892-6238	Chinese Ministry of Science and Technology [2011CB911003, 2011CB911004, 2011CB933504]; Natural Science Foundation of China [81071870]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors acknowledge the funding support from the Chinese Ministry of Science and Technology (2011CB911003, 2011CB911004, 2011CB933504) and the Natural Science Foundation of China (81071870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARYA S, 2010, ADV DRUG DELIV REV; Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/NMAT2992, 10.1038/nmat2992]; Brown KC, 2010, CURR PHARM DESIGN, V16, P1040, DOI 10.2174/138161210790963788; Chauhan SC, 2007, J HISTOCHEM CYTOCHEM, V55, P867, DOI 10.1369/jhc.7A7213.2007; Cheng J, 2007, BIOMATERIALS, V28, P869, DOI 10.1016/j.biomaterials.2006.09.047; Croce MV, 2001, BREAST CANCER RES TR, V69, P1, DOI 10.1023/A:1012220902991; Da Pieve C, 2009, NUCL MED BIOL, V36, P703, DOI 10.1016/j.nucmedbio.2009.04.004; Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105; Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550; Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferreira CSM, 2006, TUMOR BIOL, V27, P289, DOI 10.1159/000096085; Ferreira CSM, 2009, NUCLEIC ACIDS RES, V37, P866, DOI 10.1093/nar/gkn967; Huang YF, 2009, CHEMBIOCHEM, V10, P862, DOI 10.1002/cbic.200800805; LEE RJ, 1994, J BIOL CHEM, V269, P3198; Levy-Nissenbaum E, 2008, TRENDS BIOTECHNOL, V26, P442, DOI 10.1016/j.tibtech.2008.04.006; Manchanda R, 2010, COLLOID SURFACE B, V75, P260, DOI 10.1016/j.colsurfb.2009.08.043; O'Connor JC, 2005, PROSTATE CANCER P D, V8, P36, DOI 10.1038/sj.pcan.4500762; Ohuchida K, 2006, INT J CANCER, V118, P405, DOI 10.1002/ijc.21317; Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0; Patil YB, 2009, BIOMATERIALS, V30, P859, DOI 10.1016/j.biomaterials.2008.09.056; Ren LF, 1997, CHEM-BIOL INTERACT, V104, P55, DOI 10.1016/S0009-2797(97)03767-8; Shi H, 2011, P NATL ACAD SCI USA, V108, P3900, DOI 10.1073/pnas.1016197108; Sudimack J, 2000, ADV DRUG DELIVER REV, V41, P147, DOI 10.1016/S0169-409X(99)00062-9; Taylor-Papadimitriou J, 1999, BBA-MOL BASIS DIS, V1455, P301, DOI 10.1016/S0925-4439(99)00055-1; Wang MD, 2007, EXPERT REV ANTICANC, V7, P833, DOI 10.1586/14737140.7.6.833; Yu B, 2010, MOL MEMBR BIOL, V27, P286, DOI 10.3109/09687688.2010.521200	28	135	140	2	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24077	10.1371/journal.pone.0024077	http://dx.doi.org/10.1371/journal.pone.0024077			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21912664	gold, Green Published, Green Submitted			2022-12-25	WOS:000294683900026
J	Jonak, C; Skvara, H; Kunstfeld, R; Trautinger, F; Schmid, JA				Jonak, Constanze; Skvara, Hans; Kunstfeld, Rainer; Trautinger, Franz; Schmid, Johannes A.			Intradermal Indocyanine Green for In Vivo Fluorescence Laser Scanning Microscopy of Human Skin: A Pilot Study	PLOS ONE			English	Article							REFLECTANCE CONFOCAL MICROSCOPY; CONTACT-DERMATITIS; ANALYSIS SOFTWARE; HISTOLOGY; FLUOROPHORES; SPECIFICITY; DERMATOLOGY; LESIONS; CANCER	Background: In clinical diagnostics, as well as in routine dermatology, the increased need for non-invasive diagnosis is currently satisfied by reflectance laser scanning microscopy. However, this technique has some limitations as it relies solely on differences in the reflection properties of epidermal and dermal structures. To date, the superior method of fluorescence laser scanning microscopy is not generally applied in dermatology and predominantly restricted to fluorescein as fluorescent tracer, which has a number of limitations. Therefore, we searched for an alternative fluorophore matching a novel skin imaging device to advance this promising diagnostic approach. Methodology/Principal Findings: Using a Vivascope(R)-1500 Multilaser microscope, we found that the fluorophore Indocyanine-Green (ICG) is well suited as a fluorescent marker for skin imaging in vivo after intradermal injection. ICG is one of few fluorescent dyes approved for use in humans. Its fluorescence properties are compatible with the application of a near-infrared laser, which penetrates deeper into the tissue than the standard 488 nm laser for fluorescein. ICG-fluorescence turned out to be much more stable than fluorescein in vivo, persisting for more than 48 hours without significant photobleaching whereas fluorescein fades within 2 hours. The well-defined intercellular staining pattern of ICG allows automated cell-recognition algorithms, which we accomplished with the free software CellProfiler, providing the possibility of quantitative high-content imaging. Furthermore, we demonstrate the superiority of ICG-based fluorescence microscopy for selected skin pathologies, including dermal nevi, irritant contact dermatitis and necrotic skin. Conclusions/Significance: Our results introduce a novel in vivo skin imaging technique using ICG, which delivers a stable intercellular fluorescence signal ideal for morphological assessment down to sub-cellular detail. The application of ICG in combination with the near infrared laser opens new ways for minimal-invasive diagnosis and monitoring of skin disorders.	[Jonak, Constanze; Kunstfeld, Rainer] Med Univ Vienna, Div Gen Dermatol, Dept Dermatol, Vienna, Austria; [Jonak, Constanze; Trautinger, Franz] Landesklinikum St Polten, Karl Landsteiner Inst Dermatol Res, St Polten, Austria; [Skvara, Hans] Med Univ Vienna, Div Immunol Allergy & Infect Dis, Dept Dermatol, Vienna, Austria; [Schmid, Johannes A.] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Jonak, C (corresponding author), Med Univ Vienna, Div Gen Dermatol, Dept Dermatol, Vienna, Austria.	constanze.jonak@meduniwien.ac.at; johannes.schmid@meduniwien.ac.at	Trautinger, Franz/M-5041-2019; Schmid, Johannes A./C-7659-2009	Schmid, Johannes A./0000-0002-6586-3507	Austrian Federal Reserve Bank [12747]; Austrian Federal Reserve Bank, in Austria	Austrian Federal Reserve Bank; Austrian Federal Reserve Bank, in Austria	This study was supported by the Austrian Federal Reserve Bank (Grant number 12747 to Dr. Kunstfeld). Pulsion Medical Systems provided some of the fluorescent dye for free. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Pulsion Medical Systems provided some of the fluorescent dye for free. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The Austrian Federal Reserve Bank, is a public institution in Austria providing funding for research without any commercial interests or any potentially biasing relation to the authors.	Abe H, 2011, SURG TODAY, V41, P197, DOI 10.1007/s00595-009-4254-8; Ahlgrimm-Siess V, 2008, BRIT J DERMATOL, V158, P1000, DOI 10.1111/j.1365-2133.2008.08460.x; Alford R, 2009, MOL IMAGING, V8, P341, DOI 10.2310/7290.2009.00031; Ardigo M, 2009, J EUR ACAD DERMATOL, V23, P660, DOI 10.1111/j.1468-3083.2009.03134.x; Ardigo M, 2011, SKIN RES TECHNOL; Astner S, 2005, J INVEST DERMATOL, V124, P351, DOI 10.1111/j.0022-202X.2004.23605.x; Astner S, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2837411; Bal SM, 2010, J CONTROL RELEASE, V147, P218, DOI 10.1016/j.jconrel.2010.07.104; Branzan AL, 2007, LASER MED SCI, V22, P73, DOI 10.1007/s10103-006-0416-8; Calzavara-Pinton P, 2008, PHOTOCHEM PHOTOBIOL, V84, P1421, DOI 10.1111/j.1751-1097.2008.00443.x; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHERRICK GR, 1960, J CLIN INVEST, V39, P592, DOI 10.1172/JCI104072; Desmettre T, 2000, SURV OPHTHALMOL, V45, P15, DOI 10.1016/S0039-6257(00)00123-5; Eckert RC, 2004, CYTOM PART A, V59A, P182, DOI 10.1002/cyto.a.20052; Gonzalez S, 1999, J AM ACAD DERMATOL, V40, P708, DOI 10.1016/S0190-9622(99)70151-9; Gonzalez S, 2009, ACTAS DERMO-SIFILOGR, V100, P59, DOI 10.1016/S0001-7310(09)73380-0; Gonzalez S., 2008, International Journal of Cosmetic Science, V30, P1, DOI 10.1111/j.1468-2494.2008.00406.x; Hofmann-Wellenhof R, 2009, SEMIN CUTAN MED SURG, V28, P172, DOI 10.1016/j.sder.2009.06.004; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Koller S, 2009, EXP DERMATOL, V18, P536, DOI 10.1111/j.1600-0625.2008.00822.x; LANDSMAN MLJ, 1976, J APPL PHYSIOL, V40, P575, DOI 10.1152/jappl.1976.40.4.575; Longo C, 2011, BR J DERMATOL; Luedtke MA, 2009, SKIN RES TECHNOL, V15, P482, DOI 10.1111/j.1600-0846.2009.00394.x; Meyer LE, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2337294; Nori S, 2004, J AM ACAD DERMATOL, V51, P923, DOI 10.1016/j.jaad.2004.06.028; O'goshi KI, 2006, SKIN RES TECHNOL, V12, P155, DOI 10.1111/j.0909-752X.2006.00147.x; Pellacani G, 2009, J AM ACAD DERMATOL, V61, P1001, DOI 10.1016/j.jaad.2009.04.018; Pellicani G, 2005, J AM ACAD DERMATOL, V53, P979, DOI 10.1016/j.jaad.2005.08.022; Rajadhyaksha M, 1999, J INVEST DERMATOL, V113, P293, DOI 10.1046/j.1523-1747.1999.00690.x; RAJADHYAKSHA M, 1995, J INVEST DERMATOL, V104, P946, DOI 10.1111/1523-1747.ep12606215; Scope A, 2007, J AM ACAD DERMATOL, V57, P644, DOI 10.1016/j.jaad.2007.05.044; Suihko C, 2005, SKIN RES TECHNOL, V11, P254, DOI 10.1111/j.0909-725X.2005.00152.x; Swindle LD, 2003, J INVEST DERMATOL, V121, P706, DOI 10.1046/j.1523-1747.2003.12477.x; Ulrich M, 2007, BRIT J DERMATOL, V157, P56, DOI 10.1111/j.1365-2133.2007.08275.x; Wurm EM, 2010, RECENT ADV DIAGNOSIN	36	22	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23972	10.1371/journal.pone.0023972	http://dx.doi.org/10.1371/journal.pone.0023972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904601	Green Published, Green Submitted, gold			2022-12-25	WOS:000294680800045
J	Kornhuber, J; Muehlbacher, M; Trapp, S; Pechmann, S; Friedl, A; Reichel, M; Muhle, C; Terfloth, L; Groemer, TW; Spitzer, GM; Liedl, KR; Gulbins, E; Tripal, P				Kornhuber, Johannes; Muehlbacher, Markus; Trapp, Stefan; Pechmann, Stefanie; Friedl, Astrid; Reichel, Martin; Muehle, Christiane; Terfloth, Lothar; Groemer, Teja W.; Spitzer, Gudrun M.; Liedl, Klaus R.; Gulbins, Erich; Tripal, Philipp			Identification of Novel Functional Inhibitors of Acid Sphingomyelinase	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; IN-SILICO PREDICTION; NIEMANN-PICK-DISEASE; CELL-DEATH; DRUG DISCOVERY; SPHINGOLIPID METABOLISM; ENDOTHELIAL APOPTOSIS; MOLECULAR-WEIGHT; RAT-BRAIN; CERAMIDE	We describe a hitherto unknown feature for 27 small drug-like molecules, namely functional inhibition of acid sphingomyelinase (ASM). These entities named FIASMAs (Functional Inhibitors of Acid SphingoMyelinAse), therefore, can be potentially used to treat diseases associated with enhanced activity of ASM, such as Alzheimer's disease, major depression, radiation-and chemotherapy-induced apoptosis and endotoxic shock syndrome. Residual activity of ASM measured in the presence of 10 mu M drug concentration shows a bimodal distribution; thus the tested drugs can be classified into two groups with lower and higher inhibitory activity. All FIASMAs share distinct physicochemical properties in showing lipophilic and weakly basic properties. Hierarchical clustering of Tanimoto coefficients revealed that FIASMAs occur among drugs of various chemical scaffolds. Moreover, FIASMAs more frequently violate Lipinski's Rule-of-Five than compounds without effect on ASM. Inhibition of ASM appears to be associated with good permeability across the blood-brain barrier. In the present investigation, we developed a novel structure-property-activity relationship by using a random forest-based binary classification learner. Virtual screening revealed that only six out of 768 (0.78%) compounds of natural products functionally inhibit ASM, whereas this inhibitory activity occurs in 135 out of 2028 (6.66%) drugs licensed for medical use in humans.	[Kornhuber, Johannes; Muehlbacher, Markus; Pechmann, Stefanie; Friedl, Astrid; Reichel, Martin; Muehle, Christiane; Groemer, Teja W.; Tripal, Philipp] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany; [Muehlbacher, Markus; Spitzer, Gudrun M.; Liedl, Klaus R.] Univ Innsbruck, Ctr Mol Biosci, A-6020 Innsbruck, Austria; [Trapp, Stefan] Tech Univ Denmark, Dept Environm Engn, DK-2800 Lyngby, Denmark; [Terfloth, Lothar] Mol Networks GmbH, Erlangen, Germany; [Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, Essen, Germany	University of Erlangen Nuremberg; University of Innsbruck; Technical University of Denmark; University of Duisburg Essen	Kornhuber, J (corresponding author), Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany.	Johannes.Kornhuber@uk-erlangen.de	Liedl, Klaus R/F-3099-2015; MÃhle, Christiane/AAE-7043-2019; Gulbins, Erich/L-6989-2014; Kornhuber, Johannes/B-9613-2014; Trapp, Stefan A J/G-7159-2011; Liedl, Klaus/ABB-4725-2021	Liedl, Klaus R/0000-0002-0985-2299; Gulbins, Erich/0000-0002-3117-1342; Kornhuber, Johannes/0000-0002-8096-3987; Trapp, Stefan A J/0000-0001-8968-6296; Liedl, Klaus/0000-0002-0985-2299; Reichel, Martin/0000-0001-7886-2784; Muhle, Christiane/0000-0001-7517-9154; Tripal, Philipp/0000-0003-0568-1725; Groemer, Teja/0000-0003-3854-716X	DFG [KO 947/11-1, GU 335/23-1]	DFG(German Research Foundation (DFG))	The work was supported in part by a grant from the DFG (KO 947/11-1, GU 335/23-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abraham MH, 2006, J PHARM SCI-US, V95, P2091, DOI 10.1002/jps.20595; Advanced Chemistry Development Inc, ACD LOGD SUIT; Akella LB, 2010, CURR OPIN CHEM BIOL, V14, P325, DOI 10.1016/j.cbpa.2010.03.017; ALBOUZ S, 1981, BIOMED EXPRESS, V35, P218; Alpaydin E, 2008, MASCHINELLES LERNEN; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Altura BM, 2002, BRAIN RES BULL, V58, P271, DOI 10.1016/S0361-9230(02)00772-4; Amaratunga D, 2008, BIOINFORMATICS, V24, P2010, DOI 10.1093/bioinformatics/btn356; Andres C, 2006, QSAR COMB SCI, V25, P305, DOI 10.1002/qsar.200510200; [Anonymous], 2004, World Health Organ Tech Rep Ser, V920, P1; [Anonymous], 1981, Ugeskr Laeger, V143, P1037; [Anonymous], 2007, APPROVED DRUG PRODUC; [Anonymous], 2007, 69 IOMC, V69, P1; Becker KA, 2010, AM J RESP CELL MOL, V42, P716, DOI 10.1165/rcmb.2009-0174OC; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bisiani R, 1987, ENCY ARTIFICIAL INTE, P56; BRADBURY MWB, 1993, EXP PHYSIOL, V78, P453, DOI 10.1113/expphysiol.1993.sp003698; BRADY RO, 1966, P NATL ACAD SCI USA, V55, P366, DOI 10.1073/pnas.55.2.366; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bush WS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-238; Canals D, 2011, BRIT J PHARMACOL, V163, P694, DOI 10.1111/j.1476-5381.2011.01279.x; Castillo SS, 2007, EXP CELL RES, V313, P2680, DOI 10.1016/j.yexcr.2007.04.002; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Chung HS, 2003, EXP MOL MED, V35, P181, DOI 10.1038/emm.2003.25; COX MK, 1993, EDUC PSYCHOL MEAS, V53, P951, DOI 10.1177/0013164493053004008; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Cuzzocrea S, 2009, SHOCK, V31, P634, DOI 10.1097/SHK.0b013e3181891396; Darroch PI, 2005, J LIPID RES, V46, P2315, DOI 10.1194/jlr.M500136-JLR200; Dawson G, 2011, BIOCHEM BIOPH RES CO, V404, P321, DOI 10.1016/j.bbrc.2010.11.115; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Deigner HP, 2000, EXPERT OPIN INV DRUG, V9, P747, DOI 10.1517/13543784.9.4.747; DeSimone C, 1996, IMMUNOL TODAY, V17, P48, DOI 10.1016/0167-5699(96)80570-6; Elojeimy S, 2006, FEBS LETT, V580, P4751, DOI 10.1016/j.febslet.2006.07.071; Ewing T, 2006, J CHEM INF MODEL, V46, P2423, DOI 10.1021/ci060155b; Feher M, 2000, INT J PHARMACEUT, V201, P239, DOI 10.1016/S0378-5173(00)00422-1; Fischer H, 1998, J MEMBRANE BIOL, V165, P201, DOI 10.1007/s002329900434; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Fu XC, 2008, EUR J PHARM BIOPHARM, V70, P462, DOI 10.1016/j.ejpb.2008.05.005; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Garg P, 2006, J CHEM INF MODEL, V46, P289, DOI 10.1021/ci050303i; Gerebtzoff G, 2006, J CHEM INF MODEL, V46, P2638, DOI 10.1021/ci0600814; Goede A, 2005, BIOINFORMATICS, V21, P1751, DOI 10.1093/bioinformatics/bti295; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Guerra A, 2008, QSAR COMB SCI, V27, P586, DOI 10.1002/qsar.200710019; Gulbins E, 2006, AM J PHYSIOL-REG I, V290, pR11, DOI 10.1152/ajpregu.00416.2005; GULBINS E, 1995, IMMUNITY, V2, P341, DOI 10.1016/1074-7613(95)90142-6; Gulbins E, 2000, METHOD ENZYMOL, V322, P382; Guyon Isabelle, 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; He XX, 2010, NEUROBIOL AGING, V31, P398, DOI 10.1016/j.neurobiolaging.2008.05.010; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; HURWITZ R, 1994, BIOL CHEM H-S, V375, P447, DOI 10.1515/bchm3.1994.375.7.447; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Jin S, 2008, ARTERIOSCL THROM VAS, V28, P2056, DOI 10.1161/ATVBAHA.108.172478; Kelder J, 1999, PHARMACEUT RES, V16, P1514, DOI 10.1023/A:1015040217741; KIRA K, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P129; Kirschnek S, 2000, J BIOL CHEM, V275, P27316; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127; Kolzer M, 2004, FEBS LETT, V559, P96, DOI 10.1016/S0014-5793(04)00033-X; Kolzer M, 2003, BIOL CHEM, V384, P1293, DOI 10.1515/BC.2003.144; Kononenko I., 1994, EUR C MACH LEARN, V784, P171, DOI DOI 10.1007/3-540-57868-4_57; Konovalov DA, 2007, J CHEM INF MODEL, V47, P1648, DOI 10.1021/ci700100f; Kornhuber J, 2005, J NEURAL TRANSM, V112, P1583, DOI 10.1007/s00702-005-0374-5; Kornhuber J, 1995, J NEURAL TRANSM-SUPP, V46, P311; Kornhuber J, 2008, J MED CHEM, V51, P219, DOI 10.1021/jm070524a; Kornhuber J, 2010, CELL PHYSIOL BIOCHEM, V26, P9, DOI 10.1159/000315101; Kornhuber J, 2009, EUR ARCH PSY CLIN N, V259, P199, DOI 10.1007/s00406-009-0061-x; Lanevskij K, 2009, J PHARM SCI-US, V98, P122, DOI 10.1002/jps.21405; LEVIN VA, 1980, J MED CHEM, V23, P682, DOI 10.1021/jm00180a022; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu RF, 2001, J CHEM INF COMP SCI, V41, P1623, DOI 10.1021/ci010290i; Malaplate-Armand C, 2006, NEUROBIOL DIS, V23, P178, DOI 10.1016/j.nbd.2006.02.010; Meloun M, 2007, ANAL BIOANAL CHEM, V389, P1267, DOI 10.1007/s00216-007-1502-x; Mente SR, 2005, J COMPUT AID MOL DES, V19, P465, DOI 10.1007/s10822-005-9001-7; Mikati MA, 2008, EPILEPSY RES, V81, P161, DOI 10.1016/j.eplepsyres.2008.05.009; Mintzer RJ, 2005, J BIOMOL SCREEN, V10, P225, DOI 10.1177/1087057104272546; Muehlbacher M, 2011, J COMPUT AIDED UNPUB; Narayanan R, 2005, BIOORGAN MED CHEM, V13, P3017, DOI 10.1016/j.bmc.2005.01.061; Ndengele MM, 2009, J PHARMACOL EXP THER, V329, P64, DOI 10.1124/jpet.108.146290; Norinder U, 2002, ADV DRUG DELIVER REV, V54, P291, DOI 10.1016/S0169-409X(02)00005-4; Pandey S, 2007, EXP MOL PATHOL, V82, P298, DOI 10.1016/j.yexmp.2006.07.009; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pascual M, 2003, J NEUROCHEM, V87, P1535, DOI 10.1046/j.1471-4159.2003.02130.x; Platts JA, 2001, EUR J MED CHEM, V36, P719, DOI 10.1016/S0223-5234(01)01269-7; Purvis GD, 2008, J COMPUT AID MOL DES, V22, P461, DOI 10.1007/s10822-008-9209-4; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; RAGLAND DR, 1992, EPIDEMIOLOGY, V3, P434, DOI 10.1097/00001648-199209000-00009; Rebillard A, 2008, ONCOGENE, V27, P6590, DOI 10.1038/onc.2008.257; Riethmuller J, 2009, CELL PHYSIOL BIOCHEM, V24, P65, DOI 10.1159/000227814; ROECKER E, 1991, TECHNOMETRICS, V33, P459, DOI 10.2307/1269417; Rose K, 2002, J CHEM INF COMP SCI, V42, P651, DOI 10.1021/ci010127n; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sakata A, 2007, IMMUNOLOGY, V122, P54, DOI 10.1111/j.1365-2567.2007.02612.x; SAKURAGAWA N, 1977, SCIENCE, V196, P317, DOI 10.1126/science.66749; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Scholz M., 2006, P 12 ACM SIGKDD INT, P935, DOI [10.1145/1150402.1150531, DOI 10.1145/1150402.1150531]; Schuchman EH, 1997, GENET TEST, V1, P13, DOI 10.1089/gte.1997.1.13; Schwarz A, 1997, J NEUROSCI, V17, P2929; Schwarz E, 2008, J PROTEOME RES, V7, P4266, DOI 10.1021/pr800188y; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Spiegel S, 1998, ANN NY ACAD SCI, V845, P11, DOI 10.1111/j.1749-6632.1998.tb09658.x; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Streiner DL, 2002, CAN J PSYCHIAT, V47, P262, DOI 10.1177/070674370204700307; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Testai FD, 2004, J NEUROCHEM, V89, P636, DOI 10.1046/j.1471-4159.2004.02374.x; Thevissen K, 2006, MINI-REV MED CHEM, V6, P699, DOI 10.2174/138955706777435643; Todeschini R., 2008, HDB MOL DESCRIPTORS; Toman RE, 2004, J CELL BIOL, V166, P381, DOI 10.1083/jcb.200402016; Trapp S, 2008, EUR BIOPHYS J BIOPHY, V37, P1317, DOI 10.1007/s00249-008-0338-4; Tropsha A, 2003, QSAR COMB SCI, V22, P69, DOI 10.1002/qsar.200390007; VANDERVOET H, 1994, CHEMOMETR INTELL LAB, V25, P313, DOI 10.1016/0169-7439(94)85050-X; VANVELDHOVEN PP, 1992, BIOCHEM BIOPH RES CO, V187, P209, DOI 10.1016/S0006-291X(05)81480-9; Vilar S, 2010, J MOL GRAPH MODEL, V28, P899, DOI 10.1016/j.jmgm.2010.03.010; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Willett P, 2006, DRUG DISCOV TODAY, V11, P1046, DOI 10.1016/j.drudis.2006.10.005; Williams C, 2006, MOL DIVERS, V10, P311, DOI 10.1007/s11030-006-9039-z; WITTEN IH, 2005, DATA MINING PRACTICA; Wold S, 1995, CHEMOMETRIC METHODS, P309; YOSHIDA Y, 1985, J BIOCHEM-TOKYO, V98, P1669, DOI 10.1093/oxfordjournals.jbchem.a135438; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Yu ZF, 2000, J MOL NEUROSCI, V15, P85, DOI 10.1385/JMN:15:2:85; Zerara M, 2009, J COMPUT AID MOL DES, V23, P105, DOI 10.1007/s10822-008-9243-2; Zhang LY, 2008, PHARM RES-DORDR, V25, P1902, DOI 10.1007/s11095-008-9609-0; Zhou Z.H., 2009, ENCY BIOMETRICS, P270, DOI [10.1007/978-0-387-73003-5_293, DOI 10.1007/978-0-387-73003-5_293]	132	105	107	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23852	10.1371/journal.pone.0023852	http://dx.doi.org/10.1371/journal.pone.0023852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909365	gold, Green Published			2022-12-25	WOS:000294680800027
J	Laatikainen, LE; Incoronato, M; Castellone, MD; Laurila, JP; Santoro, M; Laukkanen, MO				Laatikainen, Lilja E.; Incoronato, Mariarosaria; Castellone, Maria Domenica; Laurila, Juha P.; Santoro, Massimo; Laukkanen, Mikko O.			SOD3 Decreases Ischemic Injury Derived Apoptosis through Phosphorylation of Erk1/2, Akt, and FoxO3a	PLOS ONE			English	Article							EXTRACELLULAR-SUPEROXIDE DISMUTASE; FORKHEAD TRANSCRIPTION FACTOR; OXIDATIVE STRESS; CELL-SURVIVAL; PATHWAY; DISEASE; DAMAGE; EXPRESSION; MICE; BIM	Background: Extracellular superoxide dismutase (SOD3), which dismutates superoxide anion to hydrogen peroxide, has been shown to reduce the free radical stress derived apoptosis in tissue injuries. Since both superoxide anion and hydrogen peroxide have a marked impact on signal transduction pathways and could potentially explain a number of apoptosis and survival -related phenomena in different pathological conditions, we clarified the impact of SOD3 on Akt and Erk1/2 cell survival pathways in rat hind limb injury model. Methodology and Principal Findings: Based on our data, the hind limb ischemic rats treated with virally delivered sod3 have milder injury and less apoptosis than control animals that could be due to parallel activation of pro-proliferative and anti-apoptotic Erk1/2 and Akt pathways. The common downstream factor of both signaling pathways, the apoptosis related forkhead box protein O3a (FoxO3a), was phosphorylated and translocated to the cytoplasm in sod3 treated tissues and cell line. Additionally, we obtained increased mRNA production of elk-1, ets-1, and microRNA 21 (miR-21), whereas synthesis of bim mRNA was decreased in sod3 overexpressing tissues. We further showed that overexpression of sod3 modulated redox related gene expression by downregulating nox2 and inos when compared to injured control animals. Conclusions and Significance: The study shows the complexity of SOD3-derived effects on tissue injury recovery that are not limited to the reduction of superoxide anion caused cellular stress but highlights the impact of SOD3 related signal transduction on tissue functions and suggests an important role for SOD3 in attenuating cell stress effects in different pathological conditions.	[Laatikainen, Lilja E.; Laurila, Juha P.; Laukkanen, Mikko O.] Univ Turku, Med Res Lab, Turku, Finland; [Incoronato, Mariarosaria; Laukkanen, Mikko O.] Fdn IRCCS SDN, Naples, Italy; [Castellone, Maria Domenica; Santoro, Massimo] Univ Naples Federico 2, Dept Biol & Cellular & Mol Pathol, Inst Expt Endocrinol & Oncol CNR, Naples, Italy	University of Turku; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); University of Naples Federico II	Laatikainen, LE (corresponding author), Univ Turku, Med Res Lab, Turku, Finland.	mikko.laukkanen@utu.fi	Incoronato, Mariarosaria/K-8727-2016; Incoronato, Mariarosaria/AAA-7541-2021; Laukkanen, Mikko/K-5868-2016	Incoronato, Mariarosaria/0000-0001-7019-0581; Incoronato, Mariarosaria/0000-0001-7019-0581; CASTELLONE, MARIADOMENICA/0000-0003-0507-8037; Laukkanen, Mikko/0000-0002-1004-7131	Fondazione SDN [RC2010-M-0001]; Academy of Finland [141136]	Fondazione SDN; Academy of Finland(Academy of Finland)	This work was supported by Fondazione SDN (decision number RC2010-M-0001, http://www.sdn-napoli.it/) and Academy of Finland (decision number 141136, http://www.aka.fi/en-GB/A/Centres-of-Excellence-/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Biswas SC, 2002, J BIOL CHEM, V277, P49511, DOI 10.1074/jbc.M208086200; Brandes RP, 2010, FREE RADICAL BIO MED, V49, P687, DOI 10.1016/j.freeradbiomed.2010.04.030; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Folz RJ, 1999, J CLIN INVEST, V103, P1055, DOI 10.1172/JCI3816; FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Gao YM, 2008, J APPL PHYSIOL, V105, P1772, DOI 10.1152/japplphysiol.90636.2008; Hu YY, 2005, MOL BIOL CELL, V16, P3705, DOI 10.1091/mbc.E05-04-0301; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; KARLSSON K, 1994, LAB INVEST, V70, P705; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Landmesser U, 2000, CIRCULATION, V101, P2264, DOI 10.1161/01.CIR.101.19.2264; Laukkanen MO, 2002, CIRCULATION, V106, P1999, DOI 10.1161/01.CIR.0000031331.05368.9D; Laukkanen MO, 2001, J GENE MED, V3, P321, DOI 10.1002/jgm.194; Laurila JP, 2009, MOL THER, V17, P448, DOI 10.1038/mt.2008.282; Laurila JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005786; Lee HY, 2008, ARTERIOSCL THROM VAS, V28, P302, DOI 10.1161/ATVBAHA.107.150664; Lei H, 2009, MOL CANCER RES, V7, P1294, DOI 10.1158/1541-7786.MCR-08-0531; Leite PF, 2003, ARTERIOSCL THROM VAS, V23, P2197, DOI 10.1161/01.ATV.0000093980.46838.41; Liu JW, 2005, ONCOGENE, V24, P2020, DOI 10.1038/sj.onc.1208385; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; Oshikawa J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010189; Ozumi K, 2005, ATHEROSCLEROSIS, V181, P55, DOI 10.1016/j.atherosclerosis.2005.01.051; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Qin Z, 2008, TRANSL RES, V151, P68, DOI 10.1016/j.trsl.2007.10.003; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Wang K, 2010, J BIOL CHEM, V285, P16958, DOI 10.1074/jbc.M109.093005; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; YOUNES M, 1984, RES EXP MED, V184, P259, DOI 10.1007/BF01852385	35	26	34	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24456	10.1371/journal.pone.0024456	http://dx.doi.org/10.1371/journal.pone.0024456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909393	gold, Green Submitted, Green Published			2022-12-25	WOS:000294680800090
J	Mortier, A; Berghmans, N; Ronsse, I; Grauwen, K; Stegen, S; Van Damme, J; Proost, P				Mortier, Anneleen; Berghmans, Nele; Ronsse, Isabelle; Grauwen, Karolien; Stegen, Steve; Van Damme, Jo; Proost, Paul			Biological Activity of CXCL8 Forms Generated by Alternative Cleavage of the Signal Peptide or by Aminopeptidase-Mediated Truncation	PLOS ONE			English	Article							NEUTROPHIL CHEMOTACTIC FACTOR; PLATELET BASIC-PROTEIN; POSTTRANSLATIONAL MODIFICATION; BETA-THROMBOGLOBULIN; TERMINAL SEQUENCE; RECEPTOR-BINDING; HOST-DEFENSE; INTERLEUKIN-8; CHEMOKINES; CELLS	Background: Posttranslational modification of chemokines is one of the mechanisms that regulate leukocyte migration during inflammation. Multiple natural NH(2)-terminally truncated forms of the major human neutrophil attractant interleukin-8 or CXCL8 have been identified. Although differential activity was reported for some CXCL8 forms, no biological data are available for others. Methodology/Principal Findings: Aminopeptidase-cleaved CXCL8(2-77) and CXCL8(3-77), the product of alternative cleavage of the signal peptide CXCL8(-2-77) and the previously studied forms containing 77 and 72 amino acids, CXCL8(1-77) and CXCL8(6-77), were prepared by solid-phase peptide synthesis, purified and folded into active proteins. No differences in binding and calcium signaling potency were detected between CXCL8(1-77), CXCL8(-2-77), CXCL8(2-77) and CXCL8(3-77) on cells transfected with one of the human CXCL8 receptors, i.e. CXCR1 and CXCR2. However, CXCL8(-2-77) was more potent compared to CXCL8(1-77), CXCL8(2-77) and CXCL8(3-77) in signaling and in vitro chemotaxis of peripheral blood-derived human neutrophils. Moreover, CXCL8(-2-77) was less efficiently processed by plasmin into the more potent CXCL8(6-77). The truncated forms CXCL8(2-77) and CXCL8(3-77) had higher affinity for heparin than CXCL8(1-77), a property important for the presentation of CXCL8 on endothelial layers. Upon intraperitoneal injection in mice, elongated, truncated and intact CXCL8 were equally potent to recruit neutrophils to the peritoneal cavity. Conclusions: In terms of their ability to induce neutrophil recruitment in vivo, the multiple CXCL8 forms may be divided in three groups. The first group includes CXCL8 proteins consisting of 75 to 79 amino acids, cleaved by aminopeptidases, with intermediate activity on neutrophils. The second group, generated through proteolytic cleavage (e. g. by Ser proteases), contains 69 to 72 amino acid forms which are highly potent neutrophil attractants in vivo. A third category is generated through the modification of the arginine in the NH(2)-terminal region into citrulline by peptidylarginine deiminases and has weak potency to induce neutrophil extravasation.	[Mortier, Anneleen; Berghmans, Nele; Ronsse, Isabelle; Grauwen, Karolien; Stegen, Steve; Van Damme, Jo; Proost, Paul] Katholieke Univ Leuven, Lab Mol Immunol, Dept Microbiol & Immunol, Rega Inst, Louvain, Belgium	KU Leuven	Mortier, A (corresponding author), Katholieke Univ Leuven, Lab Mol Immunol, Dept Microbiol & Immunol, Rega Inst, Louvain, Belgium.	paul.proost@rega.kuleuven.be	Proost, Paul/V-3052-2017	Proost, Paul/0000-0002-0133-5545; Mortier, Anneleen/0000-0002-9662-674X; Stegen, Steve/0000-0002-4471-6401; Van Damme, Jo/0000-0002-6707-1167	Center of Excellence of the K. U. Leuven [EF/05/15]; Concerted Research Actions of the Regional Government of Flanders [G.O.A./2007/15]; Fund for Scientific Research of Flanders (F.W.O.- Vlaanderen); Interuniversity Attraction Poles Program-Belgian Science Policy	Center of Excellence of the K. U. Leuven; Concerted Research Actions of the Regional Government of Flanders; Fund for Scientific Research of Flanders (F.W.O.- Vlaanderen)(FWO); Interuniversity Attraction Poles Program-Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported by the Center of Excellence (credit no. EF/05/15) of the K. U. Leuven, the Concerted Research Actions (G.O.A./2007/15) of the Regional Government of Flanders, the Fund for Scientific Research of Flanders (F.W.O.- Vlaanderen) and the Interuniversity Attraction Poles Program-Belgian Science Policy. A. M. is a research assistant from the Fund for Scientific Research of Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENBARUCH A, 1995, J BIOL CHEM, V270, P9121, DOI 10.1074/jbc.270.16.9121; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; GIMBRONE MA, 1989, SCIENCE, V246, P1601, DOI 10.1126/science.2688092; HEBERT CA, 1991, J BIOL CHEM, V266, P18989; HEBERT CA, 1990, J IMMUNOL, V145, P3033; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Loos T, 2009, HAEMATOL-HEMATOL J, V94, P1346, DOI 10.3324/haematol.2009.006973; Loos T, 2009, METHOD ENZYMOL, V461, P3, DOI 10.1016/S0076-6879(09)05401-9; Mortier A, 2010, J BIOL CHEM, V285, P29750, DOI 10.1074/jbc.M110.119388; Mortier A, 2008, PHARMACOL THERAPEUT, V120, P197, DOI 10.1016/j.pharmthera.2008.08.006; NAKAGAWA H, 1991, FEBS LETT, V282, P412, DOI 10.1016/0014-5793(91)80526-9; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Proost P, 2008, J EXP MED, V205, P2085, DOI 10.1084/jem.20080305; Proost P, 2007, BLOOD, V110, P37, DOI 10.1182/blood-2006-10-049072; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; SCHRODER JM, 1989, J IMMUNOL, V142, P244; SCHRODER JM, 1990, J IMMUNOL, V144, P2223; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; SNYDERMAN R, 1984, ANNU REV IMMUNOL, V2, P257, DOI 10.1146/annurev.immunol.2.1.257; Van den Steen PE, 2003, EUR J BIOCHEM, V270, P3739, DOI 10.1046/j.1432-1033.2003.03760.x; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; VANDAMME J, 1990, EUR J IMMUNOL, V20, P2113, DOI 10.1002/eji.1830200933; VANDAMME J, 1989, EUR J BIOCHEM, V181, P337; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WALZ A, 1989, J EXP MED, V170, P1745, DOI 10.1084/jem.170.5.1745; WALZ A, 1990, J EXP MED, V171, P449, DOI 10.1084/jem.171.2.449; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005; Wuyts A, 1998, EUR J BIOCHEM, V255, P67, DOI 10.1046/j.1432-1327.1998.2550067.x; Wuyts Anja, 1998, P271; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233; YOSHIMURA T, 1989, MOL IMMUNOL, V26, P87	32	22	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23913	10.1371/journal.pone.0023913	http://dx.doi.org/10.1371/journal.pone.0023913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904597	Green Published, Green Submitted, gold			2022-12-25	WOS:000294680800040
J	Fuchikami, M; Morinobu, S; Segawa, M; Okamoto, Y; Yamawaki, S; Ozaki, N; Inoue, T; Kusumi, I; Koyama, T; Tsuchiyama, K; Terao, T				Fuchikami, Manabu; Morinobu, Shigeru; Segawa, Masahiro; Okamoto, Yasumasa; Yamawaki, Shigeto; Ozaki, Norio; Inoue, Takeshi; Kusumi, Ichiro; Koyama, Tsukasa; Tsuchiyama, Kounosuke; Terao, Takeshi			DNA Methylation Profiles of the Brain-Derived Neurotrophic Factor (BDNF) Gene as a Potent Diagnostic Biomarker in Major Depression	PLOS ONE			English	Article							LABORATORY TEST; VALIDATION; PREVALENCE; BURDEN; CANCER; MINI	Major depression, because of its recurring and life-threatening nature, is one of the top 10 diseases for global disease burden. Major depression is still diagnosed on the basis of clinical symptoms in patients. The search for specific biological markers is of great importance to advance the method of diagnosis for depression. We examined the methylation profile of 2 CpG islands (I and IV) at the promoters of the brain-derived neurotrophic factor (BDNF) gene, which is well known to be involved in the pathophysiology of depression. We analyzed genomic DNA from peripheral blood of 20 Japanese patients with major depression and 18 healthy controls to identify an appropriate epigenetic biomarker to aid in the establishment of an objective system for the diagnosis of depression. Methylation rates at each CpG unit was measured using a MassArray (R) system (SEQUENOM), and 2-dimensional hierarchical clustering analyses were undertaken to determine the validity of these methylation profiles as a diagnostic biomarker. Analyses of the dendrogram from methylation profiles of CpG I, but not IV, demonstrated that classification of healthy controls and patients at the first branch completely matched the clinical diagnosis. Despite the small number of subjects, our results indicate that classification based on the DNA methylation profiles of CpG I of the BDNF gene may be a valuable diagnostic biomarker for major depression.	[Fuchikami, Manabu; Morinobu, Shigeru; Segawa, Masahiro; Okamoto, Yasumasa; Yamawaki, Shigeto] Hiroshima Univ, Grad Sch Med Sci, Div Frontier Med, Dept Psychiat & Neurosci, Hiroshima, Japan; [Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat & Mol Psychiat, Nagoya, Aichi 4648601, Japan; [Inoue, Takeshi; Kusumi, Ichiro; Koyama, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan; [Tsuchiyama, Kounosuke; Terao, Takeshi] Oita Univ, Fac Med, Dept Neuropsychiat, Oita 87011, Japan	Hiroshima University; Nagoya University; Hokkaido University; Oita University	Fuchikami, M (corresponding author), Hiroshima Univ, Grad Sch Med Sci, Div Frontier Med, Dept Psychiat & Neurosci, Hiroshima, Japan.	smoriob@hiroshima-u.ac.jp	Kusumi, Ichiro/A-4067-2012; Inoue, Takeshi/D-7431-2012; Inoue, Takeshi/X-8057-2019; Ozaki, Norio/M-8908-2014	Inoue, Takeshi/0000-0001-5248-1289; Ozaki, Norio/0000-0002-7360-4898	Ministry of Education, Science, and Culture of Japan; Ministry of Health and Welfare of Japan; Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology (JST)	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This study was supported by a grant-in-aid for general scientific research from the Ministry of Education, Science, and Culture of Japan, a Health Science Research Grant for Research on Brain Science from the Ministry of Health and Welfare of Japan, and a grant from Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARROLL BJ, 1982, BRIT J PSYCHIAT, V140, P292, DOI 10.1192/bjp.140.3.292; CARROLL BJ, 1981, ARCH GEN PSYCHIAT, V38, P15; Chang SM, 2008, J AFFECT DISORDERS, V106, P159, DOI 10.1016/j.jad.2007.07.023; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chertkow Y, 2007, PROG NEURO-PSYCHOPH, V31, P1356, DOI 10.1016/j.pnpbp.2007.04.016; Delgado M Dolore, 2006, Clin Transl Oncol, V8, P780; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; Hashimoto K, 2010, PSYCHIAT CLIN NEUROS, V64, P341, DOI 10.1111/j.1440-1819.2010.02113.x; HEUSER I, 1994, J PSYCHIAT RES, V28, P341, DOI 10.1016/0022-3956(94)90017-5; Keller S, 2010, ARCH GEN PSYCHIAT, V67, P258, DOI 10.1001/archgenpsychiatry.2010.9; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Moner R, 2007, WORLD J BIOL PSYCHIA, V8, P141, DOI 10.1080/15622970701263303; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Rutten BPF, 2009, SCHIZOPHRENIA BULL, V35, P1045, DOI 10.1093/schbul/sbp104; Salisbury BA, 2003, MUTAT RES-FUND MOL M, V526, P53, DOI 10.1016/S0027-5107(03)00014-9; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Sengupta PK, 1998, BBA-GENE STRUCT EXPR, V1443, P75, DOI 10.1016/S0167-4781(98)00188-2; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Simon GE, 2004, AM J PSYCHIAT, V161, P1626, DOI 10.1176/appi.ajp.161.9.1626; Simon GE, 2002, PSYCHOL MED, V32, P585, DOI 10.1017/S0033291702005457; Simon R, 2005, J CLIN ONCOL, V23, P7332, DOI 10.1200/JCO.2005.02.8712; Tost J, 2010, MOL BIOTECHNOL, V44, P71, DOI 10.1007/s12033-009-9216-2; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; van Vliet J, 2007, CELL MOL LIFE SCI, V64, P1531, DOI 10.1007/s00018-007-6526-z; WEISSMAN MM, 1992, JAMA-J AM MED ASSOC, V268, P3098, DOI 10.1001/jama.1992.03490210080039; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Yasuda S, 2009, MOL PSYCHIATR, V14, P51, DOI 10.1038/sj.mp.4002099; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	32	246	263	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e23881	10.1371/journal.pone.0023881	http://dx.doi.org/10.1371/journal.pone.0023881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912609	gold, Green Published, Green Submitted			2022-12-25	WOS:000294678300012
J	Garrels, W; Mates, L; Holler, S; Dalda, A; Taylor, U; Petersen, B; Niemann, H; Izsvak, Z; Ivics, Z; Kues, WA				Garrels, Wiebke; Mates, Lajos; Holler, Stephanie; Dalda, Anna; Taylor, Ulrike; Petersen, Bjoern; Niemann, Heiner; Izsvak, Zsuzsanna; Ivics, Zoltan; Kues, Wilfried A.			Germline Transgenic Pigs by Sleeping Beauty Transposition in Porcine Zygotes and Targeted Integration in the Pig Genome	PLOS ONE			English	Article							LARGE ANIMAL-MODEL; FARM-ANIMALS; EFFICIENT TRANSGENESIS; LINE TRANSGENESIS; GENE INSERTION; SWINE MODEL; MICE; VERTEBRATES; CELLS; DNA	Genetic engineering can expand the utility of pigs for modeling human diseases, and for developing advanced therapeutic approaches. However, the inefficient production of transgenic pigs represents a technological bottleneck. Here, we assessed the hyperactive Sleeping Beauty (SB100X) transposon system for enzyme-catalyzed transgene integration into the embryonic porcine genome. The components of the transposon vector system were microinjected as circular plasmids into the cytoplasm of porcine zygotes, resulting in high frequencies of transgenic fetuses and piglets. The transgenic animals showed normal development and persistent reporter gene expression for >12 months. Molecular hallmarks of transposition were confirmed by analysis of 25 genomic insertion sites. We demonstrate germ-line transmission, segregation of individual transposons, and continued, copy number-dependent transgene expression in F1-offspring. In addition, we demonstrate target-selected gene insertion into transposon-tagged genomic loci by Cre-loxP-based cassette exchange in somatic cells followed by nuclear transfer. Transposase-catalyzed transgenesis in a large mammalian species expands the arsenal of transgenic technologies for use in domestic animals and will facilitate the development of large animal models for human diseases.	[Garrels, Wiebke; Holler, Stephanie; Taylor, Ulrike; Petersen, Bjoern; Niemann, Heiner; Kues, Wilfried A.] Friedrich Loeffler Inst, Inst Nutztiergenet, Neustadt, Germany; [Mates, Lajos; Dalda, Anna; Izsvak, Zsuzsanna; Ivics, Zoltan] Max Delbruck Ctr Mol Med, Berlin, Germany; [Izsvak, Zsuzsanna; Ivics, Zoltan] Univ Debrecen, Debrecen, Hungary	Friedrich Loeffler Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Debrecen	Garrels, W (corresponding author), Friedrich Loeffler Inst, Inst Nutztiergenet, Neustadt, Germany.	zivics@mdc-berlin.de; wilfried.kues@fli.bund.de	Kues, Wilfried/D-9232-2011; Petersen, Bjoern/AAU-2842-2021; Kues, Wilfried/AAX-2466-2020; Petersen, Björn/I-2433-2019	Kues, Wilfried/0000-0002-0850-8103; Petersen, BJoern/0000-0002-1532-4863; Mates, Lajos/0000-0002-0058-470X	EU; Deutsche Forschungsgemeinschaft [KU 1586/2-1, IV 21\6-1]; Bundesministerium fur Bildung und Forschung [NGFN-2, NGFNplus - ENGINE]	EU(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work has been supported by EU FP6 (INTHER), and grants from the Deutsche Forschungsgemeinschaft (KU 1586/2-1 and IV 21\6-1), and from the Bundesministerium fur Bildung und Forschung (NGFN-2 and NGFNplus - ENGINE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Carlson DF, 2011, TRANSGENIC RES, V20, P29, DOI 10.1007/s11248-010-9386-5; CARLSON DF, 2011, TRANSGENIC RES  0109, DOI DOI 10.1007/S1248-010-9481-7; Choi SK, 2009, J REPROD DEVELOP, V55, P128; Clark KJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S13; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Du ZQ, 2007, INT J CANCER, V120, P303, DOI 10.1002/ijc.22289; Dupuy AJ, 2002, P NATL ACAD SCI USA, V99, P4495, DOI 10.1073/pnas.062630599; Dyson M., 2006, TRANSPLANT REV, V21, P54; Fritscher-Ravens A, 2008, ENDOSCOPY, V40, P925, DOI 10.1055/s-2008-1077732; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Graham JS, 2000, J APPL TOXICOL, V21, pS161; Hackett CS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S12; Hamlet MRJ, 2006, GENESIS, V44, P438, DOI 10.1002/dvg.20234; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Hofmann A, 2006, MOL THER, V13, P59, DOI 10.1016/j.ymthe.2005.07.685; Hofmann A, 2003, EMBO REP, V4, P1054, DOI 10.1038/sj.embor.7400007; Iqbal K, 2009, BIOTECHNIQUES, V47, P959, DOI 10.2144/000113270; Ishii A, 2006, AM J NEURORADIOL, V27, P1893; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2009, NAT METHODS, V6, P415, DOI [10.1038/NMETH.1332, 10.1038/nmeth.1332]; IZSVAK Z, 2010, NAT METHODS; Jakobsen JE, 2011, TRANSGENIC RES, V20, P533, DOI 10.1007/s11248-010-9438-x; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Kawarasaki T, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3241985; Kragh PM, 2009, TRANSGENIC RES, V18, P545, DOI 10.1007/s11248-009-9245-4; Kues WA, 2004, TRENDS BIOTECHNOL, V22, P286, DOI 10.1016/j.tibtech.2004.04.003; Kues WA, 2006, FASEB J, V20, P1200, DOI 10.1096/fj.05-5415fje; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Mates L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S1; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Niemann H, 2007, REPROD FERT DEVELOP, V19, P762, DOI 10.1071/RD07040; NOWAKIMIALEK M, 2011, STEM CELL DEV   0112; Petters RM, 1997, NAT BIOTECHNOL, V15, P965, DOI 10.1038/nbt1097-965; Prather RS, 2008, BIOTECHNOL GENET ENG, V25, P245; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Sasakura Y, 2003, P NATL ACAD SCI USA, V100, P7726, DOI 10.1073/pnas.1230736100; Sauvain MO, 2008, J VIROL, V82, P7111, DOI 10.1128/JVI.00623-08; Sinzelle L, 2006, TRANSGENIC RES, V15, P751, DOI 10.1007/s11248-006-9014-6; Sumiyama K, 2010, GENOMICS, V95, P306, DOI 10.1016/j.ygeno.2010.02.006; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Towbin BD, 2009, CURR OPIN GENET DEV, V19, P180, DOI 10.1016/j.gde.2009.01.006; Turk JR, 2004, CAN J APPL PHYSIOL, V29, P657, DOI 10.1139/h04-042; Umeyama K, 2009, TRANSGENIC RES, V18, P697, DOI 10.1007/s11248-009-9262-3; Wako T, 2010, CYTOGENET GENOME RES, V129, P55, DOI 10.1159/000314639; Whitelaw CBA, 2004, FEBS LETT, V571, P233, DOI 10.1016/j.febslet.2004.06.076; Wilber A, 2006, MOL THER, V13, P625, DOI 10.1016/j.ymthe.2005.10.014; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005	51	92	97	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23573	10.1371/journal.pone.0023573	http://dx.doi.org/10.1371/journal.pone.0023573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897845	Green Published, gold, Green Accepted			2022-12-25	WOS:000294676900008
J	Oh, YS; Shin, S; Lee, YJ; Kim, EH; Jun, HS				Oh, Yoon Sin; Shin, Seungjin; Lee, Youn-Jung; Kim, Eung Hwi; Jun, Hee-Sook			Betacellulin-Induced Beta Cell Proliferation and Regeneration Is Mediated by Activation of ErbB-1 and ErbB-2 Receptors	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; INSULIN-SECRETING CELLS; DIABETIC MICE; CARDIAC DEVELOPMENT; UP-REGULATION; EGF RECEPTOR; AR42J CELLS; DIFFERENTIATION; EXPRESSION; NEOGENESIS	Background: Betacellulin (BTC), a member of the epidermal growth factor family, is known to play an important role in regulating growth and differentiation of pancreatic beta cells. Growth-promoting actions of BTC are mediated by epidermal growth factor receptors (ErbBs), namely ErbB-1, ErbB-2, ErbB-3 and ErbB-4; however, the exact mechanism for beta cell proliferation has not been elucidated. Therefore, we investigated which ErbBs are involved and some molecular mechanisms by which BTC regulates beta cell proliferation. Methodology/Principal Findings: The expression of ErbB-1, ErbB-2, ErbB-3, and ErbB-4 mRNA was detected by RT-PCR in both a beta cell line (MIN-6 cells) and C57BL/6 mouse islets. Immunoprecipitation and western blotting analysis showed that BTC treatment of MIN-6 cells induced phosphorylation of only ErbB-1 and ErbB-2 among the four EGF receptors. BTC treatment resulted in DNA synthetic activity, cell cycle progression, and bromodeoxyuridine (BrdU)-positive staining. The proliferative effect was blocked by treatment with AG1478 or AG825, specific tyrosine kinase inhibitors of ErbB-1 and ErbB-2, respectively. BTC treatment increased mRNA and protein levels of insulin receptor substrate-2 (IRS-2), and this was blocked by the ErbB-1 and ErbB-2 inhibitors. Inhibition of IRS-2 by siRNA blocked cell cycle progression induced by BTC treatment. Streptozotocin-induced diabetic mice injected with a recombinant adenovirus expressing BTC and treated with AG1478 or AG825 showed reduced islet size, reduced numbers of BrdU-positive cells in the islets, and did not attain BTC-mediated remission of diabetes. Conclusions/Significance: These results suggest that BTC exerts proliferative activity on beta cells through the activation of ErbB-1 and ErbB-2 receptors, which may increase IRS-2 expression, contributing to the regeneration of beta cells.	[Oh, Yoon Sin; Lee, Youn-Jung; Kim, Eung Hwi; Jun, Hee-Sook] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea; [Shin, Seungjin] Northwestern Univ, Evanston, IL USA; [Jun, Hee-Sook] Gachon Univ Med & Sci, Coll Pharm, Inchon, South Korea	Gachon University; Northwestern University; Gachon University	Oh, YS (corresponding author), Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea.	hsjeon@gachon.ac.kr	오, 윤신/AAS-2225-2020	Jun, Hee-Sook/0000-0002-1166-4932; Oh, Yoon Sin/0000-0003-3995-4429	National Research Foundation of Korea (NRF); Korea government (MEST) [2009-0079342]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by the grants from National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (NO. 2009-0079342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; BONNERWEIR S, 1994, RECENT PROG HORM RES, V49, P91; Brand SJ, 2002, PHARMACOL TOXICOL, V91, P414, DOI 10.1034/j.1600-0773.2002.910621.x; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Dahlhoff M, 2009, MOL CELL ENDOCRINOL, V299, P188, DOI 10.1016/j.mce.2008.11.022; Dunbar AJ, 2000, INT J BIOCHEM CELL B, V32, P805, DOI 10.1016/S1357-2725(00)00028-5; Erickson SL, 1997, DEVELOPMENT, V124, P4999; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Genetos DC, 2010, CELL TISSUE RES, V340, P81, DOI 10.1007/s00441-010-0929-0; Grzech M, 2010, MOL CELL ENDOCRINOL, V315, P219, DOI 10.1016/j.mce.2009.08.001; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Huotari MA, 1998, ENDOCRINOLOGY, V139, P1494, DOI 10.1210/en.139.4.1494; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Johns TG, 2003, P NATL ACAD SCI USA, V100, P15871, DOI 10.1073/pnas.2036503100; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kritzik MR, 2000, J ENDOCRINOL, V165, P67, DOI 10.1677/joe.0.1650067; Kuntz E, 2005, GROWTH FACTORS, V23, P285, DOI 10.1080/08977190500233367; Lee HY, 2008, J CELL MOL MED, V12, P1593, DOI 10.1111/j.1582-4934.2007.00169.x; Lee HK, 2008, KOREAN J PHYSIOL PHA, V12, P281, DOI 10.4196/kjpp.2008.12.5.281; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Li L, 2001, ENDOCRINOLOGY, V142, P5379, DOI 10.1210/en.142.12.5379; Liu MJ, 2007, MOL THER, V15, P86, DOI 10.1038/sj.mt.6300005; Mashima H, 1996, J CLIN INVEST, V97, P1647, DOI 10.1172/JCI118591; Miettinen PJ, 2000, DEVELOPMENT, V127, P2617; Nagaoka T, 2008, J MOL BIOL, V380, P83, DOI 10.1016/j.jmb.2008.03.054; Perry JE, 1998, PROSTATE, V35, P117; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sarkar SA, 2007, DIABETOLOGIA, V50, P1649, DOI 10.1007/s00125-007-0707-z; SASADA R, 1993, BIOCHEM BIOPH RES CO, V190, P1173, DOI 10.1006/bbrc.1993.1173; Seno M, 1996, GROWTH FACTORS, V13, P181, DOI 10.3109/08977199609003220; Shin HS, 2003, CIRC RES, V93, P302, DOI 10.1161/01.RES.0000086803.64109.9E; Shin S, 2008, MOL THER, V16, P854, DOI 10.1038/mt.2008.22; SHING Y, 1993, SCIENCE, V259, P1604, DOI 10.1126/science.8456283; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Suarez-Pinzon WL, 2005, J CLIN ENDOCR METAB, V90, P3401, DOI 10.1210/jc.2004-0761; Sundaresan S, 1998, ENDOCRINOLOGY, V139, P4756, DOI 10.1210/en.139.12.4756; Tokui Y, 2006, BIOCHEM BIOPH RES CO, V350, P987, DOI 10.1016/j.bbrc.2006.09.154; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yamamoto K, 2000, DIABETES, V49, P2021, DOI 10.2337/diabetes.49.12.2021; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhan XR, 2009, BIOCHEM BIOPH RES CO, V382, P375, DOI 10.1016/j.bbrc.2009.03.029	44	41	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e23894	10.1371/journal.pone.0023894	http://dx.doi.org/10.1371/journal.pone.0023894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897861	Green Submitted, Green Published, gold			2022-12-25	WOS:000294676900025
J	Urbanucci, A; Sahu, B; Seppala, J; Larjo, A; Latonen, LM; Waltering, KK; Tammela, TLJ; Vessella, RL; Lahdesmaki, H; Janne, OA; Visakorpi, T				Urbanucci, A.; Sahu, B.; Seppala, J.; Larjo, A.; Latonen, L. M.; Waltering, K. K.; Tammela, T. L. J.; Vessella, R. L.; Lahdesmaki, H.; Janne, O. A.; Visakorpi, T.			Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer	ONCOGENE			English	Article						prostatic neoplasia; AR; ChIP-seq; FEN1; SKP2; ZWINT	RESPONSE ELEMENT; TRANSCRIPTION; GENE; PROLIFERATION; AMPLIFICATION; ANTIANDROGEN; PROGRESSION; EXPRESSION; CASTRATION; NETWORK	Androgen receptor (AR) is overexpressed in the majority of castration-resistant prostate cancers (CRPCs). Our goal was to study the effect of AR overexpression on the chromatin binding of the receptor and to identify AR target genes that may be important in the emergence of CRPC. We have established two sublines of LNCaP prostate cancer (PC) cell line, one overexpressing AR 2-3-fold and the other 4-5-fold compared with the control cells. We used chromatin immunoprecipitation (ChIP) and deep-sequencing (seq) to identify AR-binding sites (ARBSs). We found that the number of ARBSs and the AR-binding strength were positively associated with the level of AR when cells were stimulated with low concentrations of androgens. In cells overexpressing AR, the chromatin binding of the receptor took place in 100-fold lower concentration of the ligand than in control cells. We confirmed the association of AR level and chromatin binding in two PC xenografts, one containing AR gene amplification with high AR expression, and the other with low expression. By combining the ChIP-seq and expression profiling, we identified AR target genes that are upregulated in PC. Of them, the expression of ZWINT, SKP2 (S-phase kinase-associated protein 2 (p45)) and FEN1 (flap structure-specific endonuclease 1) was demonstrated to be increased in CRPC, while the expression of SNAI2 was decreased in both PC and CRPC. FEN1 protein expression was also associated with poor prognosis in prostatectomy-treated patients. Finally, the knock-down of FEN1 with small interfering RNA inhibited the growth of LNCaP cells. Our data demonstrate that the overexpression of AR sensitizes the receptor binding to chromatin, thus, explaining how AR signaling pathway is reactivated in CRPC cells. Oncogene (2012) 31, 2153-2163; doi:10.1038/onc.2011.401; published online 12 September 2011	[Urbanucci, A.; Latonen, L. M.; Waltering, K. K.; Visakorpi, T.] Univ Tampere, Inst Biomed Technol, FIN-33014 Tampere, Finland; [Urbanucci, A.; Latonen, L. M.; Waltering, K. K.; Tammela, T. L. J.; Visakorpi, T.] Tampere Univ Hosp, Tampere, Finland; [Sahu, B.; Janne, O. A.] Univ Helsinki, Inst Biomed Physiol, Biomedicum Helsinki, Helsinki, Finland; [Seppala, J.; Larjo, A.] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Tammela, T. L. J.] Univ Tampere, Dept Urol, FIN-33014 Tampere, Finland; [Vessella, R. L.] Univ Washington, Med Ctr, Dept Urol, NE Pacific, Seattle, WA 98195 USA; [Lahdesmaki, H.] Aalto Univ, Sch Sci & Technol, Dept Informat & Comp Sci, Helsinki, Finland	Tampere University; Tampere University; Tampere University Hospital; University of Helsinki; Tampere University; Tampere University; University of Washington; University of Washington Seattle; Aalto University	Visakorpi, T (corresponding author), Univ Tampere, Inst Biomed Technol, Biokatu 6, FIN-33014 Tampere, Finland.	tapio.visakorpi@uta.fi	Sahu, Biswajyoti/U-6724-2017; Latonen, Leena/C-8787-2016; Urbanucci, Alfonso/S-4450-2019	Sahu, Biswajyoti/0000-0001-6576-5440; Latonen, Leena/0000-0003-4502-2193; Urbanucci, Alfonso/0000-0003-2931-3652; Visakorpi, Tapio/0000-0002-5004-0364	European Union [MEST-CT-2005-020970]; Academy of Finland; Cancer Society of Finland; Reino Lahtikari Foundation; Sigrid Juselius Foundation; Tampere University Hospital	European Union(European Commission); Academy of Finland(Academy of Finland); Cancer Society of Finland; Reino Lahtikari Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere University Hospital	We wish to thank Ms Mariitta Vakkuri, Ms Paivi Martikainen and Mr Rolle Rahikainen for the skillful technical assistance. The research leading to these results has received funding from the European Union FP6, CANCURE Programme (contract number: MEST-CT-2005-020970). In addition, grant support has been received from Academy of Finland, Cancer Society of Finland, Reino Lahtikari Foundation, Sigrid Juselius Foundation, and the Medical Research Fund of Tampere University Hospital.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cleutjens KBJM, 1997, MOL ENDOCRINOL, V11, P148, DOI 10.1210/me.11.2.148; Huggins C, 2002, J UROLOGY, V168, P9, DOI 10.1016/S0022-5347(05)64820-3; ISAACS JT, 1994, VITAM HORM, V49, P433; Jia L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003645; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; Karvonen U, 1997, J BIOL CHEM, V272, P15973, DOI 10.1074/jbc.272.25.15973; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Keller A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-552; Kokontis JM, 1998, MOL ENDOCRINOL, V12, P941, DOI 10.1210/me.12.7.941; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Lam JS, 2006, BJU INT, V98, P445, DOI 10.1111/j.1464-410X.2006.06224.x; Leinonen KA, 2010, CLIN CANCER RES, V16, P2845, DOI 10.1158/1078-0432.CCR-09-2505; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Lin YT, 2006, ONCOGENE, V25, P6901, DOI 10.1038/sj.onc.1209687; Linja MJ, 2001, CANCER RES, V61, P3550; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nguyen PL, 2011, UROL ONCOL-SEMIN ORI, V29, P302, DOI 10.1016/j.urolonc.2009.03.022; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Reid AHM, 2010, J CLIN ONCOL, V28, P1489, DOI 10.1200/JCO.2009.24.6819; Roudier Martine P, 2004, Cancer Treat Res, V118, P311; Schuur ER, 1996, J BIOL CHEM, V271, P7043, DOI 10.1074/jbc.271.12.7043; Seruga B, 2011, NAT REV CLIN ONCOL, V8, P12, DOI 10.1038/nrclinonc.2010.136; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; Starr DA, 2000, J CELL SCI, V113, P1939; Takayama K, 2011, ONCOGENE, V30, P619, DOI 10.1038/onc.2010.436; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Thompson J, 2006, EMBO J, V25, P2757, DOI 10.1038/sj.emboj.7601161; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Urbanucci A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-219; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Waltering KK, 2011, PROSTATE, V71, P604, DOI 10.1002/pros.21276; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Waltregny D, 2001, MOL ENDOCRINOL, V15, P765, DOI 10.1210/me.15.5.765; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Xu H, 2011, ONCOGENE, V30, P1072, DOI 10.1038/onc.2010.482; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	53	96	100	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	17					2153	2163		10.1038/onc.2011.401	http://dx.doi.org/10.1038/onc.2011.401			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	934BS	21909140	Bronze			2022-12-25	WOS:000303415900004
J	Kim, JY; Oh, MH; Bernard, LP; Macara, IG; Zhang, HY				Kim, Jeong-Yoon; Oh, Mi Hee; Bernard, Laura P.; Macara, Ian G.; Zhang, Huaye			The RhoG/ELMO1/Dock180 Signaling Module Is Required for Spine Morphogenesis in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; RHO-GTPASES; NEURITE OUTGROWTH; SYNAPSE FORMATION; APOPTOTIC CELLS; RAC; DOCK180; ACTIVATION; DOMAIN; PROTEINS	Dendritic spines are actin-rich structures, the formation and plasticity of which are regulated by the Rho GTPases in response to synaptic input. Although several guanine nucleotide exchange factors (GEFs) have been implicated in spine development and plasticity in hippocampal neurons, it is not known how many different Rho GEFs contribute to spine morphogenesis or how they coordinate the initiation, establishment, and maintenance of spines. In this study, we screened 70 rat Rho GEFs in cultured hippocampal neurons by RNA interference and identified a number of candidates that affected spine morphogenesis. Of these, Dock180, which plays a pivotal role in a variety of cellular processes including cell migration and phagocytosis, was further investigated. We show that depletion of Dock180 inhibits spine morphogenesis, whereas overexpression of Dock180 promotes spine morphogenesis. ELMO1, a protein necessary for in vivo functions of Dock180, functions in a complex with Dock180 in spine morphogenesis through activating the Rac GTPase. Moreover, RhoG, which functions upstream of the ELMO1/Dock180 complex, is also important for spine formation. Together, our findings uncover a role for the RhoG/ELMO1/Dock180 signaling module in spine morphogenesis in hippocampal neurons.	[Kim, Jeong-Yoon; Oh, Mi Hee] Chungnam Natl Univ, Dept Microbiol & Mol Biol, Coll Biosci & Biotechnol, Taejon 305764, South Korea; [Bernard, Laura P.; Zhang, Huaye] Univ Med & Dent New Jersey, Dept Neurosci & Cell Biol, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Macara, Ian G.] Univ Virginia Hlth Syst, Ctr Cell Signaling, Charlottesville, VA 22908 USA	Chungnam National University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Virginia	Zhang, HY (corresponding author), UMDNJ Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 675 Hoes La W, Piscataway, NJ 08854 USA.	zhang29@umdnj.edu		Kim, Jeong-Yoon/0000-0001-5873-2069	National Institutes of Health [GM070902, NS065183]; National Alliance for Research on Schizophrenia and Depression (NARSAD); Chungnam National University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS065183, K99NS065183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Chungnam National University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM070902 (to I. G. M.) and NS065183 (to H. Z.). This work was also supported by a National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award (to H. Z.).; Recipient of financial support from Chungnam National University during sabbatical leave at the University of Virginia.	Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Bryan B, 2004, J BIOL CHEM, V279, P45824, DOI 10.1074/jbc.M406216200; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fujimoto S, 2009, MOL BIOL CELL, V20, P4941, DOI 10.1091/mbc.E09-03-0200; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Jarzynka NJ, 2007, CANCER RES, V67, P7203, DOI 10.1158/0008-5472.CAN-07-0473; Kang MG, 2009, P NATL ACAD SCI USA, V106, P3549, DOI 10.1073/pnas.0812861106; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Lu MJ, 2004, NAT STRUCT MOL BIOL, V11, P756, DOI 10.1038/nsmb800; Ma XM, 2008, J NEUROSCI, V28, P12368, DOI 10.1523/JNEUROSCI.4269-08.2008; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Meller J, 2008, J CELL SCI, V121, P1981, DOI 10.1242/jcs.025130; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; Nakayama AY, 2000, HIPPOCAMPUS, V10, P582, DOI 10.1002/1098-1063(2000)10:5<582::AID-HIPO8>3.0.CO;2-K; Node-Langlois R, 2006, J CELL SCI, V119, P4986, DOI 10.1242/jcs.03273; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Xu NJ, 2009, NAT NEUROSCI, V12, P268, DOI 10.1038/nn.2254; Yamaki N, 2007, EXP CELL RES, V313, P2821, DOI 10.1016/j.yexcr.2007.05.010; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005	49	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37615	37624		10.1074/jbc.M111.268029	http://dx.doi.org/10.1074/jbc.M111.268029			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900250	Green Published, hybrid			2022-12-25	WOS:000296542400059
J	Sigurdsson, V; Hilmarsdottir, B; Sigmundsdottir, H; Fridriksdottir, AJR; Ringner, M; Villadsen, R; Borg, A; Agnarsson, BA; Petersen, OW; Magnusson, MK; Gudjonsson, T				Sigurdsson, Valgardur; Hilmarsdottir, Bylgja; Sigmundsdottir, Hekla; Fridriksdottir, Agla J. R.; Ringner, Markus; Villadsen, Rene; Borg, Ake; Agnarsson, Bjarni A.; Petersen, Ole William; Magnusson, Magnus K.; Gudjonsson, Thorarinn			Endothelial Induced EMT in Breast Epithelial Cells with Stem Cell Properties	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; BASAL-LIKE; TUMOR PROGRESSION; CANCER; EXPRESSION; MICROENVIRONMENT; MORPHOGENESIS; CARCINOMAS; SURVIVAL; DENSITY	Epithelial to mesenchymal transition (EMT) is a critical event in cancer progression and is closely linked to the breast epithelial cancer stem cell phenotype. Given the close interaction between the vascular endothelium and cancer cells, especially at the invasive front, we asked whether endothelial cells might play a role in EMT. Using a 3D culture model we demonstrate that endothelial cells are potent inducers of EMT in D492 an immortalized breast epithelial cell line with stem cell properties. Endothelial induced mesenchymal-like cells (D492M) derived from D492, show reduced expression of keratins, a switch from E-Cadherin (E-Cad) to N-Cadherin (N-Cad) and enhanced migration. Acquisition of cancer stem cell associated characteristics like increased CD44(high)/CD24(low) ratio, resistance to apoptosis and anchorage independent growth was also seen in D492M cells. Endothelial induced EMT in D492 was partially blocked by inhibition of HGF signaling. Basal-like breast cancer, a vascular rich cancer with stem cell properties and adverse prognosis has been linked with EMT. We immunostained several basal-like breast cancer samples for endothelial and EMT markers. Cancer cells close to the vascular rich areas show no or decreased expression of E-Cad and increased N-Cad expression suggesting EMT. Collectively, we have shown in a 3D culture model that endothelial cells are potent inducers of EMT in breast epithelial cells with stem cell properties. Furthermore, we demonstrate that basal-like breast cancer contains cells with an EMT phenotype, most prominently close to vascular rich areas of these tumors. We conclude that endothelial cells are potent inducers of EMT and may play a role in progression of basal-like breast cancer.	[Sigurdsson, Valgardur; Hilmarsdottir, Bylgja; Sigmundsdottir, Hekla; Magnusson, Magnus K.; Gudjonsson, Thorarinn] Univ Iceland, Sch Hlth Sci, Biomed Ctr, Stem Cell Res Unit, Reykjavik, Iceland; [Sigurdsson, Valgardur; Hilmarsdottir, Bylgja; Sigmundsdottir, Hekla; Magnusson, Magnus K.; Gudjonsson, Thorarinn] Landspitali Univ Hosp, Dept Lab Hematol, Reykjavik, Iceland; [Fridriksdottir, Agla J. R.; Villadsen, Rene; Petersen, Ole William] Univ Copenhagen, Dept Cellular & Mol Med, Ctr Cell Biol Dis Anal, Fac Hlth Sci, Copenhagen, Denmark; [Fridriksdottir, Agla J. R.; Villadsen, Rene; Petersen, Ole William] Univ Copenhagen, Fac Hlth Sci, Danish Stem Cell Ctr, Copenhagen, Denmark; [Ringner, Markus; Borg, Ake] Lund Univ, Dept Oncol, Lund, Sweden; [Agnarsson, Bjarni A.] Univ Iceland, Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland	University of Iceland; Landspitali National University Hospital; University of Copenhagen; University of Copenhagen; Lund University; Landspitali National University Hospital; University of Iceland	Sigurdsson, V (corresponding author), Univ Iceland, Sch Hlth Sci, Biomed Ctr, Stem Cell Res Unit, Reykjavik, Iceland.	tgudjons@hi.is	Fridriksdottir, Agla/O-3768-2015; Ringnér, Markus/G-3641-2011; Hilmarsdottir, Bylgja/AAV-7406-2020	Fridriksdottir, Agla/0000-0002-5582-5996; Ringnér, Markus/0000-0001-5469-8940; Petersen, Ole William/0000-0003-1691-749X; Gudjonsson, Thorarinn/0000-0001-9645-9665; Magnusson, Magnus Karl/0000-0001-8593-4934; Sigurdsson, Valgardur/0000-0003-4146-7179; Villadsen, Rene/0000-0002-5226-381X; Hilmarsdottir, Bylgja/0000-0001-8693-5541	Landspitali University Hospital; University of Iceland; Science and Technology Policy Council; European Science Foundation	Landspitali University Hospital; University of Iceland; Science and Technology Policy Council; European Science Foundation(European Science Foundation (ESF)European Commission)	This work was supported by grants from Landspitali University Hospital Research Fund, University of Iceland Research Fund (www.hi.is/research_degrees), Science and Technology Policy Council-Thematic program in postgenomic biomedicine (www.rannis.is), Science and Technology Policy Council Research fund (TG, MKM), European Science Foundation (EuroCORES program, EuroSTELLS) (TG). "Gongum saman", a supporting group for breast cancer research in Iceland (www.gongumsaman.is) (VS). Nordforsk, the Nordic Research Board (www.nordforsk.org), Nordic Stem Cell Mobility Program (HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; Chu SH, 2009, MOL BIOL REP, V36, P1967, DOI 10.1007/s11033-008-9406-1; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Elenbaas B, 2001, EXP CELL RES, V264, P169, DOI 10.1006/excr.2000.5133; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Franzdottir SR, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-162; Gastaldi S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2617; Giatromanolaki A, 2010, MED ONCOL; Greenberg S, 2010, CANCER J, V16, P33, DOI 10.1097/PPO.0b013e3181d38514; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Gudjonsson T, 2002, J CELL SCI, V115, P39; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Ingthorsson Saevar, 2010, BMC Res Notes, V3, P184, DOI 10.1186/1756-0500-3-184; Ishihara A, 2009, BREAST CANCER-TOKYO, V16, P179, DOI 10.1007/s12282-009-0108-x; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Leroy P, 2007, MOL BIOL CELL, V18, P1943, DOI 10.1091/mbc.E06-09-0823; Linderholm BK, 2009, ANN ONCOL, V20, P1639, DOI 10.1093/annonc/mdp062; Lopes N, 2009, HISTOPATHOLOGY, V55, P594, DOI 10.1111/j.1365-2559.2009.03417.x; Mahler-Araujo B, 2008, J CLIN PATHOL, V61, P615, DOI 10.1136/jcp.2007.053991; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; MIYASHITA M, 2010, VIRCHOWS ARCH; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Niu RF, 2007, J EXP CLIN CANC RES, V26, P385; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Petersen OW, 2003, AM J PATHOL, V162, P391, DOI 10.1016/S0002-9440(10)63834-5; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Ronnov-Jessen L, 2009, TRENDS MOL MED, V15, P5, DOI 10.1016/j.molmed.2008.11.001; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Shekhar MPV, 2000, CANCER RES, V60, P439; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Sigurdsson V, 2006, IN VITRO CELL DEV-AN, V42, P332; Uzzan B, 2004, CANCER RES, V64, P2941, DOI 10.1158/0008-5472.CAN-03-1957; van Zijl F, 2009, ONCOGENE, V28, P4022, DOI 10.1038/onc.2009.253; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Weaver VM, 1996, BIOCHEM CELL BIOL, V74, P833, DOI 10.1139/o96-089; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yehiely F, 2006, TRENDS MOL MED, V12, P537, DOI 10.1016/j.molmed.2006.09.004; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	52	76	80	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e23833	10.1371/journal.pone.0023833	http://dx.doi.org/10.1371/journal.pone.0023833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915264	Green Published, Green Submitted, gold			2022-12-25	WOS:000294689200011
J	Tsai, JJ; Liu, SH; Yin, SC; Yang, CN; Hsu, HS; Chen, WB; Liao, EC; Lee, WJ; Pan, HC; Sheu, ML				Tsai, Jaw Ji; Liu, Shing Hwa; Yin, Sui Chu; Yang, Cheng Ning; Hsu, Hong Sheng; Chen, Wen Bao; Liao, En Chih; Lee, Wen Jane; Pan, Hung Chuan; Sheu, Meei Ling			Mite Allergen Der-p2 Triggers Human B Lymphocyte Activation and Toll-Like Receptor-4 Induction	PLOS ONE			English	Article							MAP KINASE PHOSPHATASE-1; INNATE IMMUNE-RESPONSES; NEGATIVE REGULATOR; PROTEIN; TLR4; LUNG; MICE; LIPOPOLYSACCHARIDE; INFECTION; MEDIATOR	Background: Allergic disease can be characterized as manifestations of an exaggerated inflammatory response to environmental allergens triggers. Mite allergen Der-p2 is one of the major allergens of the house dust mite, which contributes to TLR4 expression and function in B cells in allergic patients. However, the precise mechanisms of Der-p2 on B cells remain obscure. Methodology/Principal Findings: We investigated the effects of Der-p2 on proinflammatory cytokines responses and Toll-like receptor-4 (TLR4)-related signaling in human B cells activation. We demonstrated that Der-p2 activates proinflammatory cytokines, TLR4 and its co-receptor MD2. ERK inhibitor PD98059 significantly enhanced TLR4/MD2 expression in Der-p2-treated B cells. Der-p2 markedly activated mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) and decreased p38 phosphorylation in B cells. MKP-1-siRNA downregulated TLR4/MD2 expression in Der-p2-treated B cells. In addition, Der-p2 significantly up-regulated expression of co-stimulatory molecules and increased B cell proliferation. Neutralizing Der-p2 antibody could effectively abrogate the Der-p2-induced B cell proliferation. Der-p2 could also markedly induce NF-kappa B activation in B cells, which could be counteracted by dexamethasone. Conclusions/Significance: These results strongly suggest that Der-p2 is capable of triggering B cell activation and MKP-1-activated p38/MAPK dephosphorylation-regulated TLR4 induction, which subsequently enhances host immune, defense responses and development of effective allergic disease therapeutics in B cells.	[Tsai, Jaw Ji; Hsu, Hong Sheng; Chen, Wen Bao; Pan, Hung Chuan; Sheu, Meei Ling] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Tsai, Jaw Ji; Liu, Shing Hwa; Liao, En Chih; Lee, Wen Jane; Pan, Hung Chuan; Sheu, Meei Ling] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Yin, Sui Chu] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 10764, Taiwan; [Yang, Cheng Ning] Natl Yang Ming Univ, Sch Life Sci, Inst Neurosci, Taipei 112, Taiwan	National Chung Hsing University; Taichung Veterans General Hospital; National Taiwan University; National Yang Ming Chiao Tung University	Tsai, JJ (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan.	mlsheu@nchu.edu.tw	Sheu, Meei-Ling/AAT-3401-2020	Sheu, Meei-Ling/0000-0002-0431-1282; LIU, SHING-HWA/0000-0002-9976-1197	Taichung Veterans General Hospital, Taiwan [TCVGH987320D, TCVGH-NCHU987613]; National Science Council of Taiwan [NSC96-2320-B-040-003-MY3]	Taichung Veterans General Hospital, Taiwan; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by research grants from Taichung Veterans General Hospital, Taiwan (TCVGH987320D) and (TCVGH-NCHU987613) and the National Science Council of Taiwan (NSC96-2320-B-040-003-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2004, J PEDIATR-US, V144, P421, DOI 10.1016/j.jpeds.2004.01.057; Bhattacharyya S, 2007, BLOOD, V109, P4313, DOI 10.1182/blood-2006-10-048215; Branger J, 2004, INFECT IMMUN, V72, P788, DOI 10.1128/IAI.72.2.788-794.2004; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Clark AR, 2003, J ENDOCRINOL, V178, P5, DOI 10.1677/joe.0.1780005; Cohen-Sfady M, 2005, J IMMUNOL, V175, P3594, DOI 10.4049/jimmunol.175.6.3594; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Ghaemmaghami AM, 2002, CLIN EXP ALLERGY, V32, P728, DOI 10.1046/j.1365-2222.2002.01374.x; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Haagenson KK, 2010, CANCER BIOL THER, V9, P337, DOI 10.4161/cbt.9.5.11217; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jeyaseelan S, 2006, J IMMUNOL, V177, P538, DOI 10.4049/jimmunol.177.1.538; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; Li LW, 2009, INT J CLIN EXP MED, V2, P48; Liu CF, 2005, CLIN EXP ALLERGY, V35, P1615, DOI 10.1111/j.1365-2222.2005.02387.x; Liu SH, 2010, CELL MOL LIFE SCI, V67, P1465, DOI 10.1007/s00018-009-0255-4; Okumura A, 2010, J VIROL, V84, P27, DOI 10.1128/JVI.01462-09; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pucci S, 2008, CLIN EXP IMMUNOL, V153, P1, DOI 10.1111/j.1365-2249.2008.03712.x; Rudeschko O, 2004, ALLERGY, V59, P332, DOI 10.1111/j.1398-9995.2003.00401.x; Trombone APF, 2002, CLIN EXP ALLERGY, V32, P1323, DOI 10.1046/j.1365-2745.2002.01455.x; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Tsai Jaw-Ji, 2002, Journal of Microbiology Immunology and Infection, V35, P152; Viau M, 2005, CLIN IMMUNOL, V114, P17, DOI 10.1016/j.clim.2004.08.019; Viriyakosol S, 2006, INFECT IMMUN, V74, P887, DOI 10.1128/IAI.74.2.887-895.2006; Wang XX, 2008, LIFE SCI, V83, P671, DOI 10.1016/j.lfs.2008.09.003; Wang XX, 2007, CELL SIGNAL, V19, P1372, DOI 10.1016/j.cellsig.2007.03.013; Wang XR, 2002, J IMMUNOL, V168, P810, DOI 10.4049/jimmunol.168.2.810; Xaus J, 2001, IMMUNOBIOLOGY, V204, P543, DOI 10.1078/0171-2985-00091; Zhao H, 2010, J IMMUNOL, V184, P5308, DOI 10.4049/jimmunol.1000009; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zouali M, 2008, FRONT BIOSCI, V13, P4852, DOI 10.2741/3044	33	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e23249	10.1371/journal.pone.0023249	http://dx.doi.org/10.1371/journal.pone.0023249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21909400	Green Submitted, Green Published, gold			2022-12-25	WOS:000294689200004
J	Martens, GA; Jiang, L; Hellemans, KH; Stange, G; Heimberg, H; Nielsen, FC; Sand, O; Van Helden, J; Gorus, FK; Pipeleers, DG; Van Lommel, L; Schuit, F				Martens, Geert A.; Jiang, Lei; Hellemans, Karine H.; Stange, Geert; Heimberg, Harry; Nielsen, Finn C.; Sand, Olivier; Van Helden, Jacques; Gorus, Frans K.; Pipeleers, Daniel G.; Van Lommel, Leentje; Schuit, Frans			Clusters of Conserved Beta Cell Marker Genes for Assessment of Beta Cell Phenotype	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GLUCOSE-HOMEOSTASIS; GENOME SEQUENCES; NEURONAL TRAITS; EXPRESSION; TISSUE; MODEL; IDENTIFICATION; SPECIFICITY; DYSFUNCTION	Background and Methodology: The aim of this study was to establish a gene expression blueprint of pancreatic beta cells conserved from rodents to humans and to evaluate its applicability to assess shifts in the beta cell differentiated state. Genome-wide mRNA expression profiles of isolated beta cells were compared to those of a large panel of other tissue and cell types, and transcripts with beta cell-abundant and -selective expression were identified. Iteration of this analysis in mouse, rat and human tissues generated a panel of conserved beta cell biomarkers. This panel was then used to compare isolated versus laser capture microdissected beta cells, monitor adaptations of the beta cell phenotype to fasting, and retrieve possible conserved transcriptional regulators. Principal Findings: A panel of 332 conserved beta cell biomarker genes was found to discriminate both isolated and laser capture microdissected beta cells from all other examined cell types. Of all conserved beta cell-markers, 15% were strongly beta cell-selective and functionally associated to hormone processing, 15% were shared with neuronal cells and associated to regulated synaptic vesicle transport and 30% with immune plus gut mucosal tissues reflecting active protein synthesis. Fasting specifically down-regulated the latter cluster, but preserved the neuronal and strongly beta cell-selective traits, indicating preserved differentiated state. Analysis of consensus binding site enrichment indicated major roles of CREB/ATF and various nutrient- or redox-regulated transcription factors in maintenance of differentiated beta cell phenotype. Conclusions: Conserved beta cell marker genes contain major gene clusters defined by their beta cell selectivity or by their additional abundance in either neural cells or in immune plus gut mucosal cells. This panel can be used as a template to identify changes in the differentiated state of beta cells.	[Martens, Geert A.; Jiang, Lei; Hellemans, Karine H.; Stange, Geert; Heimberg, Harry; Gorus, Frans K.; Pipeleers, Daniel G.] Vrije Univ Brussel, Diabet Res Ctr, Brussels, Belgium; [Martens, Geert A.; Gorus, Frans K.] Univ Ziekenhuis Brussel, Dept Clin Chem & Radioimmunol, Brussels, Belgium; [Nielsen, Finn C.] Rigshosp, Microarray Facil, DK-2100 Copenhagen, Denmark; [Sand, Olivier; Van Helden, Jacques] Univ Libre Bruxelles, Brussels, Belgium	Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; Rigshospitalet; University of Copenhagen; Universite Libre de Bruxelles	Martens, GA (corresponding author), Vrije Univ Brussel, Diabet Res Ctr, Brussels, Belgium.	geert.martens@vub.ac.be	Martens, Geert/ABA-6297-2020; Hellemans, Karine/B-7573-2013; Nielsen, Finn Cilius/AAA-4926-2020; van Helden, Jacques/D-8590-2013; stange, geert m/C-1092-2009; Martens, Geert A./F-6920-2015	Martens, Geert/0000-0003-1208-6289; Hellemans, Karine/0000-0001-9306-4369; van Helden, Jacques/0000-0002-8799-8584; stange, geert m/0000-0003-3148-1372; Martens, Geert A./0000-0003-1208-6289; Gorus, Frans/0000-0002-9007-6177; Heimberg, Harry/0000-0003-1954-7375; Sand, Olivier/0000-0003-1465-1640; Pipeleers, Daniel/0000-0002-6440-2485	Research Foundation-Flanders (FWO-Vlaanderen) [G.0374.08, G.0428.09N]; Juvenile Diabetes Research Foundation [4-2005-1327]; European Union [241883]	Research Foundation-Flanders (FWO-Vlaanderen)(FWO); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union(European Commission)	This work was supported by research grants from the Research Foundation-Flanders (FWO-Vlaanderen G.0374.08 and G.0428.09N), the Juvenile Diabetes Research Foundation (Center grant 4-2005-1327) and from the European Union Seventh Framework Program under grant agreement no241883. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmani A, 2004, FEBS LETT, V565, P133, DOI 10.1016/j.febslet.2004.04.002; Aerts S, 2003, BIOINFORMATICS, V19, pII5, DOI 10.1093/bioinformatics/btg1052; Allen-Jennings AE, 2001, J BIOL CHEM, V276, P29507, DOI 10.1074/jbc.M100986200; Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; BOROWIAK M, 2009, CURR OPIN CELL BIOL; CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; Cheung AT, 2000, SCIENCE, V290, P1959, DOI 10.1126/science.290.5498.1959; Cras-Meneur C, 2004, DIABETOLOGIA, V47, P284, DOI 10.1007/s00125-003-1300-8; Fiaschi-Taesch NM, 2010, DIABETES, V59, P1926, DOI 10.2337/db09-1776; FLAMEZ D, 2010, DIABETOLOGIA; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Hay CW, 2007, BBA-GENE STRUCT EXPR, V1769, P79, DOI 10.1016/j.bbaexp.2007.01.005; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hinke SA, 2004, J PHYSIOL-LONDON, V558, P369, DOI 10.1113/jphysiol.2004.064881; Jandrig B, 2004, ONCOGENE, V23, P9295, DOI 10.1038/sj.onc.1208131; JUHL K, 2008, DIABETES; Keymeulen B, 2006, P NATL ACAD SCI USA, V103, P17444, DOI 10.1073/pnas.0608141103; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Krutzfeldt J, 2010, DIABETOLOGIA, V53, P123, DOI 10.1007/s00125-009-1578-2; Kutlu B, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-3; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu MT, 1999, J NEUROSCI, V19, P10305; MacDonald MJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE302, DOI 10.1152/ajpendo.00041.2002; Maffei A, 2004, ENDOCRINOLOGY, V145, P4513, DOI 10.1210/en.2004-0691; Marselli L, 2008, J CLIN ENDOCR METAB, V93, P1046, DOI 10.1210/jc.2007-0931; Martens GA, 2007, J BIOL CHEM, V282, P21134, DOI 10.1074/jbc.M700083200; Martens GA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014214; Martens GA, 2009, VITAM HORM, V80, P507, DOI 10.1016/S0083-6729(08)00617-1; Martin M, 2007, ENDOCR DEV, V12, P24, DOI 10.1159/000109602; Martinez O, 2008, P NATL ACAD SCI USA, V105, P9709, DOI 10.1073/pnas.0803479105; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Nicolaou P, 2009, CIRC RES, V104, P1012, DOI 10.1161/CIRCRESAHA.108.189811; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; PIPELEERS DG, 1991, DIABETES, V40, P908, DOI 10.2337/diabetes.40.7.908; Prakash N, 2006, J PHYSIOL-LONDON, V575, P403, DOI 10.1113/jphysiol.2006.113464; Sand O, 2009, BIOINFORMATICS, V25, P2739, DOI 10.1093/bioinformatics/btp519; Schuit F, 2002, DIABETES, V51, pS326, DOI 10.2337/diabetes.51.2007.S326; Schuit FC, 2001, DIABETES, V50, P1, DOI 10.2337/diabetes.50.1.1; Servitja JM, 2004, DIABETOLOGIA, V47, P597, DOI 10.1007/s00125-004-1368-9; Sharan R, 2004, NUCLEIC ACIDS RES, V32, pW253, DOI 10.1093/nar/gkh385; Sharma A, 1999, MOL CELL BIOL, V19, P704; SORENSON RL, 1991, DIABETES, V40, P1365, DOI 10.2337/diabetes.40.11.1365; SPENCER J, 1985, GUT, V26, P672, DOI 10.1136/gut.26.7.672; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Waldrop MA, 2007, ENDOCRINOLOGY, V148, P4572, DOI 10.1210/en.2006-1367; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Zelent D, 2006, DIABETES, V55, P1923, DOI 10.2337/db06-0151	53	35	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24134	10.1371/journal.pone.0024134	http://dx.doi.org/10.1371/journal.pone.0024134			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912665	Green Published, gold			2022-12-25	WOS:000294686100012
J	Hollestelle, MJ; Lai, KW; van Deuren, M; Lenting, PJ; de Groot, PG; Sprong, T; Bovenschen, N				Hollestelle, Martine J.; Lai, Ka Wai; van Deuren, Marcel; Lenting, Peter J.; de Groot, Philip G.; Sprong, Tom; Bovenschen, Niels			Cleavage of von Willebrand Factor by Granzyme M Destroys Its Factor VIII Binding Capacity	PLOS ONE			English	Article							THROMBOTIC THROMBOCYTOPENIC PURPURA; EXTRACELLULAR GRANZYMES; VONWILLEBRAND-FACTOR; D3 DOMAIN; IN-VITRO; PROTEASE; PLASMA; ADAMTS13; DISEASE; CONFORMATION	Von Willebrand factor (VWF) is a pro-hemostatic multimeric plasma protein that promotes platelet aggregation and stabilizes coagulation factor VIII (FVIII) in plasma. The metalloproteinase ADAMTS13 regulates the platelet aggregation function of VWF via proteolysis. Severe deficiency of ADAMTS13 is associated with thrombotic thrombocytopenic purpura, but does not always correlate with its clinical course. Therefore, other proteases could also be important in regulating VWF activity. In the present study, we demonstrate that VWF is cleaved by the cytotoxic lymphocyte granule component granzyme M (GrM). GrM cleaved both denaturated and soluble plasma-derived VWF after Leu at position 276 in the D3 domain. GrM is unique in that it did not affect the multimeric size and pro-hemostatic platelet aggregation ability of VWF, but instead destroyed the binding of VWF to FVIII in vitro. In meningococcal sepsis patients, we found increased plasma GrM levels that positively correlated with an increased plasma VWF/FVIII ratio in vivo. We conclude that, next to its intracellular role in triggering apoptosis, GrM also exists extracellularly in plasma where it could play a physiological role in controlling blood coagulation by determining plasma FVIII levels via proteolytic processing of its carrier VWF.	[Hollestelle, Martine J.; Lai, Ka Wai; Lenting, Peter J.; de Groot, Philip G.] Univ Med Ctr Utrecht, Dept Clin Chem & Hematol, Utrecht, Netherlands; [Lai, Ka Wai; Bovenschen, Niels] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [van Deuren, Marcel; Sprong, Tom] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands; [van Deuren, Marcel; Sprong, Tom] Radboud Univ Nijmegen, Med Ctr, N4i, NL-6525 ED Nijmegen, Netherlands; [Lenting, Peter J.] INSERM, U770, F-94275 Le Kremlin Bicetre, France	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hollestelle, MJ (corresponding author), Univ Med Ctr Utrecht, Dept Clin Chem & Hematol, Utrecht, Netherlands.	M.J.Hollestelle@umcutrecht.nl	Lenting, Peter/F-8269-2013; Lenting, Peter/AAH-5663-2019	Lenting, Peter/0000-0002-7937-3429; Lenting, Peter/0000-0002-7937-3429	Dutch Cancer Society (KWF) [UU-2009-4302]; Netherlands Organization for Scientific Research (NWO) [916.66.044]; Netherlands Heart Foundation [2006B010]	Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Heart Foundation(Netherlands Heart Foundation)	This study was supported by the Dutch Cancer Society (KWF) (grant UU-2009-4302 to NB), the Netherlands Organization for Scientific Research (NWO) (grant 916.66.044 to NB), and the Netherlands Heart Foundation (grant 2006B010 to PJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bade B, 2005, EUR J IMMUNOL, V35, P2940, DOI 10.1002/eji.200526249; Banno F, 2006, BLOOD, V107, P3161, DOI 10.1182/blood-2005-07-2765; Bovenschen N, 2008, J IMMUNOL, V180, P8184, DOI 10.4049/jimmunol.180.12.8184; Bovenschen N, 2009, J BIOL CHEM, V284, P3504, DOI 10.1074/jbc.M806716200; Buzza MS, 2008, J BIOL CHEM, V283, P22498, DOI 10.1074/jbc.M709080200; Buzza MS, 2006, BIOL CHEM, V387, P827, DOI 10.1515/BC.2006.106; Chamberlain CM, 2007, CAN J PHYSIOL PHARM, V85, P89, DOI 10.1139/Y06-090; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Choy JC, 2003, MODERN PATHOL, V16, P460, DOI 10.1097/01.MP.0000067424.12280.BC; Cullen SP, 2007, J CELL BIOL, V176, P435, DOI 10.1083/jcb.200612025; DE CR, 2005, J BIOL CHEM, V280, P23295; de Koning PJA, 2010, MOL IMMUNOL, V47, P903, DOI 10.1016/j.molimm.2009.10.001; Desch KC, 2007, ARTERIOSCL THROM VAS, V27, P1901, DOI 10.1161/ATVBAHA.107.145797; Dong JF, 2005, J THROMB HAEMOST, V3, P1710, DOI 10.1111/j.1538-7836.2005.01360.x; Froelich CJ, 2009, TRENDS IMMUNOL, V30, P117, DOI 10.1016/j.it.2009.01.002; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Gao WQ, 2008, BLOOD, V112, P1713, DOI 10.1182/blood-2008-04-148759; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Groot E, 2009, J THROMB HAEMOST, V7, P962, DOI 10.1111/j.1538-7836.2009.03433.x; Groot E, 2007, CURR OPIN HEMATOL, V14, P284, DOI 10.1097/MOH.0b013e3280dce531; Hilbert L, 2003, BRIT J HAEMATOL, V120, P627, DOI 10.1046/j.1365-2141.2003.04163.x; HOLLESTELLE MJ, 2010, J THROMB HAEMOSTASIS; Hulstein JJJ, 2005, BLOOD, V106, P3035, DOI 10.1182/blood-2005-03-1153; Jorieux S, 1998, BLOOD, V92, P4663, DOI 10.1182/blood.V92.12.4663.424k06_4663_4670; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Mahrus S, 2004, J BIOL CHEM, V279, P54275, DOI 10.1074/jbc.M411482200; MANNUCCI PM, 1989, BLOOD, V74, P978; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Raife TJ, 2009, BLOOD, V114, P1666, DOI 10.1182/blood-2009-01-195461; Ruggeri ZM, 1999, THROMB HAEMOSTASIS, V82, P576; Ruggeri ZM, 2003, J THROMB HAEMOST, V1, P1335, DOI 10.1046/j.1538-7836.2003.00260.x; Sadler JE, 2002, P NATL ACAD SCI USA, V99, P11552, DOI 10.1073/pnas.192448999; SODETZ JM, 1977, J BIOL CHEM, V252, P5538; Spaeny-Dekking EHA, 1998, J IMMUNOL, V160, P3610; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; TSAI HM, 1989, BIOCHEM BIOPH RES CO, V158, P980, DOI 10.1016/0006-291X(89)92818-0; Ulrichts H, 2006, J BIOL CHEM, V281, P4699, DOI 10.1074/jbc.M513314200; van der Plas RM, 2000, THROMB HAEMOSTASIS, V84, P1005; van Woensel JBM, 2005, INTENS CARE MED, V31, P1239, DOI 10.1007/s00134-005-2720-3; Weeterings C, 2008, BLOOD, V112, P3227, DOI 10.1182/blood-2008-02-139113; WEISS HJ, 1977, J CLIN INVEST, V60, P390, DOI 10.1172/JCI108788	43	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e24216	10.1371/journal.pone.0024216	http://dx.doi.org/10.1371/journal.pone.0024216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21909423	Green Published, gold			2022-12-25	WOS:000294683900039
J	Perala, MM; Valsta, LM; Kajantie, E; Leiviska, J; Eriksson, JG				Perala, Mia-Maria; Valsta, Liisa M.; Kajantie, Eero; Leiviska, Jaana; Eriksson, Johan G.			Impact of Early Growth on Postprandial Responses in Later Life	PLOS ONE			English	Article							INSULIN-RESISTANCE SYNDROME; ISCHEMIC-HEART-DISEASE; BIRTH-WEIGHT; CHILDHOOD GROWTH; INFANT GROWTH; NONFASTING TRIGLYCERIDES; GLUCOSE-TOLERANCE; FETAL-GROWTH; YOUNG MEN; RISK	Background: Low birth weight and slow growth during infancy are associated with increased rates of chronic diseases in adulthood. Associations with risk factors such as fasting glucose and lipids concentrations are weaker than expected based on associations with disease. This could be explained by differences in postprandial responses, which, however, have been little studied. Our aim was to examine the impact of growth during infancy on postprandial responses to a fast-food meal (FF-meal) and a meal, which followed the macro-nutrient composition of the dietary guidelines (REC-meal). Methodology/Principal Findings: We recruited 24 overweight 65-75 year-old subjects, 12 with slow growth during infancy (SGI-group) and 12 with normal early growth. All the subjects were born at term. The study meals were isocaloric and both meals were consumed once. Plasma glucose, insulin, triglycerides (TG) and free fatty acids (FFA) were measured in fasting state and over a 4-h period after both meals. Subjects who grew slowly during infancy were also smaller at birth. Fasting glucose, insulin or lipid concentrations did not differ significantly between the groups. The TG responses were higher for the SGI-group both during the FF-meal (P = 0.047) and the REC-meal (P = 0.058). The insulin responses were significantly higher for the SGI-group after the FF-meal (P = 0.036). Glucose and FFA responses did not differ significantly between the groups. Conclusions: Small birth size and slow early growth predict postprandial TG and insulin responses. Elevated responses might be one explanation why subjects who were small at birth and experiencing slow growth in infancy are at an increased risk of developing cardiovascular diseases in later life.	[Perala, Mia-Maria; Kajantie, Eero; Leiviska, Jaana; Eriksson, Johan G.] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Valsta, Liisa M.] Natl Inst Hlth & Welf, Dept Lifestyle & Participat, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Vaasa Central Hospital	Perala, MM (corresponding author), Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland.	mia.perala@thl.fi		Perala, Mia-Maria/0000-0002-6349-6301; Eriksson, Johan/0000-0002-2516-2060	Academy of Finland; British Heart Foundation; Emil Aaltonen Foundation; Finnish Foundation for Pediatric Research; Finska Lakaresallskapet; Samfundet Folkhalsan; Juho Vainio Foundation; Novo Nordisk Foundation; Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Yrjo Jahnsson Foundation; Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Finnish Graduate School on Applied Bioscience	Academy of Finland(Academy of Finland); British Heart Foundation(British Heart Foundation); Emil Aaltonen Foundation; Finnish Foundation for Pediatric Research; Finska Lakaresallskapet; Samfundet Folkhalsan; Juho Vainio Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Yrjo Jahnsson Foundation; Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Finnish Graduate School on Applied Bioscience	This work was supported by the Academy of Finland, British Heart Foundation, Emil Aaltonen Foundation, Finnish Foundation for Pediatric Research, Finska Lakaresallskapet, Samfundet Folkhalsan, Juho Vainio Foundation, Novo Nordisk Foundation, Paivikki and Sakari Sohlberg Foundation, Signe and Ane Gyllenberg Foundation, Sigrid Juselius Foundation, Yrjo Jahnsson Foundation, the Diabetes Research Foundation, Finnish Foundation for Cardiovascular Research, and the Finnish Graduate School on Applied Bioscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANAUCH D, 1975, Z KLIN CHEM KLIN BIO, V13, P101; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Bansilal S, 2007, AM J CARDIOL, V99, p6B, DOI 10.1016/j.amjcard.2006.11.002; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Barker DJP, 2004, J EPIDEMIOL COMMUN H, V58, P114, DOI 10.1136/jech.58.2.114; BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; Boiko J, 2005, INT J OBESITY, V29, P565, DOI 10.1038/sj.ijo.0802901; Burns SP, 1997, J CLIN INVEST, V100, P1768, DOI 10.1172/JCI119703; Byrne CD, 1997, DIABETIC MED, V14, P942, DOI 10.1002/(SICI)1096-9136(199711)14:11<942::AID-DIA500>3.0.CO;2-B; Eriksson J, 2002, HORM METAB RES, V34, P72, DOI 10.1055/s-2002-20518; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Eriksson JG, 2003, DIABETES CARE, V26, P3006, DOI 10.2337/diacare.26.11.3006; Eriksson JG, 2002, ANN MED, V34, P157, DOI 10.1080/713782141; Eriksson JG, 2002, DIABETOLOGIA, V45, P342, DOI 10.1007/s00125-001-0757-6; FOSSATI P, 1982, CLIN CHEM, V28, P2077; Fraser A, 2008, PAEDIATR PERINAT EP, V22, P12, DOI 10.1111/j.1365-3016.2007.00876.x; Gonzalez-Barranco J, 2003, METABOLISM, V52, P1005, DOI 10.1016/S0026-0495(03)00151-3; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; HealthyPeople.gov, 2020, NUTR PHYS ACT; Huxley R, 2004, JAMA-J AM MED ASSOC, V292, P2755, DOI 10.1001/jama.292.22.2755; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; Jensen CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003738; Kajantie E, 2008, INT J EPIDEMIOL, V37, P280, DOI 10.1093/ije/dyn012; Kensara OA, 2006, AM J PHYSIOL-ENDOC M, V291, pE365, DOI 10.1152/ajpendo.00599.2005; Kim HS, 2001, AM J CLIN NUTR, V74, P592; Kolovou GD, 2011, CURR VASC PHARMACOL, V9, P258; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Lairon D, 2007, EUR J CLIN NUTR, V61, P1145, DOI 10.1038/sj.ejcn.1602749; Lane RH, 2001, AM J PHYSIOL-REG I, V280, pR183, DOI 10.1152/ajpregu.2001.280.1.R183; Maiorana Arianna, 2007, Rev Diabet Stud, V4, P134, DOI 10.1900/RDS.2007.4.134; Mi J, 2000, ANN INTERN MED, V132, P253, DOI 10.7326/0003-4819-132-4-200002150-00002; Moriyama M, 2006, CLIN CHEM, V52, P1423, DOI 10.1373/clinchem.2005.065995; MULDER C, 1983, J CLIN CHEM CLIN BIO, V21, P823; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; O'Keefe JH, 2007, AM J CARDIOL, V100, P899, DOI 10.1016/j.amjcard.2007.03.107; Osmond C, 2007, STROKE, V38, P264, DOI 10.1161/01.STR.0000254471.72186.03; Perala MM, 2011, BRIT J NUTR, V105, P1627, DOI 10.1017/S0007114510005477; Phillips DIW, 2005, DIABETES, V54, pS145, DOI 10.2337/diabetes.54.suppl_2.S145; PHILLIPS DIW, 1994, DIABETOLOGIA, V37, P150, DOI 10.1007/s001250050086; Rendell MS, 2006, METABOLISM, V55, P1263, DOI 10.1016/j.metabol.2006.05.012; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Schou JH, 2005, J CLIN ENDOCR METAB, V90, P4912, DOI 10.1210/jc.2005-0382; SPSS Inc, 2009, PASW STAT REL 18 0 0; TAYLOR DJ, 1995, DIABETOLOGIA, V38, P1205, DOI 10.1007/BF00422370; Warner MJ, 2010, BIOCHEM J, V427, P333, DOI 10.1042/BJ20091861; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; WINICK M, 1966, J NUTR, V89, P300, DOI 10.1093/jn/89.3.300; World Health Organisation, 2004, HUM EN REQ; World Health Organization, 1998, CARB HUM NUTR	49	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24070	10.1371/journal.pone.0024070	http://dx.doi.org/10.1371/journal.pone.0024070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904606	Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800052
J	North, M; Tandon, VJ; Thomas, R; Loguinov, A; Gerlovina, I; Hubbard, AE; Zhang, LP; Smith, MT; Vulpe, CD				North, Matthew; Tandon, Vickram J.; Thomas, Reuben; Loguinov, Alex; Gerlovina, Inna; Hubbard, Alan E.; Zhang, Luoping; Smith, Martyn T.; Vulpe, Chris D.			Genome-Wide Functional Profiling Reveals Genes Required for Tolerance to Benzene Metabolites in Yeast	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; ENDOPLASMIC-RETICULUM STRESS; SACCHAROMYCES-CEREVISIAE; IN-VITRO; TRANSCRIPTION FACTOR; ESCHERICHIA-COLI; IRON-METABOLISM; NAD(P)H-QUINONE OXIDOREDUCTASE-1; COPPER DETOXIFICATION; NUCLEAR-LOCALIZATION	Benzene is a ubiquitous environmental contaminant and is widely used in industry. Exposure to benzene causes a number of serious health problems, including blood disorders and leukemia. Benzene undergoes complex metabolism in humans, making mechanistic determination of benzene toxicity difficult. We used a functional genomics approach to identify the genes that modulate the cellular toxicity of three of the phenolic metabolites of benzene, hydroquinone (HQ), catechol (CAT) and 1,2,4-benzenetriol (BT), in the model eukaryote Saccharomyces cerevisiae. Benzene metabolites generate oxidative and cytoskeletal stress, and tolerance requires correct regulation of iron homeostasis and the vacuolar ATPase. We have identified a conserved bZIP transcription factor, Yap3p, as important for a HQ-specific response pathway, as well as two genes that encode putative NAD(P)H:quinone oxidoreductases, PST2 and YCP4. Many of the yeast genes identified have human orthologs that may modulate human benzene toxicity in a similar manner and could play a role in benzene exposure-related disease.	[North, Matthew; Tandon, Vickram J.; Loguinov, Alex; Vulpe, Chris D.] Univ Calif Berkeley, Dept Nutrit Sci & Toxicol, Berkeley, CA 94720 USA; [Thomas, Reuben; Hubbard, Alan E.; Zhang, Luoping; Smith, Martyn T.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Gerlovina, Inna; Hubbard, Alan E.] Univ Calif Berkeley, Sch Publ Hlth, Div Biostat, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	North, M (corresponding author), Univ Calif Berkeley, Dept Nutrit Sci & Toxicol, Berkeley, CA 94720 USA.	vulpe@berkeley.edu	Vulpe, Chris/AAF-9170-2020	Vulpe, Chris/0000-0001-5134-8929	United States National Institute of Environmental Health Sciences [P42 ES004705]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705] Funding Source: NIH RePORTER	United States National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the United States National Institute of Environmental Health Sciences Superfund Research Program through grant P42 ES004705 to MTS, LZ and CDV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akada R, 2002, YEAST, V19, P17, DOI 10.1002/yea.797; Akileswaran L, 1999, APPL ENVIRON MICROB, V65, P415; Alexa A., 2009, TOPGO ENRICHMENT ANA, V27, P1; Andrade SLA, 2007, J BACTERIOL, V189, P9101, DOI 10.1128/JB.01336-07; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badham HJ, 2010, TOXICOL SCI, V113, P207, DOI 10.1093/toxsci/kfp242; Ballman KV, 2004, BIOINFORMATICS, V20, P2778, DOI 10.1093/bioinformatics/bth327; Barreto G, 2009, ENVIRON MOL MUTAGEN, V50, P771, DOI 10.1002/em.20500; Birrell GW, 2002, P NATL ACAD SCI USA, V99, P8778, DOI 10.1073/pnas.132275199; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; BOSSIER P, 1993, J BIOL CHEM, V268, P23640; Brennan RJ, 1998, MUTAT RES-FUND MOL M, V403, P65, DOI 10.1016/S0027-5107(98)00050-5; Buthbumrung N, 2008, CHEM-BIOL INTERACT, V172, P185, DOI 10.1016/j.cbi.2008.01.005; Carey J, 2007, PROTEIN SCI, V16, P2301, DOI 10.1110/ps.073018907; Cha MK, 2003, J BIOL CHEM, V278, P34952, DOI 10.1074/jbc.M301819200; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; De Freitas JM, 2004, J BIOL CHEM, V279, P4450, DOI 10.1074/jbc.M212308200; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Deller S, 2008, CELL MOL LIFE SCI, V65, P141, DOI 10.1007/s00018-007-7300-y; Dougherty D, 2008, TOXICOL LETT, V182, P7, DOI 10.1016/j.toxlet.2008.09.008; Eastmond DA, 2005, CHEM-BIOL INTERACT, V153, P207, DOI 10.1016/j.cbi.2005.03.024; EASTMOND DA, 1987, TOXICOL APPL PHARM, V91, P85, DOI 10.1016/0041-008X(87)90196-7; EIDE DJ, 1993, MOL GEN GENET, V241, P447, DOI 10.1007/BF00284699; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Galvan N, 2008, MUTAT RES-GEN TOX EN, V649, P54, DOI 10.1016/j.mrgentox.2007.07.011; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Garg Tarun K, 2003, BMC Ophthalmol, V3, P5, DOI 10.1186/1471-2415-3-5; Gaskell M, 2005, CHEM-BIOL INTERACT, V153, P267, DOI 10.1016/j.cbi.2005.03.034; Gaskell M, 2005, CARCINOGENESIS, V26, P673, DOI 10.1093/carcin/bgi007; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gerlovina I, 2010, THESIS U CALIFORNIA; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GILL DP, 1981, BIOCHEM PHARMACOL, V30, P1127, DOI 10.1016/0006-2952(81)90452-4; Gillis B, 2007, GENOMICS, V90, P324, DOI 10.1016/j.ygeno.2007.05.003; Girao H, 2008, FEBS LETT, V582, P2112, DOI 10.1016/j.febslet.2008.04.011; GOPALAKRISHNA R, 1994, P NATL ACAD SCI USA, V91, P12233, DOI 10.1073/pnas.91.25.12233; Gosling J., 2000, JAVA LANGUAGE SPECIF, V7th; GRANDORI R, 1994, PROTEIN SCI, V3, P2185, DOI 10.1002/pro.5560031204; Gulshan K, 2005, J BIOL CHEM, V280, P40524, DOI 10.1074/jbc.M504716200; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hirakawa K, 2002, CHEM RES TOXICOL, V15, P76, DOI 10.1021/tx010121s; Holland S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r268; Hoon S, 2008, TRENDS PHARMACOL SCI, V29, P499, DOI 10.1016/j.tips.2008.07.006; IRONS RD, 1980, ARCH TOXICOL, V45, P297, DOI 10.1007/BF00293810; Jemnitz K, 2004, MUTAGENESIS, V19, P245, DOI 10.1093/mutage/geh026; Jo WJ, 2008, TOXICOL SCI, V101, P140, DOI 10.1093/toxsci/kfm226; Jo WJ, 2009, TOXICOL SCI, V111, P424, DOI 10.1093/toxsci/kfp162; Jo WJ, 2009, TOXICOL APPL PHARM, V241, P294, DOI 10.1016/j.taap.2009.08.027; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kumar M, 2009, TOXICOL MECH METHOD, V19, P59, DOI 10.1080/15376510802399057; Lan Q, 2004, SCIENCE, V306, P1774, DOI 10.1126/science.1102443; Lan Q, 2009, CARCINOGENESIS, V30, P50, DOI 10.1093/carcin/bgn249; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Lindsey RH, 2005, CHEM-BIOL INTERACT, V153, P197, DOI 10.1016/j.cbi.2005.03.035; Lyu BN, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-23; Menezes RA, 2008, BIOCHEM J, V414, P301, DOI 10.1042/BJ20071537; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Milgrom E, 2007, J BIOL CHEM, V282, P7125, DOI 10.1074/jbc.M608293200; Oikawa S, 2001, CARCINOGENESIS, V22, P1239, DOI 10.1093/carcin/22.8.1239; Okazaki S, 2005, ANTIOXID REDOX SIGN, V7, P327, DOI 10.1089/ars.2005.7.327; Patridge EV, 2006, J BACTERIOL, V188, P3498, DOI 10.1128/JB.188.10.3498-3506.2006; Pfeiffer E, 1996, CHEM-BIOL INTERACT, V102, P37, DOI 10.1016/0009-2797(96)03730-1; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pollard KS, 2010, MULTTEST RESAMPLING; Pons M, 2010, AM J PATHOL, V177, P1198, DOI 10.2353/ajpath.2010.091108; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Rao G. Subba, 2002, Functional and Integrative Genomics, V1, P357; Ren XF, 2009, TOXICOL SCI, V107, P367, DOI 10.1093/toxsci/kfn254; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Ross D, 2005, CHEM-BIOL INTERACT, V153, P137, DOI 10.1016/j.cbi.2005.03.018; Sanchez P, 2005, DALTON T, P811, DOI 10.1039/b416669h; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Seow HA, 2004, J BIOL CHEM, V279, P31606, DOI 10.1074/jbc.M404910200; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen Y, 1996, HUM EXP TOXICOL, V15, P422, DOI 10.1177/096032719601500510; Shiga T, 2010, J RADIAT RES, V51, P405, DOI 10.1269/jrr.10014; Singh MP, 2009, TOXICOL APPL PHARM, V235, P226, DOI 10.1016/j.taap.2008.12.002; SINGH V, 1994, TOXICOLOGY, V89, P25, DOI 10.1016/0300-483X(94)90130-9; Smith MT, 2010, ANNU REV PUBL HEALTH, V31, P133, DOI 10.1146/annurev.publhealth.012809.103646; Smith MT, 1996, ENVIRON HEALTH PERSP, V104, P1219, DOI 10.2307/3433166; Snyder R, 2007, HUM EXP TOXICOL, V26, P687, DOI 10.1177/0960327107083975; Snyder R, 1996, ENVIRON HEALTH PERSP, V104, P1165, DOI 10.1289/ehp.961041165; Sollner S, 2007, FEBS J, V274, P1328, DOI 10.1111/j.1742-4658.2007.05682.x; Sul D, 2005, J APPL TOXICOL, V25, P74, DOI 10.1002/jat.1042; Szczypka MS, 1997, YEAST, V13, P1423, DOI 10.1002/(SICI)1097-0061(199712)13:15<1423::AID-YEA190>3.3.CO;2-3; Tan SX, 2009, MOL BIOL CELL, V20, P1493, DOI 10.1091/mbc.E08-07-0697; Team R, 2008, R LANG ENV STAT COMP; Thomas R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r44; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Toledano MB, 2007, FEBS LETT, V581, P3598, DOI 10.1016/j.febslet.2007.07.002; Varela E, 2003, APPL ENVIRON MICROB, V69, P6025, DOI 10.1128/AEM.69.10.6025-6031.2003; Veal EA, 2003, J BIOL CHEM, V278, P30896, DOI 10.1074/jbc.M303542200; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Vignols F, 2005, P NATL ACAD SCI USA, V102, P16729, DOI 10.1073/pnas.0506880102; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wan JX, 2002, ENVIRON HEALTH PERSP, V110, P1213, DOI 10.1289/ehp.021101213; Winn LM, 2003, TOXICOL SCI, V72, P143, DOI 10.1093/toxsci/kfg008; Wong CM, 2004, J BIOL CHEM, V279, P23207, DOI 10.1074/jbc.M402095200; Wysocki R, 2004, MOL BIOL CELL, V15, P2049, DOI 10.1091/mbc.E03-04-0236; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; Yang XS, 2001, YEAST, V18, P1217, DOI 10.1002/yea.770; Zappa F, 2001, J HISTOCHEM CYTOCHEM, V49, P1187, DOI 10.1177/002215540104900913; Zhang L, 1994, FREE RADICALS ENV ME, P521; ZHANG LP, 1993, ENVIRON MOL MUTAGEN, V21, P339, DOI 10.1002/em.2850210405	109	41	44	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24205	10.1371/journal.pone.0024205	http://dx.doi.org/10.1371/journal.pone.0024205			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21912624	Green Published, gold, Green Submitted			2022-12-25	WOS:000294678300030
J	Lien, YJ; Hsiao, PC; Liu, CM; Faraone, SV; Tsuang, MT; Hwu, HG; Chen, WJ				Lien, Yin-Ju; Hsiao, Po-Chang; Liu, Chih-Min; Faraone, Stephen V.; Tsuang, Ming T.; Hwu, Hai-Gwo; Chen, Wei J.			A Genome-Wide Linkage Scan for Distinct Subsets of Schizophrenia Characterized by Age at Onset and Neurocognitive Deficits	PLOS ONE			English	Article							SUSTAINED ATTENTION DEFICITS; CONTINUOUS PERFORMANCE-TEST; CARD SORTING TEST; 1ST-DEGREE RELATIVES; SYMPTOM DIMENSIONS; COMMUNITY SAMPLES; GENETIC-LINKAGE; COMPLEX TRAITS; DISORDER; METAANALYSIS	Background: As schizophrenia is genetically and phenotypically heterogeneous, targeting genetically informative phenotypes may help identify greater linkage signals. The aim of the study is to evaluate the genetic linkage evidence for schizophrenia in subsets of families with earlier age at onset or greater neurocognitive deficits. Methods: Patients with schizophrenia (n = 1,207) and their first-degree relatives (n = 1,035) from 557 families with schizophrenia were recruited from six data collection field research centers throughout Taiwan. Subjects completed a face-to-face semi-structured interview, the Continuous Performance Test (CPT), the Wisconsin Card Sorting Test, and were genotyped with 386 microsatellite markers across the genome. Results: A maximum nonparametric logarithm of odds (LOD) score of 4.17 at 2q22.1 was found in 295 families ranked by increasing age at onset, which had significant increases in the maximum LOD score compared with those obtained in initial linkage analyses using all available families. Based on this subset, a further subsetting by false alarm rate on the undegraded and degraded CPT obtained further increase in the nested subset-based LOD on 2q22.1, with a score of 7.36 in 228 families and 7.71 in 243 families, respectively. Conclusion: We found possible evidence of linkage on chromosome 2q22.1 in families of schizophrenia patients with more CPT false alarm rates nested within the families with younger age at onset. These results highlight the importance of incorporating genetically informative phenotypes in unraveling the complex genetics of schizophrenia.	[Lien, Yin-Ju; Hwu, Hai-Gwo; Chen, Wei J.] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes, Taipei 10764, Taiwan; [Lien, Yin-Ju; Hwu, Hai-Gwo; Chen, Wei J.] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lien, Yin-Ju; Hsiao, Po-Chang; Chen, Wei J.] Natl Taiwan Univ, Genet Epidemiol Core Lab, Ctr Genom Med, Taipei 10764, Taiwan; [Lien, Yin-Ju; Chen, Wei J.] Natl Taiwan Univ, Dept Publ Hlth, Coll Publ Hlth, Taipei 10764, Taiwan; [Liu, Chih-Min; Hwu, Hai-Gwo; Chen, Wei J.] Natl Taiwan Univ, Dept Psychiat, Coll Med, Taipei 10764, Taiwan; [Liu, Chih-Min; Hwu, Hai-Gwo; Chen, Wei J.] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan; [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY USA; [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY USA; [Tsuang, Ming T.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Tsuang, Ming T.] Univ Calif San Diego, Ctr Behav Genom, San Diego, CA 92103 USA; [Tsuang, Ming T.] Harvard Inst Psychiat Epidemiol & Genet, Harvard Dept Epidemiol, Boston, MA USA; [Tsuang, Ming T.] Harvard Inst Psychiat Epidemiol & Genet, Harvard Dept Psychiat, Boston, MA USA	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Lien, YJ (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes, Taipei 10764, Taiwan.	wjchen@ntu.edu.tw	Faraone, Stephen/AAE-7334-2019; Faraone, Stephen V/O-7239-2018	Faraone, Stephen/0000-0002-9217-3982; Faraone, Stephen V/0000-0002-9217-3982; Hsiao, Po-Chang/0000-0002-5813-3389; HWU, HAI-GWO/0000-0002-2582-2807; Chen, Wei Jen/0000-0001-5899-5870; LIU, CHIH-MIN/0000-0001-7016-8990	National Health Research Institutes, Taiwan [DOH 88-HR-825, NHRI-GT-EX89P825P, NHRI-EX90-8825PP, NHRI-EX91, 92, 93-9113PP, NHRI-EX95, 96, 97, 98-9511PP]; National Science Council, Taiwan [NSC83-0412-B-002-310, NSC84-2331-B-002-187]; National Institute of Mental Health (NIMH) [1R01-MH-59624-01]; NTU [97HP0023]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059624] Funding Source: NIH RePORTER	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NTU(Nanyang Technological University); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by grants from the National Health Research Institutes, Taiwan (DOH 88-HR-825; NHRI-GT-EX89P825P; NHRI-EX90-8825PP; NHRI-EX91, 92, 93-9113PP; NHRI-EX95, 96, 97, 98-9511PP) and the National Science Council, Taiwan (NSC83-0412-B-002-310, NSC84-2331-B-002-187), National Institute of Mental Health (NIMH) grant 1R01-MH-59624-01, and NTU grant 97HP0023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Barcelo F, 1999, NEUROREPORT, V10, P1299, DOI 10.1097/00001756-199904260-00027; Buervenich S, 2000, AM J MED GENET, V96, P808, DOI 10.1002/1096-8628(20001204)96:6<808::AID-AJMG23>3.0.CO;2-E; Chen WJ, 2000, AM J MED GENET, V97, P52, DOI 10.1002/(SICI)1096-8628(200021)97:1<52::AID-AJMG7>3.0.CO;2-6; Chen WJ, 1997, J ABNORM PSYCHOL, V106, P649, DOI 10.1037/0021-843X.106.4.649; Chen WJ, 2004, BIOL PSYCHIAT, V55, P995, DOI 10.1016/j.biopsych.2004.01.010; Chen WJ, 1998, SCHIZOPHRENIA BULL, V24, P163, DOI 10.1093/oxfordjournals.schbul.a033308; Chen YH, 2001, AM J MED GENET, V105, P753, DOI 10.1002/ajmg.10036; Crow TJ, 2007, AM J PSYCHIAT, V164, P13, DOI 10.1176/appi.ajp.164.1.13; Doyle AE, 2008, AM J MED GENET B, V147B, P1399, DOI 10.1002/ajmg.b.30868; Faraone SV, 2006, AM J PSYCHIAT, V163, P1760, DOI 10.1176/appi.ajp.163.10.1760; Faraone SV, 2006, BIPOLAR DISORD, V8, P144, DOI 10.1111/j.1399-5618.2006.00289.x; GOLDBERG TE, 1987, ARCH GEN PSYCHIAT, V44, P1008; Gooding DC, 2002, SCHIZOPHR RES, V53, P209, DOI 10.1016/S0920-9964(01)00258-4; Gourion D, 2005, NEUROREPORT, V16, P1407, DOI 10.1097/01.wnr.0000175245.58708.6b; Hallmayer JF, 2005, AM J HUM GENET, V77, P468, DOI 10.1086/432816; Hallmayer JF, 2003, MOL PSYCHIATR, V8, P511, DOI 10.1038/sj.mp.4001273; Hauser ER, 2004, GENET EPIDEMIOL, V27, P53, DOI 10.1002/gepi.20000; Heaton R.K., 1993, WISCONSIN CARD SORTI; Hollis C, 2000, AM J PSYCHIAT, V157, P1652, DOI 10.1176/appi.ajp.157.10.1652; Hwu HG, 2005, AM J MED GENET B, V134B, P30, DOI 10.1002/ajmg.b.30139; Joyce E, 2005, BRIT J PSYCHIAT, V186, P93, DOI 10.1192/bjp.186.2.93; Joyce EM, 2007, CURR OPIN PSYCHIATR, V20, P268; KENDLER KS, 1987, ARCH GEN PSYCHIAT, V44, P881; KENDLER KS, 1990, GENET EPIDEMIOL, V7, P409, DOI 10.1002/gepi.1370070603; KIDD KK, 1984, CYTOGENET CELL GENET, V37, P510; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Lacerda ALT, 2003, PROG NEURO-PSYCHOPH, V27, P657, DOI 10.1016/S0278-5846(03)00076-9; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Laurent A, 2000, SCHIZOPHR RES, V46, P269, DOI 10.1016/S0920-9964(99)00232-7; Lien YJ, 2010, GENES BRAIN BEHAV, V9, P695, DOI 10.1111/j.1601-183X.2010.00599.x; Lin CCH, 2000, J CLIN EXP NEUROPSYC, V22, P69, DOI 10.1076/1380-3395(200002)22:1;1-8;FT069; LIN SH, 2011, SCHIZOPHR B; Liu SK, 1997, SCHIZOPHR RES, V25, P211, DOI 10.1016/S0920-9964(97)00026-1; Liu SK, 2000, NEUROPSYCHOPHARMACOL, V22, P311, DOI 10.1016/S0893-133X(99)00137-2; Liu YL, 2007, MOL PSYCHIATR, V12, P966, DOI 10.1038/sj.mp.4001977; Ng MYM, 2009, MOL PSYCHIATR, V14, P774, DOI 10.1038/mp.2008.135; Nieuwenstein MR, 2001, J PSYCHIATR RES, V35, P119, DOI 10.1016/S0022-3956(01)00014-0; NIMH Genetics Initiative, 1992, FAM INT GEN STUD; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; OTT J, 1986, GENET EPIDEMIOL, P251; Renou J, 2007, MOL PSYCHIATR, V12, P1058, DOI 10.1038/sj.mp.4002092; RISCH N, 1988, AM J HUM GENET, V42, P353; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Scott WK, 2003, AM J HUM GENET, V73, P1041, DOI 10.1086/379083; Shao YJ, 2003, AM J HUM GENET, V72, P539, DOI 10.1086/367846; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Sullivan PF, 2008, CURR OPIN PSYCHIATR, V21, P157, DOI 10.1097/YCO.0b013e3282f4efde; Szatmari P, 2007, AM J MED GENET B, V144B, P581, DOI 10.1002/ajmg.b.30426; Szoke A, 2005, PSYCHOL MED, V35, P771, DOI 10.1017/S0033291704003460; Talkowski ME, 2008, HUM MOL GENET, V17, P747, DOI 10.1093/hmg/ddm347; Tsuang HC, 2006, SCHIZOPHR RES, V87, P172, DOI 10.1016/j.schres.2006.03.045; Tsuang M, 2000, BIOL PSYCHIAT, V47, P210, DOI 10.1016/S0006-3223(99)00289-9; Tuulio-Henriksson A, 2004, BRIT J PSYCHIAT, V185, P215, DOI 10.1192/bjp.185.3.215; Wang Q, 2007, SCHIZOPHR RES, V89, P293, DOI 10.1016/j.schres.2006.08.030; Yan L, 2000, AM J MED GENET, V96, P404, DOI 10.1002/1096-8628(20000612)96:3<404::AID-AJMG31>3.0.CO;2-D	57	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2011	6	8							e24103	10.1371/journal.pone.0024103	http://dx.doi.org/10.1371/journal.pone.0024103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MF	21897869	Green Published, gold, Green Submitted			2022-12-25	WOS:000294676900033
J	Capitan, JA; Cuesta, JA; Manrubia, SC; Aguirre, J				Capitan, Jose A.; Cuesta, Jose A.; Manrubia, Susanna C.; Aguirre, Jacobo			Severe Hindrance of Viral Infection Propagation in Spatially Extended Hosts	PLOS ONE			English	Article							ERROR CATASTROPHE; PHASE-TRANSITIONS; MUTATION-RATES; VIRUS; EVOLUTION; EXTINCTION; BOTTLENECKS; SUPPRESSION; THRESHOLD; GENETICS	The production of large progeny numbers affected by high mutation rates is a ubiquitous strategy of viruses, as it promotes quick adaptation and survival to changing environments. However, this situation often ushers in an arms race between the virus and the host cells. In this paper we investigate in depth a model for the dynamics of a phenotypically heterogeneous population of viruses whose propagation is limited to two-dimensional geometries, and where host cells are able to develop defenses against infection. Our analytical and numerical analyses are developed in close connection to directed percolation models. In fact, we show that making the space explicit in the model, which in turn amounts to reducing viral mobility and hindering the infective ability of the virus, connects our work with similar dynamical models that lie in the universality class of directed percolation. In addition, we use the fact that our model is a multicomponent generalization of the Domany-Kinzel probabilistic cellular automaton to employ several techniques developed in the past in that context, such as the two-site approximation to the extinction transition line. Our aim is to better understand propagation of viral infections with mobility restrictions, e. g., in crops or in plant leaves, in order to inspire new strategies for effective viral control.	[Capitan, Jose A.] Univ Rovira & Virgili, Dept Engn Informat & Matemat, Tarragona, Spain; [Capitan, Jose A.; Cuesta, Jose A.] GISC, Madrid, Spain; [Cuesta, Jose A.] Univ Carlos III Madrid, Escuela Politecn Super, Dept Matemat, Madrid, Spain; [Manrubia, Susanna C.; Aguirre, Jacobo] CSIC INTA, Ctr Astrobiol, Madrid, Spain	Universitat Rovira i Virgili; Universidad Carlos III de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA)	Capitan, JA (corresponding author), Univ Rovira & Virgili, Dept Engn Informat & Matemat, Tarragona, Spain.	aguirreaj@cab.inta-csic.es	Cuesta, Jose A/A-7157-2008; Capitan, Jose A./D-8669-2012; Manrubia, Susanna/K-4501-2014; Cuesta, Jose A/Z-4696-2019; Aguirre, Jacobo/K-5855-2014	Cuesta, Jose A/0000-0001-9890-9367; Capitan, Jose A./0000-0002-6245-0088; Manrubia, Susanna/0000-0003-0134-2785; Aguirre, Jacobo/0000-0003-2196-5103	Ministerio de Ciencia e Innovacion (Spain) [FIS2008-05273]; Comunidad Autonoma de Madrid (Spain)	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad Autonoma de Madrid (Spain)(Comunidad de Madrid)	Projects FIS2008-05273, MOSAICO, and Complexity-NET RESINEE from Ministerio de Ciencia e Innovacion (Spain), and MODELICO-CM from Comunidad Autonoma de Madrid (Spain) provided funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2009, J THEOR BIOL, V261, P148, DOI 10.1016/j.jtbi.2009.07.034; Aguirre J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.038106; Altmeyer S, 2001, PHYS REV LETT, V86, P5819, DOI 10.1103/PhysRevLett.86.5819; Atman APF, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046135; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Broadbent S. R., 1957, P CAMB PHILOS SOC, V53, P629, DOI DOI 10.1017/S0305004100032680; Bull JJ, 2005, PLOS COMPUT BIOL, V1, P450, DOI 10.1371/journal.pcbi.0010061; Cases-Gonzalez C, 2008, J MOL BIOL, V384, P1120, DOI 10.1016/j.jmb.2008.10.014; Coutts BA, 2004, ANN APPL BIOL, V145, P339, DOI 10.1111/j.1744-7348.2004.tb00391.x; CUESTA JA, 2010, MATH COMP M IN PRESS; Cuesta JA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028104; DOMANY E, 1984, PHYS REV LETT, V53, P311, DOI 10.1103/PhysRevLett.53.311; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Eigen M, 2002, P NATL ACAD SCI USA, V99, P13374, DOI 10.1073/pnas.212514799; Eigen M, 1979, THE HYPERCYCLE, P60; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; GABRIEL W, 1993, EVOLUTION, V47, P1744, DOI 10.1111/j.1558-5646.1993.tb01266.x; Garcia-Arenal F, 2001, ANNU REV PHYTOPATHOL, V39, P157, DOI 10.1146/annurev.phyto.39.1.157; Grande-Perez A, 2005, P NATL ACAD SCI USA, V102, P4448, DOI 10.1073/pnas.0408871102; GRASSBERGER P, 1982, Z PHYS B CON MAT, V47, P365, DOI 10.1007/BF01313803; GRASSBERGER P, 1983, MATH BIOSCI, V63, P157, DOI 10.1016/0025-5564(82)90036-0; Hinrichsen H, 2000, ADV PHYS, V49, P815, DOI 10.1080/00018730050198152; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Iranzo J, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/18001; JANSSEN HK, 1981, Z PHYS B CON MAT, V42, P151, DOI 10.1007/BF01319549; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; KINZEL W, 1983, ANN ISRAEL PHYS SOC, V5, P143; KNIPE DM, 2007, FIELDS VIROLOGY, V1; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-29; Lazaro E, 2003, P NATL ACAD SCI USA, V100, P10830, DOI 10.1073/pnas.1332668100; Lee Y, 1996, NAT BIOTECHNOL, V14, P491, DOI 10.1038/nbt0496-491; Manrubia SC, 2006, EUROPHYS LETT, V74, P547, DOI 10.1209/epl/i2005-10560-9; Manrubia SC, 2005, GENE, V347, P273, DOI 10.1016/j.gene.2004.12.033; Manrubia SC, 2006, PHYS LIFE REV, V3, P65, DOI 10.1016/j.plrev.2005.11.002; Manrubia SC, 2010, PHILOS T R SOC B, V365, P1943, DOI 10.1098/rstb.2010.0076; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; Orr HA, 2003, GENETICS, V163, P1519; Parera M, 2007, MOL BIOL EVOL, V24, P382, DOI 10.1093/molbev/msl168; Pastor-Satorras R, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051909; Perales C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000658; Petermann T, 2004, J THEOR BIOL, V229, P1, DOI 10.1016/j.jtbi.2004.02.017; RAND DA, 1995, P ROY SOC B-BIOL SCI, V259, P55, DOI 10.1098/rspb.1995.0009; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Sanjuan R, 2010, PHILOS T R SOC B, V365, P1975, DOI 10.1098/rstb.2010.0063; Takahashi T, 2007, PHYTOPATHOLOGY, V97, P1200, DOI 10.1094/PHYTO-97-10-1200; Takeuchi N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-15; TOME T, 1994, PHYSICA A, V212, P99, DOI 10.1016/0378-4371(94)90139-2; Toyabe S, 2005, PHYSICA D, V203, P1, DOI 10.1016/j.physd.2005.02.011; Wahl LM, 2000, GENETICS, V156, P1437; Wilke CO, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-44	50	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23358	10.1371/journal.pone.0023358	http://dx.doi.org/10.1371/journal.pone.0023358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21912595	gold, Green Submitted, Green Published			2022-12-25	WOS:000294253500013
J	Shum, MSY; Pasquier, E; Po'uha, ST; O'Neill, GM; Chaponnier, C; Gunning, PW; Kavallaris, M				Shum, Michael S. Y.; Pasquier, Eddy; Po'uha, Sela T.; O'Neill, Geraldine M.; Chaponnier, Christine; Gunning, Peter W.; Kavallaris, Maria			gamma-Actin regulates cell migration and modulates the ROCK signaling pathway	FASEB JOURNAL			English	Article						cytoskeleton; focal adhesion; motility; polarity; beta-actin; paxillin	BETA-ACTIN; POLARITY PROTEINS; CDC42 CONTROLS; ISOFORMS; EXPRESSION; ADHESION; MYOSIN; IMMUNOLOCALIZATION; ARGINYLATION; CYTOSKELETON	Cell migration plays a crucial role in numerous cellular functions, and alterations in the regulation of cell migration are required for invasive transformation of a tumor cell. While the mechanistic process of actin-based migration has been well documented, little is known as to the specific function of the nonmuscle actin isoforms in mammalian cells. Here, we present a comprehensive examination of gamma-actin's role in cell migration using an RNAi approach. The partial suppression of gamma-actin expression in SH-EP neuroblastoma cells resulted in a significant decrease in wound healing and transwell migration. Similarly, the knockdown of gamma-actin significantly reduced speed of motility and severely affected the cell's ability to explore, which was, in part, due to a loss of cell polarity. Moreover, there was a significant increase in the size and number of paxillin-containing focal adhesions, coupled with a significant decrease in phosphorylated paxillin in gamma-actin-knockdown cells. In addition, there was a significant increase in the phosphorylation of cofilin and myosin regulatory light chain, suggesting an overactivated Rhoassociated kinase (ROCK) signaling pathway in gamma-actin-knockdown cells. The alterations in the phosphorylation of paxillin and myosin regulatory light chain were unique to gamma-actin and not beta-actin knockdown. Inhibition of the ROCK pathway with the inhibitor Y-27632 restored the ability of gamma-actin-knockdown cells to migrate. This study demonstrates gamma-actin as a potential upstream regulator of ROCK mediated cell migration.-Shum, M. S. Y., Pasquier, E., Po'uha, S. T., O'Neill, G. M., Chaponnier, C., Gunning, P. W., Kavallaris, M. gamma-Actin regulates cell migration and modulates the ROCK signaling pathway. FASEB J. 25, 4423-4433 (2011). www.fasebj.org	[Shum, Michael S. Y.; Pasquier, Eddy; Po'uha, Sela T.; Kavallaris, Maria] Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia, Sydney, NSW, Australia; [Gunning, Peter W.] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Oncol Res Unit, Sydney, NSW, Australia; [O'Neill, Geraldine M.] Childrens Hosp Westmead, Kids Res Inst, Focal Adhes Biol Grp, Westmead, NSW, Australia; [O'Neill, Geraldine M.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Chaponnier, Christine] Univ Geneva, Fac Med, Dept Pathol Immunol, Geneva, Switzerland	Children's Cancer Institute; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney; University of Geneva	Kavallaris, M (corresponding author), UNSW, Lowy Canc Res Ctr, Childrens Canc Inst Australia, POB 81, Randwick, NSW 2031, Australia.	m.kavallaris@ccia.unsw.edu.au	Gunning, Peter W/E-9058-2010; O'Neill, Geraldine/F-3112-2014; Pasquier, Eddy/A-8112-2018; Kavallaris, Maria/J-5240-2014	Pasquier, Eddy/0000-0003-2824-5002; O'Neill, Geraldine/0000-0001-9997-8794; Gunning, Peter/0000-0003-0833-3128	Children's Cancer Institute Australia for Medical Research; Australian Postgraduate Award; Swiss National Foundation; National Health and Medical Research Council (NHMRC); Oncology Children's Foundation; NHMRC	Children's Cancer Institute Australia for Medical Research; Australian Postgraduate Award(Australian Government); Swiss National Foundation(Swiss National Science Foundation (SNSF)); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Oncology Children's Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank Ms. Frances Byrne for insightful discussions. This work was supported by Children's Cancer Institute Australia for Medical Research, which is affiliated with the University of New South Wales and the Sydney Children's Hospital, and funding from an Australian Postgraduate Award (M.S.Y.S.), grants from the Swiss National Foundation (C.C.), the National Health and Medical Research Council (NHMRC; M.K. and P.W.G.), the Oncology Children's Foundation, and NHMRC Senior and Principal Research Fellowships to M. K. and P. W. G., respectively.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bach CTT, 2009, MOL CELL BIOL, V29, P1506, DOI 10.1128/MCB.00857-08; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Bryan KE, 2006, J BIOL CHEM, V281, P20129, DOI 10.1074/jbc.M601514200; Cau JL, 2005, J CELL SCI, V118, P2579, DOI 10.1242/jcs.02385; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; DENOFRIO D, 1989, J CELL BIOL, V109, P191, DOI 10.1083/jcb.109.1.191; Dugina V, 2009, J CELL SCI, V122, P2980, DOI 10.1242/jcs.041970; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; HILL MA, 1993, J CELL BIOL, V122, P825, DOI 10.1083/jcb.122.4.825; HOOCK TC, 1991, J CELL BIOL, V112, P653, DOI 10.1083/jcb.112.4.653; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; Kouvroukoglou S, 2000, BIOMATERIALS, V21, P1725, DOI 10.1016/S0142-9612(99)00205-7; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; OTEY CA, 1988, CELL MOTIL CYTOSKEL, V9, P337, DOI 10.1002/cm.970090406; OTEY CA, 1986, J CELL BIOL, V102, P1726, DOI 10.1083/jcb.102.5.1726; OTEY CA, 1987, J CELL BIOCHEM, V34, P113, DOI 10.1002/jcb.240340205; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Pasquier E, 2010, MOL CANCER THER, V9, P1408, DOI 10.1158/1535-7163.MCT-09-0894; Pourroy B, 2006, CANCER RES, V66, P3256, DOI 10.1158/0008-5472.CAN-05-3885; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Schevzov G, 2005, J HISTOCHEM CYTOCHEM, V53, P557, DOI 10.1369/jhc.4A6505.2005; SCHEVZOV G, 1992, J CELL BIOL, V117, P775, DOI 10.1083/jcb.117.4.775; SCHEVZOV G, 1995, DNA CELL BIOL, V14, P689, DOI 10.1089/dna.1995.14.689; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Verrills NM, 2006, J NATL CANCER I, V98, P1363, DOI 10.1093/jnci/djj372; Verrills NM, 2006, PROTEOMICS, V6, P1681, DOI 10.1002/pmic.200500417; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Watanabe H, 1998, J CELL SCI, V111, P1287; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zhang FL, 2010, SCIENCE, V329, P1534, DOI 10.1126/science.1191701; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	41	48	50	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4423	4433		10.1096/fj.11-185447	http://dx.doi.org/10.1096/fj.11-185447			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21908715	Green Published			2022-12-25	WOS:000298138100033
J	Bate, C; Williams, A				Bate, Clive; Williams, Alun			Amyloid-beta-induced Synapse Damage Is Mediated via Cross-linkage of Cellular Prion Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; A-BETA; PHOSPHOLIPASE A(2); CYTOSOLIC PHOSPHOLIPASE-A(2); NATURAL OLIGOMERS; MOLECULAR-BASIS; PEPTIDE; A-BETA(1-42); DYSFUNCTION; ACTIVATION	The cellular prion protein (PrPC), which is highly expressed at synapses, was identified as a receptor for the amyloid-beta (A beta) oligomers that are associated with dementia in Alzheimer disease. Here, we report that A beta oligomers secreted by 7PA2 cells caused synapse damage in cultured neurons via a PrPC-dependent process. Exogenous PrPC added to Prnp knock-out((0/0)) neurons was targeted to synapses and significantly increased A beta-induced synapse damage. In contrast, the synapse damage induced by a phospholipase A(2)-activating peptide was independent of PrPC. In Prnp wild-type((+/+)) neurons A beta oligomers activated synaptic cytoplasmic phospholipase A(2) (cPLA(2)). In these cells, the addition of A beta oligomers triggered the translocation of cPLA(2) in synapses to cholesterol dense membranes (lipid rafts) where it formed a complex also containing A beta and PrPC. In contrast, the addition of A beta to Prnp((0/0)) neurons did not activate synaptic cPLA(2), which remained in the cytoplasm and was not associated with A beta. Filtration assays and non-denaturing gels demonstrated that A beta oligomers cross-link PrPC. We propose that it is the cross-linkage of PrPC by A beta oligomers that triggers abnormal activation of cPLA(2) and synapse damage. This hypothesis was supported by our observation that monoclonal antibody mediated cross-linkage of PrPC also activated synaptic cPLA(2) and caused synapse damage.	[Bate, Clive] Royal Vet Coll, Dept Pathol & Infect Dis, N Mymms AL9 7TA, Herts, England; [Williams, Alun] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	University of London; University of London Royal Veterinary College; University of Cambridge	Bate, C (corresponding author), Royal Vet Coll, Dept Pathol & Infect Dis, Hawkshead Lane, N Mymms AL9 7TA, Herts, England.	cbate@rvc.ac.uk						Anfuso CD, 2004, BBA-MOL CELL BIOL L, V1686, P125, DOI 10.1016/j.bbalip.2004.09.006; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Bate C, 2007, NEUROPHARMACOLOGY, V53, P222, DOI 10.1016/j.neuropharm.2007.05.003; Bate C, 2011, J BIOL CHEM, V286, P8752, DOI 10.1074/jbc.M110.186833; Bate C, 2010, J ALZHEIMERS DIS, V21, P985, DOI 10.3233/JAD-2010-100528; Bate C, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-13; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Brown DR, 2001, TRENDS NEUROSCI, V24, P85, DOI 10.1016/S0166-2236(00)01689-1; Chiesa R, 2008, J NEUROSCI, V28, P13258, DOI 10.1523/JNEUROSCI.3109-08.2008; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Counts SE, 2006, J NEUROPATH EXP NEUR, V65, P592, DOI 10.1097/00005072-200606000-00007; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Gaudreault SB, 2004, J BIOL CHEM, V279, P356, DOI 10.1074/jbc.M304777200; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HAMOS JE, 1989, NEUROLOGY, V39, P355, DOI 10.1212/WNL.39.3.355; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; Jeng CJ, 1998, J CELL BIOL, V140, P685, DOI 10.1083/jcb.140.3.685; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Lorenzo A, 2000, NAT NEUROSCI, V3, P460, DOI 10.1038/74833; Manzoni C, 2009, AMYLOID, V16, P71, DOI 10.1080/13506120902879848; MOSKOWITZ N, 1982, SCIENCE, V216, P305, DOI 10.1126/science.6278597; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Reddy PH, 2005, J ALZHEIMERS DIS, V7, P103, DOI 10.3233/jad-2005-7203; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Shelat PB, 2008, J NEUROCHEM, V106, P45, DOI 10.1111/j.1471-4159.2008.05347.x; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; Tanzi RE, 2005, NAT NEUROSCI, V8, P977, DOI 10.1038/nn0805-977; Thais ME, 2006, BRAIN RES, V1075, P13, DOI 10.1016/j.brainres.2005.12.045; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; Vassar R, 2000, NEURON, V27, P419, DOI 10.1016/S0896-6273(00)00051-9; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang SSS, 2001, J BIOL CHEM, V276, P42027, DOI 10.1074/jbc.M102834200; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0	52	76	78	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					37955	37963		10.1074/jbc.M111.248724	http://dx.doi.org/10.1074/jbc.M111.248724			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900234	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000296594200008
J	Hanzelmann, P; Schindelin, H				Haenzelmann, Petra; Schindelin, Hermann			The Structural and Functional Basis of the p97/Valosin-containing Protein (VCP)-interacting Motif (VIM) MUTUALLY EXCLUSIVE BINDING OF COFACTORS TO THE N-TERMINAL DOMAIN OF p97	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA ATPASE P97/VCP; INCLUSION-BODY MYOPATHY; P97; UBIQUITIN; DISEASE; BINDING; INSIGHTS; UBXD1; COFACTORS; INTERACTS	The AAA (ATPase associated with various cellular activities) ATPase p97, also referred to as valosin-containing protein (VCP), mediates essential cellular processes, including ubiquitin-dependent protein degradation, and has been linked to several human proteinopathies. p97 interacts with multiple cofactors via its N-terminal (p97N) domain, a subset of which contain the VCP-interacting motif (VIM). We have determined the crystal structure of the p97N domain in complex with the VIM of the ubiquitin E3 ligase gp78 at 1.8 angstrom resolution. The alpha-helical VIM peptide binds into a groove located in between the two subdomains of the p97N domain. Interaction studies of several VIM proteins reveal that these cofactors display dramatically different affinities, ranging from high affinity interactions characterized by dissociation constants of similar to 20 nM for gp78 and ANKZF1 to only weak binding in our assays. The contribution of individual p97 residues to VIM binding was analyzed, revealing that identical substitutions do not affect all cofactors in the same way. Taken together, the biochemical and structural studies define the framework for recognition of VIM-containing cofactors by p97. Of particular interest to the regulation of p97 by its cofactors, our structure reveals that the bound alpha-helical peptides of VIM-containing cofactors overlap with the binding site for cofactors containing the ubiquitin regulatory X (UBX) domain present in the UBX protein family or the ubiquitin-like domain of NPL4 as further corroborated by biochemical data. These results extend the concept that competitive binding is a crucial determinant in p97-cofactor interactions.	[Haenzelmann, Petra; Schindelin, Hermann] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany	University of Wurzburg	Hanzelmann, P (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	petra.haenzelmann@virchow.uni-wuerzburg.de	Schindelin, Hermann/Q-2697-2019		Deutsche Forschungsgemeinschaft (Rudolf Virchow Center for Experimental Biomedicine) [FZ 82]	Deutsche Forschungsgemeinschaft (Rudolf Virchow Center for Experimental Biomedicine)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Rudolf Virchow Center for Experimental Biomedicine, FZ 82) (to H. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Ballar P, 2011, INT J BIOCHEM CELL B, V43, P613, DOI 10.1016/j.biocel.2010.12.021; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Haines Dale S, 2010, Genes Cancer, V1, P753; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Isaacson RL, 2007, J BIOL CHEM, V282, P21361, DOI 10.1074/jbc.M610069200; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Ju JS, 2010, HUM MOL GENET, V19, pR38, DOI 10.1093/hmg/ddq157; Kern M, 2009, BIOCHEM BIOPH RES CO, V380, P303, DOI 10.1016/j.bbrc.2009.01.076; Madsen L, 2008, INT J BIOCHEM CELL B, V40, P2927, DOI 10.1016/j.biocel.2008.06.008; Madsen L, 2009, INT J BIOCHEM CELL B, V41, P2380, DOI 10.1016/j.biocel.2009.05.017; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Morreale G, 2009, FEBS J, V276, P1208, DOI 10.1111/j.1742-4658.2008.06858.x; Nagahama M, 2003, MOL BIOL CELL, V14, P262, DOI 10.1091/mbc.02-07-0115; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Rich RL, 2007, ANAL BIOCHEM, V361, P1, DOI 10.1016/j.ab.2006.10.040; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Rouiller I, 2000, MOL CELL, V6, P1485, DOI 10.1016/S1097-2765(00)00144-1; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Stapf C, 2011, J BIOL CHEM, V286, P38670, DOI 10.1074/jbc.M111.274472; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Vagenende V, 2009, BIOCHEMISTRY-US, V48, P11084, DOI 10.1021/bi900649t; Vij N, 2008, J CELL MOL MED, V12, P2511, DOI 10.1111/j.1582-4934.2008.00462.x; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104; Zhao G, 2009, P NATL ACAD SCI USA, V106, P16197, DOI 10.1073/pnas.0908321106	46	54	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38679	38690		10.1074/jbc.M111.274506	http://dx.doi.org/10.1074/jbc.M111.274506			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914798	hybrid, Green Published			2022-12-25	WOS:000296594200080
J	Zhuang, CM; Tang, HX; Dissanaike, S; Cobos, E; Tao, YX; Dai, ZH				Zhuang, Chunmei; Tang, Hongxing; Dissanaike, Sharmila; Cobos, Everardo; Tao, Yunxia; Dai, Zonghan			CDK1-mediated Phosphorylation of Abi1 Attenuates Bcr-Abl-induced F-actin Assembly and Tyrosine Phosphorylation of WAVE Complex during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; C-ABL; MITOTIC PHOSPHORYLATION; POLARIZED DISTRIBUTION; TRANSFORMING ACTIVITY; REGULATORY COMPLEX; SIGNALING COMPLEX; TARGET PROTEINS; KINASE; ACTIVATION	Coordinated actin remodeling is crucial for cell entry into mitosis. The WAVE regulatory complex is a key regulator of actin assembly, yet how the WAVE signaling is regulated to coordinate actin assembly with mitotic entry is not clear. Here, we have uncovered a novel mechanism that regulates the WAVE complex at the onset of mitosis. We found that the Bcr-Abl-stimulated F-actin assembly is abrogated during mitosis. This mitotic inhibition of F-actin assembly is accompanied by an attenuation of Bcr-Abl-induced tyrosine phosphorylation of the WAVE complex. We identified serine 216 of Abi1 as a target of CDK1/cyclin B kinase that is phosphorylated in cells at the onset of mitosis. The Abi1 phosphorylated on serine 216 displayed greatly reduced tyrosine phosphorylation in the hematopoietic cells transformed by Bcr-Abl. Moreover, a phosphomimetic mutation of serine 216 to aspartic acid in Abi1 was sufficient to attenuate Bcr-Abl-induced tyrosine phosphorylation of the WAVE complex and F-actin assembly. Ectopic expression of Abi1 with serine 216 mutations interfered with cell cycle progression. Together, these data show that CDK1-mediated phosphorylation of serine 216 in Abi1 serves as a regulatory mechanism that may contribute to coordinated actin cytoskeleton remodeling during mitosis.	[Zhuang, Chunmei; Tang, Hongxing; Cobos, Everardo; Tao, Yunxia; Dai, Zonghan] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Amarillo, TX 79106 USA; [Dissanaike, Sharmila] Texas Tech Univ, Hlth Sci Ctr, Dept Surg, Amarillo, TX 79106 USA; [Cobos, Everardo; Dai, Zonghan] Texas Tech Univ, Hlth Sci Ctr, Stem Cell Transplant Program, Amarillo, TX 79106 USA; [Zhuang, Chunmei] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Shandong University	Dai, ZH (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, 1406 Coulter St, Amarillo, TX 79106 USA.	zonghan.dai@ttuhsc.edu			National Institutes of Health from NCI [R01 CA094921, R21 CA133597]; National Institutes of Health from NIDDK [K01 DK067191]; When Everyone Survives Foundation; NATIONAL CANCER INSTITUTE [R21CA133597, R01CA094921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK067191] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health from NIDDK; When Everyone Survives Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA094921 and R21 CA133597 (to Z. D.) from NCI and Grant K01 DK067191 (to Y. T.) from NIDDK. This work was also supported by a grant from the When Everyone Survives Foundation (to Z. D.).	Ardern H, 2006, CELL MOTIL CYTOSKEL, V63, P6, DOI 10.1002/cm.20101; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Courtney KD, 2000, MOL CELL NEUROSCI, V16, P244, DOI 10.1006/mcne.2000.0865; Cramer LP, 1997, MOL BIOL CELL, V8, P109, DOI 10.1091/mbc.8.1.109; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Dai ZH, 1998, GENE DEV, V12, P1415, DOI 10.1101/gad.12.10.1415; Dai ZH, 2001, J BIOL CHEM, V276, P28954, DOI 10.1074/jbc.M101170200; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Derivery E, 2009, CELL MOTIL CYTOSKEL, V66, P777, DOI 10.1002/cm.20342; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Gautreau A, 2004, P NATL ACAD SCI USA, V101, P4379, DOI 10.1073/pnas.0400628101; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Ismail AM, 2009, NAT STRUCT MOL BIOL, V16, P561, DOI 10.1038/nsmb.1587; Juang JL, 1999, ONCOGENE, V18, P5138, DOI 10.1038/sj.onc.1202911; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; KIPREOS ET, 1990, SCIENCE, V248, P217, DOI 10.1126/science.2183353; Kondylis V, 2007, DEV CELL, V12, P901, DOI 10.1016/j.devcel.2007.03.008; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Li YZ, 2007, J CELL SCI, V120, P1436, DOI 10.1242/jcs.03430; Lin TY, 2004, J BIOMED SCI, V11, P902, DOI 10.1159/000081837; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; McWhirter JR, 1997, ONCOGENE, V15, P1625, DOI 10.1038/sj.onc.1201342; Mendoza MC, 2011, MOL CELL, V41, P661, DOI 10.1016/j.molcel.2011.02.031; Messenger MM, 2002, J BIOL CHEM, V277, P23054, DOI 10.1074/jbc.M200111200; Mistry SJ, 2001, J BIOL CHEM, V276, P31209, DOI 10.1074/jbc.M011654200; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Salgia R, 1997, J CLIN INVEST, V100, P46, DOI 10.1172/JCI119520; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Skourides PA, 1999, ONCOGENE, V18, P1165, DOI 10.1038/sj.onc.1202407; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Stuart JR, 2006, J BIOL CHEM, V281, P31290, DOI 10.1074/jbc.M602389200; Sun X, 2008, LEUKEMIA, V22, P1053, DOI 10.1038/sj.leu.2404990; Sun XL, 2009, CARCINOGENESIS, V30, P2109, DOI 10.1093/carcin/bgp251; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Woodring PJ, 2005, J BIOL CHEM, V280, P10318, DOI 10.1074/jbc.M410658200; Yu WD, 2008, CARCINOGENESIS, V29, P1717, DOI 10.1093/carcin/bgn098	43	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38614	38626		10.1074/jbc.M111.281139	http://dx.doi.org/10.1074/jbc.M111.281139			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900237	Green Published, hybrid			2022-12-25	WOS:000296594200074
J	Bau, DT; Tsai, CW; Lin, CC; Tsai, RY; Tsai, MH				Bau, Da-Tian; Tsai, Chia-Wen; Lin, Cheng-Chieh; Tsai, Ru-Yin; Tsai, Ming-Hsui			Association of Alpha B-Crystallin Genotypes with Oral Cancer Susceptibility, Survival, and Recurrence in Taiwan	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED-STATES; NECK-CANCER; HEAD; GENE; IDENTIFICATION; PHARYNX; TISSUES; CAVITY	Background: Alpha B-crystallin (CRYAB) is a protein that functions as "molecular chaperone'' in preserving intracellular architecture and cell membrane. Also, CRYAB is highly antiapoptotic. Abnormal CRYAB expression is a prognostic biomarker for oral cancer, while its genomic variations and the association with carcinogenesis have never been studied. Methodology/Finding: Therefore, we hypothesized that CRYAB single nucleotide polymorphisms may be associated with oral cancer risk. In this hospital-based study, the association of CRYAB A-1215G (rs2228387), C-802G (rs14133) and intron2 (rs2070894) polymorphisms with oral cancer in a Taiwan population was investigated. In total, 496 oral cancer patients and 992 age-and gender-matched healthy controls were genotyped and analyzed. A significantly different frequency distribution was found in CRYAB C-802G genotypes, but not in A-1215G and intron2 genotypes, between the oral cancer and control groups. The CRYAB C-802G G allele conferred an increased risk of oral cancer (P = 1.49610(-5)). Patients carrying CG/GG at CRYAB C-802G were of lower 5-year survival and higher recurrence rate than those of CC (P < 0.05). Conclusion/Significance: Our results provide the first evidence that the G allele of CRYAB C-802G is correlated with oral cancer risk and this polymorphism may be a useful marker for oral cancer recurrence and survival prediction for clinical reference.	[Bau, Da-Tian; Tsai, Chia-Wen; Lin, Cheng-Chieh; Tsai, Ru-Yin; Tsai, Ming-Hsui] China Med Univ Hosp, Terry Fox Canc Res Lab, Taichung, Taiwan; [Bau, Da-Tian; Tsai, Chia-Wen] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Bau, Da-Tian] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Tsai, Ming-Hsui] China Med Univ Hosp, Dept Otolaryngol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Bau, DT (corresponding author), China Med Univ Hosp, Terry Fox Canc Res Lab, Taichung, Taiwan.	datian@mail.cmuh.org.tw; francisloyl@gmail.com	Lin, Cheng-Chieh/P-2564-2015	Lin, Cheng-Chieh/0000-0002-9625-6216	National Science Council (NSC) [98-2320-B-039-010-MY3]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	This study was supported by research grants from the National Science Council (NSC 98-2320-B-039-010-MY3) (https://nscnt12.nsc.gov.tw/RS09/Modules/Personal/Personal_Researcher_index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bau DT, 2007, ANTICANCER RES, V27, P1559; Bau DT, 2008, ORAL ONCOL, V44, P1047, DOI 10.1016/j.oraloncology.2008.02.008; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Boslooper K, 2008, PATHOLOGY, V40, P500, DOI 10.1080/00313020802198010; Caplan DJ, 1998, J PUBLIC HEALTH DENT, V58, P36, DOI 10.1111/j.1752-7325.1998.tb02988.x; Chang NW, 2010, CHEM-BIOL INTERACT, V183, P231, DOI 10.1016/j.cbi.2009.10.005; Chin D, 2005, LARYNGOSCOPE, V115, P1239, DOI 10.1097/01.MLG.0000164715.86240.55; Chiu CF, 2008, ORAL ONCOL, V44, P898, DOI 10.1016/j.oraloncology.2007.11.007; Chiu CF, 2008, ORAL ONCOL, V44, P582, DOI 10.1016/j.oraloncology.2007.07.006; *DEP HLTH TAIW, 2008, CAN REG SYST ANN REP; Hsu CF, 2009, ORAL ONCOL, V45, P789, DOI 10.1016/j.oraloncology.2008.12.002; IWAKI T, 1990, J HISTOCHEM CYTOCHEM, V38, P31, DOI 10.1177/38.1.2294148; Khuri FR, 2006, JNCI-J NATL CANCER I, V98, P441, DOI 10.1093/jnci/djj091; Khuri FR, 2001, CANCER EPIDEM BIOMAR, V10, P823; Lo WY, 2007, CLIN CHIM ACTA, V376, P101, DOI 10.1016/j.cca.2006.06.030; Moore RJ, 2001, ETHNIC HEALTH, V6, P165, DOI 10.1080/13557850120078099; Moyano JV, 2006, J CLIN INVEST, V116, P261, DOI 10.1172/JCI25888; Sax C M, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P155; Shiboski CH, 2000, COMMUNITY DENT ORAL, V28, P249, DOI 10.1034/j.1600-0528.2000.280402.x; Solares CA, 2010, OTOLARYNG HEAD NECK, V142, pS15, DOI 10.1016/j.otohns.2009.12.001; Stronach EA, 2003, CANCER RES, V63, P8648; Swango PA, 1996, J PUBLIC HEALTH DENT, V56, P309, DOI 10.1111/j.1752-7325.1996.tb02458.x; Tsai MH, 2009, ORAL ONCOL, V45, pE90, DOI 10.1016/j.oraloncology.2009.03.011; Tseng HC, 2008, ANTICANCER RES, V28, P1687	24	35	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e16374	10.1371/journal.pone.0016374	http://dx.doi.org/10.1371/journal.pone.0016374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915251	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802500003
J	Bi, YT; Kim, H; Gupta, R; Davuluri, RV				Bi, Yingtao; Kim, Hyunsoo; Gupta, Ravi; Davuluri, Ramana V.			Tree-Based Position Weight Matrix Approach to Model Transcription Factor Binding Site Profiles	PLOS ONE			English	Article							IDENTIFICATION; DISCOVERY; MOTIFS; REFINEMENT; TOOLS	Most of the position weight matrix (PWM) based bioinformatics methods developed to predict transcription factor binding sites (TFBS) assume each nucleotide in the sequence motif contributes independently to the interaction between protein and DNA sequence, usually producing high false positive predictions. The increasing availability of TF enrichment profiles from recent ChIP-Seq methodology facilitates the investigation of dependent structure and accurate prediction of TFBSs. We develop a novel Tree-based PWM (TPWM) approach to accurately model the interaction between TF and its binding site. The whole tree-structured PWM could be considered as a mixture of different conditional-PWMs. We propose a discriminative approach, called TPD (TPWM based Discriminative Approach), to construct the TPWM from the ChIP-Seq data with a pre-existing PWM. To achieve the maximum discriminative power between the positive and negative datasets, the cutoff value is determined based on the Matthew Correlation Coefficient (MCC). The resulting TPWMs are evaluated with respect to accuracy on extensive synthetic datasets. We then apply our TPWM discriminative approach on several real ChIP-Seq datasets to refine the current TFBS models stored in the TRANSFAC database. Experiments on both the simulated and real ChIP-Seq data show that the proposed method starting from existing PWM has consistently better performance than existing tools in detecting the TFBSs. The improved accuracy is the result of modelling the complete dependent structure of the motifs and better prediction of true positive rate. The findings could lead to better understanding of the mechanisms of TF-DNA interactions.	[Bi, Yingtao; Kim, Hyunsoo; Gupta, Ravi; Davuluri, Ramana V.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA	The Wistar Institute	Bi, YT (corresponding author), Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA.	rdavuluri@wistar.org		Gupta, Ravi/0000-0001-5242-9528	National Human Genome Research Institute [R01HG003362]; Philadelphia Healthcare Trust; Centre for Systems and Computational Biology and Bioinformatics Facility of Wistar Cancer Centre [P30 CA010815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003362] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Philadelphia Healthcare Trust; Centre for Systems and Computational Biology and Bioinformatics Facility of Wistar Cancer Centre; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Human Genome Research Institute (grant # R01HG003362) to RVD. RVD holds a Philadelphia Healthcare Trust Endowed Chair Position and this work is also supported by Philadelphia Healthcare Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The use of computational resources in the Centre for Systems and Computational Biology and Bioinformatics Facility of Wistar Cancer Centre (grant # P30 CA010815) are gratefully acknowledged.	BAILEY TL, 1994, P 2 INT C INT SYST M, P28; BARASH Y, 2003, P 7 ANN INT C RES CO, P28; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chin F, 2008, IEEE ACM T COMPUT BI, V5, P110, DOI 10.1109/TCBB.2007.70220; da Piedade I, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-388; Dunson DB, 2009, J AM STAT ASSOC, V104, P1042, DOI 10.1198/jasa.2009.tm08439; Ellrott K, 2002, BIOINFORMATICS, V18, pS100, DOI 10.1093/bioinformatics/18.suppl_2.S100; Essien K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r131; Georgi B, 2006, BIOINFORMATICS, V22, pE166, DOI 10.1093/bioinformatics/btl249; Hannenhalli S, 2005, BIOINFORMATICS, V21, pI204, DOI 10.1093/bioinformatics/bti1001; Hannenhalli S, 2008, BIOINFORMATICS, V24, P1325, DOI 10.1093/bioinformatics/btn198; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hu M, 2010, NUCLEIC ACIDS RES, V38, P2154, DOI 10.1093/nar/gkp1180; Ji HK, 2010, NAT BIOTECHNOL, V28, P337, DOI 10.1038/nbt.1619; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kielbasa SM, 2001, BIOINFORMATICS, V17, P1019, DOI 10.1093/bioinformatics/17.11.1019; King OD, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng117; Kulakovskiy IV, 2010, BIOINFORMATICS, V26, P2622, DOI 10.1093/bioinformatics/btq488; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; Narlikar Leelavati, 2009, Briefings in Functional Genomics & Proteomics, V8, P215, DOI 10.1093/bfgp/elp014; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Reid JE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-30; Salama RA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq274; Sandve GK, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-11; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Seth KA, 2001, J BIOL CHEM, V276, P13917, DOI 10.1074/jbc.M007745200; Sharon E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000154; Tanay A, 2004, GENOME RES, V14, P829, DOI 10.1101/gr.2064404; Tomovic A, 2007, BIOINFORMATICS, V23, P933, DOI 10.1093/bioinformatics/btm055; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Wang C, 2006, STAT METHODOL, V3, P55; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Zhao XY, 2005, J COMPUT BIOL, V12, P894, DOI 10.1089/cmb.2005.12.894; Zhou Q, 2004, BIOINFORMATICS, V20, P909, DOI 10.1093/bioinformatics/bth006	44	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24210	10.1371/journal.pone.0024210	http://dx.doi.org/10.1371/journal.pone.0024210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912677	gold, Green Submitted, Green Published			2022-12-25	WOS:000294686100024
J	LaFerriere, H; Speichinger, K; Stromhaug, A; Zars, T				LaFerriere, Holly; Speichinger, Katherine; Stromhaug, Astrid; Zars, Troy			The Radish Gene Reveals a Memory Component with Variable Temporal Properties	PLOS ONE			English	Article							LONG-TERM-MEMORY; ANESTHESIA-RESISTANT MEMORY; DROSOPHILA-MELANOGASTER; CONSOLIDATED MEMORY; MUTANT DROSOPHILA; ADENYLYL-CYCLASE; LEARNING-CENTER; PROTEIN-KINASE; PKA DYNAMICS; OPERANT	Memory phases, dependent on different neural and molecular mechanisms, strongly influence memory performance. Our understanding, however, of how memory phases interact is far from complete. In Drosophila, aversive olfactory learning is thought to progress from short-term through long-term memory phases. Another memory phase termed anesthesia resistant memory, dependent on the radish gene, influences memory hours after aversive olfactory learning. How does the radish-dependent phase influence memory performance in different tasks? It is found that the radish memory component does not scale with the stability of several memory traces, indicating a specific recruitment of this component to influence different memories, even within minutes of learning.	[LaFerriere, Holly; Speichinger, Katherine; Stromhaug, Astrid; Zars, Troy] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	LaFerriere, H (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	zarst@missouri.edu		Zars, Troy/0000-0003-4114-9322	National Science Foundation [IOS 0613708]; University of Missouri (MU) Research Board	National Science Foundation(National Science Foundation (NSF)); University of Missouri (MU) Research Board	This study was supported by grants from the National Science Foundation (IOS 0613708) and the University of Missouri (MU) Research Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Colomb J, 2009, GENES BRAIN BEHAV, V8, P407, DOI 10.1111/j.1601-183X.2009.00482.x; Diegelmann S, 2006, LEARN MEMORY, V13, P72, DOI 10.1101/lm.45506; FOLKERS E, 1993, P NATL ACAD SCI USA, V90, P8123, DOI 10.1073/pnas.90.17.8123; Folkers E, 2006, P NATL ACAD SCI USA, V103, P17496, DOI 10.1073/pnas.0608377103; Gervasi N, 2010, NEURON, V65, P516, DOI 10.1016/j.neuron.2010.01.014; Gioia A, 2009, J COMP PHYSIOL A, V195, P777, DOI 10.1007/s00359-009-0455-2; Gong ZF, 1998, J INSECT PHYSIOL, V44, P1149, DOI 10.1016/S0022-1910(98)00076-6; Horiuchi J, 2008, P NATL ACAD SCI USA, V105, P20976, DOI 10.1073/pnas.0810119105; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; KAHSAI L, INT REV NEU IN PRESS; Knapek S, 2011, J NEUROSCI, V31, P3453, DOI 10.1523/JNEUROSCI.2585-10.2011; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; LaFerriere H, 2008, GENETICS, V178, P1895, DOI 10.1534/genetics.107.084582; LaFerriere H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022867; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; Putz G, 2004, J NEUROSCI, V24, P9745, DOI 10.1523/JNEUROSCI.3211-04.2004; Putz G, 2002, LEARN MEMORY, V9, P349, DOI 10.1101/lm.50402; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Sitaraman D, 2007, J COMP PHYSIOL A, V193, P903, DOI 10.1007/s00359-007-0243-9; Sitaraman D, 2010, J COMP PHYSIOL A, V196, P299, DOI 10.1007/s00359-010-0517-5; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tanimoto H, 2004, NATURE, V430, P983, DOI 10.1038/430983a; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; Tomchik SM, 2009, NEURON, V64, P510, DOI 10.1016/j.neuron.2009.09.029; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; van Swinderen B, 2010, J NEUROSCI, V30, P1003, DOI 10.1523/JNEUROSCI.4516-09.2010; Wustmann G, 1996, J COMP PHYSIOL A, V179, P429, DOI 10.1007/BF00194996; Yarali A, 2009, J NEUROGENET, V23, P235, DOI 10.1080/01677060802441372; Zars M, 2006, J COMP PHYSIOL A, V192, P727, DOI 10.1007/s00359-006-0109-6; Zars M, 2009, NATURWISSENSCHAFTEN, V96, P927, DOI 10.1007/s00114-009-0550-9; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18; Zars T, 2010, LEARN MEMORY, V17, P246, DOI 10.1101/lm.1706110; Zars T, 2010, NEURON, V65, P442, DOI 10.1016/j.neuron.2010.02.009; Zars T, 2009, J NEUROGENET, V23, P104, DOI 10.1080/01677060802441364	42	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2011	6	9							e24557	10.1371/journal.pone.0024557	http://dx.doi.org/10.1371/journal.pone.0024557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817PK	21912703	Green Published, Green Submitted, gold			2022-12-25	WOS:000294686100049
J	De Luca, G; Barakat, M; Ortet, P; Fochesato, S; Jourlin-Castelli, C; Ansaldi, M; Py, B; Fichant, G; Coutinho, PM; Voulhoux, R; Bastien, O; Marechal, E; Henrissat, B; Quentin, Y; Noirot, P; Filloux, A; Mejean, V; DuBow, MS; Barras, F; Barbe, V; Weissenbach, J; Mihalcescu, I; Vermeglio, A; Achouak, W; Heulin, T				De Luca, Gilles; Barakat, Mohamed; Ortet, Philippe; Fochesato, Sylvain; Jourlin-Castelli, Cecile; Ansaldi, Mireille; Py, Beatrice; Fichant, Gwennaele; Coutinho, Pedro M.; Voulhoux, Rome; Bastien, Olivier; Marechal, Eric; Henrissat, Bernard; Quentin, Yves; Noirot, Philippe; Filloux, Alain; Mejean, Vincent; DuBow, Michael S.; Barras, Frederic; Barbe, Valerie; Weissenbach, Jean; Mihalcescu, Irina; Vermeglio, Andre; Achouak, Wafa; Heulin, Thierry			The Cyst-Dividing Bacterium Ramlibacter tataouinensis TTB310 Genome Reveals a Well-Stocked Toolbox for Adaptation to a Desert Environment	PLOS ONE			English	Article							CIRCADIAN CLOCK; STRUCTURAL INSIGHTS; BIOFILM FORMATION; ESCHERICHIA-COLI; IV PILI; PROTEINS; IDENTIFICATION; EVOLUTION; DATABASE; SYSTEM	Ramlibacter tataouinensis TTB310(T) (strain TTB310), a betaproteobacterium isolated from a semi-arid region of South Tunisia (Tataouine), is characterized by the presence of both spherical and rod-shaped cells in pure culture. Cell division of strain TTB310 occurs by the binary fission of spherical "cyst-like'' cells ("cyst-cyst'' division). The rod-shaped cells formed at the periphery of a colony (consisting mainly of cysts) are highly motile and colonize a new environment, where they form a new colony by reversion to cyst-like cells. This unique cell cycle of strain TTB310, with desiccation tolerant cyst-like cells capable of division and desiccation sensitive motile rods capable of dissemination, appears to be a novel adaptation for life in a hot and dry desert environment. In order to gain insights into strain TTB310's underlying genetic repertoire and possible mechanisms responsible for its unusual lifestyle, the genome of strain TTB310 was completely sequenced and subsequently annotated. The complete genome consists of a single circular chromosome of 4,070,194 bp with an average G+C content of 70.0%, the highest among the Betaproteobacteria sequenced to date, with total of 3,899 predicted coding sequences covering 92% of the genome. We found that strain TTB310 has developed a highly complex network of two-component systems, which may utilize responses to light and perhaps a rudimentary circadian hourglass to anticipate water availability at the dew time in the middle/end of the desert winter nights and thus direct the growth window to cyclic water availability times. Other interesting features of the strain TTB310 genome that appear to be important for desiccation tolerance, including intermediary metabolism compounds such as trehalose or polyhydroxyalkanoate, and signal transduction pathways, are presented and discussed.	[De Luca, Gilles; Barakat, Mohamed; Ortet, Philippe; Fochesato, Sylvain; Vermeglio, Andre; Achouak, Wafa; Heulin, Thierry] CEA, Lab Ecol Microbienne Rhizosphere & Environm Extre, IBEB, DSV, St Paul Les Durance, France; [De Luca, Gilles; Barakat, Mohamed; Ortet, Philippe; Fochesato, Sylvain; Vermeglio, Andre; Achouak, Wafa; Heulin, Thierry] CNRS, Unite Mixte Rech Biol Vegetale & Microbiol Enviro, UMR 6191, St Paul Les Durance, France; [De Luca, Gilles; Barakat, Mohamed; Ortet, Philippe; Fochesato, Sylvain; Vermeglio, Andre; Achouak, Wafa; Heulin, Thierry] Univ Aix Marseille, St Paul Les Durance, France; [Jourlin-Castelli, Cecile; Ansaldi, Mireille; Py, Beatrice; Mejean, Vincent; Barras, Frederic] Aix Marseille Univ, Inst Microbiol Mediterrane, UPR CNRS 9043, Chim Bacterienne Lab, Marseille, France; [Fichant, Gwennaele; Quentin, Yves] Univ Toulouse, UPS, Lab Microbiol & Genet Mol, Toulouse, France; [Fichant, Gwennaele; Quentin, Yves] CNRS, LMGM, Toulouse, France; [Coutinho, Pedro M.; Henrissat, Bernard] Univ Mediterranee, CNRS, UMR 6098, Marseille, France; [Voulhoux, Rome; Filloux, Alain] Aix Marseille Univ, CNRS, Inst Microbiol & Mediterranee, Lab Ingn Syst Macromol, Marseille, France; [Bastien, Olivier; Marechal, Eric] Univ Grenoble 1, CEA Grenoble, CNRS CEA INRA, Physiol Cellulaire Vegetale Lab, Grenoble, France; [Noirot, Philippe] INRA, Micalis, F-78850 Thiverval Grignon, France; [DuBow, Michael S.] Univ Paris 11, CNRS UMR 8621, Inst Genet & Microbiol, Lab Genom & Biodivers Microbienne Biofilms, Orsay, France; [Barbe, Valerie; Weissenbach, Jean] CEA, DSV, IG, Evry, France; [Mihalcescu, Irina] Univ Grenoble 1, Ctr Natl Rech Sci, Lab Interdisciplinaire Phys, Unite Mixte Rech 5588, Grenoble, France	CEA; UDICE-French Research Universities; Aix-Marseille Universite; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	De Luca, G (corresponding author), CEA, Lab Ecol Microbienne Rhizosphere & Environm Extre, IBEB, DSV, St Paul Les Durance, France.	gilles.deluca@cea.fr	, HEULIN/C-1689-2010; ORTET, Philippe/T-8172-2018; Voulhoux, Rome/AAT-5333-2021; Achouak, Wafa/AAX-8916-2021; Henrissat, Bernard/J-2475-2012; Bastien, Olivier/B-9723-2008; Mihalcescu, Irina/AAT-7917-2020; Bastien, Olivier/J-3827-2014	ORTET, Philippe/0000-0002-2648-8978; Achouak, Wafa/0000-0003-4297-6661; Henrissat, Bernard/0000-0002-3434-8588; Barras, Frederic/0000-0003-3458-2574; Mejean, Vincent/0000-0001-6533-5846; Mihalcescu, Irina/0000-0002-8762-8241; ANSALDI, Mireille/0000-0002-2878-0702; Fichant, Gwennaele/0000-0001-5480-0239; Barakat, Mohamed/0000-0003-0540-6272; Quentin, Yves/0000-0001-8248-0586; Jourlin-Castelli, Cecile/0000-0001-8581-2590	Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA); Centre National de la Recherche Scientifique (CNRS); Ministry of Higher Education and Research	Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)(French Atomic Energy Commission); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ministry of Higher Education and Research(Ministry of Higher Education & Scientific Research (MHESR))	Work in our laboratories is supported by the Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA), and the Centre National de la Recherche Scientifique (CNRS). Genome sequencing was realized by the Genoscope (Evry, France) with the financial support of the GEOMEX ("Geomicrobiology of Extreme Environments'', CNRS) and SAGE ("Large Scale Sequencing'', Ministry of Higher Education and Research) programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Axmann IM, 2009, J BACTERIOL, V191, P5342, DOI 10.1128/JB.00419-09; Babu M. Madan, 2007, V3, P66, DOI 10.1159/000107604; Bahar O, 2009, MOL PLANT MICROBE IN, V22, P909, DOI 10.1094/MPMI-22-8-0909; Barakat M, 2011, NUCLEIC ACIDS RES, V39, pD771, DOI 10.1093/nar/gkq1023; Barakat M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-315; Barrat JA, 1998, SCIENCE, V280, P412, DOI 10.1126/science.280.5362.412; Barrat JA, 1999, METEORIT PLANET SCI, V34, P91, DOI 10.1111/j.1945-5100.1999.tb01734.x; Bastien O, 2004, GENE, V336, P163, DOI 10.1016/j.gene.2004.04.029; Bastien O, 2004, BIOINFORMATICS, V20, P534, DOI 10.1093/bioinformatics/btg440; Benzerara K, 2004, GEOMICROBIOL J, V21, P341, DOI 10.1080/01490450490462039; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Bocs S, 2003, NUCLEIC ACIDS RES, V31, P3723, DOI 10.1093/nar/gkg590; Brunner M, 2008, GENE DEV, V22, P1422, DOI 10.1101/gad.1686608; Calamita G, 2000, MOL MICROBIOL, V37, P254, DOI 10.1046/j.1365-2958.2000.02016.x; Chanal A, 2006, ENVIRON MICROBIOL, V8, P514, DOI 10.1111/j.1462-2920.2005.00921.x; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; CHRISPEELS MJ, 1994, TRENDS BIOCHEM SCI, V19, P421, DOI 10.1016/0968-0004(94)90091-4; COUTINHO PM, RECENT ADV CARBOHYDR, P3; Curtis PD, 2010, MICROBIOL MOL BIOL R, V74, P13, DOI 10.1128/MMBR.00040-09; Davies GJ, 2005, CURR OPIN STRUC BIOL, V15, P637, DOI 10.1016/j.sbi.2005.10.008; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dong GG, 2010, CURR OPIN GENET DEV, V20, P619, DOI 10.1016/j.gde.2010.09.002; Dong GG, 2008, CURR OPIN MICROBIOL, V11, P541, DOI 10.1016/j.mib.2008.10.003; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Dvornyk V, 2003, P NATL ACAD SCI USA, V100, P2495, DOI 10.1073/pnas.0130099100; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Fritsche K, 2008, FEMS MICROBIOL ECOL, V66, P123, DOI 10.1111/j.1574-6941.2008.00547.x; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Gillet P, 2000, EARTH PLANET SC LETT, V175, P161, DOI 10.1016/S0012-821X(99)00291-5; Giraud E, 2008, PHOTOSYNTH RES, V97, P141, DOI 10.1007/s11120-008-9323-0; Gornmeaux M, 2005, RES MICROBIOL, V156, P1026, DOI 10.1016/j.resmic.2005.05.010; Haldenby S, 2009, BIOCHEM SOC T, V37, P102, DOI 10.1042/BST0370102; Hendrischk AK, 2007, MICROBIOL-SGM, V153, P1842, DOI 10.1099/mic.0.2006/004390-0; Henrissat B, 2002, TRENDS GENET, V18, P437, DOI 10.1016/S0168-9525(02)02734-8; Heulin T, 2003, INT J SYST EVOL MICR, V53, P589, DOI 10.1099/ijs.0.02482-0; Hinsa SM, 2003, MOL MICROBIOL, V49, P905, DOI 10.1046/j.1365-2958.2003.03615.x; Holtzendorff J, 2008, J BIOL RHYTHM, V23, P187, DOI 10.1177/0748730408316040; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Johnson CH, 2008, SCIENCE, V322, P697, DOI 10.1126/science.1150451; Johnson CH, 2008, CURR BIOL, V18, pR816, DOI 10.1016/j.cub.2008.07.012; Jouhet J, 2003, FEBS LETT, V544, P63, DOI 10.1016/S0014-5793(03)00477-0; Jung A, 2005, P NATL ACAD SCI USA, V102, P12350, DOI 10.1073/pnas.0500722102; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; Loza-Correa M, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00130; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Michel Gerard P. F., 2009, P67; Morbach S, 2002, CHEMBIOCHEM, V3, P385, DOI 10.1002/1439-7633(20020503)3:5<384::AID-CBIC384>3.0.CO;2-H; Mullineaux CW, 2009, J BACTERIOL, V191, P5333, DOI 10.1128/JB.00719-09; Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001; Perez-Rueda E, 2004, COMPUT BIOL CHEM, V28, P341, DOI 10.1016/j.compbiolchem.2004.09.004; Quentin Y, 2002, COMPUT CHEM, V26, P447, DOI 10.1016/S0097-8485(02)00007-4; Ramos-Vera WH, 2010, J BACTERIOL, V192, P5329, DOI 10.1128/JB.00729-10; Ren QH, 2004, NUCLEIC ACIDS RES, V32, pD284, DOI 10.1093/nar/gkh016; Russell NJ, 2002, INT J FOOD MICROBIOL, V79, P27, DOI 10.1016/S0168-1605(02)00176-9; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schiex T, 2003, NUCLEIC ACIDS RES, V31, P3738, DOI 10.1093/nar/gkg610; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sohlenkamp C, 2003, PROG LIPID RES, V42, P115, DOI 10.1016/S0163-7827(02)00050-4; Soriano Maria I, 2010, J Circadian Rhythms, V8, P8, DOI 10.1186/1740-3391-8-8; Stam MR, 2005, CARBOHYD RES, V340, P2728, DOI 10.1016/j.carres.2005.09.018; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Suzuki N, 2007, J GEN APPL MICROBIOL, V53, P81, DOI 10.2323/jgam.53.81; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tokuda H, 2009, BIOSCI BIOTECH BIOCH, V73, P465, DOI 10.1271/bbb.80778; Trchounian A, 1999, FEBS LETT, V447, P144, DOI 10.1016/S0014-5793(99)00288-4; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; van der Horst MA, 2007, TRENDS MICROBIOL, V15, P554, DOI 10.1016/j.tim.2007.09.009; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973	77	27	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e23784	10.1371/journal.pone.0023784	http://dx.doi.org/10.1371/journal.pone.0023784			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21912644	Green Published, Green Submitted, gold			2022-12-25	WOS:000294683900009
J	Perin, EC; Tian, M; Marini, FC; Silva, GV; Zheng, Y; Baimbridge, F; Quan, X; Fernandes, MR; Gahremanpour, A; Young, D; Paolillo, V; Mukhopadhyay, U; Borne, AT; Uthamanthil, R; Brammer, D; Jackson, J; Decker, WK; Najjar, AM; Thomas, MW; Volgin, A; Rabinovich, B; Soghomonyan, S; Jeong, HJ; Rios, JM; Steiner, D; Robinson, S; Mawlawi, O; Pan, TS; Stafford, J; Kundra, V; Li, C; Alauddin, MM; Willerson, JT; Shpall, E; Gelovani, JG				Perin, Emerson C.; Tian, Mei; Marini, Frank C., III; Silva, Guilherme V.; Zheng, Yi; Baimbridge, Fred; Quan, Xin; Fernandes, Marlos R.; Gahremanpour, Amir; Young, Daniel; Paolillo, Vincenzo; Mukhopadhyay, Uday; Borne, Agatha T.; Uthamanthil, Rajesh; Brammer, David; Jackson, James; Decker, William K.; Najjar, Amer M.; Thomas, Michael W.; Volgin, Andrei; Rabinovich, Brian; Soghomonyan, Suren; Jeong, Hwan-Jeong; Rios, Jesse M.; Steiner, David; Robinson, Simon; Mawlawi, Osama; Pan, Tinsu; Stafford, Jason; Kundra, Vikas; Li, Chun; Alauddin, Mian M.; Willerson, James T.; Shpall, Elizabeth; Gelovani, Juri G.			Imaging Long-Term Fate of Intramyocardially Implanted Mesenchymal Stem Cells in a Porcine Myocardial Infarction Model	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; REPORTER GENE-EXPRESSION; IMPROVE HEART FUNCTION; T-CELLS; PET; THERAPY; ISCHEMIA; PIG; LYMPHANGIOGENESIS; HYALURONIDASE	The long-term fate of stem cells after intramyocardial delivery is unknown. We used noninvasive, repetitive PET/CT imaging with [F-18]FEAU to monitor the long-term (up to 5 months) spatial-temporal dynamics of MSCs retrovirally transduced with the sr39HSV1-tk gene (sr39HSV1-tk-MSC) and implanted intramyocardially in pigs with induced acute myocardial infarction. Repetitive [F-18]FEAU PET/CT revealed a biphasic pattern of sr39HSV1-tk-MSC dynamics; cell proliferation peaked at 33-35 days after injection, in periinfarct regions and the major cardiac lymphatic vessels and lymph nodes. The sr39HSV1-tk-MSC-associated [F-18] FEAU signals gradually decreased thereafter. Cardiac lymphography studies using PG-Gd-NIRF813 contrast for MRI and near-infrared fluorescence imaging showed rapid clearance of the contrast from the site of intramyocardial injection through the subepicardial lymphatic network into the lymphatic vessels and periaortic lymph nodes. Immunohistochemical analysis of cardiac tissue obtained at 35 and 150 days demonstrated several types of sr39HSV1-tk expressing cells, including fibro-myoblasts, lymphovascular cells, and microvascular and arterial endothelium. In summary, this study demonstrated the feasibility and sensitivity of [F-18] FEAU PET/CT imaging for long-term, in-vivo monitoring (up to 5 months) of the fate of intramyocardially injected sr39HSV1-tk-MSC cells. Intramyocardially transplanted MSCs appear to integrate into the lymphatic endothelium and may help improve myocardial lymphatic system function after MI.	[Perin, Emerson C.; Silva, Guilherme V.; Zheng, Yi; Baimbridge, Fred; Quan, Xin; Fernandes, Marlos R.; Gahremanpour, Amir; Rios, Jesse M.; Willerson, James T.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA; [Tian, Mei; Young, Daniel; Paolillo, Vincenzo; Mukhopadhyay, Uday; Najjar, Amer M.; Volgin, Andrei; Rabinovich, Brian; Soghomonyan, Suren; Jeong, Hwan-Jeong; Kundra, Vikas; Li, Chun; Alauddin, Mian M.; Gelovani, Juri G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA; [Marini, Frank C., III; Decker, William K.; Thomas, Michael W.; Steiner, David; Robinson, Simon; Shpall, Elizabeth] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplant & Cellular Therapy, Houston, TX 77030 USA; [Borne, Agatha T.; Uthamanthil, Rajesh; Brammer, David] Univ Texas MD Anderson Canc Ctr, Dept Vet Surg & Med, Houston, TX 77030 USA; [Jackson, James] Univ Texas MD Anderson Canc Ctr, Dept Nucl Med, Houston, TX 77030 USA; [Mawlawi, Osama; Pan, Tinsu; Stafford, Jason] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA	Saint Lukes Episcopal Hospital; Texas Heart Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Perin, EC (corresponding author), St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA.	jgelovani@mdanderson.org	Tian, Mei/E-3751-2012; Marini, Frank C/L-8018-2016	Steiner, David/0000-0002-2342-5437	Cordis Corporation; Johnson & Johnson company (Irwindale, CA) [R01HL086983];  [NIH-NCICA-16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086983] Funding Source: NIH RePORTER	Cordis Corporation; Johnson & Johnson company (Irwindale, CA)(Johnson & JohnsonJohnson & Johnson USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by Cordis Corporation, a Johnson & Johnson company (Irwindale, CA), by the R01HL086983 grant (JG), and by the Cancer Center Support grant NIH-NCICA-16672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Beeres SLMA, 2008, HEART, V94, P1214, DOI 10.1136/hrt.2008.149476; Bennett JJ, 2001, NAT MED, V7, P859, DOI 10.1038/89991; Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249; Burchfield JS, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-4; Conrad C, 2009, CIRCULATION, V119, P281, DOI 10.1161/CIRCULATIONAHA.108.793208; Crick SJ, 1998, J ANAT, V193, P105, DOI 10.1046/j.1469-7580.1998.19310105.x; Dotti G, 2009, MOL IMAGING, V8, P230, DOI 10.2310/7290.2009.00022; Fernandes MR, 2008, TEX HEART I J, V35, P240; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Gambhir SS, 2000, P NATL ACAD SCI USA, V97, P2785, DOI 10.1073/pnas.97.6.2785; Gyongyosi M, 2008, CIRC-CARDIOVASC IMAG, V1, P94, DOI 10.1161/CIRCIMAGING.108.797449; Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042; Herrmann JL, 2009, ANN THORAC SURG, V88, P1714, DOI 10.1016/j.athoracsur.2009.05.079; Higuchi T, 2009, J NUCL MED, V50, P1088, DOI 10.2967/jnumed.108.060665; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Hung SC, 2005, CLIN CANCER RES, V11, P7749, DOI 10.1158/1078-0432.CCR-05-0876; Ishikawa Y, 2007, HISTOPATHOLOGY, V51, P345, DOI 10.1111/j.1365-2559.2007.02785.x; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Koehne G, 2003, NAT BIOTECHNOL, V21, P405, DOI 10.1038/nbt805; Kornblau SM, 2001, CANCER RES, V61, P3355; LAINE GA, 1995, PORTL PR P, P271; Lee SW, 2009, J ORTHOP RES, V27, P295, DOI 10.1002/jor.20736; Li LL, 2008, TRANSPL INT, V21, P1181, DOI 10.1111/j.1432-2277.2008.00742.x; Ly HQ, 2008, NAT CLIN PRACT CARD, V5, pS96, DOI 10.1038/ncpcardio1159; MACLEAN D, 1976, SCIENCE, V194, P199, DOI 10.1126/science.959848; MAROKO PR, 1977, NEW ENGL J MED, V296, P898, DOI 10.1056/NEJM197704212961603; Mayer-Kuckuk P, 2006, CELL TRANSPLANT, V15, P75, DOI 10.3727/000000006783982278; McFalls EO, 1996, J NUCL MED, V37, P2006; MEHLHORN U, 1995, AM J PHYSIOL-HEART C, V268, pH178, DOI 10.1152/ajpheart.1995.268.1.H178; Mehlhorn U, 2001, EUR J CARDIO-THORAC, V20, P1220, DOI 10.1016/S1010-7940(01)01031-4; MEHLHORN U, 1995, CIRCULATION, V92, P1940, DOI 10.1161/01.CIR.92.7.1940; Melancon MP, 2007, INVEST RADIOL, V42, P569, DOI 10.1097/RLI.0b013e31804f5a79; Melancon MP, 2007, PHARM RES-DORDR, V24, P1217, DOI 10.1007/s11095-007-9253-0; Miyagawa M, 2004, J NUCL MED, V45, P1917; MORILLO CA, 1995, CIRCULATION, V91, P1588, DOI 10.1161/01.CIR.91.5.1588; Najjar AM, 2009, J NUCL MED, V50, P409, DOI 10.2967/jnumed.108.058735; Nakamura K, 2008, INT J CARDIOL, V129, P309, DOI 10.1016/j.ijcard.2008.02.007; Paolillo V, 2009, J LABELLED COMPD RAD, V52, P553, DOI 10.1002/jlcr.1674; Penuelas I, 2005, EUR J NUCL MED MOL I, V32, pS384, DOI 10.1007/s00259-005-1928-3; Perin Emerson C, 2007, EuroIntervention, V3, P142; Qiao H, 2009, RADIOLOGY, V250, P821, DOI 10.1148/radiol.2503080205; Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106; Riquet M, 2000, SURG RADIOL ANAT, V22, P47, DOI 10.1007/s00276-000-0047-x; Roelants V, 2008, J NUCL MED, V49, P1836, DOI 10.2967/jnumed.108.052175; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Sahni D, 2008, INDIAN J MED RES, V127, P564; Santos AC, 1998, NUCL MED BIOL, V25, P685, DOI 10.1016/S0969-8051(98)00037-7; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Soghomonyan S, 2007, NAT PROTOC, V2, P416, DOI 10.1038/nprot.2007.49; Tang JM, 2006, EUR J CARDIO-THORAC, V30, P353, DOI 10.1016/j.ejcts.2006.02.070; TJUVAJEV JG, 1995, CANCER RES, V55, P6126; Tjuvajev JG, 2002, J NUCL MED, V43, P1072; Tjuvajev JG, 1998, CANCER RES, V58, P4333; Tjuvajev JG, 1996, CANCER RES, V56, P4087; Vazquez-Jimenez JF, 2000, EUR J CARDIO-THORAC, V18, P228, DOI 10.1016/S1010-7940(00)00396-1; Vela DC, 2009, J HISTOCHEM CYTOCHEM, V57, P167, DOI 10.1369/jhc.2008.952507; Wang JX, 2010, CIRC RES, V106, P1904, DOI 10.1161/CIRCRESAHA.110.221762; Willmann JK, 2009, RADIOLOGY, V252, P117, DOI 10.1148/radiol.2513081616; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278; Yotsumoto G, 1998, ANGIOLOGY, V49, P299, DOI 10.1177/000331979804900408; Zheng Yi, 2008, Exp Clin Cardiol, V13, P198	62	44	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e22949	10.1371/journal.pone.0022949	http://dx.doi.org/10.1371/journal.pone.0022949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	21912635	gold, Green Published, Green Submitted			2022-12-25	WOS:000294683900002
J	He, R; Mott, BT; Rosenthal, AS; Genna, DT; Posner, GH; Arav-Boger, R				He, Ran; Mott, Bryan T.; Rosenthal, Andrew S.; Genna, Douglas T.; Posner, Gary H.; Arav-Boger, Ravit			An Artemisinin-Derived Dimer Has Highly Potent Anti-Cytomegalovirus (CMV) and Anti-Cancer Activities	PLOS ONE			English	Article							CYTOMEGALOVIRUS-INFECTION; ARTESUNATE; ACCUMULATION; RECOMBINANT; DERIVATIVES	We recently reported that two artemisinin-derived dimers (dimer primary alcohol 606 and dimer sulfone 4-carbamate 832-4) are significantly more potent in inhibiting human cytomegalovirus (CMV) replication than artemisinin-derived monomers. In our continued evaluation of the activities of artemisinins in CMV inhibition, twelve artemisinin-derived dimers and five artemisinin-derived monomers were used. Dimers as a group were found to be potent inhibitors of CMV replication. Comparison of CMV inhibition and the slope parameter of dimers and monomers suggest that dimers are distinct in their anti-CMV activities. A deoxy dimer (574), lacking the endoperoxide bridge, did not have any effect on CMV replication, suggesting a role for the endoperoxide bridge in CMV inhibition. Differences in anti-CMV activity were observed among three structural analogs of dimer sulfone 4-carbamate 832-4 indicating that the exact placement and oxidation state of the sulfur atom may contribute to its anti-CMV activity. Of all tested dimers, artemisinin-derived diphenyl phosphate dimer 838 proved to be the most potent inhibitor of CMV replication, with a selectivity index of approximately 1500, compared to our previously reported dimer sulfone 4-carbamate 832-4 with a selectivity index of about 900. Diphenyl phosphate dimer 838 was highly active against a Ganciclovir-resistant CMV strain and was also the most active dimer in inhibition of cancer cell growth. Thus, diphenyl phosphate dimer 838 may represent a lead for development of a highly potent and safe anti-CMV compound.	[He, Ran; Arav-Boger, Ravit] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Mott, Bryan T.; Rosenthal, Andrew S.; Genna, Douglas T.; Posner, Gary H.] Johns Hopkins Univ, Dept Chem, Sch Arts & Sci, Baltimore, MD 21218 USA; [Posner, Gary H.] Johns Hopkins Univ, Sch Med, Bloomberg Sch Publ Hlth, Malaria Res Inst, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	He, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	boger@jhmi.edu		Mott, Bryan/0000-0002-1912-6362	NIH [AI 34885, KO8 AI074907, 1R01AI093701]; March of Dimes [6 FY11 268]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093701, K08AI074907, R37AI034885, R01AI034885] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by NIH AI 34885 (GHP), NIH KO8 AI074907, NIH 1R01AI093701 and March of Dimes 6 FY11 268 (RAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagbala AA, 2006, J MED CHEM, V49, P7836, DOI 10.1021/jm060803i; Arav-Boger R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010370; Beekman AC, 1998, PLANTA MED, V64, P615, DOI 10.1055/s-2006-957533; DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315; Efferth T, 2006, CURR DRUG TARGETS, V7, P407, DOI 10.2174/138945006776359412; Efferth T, 2005, DRUG RESIST UPDATE, V8, P85, DOI 10.1016/j.drup.2005.04.003; Efferth T, 2002, J MOL MED-JMM, V80, P233, DOI 10.1007/s00109-001-0300-8; Efferth T, 2001, INT J ONCOL, V18, P767; Efferth T, 2008, CLIN INFECT DIS, V47, P804, DOI 10.1086/591195; Efferth T, 2007, PLANTA MED, V73, P299, DOI 10.1055/s-2007-967138; Firestone GL, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001239; Griffiths PD, 2000, J ANTIMICROB CHEMOTH, V45, P29, DOI 10.1093/jac/45.suppl_4.29; Hartwig CL, 2009, BIOCHEM PHARMACOL, V77, P322, DOI 10.1016/j.bcp.2008.10.015; He R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-40; Horwedel C, 2010, J MED CHEM, V53, P4842, DOI 10.1021/jm100404t; Jabs DA, 2010, OPHTHALMOLOGY, V117, P128, DOI 10.1016/j.ophtha.2009.06.016; Kaptein SJF, 2006, ANTIVIR RES, V69, P60, DOI 10.1016/j.antiviral.2005.10.003; Konkimalla VB, 2008, NITRIC OXIDE-BIOL CH, V19, P184, DOI 10.1016/j.niox.2008.04.008; Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Michaelis M, 2011, CELL MOL LIFE SCI, V68, P1079, DOI 10.1007/s00018-010-0510-8; Mitchell DA, 2008, NEURO-ONCOLOGY, V10, P10, DOI 10.1215/15228517-2007-035; Moon DK, 2011, BIOORG MED CHEM LETT, V21, P2773, DOI 10.1016/j.bmcl.2010.09.123; Osawa R, 2009, CRIT CARE, V13, DOI 10.1186/cc7875; Rosenthal AS, 2009, J MED CHEM, V52, P1198, DOI 10.1021/jm801484v; Sanchez V, 2004, J VIROL, V78, P11219, DOI 10.1128/JVI.78.20.11219-11232.2004; Schreiber A, 2009, EXPERT OPIN PHARMACO, V10, P191, DOI [10.1517/14656560802678138, 10.1517/14656560802678138 ]; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Steininger Christoph, 2007, Recent Pat Antiinfect Drug Discov, V2, P53, DOI 10.2174/157489107779561634; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; Woodard LE, 2009, J MED CHEM, V52, P7458, DOI 10.1021/jm9005934	32	55	59	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24334	10.1371/journal.pone.0024334	http://dx.doi.org/10.1371/journal.pone.0024334			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904628	gold, Green Submitted, Green Published			2022-12-25	WOS:000294680800082
J	Mah, N; Wang, Y; Liao, MC; Prigione, A; Jozefczuk, J; Lichtner, B; Wolfrum, K; Haltmeier, M; Flottmann, M; Schaefer, M; Hahn, A; Mrowka, R; Klipp, E; Andrade-Navarro, MA; Adjaye, J				Mah, Nancy; Wang, Ying; Liao, Mei-Chih; Prigione, Alessandro; Jozefczuk, Justyna; Lichtner, Bjoern; Wolfrum, Katharina; Haltmeier, Manuela; Floettmann, Max; Schaefer, Martin; Hahn, Alexander; Mrowka, Ralf; Klipp, Edda; Andrade-Navarro, Miguel A.; Adjaye, James			Molecular Insights into Reprogramming-Initiation Events Mediated by the OSKM Gene Regulatory Network	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; DNA-DAMAGE RESPONSE; SYSTEMATIC DISCOVERY; HUMAN FIBROBLASTS; SELF-RENEWAL; INDUCTION; DIFFERENTIATION; TRANSCRIPTION; ACTIVATION; EXPRESSION	Somatic cells can be reprogrammed to induced pluripotent stem cells by over-expression of OCT4, SOX2, KLF4 and c-MYC (OSKM). With the aim of unveiling the early mechanisms underlying the induction of pluripotency, we have analyzed transcriptional profiles at 24, 48 and 72 hours post-transduction of OSKM into human foreskin fibroblasts. Experiments confirmed that upon viral transduction, the immediate response is innate immunity, which induces free radical generation, oxidative DNA damage, p53 activation, senescence, and apoptosis, ultimately leading to a reduction in the reprogramming efficiency. Conversely, nucleofection of OSKM plasmids does not elicit the same cellular stress, suggesting viral response as an early reprogramming roadblock. Additional initiation events include the activation of surface markers associated with pluripotency and the suppression of epithelial-to-mesenchymal transition. Furthermore, reconstruction of an OSKM interaction network highlights intermediate path nodes as candidates for improvement intervention. Overall, the results suggest three strategies to improve reprogramming efficiency employing: 1) anti-inflammatory modulation of innate immune response, 2) pre-selection of cells expressing pluripotency-associated surface antigens, 3) activation of specific interaction paths that amplify the pluripotency signal.	[Mah, Nancy; Schaefer, Martin; Andrade-Navarro, Miguel A.] Max Delbruck Ctr Mol Med, Comp Biol & Data Min Grp, Berlin, Germany; [Wang, Ying; Liao, Mei-Chih; Prigione, Alessandro; Jozefczuk, Justyna; Lichtner, Bjoern; Wolfrum, Katharina; Adjaye, James] Max Planck Inst Mol Genet, Mol Embryol & Aging Grp, Dresden, Germany; [Haltmeier, Manuela; Hahn, Alexander] Genomatix Software GmbH, Munich, Germany; [Floettmann, Max; Klipp, Edda] Humboldt Univ, Berlin, Germany; [Mrowka, Ralf] Univ Jena, Univ Klinikum Jena, Jena, Germany; [Adjaye, James] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society; Humboldt University of Berlin; Friedrich Schiller University of Jena; King Saud University	Mah, N (corresponding author), Max Delbruck Ctr Mol Med, Comp Biol & Data Min Grp, Berlin, Germany.	adjaye@molgen.mpg.de; adjaye@molgen.mpg.de	Mrowka, Ralf/AAW-1480-2021; Prigione, Alessandro/ABA-1584-2021; Andrade, Miguel A/B-6565-2008; Alessandro, Prigione/B-2959-2013	Mrowka, Ralf/0000-0002-0991-3418; Andrade, Miguel A/0000-0001-6650-1711; Schaefer, Martin/0000-0001-7503-6364; Mah, Nancy/0000-0002-1240-8076; Alessandro, Prigione/0000-0001-9457-1952	German Ministry of Education and Research (BMBF) [FKZ 0315398A-F]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was funded by German Ministry of Education and Research (BMBF; http://www.bmbf.de/), within the Medical Systems Biology Project: Drug-iPS (No. FKZ 0315398A-F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Angel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011756; Antoine K, 2005, J CELL BIOCHEM, V95, P763, DOI 10.1002/jcb.20487; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Chang JTC, 2002, EUR J BIOCHEM, V269, P3442, DOI 10.1046/j.1432-1033.2002.03025.x; Chavez L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-314; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Couzin J, 2009, SCIENCE, V323, P568, DOI 10.1126/science.323.5914.568; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Desbordes SC, 2008, CELL STEM CELL, V2, P602, DOI 10.1016/j.stem.2008.05.010; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Fairchild PJ, 2010, NAT REV IMMUNOL, V10, P868, DOI 10.1038/nri2878; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Jee MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009026; Ji AR, 2010, EXP MOL MED, V42, P175, DOI 10.3858/emm.2010.42.3.018; Kannan K, 2000, FEBS LETT, V470, P77, DOI 10.1016/S0014-5793(00)01291-6; Kielbasa SM, 2010, NUCLEIC ACIDS RES, V38, pW233, DOI 10.1093/nar/gkq374; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Kolle G, 2009, STEM CELLS, V27, P2446, DOI 10.1002/stem.182; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Koyabu Y, 2001, J BIOL CHEM, V276, P6889, DOI 10.1074/jbc.C000773200; Kunisato A, 2010, STEM CELLS DEV, V19, P229, DOI 10.1089/scd.2009.0149; Lacroix M, 2008, EMBO REP, V9, P452, DOI 10.1038/embor.2008.45; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liang GY, 2010, J BIOL CHEM, V285, P25516, DOI 10.1074/jbc.M110.142059; Lim LS, 2010, STEM CELLS, V28, P1961, DOI 10.1002/stem.527; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Lluis F, 2008, CELL STEM CELL, V3, P493, DOI 10.1016/j.stem.2008.08.017; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Mrowka R, 2008, FEBS J, V275, P3178, DOI 10.1111/j.1742-4658.2008.06471.x; Nagamatsu G, 2011, J BIOL CHEM, V286, P10641, DOI 10.1074/jbc.M110.216390; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Popkie AP, 2010, J BIOL CHEM, V285, P41337, DOI 10.1074/jbc.M110.170704; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Ren TN, 2011, MED ONCOL, V28, pS91, DOI 10.1007/s12032-010-9718-6; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sato N, 2006, METH MOL B, V331, P115; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Soutar MPM, 2010, J NEUROCHEM, V115, P974, DOI 10.1111/j.1471-4159.2010.06988.x; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tang C, 2011, SEMIN IMMUNOPATHOL, V33, P563, DOI 10.1007/s00281-011-0269-5; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Ullmann U, 2008, MOL HUM REPROD, V14, P169, DOI 10.1093/molehr/gan001; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; van Amerongen R, 2010, ONCOGENE, V29, P93, DOI 10.1038/onc.2009.310; Vancova I, 1998, J GEN VIROL, V79, P1647, DOI 10.1099/0022-1317-79-7-1647; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Wang Y, 2011, STEM CELL REV REP, V7, P331, DOI 10.1007/s12015-010-9209-3; Wang Y, 2010, STEM CELL REV REP, V6, P282, DOI 10.1007/s12015-010-9137-2; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wolfrum K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013703; Xie A, 2007, MOL CELL, V27, P178, DOI 10.1016/j.molcel.2007.07.005; Yaari S, 2005, CLIN CANCER RES, V11, P4321, DOI 10.1158/1078-0432.CCR-04-2071; Yamauchi K, 2010, ARCH DERMATOL RES, V302, P263, DOI 10.1007/s00403-009-0987-x; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuan X, 2011, STEM CELLS, V29, P549, DOI 10.1002/stem.594; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhu LR, 2008, HUM MUTAT, V29, P99, DOI 10.1002/humu.20606; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	81	48	48	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24351	10.1371/journal.pone.0024351	http://dx.doi.org/10.1371/journal.pone.0024351			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21909390	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000294680800086
J	Miranda, NAF; Perissinotto, R; Appleton, CC				Miranda, Nelson A. F.; Perissinotto, Renzo; Appleton, Christopher C.			Population Structure of an Invasive Parthenogenetic Gastropod in Coastal Lakes and Estuaries of Northern KwaZulu-Natal, South Africa	PLOS ONE			English	Article							TAREBIA-GRANIFERA LAMARCK; POTENTIAL IMPACTS; TEMPORAL PATTERNS; WATER; SNAIL; OVOVIVIPARITY; CONSEQUENCES; THIARIDAE; DYNAMICS; INVADER	Background: Estuaries and coastal lakes receive little attention despite being heavily invaded by non-indigenous invasive species (NIS). In these situations, studies of population dynamics in invaded habitats can provide valuable insights into how NIS interact with new environments. Tarebia granifera is a prosobranch gastropod from south-east Asia which has invaded other sub-tropical parts of the world. This study addresses whether a small number of key environmental factors influences gastropod communities, and specifically how the population density and size structure of T. granifera were influenced by environmental change in estuaries and coastal lakes in southern Africa. Methodology/Principal Findings: T. granifera's density, number of brooded juveniles and size structure were measured at the St. Lucia Estuary, Mgobozeleni Estuary, Lake Sibaya and Lake Nhlange. Size structure was classified according to shell height (SH). All dissected individuals were found to be female and free from trematode infection. Salinity, water depth, temperature, and pH were the main factors correlated with population density of gastropod communities. T. granifera often reached densities well over 1000 ind. m(-2), displacing indigenous gastropods and becoming a dominant component of the benthic community. T. granifera successfully invaded estuaries despite frequent exposure to high salinity and desiccation, which could together eliminate >97% of the population. The persistence of T. granifera was ensured due to its high fecundity and the environmental tolerance of large adults (20-30 mm SH) which carried an average of 158 +/- 12.8 SD brooded juveniles. Repeat introductions were not essential for the success of this parthenogenetic NIS. Conclusion/Significance: There is a need for a broader study on the reproductive biology of T. granifera (including the previously overlooked "brood pouch ecology''), which affects population dynamics and may be relevant to other parthenogenetic NIS, such as Melanoides tuberculata and Potamopyrgus antipodarum.	[Miranda, Nelson A. F.; Perissinotto, Renzo; Appleton, Christopher C.] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Durban, South Africa	University of Kwazulu Natal	Miranda, NAF (corresponding author), Univ KwaZulu Natal, Sch Biol & Conservat Sci, Westville Campus, Durban, South Africa.	204507499@ukzn.ac.za	Miranda, Nelson/H-9349-2013	Miranda, Nelson/0000-0002-9308-6688	National Research Foundation, South Africa; Marine and Coastal Management (DEAT-MCM); World Wide Fund (WWF)	National Research Foundation, South Africa(National Research Foundation - South Africa); Marine and Coastal Management (DEAT-MCM); World Wide Fund (WWF)	This project was funded by the National Research Foundation, South Africa (www.nrf.ac.za); Marine and Coastal Management (DEAT-MCM, www.mcm-deat.gov.za); and the World Wide Fund (WWF, www.wwf.org.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RT, 1952, P US NATL MUS, V102, P72; Appleton C. C., 2009, Zoologische Mededelingen (Leiden), V83, P525; Appleton CC, 1980, STUDIES ECOLOGY MAPU; Arking R, 2002, ANN NY ACAD SCI, V959, P251, DOI 10.1111/j.1749-6632.2002.tb02097.x; Bate GC, 2008, ENVIRON GEOL, V55, P1089, DOI 10.1007/s00254-007-1057-3; Begg G.M., 1978, 41 NAT TOWN REG PLAN; BEGG GW, 1980, STUDIES ECOLOGY MAPU; Ben-Ami F, 2005, J MORPHOL, V263, P322, DOI 10.1002/jmor.10307; Ben-Ami F, 2005, J EVOLUTION BIOL, V18, P138, DOI 10.1111/j.1420-9101.2004.00791.x; Ben-Ami F, 2007, BIOL J LINN SOC, V91, P711, DOI 10.1111/j.1095-8312.2007.00832.x; Ben-Ami F, 2006, NAUTILUS, V120, P156; Bruton M.N., 1979, Monographiae Biologicae, V36, P162; Bruton M.N., 1980, STUDIES ECOLOGY MAPU; BRUTON MN, 1975, T ROY SOC S AFR, V41, P283, DOI 10.1080/00359197509519444; Burlakova LE, 2010, BIOL INVASIONS, V12, P927, DOI 10.1007/s10530-009-9513-5; Caley P, 2006, BIOL INVASIONS, V8, P1595, DOI 10.1007/s10530-004-0010-6; CHANIOTIS B N, 1980, Caribbean Journal of Science, V16, P81; Davis M. A., 2009, INVASION BIOL; de la Vega RAR, 2003, REV SAUDE PUBL, V37, P297, DOI 10.1590/S0034-89102003000300006; Facon B, 2004, BIOL INVASIONS, V6, P283, DOI 10.1023/B:BINV.0000034588.63264.4e; Facon B, 2006, AM NAT, V168, P769, DOI 10.1086/508669; GERRITSEN J, 1980, AM NAT, V115, P718, DOI 10.1086/283594; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; Haag CR, 2004, ANN ZOOL FENN, V41, P539; Hart R. C., 1992, Southern African Journal of Aquatic Sciences, V18, P20; Hofmann H, 2008, HYDROBIOLOGIA, V613, P85, DOI 10.1007/s10750-008-9474-1; Jacobsen R, 1997, FUNCT ECOL, V11, P260, DOI 10.1046/j.1365-2435.1997.00082.x; Jokela J, 1997, ECOLOGY, V78, P452; Jones JPG, 2009, BIOL INVASIONS, V11, P1475, DOI 10.1007/s10530-008-9334-y; Joordens JCA, 2009, J HUM EVOL, V57, P656, DOI 10.1016/j.jhevol.2009.06.003; Karatayev AY, 2009, HYDROBIOLOGIA, V619, P181, DOI 10.1007/s10750-008-9639-y; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lively CM, 2001, PARASITOLOGY, V123, pS19, DOI 10.1017/S0031182001008113; Lockwood JL, 2007, INVASION ECOLOGY; Lopez-Lopez Eugenia, 2009, Aquatic Invasions, V4, P435, DOI 10.3391/ai.2009.4.3.2; Miller AW, 2007, MAR ECOL PROG SER, V332, P41, DOI 10.3354/meps332041; Miranda NAF, 2010, S AFR J SCI, V106, P55, DOI 10.4102/sajs.v106i3/4.156; Miranda NAF, 2011, ESTUAR COAST SHELF S, V91, P442, DOI 10.1016/j.ecss.2010.11.007; Nunez V, 2010, IHERINGIA SER ZOOL, V100, P275, DOI 10.1590/S0073-47212010000300014; Perera G., 1984, Walkerana, V2, P131; Perissinotto R, 2010, TEMPORARILY OPEN CLO; POINTIER JP, 2003, XENOPHORA, V104, P14; Ruiz GM, 1999, LIMNOL OCEANOGR, V44, P950, DOI 10.4319/lo.1999.44.3_part_2.0950; SMITH JM, 1971, J THEOR BIOL, V30, P319, DOI 10.1016/0022-5193(71)90058-0; Snider SB, 2008, ECOLOGY, V89, P1961, DOI 10.1890/07-0715.1; Strong EE, 2007, ORG DIVERS EVOL, V7, P81, DOI 10.1016/j.ode.2006.02.003; Taylor Ricky, 2006, African Journal of Aquatic Science, V31, P31, DOI 10.2989/16085910609503869; Vaeret L, 2009, HYDROGEOL J, V17, P1949, DOI 10.1007/s10040-009-0476-5; van der Molen JS, 2011, ESTUAR COAST SHELF S, V92, P1, DOI 10.1016/j.ecss.2010.12.002; Vrijenhoek RC, 1998, BIOSCIENCE, V48, P617, DOI 10.2307/1313421; VRIJENHOEK RC, 1979, AM ZOOL, V19, P787; Williams SL, 2008, ESTUAR COAST, V31, P3, DOI 10.1007/s12237-007-9031-6; Williamson M., 1996, BIOL INVASIONS; Yong M., 1987, Walkerana, V2, P159	54	19	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24337	10.1371/journal.pone.0024337	http://dx.doi.org/10.1371/journal.pone.0024337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904629	gold, Green Published, Green Submitted			2022-12-25	WOS:000294680800083
J	Neusser, TP; Jorger, KM; Schrodl, M				Neusser, Timea P.; Joerger, Katharina M.; Schroedl, Michael			Cryptic Species in Tropic Sands - Interactive 3D Anatomy, Molecular Phylogeny and Evolution of Meiofaunal Pseudunelidae (Gastropoda, Acochlidia)	PLOS ONE			English	Article							3-DIMENSIONAL RECONSTRUCTION; OPISTHOBRANCHIA MOLLUSCA; MITOCHONDRIAL LINEAGES; RAPD-PCR; DNA; TAXONOMY; VISUALIZATION; IDENTIFICATION; MICROANATOMY; IMPROVEMENT	Background: Towards realistic estimations of the diversity of marine animals, tiny meiofaunal species usually are underrepresented. Since the biological species concept is hardly applicable on exotic and elusive animals, it is even more important to apply a morphospecies concept on the best level of information possible, using accurate and efficient methodology such as 3D modelling from histological sections. Molecular approaches such as sequence analyses may reveal further, cryptic species. This is the first case study on meiofaunal gastropods to test diversity estimations from traditional taxonomy against results from modern microanatomical methodology and molecular systematics. Results: The examined meiofaunal Pseudunela specimens from several Indo-Pacific islands cannot be distinguished by external features. Their 3D microanatomy shows differences in the organ systems and allows for taxonomic separation in some cases. Additional molecular analyses based on partial mitochondrial cytochrome c oxidase subunit I (COI) and 16S rRNA markers revealed considerable genetic structure that is largely congruent with anatomical or geographical patterns. Two new species (Pseudunela viatoris and P. marteli spp. nov.) are formally described integrating morphological and genetic analyses. Phylogenetic analysis using partial 16S rRNA, COI and the nuclear 18S rRNA markers shows a clade of Pseudunelidae species as the sister group to limnic Acochlidiidae. Within Pseudunela, two subtypes of complex excretory systems occur. A complex kidney already evolved in the ancestor of Hedylopsacea. Several habitat shifts occurred during hedylopsacean evolution. Conclusions: Cryptic species occur in tropical meiofaunal Pseudunela gastropods, and likely in other meiofaunal groups with poor dispersal abilities, boosting current diversity estimations. Only a combined 3D microanatomical and molecular approach revealed actual species diversity within Pseudunela reliably. Such integrative methods are recommended for all taxonomic approaches and biodiversity surveys on soft-bodied and small-sized invertebrates. With increasing taxon sampling and details studied, the evolution of acochlidian panpulmonates is even more complex than expected.	[Neusser, Timea P.; Joerger, Katharina M.; Schroedl, Michael] Bavarian State Collect Zool, Munich, Germany; [Neusser, Timea P.; Joerger, Katharina M.; Schroedl, Michael] Univ Munich, Dept Biol 1, Planegg Martinsried, Germany	University of Munich	Neusser, TP (corresponding author), Bavarian State Collect Zool, Munich, Germany.	timea-neusser@gmx.de	Neusser, Timea/ABB-1594-2020	Neusser, Timea/0000-0001-9677-9095	German Research Foundation [SCHR 667/4-2]; VW-Stiftung; Total Foundation; Sloan Foundation; University of Tokyo, Japan	German Research Foundation(German Research Foundation (DFG)); VW-Stiftung; Total Foundation(Total SA); Sloan Foundation(Alfred P. Sloan Foundation); University of Tokyo, Japan	This study benefited from financial support by the German Research Foundation (www.dfg.de) (SCHR 667/4-2, 3, 4 to MS). Molecular studies were supported by the VW-Stiftung (http://www.volkswagenstiftung.de) (grant to KMJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; TPN is grateful to Dr. Philippe Bouchet (Museum National d'Histoire Naturelle, Paris, France) for the opportunity to join the "Mission MNHN/PNI/IRD Santo 2006" to Vanuatu. The SANTO 2006 Expedition was organized by Museum National d'Histoire Naturelle, Paris, Pro Natura International (PNI), and Institut de Recherche pour le Developpement (IRD). It operated under a permit granted to Philippe Bouchet (MNHN) by the Environment Unit of the Government of Vanuatu. The Marine Biodiversity part of the expedition, a part of Census of Marine Life's CReefs programme, was specifically funded by grants from the Total Foundation and the Sloan Foundation. Dr. Fontje Kaligis (University of Sam Ratulangi, Manado, Indonesia) is thanked for the availability of material from Indonesia and Dr. Yasunori Kano (University of Tokyo, Japan) for support and company during the expedition to the Solomon Islands. Johnson Seeto (University of the South Pacific, Suva, Fiji) is thanked for kind support. 3D reconstruction was facilitated by the GeoBioCenter/LMU Munchen, Germany. Dr. Martin Hess (LMU) is thanked for assistance in preparing the interactive 3D-model. We would like to express our gratitude to three anonymous reviewers for valuable comments on the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BEKIUS R, 1972, Netherlands Journal of Zoology, V22, P1; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boyer SL, 2007, MOL ECOL, V16, P4999, DOI 10.1111/j.1365-294X.2007.03555.x; Brenzinger B, 2011, J NAT HIST, V45, P183, DOI 10.1080/00222933.2010.521862; Brenzinger B, J MOLL STUD IN PRESS; Casu M, 2004, MAR BIOL, V145, P669, DOI 10.1007/s00227-004-1367-x; Casu M, 2009, BIOL J LINN SOC, V98, P907, DOI 10.1111/j.1095-8312.2009.01316.x; Challis D. A., 1970, Trans. R. Soc. N.Z. (Biol. Sci.), V12, P29; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cook LG, 2010, INVERTEBR SYST, V24, P322, DOI 10.1071/IS10011; Fahrner A, 2002, J MOLLUS STUD, V68, P87, DOI 10.1093/mollus/68.1.87; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Ghiselin MT, 1966, MALACOLOGIA, V3, P327; Golding RE, 2007, ZOOTAXA, P1; Haase M, 1996, MALACOLOGIA, V38, P143; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubendick B., 1978, P1; HUGHES HPI, 1991, J MOLLUS STUD, V57, P425, DOI 10.1093/mollus/57.4.425; Jorger KM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-323; Jorger KM, 2008, ORG DIVERS EVOL, V8, P194, DOI 10.1016/j.ode.2007.09.002; Kano Y, 2009, BIOL LETTERS, V5, P465, DOI 10.1098/rsbl.2009.0191; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kirsteuer E., 1973, Mitteilungen Inst Colombo-Aleman Invest Cient Punta Betin, V7, P41; Klussmann-Kolb A, 2001, ZOOMORPHOLOGY, V120, P215, DOI 10.1007/s004350100041; Krabbe K, 2010, POLAR BIOL, V33, P281, DOI 10.1007/s00300-009-0703-5; Leasi F, 2009, MAR BIOL, V156, P1335, DOI 10.1007/s00227-009-1175-4; Little C, 1983, COLONISATION LAND OR; Marcus E., 1953, Boletim da Faculdade de Filosofia Ciencias e Letras Sao Paulo (Zool), VNo. 18, P165; MARCUS EVELINE, 1954, KIELER MEERESFORSCH, V10, P215; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; MILEIKOVSKY SA, 1971, MAR BIOL, V10, P193, DOI 10.1007/BF00352809; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; MORSE MP, 1994, REPRODUCTION AND DEVELOPMENT OF MARINE INVERTEBRATES, P195; MORSE MP, 1987, AM MALACOL BULL, V5, P281; Neusser TP, 2007, INVERTEBR BIOL, V126, P18, DOI 10.1111/j.1744-7410.2007.00073.x; Neusser TP, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-20; Neusser TP, 2009, ZOOSYSTEMA, V31, P453, DOI 10.5252/z2009n3a4; Neusser TP, 2009, ACTA ZOOL-STOCKHOLM, V90, P228, DOI 10.1111/j.1463-6395.2008.00342.x; Neusser TP, 2006, J MORPHOL, V267, P231, DOI 10.1002/jmor.10398; Neusser TP, J MOLLUSCAN IN PRESS; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Puillandre N, 2010, J MOLLUS STUD, V76, P11, DOI 10.1093/mollus/eyp042; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Raupach MJ, 2006, ANTARCT SCI, V18, P191, DOI 10.1017/S0954102006000228; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; Ruckert IM, 2008, ORG DIVERS EVOL, V8, P358, DOI 10.1016/j.ode.2008.09.001; Ruthensteiner B, 2008, MICROSC RES TECHNIQ, V71, P778, DOI 10.1002/jemt.20618; Ruthensteiner B, 2008, ZOOSYMPOSIA, V1, P63, DOI 10.11646/zoosymposia.1.1.8; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schmidt H, 2000, ZOOL SCR, V29, P17, DOI 10.1046/j.1463-6409.2000.00026.x; Schmidt H, 1999, BIOL BULL-US, V196, P216, DOI 10.2307/1542567; Schrodl M, 2006, TECHNIQUES COLLECTIN; Schrodl M, 2010, ZOOL J LINN SOC-LOND, V158, P124, DOI 10.1111/j.1096-3642.2009.00544.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sommerfeldt N, 2005, J MOLLUS STUD, V71, P153, DOI 10.1093/mollus/eyi018; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swedmark B., 1968, Symposia of the Zoological Society of London, VNo. 22, P135; SWEDMARK B, 1964, BIOL REV, V39, P1, DOI 10.1111/j.1469-185X.1964.tb00948.x; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Todaro MA, 1996, MAR BIOL, V125, P735, DOI 10.1007/BF00349256; Trontelj P, 2009, SYST BIODIVERS, V7, P1, DOI 10.1017/S1477200008002909; Vonnemann V, 2005, J MOLLUS STUD, V71, P113, DOI 10.1093/mollus/eyi014; Wawra E., 1988, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V90, P427; WESTHEIDE W, 1974, HELGOLAND WISS MEER, V26, P27, DOI 10.1007/BF01613303; Westheide W, 2003, MAR BIOL, V142, P637, DOI 10.1007/s00227-002-0960-0; Wilson NG, 2007, MAR BIOL, V152, P895, DOI 10.1007/s00227-007-0742-9; Wilson NG, 2009, MOL ECOL, V18, P965, DOI 10.1111/j.1365-294X.2008.04071.x; Wollscheid E, 1999, MOL PHYLOGENET EVOL, V13, P215, DOI 10.1006/mpev.1999.0664	72	37	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e23313	10.1371/journal.pone.0023313	http://dx.doi.org/10.1371/journal.pone.0023313			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21912592	Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800007
J	Xing, DQ; Gong, KZ; Feng, WG; Nozell, SE; Chen, YF; Chatham, JC; Oparil, S				Xing, Dongqi; Gong, Kaizheng; Feng, Wenguang; Nozell, Susan E.; Chen, Yiu-Fai; Chatham, John C.; Oparil, Suzanne			O-GlcNAc Modification of NF kappa B p65 Inhibits TNF-alpha-Induced Inflammatory Mediator Expression in Rat Aortic Smooth Muscle Cells	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; INTIMAL HYPERPLASIA; HEXOSAMINE BIOSYNTHESIS; TRAUMA-HEMORRHAGE; CARDIAC-FUNCTION; IN-VITRO; ACTIVATION; GLUCOSAMINE; PHOSPHORYLATION; PATHWAY	Background: We have shown that glucosamine (GlcN) or O-(2-acetamido-2-deoxy-D-glucopyranosylidene) amino-N-phenylcarbamate (PUGNAc) treatment augments O-linked-N-acetylglucosamine (O-GlcNAc) protein modification and attenuates inflammatory mediator expression, leukocyte infiltration and neointima formation in balloon injured rat carotid arteries and have identified the arterial smooth muscle cell (SMC) as the target cell in the injury response. NF kappa B signaling has been shown to mediate the expression of inflammatory genes and neointima formation in injured arteries. Phosphorylation of the p65 subunit of NF kappa B is required for the transcriptional activation of NF kappa B. This study tested the hypothesis that GlcN or PUGNAc treatment protects vascular SMCs against tumor necrosis factor (TNF)-alpha induced inflammatory stress by enhancing O-GlcNAcylation and inhibiting TNF-alpha induced phosphorylation of NF kappa B p65, thus inhibiting NF kappa B signaling. Methodology/ Principal Findings: Quiescent rat aortic SMCs were pretreated with GlcN (5 mM), PUGNAc (10(-4) M) or vehicle and then stimulated with TNF-alpha (10 ng/ml). Both treatments inhibited TNF-alpha-induced expression of chemokines [cytokine-induced neutrophil chemoattractant (CINC)-2 beta and monocyte chemotactic protein (MCP)-1] and adhesion molecules [vascular cell adhesion molecule (VCAM)-1 and P-Selectin]. Both treatments inhibited TNF-alpha induced NF kappa B p65 activation and promoter activity, increased NF kappa B p65 O-GlcNAcylation and inhibited NF kappa B p65 phosphorylation at Serine 536, thus promoting I kappa B alpha binding to NF kappa B p65. Conclusions: There is a reciprocal relationship between O-GlcNAcylation and phosphorylation of NF kappa B p65, such that increased NF kappa B p65 O-GlcNAc modification inhibits TNF-alpha-Induced expression of inflammatory mediators through inhibition of NF kappa B p65 signaling. These findings provide a mechanistic basis for our previous observations that GlcN and PUGNAc treatments inhibit inflammation and remodeling induced by acute endoluminal arterial injury.	[Xing, Dongqi; Gong, Kaizheng; Feng, Wenguang; Chen, Yiu-Fai; Oparil, Suzanne] Univ Alabama, Dept Med, Div Cardiovasc Dis, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USA; [Nozell, Susan E.] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Chatham, John C.] Univ Alabama, Dept Pathol, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA; [Gong, Kaizheng] Yangzhou Univ, Dept Med, Div Cardiovasc Dis, Yangzhou, Jiangsu, Peoples R China	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Yangzhou University	Xing, DQ (corresponding author), Univ Alabama, Dept Med, Div Cardiovasc Dis, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USA.	dqxing@uab.edu			NIH [1R01CA138517, HL101192, HL079364, HL080017, HL044195, HL07457, HL75211, HL087980]; AHA [0765398B, 09BGIA2250367, 10POST3180007]; UAB Diabetes Research and Training Center [P60 DK-079626]; NATIONAL CANCER INSTITUTE [R01CA138517] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087980, R01HL101192, T32HL007457, R01HL044195, R01HL075211, R01HL079364, R01HL080017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079626] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); UAB Diabetes Research and Training Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants 1R01CA138517 (Nozell SE), HL101192, HL079364 (Chatham JC); HL080017, HL044195 (Chen YF); HL07457, HL75211, HL087980 (Oparil S) and by AHA Greater Southeast Affiliate grant 0765398B, 09BGIA2250367 (Xing D), 10POST3180007 (Gong K) and UAB Diabetes Research and Training Center P60 DK-079626 (Xing D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUTIERI MV, 1995, BIOCHEM BIOPH RES CO, V213, P827, DOI 10.1006/bbrc.1995.2204; Breuss JM, 2002, CIRCULATION, V105, P633, DOI 10.1161/hc0502.102966; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Bu DX, 2005, FASEB J, V19, P1293, DOI 10.1096/fj.04-2645fje; Champattanachai V, 2007, AM J PHYSIOL-CELL PH, V292, pC178, DOI 10.1152/ajpcell.00162.2006; Chen JT, 2006, INVEST OPHTH VIS SCI, V47, P664, DOI 10.1167/iovs.05-1008; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Forchhammer L, 2003, SCAND J IMMUNOL, V58, P404, DOI 10.1046/j.1365-3083.2003.01313.x; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Gouze JN, 2002, FEBS LETT, V510, P166, DOI 10.1016/S0014-5793(01)03255-0; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HORSCH M, 1991, EUR J BIOCHEM, V197, P815, DOI 10.1111/j.1432-1033.1991.tb15976.x; Hua J, 2002, J LEUKOCYTE BIOL, V71, P632; James LR, 2002, DIABETES, V51, P1146, DOI 10.2337/diabetes.51.4.1146; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; LACZY B, 2010, AM J PHYSIOL-HEART C, V297, pH1715; Largo R, 2003, OSTEOARTHR CARTILAGE, V11, P290, DOI 10.1016/S1063-4584(03)00028-1; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu J, 2006, J MOL CELL CARDIOL, V40, P303, DOI 10.1016/j.yjmcc.2005.11.003; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Liu J, 2007, J MOL CELL CARDIOL, V42, P177, DOI 10.1016/j.yjmcc.2006.09.015; Macauley MS, 2008, J BIOL CHEM, V283, P34687, DOI 10.1074/jbc.M804525200; Miller AP, 2004, CIRCULATION, V110, P1664, DOI 10.1161/01.CIR.0000142050.19488.C7; Ngoh GA, 2011, AMINO ACIDS, V40, P895, DOI 10.1007/s00726-010-0728-7; Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431; Not LG, 2007, SHOCK, V28, P345, DOI 10.1097/shk.0b013e3180487ebb; Ohtsuka T, 1996, J BIOL CHEM, V271, P1651, DOI 10.1074/jbc.271.3.1651; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Shikhman AR, 2001, J IMMUNOL, V166, P5155, DOI 10.4049/jimmunol.166.8.5155; Shintani T, 2002, ANN THORAC SURG, V74, P1132, DOI 10.1016/S0003-4975(02)03921-8; Takahashi M, 2008, AM J PHYSIOL-HEART C, V294, pH2879, DOI 10.1152/ajpheart.91406.2007; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Xing DQ, 2008, AM J PHYSIOL-HEART C, V295, pH335, DOI 10.1152/ajpheart.01259.2007; Xing DQ, 2007, AM J PHYSIOL-HEART C, V292, pH2607, DOI 10.1152/ajpheart.01107.2006; Xing DQ, 2004, CIRCULATION, V109, P234, DOI 10.1161/01.CIR.0000105700.95607.49; Yang WH, 2008, P NATL ACAD SCI USA, V105, P17345, DOI 10.1073/pnas.0806198105; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zerfaoui M, 2008, CELL SIGNAL, V20, P186, DOI 10.1016/j.cellsig.2007.10.007; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zou LY, 2007, SHOCK, V27, P402, DOI 10.1097/01.shk.0000245031.31859.29; Zou LY, 2009, AM J PHYSIOL-HEART C, V296, pH515, DOI 10.1152/ajpheart.01025.2008; Zuckerbraun BS, 2003, J VASC SURG, V38, P812, DOI 10.1016/S0741-5214(03)00427-0	50	75	84	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24021	10.1371/journal.pone.0024021	http://dx.doi.org/10.1371/journal.pone.0024021			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21904602	Green Submitted, gold, Green Published			2022-12-25	WOS:000294680800047
J	Cho, EG; Zaremba, JD; McKercher, SR; Talantova, M; Tu, SC; Masliah, E; Chan, SF; Nakanishi, N; Terskikh, A; Lipton, SA				Cho, Eun-Gyung; Zaremba, Jeffrey D.; McKercher, Scott R.; Talantova, Maria; Tu, Shichun; Masliah, Eliezer; Chan, Shing Fai; Nakanishi, Nobuki; Terskikh, Alexey; Lipton, Stuart A.			MEF2C Enhances Dopaminergic Neuron Differentiation of Human Embryonic Stem Cells in a Parkinsonian Rat Model	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; SERUM-FREE SUSPENSION; SPINAL-CORD-INJURY; TRANSCRIPTION FACTOR; FACTOR 2C; FUNCTIONAL ENGRAFTMENT; BINDING FACTOR; TRANSPLANTATION; EXPRESSION; DISEASE	Human embryonic stem cells (hESCs) can potentially differentiate into any cell type, including dopaminergic neurons to treat Parkinson's disease (PD), but hyperproliferation and tumor formation must be avoided. Accordingly, we use myocyte enhancer factor 2C (MEF2C) as a neurogenic and anti-apoptotic transcription factor to generate neurons from hESC-derived neural stem/progenitor cells (NPCs), thus avoiding hyperproliferation. Here, we report that forced expression of constitutively active MEF2C (MEF2CA) generates significantly greater numbers of neurons with dopaminergic properties in vitro. Conversely, RNAi knockdown of MEF2C in NPCs decreases neuronal differentiation and dendritic length. When we inject MEF2CA-programmed NPCs into 6-hydroxydopamine-lesioned Parkinsonian rats in vivo, the transplanted cells survive well, differentiate into tyrosine hydroxylase-positive neurons, and improve behavioral deficits to a significantly greater degree than non-programmed cells. The enriched generation of dopaminergic neuronal lineages from hESCs by forced expression of MEF2CA in the proper context may prove valuable in cell-based therapy for CNS disorders such as PD.	[Cho, Eun-Gyung; Zaremba, Jeffrey D.; McKercher, Scott R.; Talantova, Maria; Tu, Shichun; Chan, Shing Fai; Nakanishi, Nobuki; Terskikh, Alexey; Lipton, Stuart A.] Sanford Burnham Med Res Inst, Del E Webb Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA; [Masliah, Eliezer; Lipton, Stuart A.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Cho, EG (corresponding author), Sanford Burnham Med Res Inst, Del E Webb Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA.	slipton@sanfordburnham.org	Terskikh, Alexey/U-8407-2019	Zaremba, Jeffrey/0000-0001-6531-5474; Lipton, Stuart/0000-0002-3490-1259	CIRM [RC1-00125-1]; NIH [P01 HD29587, P01 ES016738, R01 NS044326]; La Jolla Interdisciplinary Neuroscience Center Cores, NIH [P30 NS057096]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044326, P30NS057096] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); La Jolla Interdisciplinary Neuroscience Center Cores, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by CIRM Comprehensive Grant RC1-00125-1, and NIH grants P01 HD29587, P01 ES016738 and R01 NS044326 (to S. A. L.). The support of facilities by the La Jolla Interdisciplinary Neuroscience Center Cores, NIH Blueprint Grant P30 NS057096, is kindly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan LE, 2010, CURR OPIN NEUROL, V23, P426, DOI 10.1097/WCO.0b013e32833b1f62; Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Arenas E, 2010, BIOCHEM BIOPH RES CO, V396, P152, DOI 10.1016/j.bbrc.2010.04.037; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Ben-Hur T, 2004, STEM CELLS, V22, P1246, DOI 10.1634/stemcells.2004-0094; Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2005-0393; Buzzard JJ, 2004, NAT BIOTECHNOL, V22, P381, DOI 10.1038/nbt0404-381; CALON F, 1995, BRAIN RES, V680, P43, DOI 10.1016/0006-8993(95)00229-J; Chiba S, 2008, STEM CELLS, V26, P2810, DOI 10.1634/stemcells.2008-0085; Cho MS, 2008, P NATL ACAD SCI USA, V105, P3392, DOI 10.1073/pnas.0712359105; Daadi MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001644; De Val S, 2004, DEV BIOL, V275, P424, DOI 10.1016/j.ydbio.2004.08.016; Elkabetz Y, 2008, COLD SH Q B, V73, P377, DOI 10.1101/sqb.2008.73.052; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; HATAMI M, 2009, CYTOTHERAPY, P1; Hedlund E, 2009, J INTERN MED, V266, P358, DOI 10.1111/j.1365-2796.2009.02155.x; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hicks AU, 2009, EUR J NEUROSCI, V29, P562, DOI 10.1111/j.1460-9568.2008.06599.x; Jankovic J, 2005, PROG NEUROBIOL, V77, P128, DOI 10.1016/j.pneurobio.2005.09.001; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kim DW, 2006, STEM CELLS, V24, P557, DOI 10.1634/stemcells.2005-0233; Kim JY, 2003, J NEUROCHEM, V85, P1443, DOI 10.1046/j.1471-4159.2003.01780.x; LEIFER D, 1994, NEUROSCIENCE, V63, P1067, DOI 10.1016/0306-4522(94)90573-8; LEIFER D, 1993, P NATL ACAD SCI USA, V90, P1546, DOI 10.1073/pnas.90.4.1546; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Li JY, 2008, TRENDS NEUROSCI, V31, P146, DOI 10.1016/j.tins.2007.12.001; Li Z, 2008, J NEUROSCI, V28, P6557, DOI 10.1523/JNEUROSCI.0134-08.2008; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; MCDERMOTT JC, 1993, MOL CELL BIOL, V13, P2564, DOI 10.1128/MCB.13.4.2564; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Okamoto S, 2000, P NATL ACAD SCI USA, V97, P7561, DOI 10.1073/pnas.130502697; Perlmann T, 2004, CELL TISSUE RES, V318, P45, DOI 10.1007/s00441-004-0974-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schulz TC, 2004, STEM CELLS, V22, P1218, DOI 10.1634/stemcells.2004-0114; Schwartz PH, 2008, METHODS, V45, P142, DOI 10.1016/j.ymeth.2008.03.007; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Thompson L, 2005, J NEUROSCI, V25, P6467, DOI 10.1523/JNEUROSCI.1676-05.2005; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Yang DL, 2008, STEM CELLS, V26, P55, DOI 10.1634/stemcells.2007-0494; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhu BM, 2005, J BIOL CHEM, V280, P28749, DOI 10.1074/jbc.M502491200; Zhu BM, 2004, MOL CELL BIOL, V24, P8264, DOI 10.1128/MCB.24.18.8264-8275.2004	54	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e24027	10.1371/journal.pone.0024027	http://dx.doi.org/10.1371/journal.pone.0024027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901155	Green Published, Green Submitted, gold			2022-12-25	WOS:000294298000040
J	Holland, DO; Krainak, NC; Saucerman, JJ				Holland, David O.; Krainak, Nicholas C.; Saucerman, Jeffrey J.			Graphical Approach to Model Reduction for Nonlinear Biochemical Networks	PLOS ONE			English	Article							SYSTEMS; ACTIVATION; DYNAMICS; BIOLOGY; HEART	Model reduction is a central challenge to the development and analysis of multiscale physiology models. Advances in model reduction are needed not only for computational feasibility but also for obtaining conceptual insights from complex systems. Here, we introduce an intuitive graphical approach to model reduction based on phase plane analysis. Timescale separation is identified by the degree of hysteresis observed in phase-loops, which guides a "concentration-clamp" procedure for estimating explicit algebraic relationships between species equilibrating on fast timescales. The primary advantages of this approach over Jacobian-based timescale decomposition are that: 1) it incorporates nonlinear system dynamics, and 2) it can be easily visualized, even directly from experimental data. We tested this graphical model reduction approach using a 25-variable model of cardiac beta(1)-adrenergic signaling, obtaining 6- and 4-variable reduced models that retain good predictive capabilities even in response to new perturbations. These 6 signaling species appear to be optimal "kinetic biomarkers" of the overall beta(1)-adrenergic pathway. The 6-variable reduced model is well suited for integration into multiscale models of heart function, and more generally, this graphical model reduction approach is readily applicable to a variety of other complex biological systems.	[Holland, David O.; Krainak, Nicholas C.; Saucerman, Jeffrey J.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Dept Biomed Engn, Charlottesville, VA 22903 USA	University of Virginia	Holland, DO (corresponding author), Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Dept Biomed Engn, Charlottesville, VA 22903 USA.	jsaucerman@virginia.edu		Saucerman, Jeffrey/0000-0001-9464-8374	National Institutes of Health [HL094476]; American Heart Association [0830470N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant HL094476 and the American Heart Association grant 0830470N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2006, ACS CHEM BIOL, V1, P371, DOI 10.1021/cb600202f; Antoulas A, 2004, LECT NOTES COMPUT SC, V3038, P740; Barik D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.55; Bassingthwaighte J, 2009, EXP PHYSIOL, V94, P597, DOI 10.1113/expphysiol.2008.044099; Bassingthwaighte JB, 2005, ANN NY ACAD SCI, V1047, P395, DOI 10.1196/annals.1341.035; Bassingthwaighte JB, 2000, ANN BIOMED ENG, V28, P1043, DOI 10.1114/1.1313771; Crampin EJ, 2004, EXP PHYSIOL, V89, P1, DOI 10.1113/expphysiol.2003.026740; DELGADO J, 1995, BIOSYSTEMS, V36, P55, DOI 10.1016/0303-2647(95)01528-S; Deuflhard P., 1996, SCI COMPUTING CHEM E, P29, DOI [10.3109/02656739609023525, DOI 10.3109/02656739609023525, 10.1007/978-3-642-80149-5_4, DOI 10.1007/978-3-642-80149-5_4]; Di Benedetto G, 2008, CIRC RES, V103, P836, DOI 10.1161/CIRCRESAHA.108.174813; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Garny A, 2009, PHILOS T R SOC A, V367, P1885, DOI 10.1098/rsta.2008.0289; Gomez-Uribe CA, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3050350; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Jamshidi N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000177; Kauffman KJ, 2002, BIOPHYS J, V83, P646, DOI 10.1016/S0006-3495(02)75198-9; LAM SH, 1994, INT J CHEM KINET, V26, P461, DOI 10.1002/kin.550260408; LIAO JC, 1988, BIOTECHNOL BIOENG, V31, P869, DOI 10.1002/bit.260310815; Lloyd CM, 2008, BIOINFORMATICS, V24, P2122, DOI 10.1093/bioinformatics/btn390; Lloyd CM, 2004, MECH SYSTEMS MODELS; MAAS U, 1992, COMBUST FLAME, V88, P239, DOI 10.1016/0010-2180(92)90034-M; Maltsev VA, 2010, AM J PHYSIOL-HEART C, V298, pH2010, DOI 10.1152/ajpheart.00783.2009; McCulloch A, 1998, PROG BIOPHYS MOL BIO, V69, P153; Mease KD, 2003, J GUID CONTROL DYNAM, V26, P318, DOI 10.2514/2.5049; Okino MS, 1998, CHEM REV, V98, P391, DOI 10.1021/cr950223l; Popel AS, 2009, WIRES SYST BIOL MED, V1, P153, DOI 10.1002/wsbm.67; Rochais F, 2007, J CLIN INVEST, V117, P229, DOI 10.1172/JCI30012; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Saucerman JJ, 2004, PROG BIOPHYS MOL BIO, V85, P261, DOI 10.1016/j.pbiomolbio.2004.01.005; Saucerman JJ, 2003, J BIOL CHEM, V278, P47997, DOI 10.1074/jbc.M308362200; Silva JR, 2009, P NATL ACAD SCI USA, V106, P11102, DOI 10.1073/pnas.0904505106; Simpson PB, 2006, DRUG DISCOV TODAY, V11, P237, DOI 10.1016/S1359-6446(05)03696-2; SLAATS PMA, 1995, COMPUT STRUCT, V54, P1155, DOI 10.1016/0045-7949(94)00389-K; Surovtsova I, 2009, BIOINFORMATICS, V25, P2816, DOI 10.1093/bioinformatics/btp451; Tanskanen AJ, 2007, BIOPHYS J, V92, P3379, DOI 10.1529/biophysj.106.089425; TYSON JJ, 1988, PHYSICA D, V32, P327, DOI 10.1016/0167-2789(88)90062-0; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Williams GSB, 2008, BIOPHYS J, V95, P1689, DOI 10.1529/biophysj.107.125948; Zobeley J, 2005, LECT NOTES COMPUT SC, P90	39	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2011	6	8							e23795	10.1371/journal.pone.0023795	http://dx.doi.org/10.1371/journal.pone.0023795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MQ	21901136	Green Published, Green Submitted, gold			2022-12-25	WOS:000294298000021
J	Yang, J; Liang, SY; Zhang, Y				Yang, Jing; Liang, Siyang; Zhang, Yi			Travelling Waves of a Delayed SIR Epidemic Model with Nonlinear Incidence Rate and Spatial Diffusion	PLOS ONE			English	Article							PREDATOR-PREY SYSTEM; GLOBAL STABILITY; STAGE STRUCTURE; TIME-DELAY; DEPENDENCE; FRONTS; TERMS	This paper is concerned with the existence of travlelling waves to a SIR epidemic model with nonlinear incidence rate, spatial diffusion and time delay. By analyzing the corresponding characteristic equations, the local stability of a disease-free steady state and an endemic steady state to this system under homogeneous Neumann boundary conditions is discussed. By using the cross iteration method and the Schauder's fixed point theorem, we reduce the existence of travelling waves to the existence of a pair of upper-lower solutions. By constructing a pair of upper-lower solutions, we derive the existence of a travelling wave connecting the disease-free steady state and the endemic steady state. Numerical simulations are carried out to illustrate the main results.	[Yang, Jing; Zhang, Yi] Hebei Med Univ, Dept Physiol, Shijiazhuang, Peoples R China; [Liang, Siyang] Beijing Inst Technol, Beijing 100081, Peoples R China	Hebei Medical University; Beijing Institute of Technology	Yang, J (corresponding author), Hebei Med Univ, Dept Physiol, Shijiazhuang, Peoples R China.	zhyhenry@sina.cn	Anderson, Alisha/C-1499-2008	Anderson, Alisha/0000-0001-7013-116X	National Natural Science Foundation of China [31071002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (No. 31071002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON C, 1976, MATH PROC CAMBRIDGE, V80, P315, DOI 10.1017/S0305004100052944; BERETTA E, 1995, J MATH BIOL, V33, P250, DOI 10.1007/BF00169563; Cooke K. L., 1979, ROCKY MT J MATH, V9, P31, DOI [10.1216/RMJ-1979-9-1-31, DOI 10.1216/RMJ-1979-9-1-31]; Fuentes MA, 1999, PHYSICA A, V267, P471, DOI 10.1016/S0378-4371(99)00027-8; Ge ZH, 2009, NONLINEAR ANAL-REAL, V10, P1691, DOI 10.1016/j.nonrwa.2008.02.007; Ge ZH, 2009, APPL MATH MODEL, V33, P1356, DOI 10.1016/j.apm.2007.09.037; HUANG J, 2006, ACTA MATH APPL SIN-E, V22, P243; Jianhong Wu, 2001, Journal of Dynamics and Differential Equations, V13, P651, DOI 10.1023/A:1016690424892; Kim KI, 2010, NONLINEAR ANAL-REAL, V11, P313, DOI 10.1016/j.nonrwa.2008.11.015; Kuperman MN, 1999, PHYSICA A, V272, P206, DOI 10.1016/S0378-4371(99)00284-8; Leung A.W., 1989, SYSTEMS NONLINEAR PA; Li WT, 2006, NONLINEARITY, V19, P1253, DOI 10.1088/0951-7715/19/6/003; Ma WB, 2004, APPL MATH LETT, V17, P1141, DOI 10.1016/j.aml.2003.11.005; Maidana NA, 2009, J THEOR BIOL, V258, P403, DOI 10.1016/j.jtbi.2008.12.032; Murray J. D., 1989, MATH BIOL, DOI DOI 10.1007/978-3-662-08539-4; NOBLE JV, 1974, NATURE, V250, P276; Peng R, 2009, NONLINEAR ANAL-THEOR, V71, P239, DOI 10.1016/j.na.2008.10.043; Saccomandi G, 1997, MATH COMPUT MODEL, V25, P83, DOI 10.1016/S0895-7177(97)00096-4; Sazonov I, 2011, MATH MED BIOL, V28, P165, DOI 10.1093/imammb/dqq016; Sazonov I, 2008, MATH MODEL NAT PHENO, V3, P28, DOI 10.1051/mmnp:2008069; Takeuchi Y, 2000, NONLINEAR ANAL-THEOR, V42, P931, DOI 10.1016/S0362-546X(99)00138-8; Taylor ML, 2009, J MATH BIOL, V59, P841, DOI 10.1007/s00285-009-0256-9; Wu J., 1998, CANAD APPL MATH Q, V6, P397; Xu R, 2009, NONLINEAR ANAL-REAL, V10, P3175, DOI 10.1016/j.nonrwa.2008.10.013; Zeidler E., 1986, NONLINEAR FUNCTIONAL	25	144	145	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21128	10.1371/journal.pone.0021128	http://dx.doi.org/10.1371/journal.pone.0021128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21912618	gold, Green Published			2022-12-25	WOS:000292036900011
J	Weller, K; Ziege, C; Staubach, P; Brockow, K; Siebenhaar, F; Krause, K; Altrichter, S; Church, MK; Maurer, M				Weller, Karsten; Ziege, Claudia; Staubach, Petra; Brockow, Knut; Siebenhaar, Frank; Krause, Karoline; Altrichter, Sabine; Church, Martin K.; Maurer, Marcus			H-1-Antihistamine Up-Dosing in Chronic Spontaneous Urticaria: Patients' Perspective of Effectiveness and Side Effects - A Retrospective Survey Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; H-1-RECEPTOR ANTAGONISTS; ANTIHISTAMINES; CETIRIZINE; LEVOCETIRIZINE; DESLORATADINE; RUPATADINE; IMPACT; SAFETY; NEEDS	Background: The guidelines recommend that first line treatment of chronic spontaneous urticaria should be second generation non-sedating H-1-antihistamines with a positive recommendation against the use of old sedating first generation antihistamines. If standard dosing is not effective, increasing the dosage up to four-fold is recommended. The objective of this study was to obtain the chronic spontaneous urticaria-patient perspective on the effectiveness and unwanted effects of H1-antihistamines in standard and higher doses. Methodology/Principal Findings: This was a questionnaire based survey, initially completed by 368 individuals. 319 (248 female, 71 male, median age 42 years) had a physician-confirmed diagnosis of chronic spontaneous urticaria and were included in the results. Participants believed standard doses (manufacturers recommended dose) of second generation antihistamines to be significantly (P<0.005) more effective than first generation drugs. Furthermore, they believed that second generation drugs caused significantly (P<0.001) fewer unwanted effects and caused significantly (P<0.001) less sedation than first generation antihistamines. Three-quarters of the patients stated that they had up-dosed with antihistamines with 40%, 42% and 54% reporting significant added benefit from taking 2, 3 or 4 tablets daily respectively. The number of reports of unwanted effects and sedation following up-dosing were not significantly different from those reported for standard doses. Conclusions: This survey supports the urticaria guidelines recommendations that the first line treatment for chronic spontaneous urticaria should be second generation rather than first generation H1-antihistamines and that, if standard dosing is not effective, the dosage should be increased up to four-fold.	[Weller, Karsten; Ziege, Claudia; Siebenhaar, Frank; Krause, Karoline; Altrichter, Sabine; Church, Martin K.; Maurer, Marcus] Charite, Dept Dermatol & Allergy, Allergie Ctr Charite, D-13353 Berlin, Germany; [Staubach, Petra] Univ Med Mainz, Dept Dermatol, Mainz, Germany; [Brockow, Knut] Tech Univ, Dept Dermatol & Allergy Biederstein, Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Johannes Gutenberg University of Mainz; Technical University of Munich	Weller, K (corresponding author), Charite, Dept Dermatol & Allergy, Allergie Ctr Charite, D-13353 Berlin, Germany.	marcus.maurer@charite.de	Krause, Karoline/G-5218-2018; Maurer, Marcus/ABG-2174-2020	Krause, Karoline/0000-0001-9711-9654; Maurer, Marcus/0000-0002-4121-481X; Siebenhaar, Frank/0000-0003-4532-1644; Altrichter, Sabine/0000-0001-9955-385X; Weller, Karsten/0000-0003-4437-0313; Palmer, Kirsten/0000-0001-7421-6291; Tong, Stephen/0000-0002-2319-0586	Essex Pharma (now MSD); Urtikaria Network e.V. (UNEV); Regeneron Pharmaceuticals	Essex Pharma (now MSD); Urtikaria Network e.V. (UNEV); Regeneron Pharmaceuticals(Regeneron)	This work was supported by Essex Pharma (now MSD) and the Urtikaria Network e.V. (UNEV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. This work was supported by Essex Pharma (now MSD). KW: The author declares that he is or recently was involved in clinical trials supported by Essex Pharma (now MSD) and was compensated for educational lectures by Essex Pharma (now MSD), Novartis, Shire and UCB. PS: The author declares that he is or recently was involved in clinical trials supported by Essex Pharma (now MSD) and was compensated for educational lectures by Essex Pharma (now MSD), Novartis and Shire. FS: The author declares that he was previously involved in clinical trials supported by Essex Pharma (now MSD) and was compensated for educational lectures. KK: The author declares that she was compensated for educational lectures by Novartis, Dr. Pfleger, Shire and received a travel grant from Regeneron Pharmaceuticals. MKC: The author declares that he has received honoraria for lectures or consulting from UCB Pharma, Glaxo Smith Kline, Aventis, FAES Pharma and Schering Plough. MM: The author declares that he is or recently was a speaker and/or advisor for Almirall Hermal, Bayer Schering Pharma, Biofrontera, Essex Pharma, Genentech, JADO Technologies, Jerini, Merckle Recordati, Novartis, Sanofi Aventis, Schering-Plough, Leo, MSD, Merck, Shire, Symbiopharm, UCB, and Uriach. None of the authors has patents or commercial interests in products in development or marketed products to declare. This does not alter their adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Asero R, 2007, CLIN EXP DERMATOL, V32, P34, DOI 10.1111/j.1365-2230.2006.02278.x; Church MK, 2010, ALLERGY, V65, P459, DOI 10.1111/j.1398-9995.2009.02325.x; Devillier P, 2008, CLIN PHARMACOKINET, V47, P217, DOI 10.2165/00003088-200847040-00001; ESTELLE F, 1994, DRUG SAFETY, V10, P350, DOI 10.2165/00002018-199410050-00002; Gimenez-Arnau A, 2009, J EUR ACAD DERMATOL, V23, P1088, DOI 10.1111/j.1468-3083.2009.03289.x; Godse Kiran V, 2010, Indian Dermatol Online J, V1, P45, DOI 10.4103/2229-5178.73262; Grob JJ, 2005, BRIT J DERMATOL, V152, P289, DOI 10.1111/j.1365-2133.2005.06385.x; Kameyoshi Y, 2007, BRIT J DERMATOL, V157, P803, DOI 10.1111/j.1365-2133.2007.08060.x; Maurer M, 2011, ALLERGY, V66, P317, DOI 10.1111/j.1398-9995.2010.02496.x; Maurer M, 2009, BRIT J DERMATOL, V160, P633, DOI 10.1111/j.1365-2133.2008.08920.x; Metz M, 2010, ANN ALLERG ASTHMA IM, V104, P86, DOI 10.1016/j.anai.2009.11.013; ODonnell BF, 1997, BRIT J DERMATOL, V136, P197; Poon E, 1999, BRIT J DERMATOL, V140, P667; Richardson GS, 2002, J CLIN PSYCHOPHARM, V22, P511, DOI 10.1097/00004714-200210000-00012; Siebenhaar F, 2009, J ALLERGY CLIN IMMUN, V123, P672, DOI 10.1016/j.jaci.2008.12.008; Simons FER, 1999, ANN ALLERG ASTHMA IM, V83, P481, DOI 10.1016/S1081-1206(10)62855-4; Simons FER, 2004, NEW ENGL J MED, V351, P2203, DOI 10.1056/NEJMra033121; Simons FER, 2002, J ALLERGY CLIN IMMUN, V110, P777, DOI 10.1067/mai.2002.129123; Staevska M, 2010, J ALLERGY CLIN IMMUN, V125, P676, DOI 10.1016/j.jaci.2009.11.047; Toubi E, 2004, ALLERGY, V59, P869, DOI 10.1111/j.1398-9995.2004.00473.x; Van der Valk PGM, 2002, BRIT J DERMATOL, V146, P110, DOI 10.1046/j.1365-2133.2002.04582.x; Verster JC, 2004, ANN ALLERG ASTHMA IM, V92, P294, DOI 10.1016/S1081-1206(10)61566-9; Zuberbier T, 1996, DERMATOLOGY, V193, P324, DOI 10.1159/000246281; Zuberbier T, 2009, ALLERGY, V64, P1427, DOI 10.1111/j.1398-9995.2009.02178.x; Zuberbier T, 2009, ALLERGY, V64, P1417, DOI 10.1111/j.1398-9995.2009.02179.x	25	68	69	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e23931	10.1371/journal.pone.0023931	http://dx.doi.org/10.1371/journal.pone.0023931			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	22046419	Green Published, gold, Green Submitted			2022-12-25	WOS:000294683900014
J	Chen, YJ; Huang, WC; Wei, YL; Hsu, SC; Yuan, P; Lin, HY; Wistuba, II; Lee, JJ; Yen, CJ; Su, WC; Chang, KY; Chang, WC; Chou, TC; Chou, CK; Tsai, CH; Hung, MC				Chen, Yun-Ju; Huang, Wei-Chien; Wei, Ya-Ling; Hsu, Sheng-Chieh; Yuan, Ping; Lin, Heather Y.; Wistuba, Ignacio I.; Lee, J. Jack; Yen, Chia-Jui; Su, Wu-Chou; Chang, Kwang-Yu; Chang, Wen-Chang; Chou, Tse-Chuan; Chou, Chao-Kai; Tsai, Chang-Hai; Hung, Mien-Chie			Elevated BCRP/ABCG2 Expression Confers Acquired Resistance to Gefitinib in Wild-Type EGFR-Expressing Cells	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; FACTOR RECEPTOR MUTATIONS; LUNG-CANCER PATIENTS; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; ANTITUMOR-ACTIVITY; GENE-MUTATIONS; PHASE-II; ERLOTINIB; PROTEIN	Background: The sensitivity of non-small cell lung cancer (NSCLC) patients to EGFR tyrosine kinase inhibitors (TKIs) is strongly associated with activating EGFR mutations. Although not as sensitive as patients harboring these mutations, some patients with wild-type EGFR (wtEGFR) remain responsive to EGFR TKIs, suggesting that the existence of unexplored mechanisms renders most of wtEGFR-expressing cancer cells insensitive. Methodology/Principal Findings: Here, we show that acquired resistance of wtEGFR-expressing cancer cells to an EGFR TKI, gefitinib, is associated with elevated expression of breast cancer resistance protein (BCRP/ABCG2), which in turn leads to gefitinib efflux from cells. In addition, BCRP/ABCG2 expression correlates with poor response to gefitinib in both cancer cell lines and lung cancer patients with wtEGFR. Co-treatment with BCRP/ABCG2 inhibitors enhanced the anti-tumor activity of gefitinib. Conclusions/Significance: Thus, BCRP/ABCG2 expression may be a predictor for poor efficacy of gefitinib treatment, and targeting BCRP/ABCG2 may broaden the use of gefitinib in patients with wtEGFR.	[Chen, Yun-Ju; Huang, Wei-Chien; Wei, Ya-Ling; Hsu, Sheng-Chieh; Hung, Mien-Chie] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Tsai, Chang-Hai] China Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Huang, Wei-Chien] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Huang, Wei-Chien] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Tsai, Chang-Hai] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chou, Chao-Kai; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Yuan, Ping; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Lin, Heather Y.; Lee, J. Jack] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Chang, Wen-Chang] Natl Cheng Kung Univ, Dept Pharmacol, Tainan 70101, Taiwan; [Yen, Chia-Jui; Su, Wu-Chou] Natl Cheng Kung Univ, Inst Clin Med, Tainan 70101, Taiwan; [Chou, Tse-Chuan] Natl Cheng Kung Univ, Dept Chem Engn, Tainan, Taiwan; [Huang, Wei-Chien] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Tsai, Chang-Hai] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Chang, Kwang-Yu] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Chou, Tse-Chuan] Tatung Univ, Dept Chem Engn, Taipei 104, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Asia University Taiwan; Asia University Taiwan; National Health Research Institutes - Taiwan; Tatung University	Chen, YJ (corresponding author), China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan.	whuang@mail.cmu.edu.tw; mhung@mdanderson.org	Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Hung, Mien-Chie/ABD-5911-2021; Huang, Wei-Chien/D-1740-2012; Chang, Kwang-Yu/G-9161-2011; Huang, Wei-Chien/H-3126-2019; Lee, Jack/P-7331-2019; Zhang, Jun/G-4598-2010	Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Hung, Mien-Chie/0000-0003-4317-4740; Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716; Lee, Jack/0000-0002-4584-929X; CHOU, CHAO-KAI/0000-0001-5231-5264; Zhang, Jun/0000-0002-6601-9180; SHENG, WANG-HUEI/0000-0002-5605-7853; Su, Wu-Chou/0000-0003-2953-4105; CHEN, YEE-CHUN/0000-0002-1816-9010; Xia, Ningshao/0000-0003-0179-5266; TSAI, KEH-SUNG/0000-0001-8528-1566; WANG, JANN-TAY/0000-0002-0924-3469; Mizuguchi, Kenji/0000-0003-3021-7078; CHANG, SHAN-CHWEN/0000-0001-6505-4139	National Science Council of Taiwan [NSC-96-2917-I-006-004, NSC-97-2320-B-039-033-MY3, NSC-98-3112-B-039-002]; National Health Research Institutes of Taiwan [NHRI-EX-98-9812BC, NSC-2632-B-001]; Cancer Center Research of Excellence [DOH-TD-C-111-005]; National Institutes of Health [NIH PO1 CA099031, NIH RO1 CA109311]; National Breast Cancer Foundation, Inc.; Kadoorie Charitable Foundation; University of Texas MD Anderson Cancer Center; CMUH Sister Institution Fund; NATIONAL CANCER INSTITUTE [P01CA099031, R01CA109311] Funding Source: NIH RePORTER	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); Cancer Center Research of Excellence; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Breast Cancer Foundation, Inc.; Kadoorie Charitable Foundation; University of Texas MD Anderson Cancer Center; CMUH Sister Institution Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Science Council of Taiwan (NSC-96-2917-I-006-004 to Y.J. Chen; NSC-97-2320-B-039-033-MY3 and NSC-98-3112-B-039-002 to W.C. Huang), the National Health Research Institutes of Taiwan (NHRI-EX-98-9812BC to W.C. Huang), NSC-2632-B-001, and Cancer Center Research of Excellence (DOH-TD-C-111-005), National Institutes of Health (NIH PO1 CA099031 and NIH RO1 CA109311), National Breast Cancer Foundation, Inc., Kadoorie Charitable Foundation, and The University of Texas MD Anderson Cancer Center and CMUH Sister Institution Fund (to M.C. Hung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chang GC, 2006, J THORAC ONCOL, V1, P520, DOI 10.1097/01243894-200607000-00004; Coldren CD, 2006, MOL CANCER RES, V4, P521, DOI 10.1158/1541-7786.MCR-06-0095; Diestra JE, 2003, J UROLOGY, V170, P1383, DOI 10.1097/01.ju.0000074710.96154.c9; Diestra JE, 2002, J PATHOL, V198, P213, DOI 10.1002/path.1203; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; HUANG WC, 2011, J BIOL CHEM; Kalish LH, 2004, CLIN CANCER RES, V10, P7764, DOI 10.1158/1078-0432.CCR-04-0012; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kuo MT, 2007, ADV EXP MED BIOL, V608, P23; Lee DH, 2008, ANN ONCOL, V19, P2039, DOI 10.1093/annonc/mdn423; Lemos C, 2009, BRIT J CANCER, V100, P1120, DOI 10.1038/sj.bjc.6604980; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti S, 2008, MOL CANCER THER, V7, P2280, DOI 10.1158/1535-7163.MCT-07-2250; Nakamura Y, 2005, CANCER RES, V65, P1541, DOI 10.1158/0008-5472.CAN-03-2417; Nishimura Y, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-42; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Rho JK, 2009, MOL CANCER RES, V7, P1736, DOI 10.1158/1541-7786.MCR-08-0504; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Shi Z, 2009, BIOCHEM PHARMACOL, V77, P781, DOI 10.1016/j.bcp.2008.11.007; Shi Z, 2009, ONCOL REP, V21, P483, DOI 10.3892/or_00000248; Sugimoto Y, 2005, CANCER SCI, V96, P457, DOI 10.1111/j.1349-7006.2005.00081.x; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Takara K, 2006, CURR PHARM DESIGN, V12, P273, DOI 10.2174/138161206775201965; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Usuda J, 2007, LUNG CANCER, V58, P296, DOI 10.1016/j.lungcan.2007.05.019; Vasile E, 2008, J THORAC ONCOL, V3, P912, DOI 10.1097/JTO.0b013e318180275e; Wang XD, 2007, DRUG METAB DISPOS, V35, P268, DOI 10.1124/dmd.106.011684; Wu JY, 2008, AM J RESP CRIT CARE, V178, P847, DOI 10.1164/rccm.200803-389OC; Yang CH, 2005, CANCER RES, V65, P6943, DOI 10.1158/0008-5472.CAN-05-0641; Yang CH, 2006, CANCER-AM CANCER SOC, V107, P1873, DOI 10.1002/cncr.22220; Yoh K, 2004, CLIN CANCER RES, V10, P1691, DOI 10.1158/1078-0432.CCR-0937-3; Zhang SZ, 2005, DRUG METAB DISPOS, V33, P341, DOI 10.1124/dmd.104.002501; Zhang SZ, 2004, MOL PHARMACOL, V65, P1208, DOI 10.1124/mol.65.5.1208	43	463	478	15	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21428	10.1371/journal.pone.0021428	http://dx.doi.org/10.1371/journal.pone.0021428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21437249	Green Published, Green Submitted, gold			2022-12-25	WOS:000292035400036
J	Chen, YT; Ross, DS; Chiu, R; Zhou, XK; Chen, YY; Lee, PS; Hoda, SA; Simpson, AJ; Old, LJ; Caballero, O; Neville, AM				Chen, Yao-Tseng; Ross, Dara S.; Chiu, Rita; Zhou, Xi K.; Chen, Yunn-Yi; Lee, Peishan; Hoda, Syed A.; Simpson, Andrew J.; Old, Lloyd J.; Caballero, Otavia; Neville, A. Munro			Multiple Cancer/Testis Antigens Are Preferentially Expressed in Hormone-Receptor Negative and High-Grade Breast Cancers	PLOS ONE			English	Article							T-CELL RESPONSES; NY-ESO-1 EXPRESSION; PROTEIN EXPRESSION; ANTIBODY; IMMUNOGENICITY; IDENTIFICATION; CARCINOMA; FAMILY; GENES; CT45	Background: Cancer/testis (CT) antigens are protein antigens normally expressed only in germ cells of testis, and yet are expressed in a proportion of a wide variety of human cancers. CT antigens can elicit spontaneous immune responses in cancer patients with CT-positive cancers, and CT antigen-based therapeutic cancer vaccine trials are ongoing for "CT-rich" tumors. Although some previous studies found breast cancer to be "CT-poor", our recent analysis identified increased CT mRNA transcripts in the ER-negative subset of breast cancer. Methodology/Principal Findings: In this study, we performed a comprehensive immunohistochemical study to investigate the protein expression of eight CT genes in 454 invasive ductal carcinomas, including 225 ER/PR/HER2-negative (triple-negative) carcinomas. We found significantly more frequent expression of all eight CT antigens in ER-negative cancers, and five of them-MAGEA, CT7, NY-ESO-1, CT10 and CT45, were expressed in 12-24% of ER-negative cancers, versus 2-6% of ER-positive cancers (p < 0.001 to 0.003). In comparison, GAGE, SAGE1 and NXF2 were only expressed in 3-5% of ER-negative and 0-2% of ER-positive cancers. ER-negative cancers were also more likely to simultaneously co-express multiple CT antigens, with 27% (34/125) of ER-negative, CT-positive tumors expressing three or more CT antigens. HER2 status had no consistent effect on CT expression, and triple-negative carcinomas showed similar frequencies of MAGEA and NY-ESO-1 expression as ER-negative/HER2-positive carcinomas. More frequent CT expression was also found in tumors with higher nuclear grade (p < 0.001 to p = 0.01) and larger in size (> 2 cm). Conclusions/Significance: CT antigens are preferentially expressed in hormone receptor-negative and high-grade breast cancer. Considering the limited treatment options for ER/PR/HER2 triple-negative breast cancer, the potential of CT-based immunotherapy should be explored.	[Chen, Yao-Tseng; Ross, Dara S.; Hoda, Syed A.] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Chiu, Rita; Lee, Peishan; Simpson, Andrew J.; Old, Lloyd J.; Caballero, Otavia; Neville, A. Munro] Ludwig Inst Canc Res, New York Branch, New York, NY USA; [Zhou, Xi K.] Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10021 USA; [Chen, Yunn-Yi] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA	Cornell University; Ludwig Institute for Cancer Research; Cornell University; University of California System; University of California San Francisco	Chen, YT (corresponding author), Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA.	ytchen@med.cornell.edu	Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Hung, Mien-Chie/ABD-5911-2021; Huang, Wei-Chien/D-1740-2012; Chang, Kwang-Yu/G-9161-2011; Huang, Wei-Chien/H-3126-2019; Lee, Jack/P-7331-2019; Zhang, Jun/G-4598-2010	Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Hung, Mien-Chie/0000-0003-4317-4740; Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716; Lee, Jack/0000-0002-4584-929X; CHOU, CHAO-KAI/0000-0001-5231-5264; Zhang, Jun/0000-0002-6601-9180; SHENG, WANG-HUEI/0000-0002-5605-7853; Su, Wu-Chou/0000-0003-2953-4105; CHEN, YEE-CHUN/0000-0002-1816-9010; Xia, Ningshao/0000-0003-0179-5266; TSAI, KEH-SUNG/0000-0001-8528-1566; WANG, JANN-TAY/0000-0002-0924-3469; Mizuguchi, Kenji/0000-0003-3021-7078; CHANG, SHAN-CHWEN/0000-0001-6505-4139	Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE [P01CA099031, R01CA109311] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Ludwig Institute for Cancer Research < http://www.licr.org/>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandic D, 2006, CROAT MED J, V47, P32; Boon T, 1997, IMMUNOL TODAY, V18, P267, DOI 10.1016/S0167-5699(97)80020-5; BRASSEUR F, 1995, INT J CANCER, V63, P375, DOI 10.1002/ijc.2910630313; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Chen YT, 2010, P NATL ACAD SCI USA, V107, P3093, DOI 10.1073/pnas.0915050107; Chen YT, 2009, INT J CANCER, V124, P2893, DOI 10.1002/ijc.24296; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; CHEN YT, 1994, P NATL ACAD SCI USA, V91, P1004, DOI 10.1073/pnas.91.3.1004; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Davis ID, 2004, P NATL ACAD SCI USA, V101, P10697, DOI 10.1073/pnas.0403572101; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Grigoriadis A, 2009, P NATL ACAD SCI USA, V106, P13493, DOI 10.1073/pnas.0906840106; Gure AO, 2000, INT J CANCER, V85, P726, DOI 10.1002/(SICI)1097-0215(20000301)85:5<726::AID-IJC21>3.0.CO;2-F; Jager E, 2000, P NATL ACAD SCI USA, V97, P4760, DOI 10.1073/pnas.97.9.4760; Jager E, 1999, INT J CANCER, V84, P506, DOI 10.1002/(SICI)1097-0215(19991022)84:5<506::AID-IJC10>3.0.CO;2-6; Jungbluth AA, 2002, INT J CANCER, V99, P839, DOI 10.1002/ijc.10416; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Kurashige T, 2001, CANCER RES, V61, P4671; Marchand M, 1999, INT J CANCER, V80, P219, DOI 10.1002/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S; Mischo A, 2006, INT J CANCER, V118, P696, DOI 10.1002/ijc.21352; Rimoldi D, 2000, INT J CANCER, V86, P749; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stockert E, 1998, J EXP MED, V187, P1349, DOI 10.1084/jem.187.8.1349; Sugita Y, 2004, CANCER RES, V64, P2199, DOI 10.1158/0008-5472.CAN-03-3070; Theurillat JP, 2007, INT J CANCER, V120, P2411, DOI 10.1002/ijc.22376; Tinguely M, 2008, CANCER SCI, V99, P720, DOI 10.1111/j.1349-7006.2008.00738.x; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Zhuang Ran, 2006, Cancer Immun, V6, P7	29	463	478	15	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17876	10.1371/journal.pone.0017876	http://dx.doi.org/10.1371/journal.pone.0017876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437249	Green Submitted, Green Published, gold			2022-12-25	WOS:000288545100041
